Citrus Sinensis ID: 011359

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------49
Protein Sequence
MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNLPETISVLKSRPGPASSNQKSAPNSSQSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKLGPMHPHSSPMPKPKFT
Secondary Structure (PSIPRED)
ccccccccEEEccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccEEEEEEccccEEEEEEEcccccHHHHHHHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEEcccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEEccccccccccccccccccccccccccHHcccccccccccHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHcccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccHHEEcccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccccEEEEEccccccccccccccccccccHccccccccccccccccccccHHccccccccccccccccEEEcHHHEEEEEEEccccccEEEEEEEcccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEEEEEcccccEEEEEccccccEHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEccccccHHHccHHHHHccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHHHccHcccccHHHHHHHHHHHHHHcccccccccccccccccccccccHHHccccccccccccccccccc
Coil and Loop (DISEMBL)
mgdganswirRTKFSHtvchrldssilaslplnlpetisvlksrpgpassnqksapnssqsqqnpaankprsvsplpetvlpdtFKEARSatkrfstphprrkesdkglvgkflykqpqqetkassnsystsplrhlgslrvTERYKSRKESAwtkyfdhggvrvnavdaadehtVDLSQLFLglrfahgahsrlyhgiykdepvavkiiripdddeNETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMeyihsqgvihrdlkpenvliDQEFHLKIADFGIACEEVYCDalsddpgtyrwmapemikhksygrkvdvYSFGLILWEMVagtipyeemnpIQAAFAVVNknlrpaipgdcppAMAALIEQCwslqpdkrpeFWHIVKVLEQFETslacngtlnlvqnpicqdhKKGLLHWIQklgpmhphsspmpkpkft
Flexible Loop (DISEMBL)
mgdganswirrTKFSHTVCHRLDSSILASLPLNLPETISVLKSRPGPAssnqksapnssqsqqnpaankprsvsplpetVLPDTFKEARsatkrfstphprrkesdkglvGKFLYKqpqqetkassnsystsplrhlgslrvtERYKSRKEsawtkyfdhgGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKLgpmhphsspmpkpkft
Low Complexity Region (SEG)
MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNLPETISVLKSRPGpassnqksapnssqsqqnpaankPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKLGpmhphsspmpkpkFT
Disordered region (IsUnstruct)
*******WIRRTKFSHTVCHRLDSSILASLPLNLPET******************************************************************************************************************SAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKL****************
Disordered Region (DISOPRED)
*****NS*IRRTKFS*************************************************************************************************************************************************************EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD*LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE***********************************************
Disordered Region (DISEMBL)
MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNLPETISVLK*******************************SPLPETVLPDTFKEARS***************DKGLVGKFLYKQP**************PLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKLGPMH************
Disordered Region (DISPRO)
******SWIRRTKFSHTVCHRLDSSILA*************************************************ETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQ**********************************SAWT***DHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGT*****NPIC****KGLLHWIQ******************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNLPETISVLKSRPGPASSNQKSAPNSSQSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKLGPMHPHSSPMPKPKFT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	488	2.2.26 [Sep-21-2011]
Q2MHE4	390	Serine/threonine-protein	no	no	0.598	0.748	0.548	1e-95
Q55GU0	916	Probable serine/threonine	yes	no	0.528	0.281	0.386	2e-53
Q54I36	1338	Dual specificity protein	no	no	0.520	0.189	0.374	3e-47
Q54TM7	1288	Probable serine/threonine	no	no	0.547	0.207	0.348	1e-46
Q55A09	1331	Probable serine/threonine	no	no	0.526	0.193	0.353	1e-46
P18161	1155	Dual specificity protein	no	no	0.532	0.225	0.344	6e-46
Q54H46	642	Probable serine/threonine	no	no	0.540	0.411	0.357	5e-45
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.522	0.153	0.362	1e-44
Q54H45	690	Probable serine/threonine	no	no	0.538	0.381	0.351	1e-43
Q54L00	650	Probable LIM domain-conta	no	no	0.526	0.395	0.375	3e-43

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  350 bits (899), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 165/301 (54%), Positives = 217/301 (72%), Gaps = 9/301 (2%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           +E T DLSQLF+G +FA GAHSR+Y GIYK   VAVK++RIP   E     A+LE+QF  
Sbjct: 77  EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETR--AKLEQQFKS 134

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           EVALLSRL +PN+++F+AACKKPPVYC+ITEY+S+G+LR YL+K E  +L +  ++ +AL
Sbjct: 135 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLAL 194

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
           DI+RGMEY+HSQGVIHRDLK  N+L++ E  +K+ADFG +C E  C     + GTYRWMA
Sbjct: 195 DISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMA 254

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
           PEMIK K Y RKVDVYSFG++LWE+    +P++ M P+QAAFAV  KN RP +P  C PA
Sbjct: 255 PEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPA 314

Query: 412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFETS------LACNGTLNLVQNPICQDHKKGL 465
           +A LI++CWS  P KRP+F +IV VLE+++        L  + +L   +  I  DH KG 
Sbjct: 315 LAHLIKRCWSENPSKRPDFSNIVAVLEKYDECVKEGLPLTSHASLTKTKKAIL-DHLKGC 373

Query: 466 L 466
           +
Sbjct: 374 V 374

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  211 bits (536), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 102/264 (38%), Positives = 160/264 (60%), Gaps = 6/264 (2%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           +  S+L +  +   G    +Y G+++   VA+K I+I +D  N+ L     ++F +E+ +
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVL-----EEFRKELTI 711

Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
           LSRL +PN++  +AAC  PP  C ITEYL  GSL   LH  + K + +     +A+ IA+
Sbjct: 712 LSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQLYKKLAIQIAQ 770

Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
           GM Y+H  GVIHRD+K  N+L+D+  ++KI DFG++  +     ++   G+  WM+PE++
Sbjct: 771 GMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELL 830

Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
             + Y  KVDVY+FG+ILWE+  G +PY  ++ +Q A AV  K+LRP IP   P  ++ L
Sbjct: 831 MGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHL 890

Query: 416 IEQCWSLQPDKRPEFWHIVKVLEQ 439
           I+ CW   P KRP F  I+ +L +
Sbjct: 891 IQACWHQDPLKRPSFTEILNLLNE 914

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1

 Score =  189 bits (481), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 104/278 (37%), Positives = 164/278 (58%), Gaps = 24/278 (8%)

Query: 186  RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
            +   G+ + ++ GI+    VA+KI++      NE+++   +++F +EV+ L + H+PNV+
Sbjct: 1062 KVGAGSFANVFLGIWNGYKVAIKILK------NESISN--DEKFIKEVSSLIKSHHPNVV 1113

Query: 246  KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
             F+ AC  PP  C+ TEYL  GSL   LH  + K  PL  +  +  D++ GME++HS  +
Sbjct: 1114 TFMGACIDPP--CIFTEYLQGGSLYDVLHIQKIKLNPL-MMYKMIHDLSLGMEHLHSIQM 1170

Query: 306  IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-----RWMAPEMIKHKSY 360
            +HRDL  +N+L+D+  ++KIADFG+A        LSDD         RW +PE+ K   Y
Sbjct: 1171 LHRDLTSKNILLDEFKNIKIADFGLAT------TLSDDMTLSGITNPRWRSPELTKGLVY 1224

Query: 361  GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
              KVDVYSFGL+++E+  G IP+E ++   +A     +N RPAIP DCP ++  LI +CW
Sbjct: 1225 NEKVDVYSFGLVVYEIYTGKIPFEGLDGTASAAKAAFENYRPAIPPDCPVSLRKLITKCW 1284

Query: 421  SLQPDKRPEFWHIVKVLEQFETSLACNGTL--NLVQNP 456
            +  P +RP F  I+  LE  ++      +   +L+QNP
Sbjct: 1285 ASDPSQRPSFTEILTELETMKSKFIKQLSFLNDLIQNP 1322

Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  188 bits (477), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 97/278 (34%), Positives = 159/278 (57%), Gaps = 11/278 (3%)

Query: 163  VRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLA 222
             ++  V+   E  V LS++ +G R   G + +++ G ++   VAVK++       N+ + 
Sbjct: 833  AKIIEVEKPFEWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLF------NDNVN 886

Query: 223  ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
             +L     +EV LL +L +PN++ F+ AC +P   C++TEYLS GSL   L   E   + 
Sbjct: 887  LKLISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLD-ESIEMD 945

Query: 283  LPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
                + +  D ARGM Y+HS+   +IHRDLK +N+L+D  + +K+ADFG+A  + +  A 
Sbjct: 946  WGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAK 1005

Query: 341  SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL 400
            +   GT  W+APE++  + Y  K DVYS+ ++LWE++   IPY   N +Q   + +++  
Sbjct: 1006 T-MCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRS-IDRGE 1063

Query: 401  RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
            R  +P  CPP  AAL+ +CW   P  RP F  I+ ++E
Sbjct: 1064 RLPMPAWCPPKYAALMNRCWETDPTHRPSFPEILPIME 1101

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1

 Score =  187 bits (475), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 95/269 (35%), Positives = 155/269 (57%), Gaps = 12/269 (4%)

Query: 176  VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
            ++ S + +      G  S++  G +K + VAVK +    D   E +     ++F  EV L
Sbjct: 1068 INYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMI----QEFKAEVEL 1123

Query: 236  LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL---EHKTLPLPK--LIAIA 290
            L  L +PN++        P   C++ E+L  G+L   +H     + +++ L    ++AIA
Sbjct: 1124 LGSLQHPNLVTCYGYSLNP--MCIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTLILAIA 1181

Query: 291  LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM 350
             DIARGM+++H++ +IHRDLK  N+L+D+ F++KIAD GIA E  +   ++   GT  W 
Sbjct: 1182 FDIARGMQHLHTRNIIHRDLKSSNLLMDKHFNIKIADLGIARETSFTQTMTT-IGTVAWT 1240

Query: 351  APEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
            APE+++H+SY +K DVYS+ ++L+E++ G  PY+ + P+ A   V +K LRP +P +C P
Sbjct: 1241 APEILRHESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNCDP 1300

Query: 411  AMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
                L+  CWS  P+KRP F  I   L +
Sbjct: 1301 NWKKLVVWCWSEDPNKRPSFEEITNYLTK 1329

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2

 Score =  185 bits (470), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 95/276 (34%), Positives = 160/276 (57%), Gaps = 16/276 (5%)

Query: 173  EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNRE 232
            E+ +D++ +    +   GA S ++ G +K   VA+K ++I  D+E      + +++F RE
Sbjct: 845  EYIIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGDEE------QFKERFIRE 898

Query: 233  VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT----LPLPKLIA 288
            V  L + ++ N++ F+ AC KP   C+ITEY++ GSL   LH     T       P ++ 
Sbjct: 899  VQNLKKGNHQNIVMFIGACYKPA--CIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLK 956

Query: 289  IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY- 347
            +A D+A G+ ++HS  ++HRDL  +N+L+D+  ++KI+DFG++ E+    +++   G   
Sbjct: 957  MATDMALGLLHLHSITIVHRDLTSQNILLDELGNIKISDFGLSREKSREGSMTMTNGGIC 1016

Query: 348  --RWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI 404
              RW  PE+ K+   Y  KVDVY F L++WE++ G IP+ +++  QA+  V    LRP I
Sbjct: 1017 NPRWRPPELTKNLGHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRPPI 1076

Query: 405  PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            P  C P +  L+ QCW   P+ RP F +IV  L++ 
Sbjct: 1077 PEYCDPELKLLLTQCWEADPNDRPPFTYIVNKLKEI 1112

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1

 Score =  182 bits (462), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 98/274 (35%), Positives = 156/274 (56%), Gaps = 10/274 (3%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   +D+ Q+ +G+R   G +  +Y G ++   VAVK  ++P  + NE +     K+F+R
Sbjct: 365 DGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVK--KLPAHNINENIL----KEFHR 418

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ L+  L +PNVI+F+ +C  PP  C+ TEY+  GSL + LH  +   L    LI + +
Sbjct: 419 EINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHD-QALQLQWSLLIKMMI 477

Query: 292 DIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
           D A+G+ Y+H+    ++HRDLK  N+L+D+ + +K+ADFG++  E    A     GT  W
Sbjct: 478 DAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQ-GATMTACGTPCW 536

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
            +PE+++ + Y  K DVYSFG+ILWE      PY  + P Q  FAV  + +RP +P + P
Sbjct: 537 TSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGP 596

Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           P    L+  C +  P  RP     ++ LE  ++S
Sbjct: 597 PKYIQLLIDCLNENPSHRPTMEQCLERLESIDSS 630

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  181 bits (459), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 98/270 (36%), Positives = 159/270 (58%), Gaps = 15/270 (5%)

Query: 175  TVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
             ++  ++ +G +   G++  +Y G +K+  VA+K       DEN  L  R       E+A
Sbjct: 1393 VINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIR------EEIA 1446

Query: 235  LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
             L +LH+PN+I  V A  K P  C++TEY+++G+LR  +     K L   + I I ++IA
Sbjct: 1447 FLKKLHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPK-LEWHQKIKILVNIA 1505

Query: 295  RGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWM 350
            +G+ Y+HS    +IHRD+KP N+LID+ +++KIADFG A   EE   +A+    GT  W 
Sbjct: 1506 KGISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEE---NAIMTRCGTPCWT 1562

Query: 351  APEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
            APE+I++  Y  KVDV+SFG+++WE++    P+   N ++    ++ +++RP IP DCP 
Sbjct: 1563 APEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDIL-EDVRPKIPQDCPE 1621

Query: 411  AMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
              A L+ +CW  +  KRP    ++ VL +F
Sbjct: 1622 EFAKLMRKCWHAKSTKRPTMDDVIIVLAKF 1651

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1

 Score =  177 bits (450), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 96/273 (35%), Positives = 151/273 (55%), Gaps = 10/273 (3%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   +D  Q+ +G+R   G    +Y G ++   VAVK  ++P  + NE +     K+F+R
Sbjct: 382 DGKDIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVK--KLPAHNINENIL----KEFHR 435

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ L+  L +PNVI+F+ +C   P  C+ TEY+  GSL + LH  E   +    +  + +
Sbjct: 436 EINLMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHN-EKIKISWSLVKRMMI 494

Query: 292 DIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
           D A+G+ Y+H     ++HRDLK  N+L+D+ + +K+ADFG++  E    A     GT  W
Sbjct: 495 DAAKGIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQ-GATMTACGTPCW 553

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
            +PE+++ + Y  K DVYSFG+ILWE      PY  + P Q  FAV  + +RP  P   P
Sbjct: 554 TSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGP 613

Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
           P    L++ C +  P +RP     +++LE  ET
Sbjct: 614 PKYIQLLKDCLNENPSQRPTMEQCLEILESIET 646

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54L00|LIMKA_DICDI Probable LIM domain-containing serine/threonine-protein kinase DDB_G0287001 OS=Dictyostelium discoideum GN=DDB_G0287001 PE=3 SV=1

 Score =  176 bits (447), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 101/269 (37%), Positives = 148/269 (55%), Gaps = 12/269 (4%)

Query: 180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
           ++  G   A GA  ++Y GIYK   VA+K+        +E     +E +F+REV ++S +
Sbjct: 385 EVAFGDVIASGASGKVYKGIYKGRDVAIKVY------SSENFCFNIE-EFDREVTIMSLI 437

Query: 240 HN--PNVIKFVAACKKPPVYCV-ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARG 296
            +  PN  +F  A K+   Y   ++E +  GSLR  L   E K L     ++IA DIA  
Sbjct: 438 DSDHPNFTRFYGANKQNKKYLFHVSELVKSGSLRDLLLDKE-KPLAYFTQLSIASDIANA 496

Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK 356
           M+++HS GVIHRDLK  NVLI ++F  K+ DFG +        ++ + GT  +M+PE+ K
Sbjct: 497 MKHLHSIGVIHRDLKSLNVLITEDFTAKVIDFGTSRNVDLAKQMTLNLGTSCYMSPELFK 556

Query: 357 HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
              Y    DVY+FG++LWE++A   PYE +N       +V K  RP IP DCP   + LI
Sbjct: 557 GNGYDETCDVYAFGIVLWEIIARKEPYENINSWSIP-VLVAKGERPTIPADCPSEYSKLI 615

Query: 417 EQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
           + CW+ +P KRP F  I   L++   SL 
Sbjct: 616 KACWTDKPKKRPSFKEICDTLKKISESLT 644

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	488
255536799	496	protein-tyrosine kinase, putative [Ricin	0.975	0.959	0.746	0.0
10241603	480	protein kinase (PK) [Fagus sylvatica]	0.979	0.995	0.755	0.0
224093814	464	predicted protein [Populus trichocarpa]	0.948	0.997	0.752	0.0
224081216	514	predicted protein [Populus trichocarpa]	0.991	0.941	0.718	0.0
147862319	489	hypothetical protein VITISV_022074 [Viti	0.995	0.993	0.729	0.0
356521372	498	PREDICTED: serine/threonine-protein kina	0.987	0.967	0.697	0.0
356548711	494	PREDICTED: serine/threonine-protein kina	0.979	0.967	0.689	0.0
255638494	494	unknown [Glycine max]	0.979	0.967	0.687	0.0
449433834	492	PREDICTED: serine/threonine-protein kina	0.995	0.987	0.694	0.0
356549321	463	PREDICTED: serine/threonine-protein kina	0.948	1.0	0.686	0.0

>gi|255536799|ref|XP_002509466.1| protein-tyrosine kinase, putative [Ricinus communis] gi|223549365|gb|EEF50853.1| protein-tyrosine kinase, putative [Ricinus communis]

 Score =  768 bits (1984), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/508 (74%), Positives = 418/508 (82%), Gaps = 32/508 (6%)

Query: 1   MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNLPETI-SVLKSRPGPASSNQKSAPNSS 59
           M +  +SWIRRTKFSHTVCHRLDSS LASL L + E   S LKSRPG +S N+KS   S+
Sbjct: 1   MEEENSSWIRRTKFSHTVCHRLDSSRLASLALAVQEERNSGLKSRPGTSSPNRKSLYFSN 60

Query: 60  QS-------------------QQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHP 100
           Q                    Q+NP  NK RS+SPLP+T L DTFKEARS  KRFSTPHP
Sbjct: 61  QRSASFPNKKSSSSVTSNSQIQRNPVTNKLRSLSPLPQTALSDTFKEARSDRKRFSTPHP 120

Query: 101 RRKESDKGLVGKFLYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDH 160
           R K+ DKG              K S ++ +TSPLR L SL+  E+ KS+K+SAWTKYFDH
Sbjct: 121 RSKDQDKGFA------------KPSKHASNTSPLRQLASLKGHEKLKSKKDSAWTKYFDH 168

Query: 161 GGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENET 220
            G RVNAV+AADE +VD+S+LFLGLRFAHGAHSRLYHG+YKDEPVAVKIIR PDDD+N T
Sbjct: 169 AGGRVNAVEAADEFSVDMSKLFLGLRFAHGAHSRLYHGVYKDEPVAVKIIRAPDDDDNGT 228

Query: 221 LAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT 280
           L+ RL+ Q++REV LLSRLH+PNVIKFVAACK PPVYCVITEYLSEGSLRAYLHKLEHK+
Sbjct: 229 LSIRLKNQYDREVTLLSRLHHPNVIKFVAACKMPPVYCVITEYLSEGSLRAYLHKLEHKS 288

Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           LPL KLIAIALDIARGMEYIHSQ +IHRDLKPENVLIDQEF +KIADFGIACEE YCD+L
Sbjct: 289 LPLEKLIAIALDIARGMEYIHSQSIIHRDLKPENVLIDQEFRMKIADFGIACEEAYCDSL 348

Query: 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL 400
           +DDPGTYRWMAPEMIK KSYG++VDVYSFGLILWE+VAGTIPYE+MNPIQAAFAVVNKNL
Sbjct: 349 ADDPGTYRWMAPEMIKKKSYGKRVDVYSFGLILWELVAGTIPYEDMNPIQAAFAVVNKNL 408

Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQD 460
           RP IP DC PAM ALIEQCWSLQPDKRPEFW IVKVLEQF +SLA +GTLNLVQNP CQD
Sbjct: 409 RPVIPRDCHPAMRALIEQCWSLQPDKRPEFWQIVKVLEQFGSSLARDGTLNLVQNPTCQD 468

Query: 461 HKKGLLHWIQKLGPMHPHSSPMPKPKFT 488
           HKKGLLHWIQKLGPMHP SSPMPKPKFT
Sbjct: 469 HKKGLLHWIQKLGPMHPSSSPMPKPKFT 496

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|10241603|emb|CAC09580.1| protein kinase (PK) [Fagus sylvatica]

 Score =  761 bits (1965), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/490 (75%), Positives = 413/490 (84%), Gaps = 12/490 (2%)

Query: 1   MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNL-PETISVLKSRPGPASSNQKSAPNSS 59
           MG+  NSWIRRTKFSHTVCHRLD+S LAS P+ + PE  S LKSRPG  SS++K      
Sbjct: 1   MGEEGNSWIRRTKFSHTVCHRLDASRLASFPIIIRPERNSGLKSRPGATSSSEKFGT--- 57

Query: 60  QSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQ 119
                   NK RS+SPLPE+ L D FKEARS TKRF TP PRR+E  KG++GKF++K   
Sbjct: 58  ------IYNKQRSLSPLPESRLSDVFKEARSETKRFMTPLPRRREQAKGVMGKFVHKDFH 111

Query: 120 QETKASSNSYS-TSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDL 178
           +   + S S + +S LRHL S++V ++ K RKES+W KYFDHGG RVNAV+ +DE TVDL
Sbjct: 112 EVKASDSKSLANSSALRHLSSMKVNDKSKYRKESSWAKYFDHGGGRVNAVETSDEWTVDL 171

Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR 238
           S+LFLGL+FAHGAHSRLYHGIY DEPVAVKIIR+P+DDEN  L ARLEKQFNREV LLSR
Sbjct: 172 SKLFLGLKFAHGAHSRLYHGIYNDEPVAVKIIRVPEDDENGALGARLEKQFNREVTLLSR 231

Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
           LH  N+IKFVAAC+KPPVYCV+TEYLSEGSLRAYLHKLE K+LPL KLIA ALDIARGME
Sbjct: 232 LHFHNIIKFVAACRKPPVYCVVTEYLSEGSLRAYLHKLERKSLPLQKLIAFALDIARGME 291

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
           YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE YCD+L+DDPGTYRWMAPEMIKHK
Sbjct: 292 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEAYCDSLADDPGTYRWMAPEMIKHK 351

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
           SYGRKVDVYSFGLILWEMVAGTIPYE+MNP+QAAFAVVNKNLRP IP  CPPAM ALIEQ
Sbjct: 352 SYGRKVDVYSFGLILWEMVAGTIPYEDMNPVQAAFAVVNKNLRPVIPRYCPPAMRALIEQ 411

Query: 419 CWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKLGPMHPH 478
           CWSLQ +KRPEFW +VKVLEQFE+SLA +GTLNLVQ+  CQDHKKGLLHWI KLGP+HP+
Sbjct: 412 CWSLQSEKRPEFWQVVKVLEQFESSLARDGTLNLVQSLTCQDHKKGLLHWIHKLGPVHPN 471

Query: 479 SSPMPKPKFT 488
            S MPKPK T
Sbjct: 472 GS-MPKPKLT 480

Source: Fagus sylvatica

Species: Fagus sylvatica

Genus: Fagus

Family: Fagaceae

Order: Fagales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224093814|ref|XP_002310003.1| predicted protein [Populus trichocarpa] gi|222852906|gb|EEE90453.1| predicted protein [Populus trichocarpa]

 Score =  757 bits (1955), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/489 (75%), Positives = 412/489 (84%), Gaps = 26/489 (5%)

Query: 1   MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNLPETISVLKSRPGPASSNQKSAPNSSQ 60
           M + ANSWIRRT FSHTV HRLDSS +AS P+N+ +T  ++                   
Sbjct: 1   MEEEANSWIRRTNFSHTVYHRLDSSRMASFPINI-QTERII------------------- 40

Query: 61  SQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQ 120
            Q+NP +NK RS+SPLP+T+LPDTFKEARS  KRFSTP PRRK+ D G++GKFL+K    
Sbjct: 41  -QRNPLSNKQRSLSPLPKTILPDTFKEARSVNKRFSTPLPRRKDQDMGIIGKFLHK---- 95

Query: 121 ETKASSNSYSTSPLRHLGSLRVT-ERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLS 179
           E K +    +TSPLRHL  ++   E+ +S+KESAWTKYFDHGG +VNAV+AADE +VDLS
Sbjct: 96  ELKETKEKLNTSPLRHLALMKGGHEKSRSKKESAWTKYFDHGGGKVNAVEAADECSVDLS 155

Query: 180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
           +LFLGLRFAHGAHSRLYHG+YKDEPVAVK+IR+PDDDEN  LA RLE QFNREV LLS L
Sbjct: 156 KLFLGLRFAHGAHSRLYHGLYKDEPVAVKLIRVPDDDENGNLAIRLENQFNREVMLLSHL 215

Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
           H+PNVIKFVAAC+KPPVYCVITEYLSEGSLRAYLHKLEHKTL L KL+ IALDIARGMEY
Sbjct: 216 HHPNVIKFVAACRKPPVYCVITEYLSEGSLRAYLHKLEHKTLSLGKLMTIALDIARGMEY 275

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKS 359
           IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC + YCD+L+DDPGTYRWMAPEMIK KS
Sbjct: 276 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACGDAYCDSLADDPGTYRWMAPEMIKKKS 335

Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC 419
           YGRKVDVYSFGLILWEMVAGTIPYE+M PIQAAFAVVNKN RP IP DCP AM ALIEQC
Sbjct: 336 YGRKVDVYSFGLILWEMVAGTIPYEDMTPIQAAFAVVNKNSRPVIPRDCPAAMGALIEQC 395

Query: 420 WSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKLGPMHPHS 479
           WSLQPDKRPEFW IVKVLEQFE+SLA +GTLNLV NP CQDHKKG+LHWIQKLG ++P+S
Sbjct: 396 WSLQPDKRPEFWQIVKVLEQFESSLAHDGTLNLVPNPACQDHKKGMLHWIQKLGTVNPNS 455

Query: 480 SPMPKPKFT 488
           +PMPKPKFT
Sbjct: 456 TPMPKPKFT 464

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081216|ref|XP_002306338.1| predicted protein [Populus trichocarpa] gi|222855787|gb|EEE93334.1| predicted protein [Populus trichocarpa]

 Score =  750 bits (1937), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/518 (71%), Positives = 416/518 (80%), Gaps = 34/518 (6%)

Query: 1   MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNL-PETISVLKSRPGPASSN-------- 51
           MG+ ANSWIRRTKFSHT+ +RLD S  AS P+++  E IS LKSRPG  +++        
Sbjct: 1   MGEEANSWIRRTKFSHTIYYRLDPSRSASFPISIQAERISGLKSRPGTGTASPKQNSQQS 60

Query: 52  ------QKSAPN---------------SSQSQQNPAANKPRSVSPLPETVLPDTFKEARS 90
                 Q+S PN               +SQ ++N   NK RS+SPLPET L DTFKEARS
Sbjct: 61  LSNQNFQQSFPNQKSLSFPSQKSLVSDNSQMRRNLLTNKQRSLSPLPETNLSDTFKEARS 120

Query: 91  ATKRFSTPHPRRKESDKGLVGKFLYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRK 150
             KRFSTPHPRRK  D G++GKFL+++  QE+K  SN    SPLRHL S++V       K
Sbjct: 121 DKKRFSTPHPRRKNQDMGIIGKFLHRE-SQESKEKSNR---SPLRHLASMKVGHEKSRIK 176

Query: 151 ESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKII 210
           ESAW KYFDHGG +VNAV+AADE  VD+S+LFLGLRFAHGAHSRLYHG+YKD+PVAVKII
Sbjct: 177 ESAWAKYFDHGGGKVNAVEAADECIVDMSKLFLGLRFAHGAHSRLYHGLYKDKPVAVKII 236

Query: 211 RIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLR 270
           R+PDDDEN  LA RLE QFNREV LLS+LH+PNVIKFVAAC+KPPVYCVITEYLSEGSLR
Sbjct: 237 RVPDDDENGNLATRLENQFNREVMLLSQLHHPNVIKFVAACRKPPVYCVITEYLSEGSLR 296

Query: 271 AYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
           AYLHKLEHK L L KL+ IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI
Sbjct: 297 AYLHKLEHKALSLEKLMTIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 356

Query: 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
           AC E YCD+L+DDPGTYRWMAPEMIK KSYGRK DVYSFGLILWEMVAGTIPYE+M PIQ
Sbjct: 357 ACGEAYCDSLADDPGTYRWMAPEMIKKKSYGRKADVYSFGLILWEMVAGTIPYEDMTPIQ 416

Query: 391 AAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTL 450
           AAFAVVNKN RP IP DCPPAM ALI QCWSLQP+KRPEF  IVKVLEQFE+SLA +GTL
Sbjct: 417 AAFAVVNKNSRPVIPRDCPPAMGALINQCWSLQPEKRPEFRQIVKVLEQFESSLAHDGTL 476

Query: 451 NLVQNPICQDHKKGLLHWIQKLGPMHPHSSPMPKPKFT 488
           NLVQN  CQDHKKG+ HWIQKLG ++P S+ +PKPKFT
Sbjct: 477 NLVQNLTCQDHKKGMPHWIQKLGTVNPSSTHVPKPKFT 514

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147862319|emb|CAN83589.1| hypothetical protein VITISV_022074 [Vitis vinifera]

 Score =  740 bits (1910), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/488 (72%), Positives = 410/488 (84%), Gaps = 2/488 (0%)

Query: 3   DGANSWIRRTKFSHTVCHRLDSSILASLPLNL-PETISVLKSRPGPASSNQKSAPNSSQS 61
           + ANSWIRRTKFSHT+ HRLDS+ LAS PL + PE  S LKSRP   S N KS P+  Q 
Sbjct: 2   EDANSWIRRTKFSHTIFHRLDSTRLASFPLTISPERNSGLKSRPQRGSLNLKSEPSDPQG 61

Query: 62  QQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQE 121
           ++N   NK RS+SPLPE+ L D FKEARS  KRFSTP PRRKE +KG++GK   K  Q  
Sbjct: 62  RRNAFTNKQRSLSPLPESKLSDEFKEARSDRKRFSTPVPRRKEHEKGIMGKLFSKDSQDP 121

Query: 122 TKASSNSYS-TSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQ 180
             ++SN  S TSPLRHL S +  ++ K RKE +W KYFDHGG RV AV+AADE   DLS+
Sbjct: 122 KASNSNKQSNTSPLRHLTSTKNHDKAKFRKEPSWIKYFDHGGGRVTAVEAADEWMADLSK 181

Query: 181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
           L+LGLRF+HGAHSRLYHG+Y+++PVAVK+I +PD++EN  LA++LEKQFN EV+ LSRLH
Sbjct: 182 LYLGLRFSHGAHSRLYHGVYEEQPVAVKVIMVPDEEENGALASKLEKQFNGEVSCLSRLH 241

Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           + NVIKFVAA ++PPV+ VITEYLSEGSLRAYLHKLEHK+LPL KLI IALDIARGMEYI
Sbjct: 242 HQNVIKFVAAWRRPPVFVVITEYLSEGSLRAYLHKLEHKSLPLEKLITIALDIARGMEYI 301

Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HSQG+IHRDLKPENVL+ ++FH+KIADFGIACEE YCD+L+DDPGTYRWMAPEMIKHKSY
Sbjct: 302 HSQGIIHRDLKPENVLVTKDFHMKIADFGIACEEAYCDSLADDPGTYRWMAPEMIKHKSY 361

Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
           GRKVDVYSFGLILWEMVAGTIPYE+M PIQAAFAVVNKNLRP IP DCPPAM ALIEQCW
Sbjct: 362 GRKVDVYSFGLILWEMVAGTIPYEDMAPIQAAFAVVNKNLRPVIPVDCPPAMRALIEQCW 421

Query: 421 SLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKLGPMHPHSS 480
           SL PDKRPEFW +VKVLEQF++SLA +GTLNLV+   CQDHKKGLLHWIQKLGP+H ++S
Sbjct: 422 SLHPDKRPEFWQVVKVLEQFKSSLALDGTLNLVRYATCQDHKKGLLHWIQKLGPVHHNTS 481

Query: 481 PMPKPKFT 488
            MPKPKFT
Sbjct: 482 SMPKPKFT 489

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356521372|ref|XP_003529330.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max]

 Score =  707 bits (1826), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 348/499 (69%), Positives = 403/499 (80%), Gaps = 17/499 (3%)

Query: 3   DGANSWIRRTKFSHTVCHRLDSSILASLPLNL---PETISVLKSRPGPASSNQKSAPNSS 59
           D +NSWIRR KFSHTVCHRL+ S       ++    +  S LKSRP  A +++ S    S
Sbjct: 4   DSSNSWIRRAKFSHTVCHRLNYSSSGFGSFSIQPRAQHSSSLKSRPEVAFASKAS----S 59

Query: 60  QSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKG--LVGKFLYK- 116
           Q+Q+ P  NK RS+SPLP+T L +TFKEAR   KRFSTP PRRKE DK   ++GK L K 
Sbjct: 60  QAQKKPIMNKQRSLSPLPQTSLSETFKEARHEQKRFSTPGPRRKEQDKDKRIMGKLLNKD 119

Query: 117 ------QPQQETKASSNSYSTSPLRHLGSLRVTERYKS-RKESAWTKYFDHGGVRVNAVD 169
                 +    +  ++ S  +SP+RHL S++++++ K  RK+  WTKYFDHGG +V AV+
Sbjct: 120 SHVFNSKSNHSSPITTKSPYSSPIRHLASMKLSDKSKQHRKDLGWTKYFDHGGGKVTAVE 179

Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQF 229
            A+E  VDLS+LF+G+RFAHGAHSRLYHG+YKDE VAVKII +PDDDEN  LA RLEKQF
Sbjct: 180 TAEEWNVDLSKLFVGVRFAHGAHSRLYHGMYKDEAVAVKIITVPDDDENGMLADRLEKQF 239

Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            REV+LLSRLH+ NVIKFVAAC+KPPVYCVITEYLSEGSLR+YLHKLE KT+PL KLIA 
Sbjct: 240 IREVSLLSRLHHQNVIKFVAACRKPPVYCVITEYLSEGSLRSYLHKLERKTIPLEKLIAF 299

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
           ALDIARGMEYIHSQGVIHRDLKPENVLI ++FHLKIADFGIACEE YCD  +DDPGTYRW
Sbjct: 300 ALDIARGMEYIHSQGVIHRDLKPENVLIKEDFHLKIADFGIACEEAYCDLFADDPGTYRW 359

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           MAPEMIK KSYGRKVDVYSFGLILWEMV GTIPYE+M PIQAAFAVVNKN+RP IP +CP
Sbjct: 360 MAPEMIKRKSYGRKVDVYSFGLILWEMVTGTIPYEDMTPIQAAFAVVNKNVRPVIPSNCP 419

Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWI 469
           PAM ALIEQCWSL PDKRPEFW +VKVLEQFE+SLA +GTL LV+NP C DHKKGLLHWI
Sbjct: 420 PAMRALIEQCWSLHPDKRPEFWQVVKVLEQFESSLAHDGTLTLVENPCCPDHKKGLLHWI 479

Query: 470 QKLGPMHPHSSPMPKPKFT 488
           QKLGP+H ++ P+PKPKFT
Sbjct: 480 QKLGPVHHNNGPVPKPKFT 498

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356548711|ref|XP_003542743.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max]

 Score =  694 bits (1791), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/499 (68%), Positives = 394/499 (78%), Gaps = 21/499 (4%)

Query: 3   DGANSWIRRTKFSHTVCHRLDSSILASLPLNLP----ETISVLKSRPGPASSNQKSAPNS 58
           D +NSWIRR KFSHTVCHRL+ S       ++      + S LKSRP  A +       S
Sbjct: 4   DSSNSWIRRAKFSHTVCHRLNYSSSGFGSFSIQPRAQHSSSSLKSRPEVAFA-------S 56

Query: 59  SQSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKES--DKGLVGKFLYK 116
           +++Q+ P  NK RS+SPLP T L +TFKEAR   KRFSTP PRRKE   DK ++GK L K
Sbjct: 57  NKAQKKPIMNKQRSLSPLPRTSLSETFKEARHEQKRFSTPGPRRKEQNKDKRIMGKLLNK 116

Query: 117 QPQQETKAS-------SNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVD 169
                   S       + S  +SP+RHL S++++ + + RK+  WTKYFDHGG +V AV+
Sbjct: 117 DSHVSNSKSPRSSPITTKSPYSSPIRHLASMKLSSK-QHRKDLGWTKYFDHGGGKVTAVE 175

Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQF 229
            A+E  VDLS+LF+G+RFAHGAHSRLYHG+YKDE VAVKII +PDDDEN  L  RLEKQF
Sbjct: 176 TAEEWNVDLSKLFVGVRFAHGAHSRLYHGMYKDEAVAVKIITVPDDDENGMLVDRLEKQF 235

Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            REV+LLS LH+ NVIKFVAAC+KP VYCVITEYLSEGSLR+YLHKLE KT+ L KLIA 
Sbjct: 236 IREVSLLSCLHHQNVIKFVAACRKPHVYCVITEYLSEGSLRSYLHKLERKTISLGKLIAF 295

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
           ALDIARGMEYIHSQGVIHRDLKPENVLI+++FHLKIADFGIACEE YCD  +DDPGTYRW
Sbjct: 296 ALDIARGMEYIHSQGVIHRDLKPENVLINEDFHLKIADFGIACEEAYCDLFADDPGTYRW 355

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           MAPEMIK KSYGRKVDVYSFGLILWEMV GTIPYE+M PIQAAFAVVNKN RP IP DCP
Sbjct: 356 MAPEMIKRKSYGRKVDVYSFGLILWEMVTGTIPYEDMTPIQAAFAVVNKNARPVIPSDCP 415

Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWI 469
           PAM ALIEQCWSL PDKRPEFW +VKVLEQFE+SLA +GTL LV+NP CQDHKKGLLHWI
Sbjct: 416 PAMRALIEQCWSLHPDKRPEFWQVVKVLEQFESSLAHDGTLTLVENPCCQDHKKGLLHWI 475

Query: 470 QKLGPMHPHSSPMPKPKFT 488
           QKLGP+H ++ P+PKPKFT
Sbjct: 476 QKLGPVHHNNGPVPKPKFT 494

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255638494|gb|ACU19556.1| unknown [Glycine max]

 Score =  691 bits (1783), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/499 (68%), Positives = 393/499 (78%), Gaps = 21/499 (4%)

Query: 3   DGANSWIRRTKFSHTVCHRLDSSILASLPLNLP----ETISVLKSRPGPASSNQKSAPNS 58
           D +NSWIRR KFSHTVCHRL+ S       ++      + S LKSRP  A +       S
Sbjct: 4   DSSNSWIRRAKFSHTVCHRLNYSSSGFGSFSIQPRAQHSSSSLKSRPEVAFA-------S 56

Query: 59  SQSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKES--DKGLVGKFLYK 116
           +++Q+ P  NK RS+SPLP T L +TFKEAR   KRFSTP PRRKE   DK ++GK L K
Sbjct: 57  NKAQKKPIMNKQRSLSPLPRTSLSETFKEARHEQKRFSTPGPRRKEQNKDKRIMGKLLNK 116

Query: 117 QPQQETKAS-------SNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVD 169
                   S       + S  +SP+RHL S++++ + + RK+  WTKYFDHGG +V AV+
Sbjct: 117 DSHVSNSKSPRSSPITTKSPYSSPIRHLASMKLSSK-QHRKDLGWTKYFDHGGGKVTAVE 175

Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQF 229
            A+E  VDLS+LF+G+RFAHGAHSRLYHG+YKDE VAVKII +PDDDEN  L  RLEKQF
Sbjct: 176 TAEEWNVDLSKLFVGVRFAHGAHSRLYHGMYKDEAVAVKIITVPDDDENGMLVDRLEKQF 235

Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            REV+LLS LH+ NVIKFVAAC+KP VYCVITEYLSEGSLR+YLHKLE KT+ L KLIA 
Sbjct: 236 IREVSLLSCLHHQNVIKFVAACRKPHVYCVITEYLSEGSLRSYLHKLERKTISLGKLIAF 295

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
           ALDIARGMEYIHSQGVIHRDLKPENVLI+++FHLKIADFGIACEE YCD  +DDPGTYRW
Sbjct: 296 ALDIARGMEYIHSQGVIHRDLKPENVLINEDFHLKIADFGIACEEAYCDLFADDPGTYRW 355

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           MAPEMIK KSYGRKVDVYSFGLILWEMV GTIPYE+M PIQAAFAVVNKN RP IP DCP
Sbjct: 356 MAPEMIKRKSYGRKVDVYSFGLILWEMVTGTIPYEDMTPIQAAFAVVNKNARPVIPSDCP 415

Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWI 469
           PAM ALIEQCWSL PDKRPEFW +VKVLEQFE+SLA +GTL LV+NP CQDHKKGLLHWI
Sbjct: 416 PAMRALIEQCWSLHPDKRPEFWQVVKVLEQFESSLAHDGTLTLVENPCCQDHKKGLLHWI 475

Query: 470 QKLGPMHPHSSPMPKPKFT 488
           QKLG +H ++ P+PKPKFT
Sbjct: 476 QKLGHVHHNNGPVPKPKFT 494

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449433834|ref|XP_004134702.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449479300|ref|XP_004155563.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus]

 Score =  682 bits (1760), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/494 (69%), Positives = 397/494 (80%), Gaps = 8/494 (1%)

Query: 1   MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNL-PETISVLKSRPGPASSNQKSAPNSS 59
           M + ANSW+RRTKFSHTV HR DS  L  +P  + P   S LKSRP  ASS QK  P+ S
Sbjct: 1   MDEEANSWLRRTKFSHTVYHRWDSLKLNPVPFIVEPPRNSGLKSRPPSASSAQKPNPDIS 60

Query: 60  QSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQ 119
           + Q++  +NK RS+SPLPE+ L + FKEA+S +KRFSTP PR +E  K    K   K PQ
Sbjct: 61  KIQRSFISNKQRSLSPLPESNLSEVFKEAKSESKRFSTPTPRLRERTKEFKNKLFNKDPQ 120

Query: 120 QETKASSNSYSTS-PLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDL 178
               ++S S   + PL+ L S +  ++ K +K+S+WTKYFD G  +V AV+ AD+ TVDL
Sbjct: 121 DSKSSNSKSSLNTSPLKQLSSGKGGDKSKLKKDSSWTKYFDSG--KVTAVETADDWTVDL 178

Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR 238
           S+LF+GLRFAHGAHSRLYHG Y DEPVAVKIIR+PDDDEN TLAARLEKQF REV LLSR
Sbjct: 179 SKLFVGLRFAHGAHSRLYHGKYNDEPVAVKIIRVPDDDENGTLAARLEKQFTREVTLLSR 238

Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
           L++PNVIKFVAAC+ PPVYCVITEYLS+GSLRAYLHKLEH++LPL KLI  ALD+ARGME
Sbjct: 239 LYHPNVIKFVAACRNPPVYCVITEYLSQGSLRAYLHKLEHQSLPLQKLIKFALDVARGME 298

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
           Y+HSQGVIHRDLKPENVLID++ HLKIADFGIAC E + D L+DDPGTYRWMAPEMIKHK
Sbjct: 299 YLHSQGVIHRDLKPENVLIDEDMHLKIADFGIACPEAFFDPLADDPGTYRWMAPEMIKHK 358

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
              RKVDVYSFGL+LWEMV+G IPYE+M PIQAAFAVVNKNLRP I  DCP AM ALIEQ
Sbjct: 359 PCSRKVDVYSFGLMLWEMVSGAIPYEDMTPIQAAFAVVNKNLRPVISSDCPLAMRALIEQ 418

Query: 419 CWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPIC--QDHKKGLLHWIQKLGPMH 476
           CWSLQPDKRP+FW IVKVLEQFE+SLA +GTLNL+ NP+    DHKKGLLHWIQKLGP+H
Sbjct: 419 CWSLQPDKRPDFWQIVKVLEQFESSLARDGTLNLLGNPLSSFHDHKKGLLHWIQKLGPLH 478

Query: 477 PH--SSPMPKPKFT 488
           P   SSP+PKPKF+
Sbjct: 479 PEVSSSPVPKPKFS 492

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356549321|ref|XP_003543042.1| PREDICTED: serine/threonine-protein kinase HT1 [Glycine max]

 Score =  682 bits (1759), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/488 (68%), Positives = 396/488 (81%), Gaps = 25/488 (5%)

Query: 1   MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNLPETISVLKSRPGPASSNQKSAPNSSQ 60
           MG+   SWIRRTKFSHTVCHRLD + L S+P+++               S QKS P +S+
Sbjct: 1   MGEDGYSWIRRTKFSHTVCHRLDPARLGSIPISV--------------QSEQKSRPAASK 46

Query: 61  SQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQ 120
           +Q++P  NK RS+SPLPET L + F+EAR   KRFSTP+PRR   +K ++GK L K  ++
Sbjct: 47  AQRHPITNKQRSLSPLPETYLSEAFREARHEQKRFSTPNPRR---EKRIMGKLLNKDSRE 103

Query: 121 ETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQ 180
             ++SS S S SP R + S       K+RK+SAWTK  D+GG ++ AV+ A+E  VD+SQ
Sbjct: 104 TKESSSKSPSHSPNRQVKS-------KNRKDSAWTKLLDNGGGKITAVETAEEWNVDMSQ 156

Query: 181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
           LF GL+FAHGAHSRLYHG+YK+E VAVKII +P+DDEN  LA+RLEKQF REV LLSRLH
Sbjct: 157 LFFGLKFAHGAHSRLYHGVYKEEAVAVKIIMVPEDDENGALASRLEKQFIREVTLLSRLH 216

Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           + NVIKF AAC+KPPVYC+ITEYL+EGSLRAYLHKLEH+T+ L KLIA ALDIARGMEYI
Sbjct: 217 HQNVIKFSAACRKPPVYCIITEYLAEGSLRAYLHKLEHQTVSLQKLIAFALDIARGMEYI 276

Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HSQGVIHRDLKPENVLI+++ HLKIADFGIACEE  CD L+DDPGTYRWMAPEMIK KSY
Sbjct: 277 HSQGVIHRDLKPENVLINEDNHLKIADFGIACEEASCDLLADDPGTYRWMAPEMIKRKSY 336

Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
           G+KVDVYSFGL++WEM+ GTIPYE+MNPIQAAFAVVNKN RP IP +CPPAM ALIEQCW
Sbjct: 337 GKKVDVYSFGLMIWEMLTGTIPYEDMNPIQAAFAVVNKNSRPVIPSNCPPAMRALIEQCW 396

Query: 421 SLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKLGPMHPHSS 480
           SLQPDKRPEFW +VK+LEQFE+SLA +GTL+LV NP C DHKKGLLHWIQKLGP+H +S 
Sbjct: 397 SLQPDKRPEFWQVVKILEQFESSLASDGTLSLVPNP-CWDHKKGLLHWIQKLGPLHQNSG 455

Query: 481 PMPKPKFT 488
           P+PKPKFT
Sbjct: 456 PVPKPKFT 463

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	488
TAIR|locus:2154573	525	AT5G58950 [Arabidopsis thalian	0.821	0.763	0.698	5.2e-162
TAIR|locus:2102802	475	AT3G46930 [Arabidopsis thalian	0.819	0.842	0.559	6.4e-115
TAIR|locus:2061092	411	AT2G24360 [Arabidopsis thalian	0.555	0.659	0.465	3.6e-73
TAIR|locus:2126311	412	AT4G31170 [Arabidopsis thalian	0.561	0.665	0.467	3.2e-72
TAIR|locus:2121154	575	STY46 "serine/threonine/tyrosi	0.559	0.474	0.407	2.4e-60
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.540	0.483	0.402	8.1e-60
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.538	0.461	0.389	1.9e-58
TAIR|locus:2168778	353	AT5G40540 [Arabidopsis thalian	0.555	0.767	0.412	5.9e-57
TAIR|locus:2091423	356	ATN1 [Arabidopsis thaliana (ta	0.543	0.744	0.405	1.2e-56
TAIR|locus:2157717	346	AT5G50180 [Arabidopsis thalian	0.526	0.742	0.420	1.4e-55

TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)]

 Score = 1493 (530.6 bits), Expect = 5.2e-162, Sum P(2) = 5.2e-162
 Identities = 282/404 (69%), Positives = 331/404 (81%)

Query:    71 RSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQETKASSNSYS 130
             RSVSP P+  +PD FKEARS  KRFSTPHPRR ES+KG+  K  +K      K S N  S
Sbjct:    98 RSVSPSPQMAVPDVFKEARSERKRFSTPHPRRVESEKGMKPKLSHKNSFD--KRSFNLRS 155

Query:   131 TS-PLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAH 189
              S P+R LG+LR+ ER KS+K++ W+K FD+ G RV+AV+A++E  VD+S+LF GL+FAH
Sbjct:   156 PSGPIRDLGTLRIQERVKSKKDTGWSKLFDNTGRRVSAVEASEEFRVDMSKLFFGLKFAH 215

Query:   190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
             G +SRLYHG Y+D+ VAVK+I +PDDD+N  L ARLEKQF +EV LLSRL +PNVIKFV 
Sbjct:   216 GLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQFTKEVTLLSRLTHPNVIKFVG 275

Query:   250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
             A K PPVYCV+T+YL EGSLR++LHK E+++LPL KLI  A+DIARGMEYIHS+ +IHRD
Sbjct:   276 AYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHSRRIIHRD 335

Query:   310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
             LKPENVLID+EFHLKIADFGIACEE YCD L+DDPGTYRWMAPEMIK K +GRK DVYSF
Sbjct:   336 LKPENVLIDEEFHLKIADFGIACEEEYCDMLADDPGTYRWMAPEMIKRKPHGRKADVYSF 395

Query:   370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
             GL+LWEMVAG IPYE+MNPIQAAFAVV+KN+RPAIPGDCP AM ALIEQCWS+ PDKRPE
Sbjct:   396 GLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDCPVAMKALIEQCWSVAPDKRPE 455

Query:   430 FWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKLG 473
             FW IVKVLEQF  SL   G LNL  + IC+D +KGL HWIQKLG
Sbjct:   456 FWQIVKVLEQFAISLEREGNLNLSSSKICKDPRKGLKHWIQKLG 499

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1133 (403.9 bits), Expect = 6.4e-115, P = 6.4e-115
 Identities = 227/406 (55%), Positives = 285/406 (70%)

Query:    71 RSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQETKASS-NSY 129
             RSVSPLP   L D F EA+S  KRFSTPHPRR E +KG+  K   ++   E K+ +  S 
Sbjct:    49 RSVSPLPHMALSDAFIEAKSDIKRFSTPHPRRVEPEKGMKAKSSSRKDSSEKKSVNLRSL 108

Query:   130 STS-PLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFA 188
             S S P+R L + +V ER KS+ +   +K  D+ G +V++    +E  +D+S+L  G RFA
Sbjct:   109 SHSGPIRDLSTQKVKERGKSKIDKKSSKSVDYRGSKVSSAGVLEECLIDVSKLSYGDRFA 168

Query:   189 HGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248
             HG +S++YHG Y+ + VA+KII  P+D ++  L ARLEK+F  E  LLSRL +PNV+KFV
Sbjct:   169 HGKYSQIYHGEYEGKAVALKIITAPEDSDDIFLGARLEKEFIVEATLLSRLSHPNVVKFV 228

Query:   249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
                      C+ITEY+  GSLR+YLHKLE K+LPL +LI   LDIA+GMEYIHS+ ++H+
Sbjct:   229 GVNTGN---CIITEYVPRGSLRSYLHKLEQKSLPLEQLIDFGLDIAKGMEYIHSREIVHQ 285

Query:   309 DLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
             DLKPENVLID +FHLKIADFGIACEE YCD L D+ GTYRWMAPE++K   +GRK DVYS
Sbjct:   286 DLKPENVLIDNDFHLKIADFGIACEEEYCDVLGDNIGTYRWMAPEVLKRIPHGRKCDVYS 345

Query:   369 FGLILWEMVAGTIPYEEMN-PIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
             FGL+LWEMVAG +PYEEM    Q A+AV+ K +RP IP DCP AM  LIE+CWS Q DKR
Sbjct:   346 FGLLLWEMVAGALPYEEMKFAEQIAYAVIYKKIRPVIPTDCPAAMKELIERCWSSQTDKR 405

Query:   428 PEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHWIQKLG 473
             PEFW IVKVLE F+ SL   G LNL+ + IC + KK    WI   G
Sbjct:   406 PEFWQIVKVLEHFKKSLTSEGKLNLLPSQICPELKKCPKFWIHIFG 451

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009644 "response to high light intensity" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0042542 "response to hydrogen peroxide" evidence=RCA

TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)]

 Score = 739 (265.2 bits), Expect = 3.6e-73, P = 3.6e-73
 Identities = 127/273 (46%), Positives = 195/273 (71%)

Query:   172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
             DE T+DL +L +G  FA GA  +LY G Y  E VA+KI+  P++   +  A  +E+QF +
Sbjct:   121 DEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEK--AQFMEQQFQQ 178

Query:   232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
             EV++L+ L +PN+++F+ AC+KP V+C++TEY   GS+R +L + +++ +PL   +  AL
Sbjct:   179 EVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 238

Query:   292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
             D+ARGM Y+H +  IHRDLK +N+LI  +  +KIADFG+A  EV  + ++ + GTYRWMA
Sbjct:   239 DVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMA 298

Query:   352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
             PEMI+H++Y +KVDVYSFG++LWE++ G +P++ M  +QAAFAVVN+ +RP +P DC P 
Sbjct:   299 PEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDCLPV 358

Query:   412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
             ++ ++ +CW   P+ RP F  +VK+LE  ET +
Sbjct:   359 LSDIMTRCWDANPEVRPCFVEVVKLLEAAETEI 391

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)]

 Score = 730 (262.0 bits), Expect = 3.2e-72, P = 3.2e-72
 Identities = 129/276 (46%), Positives = 190/276 (68%)

Query:   172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
             +E T+DL +L +G  FA GA  +LY G Y  E VA+K++     D N   A  LE+QF +
Sbjct:   122 EEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLE--RSDSNPEKAQALEQQFQQ 179

Query:   232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
             EV++L+ L +PN+++F+ AC KP V+C++TEY   GS+R +L K +++ +PL   +  AL
Sbjct:   180 EVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQAL 239

Query:   292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
             D+ARGM Y+H +  IHRDLK +N+LI  +  +KIADFG+A  EV  + ++ + GTYRWMA
Sbjct:   240 DVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRWMA 299

Query:   352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
             PEMI+H+ Y +KVDVYSFG++LWE++ G +P++ M  +QAAFAVVN+ +RP +P DC P 
Sbjct:   300 PEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCLPV 359

Query:   412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACN 447
             +  ++ +CW   P+ RP F  IV +LE  ET +  N
Sbjct:   360 LGEIMTRCWDADPEVRPCFAEIVNLLEAAETEIMTN 395

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006914 "autophagy" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)]

 Score = 618 (222.6 bits), Expect = 2.4e-60, P = 2.4e-60
 Identities = 114/280 (40%), Positives = 177/280 (63%)

Query:   169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
             D  D   ++L  L  G + A G++  LY G Y  + VA+K+++ P     E L + LEK+
Sbjct:   278 DGTDVWEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLK-P-----ERLDSDLEKE 331

Query:   229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
             F +EV ++ ++ + NV++F+ AC KPP  C++TE++  GS+  YLHK +     LP L  
Sbjct:   332 FAQEVFIMRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHK-QKGVFKLPTLFK 390

Query:   289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348
             +A+DI +GM Y+H   +IHRDLK  N+L+D+   +K+ADFG+A  +     ++ + GTYR
Sbjct:   391 VAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYR 450

Query:   349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC 408
             WMAPE+I+HK Y  K DV+S+G++LWE++ G +PYE M P+QAA  VV K LRP IP + 
Sbjct:   451 WMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNT 510

Query:   409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNG 448
              P +A L+E+ W     +RP+F  I++ L++    +   G
Sbjct:   511 HPKLAELLERLWEHDSTQRPDFSEIIEQLQEIAKEVGEEG 550

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 613 (220.8 bits), Expect = 8.1e-60, P = 8.1e-60
 Identities = 109/271 (40%), Positives = 178/271 (65%)

Query:   169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
             D  DE  +D++QL +  + A G++  L+ G Y  + VA+K ++ PD   NE L     ++
Sbjct:   274 DGTDEWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLK-PDRVNNEML-----RE 327

Query:   229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
             F++EV ++ ++ + NV++F+ AC + P  C++TE+++ GS+  +LHK +     L  L+ 
Sbjct:   328 FSQEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHK-QKCAFKLQTLLK 386

Query:   289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348
             +ALD+A+GM Y+H   +IHRDLK  N+L+D+   +K+ADFG+A  ++    ++ + GTYR
Sbjct:   387 VALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVADFGVARVQIESGVMTAETGTYR 446

Query:   349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC 408
             WMAPE+I+HK Y  K DV+S+ ++LWE++ G IPY  + P+QAA  VV K LRP IP   
Sbjct:   447 WMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKT 506

Query:   409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
              P +  L+E+CW   P++RP F  I+++L+Q
Sbjct:   507 HPKVKGLLERCWHQDPEQRPLFEEIIEMLQQ 537

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 600 (216.3 bits), Expect = 1.9e-58, P = 1.9e-58
 Identities = 106/272 (38%), Positives = 176/272 (64%)

Query:   169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
             D  DE  +D+ QL +  + A G++  L+ G Y  + VA+KI++ P     E + A + ++
Sbjct:   280 DGTDEWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILK-P-----ERVNAEMLRE 333

Query:   229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLI 287
             F++EV ++ ++ + NV++F+ AC + P  C++TE+++ GS+  +LHK  HK    +  L+
Sbjct:   334 FSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHK--HKGVFKIQSLL 391

Query:   288 AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY 347
              +ALD+++GM Y+H   +IHRDLK  N+L+D+   +K+ADFG+A  +     ++ + GTY
Sbjct:   392 KVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVMTAETGTY 451

Query:   348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
             RWMAPE+I+HK Y  + DV+S+ ++LWE++ G +PY  + P+QAA  VV K LRP IP +
Sbjct:   452 RWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKE 511

Query:   408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
               P +  L+E+CW   P  RP F  I+++L Q
Sbjct:   512 THPKLTELLEKCWQQDPALRPNFAEIIEMLNQ 543

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)]

 Score = 586 (211.3 bits), Expect = 5.9e-57, P = 5.9e-57
 Identities = 118/286 (41%), Positives = 182/286 (63%)

Query:   162 GVRVNAVDAAD-EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENET 220
             G   N V   D +  VD   LF+G +   GAH+++Y G YK++ VA+KI++  +  E   
Sbjct:     6 GFYSNEVFELDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGESPEE-- 63

Query:   221 LAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT 280
               A+ E +F REV++LSR+ + N++KF+ ACK+P +  ++TE L  G+LR YL  L   +
Sbjct:    64 -IAKRESRFAREVSMLSRVQHKNLVKFIGACKEP-IMVIVTELLLGGTLRKYLVSLRPGS 121

Query:   281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDA 339
             L +   +  ALDIAR ME +HS GVIHRDLKPE++++  ++  +K+ADFG+A EE   + 
Sbjct:   122 LDIRVAVGYALDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEM 181

Query:   340 LSDDPGTYRWMAPEM-----IKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
             ++ + GTYRWMAPE+     ++H   K Y  KVD YSF ++LWE++   +P+E M+ +QA
Sbjct:   182 MTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQA 241

Query:   392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
             A+A   KN+RP+   D P  +A ++  CW   P+ RP F  I+++L
Sbjct:   242 AYAAAFKNVRPSAD-DLPKDLAMIVTSCWKEDPNDRPNFTEIIQML 286

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)]

 Score = 583 (210.3 bits), Expect = 1.2e-56, P = 1.2e-56
 Identities = 113/279 (40%), Positives = 180/279 (64%)

Query:   176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
             VD   LF+G +   GAH+++Y G Y+++ VA+KII+  +  E     A+ + +F RE+A+
Sbjct:    21 VDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGESPEE---IAKRDNRFAREIAM 77

Query:   236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
             LS++ + N++KF+ ACK+P +  ++TE L  G+LR YL  L  K L +   +  ALDIAR
Sbjct:    78 LSKVQHKNLVKFIGACKEP-MMVIVTELLLGGTLRKYLVSLRPKRLDIRLAVGFALDIAR 136

Query:   296 GMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDALSDDPGTYRWMAPEM 354
              ME +HS G+IHRDLKPEN+++  +   +K+ADFG+A EE   + ++ + GTYRWMAPE+
Sbjct:   137 AMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 196

Query:   355 I--------KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
                      + K Y  KVD YSF ++LWE++   +P+E M+ +QAA+A   KNLRP+   
Sbjct:   197 YSTVTLRQGEKKHYNHKVDAYSFAIVLWELILNKLPFEGMSNLQAAYAAAFKNLRPSAE- 255

Query:   407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
             D P  +  ++  CW   P++RP F  I+++L ++ T+++
Sbjct:   256 DLPGDLEMIVTSCWKEDPNERPNFTEIIQMLLRYLTTVS 294

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005739 "mitochondrion" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)]

 Score = 573 (206.8 bits), Expect = 1.4e-55, P = 1.4e-55
 Identities = 114/271 (42%), Positives = 171/271 (63%)

Query:   176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
             +D   LF+G +   GAH+++Y G YK++ VA+KI+   +  E     A+ + +F REV +
Sbjct:    15 IDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGETPEE---IAKRDSRFLREVEM 71

Query:   236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
             LSR+ + N++KF+ ACK+P V  ++TE L  G+LR YL  L    L     I  ALDIAR
Sbjct:    72 LSRVQHKNLVKFIGACKEP-VMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIAR 130

Query:   296 GMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDALSDDPGTYRWMAPEM 354
             GME +HS G+IHRDLKPEN+L+  +   +K+ADFG+A EE   + ++ + GTYRWMAPE+
Sbjct:   131 GMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 190

Query:   355 I--------KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
                      + K Y  KVD YSF ++LWE++   +P+E M+ +QAA+A   KN+RP+   
Sbjct:   191 YSTVTLRLGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAES 250

Query:   407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
               P  +  ++  CW+  P+ RP F HI+++L
Sbjct:   251 -LPEELGDIVTSCWNEDPNARPNFTHIIELL 280

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0007020 "microtubule nucleation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	488
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-87
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-85
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-69
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-68
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-66
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-66
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-61
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-55
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-53
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-48
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-47
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-44
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-44
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-43
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-43
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-43
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-41
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-41
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-41
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-40
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-40
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-40
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-40
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-39
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-39
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-39
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-39
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-39
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-38
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-38
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-38
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-38
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-38
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-38
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-37
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-37
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-37
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-37
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-36
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-36
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-36
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-36
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-36
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-36
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-35
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-35
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-35
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-35
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-35
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-35
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-35
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-35
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-35
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-34
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-34
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-34
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-34
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-34
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-33
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-33
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-33
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-33
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-33
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-33
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	9e-33
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-33
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-33
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-32
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-32
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-32
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-32
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-31
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-31
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-30
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-30
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-30
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-30
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-30
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-30
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-30
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-30
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-30
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-30
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-30
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-30
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-30
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-30
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-29
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-29
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-29
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-29
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-29
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-29
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-28
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-28
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-28
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-28
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-28
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-27
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-27
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-27
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-27
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-26
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-26
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-26
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-26
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-26
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-26
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-26
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-25
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-25
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-25
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-25
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-25
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-25
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-25
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-25
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-25
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-25
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-25
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-24
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-24
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-24
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-24
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-24
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-24
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-23
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-23
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-23
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-23
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-23
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-23
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-23
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-22
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-22
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-22
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-22
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-22
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-22
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-22
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-22
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-21
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-21
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-21
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-21
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-21
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-21
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-21
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-21
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-21
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-21
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-21
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-20
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-20
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-20
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-20
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-20
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-20
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-20
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-20
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-20
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-19
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-19
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-19
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-19
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-19
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-19
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-18
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-18
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-18
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-18
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-18
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-18
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-18
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-18
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-18
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-18
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-18
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-17
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-17
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-17
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-17
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-17
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-17
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-17
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-17
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-17
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-16
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-16
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-16
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-16
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-15
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-15
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-14
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-13
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-12
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-10
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	3e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-07
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	3e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	3e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.001
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.002
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.002
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  268 bits (687), Expect = 2e-87
 Identities = 90/268 (33%), Positives = 139/268 (51%), Gaps = 21/268 (7%)

Query: 181 LFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
           L LG +   GA   +Y G  K      +  VAVK ++    ++         ++F RE  
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI-------EEFLREAR 53

Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
           ++ +L +PN++K +  C +     ++ EY+  G L  YL K   K L L  L++ AL IA
Sbjct: 54  IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPGTYRWM 350
           RGMEY+ S+  IHRDL   N L+ +   +KI+DFG++ +    + Y       P   RWM
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP--IRWM 171

Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           APE +K   +  K DV+SFG++LWE+   G  PY  M+  +    +     R   P +CP
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY-RLPKPPNCP 230

Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           P +  L+ QCW+  P+ RP F  +V++L
Sbjct: 231 PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  262 bits (672), Expect = 4e-85
 Identities = 91/267 (34%), Positives = 139/267 (52%), Gaps = 20/267 (7%)

Query: 181 LFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
           L LG +   GA   +Y G  K         VAVK ++    ++         ++F RE  
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI-------EEFLREAR 53

Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
           ++ +L +PNV+K +  C +     ++ EY+  G L +YL K   K L L  L++ AL IA
Sbjct: 54  IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIA 112

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE---EVYCDALSDDPGTYRWMA 351
           RGMEY+ S+  IHRDL   N L+ +   +KI+DFG++ +   + Y           RWMA
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK-RGGKLPIRWMA 171

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
           PE +K   +  K DV+SFG++LWE+   G  PY  M+  +    + N   R   P +CPP
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGY-RLPQPPNCPP 230

Query: 411 AMAALIEQCWSLQPDKRPEFWHIVKVL 437
            +  L+ QCW+  P+ RP F  +V++L
Sbjct: 231 ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  221 bits (565), Expect = 3e-69
 Identities = 82/259 (31%), Positives = 133/259 (51%), Gaps = 19/259 (7%)

Query: 189 HGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
            GA   +Y G  K      +  VAVK ++    +E         ++F  E +++ +L +P
Sbjct: 9   EGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER-------EEFLEEASIMKKLSHP 61

Query: 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           N+++ +  C +     ++TEY+  G L  +L K   K L L  L+ +AL IA+GMEY+ S
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLES 120

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---RWMAPEMIKHKS 359
           +  +HRDL   N L+ +   +KI+DFG++ +    D      G     +WMAPE +K   
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
           +  K DV+SFG++LWE+   G  PY  M+  +     +    R   P +CP  +  L+ Q
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL-LEDGYRLPRPENCPDELYELMLQ 239

Query: 419 CWSLQPDKRPEFWHIVKVL 437
           CW+  P+ RP F  +V+ L
Sbjct: 240 CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  219 bits (560), Expect = 2e-68
 Identities = 73/244 (29%), Positives = 126/244 (51%), Gaps = 13/244 (5%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+  ++Y    K   + VA+K+I+     ++        ++  RE+ +L +L +PN+++
Sbjct: 9   EGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR-------ERILREIKILKKLKHPNIVR 61

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                +      ++ EY   G L   L K     L   +       I   +EY+HS+G++
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           HRDLKPEN+L+D++ H+K+ADFG+A +    + L+   GT  +MAPE++  K YG+ VD+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPAMAALIEQCWSLQP 424
           +S G+IL+E++ G  P+   + +   F  + K   P  P   D  P    LI +     P
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDP 239

Query: 425 DKRP 428
           +KR 
Sbjct: 240 EKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  213 bits (545), Expect = 3e-66
 Identities = 85/261 (32%), Positives = 131/261 (50%), Gaps = 29/261 (11%)

Query: 194 RLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253
           +L     K   VAVK ++    +E         K F +E  ++ +L +PNV++ +  C +
Sbjct: 15  KLKGKDGKTTEVAVKTLKEDASEEER-------KDFLKEARVMKKLGHPNVVRLLGVCTE 67

Query: 254 PPVYCVITEYLSEGSLRAYLHK-------LEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                ++ EY+  G L  YL K        E  TL L  L++ A+ IA+GMEY+ S+  +
Sbjct: 68  EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFV 127

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY--------RWMAPEMIKHK 358
           HRDL   N L+ ++  +KI+DFG++  +VY     DD            RWMAPE +K  
Sbjct: 128 HRDLAARNCLVGEDLVVKISDFGLS-RDVY----DDDYYRKKTGGKLPIRWMAPESLKDG 182

Query: 359 SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIE 417
            +  K DV+SFG++LWE+   G  PY  ++  +     + K  R   P  CP  +  L+ 
Sbjct: 183 IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEYLRKGYRLPKPEYCPDELYELML 241

Query: 418 QCWSLQPDKRPEFWHIVKVLE 438
            CW L P+ RP F  +V+ LE
Sbjct: 242 SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  212 bits (543), Expect = 6e-66
 Identities = 84/256 (32%), Positives = 134/256 (52%), Gaps = 19/256 (7%)

Query: 190 GAHSRLYHGIYKDEP--VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G+   +Y   +K     VAVKI++   +   +      ++   RE+ +L RL +PN+++ 
Sbjct: 10  GSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK------DQTARREIRILRRLSHPNIVRL 63

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
           + A +      ++ EY   G L  YL +     L   +   IAL I RG+EY+HS G+IH
Sbjct: 64  IDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHSNGIIH 121

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIK-HKSYGRKVD 365
           RDLKPEN+L+D+   +KIADFG+A + +   +      GT  +MAPE++     YG KVD
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181

Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP------PAMAALIEQC 419
           V+S G+IL+E++ G  P+     I     ++ + L P +  D P           LI++C
Sbjct: 182 VWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKC 240

Query: 420 WSLQPDKRPEFWHIVK 435
            +  P KRP    I++
Sbjct: 241 LNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  199 bits (508), Expect = 3e-61
 Identities = 72/245 (29%), Positives = 113/245 (46%), Gaps = 46/245 (18%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G    +Y    K   + VA+KII+  D            ++  RE+ +L +L++PN++K
Sbjct: 3   EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL-------EELLREIEILKKLNHPNIVK 55

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                +      ++ EY   GSL+  L + E   L   +++ I L I  G+EY+HS G+I
Sbjct: 56  LYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGII 114

Query: 307 HRDLKPENVLIDQ-EFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHK-SYGRK 363
           HRDLKPEN+L+D     +K+ADFG++         L    GT  +MAPE++  K  Y  K
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQ 423
            D++S G+IL+E+                                 P +  LI +     
Sbjct: 175 SDIWSLGVILYEL---------------------------------PELKDLIRKMLQKD 201

Query: 424 PDKRP 428
           P+KRP
Sbjct: 202 PEKRP 206

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  185 bits (473), Expect = 1e-55
 Identities = 80/248 (32%), Positives = 125/248 (50%), Gaps = 16/248 (6%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+   +Y  + KD  E +AVK + +  D E E     LE    RE+ +LS L +PN+++
Sbjct: 10  RGSFGSVYLALDKDTGELMAVKSVELSGDSEEE--LEALE----REIRILSSLQHPNIVR 63

Query: 247 FVAACKKPP--VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           +  + +        +  EY+S GSL + L K     LP P +      I  G+ Y+HS G
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNG 121

Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWMAPEMIKHKSYG 361
           ++HRD+K  N+L+D +  +K+ADFG A    +    +      GT  WMAPE+I+ + YG
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181

Query: 362 RKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
           R  D++S G  + EM  G  P+ E+ NP+ A + + +    P IP          + +C 
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCL 241

Query: 421 SLQPDKRP 428
              P KRP
Sbjct: 242 RRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  179 bits (456), Expect = 4e-53
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 18/254 (7%)

Query: 183 LGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN 241
           L  +   G    ++ G++K+   VA+KI++      ++ L  +    F +EV  L RL +
Sbjct: 10  LERKLGSGYFGEVWEGLWKNRVRVAIKILK-----SDDLLKQQ---DFQKEVQALKRLRH 61

Query: 242 PNVIKFVAACKK-PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
            ++I   A C    PVY +ITE + +GSL A+L   E + LP+  LI +A  +A GM Y+
Sbjct: 62  KHLISLFAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120

Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWMAPEMIKH 357
             Q  IHRDL   N+L+ ++   K+ADFG+A    E+VY  +    P  Y+W APE   H
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASH 178

Query: 358 KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
            ++  K DV+SFG++L+EM   G +PY  MN     +  +    R   P  CP  +  ++
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIYKIM 237

Query: 417 EQCWSLQPDKRPEF 430
            +CW+ +P+ RP F
Sbjct: 238 LECWAAEPEDRPSF 251

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  166 bits (422), Expect = 3e-48
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 15/267 (5%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           ++  +L LG     G    +  G Y+ + VAVK ++   DD          + F  E ++
Sbjct: 3   INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK---DDSTAA------QAFLAEASV 53

Query: 236 LSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
           ++ L +PN+++ +    +  P+Y ++TEY+++GSL  YL       + L + +  ALD+ 
Sbjct: 54  MTTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEM 354
            GMEY+  +  +HRDL   NVL+ ++   K++DFG+A E          P   +W APE 
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP--VKWTAPEA 170

Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           ++ K +  K DV+SFG++LWE+ + G +PY  + P++     V K  R   P  CPP + 
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEAPEGCPPEVY 229

Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            +++ CW L P KRP F  + + L   
Sbjct: 230 KVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  164 bits (418), Expect = 2e-47
 Identities = 87/273 (31%), Positives = 137/273 (50%), Gaps = 28/273 (10%)

Query: 179 SQLFLGLRFAHGAHSRLYHGIY-KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLS 237
             L L  +   G    ++ G +     VAVK ++        +  A     F +E  ++ 
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK----PGTMSPEA-----FLQEAQIMK 56

Query: 238 RLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARG 296
           +L +  +++  A C ++ P+Y ++TEY+S+GSL  +L   E K L LP+L+ +A  IA G
Sbjct: 57  KLRHDKLVQLYAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115

Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR-------- 348
           M Y+ S+  IHRDL   N+L+ +    KIADFG+A        + DD  T R        
Sbjct: 116 MAYLESRNYIHRDLAARNILVGENLVCKIADFGLA------RLIEDDEYTAREGAKFPIK 169

Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE   +  +  K DV+SFG++L E+V  G +PY  M   +     V +  R   P +
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPN 228

Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           CP  +  L+ QCW   P++RP F ++   LE +
Sbjct: 229 CPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  155 bits (394), Expect = 3e-44
 Identities = 88/261 (33%), Positives = 139/261 (53%), Gaps = 20/261 (7%)

Query: 186 RFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
           +   G    +Y G+ K    VAVK  R        TL   L+++F +E  +L +  +PN+
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCR-------STLPPDLKRKFLQEAEILKQYDHPNI 54

Query: 245 IKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           +K +  C +K P+Y ++ E +  GSL  +L K +++ L + KL+ ++LD A GMEY+ S+
Sbjct: 55  VKLIGVCVQKQPIY-IVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESK 112

Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEE---VYCDALSDDPGT--YRWMAPEMIKHK 358
             IHRDL   N L+ +   LKI+DFG++ EE   +Y   +SD       +W APE + + 
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--TVSDGLKQIPIKWTAPEALNYG 170

Query: 359 SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIE 417
            Y  + DV+S+G++LWE  + G  PY  M+  Q     +    R   P  CP  +  L+ 
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-ERIESGYRMPAPQLCPEEIYRLML 229

Query: 418 QCWSLQPDKRPEFWHIVKVLE 438
           QCW+  P+ RP F  I   L+
Sbjct: 230 QCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  154 bits (392), Expect = 9e-44
 Identities = 86/271 (31%), Positives = 137/271 (50%), Gaps = 18/271 (6%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVA 234
           +D + + L  +   G    ++ G++ +  PVAVK ++    D  +         F  E  
Sbjct: 3   IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD---------FLAEAQ 53

Query: 235 LLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
           ++ +L +P +I+  A C  + P+Y ++TE +  GSL  YL     + L LP+LI +A  +
Sbjct: 54  IMKKLRHPKLIQLYAVCTLEEPIY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112

Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWM 350
           A GM Y+ +Q  IHRDL   NVL+ +    K+ADFG+A    E++Y +A        +W 
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWT 171

Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           APE   +  +  K DV+SFG++L E+V  G +PY  M   +     V++  R   P  CP
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGYRMPCPPGCP 230

Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
             +  ++  CW   PD RP F  +   LE F
Sbjct: 231 KELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  153 bits (389), Expect = 1e-43
 Identities = 83/265 (31%), Positives = 144/265 (54%), Gaps = 15/265 (5%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           ++L +L LG     G    +  G Y  + VAVK I+      + T  A LE     E A+
Sbjct: 3   LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKC-----DVTAQAFLE-----ETAV 52

Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
           +++LH+ N+++ +       +Y ++ E +S+G+L  +L       + + +L+  +LD+A 
Sbjct: 53  MTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111

Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
           GMEY+ S+ ++HRDL   N+L+ ++   K++DFG+A   V    + +     +W APE +
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA--RVGSMGVDNSKLPVKWTAPEAL 169

Query: 356 KHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA 414
           KHK +  K DV+S+G++LWE+ + G  PY +M+ ++     V K  R   P  CP  +  
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVYV 228

Query: 415 LIEQCWSLQPDKRPEFWHIVKVLEQ 439
           L+  CW  +P KRP F  + + LE+
Sbjct: 229 LMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  153 bits (388), Expect = 4e-43
 Identities = 61/232 (26%), Positives = 116/232 (50%), Gaps = 14/232 (6%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
            +   +K I + +  E E   A        EV +L +L++PN+IK+  + ++    C++ 
Sbjct: 25  GKLYVLKEIDLSNMSEKEREDAL------NEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78

Query: 262 EYLSEGSLRAYLH--KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           EY   G L   +   K E K  P  +++   + +   ++Y+HS+ ++HRD+KP+N+ +  
Sbjct: 79  EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS 138

Query: 320 EFHLKIADFGIACEEVY---CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
              +K+ DFGI+  +V     D      GT  +++PE+ ++K Y  K D++S G +L+E+
Sbjct: 139 NGLVKLGDFGIS--KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYEL 196

Query: 377 VAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
                P+E  N ++ A  ++     P IP      +  L+       P++RP
Sbjct: 197 CTLKHPFEGENLLELALKILKGQYPP-IPSQYSSELRNLVSSLLQKDPEERP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  153 bits (388), Expect = 7e-43
 Identities = 71/252 (28%), Positives = 126/252 (50%), Gaps = 32/252 (12%)

Query: 190 GAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           GA   +Y    +   + VA+K +R+   ++   +          E+ ++    +PN++ +
Sbjct: 30  GASGEVYKATDRATGKEVAIKKMRLRKQNKELII---------NEILIMKDCKHPNIVDY 80

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL--PKLIAIALDIARGMEYIHSQGV 305
             +        V+ EY+  GSL   +  +    + +  P++  +  ++ +G+EY+HSQ V
Sbjct: 81  YDSYLVGDELWVVMEYMDGGSL-TDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHK 358
           IHRD+K +N+L+ ++  +K+ADFG      +   L+ +        GT  WMAPE+IK K
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFG------FAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPAMAALI 416
            YG KVD++S G++  EM  G  PY    P++A F +  K + P +  P    P     +
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLKNPEKWSPEFKDFL 250

Query: 417 EQCWSLQPDKRP 428
            +C    P+KRP
Sbjct: 251 NKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  150 bits (379), Expect = 5e-42
 Identities = 77/216 (35%), Positives = 119/216 (55%), Gaps = 7/216 (3%)

Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  E  L+ +L +P +++  A   + P+Y +ITEY+  GSL  +L   E   L + KLI 
Sbjct: 48  FLAEANLMKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLID 106

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY- 347
           +A  IA GM +I  +  IHRDL+  N+L+ +    KIADFG+A      +  + +   + 
Sbjct: 107 MAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP 166

Query: 348 -RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAI 404
            +W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYRMPR 224

Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           P +CP  +  L+  CW  +P++RP F ++  VLE F
Sbjct: 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  148 bits (377), Expect = 1e-41
 Identities = 72/244 (29%), Positives = 126/244 (51%), Gaps = 28/244 (11%)

Query: 196 YHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA-CK 252
           Y   +K   + VA+K+I++   ++ E +          E+ +L +  +PN++K+  +  K
Sbjct: 17  YKARHKRTGKEVAIKVIKLESKEKKEKII--------NEIQILKKCKHPNIVKYYGSYLK 68

Query: 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312
           K  ++ V+ E+ S GSL+  L      TL   ++  +  ++ +G+EY+HS G+IHRD+K 
Sbjct: 69  KDELWIVM-EFCSGGSLKDLLKSTNQ-TLTESQIAYVCKELLKGLEYLHSNGIIHRDIKA 126

Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDP------GTYRWMAPEMIKHKSYGRKVDV 366
            N+L+  +  +K+ DFG++ +      LSD        GT  WMAPE+I  K Y  K D+
Sbjct: 127 ANILLTSDGEVKLIDFGLSAQ------LSDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180

Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD--CPPAMAALIEQCWSLQP 424
           +S G+   E+  G  PY E+ P++A F  +  N  P +             +++C    P
Sbjct: 181 WSLGITAIELAEGKPPYSELPPMKALF-KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNP 239

Query: 425 DKRP 428
           +KRP
Sbjct: 240 EKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  148 bits (376), Expect = 3e-41
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 40/263 (15%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--PVYCVI 260
           E VAVK +      E +  +      F RE+ +L  L + N++K+   C+KP      +I
Sbjct: 34  EQVAVKSLNH--SGEEQHRS-----DFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EYL  GSLR YL +   + + L +L+  +  I +GM+Y+ SQ  IHRDL   N+L++ E
Sbjct: 87  MEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE 145

Query: 321 FHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFG 370
             +KI+DFG+A        L +D   Y           W APE ++   +    DV+SFG
Sbjct: 146 DLVKISDFGLA------KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFG 199

Query: 371 LILWEM--------VAGTIPYEEMNPIQAAFAV------VNKNLRPAIPGDCPPAMAALI 416
           + L+E+                 +   Q    V      + +  R   P  CP  +  L+
Sbjct: 200 VTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLM 259

Query: 417 EQCWSLQPDKRPEFWHIVKVLEQ 439
           + CW  +P  RP F  ++ ++++
Sbjct: 260 KLCWEAEPQDRPSFADLILIVDR 282

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  146 bits (371), Expect = 7e-41
 Identities = 72/242 (29%), Positives = 118/242 (48%), Gaps = 8/242 (3%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G+   +Y G+  D  +  AVK + + DD +         KQ  +E+ALLS+L +PN++++
Sbjct: 11  GSFGSVYEGLNLDDGDFFAVKEVSLADDGQ---TGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
           +   ++     +  E +  GSL   L K  + + P P +      I  G+EY+H +  +H
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDV 366
           RD+K  N+L+D    +K+ADFG+A + V         G+  WMAPE+I  +  YG   D+
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185

Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
           +S G  + EM  G  P+ ++  + A F +      P IP          I +C    P  
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSL 245

Query: 427 RP 428
           RP
Sbjct: 246 RP 247

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 1e-40
 Identities = 78/247 (31%), Positives = 129/247 (52%), Gaps = 22/247 (8%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           GA   +Y G+  +  + VA+K I +    E         K   +E+ LL  L +PN++K+
Sbjct: 11  GAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL------KSIMQEIDLLKNLKHPNIVKY 64

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK-LIAIAL-DIARGMEYIHSQGV 305
           + + +      +I EY   GSLR  + K      P P+ L+A+ +  + +G+ Y+H QGV
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQGV 120

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----GTYRWMAPEMIKHKSYG 361
           IHRD+K  N+L  ++  +K+ADFG+A      + +S D     GT  WMAPE+I+     
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177

Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS 421
              D++S G  + E++ G  PY ++NP+ A F +V  +  P +P    P +   + QC+ 
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQCFQ 236

Query: 422 LQPDKRP 428
             P+ RP
Sbjct: 237 KDPNLRP 243

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  146 bits (371), Expect = 1e-40
 Identities = 77/250 (30%), Positives = 122/250 (48%), Gaps = 25/250 (10%)

Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           K+  VA+K ++    D+      RL+  F  E +++ +  +PN+I+      K     +I
Sbjct: 31  KEIDVAIKTLKAGSSDK-----QRLD--FLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           TEY+  GSL  +L + + K     +L+ +   IA GM+Y+     +HRDL   N+L++  
Sbjct: 84  TEYMENGSLDKFLRENDGKFTVG-QLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN 142

Query: 321 FHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPEMIKHKSYGRKVDVYSFGL 371
              K++DFG++        L D   TY         RW APE I ++ +    DV+SFG+
Sbjct: 143 LVCKVSDFGLSRR------LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGI 196

Query: 372 ILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           ++WE M  G  PY +M   Q     V    R   P DCP A+  L+  CW    ++RP F
Sbjct: 197 VMWEVMSYGERPYWDM-SNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTF 255

Query: 431 WHIVKVLEQF 440
             IV  L++ 
Sbjct: 256 SQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  145 bits (367), Expect = 3e-40
 Identities = 73/255 (28%), Positives = 133/255 (52%), Gaps = 17/255 (6%)

Query: 190 GAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G +  +Y G++K     VAVK ++       +T+     ++F +E A++  + +PN+++ 
Sbjct: 17  GQYGEVYEGVWKKYSLTVAVKTLK------EDTMEV---EEFLKEAAVMKEIKHPNLVQL 67

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
           +  C + P + +ITE+++ G+L  YL +   + +    L+ +A  I+  MEY+  +  IH
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 308 RDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKV 364
           RDL   N L+ +   +K+ADFG++     + Y  A +      +W APE + +  +  K 
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 365 DVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQ 423
           DV++FG++LWE+   G  PY  ++ +   + ++ K  R   P  CPP +  L+  CW   
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKGYRMERPEGCPPKVYELMRACWQWN 245

Query: 424 PDKRPEFWHIVKVLE 438
           P  RP F  I +  E
Sbjct: 246 PSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  145 bits (367), Expect = 6e-40
 Identities = 74/253 (29%), Positives = 125/253 (49%), Gaps = 38/253 (15%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K ++    +  E    +++++F +E  L+S L +PN++  +  C K    C++ EYL
Sbjct: 38  VAIKTLK----ENAE---PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYL 90

Query: 265 SEGSLRAYL-------------------HKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           + G L  +L                     L+         + IA+ IA GMEY+ S   
Sbjct: 91  AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC-----SDFLHIAIQIAAGMEYLSSHHF 145

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYG 361
           +HRDL   N L+ +   +KI+DFG++  ++Y        S      RWM PE I +  + 
Sbjct: 146 VHRDLAARNCLVGEGLTVKISDFGLS-RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT 204

Query: 362 RKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
            + D++SFG++LWE+ + G  PY   +  +    + ++ L P  P DCP  + AL+ +CW
Sbjct: 205 TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPC-PEDCPARVYALMIECW 263

Query: 421 SLQPDKRPEFWHI 433
           +  P +RP F  I
Sbjct: 264 NEIPARRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  142 bits (359), Expect = 3e-39
 Identities = 81/241 (33%), Positives = 131/241 (54%), Gaps = 15/241 (6%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVI 260
           + PVAVK  R       ETL   L+ +F +E  +L +  +PN+++ +  C +K P+Y ++
Sbjct: 20  NTPVAVKSCR-------ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY-IV 71

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            E +  G    +L + E   L + +LI +  + A GMEY+ S+  IHRDL   N L+ ++
Sbjct: 72  MELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK 130

Query: 321 FHLKIADFGIACEE---VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
             LKI+DFG++ EE   VY           +W APE + +  Y  + DV+SFG++LWE  
Sbjct: 131 NVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF 190

Query: 378 A-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV 436
           + G +PY  ++  Q   A + + +R   P  CP A+  L+E+CW   P +RP F  + + 
Sbjct: 191 SLGAVPYANLSNQQTREA-IEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249

Query: 437 L 437
           L
Sbjct: 250 L 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  143 bits (362), Expect = 4e-39
 Identities = 81/252 (32%), Positives = 118/252 (46%), Gaps = 29/252 (11%)

Query: 201 KDEP--VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258
            D P  VAVK++R PD  +N        + F +EV +LSRL +PN+ + +  C   P  C
Sbjct: 43  ADAPVLVAVKVLR-PDASDN------AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLC 95

Query: 259 VITEYLSEGSLRAYLHKLE---------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
           +I EY+  G L  +L K            K+L    L+ +A  IA GM Y+ S   +HRD
Sbjct: 96  MIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD 155

Query: 310 LKPENVLIDQEFHLKIADFGI---ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           L   N L+ + + +KIADFG+        Y       P   RWMA E +    +  K DV
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215

Query: 367 YSFGLILWE--MVAGTIPYEEMNP---IQAAFAVVNKNLRPAI---PGDCPPAMAALIEQ 418
           ++FG+ LWE   +    PYE +     I+ A      + R      P +CP  +  L+ +
Sbjct: 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLE 275

Query: 419 CWSLQPDKRPEF 430
           CW    + RP F
Sbjct: 276 CWRRDEEDRPTF 287

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  142 bits (360), Expect = 5e-39
 Identities = 74/256 (28%), Positives = 123/256 (48%), Gaps = 23/256 (8%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIP------DDDENETLAARLEKQFNREVALLSRLHN 241
           G + R+Y  +     E +AVK + +P       D   + +   L      E+  L  L +
Sbjct: 12  GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKAL----RSEIETLKDLDH 67

Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
            N+++++          +  EY+  GS+ + L         L +       +  G+ Y+H
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR--FFTEQVLEGLAYLH 125

Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYC-DALSDDPGTYRWMAPEMI--K 356
           S+G++HRDLK +N+L+D +   KI+DFGI+   +++Y  D      G+  WMAPE+I   
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 357 HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP----PAM 412
            + Y  KVD++S G ++ EM AG  P+ +   I A F + NK   P IP D      P  
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA 245

Query: 413 AALIEQCWSLQPDKRP 428
              +  C+++ PD RP
Sbjct: 246 LDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  142 bits (359), Expect = 5e-39
 Identities = 80/261 (30%), Positives = 128/261 (49%), Gaps = 33/261 (12%)

Query: 186 RFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              HG    +  G+Y     K+  VAVK ++       E +AA  +K+F RE +++++L 
Sbjct: 2   ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK------QEHIAA-GKKEFLREASVMAQLD 54

Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           +P +++ +  CK  P   ++ E    G L  YL K   + +P+  L  +A  +A GM Y+
Sbjct: 55  HPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYL 111

Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----------WM 350
            S+  +HRDL   NVL+      KI+DFG++       AL      YR          W 
Sbjct: 112 ESKHFVHRDLAARNVLLVNRHQAKISDFGMS------RALGAGSDYYRATTAGRWPLKWY 165

Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           APE I +  +  K DV+S+G+ LWE  + G  PY EM   +   A++    R   P +CP
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAMLESGERLPRPEECP 224

Query: 410 PAMAALIEQCWSLQPDKRPEF 430
             + +++  CW  +P+ RP F
Sbjct: 225 QEIYSIMLSCWKYRPEDRPTF 245

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  141 bits (357), Expect = 7e-39
 Identities = 85/264 (32%), Positives = 135/264 (51%), Gaps = 15/264 (5%)

Query: 181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
           L L  +  +G    ++ G +  +  VAVK ++ P     E+        F  E  ++ +L
Sbjct: 8   LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPES--------FLEEAQIMKKL 58

Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
            +  +++  A   + P+Y ++TEY+S+GSL  +L   E + L LP L+ +A  +A GM Y
Sbjct: 59  RHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWMAPEMIKH 357
           I     IHRDL+  N+L+      KIADFG+A   E+    A        +W APE   +
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177

Query: 358 KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
             +  K DV+SFG++L E+V  G +PY  MN  +     V +  R   P DCP ++  L+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHELM 236

Query: 417 EQCWSLQPDKRPEFWHIVKVLEQF 440
            QCW   P++RP F ++   LE +
Sbjct: 237 LQCWKKDPEERPTFEYLQSFLEDY 260

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  140 bits (353), Expect = 2e-38
 Identities = 84/255 (32%), Positives = 136/255 (53%), Gaps = 19/255 (7%)

Query: 190 GAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248
           G    ++ G  KD+ PVAVK  +       E L   L+ +F  E  +L +  +PN++K +
Sbjct: 6   GNFGEVFKGTLKDKTPVAVKTCK-------EDLPQELKIKFLSEARILKQYDHPNIVKLI 58

Query: 249 AAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
             C ++ P+Y ++ E +  G   ++L K +   L   +L+  ALD A GM Y+ S+  IH
Sbjct: 59  GVCTQRQPIY-IVMELVPGGDFLSFLRK-KKDELKTKQLVKFALDAAAGMAYLESKNCIH 116

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEE---VYCDA-LSDDPGTYRWMAPEMIKHKSYGRK 363
           RDL   N L+ +   LKI+DFG++ +E   +Y  + L   P   +W APE + +  Y  +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP--IKWTAPEALNYGRYSSE 174

Query: 364 VDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSL 422
            DV+S+G++LWE  + G  PY  M   Q A   V K  R + P  CP  +  ++++CW  
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY 233

Query: 423 QPDKRPEFWHIVKVL 437
           +P+ RP+F  + K L
Sbjct: 234 KPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  139 bits (352), Expect = 3e-38
 Identities = 76/260 (29%), Positives = 130/260 (50%), Gaps = 17/260 (6%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVA 234
           +D S+L        G    ++ G ++ +  VA+K+IR           A  E  F  E  
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIR---------EGAMSEDDFIEEAK 51

Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
           ++ +L +PN+++    C K     ++TEY++ G L  YL + + K L    L+ +  D+ 
Sbjct: 52  VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVC 110

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWMA 351
             MEY+ S G IHRDL   N L+ ++  +K++DFG+A   V  D  +   GT    +W  
Sbjct: 111 EAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA-RYVLDDQYTSSQGTKFPVKWAP 169

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
           PE+  +  +  K DV+SFG+++WE+ + G +PYE  +  +   + V+   R   P   P 
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VSAGYRLYRPKLAPT 228

Query: 411 AMAALIEQCWSLQPDKRPEF 430
            +  ++  CW  +P+ RP F
Sbjct: 229 EVYTIMYSCWHEKPEDRPAF 248

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  140 bits (354), Expect = 4e-38
 Identities = 90/284 (31%), Positives = 144/284 (50%), Gaps = 49/284 (17%)

Query: 190 GAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G   R+++GI       K+E V VK ++   D  +E     L +    E  LL  L + N
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVK---DHASEIQVTLLLQ----ESCLLYGLSHQN 69

Query: 244 VIKFVAAC---KKPPVYCVITEYLSEGSLRAYLHKLEH------KTLPLPKLIAIALDIA 294
           ++  +  C    +PP   V+  Y++ G+L+ +L +         + L   +L+ +A+ IA
Sbjct: 70  ILPILHVCIEDGEPPF--VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD--PGTY----- 347
            GM Y+H +GVIH+D+   N +ID+E  +KI D          +ALS D  P  Y     
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVIDEELQVKITD----------NALSRDLFPMDYHCLGD 177

Query: 348 ------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 +WMA E + +K Y    DV+SFG++LWE++  G  PY E++P + A A +    
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGY 236

Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
           R A P +CP  + A++  CW+L P++RP F  +V+ L  F   L
Sbjct: 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  140 bits (354), Expect = 4e-38
 Identities = 83/281 (29%), Positives = 136/281 (48%), Gaps = 39/281 (13%)

Query: 190 GAHSRLYH----GIYKDEP---VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
           GA  R++     G+   EP   VAVK+++       E  +A ++  F RE AL++   +P
Sbjct: 16  GAFGRVFQARAPGLLPYEPFTMVAVKMLK-------EEASADMQADFQREAALMAEFDHP 68

Query: 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------HKLEHKTLPL----------- 283
           N++K +  C      C++ EY++ G L  +L          L H T              
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 284 -PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE---EVYCDA 339
             + + IA  +A GM Y+  +  +HRDL   N L+ +   +KIADFG++       Y  A
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398
             +D    RWM PE I +  Y  + DV+++G++LWE+ + G  PY  M   +  + V + 
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248

Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
           N+  + P +CP  +  L+  CWS  P  RP F  I ++L++
Sbjct: 249 NVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  140 bits (355), Expect = 4e-38
 Identities = 82/290 (28%), Positives = 142/290 (48%), Gaps = 36/290 (12%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEP-------VAVKIIRIPDDDENETLAARLEKQ 228
           +   +L LG     GA  ++                VAVK+++   DD  E    +    
Sbjct: 9   LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK---DDATE----KDLSD 61

Query: 229 FNREVALLSRL-HNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLH------------ 274
              E+ ++  +  + N+I  +  C ++ P+Y V+ EY + G+LR +L             
Sbjct: 62  LVSEMEMMKMIGKHKNIINLLGVCTQEGPLY-VVVEYAAHGNLRDFLRARRPPGEYASPD 120

Query: 275 --KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332
             +   +TL    L++ A  +ARGME++ S+  IHRDL   NVL+ ++  +KIADFG+A 
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Query: 333 EEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388
           +  + D     ++     +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  + P
Sbjct: 181 DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-P 239

Query: 389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           ++  F ++ +  R   P +C   +  L+  CW   P +RP F  +V+ L+
Sbjct: 240 VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  139 bits (352), Expect = 5e-38
 Identities = 73/246 (29%), Positives = 133/246 (54%), Gaps = 21/246 (8%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G++  +Y  I+K+  + VA+K++ + +D +       + K    E+++L +  +P ++K+
Sbjct: 14  GSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIK----EISILKQCDSPYIVKY 63

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
             +  K     ++ EY   GS+   + K+ +KTL   ++ AI     +G+EY+HS   IH
Sbjct: 64  YGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVDV 366
           RD+K  N+L+++E   K+ADFG++ +     A  +   GT  WMAPE+I+   Y  K D+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADI 182

Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP----AIPGDCPPAMAALIEQCWSL 422
           +S G+   EM  G  PY +++P++A F + NK   P    + P    P     +++C   
Sbjct: 183 WSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPPTLSDPEKWSPEFNDFVKKCLVK 239

Query: 423 QPDKRP 428
            P++RP
Sbjct: 240 DPEERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 1e-37
 Identities = 66/225 (29%), Positives = 117/225 (52%), Gaps = 14/225 (6%)

Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           A+K+++     + + +  +  +    E  +LSR+++P ++K   A +      ++ EY  
Sbjct: 22  AMKVLK-----KKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAP 76

Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
            G L ++L K    +    +  A A +I   +EY+HS G+I+RDLKPEN+L+D + H+K+
Sbjct: 77  GGELFSHLSKEGRFSEERARFYA-A-EIVLALEYLHSLGIIYRDLKPENILLDADGHIKL 134

Query: 326 ADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
            DFG+A E     + ++   GT  ++APE++  K YG+ VD +S G++L+EM+ G  P+ 
Sbjct: 135 TDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY 194

Query: 385 EMNPIQAAFAVVNKNLR--PAIPGDCPPAMAALIEQCWSLQPDKR 427
             +  +    +  K L+     P    P    LI       P KR
Sbjct: 195 AEDRKE----IYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  137 bits (346), Expect = 4e-37
 Identities = 77/272 (28%), Positives = 132/272 (48%), Gaps = 33/272 (12%)

Query: 189 HGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN 241
            G+   +Y G+ K       +  VA+K +     +EN ++  R+E  F  E +++   + 
Sbjct: 16  QGSFGMVYEGLAKGVVKGEPETRVAIKTV-----NENASMRERIE--FLNEASVMKEFNC 68

Query: 242 PNVIKF--VAACKKPPVYCVITEYLSEGSLRAYLHKL----EHKTLPLP----KLIAIAL 291
            +V++   V +  +P +  V+ E +++G L++YL       E+     P    K I +A 
Sbjct: 69  HHVVRLLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---R 348
           +IA GM Y+ ++  +HRDL   N ++ ++  +KI DFG+  +    D            R
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA-AFAVVNKNLRPAIPG 406
           WMAPE +K   +  K DV+SFG++LWEM      PY+ ++  +   F +   +L    P 
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL--PE 244

Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           +CP  +  L+  CW   P  RP F  IV  L+
Sbjct: 245 NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  136 bits (343), Expect = 6e-37
 Identities = 78/224 (34%), Positives = 120/224 (53%), Gaps = 18/224 (8%)

Query: 227 KQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK 285
           + F  E  L+  L +  +++  A   K+ P+Y +ITEY+++GSL  +L   E   + LPK
Sbjct: 46  QAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY-IITEYMAKGSLLDFLKSDEGGKVLLPK 104

Query: 286 LIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG 345
           LI  +  IA GM YI  +  IHRDL+  NVL+ +    KIADFG+A        + D+  
Sbjct: 105 LIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA------RVIEDNEY 158

Query: 346 TYR--------WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVV 396
           T R        W APE I   S+  K DV+SFG++L+E+V  G IPY  M+      A +
Sbjct: 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-L 217

Query: 397 NKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            +  R     +CP  +  +++ CW  + ++RP F ++  VL+ F
Sbjct: 218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  136 bits (344), Expect = 6e-37
 Identities = 81/270 (30%), Positives = 128/270 (47%), Gaps = 37/270 (13%)

Query: 190 GAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQ---FNREVALLSRLHN 241
           G    ++ GI K     +  VA+K ++              EKQ   F  E +++ +  +
Sbjct: 16  GEFGEVFRGILKMPGRKEVAVAIKTLK----------PGYTEKQRQDFLSEASIMGQFSH 65

Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
            N+I+      K     +ITEY+  G+L  YL   + +     +L+ +   IA GM+Y+ 
Sbjct: 66  HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYLS 124

Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTY---------RWMA 351
               +HRDL   N+L++     K++DFG++        L DDP GTY         RW A
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLS------RVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 352 PEMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
           PE I ++ +    DV+SFG+++WE M  G  PY +M+        +N   R   P DCP 
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDCPS 237

Query: 411 AMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           A+  L+ QCW     +RP F  IV +L++ 
Sbjct: 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  135 bits (341), Expect = 1e-36
 Identities = 76/245 (31%), Positives = 129/245 (52%), Gaps = 17/245 (6%)

Query: 198 GIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPP 255
           G Y+   VAVK I+      N+  A    + F  E +++++L + N+++ +     +K  
Sbjct: 25  GDYRGNKVAVKCIK------NDATA----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74

Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
           +Y ++TEY+++GSL  YL       L    L+  +LD+   MEY+ +   +HRDL   NV
Sbjct: 75  LY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNV 133

Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           L+ ++   K++DFG+  E          P   +W APE ++ K +  K DV+SFG++LWE
Sbjct: 134 LVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWE 191

Query: 376 MVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIV 434
           + + G +PY  + P++     V K  +   P  CPP +  +++QCW L    RP F  + 
Sbjct: 192 IYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLR 250

Query: 435 KVLEQ 439
           + LE 
Sbjct: 251 EQLEH 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  135 bits (342), Expect = 1e-36
 Identities = 68/235 (28%), Positives = 124/235 (52%), Gaps = 13/235 (5%)

Query: 203 EPVAVKIIRIPDDDE-NETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           E +AVK + +P     ++     +     RE+ALL  L + N+++++ +        +  
Sbjct: 26  ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL 85

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           EY+  GS+ A L+   +       +      I +G+ Y+H++G+IHRD+K  N+L+D + 
Sbjct: 86  EYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG 143

Query: 322 HLKIADFGIACEEVYCDALSDDPGTYR--------WMAPEMIKHKSYGRKVDVYSFGLIL 373
            +KI+DFGI+ +++  ++LS      R        WMAPE++K  SY RK D++S G ++
Sbjct: 144 GIKISDFGIS-KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLV 202

Query: 374 WEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
            EM+ G  P+ +   +QA F  + +N  P IP +        +E+ + +  +KRP
Sbjct: 203 VEMLTGKHPFPDCTQLQAIFK-IGENASPEIPSNISSEAIDFLEKTFEIDHNKRP 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  135 bits (342), Expect = 3e-36
 Identities = 82/254 (32%), Positives = 133/254 (52%), Gaps = 23/254 (9%)

Query: 197 HGIYKDEP---VAVKIIR-IPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAAC 251
           +G+ K +    VAVK+++      E E L +        E+ ++S L N  N++  + AC
Sbjct: 57  YGLSKSDAVMKVAVKMLKPTAHSSEREALMS--------ELKIMSHLGNHENIVNLLGAC 108

Query: 252 KKP-PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
               P+  VITEY   G L  +L +     L L  L++ +  +A+GM ++ S+  IHRDL
Sbjct: 109 TIGGPIL-VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDL 167

Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDV 366
              NVL+     +KI DFG+A  ++  D+     G  R    WMAPE I +  Y  + DV
Sbjct: 168 AARNVLLTHGKIVKICDFGLA-RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 226

Query: 367 YSFGLILWEMVA-GTIPYEEMNPIQAAF-AVVNKNLRPAIPGDCPPAMAALIEQCWSLQP 424
           +S+G++LWE+ + G+ PY  M P+ + F  ++ +  R A P   P  +  +++ CW   P
Sbjct: 227 WSYGILLWEIFSLGSNPYPGM-PVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADP 285

Query: 425 DKRPEFWHIVKVLE 438
            KRP F  IV+++ 
Sbjct: 286 LKRPTFKQIVQLIG 299

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  134 bits (338), Expect = 6e-36
 Identities = 76/252 (30%), Positives = 120/252 (47%), Gaps = 22/252 (8%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G   ++Y  +  D  E +AVK IRI D+D       +  K+   E+ +L  L +PN++K+
Sbjct: 11  GTFGKVYTAVNLDTGELMAVKEIRIQDNDP------KTIKEIADEMKVLELLKHPNLVKY 64

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
                      +  EY S G+L   L     + L    +    L +  G+ Y+HS G++H
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122

Query: 308 RDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALSDDPGTYRWMAPEMI---KHKS 359
           RD+KP N+ +D    +K+ DFG A +         + +    GT  +MAPE+I   K K 
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAIPG--DCPPAMAALI 416
           +GR  D++S G ++ EM  G  P+ E+ N  Q  F V   + +P IP      P     +
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQLSPEGKDFL 241

Query: 417 EQCWSLQPDKRP 428
           ++C    P KRP
Sbjct: 242 DRCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  133 bits (337), Expect = 7e-36
 Identities = 79/254 (31%), Positives = 129/254 (50%), Gaps = 32/254 (12%)

Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQ---FNREVALLSRLHNPNVIKFVAACKKPPVY 257
           ++ PVA+K ++          A   EKQ   F  E +++ +  +PN+I       K    
Sbjct: 31  REIPVAIKTLK----------AGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
            ++TEY+  GSL A+L K + +   + +L+ +   IA GM+Y+   G +HRDL   N+L+
Sbjct: 81  MIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV 139

Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP-GTY---------RWMAPEMIKHKSYGRKVDVY 367
           +     K++DFG++        L DDP   Y         RW APE I ++ +    DV+
Sbjct: 140 NSNLVCKVSDFGLS------RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVW 193

Query: 368 SFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
           S+G+++WE M  G  PY EM+  Q     + +  R   P DCP A+  L+  CW    ++
Sbjct: 194 SYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNE 252

Query: 427 RPEFWHIVKVLEQF 440
           RP+F  IV +L++ 
Sbjct: 253 RPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  133 bits (336), Expect = 8e-36
 Identities = 83/265 (31%), Positives = 133/265 (50%), Gaps = 37/265 (13%)

Query: 195 LYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248
           +YHG   D        AVK + RI D +E E        QF +E  ++    +PNV+  +
Sbjct: 11  VYHGTLIDSDGQKIHCAVKSLNRITDLEEVE--------QFLKEGIIMKDFSHPNVLSLL 62

Query: 249 AACKKP---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPK-LIAIALDIARGMEYIHSQG 304
             C      P+  V+  Y+  G LR ++    H   P  K LI   L +A+GMEY+ S+ 
Sbjct: 63  GICLPSEGSPL--VVLPYMKHGDLRNFIRSETHN--PTVKDLIGFGLQVAKGMEYLASKK 118

Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVY---CDALSDDPGT---YRWMAPEMIKHK 358
            +HRDL   N ++D+ F +K+ADFG+A  ++Y     ++ +  G     +WMA E ++ +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLA-RDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 359 SYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVN---KNLRPAIPGDCPPAMAA 414
            +  K DV+SFG++LWE M  G  PY +++     F +     +  R   P  CP  +  
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVYLLQGRRLLQPEYCPDPLYE 233

Query: 415 LIEQCWSLQPDKRPEFWHIVKVLEQ 439
           ++  CW  +P+ RP F  +V  +EQ
Sbjct: 234 VMLSCWHPKPEMRPTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  133 bits (336), Expect = 1e-35
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 30/254 (11%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+   +Y   +K   +  A+K I +  D+E         KQ  RE+  L    +P V+K
Sbjct: 11  QGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-------KQLLRELKTLRSCESPYVVK 63

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GV 305
              A  K     ++ EY+  GSL   L K     +P P L  IA  I +G++Y+H++  +
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKRHI 121

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIA--------CEEVYCDALSDDPGTYRWMAPEMIKH 357
           IHRD+KP N+LI+ +  +KIADFGI+            +        GT  +M+PE I+ 
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-------GTVTYMSPERIQG 174

Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPY---EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA 414
           +SY    D++S GL L E   G  P+    + +  +   A+ +         +  P    
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234

Query: 415 LIEQCWSLQPDKRP 428
            I  C    P KRP
Sbjct: 235 FISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 2e-35
 Identities = 73/246 (29%), Positives = 120/246 (48%), Gaps = 33/246 (13%)

Query: 196 YHGIYKD--EPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252
           Y  I K   + VA+K+I +   +DE E +         +E+  LS+  +P + K+  +  
Sbjct: 18  YKAIDKRTNQVVAIKVIDLEEAEDEIEDI--------QQEIQFLSQCRSPYITKYYGSFL 69

Query: 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP-KLIA-IALDIARGMEYIHSQGVIHRDL 310
           K     +I EY   GS    L     K   L    IA I  ++  G+EY+H +G IHRD+
Sbjct: 70  KGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDI 124

Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKSYGRK 363
           K  N+L+ +E  +K+ADFG++ +      L+          GT  WMAPE+IK   Y  K
Sbjct: 125 KAANILLSEEGDVKLADFGVSGQ------LTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK 178

Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC-PPAMAALIEQCWSL 422
            D++S G+   E+  G  P  +++P++  F ++ KN  P++ G+         +  C + 
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHPMRVLF-LIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237

Query: 423 QPDKRP 428
            P +RP
Sbjct: 238 DPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  132 bits (334), Expect = 2e-35
 Identities = 63/254 (24%), Positives = 124/254 (48%), Gaps = 27/254 (10%)

Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
            +  V VK ++   D+        L+ +F RE+ +  +L + NV++ +  C++   + +I
Sbjct: 34  GETLVLVKALQKTKDEN-------LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86

Query: 261 TEYLSEGSLRAYL-------HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
            EY   G L+ +L        KL+   L   + +A+   IA GM+++ +   +HRDL   
Sbjct: 87  LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAAR 146

Query: 314 NVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-------RWMAPEMIKHKSYGRKVDV 366
           N L+  +  +K++   +  ++VY    + +           RW+APE ++   +  K DV
Sbjct: 147 NCLVSSQREVKVSLLSL-SKDVY----NSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDV 201

Query: 367 YSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPD 425
           +SFG+++WE+   G +P+  ++  +    +    L   +P  CP  +  L+ +CW++ P 
Sbjct: 202 WSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPK 261

Query: 426 KRPEFWHIVKVLEQ 439
            RP F  +V  L +
Sbjct: 262 DRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  132 bits (334), Expect = 4e-35
 Identities = 88/262 (33%), Positives = 123/262 (46%), Gaps = 37/262 (14%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVKI+R PD ++N    AR    F +EV +LSRL +PN+I+ +  C      C+ITEY+
Sbjct: 49  VAVKILR-PDANKN----AR--NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYM 101

Query: 265 SEGSLRAYL--HKLEHKTLP---------------LPKLIAIALDIARGMEYIHSQGVIH 307
             G L  +L  H L+ K                     L+ +AL IA GM+Y+ S   +H
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG----TYRWMAPEMIKHKSYGRK 363
           RDL   N L+ +   +KIADFG++   +Y        G      RWMA E I    +   
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMS-RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220

Query: 364 VDVYSFGLILWE--MVAGTIPYEEMNPIQAA------FAVVNKNLRPAIPGDCPPAMAAL 415
            DV++FG+ LWE  M+    PY E+   Q        F    + +    P  CP  +  L
Sbjct: 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYEL 280

Query: 416 IEQCWSLQPDKRPEFWHIVKVL 437
           + QCWS    +RP F  I   L
Sbjct: 281 MLQCWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  132 bits (333), Expect = 4e-35
 Identities = 84/262 (32%), Positives = 133/262 (50%), Gaps = 36/262 (13%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVK+++   ++ + +    L  +FN    LL ++++P+VIK   AC +     +I EY 
Sbjct: 33  VAVKMLK---ENASSSELRDLLSEFN----LLKQVNHPHVIKLYGACSQDGPLLLIVEYA 85

Query: 265 SEGSLRAYLH---KLE-------------------HKTLPLPKLIAIALDIARGMEYIHS 302
             GSLR++L    K+                     + L +  LI+ A  I+RGM+Y+  
Sbjct: 86  KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE 145

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHK 358
             ++HRDL   NVL+ +   +KI+DFG++  +VY +      S      +WMA E +   
Sbjct: 146 MKLVHRDLAARNVLVAEGRKMKISDFGLS-RDVYEEDSYVKRSKGRIPVKWMAIESLFDH 204

Query: 359 SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIE 417
            Y  + DV+SFG++LWE+V  G  PY  + P +  F ++    R   P +C   M  L+ 
Sbjct: 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERLFNLLKTGYRMERPENCSEEMYNLML 263

Query: 418 QCWSLQPDKRPEFWHIVKVLEQ 439
            CW  +PDKRP F  I K LE+
Sbjct: 264 TCWKQEPDKRPTFADISKELEK 285

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  132 bits (332), Expect = 5e-35
 Identities = 71/225 (31%), Positives = 116/225 (51%), Gaps = 20/225 (8%)

Query: 228 QFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL-HKLEHK------- 279
           +F +E +L++ LH+PN++  +    +    C++ EYL++G L  +L  +  H        
Sbjct: 53  EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112

Query: 280 -------TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332
                  +L     + IA+ IA GMEY+ S   +H+DL   N+LI ++ H+KI+D G++ 
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Query: 333 EEVYCDALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388
           E    D     P +    RWM PE I +  +    D++SFG++LWE+ + G  PY   + 
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232

Query: 389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
            +    V  + L P    DCPP M +L+ +CW   P +RP F  I
Sbjct: 233 QEVIEMVRKRQLLPC-SEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  131 bits (330), Expect = 5e-35
 Identities = 80/264 (30%), Positives = 132/264 (50%), Gaps = 15/264 (5%)

Query: 181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
           L L ++   G    ++ G +     VA+K ++             + + F +E  ++ +L
Sbjct: 8   LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP---------GTMMPEAFLQEAQIMKKL 58

Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
            +  ++   A   + P+Y ++TE++ +GSL  +L + + K L LP+L+ +A  IA GM Y
Sbjct: 59  RHDKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWMAPEMIKH 357
           I     IHRDL+  N+L+      KIADFG+A   E+    A        +W APE   +
Sbjct: 118 IERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177

Query: 358 KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
             +  K DV+SFG++L E+V  G +PY  M   +     V +  R   P  CP ++  L+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVERGYRMPCPQGCPESLHELM 236

Query: 417 EQCWSLQPDKRPEFWHIVKVLEQF 440
           + CW   PD+RP F +I   LE +
Sbjct: 237 KLCWKKDPDERPTFEYIQSFLEDY 260

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  131 bits (332), Expect = 6e-35
 Identities = 72/265 (27%), Positives = 121/265 (45%), Gaps = 35/265 (13%)

Query: 189 HGAHSRLYHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245
            G+ S +     K+     A+KI+     D+ + +  +  K    E  +L+RL  +P +I
Sbjct: 11  EGSFSTVVLAKEKETNKEYAIKIL-----DKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65

Query: 246 KFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           K     +    +Y V+ EY   G L  Y+ K  + +L        A +I   +EY+HS+G
Sbjct: 66  KLYYTFQDEENLYFVL-EYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIAC-----------EEVYCDALSDDP--------- 344
           +IHRDLKPEN+L+D++ H+KI DFG A            +    +  S            
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 345 -GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
            GT  +++PE++  K  G+  D+++ G I+++M+ G  P+   N       ++       
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS-- 240

Query: 404 IPGDCPPAMAALIEQCWSLQPDKRP 428
            P + PP    LIE+   L P  R 
Sbjct: 241 FPPNFPPDAKDLIEKLLVLDPQDRL 265

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  130 bits (329), Expect = 8e-35
 Identities = 78/215 (36%), Positives = 118/215 (54%), Gaps = 5/215 (2%)

Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  E  ++  L +  ++K  A   K P+Y +ITE++++GSL  +L   E    PLPKLI 
Sbjct: 48  FLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLID 106

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
            +  IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A       
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 166

Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE I   S+  K DV+SFG++L E+V  G IPY  M+  +   A + +  R   P
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRP 225

Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            +CP  +  ++ +CW  +P++RP F +I  VL+ F
Sbjct: 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  130 bits (330), Expect = 1e-34
 Identities = 75/268 (27%), Positives = 128/268 (47%), Gaps = 34/268 (12%)

Query: 190 GAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           GA   +Y G++  E      PVA+K++R       E  + +  K+   E  +++ + +P+
Sbjct: 18  GAFGTVYKGVWIPEGEKVKIPVAIKVLR-------EETSPKANKEILDEAYVMASVDHPH 70

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHS 302
           V++ +  C    V  +IT+ +  G L  Y+    HK  +    L+   + IA+GM Y+  
Sbjct: 71  VVRLLGICLSSQV-QLITQLMPLGCLLDYVR--NHKDNIGSQYLLNWCVQIAKGMSYLEE 127

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPE 353
           + ++HRDL   NVL+    H+KI DFG+A        L  D   Y         +WMA E
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLA------KLLDVDEKEYHAEGGKVPIKWMALE 181

Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            I H+ Y  K DV+S+G+ +WE M  G  PYE +  ++    ++ K  R   P  C   +
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-DLLEKGERLPQPPICTIDV 240

Query: 413 AALIEQCWSLQPDKRPEFWHIVKVLEQF 440
             ++ +CW +  + RP F  ++    + 
Sbjct: 241 YMVLVKCWMIDAESRPTFKELINEFSKM 268

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  131 bits (331), Expect = 2e-34
 Identities = 94/294 (31%), Positives = 155/294 (52%), Gaps = 41/294 (13%)

Query: 198 GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC 251
           GI KD+P     VAVK+++  DD  ++ L+  +      E+ ++  +  + N+I  + AC
Sbjct: 35  GIDKDKPNKPVTVAVKMLK--DDATDKDLSDLVS-----EMEMMKMIGKHKNIINLLGAC 87

Query: 252 KKP-PVYCVITEYLSEGSLRAYLH--------------KLEHKTLPLPKLIAIALDIARG 296
            +  P+Y V+ EY S+G+LR YL               KL  + L    L++ A  +ARG
Sbjct: 88  TQDGPLY-VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARG 146

Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV----YCDALSDDPGTYRWMAP 352
           MEY+ SQ  IHRDL   NVL+ ++  +KIADFG+A  +V    Y    ++     +WMAP
Sbjct: 147 MEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA-RDVHNIDYYKKTTNGRLPVKWMAP 205

Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
           E +  + Y  + DV+SFG++LWE+   G  PY  + P++  F ++ +  R   P +C   
Sbjct: 206 EALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPANCTHE 264

Query: 412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLV-----QNPICQD 460
           +  ++ +CW   P +RP F  +V+ L++  T  + +  L+L       +P C D
Sbjct: 265 LYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSPGCPD 318

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  129 bits (325), Expect = 3e-34
 Identities = 73/251 (29%), Positives = 110/251 (43%), Gaps = 37/251 (14%)

Query: 204 PVAVKIIR------IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
           PVAVK ++      I DD             F +E A++  L + N+I+        P+ 
Sbjct: 25  PVAVKCLKSDKLSDIMDD-------------FLKEAAIMHSLDHENLIRLYGVVLTHPLM 71

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
            V TE    GSL   L K       +  L   A+ IA GM Y+ S+  IHRDL   N+L+
Sbjct: 72  MV-TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL 130

Query: 318 DQEFHLKIADFGIACEEVYCDALSDDPGTYR----------WMAPEMIKHKSYGRKVDVY 367
             +  +KI DFG+        AL  +   Y           W APE ++ +++    DV+
Sbjct: 131 ASDDKVKIGDFGLM------RALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVW 184

Query: 368 SFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
            FG+ LWEM   G  P+  ++  Q    +  +  R   P  CP  +  ++ QCW+  P  
Sbjct: 185 MFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPAD 244

Query: 427 RPEFWHIVKVL 437
           RP F  + + L
Sbjct: 245 RPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  129 bits (326), Expect = 3e-34
 Identities = 69/261 (26%), Positives = 119/261 (45%), Gaps = 36/261 (13%)

Query: 196 YHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250
           Y G+Y         VAVK  +              EK F +E  ++ +  +P+++K +  
Sbjct: 23  YQGVYMSPENEKIAVAVKTCKNCTSPSVR------EK-FLQEAYIMRQFDHPHIVKLIGV 75

Query: 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
             + PV+ ++ E    G LR+YL      +L L  LI  +  ++  + Y+ S+  +HRD+
Sbjct: 76  ITENPVW-IVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESKRFVHRDI 133

Query: 311 KPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
              NVL+     +K+ DFG    +  E  Y  +    P   +WMAPE I  + +    DV
Sbjct: 134 AARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IKWMAPESINFRRFTSASDV 191

Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL--------RPAIPGDCPPAMAALIEQ 418
           + FG+ +WE++        M  ++    V N ++        R  +P +CPP + +L+ +
Sbjct: 192 WMFGVCMWEIL--------MLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 243

Query: 419 CWSLQPDKRPEFWHIVKVLEQ 439
           CW+  P KRP F  +   L  
Sbjct: 244 CWAYDPSKRPRFTELKAQLSD 264

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  129 bits (325), Expect = 8e-34
 Identities = 85/273 (31%), Positives = 145/273 (53%), Gaps = 32/273 (11%)

Query: 197 HGIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251
           +GI K  P     VAVK+++  D+  ++ LA  + +    E+  L   H  N+I  +  C
Sbjct: 34  YGIDKSRPDQTVTVAVKMLK--DNATDKDLADLISEM---ELMKLIGKHK-NIINLLGVC 87

Query: 252 KKP-PVYCVITEYLSEGSLRAYLH--------------KLEHKTLPLPKLIAIALDIARG 296
            +  P+Y VI EY ++G+LR +L               K+  + L    L++ A  +ARG
Sbjct: 88  TQEGPLY-VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARG 146

Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEV-YCDALSDDPGTYRWMAPE 353
           MEY+ S+  IHRDL   NVL+ ++  +KIADFG+A    ++ Y    S+     +WMAPE
Sbjct: 147 MEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE 206

Query: 354 MIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            +  + Y  + DV+SFG+++WE+   G  PY  + P++  F ++ +  R   P +C   +
Sbjct: 207 ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLLREGHRMDKPSNCTHEL 265

Query: 413 AALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
             L+ +CW   P +RP F  +V+ L++   +++
Sbjct: 266 YMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  127 bits (322), Expect = 1e-33
 Identities = 74/265 (27%), Positives = 122/265 (46%), Gaps = 30/265 (11%)

Query: 195 LYHGIYKDEP--VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252
            YH   +++   VAVK ++    ++         K F RE  LL+   + N++KF   C 
Sbjct: 26  CYHLEPENDKELVAVKTLKETASND-------ARKDFEREAELLTNFQHENIVKFYGVCT 78

Query: 253 KPPVYCVITEYLSEGSLRAYLH------------KLEHKTLPLPKLIAIALDIARGMEYI 300
           +     ++ EY+  G L  +L                   L L +L+ IA+ IA GM Y+
Sbjct: 79  EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL 138

Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALSDDPGTY---RWMAPEMIK 356
            SQ  +HRDL   N L+  +  +KI DFG++  +VY  D       T    RWM PE I 
Sbjct: 139 ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS-RDVYTTDYYRVGGHTMLPIRWMPPESIM 197

Query: 357 HKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKN-LRPAIPGDCPPAMAA 414
           ++ +  + DV+SFG++LWE+   G  P+  ++  +    +     L+   P  CP  +  
Sbjct: 198 YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR--PRTCPSEVYD 255

Query: 415 LIEQCWSLQPDKRPEFWHIVKVLEQ 439
           ++  CW   P +R     I + L++
Sbjct: 256 IMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  127 bits (321), Expect = 1e-33
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 17/231 (7%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           +AVK IR+  ++        ++KQ  RE+ +L + ++P ++ F  A        +  EY+
Sbjct: 29  MAVKTIRLEINEA-------IQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81

Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHL 323
             GSL   L K     +P   L  IA+ + +G+ Y+H +  +IHRD+KP N+L++    +
Sbjct: 82  DGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQI 140

Query: 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           K+ DFG++ + V   A     GT  +MAPE I+   Y  K D++S GL L E+  G  PY
Sbjct: 141 KLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Query: 384 -----EEMNPIQAAFAVVNKNLRPAIPGDC-PPAMAALIEQCWSLQPDKRP 428
                      +    +VN+   P +P     P     +  C    P +RP
Sbjct: 200 PPENDPPDGIFELLQYIVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERP 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  126 bits (318), Expect = 2e-33
 Identities = 70/239 (29%), Positives = 126/239 (52%), Gaps = 18/239 (7%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEY 263
           VA+K+I+     E+E         F  E  ++ +L +  +++    C K+ P+Y ++TEY
Sbjct: 31  VAIKMIKEGSMSEDE---------FIEEAKVMMKLSHEKLVQLYGVCTKQRPIY-IVTEY 80

Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
           +S G L  YL +   +  P  +L+ +  D+  GM Y+ S+  IHRDL   N L+D +  +
Sbjct: 81  MSNGCLLNYLREHGKRFQPS-QLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCV 139

Query: 324 KIADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-G 379
           K++DFG++   V  D  +   G+    RW  PE++ +  +  K DV++FG+++WE+ + G
Sbjct: 140 KVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198

Query: 380 TIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
            +PYE  N  +    V  + LR   P      + A++  CW  + ++RP F  ++  +E
Sbjct: 199 KMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  126 bits (319), Expect = 3e-33
 Identities = 85/282 (30%), Positives = 132/282 (46%), Gaps = 38/282 (13%)

Query: 181 LFLGLRFAHGAHSRLYHGIYKDE--------PVAVKIIRIPDDDENETLAARLEKQFNRE 232
            FLG     GA   +Y G   D          VAVK +R    D+ +       K+F +E
Sbjct: 1   NFLG----SGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-------KEFLKE 49

Query: 233 VALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP-----KL 286
             L+S  ++PN++K +  C    P Y +I E +  G L +YL     +    P     +L
Sbjct: 50  AHLMSNFNHPNIVKLLGVCLLNEPQY-IIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108

Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-----LKIADFGIACEEVYCDALS 341
           + I LD+A+G  Y+     IHRDL   N L+ ++ +     +KI DFG+A  ++Y     
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA-RDIYKSDYY 167

Query: 342 DDPG----TYRWMAPEMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVV 396
              G      RWMAPE +    +  + DV+SFG+++WE +  G  PY  +N  +     V
Sbjct: 168 RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHV 226

Query: 397 NKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
               R   P +CP  +  L+  CW+  P +RP F  I ++L+
Sbjct: 227 TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (324), Expect = 4e-33
 Identities = 65/247 (26%), Positives = 121/247 (48%), Gaps = 22/247 (8%)

Query: 189 HGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKF 247
            G+   +Y    + + VA+K++    + +++       ++F RE+ +L+ L H PN++K 
Sbjct: 10  EGSFGEVYLARDR-KLVALKVLAKKLESKSK-----EVERFLREIQILASLNHPPNIVKL 63

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
               +      ++ EY+  GSL   L K+     L   + + I   I   +EY+HS+G+I
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGII 123

Query: 307 HRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHK 358
           HRD+KPEN+L+D++   +K+ DFG+A       + S  P       GT  +MAPE++   
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183

Query: 359 S---YGRKVDVYSFGLILWEMVAGTIPYE---EMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
           S        D++S G+ L+E++ G  P+E     +       ++ +   P++     P+ 
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSN 243

Query: 413 AALIEQC 419
             LI + 
Sbjct: 244 PELISKA 250

Length = 384

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  125 bits (315), Expect = 6e-33
 Identities = 71/217 (32%), Positives = 118/217 (54%), Gaps = 5/217 (2%)

Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 48  FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 106

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166

Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 225

Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            +CP ++  L+ QCW  +P++RP F ++   LE + T
Sbjct: 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  126 bits (318), Expect = 7e-33
 Identities = 85/269 (31%), Positives = 136/269 (50%), Gaps = 32/269 (11%)

Query: 198 GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252
           GI KD+P     VAVK+++   DD  E   + L  +   E+  +   H  N+I  + AC 
Sbjct: 38  GIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM--EMMKMIGKHK-NIINLLGACT 91

Query: 253 KPPVYCVITEYLSEGSLRAYLH--------------KLEHKTLPLPKLIAIALDIARGME 298
           +     VI EY S+G+LR YL               ++  + +    L++    +ARGME
Sbjct: 92  QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGME 151

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV----YCDALSDDPGTYRWMAPEM 354
           Y+ SQ  IHRDL   NVL+ +   +KIADFG+A  +V    Y    ++     +WMAPE 
Sbjct: 152 YLASQKCIHRDLAARNVLVTENNVMKIADFGLA-RDVNNIDYYKKTTNGRLPVKWMAPEA 210

Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           +  + Y  + DV+SFG+++WE+   G  PY  + P++  F ++ +  R   P +C   + 
Sbjct: 211 LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPANCTNELY 269

Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            ++  CW   P  RP F  +V+ L++  T
Sbjct: 270 MMMRDCWHAIPSHRPTFKQLVEDLDRILT 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  125 bits (316), Expect = 9e-33
 Identities = 73/241 (30%), Positives = 113/241 (46%), Gaps = 34/241 (14%)

Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C         ++ EYL  GSLR YL K   + L   
Sbjct: 50  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER-LDHR 108

Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           KL+  A  I +GMEY+ S+  +HRDL   N+L++ E  +KI DFG+         L  D 
Sbjct: 109 KLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT------KVLPQDK 162

Query: 345 GTYR----------WMAPEMIKHKSYGRKVDVYSFGLILWEM-----VAGTIPYEEM--- 386
             Y+          W APE +    +    DV+SFG++L+E+      + + P E M   
Sbjct: 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMM 222

Query: 387 -NPIQAAFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            N  Q    V      +  N R   P  CP  + A++++CW+  P +RP F  +   +E 
Sbjct: 223 GNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282

Query: 440 F 440
            
Sbjct: 283 I 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  125 bits (315), Expect = 9e-33
 Identities = 76/256 (29%), Positives = 124/256 (48%), Gaps = 35/256 (13%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC------KKPPVYC 258
           VAVK +++     +E       ++F  E A +    +PNV+K +  C      +K P   
Sbjct: 30  VAVKTMKLDIHTYSEI------EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83

Query: 259 VITEYLSEGSLRAYL--HKLEH--KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
           VI  ++  G L ++L   +L    + LPL  L+   +DIA GMEY+ ++  IHRDL   N
Sbjct: 84  VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARN 143

Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----------WMAPEMIKHKSYGRKV 364
            ++ ++  + +ADFG++ +++Y    S D   YR          W+A E +  + Y  K 
Sbjct: 144 CMLREDMTVCVADFGLS-KKIY----SGD--YYRQGRIAKMPVKWIAIESLADRVYTSKS 196

Query: 365 DVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQ 423
           DV++FG+ +WE    G  PY  +   +    + + N R   P DC   +  L+  CW   
Sbjct: 197 DVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQPEDCLDELYDLMYSCWRAD 255

Query: 424 PDKRPEFWHIVKVLEQ 439
           P  RP F  + +VLE 
Sbjct: 256 PKDRPTFTKLREVLEN 271

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  125 bits (314), Expect = 9e-33
 Identities = 70/242 (28%), Positives = 124/242 (51%), Gaps = 19/242 (7%)

Query: 198 GIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253
           G+YK    ++ VAVKI++  ++D        L+ +  RE  ++ +L NP +++ +  C+ 
Sbjct: 14  GMYKMKKSEKTVAVKILKNDNNDPA------LKDELLREANVMQQLDNPYIVRMIGICEA 67

Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
              + ++ E    G L  +L K +H T     +  +   ++ GM+Y+     +HRDL   
Sbjct: 68  ES-WMLVMELAELGPLNKFLQKNKHVTEK--NITELVHQVSMGMKYLEETNFVHRDLAAR 124

Query: 314 NVLIDQEFHLKIADFGIA----CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
           NVL+  + + KI+DFG++     +E Y  A +      +W APE + +  +  K DV+SF
Sbjct: 125 NVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSF 184

Query: 370 GLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
           G+++WE  + G  PY+ M   +    ++    R   P  CPP M  L++ CW+   D+RP
Sbjct: 185 GVLMWEAFSYGQKPYKGMKGNEVT-QMIESGERMECPQRCPPEMYDLMKLCWTYGVDERP 243

Query: 429 EF 430
            F
Sbjct: 244 GF 245

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  125 bits (315), Expect = 1e-32
 Identities = 79/258 (30%), Positives = 122/258 (47%), Gaps = 30/258 (11%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--PVYCVI 260
           E VAVK ++     +N +        + +E+ +L  L++ N++K+   C +       +I
Sbjct: 34  EMVAVKTLKRECGQQNTS-------GWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY+  GSLR YL K  HK L L +L+  A  I  GM Y+HSQ  IHRDL   NVL+D +
Sbjct: 87  MEYVPLGSLRDYLPK--HK-LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND 143

Query: 321 FHLKIADFGIACE----EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
             +KI DFG+A        Y     D      W A E +K   +    DV+SFG+ L+E+
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203

Query: 377 VAGTIPY--------EEMNPIQAAFAVV------NKNLRPAIPGDCPPAMAALIEQCWSL 422
           +              E + P Q    VV       + +R   P +CP  +  L++ CW  
Sbjct: 204 LTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWET 263

Query: 423 QPDKRPEFWHIVKVLEQF 440
           +   RP F  ++ +L++ 
Sbjct: 264 EAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  124 bits (313), Expect = 1e-32
 Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 17/260 (6%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIY-KDEPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
           +  S+L L      G    ++ G + +   VA+K IR           A  E+ F  E  
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR---------EGAMSEEDFIEEAQ 51

Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
           ++ +L +P +++    C +    C++ E++  G L  YL + +        L+ + LD+ 
Sbjct: 52  VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVC 110

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWMA 351
            GM Y+ S  VIHRDL   N L+ +   +K++DFG+    V  D  +   GT    +W +
Sbjct: 111 EGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT-RFVLDDQYTSSTGTKFPVKWSS 169

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
           PE+     Y  K DV+SFG+++WE+ + G  PYE  +  +     +N   R   P     
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV-ETINAGFRLYKPRLASQ 228

Query: 411 AMAALIEQCWSLQPDKRPEF 430
           ++  L++ CW  +P+ RP F
Sbjct: 229 SVYELMQHCWKERPEDRPSF 248

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  125 bits (314), Expect = 1e-32
 Identities = 75/258 (29%), Positives = 126/258 (48%), Gaps = 25/258 (9%)

Query: 198 GIYKDEP---VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254
           G+ KDEP   VA+K +       NE  + R   +F  E +++   +  +V++ +    + 
Sbjct: 29  GVVKDEPETRVAIKTV-------NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81

Query: 255 PVYCVITEYLSEGSLRAYLHKLEHKTL--------PLPKLIAIALDIARGMEYIHSQGVI 306
               VI E ++ G L++YL  L  +           L K+I +A +IA GM Y+++   +
Sbjct: 82  QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFV 141

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGR 362
           HRDL   N ++ ++F +KI DFG+   ++Y        G      RWM+PE +K   +  
Sbjct: 142 HRDLAARNCMVAEDFTVKIGDFGMT-RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT 200

Query: 363 KVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS 421
             DV+SFG++LWE+      PY+ M+  Q    V+   L    P +CP  +  L+  CW 
Sbjct: 201 YSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQ 259

Query: 422 LQPDKRPEFWHIVKVLEQ 439
             P  RP F  I+  +++
Sbjct: 260 YNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  123 bits (309), Expect = 5e-32
 Identities = 71/265 (26%), Positives = 128/265 (48%), Gaps = 24/265 (9%)

Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
           F      RL     ++  VA+K ++    +       +  + F  E +++ +  +PN+I 
Sbjct: 17  FGEVCRGRLKLPGKREIFVAIKTLKSGYTE-------KQRRDFLSEASIMGQFDHPNIIH 69

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                 K     +ITE++  G+L ++L +       + +L+ +   IA GM+Y+     +
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIK 356
           HRDL   N+L++     K++DFG++    + +  + DP TY          RW APE I 
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLS---RFLEDDTSDP-TYTSSLGGKIPIRWTAPEAIA 184

Query: 357 HKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           ++ +    DV+S+G+++WE M  G  PY +M+  Q     + ++ R   P DCP A+  L
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPTALHQL 243

Query: 416 IEQCWSLQPDKRPEFWHIVKVLEQF 440
           +  CW    + RP+F  IV  L++ 
Sbjct: 244 MLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  121 bits (304), Expect = 6e-31
 Identities = 81/247 (32%), Positives = 123/247 (49%), Gaps = 21/247 (8%)

Query: 227 KQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK---------- 275
           + F  E+ +L +L H+PN+I  + AC+      +  EY   G+L  +L K          
Sbjct: 47  RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAF 106

Query: 276 -LEH---KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
             EH    TL   +L+  A D+A GM+Y+  +  IHRDL   NVL+ +    KIADFG++
Sbjct: 107 AKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS 166

Query: 332 -CEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388
             EEVY    +   P   RWMA E + +  Y  K DV+SFG++LWE+V+ G  PY  M  
Sbjct: 167 RGEEVYVKKTMGRLP--VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224

Query: 389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNG 448
            +  +  + +  R   P +C   +  L+ QCW  +P +RP F  I   L +   +     
Sbjct: 225 AE-LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283

Query: 449 TLNLVQN 455
            + L +N
Sbjct: 284 NMALFEN 290

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  120 bits (301), Expect = 9e-31
 Identities = 78/251 (31%), Positives = 126/251 (50%), Gaps = 27/251 (10%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA------ACKKPPVYC 258
           VAVK+++       +  ++   ++F RE A +    +PNVIK +       A  + P+  
Sbjct: 30  VAVKMLK------ADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83

Query: 259 VITEYLSEGSLRAYL--HKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
           VI  ++  G L  +L   ++  E  TLPL  L+   +DIA GMEY+ S+  IHRDL   N
Sbjct: 84  VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARN 143

Query: 315 VLIDQEFHLKIADFGIACEEVYC------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
            ++++   + +ADFG++ +++Y          S  P   +W+A E +    Y    DV++
Sbjct: 144 CMLNENMTVCVADFGLS-KKIYSGDYYRQGCASKLP--VKWLALESLADNVYTTHSDVWA 200

Query: 369 FGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           FG+ +WE M  G  PY  +   +    ++  N R   P DC   +  L+ QCWS +P  R
Sbjct: 201 FGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCR 259

Query: 428 PEFWHIVKVLE 438
           P F H+   LE
Sbjct: 260 PSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  119 bits (300), Expect = 1e-30
 Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 29/270 (10%)

Query: 177 DLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPD-DDENETLAARLEKQFNRE 232
           D  +LF  L +   G+   ++ GI     + VA+KII + + +DE E +         +E
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI--------QQE 52

Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           + +LS+  +P V K+  +  K     +I EYL  GS    L  LE   L   ++  I  +
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILRE 109

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------G 345
           I +G++Y+HS+  IHRD+K  NVL+ +   +K+ADFG+A +      L+D         G
Sbjct: 110 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ------LTDTQIKRNTFVG 163

Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
           T  WMAPE+IK  +Y  K D++S G+   E+  G  P+ E++P++  F ++ KN  P + 
Sbjct: 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF-LIPKNNPPTLE 222

Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           G+    +   +E C + +P  RP    ++K
Sbjct: 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  119 bits (299), Expect = 1e-30
 Identities = 70/232 (30%), Positives = 121/232 (52%), Gaps = 11/232 (4%)

Query: 207 VKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE 266
           +K I + + + NET+ A  E Q      LLS+L +P ++KF A+  +   +C+ITEY   
Sbjct: 33  LKEIPVGELNPNETVQANQEAQ------LLSKLDHPAIVKFHASFLERDAFCIITEYCEG 86

Query: 267 GSLRAYLHKLEH--KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
             L   L +L+H  KTL   ++    + +  G+ Y+H + ++HRDLK +N+ +     LK
Sbjct: 87  RDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LK 145

Query: 325 IADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           I DFG++   +  CD  +   GT  +M+PE +KH+ Y  K D++S G IL+EM      +
Sbjct: 146 IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF 205

Query: 384 EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           E  N +     +V     P++P      + ++++   +  P  RP    I++
Sbjct: 206 EGQNFLSVVLRIVEGP-TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  120 bits (301), Expect = 1e-30
 Identities = 73/216 (33%), Positives = 117/216 (54%), Gaps = 21/216 (9%)

Query: 243 NVIKFVAACKKP-PVYCVITEYLSEGSLRAYLHK-----LEH---------KTLPLPKLI 287
           N+I  + AC +  P+Y VI EY S+G+LR YL       +E+         + L    L+
Sbjct: 85  NIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG-- 345
           + A  +ARGMEY+ S+  IHRDL   NVL+ ++  +KIADFG+A +  + D         
Sbjct: 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203

Query: 346 -TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA 403
              +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  + P++  F ++ +  R  
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMD 262

Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            P +C   +  ++  CW   P +RP F  +V+ L++
Sbjct: 263 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  118 bits (297), Expect = 3e-30
 Identities = 83/270 (30%), Positives = 136/270 (50%), Gaps = 29/270 (10%)

Query: 177 DLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPD-DDENETLAARLEKQFNRE 232
           D  +LF  L R   G+   +Y GI     E VA+KII + + +DE E +         +E
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDI--------QQE 52

Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           + +LS+  +P + ++  +  K     +I EYL  GS    L  L+   L    +  I  +
Sbjct: 53  ITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILRE 109

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------G 345
           I +G++Y+HS+  IHRD+K  NVL+ ++  +K+ADFG+A +      L+D         G
Sbjct: 110 ILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQ------LTDTQIKRNTFVG 163

Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
           T  WMAPE+IK  +Y  K D++S G+   E+  G  P  +++P++  F ++ KN  P + 
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-LIPKNSPPTLE 222

Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           G         +E C +  P  RP    ++K
Sbjct: 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  119 bits (299), Expect = 3e-30
 Identities = 76/238 (31%), Positives = 125/238 (52%), Gaps = 25/238 (10%)

Query: 227 KQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK---------- 275
           + F  E+ +L +L H+PN+I  + AC+      +  EY   G+L  +L K          
Sbjct: 52  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 111

Query: 276 -LEHKT---LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
            + + T   L   +L+  A D+ARGM+Y+  +  IHRDL   N+L+ + +  KIADFG++
Sbjct: 112 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171

Query: 332 -CEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388
             +EVY    +   P   RWMA E + +  Y    DV+S+G++LWE+V+ G  PY  M  
Sbjct: 172 RGQEVYVKKTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229

Query: 389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIV----KVLEQFET 442
            +  +  + +  R   P +C   +  L+ QCW  +P +RP F  I+    ++LE+ +T
Sbjct: 230 AE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  118 bits (298), Expect = 3e-30
 Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 29/273 (10%)

Query: 187 FAHGAHSRLYHGIYKD----EP---VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
              G+   +Y G  +D    E    VAVK +       NE+ + R   +F  E +++   
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------NESASLRERIEFLNEASVMKGF 66

Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-----LPLPKL---IAIAL 291
              +V++ +    K     V+ E ++ G L++YL  L  +       P P L   I +A 
Sbjct: 67  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----Y 347
           +IA GM Y++++  +HRDL   N ++  +F +KI DFG+   ++Y        G      
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT-RDIYETDYYRKGGKGLLPV 185

Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
           RWMAPE +K   +    D++SFG++LWE+ +    PY+ ++  Q    V++       P 
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PD 244

Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
           +CP  +  L+  CW   P  RP F  IV +L+ 
Sbjct: 245 NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score =  117 bits (294), Expect = 5e-30
 Identities = 67/242 (27%), Positives = 125/242 (51%), Gaps = 19/242 (7%)

Query: 198 GIYKDEP----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253
           G+YK       VA+K+++    +ENE     +  +  RE  ++ +L NP +++ +  C+ 
Sbjct: 14  GVYKMRKKQIDVAIKVLK----NENEK---SVRDEMMREAEIMHQLDNPYIVRMIGVCEA 66

Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
             +  V+ E  S G L  +L   +   + +  ++ +   ++ GM+Y+  +  +HRDL   
Sbjct: 67  EALMLVM-EMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAAR 124

Query: 314 NVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
           NVL+  + + KI+DFG    +  ++ Y  A S      +W APE I  + +  + DV+S+
Sbjct: 125 NVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSY 184

Query: 370 GLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
           G+ +WE  + G  PY++M   +   + + +  R   P +CPP M AL++ CW  + + RP
Sbjct: 185 GITMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRP 243

Query: 429 EF 430
            F
Sbjct: 244 NF 245

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  117 bits (294), Expect = 7e-30
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 11/202 (5%)

Query: 231 REVALLSRLHNPNVIKFVAA-CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            E  +L  L++P ++    +   +  +Y V  + L  G LR +L +    +    K    
Sbjct: 49  NERRILQELNHPFLVNLWYSFQDEENMYLV-VDLLLGGDLRYHLSQKVKFSEEQVKFWIC 107

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
             +I   +EY+HS+G+IHRD+KP+N+L+D++ H+ I DF IA +       +   GT  +
Sbjct: 108 --EIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGY 165

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE----EMNPIQAAFAVVNKNLRPAIP 405
           MAPE++  + Y   VD +S G+  +E + G  PY      +     A       L P   
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP--A 223

Query: 406 GDCPPAMAALIEQCWSLQPDKR 427
                     I +     P KR
Sbjct: 224 TW-STEAIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  118 bits (296), Expect = 7e-30
 Identities = 80/263 (30%), Positives = 126/263 (47%), Gaps = 43/263 (16%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVK++R  D ++N    AR    F +E+ ++SRL +PN+I+ +A C      C+ITEY+
Sbjct: 49  VAVKMLR-EDANKN----AR--NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYM 101

Query: 265 SEGSLRAYLHKLEHK---------TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
             G L  +L + E +         T+    LI +A  IA GM+Y+ S   +HRDL   N 
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161

Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTY-----------RWMAPEMIKHKSYGRKV 364
           L+ + + +KIADFG++   +Y        G Y           RWM+ E I    +    
Sbjct: 162 LVGKNYTIKIADFGMS-RNLY-------SGDYYRIQGRAVLPIRWMSWESILLGKFTTAS 213

Query: 365 DVYSFGLILWEMVA--GTIPYEEMNPIQAA------FAVVNKNLRPAIPGDCPPAMAALI 416
           DV++FG+ LWE++      PY +++  Q        F    + +    P  CP ++  L+
Sbjct: 214 DVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLM 273

Query: 417 EQCWSLQPDKRPEFWHIVKVLEQ 439
             CW     +RP F  I   L +
Sbjct: 274 LSCWRRNAKERPSFQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 7e-30
 Identities = 62/190 (32%), Positives = 100/190 (52%), Gaps = 26/190 (13%)

Query: 201 KDEPVAVKIIRIPDDDEN---ETLAARLEKQFNREVALLSRLHNPNVIKFV-AACKKPPV 256
             E VA+K IR+ +++E      L         RE++LL  L +PN++K +     +  +
Sbjct: 23  TGEIVALKKIRLDNEEEGIPSTAL---------REISLLKELKHPNIVKLLDVIHTERKL 73

Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
           Y ++ EY  +  L+ YL K     L    + +I   + RG+ Y HS  ++HRDLKP+N+L
Sbjct: 74  Y-LVFEYC-DMDLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNIL 130

Query: 317 IDQEFHLKIADFGIACEEVYC---DALSDDPGT--YRWMAPEMI-KHKSYGRKVDVYSFG 370
           I+++  LK+ADFG+A    +       + +  T  YR  APE++   K Y   VD++S G
Sbjct: 131 INRDGVLKLADFGLA--RAFGIPLRTYTHEVVTLWYR--APEILLGSKHYSTAVDIWSVG 186

Query: 371 LILWEMVAGT 380
            I  EM+ G 
Sbjct: 187 CIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  117 bits (296), Expect = 7e-30
 Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 29/198 (14%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-VYCVIT 261
           +  A+KI+      + + +  +  +    E  +L  + +P ++    + +    +Y V+ 
Sbjct: 27  KYYALKIL-----SKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM- 80

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
           EY+  G L ++L K      P+ +     + +AL      EY+HS  +++RDLKPEN+L+
Sbjct: 81  EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL------EYLHSLDIVYRDLKPENLLL 134

Query: 318 DQEFHLKIADFGIACEEVY-----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
           D + ++KI DFG A          C       GT  ++APE+I  K YG+ VD ++ G++
Sbjct: 135 DSDGYIKITDFGFAKRVKGRTYTLC-------GTPEYLAPEIILSKGYGKAVDWWALGIL 187

Query: 373 LWEMVAGTIPYEEMNPIQ 390
           ++EM+AG  P+ + NPIQ
Sbjct: 188 IYEMLAGYPPFFDDNPIQ 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 9e-30
 Identities = 63/245 (25%), Positives = 110/245 (44%), Gaps = 11/245 (4%)

Query: 190 GAHSRLY--HGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           GA  R+Y  + +     +AVK  ++P D ++      +      E+ LL  L +  ++++
Sbjct: 13  GAFGRVYLCYDVDTGRELAVK--QVPFDPDSPETKKEV-NALECEIQLLKNLQHERIVQY 69

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
               +      +  EY+  GS++  L    +  L           I  G+EY+HS  ++H
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHSNMIVH 127

Query: 308 RDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRK 363
           RD+K  N+L D   ++K+ DFG +   + +           GT  WM+PE+I  + YGRK
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187

Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQ 423
            DV+S G  + EM+    P+ E   + A F +  +   P +P    P     + + +   
Sbjct: 188 ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVEN 247

Query: 424 PDKRP 428
             KRP
Sbjct: 248 AKKRP 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  117 bits (294), Expect = 9e-30
 Identities = 79/252 (31%), Positives = 126/252 (50%), Gaps = 26/252 (10%)

Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRI--PDDDENETLAARLEKQFNREVALLSRLHN-- 241
           R A+GA  R  H +     VA+KII +  PDDD ++           REVALLS+L    
Sbjct: 11  RGAYGAVYRGKH-VPTGRVVALKIINLDTPDDDVSD---------IQREVALLSQLRQSQ 60

Query: 242 -PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLH--KLEHKTLPLPKLIAIALDIARGME 298
            PN+ K+  +  K P   +I EY   GS+R  +    +  K + +     I  ++   ++
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALK 115

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA-LSDDPGTYRWMAPEMIKH 357
           YIH  GVIHRD+K  N+L+    ++K+ DFG+A       +  S   GT  WMAPE+I  
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175

Query: 358 -KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC-PPAMAAL 415
            K Y  K D++S G+ ++EM  G  PY +++  +A   ++ K+  P +  +     +   
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-LIPKSKPPRLEDNGYSKLLREF 234

Query: 416 IEQCWSLQPDKR 427
           +  C   +P +R
Sbjct: 235 VAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  116 bits (292), Expect = 9e-30
 Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 20/209 (9%)

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  +L++L +  +I++  +        ++ EY   G L   L     + LP  ++    
Sbjct: 48  DEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF 107

Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------ 344
           + I  G+ ++HS+ ++HRD+K  N+ +D   ++KI D G+A        LSD+       
Sbjct: 108 IQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVA------KLLSDNTNFANTI 161

Query: 345 -GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-- 401
            GT  +++PE+ + K Y  K DV++ G++L+E   G  P++  N      A++ K +R  
Sbjct: 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----ALILKIIRGV 217

Query: 402 -PAIPGDCPPAMAALIEQCWSLQPDKRPE 429
            P +       +A LI+QC +    +RP+
Sbjct: 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPD 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  117 bits (294), Expect = 1e-29
 Identities = 72/257 (28%), Positives = 124/257 (48%), Gaps = 28/257 (10%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--I 260
           E VAVK ++ P+   N            +E+ +L  L++ N++K+   C +     +  I
Sbjct: 34  EQVAVKSLK-PESGGNHI------ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            E+L  GSL+ YL + ++K + L + +  A+ I +GM+Y+ S+  +HRDL   NVL++ E
Sbjct: 87  MEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 145

Query: 321 FHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
             +KI DFG    I  ++ Y     D      W APE +    +    DV+SFG+ L+E+
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205

Query: 377 V----AGTIPYEE----MNPIQAAFAV------VNKNLRPAIPGDCPPAMAALIEQCWSL 422
           +    + + P       + P      V      + +  R   P +CP  +  L+ +CW  
Sbjct: 206 LTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEF 265

Query: 423 QPDKRPEFWHIVKVLEQ 439
           QP KR  F ++++  E 
Sbjct: 266 QPSKRTTFQNLIEGFEA 282

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 1e-29
 Identities = 73/225 (32%), Positives = 117/225 (52%), Gaps = 21/225 (9%)

Query: 227 KQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK---------- 275
           + F  E+ +L +L H+PN+I  + AC+      +  EY   G+L  +L K          
Sbjct: 40  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 99

Query: 276 -LEH---KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
            + +    TL   +L+  A D+ARGM+Y+  +  IHRDL   N+L+ + +  KIADFG++
Sbjct: 100 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159

Query: 332 -CEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388
             +EVY    +   P   RWMA E + +  Y    DV+S+G++LWE+V+ G  PY  M  
Sbjct: 160 RGQEVYVKKTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 217

Query: 389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
            +  +  + +  R   P +C   +  L+ QCW  +P +RP F  I
Sbjct: 218 AE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  115 bits (290), Expect = 2e-29
 Identities = 73/251 (29%), Positives = 122/251 (48%), Gaps = 19/251 (7%)

Query: 190 GAHSRLYHGIY-KDEPVAVKIIRIPDDDENETLAARLEKQFNR---EVALLSRLHNPNVI 245
           GA+  +Y G+  + + +AVK + +   D +  LAA  EK++ +   EV LL  L + N++
Sbjct: 11  GAYGTVYCGLTNQGQLIAVKQVEL---DTSNVLAA--EKEYEKLQEEVDLLKSLKHVNIV 65

Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           +++  C       +  E++  GS+ + L++     LP P        I  G+ Y+H+  V
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIA-------CEEVYCDALSDDPGTYRWMAPEMIKHK 358
           +HRD+K  NV++     +K+ DFG A           + + L    GT  WMAPE+I   
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN-KNLRPAIPGDCPPAMAALIE 417
            YGRK D++S G  ++EM  G  P   M+ + A F +   + L P +P     A    + 
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVT 243

Query: 418 QCWSLQPDKRP 428
            C +    +RP
Sbjct: 244 SCLTRDQHERP 254

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  115 bits (290), Expect = 3e-29
 Identities = 73/255 (28%), Positives = 116/255 (45%), Gaps = 28/255 (10%)

Query: 190 GAHSRLY---HGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
           GA+ R++        D   A+K+I     D    +      Q   E  +LS+  +P V+K
Sbjct: 4   GAYGRVFLAKKKSTGD-IYAIKVI--KKAD---MIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 247 FVAA-CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQ 303
              +   K  +Y V  EYL  G L + L  +      L + +A     +I   +EY+HS 
Sbjct: 58  LYYSFQGKKNLYLV-MEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLHSN 112

Query: 304 GVIHRDLKPENVLIDQEFHLKIADFG---IACEEVYCDALSDDP------GTYRWMAPEM 354
           G+IHRDLKP+N+LID   HLK+ DFG   +       +   D+       GT  ++APE+
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 355 IKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA-VVNKNLRPAIPGDCPPAMA 413
           I  + + + VD +S G IL+E + G  P+    P +  F  ++N  +      +      
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-EEIFQNILNGKIEWPEDVEVSDEAI 231

Query: 414 ALIEQCWSLQPDKRP 428
            LI +     P+KR 
Sbjct: 232 DLISKLLVPDPEKRL 246

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  115 bits (290), Expect = 4e-29
 Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 28/272 (10%)

Query: 189 HGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           HGA   +Y G+Y+        + V +  +P+    +      E  F  E  ++S+ ++ N
Sbjct: 16  HGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD-----ESDFLMEALIMSKFNHQN 70

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLH----KLEHKT-LPLPKLIAIALDIARGME 298
           +++ +    +     ++ E ++ G L+++L     + E  + L +  L+  A D+A+G +
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 299 YIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGT----YRWMA 351
           Y+     IHRD+   N L+  +      KIADFG+A  ++Y  +     G      +WM 
Sbjct: 131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA-RDIYRASYYRKGGRAMLPIKWMP 189

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
           PE      +  K DV+SFG++LWE+ + G +PY      Q     V    R   P  CP 
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVTGGGRLDPPKGCPG 248

Query: 411 AMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            +  ++  CW   P+ RP F     +LE+ + 
Sbjct: 249 PVYRIMTDCWQHTPEDRPNF---ATILERIQY 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  115 bits (290), Expect = 4e-29
 Identities = 78/254 (30%), Positives = 121/254 (47%), Gaps = 33/254 (12%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVK ++ P      TLAAR  K F RE  LL+ L + +++KF   C       ++ EY+
Sbjct: 38  VAVKALKDP------TLAAR--KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89

Query: 265 SEGSLRAYLH--------------KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
             G L  +L               +     L L +++ IA  IA GM Y+ SQ  +HRDL
Sbjct: 90  KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDL 149

Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG----TYRWMAPEMIKHKSYGRKVDV 366
              N L+     +KI DFG++  +VY        G      RWM PE I ++ +  + DV
Sbjct: 150 ATRNCLVGANLLVKIGDFGMS-RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 208

Query: 367 YSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL--RPAIPGDCPPAMAALIEQCWSLQ 423
           +SFG+ILWE+   G  P+ +++  +    +    +  RP +   CP  +  ++  CW  +
Sbjct: 209 WSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV---CPKEVYDIMLGCWQRE 265

Query: 424 PDKRPEFWHIVKVL 437
           P +R     I K+L
Sbjct: 266 PQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  113 bits (285), Expect = 1e-28
 Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 15/209 (7%)

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E+ L++RL++P++I+ + A  +   + +  E+++ GS+   L K         + + I 
Sbjct: 52  KEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIIN 107

Query: 291 --LDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDD---- 343
               + RG+ Y+H   +IHRD+K  N+LID     L+IADFG A         + +    
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY---EEMNPIQAAFAVVNKN 399
             GT  +MAPE+++ + YGR  DV+S G ++ EM     P+   +  N +   F + +  
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227

Query: 400 LRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
             P+IP    P +  +  +C  LQP+ RP
Sbjct: 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  114 bits (286), Expect = 2e-28
 Identities = 76/258 (29%), Positives = 129/258 (50%), Gaps = 34/258 (13%)

Query: 190 GAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           GA   +Y GI+  E      PVA+KI+       NET   +   +F  E  +++ + +P+
Sbjct: 18  GAFGTVYKGIWVPEGETVKIPVAIKIL-------NETTGPKANVEFMDEALIMASMDHPH 70

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHS 302
           +++ +  C  P +  ++T+ +  G L  Y+H  EHK  +    L+   + IA+GM Y+  
Sbjct: 71  LVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIAKGMMYLEE 127

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPE 353
           + ++HRDL   NVL+    H+KI DFG+A        L  D   Y         +WMA E
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLA------RLLEGDEKEYNADGGKMPIKWMALE 181

Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            I ++ +  + DV+S+G+ +WE M  G  PY+ + P +    ++ K  R   P  C   +
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDV 240

Query: 413 AALIEQCWSLQPDKRPEF 430
             ++ +CW +  D RP+F
Sbjct: 241 YMVMVKCWMIDADSRPKF 258

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  113 bits (283), Expect = 3e-28
 Identities = 77/255 (30%), Positives = 122/255 (47%), Gaps = 32/255 (12%)

Query: 200 YKDEP--VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
           +  +P  VAVK++R  D  +     AR    F +E+ ++SRL NPN+I+ +  C      
Sbjct: 40  FDGQPVLVAVKMLR-ADVTKT----AR--NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL 92

Query: 258 CVITEYLSEGSLRAYLHKLEHKT----------LPLPKLIAIALDIARGMEYIHSQGVIH 307
           C+ITEY+  G L  +L + E ++          + +  L+ +A+ IA GM+Y+ S   +H
Sbjct: 93  CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVH 152

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG----TYRWMAPEMIKHKSYGRK 363
           RDL   N L+   + +KIADFG++   +Y        G      RWMA E I    +   
Sbjct: 153 RDLATRNCLVGNHYTIKIADFGMS-RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA 211

Query: 364 VDVYSFGLILWEM--VAGTIPYEEMNPIQAA------FAVVNKNLRPAIPGDCPPAMAAL 415
            DV++FG+ LWEM  +    PY  ++  Q        F    + +  +    CP  +  L
Sbjct: 212 SDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKL 271

Query: 416 IEQCWSLQPDKRPEF 430
           + +CWS     RP F
Sbjct: 272 MMRCWSRDIKDRPTF 286

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  112 bits (281), Expect = 5e-28
 Identities = 80/270 (29%), Positives = 135/270 (50%), Gaps = 29/270 (10%)

Query: 177 DLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPD-DDENETLAARLEKQFNRE 232
           D  +LF  L R   G+   ++ GI     + VA+KII + + +DE E +         +E
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI--------QQE 52

Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           + +LS+  +P V K+  +  K     +I EYL  GS    L         +  ++    +
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---E 109

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------G 345
           I +G++Y+HS+  IHRD+K  NVL+ ++  +K+ADFG+A +      L+D         G
Sbjct: 110 ILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ------LTDTQIKRNTFVG 163

Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
           T  WMAPE+I+  +Y  K D++S G+   E+  G  P  +M+P++  F ++ KN  P + 
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-LIPKNNPPTLT 222

Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           G+        I+ C +  P  RP    ++K
Sbjct: 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  112 bits (280), Expect = 6e-28
 Identities = 71/241 (29%), Positives = 121/241 (50%), Gaps = 28/241 (11%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVK ++    + +E+  AR +  F RE  LL+ L + ++++F   C +     ++ EY+
Sbjct: 38  VAVKALK----EASES--ARQD--FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89

Query: 265 SEGSLRAYL-------HKLEHKT------LPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311
             G L  +L         L          L L +++AIA  IA GM Y+ S   +HRDL 
Sbjct: 90  RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLA 149

Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDPG----TYRWMAPEMIKHKSYGRKVDVY 367
             N L+ Q   +KI DFG++  ++Y        G      RWM PE I ++ +  + D++
Sbjct: 150 TRNCLVGQGLVVKIGDFGMS-RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIW 208

Query: 368 SFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
           SFG++LWE+   G  P+ +++  + A   + +      P  CPP + A+++ CW  +P +
Sbjct: 209 SFGVVLWEIFTYGKQPWYQLSNTE-AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQ 267

Query: 427 R 427
           R
Sbjct: 268 R 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score =  111 bits (279), Expect = 8e-28
 Identities = 64/241 (26%), Positives = 114/241 (47%), Gaps = 16/241 (6%)

Query: 204 PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY 263
           PVA+  +R          + +  + F  E   L +  + N+++      +     ++TEY
Sbjct: 35  PVAIHTLR-------AGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEY 87

Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
           +S G+L ++L K E + L   +L+ +   +A GM+Y+   G +H+ L    VL++ +   
Sbjct: 88  MSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVC 146

Query: 324 KIADFGIA----CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA- 378
           KI+ F        E +Y       P    W APE I++  +    DV+SFG+++WE+++ 
Sbjct: 147 KISGFRRLQEDKSEAIYTTMSGKSPVL--WAAPEAIQYHHFSSASDVWSFGIVMWEVMSY 204

Query: 379 GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           G  PY +M+  Q     V    R   P +CP  +  L+  CW  +  +RP F  I  +L 
Sbjct: 205 GERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263

Query: 439 Q 439
           +
Sbjct: 264 K 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  110 bits (278), Expect = 1e-27
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 22/254 (8%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA + +Y  I     E VA+K I +      E     ++ +  +EV  +S+ ++PNV+K
Sbjct: 11  VGATAVVYAAICLPNNEKVAIKRIDL------EKCQTSVD-ELRKEVQAMSQCNHPNVVK 63

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYL-HKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           +  +        ++  YLS GSL   +        L    +  +  ++ +G+EY+HS G 
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123

Query: 306 IHRDLKPENVLIDQEFHLKIADFGI-ACEEVYCD----ALSDDPGTYRWMAPEMIK-HKS 359
           IHRD+K  N+L+ ++  +KIADFG+ A      D          GT  WMAPE+++    
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD-----CPPAMAA 414
           Y  K D++SFG+   E+  G  PY +  P++     +  +  P++           +   
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYSKSFRK 242

Query: 415 LIEQCWSLQPDKRP 428
           +I  C    P KRP
Sbjct: 243 MISLCLQKDPSKRP 256

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  110 bits (276), Expect = 1e-27
 Identities = 64/238 (26%), Positives = 117/238 (49%), Gaps = 18/238 (7%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEY 263
           VA+K I            A  E+ F  E  ++ +L +P +++    C ++ P+Y ++TE+
Sbjct: 31  VAIKAIN---------EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY-IVTEF 80

Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
           +  G L  YL + + K L    L+++  D+  GMEY+     IHRDL   N L+     +
Sbjct: 81  MENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVV 139

Query: 324 KIADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-G 379
           K++DFG+    V  D  +   G     +W  PE+     Y  K DV+SFG+++WE+   G
Sbjct: 140 KVSDFGMT-RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198

Query: 380 TIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
            +P+E+ +  +     +++  R   P      +  ++  CW  +P+ RP F  +++ +
Sbjct: 199 KMPFEKKSNYEVVEM-ISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score =  110 bits (275), Expect = 3e-27
 Identities = 72/253 (28%), Positives = 122/253 (48%), Gaps = 29/253 (11%)

Query: 205 VAVKIIRIPDDDENETLAARLE-KQFNREVALLSRLHNPNVIKFVAACKKP------PVY 257
           VAVK ++I        +  R E + F  E   +    +PNV++ +  C +       P  
Sbjct: 29  VAVKTMKI-------AICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81

Query: 258 CVITEYLSEGSLRAYL--HKLEHKTLPLPK--LIAIALDIARGMEYIHSQGVIHRDLKPE 313
            VI  ++  G L ++L   +L      LP   L+    DIA GMEY+ S+  IHRDL   
Sbjct: 82  VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAAR 141

Query: 314 NVLIDQEFHLKIADFGIACEEVYC------DALSDDPGTYRWMAPEMIKHKSYGRKVDVY 367
           N ++++  ++ +ADFG++ +++Y         ++  P   +W+A E +  + Y  K DV+
Sbjct: 142 NCMLNENMNVCVADFGLS-KKIYNGDYYRQGRIAKMP--VKWIAIESLADRVYTTKSDVW 198

Query: 368 SFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
           SFG+ +WE+   G  PY  +   +  +  + +  R   P DC   + +L+  CW L P  
Sbjct: 199 SFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKD 257

Query: 427 RPEFWHIVKVLEQ 439
           RP F  +   LE+
Sbjct: 258 RPSFETLRCELEK 270

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  110 bits (277), Expect = 4e-27
 Identities = 77/262 (29%), Positives = 128/262 (48%), Gaps = 34/262 (12%)

Query: 190 GAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + NP+
Sbjct: 18  GAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVDNPH 70

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHS 302
           V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y+  
Sbjct: 71  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEE 127

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPE 353
           + ++HRDL   NVL+    H+KI DFG+A        L  D   Y         +WMA E
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLA------KLLGADEKEYHAEGGKVPIKWMALE 181

Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   +
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDV 240

Query: 413 AALIEQCWSLQPDKRPEFWHIV 434
             ++ +CW +  D RP+F  ++
Sbjct: 241 YMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  108 bits (272), Expect = 1e-26
 Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 21/228 (9%)

Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL----------- 273
           L ++F  E  + SRL +PN++  +    K     +I  Y S   L  +L           
Sbjct: 51  LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS 110

Query: 274 ---HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
               K    TL     + I   IA GME++ S  V+H+DL   NVL+  + ++KI+D G+
Sbjct: 111 TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170

Query: 331 ACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE 385
              EVY       + +     RWM+PE I +  +    D++S+G++LWE+ + G  PY  
Sbjct: 171 F-REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229

Query: 386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
            +       + N+ + P  P DCP  +  L+ +CW+  P +RP F  I
Sbjct: 230 YSNQDVIEMIRNRQVLPC-PDDCPAWVYTLMLECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  108 bits (271), Expect = 1e-26
 Identities = 71/261 (27%), Positives = 133/261 (50%), Gaps = 20/261 (7%)

Query: 190 GAHSRLYHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G  S +Y  I   +   VA+K ++I      E + A+  +   +E+ LL +L +PNVIK+
Sbjct: 13  GQFSVVYKAICLLDGRVVALKKVQI-----FEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67

Query: 248 VAACKKPPVYCVITEYLSEGSL-RAYLH-KLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           +A+  +     ++ E    G L R   H K + + +P   +    + +   +E++HS+ +
Sbjct: 68  LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127

Query: 306 IHRDLKPENVLIDQEFHLKIADFGI----ACEEVYCDALSDDPGTYRWMAPEMIKHKSYG 361
           +HRD+KP NV I     +K+ D G+    + +     +L    GT  +M+PE I    Y 
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHENGYN 184

Query: 362 RKVDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIPGDCPPA-MAALIEQ 418
            K D++S G +L+EM A   P+  ++MN + +    + K   P +P D     +  L+ +
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243

Query: 419 CWSLQPDKRPEFWHIVKVLEQ 439
           C +  P+KRP+  ++++V ++
Sbjct: 244 CINPDPEKRPDISYVLQVAKE 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  108 bits (272), Expect = 1e-26
 Identities = 65/244 (26%), Positives = 117/244 (47%), Gaps = 35/244 (14%)

Query: 197 HGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
                   VAVK + +      E L       FN EV ++    +PN+++  ++      
Sbjct: 39  TDKSTGRQVAVKKMDLRKQQRRELL-------FN-EVVIMRDYQHPNIVEMYSSYLVGDE 90

Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             V+ E+L  G+L   +    H  +   ++  + L + + + ++H+QGVIHRD+K +++L
Sbjct: 91  LWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSIL 147

Query: 317 IDQEFHLKIADFGIACEEVYCDALSDD-P------GTYRWMAPEMIKHKSYGRKVDVYSF 369
           +  +  +K++DFG      +C  +S + P      GT  WMAPE+I    YG +VD++S 
Sbjct: 148 LTSDGRVKLSDFG------FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 201

Query: 370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP------GDCPPAMAALIEQCWSLQ 423
           G+++ EMV G  PY    P+QA      K +R  +P          P + + +++     
Sbjct: 202 GIMVIEMVDGEPPYFNEPPLQAM-----KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRD 256

Query: 424 PDKR 427
           P +R
Sbjct: 257 PAQR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  107 bits (269), Expect = 3e-26
 Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 7/211 (3%)

Query: 224 RLEKQFNREVAL-----LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH 278
           RL+K+   ++AL     L ++ +  ++    A +     C++   ++ G L+ +++ +  
Sbjct: 30  RLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE 89

Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
              P  + I  A  I  G+E++H + +++RDLKPENVL+D   +++I+D G+A E     
Sbjct: 90  PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK 149

Query: 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +    GT  +MAPE+++ + Y   VD ++ G  L+EM+AG  P+ +         +  +
Sbjct: 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR 209

Query: 399 NLRPAI--PGDCPPAMAALIEQCWSLQPDKR 427
            L  A+  P    P    L E      P+KR
Sbjct: 210 TLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  107 bits (268), Expect = 4e-26
 Identities = 71/232 (30%), Positives = 116/232 (50%), Gaps = 23/232 (9%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           +AVK+I  P D     +   L+KQ   E+ +L +  +P +I F  A        + TE++
Sbjct: 29  LAVKVI--PLD-----ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81

Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
             GSL  Y      + +P   L  IA+ + +G+ Y+ S  ++HRD+KP N+L++    +K
Sbjct: 82  DGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVK 135

Query: 325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
           + DFG++ + V   A +   GT  +MAPE I  + YG   DV+S G+   E+  G  PY 
Sbjct: 136 LCDFGVSTQLVNSIAKT-YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194

Query: 385 EMN-------PIQAAFAVVNKNLRPAIP-GDCPPAMAALIEQCWSLQPDKRP 428
           ++        P+Q    +V+++  P +P G         I QC   QP +RP
Sbjct: 195 QIQKNQGSLMPLQLLQCIVDED-PPVLPVGQFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  107 bits (268), Expect = 5e-26
 Identities = 56/205 (27%), Positives = 106/205 (51%), Gaps = 19/205 (9%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ ++    +PN++ ++ +        V+ EYL+ GSL   + +     +   ++ A+  
Sbjct: 66  EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCR 122

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------- 344
           +  + +E++HS  VIHRD+K +N+L+  +  +K+ DFG      +C  ++ +        
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG------FCAQITPEQSKRSTMV 176

Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI 404
           GT  WMAPE++  K+YG KVD++S G++  EMV G  PY   NP++A + ++  N  P +
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPEL 235

Query: 405 PG--DCPPAMAALIEQCWSLQPDKR 427
                        + +C  +  +KR
Sbjct: 236 QNPEKLSAIFRDFLNRCLEMDVEKR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  107 bits (267), Expect = 5e-26
 Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 17/229 (7%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
           + VA+K I +    + E +          E+ ++  L NPN++ F+ +        V+ E
Sbjct: 45  QEVAIKQINLQKQPKKELII--------NEILVMKELKNPNIVNFLDSFLVGDELFVVME 96

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
           YL+ GSL   + +     +   ++ A+  +  + +E++H+  VIHRD+K +NVL+  +  
Sbjct: 97  YLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS 153

Query: 323 LKIADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
           +K+ DFG  C ++  +    S   GT  WMAPE++  K+YG KVD++S G++  EMV G 
Sbjct: 154 VKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Query: 381 IPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPAMAALIEQCWSLQPDKR 427
            PY   NP++A + ++  N  P +  P    P     + +C  +  +KR
Sbjct: 213 PPYLNENPLRALY-LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 7e-26
 Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 54/264 (20%)

Query: 205 VAVKIIRIPDDDEN---ETLAARLEKQFNREVALLSRLHN---PNVIKFVAACKKPPVYC 258
           VA+K +R+P  +E     TL         RE+ALL +L +   PN+++ +  C  P    
Sbjct: 27  VALKKVRVPLSEEGIPLSTL---------REIALLKQLESFEHPNIVRLLDVCHGPRTDR 77

Query: 259 VITEYL----SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
            +   L     +  L  YL K     LP   +  +   + RG++++HS  ++HRDLKP+N
Sbjct: 78  ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQN 137

Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFG 370
           +L+  +  +KIADFG+A   +Y   ++         YR  APE++   SY   VD++S G
Sbjct: 138 ILVTSDGQVKIADFGLA--RIYSFEMALTSVVVTLWYR--APEVLLQSSYATPVDMWSVG 193

Query: 371 LILWEM---------------------VAGTIPYEEMNPIQAAFAVVNKNLRPAIPG-DC 408
            I  E+                     V G  P EE  P   +    +            
Sbjct: 194 CIFAELFRRRPLFRGTSEADQLDKIFDVIGL-PSEEEWPRNVSLPRSSFPSYTPRSFKSF 252

Query: 409 PPAMAA----LIEQCWSLQPDKRP 428
            P +      L+++  +  P KR 
Sbjct: 253 VPEICEEGLDLLKKMLTFNPHKRI 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  107 bits (268), Expect = 1e-25
 Identities = 66/190 (34%), Positives = 115/190 (60%), Gaps = 19/190 (10%)

Query: 202 DEPVAVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-- 255
           DE  A+KI++    I DDD   T+   +EK   R +AL  +   P  +  + +C +    
Sbjct: 25  DELYAIKILKKDVIIQDDDVECTM---VEK---RVLALPGK---PPFLTQLHSCFQTMDR 75

Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
           +Y V+ EY++ G L  ++ ++       P  +  A +IA G+ ++HS+G+I+RDLK +NV
Sbjct: 76  LYFVM-EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132

Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
           ++D E H+KIADFG+  E ++    +    GT  ++APE+I ++ YG+ VD ++FG++L+
Sbjct: 133 MLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 192

Query: 375 EMVAGTIPYE 384
           EM+AG  P++
Sbjct: 193 EMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 63/242 (26%), Positives = 114/242 (47%), Gaps = 32/242 (13%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
            E VA+K+I++   D+ E +         +E+++L    +PN++ +  +  +     ++ 
Sbjct: 28  GELVAIKVIKLEPGDDFEII--------QQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79

Query: 262 EYLSEGSLRAYLHKLEHKTLPLP-KLIA-IALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           EY   GSL+           PL    IA +  +  +G+ Y+H  G IHRD+K  N+L+ +
Sbjct: 80  EYCGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE 136

Query: 320 EFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMI---KHKSYGRKVDVYSF 369
           +  +K+ADFG++ +      L+          GT  WMAPE+    +   Y  K D+++ 
Sbjct: 137 DGDVKLADFGVSAQ------LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWAL 190

Query: 370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD---CPPAMAALIEQCWSLQPDK 426
           G+   E+     P  +++P++A F +   N  P    D     P     I++C +  P K
Sbjct: 191 GITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKK 250

Query: 427 RP 428
           RP
Sbjct: 251 RP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  105 bits (264), Expect = 1e-25
 Identities = 72/255 (28%), Positives = 116/255 (45%), Gaps = 32/255 (12%)

Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
           G +  +Y        V + I  IP+ D          +  + E+AL S L + N+++++ 
Sbjct: 19  GTYGIVYAARDLSTQVRIAIKEIPERDSRYV------QPLHEEIALHSYLKHRNIVQYLG 72

Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL----PKLIAIALDIARGMEYIHSQGV 305
           +  +   + +  E +  GSL A L     K  PL      +I     I  G++Y+H   +
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 306 IHRDLKPENVLIDQ-EFHLKIADFGIA--------CEEVYCDALSDDPGTYRWMAPEMIK 356
           +HRD+K +NVL++     +KI+DFG +        C E +        GT ++MAPE+I 
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-------TGTLQYMAPEVID 182

Query: 357 H--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA-FAVVNKNLRPAIPGDCPPAMA 413
              + YG   D++S G  + EM  G  P+ E+   QAA F V    + P IP        
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK 242

Query: 414 ALIEQCWSLQPDKRP 428
             I +C+   PDKR 
Sbjct: 243 NFILRCFEPDPDKRA 257

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  106 bits (266), Expect = 1e-25
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 15/206 (7%)

Query: 201 KDEPVAVKIIR---IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
            DE  AVK+++   I  DD+ E           + V  L+  H P + +  +  +     
Sbjct: 19  TDELYAVKVLKKDVILQDDDVECT------MTEKRVLALAGKH-PFLTQLHSCFQTKDRL 71

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
             + EY++ G L    H         P+    A +I  G++++H +G+I+RDLK +NVL+
Sbjct: 72  FFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129

Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           D E H+KIADFG+ C+E     ++     GT  ++APE++ ++ YG  VD ++ G++L+E
Sbjct: 130 DSEGHIKIADFGM-CKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188

Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLR 401
           M+AG  P+E  +  +   +++   +R
Sbjct: 189 MLAGQSPFEGDDEDELFQSILEDEVR 214

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 2e-25
 Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 22/186 (11%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
            E VA+K I++  + E         K   RE+ LL  L++PN+IK +   +      ++ 
Sbjct: 24  GEIVAIKKIKLRFESEGI------PKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           E++     +  L K   + LP   + +    + +G+ + HS G++HRDLKPEN+LI+ E 
Sbjct: 78  EFMDTDLYK--LIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG 135

Query: 322 HLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGRKVDVYSFGLIL 373
            LK+ADFG+A       +       Y      RW  APE ++  K Y   VD++S G I 
Sbjct: 136 VLKLADFGLA------RSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF 189

Query: 374 WEMVAG 379
            E+++ 
Sbjct: 190 AELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  105 bits (263), Expect = 3e-25
 Identities = 73/234 (31%), Positives = 129/234 (55%), Gaps = 23/234 (9%)

Query: 202 DEPVAVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--P 255
           DE  A+KI++    I DDD   T+  +     + +   L++LH         +C +    
Sbjct: 25  DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH---------SCFQTMDR 75

Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
           +Y V+ EY++ G L   + ++       P  +  A +IA G+ ++HS+G+I+RDLK +NV
Sbjct: 76  LYFVM-EYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132

Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
           ++D E H+KIADFG+ C+E   D ++     GT  ++APE+I ++ YG+ VD ++FG++L
Sbjct: 133 MLDSEGHIKIADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191

Query: 374 WEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           +EM+AG  P+E  +  +   +++  N+  A P        A+ +   +  P KR
Sbjct: 192 YEMLAGQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score =  104 bits (261), Expect = 3e-25
 Identities = 59/254 (23%), Positives = 112/254 (44%), Gaps = 16/254 (6%)

Query: 194 RLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK----FVA 249
            +Y GI+ ++ V ++  +         +          E+  L R+ + N++K     + 
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLI-----DITENEIKNLRRIDSNNILKIYGFIID 89

Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH-SQGVIHR 308
                P   +I EY + G LR  L K   K L     + +A+D  +G+  ++      ++
Sbjct: 90  IVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYK 147

Query: 309 DLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH--KSYGRKVDV 366
           +L   + L+ + + LKI   G+  E++       +     + + +M+      Y  K D+
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL--EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205

Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
           YS G++LWE+  G IP+E +   +    ++NKN    +P DCP  +  ++E C S    K
Sbjct: 206 YSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIK 265

Query: 427 RPEFWHIVKVLEQF 440
           RP    I+  L  +
Sbjct: 266 RPNIKEILYNLSLY 279

Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  105 bits (264), Expect = 4e-25
 Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 35/198 (17%)

Query: 202 DEPVAVKIIRIPDDDENETLAAR-LEKQFNREVALLSRLHNPNVIKF--VAACKKPP--- 255
              VA+K  +I +  ++   A R L     RE+ LL  L + N+I    +     P    
Sbjct: 25  GRKVAIK--KISNVFDDLIDAKRIL-----REIKLLRHLRHENIIGLLDILRPPSPEDFN 77

Query: 256 -VYCVITEYLSEGSLRAYLHKLEHKTLPL-PKLIA-IALDIARGMEYIHSQGVIHRDLKP 312
            VY ++TE +        LHK+     PL    I      I RG++Y+HS  VIHRDLKP
Sbjct: 78  DVY-IVTELM-----ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKP 131

Query: 313 ENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPGTY---RWM-APE-MIKHKSYGRK 363
            N+L++    LKI DFG+A     +E     L++    Y   RW  APE ++    Y + 
Sbjct: 132 SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE----YVVTRWYRAPELLLSSSRYTKA 187

Query: 364 VDVYSFGLILWEMVAGTI 381
           +D++S G I  E++    
Sbjct: 188 IDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 4e-25
 Identities = 55/187 (29%), Positives = 101/187 (54%), Gaps = 17/187 (9%)

Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           A+K++ IP+      +  + E+  + E  +L  + +P +I+            ++ EY+ 
Sbjct: 30  ALKVMAIPE-----VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84

Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
            G L +YL      +       A   +I   +EY+HS+ +++RDLKPEN+L+D+E H+K+
Sbjct: 85  GGELFSYLRNSGRFSNSTGLFYAS--EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKL 142

Query: 326 ADFGIACEEVYCDALSDDP----GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381
            DFG A +      L D      GT  ++APE+I+ K + + VD ++ G++++EM+ G  
Sbjct: 143 TDFGFAKK------LRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196

Query: 382 PYEEMNP 388
           P+ + NP
Sbjct: 197 PFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  104 bits (260), Expect = 6e-25
 Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 21/228 (9%)

Query: 225 LEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKLEHKTL- 281
           L+KQ  RE+ +     +P ++K+  A   +      +  EY   GSL +   K++ +   
Sbjct: 42  LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR 101

Query: 282 ----PLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
                L K   IA  + +G+ Y+HS+ +IHRD+KP N+L+ ++  +K+ DFG++ E V  
Sbjct: 102 IGEKVLGK---IAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158

Query: 338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE-EMNPIQAAFAVV 396
            A     GT  +MAPE I+ K Y    DV+S GL L E+     P+  E  P      ++
Sbjct: 159 LA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL 217

Query: 397 NKNLRPAIP--GDCP-------PAMAALIEQCWSLQPDKRPEFWHIVK 435
           +  +    P   D P             I+QC    P +RP  W +++
Sbjct: 218 SYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  102 bits (257), Expect = 7e-25
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 4/199 (2%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI--AI 289
           E+ +L+ +++PN+I +  A       C++ EY   G L   + K + K   +P+     I
Sbjct: 49  EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
            + + RG++ +H Q ++HRDLK  N+L+     +KI D GI+ + +  +      GT  +
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGIS-KVLKKNMAKTQIGTPHY 167

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           MAPE+ K + Y  K D++S G +L+EM     P+E  + +Q     V +   P IP    
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYS 226

Query: 410 PAMAALIEQCWSLQPDKRP 428
             +   I     ++P  RP
Sbjct: 227 QDLQNFIRSMLQVKPKLRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score =  103 bits (258), Expect = 7e-25
 Identities = 73/262 (27%), Positives = 125/262 (47%), Gaps = 34/262 (12%)

Query: 190 GAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           GA   +Y GI+  +      PVA+K++R       E  + +  K+   E  +++ + +P 
Sbjct: 18  GAFGTVYKGIWIPDGENVKIPVAIKVLR-------ENTSPKANKEILDEAYVMAGVGSPY 70

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHS 302
           V + +  C    V  ++T+ +  G L  Y+   E+K  +    L+   + IA+GM Y+  
Sbjct: 71  VCRLLGICLTSTVQ-LVTQLMPYGCLLDYVR--ENKDRIGSQDLLNWCVQIAKGMSYLEE 127

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPE 353
             ++HRDL   NVL+    H+KI DFG+A        L  D   Y         +WMA E
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLA------RLLDIDETEYHADGGKVPIKWMALE 181

Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            I H+ +  + DV+S+G+ +WE M  G  PY+ + P +    ++ K  R   P  C   +
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDV 240

Query: 413 AALIEQCWSLQPDKRPEFWHIV 434
             ++ +CW +  + RP F  +V
Sbjct: 241 YMIMVKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score =  104 bits (262), Expect = 1e-24
 Identities = 57/166 (34%), Positives = 91/166 (54%), Gaps = 8/166 (4%)

Query: 280 TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA 339
            L    L++ +  +A+GM ++ S+  IHRDL   N+L+      KI DFG+A  ++  D+
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RDIRNDS 268

Query: 340 LSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF- 393
                G  R    WMAPE I +  Y  + DV+S+G++LWE+ + G+ PY  M P+ + F 
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM-PVDSKFY 327

Query: 394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            ++ +  R   P   P  M  +++ CW   P KRP F  IV+++EQ
Sbjct: 328 KMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  102 bits (257), Expect = 2e-24
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 26/202 (12%)

Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           AHG   +        E VA+K + +   +        +  Q  RE+  L    +P V+K 
Sbjct: 12  AHGIVFKAKD-RETGETVALKKVALRRLEGG------IPNQALREIKALQACQHPYVVKL 64

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGV 305
           +        + ++ EY+    L   L   E    PLP+         + +G+ Y+H+ G+
Sbjct: 65  LDVFPHGSGFVLVMEYMPS-DLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHANGI 120

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RW-MAPEMI-KH 357
           +HRDLKP N+LI  +  LKIADFG+A   ++     ++P  Y      RW  APE++   
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLA--RLFS---EEEPRLYSHQVATRWYRAPELLYGA 175

Query: 358 KSYGRKVDVYSFGLILWEMVAG 379
           + Y   VD+++ G I  E++ G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 3e-24
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 17/214 (7%)

Query: 190 GAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           GA  ++Y   +K+  +  A KII+I  ++E E         F  E+ +LS   +PN++  
Sbjct: 16  GAFGKVYKAQHKETGLFAAAKIIQIESEEELE--------DFMVEIDILSECKHPNIVGL 67

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
             A        ++ E+   G+L + + +LE   L  P++  +   +   + ++HS  VIH
Sbjct: 68  YEAYFYENKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKVIH 126

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI-----KHKSYG 361
           RDLK  N+L+  +  +K+ADFG++ +        D   GT  WMAPE++     K   Y 
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186

Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
            K D++S G+ L E+     P+ E+NP++    +
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPMRVLLKI 220

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  100 bits (251), Expect = 4e-24
 Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 14/204 (6%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ +LS L +PN+I +           +  EY + G+L   + + + +      ++    
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------- 344
            I   + YIH  G++HRD+K  N+ + +   +K+ DFGI+        L  +        
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS------KILGSEYSMAETVV 162

Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI 404
           GT  +M+PE+ +   Y  K D+++ G +L+E++     ++  NP+     +V  N  P +
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-V 221

Query: 405 PGDCPPAMAALIEQCWSLQPDKRP 428
                  + +L+       P+KRP
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  100 bits (252), Expect = 6e-24
 Identities = 57/167 (34%), Positives = 84/167 (50%), Gaps = 9/167 (5%)

Query: 272 YLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFG 329
           Y    +   T+P   L  IA+ I + +EY+HS+  VIHRD+KP NVLI++   +K+ DFG
Sbjct: 90  YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149

Query: 330 IACEEVYCDALSDDPGTYRWMAPEMI----KHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           I+   V   A + D G   +MAPE I      K Y  K DV+S G+ + E+  G  PY+ 
Sbjct: 150 ISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209

Query: 386 M-NPIQAAFAVVNKNLRPAIPGDC-PPAMAALIEQCWSLQPDKRPEF 430
              P Q    VV +   P +P +   P     + +C      +RP +
Sbjct: 210 WKTPFQQLKQVV-EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNY 255

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score =  103 bits (257), Expect = 6e-24
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 8/192 (4%)

Query: 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312
           +P  Y    +  ++  ++  L     + L    L++    +ARGME++ S+  +HRDL  
Sbjct: 210 RPASY----KGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA 265

Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSF 369
            NVL+ Q   +KI DFG+A + ++         T+   +WMAPE I    Y    DV+S+
Sbjct: 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325

Query: 370 GLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
           G++LWE+ + G  PY  M      +  +    R A P      +  ++ +CW+ +P+KRP
Sbjct: 326 GILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385

Query: 429 EFWHIVKVLEQF 440
            F H+  ++E  
Sbjct: 386 SFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  100 bits (251), Expect = 7e-24
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 28/218 (12%)

Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
             ++    E  +L   ++P ++K     K K  +Y ++ EY   G L   L         
Sbjct: 35  GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIY-MLMEYCLGGELWTILRDRGL---- 89

Query: 283 LPKLIA---IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY--- 336
             +  A   IA  +    EY+H++G+I+RDLKPEN+L+D   ++K+ DFG A +++    
Sbjct: 90  FDEYTARFYIAC-VVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFA-KKLKSGQ 147

Query: 337 -----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY--EEMNPI 389
                C       GT  ++APE+I +K Y   VD +S G++L+E++ G  P+  ++ +P+
Sbjct: 148 KTWTFC-------GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200

Query: 390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           +    ++  N +   P     A   LI+Q     P++R
Sbjct: 201 EIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  101 bits (252), Expect = 1e-23
 Identities = 63/191 (32%), Positives = 116/191 (60%), Gaps = 21/191 (10%)

Query: 202 DEPVAVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--P 255
           DE  A+KI++    I DDD   T+   +EK+      +L+    P  +  + +C +    
Sbjct: 25  DELYAIKILKKDVVIQDDDVECTM---VEKR------VLALQDKPPFLTQLHSCFQTVDR 75

Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
           +Y V+ EY++ G L  ++ ++       P+ +  A +I+ G+ ++H +G+I+RDLK +NV
Sbjct: 76  LYFVM-EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNV 132

Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
           ++D E H+KIADFG+ C+E   D ++     GT  ++APE+I ++ YG+ VD +++G++L
Sbjct: 133 MLDSEGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL 191

Query: 374 WEMVAGTIPYE 384
           +EM+AG  P++
Sbjct: 192 YEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =   99 bits (250), Expect = 2e-23
 Identities = 59/186 (31%), Positives = 96/186 (51%), Gaps = 21/186 (11%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF---VAACKKPPVYCV 259
           E VA+K IR+  ++E E           RE+ LL +L +PN+++    V +  K  +Y +
Sbjct: 25  ELVALKKIRM--ENEKEGFPI----TAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY-M 77

Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + EY+ +  L   L   E K     ++      +  G++Y+HS G++HRD+K  N+LI+ 
Sbjct: 78  VFEYM-DHDLTGLLDSPEVK-FTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN 135

Query: 320 EFHLKIADFGIACEEVYCDALSDDPGTYR----WM-APEMIKH-KSYGRKVDVYSFGLIL 373
           +  LK+ADFG+A    Y    +    T R    W   PE++     YG +VD++S G IL
Sbjct: 136 DGVLKLADFGLA--RPYTKR-NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCIL 192

Query: 374 WEMVAG 379
            E+  G
Sbjct: 193 AELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 99.3 bits (247), Expect = 2e-23
 Identities = 47/167 (28%), Positives = 99/167 (59%), Gaps = 5/167 (2%)

Query: 224 RLEKQFNREVALLSR-----LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH 278
           RL+K+   ++ALL +     +++P ++    A +     C++   ++ G L+ +++ +  
Sbjct: 30  RLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE 89

Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
           + L + ++I  +  I  G+ ++HS  +++RD+KPENVL+D + + +++D G+A E     
Sbjct: 90  RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK 149

Query: 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
            ++   GT  +MAPE++K + Y   VD ++ G  ++EMVAG  P+++
Sbjct: 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 38/248 (15%)

Query: 208 KIIRIPDDDENETLA---------ARLEK-QFNREVALLSRLHNPNVIKFVAACKKPP-- 255
           K+ R  D    + L             EK Q   EV +L  L +PN++++          
Sbjct: 18  KVRRKSD---GKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74

Query: 256 -VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIH-----SQGVIH 307
            +Y ++ EY   G L   + K   E K +    +  I   +   +   H        V+H
Sbjct: 75  TLY-IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLH 133

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKSY 360
           RDLKP N+ +D   ++K+ DFG+A        L  D        GT  +M+PE + H SY
Sbjct: 134 RDLKPANIFLDANNNVKLGDFGLAKI------LGHDSSFAKTYVGTPYYMSPEQLNHMSY 187

Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
             K D++S G +++E+ A + P+   N +Q A  +     R  IP      +  +I+   
Sbjct: 188 DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR-IPYRYSSELNEVIKSML 246

Query: 421 SLQPDKRP 428
           ++ PDKRP
Sbjct: 247 NVDPDKRP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 99.8 bits (248), Expect = 2e-23
 Identities = 59/202 (29%), Positives = 111/202 (54%), Gaps = 13/202 (6%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ ++    NPN++ ++ +        V+ EYL+ GSL   + +     +   ++ A+  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCR 123

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD--ALSDDPGTYRW 349
           +  + +E++HS  VIHRD+K +N+L+  +  +K+ DFG  C ++  +    S   GT  W
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYW 182

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           MAPE++  K+YG KVD++S G++  EM+ G  PY   NP++A + ++  N  P +    P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQN--P 239

Query: 410 PAMAAL----IEQCWSLQPDKR 427
             ++A+    + +C  +  +KR
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKR 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 99.0 bits (246), Expect = 3e-23
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 26/252 (10%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVK ++   D+      AR  K F+RE  LL+ L + +++KF   C +     ++ EY+
Sbjct: 38  VAVKTLKDASDN------AR--KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 89

Query: 265 SEGSLRAYLHKL-----------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
             G L  +L                  L   +++ IA  IA GM Y+ SQ  +HRDL   
Sbjct: 90  KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 149

Query: 314 NVLIDQEFHLKIADFGIACEEVYCDALSDDPG----TYRWMAPEMIKHKSYGRKVDVYSF 369
           N L+ +   +KI DFG++  +VY        G      RWM PE I ++ +  + DV+S 
Sbjct: 150 NCLVGENLLVKIGDFGMS-RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 208

Query: 370 GLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
           G++LWE+   G  P+ +++  +    +    +    P  CP  +  L+  CW  +P  R 
Sbjct: 209 GVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRL 267

Query: 429 EFWHIVKVLEQF 440
               I  +L+  
Sbjct: 268 NIKEIHSLLQNL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 98.5 bits (245), Expect = 3e-23
 Identities = 63/221 (28%), Positives = 115/221 (52%), Gaps = 7/221 (3%)

Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYCVITEYLSEGSLRAYLHKLE 277
              + R  K   +E  LLS+L +PN++ +  + + +  +  ++  +   G L   L + +
Sbjct: 36  RNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK 95

Query: 278 HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVY 336
            K LP  +++   + IA  ++Y+H + ++HRDLK +NV + +   +K+ D GIA   E  
Sbjct: 96  GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155

Query: 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY--EEMNPIQAAFA 394
           CD  S   GT  +M+PE+  +K Y  K DV++ G  ++EM      +  ++MN +   + 
Sbjct: 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL--VYR 213

Query: 395 VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           ++   L P +P D  P +  LI    S +P+KRP    I++
Sbjct: 214 IIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 98.6 bits (245), Expect = 5e-23
 Identities = 66/248 (26%), Positives = 123/248 (49%), Gaps = 19/248 (7%)

Query: 186 RFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   GA   +Y    I   + VA+K + +    + E +          E+ ++    NPN
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII--------NEILVMRENKNPN 77

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++ ++ +        V+ EYL+ GSL   + +     +   ++ A+  +  + ++++HS 
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN 134

Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYG 361
            VIHRD+K +N+L+  +  +K+ DFG  C ++  +    S   GT  WMAPE++  K+YG
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPAMAALIEQC 419
            KVD++S G++  EMV G  PY   NP++A + ++  N  P +  P          + +C
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPERLSAVFRDFLNRC 252

Query: 420 WSLQPDKR 427
             +  D+R
Sbjct: 253 LEMDVDRR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 99.5 bits (248), Expect = 5e-23
 Identities = 57/162 (35%), Positives = 88/162 (54%), Gaps = 6/162 (3%)

Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           L L  LI+ +  +ARGME++ S+  IHRDL   N+L+ +   +KI DFG+A  ++Y D  
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA-RDIYKDPD 228

Query: 341 SDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
               G  R    WMAPE I  K Y  + DV+SFG++LWE+ + G  PY  +   +     
Sbjct: 229 YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR 288

Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           + +  R   P    P + +++  CW   P+ RP F  +V++L
Sbjct: 289 LKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 98.3 bits (245), Expect = 5e-23
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 19/218 (8%)

Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           + KQ  RE+ ++    +P ++ F  A       C+  E++  GSL     K     +P+ 
Sbjct: 46  VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG--GPIPVE 103

Query: 285 KLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  IA+ +  G+ Y+++   ++HRD+KP N+L++    +K+ DFG++ E +  ++++D 
Sbjct: 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADT 161

Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA-------- 394
             GT  +M+PE I+   Y  K DV+S G+ + E+  G  P+   N               
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL 221

Query: 395 ---VVNKNLRPAIP-GDCPPAMAALIEQCWSLQPDKRP 428
              +V +   P +P  D P  +   ++ C    P +RP
Sbjct: 222 LQQIVQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 99.1 bits (247), Expect = 5e-23
 Identities = 45/125 (36%), Positives = 76/125 (60%), Gaps = 3/125 (2%)

Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + EYL+ G L    H          +    A +I  G++++H +G+I+RDLK +NVL+D+
Sbjct: 74  VMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131

Query: 320 EFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           + H+KIADFG+  E +  +  +    GT  ++APE++K + Y   VD +SFG++L+EM+ 
Sbjct: 132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191

Query: 379 GTIPY 383
           G  P+
Sbjct: 192 GQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 99.3 bits (247), Expect = 6e-23
 Identities = 56/162 (34%), Positives = 87/162 (53%), Gaps = 6/162 (3%)

Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           L +  LI  +  +ARGME++ S+  IHRDL   N+L+ +   +KI DFG+A  ++Y D  
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA-RDIYKDPD 229

Query: 341 SDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
               G+ R    WMAPE I  K Y  + DV+SFG++LWE+ + G  PY  +   +     
Sbjct: 230 YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR 289

Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +    R   P +  P +  ++  CW   P +RP F  +V++L
Sbjct: 290 LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 96.9 bits (241), Expect = 1e-22
 Identities = 60/231 (25%), Positives = 114/231 (49%), Gaps = 8/231 (3%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           V +K I +    ++E LAA+       E  +L  L +PN+I++     +     ++ EY 
Sbjct: 28  VIIKQIPVEQMTKDERLAAQ------NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81

Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHL 323
             G+L  Y+ K  +  L    ++   + I   + ++H++ ++HRDLK +N+L+D+ +  +
Sbjct: 82  PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVV 141

Query: 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           KI DFGI+             GT  +++PE+ + K Y +K D+++ G +L+E+ +    +
Sbjct: 142 KIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201

Query: 384 EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIV 434
           E  N       +++    P I     P +  LI    +L P KRP+   I+
Sbjct: 202 EAANLPALVLKIMSGTFAP-ISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 1e-22
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 33/229 (14%)

Query: 231 REVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
           REV  L +L  +PN++K     ++      + EY+ EG+L   +   + K      + +I
Sbjct: 46  REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSI 104

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
              I +G+ +IH  G  HRDLKPEN+L+     +KIADFG+A E       +D   T RW
Sbjct: 105 IYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-RW 163

Query: 350 M-APEMI-KHKSYGRKVDVYSFGLILWEMV------AGTIPYEEMNPIQA---------- 391
             APE++ +  SY   VD+++ G I+ E+        G+   +++  I +          
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223

Query: 392 --AFAVVNK-NLR-PAIPG--------DCPPAMAALIEQCWSLQPDKRP 428
              + + +K   R P            +  P    LI+      P KRP
Sbjct: 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP 272

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)

Query: 206 AVKIIRIPD-DDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           A+K+++  D   +N+    + E+       ++ +  +P V K   + +      ++ EYL
Sbjct: 25  AIKVLKKSDMIAKNQVTNVKAERAI-----MMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79

Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
           + G   + +  L    LP         ++  G+E +H +G+IHRD+KPEN+LIDQ  HLK
Sbjct: 80  NGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK 137

Query: 325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
           + DFG++      +      GT  ++APE I      +  D +S G +++E + G  P+ 
Sbjct: 138 LTDFGLS-RNGLEN--KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194

Query: 385 EMNPIQAAFAVVNKNLRPAIPGD----CPPAMAALIEQCWSLQPDKR 427
              P  A F  +    R   P +    C P    LI +   + P KR
Sbjct: 195 AETP-DAVFDNILSR-RINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 55/182 (30%), Positives = 95/182 (52%), Gaps = 12/182 (6%)

Query: 206 AVKIIR---IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
           A+K ++   I   DE E+L    EK   R     +   +P ++   A  +     C + E
Sbjct: 28  AIKALKKGDIIARDEVESL--MCEK---RIFETANSERHPFLVNLFACFQTEDHVCFVME 82

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
           Y + G L  ++H         P+ +  A  +  G++Y+H   +++RDLK +N+L+D E  
Sbjct: 83  YAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF 139

Query: 323 LKIADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381
           +KIADFG+  E + + D  S   GT  ++APE++   SY R VD +  G++++EM+ G  
Sbjct: 140 VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199

Query: 382 PY 383
           P+
Sbjct: 200 PF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 63/237 (26%), Positives = 110/237 (46%), Gaps = 26/237 (10%)

Query: 204 PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY 263
           PVA+K I+  D    +T     +         +  L +  +++ +  C    +  ++T+ 
Sbjct: 38  PVAIKTIQ--DRSGRQTFQEITDHMLA-----MGSLDHAYIVRLLGICPGASLQ-LVTQL 89

Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
              GSL  ++ +      P  +L+   + IA+GM Y+    ++HR+L   N+L+  +  +
Sbjct: 90  SPLGSLLDHVRQHRDSLDP-QRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIV 148

Query: 324 KIADFGIACEEVYCDALSDDPGTY---------RWMAPEMIKHKSYGRKVDVYSFGLILW 374
           +IADFG+A      D L  D   Y         +WMA E I    Y  + DV+S+G+ +W
Sbjct: 149 QIADFGVA------DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVW 202

Query: 375 EMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           EM++ G  PY  M P      ++ K  R A P  C   +  ++ +CW +  + RP F
Sbjct: 203 EMMSYGAEPYAGMRP-HEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTF 258

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 97.0 bits (241), Expect = 3e-22
 Identities = 48/125 (38%), Positives = 81/125 (64%), Gaps = 3/125 (2%)

Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + EYL+ G L  ++    HK   LP+    A +I  G++++HS+G+++RDLK +N+L+D 
Sbjct: 74  VMEYLNGGDLMFHIQSC-HK-FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131

Query: 320 EFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           + H+KIADFG+  E +  DA +    GT  ++APE++  + Y   VD +SFG++L+EM+ 
Sbjct: 132 DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI 191

Query: 379 GTIPY 383
           G  P+
Sbjct: 192 GQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 97.0 bits (241), Expect = 3e-22
 Identities = 58/167 (34%), Positives = 87/167 (52%), Gaps = 6/167 (3%)

Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           L  K L L  LI  +  +A+GME++ S+  IHRDL   N+L+ +   +KI DFG+A  ++
Sbjct: 171 LYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA-RDI 229

Query: 336 YCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390
           Y D      G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  +   +
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289

Query: 391 AAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
                + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 290 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 95.9 bits (238), Expect = 5e-22
 Identities = 56/170 (32%), Positives = 93/170 (54%), Gaps = 7/170 (4%)

Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           R E  FN EV ++   H+ NV+    +        V+ E+L  G+L   +    H  +  
Sbjct: 62  RRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNE 117

Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            ++  + L + R + Y+H+QGVIHRD+K +++L+  +  +K++DFG  C +V  +     
Sbjct: 118 EQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGF-CAQVSKEVPKRK 176

Query: 344 P--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
              GT  WMAPE+I    YG +VD++S G+++ EM+ G  PY    P+QA
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 95.6 bits (238), Expect = 8e-22
 Identities = 76/267 (28%), Positives = 118/267 (44%), Gaps = 20/267 (7%)

Query: 177 DLSQLFLGLR-FAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           D  +LF  LR   HG+   +Y    +  +E VA+K +       NE     +     +EV
Sbjct: 12  DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII-----KEV 66

Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
             L +L +PN I++     +     ++ EY L   S    +HK   K L   ++ AI   
Sbjct: 67  RFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK---KPLQEVEIAAICHG 123

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
             +G+ Y+HS   IHRD+K  N+L+ +   +K+ADFG A         +   GT  WMAP
Sbjct: 124 ALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSAS---LVSPANSFVGTPYWMAP 180

Query: 353 EMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI-PGDC 408
           E+I       Y  KVDV+S G+   E+     P   MN + A + +  +N  P +   D 
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLSSNDW 239

Query: 409 PPAMAALIEQCWSLQPDKRPEFWHIVK 435
                  ++ C    P  RP    ++K
Sbjct: 240 SDYFRNFVDSCLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 82/272 (30%), Positives = 119/272 (43%), Gaps = 63/272 (23%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVA---ACKKPPVYC 258
           E VA+K  +I D   N T A R    F RE+  L  L  +PN++K +    A     +Y 
Sbjct: 33  EVVALK--KIFDAFRNATDAQR---TF-REIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86

Query: 259 VITEYLSEGSLRAYLHK--LE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
           V  EY+ E  L A +    LE  HK         I   + + ++YIHS  VIHRDLKP N
Sbjct: 87  VF-EYM-ETDLHAVIRANILEDVHK-------RYIMYQLLKALKYIHSGNVIHRDLKPSN 137

Query: 315 VLIDQEFHLKIADFGIA------CEEVYCDALSDDPGTYRWM-APE-MIKHKSYGRKVDV 366
           +L++ +  +K+ADFG+A       E      L+D   T RW  APE ++    Y + VD+
Sbjct: 138 ILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT-RWYRAPEILLGSTRYTKGVDM 196

Query: 367 YSFGLILWEMVAG------------------TIPY---EEMNPIQAAFAVV--------- 396
           +S G IL EM+ G                   I     E++  I++ FA           
Sbjct: 197 WSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRP 256

Query: 397 NKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
            K L   +P         L+++     P+KR 
Sbjct: 257 RKPLDELLP-KASDDALDLLKKLLVFNPNKRL 287

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 27/186 (14%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K  +  +DDE+      ++K   REV +L +L + N++    A ++     ++ EY+
Sbjct: 29  VAIKKFKESEDDED------VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82

Query: 265 SEGSLRAYLHKLEHKTLPLPKLI--AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
                R  L  LE     LP     +    + + + Y HS  +IHRD+KPEN+L+ +   
Sbjct: 83  E----RTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV 138

Query: 323 LKIADFGIACEEVYCDALSDDPGTY-------RWM-APE-MIKHKSYGRKVDVYSFGLIL 373
           LK+ DFG A       AL   P +        RW  APE ++   +YG+ VDV++ G I+
Sbjct: 139 LKLCDFGFA------RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIM 192

Query: 374 WEMVAG 379
            E++ G
Sbjct: 193 AELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 41/154 (26%), Positives = 87/154 (56%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L ++++  V+    A +     C++   ++ G L+ +++ + +      + +  A 
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
           +I  G+E +H + +++RDLKPEN+L+D   H++I+D G+A E    + +    GT  +MA
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMA 169

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           PE++K++ Y    D +  G +++EM+ G  P+ +
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 56/180 (31%), Positives = 96/180 (53%), Gaps = 15/180 (8%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAAC-----KKPPV 256
           VA+K +R+  +++   L+        REVALL RL    +PN+++ +  C      +   
Sbjct: 28  VALKSVRVQTNEDGLPLSTV------REVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81

Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             ++ E++ +  LR YL K+    LP   +  +     RG++++H+  ++HRDLKPEN+L
Sbjct: 82  VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 140

Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     +K+ADFG+A       AL+    T  + APE++   +Y   VD++S G I  EM
Sbjct: 141 VTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 59/273 (21%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIK 246
           G + ++Y   +K   + VA+KI+ I +D+E E            E  +L +  ++PN+  
Sbjct: 17  GTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---------EYNILRKYSNHPNIAT 67

Query: 247 FVAACKKPPVYCV------ITEYLSEGSLRAYLHKLEHKTLPLPK-LIA-IALDIARGME 298
           F  A  K            + E    GS+   +  L  K   L +  IA I  +  RG+ 
Sbjct: 68  FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--------GTYRWM 350
           Y+H   VIHRD+K +N+L+ +   +K+ DFG++       A  D          GT  WM
Sbjct: 128 YLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS-------AQLDSTLGRRNTFIGTPYWM 180

Query: 351 APEMIKHK-----SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
           APE+I        SY  + DV+S G+   E+  G  P  +M+P++A F          IP
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF---------KIP 231

Query: 406 GDCPPAMAA----------LIEQCWSLQPDKRP 428
            + PP + +           I +C     ++RP
Sbjct: 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRP 264

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 40/127 (31%), Positives = 72/127 (56%), Gaps = 3/127 (2%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
           C + EY + G L  + H    +     +      +I   + Y+HS  V++RDLK EN+++
Sbjct: 71  CFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128

Query: 318 DQEFHLKIADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           D++ H+KI DFG+  E +     +    GT  ++APE+++   YGR VD +  G++++EM
Sbjct: 129 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188

Query: 377 VAGTIPY 383
           + G +P+
Sbjct: 189 MCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 61/216 (28%), Positives = 111/216 (51%), Gaps = 10/216 (4%)

Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           R E  FN EV ++    + NV++   +        V+ E+L  G+L   +    H  +  
Sbjct: 60  RRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNE 115

Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            ++ A+ L + + +  +H+QGVIHRD+K +++L+  +  +K++DFG  C +V  +     
Sbjct: 116 EQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF-CAQVSKEVPRRK 174

Query: 344 P--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
              GT  WMAPE+I    YG +VD++S G+++ EMV G  PY    P++ A  ++  NL 
Sbjct: 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLP 233

Query: 402 PAIPG--DCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           P +       P++   +++     P +R     ++K
Sbjct: 234 PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 39/152 (25%), Positives = 85/152 (55%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L ++++  V+    A +     C++   ++ G L+ +++ + +      + +  A 
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
           +I  G+E +H +  ++RDLKPEN+L+D   H++I+D G+A +    +++    GT  +MA
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMA 169

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           PE++ ++ Y    D +  G +++EM+ G  P+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 93.2 bits (231), Expect = 3e-21
 Identities = 42/154 (27%), Positives = 87/154 (56%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L ++++  V+    A +     C++   ++ G L+ +++ +        + +  A 
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
           +I  G+E +H + +++RDLKPEN+L+D   H++I+D G+A        +    GT  +MA
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 169

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           PE++K++ Y    D ++ G +L+EM+AG  P+++
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 94.5 bits (235), Expect = 4e-21
 Identities = 52/164 (31%), Positives = 92/164 (56%), Gaps = 6/164 (3%)

Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           L L  L+  +  +A+GM+++ S+  IHRD+   NVL+      KI DFG+A  ++  D+ 
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA-RDIMNDSN 267

Query: 341 SDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
               G  R    WMAPE I    Y  + DV+S+G++LWE+ + G  PY  +      + +
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327

Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
           V +  + + P   PP + ++++ CW+L+P +RP F  I +++++
Sbjct: 328 VKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 92.8 bits (230), Expect = 5e-21
 Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 34/213 (15%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVK++ +      E L       FN EV ++    + NV++   +        V+ E+L
Sbjct: 49  VAVKMMDLRKQQRRELL-------FN-EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100

Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
             G+L   + +     L   ++  +   + + + Y+HSQGVIHRD+K +++L+  +  +K
Sbjct: 101 QGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVK 157

Query: 325 IADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
           ++DFG      +C  +S D        GT  WMAPE+I    YG +VD++S G+++ EMV
Sbjct: 158 LSDFG------FCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211

Query: 378 AGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
            G  PY   +P+QA      K LR     D PP
Sbjct: 212 DGEPPYFSDSPVQAM-----KRLR-----DSPP 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 93.3 bits (232), Expect = 6e-21
 Identities = 47/131 (35%), Positives = 82/131 (62%), Gaps = 5/131 (3%)

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYIHSQGVIHRDLKPENVLI 317
           +I EYLS G L  ++H LE + + +       L +I+  +E++H QG+I+RDLKPEN+L+
Sbjct: 77  LILEYLSGGEL--FMH-LEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133

Query: 318 DQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           D + H+K+ DFG+  E ++   ++    GT  +MAPE++    +G+ VD +S G ++++M
Sbjct: 134 DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDM 193

Query: 377 VAGTIPYEEMN 387
           + G  P+   N
Sbjct: 194 LTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 92.2 bits (229), Expect = 7e-21
 Identities = 52/174 (29%), Positives = 96/174 (55%), Gaps = 20/174 (11%)

Query: 224 RLEKQFNREVAL-----LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-- 276
           RL+K+   E A+     L+++H+  ++    A +     C++   ++ G LR +++ +  
Sbjct: 30  RLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDE 89

Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
           E+   P P+       I  G+E++H + +I+RDLKPENVL+D + +++I+D G+A E   
Sbjct: 90  ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVE--- 146

Query: 337 CDALSDD-------PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
              L D         GT  +MAPE+++ + Y   VD ++ G+ L+EM+A   P+
Sbjct: 147 ---LKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 93.9 bits (233), Expect = 9e-21
 Identities = 52/169 (30%), Positives = 88/169 (52%), Gaps = 6/169 (3%)

Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
           E   L    L+  +  +A GME++ S+  +HRDL   NVLI +   +KI DFG+A  ++ 
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA-RDIM 290

Query: 337 CDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
            D+     G+     +WMAPE I +  Y    DV+SFG++LWE+   G  PY E+   + 
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350

Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            +  + +  R A P      +  ++++CW  + + RP+F  +V ++   
Sbjct: 351 FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 54/192 (28%), Positives = 98/192 (51%), Gaps = 15/192 (7%)

Query: 201 KDEPVAVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
            DE  A+K+++    + DDD + T+         + +  L+  H P +       +    
Sbjct: 19  TDEVYAIKVLKKDVILQDDDVDCTMT-------EKRILALAAKH-PFLTALHCCFQTKDR 70

Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
              + EY++ G L   + +      P  +  A  + +A  + ++H  GVI+RDLK +N+L
Sbjct: 71  LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--LMFLHRHGVIYRDLKLDNIL 128

Query: 317 IDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           +D E H K+ADFG+  E +     +    GT  ++APE+++   YG  VD ++ G++++E
Sbjct: 129 LDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYE 188

Query: 376 MVAGTIPYEEMN 387
           M+AG  P+E  N
Sbjct: 189 MMAGQPPFEADN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 69/265 (26%), Positives = 115/265 (43%), Gaps = 59/265 (22%)

Query: 205 VAVKI-IRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY 263
           VA+K  +   DD   + +A R       E+ +L +L + N++  +   ++     ++ E+
Sbjct: 29  VAIKKFLESEDDKMVKKIAMR-------EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81

Query: 264 LSE---GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           +       L  Y + L+   +           I RG+E+ HS  +IHRD+KPEN+L+ Q 
Sbjct: 82  VDHTVLDDLEKYPNGLDESRVR-----KYLFQILRGIEFCHSHNIIHRDIKPENILVSQS 136

Query: 321 FHLKIADFGIA-----CEEVYCDALSDDPGTYRWM-APEM-IKHKSYGRKVDVYSFGLIL 373
             +K+ DFG A       EVY D ++      RW  APE+ +    YGR VD+++ G ++
Sbjct: 137 GVVKLCDFGFARTLAAPGEVYTDYVAT-----RWYRAPELLVGDTKYGRAVDIWAVGCLV 191

Query: 374 WEMVAGT----------------------IP-YEEM---NPIQA----AFAVVNKNLRPA 403
            EM+ G                       IP ++E+   NP+ A          + L   
Sbjct: 192 TEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKR 251

Query: 404 IPGDCPPAMAALIEQCWSLQPDKRP 428
            P      +  L +QC  + PD RP
Sbjct: 252 FP-KLSGLVLDLAKQCLRIDPDDRP 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 68/260 (26%), Positives = 122/260 (46%), Gaps = 23/260 (8%)

Query: 190 GAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           GA  ++Y    K+  V  A K+I    ++E E         +  E+ +L+   +PN++K 
Sbjct: 16  GAFGKVYKAQNKETGVLAAAKVIDTKSEEELE--------DYMVEIDILASCDHPNIVKL 67

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
           + A        ++ E+ + G++ A + +LE + L  P++  +       + Y+H   +IH
Sbjct: 68  LDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIH 126

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI-----KHKSYG 361
           RDLK  N+L   +  +K+ADFG++ +        D   GT  WMAPE++     K + Y 
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186

Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPAMAALIEQC 419
            K DV+S G+ L EM     P+ E+NP++    +  K+  P +  P          +++C
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRWSSEFKDFLKKC 245

Query: 420 WSLQPDKRPEFWHIVKVLEQ 439
                D R   W   ++L+ 
Sbjct: 246 LEKNVDAR---WTTTQLLQH 262

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 19/202 (9%)

Query: 194 RLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253
           R+       E  A+K ++     + E L  +  +   +E ++L  L +P ++  + + + 
Sbjct: 35  RIAKHKGTGEYYAIKCLK-----KREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89

Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
                 + E++  G L  +L K       + K     L +A   EY+HS+ +I+RDLKPE
Sbjct: 90  ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--FEYLHSKDIIYRDLKPE 147

Query: 314 NVLIDQEFHLKIADFGIA---CEEVY--CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
           N+L+D + H+K+ DFG A    +  +  C       GT  ++APE+I+ K +G+ VD ++
Sbjct: 148 NLLLDNKGHVKVTDFGFAKKVPDRTFTLC-------GTPEYLAPEVIQSKGHGKAVDWWT 200

Query: 369 FGLILWEMVAGTIPYEEMNPIQ 390
            G++L+E +AG  P+ +  P +
Sbjct: 201 MGVLLYEFIAGYPPFFDDTPFR 222

Length = 329

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 91.0 bits (226), Expect = 3e-20
 Identities = 57/187 (30%), Positives = 99/187 (52%), Gaps = 23/187 (12%)

Query: 220 TLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK 279
           TL  R   +   E  +L+ +++P ++K   A +      +I ++L  G L   L K    
Sbjct: 36  TLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 95

Query: 280 TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV---- 335
           T    K     L  A  ++++HS G+I+RDLKPEN+L+D+E H+K+ DFG++ E +    
Sbjct: 96  TEEDVKFYLAEL--ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153

Query: 336 ----YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY------EE 385
               +C       GT  +MAPE++  + + +  D +SFG++++EM+ G++P+      E 
Sbjct: 154 KAYSFC-------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET 206

Query: 386 MNPIQAA 392
           M  I  A
Sbjct: 207 MTMILKA 213

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 20/248 (8%)

Query: 190 GAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           GA  ++Y    K+     A K+I    ++E E         +  E+ +L+  ++P ++K 
Sbjct: 23  GAFGKVYKAKNKETGALAAAKVIETKSEEELE--------DYMVEIEILATCNHPYIVKL 74

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
           + A        ++ E+   G++ A + +L+ + L  P++  I   +   ++Y+HS  +IH
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIH 133

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI-----KHKSYG 361
           RDLK  NVL+  +  +K+ADFG++ + V      D   GT  WMAPE++     K   Y 
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193

Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS 421
            K D++S G+ L EM     P+ E+NP++    +  K+  P +    P   +        
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTL--SQPSKWSMEFRDFLK 250

Query: 422 LQPDKRPE 429
              DK PE
Sbjct: 251 TALDKHPE 258

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 58/185 (31%), Positives = 91/185 (49%), Gaps = 21/185 (11%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K  +IP   +  TLA R      RE+ +L    + N+I  +    +PP       Y+
Sbjct: 33  VAIK--KIPHAFDVPTLAKRTL----RELKILRHFKHDNIIA-IRDILRPPGADFKDVYV 85

Query: 265 SEGSLRAYLHKLEHKTLPLP-KLIAIAL-DIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
               + + LH + H   PL  + I   L  + RG++YIHS  VIHRDLKP N+L++++  
Sbjct: 86  VMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE 145

Query: 323 LKIADFGIACEEVYCDALSDDPGTY-------RWM-APE-MIKHKSYGRKVDVYSFGLIL 373
           L+I DFG+A       +   +   +       RW  APE ++    Y   +D++S G I 
Sbjct: 146 LRIGDFGMA--RGLSSS-PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIF 202

Query: 374 WEMVA 378
            EM+ 
Sbjct: 203 AEMLG 207

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 68/275 (24%), Positives = 132/275 (48%), Gaps = 20/275 (7%)

Query: 178 LSQLFLGLRFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           L+   +  +   G  S +Y    +   +PVA+K ++I      E + A+  +   +E+ L
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQI-----FEMMDAKARQDCVKEIDL 55

Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLH--KLEHKTLPLPKLIAIALDI 293
           L +L++PNVIK++ +  +     ++ E    G L   +   K + + +P   +    + +
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI----ACEEVYCDALSDDPGTYRW 349
              +E++HS+ V+HRD+KP NV I     +K+ D G+    + +     +L    GT  +
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYY 172

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIPGD 407
           M+PE I    Y  K D++S G +L+EM A   P+  ++MN       +   +  P +P +
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY-PPLPTE 231

Query: 408 -CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE 441
                +  L+  C    PD+RP+  ++ ++ +Q  
Sbjct: 232 HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 89.7 bits (222), Expect = 4e-20
 Identities = 69/259 (26%), Positives = 123/259 (47%), Gaps = 14/259 (5%)

Query: 186 RFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G  S +Y         PVA+K ++I D      + A+      +E+ LL +L++PN
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFD-----LMDAKARADCIKEIDLLKQLNHPN 63

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLH--KLEHKTLPLPKLIAIALDIARGMEYIH 301
           VIK+ A+  +     ++ E    G L   +   K + + +P   +    + +   +E++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           S+ V+HRD+KP NV I     +K+ D G+         A     GT  +M+PE I    Y
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 361 GRKVDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIPGD-CPPAMAALIE 417
             K D++S G +L+EM A   P+  ++MN + +    + +   P +P D     +  L+ 
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPPLPSDHYSEELRQLVN 242

Query: 418 QCWSLQPDKRPEFWHIVKV 436
            C +  P+KRP+  ++  V
Sbjct: 243 MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 57/262 (21%)

Query: 199 IYKDEPVAVKIIRIPD-DDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
               +  A+K++R  D    N+    R E+        L+   +P ++K   + +     
Sbjct: 23  KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI------LADADSPWIVKLYYSFQDEEHL 76

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKL-------IAIALDIARGMEYIHSQGVIHRDL 310
            ++ EY+  G L   L + +    P  +        + +ALD       +H  G IHRD+
Sbjct: 77  YLVMEYMPGGDLMNLLIRKD--VFP-EETARFYIAELVLALD------SVHKLGFIHRDI 127

Query: 311 KPENVLIDQEFHLKIADFGIA-------CEEVYCDALSDDP------------------- 344
           KP+N+LID + H+K+ADFG+          E Y +   +                     
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187

Query: 345 ----GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN--K 398
               GT  ++APE+++   YG + D +S G+IL+EM+ G  P+      +    ++N  +
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKE 247

Query: 399 NLR-PAIPGDCPPAMAALIEQC 419
           +LR P  P   P A+  LI + 
Sbjct: 248 SLRFPPDPPVSPEAI-DLICRL 268

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 89.5 bits (222), Expect = 4e-20
 Identities = 48/202 (23%), Positives = 100/202 (49%), Gaps = 6/202 (2%)

Query: 238 RLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK--TLPLPKLIAIALDIAR 295
           +L +PN++++     +     ++ + +    L  + + L+ K       ++  I + +  
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 296 GMEYIHSQG-VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEM 354
            + Y+H +  ++HRDL P N+++ ++  + I DFG+A ++     L+   GT  +  PE+
Sbjct: 125 ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEI 184

Query: 355 IKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA 414
           +K++ YG K DV++FG IL++M     P+   N +  A  +V     P   G     +  
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTD 244

Query: 415 LIEQCWSLQPDKRPEFWHIVKV 436
           +I  C +   + RP+   I++V
Sbjct: 245 VITSCLTPDAEARPD---IIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 90.0 bits (223), Expect = 6e-20
 Identities = 47/125 (37%), Positives = 79/125 (63%), Gaps = 3/125 (2%)

Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + E+L+ G L    H  +     L +    A +I  G++++HS+G+I+RDLK +NV++D+
Sbjct: 74  VMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131

Query: 320 EFHLKIADFGIACEEVYCDA-LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           + H+KIADFG+  E V+ D   S   GT  ++APE+++   Y   VD +SFG++L+EM+ 
Sbjct: 132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191

Query: 379 GTIPY 383
           G  P+
Sbjct: 192 GQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 17/233 (7%)

Query: 183 LGLRFAHGAHSRLY--HGIYKDEPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRL 239
           LG     GA  R+Y  +       +AVK ++  P+  E       LE     E+ LL  L
Sbjct: 6   LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC----EIQLLKNL 61

Query: 240 HNPNVIKFVAACKKPP--VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGM 297
            +  ++++    + P      +  E++  GS++  L      T  + +       I  G+
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR--KYTRQILEGV 119

Query: 298 EYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-----PGTYRWMAP 352
            Y+HS  ++HRD+K  N+L D   ++K+ DFG A + +    LS        GT  WM+P
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFG-ASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
           E+I  + YGRK D++S G  + EM+    P+ E   + A F +  +   P +P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 90.0 bits (223), Expect = 8e-20
 Identities = 57/188 (30%), Positives = 102/188 (54%), Gaps = 17/188 (9%)

Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           AVK+++    + DDD   T+    EK+    +  L+R H P + +     + P     + 
Sbjct: 24  AVKVLKKDVILQDDDVECTMT---EKR----ILSLARNH-PFLTQLYCCFQTPDRLFFVM 75

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           E+++ G L  ++ K   +     +    A +I   + ++H +G+I+RDLK +NVL+D E 
Sbjct: 76  EFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG 133

Query: 322 HLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
           H K+ADFG+ C+E   +  +     GT  ++APE+++   YG  VD ++ G++L+EM+ G
Sbjct: 134 HCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Query: 380 TIPYEEMN 387
             P+E  N
Sbjct: 193 HAPFEAEN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 70/257 (27%), Positives = 122/257 (47%), Gaps = 21/257 (8%)

Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNV 244
           R A G  +++ H       +AVK IR   D+       + +K+   ++ ++ R  + P +
Sbjct: 14  RGAFGTVNKMLHKPSGTI-MAVKRIRSTVDE-------KEQKRLLMDLDVVMRSSDCPYI 65

Query: 245 IKFVAACKKPPVYCVITEYLSEGSLR---AYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
           +KF  A  +    C I   L + SL     Y++++    +P   L  IA+   + + Y+ 
Sbjct: 66  VKFYGALFREGD-CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124

Query: 302 SQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI---KH 357
            +  +IHRD+KP N+L+D+  ++K+ DFGI+ + V   A + D G   +MAPE I     
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAR 184

Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI-QAAFAVVNKN---LRPAIPGDCPPAMA 413
             Y  + DV+S G+ L+E+  G  PY + N +      VV  +   L  +   +  P+  
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFV 244

Query: 414 ALIEQCWSLQPDKRPEF 430
             I  C      KRP++
Sbjct: 245 NFINLCLIKDESKRPKY 261

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 73/233 (31%), Positives = 106/233 (45%), Gaps = 60/233 (25%)

Query: 196 YHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF-- 247
           Y  +YK       E VA+K IR+  +DE     A       RE++LL  L++PN+++   
Sbjct: 12  YGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI------REISLLKELNHPNIVRLLD 65

Query: 248 -VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
            V +  K  +Y V  E+L    L+ Y+       L  P + +    + +G+ Y HS  V+
Sbjct: 66  VVHSENK--LYLVF-EFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121

Query: 307 HRDLKPENVLIDQEFHLKIADFGIA----------CEEVYCDALSDDPGTYRWMAPE-MI 355
           HRDLKP+N+LID+E  LK+ADFG+A            EV          T  + APE ++
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILL 172

Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC 408
             + Y   VD++S G I  EMV                     N RP  PGD 
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMV---------------------NRRPLFPGDS 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 57/177 (32%), Positives = 95/177 (53%), Gaps = 9/177 (5%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
           E VA+K IR+  + E     A       RE++LL  L++PN++K +          ++ E
Sbjct: 26  EVVALKKIRLDTETEGVPSTAI------REISLLKELNHPNIVKLLDVIHTENKLYLVFE 79

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
           +L +  L+ ++       +PLP + +    + +G+ + HS  V+HRDLKP+N+LI+ E  
Sbjct: 80  FLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 138

Query: 323 LKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMV 377
           +K+ADFG+A    V     + +  T  + APE ++  K Y   VD++S G I  EMV
Sbjct: 139 IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 52/169 (30%), Positives = 93/169 (55%), Gaps = 7/169 (4%)

Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + +Y++ G L  + H    ++ P P+    A +IA  + Y+HS  +I+RDLKPEN+L+D 
Sbjct: 74  VLDYVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS 131

Query: 320 EFHLKIADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           + H+ + DFG+  E + +    S   GT  ++APE+++ + Y R VD +  G +L+EM+ 
Sbjct: 132 QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191

Query: 379 GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           G  P+   +  +    ++NK LR  +  +   +   L+E    LQ D+ 
Sbjct: 192 GLPPFYSRDTAEMYDNILNKPLR--LKPNISVSARHLLEGL--LQKDRT 236

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 48/172 (27%), Positives = 91/172 (52%), Gaps = 7/172 (4%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
           C + EY + G L  + H    +     +      +I   +EY+HS+ V++RD+K EN+++
Sbjct: 71  CFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128

Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           D++ H+KI DFG+ C+E   D  +     GT  ++APE+++   YGR VD +  G++++E
Sbjct: 129 DKDGHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 187

Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           M+ G +P+   +  +    ++ + +R   P    P   +L+       P +R
Sbjct: 188 MMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 42/128 (32%), Positives = 77/128 (60%), Gaps = 5/128 (3%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
           C + EY++ G L  + H    +     +      +I   ++Y+HS  +++RDLK EN+++
Sbjct: 71  CFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128

Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           D++ H+KI DFG+ C+E   DA +     GT  ++APE+++   YGR VD +  G++++E
Sbjct: 129 DKDGHIKITDFGL-CKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 187

Query: 376 MVAGTIPY 383
           M+ G +P+
Sbjct: 188 MMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 87.5 bits (216), Expect = 2e-19
 Identities = 68/264 (25%), Positives = 125/264 (47%), Gaps = 26/264 (9%)

Query: 188 AHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNV 244
            +G + ++Y G  +   +  A+K++ +  D+E E           +E+ +L +  H+ N+
Sbjct: 15  GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---------IKQEINMLKKYSHHRNI 65

Query: 245 IKFVAAC--KKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
             +  A   K PP       ++ E+   GS+   +   +  TL    +  I  +I RG+ 
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIK- 356
           ++H   VIHRD+K +NVL+ +   +K+ DFG++ + +      +   GT  WMAPE+I  
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 357 ----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG-DCPPA 411
                 +Y  K D++S G+   EM  G  P  +M+P++A F ++ +N  P +        
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSKKWSKK 244

Query: 412 MAALIEQCWSLQPDKRPEFWHIVK 435
             + IE C      +RP    ++K
Sbjct: 245 FQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 73/259 (28%), Positives = 118/259 (45%), Gaps = 18/259 (6%)

Query: 177 DLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           D  ++F+GL    HG+   +Y     + +E VAVK +       NE       +   +EV
Sbjct: 18  DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW-----QDIIKEV 72

Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
             L +L +PN I++     K     ++ EY L   S    +HK   K L   ++ AI   
Sbjct: 73  KFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHG 129

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
             +G+ Y+HS  +IHRD+K  N+L+ +   +K+ADFG A +    ++     GT  WMAP
Sbjct: 130 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV---GTPYWMAP 186

Query: 353 EMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           E+I       Y  KVDV+S G+   E+     P   MN + A + +   +       +  
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWT 246

Query: 410 PAMAALIEQCWSLQPDKRP 428
            +    ++ C    P +RP
Sbjct: 247 DSFRGFVDYCLQKIPQERP 265

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 64/182 (35%), Positives = 91/182 (50%), Gaps = 20/182 (10%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--PVYCVI 260
           + VA+K I  P           L K+  RE+ LL  L + N+I        P   +Y V 
Sbjct: 36  QNVAIKKIMKPFS------TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV- 88

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVLID 318
           TE L        LH+L   + PL K         I RG++Y+HS GV+HRDLKP N+LI+
Sbjct: 89  TELLGTD-----LHRL-LTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142

Query: 319 QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMV 377
           +   LKI DFG+A   +    ++    T  + APE M+  + Y  +VD++S G I  EM+
Sbjct: 143 ENCDLKICDFGLA--RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Query: 378 AG 379
            G
Sbjct: 201 EG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 86.9 bits (215), Expect = 3e-19
 Identities = 54/213 (25%), Positives = 108/213 (50%), Gaps = 15/213 (7%)

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +EV LL+++ +PN++ F A+ ++     ++ EY   G L   +++         ++++  
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107

Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL-KIADFGIACEEVYCDALSDD------ 343
           + I+ G+++IH + ++HRD+K +N+ + +   + K+ DFGIA        L+D       
Sbjct: 108 VQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA------RQLNDSMELAYT 161

Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  +++PE+ +++ Y  K D++S G +L+E+     P+E  N  Q    +      P
Sbjct: 162 CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP 221

Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
             P      + +LI Q + + P  RP    I+K
Sbjct: 222 ISPN-FSRDLRSLISQLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 56/161 (34%), Positives = 83/161 (51%), Gaps = 16/161 (9%)

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITE-YLSEGSLRAYLHKLEHKTLPLPK--LI 287
           RE+ +L R  + N+I  +    +PP +    + Y+ +  +   L+KL  KT  L    + 
Sbjct: 52  REIKILRRFKHENIIGILDI-IRPPSFESFNDVYIVQELMETDLYKLI-KTQHLSNDHIQ 109

Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY 347
                I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A      D   D  G  
Sbjct: 110 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA---RIADPEHDHTGFL 166

Query: 348 ------RWM-APE-MIKHKSYGRKVDVYSFGLILWEMVAGT 380
                 RW  APE M+  K Y + +D++S G IL EM++  
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 86.7 bits (214), Expect = 4e-19
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 23/235 (9%)

Query: 184 GLRFAHGAHSRLY--HGIYKDEPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRLH 240
           G     GA  R+Y  + +     +A K ++  P+  E     + LE     E+ LL  L 
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQ 62

Query: 241 NPNVIKFVAACKK--PPVYCVITEYLSEGS----LRAYLHKLEHKTLPLPKLIAIALDIA 294
           +  ++++    +        +  EY+  GS    L+AY    E  T    +       I 
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR------QIL 116

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-EVYC---DALSDDPGTYRWM 350
            GM Y+HS  ++HRD+K  N+L D   ++K+ DFG +   +  C     +    GT  WM
Sbjct: 117 EGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
           +PE+I  + YGRK DV+S G  + EM+    P+ E   + A F +  +   P +P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 39/217 (17%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L+   NP V+    + +     C++ EY+  G     L  +      LP      +
Sbjct: 51  ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG----ALP------V 100

Query: 292 DIAR--------GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-------CEEVY 336
           D+AR         +EY+H+ G++HRDLKP+N+LI    H+K+ DFG++          +Y
Sbjct: 101 DMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160

Query: 337 CDALSDDP---------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
              +  D          GT  ++APE+I  + YG+ VD ++ G+IL+E + G +P+    
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220

Query: 388 PIQAAFAVVNKNLR-----PAIPGDCPPAMAALIEQC 419
           P +    V++ ++       A+P D    ++ L+ Q 
Sbjct: 221 PEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQN 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 87.1 bits (215), Expect = 8e-19
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 22/279 (7%)

Query: 177 DLSQLFLGLR-FAHGAHSRLY--HGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           D  +LF  LR   HG+   +Y    +  +E VA+K +       NE       +   +EV
Sbjct: 22  DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW-----QDIIKEV 76

Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
             L R+ +PN I++     +     ++ EY L   S    +HK   K L   ++ AI   
Sbjct: 77  KFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHG 133

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
             +G+ Y+HS  +IHRD+K  N+L+ +   +K+ADFG A      ++     GT  WMAP
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV---GTPYWMAP 190

Query: 353 EMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           E+I       Y  KVDV+S G+   E+     P   MN + A + +           +  
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS 250

Query: 410 PAMAALIEQCWSLQPDKRPE----FWHIVKVLEQFETSL 444
                 ++ C    P  RP       H+  + E+ ET L
Sbjct: 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVL 289

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 54/154 (35%), Positives = 80/154 (51%), Gaps = 18/154 (11%)

Query: 231 REVALLSRLHNPNVIKFVAA-CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL-PKLI- 287
           RE+ LL  L +PN+I  +     K  +  V  E++ E  L   +     K++ L P  I 
Sbjct: 51  REIKLLQELKHPNIIGLLDVFGHKSNINLVF-EFM-ETDLEKVIKD---KSIVLTPADIK 105

Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY 347
           +  L   RG+EY+HS  ++HRDLKP N+LI  +  LK+ADFG+A          +   T+
Sbjct: 106 SYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS----PNRKMTH 161

Query: 348 ----RWM-APEMI-KHKSYGRKVDVYSFGLILWE 375
               RW  APE++   + YG  VD++S G I  E
Sbjct: 162 QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 4/148 (2%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYC-VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           E  LL  +++P+VI+         + C V+  Y S+  L  YL K   + LP+ + + I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD--LYTYLTK-RSRPLPIDQALIIE 163

Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM 350
             I  G+ Y+H+Q +IHRD+K EN+ I+    + I D G A   V   A     GT    
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223

Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA 378
           APE++    Y  K D++S G++L+EM+A
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 56/180 (31%), Positives = 94/180 (52%), Gaps = 15/180 (8%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACK-----KPPV 256
           VA+K +R+   +E   L+        REVA+L  L    +PNV++    C      +   
Sbjct: 30  VALKRVRVQTGEEGMPLSTI------REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83

Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             ++ E++ +  L  YL K+    +P   +  +   + RG++++HS  V+HRDLKP+N+L
Sbjct: 84  LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 142

Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     +K+ADFG+A    +  AL+    T  + APE++   SY   VD++S G I  EM
Sbjct: 143 VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 47/162 (29%), Positives = 88/162 (54%), Gaps = 5/162 (3%)

Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + ++++ G L  + H    ++ P P+    A +IA  + Y+HS  +++RDLKPEN+L+D 
Sbjct: 74  VLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS 131

Query: 320 EFHLKIADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           + H+ + DFG+  E +   D  +   GT  ++APE+I+ + Y   VD +  G +L+EM+ 
Sbjct: 132 QGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY 191

Query: 379 GTIPYEEMNPIQAAFAVVNK--NLRPAIPGDCPPAMAALIEQ 418
           G  P+   +  +    +++K   LRP         +  L+E+
Sbjct: 192 GLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEK 233

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 7/205 (3%)

Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
           LL  L +P ++    + +       + +Y++ G L  + H    +    P+    A ++A
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVA 106

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-DALSDDPGTYRWMAPE 353
             + Y+HS  +I+RDLKPEN+L+D + H+ + DFG+  E V   +  S   GT  ++APE
Sbjct: 107 SAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE 166

Query: 354 MIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           +++ + Y R VD +  G +L+EM+ G  P+   +  Q    +++K L+  +PG    A  
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ--LPGGKTVAAC 224

Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLE 438
            L+     L  D+R         LE
Sbjct: 225 DLLVGL--LHKDQRRRLGAKADFLE 247

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 71/261 (27%), Positives = 120/261 (45%), Gaps = 28/261 (10%)

Query: 183 LGLRFAHGAHSRLYHGIYKDEPVAVKIIRIP-DDDENETLAARLEKQFNR---EVALLSR 238
           LG     GA   +Y     D    + + ++P D D  ET      K+ N    E+ LL  
Sbjct: 6   LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQET-----SKEVNALECEIQLLKN 60

Query: 239 LHNPNVIKFVAACKKPP--VYCVITEYLSEGS----LRAYLHKLEHKTLPLPKLIAIALD 292
           L +  ++++    + P      +  EY+  GS    L+AY    E+ T    +       
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR------Q 114

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-----PGTY 347
           I +G+ Y+HS  ++HRD+K  N+L D   ++K+ DFG A + +    +S        GT 
Sbjct: 115 ILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG-ASKRIQTICMSGTGIKSVTGTP 173

Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
            WM+PE+I  + YGRK DV+S    + EM+    P+ E   + A F +  +  +P +P  
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233

Query: 408 CPPAMAALIEQCWSLQPDKRP 428
              A    ++Q + ++  +RP
Sbjct: 234 VSDACRDFLKQIF-VEEKRRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 55/178 (30%), Positives = 98/178 (55%), Gaps = 14/178 (7%)

Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + EY++ G L    H    + LP       + +I+  + Y+H +G+I+RDLK +NVL+D 
Sbjct: 74  VIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131

Query: 320 EFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           E H+K+ D+G+  E +   D  S   GT  ++APE+++ + YG  VD ++ G++++EM+A
Sbjct: 132 EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191

Query: 379 GTIPYEEM----NPIQAA----FAVV-NKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           G  P++ +    NP Q      F V+  K +R  IP       A++++   +  P +R
Sbjct: 192 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 46/145 (31%), Positives = 83/145 (57%), Gaps = 9/145 (6%)

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           ++ EY++ G L    H    + LP       A +I   + ++H +G+I+RDLK +NVL+D
Sbjct: 73  LVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130

Query: 319 QEFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
            + H+K+ D+G+  E +   D  S   GT  ++APE+++ + YG  VD ++ G++++EM+
Sbjct: 131 ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 190

Query: 378 AGTIPYE------EMNPIQAAFAVV 396
           AG  P++      +MN     F V+
Sbjct: 191 AGRSPFDIITDNPDMNTEDYLFQVI 215

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 62/242 (25%), Positives = 117/242 (48%), Gaps = 33/242 (13%)

Query: 188 AHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNV 244
            +G + ++Y G  +   +  A+K++ + +D+E E            E+ +L +  H+ N+
Sbjct: 25  GNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEE---------IKLEINMLKKYSHHRNI 75

Query: 245 IKFVAAC--KKPPVY----CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
             +  A   K PP +     ++ E+   GS+   +   +   L    +  I  +I RG+ 
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIK- 356
           ++H+  VIHRD+K +NVL+ +   +K+ DFG++ + +      +   GT  WMAPE+I  
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 357 ----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
                 +Y  + D++S G+   EM  G  P  +M+P++A F          IP + PP +
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPPPKL 246

Query: 413 AA 414
            +
Sbjct: 247 KS 248

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 87.6 bits (217), Expect = 4e-18
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 26/224 (11%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP--VYCVITE 262
           VA+K++R  D  E E   AR    F RE AL +RL++PN++  + + + PP  ++ V  E
Sbjct: 6   VAIKLLRT-DAPEEEHQRAR----FRRETALCARLYHPNIVALLDSGEAPPGLLFAVF-E 59

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQ 319
           Y+   +LR  L       LP  +   + L +   +   H+QG++HRDLKP+N+++     
Sbjct: 60  YVPGRTLREVLAA--DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117

Query: 320 EFHLKIADFGI--------ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGL 371
             H K+ DFGI          +       ++  GT  + APE ++ +      D+Y++GL
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 372 ILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           I  E + G    +  +  +    ++ + L P +    PP +A  
Sbjct: 178 IFLECLTGQRVVQGASVAE----ILYQQLSP-VDVSLPPWIAGH 216

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 83.8 bits (207), Expect = 5e-18
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 21/195 (10%)

Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           ++L+S    P ++    A   P     I + ++ G L  + H  +H      ++   A +
Sbjct: 48  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEAEMRFYAAE 105

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----GTYR 348
           I  G+E++H++ V++RDLKP N+L+D+  H++I+D G+A     CD     P    GT+ 
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 160

Query: 349 WMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEEM-----NPIQAAFAVVNKNLRP 402
           +MAPE++ K  +Y    D +S G +L++++ G  P+ +      + I      +      
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----V 216

Query: 403 AIPGDCPPAMAALIE 417
            +P    P + +L+E
Sbjct: 217 ELPDSFSPELRSLLE 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 57/180 (31%), Positives = 93/180 (51%), Gaps = 18/180 (10%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K IR+  ++E     A       RE++LL  L +PN++       +     +I E+L
Sbjct: 28  VAMKKIRLESEEEGVPSTAI------REISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81

Query: 265 SEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
           S   L+ YL  L + + +    + +    I +G+ + HS+ V+HRDLKP+N+LID +  +
Sbjct: 82  SM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVI 140

Query: 324 KIADFGIACE-----EVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMV 377
           K+ADFG+A        VY    + +  T  + APE ++    Y   VD++S G I  EM 
Sbjct: 141 KLADFGLARAFGIPVRVY----THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 83.9 bits (207), Expect = 8e-18
 Identities = 47/162 (29%), Positives = 87/162 (53%), Gaps = 5/162 (3%)

Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + +Y++ G L  + H    +    P+    A +IA  + Y+HS  +++RDLKPEN+L+D 
Sbjct: 74  VLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS 131

Query: 320 EFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           + H+ + DFG+  E +  +  +    GT  ++APE++  + Y R VD +  G +L+EM+ 
Sbjct: 132 QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 191

Query: 379 GTIPYEEMNPIQAAFAVVNK--NLRPAIPGDCPPAMAALIEQ 418
           G  P+   N  +    ++NK   L+P I       +  L+++
Sbjct: 192 GLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 233

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 83.5 bits (206), Expect = 8e-18
 Identities = 39/154 (25%), Positives = 85/154 (55%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L ++++  V+    A +     C++   ++ G L+ +++ + +      + I  A 
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
           ++  G+E +  + +++RDLKPEN+L+D   H++I+D G+A +    + +    GT  +MA
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMA 169

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           PE+I ++ Y    D +  G +++EM+ G  P+ +
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.6 bits (206), Expect = 9e-18
 Identities = 73/260 (28%), Positives = 114/260 (43%), Gaps = 20/260 (7%)

Query: 177 DLSQLFLGLR-FAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           D  +LF  LR   HG+   +Y    +   E VA+K +       NE       +   +EV
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-----QDIIKEV 66

Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
             L +L +PN I++     +     ++ EY L   S    +HK   K L   ++ A+   
Sbjct: 67  RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHG 123

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
             +G+ Y+HS  +IHRD+K  N+L+ +   +K+ DFG A      +      GT  WMAP
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV---GTPYWMAP 180

Query: 353 EMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD-C 408
           E+I       Y  KVDV+S G+   E+     P   MN + A + +  +N  PA+     
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQSGHW 239

Query: 409 PPAMAALIEQCWSLQPDKRP 428
                  ++ C    P  RP
Sbjct: 240 SEYFRNFVDSCLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 84.1 bits (208), Expect = 9e-18
 Identities = 42/126 (33%), Positives = 77/126 (61%), Gaps = 3/126 (2%)

Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + E++S G L    H    + LP       + +I+  + ++H +G+I+RDLK +NVL+D 
Sbjct: 74  VIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131

Query: 320 EFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           E H+K+ D+G+  E +   D  S   GT  ++APE+++ + YG  VD ++ G++++EM+A
Sbjct: 132 EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191

Query: 379 GTIPYE 384
           G  P++
Sbjct: 192 GRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 19/219 (8%)

Query: 228 QFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK-- 285
            F +EV     L++PNV++ +  C +   Y ++ E+   G L+ YL         + +  
Sbjct: 41  LFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD 100

Query: 286 -LIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
            L  +A ++A G+ ++H    IH DL   N  +  +  +KI D+G+A E+   D      
Sbjct: 101 VLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160

Query: 345 GTY---RWMAPEM-------IKHKSYGRKVDVYSFGLILWEMV-AGTIPYEEMNPIQAAF 393
                 RW+APE+       +  K   +K +++S G+ +WE+  A   PY +++  Q   
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK 220

Query: 394 AVVN----KNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
            VV     K  +P +          +++ CW L P+ RP
Sbjct: 221 QVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRP 258

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 22/167 (13%)

Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-----EHKTL 281
           K   RE+ +L  + +  +I  + A +     C++        +  Y   L         L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV--------MPKYKCDLFTYVDRSGPL 182

Query: 282 PLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS 341
           PL + I I   +   + Y+H +G+IHRD+K EN+ +D+  +  + DFG AC+    DA  
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACK---LDAHP 239

Query: 342 DDPGTYRWM------APEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
           D P  Y W       +PE++    Y  K D++S GL+L+EM    + 
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 37/90 (41%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHK 358
           +H  G IHRDLKPEN LID   H+K+ DFG++   V Y +++   P    +MAPE+++ K
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSP---DYMAPEVLRGK 173

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388
            Y   VD +S G +L+E + G  P+    P
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 20/254 (7%)

Query: 189 HGAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G +  +Y  +++   V  A+K IR+  D+      ++   Q   E+ +L +  +P ++ 
Sbjct: 11  KGNYGSVYKVLHRPTGVTMAMKEIRLELDE------SKF-NQIIMELDILHKAVSPYIVD 63

Query: 247 FVAACKKPPVYCVITEYLSEGSL-RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-G 304
           F  A        +  EY+  GSL + Y   +  + +P   L  I   + +G++++  +  
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK------HK 358
           +IHRD+KP NVL++    +K+ DFG++   V   A + + G   +MAPE IK      + 
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAPERIKSGGPNQNP 182

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
           +Y  + DV+S GL + EM  G  PY  E    I A  + +     P +P          +
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFV 242

Query: 417 EQCWSLQPDKRPEF 430
            +C +  P++RP +
Sbjct: 243 AKCLNKIPNRRPTY 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 38/226 (16%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF-------------- 247
           D+ VAVK I + D         +  K   RE+ ++ RL + N++K               
Sbjct: 30  DKRVAVKKIVLTD--------PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
           V +  +     ++ EY+ E  L   L   E   L           + RG++YIHS  V+H
Sbjct: 82  VGSLTELNSVYIVQEYM-ETDLANVL---EQGPLSEEHARLFMYQLLRGLKYIHSANVLH 137

Query: 308 RDLKPENVLIDQE-FHLKIADFGIA----CEEVYCDALSDDPGTYRWMAPEMIKH-KSYG 361
           RDLKP NV I+ E   LKI DFG+A        +   LS+   T  + +P ++    +Y 
Sbjct: 138 RDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYT 197

Query: 362 RKVDVYSFGLILWEMV------AGTIPYEEMNPIQAAFAVVNKNLR 401
           + +D+++ G I  EM+      AG    E+M  I  +  VV +  R
Sbjct: 198 KAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 84.4 bits (209), Expect = 4e-17
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 37/209 (17%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEY 263
           VA+K IR  D  EN      L+K+F RE  + + L +P ++   + C    PVY  +  Y
Sbjct: 30  VALKKIR-EDLSENP----LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP-Y 83

Query: 264 LSEGSLRAYLH----------KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
           +   +L++ L           +L  KT  +   ++I   I   +EY+HS+GV+HRDLKP+
Sbjct: 84  IEGYTLKSLLKSVWQKESLSKELAEKT-SVGAFLSIFHKICATIEYVHSKGVLHRDLKPD 142

Query: 314 NVLIDQEFHLKIADFGIAC-----EEVYCDALSDDP--------------GTYRWMAPEM 354
           N+L+     + I D+G A      EE   D   D+               GT  +MAPE 
Sbjct: 143 NILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER 202

Query: 355 IKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           +         D+Y+ G+IL++M+  + PY
Sbjct: 203 LLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 49/180 (27%), Positives = 90/180 (50%), Gaps = 25/180 (13%)

Query: 216 DENETLAARLEKQFN--------REVALLSRL-HNPNVIKFVAACKKPPVYCV--ITEYL 264
                    ++K F         RE+  L RL  +PN+++ +          +  + E L
Sbjct: 23  TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE-L 81

Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
            + +L   + K   + LP  ++ +    + + ++++H  G+ HRD+KPEN+LI  +  LK
Sbjct: 82  MDMNLYELI-KGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILK 139

Query: 325 IADFGIACEEVYCDALSDDPGT-Y---RWM-APE-MIKHKSYGRKVDVYSFGLILWEMVA 378
           +ADFG +C  +Y    S  P T Y   RW  APE ++    YG K+D+++ G + +E+++
Sbjct: 140 LADFG-SCRGIY----SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 42/129 (32%), Positives = 76/129 (58%), Gaps = 6/129 (4%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL 316
           C + EY + G L  + H    +     +      +I   ++Y+HS+  V++RDLK EN++
Sbjct: 71  CFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128

Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
           +D++ H+KI DFG+ C+E   D  +     GT  ++APE+++   YGR VD +  G++++
Sbjct: 129 LDKDGHIKITDFGL-CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 187

Query: 375 EMVAGTIPY 383
           EM+ G +P+
Sbjct: 188 EMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 6e-17
 Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 36/229 (15%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L+ L +P +    A+ +     C++ +Y   G L   L +   K L        A 
Sbjct: 51  EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC------------------- 332
           ++   +EY+H  G+++RDLKPEN+L+ +  H+ ++DF ++                    
Sbjct: 111 EVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 333 ---EEVYCDALSDDP--------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381
                +  +  S++P        GT  ++APE+I    +G  VD ++ G++L+EM+ GT 
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230

Query: 382 PYEEMNPIQAAFA-VVNKNLRPAIPGDCPPAMAA--LIEQCWSLQPDKR 427
           P++  N     F+ ++ K +    PG  P + +A  LI +     P KR
Sbjct: 231 PFKGSN-RDETFSNILKKEVT--FPGSPPVSSSARDLIRKLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 34/212 (16%)

Query: 189 HGAH----SRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PN 243
            GA+    S       ++E VA+K  +I +    + LA R      RE+ LL       N
Sbjct: 10  QGAYGIVCSARNAETSEEETVAIK--KITNVFSKKILAKRAL----RELKLLRHFRGHKN 63

Query: 244 VIKFVAACKKPPVYCVITE-YLSEGSLRAYLHKLEHKTLPLPK--LIAIALDIARGMEYI 300
           +                 E YL E  + A LH++     PL      +    I  G++YI
Sbjct: 64  ITCLYDM--DIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121

Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG----------TYRWM 350
           HS  V+HRDLKP N+L++ +  LKI DFG+A         S++PG            RW 
Sbjct: 122 HSANVLHRDLKPGNLLVNADCELKICDFGLAR------GFSENPGENAGFMTEYVATRWY 175

Query: 351 -APE-MIKHKSYGRKVDVYSFGLILWEMVAGT 380
            APE M+  +SY + +DV+S G IL E++   
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 47/158 (29%), Positives = 87/158 (55%), Gaps = 12/158 (7%)

Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           ++L+S    P ++    A   P   C I + ++ G L  + H  +H      ++   A +
Sbjct: 48  LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDL--HYHLSQHGVFSEKEMRFYATE 105

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----GTYR 348
           I  G+E++H++ V++RDLKP N+L+D+  H++I+D G+A     CD     P    GT+ 
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 160

Query: 349 WMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           +MAPE++ K  +Y    D +S G +L++++ G  P+ +
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 16/199 (8%)

Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
            Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L K     +P   L
Sbjct: 44  NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPENIL 101

Query: 287 IAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-P 344
             I++ + RG+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++   
Sbjct: 102 GKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV 159

Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP--------YEEMN--PIQAAFA 394
           GT  +M+PE ++   Y  + D++S GL L EM  G  P         E M   P+    A
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEA 219

Query: 395 VVNKNLRPAIPGDCPPAMA 413
             +       P D P  MA
Sbjct: 220 KESHRPVSGHPPDSPRPMA 238

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 81.6 bits (201), Expect = 8e-17
 Identities = 49/164 (29%), Positives = 89/164 (54%), Gaps = 15/164 (9%)

Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  E  +++  ++P V++   A +      ++ EY+  G L   ++ + +  +P      
Sbjct: 90  FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL---VNLMSNYDVPEKWAKF 146

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALSDD 343
              ++   ++ IHS G+IHRD+KP+N+L+D+  HLK+ADFG   +      V CD     
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-- 204

Query: 344 PGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPY 383
            GT  +++PE++K +     YGR+ D +S G+ L+EM+ G  P+
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 52/199 (26%), Positives = 103/199 (51%), Gaps = 13/199 (6%)

Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G ++ +Y G  +   E VA+K I +  D E  T +  +     RE++L+  L + N
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHL--DAEEGTPSTAI-----REISLMKELKHEN 59

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHS 302
           +++            ++ EY+ +  L+ Y+     +  L    + +    + +G+ + H 
Sbjct: 60  IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSY 360
             V+HRDLKP+N+LI++   LK+ADFG+A    +  +  S++  T  + AP+ ++  ++Y
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178

Query: 361 GRKVDVYSFGLILWEMVAG 379
              +D++S G I+ EM+ G
Sbjct: 179 STSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 15/161 (9%)

Query: 282 PLPKLIA--IALDIARGMEYI-HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
           P+P+ I   + + I + + Y+    GVIHRD+KP N+L+D   ++K+ DFGI+   V   
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169

Query: 339 ALSDDPGTYRWMAPEMI----KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA 394
           A +   G   +MAPE I     +  Y  + DV+S G+ L E+  G  PY+        F 
Sbjct: 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK---TEFE 226

Query: 395 VVNKNLR---PAIPGD--CPPAMAALIEQCWSLQPDKRPEF 430
           V+ K L+   P++P +    P   + ++ C +    KRP++
Sbjct: 227 VLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKY 267

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 54/225 (24%), Positives = 110/225 (48%), Gaps = 20/225 (8%)

Query: 186 RFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           R   G +  +Y    +   E  A+K+I++   ++   +         +E+ ++    + N
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVV--------QQEIIMMKDCKHSN 67

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL-IA-IALDIARGMEYIH 301
           ++ +  +  +     +  E+   GSL+     + H T PL +  IA ++ +  +G+ Y+H
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQ----DIYHVTGPLSESQIAYVSRETLQGLYYLH 123

Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI---KH 357
           S+G +HRD+K  N+L+    H+K+ADFG++ +     A      GT  WMAPE+    + 
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183

Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             Y +  D+++ G+   E+     P  +++P++A F +   N +P
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 48/184 (26%), Positives = 94/184 (51%), Gaps = 26/184 (14%)

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           +I +Y++ G L  +L++ EH T    ++    + +A  ++++H  G+I+RD+K EN+L+D
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA--LDHLHQLGIIYRDIKLENILLD 139

Query: 319 QEFHLKIADFGIACEEV---------YCDALSDDPGTYRWMAPEMIKHKS--YGRKVDVY 367
            E H+ + DFG++ E +         +C       GT  +MAPE+I+  S  + + VD +
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFC-------GTIEYMAPEVIRGGSGGHDKAVDWW 192

Query: 368 SFGLILWEMVAGTIPY----EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQ 423
           S G++ +E++ G  P+    E+ +  + +  ++     P  P          I++     
Sbjct: 193 SLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTMSAEARDFIQKLLEKD 250

Query: 424 PDKR 427
           P KR
Sbjct: 251 PKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 56/177 (31%), Positives = 89/177 (50%), Gaps = 15/177 (8%)

Query: 220 TLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYCVITEYLSEGSLRAYLHKLEH 278
            LA      F  E  +LS  ++P + +   A + K  +Y V+ EY   G L + L++ E 
Sbjct: 39  LLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM-EYQPGGDLLSLLNRYED 97

Query: 279 KTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-EV 335
                 + +A     ++   +  +H  G +HRD+KPENVLID+  H+K+ADFG A     
Sbjct: 98  ---QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154

Query: 336 YCDALSDDP-GTYRWMAPEMIK------HKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
                S  P GT  ++APE++         +YG + D +S G+I +EM+ G  P+ E
Sbjct: 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 66/256 (25%), Positives = 121/256 (47%), Gaps = 27/256 (10%)

Query: 186 RFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           R   G +  +Y    ++  E  AVKII++   D+   +         +E+ ++    + N
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI--------QQEIFMVKECKHCN 67

Query: 244 VIKFVAA--CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL-IA-IALDIARGMEY 299
           ++ +  +   ++    C+  EY   GSL+     + H T PL +L IA +  +  +G+ Y
Sbjct: 68  IVAYFGSYLSREKLWICM--EYCGGGSLQ----DIYHVTGPLSELQIAYVCRETLQGLAY 121

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI--- 355
           +HS+G +HRD+K  N+L+     +K+ADFG+A +     A      GT  WMAPE+    
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD---CPPAM 412
           K+  Y +  D+++ G+   E+     P  +++P++A F +   N +P    D        
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241

Query: 413 AALIEQCWSLQPDKRP 428
              ++   +  P KRP
Sbjct: 242 HNFVKISLTKNPKKRP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 59/180 (32%), Positives = 92/180 (51%), Gaps = 12/180 (6%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
           E VA+K +  P   ++E  A    K+  RE+ LL  + + NVI  +             +
Sbjct: 41  EKVAIKKLSRPF--QSEIFA----KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94

Query: 263 -YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
            YL    ++  L K+    L   K+  +   +  G++YIHS G+IHRDLKP N+ ++++ 
Sbjct: 95  FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC 154

Query: 322 HLKIADFGIACEEVYCDALSDDPGTYRWM-APEMIKH-KSYGRKVDVYSFGLILWEMVAG 379
            LKI DFG+A    + DA        RW  APE+I +   Y + VD++S G I+ EM+ G
Sbjct: 155 ELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 27/237 (11%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           D+  A+K IR+P         +R      +E  LL+++ +PN++ F  + +      ++ 
Sbjct: 25  DQKYAMKEIRLPKSSSA-VEDSR------KEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           EY   G L   +     K  P   ++   + +  G+++IH + V+HRD+K +N+ + Q  
Sbjct: 78  EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG 137

Query: 322 HLKIADFG----------IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGL 371
            +K+ DFG           AC  V         GT  ++ PE+ ++  Y  K D++S G 
Sbjct: 138 KVKLGDFGSARLLTSPGAYACTYV---------GTPYYVPPEIWENMPYNNKSDIWSLGC 188

Query: 372 ILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
           IL+E+     P++  +       V   + +P +P      + +LI+Q +   P  RP
Sbjct: 189 ILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRP 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 49/164 (29%), Positives = 88/164 (53%), Gaps = 15/164 (9%)

Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  E  +++  ++P V++   A +      ++ EY+  G L   ++ + +  +P      
Sbjct: 90  FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARF 146

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALSDD 343
              ++   ++ IHS G IHRD+KP+N+L+D+  HLK+ADFG   +      V CD     
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-- 204

Query: 344 PGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPY 383
            GT  +++PE++K +     YGR+ D +S G+ L+EM+ G  P+
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 54/176 (30%), Positives = 95/176 (53%), Gaps = 19/176 (10%)

Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYC-----VITEYLSEGSLRAYLHKLEHKTL 281
           K+  RE+ +L    + NV+  +   + P +       V+TE +     ++ LHK+     
Sbjct: 44  KRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-----QSDLHKIIVSPQ 98

Query: 282 PL-PKLIAIAL-DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA 339
           PL    + + L  I RG++Y+HS G++HRD+KP N+L++    LKI DFG+A  E   ++
Sbjct: 99  PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158

Query: 340 --LSDDPGTYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
             ++ +  T  + APE++   +H  Y   VD++S G I  E++   I ++  +PIQ
Sbjct: 159 KHMTQEVVTQYYRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 24/222 (10%)

Query: 183 LGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
           +G  F       L      +  VAVK I + D    E L     K   +E+    +L +P
Sbjct: 6   IGKCFEDLMIVHLAKHKPTNTLVAVKKINL-DSCSKEDL-----KLLQQEIITSRQLQHP 59

Query: 243 NVIKFVAA-CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL---DIARGME 298
           N++ +V +      +Y V++  ++ GS    L    H    LP+L AIA    D+   ++
Sbjct: 60  NILPYVTSFIVDSELY-VVSPLMAYGSCEDLLK--THFPEGLPEL-AIAFILKDVLNALD 115

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTY-----RWM 350
           YIHS+G IHR +K  ++L+  +  + ++    +   +       +  D          W+
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 351 APEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
           +PE+++   + Y  K D+YS G+   E+  G +P+++M   Q
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 43/217 (19%)

Query: 200 YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF--VAACKKPPVY 257
             +E +A+K IR+  +DE     A       RE++LL  + + N+++   V   +K  +Y
Sbjct: 25  VTNETIALKKIRLEQEDEGVPSTAI------REISLLKEMQHGNIVRLQDVVHSEKR-LY 77

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPL---PKLIAIAL-DIARGMEYIHSQGVIHRDLKPE 313
            V  EYL        L K    +      P+LI   L  I RG+ Y HS  V+HRDLKP+
Sbjct: 78  LVF-EYLDLD-----LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQ 131

Query: 314 NVLIDQEFH-LKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFG 370
           N+LID+  + LK+ADFG+A    +     + +  T  + APE ++  + Y   VD++S G
Sbjct: 132 NLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVG 191

Query: 371 LILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
            I  EMV                     N +P  PGD
Sbjct: 192 CIFAEMV---------------------NQKPLFPGD 207

Length = 294

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (193), Expect = 7e-16
 Identities = 40/127 (31%), Positives = 74/127 (58%), Gaps = 4/127 (3%)

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           ++T+Y+S G L  +L K    +    K     L +A  +E++H   +++RDLKPEN+L+D
Sbjct: 73  LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA--LEHLHKYDIVYRDLKPENILLD 130

Query: 319 QEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEM 376
              H+ + DFG++   +  +  ++   GT  ++APE ++  K Y + VD +S G++++EM
Sbjct: 131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Query: 377 VAGTIPY 383
             G  P+
Sbjct: 191 CCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G ++ +Y G  K  D  VA+K IR+  ++     A R       EV+LL  L + N
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHAN 65

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++             ++ EYL +  L+ YL    + ++ +  +      + RG+ Y H +
Sbjct: 66  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRR 123

Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI++   LK+ADFG+A  + +     S++  T  +  P+ ++    Y 
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183

Query: 362 RKVDVYSFGLILWEMVAG 379
            ++D++  G I +EM  G
Sbjct: 184 TQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 78.7 bits (194), Expect = 8e-16
 Identities = 42/106 (39%), Positives = 62/106 (58%), Gaps = 18/106 (16%)

Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALS 341
           + +ALD       IHS G IHRD+KP+N+L+D+  HLK+ADFG   +      V CD   
Sbjct: 151 VVLALDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204

Query: 342 DDPGTYRWMAPEMIK----HKSYGRKVDVYSFGLILWEMVAGTIPY 383
              GT  +++PE++K       YGR+ D +S G+ L+EM+ G  P+
Sbjct: 205 ---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 37/89 (41%), Positives = 56/89 (62%), Gaps = 5/89 (5%)

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW-MA 351
           I RG++YIHS G+IHRDLKP N+ ++++  LKI DFG+A    + D         RW  A
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRA 183

Query: 352 PEMIKHK-SYGRKVDVYSFGLILWEMVAG 379
           PE++ +   Y + VD++S G I+ E++ G
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 68/247 (27%), Positives = 114/247 (46%), Gaps = 28/247 (11%)

Query: 206 AVKIIR-IPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAACKKPPVYC----- 258
           AVKI+  I D DE       +E ++N    +L  L N PNV+KF     K          
Sbjct: 51  AVKILDPISDVDE------EIEAEYN----ILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100

Query: 259 VITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
           ++ E  + GS+   +  L    + L    +  I      G++++H+  +IHRD+K  N+L
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160

Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHK-----SYGRKVDVYSFG 370
           +  E  +K+ DFG++ +        +   GT  WMAPE+I  +     SY  + DV+S G
Sbjct: 161 LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLG 220

Query: 371 LILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPAMAALIEQCWSLQPDKRP 428
           +   E+  G  P  +M+P++  F  + +N  P +  P     +    I QC     + RP
Sbjct: 221 ITAIELGDGDPPLFDMHPVKTLFK-IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARP 279

Query: 429 EFWHIVK 435
              H+++
Sbjct: 280 SVTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 35/176 (19%)

Query: 231 REVALLSRLHNPNVIKFV--------AACKKPPVYCVITEYLSEGSLRAYLH----KLEH 278
           RE+ +L +L +PNV+  +         + +K     ++T Y+ +  L   L     KL  
Sbjct: 56  REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTE 114

Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
                 ++    L +  G+ Y+H   ++HRD+K  N+LID +  LKIADFG+A    Y  
Sbjct: 115 -----SQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA--RPYDG 167

Query: 339 ALSDDPGTY-------------RWM-APEMIKH-KSYGRKVDVYSFGLILWEMVAG 379
              +  G               RW   PE++   + Y   VD++  G +  EM   
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 23/166 (13%)

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLH-KLEHKTLPLPKLI 287
           RE+ALL  L + NV+  V    +     V  + +Y +E  L   +    + K + +P  +
Sbjct: 51  REIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSM 109

Query: 288 --AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH----LKIADFGIACEEVYCDAL- 340
             ++   I  G+ Y+HS  V+HRDLKP N+L+  E      +KI D G+A   ++   L 
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA--RLFNAPLK 167

Query: 341 ---SDDPG--TYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVA 378
                DP   T  + APE++   +H  Y + +D+++ G I  E++ 
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 13/198 (6%)

Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G ++ ++ G  K  +  VA+K IR+  ++     A R       EV+LL  L + N
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHAN 65

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++             ++ EYL +  L+ Y+    +  + +  +      I RG+ Y H +
Sbjct: 66  IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRR 123

Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMIKHKS-YG 361
            V+HRDLKP+N+LI++   LK+ADFG+A  + V     S++  T  +  P+++   S Y 
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 362 RKVDVYSFGLILWEMVAG 379
            ++D++  G I +EM +G
Sbjct: 184 TQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 29/218 (13%)

Query: 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           LS+L    R   GA   +Y  I++      A+K+I    +D        + +Q  RE+ +
Sbjct: 73  LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-------VRRQICREIEI 125

Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
           L  +++PNV+K            V+ E++  GSL      +  +      L  +A  I  
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIADE----QFLADVARQILS 179

Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-----GTYRWM 350
           G+ Y+H + ++HRD+KP N+LI+   ++KIADFG++       A + DP     GT  +M
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS----RILAQTMDPCNSSVGTIAYM 235

Query: 351 APEMI----KHKSY-GRKVDVYSFGLILWEMVAGTIPY 383
           +PE I     H +Y G   D++S G+ + E   G  P+
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 55/187 (29%), Positives = 95/187 (50%), Gaps = 7/187 (3%)

Query: 204 PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE- 262
            VAVK +  P   +N+T A R      RE+ LL  +++ N+I  +             + 
Sbjct: 48  NVAVKKLSRPF--QNQTHAKRAY----RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
           YL    + A L ++ H  L   ++  +   +  G++++HS G+IHRDLKP N+++  +  
Sbjct: 102 YLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 161

Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
           LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ E+V G++ 
Sbjct: 162 LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVI 221

Query: 383 YEEMNPI 389
           ++  + I
Sbjct: 222 FQGTDHI 228

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 10/154 (6%)

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI--A 288
           RE+ +L +L +PN++  +   ++     ++ EY         L++LE     +P+ +   
Sbjct: 49  REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKK 104

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTY 347
           I     + + + H    IHRD+KPEN+LI ++  +K+ DFG A       D  +D   T 
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT- 163

Query: 348 RWM-APEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
           RW  APE++     YG  VDV++ G +  E++ G
Sbjct: 164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 51/187 (27%), Positives = 98/187 (52%), Gaps = 14/187 (7%)

Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L   E K +P  
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--EAKRIPEE 103

Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + RG+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++ 
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 161

Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG--TIPYEEMNPIQAAFAVVNKNL 400
             GT  +M+PE ++   Y  + D++S GL L E+  G   IP  +   ++A F       
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG------ 215

Query: 401 RPAIPGD 407
           RP + G+
Sbjct: 216 RPVVDGE 222

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 49/179 (27%), Positives = 94/179 (52%), Gaps = 17/179 (9%)

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           +I +Y+S G +  +L++ ++      ++   + +I   +E++H  G+++RD+K EN+L+D
Sbjct: 82  LILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139

Query: 319 QEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKS-YGRKVDVYSFG 370
            E H+ + DFG++ E      LS++        GT  +MAPE+I+ K  +G+ VD +S G
Sbjct: 140 SEGHVVLTDFGLSKE-----FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLG 194

Query: 371 LILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--PAIPGDCPPAMAALIEQCWSLQPDKR 427
           ++++E++ G  P+           V  + L+  P  P    P    L+ +     P KR
Sbjct: 195 ILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 45/206 (21%), Positives = 103/206 (50%), Gaps = 2/206 (0%)

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +EVA+LS + +PN++++  + ++     ++ +Y   G L   ++       P  +++   
Sbjct: 48  KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF 107

Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRW 349
           + I   ++++H + ++HRD+K +N+ + ++  +K+ DFGIA        L+    GT  +
Sbjct: 108 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           ++PE+ +++ Y  K D+++ G +L+EM      +E  N       ++  +  P +     
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHYS 226

Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVK 435
             +  L+ Q +   P  RP    I++
Sbjct: 227 YDLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G ++ ++ G  K  +  VA+K IR+  ++     A R       EV+LL  L + N
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-------EVSLLKNLKHAN 64

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++             ++ EYL +  L+ YL    +  + +  +      + RG+ Y H +
Sbjct: 65  IVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            ++HRDLKP+N+LI+++  LK+ADFG+A  + V     S++  T  +  P+ ++    Y 
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 362 RKVDVYSFGLILWEMVAG 379
             +D++  G IL+EM  G
Sbjct: 183 TPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 16/199 (8%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G +  ++    ++  E VA+K +R+ DDDE    +A       RE+ LL  L + N+++ 
Sbjct: 11  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKNIVRL 64

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
                      ++ EY  +  L+ Y         P   + +    + +G+ + HS  V+H
Sbjct: 65  YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDP-EIVKSFMFQLLKGLAFCHSHNVLH 122

Query: 308 RDLKPENVLIDQEFHLKIADFGIACE---EVYCDALSDDPGTYRWMAPE-MIKHKSYGRK 363
           RDLKP+N+LI++   LK+ADFG+A      V C   S +  T  +  P+ +   K Y   
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTS 180

Query: 364 VDVYSFGLILWEMVAGTIP 382
           +D++S G I  E+     P
Sbjct: 181 IDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 28/195 (14%)

Query: 199 IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP--- 255
               + VA+K + + ++ E   + A       RE+ +L  L + NV+  +  C+      
Sbjct: 34  KKTKQIVALKKVLMENEKEGFPITAL------REIKILQLLKHENVVNLIEICRTKATPY 87

Query: 256 ------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
                  Y V      E  L   L   ++    L ++  +   +  G+ YIH   ++HRD
Sbjct: 88  NRYKGSFYLVFE--FCEHDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRD 144

Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR------WM-APE-MIKHKSYG 361
           +K  N+LI ++  LK+ADFG+A    +  + +  P  Y       W   PE ++  + YG
Sbjct: 145 MKAANILITKDGILKLADFGLA--RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYG 202

Query: 362 RKVDVYSFGLILWEM 376
             +D++  G I+ EM
Sbjct: 203 PPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 75.4 bits (185), Expect = 9e-15
 Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 5/150 (3%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  +++P++I+           C+I   L       Y +    + + +  ++AI  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRW 349
            + R ++Y+H   +IHRD+K EN+ I+    + + DFG AC  V  +A       GT   
Sbjct: 190 SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
            APE++    YG  VD++S G++L+EM   
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 60/248 (24%), Positives = 114/248 (45%), Gaps = 29/248 (11%)

Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           ++  V +K+      D  ++LA      F    +L+S+L + +++K    C +     ++
Sbjct: 29  QEVSVVLKV---LGSDHRDSLA------FFETASLMSQLSHKHLVKLYGVCVRDE-NIMV 78

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY+  G L  +LH+ E   + L   + +A  +A  + Y+  + ++H ++  +N+L+ + 
Sbjct: 79  EEYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY 137

Query: 321 -------FHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMIK--HKSYGRKVDVYSFG 370
                    +K++D GI        + +   P    W+APE I+    S     D +SFG
Sbjct: 138 GLNEGYVPFIKLSDPGIPITVLSREERVERIP----WIAPECIRNGQASLTIAADKWSFG 193

Query: 371 LILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
             L E+ + G  P   ++  +      +++  P    DC   +A LI QCW+  P KRP 
Sbjct: 194 TTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMP--DCAE-LANLINQCWTYDPTKRPS 250

Query: 430 FWHIVKVL 437
           F  I++ L
Sbjct: 251 FRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 44/158 (27%), Positives = 85/158 (53%), Gaps = 5/158 (3%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L++++ P ++    + + P    ++  +++ G L  +L +     L   +     L
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRW 349
             A  +E +H   VI+RDLKPEN+L+D + H+ + DFG+ C+    D    +   GT  +
Sbjct: 103 LCA--LENLHKFNVIYRDLKPENILLDYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPEY 159

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
           +APE++    Y + VD ++ G++L+EM+ G  P+ + N
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 51/157 (32%), Positives = 84/157 (53%), Gaps = 7/157 (4%)

Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE-YLSEGSLRAYLHKL-EHKTLPLP 284
           K+  RE+ LL  + + NVI  +             + YL    +   L KL +H+ L   
Sbjct: 59  KRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED 118

Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           ++  +   + +G++YIH+ G+IHRDLKP N+ ++++  LKI DFG+A +    D+     
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---TDSEMTGY 175

Query: 345 GTYRWM-APEMIKH-KSYGRKVDVYSFGLILWEMVAG 379
              RW  APE+I +   Y + VD++S G I+ EM+ G
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 19/221 (8%)

Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLH---KLEHKTLP 282
           + +F  E      L + N+++ +  C +   Y ++ E+   G L+ YL    K E  T  
Sbjct: 39  QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPD 98

Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
              L  +A +IA G+ ++H    IH DL   N L+  +  +KI D+G++  +   D    
Sbjct: 99  PTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158

Query: 343 DPGTY---RWMAPEMIK--HKSY-----GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
               +   RW+APE++   H +       ++ +V+S G+ +WE+   G+ PY  ++  Q 
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218

Query: 392 -AFAVVNKNLRPAIPGDCPPAMA---ALIEQCWSLQPDKRP 428
             + V  + L+   P    P       +++ CW LQP++RP
Sbjct: 219 LTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRP 258

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 15/210 (7%)

Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G+++ +Y G  K   + VA+K+IR+ +++     A R       E +LL  L + N
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-------EASLLKGLKHAN 64

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYIHS 302
           ++             ++ EY+    L  Y+ K  H     P+ + + L  + RG+ YIH 
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSY 360
           + ++HRDLKP+N+LI     LK+ADFG+A  + V     S++  T  +  P+ ++    Y
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
              +D++  G I  EM+ G   +  M  IQ
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 34/86 (39%), Positives = 53/86 (61%)

Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
           G++++HS G+IHRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 189

Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTI 381
               Y   VD++S G I+ EM+ GT+
Sbjct: 190 LGMGYKENVDIWSVGCIMGEMIRGTV 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.4 bits (177), Expect = 7e-14
 Identities = 44/160 (27%), Positives = 86/160 (53%), Gaps = 6/160 (3%)

Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L K     +P  
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQ 103

Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + +G+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++ 
Sbjct: 104 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 161

Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
             GT  +M+PE ++   Y  + D++S GL L EM  G  P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 46/182 (25%)

Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + +Y+  G + + L +L      L +     L  A  +E +H  G IHRD+KP+N+LID+
Sbjct: 79  VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCA--IESVHKMGFIHRDIKPDNILIDR 136

Query: 320 EFHLKIADFGIAC--------------EEVYCDALSDDP--------------------- 344
           + H+K+ DFG+                +    D++                         
Sbjct: 137 DGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQH 196

Query: 345 ---------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
                    GT  ++APE++    Y +  D +S G+IL+EM+ G  P+    P +    V
Sbjct: 197 QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256

Query: 396 VN 397
           +N
Sbjct: 257 IN 258

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.3 bits (180), Expect = 1e-13
 Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 44/234 (18%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+A + +L +PN++K +  C+      +I EY+   +L   L     + L   +   IA+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAI 787

Query: 292 DIARGMEYIH---SQGVIHRDLKPENVLID--QEFHLKIADFGIACEEVYCDALSDDPGT 346
            IA+ + ++H   S  V+  +L PE ++ID   E HL+++  G+ C +  C   S     
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS----- 842

Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV----------- 395
             ++APE  + K    K D+Y FGLIL E++ G       +P  A F V           
Sbjct: 843 -AYVAPETRETKDITEKSDIYGFGLILIELLTGK------SPADAEFGVHGSIVEWARYC 895

Query: 396 -----VNKNLRPAIPGDCPPAMAALIE------QCWSLQPDKRPEFWHIVKVLE 438
                ++  + P+I GD       ++E       C +  P  RP    ++K LE
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 71/250 (28%), Positives = 114/250 (45%), Gaps = 48/250 (19%)

Query: 206 AVKIIR-IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV-----YCV 259
           AVKI+  I D DE       +E ++N   AL     +PNV+KF     K  V       +
Sbjct: 47  AVKILDPIHDIDE------EIEAEYNILKALSD---HPNVVKFYGMYYKKDVKNGDQLWL 97

Query: 260 ITEYLSEGSL----RAYLHKLEHKTLPLPKLIAIALDIA-RGMEYIHSQGVIHRDLKPEN 314
           + E  + GS+    + +L + E    P+   IA  L  A  G++++H    IHRD+K  N
Sbjct: 98  VLELCNGGSVTDLVKGFLKRGERMEEPI---IAYILHEALMGLQHLHVNKTIHRDVKGNN 154

Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIK-----HKSYGRKVDVYS 368
           +L+  E  +K+ DFG++ +        +   GT  WMAPE+I        +Y  + DV+S
Sbjct: 155 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214

Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA----------LIEQ 418
            G+   E+  G  P  +++P++A F          IP + PP +             I +
Sbjct: 215 LGITAIELGDGDPPLADLHPMRALF---------KIPRNPPPTLHQPELWSNEFNDFIRK 265

Query: 419 CWSLQPDKRP 428
           C +   +KRP
Sbjct: 266 CLTKDYEKRP 275

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 50/203 (24%), Positives = 101/203 (49%), Gaps = 12/203 (5%)

Query: 190 GAHSRLYHGIYKDE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
           G+  R+    YK+E   PVA+K       ++++ +  +       E  +L+ +++P  + 
Sbjct: 41  GSFGRVILATYKNEDFPPVAIKRF-----EKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
              + K      ++ E++  G    +L +  +K  P       A  I    EY+ S  ++
Sbjct: 96  LYGSFKDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           +RDLKPEN+L+D++  +K+ DFG A  +V         GT  ++APE++ +  +G+  D 
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFA--KVVDTRTYTLCGTPEYIAPEILLNVGHGKAADW 211

Query: 367 YSFGLILWEMVAGTIPYEEMNPI 389
           ++ G+ ++E++ G  P+    P+
Sbjct: 212 WTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 60/196 (30%), Positives = 91/196 (46%), Gaps = 46/196 (23%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------- 255
           E VA+K  +I +  +N   A R      RE+ LL  L + NVI  +     PP       
Sbjct: 31  EKVAIK--KIANAFDNRIDAKRTL----REIKLLRHLDHENVIA-IKDIMPPPHREAFND 83

Query: 256 VYCVI-------------TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           VY V              ++ LS+   + +L++L                  RG++YIHS
Sbjct: 84  VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQL-----------------LRGLKYIHS 126

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMIKHKS-Y 360
             V+HRDLKP N+L++    LKI DFG+A       D +++   T  + APE++ + S Y
Sbjct: 127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEY 186

Query: 361 GRKVDVYSFGLILWEM 376
              +DV+S G I  E+
Sbjct: 187 TTAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 24/210 (11%)

Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL-----HKLEHKTLPLPKLIAIALDI 293
           L +PN+++ +  C +   Y ++ EY   G L++YL     H+   + L L ++   A +I
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM---ACEI 108

Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWM 350
           A G+ ++H    +H DL   N  +  +  +K+ D+GI     +E Y +   D     RW+
Sbjct: 109 AAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168

Query: 351 APEMIKHKSYG-------RKVDVYSFGLILWEMVAGTI-PYEEMNPIQAAFAVVN----K 398
           APE++     G       +  +V++ G+ LWE+      PY  ++  +    V+     K
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228

Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
             +P +          +++ CW L P+KR 
Sbjct: 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRA 257

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 14/183 (7%)

Query: 202 DEPVAVKIIRIPDDDENETLA-ARLEKQFNREVALLSRLHNPNVI--KFVAACKKPPVYC 258
            E VA+K +R+  D+E + +  + L     RE+ LL  L +PN++  K V   K      
Sbjct: 32  GEIVALKKVRM--DNERDGIPISSL-----REITLLLNLRHPNIVELKEVVVGKHLDSIF 84

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           ++ EY  E  L + L  +        ++  + L + RG++Y+H   +IHRDLK  N+L+ 
Sbjct: 85  LVMEY-CEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT 142

Query: 319 QEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEM 376
            +  LKIADFG+A    +    ++    T  + APE++    +Y   +D+++ G IL E+
Sbjct: 143 DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202

Query: 377 VAG 379
           +A 
Sbjct: 203 LAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 53/189 (28%), Positives = 91/189 (48%), Gaps = 21/189 (11%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAA------CKKPPVY 257
           VA+K  R+  D+E     A       RE++LL  L  +  +++ +          KP +Y
Sbjct: 29  VALKKTRLEMDEEGIPPTAL------REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82

Query: 258 CVITEYLSEGSLRAYL---HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
            V  EYL    L+ ++    +   + LP   + +    + +G+ + H  GV+HRDLKP+N
Sbjct: 83  LVF-EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQN 140

Query: 315 VLIDQEFH-LKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGL 371
           +L+D++   LKIAD G+     +   + + +  T  + APE ++    Y   VD++S G 
Sbjct: 141 LLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200

Query: 372 ILWEMVAGT 380
           I  EM    
Sbjct: 201 IFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 33/185 (17%)

Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG-----TYRWMA 351
           + ++HS+ +IHRD+K  N+L+     +K+ DFG +  ++Y   +SDD G     T  ++A
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS--KMYAATVSDDVGRTFCGTPYYVA 213

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR---PAIPGDC 408
           PE+ + K Y +K D++S G++L+E++    P++  N ++    V++K L      +P   
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-ME---EVMHKTLAGRYDPLPPSI 269

Query: 409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLLHW 468
            P M  ++    S  P +RP                  +    L+  PIC+    GLL  
Sbjct: 270 SPEMQEIVTALLSSDPKRRP-----------------SSSK--LLNMPICKLFISGLLEI 310

Query: 469 IQKLG 473
           +Q   
Sbjct: 311 VQTQP 315

Length = 496

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 52/192 (27%), Positives = 96/192 (50%), Gaps = 8/192 (4%)

Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
           GA+  +    +K+    V I +  D +ENE     +++   RE+ +L  L   N+++   
Sbjct: 12  GAYGVVLKCRHKETKEIVAIKKFKDSEENE----EVKETTLRELKMLRTLKQENIVELKE 67

Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
           A ++     ++ EY+ E ++   L ++ +   P  K+ +    + + + + H   ++HRD
Sbjct: 68  AFRRRGKLYLVFEYV-EKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHWCHKNDIVHRD 125

Query: 310 LKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWM-APEMIKHKSYGRKVDVY 367
           +KPEN+LI     LK+ DFG A       +A   +    RW  +PE++    YG+ VD++
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185

Query: 368 SFGLILWEMVAG 379
           S G IL E+  G
Sbjct: 186 SVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 39/91 (42%), Positives = 57/91 (62%), Gaps = 13/91 (14%)

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----YRWM 350
           RG++YIHS G+IHRDLKP NV ++++  L+I DFG+A +       +DD  T     RW 
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ-------ADDEMTGYVATRWY 181

Query: 351 -APE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
            APE M+    Y + VD++S G I+ E++ G
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 70.5 bits (172), Expect = 3e-13
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 186

Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 43/177 (24%), Positives = 91/177 (51%), Gaps = 12/177 (6%)

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           +I +Y++ G L  + H  + +     ++   + +I   +E++H  G+I+RD+K EN+L+D
Sbjct: 82  LILDYINGGEL--FTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139

Query: 319 QEFHLKIADFGIACE--EVYCDALSDDPGTYRWMAPEMIKHKSYG--RKVDVYSFGLILW 374
              H+ + DFG++ E  E   +      GT  +MAP++++    G  + VD +S G++++
Sbjct: 140 SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199

Query: 375 EMVAGTIPY----EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           E++ G  P+    E+ +  + +  ++     P  P +       +I++     P KR
Sbjct: 200 ELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 63/257 (24%), Positives = 108/257 (42%), Gaps = 54/257 (21%)

Query: 205 VAVKIIRIPDDDENETLA-ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY 263
            A+K +R  +  E E +A  R E+       +L+   NP V+K   + +      +I EY
Sbjct: 29  YAMKKLRKSEMLEKEQVAHVRAERD------ILAEADNPWVVKLYYSFQDENYLYLIMEY 82

Query: 264 LSEGSLRAYLHKLEHKTLPLPKL-IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
           L  G +   L K +  T    +  IA   +    ++ IH  G IHRD+KP+N+L+D + H
Sbjct: 83  LPGGDMMTLLMKKDTFTEEETRFYIA---ETILAIDSIHKLGYIHRDIKPDNLLLDAKGH 139

Query: 323 LKIADFGIACEEVYCDALSDDP-------------------------------------- 344
           +K++DFG+ C  +     ++                                        
Sbjct: 140 IKLSDFGL-CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYS 198

Query: 345 --GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++APE+     Y ++ D +S G+I++EM+ G  P+   NP +    ++N     
Sbjct: 199 TVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETL 258

Query: 403 AIPGDCP--PAMAALIE 417
             P + P  P    LI+
Sbjct: 259 QFPDEVPLSPEAKDLIK 275

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 70.0 bits (171), Expect = 7e-13
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 18/233 (7%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
           E V  K + +  +DE +   AR       E+  L+   +  ++K     K      +I E
Sbjct: 94  EKVVAKFVML--NDERQAAYAR------SELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           Y S G L   + +   + LP  +     L   I   ++ +HS+ ++HRDLK  N+ +   
Sbjct: 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205

Query: 321 FHLKIADFGIACEEVYCDALSDDP-----GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
             +K+ DFG + +  Y D++S D      GT  ++APE+ + K Y +K D++S G+IL+E
Sbjct: 206 GIIKLGDFGFSKQ--YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYE 263

Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
           ++    P++  +  +    V+     P  P      M AL++   S  P  RP
Sbjct: 264 LLTLHRPFKGPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRP 315

Length = 478

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 40/120 (33%), Positives = 63/120 (52%), Gaps = 5/120 (4%)

Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
           G++++HS G+IHRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
               Y   VD++S G I+ EM+ G + +   + I     V+ +   P     CP  M  L
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKL 252

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 13/151 (8%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYC-VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           E  LL RL +P V+  +       + C V+ +Y S+  L  YL     + L L ++ A+A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGA-RLRPLGLAQVTAVA 266

Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------ 344
             +   ++YIH +G+IHRD+K ENVL++    + + DFG AC   +       P      
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC---FARGSWSTPFHYGIA 323

Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           GT    APE++    Y   VD++S GL+++E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 25/168 (14%)

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAI 289
           RE+ +++ + + N++  V    +     ++ + +    L+  +   + K  L   ++  I
Sbjct: 69  RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRKIRLTESQVKCI 124

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
            L I  G+  +H    +HRDL P N+ I+ +   KIADFG+A       Y D LS D   
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 347 --------------YRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
                         YR  APE++   + Y   VD++S G I  E++ G
Sbjct: 185 QRREEMTSKVVTLWYR--APELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 44/157 (28%), Positives = 81/157 (51%), Gaps = 14/157 (8%)

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVL 316
           ++ +Y   G L   L K E +   LP+ +A     ++   +  IH    +HRD+KP+NVL
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDR---LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL 134

Query: 317 IDQEFHLKIADFGIACEEVYCDAL---SDDPGTYRWMAPEMIKHKS-----YGRKVDVYS 368
           +D   H+++ADFG +C ++  D     S   GT  +++PE+++        YG + D +S
Sbjct: 135 LDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 193

Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            G+ ++EM+ G  P+   + ++    ++N   R   P
Sbjct: 194 LGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 41/135 (30%), Positives = 75/135 (55%), Gaps = 16/135 (11%)

Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIA---IALDIARGMEYIHSQGVIHRDLKPENVL 316
           + +Y   G L   L K E +   LP+ +A   +A ++   ++ +H  G +HRD+KP+NVL
Sbjct: 79  VMDYYVGGDLLTLLSKFEDR---LPEDMARFYLA-EMVLAIDSVHQLGYVHRDIKPDNVL 134

Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP---GTYRWMAPEMIK-----HKSYGRKVDVYS 368
           +D+  H+++ADFG +C  +  D         GT  +++PE+++        YG + D +S
Sbjct: 135 LDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWS 193

Query: 369 FGLILWEMVAGTIPY 383
            G+ ++EM+ G  P+
Sbjct: 194 LGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 71/284 (25%), Positives = 116/284 (40%), Gaps = 50/284 (17%)

Query: 183 LGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
           LG    +G+   +Y  I  D    V I ++  D + +          NRE+ ++  L++ 
Sbjct: 70  LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK----------NRELLIMKNLNHI 119

Query: 243 NVI--------KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALD 292
           N+I        +     +K     V+ E++ + ++  Y+         LP  +    +  
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ 178

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDALSDDPGTYRWMA 351
           + R + YIHS+ + HRDLKP+N+LID   H LK+ DFG A   +          +  + A
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRA 238

Query: 352 PE-MIKHKSYGRKVDVYSFGLILWEMVAG--------------------TIPYEE----M 386
           PE M+   +Y   +D++S G I+ EM+ G                      P E+    M
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298

Query: 387 NPIQAAFA---VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           NP  A      V  K+L+   P   P      I Q    +P KR
Sbjct: 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342

Length = 440

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             
Sbjct: 42  DRNVAIKKLSRPF--QNQTHAKRAY----RELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95

Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           + YL    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +
Sbjct: 96  DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 155

Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
             LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ EMV   
Sbjct: 156 CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           I +   + I     V+ +   P     CP  M  L
Sbjct: 216 ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 245

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 24/162 (14%)

Query: 231 REVALLSRLHNPNVIK---FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL--PK 285
           RE+ +L +L +PN++     V       +Y V+ EY+ E  L++ +   E    P    +
Sbjct: 53  REINILLKLQHPNIVTVKEVVVGSNLDKIYMVM-EYV-EHDLKSLM---ETMKQPFLQSE 107

Query: 286 LIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG 345
           +  + L +  G+ ++H   ++HRDLK  N+L++    LKI DFG+A E  Y   L   P 
Sbjct: 108 VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE--YGSPL--KPY 163

Query: 346 T-------YRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T       YR  APE ++  K Y   +D++S G I  E++  
Sbjct: 164 TQLVVTLWYR--APELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 27/201 (13%)

Query: 190 GAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G+++ +Y G  K   + VA+K IR+ + +E     A       RE +LL  L + N++  
Sbjct: 16  GSYATVYKGRSKLTGQLVALKEIRL-EHEEGAPFTAI------REASLLKDLKHANIVTL 68

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYIHSQGVI 306
                      ++ EYL +  L+ Y+             + + L  + RG+ Y H + V+
Sbjct: 69  HDIIHTKKTLTLVFEYL-DTDLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR------WMAPE--MIKHK 358
           HRDLKP+N+LI +   LK+ADFG+A       A S    TY       W  P   ++   
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLA------RAKSVPSKTYSNEVVTLWYRPPDVLLGST 179

Query: 359 SYGRKVDVYSFGLILWEMVAG 379
            Y   +D++  G I +EM  G
Sbjct: 180 EYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 52/204 (25%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------- 255
           E VA+K  +I D  E+ + A R+     RE+ LL  L +P++++ +     PP       
Sbjct: 26  EKVAIK--KINDVFEHVSDATRIL----REIKLLRLLRHPDIVE-IKHIMLPPSRREFKD 78

Query: 256 VYCVITEYLSEGSLRAYLHKL---------EHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           +Y V     S+      LH++         EH    L +L+       R ++YIH+  V 
Sbjct: 79  IYVVFELMESD------LHQVIKANDDLTPEHHQFFLYQLL-------RALKYIHTANVF 125

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM---------APEMIK- 356
           HRDLKP+N+L + +  LKI DFG+A       A +D P    W          APE+   
Sbjct: 126 HRDLKPKNILANADCKLKICDFGLARV-----AFNDTPTAIFWTDYVATRWYRAPELCGS 180

Query: 357 -HKSYGRKVDVYSFGLILWEMVAG 379
               Y   +D++S G I  E++ G
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 15/199 (7%)

Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G+++ +Y GI +   + VA+K+I +  ++     A R       E +LL  L + N
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-------EASLLKGLKHAN 64

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYIHS 302
           ++              + EY+    L  Y+  ++H     P  + + +  + RG+ YIH 
Sbjct: 65  IVLLHDIIHTKETLTFVFEYM-HTDLAQYM--IQHPGGLHPYNVRLFMFQLLRGLAYIHG 121

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSY 360
           Q ++HRDLKP+N+LI     LK+ADFG+A  + +     S +  T  +  P+ ++    Y
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181

Query: 361 GRKVDVYSFGLILWEMVAG 379
              +D++  G I  EM+ G
Sbjct: 182 SSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 41/158 (25%), Positives = 81/158 (51%), Gaps = 14/158 (8%)

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVL 316
           ++ +Y   G L   L K E +   LP+ +A     ++   ++ +H    +HRD+KP+N+L
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDR---LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134

Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP---GTYRWMAPEMIK-----HKSYGRKVDVYS 368
           +D   H+++ADFG +C ++  D         GT  +++PE+++        YG + D +S
Sbjct: 135 MDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWS 193

Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            G+ ++EM+ G  P+   + ++    ++N   R   P 
Sbjct: 194 LGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPA 231

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 6/147 (4%)

Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
            NPN IK   +      + +I +Y+ +G L   L K    +    K I   L     +  
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQL--VEALND 124

Query: 300 IHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
           +H   +IH D+K ENVL D+ +  + + D+G+ C+ +   +  D  GT  + +PE IK  
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-CKIIGTPSCYD--GTLDYFSPEKIKGH 181

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEE 385
           +Y    D ++ G++ +E++ G  P++E
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGKHPFKE 208

Length = 267

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 59/240 (24%), Positives = 97/240 (40%), Gaps = 43/240 (17%)

Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           A+KI+R  D  E E +A         E  +L       V+K   + +      +I E+L 
Sbjct: 30  AMKILRKADMLEKEQVA-----HIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84

Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
            G +   L K +  TL          +    ++ IH  G IHRD+KP+N+L+D + H+K+
Sbjct: 85  GGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKL 142

Query: 326 ADFGIAC-------EEVYCDALSDDP-----------------------------GTYRW 349
           +DFG+          E Y +   + P                             GT  +
Sbjct: 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDY 202

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +APE+     Y +  D +S G+I++EM+ G  P+    P +    V+N       P + P
Sbjct: 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVP 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 53/183 (28%)

Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC--------------EEVYCDALS 341
            +E +H  G IHRD+KP+N+LID++ H+K+ DFG+                + V  D++ 
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172

Query: 342 -----DDP-----------------------------GTYRWMAPEMIKHKSYGRKVDVY 367
                 DP                             GT  ++APE++    Y +  D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232

Query: 368 SFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC---PPAMAALIEQCWSLQP 424
           S G+IL+EM+ G  P+    P++    V+N      IP      P A   +I+ C    P
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRG--P 290

Query: 425 DKR 427
           + R
Sbjct: 291 EDR 293

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 50/214 (23%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L+   N  V+K   + +       + +Y+  G + + L ++E     L +     L
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAEL 110

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC--------------EEVYC 337
            +A  +E +H  G IHRD+KP+N+LID + H+K+ DFG+                  +  
Sbjct: 111 TLA--IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168

Query: 338 DALS-----DDPGTYR-----------------------------WMAPEMIKHKSYGRK 363
           D++      DD    R                             ++APE++  K Y + 
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228

Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
            D +S G+IL+EM+ G  P+    P +    V+N
Sbjct: 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVIN 262

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 65/272 (23%), Positives = 123/272 (45%), Gaps = 42/272 (15%)

Query: 189 HGAHSRLYHGIYKDEPVAVKIIRIPDDDE---NETLAARLEK-------QFNREVALLSR 238
            G  ++++ GI ++         + D  E    E L   L+K        F    +++S+
Sbjct: 5   QGTFTKIFKGIRRE---------VGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQ 55

Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
           L + +++     C       ++ EY+  GSL  YL K ++      KL  +A  +A  + 
Sbjct: 56  LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL-EVAKQLAWALH 114

Query: 299 YIHSQGVIHRDLKPENVLIDQE---------FHLKIADFGIACEEVYCDALSDDPGTYRW 349
           ++  +G+ H ++  +NVL+ +E         F +K++D GI+   +  + L +      W
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPF-IKLSDPGISITVLPKEILLE---RIPW 170

Query: 350 MAPEMIKH-KSYGRKVDVYSFGLILWEMVAG-TIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           + PE I++ ++     D +SFG  LWE+ +G   P   ++  +      +++  PA    
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPA---- 226

Query: 408 CP--PAMAALIEQCWSLQPDKRPEFWHIVKVL 437
            P    +A LI QC   +PD RP F  I++ L
Sbjct: 227 -PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 59.0 bits (143), Expect = 3e-10
 Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 16/119 (13%)

Query: 276 LEHKTLPL--PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF-GIAC 332
           LE +  PL   ++ A+ L     +  +H Q       K  N+L+  +  LK+        
Sbjct: 7   LEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKLDGSVAFKT 60

Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
            E         P  Y +MAPE+I+ +SY  K D+YS G+ L+E +   +PY E   + A
Sbjct: 61  PE------QSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA 112

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 58/240 (24%), Positives = 97/240 (40%), Gaps = 43/240 (17%)

Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           A+KI+R  D  E E +          E  +L    +  V+K   + +      +I E+L 
Sbjct: 30  AMKILRKADMLEKEQVG-----HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84

Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
            G +   L K +  TL   +      +    ++ IH  G IHRD+KP+N+L+D + H+K+
Sbjct: 85  GGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKL 142

Query: 326 ADFGIAC-------EEVYCDALSDDP-----------------------------GTYRW 349
           +DFG+          E Y +     P                             GT  +
Sbjct: 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDY 202

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +APE+     Y +  D +S G+I++EM+ G  P+    P +    V+N       P + P
Sbjct: 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVP 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 39/206 (18%)

Query: 196 YHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF-- 247
           Y  +YK       E VA+K +R+ ++ E   + A       RE+ +L +L++ N++    
Sbjct: 20  YGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI------REIKILRQLNHRNIVNLKE 73

Query: 248 VAACKKPPV--------YCVITEYLSE---GSLRAYLHKLEHKTLPLPKLIAIALDIARG 296
           +   K+  +        + ++ EY+     G L + L            + +    +  G
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-----HIKSFMKQLLEG 128

Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----WMAP 352
           + Y H +  +HRD+K  N+L++ +  +K+ADFG+A   +Y ++    P T +    W  P
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA--RLY-NSEESRPYTNKVITLWYRP 185

Query: 353 E--MIKHKSYGRKVDVYSFGLILWEM 376
              ++  + YG  +DV+S G IL E+
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 16/166 (9%)

Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEHKTL 281
           +R   Q   E+  L RL++ N++K     +     Y +  +Y  +     Y    + K  
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR 263

Query: 282 PLPKLI-AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC--EEVYCD 338
           PL K   AI   +   +EYIH + +IHRD+K EN+ ++ +  + + DFG A   E+    
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK---- 319

Query: 339 ALSDDPGTYRWM------APEMIKHKSYGRKVDVYSFGLILWEMVA 378
               +   Y W+      +PE++    Y    D++S GLIL +M++
Sbjct: 320 --EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 31/77 (40%), Positives = 50/77 (64%), Gaps = 5/77 (6%)

Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLP-KLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
           VY V+ EYL  G +++ LH   +    +  K I+   ++A  ++Y+H  G+IHRDLKP+N
Sbjct: 79  VYLVM-EYLIGGDVKSLLHIYGYFDEEMAVKYIS---EVALALDYLHRHGIIHRDLKPDN 134

Query: 315 VLIDQEFHLKIADFGIA 331
           +LI  E H+K+ DFG++
Sbjct: 135 MLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 22/221 (9%)

Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F    +L+S++ + ++      C +     ++ E++  G L   L K E   +P+   I 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKIT 121

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLI--------DQEFHLKIADFGIACEEVYCDAL 340
           +A  +A  + Y+  + ++H ++  +N+L+           F +K++D G++       AL
Sbjct: 122 VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPF-IKLSDPGVSF-----TAL 175

Query: 341 SDDPGTYR--WMAPEMIKH-KSYGRKVDVYSFGLILWEMV-AGTIPYEEMNPIQAAFAVV 396
           S +    R  W+APE +    S     D +SFG  L E+   G +P +E  P +      
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-RFY 234

Query: 397 NKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
            K  R  +P      +A LI QC + +P +RP F  I++ L
Sbjct: 235 EKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 41/176 (23%)

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL------HKLEH------ 278
           RE+ALL  L +PNVI                 +LS    + +L      H L H      
Sbjct: 47  REIALLRELKHPNVIALQKV------------FLSHSDRKVWLLFDYAEHDLWHIIKFHR 94

Query: 279 ------KTLPLPKLIAIAL--DIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIA 326
                 K + LP+ +  +L   I  G+ Y+H+  V+HRDLKP N+L+     +   +KIA
Sbjct: 95  ASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154

Query: 327 DFGIA-CEEVYCDALSD-DP--GTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMV 377
           D G A         L+D DP   T+ + APE ++  + Y + +D+++ G I  E++
Sbjct: 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 41/176 (23%)

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL------HKLEH------ 278
           RE+ALL  L +PNVI                 +LS    + +L      H L H      
Sbjct: 47  REIALLRELKHPNVISLQKV------------FLSHADRKVWLLFDYAEHDLWHIIKFHR 94

Query: 279 ------KTLPLPKLIAIAL--DIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIA 326
                 K + LP+ +  +L   I  G+ Y+H+  V+HRDLKP N+L+     +   +KIA
Sbjct: 95  ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154

Query: 327 DFGIA-CEEVYCDALSD-DP--GTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMV 377
           D G A         L+D DP   T+ + APE ++  + Y + +D+++ G I  E++
Sbjct: 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 36/149 (24%), Positives = 66/149 (44%), Gaps = 48/149 (32%)

Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC------------------------ 332
           +E +H  G IHRD+KP+N+LID+  H+K++DFG++                         
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173

Query: 333 ---EEVYCDALS------DDPGTYR---------------WMAPEMIKHKSYGRKVDVYS 368
                V  D+++      D   T++               ++APE+   + YG++ D +S
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233

Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
            G I++E + G  P+   N  +    ++N
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKIIN 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 41/178 (23%), Positives = 76/178 (42%), Gaps = 18/178 (10%)

Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           K    EV L     +PN++             VI+ +++ GS  + L     + +    +
Sbjct: 44  KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALI 103

Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC--------D 338
             I     RG+ Y+H  G IHR++K  ++LI  +  + ++        +Y          
Sbjct: 104 GNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGL----SHLYSLVRNGQKAK 159

Query: 339 ALSDDP----GTYRWMAPEMIKHKSYGRKV--DVYSFGLILWEMVAGTIPYEEMNPIQ 390
            + D P        W++PE+++   YG  V  D+YS G+   E+  G +P+++M   Q
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 37/167 (22%), Positives = 74/167 (44%), Gaps = 12/167 (7%)

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           ++   G L +++ K  +  +P   +   A ++   ++ +H +G++ RDL P N+L+D   
Sbjct: 65  QHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG 122

Query: 322 HLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
           H+++  F    E E  CD    +     + APE+          D +S G IL+E++ G 
Sbjct: 123 HIQLTYFSRWSEVEDSCDG---EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTG- 178

Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
                   ++   + +N +    IP        +L++Q     P +R
Sbjct: 179 -----KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 55/245 (22%), Positives = 107/245 (43%), Gaps = 45/245 (18%)

Query: 221 LAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKL-- 276
           L  R + Q   EV ++  L + N+++++     K      ++ E+   G L   + K   
Sbjct: 51  LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK 110

Query: 277 ------EHKTLPLPKLIAIALDIARGMEYIHS-------QGVIHRDLKPENVLID----- 318
                 EH       ++ I   +   + Y H+       + V+HRDLKP+N+ +      
Sbjct: 111 MFGKIEEHA------IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164

Query: 319 ------QEFHL------KIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKH--KSYGRK 363
                 Q  +L      KI DFG++ + +  ++++    GT  + +PE++ H  KSY  K
Sbjct: 165 IGKITAQANNLNGRPIAKIGDFGLS-KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK 223

Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQ 423
            D+++ G I++E+ +G  P+ + N      + + +     I G     +  LI+   +L 
Sbjct: 224 SDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGK-SKELNILIKNLLNLS 282

Query: 424 PDKRP 428
             +RP
Sbjct: 283 AKERP 287

Length = 1021

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 20/53 (37%), Positives = 29/53 (54%)

Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
           K      +  I  D+   +EYIH  G+ H D+KPEN+++D      I D+GIA
Sbjct: 121 KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 20/188 (10%)

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL-- 316
           ++ E++  G L  ++H+ +   L  P    +A  +A  + Y+  + ++H ++  +N+L  
Sbjct: 81  MVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLA 139

Query: 317 ---IDQEF--HLKIADFGIACEEVYCDALSDDPGTYR--WMAPEMIK-HKSYGRKVDVYS 368
              ID E    +K++D GI         LS      R  W+APE ++  K+     D +S
Sbjct: 140 REGIDGECGPFIKLSDPGIPIT-----VLSRQECVERIPWIAPECVEDSKNLSIAADKWS 194

Query: 369 FGLILWEMV-AGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           FG  LWE+   G IP ++    +              P  C   +A L+  C +  P++R
Sbjct: 195 FGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTP-SCK-ELADLMTHCMNYDPNQR 251

Query: 428 PEFWHIVK 435
           P F  I++
Sbjct: 252 PFFRAIMR 259

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 39/164 (23%), Positives = 79/164 (48%), Gaps = 14/164 (8%)

Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL-IA-IALDIARG 296
            ++PN++ + A         V+T +++ GS +  +    H    + +L IA I   + + 
Sbjct: 56  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMSELAIAYILQGVLKA 113

Query: 297 MEYIHSQGVIHRDLKPENVLI--DQEFHLK--IADFGIACEEVYCDALSDDP----GTYR 348
           ++YIH  G +HR +K  ++LI  D + +L    ++  +         + D P        
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP 173

Query: 349 WMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
           W++PE+++   + Y  K D+YS G+   E+  G +P+++M   Q
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 38/133 (28%), Positives = 63/133 (47%), Gaps = 36/133 (27%)

Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP--- 352
           G+  +H  G++HRD+KPEN+L+  +  +KI DFG A +   C  ++ +P  Y  + P   
Sbjct: 321 GLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVD--MCTGINFNP-LYGMLDPRYS 377

Query: 353 ---EMIKHKS-------------------YGRK--VDVYSFGLILWEMVAGTIPYEEMNP 388
              E++  +S                   YGR    D Y+ G++L +M    +P  E+ P
Sbjct: 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMC---VP--ELRP 432

Query: 389 IQAAFAVVNKNLR 401
           + A   + N  LR
Sbjct: 433 V-ANIRLFNTELR 444

Length = 507

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 31/150 (20%), Positives = 57/150 (38%), Gaps = 22/150 (14%)

Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFN-REVALLSRLHN----- 241
             GA + +Y   +   P  VK  RIP    +  L  +L ++   RE  +L++        
Sbjct: 5   KQGAEAIIYLTDFLGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPV 63

Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
           P V         P    ++ EY+    L+  L     +      L  +   + +    +H
Sbjct: 64  PIVYDV-----DPDNGLIVMEYIEGELLKDAL-----EEARPDLLREVGRLVGK----LH 109

Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
             G++H DL   N+++     +   DFG+ 
Sbjct: 110 KAGIVHGDLTTSNIILSGG-RIYFIDFGLG 138

Length = 204

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 38/156 (24%), Positives = 68/156 (43%), Gaps = 29/156 (18%)

Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR-EVALLSRLHNPNVI 245
              GA + +Y G +      +K  RIP    +  L  R+ ++  R E  ++SR     V 
Sbjct: 4   IKRGAEAEIYLGDFLGIKAVIKW-RIPKRYRHPELDERIRRERTRREARIMSRARKAGV- 61

Query: 246 KFVAACKKPPVYCV-------ITEYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGM 297
                   P VY V       + EY+ EG  L+  ++          + + ++ +I R +
Sbjct: 62  ------NVPAVYFVDPENFIIVMEYI-EGEPLKDLINSNG------MEELELSREIGRLV 108

Query: 298 EYIHSQGVIHRDLKPENVLI--DQEFHLKIADFGIA 331
             +HS G+IH DL   N+++   + +   + DFG+A
Sbjct: 109 GKLHSAGIIHGDLTTSNMILSGGKIY---LIDFGLA 141

Length = 211

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 34/149 (22%), Positives = 63/149 (42%), Gaps = 24/149 (16%)

Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR-EVALLSRLH----NPNV 244
           GA + +Y G +      +K  R+P    +  L  R+ ++  R E  LLSR      N  V
Sbjct: 5   GAEAIIYLGDFLGLKAVIKE-RVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPV 63

Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           +  V     P    ++ EY+    L+  + +   + L       I   + +    +H  G
Sbjct: 64  VYDV----DPDNKTIVMEYIEGKPLKDVIEEGNDELLR-----EIGRLVGK----LHKAG 110

Query: 305 VIHRDLKPENVLI--DQEFHLKIADFGIA 331
           ++H DL   N+++  D+ +   + DFG+ 
Sbjct: 111 IVHGDLTTSNIIVRDDKLY---LIDFGLG 136

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 19/112 (16%)

Query: 180 QLFLGLRFAHGAHSRLY----HGIYKDEP---VAVKIIRIPDDDENETLAARLEKQ-FNR 231
            L LG     GA  R+     HG+   +    VAVK+++        + A   EKQ    
Sbjct: 38  NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLK--------STARSSEKQALMS 89

Query: 232 EVALLSRLH-NPNVIKFVAACKK-PPVYCVITEYLSEGSLRAYLHKLEHKTL 281
           E+ ++S L  + N++  + AC K  P+Y +ITEY   G L  YLH+ +H  L
Sbjct: 90  ELKIMSHLGPHLNIVNLLGACTKGGPIY-IITEYCRYGDLVDYLHRNKHTFL 140

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 30/126 (23%), Positives = 56/126 (44%), Gaps = 19/126 (15%)

Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL-------IDQEFH----- 322
           ++H       L  I       ++Y H++  ++H DLKPEN+L       +D   +     
Sbjct: 223 MKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282

Query: 323 ----LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
               ++I D G  C+E +          YR  +PE++    +    D++S G I++E+  
Sbjct: 283 DPCRVRICDLGGCCDERHSRTAIVSTRHYR--SPEVVLGLGWMYSTDMWSMGCIIYELYT 340

Query: 379 GTIPYE 384
           G + Y+
Sbjct: 341 GKLLYD 346

Length = 467

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 14/33 (42%), Positives = 22/33 (66%), Gaps = 1/33 (3%)

Query: 300 IHSQGVIHRDLKPENVLIDQEFH-LKIADFGIA 331
           +HS G++HRD+KP+N++  +     KI D G A
Sbjct: 271 LHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.9 bits (94), Expect = 0.003
 Identities = 34/150 (22%), Positives = 56/150 (37%), Gaps = 27/150 (18%)

Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVA-LLSRLHNPNVIKFV 248
           GA + +  G Y      +K  R+P    +  L  RL  +  R  A LLS      V    
Sbjct: 344 GAEADIKKGEYLGRDAVIKE-RVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT-- 400

Query: 249 AACKKPPVYCV-------ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
                P +Y V       + EY+    L+  L            +  +   +A+    +H
Sbjct: 401 -----PVIYDVDPEEKTIVMEYIGGKDLKDVLEGNPEL------VRKVGEIVAK----LH 445

Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
             G++H DL   N ++  +  L + DFG+ 
Sbjct: 446 KAGIVHGDLTTSNFIVRDD-RLYLIDFGLG 474

Length = 535

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	488
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PRK10345	210	hypothetical protein; Provisional	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
smart00090	237	RIO RIO-like kinase.	99.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.6
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.42
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.4
KOG1243	690	consensus Protein kinase [General function predict	99.39
KOG3087	229	consensus Serine/threonine protein kinase [General	99.38
COG4248	637	Uncharacterized protein with protein kinase and he	99.37
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.2
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.19
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.98
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.88
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.87
PRK09902	216	hypothetical protein; Provisional	98.8
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.74
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.61
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.6
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.57
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.56
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.48
PF01636	239	APH: Phosphotransferase enzyme family This family	98.38
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.34
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.31
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.25
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.11
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.07
PLN02876	822	acyl-CoA dehydrogenase	98.06
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.01
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.01
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.88
PRK10593	297	hypothetical protein; Provisional	97.87
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.7
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.69
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.63
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.6
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.53
PRK05231	319	homoserine kinase; Provisional	97.52
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.52
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.24
KOG2270	520	consensus Serine/threonine protein kinase involved	97.07
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.02
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.97
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.75
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.58
PLN02756	418	S-methyl-5-thioribose kinase	96.52
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.34
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.3
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.23
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.22
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.17
PLN02236	344	choline kinase	96.16
COG2334	331	Putative homoserine kinase type II (protein kinase	96.07
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.04
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.81
PRK12396	409	5-methylribose kinase; Reviewed	95.47
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.21
PTZ00384	383	choline kinase; Provisional	95.21
PRK11768	325	serine/threonine protein kinase; Provisional	94.88
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	94.33
PTZ00296	442	choline kinase; Provisional	94.28
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.06

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-53  Score=433.71  Aligned_cols=274  Identities=46%  Similarity=0.897  Sum_probs=250.4

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEECCcc-EEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~-vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      ...++.+|..++.+++.||.|+||+||+|.|.|+. ||||++...+.+...      .+.|.+|+.+|.+++|||||+|+
T Consensus        32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~------~~~f~~E~~il~~l~HpNIV~f~  105 (362)
T KOG0192|consen   32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES------RKAFRREASLLSRLRHPNIVQFY  105 (362)
T ss_pred             cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH------HHHHHHHHHHHHhCCCCCeeeEE
Confidence            34678899999999999999999999999999988 999999865544322      67899999999999999999999


Q ss_pred             eeeecCC-eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCeEEEcCCC-cEEE
Q 011359          249 AACKKPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG-VIHRDLKPENVLIDQEF-HLKI  325 (488)
Q Consensus       249 ~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g-iiHrDIkp~NILl~~~~-~vkl  325 (488)
                      |+|..+. .++|||||+++|+|.++++......+++..++.++.||++||+|||+++ |||||||++|||++.++ ++||
T Consensus       106 G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI  185 (362)
T KOG0192|consen  106 GACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKI  185 (362)
T ss_pred             EEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEE
Confidence            9999888 7999999999999999999866778999999999999999999999999 99999999999999998 9999


Q ss_pred             eeeccccccccc-CcCCCCCCCcccCChhhhh--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 011359          326 ADFGIACEEVYC-DALSDDPGTYRWMAPEMIK--HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP  402 (488)
Q Consensus       326 ~DFgla~~~~~~-~~~~~~~gt~~y~aPE~l~--~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~  402 (488)
                      +|||+++..... ...+...||..|||||++.  ...|+.|+||||||+++|||+||..||.+....+....++..+.++
T Consensus       186 ~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp  265 (362)
T KOG0192|consen  186 ADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP  265 (362)
T ss_pred             CCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            999999766544 3445578999999999999  5689999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhcccCc
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGT  449 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~~~~  449 (488)
                      .++..+++.+..||..||+.||.+||++.+|+..|+.+.........
T Consensus       266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~  312 (362)
T KOG0192|consen  266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGP  312 (362)
T ss_pred             CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCc
Confidence            99999999999999999999999999999999999999887654433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-50  Score=393.95  Aligned_cols=250  Identities=30%  Similarity=0.502  Sum_probs=222.6

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .+..++++.++.||+|..|+||+++++  ++.+|+|++....+       ..+.+|+.+|+++++.++|||||.+||+|.
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~-------~~~~~Qi~rEl~il~~~~spyIV~~ygaF~  147 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID-------PALQKQILRELEILRSCQSPYIVGFYGAFY  147 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC-------HHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence            355567778899999999999999987  78999999964332       234789999999999999999999999999


Q ss_pred             cCC-eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          253 KPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       253 ~~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      .+. ..+|+||||++|+|++++...  +.+++..+.+|+.++++||.|||+ .+||||||||+|||++..|.+||||||.
T Consensus       148 ~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  148 SNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             eCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccc
Confidence            999 499999999999999999874  779999999999999999999995 8999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhccCCCCCC
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM-----NPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~-----~~~~~~~~~~~~~~~~~~~  405 (488)
                      +...... ...+.+||..|||||.+.+..|+.++||||||+.++|+++|+.||...     ...+....++.+ ..|.+|
T Consensus       226 S~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP  303 (364)
T KOG0581|consen  226 SGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-PPPRLP  303 (364)
T ss_pred             cHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-CCCCCC
Confidence            9766655 456788999999999999999999999999999999999999999874     556666666654 456777


Q ss_pred             CC-CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          406 GD-CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       406 ~~-~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .. ++++++.||..||++||.+||++.|+++
T Consensus       304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            76 9999999999999999999999999886

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=404.26  Aligned_cols=263  Identities=33%  Similarity=0.605  Sum_probs=237.2

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECCc-cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~-~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .+.|.|+.+.+.+.++||+|.||.||.|.|++. .||||.++.....         ...|.+|+++|++|+|+|||+++|
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---------~~~f~~Ea~iMk~L~H~~lV~l~g  268 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---------PEAFLREAQIMKKLRHEKLVKLYG  268 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---------hhHHHHHHHHHHhCcccCeEEEEE
Confidence            578999999999999999999999999999985 9999999865432         356889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +|..+..+|||||||..|+|.+||.......+...+.+.++.|||+|++||+++++|||||-..|||++++..+||+|||
T Consensus       269 V~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  269 VCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             EEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccc
Confidence            99998899999999999999999998677789999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          330 IACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       330 la~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      +|+......  ..........|.|||.+....++.|+|||||||+||||+| |+.||.++...+.+. .+..+.|...|.
T Consensus       349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~-~le~GyRlp~P~  427 (468)
T KOG0197|consen  349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-LLERGYRLPRPE  427 (468)
T ss_pred             cccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH-HHhccCcCCCCC
Confidence            998422221  1223334668999999999999999999999999999999 999999999877654 567788999999


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      .||+++.+||..||..+|++||||..+...|+++...
T Consensus       428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            9999999999999999999999999999999988653

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2e-48  Score=398.20  Aligned_cols=267  Identities=34%  Similarity=0.674  Sum_probs=231.4

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ..++|+|..+++.++.+||+|.||+||+|.|.| .||||++........      ..+.|.+|+.++++-+|.||+-|.|
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~------qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPE------QLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHH------HHHHHHHHHHHHhhcchhhheeeeh
Confidence            358999999999999999999999999999998 599999998776653      2578999999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +|..++. .||+-+|+|-+|+.+|+-.+ ..+.....+.|+.||++|+.|||.++|||||||..||++.+++.|||+|||
T Consensus       456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  456 ACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             hhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccc
Confidence            9998888 89999999999999999743 568889999999999999999999999999999999999999999999999


Q ss_pred             cccccc---ccCcCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-
Q 011359          330 IACEEV---YCDALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP-  402 (488)
Q Consensus       330 la~~~~---~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~-  402 (488)
                      ++....   .........|...|||||+++   ..+|++.+||||||+++|||++|.+||......+.++.+-.+-+.+ 
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd  613 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD  613 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc
Confidence            984322   222334456888999999996   3478999999999999999999999999666666665554442222 


Q ss_pred             --CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          403 --AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       403 --~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                        ....+|++++++|+..||.+++++||.|.+|+..|+.+...+.
T Consensus       614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p  658 (678)
T KOG0193|consen  614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP  658 (678)
T ss_pred             chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence              3456899999999999999999999999999999988877643

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-48  Score=398.86  Aligned_cols=248  Identities=24%  Similarity=0.422  Sum_probs=225.4

Q ss_pred             cceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      .+|..++.||+|||+.||.+++  .|+.||+|++......+     ....+.+.+||+|.++|+|||||+++++|++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k-----~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK-----PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC-----cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence            5689999999999999999998  48999999997643222     2235678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc-
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-  335 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~-  335 (488)
                      .|||.|+|..++|..++++  .+.+++.++..++.||+.||.|||+++|+|||||..|+||+++.+|||+|||+|.... 
T Consensus        93 VYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             eEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999999999984  5789999999999999999999999999999999999999999999999999997655 


Q ss_pred             ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      ..+...+.+||+.|.|||++.....+..+||||+||++|.||.|++||+..+-.+.+..+....+  .+|..++.+.++|
T Consensus       171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--~~P~~ls~~A~dL  248 (592)
T KOG0575|consen  171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--SMPSHLSAEAKDL  248 (592)
T ss_pred             cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--ccccccCHHHHHH
Confidence            34677888999999999999999999999999999999999999999999888888877776654  4677999999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      |.++|+.+|.+||++++|+.
T Consensus       249 I~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  249 IRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHHhcCCcccCCCHHHHhc
Confidence            99999999999999999996

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-48  Score=382.25  Aligned_cols=249  Identities=26%  Similarity=0.470  Sum_probs=219.7

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      ..+|.++++||+|+||+||+|+++  +..||||.+....      +..+..+-+..|+.+|+.++|||||.+++++..++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~------l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK------LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc------cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            467889999999999999999986  6899999998643      22344667889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC------CcEEEeeec
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE------FHLKIADFG  329 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~------~~vkl~DFg  329 (488)
                      .+|||||||+||+|.+||+.  .+.+++..+..++.||+.||++||+++||||||||+||||+..      -.+||+|||
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            99999999999999999997  4589999999999999999999999999999999999999764      468999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCCCCCC
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK-NLRPAIPGDC  408 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~  408 (488)
                      +|+.........+.+|++.|||||+++...|+.|+|+||+|+|+|+|++|..||...+..+....+... ...+.++..+
T Consensus       161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~  240 (429)
T KOG0595|consen  161 FARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL  240 (429)
T ss_pred             hhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence            998877777778889999999999999999999999999999999999999999999888876655443 3445666777


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIV  434 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil  434 (488)
                      +..+.+|+...+..++.+|-++.+-.
T Consensus       241 s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  241 SNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             cCchhhhhhHHHhcCccccCchHHhh
Confidence            78888999999999999998776543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-49  Score=387.48  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=215.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +.|.+.+.||+|+||.|-+|..+  ++.||||++............+ ......+|++||++|+|||||+++++|+.+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~-~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIA-KTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccccccc-chhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            56889999999999999999875  7999999997544332111000 12235699999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC---CcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~---~~vkl~DFgla~~  333 (488)
                      .||||||++||+|.+++-.  ++.+.+..-..+++||+.||.|||++||+||||||+|||+..+   ..+||+|||+|..
T Consensus       251 ~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             eEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            9999999999999999986  5778888889999999999999999999999999999999765   7899999999988


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCC--CCCCCC
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ-AAFAVVNKNLR--PAIPGD  407 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~k~DvwSlGvll~elltG~~Pf~~~~~~~-~~~~~~~~~~~--~~~~~~  407 (488)
                      ......+.+.+||+.|.|||++.+..   +..++|+|||||+||-+|+|.+||.+..... ....+..+.+.  +.....
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence            77777888999999999999997654   3458999999999999999999998765544 44455554433  334467


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.+..+||++||..||++||++.++++
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            8999999999999999999999999885

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-48  Score=363.89  Aligned_cols=251  Identities=23%  Similarity=0.407  Sum_probs=215.9

Q ss_pred             cccceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee-eeec
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA-ACKK  253 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~  253 (488)
                      .+.+|.+.++||+|.||+||++..  +|..||.|.+.-..      +.++...++..|+.+|++|+|||||++++ .+.+
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~------md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~   90 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM------MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE   90 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh------ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence            346788999999999999999976  58999999997433      33445788999999999999999999999 4444


Q ss_pred             -CCeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH--CC--cccCCCCCCeEEEcCCCcEEEe
Q 011359          254 -PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHS--QG--VIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       254 -~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~--~g--iiHrDIkp~NILl~~~~~vkl~  326 (488)
                       ...++||||||++|+|...++..  +.+.+++..+|+++.|++.||..||+  ..  |+||||||.||+|+.+|.+||+
T Consensus        91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence             44599999999999999999865  56679999999999999999999999  45  9999999999999999999999


Q ss_pred             eecccccccccC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          327 DFGIACEEVYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       327 DFgla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      |||+++...... .....+||++||+||.+....|+.++||||+||++|||+.-..||.+.+-.+...++.+..+.+...
T Consensus       171 DfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~  250 (375)
T KOG0591|consen  171 DFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD  250 (375)
T ss_pred             cchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence            999997554332 3345689999999999999999999999999999999999999999998777777777775544333


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHI  433 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~ei  433 (488)
                      ..++..+..||..|+..|++.||+.-.+
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t~~~  278 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDTVPY  278 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCcchH
Confidence            7889999999999999999999995333

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=367.94  Aligned_cols=246  Identities=25%  Similarity=0.430  Sum_probs=219.4

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .+..++|.+.+.||+|+||+||.++.+  ++.+|+|+++.....+.     .-.+....|..||.+++||+||+++..|+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ   95 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-----KEVRHTKAERNILSKIKHPFIVKLIYSFQ   95 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-----hhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence            455678999999999999999999875  68999999986543332     22467889999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +...+|||+||+.||.|+.+|++  .+.+++..+..++.+|+.||.|||++|||||||||+|||||.+|+++|+|||++.
T Consensus        96 t~~kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen   96 TEEKLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             cCCeEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccch
Confidence            99999999999999999999986  5789999999999999999999999999999999999999999999999999997


Q ss_pred             ccccc-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          333 EEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       333 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      ..... ....+.+||+.|||||++....|+..+|.||||+++|||++|..||...+..+....+.... .+..+..++.+
T Consensus       174 ~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~  252 (357)
T KOG0598|consen  174 EDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEE  252 (357)
T ss_pred             hcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHH
Confidence            55443 34455699999999999999999999999999999999999999999999888888887765 34456668999


Q ss_pred             HHHHHHHHhhhCCCCCC
Q 011359          412 MAALIEQCWSLQPDKRP  428 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RP  428 (488)
                      .+++|+++|..+|++|.
T Consensus       253 ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  253 ARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHHHHHHHhccCHHHhc
Confidence            99999999999999995

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-48  Score=388.91  Aligned_cols=259  Identities=32%  Similarity=0.633  Sum_probs=238.7

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ..+.|+|.++.+.-.+-||.|+.|.||+|+..++.||||.++.               .-..+|.-|++|+|+||+.|.|
T Consensus       115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e---------------lkETdIKHLRkLkH~NII~FkG  179 (904)
T KOG4721|consen  115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE---------------LKETDIKHLRKLKHPNIITFKG  179 (904)
T ss_pred             hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh---------------hhhhhHHHHHhccCcceeeEee
Confidence            4678999999999999999999999999999999999999862               1226888999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +|.....||||||||..|-|...|+.  ...++....+.|..+||.|+.|||.+.|||||||.-||||..+..|||+|||
T Consensus       180 VCtqsPcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFG  257 (904)
T KOG4721|consen  180 VCTQSPCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFG  257 (904)
T ss_pred             eecCCceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEecccc
Confidence            99999999999999999999999987  5678899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      -+.......+.....||..|||||++++.+.++|+|||||||+|||||||..||.+.+....++.+-...+....|..||
T Consensus       258 TS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP  337 (904)
T KOG4721|consen  258 TSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCP  337 (904)
T ss_pred             chHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCc
Confidence            99776665667778899999999999999999999999999999999999999999998888888877778888999999


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ..|+-||++||+..|..||+|.+|+..|+-+...+.
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell  373 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL  373 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence            999999999999999999999999998887765543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.2e-45  Score=370.94  Aligned_cols=262  Identities=29%  Similarity=0.532  Sum_probs=218.3

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI  245 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv  245 (488)
                      |.|..++|.+++.||+|+||.||+|.+.       ++.||||++.......       ..+.+.+|+.++.++ +||||+
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~h~niv   74 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS-------EHKALMSELKILIHIGNHLNVV   74 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH-------HHHHHHHHHHHHHHhccCccee
Confidence            6777889999999999999999999752       3579999987432211       135688999999999 899999


Q ss_pred             eEeeeeecC-CeeeEEEeecCCCCHHHHHHHhC-----------------------------------------------
Q 011359          246 KFVAACKKP-PVYCVITEYLSEGSLRAYLHKLE-----------------------------------------------  277 (488)
Q Consensus       246 ~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------  277 (488)
                      +++++|... ..+++||||+++|+|.+++....                                               
T Consensus        75 ~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (338)
T cd05102          75 NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTS  154 (338)
T ss_pred             eEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccC
Confidence            999988764 46889999999999999997532                                               


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC---cCC
Q 011359          278 -------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALS  341 (488)
Q Consensus       278 -------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~  341 (488)
                                   ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......   ...
T Consensus       155 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~  234 (338)
T cd05102         155 GSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  234 (338)
T ss_pred             cccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhccc
Confidence                         1347788899999999999999999999999999999999999999999999986432111   112


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW  420 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL  420 (488)
                      ...++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.....+..+.....+..+++.+.+||.+||
T Consensus       235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  314 (338)
T cd05102         235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACW  314 (338)
T ss_pred             CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence            2345678999999998899999999999999999997 999998866544444555555556667888999999999999


Q ss_pred             hhCCCCCCCHHHHHHHHHHHHH
Q 011359          421 SLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       421 ~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +.||++||++.++++.|+.+..
T Consensus       315 ~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         315 QGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             cCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-45  Score=372.07  Aligned_cols=258  Identities=28%  Similarity=0.481  Sum_probs=224.9

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeec
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK  253 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~  253 (488)
                      -.+.|.+++.||+|.||.|++|...  ++.||||++.........   ....+.+.+|+.++++++ ||||++++.++..
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t   91 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFAT   91 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence            4568999999999999999999874  799999987653111000   122456679999999999 9999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-CcEEEeeecccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIAC  332 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-~~vkl~DFgla~  332 (488)
                      ...+++|||||.||+|.+++..  .+.+.+.++..++.||+.|++|||++||+||||||+|||++.+ +++||+|||++.
T Consensus        92 ~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   92 PTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             CCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            9999999999999999999987  6789999999999999999999999999999999999999999 999999999997


Q ss_pred             cc-cccCcCCCCCCCcccCChhhhhcCC-CC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC-
Q 011359          333 EE-VYCDALSDDPGTYRWMAPEMIKHKS-YG-RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC-  408 (488)
Q Consensus       333 ~~-~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-  408 (488)
                      .. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.+.+.......+....  ..+|..+ 
T Consensus       170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~--~~~p~~~~  247 (370)
T KOG0583|consen  170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE--FKIPSYLL  247 (370)
T ss_pred             ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC--ccCCCCcC
Confidence            66 4556778889999999999999877 84 89999999999999999999999987777766655543  3467777 


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +.++..||.+||..+|.+|+++.+|+ .-.-++.
T Consensus       248 S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  248 SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence            99999999999999999999999999 6666655

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.5e-44  Score=355.95  Aligned_cols=259  Identities=23%  Similarity=0.406  Sum_probs=221.4

Q ss_pred             ccccceecc--ceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLG--LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~--~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      ++.+++...  ..||+|++|.||+|.++|+.||||++.......     ....+.|.+|+.+|.+++||||+++++++.+
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~   89 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH-----KVLIDITENEIKNLRRIDSNNILKIYGFIID   89 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccccc-----HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence            333444444  568999999999999999999999997543322     1224678899999999999999999999876


Q ss_pred             ----CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeee
Q 011359          254 ----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       254 ----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                          ...+++||||+++|+|.+++.+  ...+++...+.++.|++.||.|||+. +++||||||+|||++.++.+||+||
T Consensus        90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~df  167 (283)
T PHA02988         90 IVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICH  167 (283)
T ss_pred             cccCCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEccc
Confidence                3478899999999999999986  35688899999999999999999984 9999999999999999999999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      |++.....  ......|+..|+|||++.+  ..++.++|||||||++|||++|..||.+.+..+....+.....++..+.
T Consensus       168 g~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  245 (283)
T PHA02988        168 GLEKILSS--PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPL  245 (283)
T ss_pred             chHhhhcc--ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Confidence            99854322  2234568899999999976  6789999999999999999999999999888777777766666777777


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      .++..+.+||.+||+.||++||++.++++.|++++..
T Consensus       246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~~  282 (283)
T PHA02988        246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKFY  282 (283)
T ss_pred             cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHhc
Confidence            8999999999999999999999999999999998753

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=362.80  Aligned_cols=249  Identities=29%  Similarity=0.539  Sum_probs=215.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  255 (488)
                      .++..++.||+|+||.||++...  |+..|||.+...+...        .+.+.+|+.+|.+|+|||||+++|...... 
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--------SESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--------HHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            34557888999999999999986  5899999998652211        356789999999999999999999754433 


Q ss_pred             -eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-CCcEEEeeeccccc
Q 011359          256 -VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIACE  333 (488)
Q Consensus       256 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-~~~vkl~DFgla~~  333 (488)
                       .++++|||+++|+|.+++.+... .++++.+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence             79999999999999999998655 8999999999999999999999999999999999999999 79999999999865


Q ss_pred             ccc----cCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCCCCCC
Q 011359          334 EVY----CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       334 ~~~----~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      ...    ........||+.|||||++.++ ....++|||||||++.||+||..||.. ....+..+.+......|.+|..
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~  247 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDS  247 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcc
Confidence            442    2223456799999999999853 334599999999999999999999998 6666777777777777899999


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      ++.+.++||.+|+..+|++||++.++++.
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            99999999999999999999999999873

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-45  Score=370.60  Aligned_cols=249  Identities=26%  Similarity=0.399  Sum_probs=217.8

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  254 (488)
                      ..+|.+|+.||+|+|++||+|+..  ++.||||++...--     +..+-.+.+.+|-.+|.+| .||.|++|+..|.++
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I-----ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~  146 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI-----IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE  146 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH-----HhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence            467889999999999999999976  78999999864221     1122345678899999999 699999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+|+|+||+++|+|.++|++.  +.+.+.-...++.+|+.||+|||++|||||||||+|||||.|++++|+|||.|...
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999999999984  77899899999999999999999999999999999999999999999999988532


Q ss_pred             cccC------------c--CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 011359          335 VYCD------------A--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL  400 (488)
Q Consensus       335 ~~~~------------~--~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  400 (488)
                      ....            .  ....+||..|++||+|.....+..+|+|+||||||.|+.|.+||.+.+..-....++.-. 
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~-  303 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD-  303 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc-
Confidence            2110            1  134689999999999999999999999999999999999999999999887777776644 


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 ~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                       -.+|...++.+.+||+++|..||.+|++..+|.+
T Consensus       304 -y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  304 -YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             -ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence             4578899999999999999999999999988765

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=349.60  Aligned_cols=250  Identities=22%  Similarity=0.392  Sum_probs=212.0

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|+...++|+|+||+||+++.+  |+.||||.+.-..++.  .    ..+-..+|+++|++|+|+|+|.++.+|....
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~--~----VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr   74 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP--V----VKKIALREIRMLKQLKHENLVNLIEVFRRKR   74 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH--H----HHHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence            356778889999999999999976  7999999997544432  2    2466789999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .++||+|||+. ++.+-|... ...++.+.+.++++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+...
T Consensus        75 klhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   75 KLHLVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             eeEEEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence            99999999976 555555553 4568889999999999999999999999999999999999999999999999998765


Q ss_pred             -ccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Q 011359          336 -YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK---------------  398 (488)
Q Consensus       336 -~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~---------------  398 (488)
                       .+...++.+.|.+|.|||.+.+ .+|+..+|||++||++.||++|.+-|.+....+.++.+...               
T Consensus       153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence             6667788889999999999976 68999999999999999999999999999888776665431               


Q ss_pred             ----cCCCCCC----------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          399 ----NLRPAIP----------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       399 ----~~~~~~~----------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                          +++...+          ..++..+.+|+.+||..||++|++.++++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                1111111          245567899999999999999999999884

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=373.83  Aligned_cols=246  Identities=27%  Similarity=0.524  Sum_probs=221.1

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ..|..-.+||+|+.|.||.+...  ++.||||.+.+.....        +.-+.+|+.+|+..+|+|||.+++.|.....
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--------keLilnEi~Vm~~~~H~NiVnfl~Sylv~de  344 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--------KELLLNEILVMRDLHHPNIVNFLDSYLVGDE  344 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--------hhhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence            45777789999999999999875  6789999998766544        3457799999999999999999999988899


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|+|||||+||+|.+.+..   ..+++.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||++.....
T Consensus       345 LWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  345 LWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             eEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            9999999999999999976   5599999999999999999999999999999999999999999999999999865544


Q ss_pred             cC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCcHHHHH
Q 011359          337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-LRPAIPGDCPPAMAA  414 (488)
Q Consensus       337 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~  414 (488)
                      .. ...+.+||++|||||++....|++++||||||++++||+.|.+||-..++...++.+...+ .....+..+++.|++
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd  501 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD  501 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence            33 4567789999999999999999999999999999999999999999999988888777654 334567889999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      |+.+||+.|+++|+++.++|+
T Consensus       502 FL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  502 FLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHHHhhcchhcCCCHHHHhc
Confidence            999999999999999999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=342.39  Aligned_cols=241  Identities=28%  Similarity=0.433  Sum_probs=220.5

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      ..+++|.+.+.||.|+||+|.+++.+  |..+|+|++....     .+.-+..+...+|..+|+.+.||+++++++.|.+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-----vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-----VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-----HHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            45678889999999999999999876  7899999997532     3444556778999999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ...++|||||++||.|+.++++  .+.+++..+..++.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|..
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            9999999999999999999987  46899999999999999999999999999999999999999999999999999976


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                      ....  ..+.+||+.|+|||.+....|+.++|.|+|||++|||+.|..||...++.+...+++..++.  +|...+.+++
T Consensus       194 v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~~fs~~~k  269 (355)
T KOG0616|consen  194 VSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPSYFSSDAK  269 (355)
T ss_pred             ecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCcccCHHHH
Confidence            5432  45678999999999999999999999999999999999999999999999999999988765  7889999999


Q ss_pred             HHHHHHhhhCCCCC
Q 011359          414 ALIEQCWSLQPDKR  427 (488)
Q Consensus       414 ~Li~~cL~~dp~~R  427 (488)
                      +||.++|+.|-.+|
T Consensus       270 dLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  270 DLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHHHhhhhHhh
Confidence            99999999999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=356.50  Aligned_cols=257  Identities=25%  Similarity=0.456  Sum_probs=223.6

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ..|.++.++|.+...||.|..++||+|++.  ++.||||++..+.-+.+       .+.+.+|+..|+.++||||++++.
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-------ld~l~kE~~~msl~~HPNIv~~~~   91 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-------LDALRKEVQTMSLIDHPNIVTYHC   91 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-------HHHHHHHHHHhhhcCCCCcceEEE
Confidence            467778899999999999999999999985  89999999987654332       467889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      .|..+..+|+||.||.+|++.+++...-...+.+..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||
T Consensus        92 sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   92 SFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             EEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCce
Confidence            99999999999999999999999998877789999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC-c----CCCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 011359          330 IACEEVYCD-A----LSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP  402 (488)
Q Consensus       330 la~~~~~~~-~----~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~  402 (488)
                      .+....... .    ..+.+||++|||||++..  ..|+.|+||||||++..||.+|..||..+.+.+.+..-++.....
T Consensus       172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~  251 (516)
T KOG0582|consen  172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT  251 (516)
T ss_pred             eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence            874322211 1    145689999999999643  479999999999999999999999999999999887766654321


Q ss_pred             --------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 --------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 --------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                              .....++..++.+|..||.+||.+||++.++++
T Consensus       252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                    112345678999999999999999999999985

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=369.29  Aligned_cols=270  Identities=31%  Similarity=0.570  Sum_probs=239.2

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEEC--C---cc-EEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--D---EP-VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV  244 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~---~~-vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI  244 (488)
                      ...|.+..++..++++||+|+||.||+|.+.  +   .. ||||..+....     ......++|.+|+++|++++||||
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-----~~~~~~~e~m~EArvMr~l~H~NV  223 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-----LTKEQIKEFMKEARVMRQLNHPNV  223 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-----ccHHHHHHHHHHHHHHHhCCCCCE
Confidence            4679999999999999999999999999975  1   23 89999885221     223346889999999999999999


Q ss_pred             eeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEE
Q 011359          245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK  324 (488)
Q Consensus       245 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vk  324 (488)
                      |++||++....-++||||+|.||+|.++|.+.. ..++..+.+.++.+.+.||+|||++++|||||-.+|+|++.++.+|
T Consensus       224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEE
Confidence            999999999999999999999999999999843 3699999999999999999999999999999999999999999999


Q ss_pred             Eeeeccccccc-ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 011359          325 IADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRP  402 (488)
Q Consensus       325 l~DFgla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  402 (488)
                      |+|||+++... +........-...|+|||.+....|+.++|||||||++||+++ |..||.+....+....+...+.+.
T Consensus       303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~  382 (474)
T KOG0194|consen  303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM  382 (474)
T ss_pred             eCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC
Confidence            99999996543 1111112235678999999999999999999999999999999 899999999999999998999999


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhcc
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLAC  446 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~  446 (488)
                      ..+...|.++..++.+||..+|++||+|.++.+.|+.+......
T Consensus       383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            99999999999999999999999999999999999999887553

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-44  Score=365.32  Aligned_cols=267  Identities=31%  Similarity=0.544  Sum_probs=211.0

Q ss_pred             cccCCCceeecccccccccccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHH
Q 011359          157 YFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVAL  235 (488)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~i  235 (488)
                      .|....+..++.+|.++           ..||+|+||.||+|...+ ..||||.+.......        .++|.+|+.+
T Consensus        64 ~fs~~el~~AT~~Fs~~-----------~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--------~~eF~~Ei~~  124 (361)
T KOG1187|consen   64 SFSYDELRKATNNFSES-----------NLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--------EREFLNEVEI  124 (361)
T ss_pred             eeeHHHHHHHHhCCchh-----------cceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--------hhHHHHHHHH
Confidence            34444455555554444           456999999999999986 899999776543321        2459999999


Q ss_pred             HHhcCCCCeeeEeeeeecCC-eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Q 011359          236 LSRLHNPNVIKFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG---VIHRDLK  311 (488)
Q Consensus       236 l~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---iiHrDIk  311 (488)
                      +.+++|||+|+|+|||.+.. ..+||+||+++|+|.++|+......++|..+++||.++|+||+|||...   |||||||
T Consensus       125 ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiK  204 (361)
T KOG1187|consen  125 LSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIK  204 (361)
T ss_pred             HhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCC
Confidence            99999999999999999888 5999999999999999999743338899999999999999999999864   9999999


Q ss_pred             CCeEEEcCCCcEEEeeecccccccc-cCcCCCC-CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--
Q 011359          312 PENVLIDQEFHLKIADFGIACEEVY-CDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN--  387 (488)
Q Consensus       312 p~NILl~~~~~vkl~DFgla~~~~~-~~~~~~~-~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~--  387 (488)
                      ++|||+|+++.+||+|||+|..... ....... .||.+|+|||++..+..+.|+|||||||+++||++|+.+.+...  
T Consensus       205 ssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~  284 (361)
T KOG1187|consen  205 SSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR  284 (361)
T ss_pred             HHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence            9999999999999999999965443 3333333 89999999999998999999999999999999999998887532  


Q ss_pred             ----HHHHHHHHHhc-----cCCCCCC-CCCc-----HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          388 ----PIQAAFAVVNK-----NLRPAIP-GDCP-----PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       388 ----~~~~~~~~~~~-----~~~~~~~-~~~~-----~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                          -.+-....+..     -..+.+. ..++     ..+..+..+|++.+|.+||++.++++.|+.+..
T Consensus       285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  285 GELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             ccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence                11111111111     1223332 2333     346788899999999999999999999966544

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.5e-43  Score=363.63  Aligned_cols=264  Identities=28%  Similarity=0.519  Sum_probs=223.9

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN  241 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H  241 (488)
                      ..+.|.+..++|.+++.||+|+||.||+|++.       +..||||++......+       ....+.+|+.+++.+ +|
T Consensus        29 ~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~il~~l~~h  101 (374)
T cd05106          29 YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD-------EREALMSELKILSHLGQH  101 (374)
T ss_pred             ccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH-------HHHHHHHHHHHHHhhccC
Confidence            45678888899999999999999999999863       2479999997543221       135688999999999 79


Q ss_pred             CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC--------------------------------------------
Q 011359          242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------------------------------------  277 (488)
Q Consensus       242 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------------  277 (488)
                      +||++++++|.....+++||||+.+|+|.+++....                                            
T Consensus       102 ~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (374)
T cd05106         102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTY  181 (374)
T ss_pred             CceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccc
Confidence            999999999999999999999999999999986531                                            


Q ss_pred             ------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          278 ------------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       278 ------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                                              ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~  261 (374)
T cd05106         182 VEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARD  261 (374)
T ss_pred             cccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeee
Confidence                                    12477888999999999999999999999999999999999999999999999864


Q ss_pred             ccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          334 EVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       334 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ......   .....++..|+|||++.+..++.++|||||||++|+|++ |..||..................+..+..++
T Consensus       262 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (374)
T cd05106         262 IMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAP  341 (374)
T ss_pred             ccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCC
Confidence            332211   112234567999999988899999999999999999997 9999988776666666666666666777789


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      +++.++|.+||+.+|++||++.++++.|+++
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.4e-43  Score=362.82  Aligned_cols=262  Identities=29%  Similarity=0.504  Sum_probs=221.5

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPN  243 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn  243 (488)
                      -.|.++.++|.+++.||+|+||.||+|.+.       +..||||+++......       ..+.+.+|+.+|..+ +|||
T Consensus        28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~Ei~il~~l~~Hpn  100 (375)
T cd05104          28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT-------EREALMSELKVLSYLGNHIN  100 (375)
T ss_pred             cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH-------HHHHHHHHHHHHHHhcCCcc
Confidence            467778889999999999999999999752       3579999997433221       135688999999999 7999


Q ss_pred             eeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC----------------------------------------------
Q 011359          244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE----------------------------------------------  277 (488)
Q Consensus       244 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------  277 (488)
                      |++++++|......++|||||++|+|.+++....                                              
T Consensus       101 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  180 (375)
T cd05104         101 IVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP  180 (375)
T ss_pred             eeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence            9999999999999999999999999999997532                                              


Q ss_pred             ---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          278 ---------------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       278 ---------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                                                 ...++++.++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~  260 (375)
T cd05104         181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL  260 (375)
T ss_pred             cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcc
Confidence                                       12477888999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          331 ACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       331 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      +........   .....++..|+|||++.+..++.++|||||||++|||++ |..||............+....+...+.
T Consensus       261 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (375)
T cd05104         261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPE  340 (375)
T ss_pred             ceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCC
Confidence            864332211   112234567999999998899999999999999999998 8999988776666666677666666677


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ..+.++.+||.+||+.||++||++.+|++.|++.
T Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            7889999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-44  Score=329.67  Aligned_cols=253  Identities=25%  Similarity=0.396  Sum_probs=227.9

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      ...+++|.+|+.||+|-||.||.|+.+  +-.||+|++....     -...+.+.++.+|++|...|+||||+++|++|.
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-----i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh   92 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-----ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH   92 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-----HHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence            344578999999999999999999986  4789999998532     333556889999999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +....||++||..+|+|+..|.......+++...+.++.|+|.||.|+|..+|+||||||+|+|++.++.+||+|||-+.
T Consensus        93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            99999999999999999999998778889999999999999999999999999999999999999999999999999886


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      ... +....+.+||..|++||+..+..++..+|+|++|++.||++.|..||+.....+....+..-  +..+|..++...
T Consensus       173 ~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--~~~~p~~is~~a  249 (281)
T KOG0580|consen  173 HAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--DLKFPSTISGGA  249 (281)
T ss_pred             ecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--cccCCcccChhH
Confidence            554 55567788999999999999999999999999999999999999999998876666666554  445778999999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++||.+|+..+|.+|....++++
T Consensus       250 ~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  250 ADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             HHHHHHHhccCccccccHHHHhh
Confidence            99999999999999999988876

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.7e-44  Score=366.89  Aligned_cols=248  Identities=27%  Similarity=0.468  Sum_probs=225.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +-|.+|+.||.|+-|.|-.|++.  |+.+|||++.......     .-....+.+||.||+.+.||||+.+|++++....
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s-----~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS-----SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccc-----cccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            44678999999999999999874  8999999997542111     1113457799999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|+|.||++||.|++++..  .+.+++.++.+++.||+.|+.|||..+|+||||||+|+|||..+++||+|||+|.....
T Consensus        87 lylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EEEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            9999999999999999986  68899999999999999999999999999999999999999999999999999988888


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      +..+.+.+|++.|.|||++.+.+| +.++||||-|||||.||+|++||++.+-...+.++..+.+  .+|..++.+.++|
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is~eaQdL  242 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNISSEAQDL  242 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCCHHHHHH
Confidence            888899999999999999999998 6899999999999999999999999888888877777654  5789999999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      |.+||..||.+|.++.+|++
T Consensus       243 Lr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  243 LRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             HHHHhccCccccccHHHHhh
Confidence            99999999999999999997

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-42  Score=340.85  Aligned_cols=256  Identities=26%  Similarity=0.529  Sum_probs=217.3

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ++..+|.+++.||+|+||.||+|.+.     +..||+|+++.....       .....|.+|+.++.+++||||++++++
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~   74 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-------KQRRGFLAEALTLGQFDHSNIVRLEGV   74 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-------HHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            56678999999999999999999864     468999999754321       123568899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +..+...++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.|++||||||+|||++.++.++++|||.
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~  153 (266)
T cd05064          75 ITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRR  153 (266)
T ss_pred             EecCCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcc
Confidence            99999999999999999999999763 34689999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCcC--CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          331 ACEEVYCDAL--SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       331 a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      +.........  ....++..|+|||.+.+..++.++|||||||++||+++ |..||......+....+ ........+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~  232 (266)
T cd05064         154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRN  232 (266)
T ss_pred             cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCC
Confidence            7543221111  12335678999999998999999999999999999875 99999988776655444 34445567788


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ++..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       233 ~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         233 CPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=359.01  Aligned_cols=249  Identities=27%  Similarity=0.407  Sum_probs=217.9

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  254 (488)
                      .++|.+.++||.|.||.||+|.-.  ++.||||.++..-.. ++      +-.=.+|+..|++|+ |||||++.+++.+.
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~e------e~~nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WE------ECMNLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HH------HHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            467999999999999999999864  789999999754332 22      122358999999999 99999999999887


Q ss_pred             C-eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          255 P-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       255 ~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      . .+++||||| ..+|+++++.+ .+.++++.+..|++||++||+|+|.+|+.|||+||+|||+.....+||+|||+|+.
T Consensus        82 ~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   82 DRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             CceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence            7 999999999 56999999985 78999999999999999999999999999999999999999888999999999998


Q ss_pred             ccccCcCCCCCCCcccCChhhh-hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------
Q 011359          334 EVYCDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--------------  398 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~--------------  398 (488)
                      .......+..+.|.+|.|||++ +..-|+.+.|+|++|||++|+.+-++-|.+.+..+.+++++.-              
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            8888888899999999999988 5567899999999999999999999999999998888877641              


Q ss_pred             -----cCCC---------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          399 -----NLRP---------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       399 -----~~~~---------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                           +++.         .+-..++.++.+||.+||.-||++||++.+.++
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                 0110         011347889999999999999999999999987

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1e-43  Score=377.62  Aligned_cols=266  Identities=28%  Similarity=0.581  Sum_probs=234.3

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV  244 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI  244 (488)
                      ....+.++++.+.+.||+|+||+||+|...+       .-||||.++....       .+..++|.+|+++|..|+||||
T Consensus       479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-------~~~~~dF~REaeLla~l~H~nI  551 (774)
T KOG1026|consen  479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-------NQARQDFRREAELLAELQHPNI  551 (774)
T ss_pred             ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-------HHHHHHHHHHHHHHHhccCCCe
Confidence            4456777888999999999999999998752       4699999984332       3347899999999999999999


Q ss_pred             eeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC--------CC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCC
Q 011359          245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------HK----TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP  312 (488)
Q Consensus       245 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~----~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp  312 (488)
                      |+|+|+|..++-+|+|+|||..|+|.+||....        +.    .++..+.+.||.|||.|+.||-++.+|||||-.
T Consensus       552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT  631 (774)
T KOG1026|consen  552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT  631 (774)
T ss_pred             EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence            999999999999999999999999999998542        12    278889999999999999999999999999999


Q ss_pred             CeEEEcCCCcEEEeeecccccccccCcC---CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 011359          313 ENVLIDQEFHLKIADFGIACEEVYCDAL---SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP  388 (488)
Q Consensus       313 ~NILl~~~~~vkl~DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~  388 (488)
                      .|+||+++..|||+|||+++.....+..   ....-..+||+||.+..+.|+.++||||+||+|||+++ |..||.+..+
T Consensus       632 RNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn  711 (774)
T KOG1026|consen  632 RNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN  711 (774)
T ss_pred             hhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence            9999999999999999999754433222   23345679999999999999999999999999999998 9999999999


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      .+++..+....+ ...|..||.++..||..||+.+|.+||+|.+|-..|+.......
T Consensus       712 ~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  712 QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            999888887777 78899999999999999999999999999999999998876533

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.6e-44  Score=360.85  Aligned_cols=247  Identities=27%  Similarity=0.486  Sum_probs=218.1

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+.+.||+|.||+||+|+.+  .+.||+|.+......+.+      .+.+.+|++|++.|+|||||.++++|+...
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~------l~~l~~ev~i~r~lkHpniv~m~esfEt~~   74 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE------LKNLRQEVRILRSLKHPNIVEMLESFETSA   74 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH------HHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence            357888999999999999999876  478999999765544322      456889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ++|+|.||+.| +|..+|..  ++.++++.+..|+.+++.||.|||+.+|+|||+||.|||++..|.+|+||||+|+.+.
T Consensus        75 ~~~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   75 HLWVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS  151 (808)
T ss_pred             eEEEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc
Confidence            99999999976 99999986  6789999999999999999999999999999999999999999999999999997665


Q ss_pred             ccC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          336 YCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       336 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      ... ..+...||+.|||||++.+.+|+..+|+||||||+|||+.|++||....-.+....+.....  ..|...+..+.+
T Consensus       152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v--~~p~~~S~~f~n  229 (808)
T KOG0597|consen  152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV--KPPSTASSSFVN  229 (808)
T ss_pred             cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC--CCcccccHHHHH
Confidence            443 34566799999999999999999999999999999999999999987766666666655543  345688999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      |+..+|.+||.+|.+..+++.
T Consensus       230 fl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  230 FLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHHHHhhcChhhcccHHHHhc
Confidence            999999999999999988874

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-45  Score=361.41  Aligned_cols=246  Identities=28%  Similarity=0.521  Sum_probs=217.3

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      .|...+.||+|.||.||+|.+.  ++.||+|++.+....+.       ..++.+|+.+|.+++++||.++|+.|..+..+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-------Iediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-------IEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchh-------hHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            3555688999999999999986  68999999987654432       45678999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      +++||||.||++.+.+..  ...+.+..+.-++.+++.||.|||.++.+|||||+.|||+..+|.+||+|||++......
T Consensus        87 wiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence            999999999999999986  344488889999999999999999999999999999999999999999999999665443


Q ss_pred             Cc-CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          338 DA-LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       338 ~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      .. ..+.+||+.|||||+++...|+.|+||||||++.+||++|.+||.+..++..++.+ -+...|.+...+++.+++||
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-pk~~PP~L~~~~S~~~kEFV  243 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-PKSAPPRLDGDFSPPFKEFV  243 (467)
T ss_pred             hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-cCCCCCccccccCHHHHHHH
Confidence            33 36778999999999999889999999999999999999999999999997665544 34456667779999999999


Q ss_pred             HHHhhhCCCCCCCHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~  435 (488)
                      ..||+++|+.||++.++++
T Consensus       244 ~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  244 EACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             HHHhhcCcccCcCHHHHhh
Confidence            9999999999999999886

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-42  Score=352.68  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=214.9

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      ...+++|.+.+.||+|+||.||+|.+.  ++.||||++.....     ........+.+|+.++++++||||+++++++.
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   88 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-----LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ   88 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            345678999999999999999999986  68899999974211     11223456889999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .+..+++||||+.+|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        89 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         89 DENRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             cCCEEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence            99999999999999999999986  4568899999999999999999999999999999999999999999999999986


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....  ..++..++..+
T Consensus       167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~  242 (329)
T PTZ00263        167 KVPD--RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNWFDGRA  242 (329)
T ss_pred             EcCC--CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cCCCCCCCHHH
Confidence            4332  2234568999999999998889999999999999999999999999888776666655543  44677789999


Q ss_pred             HHHHHHHhhhCCCCCCC-----HHHHHH
Q 011359          413 AALIEQCWSLQPDKRPE-----FWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs-----~~eil~  435 (488)
                      .+||.+||+.||.+|++     +.+++.
T Consensus       243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        243 RDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            99999999999999997     566663

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.2e-43  Score=354.87  Aligned_cols=247  Identities=27%  Similarity=0.400  Sum_probs=214.2

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .+..++|.+...||+|+||.||+|+-+  |+.+|+|+++........     ..+.+..|-.+|...++++||++|.+|.
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~-----Qv~hV~aERdiL~~~ds~~vVKLyYsFQ  211 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKN-----QVEHVRAERDILAEVDSPWVVKLYYSFQ  211 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhh-----hHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence            456788999999999999999999864  799999999875543322     2456788999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +...+||||||++||++..+|.+  .+.|+++.+..++.+++.||+.||+.|+|||||||+|+|||..|++||+||||+.
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence            99999999999999999999987  5789999999999999999999999999999999999999999999999999982


Q ss_pred             ccc----------------------ccCcC-----C---------------------CCCCCcccCChhhhhcCCCCchh
Q 011359          333 EEV----------------------YCDAL-----S---------------------DDPGTYRWMAPEMIKHKSYGRKV  364 (488)
Q Consensus       333 ~~~----------------------~~~~~-----~---------------------~~~gt~~y~aPE~l~~~~~~~k~  364 (488)
                      -..                      .....     .                     ..+||+.|||||++.+..|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            100                      00000     0                     12499999999999999999999


Q ss_pred             HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHHhhhCCCCCCC
Q 011359          365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPAMAALIEQCWSLQPDKRPE  429 (488)
Q Consensus       365 DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~cL~~dp~~RPs  429 (488)
                      |.||||||+||||.|.+||...++.+....++.-.....+|  ..++.+..+||.+||. ||++|..
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999999999999999999999988888766444444  4567999999999999 9999976

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.3e-42  Score=344.55  Aligned_cols=250  Identities=19%  Similarity=0.300  Sum_probs=207.2

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.+.+.||+|+||.||+|.+.  ++.||||++.......     ......+.+|+.++.+++|+||+++++++..+..++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-----hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEE
Confidence            567788999999999999874  7899999987432111     112346789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +||||+.+|+|.+++.......+++..++.++.|++.||+|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus        77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999999999998876555578999999999999999999999999999999999999999999999999986543333


Q ss_pred             cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCCCCCCCCCcHHHHHHH
Q 011359          339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV--NKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       339 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~Li  416 (488)
                      ......||..|+|||++.+..++.++|||||||++|+|++|..||...........+.  ........+..++..+.+||
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            3345578999999999998899999999999999999999999998765322211111  12223345667899999999


Q ss_pred             HHHhhhCCCCCCC-----HHHHHH
Q 011359          417 EQCWSLQPDKRPE-----FWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs-----~~eil~  435 (488)
                      .+||+.||++||+     +.++++
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhc
Confidence            9999999999997     666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.1e-42  Score=359.56  Aligned_cols=264  Identities=30%  Similarity=0.537  Sum_probs=223.2

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPN  243 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-Hpn  243 (488)
                      ..|.++.++|.+++.||.|+||.||+|.+.+       ..||||++......       ...+.|.+|+.+|.++. |||
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-------~~~~~~~~Ei~~l~~l~~Hpn  102 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS-------SEKQALMSELKIMTHLGPHLN  102 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh-------HHHHHHHHHHHHHHhcCCCCC
Confidence            4678889999999999999999999998642       35999999754322       12457889999999996 999


Q ss_pred             eeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC----------------------------------------------
Q 011359          244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE----------------------------------------------  277 (488)
Q Consensus       244 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------  277 (488)
                      |++++++|......|||||||++|+|.+++....                                              
T Consensus       103 Iv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (400)
T cd05105         103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ  182 (400)
T ss_pred             eeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence            9999999999999999999999999999987531                                              


Q ss_pred             ------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 011359          278 ------------------------------------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRD  309 (488)
Q Consensus       278 ------------------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrD  309 (488)
                                                                      ...+++..++.++.||+.||+|||+.||+|||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~d  262 (400)
T cd05105         183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRD  262 (400)
T ss_pred             ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence                                                            12477888999999999999999999999999


Q ss_pred             CCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 011359          310 LKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE  385 (488)
Q Consensus       310 Ikp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~  385 (488)
                      |||+|||++.++.+||+|||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus       263 ikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             CChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            99999999999999999999986432211   1122346678999999988889999999999999999997 9999988


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ..........+....++..+..++..+.++|.+||+.+|++||++.+|.+.|+++..
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         343 MIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             cchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            765555555556666666778899999999999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-43  Score=346.55  Aligned_cols=246  Identities=24%  Similarity=0.377  Sum_probs=211.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++......     ..+....+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-----RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence            36788899999999999999986  789999999753211     11234568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||+.+|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999999999976  45688999999999999999999999999999999999999999999999999864332


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                        ......|+..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ..++..++..+.+||
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li  229 (291)
T cd05612         154 --RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLDLYAKDLI  229 (291)
T ss_pred             --CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cCCCccCCHHHHHHH
Confidence              2234468999999999998889999999999999999999999999888776666655543  346677899999999


Q ss_pred             HHHhhhCCCCCCC-----HHHHHH
Q 011359          417 EQCWSLQPDKRPE-----FWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs-----~~eil~  435 (488)
                      .+||+.||.+||+     +.++++
T Consensus       230 ~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         230 KKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             HHHcCCCHHHccCCccCCHHHHhc
Confidence            9999999999995     676664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.7e-42  Score=336.47  Aligned_cols=257  Identities=28%  Similarity=0.600  Sum_probs=220.7

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      |+++..+|.+.+.||+|+||.||+|.+.  ++.||+|++.....         ...++.+|++++++++|+||+++++++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGVC   71 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch---------HHHHHHHHHHHHHhCCCCChhheEEEE
Confidence            5677888999999999999999999985  68899999863211         134688999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ..+..+++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~  151 (263)
T cd05052          72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  151 (263)
T ss_pred             cCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccc
Confidence            99999999999999999999998755567899999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCc--CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 011359          332 CEEVYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       332 ~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      ........  .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+. ............+..+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  230 (263)
T cd05052         152 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKGYRMERPEGC  230 (263)
T ss_pred             cccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCC
Confidence            54332211  112234567999999988899999999999999999998 9999988766544 3444555566778889


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      +.++.++|.+||+.+|++||++.++++.|+.+
T Consensus       231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         231 PPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            99999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-42  Score=340.36  Aligned_cols=248  Identities=33%  Similarity=0.658  Sum_probs=208.1

Q ss_pred             eccceeeeeccEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          182 FLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~~------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .+.+.||.|.||.||+|.+.      +..|+||++......       ...+.|.+|++++++++||||++++|++....
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~-------~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~   74 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE-------EEEEEFLNEIQILRKLRHPNIVKLYGFCIENE   74 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH-------HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc-------ccceeeeecccccccccccccccccccccccc
Confidence            35678999999999999998      578999999643221       12567899999999999999999999999888


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++|+||+.+|+|.++|.......+++..++.|+.||+.||+|||+++++||||+++|||++.++.+||+|||++....
T Consensus        75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            89999999999999999998656789999999999999999999999999999999999999999999999999986542


Q ss_pred             cc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          336 YC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       336 ~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      ..   .......+...|+|||.+....++.++||||||+++|||++ |..||.+.+..+....+ ....+...+..++..
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKD  233 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHH
Confidence            11   12233447788999999998889999999999999999999 78999999887766666 555556678889999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~L  437 (488)
                      +.++|.+||+.+|++||++.+|++.|
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            99999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.1e-42  Score=336.15  Aligned_cols=257  Identities=32%  Similarity=0.557  Sum_probs=220.2

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      |.|+.++|.+.++||+|+||.||+|.+. +..||+|.+......         .+.+.+|+.++++++|+||+++++.+.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---------VQAFLEEANLMKTLQHDKLVRLYAVVT   71 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh---------HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            6788899999999999999999999876 477999998643211         356889999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .....+++|||+.+++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence            99999999999999999999987666678999999999999999999999999999999999999999999999999986


Q ss_pred             cccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          333 EEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       333 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ......  ......++..|+|||++....++.++|||||||++|+|++ |..||......+....+.. ..+......++
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~  230 (261)
T cd05072         152 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPRMENCP  230 (261)
T ss_pred             ecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCC
Confidence            433211  1122345678999999988889999999999999999998 9999988776665554433 34444556789


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .++.++|.+||..+|++||++.++++.|+++
T Consensus       231 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         231 DELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            9999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4e-42  Score=343.78  Aligned_cols=255  Identities=31%  Similarity=0.542  Sum_probs=208.3

Q ss_pred             cccceeccceeeeeccEEEEEEEEC------------------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK------------------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR  238 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~------------------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~  238 (488)
                      ..++|.+.++||+|+||.||+|.+.                  +..||||++......       ....+|.+|+.++.+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~   75 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-------NARNDFLKEVKILSR   75 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-------HHHHHHHHHHHHHhh
Confidence            3467889999999999999999863                  236999998754321       124678999999999


Q ss_pred             cCCCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC-----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 011359          239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH-----------------KTLPLPKLIAIALDIARGMEYIH  301 (488)
Q Consensus       239 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----------------~~l~~~~~~~i~~qi~~~L~~LH  301 (488)
                      ++||||+++++++......++||||+.+|+|.+++.....                 ..+++..++.++.||+.||.|||
T Consensus        76 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH  155 (304)
T cd05096          76 LKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS  155 (304)
T ss_pred             cCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999999975321                 24677889999999999999999


Q ss_pred             HCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh
Q 011359          302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA  378 (488)
Q Consensus       302 ~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt  378 (488)
                      +.||+||||||+|||++.++.+||+|||++.......   ......++..|+|||++....++.++||||||+++|+|++
T Consensus       156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence            9999999999999999999999999999985432211   1123345788999999988889999999999999999986


Q ss_pred             --CCCCCCCCCHHHHHHHHHh------ccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          379 --GTIPYEEMNPIQAAFAVVN------KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       379 --G~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                        +..||......+....+..      .......+..++..+.+||.+||+.+|++||++.+|.+.|+
T Consensus       236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence              6778887766554332211      11123345678999999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=353.34  Aligned_cols=261  Identities=26%  Similarity=0.396  Sum_probs=216.2

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHH----H--HHHHHHHHHHHHHHHhcCCCCe
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETL----A--ARLEKQFNREVALLSRLHNPNV  244 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~----~--~~~~~~~~~Ei~il~~l~HpnI  244 (488)
                      +....+++|+++..||+|.||.|-+|+..  ++.||||++....-......    +  -.-.++..+||.||++|.|+||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            34456789999999999999999999985  78999999964321111000    0  0012468899999999999999


Q ss_pred             eeEeeeeecC--CeeeEEEeecCCCCHHHHHHHhCCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC
Q 011359          245 IKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF  321 (488)
Q Consensus       245 v~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~  321 (488)
                      |+|+.+..+.  ..+|||+|||..|.+...-   ..+. +.+.++++++.+++.||+|||.+|||||||||+|+||+++|
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence            9999998764  5799999999988875533   2344 89999999999999999999999999999999999999999


Q ss_pred             cEEEeeeccccccc------ccCcCCCCCCCcccCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 011359          322 HLKIADFGIACEEV------YCDALSDDPGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA  391 (488)
Q Consensus       322 ~vkl~DFgla~~~~------~~~~~~~~~gt~~y~aPE~l~~~~----~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~  391 (488)
                      ++||+|||.+....      ....+...+||+.|+|||.+.+..    .+.+.||||+||+||.|+.|..||-+....+.
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            99999999986441      222234468999999999997632    36899999999999999999999999998898


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      ..++++..+.....+.+...+++||.+||.+||++|.++.+|...
T Consensus       328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            899998877666566788999999999999999999999888754

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4e-42  Score=339.37  Aligned_cols=256  Identities=30%  Similarity=0.610  Sum_probs=217.4

Q ss_pred             ccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      ++.++|.+.+.||+|+||.||+|.+.+       ..||+|.+.....       ......|.+|+.++.+++||||++++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~~~ei~~l~~l~h~~i~~~~   74 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-------PKVQQEFRQEAELMSDLQHPNIVCLL   74 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-------HHHHHHHHHHHHHHHhcCCcccceEE
Confidence            456788999999999999999998753       4699999874332       12245688999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCe
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEH--------------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN  314 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~N  314 (488)
                      +++......+++|||+++++|.+++.....              ..+++..++.++.|++.||+|||+.|++||||||+|
T Consensus        75 ~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N  154 (283)
T cd05048          75 GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARN  154 (283)
T ss_pred             EEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccce
Confidence            999998999999999999999999986421              457888999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 011359          315 VLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ  390 (488)
Q Consensus       315 ILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~  390 (488)
                      |+++.++.++|+|||++.......   ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+
T Consensus       155 il~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05048         155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE  234 (283)
T ss_pred             EEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999985432211   1223456788999999988889999999999999999998 999999888766


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHH
Q 011359          391 AAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ  439 (488)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~  439 (488)
                      ....+. ....+..+..++.++.+|+.+||+.+|.+||++.+|++.|+.
T Consensus       235 ~~~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            554443 444556678899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-42  Score=351.13  Aligned_cols=241  Identities=23%  Similarity=0.380  Sum_probs=206.8

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEee
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY  263 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  263 (488)
                      .||+|+||.||++...  |+.||||++......     .......+.+|+.++++++||||+++++++.....+|+||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   76 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVII-----AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEY   76 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeC
Confidence            5899999999999875  689999999743211     112245678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcCCC
Q 011359          264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALSD  342 (488)
Q Consensus       264 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~~~  342 (488)
                      +.+|+|.+++..  ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..... ......
T Consensus        77 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          77 ANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            999999999976  45789999999999999999999999999999999999999999999999999864322 222334


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 011359          343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSL  422 (488)
Q Consensus       343 ~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~  422 (488)
                      ..||..|+|||++.+..++.++|||||||++|||++|..||...+.......+....  ..++..++.++.+||.+||+.
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~  232 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccC
Confidence            569999999999998899999999999999999999999999887766555554443  356778999999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 011359          423 QPDKRP-----EFWHIVK  435 (488)
Q Consensus       423 dp~~RP-----s~~eil~  435 (488)
                      ||++||     ++.++++
T Consensus       233 dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         233 DPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CHHHcCCCCCCCHHHHHc
Confidence            999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.2e-42  Score=324.95  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=211.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      .+|...++||+|.||.||+|++.  |+.||||.++.....+.-      .....+|+.+|+.++|+||+.++++|.+...
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi------~~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI------NRTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc------cHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            46778889999999999999985  799999999987654433      2345699999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +.||+||++ .+|+..++. ....++...+..++.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+....
T Consensus        76 l~lVfEfm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   76 LSLVFEFMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             eEEEEEecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            999999995 599999876 456788999999999999999999999999999999999999999999999999976553


Q ss_pred             cCc-CCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------cCCCC-----
Q 011359          337 CDA-LSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK------NLRPA-----  403 (488)
Q Consensus       337 ~~~-~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~------~~~~~-----  403 (488)
                      ... ....+.|.+|.|||.+.+ ..|+..+|+||.|||+.||+.|.+-|.+.+..+.+..+...      ..++.     
T Consensus       154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            332 334478999999999865 57999999999999999999999888888877766555431      11111     


Q ss_pred             ---------------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          404 ---------------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       404 ---------------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                                     +...++....+|+.+||..||.+|+++.|+++.
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                           113456788999999999999999999998873

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-43  Score=351.81  Aligned_cols=250  Identities=28%  Similarity=0.436  Sum_probs=210.7

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  254 (488)
                      .+.|+..++||+|.||.||+|++.  |+.||+|.++.......      ......+||.||++|+||||++|.+..... 
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~------~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG------FPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc------chHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            356888899999999999999975  78899999997654332      134567999999999999999999988765 


Q ss_pred             -CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          255 -PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       255 -~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                       ..+|||+|||+. +|.-++.. ..-.+++.++..++.||+.||+|||++||+|||||.+|||||.+|.+||+|||+|+.
T Consensus       190 ~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  190 SGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             CceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceee
Confidence             689999999965 78777765 334689999999999999999999999999999999999999999999999999985


Q ss_pred             cccc--CcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------cCCC--
Q 011359          334 EVYC--DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK------NLRP--  402 (488)
Q Consensus       334 ~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~------~~~~--  402 (488)
                      ....  ...+..+.|.+|.|||++.+. .|+.++|+||.||||.||+.|++.|.+.+..+.+..|..-      ..++  
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            4433  346778899999999999764 7999999999999999999999999999887766655431      1121  


Q ss_pred             CCC-------------------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 AIP-------------------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 ~~~-------------------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+|                   ...+....+|+..+|..||++|.++.+++.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            111                   246778999999999999999999998885

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=381.05  Aligned_cols=263  Identities=31%  Similarity=0.591  Sum_probs=230.3

Q ss_pred             ccccceeccceeeeeccEEEEEEEECC---c----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYKD---E----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~~---~----~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      +......++..||+|+||.||+|.+.+   .    .||||.+....+.       +...+|.+|..+|+.++|||||+++
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~-------~~~~~Fl~Ea~~m~~f~HpNiv~li  761 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE-------QEVSDFLKEALLMSKFDHPNIVSLI  761 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH-------HHHHHHHHHHHHHhcCCCcceeeEE
Confidence            346778899999999999999999863   2    3888888754332       2257899999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcE
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLE-----HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL  323 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~v  323 (488)
                      |+|.+....+|++|||+||+|..||++.+     ...++...++.++.|||+|+.||+++++|||||-..|+||+....+
T Consensus       762 Gv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~V  841 (1025)
T KOG1095|consen  762 GVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVV  841 (1025)
T ss_pred             EeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcE
Confidence            99999999999999999999999999752     4568899999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccccCcCCC---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 011359          324 KIADFGIACEEVYCDALSD---DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKN  399 (488)
Q Consensus       324 kl~DFgla~~~~~~~~~~~---~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~  399 (488)
                      ||+|||+|+..........   ..-...|||||.+..+.++.|+|||||||++||+++ |..||.+.++.+....++..+
T Consensus       842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg  921 (1025)
T KOG1095|consen  842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG  921 (1025)
T ss_pred             EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence            9999999974332222111   123468999999999999999999999999999999 999999999999888788777


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhcc
Q 011359          400 LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLAC  446 (488)
Q Consensus       400 ~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~  446 (488)
                       +...|..||..+.+||.+||+.+|++||+|..|++.+.++...+..
T Consensus       922 -RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  922 -RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             -ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence             8899999999999999999999999999999999999998876543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-42  Score=349.44  Aligned_cols=249  Identities=22%  Similarity=0.295  Sum_probs=211.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|++.  ++.||||++......     .......+.+|+.++..++|+||+++++++.....
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence            36888999999999999999985  689999999743211     11224568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|+||||+++|+|.+++..  ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        76 ~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999999999976  35688999999999999999999999999999999999999999999999999864432


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC------CCCcH
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP------GDCPP  410 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~  410 (488)
                        ......||..|+|||++.+..++.++|||||||++|||++|..||...+..+....+.........+      ..++.
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~  231 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD  231 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence              2345569999999999998899999999999999999999999999887766555444322111111      25688


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      ++.+||.+||..+|++||++.++++.
T Consensus       232 ~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         232 EAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            99999999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-43  Score=344.61  Aligned_cols=248  Identities=25%  Similarity=0.423  Sum_probs=222.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      .+|.+.+.||+|.||.|-++...  |+.||||.|+.....+...     .-.+.+||+||..|+||||+++|.+|+....
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD-----lvhIRREIeIMSsLNHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD-----LVHIRREIEIMSSLNHPHIIQIYEVFENKDK  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH-----HHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence            56889999999999999999874  8999999998765444332     2457899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +.|||||..+|.|++|+..  .+.+++.++..+++||+.|+.|||.++++|||||.+|||+|.++++||+|||++..+..
T Consensus       128 IvivMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEEEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999999999987  46799999999999999999999999999999999999999999999999999987777


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      ...+.+.+|++-|.+||++++.+| ++.+|.|||||+||.|+.|..||++.+......++..+.++.   +.-|....-|
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gL  282 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGL  282 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHH
Confidence            788889999999999999999998 689999999999999999999999999888888777776653   2335567899


Q ss_pred             HHHHhhhCCCCCCCHHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~~  436 (488)
                      |++||-.+|++|.++.+|...
T Consensus       283 IRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  283 IRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HHHHHhcCcccchhHHHHhhh
Confidence            999999999999998887753

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-43  Score=354.76  Aligned_cols=252  Identities=23%  Similarity=0.389  Sum_probs=230.4

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|..++.+|+|+||.++..+.+  ++.|++|.+......+.+      +....+|+.+++++.|||||.+.+.|..++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~------r~~A~~E~~lis~~~hP~iv~y~ds~~~~~   76 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE------RRSAIQEMDLLSKLLHPNIVEYKDSFEEDG   76 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh------hHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence            467889999999999999988876  578999999987766543      335679999999999999999999999888


Q ss_pred             e-eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          256 V-YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       256 ~-~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      . .+|||+||+||+|.+.|.+.+...++++.++.++.||+.|+.|||+++|+|||||+.||+++.++.|+|+|||+|+..
T Consensus        77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            8 999999999999999999987788999999999999999999999999999999999999999999999999999876


Q ss_pred             cccC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          335 VYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       335 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                      .... ......||+.||.||.+.+.+|+.|+|||||||++|||++-+.+|...+.......+.... -..+|..++.+++
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~  235 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELR  235 (426)
T ss_pred             CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHH
Confidence            6655 5677889999999999999999999999999999999999999999999888888877766 4567889999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHH
Q 011359          414 ALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      .||..||..+|+.||++.+++..
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhC
Confidence            99999999999999999999975

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=332.32  Aligned_cols=257  Identities=32%  Similarity=0.564  Sum_probs=218.7

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      |+++.++|.+.+.||+|++|.||+|.+. ++.||||.++.....         .+++.+|+.++++++|+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---------PKDFLAEAQIMKKLRHPKLIQLYAVCT   71 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---------HHHHHHHHHHHHHCCCCCccceeEEEe
Confidence            5677788999999999999999999875 468999998753321         356789999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .....++||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  151 (261)
T cd05068          72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR  151 (261)
T ss_pred             cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence            99999999999999999999987554578999999999999999999999999999999999999999999999999985


Q ss_pred             cccccCcC--CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          333 EEVYCDAL--SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       333 ~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ........  .....+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+ ........+..++
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  230 (261)
T cd05068         152 VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCP  230 (261)
T ss_pred             EccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCC
Confidence            44321111  11123457999999988889999999999999999999 99999988776655544 3344445567789


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       231 ~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         231 KELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            9999999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.2e-42  Score=348.40  Aligned_cols=263  Identities=30%  Similarity=0.532  Sum_probs=219.4

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCe
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNV  244 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnI  244 (488)
                      .|.+..++|.+++.||+|+||.||+|.+.       ++.||+|+++.....       ...+.+.+|+.++.++ +|+||
T Consensus         1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-------~~~~~~~~E~~~~~~l~~h~ni   73 (337)
T cd05054           1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-------SEYKALMTELKILIHIGHHLNV   73 (337)
T ss_pred             CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-------HHHHHHHHHHHHHHhhccCcch
Confidence            37788889999999999999999999753       367999998743321       1135678899999999 79999


Q ss_pred             eeEeeeeec-CCeeeEEEeecCCCCHHHHHHHhCC---------------------------------------------
Q 011359          245 IKFVAACKK-PPVYCVITEYLSEGSLRAYLHKLEH---------------------------------------------  278 (488)
Q Consensus       245 v~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------  278 (488)
                      ++++++|.. +..++++|||+.+++|.+++.....                                             
T Consensus        74 v~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (337)
T cd05054          74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL  153 (337)
T ss_pred             hheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence            999998864 4578899999999999999975321                                             


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC---cCC
Q 011359          279 --------------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALS  341 (488)
Q Consensus       279 --------------~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~  341 (488)
                                    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......   ...
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~  233 (337)
T cd05054         154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  233 (337)
T ss_pred             hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhcc
Confidence                          267899999999999999999999999999999999999999999999999986432211   112


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW  420 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL  420 (488)
                      ...++..|+|||++.+..++.++|||||||++|||++ |..||.+....+..........+...+..++.++.+++.+||
T Consensus       234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl  313 (337)
T cd05054         234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCW  313 (337)
T ss_pred             CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHc
Confidence            3345678999999998999999999999999999998 999998766555555555565666677788999999999999


Q ss_pred             hhCCCCCCCHHHHHHHHHHHHH
Q 011359          421 SLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       421 ~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +.+|++||++.++++.|+++..
T Consensus       314 ~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         314 HNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             cCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-41  Score=330.30  Aligned_cols=254  Identities=29%  Similarity=0.584  Sum_probs=217.5

Q ss_pred             ccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee-
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-  252 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-  252 (488)
                      |.+++.+|.+.+.||+|+||.||++...+..||+|.+.....          .+.|.+|+.++++++|+||+++++++. 
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGVIVE   70 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch----------HHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence            567888999999999999999999999999999999864221          346789999999999999999999764 


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .+...++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             CCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence            55678999999999999999987555568899999999999999999999999999999999999999999999999986


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      .....  .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+.... +.....+..+..++..
T Consensus       151 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  227 (256)
T cd05082         151 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPV  227 (256)
T ss_pred             ecccc--CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCCCCCCHH
Confidence            43321  123345668999999988889999999999999999997 9999987766554433 3344556667789999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      +.++|.+||+.+|++||++.++++.|+++
T Consensus       228 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         228 VYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            99999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-42  Score=348.60  Aligned_cols=251  Identities=21%  Similarity=0.342  Sum_probs=215.3

Q ss_pred             ccccccceeccceeeeeccEEEEEEEECC---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~~---~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      +.++.++|.+.+.||+|+||.||+|.+.+   ..||||++.....     ......+.+.+|+.++..++||||++++++
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~   99 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-----IKQKQVDHVFSERKILNYINHPFCVNLYGS   99 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-----hhhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence            45677889999999999999999998753   5799999974321     112234568899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +.....+++||||+.+|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~~~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        100 FKDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCC
Confidence            9999999999999999999999976  45689999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      +.....  ......||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+....  ..++..++.
T Consensus       178 a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~  253 (340)
T PTZ00426        178 AKVVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYFPKFLDN  253 (340)
T ss_pred             CeecCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCH
Confidence            864322  2234568999999999998889999999999999999999999999888766666655543  345777899


Q ss_pred             HHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RP-----s~~eil~  435 (488)
                      .+.++|++||+.+|.+|+     ++.++++
T Consensus       254 ~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        254 NCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             HHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            999999999999999995     7887775

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-42  Score=337.90  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=226.5

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~--~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      .....+.++.|++.++||.|.-|+||++...+  ..+|+|++......     ..+...+...|-+||+.++||.++.||
T Consensus        69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-----~rkKl~Ra~tE~eIL~~lDHPFlPTLY  143 (459)
T KOG0610|consen   69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-----SRKKLKRAQTEREILSLLDHPFLPTLY  143 (459)
T ss_pred             cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-----hhhHHHHHHHHHHHHHhcCCCccchhh
Confidence            34566788899999999999999999999986  78999999753221     123356678899999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      +.|+.+...|++||||+||+|..+++++.++.++++.+..++.+++.||+|||-.|||.|||||+||||.++|++.|+||
T Consensus       144 a~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  144 ASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             heeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccc---------------------------------cCc------------------------CCCCCCCcccCC
Q 011359          329 GIACEEVY---------------------------------CDA------------------------LSDDPGTYRWMA  351 (488)
Q Consensus       329 gla~~~~~---------------------------------~~~------------------------~~~~~gt~~y~a  351 (488)
                      .++.....                                 ...                        ....+||-.|+|
T Consensus       224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA  303 (459)
T KOG0610|consen  224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA  303 (459)
T ss_pred             cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence            98732100                                 000                        001248999999


Q ss_pred             hhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCC--
Q 011359          352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE--  429 (488)
Q Consensus       352 PE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs--  429 (488)
                      ||++.+...+.++|.|+|||++||||.|..||.+.+..+.+..++.+.+...-...++..+++||+++|.+||.+|..  
T Consensus       304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~  383 (459)
T KOG0610|consen  304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK  383 (459)
T ss_pred             ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc
Confidence            999999999999999999999999999999999999999999999887765555577899999999999999999988  


Q ss_pred             --HHHHHH
Q 011359          430 --FWHIVK  435 (488)
Q Consensus       430 --~~eil~  435 (488)
                        +.+|.+
T Consensus       384 rGA~eIK~  391 (459)
T KOG0610|consen  384 RGAAEIKR  391 (459)
T ss_pred             cchHHhhc
Confidence              566553

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.2e-41  Score=351.89  Aligned_cols=264  Identities=29%  Similarity=0.540  Sum_probs=224.7

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CC
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NP  242 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-Hp  242 (488)
                      ...|.++.++|.+++.||+|+||.||+|++.+       +.||||++.......       ....+.+|+.+|.++. ||
T Consensus        29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~E~~~l~~l~~H~  101 (401)
T cd05107          29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS-------EKQALMSELKIMSHLGPHL  101 (401)
T ss_pred             CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh-------HHHHHHHHHHHHHhcCCCC
Confidence            34688888999999999999999999999743       579999997543221       1346889999999998 99


Q ss_pred             CeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC--------------------------------------------
Q 011359          243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH--------------------------------------------  278 (488)
Q Consensus       243 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------  278 (488)
                      ||++++++|......++||||+.+|+|.++++....                                            
T Consensus       102 niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (401)
T cd05107         102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDM  181 (401)
T ss_pred             CeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccccc
Confidence            999999999999999999999999999999976321                                            


Q ss_pred             ----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 011359          279 ----------------------------------------------------KTLPLPKLIAIALDIARGMEYIHSQGVI  306 (488)
Q Consensus       279 ----------------------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~gii  306 (488)
                                                                          ..+++..++.++.||+.||+|||+.||+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv  261 (401)
T cd05107         182 SKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV  261 (401)
T ss_pred             CCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcC
Confidence                                                                2356778899999999999999999999


Q ss_pred             cCCCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 011359          307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP  382 (488)
Q Consensus       307 HrDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~P  382 (488)
                      ||||||+|||++.++.++|+|||++.......   ......++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus       262 Hrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P  341 (401)
T cd05107         262 HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP  341 (401)
T ss_pred             cccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999999986432211   1122346788999999988889999999999999999998 8999


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          383 YEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       383 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      |......+.....+..+.++..+..++.++.+||.+||..+|.+||++.+|++.|+++.
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         342 YPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            98877666666666667777778889999999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=359.81  Aligned_cols=247  Identities=25%  Similarity=0.420  Sum_probs=221.3

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAA  250 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~  250 (488)
                      ..+.+++|++.+.||+|.||+|+++..+  ++.+|||+++....-.+.+     ......|..|+...+ ||.++.++..
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~-----Ve~~~~EkrI~~la~~HPFL~~L~~~  437 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE-----VESLMCEKRIFELANRHPFLVNLFSC  437 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc-----HHHHHHHHHHHHHhccCCeEeecccc
Confidence            4567788999999999999999999986  5899999999766443333     356778888888886 9999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      |....++|+||||+.||++..+.+   ...+++..+..++..|+.||.|||++|||+||||.+|||+|.+|++||+|||+
T Consensus       438 fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  438 FQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             cccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccc
Confidence            999999999999999999544443   36799999999999999999999999999999999999999999999999999


Q ss_pred             ccccc-ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          331 ACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       331 a~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      +++.. .+....+.+||+.|||||++.+..|+.++|.|+|||+|||||.|..||.+.+..+....++...  +..|..++
T Consensus       515 cKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--~~yP~~ls  592 (694)
T KOG0694|consen  515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLS  592 (694)
T ss_pred             ccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCCccc
Confidence            98766 5667788999999999999999999999999999999999999999999999988888888764  45788899


Q ss_pred             HHHHHHHHHHhhhCCCCCCCH
Q 011359          410 PAMAALIEQCWSLQPDKRPEF  430 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~  430 (488)
                      .+...+++++|.++|++|..+
T Consensus       593 ~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  593 KEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHHHHHHhccCcccccCC
Confidence            999999999999999999776

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.5e-41  Score=329.11  Aligned_cols=251  Identities=25%  Similarity=0.514  Sum_probs=213.3

Q ss_pred             ccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      +|.++|.+.+.||+|+||.||++.+.+ ..+|+|.+......         ..+|.+|+.++++++||||+++++++...
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd05114           1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQ   71 (256)
T ss_pred             CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---------HHHHHHHHHHHHHCCCCCceeEEEEEccC
Confidence            466788899999999999999999874 58999988643221         34678999999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus        72 ~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~  150 (256)
T cd05114          72 KPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV  150 (256)
T ss_pred             CCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence            99999999999999999997632 46889999999999999999999999999999999999999999999999988543


Q ss_pred             cccCc--CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          335 VYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       335 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      .....  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+... .+...+...+..
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~  229 (256)
T cd05114         151 LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-FRLYRPKLASMT  229 (256)
T ss_pred             CCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHH
Confidence            22111  122235668999999988889999999999999999999 99999988776665555443 344556677899


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~L  437 (488)
                      +.+++.+||+.+|++||++.++++.|
T Consensus       230 ~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         230 VYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHhh
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.7e-41  Score=343.81  Aligned_cols=245  Identities=27%  Similarity=0.424  Sum_probs=199.7

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||.||+|.+.  ++.||||++.....       ......+.+|+++++.++|+||+++++++..+.
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  145 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-------DTVRRQICREIEILRDVNHPNVVKCHDMFDHNG  145 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-------HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence            456677889999999999999985  68999999964332       122467889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+++++|.+.      ....+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       146 ~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             eEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            99999999999998653      235677888999999999999999999999999999999999999999999986433


Q ss_pred             cc-CcCCCCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCCCCCCCC
Q 011359          336 YC-DALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI--QAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       336 ~~-~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~  407 (488)
                      .. .......||..|+|||++..     ...+.++|||||||++|||++|..||......  ............+..+..
T Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
T PLN00034        220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT  299 (353)
T ss_pred             cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence            21 12234568999999998843     23356899999999999999999999743321  112222223334556678


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.++.+||.+||+.||++||++.++++
T Consensus       300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        300 ASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            8999999999999999999999999887

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.6e-41  Score=337.56  Aligned_cols=267  Identities=30%  Similarity=0.562  Sum_probs=222.7

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-  239 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~---------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-  239 (488)
                      ..+.|.+..++|.+++.||+|+||.||++.+.+         ..||+|++.......       ...++..|+.+++.+ 
T Consensus         9 ~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~e~~~l~~l~   81 (307)
T cd05098           9 EDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-------DLSDLISEMEMMKMIG   81 (307)
T ss_pred             CCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH-------HHHHHHHHHHHHHHhc
Confidence            346678888899999999999999999998642         369999987432111       135678899999999 


Q ss_pred             CCCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 011359          240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH--------------KTLPLPKLIAIALDIARGMEYIHSQGV  305 (488)
Q Consensus       240 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~gi  305 (488)
                      +|+||+++++++......++||||+.+|+|.+++.....              ..+++..++.++.|++.||+|||+.|+
T Consensus        82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi  161 (307)
T cd05098          82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC  161 (307)
T ss_pred             CCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            699999999999999999999999999999999986421              247889999999999999999999999


Q ss_pred             ccCCCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 011359          306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTI  381 (488)
Q Consensus       306 iHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~  381 (488)
                      +||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++ |..
T Consensus       162 ~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~  241 (307)
T cd05098         162 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS  241 (307)
T ss_pred             ccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999985432211   1122234568999999988889999999999999999998 889


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       382 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      ||......+ ....+........+..++.++.+||.+||..+|++||++.++++.|+.+....
T Consensus       242 p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         242 PYPGVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             CCCcCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            998766544 34444555556677888999999999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=349.55  Aligned_cols=249  Identities=24%  Similarity=0.390  Sum_probs=213.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++......     .......+..|+.++..++|+||+++++++.++..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-----KRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence            36888999999999999999987  789999999743211     11234668899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||+.+++|.+++...  ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            99999999999999999873  6789999999999999999999999999999999999999999999999999854332


Q ss_pred             cC------------------------------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 011359          337 CD------------------------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM  386 (488)
Q Consensus       337 ~~------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~  386 (488)
                      ..                              ......||..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            22                              223446899999999999899999999999999999999999999998


Q ss_pred             CHHHHHHHHHh--ccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCC-HHHHHH
Q 011359          387 NPIQAAFAVVN--KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE-FWHIVK  435 (488)
Q Consensus       387 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs-~~eil~  435 (488)
                      ...+....+..  ..........+++.+.+||.+||. +|.+||+ +.++++
T Consensus       234 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            87776666665  223222233469999999999997 9999999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.5e-41  Score=336.78  Aligned_cols=250  Identities=26%  Similarity=0.425  Sum_probs=204.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeeEeeeee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACK  252 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~---~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~  252 (488)
                      .+|.+.+.||+|+||.||+|.+.   ++.||||++......+..      ...+.+|+.+++.+   +||||++++++|.
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~hpniv~~~~~~~   74 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVCT   74 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc------hHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence            36888999999999999999873   578999999765433221      23355677777665   6999999999885


Q ss_pred             -----cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          253 -----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       253 -----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                           ....+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence                 3456899999995 6999999876666789999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----
Q 011359          328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP-----  402 (488)
Q Consensus       328 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----  402 (488)
                      ||++.............|+..|+|||.+.+..++.++|||||||++|||++|..||.+....+....+......+     
T Consensus       154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            999865443333445668999999999988889999999999999999999999999887766655554321000     


Q ss_pred             --------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 --------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 --------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                          .+...++..+.+||.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                                011356788999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-41  Score=327.56  Aligned_cols=254  Identities=30%  Similarity=0.632  Sum_probs=220.7

Q ss_pred             ccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      |.++.++|.+.+.||.|+||.||+|...|+.||||.+.....         ..+++.+|+.+++.++|+||+++++++..
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---------AAQAFLAEASVMTTLRHPNLVQLLGVVLQ   71 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---------HHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence            345677889999999999999999999999999999975322         24678899999999999999999999998


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ....++||||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~  151 (256)
T cd05039          72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE  151 (256)
T ss_pred             CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence            89999999999999999999875555799999999999999999999999999999999999999999999999999865


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      .....  ....++..|+|||.+....++.++||||||+++|+|++ |..||......+... .+........+..+++.+
T Consensus       152 ~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  228 (256)
T cd05039         152 ASQGQ--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-HVEKGYRMEAPEGCPPEV  228 (256)
T ss_pred             ccccc--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhcCCCCCCccCCCHHH
Confidence            43221  23345678999999988889999999999999999997 999998877655433 334445556677889999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVKVLEQ  439 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~~Le~  439 (488)
                      .++|.+||..+|++||++.+++++|++
T Consensus       229 ~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         229 YKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             HHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-41  Score=343.88  Aligned_cols=241  Identities=23%  Similarity=0.393  Sum_probs=205.8

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEee
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY  263 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  263 (488)
                      .||+|+||.||++...  |+.||+|++......     .......+.+|+.+++.++||||+++++++.....+|+||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~   76 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   76 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeC
Confidence            5899999999999875  689999999743211     112245677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcCCC
Q 011359          264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALSD  342 (488)
Q Consensus       264 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~~~  342 (488)
                      +++|+|..++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus        77 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          77 ANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            999999998876  35789999999999999999999999999999999999999999999999999854322 122234


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 011359          343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSL  422 (488)
Q Consensus       343 ~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~  422 (488)
                      ..||..|+|||++.+..++.++|||||||++|+|++|..||...+.......+....  ..++..+++++.+||.+||..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~  232 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccC
Confidence            568999999999998899999999999999999999999999887766655555443  346778899999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 011359          423 QPDKRP-----EFWHIVK  435 (488)
Q Consensus       423 dp~~RP-----s~~eil~  435 (488)
                      ||++|+     ++.++++
T Consensus       233 dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         233 DPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CHHHhCCCCCCCHHHHHc
Confidence            999998     7777765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-42  Score=343.29  Aligned_cols=236  Identities=22%  Similarity=0.364  Sum_probs=202.2

Q ss_pred             eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeec
Q 011359          187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  264 (488)
                      ||+|+||.||+|.+.  ++.||||++.....     ........+.+|+.++.+++||||+++++++..+..+++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-----VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence            699999999999986  67899999974221     11222456789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcCCCC
Q 011359          265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALSDD  343 (488)
Q Consensus       265 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~~~~  343 (488)
                      .+|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... .......
T Consensus        76 ~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  153 (312)
T cd05585          76 NGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF  153 (312)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence            99999999976  45689999999999999999999999999999999999999999999999999864322 1223345


Q ss_pred             CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhC
Q 011359          344 PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQ  423 (488)
Q Consensus       344 ~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~d  423 (488)
                      .||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...  ...++..++..+.+||.+||..|
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~d  231 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCC
Confidence            6899999999999889999999999999999999999999988776666555544  34567788999999999999999


Q ss_pred             CCCCCCHH
Q 011359          424 PDKRPEFW  431 (488)
Q Consensus       424 p~~RPs~~  431 (488)
                      |.+||++.
T Consensus       232 p~~R~~~~  239 (312)
T cd05585         232 PTRRLGYN  239 (312)
T ss_pred             HHHcCCCC
Confidence            99998643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.7e-41  Score=330.65  Aligned_cols=255  Identities=33%  Similarity=0.611  Sum_probs=219.2

Q ss_pred             cccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      ...+|.+++.||.|+||.||+|.+. ++.+|+|++......        ...++..|+.+++.++|+||+++++++....
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   75 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL--------KQQDFQKEVQALKRLRHKHLISLFAVCSVGE   75 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh--------hHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence            3456889999999999999999986 588999998754321        1346789999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+++++|.+++.......+++..++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            99999999999999999987666778999999999999999999999999999999999999999999999999985432


Q ss_pred             ccC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          336 YCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       336 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                      ... ......++..|+|||.+....++.++||||||+++|+|++ |..||......+....+. ...+...+..++..+.
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIY  234 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHH
Confidence            211 1123345678999999988889999999999999999998 899998887666555444 4456666788999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          414 ALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ++|.+||..+|++||++.+|++.|+.+
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         235 KIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=348.20  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=209.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++.....     ........+.+|+.+|..++|+||+++++++..+..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-----LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence            36788999999999999999985  68999999974321     112234567899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|+||||+.+|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        76 ~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             EEEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999999999999976  35689999999999999999999999999999999999999999999999998843211


Q ss_pred             cC---------------------------------------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHH
Q 011359          337 CD---------------------------------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV  377 (488)
Q Consensus       337 ~~---------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ell  377 (488)
                      ..                                       ......||+.|+|||++....++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            00                                       011235899999999999889999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHHhhhCCCCCCC---HHHHHH
Q 011359          378 AGTIPYEEMNPIQAAFAVVNKNLRPAIPG--DCPPAMAALIEQCWSLQPDKRPE---FWHIVK  435 (488)
Q Consensus       378 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~Li~~cL~~dp~~RPs---~~eil~  435 (488)
                      +|..||...+..+....+.........+.  .+++.+.+||.+||. +|.+|++   +.++++
T Consensus       234 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         234 VGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99999999888777666655443333333  468999999999996 9999998   777765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.9e-41  Score=345.74  Aligned_cols=251  Identities=24%  Similarity=0.310  Sum_probs=207.6

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||+||++...  ++.||||++.....     ........+..|+.++.+++|+||+++++.+.+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-----LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence            36788899999999999999875  68999999974321     112234568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|+||||++||+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            9999999999999999976  45789999999999999999999999999999999999999999999999999853211


Q ss_pred             cC------------------------------------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCC
Q 011359          337 CD------------------------------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT  380 (488)
Q Consensus       337 ~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~  380 (488)
                      ..                                    ......||..|+|||++.+..++.++|||||||++|||++|.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            00                                    012346999999999999889999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHHhh--hCCCCCCCHHHHHHH
Q 011359          381 IPYEEMNPIQAAFAVVNKNLRPAIPG--DCPPAMAALIEQCWS--LQPDKRPEFWHIVKV  436 (488)
Q Consensus       381 ~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~Li~~cL~--~dp~~RPs~~eil~~  436 (488)
                      .||.+....+....+........++.  .++.++.++|.+|+.  .++..||++.+|++.
T Consensus       234 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            99998888777666665433333333  467899999998765  233356899998863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.4e-41  Score=331.39  Aligned_cols=257  Identities=28%  Similarity=0.547  Sum_probs=213.7

Q ss_pred             ccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      |.+..++|.+.+.||+|+||.||+|.+.+       ..||||++......       ....+|.+|+.+++.++|+||++
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~iv~   73 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-------RERIEFLNEASVMKEFNCHHVVR   73 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCeee
Confidence            56677889999999999999999998653       46999998532211       12456889999999999999999


Q ss_pred             EeeeeecCCeeeEEEeecCCCCHHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc
Q 011359          247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEH--------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID  318 (488)
Q Consensus       247 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~  318 (488)
                      +++++......++||||+.+++|.+++.....        ..+++..++.++.|++.||+|||+.|++||||||+||+++
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~  153 (277)
T cd05062          74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA  153 (277)
T ss_pred             EEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc
Confidence            99999999999999999999999999976321        2356788999999999999999999999999999999999


Q ss_pred             CCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 011359          319 QEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFA  394 (488)
Q Consensus       319 ~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~  394 (488)
                      .++.++|+|||++.......   ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....
T Consensus       154 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~  233 (277)
T cd05062         154 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF  233 (277)
T ss_pred             CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999985332111   1122345778999999998889999999999999999998 7899988877655444


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          395 VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       395 ~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      +.. ......+..++..+.++|.+||+.+|++||++.++++.|+
T Consensus       234 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            443 3334567788999999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5e-41  Score=340.57  Aligned_cols=250  Identities=22%  Similarity=0.383  Sum_probs=207.8

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      ..++|.+.+.||+|+||.||++.+.  +..||+|++.....       ....+.+.+|+++|++++|+||+++++++..+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   75 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-------PAIRNQIIRELQVLHECNSPYIVGFYGAFYSD   75 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence            4567889999999999999999986  67899999975322       12356789999999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ..+++||||+++++|.+++..  ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++..
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          76 GEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             CEEEEEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence            999999999999999999976  34688999999999999999999986 699999999999999999999999999854


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------------
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV------------------  395 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~------------------  395 (488)
                      ... .......|+..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+                  
T Consensus       154 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ccc-cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence            322 2223456899999999999888999999999999999999999999765543321111                  


Q ss_pred             ---------------------------HhccCCCCC-CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          396 ---------------------------VNKNLRPAI-PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       396 ---------------------------~~~~~~~~~-~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                                                 +.....+.. ...++.++.+||.+||..||++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                       001111111 22467899999999999999999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.9e-41  Score=327.18  Aligned_cols=255  Identities=31%  Similarity=0.559  Sum_probs=216.4

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      |.+..++|.+.++||+|+||.||+|.+. +..||+|.+......         ...+.+|+.++++++|+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~   71 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVS   71 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEEC
Confidence            5567788999999999999999999876 468999998754322         245789999999999999999999885


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      . ...+++|||+.+++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||++++++.++|+|||++.
T Consensus        72 ~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          72 E-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             C-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeee
Confidence            4 457899999999999999987555678999999999999999999999999999999999999999999999999985


Q ss_pred             cccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          333 EEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       333 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ......  ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+ ........+..++
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  229 (260)
T cd05070         151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCP  229 (260)
T ss_pred             eccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCC
Confidence            432211  1112235567999999988889999999999999999999 99999888776655444 3344556677889


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQ  439 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~Le~  439 (488)
                      ..+.+|+.+||..+|++||++.++++.|++
T Consensus       230 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         230 ISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.8e-41  Score=334.46  Aligned_cols=250  Identities=22%  Similarity=0.377  Sum_probs=204.7

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      ++++|.+.+.||.|+||.||+|...  ++.||||+++.......       ...+.+|+.++++++|+||+++++++...
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-------PCTAIREVSLLKNLKHANIVTLHDIIHTE   75 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc-------chhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            4577999999999999999999875  68999999975433221       23567899999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ...++||||+.+ +|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          76 RCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             CeEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            999999999974 899988753 345788999999999999999999999999999999999999999999999998543


Q ss_pred             cc-cCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------------
Q 011359          335 VY-CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL------------  400 (488)
Q Consensus       335 ~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~------------  400 (488)
                      .. ........++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.....            
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence            22 122334568999999999865 5689999999999999999999999988776554433322100            


Q ss_pred             --------CC--------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 --------RP--------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 --------~~--------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                              .+        .....++.++.+||.+||+.||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                    00        011246788999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-41  Score=344.54  Aligned_cols=241  Identities=22%  Similarity=0.386  Sum_probs=205.6

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEee
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY  263 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  263 (488)
                      .||+|+||.||++...  ++.||||++......     .......+.+|+.+++.++||||+++++++.....+++||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey   76 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVII-----AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEY   76 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeC
Confidence            5899999999999875  689999999753211     112245678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcCCC
Q 011359          264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALSD  342 (488)
Q Consensus       264 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~~~  342 (488)
                      +++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus        77 ~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          77 VNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            999999998875  45689999999999999999999999999999999999999999999999999864321 122234


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 011359          343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSL  422 (488)
Q Consensus       343 ~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~  422 (488)
                      ..||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...++..++.++.+||.+||..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~  232 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DIKFPRTLSADAKSLLSGLLIK  232 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--CccCCCCCCHHHHHHHHHHcCC
Confidence            56899999999999889999999999999999999999999887766655444433  2346778899999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 011359          423 QPDKRP-----EFWHIVK  435 (488)
Q Consensus       423 dp~~RP-----s~~eil~  435 (488)
                      ||++|+     ++.++++
T Consensus       233 dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CHHHcCCCCCCCHHHHhc
Confidence            999997     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.2e-41  Score=328.06  Aligned_cols=257  Identities=28%  Similarity=0.531  Sum_probs=216.1

Q ss_pred             ccccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      |.+..++|.+.++||+|+||.||+|.+.+ ..||||++......         .++|.+|++++++++|+||+++++.+.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~   71 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVS   71 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---------HHHHHHHHHHHHhCCCCCcceEEEEEC
Confidence            56777889999999999999999998864 57999998743321         246789999999999999999999875


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      . ...++||||+.+|+|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||.+.
T Consensus        72 ~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          72 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             C-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCcee
Confidence            4 457899999999999999987555568899999999999999999999999999999999999999999999999985


Q ss_pred             cccccCc--CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          333 EEVYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       333 ~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      .......  .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..++
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  229 (262)
T cd05071         151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP  229 (262)
T ss_pred             eccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccC
Confidence            4322211  122345678999999988889999999999999999999 899998877665544433 333444567789


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      ..+.+||.+||+.+|++||++.++++.|+.+.
T Consensus       230 ~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         230 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            99999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.2e-41  Score=327.49  Aligned_cols=252  Identities=27%  Similarity=0.531  Sum_probs=213.1

Q ss_pred             ccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      |+.++|.+++.||+|+||.||.|.+.+ ..||||.+......         ...|.+|+.++++++||||+++++++...
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd05113           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQ   71 (256)
T ss_pred             CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---------HHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            356788899999999999999999875 46999998743221         34588999999999999999999999988


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||.||+++.++.+||+|||++...
T Consensus        72 ~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~  150 (256)
T cd05113          72 RPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV  150 (256)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence            88999999999999999997633 36899999999999999999999999999999999999999999999999988543


Q ss_pred             cccCc--CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          335 VYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       335 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      .....  .....++..|++||.+.+..++.++||||||+++|+|++ |..||......+....+.. ..+...+...+..
T Consensus       151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  229 (256)
T cd05113         151 LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEK  229 (256)
T ss_pred             CCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCCCCCCCCCCHH
Confidence            22211  112335678999999988889999999999999999998 9999988877655544443 3445556677899


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      +.+++.+||..+|.+||++.+|++.|+
T Consensus       230 ~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         230 VYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-41  Score=330.80  Aligned_cols=257  Identities=28%  Similarity=0.541  Sum_probs=217.6

Q ss_pred             ccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      |.++.++|.+.+.||+|+||.||+|.+.+       ..||+|.+......       .....+.+|+.+++.++|+||++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~   73 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-------RERIEFLNEASVMKEFNCHHVVR   73 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-------HHHHHHHHHHHHHHhCCCCceeE
Confidence            56778899999999999999999998753       57999998643211       11356889999999999999999


Q ss_pred             EeeeeecCCeeeEEEeecCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc
Q 011359          247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID  318 (488)
Q Consensus       247 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~  318 (488)
                      +++++......++||||+++++|.+++....        ...+++..++.++.||+.||.|||+.||+||||||+||+++
T Consensus        74 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~  153 (277)
T cd05032          74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA  153 (277)
T ss_pred             EEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc
Confidence            9999999999999999999999999997532        22467889999999999999999999999999999999999


Q ss_pred             CCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 011359          319 QEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFA  394 (488)
Q Consensus       319 ~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~  394 (488)
                      .++.++|+|||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  233 (277)
T cd05032         154 EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF  233 (277)
T ss_pred             CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH
Confidence            99999999999985432221   1223346788999999988889999999999999999998 9999988877665554


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          395 VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       395 ~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      +. .......+..++..+.++|.+||+.+|++||++.+++..|+
T Consensus       234 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 VI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             Hh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            44 44456677888999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-41  Score=327.82  Aligned_cols=255  Identities=29%  Similarity=0.562  Sum_probs=216.0

Q ss_pred             cccceeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      +.++|.+.+.||+|+||.||+|.+.     ...||||++.......       ....|.+|+.++++++|+||+++++++
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK-------QRLDFLTEASIMGQFDHPNIIRLEGVV   74 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH-------HHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence            4567889999999999999999885     2479999987543221       245688999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ......++||||+.+++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus        75 ~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          75 TKSRPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             ecCCceEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchh
Confidence            9999999999999999999999763 346899999999999999999999999999999999999999999999999998


Q ss_pred             ccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          332 CEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       332 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      .......   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~  232 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMD  232 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence            6543111   1112334678999999998889999999999999999998 999998887666554443 3344456678


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ++..+.+|+.+||+.+|++||++.+|++.|+++
T Consensus       233 ~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         233 CPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.2e-41  Score=335.09  Aligned_cols=249  Identities=23%  Similarity=0.363  Sum_probs=203.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|++.  ++.||||++.......      ...+.+.+|+.++++++|+||+++++++..+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE------EVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc------cchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            36888999999999999999986  5789999997543221      124567789999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||+.++.+..+...  ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus        75 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            9999999988777655432  35689999999999999999999999999999999999999999999999999865332


Q ss_pred             c--CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------------
Q 011359          337 C--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN---------------  399 (488)
Q Consensus       337 ~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~---------------  399 (488)
                      .  .......|+..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....               
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            1  12233468999999999988889999999999999999999999998876554433222100               


Q ss_pred             ----CC-C----------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 ----LR-P----------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 ----~~-~----------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                          .. +          .....++.++.+||.+||+.||++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                00 0          001236788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.5e-41  Score=331.75  Aligned_cols=256  Identities=30%  Similarity=0.588  Sum_probs=213.9

Q ss_pred             ccccceeccceeeeeccEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~------~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      +++++|.+.+.||+|+||.||+|.+      .+..||+|.+......       .....|.+|+.++++++|+||+++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~   74 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-------QQWGEFQQEASLMAELHHPNIVCLLG   74 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-------HHHHHHHHHHHHHhhCCCCCeeeEEE
Confidence            4567888999999999999999985      2468999998743221       11356889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCe
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLE---------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN  314 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~N  314 (488)
                      ++......|+||||+.+++|.+++....               ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~n  154 (283)
T cd05090          75 VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN  154 (283)
T ss_pred             EEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccce
Confidence            9999999999999999999999996421               2347888999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 011359          315 VLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ  390 (488)
Q Consensus       315 ILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~  390 (488)
                      ||++.++.+||+|||++.......   ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.....
T Consensus       155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05090         155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE  234 (283)
T ss_pred             EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999986432211   1223345678999999988889999999999999999998 999998877654


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHH
Q 011359          391 AAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ  439 (488)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~  439 (488)
                      ... .+........+..++..+.++|.+||+.+|.+||++.+|++.|..
T Consensus       235 ~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIE-MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHH-HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            433 334444455677899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-41  Score=325.47  Aligned_cols=257  Identities=32%  Similarity=0.569  Sum_probs=219.8

Q ss_pred             ccccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      |.++.++|.+++.||+|+||.||+|.+.+ ..||||.+......         .+++.+|+.++++++|+||+++++++.
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQIMKKLRHDKLVQLYAVCS   71 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---------HHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence            56788999999999999999999998764 78999998743322         346789999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .....++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~  151 (261)
T cd05034          72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR  151 (261)
T ss_pred             cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence            88899999999999999999987555678999999999999999999999999999999999999999999999999885


Q ss_pred             cccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          333 EEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       333 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ......  ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+. .......+..++
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  230 (261)
T cd05034         152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCP  230 (261)
T ss_pred             eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence            432111  1112234568999999998889999999999999999998 999998877765554443 344555667789


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ..+.+++.+||..+|++||++.++++.|+.+
T Consensus       231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         231 EELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence            9999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-41  Score=342.59  Aligned_cols=243  Identities=23%  Similarity=0.384  Sum_probs=206.1

Q ss_pred             ceeeeeccEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeE
Q 011359          185 LRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV  259 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~-----~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  259 (488)
                      +.||+|+||.||++..     .++.||||++.......    .......+..|+.+|+.++||||+++++++..+..+|+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   77 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR----NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYL   77 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh----hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEE
Confidence            5789999999999975     36789999997432111    11223567899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-C
Q 011359          260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-D  338 (488)
Q Consensus       260 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-~  338 (488)
                      ||||+.+++|.+++..  ...+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus        78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          78 ILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             EEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            9999999999999976  456788899999999999999999999999999999999999999999999998543222 2


Q ss_pred             cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 011359          339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ  418 (488)
Q Consensus       339 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~  418 (488)
                      ......||..|+|||++.+..++.++|||||||++|||++|..||...+.......+...  ...++..+++.+.+||.+
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~  233 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEARDLLKK  233 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Confidence            223456899999999998888999999999999999999999999988877666655544  345677889999999999


Q ss_pred             HhhhCCCCCC-----CHHHHHH
Q 011359          419 CWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       419 cL~~dp~~RP-----s~~eil~  435 (488)
                      ||+.+|++||     ++.++++
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhc
Confidence            9999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8e-41  Score=334.66  Aligned_cols=262  Identities=28%  Similarity=0.519  Sum_probs=222.0

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPN  243 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn  243 (488)
                      ..|.+..++|.+++.||+|+||.||++.+.       +..||||+++......       ..+.+.+|+.+++++ +|+|
T Consensus        28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~h~~  100 (302)
T cd05055          28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS-------EREALMSELKIMSHLGNHEN  100 (302)
T ss_pred             ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH-------HHHHHHHHHHHHHhccCCCC
Confidence            356677788999999999999999999752       2479999987543211       135688999999999 7999


Q ss_pred             eeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcE
Q 011359          244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL  323 (488)
Q Consensus       244 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~v  323 (488)
                      |+++++++......++||||+.+|+|.+++.......+++..++.++.|++.||+|||++||+|+||||+|||++.++.+
T Consensus       101 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~  180 (302)
T cd05055         101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIV  180 (302)
T ss_pred             cceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeE
Confidence            99999999999999999999999999999987544558999999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 011359          324 KIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKN  399 (488)
Q Consensus       324 kl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~  399 (488)
                      +|+|||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.........
T Consensus       181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~  260 (302)
T cd05055         181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG  260 (302)
T ss_pred             EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC
Confidence            999999985432211   1122345678999999988889999999999999999998 999998877666666666666


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          400 LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       400 ~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       261 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            56566677889999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.8e-41  Score=341.29  Aligned_cols=245  Identities=24%  Similarity=0.387  Sum_probs=204.8

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHH---HhcCCCCeeeEeeeeecCC
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALL---SRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~  255 (488)
                      |.+.+.||+|+||.||+|.+.  ++.||||++.......     ....+.+.+|+.++   +.++||||+++++++....
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-----RDEVESLMCEKRIFETANSERHPFLVNLFACFQTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence            457789999999999999885  6899999997532111     11134456666554   5678999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+|+||||+++++|..++..   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            99999999999999988864   568999999999999999999999999999999999999999999999999985432


Q ss_pred             c-cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          336 Y-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       336 ~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      . ........|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+....  ...+..++..+.+
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~  230 (324)
T cd05589         153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSREAIS  230 (324)
T ss_pred             CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHH
Confidence            1 222334568999999999998899999999999999999999999999888777666655543  3467788999999


Q ss_pred             HHHHHhhhCCCCCCC-----HHHHHH
Q 011359          415 LIEQCWSLQPDKRPE-----FWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs-----~~eil~  435 (488)
                      +|.+||+.||.+||+     +.++++
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            999999999999994     555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.5e-41  Score=331.12  Aligned_cols=254  Identities=29%  Similarity=0.547  Sum_probs=214.8

Q ss_pred             cccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ...+|.+.+.||+|+||.||+|.+.       ++.||||++......       ...+.|.+|+++|+.++|+||+++++
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~   75 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-------DARKDFEREAELLTNFQHENIVKFYG   75 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-------HHHHHHHHHHHHHHhcCCCCchheee
Confidence            4567888999999999999999863       368999998754322       12467889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLE------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI  317 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl  317 (488)
                      ++......++||||+++++|.+++....            ...+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili  155 (280)
T cd05049          76 VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV  155 (280)
T ss_pred             EEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE
Confidence            9999999999999999999999997632            2347888999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 011359          318 DQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF  393 (488)
Q Consensus       318 ~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~  393 (488)
                      +.++.++|+|||++.......   ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+...
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~  235 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE  235 (280)
T ss_pred             cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999985432211   1223345778999999998999999999999999999998 999998887766555


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      .+. .+.....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus       236 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 CIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            544 33344456778999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.7e-41  Score=348.21  Aligned_cols=249  Identities=24%  Similarity=0.337  Sum_probs=206.3

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      .|.+++.||+|+||+||+|.+.  ++.||||++......     .......+.+|+.++.+++|+||+++++++.+...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-----NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE
Confidence            5778899999999999999985  578999999753211     122245788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||++||+|.+++..  ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus        77 ~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            999999999999999976  356889999999999999999999999999999999999999999999999987421000


Q ss_pred             ------------------------------------------------CcCCCCCCCcccCChhhhhcCCCCchhHHHHH
Q 011359          338 ------------------------------------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF  369 (488)
Q Consensus       338 ------------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSl  369 (488)
                                                                      .......||..|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence                                                            00113469999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHHh--hhCCCCCCCHHHHHH
Q 011359          370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPAMAALIEQCW--SLQPDKRPEFWHIVK  435 (488)
Q Consensus       370 Gvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~cL--~~dp~~RPs~~eil~  435 (488)
                      ||++|||++|..||...+..+....+.........+  ..+++++.+||.+|+  ..++..|+++.+++.
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999999999999888766666555433233333  357899999999955  455556999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-41  Score=347.68  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=205.9

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||++...  ++.||||++.....     ......+.+.+|++++.+++||||+++++++.++..+
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCee
Confidence            6788899999999999999875  68999999864211     1122346788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      |+||||++||+|.+++..  ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++......
T Consensus        77 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999999999976  456889999999999999999999999999999999999999999999999998421100


Q ss_pred             C------------------------------------------------cCCCCCCCcccCChhhhhcCCCCchhHHHHH
Q 011359          338 D------------------------------------------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF  369 (488)
Q Consensus       338 ~------------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSl  369 (488)
                      .                                                ......||..|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            0                                                0012458999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHHhhhCCCCC---CCHHHHHH
Q 011359          370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG--DCPPAMAALIEQCWSLQPDKR---PEFWHIVK  435 (488)
Q Consensus       370 Gvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~Li~~cL~~dp~~R---Ps~~eil~  435 (488)
                      ||++|||++|..||......+....+........++.  .++.++.+||.+||. +|.+|   +++.+++.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            9999999999999998877666555554333333333  578899999999997 66665   58888776

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-40  Score=325.04  Aligned_cols=245  Identities=28%  Similarity=0.592  Sum_probs=206.9

Q ss_pred             eeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEE
Q 011359          186 RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      +||+|+||.||+|.+.    ++.||||++......      ....+++..|+.+++.++|+||+++++++.. ..+++||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   74 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND------PALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVM   74 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEE
Confidence            5799999999999763    578999998754332      1235678899999999999999999999864 4668999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCc--
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--  339 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~--  339 (488)
                      ||+.+++|.+++..  ...+++..++.++.|++.||+|||++||+||||||.||+++.++.++|+|||++........  
T Consensus        75 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          75 ELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            99999999999975  35689999999999999999999999999999999999999999999999999854322211  


Q ss_pred             --CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          340 --LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       340 --~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                        .....++..|+|||.+....++.++|+|||||++|||++ |..||......+.... +.....+..+..++.++.++|
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l~~li  231 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-IESGERMECPQRCPPEMYDLM  231 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHCCCCCCCCCCCCHHHHHHH
Confidence              122234578999999988888999999999999999998 9999998776554443 444455667888999999999


Q ss_pred             HHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .+||+.+|++||++.+|.+.|+++
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         232 KLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHhccCchhCcCHHHHHHHHhcc
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=349.73  Aligned_cols=261  Identities=28%  Similarity=0.612  Sum_probs=235.7

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      .++|+.++.++.+.++||-|.||.||.|.|+  .-.||||.++-..         .-..+|+.|+.+|+.++|||+|+|+
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---------MeveEFLkEAAvMKeikHpNLVqLL  329 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLL  329 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---------hhHHHHHHHHHHHHhhcCccHHHHh
Confidence            4899999999999999999999999999998  4689999997322         2257899999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      |+|..+.-+|||+|||..|+|.+||.+.....++.-.++.++.||..|++||..+++|||||-..|+|+.++..+||+||
T Consensus       330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADF  409 (1157)
T KOG4278|consen  330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADF  409 (1157)
T ss_pred             hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeecc
Confidence            99999999999999999999999999877777888888999999999999999999999999999999999999999999


Q ss_pred             cccccccccCcCCCCC---CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 011359          329 GIACEEVYCDALSDDP---GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       329 gla~~~~~~~~~~~~~---gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  404 (488)
                      |+++.+... +.+...   ..+.|.|||-+....++.|+|||+|||+|||+.| |..||.+.+..+ .+.++.+++++..
T Consensus       410 GLsRlMtgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-VY~LLEkgyRM~~  487 (1157)
T KOG4278|consen  410 GLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYGLLEKGYRMDG  487 (1157)
T ss_pred             chhhhhcCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHhccccccC
Confidence            999765432 333333   4567999999998999999999999999999998 999999998755 4667889999999


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      |..||+.+.+|+++||+-.|.+||+|.+|-+.||.+..
T Consensus       488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            99999999999999999999999999999999998855

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.1e-41  Score=332.38  Aligned_cols=256  Identities=28%  Similarity=0.534  Sum_probs=215.9

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      |++++|.+.+.||+|+||.||+|.+.       ++.||||++.....       ......|..|+.++..++|+||++++
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~h~~iv~~~   74 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-------GPLREEFKHEAMMRSRLQHPNIVCLL   74 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-------HHHHHHHHHHHHHHhcCCCCCcCeEE
Confidence            56778999999999999999999864       36799999974332       11245688999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCe
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN  314 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~N  314 (488)
                      +++......++++||+.+++|.+++....              ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus        75 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N  154 (283)
T cd05091          75 GVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN  154 (283)
T ss_pred             EEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence            99999999999999999999999986421              2347888899999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 011359          315 VLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ  390 (488)
Q Consensus       315 ILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~  390 (488)
                      |+++.++.+||+|||++.......   ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+
T Consensus       155 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  234 (283)
T cd05091         155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  234 (283)
T ss_pred             eEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999986432211   1223345778999999988889999999999999999998 889998887766


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHH
Q 011359          391 AAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ  439 (488)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~  439 (488)
                      ....+.... ....+..++..+.+|+.+||+.+|++||++.+|+..|+.
T Consensus       235 ~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            555544443 445678899999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=323.90  Aligned_cols=252  Identities=25%  Similarity=0.448  Sum_probs=216.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +.|.+++.||+|++|.||.|...  ++.||||.+.........   ....+.+.+|+.++++++||||+++++++..+..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   78 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET---KKEVNALECEIQLLKNLQHERIVQYYGCLRDDET   78 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh---HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe
Confidence            35778899999999999999864  689999998754432211   1224568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++|+||+++++|.+++..  ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus        79 ~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            9999999999999999976  35688899999999999999999999999999999999999999999999999854322


Q ss_pred             cCc--C--CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          337 CDA--L--SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       337 ~~~--~--~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      ...  .  ....++..|+|||.+.+..++.++||||||+++|+|++|..||....................++..++..+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence            111  1  234578899999999988899999999999999999999999988877776666666666677888899999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .++|.+||..+|++||++.++++
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhh
Confidence            99999999999999999999886

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-40  Score=325.43  Aligned_cols=258  Identities=24%  Similarity=0.407  Sum_probs=213.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|++.  ++.||||.+......+.     .....+.+|+.+++.++||||+++++++.....
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA-----KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCH-----HHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence            57889999999999999999874  78999999875332221     224568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      +++|+||+++++|.+++...  ....+++..++.++.||+.||+|||++|++||||+|+||+++.++.++|+|||++...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            99999999999999988643  2345788999999999999999999999999999999999999999999999988543


Q ss_pred             cccC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCCCCCCCCCcHH
Q 011359          335 VYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP--IQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       335 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      .... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....  ......+......+.....++..
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             cchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            2211 12234688899999999888899999999999999999999999965432  23333322223333334567889


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      +.++|.+||..+|++||++.++++.|+++.
T Consensus       237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         237 LRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.6e-41  Score=331.75  Aligned_cols=262  Identities=29%  Similarity=0.563  Sum_probs=220.9

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPN  243 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn  243 (488)
                      ..+.++.++|.+.+.||+|+||.||++.+.+       ..||+|++......       +....+.+|+.++.++ +|+|
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~~~~E~~~l~~l~~h~~   77 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-------KDLSDLVSEMEMMKMIGKHKN   77 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH-------HHHHHHHHHHHHHHhhcCCCC
Confidence            4678888999999999999999999998752       57999998743221       1135688999999999 7999


Q ss_pred             eeeEeeeeecCCeeeEEEeecCCCCHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 011359          244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--------------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD  309 (488)
Q Consensus       244 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrD  309 (488)
                      |+++++++..+..+++||||+.+|+|.+++...              ....+++..++.++.|++.||+|||+.||+|||
T Consensus        78 i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~d  157 (293)
T cd05053          78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD  157 (293)
T ss_pred             eeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence            999999999999999999999999999999753              234688999999999999999999999999999


Q ss_pred             CCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 011359          310 LKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE  385 (488)
Q Consensus       310 Ikp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~  385 (488)
                      |||+||+++.++.++|+|||++.......   ......++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus       158 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  237 (293)
T cd05053         158 LAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  237 (293)
T ss_pred             cceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence            99999999999999999999986432211   1122335678999999988889999999999999999997 9999988


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      ....+... ..........+..++..+.+|+.+||..+|++||++.++++.|+.+.
T Consensus       238 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         238 IPVEELFK-LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCHHHHHH-HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            77655443 44445556677788999999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.2e-41  Score=347.48  Aligned_cols=256  Identities=21%  Similarity=0.311  Sum_probs=213.7

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ...+..++|.+.+.||+|+||.||++...  ++.||||++......     .....+.+..|+.+++.++||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~h~~iv~~~~~  111 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAHANSEWIVQLHYA  111 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            34456678999999999999999999885  689999999642111     11123457789999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +.++..+++||||++||+|.+++..   ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         112 FQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence            9999999999999999999999875   4588889999999999999999999999999999999999999999999999


Q ss_pred             cccccccC--cCCCCCCCcccCChhhhhcC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 011359          331 ACEEVYCD--ALSDDPGTYRWMAPEMIKHK----SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       331 a~~~~~~~--~~~~~~gt~~y~aPE~l~~~----~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  404 (488)
                      +.......  ......||+.|+|||++.+.    .++.++|||||||++|||++|..||.+.+.......+........+
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  268 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF  268 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCC
Confidence            86433221  12345699999999998653    3789999999999999999999999988877666666654433334


Q ss_pred             CC--CCcHHHHHHHHHHhhhCCCC--CCCHHHHHHH
Q 011359          405 PG--DCPPAMAALIEQCWSLQPDK--RPEFWHIVKV  436 (488)
Q Consensus       405 ~~--~~~~~l~~Li~~cL~~dp~~--RPs~~eil~~  436 (488)
                      +.  .++.++.+||.+||..+|++  |+++.++++.
T Consensus       269 ~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         269 PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            43  57899999999999999988  9999998763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-41  Score=333.00  Aligned_cols=250  Identities=20%  Similarity=0.313  Sum_probs=207.0

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.+.+.||+|+||.||++.+.  ++.||||++.......     ......+.+|+.++++++|+||+++++.+..+..++
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-----hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEE
Confidence            667789999999999999875  6899999997432111     112456778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +||||+.+|+|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999999999876555678999999999999999999999999999999999999999999999999986543333


Q ss_pred             cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCCCCCCCCCcHHHHHHH
Q 011359          339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV--NKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       339 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~Li  416 (488)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|..||.+.........+.  ........+..++..+.+||
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            3344578999999999988889999999999999999999999998765432221111  11223345667899999999


Q ss_pred             HHHhhhCCCCCC-----CHHHHHH
Q 011359          417 EQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RP-----s~~eil~  435 (488)
                      .+||..||++||     ++.++++
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhc
Confidence            999999999999     6666544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-40  Score=324.32  Aligned_cols=256  Identities=30%  Similarity=0.554  Sum_probs=214.9

Q ss_pred             ccccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      |.+..++|.+.+.||+|++|.||+|.+.+ ..||+|.+......         .+.+.+|+.++++++|+|++++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~   71 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---------PEAFLQEAQIMKKLRHDKLVPLYAVVS   71 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---------HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            44566778999999999999999999864 57999987643221         345788999999999999999999886


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      . ...++||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.
T Consensus        72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          72 E-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             C-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccce
Confidence            4 457899999999999999987555568899999999999999999999999999999999999999999999999985


Q ss_pred             cccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          333 EEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       333 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ......  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+ ........+...+
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  229 (260)
T cd05069         151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCP  229 (260)
T ss_pred             EccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccC
Confidence            432211  1122345678999999988889999999999999999999 99999987776554443 3344555667789


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ..+.+++.+||..+|++||++.++++.|+++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         230 ESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            9999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=324.15  Aligned_cols=251  Identities=28%  Similarity=0.554  Sum_probs=212.6

Q ss_pred             ccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      +|..+|.+++.||+|+||.||+|.+.+ ..+|||++......         ...|.+|+.++++++|+||+++++++...
T Consensus         1 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05059           1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ   71 (256)
T ss_pred             CChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            355678899999999999999998864 58999998643221         23577899999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ...++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++...
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~  150 (256)
T cd05059          72 RPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV  150 (256)
T ss_pred             CceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceec
Confidence            99999999999999999997633 46899999999999999999999999999999999999999999999999988543


Q ss_pred             cccCcC--CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          335 VYCDAL--SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       335 ~~~~~~--~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      ......  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... +....+...+..++.+
T Consensus       151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  229 (256)
T cd05059         151 LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VSAGYRLYRPKLAPTE  229 (256)
T ss_pred             ccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHH
Confidence            321111  11223457999999988889999999999999999998 8999988776655444 3445566677789999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~L  437 (488)
                      +.+++.+||..+|++||++.++++.|
T Consensus       230 ~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         230 VYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-40  Score=335.58  Aligned_cols=256  Identities=26%  Similarity=0.530  Sum_probs=213.4

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~----~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ...+|.+.+.||+|+||.||+|.+.  ++    .||||++......       ....++.+|+.+++.++|+||++++++
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~g~   77 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-------KANKEILDEAYVMASVDNPHVCRLLGI   77 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3456888999999999999999873  33    4899998643221       124568899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      |... ..++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~-~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          78 CLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             EcCC-CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccc
Confidence            9865 467999999999999999863 34588889999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          331 ACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       331 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      +........   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+. ..+.........+.
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~  234 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPP  234 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCC
Confidence            964332211   112234668999999998899999999999999999997 9999988776543 44555555666677


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      .++..+.++|.+||..+|++||++.+++..|.++..
T Consensus       235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         235 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            889999999999999999999999999999888765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-40  Score=331.55  Aligned_cols=258  Identities=30%  Similarity=0.528  Sum_probs=214.6

Q ss_pred             cceeccceeeeeccEEEEEEEECC--c--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeec
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYKD--E--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK  253 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~~--~--~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  253 (488)
                      ++|.+.+.||+|+||.||+|.+.+  .  .+|+|.++.....       ...+.|.+|+.++.++ +||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   74 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-------NDHRDFAGELEVLCKLGHHPNIINLLGACEN   74 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH-------HHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence            578889999999999999998753  2  4788887632221       1245688999999999 69999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ  319 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~  319 (488)
                      ...+++|+||+++++|.+++....              ...+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~  154 (297)
T cd05089          75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE  154 (297)
T ss_pred             CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC
Confidence            999999999999999999997632              134788999999999999999999999999999999999999


Q ss_pred             CCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 011359          320 EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK  398 (488)
Q Consensus       320 ~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~  398 (488)
                      ++.+||+|||++..............+..|+|||++.+..++.++|||||||++|||++ |..||......+....+ ..
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~-~~  233 (297)
T cd05089         155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL-PQ  233 (297)
T ss_pred             CCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hc
Confidence            99999999999853322111122233567999999988889999999999999999997 99999988776655444 34


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       399 ~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      ......+..++..+.+||.+||..+|.+||++.++++.|+.+....
T Consensus       234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            4555667789999999999999999999999999999998887644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.5e-41  Score=324.94  Aligned_cols=251  Identities=31%  Similarity=0.622  Sum_probs=215.5

Q ss_pred             ccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      |.+++++|.+++.||+|+||.||+|...++.||+|++.....          ...+.+|+.++++++|+||+++++++..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT----------AQAFLEETAVMTKLHHKNLVRLLGVILH   70 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch----------HHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence            556778899999999999999999999999999999864321          2467899999999999999999999876


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      +. .++||||+.+++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus        71 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~  149 (254)
T cd05083          71 NG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV  149 (254)
T ss_pred             CC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence            54 68999999999999999875555689999999999999999999999999999999999999999999999999854


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      ...  .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.... ......+..+..++..+
T Consensus       150 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  226 (254)
T cd05083         150 GSM--GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-VEKGYRMEPPEGCPADV  226 (254)
T ss_pred             ccc--cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhCCCCCCCCCcCCHHH
Confidence            322  1122334567999999988889999999999999999997 9999988877654443 34455566677889999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      .++|.+||+.+|++||++.++++.|+
T Consensus       227 ~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         227 YVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=361.57  Aligned_cols=257  Identities=23%  Similarity=0.398  Sum_probs=215.7

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAAC  251 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~  251 (488)
                      .|...++++.+.|++|||+.||.+.+.  |..||+|.+...+.        ...+.+.+||++|++|. |+|||.|++..
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de--------~~L~~v~~EI~~MK~L~gh~nIV~yidss  104 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE--------EALNAVKREIDIMKLLSGHKNIVSYIDSS  104 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH--------HHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence            344456778899999999999999986  38999999987632        12466889999999998 99999999932


Q ss_pred             -ec------CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCeEEEcCCCc
Q 011359          252 -KK------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFH  322 (488)
Q Consensus       252 -~~------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--iiHrDIkp~NILl~~~~~  322 (488)
                       ..      .-.++|+||||.||.|-+++..+....|++.++++|+.|+++|+++||...  |||||||-+||||+.+|.
T Consensus       105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~  184 (738)
T KOG1989|consen  105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN  184 (738)
T ss_pred             cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence             11      135789999999999999999877777999999999999999999999998  999999999999999999


Q ss_pred             EEEeeecccccccccCcCC----------CCCCCcccCChhhh---hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 011359          323 LKIADFGIACEEVYCDALS----------DDPGTYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI  389 (488)
Q Consensus       323 vkl~DFgla~~~~~~~~~~----------~~~gt~~y~aPE~l---~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~  389 (488)
                      .||||||.|..........          ...-|+.|.|||++   .+...++|+|||+|||+||-|+....||++... 
T Consensus       185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-  263 (738)
T KOG1989|consen  185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-  263 (738)
T ss_pred             EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-
Confidence            9999999985433222111          11258999999998   466889999999999999999999999998643 


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                         .+|++.++.......++..|.+||+.||+.+|++||++.+++..+..+...
T Consensus       264 ---laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 ---LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ---eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence               346677776655578999999999999999999999999999988887663

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-41  Score=343.20  Aligned_cols=250  Identities=27%  Similarity=0.417  Sum_probs=223.1

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  255 (488)
                      ..|.+++.||+|.||.||+++..  |+.+|+|++.........     ....+.+|+.+|+++. |||||.++++|+...
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----DREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            46889999999999999999986  789999999865543221     2457889999999999 999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC----CCcEEEeeeccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ----EFHLKIADFGIA  331 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~----~~~vkl~DFgla  331 (488)
                      .+++|||+|.||.|.+.+...   .+++..+..++.|++.++.|||+.||+||||||+|+|+..    ++.+|++|||++
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            999999999999999999885   3999999999999999999999999999999999999953    357999999999


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCc
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--PAIPGDCP  409 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~  409 (488)
                      ............+||+.|+|||++....|+..+||||+||++|.|++|..||.+.........+....+.  ......++
T Consensus       187 ~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is  266 (382)
T KOG0032|consen  187 KFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS  266 (382)
T ss_pred             eEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence            8776666778889999999999999999999999999999999999999999999988888888777653  33345779


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      ..++++|+.||..||.+|+++.++++.
T Consensus       267 ~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  267 ESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            999999999999999999999999983

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.4e-41  Score=347.65  Aligned_cols=249  Identities=23%  Similarity=0.328  Sum_probs=207.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||++...  ++.||||++....     .........+.+|+.+|.+++|+||+++++.+.++..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD-----VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH-----HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence            46889999999999999999875  6899999986421     1112224568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|+||||+++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        76 ~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999999999976  35688889999999999999999999999999999999999999999999998732100


Q ss_pred             c--------------------------------------------CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHH
Q 011359          337 C--------------------------------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLI  372 (488)
Q Consensus       337 ~--------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvl  372 (488)
                      .                                            .......||..|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            0                                            00112468999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcHHHHHHHHHHhhhCCCCCC---CHHHHHH
Q 011359          373 LWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPAMAALIEQCWSLQPDKRP---EFWHIVK  435 (488)
Q Consensus       373 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~Li~~cL~~dp~~RP---s~~eil~  435 (488)
                      +|+|++|..||.+....+....+........+  ...++..+.++|.+|+ .+|.+|+   ++.++++
T Consensus       234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999999999988877665555443222222  2467899999999987 5999999   8888875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.6e-40  Score=329.68  Aligned_cols=259  Identities=27%  Similarity=0.520  Sum_probs=218.1

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      |+..+|.+.+.||+|+||.||++...       +..+|||.+.....        ...+.+.+|++++++++|+||++++
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~   73 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--------NARKDFHREAELLTNLQHEHIVKFY   73 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH--------HHHHHHHHHHHHHHhCCCCCcceEE
Confidence            45567889999999999999999752       24589998864321        1245688999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLE-----------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI  317 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl  317 (488)
                      +++.....+++||||+.+++|.+++....           ...+++..++.++.|++.||+|||++|++||||||+||++
T Consensus        74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili  153 (288)
T cd05093          74 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV  153 (288)
T ss_pred             EEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence            99999999999999999999999997532           1348999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 011359          318 DQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF  393 (488)
Q Consensus       318 ~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~  393 (488)
                      +.++.++|+|||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+...
T Consensus       154 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~  233 (288)
T cd05093         154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE  233 (288)
T ss_pred             ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999985432211   1223345778999999998889999999999999999998 999998888766655


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      .+.... ....+..++.++.+|+.+||+.+|.+||++.++++.|+++...
T Consensus       234 ~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         234 CITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            555443 3445667899999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.7e-41  Score=341.30  Aligned_cols=248  Identities=23%  Similarity=0.357  Sum_probs=203.0

Q ss_pred             ceeccceeeeeccEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeec
Q 011359          180 QLFLGLRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK  253 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~-----~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~  253 (488)
                      +|.+++.||+|+||.||++..     .++.||||++.......    .....+.+..|+.++.+++ |+||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ----KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT   76 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh----hhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence            477889999999999999876     36789999997422111    1122456789999999995 8999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      +..+++||||+.+|+|.+++..  ...++++.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        77 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          77 EAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999999999999976  45689999999999999999999999999999999999999999999999999864


Q ss_pred             cccc--CcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCCCCCCC
Q 011359          334 EVYC--DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMN----PIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       334 ~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~----~~~~~~~~~~~~~~~~~~~  406 (488)
                      ....  .......||..|+|||++.+. .++.++|||||||++|+|++|..||....    .......+.  ...+.++.
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~  232 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KCDPPFPS  232 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cCCCCCCC
Confidence            3221  122345689999999999765 47899999999999999999999996432    112222222  23455677


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RP-----s~~eil~  435 (488)
                      .++..+.++|.+||+.||++||     ++.++++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            8899999999999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-40  Score=333.17  Aligned_cols=248  Identities=24%  Similarity=0.401  Sum_probs=199.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|...  ++.||||++........       ...+.+|+.+++.++||||+++++++..+..
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-------PFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-------chhHHHHHHHHhhCCCCCcCeEEEEEecCCe
Confidence            57889999999999999999985  68999999975433221       2346689999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .++||||+. ++|.+++... ...++++.+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          78 LTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             EEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            999999995 6888888652 35688999999999999999999999999999999999999999999999999854321


Q ss_pred             -cCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHh---cc-----------
Q 011359          337 -CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF-AVVN---KN-----------  399 (488)
Q Consensus       337 -~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~-~~~~---~~-----------  399 (488)
                       ........++..|+|||++.+ ..++.++|||||||++|+|++|..||.+........ .+..   ..           
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence             122334568999999999865 457899999999999999999999998765433221 1111   00           


Q ss_pred             --CCCC-----CC---------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 --LRPA-----IP---------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 --~~~~-----~~---------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                        ..+.     .+         ..++..+.+||.+||+.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence              0000     00         123567899999999999999999999885

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-40  Score=353.94  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=212.0

Q ss_pred             ccceeccceeeeeccEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~---~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      ...|.+.+.||+|+||.||+|...   ++.||+|.+...+.        +....+.+|+.+|+.++|||||++++++..+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~  137 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--------RQAAYARSELHCLAACDHFGIVKHFDDFKSD  137 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--------HHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence            345889999999999999999864   46788888754321        1134567899999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      ..+||||||++||+|.+++...  ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus       138 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~  217 (478)
T PTZ00267        138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK  217 (478)
T ss_pred             CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence            9999999999999999988653  34468899999999999999999999999999999999999999999999999996


Q ss_pred             cccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          333 EEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       333 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..... ...+..++
T Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~s  296 (478)
T PTZ00267        218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-DPFPCPVS  296 (478)
T ss_pred             ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCccCC
Confidence            543221   12345689999999999988999999999999999999999999998887766666555443 34566789


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..+.+||.+||..+|++||++.+++.
T Consensus       297 ~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        297 SGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHh
Confidence            99999999999999999999999875

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-41  Score=341.84  Aligned_cols=238  Identities=23%  Similarity=0.408  Sum_probs=203.8

Q ss_pred             ceeeeeccEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeE
Q 011359          185 LRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV  259 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~-----~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  259 (488)
                      +.||+|+||.||++..     .|+.||||++.....      .......+..|+++|++++||||+++++++..+..+|+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   75 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL   75 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence            5689999999999875     368999999974321      11223457789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-C
Q 011359          260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-D  338 (488)
Q Consensus       260 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-~  338 (488)
                      ||||+.+|+|.+++.+  ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++...... .
T Consensus        76 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          76 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            9999999999999976  356899999999999999999999999999999999999999999999999998644322 2


Q ss_pred             cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 011359          339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ  418 (488)
Q Consensus       339 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~  418 (488)
                      ......|+..|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+....  ..++..++..+.+||.+
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~  231 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLRA  231 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence            2234568999999999998889999999999999999999999999888776666555443  34677889999999999


Q ss_pred             HhhhCCCCCCCHHH
Q 011359          419 CWSLQPDKRPEFWH  432 (488)
Q Consensus       419 cL~~dp~~RPs~~e  432 (488)
                      ||+.||++||++.+
T Consensus       232 ~l~~~P~~R~~a~~  245 (318)
T cd05582         232 LFKRNPANRLGAGP  245 (318)
T ss_pred             HhhcCHhHcCCCCC
Confidence            99999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.8e-41  Score=330.80  Aligned_cols=243  Identities=21%  Similarity=0.360  Sum_probs=199.3

Q ss_pred             eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeec
Q 011359          187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  264 (488)
                      ||+|+||.||++...  |+.||+|.+.......     ....+.+..|++++++++||||+++++++..+..+++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-----KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-----chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence            699999999999875  7899999986422110     111345567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCC
Q 011359          265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP  344 (488)
Q Consensus       265 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~  344 (488)
                      .|++|.+++.......+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.............
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            99999999876555678999999999999999999999999999999999999999999999999986543333333456


Q ss_pred             CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 011359          345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI----QAAFAVVNKNLRPAIPGDCPPAMAALIEQCW  420 (488)
Q Consensus       345 gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL  420 (488)
                      |+..|+|||++.+..++.++|||||||++|+|++|..||......    +.......... ......++.++.+||.+||
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L  234 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-KFEHQNFTEESKDICRLFL  234 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-ccccccCCHHHHHHHHHHh
Confidence            899999999998888999999999999999999999999765432    22222222221 1122467899999999999


Q ss_pred             hhCCCCCCCHHHHHH
Q 011359          421 SLQPDKRPEFWHIVK  435 (488)
Q Consensus       421 ~~dp~~RPs~~eil~  435 (488)
                      +.||++||++.++++
T Consensus       235 ~~~P~~R~~~~~~~~  249 (277)
T cd05607         235 AKKPEDRLGSREKND  249 (277)
T ss_pred             ccCHhhCCCCccchh
Confidence            999999999987664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.7e-41  Score=341.60  Aligned_cols=241  Identities=23%  Similarity=0.388  Sum_probs=204.8

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEee
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY  263 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  263 (488)
                      .||+|+||.||++...  ++.||||++......     .......+..|++++..++||||+++++++.....+|+||||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~   76 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY   76 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeC
Confidence            5899999999999874  689999999753211     112245677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcCC
Q 011359          264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALS  341 (488)
Q Consensus       264 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~~  341 (488)
                      +++|+|..++..  ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++..... .....
T Consensus        77 ~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          77 ANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence            999999998875  3568999999999999999999997 7999999999999999999999999999854221 22233


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS  421 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~  421 (488)
                      ...||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...++..+++++.+||.+||+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~  232 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLSGLLK  232 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhh
Confidence            456999999999999889999999999999999999999999888776655554443  334677889999999999999


Q ss_pred             hCCCCCC-----CHHHHHH
Q 011359          422 LQPDKRP-----EFWHIVK  435 (488)
Q Consensus       422 ~dp~~RP-----s~~eil~  435 (488)
                      .||++|+     ++.++++
T Consensus       233 ~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhc
Confidence            9999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.7e-40  Score=323.94  Aligned_cols=256  Identities=32%  Similarity=0.573  Sum_probs=216.2

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      |.|..++|.++++||+|+||.||+|... ++.||||.+......         ..++.+|+.++++++|+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~   71 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---------PEAFLAEANLMKQLQHPRLVRLYAVVT   71 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---------HHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence            4566678899999999999999999875 588999998743321         246789999999999999999999875


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                       ...++++|||+.+++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus        72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  150 (260)
T cd05067          72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR  150 (260)
T ss_pred             -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence             4568899999999999999987556678999999999999999999999999999999999999999999999999985


Q ss_pred             cccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          333 EEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       333 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ......  ......++..|+|||++....++.++||||||+++|+|++ |..||.+.+..+.... +........+..++
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~  229 (260)
T cd05067         151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LERGYRMPRPDNCP  229 (260)
T ss_pred             ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH-HHcCCCCCCCCCCC
Confidence            433111  1122345678999999988889999999999999999998 9999988776554443 34445556677889


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .++.++|.+||..+|++||++.+++..|+.+
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         230 EELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            9999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-40  Score=332.71  Aligned_cols=260  Identities=28%  Similarity=0.524  Sum_probs=213.4

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--Cc--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAA  250 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~--~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~  250 (488)
                      +.+++|.+.+.||+|+||.||+|.+.  +.  .+|+|.+.....       ......|.+|+.++.++ +|+||++++++
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~   76 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLLGA   76 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC-------HHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            45678889999999999999999875  33  356666653211       12246788999999999 89999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEE
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL  316 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NIL  316 (488)
                      +.....+++||||+++++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nil  156 (303)
T cd05088          77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  156 (303)
T ss_pred             ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEE
Confidence            999999999999999999999997642              135788999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 011359          317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV  395 (488)
Q Consensus       317 l~~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~  395 (488)
                      ++.++.++|+|||++.............++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.... 
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-  235 (303)
T cd05088         157 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-  235 (303)
T ss_pred             ecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH-
Confidence            99999999999999853221111122234667999999988889999999999999999998 9999987776554433 


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       396 ~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      .........+..++..+.+||.+||+.+|++||++.+++..|+.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         236 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            333444556667889999999999999999999999999999887554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.7e-40  Score=332.37  Aligned_cols=266  Identities=29%  Similarity=0.552  Sum_probs=221.4

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN  241 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~---------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H  241 (488)
                      .+|.+..++|.+++.||+|+||.||++...         ...||+|+++.....       .....+.+|+.+++++ +|
T Consensus         5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~E~~~l~~l~~h   77 (314)
T cd05099           5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-------KDLADLISEMELMKLIGKH   77 (314)
T ss_pred             ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh-------HHHHHHHHHHHHHHhccCC
Confidence            456777789999999999999999999752         246999998743221       1135688999999999 59


Q ss_pred             CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 011359          242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIH  307 (488)
Q Consensus       242 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiH  307 (488)
                      +||+++++++.....+++||||+.+|+|.+++....              ...+++..+..++.||+.||.|||++||+|
T Consensus        78 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H  157 (314)
T cd05099          78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIH  157 (314)
T ss_pred             CCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            999999999999999999999999999999997632              235788899999999999999999999999


Q ss_pred             CCCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 011359          308 RDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY  383 (488)
Q Consensus       308 rDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf  383 (488)
                      |||||+|||++.++.+||+|||++.......   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus       158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~  237 (314)
T cd05099         158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY  237 (314)
T ss_pred             ccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999986432211   1122234567999999988889999999999999999999 89999


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          384 EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ......+....+ ........+..++..+.++|.+||..+|++||++.++++.|+++.....
T Consensus       238 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~  298 (314)
T cd05099         238 PGIPVEELFKLL-REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS  298 (314)
T ss_pred             CCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence            887765544433 4444555677889999999999999999999999999999999977654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-40  Score=331.26  Aligned_cols=264  Identities=29%  Similarity=0.542  Sum_probs=220.7

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN  241 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~---------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H  241 (488)
                      ..|.+...+|.+++.||+|+||.||+|.+.         +..||+|++......       .....+.+|+.+++.+ +|
T Consensus         8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~~h   80 (304)
T cd05101           8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-------KDLSDLVSEMEMMKMIGKH   80 (304)
T ss_pred             CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch-------HHHHHHHHHHHHHHhhccC
Confidence            457788889999999999999999999752         236999998633211       1135688999999999 79


Q ss_pred             CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 011359          242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH--------------KTLPLPKLIAIALDIARGMEYIHSQGVIH  307 (488)
Q Consensus       242 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~giiH  307 (488)
                      +||+++++++......++||||+.+|+|.+++.....              ..+++..++.++.||+.||.|||++||+|
T Consensus        81 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH  160 (304)
T cd05101          81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIH  160 (304)
T ss_pred             CCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            9999999999999999999999999999999986421              34778889999999999999999999999


Q ss_pred             CCCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 011359          308 RDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY  383 (488)
Q Consensus       308 rDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf  383 (488)
                      |||||+||+++.++.+||+|||++.......   ......++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       161 ~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  240 (304)
T cd05101         161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  240 (304)
T ss_pred             cccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence            9999999999999999999999986432211   1223345678999999988889999999999999999998 88999


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          384 EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ......+.... +....+...+..++..+.+||.+||..+|++||++.++++.|+++...
T Consensus       241 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         241 PGIPVEELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ccCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            88776554443 344445566778999999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.9e-41  Score=337.30  Aligned_cols=242  Identities=25%  Similarity=0.402  Sum_probs=205.3

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCCe
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAACKKPPV  256 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~  256 (488)
                      +|.+.+.||+|+||.||+|.+.  ++.||||++.......     ......+..|+.++..+.| ++|+++++++.....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-----DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence            4678899999999999999986  4689999997532111     1123567789999999986 568889999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|+||||+++|+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        76 ~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999999999999976  35688999999999999999999999999999999999999999999999999854221


Q ss_pred             -cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          337 -CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       337 -~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                       ........||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...  ...++..++..+.++
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~l  231 (324)
T cd05587         154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSI  231 (324)
T ss_pred             CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence             22233456899999999999889999999999999999999999999988877766666543  345677889999999


Q ss_pred             HHHHhhhCCCCCCCH
Q 011359          416 IEQCWSLQPDKRPEF  430 (488)
Q Consensus       416 i~~cL~~dp~~RPs~  430 (488)
                      |.+||..+|.+|++.
T Consensus       232 i~~~l~~~P~~R~~~  246 (324)
T cd05587         232 CKGLLTKHPAKRLGC  246 (324)
T ss_pred             HHHHhhcCHHHcCCC
Confidence            999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-40  Score=336.71  Aligned_cols=247  Identities=24%  Similarity=0.349  Sum_probs=197.3

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC---
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP---  254 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---  254 (488)
                      +|.+.+.||+|+||.||+|++.  ++.||||++.......      ....++.+|+.++++++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV------SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc------hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            4788999999999999999975  6899999987432111      1134678999999999999999999987543   


Q ss_pred             --CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          255 --PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       255 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                        ..+|+||||+ +++|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          75 EFKDIYVVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             CCceEEEEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence              3579999999 5689998875  3568999999999999999999999999999999999999999999999999986


Q ss_pred             ccccc----CcCCCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Q 011359          333 EEVYC----DALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN---------  397 (488)
Q Consensus       333 ~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~---------  397 (488)
                      .....    .......||..|+|||++.+  ..++.++|||||||++|+|++|..||.+.+.......+..         
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET  231 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            43211    11234568999999999875  5789999999999999999999999987654332211110         


Q ss_pred             -----------------ccCCCC---CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          398 -----------------KNLRPA---IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       398 -----------------~~~~~~---~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                       ......   ....+++.+.++|.+||+.+|++||++.++++
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                             000000   11246788999999999999999999999996

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-40  Score=339.33  Aligned_cols=262  Identities=30%  Similarity=0.512  Sum_probs=215.8

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI  245 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv  245 (488)
                      |.+..++|.+++.||+|+||+||+|.+.       ++.||||+++......       ....+.+|+.++.++ +|+||+
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~h~niv   74 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------EHRALMSELKILIHIGHHLNVV   74 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH-------HHHHHHHHHHHHHhccCCccHh
Confidence            6677789999999999999999999752       4789999997533211       135678999999999 689999


Q ss_pred             eEeeeeec-CCeeeEEEeecCCCCHHHHHHHhC-----------------------------------------------
Q 011359          246 KFVAACKK-PPVYCVITEYLSEGSLRAYLHKLE-----------------------------------------------  277 (488)
Q Consensus       246 ~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------  277 (488)
                      ++++++.. +..+++||||+++|+|.+++....                                               
T Consensus        75 ~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (343)
T cd05103          75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVE  154 (343)
T ss_pred             hhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccC
Confidence            99998865 456789999999999999997532                                               


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC-
Q 011359          278 ------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD-  338 (488)
Q Consensus       278 ------------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~-  338 (488)
                                        ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~  234 (343)
T cd05103         155 EKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD  234 (343)
T ss_pred             CCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc
Confidence                              1236788889999999999999999999999999999999999999999999985432111 


Q ss_pred             --cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          339 --ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       339 --~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                        ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.....+....+...+..+++.+.++
T Consensus       235 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (343)
T cd05103         235 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT  314 (343)
T ss_pred             hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence              1122335677999999988889999999999999999997 9999987665444555555555666677788899999


Q ss_pred             HHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +.+||+.+|++||++.+|++.|+.+..
T Consensus       315 ~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         315 MLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.4e-42  Score=321.78  Aligned_cols=262  Identities=25%  Similarity=0.420  Sum_probs=229.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  255 (488)
                      ..|.-.+.||.|..+.|-++..+  ++.+|+|+|.............+..+.-.+|+.||+++. ||+|+++.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            45666778899999999999875  789999999876655444446667788899999999996 999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++|+|.|+.|.|+|+|..  .-.+++.+...|+.|++.|++|||.++||||||||+|||++++.+++|+|||+|+...
T Consensus        97 F~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence            99999999999999999987  4578999999999999999999999999999999999999999999999999999988


Q ss_pred             ccCcCCCCCCCcccCChhhhhc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CCCC
Q 011359          336 YCDALSDDPGTYRWMAPEMIKH------KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--IPGD  407 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~------~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~  407 (488)
                      .+......+||++|+|||.+..      ..|+..+|+|+.|||+|.|+.|..||......-.+.-+..+++...  ...+
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad  254 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD  254 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence            8888999999999999999854      3578899999999999999999999988777777777777765443  3467


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHH--HHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVK--VLEQFET  442 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~--~Le~~~~  442 (488)
                      ++...++||.+||+.||.+|.++.|.+.  .+.++..
T Consensus       255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            8899999999999999999999999985  4444433

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-40  Score=344.77  Aligned_cols=248  Identities=24%  Similarity=0.374  Sum_probs=206.8

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      .|.+.+.||+|+||.||+|+..  ++.||||++....     .........+.+|+.++++++|+||+++++.+..+..+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD-----VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE
Confidence            5778899999999999999985  6889999997422     11223356788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      |+|||||++|+|.+++.+  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        77 ~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999999999999976  356889999999999999999999999999999999999999999999999987321100


Q ss_pred             ------------------------------------------------CcCCCCCCCcccCChhhhhcCCCCchhHHHHH
Q 011359          338 ------------------------------------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF  369 (488)
Q Consensus       338 ------------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSl  369 (488)
                                                                      .......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence                                                            00112468999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHHhhhCCCCCCC---HHHHHH
Q 011359          370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPAMAALIEQCWSLQPDKRPE---FWHIVK  435 (488)
Q Consensus       370 Gvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~cL~~dp~~RPs---~~eil~  435 (488)
                      ||++|||++|..||...++.+....+.........+  ..+++++.++|.+|+ .+|.+|++   +.+++.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999999999988877766666543333333  457889999999976 59999997   777664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-40  Score=336.34  Aligned_cols=250  Identities=22%  Similarity=0.397  Sum_probs=205.4

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      +..++|.+.++||.|+||.||++.+.  +..||+|++......       ....++.+|++++++++|+||++++++|..
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-------AIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-------HHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            34567889999999999999999986  678999998754321       124578899999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +..+++||||+.+++|.+++..  ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  152 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence            9999999999999999999976  35688999999999999999999985 79999999999999999999999999985


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------------
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA------------------  394 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~------------------  394 (488)
                      .... .......|+..|+|||++.+..++.++|||||||++|+|++|..||......+....                  
T Consensus       153 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         153 QLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhhh-hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence            4322 122344689999999999988899999999999999999999999976544322110                  


Q ss_pred             -------------------------HHhccCCCCCC-CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          395 -------------------------VVNKNLRPAIP-GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       395 -------------------------~~~~~~~~~~~-~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                               .+.....+..+ ...+.++.+||.+||+.||++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                     00111111121 235788999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3e-40  Score=327.87  Aligned_cols=255  Identities=33%  Similarity=0.602  Sum_probs=213.8

Q ss_pred             ceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      +|.+.+.||+|+||.||+|....       ..+|+|.+......       ....++.+|+.+++.++||||+++++.+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   73 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-------SELRDLLSEFNLLKQVNHPHVIKLYGACS   73 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-------HHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            36678899999999999998742       46889988643321       11356889999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLE----------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL  310 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDI  310 (488)
                      .....++++||+.+++|.+++....                      ...+++..++.++.|++.||+|||+.||+||||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~di  153 (290)
T cd05045          74 QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL  153 (290)
T ss_pred             cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence            9999999999999999999987532                      134778899999999999999999999999999


Q ss_pred             CCCeEEEcCCCcEEEeeecccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 011359          311 KPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM  386 (488)
Q Consensus       311 kp~NILl~~~~~vkl~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~  386 (488)
                      ||+|||+++++.++|+|||++........   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus       154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999854322111   122345678999999988889999999999999999998 99999887


Q ss_pred             CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          387 NPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      .+.+. ............+..++.++.++|.+||+.+|++||++.++++.|+++..
T Consensus       234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         234 APERL-FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CHHHH-HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            76554 34455555666778899999999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.7e-40  Score=327.06  Aligned_cols=259  Identities=27%  Similarity=0.533  Sum_probs=214.8

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      |.++.++|.+.+.||+|+||.||+|..+       +..||||.+.......       ....+.+|+.+++.++|+||++
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~   73 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-------ERIEFLNEASVMKGFTCHHVVR   73 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH-------HHHHHHHHHHHHHhCCCCCeee
Confidence            6788899999999999999999999754       2479999876432211       1345788999999999999999


Q ss_pred             EeeeeecCCeeeEEEeecCCCCHHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc
Q 011359          247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEH--------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID  318 (488)
Q Consensus       247 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~  318 (488)
                      +++++......++||||+.+|+|.+++.....        ..++...+..++.|++.||.|||++||+||||||+||+++
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~  153 (288)
T cd05061          74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA  153 (288)
T ss_pred             EEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc
Confidence            99999999999999999999999999976321        2346678899999999999999999999999999999999


Q ss_pred             CCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 011359          319 QEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFA  394 (488)
Q Consensus       319 ~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~  394 (488)
                      .++.++|+|||++.......   ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....
T Consensus       154 ~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~  233 (288)
T cd05061         154 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF  233 (288)
T ss_pred             CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999985432211   1122335678999999988889999999999999999998 7899988877665544


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          395 VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       395 ~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      +... .....+..++..+.++|.+||+.+|++||++.++++.|++.
T Consensus       234 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 VMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            4433 33445677889999999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.3e-40  Score=336.18  Aligned_cols=236  Identities=25%  Similarity=0.384  Sum_probs=201.2

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeeeEEEe
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE  262 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E  262 (488)
                      .||+|+||.||+|.+.  ++.||||++......     .......+..|+.++..+ +||||+++++++.....+|+|||
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~E   76 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVME   76 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEc
Confidence            5899999999999985  678999999742211     111235567888888877 69999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcCC
Q 011359          263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALS  341 (488)
Q Consensus       263 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~~  341 (488)
                      |+++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... .....
T Consensus        77 y~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          77 FVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            9999999999876  35689999999999999999999999999999999999999999999999999854321 22233


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS  421 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~  421 (488)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ...+..++.++.+||.+||+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~L~  232 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLSQDAVDILKAFMT  232 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcc
Confidence            4568999999999998899999999999999999999999999988777666655433  34566789999999999999


Q ss_pred             hCCCCCCCH
Q 011359          422 LQPDKRPEF  430 (488)
Q Consensus       422 ~dp~~RPs~  430 (488)
                      .||++||++
T Consensus       233 ~dP~~R~~~  241 (320)
T cd05590         233 KNPTMRLGS  241 (320)
T ss_pred             cCHHHCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.8e-40  Score=328.43  Aligned_cols=258  Identities=28%  Similarity=0.527  Sum_probs=217.0

Q ss_pred             cccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ...+|.+.+.||+|+||.||+|.+.       +..+|+|.+....        ....+.+.+|+.++++++|+||+++++
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~   74 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--------LAARKDFQREAELLTNLQHEHIVKFYG   74 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--------HHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence            3456888899999999999999753       2458888886422        122466889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeE
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV  315 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NI  315 (488)
                      ++......++||||+++++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  154 (291)
T cd05094          75 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNC  154 (291)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence            9999999999999999999999997632              23478899999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeeccccccccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 011359          316 LIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA  391 (488)
Q Consensus       316 Ll~~~~~vkl~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~  391 (488)
                      +++.++.++|+|||++......   .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus       155 l~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  234 (291)
T cd05094         155 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV  234 (291)
T ss_pred             EEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999998543221   11233456788999999998889999999999999999998 9999988877665


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ...+ ........+..++..+.+++.+||+.+|++||++.++++.|+++...
T Consensus       235 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         235 IECI-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHH-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            4443 34444556677899999999999999999999999999999999664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.9e-40  Score=320.56  Aligned_cols=244  Identities=30%  Similarity=0.605  Sum_probs=204.6

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEee
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY  263 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  263 (488)
                      .||+|+||.||+|.+.  ++.||+|.+.....       ......+.+|++++++++|+||+++++++.....+++||||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-------PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL   74 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCC-------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence            5899999999999874  78899999864322       11245688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcC---
Q 011359          264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL---  340 (488)
Q Consensus       264 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~---  340 (488)
                      +.+++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.........   
T Consensus        75 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          75 VQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             ccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            9999999999752 346889999999999999999999999999999999999999999999999998543221111   


Q ss_pred             CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 011359          341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC  419 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~c  419 (488)
                      .....+..|+|||.+.+..++.++||||||+++|+|++ |..||.......... ..........+..++..+.+|+.+|
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~  232 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-AIEQGVRLPCPELCPDAVYRLMERC  232 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-HHHcCCCCCCcccCCHHHHHHHHHH
Confidence            11123456999999988889999999999999999998 999998877654433 3334445566778899999999999


Q ss_pred             hhhCCCCCCCHHHHHHHHH
Q 011359          420 WSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       420 L~~dp~~RPs~~eil~~Le  438 (488)
                      |+.+|++||++.++++.|+
T Consensus       233 l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         233 WEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCChhhCcCHHHHHHHHh
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.5e-40  Score=324.22  Aligned_cols=256  Identities=29%  Similarity=0.579  Sum_probs=214.4

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--C---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--D---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~---~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ++..+|.+++.||+|+||.||+|.+.  +   ..||+|.++.....       ...+.|.+|+.++++++||||++++++
T Consensus         1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~   73 (267)
T cd05066           1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-------KQRRDFLSEASIMGQFDHPNIIHLEGV   73 (267)
T ss_pred             CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-------HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            35678889999999999999999873  2   36999998643321       124578899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +..+...++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+|||++.++.++|+|||+
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd05066          74 VTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGL  152 (267)
T ss_pred             EecCCccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCc
Confidence            99999999999999999999999763 34688999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCc----CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          331 ACEEVYCDA----LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       331 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      +........    .....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+. ...+...+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~  231 (267)
T cd05066         153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAP  231 (267)
T ss_pred             ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCCCC
Confidence            854322111    112223568999999998889999999999999999886 999998887665544443 33455566


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         232 MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            77899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-40  Score=336.00  Aligned_cols=238  Identities=26%  Similarity=0.382  Sum_probs=199.9

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeeeEEEe
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE  262 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E  262 (488)
                      .||+|+||.||+|.+.  ++.||||+++......     ......+..|..++..+ +||||+++++++..+..+++|||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e   76 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-----DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVME   76 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence            5899999999999986  5789999998532111     11133455677777654 79999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-CcCC
Q 011359          263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-DALS  341 (488)
Q Consensus       263 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-~~~~  341 (488)
                      |++||+|..++..  ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...... ....
T Consensus        77 ~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          77 YLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            9999999999876  356899999999999999999999999999999999999999999999999998643221 2233


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS  421 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~  421 (488)
                      ...||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..  ..+.++..++.++.+||.+||+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~  232 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFE  232 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHcc
Confidence            45689999999999988899999999999999999999999998887666555543  3455677889999999999999


Q ss_pred             hCCCCCCCHHH
Q 011359          422 LQPDKRPEFWH  432 (488)
Q Consensus       422 ~dp~~RPs~~e  432 (488)
                      .+|++||++.+
T Consensus       233 ~~P~~R~~~~~  243 (316)
T cd05592         233 RDPTKRLGVDG  243 (316)
T ss_pred             CCHHHcCCChH
Confidence            99999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.7e-40  Score=352.73  Aligned_cols=253  Identities=21%  Similarity=0.358  Sum_probs=213.1

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      ..++|.+.+.||+|+||+||+|.+.  ++.||||++........      ....+.+|+.++..++|+||+++++.+...
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEA------DKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHH------HHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            3468999999999999999999874  78999999976543321      245678999999999999999998876432


Q ss_pred             C--------eeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEE
Q 011359          255 P--------VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK  324 (488)
Q Consensus       255 ~--------~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vk  324 (488)
                      .        .+++||||+.+|+|.+++...  ....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+|
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence            2        468999999999999999753  235688999999999999999999999999999999999999999999


Q ss_pred             Eeeecccccccc---cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 011359          325 IADFGIACEEVY---CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR  401 (488)
Q Consensus       325 l~DFgla~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~  401 (488)
                      |+|||++.....   ........||..|+|||++.+..++.++|||||||++|||++|..||...+..+....+.... .
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-~  262 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-Y  262 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-C
Confidence            999999854322   122234569999999999998899999999999999999999999999887766655555443 3


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       402 ~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      ..++..+++++.+||.+||+.+|.+||++.+++..
T Consensus       263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            45677899999999999999999999999998863

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-40  Score=336.43  Aligned_cols=242  Identities=27%  Similarity=0.405  Sum_probs=206.0

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCe
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPV  256 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~  256 (488)
                      +|.+.+.||+|+||.||+|.+.  ++.||||++......     .......+..|..++..+. |++|+++++++.....
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence            4678899999999999999886  578999999753211     1112345677888888875 8999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||+++|+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        76 ~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999999999999876  35688999999999999999999999999999999999999999999999999864321


Q ss_pred             -cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          337 -CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       337 -~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                       ........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....  ..++..++.++.+|
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~l  231 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAI  231 (323)
T ss_pred             CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCcCCHHHHHH
Confidence             222334568999999999998999999999999999999999999999988877766665543  34677889999999


Q ss_pred             HHHHhhhCCCCCCCH
Q 011359          416 IEQCWSLQPDKRPEF  430 (488)
Q Consensus       416 i~~cL~~dp~~RPs~  430 (488)
                      |.+||+.+|++|++.
T Consensus       232 i~~~l~~~p~~R~~~  246 (323)
T cd05616         232 CKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHHcccCHHhcCCC
Confidence            999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.3e-41  Score=337.44  Aligned_cols=241  Identities=23%  Similarity=0.359  Sum_probs=203.9

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeeeEEEe
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE  262 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E  262 (488)
                      .||+|+||.||+|.+.  ++.||||++......     .......+..|+.++..+ +||||+++++++.....+|+|||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E   76 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-----QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVME   76 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEe
Confidence            5899999999999986  578999999743211     111234567889998876 79999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcCC
Q 011359          263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALS  341 (488)
Q Consensus       263 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~~  341 (488)
                      |+++|+|..++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus        77 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          77 YVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence            9999999999876  45688999999999999999999999999999999999999999999999999854321 22233


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS  421 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~  421 (488)
                      ...||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ...+..++.++.+||.+||+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~~~L~  232 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--VLYPVWLSKEAVSILKAFMT  232 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhc
Confidence            4568999999999998899999999999999999999999999988777766665543  33566788999999999999


Q ss_pred             hCCCCCC-------CHHHHHH
Q 011359          422 LQPDKRP-------EFWHIVK  435 (488)
Q Consensus       422 ~dp~~RP-------s~~eil~  435 (488)
                      .+|++|+       ++.++++
T Consensus       233 ~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         233 KNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             cCHHHcCCCCCCCCCHHHHhc
Confidence            9999999       6777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.1e-41  Score=341.58  Aligned_cols=249  Identities=23%  Similarity=0.328  Sum_probs=209.6

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||++...  ++.||||++.....     ......+.+..|+.+++.++|+||+++++++.....+
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-----LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeE
Confidence            5788999999999999999875  68999999985321     1122356788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999999999873 357899999999999999999999999999999999999999999999999998543322


Q ss_pred             Cc--CCCCCCCcccCChhhhh------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CC
Q 011359          338 DA--LSDDPGTYRWMAPEMIK------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GD  407 (488)
Q Consensus       338 ~~--~~~~~gt~~y~aPE~l~------~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~  407 (488)
                      ..  .....||..|+|||++.      ...++.++|||||||++|+|++|..||...........+.........+  ..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK  235 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence            11  12346899999999986      4567899999999999999999999999888777666665543222233  35


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++..+.+||.+||. +|.+||++.+++.
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            78999999999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.6e-40  Score=319.13  Aligned_cols=249  Identities=22%  Similarity=0.416  Sum_probs=213.4

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|++|.||+|.+.  ++.||+|.+.......      .....+.+|+.++++++|+||+++++++.....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR------REREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH------HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            3667788999999999999985  6899999987543221      2246788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+++++|.+++.......+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            99999999999999998865677899999999999999999999999999999999999999999999999988543322


Q ss_pred             C-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          338 D-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       338 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      . ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.. ...+.++..++..+.++|
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i  233 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPVSQMYSQQLAQLI  233 (256)
T ss_pred             cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHH
Confidence            1 12234578899999999988899999999999999999999999988876655554443 334456667899999999


Q ss_pred             HHHhhhCCCCCCCHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||+.+|++||++.++++
T Consensus       234 ~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         234 DQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             HHHccCCcccCcCHHHHhh
Confidence            9999999999999999886

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.1e-40  Score=320.11  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=213.3

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||.|+||.||++.+.  ++.||+|.++......       ..+.+.+|+.+++.++|+||+++++.+..+..+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   73 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS-------AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL   73 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH-------HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            4678899999999999999875  6899999997543221       245677899999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+++++|.+++.......++++.++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            99999999999999998655567899999999999999999999999999999999999999999999999998543322


Q ss_pred             C-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          338 D-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       338 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      . ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+... .....+..++..+.+||
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  232 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG-SYKPLPSHYSYELRSLI  232 (255)
T ss_pred             ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC-CCCCCCcccCHHHHHHH
Confidence            1 223356888999999998888999999999999999999999999987766555554433 34446677899999999


Q ss_pred             HHHhhhCCCCCCCHHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~~  436 (488)
                      .+||+.+|++||++.+++..
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhc
Confidence            99999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-40  Score=322.58  Aligned_cols=253  Identities=28%  Similarity=0.526  Sum_probs=210.7

Q ss_pred             eeccceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          181 LFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      |.+++.||+|+||.||+|....     ..||||++........      ....+.+|+.+++.++|+||+++++++....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   74 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS------EIEEFLSEAACMKDFDHPNVMKLIGVCFEAS   74 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHH------HHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence            4578899999999999998742     5799999975433221      1456889999999999999999999886554


Q ss_pred             e------eeEEEeecCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEE
Q 011359          256 V------YCVITEYLSEGSLRAYLHKLE----HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI  325 (488)
Q Consensus       256 ~------~~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl  325 (488)
                      .      .++|+||+.+|+|..++....    ...+++..++.++.|++.||+|||+.|++||||||+||++++++.+||
T Consensus        75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl  154 (273)
T cd05035          75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCV  154 (273)
T ss_pred             ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEE
Confidence            3      789999999999999986542    236889999999999999999999999999999999999999999999


Q ss_pred             eeecccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 011359          326 ADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLR  401 (488)
Q Consensus       326 ~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  401 (488)
                      +|||++........   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. ....
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~  233 (273)
T cd05035         155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNR  233 (273)
T ss_pred             CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence            99999864332211   112235678999999988889999999999999999999 999998887766554444 3445


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       402 ~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ...+..++..+.++|.+||+.+|++||++.++++.|+++
T Consensus       234 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            566788999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-40  Score=335.62  Aligned_cols=242  Identities=25%  Similarity=0.390  Sum_probs=204.5

Q ss_pred             ceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeeeEEE
Q 011359          185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      +.||+|+||+||+|.+.  ++.||||+++......     ......+..|+.++..+ +||||+++++++.....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-----DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            35899999999999986  5789999998532111     11234567899999888 6999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL  340 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~  340 (488)
                      ||+.+|+|..++..  ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..... ....
T Consensus        76 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          76 EYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence            99999999999876  35789999999999999999999999999999999999999999999999999854222 1222


Q ss_pred             CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 011359          341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW  420 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL  420 (488)
                      ....|+..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ...+..++..+.+||.+||
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l  231 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VRYPRWLSKEAKSILKSFL  231 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHc
Confidence            33468999999999998899999999999999999999999999887766655554443  3466778999999999999


Q ss_pred             hhCCCCCCCH-----HHHHH
Q 011359          421 SLQPDKRPEF-----WHIVK  435 (488)
Q Consensus       421 ~~dp~~RPs~-----~eil~  435 (488)
                      ..||++||++     .++++
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhc
Confidence            9999999999     66664

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-40  Score=337.04  Aligned_cols=236  Identities=23%  Similarity=0.409  Sum_probs=196.4

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeeeEEEe
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE  262 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E  262 (488)
                      .||+|+||.||++.+.  ++.||||+++......     ....+.+..|+.++..+ +||||+++++++.....+|+|||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~-----~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e   76 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND-----DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIE   76 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEe
Confidence            5899999999999985  6889999998532211     11235678899999998 69999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc-ccCcCC
Q 011359          263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDALS  341 (488)
Q Consensus       263 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~-~~~~~~  341 (488)
                      |+++|+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ......
T Consensus        77 ~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          77 FVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            9999999998875  4679999999999999999999999999999999999999999999999999985422 222334


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN--------PIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                      ...||..|+|||++.+..++.++|||||||++|+|++|..||....        ..+.....+.. ....+|..++..+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~  233 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAS  233 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CCCCCCCCCCHHHH
Confidence            4568999999999998899999999999999999999999996321        11222222222 23446778899999


Q ss_pred             HHHHHHhhhCCCCCCC
Q 011359          414 ALIEQCWSLQPDKRPE  429 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs  429 (488)
                      ++|.+||+.||.+|++
T Consensus       234 ~li~~~L~~dP~~R~~  249 (329)
T cd05588         234 SVLKGFLNKDPKERLG  249 (329)
T ss_pred             HHHHHHhccCHHHcCC
Confidence            9999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.9e-40  Score=341.80  Aligned_cols=255  Identities=22%  Similarity=0.335  Sum_probs=211.4

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      ..+..++|.+.+.||+|+||.||++.+.  ++.||+|++.....     ........+.+|+.+++.++||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~  112 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-----IKRSDSAFFWEERDIMAFANSPWVVQLFCAF  112 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3455678999999999999999999986  67899999964211     1112245578999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ..+..+|+||||+++|+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         113 QDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccc
Confidence            999999999999999999999975   35888999999999999999999999999999999999999999999999998


Q ss_pred             ccccccC--cCCCCCCCcccCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          332 CEEVYCD--ALSDDPGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       332 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~----~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      .......  ......||..|+|||++.+..    ++.++|||||||++|+|++|..||...+.......+........++
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  269 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP  269 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC
Confidence            6533211  123456999999999997543    7899999999999999999999999888777766666554444444


Q ss_pred             C--CCcHHHHHHHHHHhhhCCCC--CCCHHHHHHH
Q 011359          406 G--DCPPAMAALIEQCWSLQPDK--RPEFWHIVKV  436 (488)
Q Consensus       406 ~--~~~~~l~~Li~~cL~~dp~~--RPs~~eil~~  436 (488)
                      .  .++..++++|..||..++.+  |+++.++++.
T Consensus       270 ~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         270 EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            4  46889999999999855543  8899988874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3e-40  Score=326.33  Aligned_cols=254  Identities=28%  Similarity=0.546  Sum_probs=213.3

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      |+..+|.+.++||+|+||.||++...       +..+|+|.+....        ......|.+|+++++.++|+||++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~   73 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------ESARQDFQREAELLTVLQHQHIVRFY   73 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--------HHHHHHHHHHHHHHhcCCCCCCceEE
Confidence            45678889999999999999999742       3578999876322        12246788999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeE
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEH-------------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV  315 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NI  315 (488)
                      +++......+++|||+.+++|.+++.....             ..+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ni  153 (280)
T cd05092          74 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNC  153 (280)
T ss_pred             EEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhE
Confidence            999999999999999999999999976421             3478899999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeecccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 011359          316 LIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA  391 (488)
Q Consensus       316 Ll~~~~~vkl~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~  391 (488)
                      |+++++.++|+|||++........   .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.
T Consensus       154 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  233 (280)
T cd05092         154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA  233 (280)
T ss_pred             EEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence            999999999999999854322111   122335678999999988889999999999999999998 9999988777665


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      ...+. .......+..++..+.+||.+||+.+|++||++.+|++.|+
T Consensus       234 ~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 IECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            55443 33344566788999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.7e-40  Score=320.50  Aligned_cols=245  Identities=26%  Similarity=0.607  Sum_probs=205.5

Q ss_pred             eeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEE
Q 011359          186 RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      .||+|+||.||+|.+.    +..||||++.....       ....+.|.+|+.++++++|+||+++++++.. ..+++||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~   73 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-------KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVM   73 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-------hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEE
Confidence            3799999999999875    34699999864322       1224678899999999999999999999864 4678999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC---
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---  338 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~---  338 (488)
                      ||+++++|.+++.. ....+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......   
T Consensus        74 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          74 EMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             EeCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            99999999999875 24578999999999999999999999999999999999999999999999999985332211   


Q ss_pred             -cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          339 -ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       339 -~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                       ......++..|+|||.+....++.++||||||+++|+|++ |..||......+... .+..+.++..+..++.++.++|
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li  231 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-FIEQGKRLDCPAECPPEMYALM  231 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-HHHCCCCCCCCCCCCHHHHHHH
Confidence             1122234578999999988889999999999999999996 999999887766543 4445556677888999999999


Q ss_pred             HHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .+||..+|++||++.+|.+.|+.+
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHcCCChhhCcCHHHHHHHHhhh
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.3e-40  Score=319.85  Aligned_cols=252  Identities=29%  Similarity=0.541  Sum_probs=213.4

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChh-HHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDEN-ETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~-~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      |.++..||+|+||.||+|.+.  ++.||+|.+........ ........+.+.+|+.++++++|+||+++++++......
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            567889999999999999874  68899999976544332 222333457789999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+++++|.+++..  ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        82 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          82 NIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             EEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            999999999999999976  356888999999999999999999999999999999999999999999999988543311


Q ss_pred             C-------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          338 D-------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       338 ~-------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      .       ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.. ...+.++..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNISS  238 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCcccCH
Confidence            1       11123478899999999888899999999999999999999999998776655544433 445667788999


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.++|.+||+.+|++||++.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhh
Confidence            9999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.4e-40  Score=322.68  Aligned_cols=256  Identities=27%  Similarity=0.544  Sum_probs=213.6

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--C---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--D---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~---~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ++..+|.+++.||+|+||.||+|.+.  +   ..||||++.....       ....++|..|+.++++++||||++++++
T Consensus         1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~~~~   73 (269)
T cd05065           1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-------EKQRRDFLSEASIMGQFDHPNIIHLEGV   73 (269)
T ss_pred             CChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-------HHHHHHHHHHHHHHHhCCCcCcceEEEE
Confidence            35567889999999999999999875  2   3599999865322       1124678899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +..+..+++||||+.+++|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||+
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~  152 (269)
T cd05065          74 VTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL  152 (269)
T ss_pred             ECCCCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcc
Confidence            99999999999999999999999763 35688999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCc---CCC---CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          331 ACEEVYCDA---LSD---DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       331 a~~~~~~~~---~~~---~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      +........   ...   ...+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+ .......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~  231 (269)
T cd05065         153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLP  231 (269)
T ss_pred             ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCC
Confidence            853322111   011   112457999999998899999999999999999886 99999888776655544 3344445


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .+..++..+.+++.+||..+|++||++.+|+..|+++
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            5678899999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.5e-40  Score=323.53  Aligned_cols=257  Identities=25%  Similarity=0.473  Sum_probs=212.3

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~----~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      +...+|.+.+.||+|+||+||+|.+.  ++    .||+|.+.....       .....++..|+.++.+++|+||+++++
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~~~~l~~l~h~~iv~~~~   76 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-------RQTFQEITDHMLAMGSLDHAYIVRLLG   76 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-------hHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence            34467888999999999999999984  44    477777643211       122456788999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++.. ...++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||+.|++||||||+|||++.++.+||+|||
T Consensus        77 ~~~~-~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          77 ICPG-ASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             EECC-CccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCc
Confidence            8864 4567899999999999999763 3568999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          330 IACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       330 la~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      ++.......   ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+...... ..++..+..+..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~  233 (279)
T cd05111         155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQP  233 (279)
T ss_pred             cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCC
Confidence            986432211   1223346778999999988889999999999999999998 9999988776543 3445555566667


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ..++..+..++.+||..+|++||++.++++.|..+..
T Consensus       234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         234 QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            7788999999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.7e-40  Score=349.54  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=201.2

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  254 (488)
                      ..+|.+++.||+|+||.||+|.+.  ++.||||.+....            ....+|+.+|+.++|+||+++++++... 
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~~~~  132 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYYTEC  132 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEeecc
Confidence            357899999999999999999985  6899999986422            1234799999999999999998876432 


Q ss_pred             -------CeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC-cEE
Q 011359          255 -------PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLK  324 (488)
Q Consensus       255 -------~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~-~vk  324 (488)
                             ..+++||||++ ++|.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus       133 ~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        133 FKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             cccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCcee
Confidence                   24679999996 4787777643  345789999999999999999999999999999999999998665 699


Q ss_pred             EeeecccccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----
Q 011359          325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN----  399 (488)
Q Consensus       325 l~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~----  399 (488)
                      |+|||++.............||..|+|||++.+ ..++.++|||||||++|||++|..||.+....+....+....    
T Consensus       212 L~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        212 LCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT  291 (440)
T ss_pred             eeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999999975544344445678999999999865 468999999999999999999999999877655544433210    


Q ss_pred             -----------------------CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH--HHHHHH
Q 011359          400 -----------------------LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK--VLEQFE  441 (488)
Q Consensus       400 -----------------------~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~--~Le~~~  441 (488)
                                             +...+|...+.++.+||.+||..+|.+||++.++++  .+..+.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                                   011234457889999999999999999999999984  455443

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.6e-40  Score=324.51  Aligned_cols=250  Identities=29%  Similarity=0.509  Sum_probs=204.1

Q ss_pred             eccceeeeeccEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-
Q 011359          182 FLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-  254 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~------~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  254 (488)
                      .+.+.||+|+||+||++.+      .++.||+|++......       .....|.+|+++|+.++||||+++++++... 
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-------QNTSGWKKEINILKTLYHENIVKYKGCCSEQG   79 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            6788999999999988764      2568999999754321       1245678999999999999999999988653 


Q ss_pred             -CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          255 -PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       255 -~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                       ..+++||||+.+++|.+++..   ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence             468899999999999999976   4589999999999999999999999999999999999999999999999999854


Q ss_pred             ccccCc----CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHH
Q 011359          334 EVYCDA----LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI--------------QAAFAV  395 (488)
Q Consensus       334 ~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~--------------~~~~~~  395 (488)
                      ......    .....++..|+|||.+....++.++||||||+++|+|++|..||......              ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            322111    12234566799999998888999999999999999999999998654321              111112


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       396 ~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      .........+..++..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2233344456778999999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.7e-40  Score=320.60  Aligned_cols=252  Identities=29%  Similarity=0.523  Sum_probs=206.5

Q ss_pred             eccceeeeeccEEEEEEEECC----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC---
Q 011359          182 FLGLRFAHGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP---  254 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~~~----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---  254 (488)
                      .+++.||+|+||.||+|.+.+    ..||||.+........      ..+.+.+|+.+++.++|+||+++++++...   
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS------EMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES   75 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHH------HHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence            467889999999999999863    2599999876432221      145788999999999999999999987432   


Q ss_pred             ---CeeeEEEeecCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          255 ---PVYCVITEYLSEGSLRAYLHKL----EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       255 ---~~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                         ...++||||+.+|+|.+++...    ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|
T Consensus        76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECC
Confidence               2568999999999999988532    223478999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          328 FGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       328 Fgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      ||++........   .....++..|++||.+.+..++.++||||||+++|+|++ |..||......+....+. ......
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~  234 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLK  234 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence            999864332211   122345678999999998889999999999999999999 899998877665544443 333445


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .+..++..+.++|.+||+.+|++||++.++++.|+++
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            5677899999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.1e-40  Score=323.07  Aligned_cols=260  Identities=30%  Similarity=0.598  Sum_probs=217.2

Q ss_pred             ccccceeccceeeeeccEEEEEEEECC------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~~------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ++.++|.+.+.||+|+||.||+|.+.+      ..||+|++.....       ......+.+|+.++++++|+||+++++
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~~~   75 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-------EIQVTLLLQESCLLYGLSHQNILPILH   75 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC-------HHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            566789999999999999999999754      7899998863221       112466889999999999999999999


Q ss_pred             eeec-CCeeeEEEeecCCCCHHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc
Q 011359          250 ACKK-PPVYCVITEYLSEGSLRAYLHKLEH------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH  322 (488)
Q Consensus       250 ~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~  322 (488)
                      ++.. +...++++||+.+++|.+++.....      ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             EEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc
Confidence            8766 4678899999999999999976432      45889999999999999999999999999999999999999999


Q ss_pred             EEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 011359          323 LKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK  398 (488)
Q Consensus       323 vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~  398 (488)
                      +||+|||++.......   ......++..|+|||++.+..++.++||||||+++|++++ |..||...++.+... ....
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~  234 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-YLKD  234 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH-HHHc
Confidence            9999999985432111   1122345678999999988889999999999999999998 999999887765443 3334


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       399 ~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ......+..++.++.+++.+||..+|++||++.++++.|+++...
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         235 GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            445555667899999999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1e-40  Score=337.14  Aligned_cols=237  Identities=25%  Similarity=0.398  Sum_probs=199.3

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHH-HHHhcCCCCeeeEeeeeecCCeeeEEEe
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVA-LLSRLHNPNVIKFVAACKKPPVYCVITE  262 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E  262 (488)
                      .||+|+||+||+|.+.  ++.||||++......     .....+.+..|.. +++.++||||+++++++.....+++|||
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e   76 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-----KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLD   76 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEc
Confidence            5899999999999985  689999999743211     1112334555555 5678999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcCC
Q 011359          263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALS  341 (488)
Q Consensus       263 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~~  341 (488)
                      |+.+|+|..++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus        77 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          77 YVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            9999999999876  45789999999999999999999999999999999999999999999999999854322 22233


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS  421 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~  421 (488)
                      ...||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ..++..++..+.++|.+||+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~  232 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--LRLKPNISVSARHLLEGLLQ  232 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhh
Confidence            4568999999999998899999999999999999999999999888776666655543  33556789999999999999


Q ss_pred             hCCCCCCCHH
Q 011359          422 LQPDKRPEFW  431 (488)
Q Consensus       422 ~dp~~RPs~~  431 (488)
                      .||.+||++.
T Consensus       233 ~~p~~R~~~~  242 (323)
T cd05575         233 KDRTKRLGAK  242 (323)
T ss_pred             cCHHhCCCCC
Confidence            9999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-40  Score=340.12  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=211.3

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .+..+..++|.+.+.||+|+||.||++.+.  ++.||+|++.....     ........+.+|+.+++.++||||+++++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~e~~i~~~~~hp~iv~~~~  110 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-----IKRSDSAFFWEERDIMAFANSPWVVQLFY  110 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-----hhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            344566688999999999999999999986  68899999964211     11122455788999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++..+..+++||||+++|+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         111 AFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            99999999999999999999999975   458888999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC--cCCCCCCCcccCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          330 IACEEVYCD--ALSDDPGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       330 la~~~~~~~--~~~~~~gt~~y~aPE~l~~~~----~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      ++.......  ......||+.|+|||++....    ++.++|||||||++|||++|..||...+.......+........
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  267 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT  267 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence            986443221  123456999999999997543    78999999999999999999999998887766666665433333


Q ss_pred             CC--CCCcHHHHHHHHHHhhhCCCC--CCCHHHHHHH
Q 011359          404 IP--GDCPPAMAALIEQCWSLQPDK--RPEFWHIVKV  436 (488)
Q Consensus       404 ~~--~~~~~~l~~Li~~cL~~dp~~--RPs~~eil~~  436 (488)
                      ++  ..++..+.++|.+||..++.+  |+++.+|++.
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            33  468999999999999844433  7788888864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.1e-40  Score=322.02  Aligned_cols=258  Identities=25%  Similarity=0.412  Sum_probs=212.7

Q ss_pred             cceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||.|+||.||++.+  .++.||||.+...+..+     .....++.+|+.+++.++|+||+++++++..+..
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD-----AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh-----HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence            5678889999999999999996  47899999887543221     2234678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ++++|||+.+++|.+++...  ....+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            99999999999999998753  2356899999999999999999999999999999999999999999999999988543


Q ss_pred             cccC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCCCCCCCCCcHH
Q 011359          335 VYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI--QAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       335 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      .... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......  .....+......+..+..++..
T Consensus       157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence            2211 122346888999999998888999999999999999999999999754432  2222222222223334567889


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      +.++|.+||..+|++||++.+|++.++++.
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2e-40  Score=334.19  Aligned_cols=241  Identities=25%  Similarity=0.377  Sum_probs=201.2

Q ss_pred             ceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeeeEEE
Q 011359          185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      +.||+|+||.||+|.+.  ++.||||++......     .......+..|..++..+ +|+||+++++++.....+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-----IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence            36899999999999985  678999999753211     011134566788888764 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL  340 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~  340 (488)
                      ||+.+|+|..++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ....
T Consensus        76 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          76 EFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             CCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence            99999999999876  45688999999999999999999999999999999999999999999999999854221 2223


Q ss_pred             CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 011359          341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW  420 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL  420 (488)
                      ....||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...  .+..+..++.++.+||.+||
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESKDILEKLF  231 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHc
Confidence            4456899999999999889999999999999999999999999988776555444332  34566778999999999999


Q ss_pred             hhCCCCCCCHH-HHH
Q 011359          421 SLQPDKRPEFW-HIV  434 (488)
Q Consensus       421 ~~dp~~RPs~~-eil  434 (488)
                      +.||++||++. +++
T Consensus       232 ~~dP~~R~~~~~~~~  246 (316)
T cd05620         232 ERDPTRRLGVVGNIR  246 (316)
T ss_pred             cCCHHHcCCChHHHH
Confidence            99999999984 444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.6e-40  Score=319.57  Aligned_cols=256  Identities=32%  Similarity=0.570  Sum_probs=216.2

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      |++..++|.+.++||+|+||.||++.+. +..+|+|.+.....         ....|.+|+.++++++|+||+++++.+.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---------SVEAFLAEANVMKTLQHDKLVKLHAVVT   71 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh---------HHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence            6778889999999999999999999875 46799998864211         1356889999999999999999999988


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      . ..++++|||+++++|.+++.+.....+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.
T Consensus        72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  150 (260)
T cd05073          72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR  150 (260)
T ss_pred             C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence            7 678899999999999999987555678888999999999999999999999999999999999999999999999885


Q ss_pred             cccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          333 EEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       333 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ......  ......++..|+|||++....++.++|+|||||++|+|++ |..||...+.......+ ........+...+
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  229 (260)
T cd05073         151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCP  229 (260)
T ss_pred             eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCCCCCcccCC
Confidence            432211  1122335677999999988889999999999999999998 99999987765544433 3444445567788


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .++.+++.+||+.+|++||++.++++.|+.+
T Consensus       230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         230 EELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            9999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.4e-40  Score=336.58  Aligned_cols=247  Identities=25%  Similarity=0.358  Sum_probs=199.4

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+.+.||+|+||.||++.+.  ++.||||++.......      .....+.+|+.+++.++||||+++++++....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   93 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ------THAKRAYRELVLLKCVNHKNIISLLNVFTPQK   93 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch------hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            478999999999999999999875  6899999997543221      11356779999999999999999999986443


Q ss_pred             ------eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          256 ------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       256 ------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                            .+|+||||+.+ +|.+.+..    .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          94 SLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             CccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCC
Confidence                  47899999965 66666643    47888999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN----------  399 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~----------  399 (488)
                      ++.............||..|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....          
T Consensus       169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         169 LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             CccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            9865433333445578999999999998899999999999999999999999998776543322111100          


Q ss_pred             ----------CCC--------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 ----------LRP--------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 ----------~~~--------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                ..+                    ......+..+.+||.+||..||++||++.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                      000                    011124578899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.2e-40  Score=331.20  Aligned_cols=241  Identities=24%  Similarity=0.388  Sum_probs=200.8

Q ss_pred             ceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeeeEEE
Q 011359          185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      +.||+|+||.||+|.+.  ++.||||++......     .......+..|..++..+ +||||+++++++.....+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence            36899999999999986  578999999753210     011134456788888764 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL  340 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~  340 (488)
                      ||+++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus        76 ey~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          76 EYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence            99999999999976  35688999999999999999999999999999999999999999999999999854321 1222


Q ss_pred             CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 011359          341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW  420 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL  420 (488)
                      ....||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  .+..+..++..+.+||.+||
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLF  231 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHh
Confidence            3456899999999999889999999999999999999999999988876655544333  24456678899999999999


Q ss_pred             hhCCCCCCCHH-HHH
Q 011359          421 SLQPDKRPEFW-HIV  434 (488)
Q Consensus       421 ~~dp~~RPs~~-eil  434 (488)
                      +.+|++||++. +++
T Consensus       232 ~~~P~~R~~~~~~l~  246 (316)
T cd05619         232 VREPERRLGVKGDIR  246 (316)
T ss_pred             ccCHhhcCCChHHHH
Confidence            99999999996 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.3e-40  Score=332.23  Aligned_cols=266  Identities=30%  Similarity=0.554  Sum_probs=221.8

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-C
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-H  240 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~---------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~  240 (488)
                      ..+|++...+|.+++.||+|+||.||++.+.+         ..||+|++......       ...+++.+|+.+++++ +
T Consensus         4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~~   76 (334)
T cd05100           4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-------KDLSDLVSEMEMMKMIGK   76 (334)
T ss_pred             CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-------HHHHHHHHHHHHHHhhcC
Confidence            36788888899999999999999999997531         26899988743211       1245788999999999 7


Q ss_pred             CCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 011359          241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVI  306 (488)
Q Consensus       241 HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~gii  306 (488)
                      |+||++++++|......++++||+.+|+|.+++....              ...+++..++.++.||+.||+|||++||+
T Consensus        77 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~giv  156 (334)
T cd05100          77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI  156 (334)
T ss_pred             CCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            9999999999999999999999999999999998632              23477888999999999999999999999


Q ss_pred             cCCCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 011359          307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP  382 (488)
Q Consensus       307 HrDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~P  382 (488)
                      ||||||+|||++.++.+||+|||++.......   ......++..|+|||++.+..++.++||||||+++|||++ |..|
T Consensus       157 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  236 (334)
T cd05100         157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  236 (334)
T ss_pred             ccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence            99999999999999999999999986432211   1122334567999999998889999999999999999998 8999


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          383 YEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       383 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      |...+..+.... +........+..++..+.+||.+||+.+|++||++.++++.|+++....
T Consensus       237 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         237 YPGIPVEELFKL-LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             CCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            988776554443 3444555667788999999999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.2e-40  Score=325.95  Aligned_cols=249  Identities=21%  Similarity=0.356  Sum_probs=206.6

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.+.+.||+|+||.||++.+.  ++.||||.+.......     ......+.+|+.++++++|+||+.+++.+.....++
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-----hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEE
Confidence            556778999999999999986  6899999987432221     112355778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +||||+.+++|.+++.......+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999999999999976555578999999999999999999999999999999999999999999999999986443333


Q ss_pred             cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI---QAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       339 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|..||......   +...... .......+..++.++.+|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHH
Confidence            333457899999999999888999999999999999999999999865431   2222221 222334566788999999


Q ss_pred             HHHHhhhCCCCCCC-----HHHHHH
Q 011359          416 IEQCWSLQPDKRPE-----FWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs-----~~eil~  435 (488)
                      |.+||+.||++||+     +.++++
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHc
Confidence            99999999999999     677665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.2e-40  Score=325.01  Aligned_cols=256  Identities=29%  Similarity=0.581  Sum_probs=213.7

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      ++.++|.+...||+|+||.||++.+.       +..||||++......       ...++|.+|+.++.+++|+||++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~ei~~l~~l~h~~iv~~~   74 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------DMQADFQREAALMAEFDHPNIVKLL   74 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-------HHHHHHHHHHHHHHhcCCCchheEE
Confidence            45577889999999999999999863       468999998743321       2246788999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLE--------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHR  308 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHr  308 (488)
                      +++..+...++||||+.+++|.+++....                    ...+++..++.++.||+.||+|||+.|++||
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~  154 (288)
T cd05050          75 GVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR  154 (288)
T ss_pred             EEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            99999999999999999999999997532                    1246788899999999999999999999999


Q ss_pred             CCCCCeEEEcCCCcEEEeeeccccccccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 011359          309 DLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE  384 (488)
Q Consensus       309 DIkp~NILl~~~~~vkl~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~  384 (488)
                      ||||+||+++.++.++|+|||++......   ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus       155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999988543211   11222335667999999988899999999999999999997 889998


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHH
Q 011359          385 EMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ  439 (488)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~  439 (488)
                      +....+....+.... ....+..++.++.+||.+||+.+|++||++.++++.|++
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         235 GMAHEEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            887766555444333 334566789999999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-40  Score=316.92  Aligned_cols=246  Identities=33%  Similarity=0.655  Sum_probs=213.0

Q ss_pred             ceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeE
Q 011359          185 LRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV  259 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  259 (488)
                      +.||+|+||.||+|.+.     +..||||++.......       ..+++.+|+.++..++|+||+++++++.....+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   73 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-------ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL   73 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-------HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEE
Confidence            35799999999999986     6789999997544322       24678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          260 ITEYLSEGSLRAYLHKLE-------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       260 V~E~~~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      ||||+++++|.+++....       ...+++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+.
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccc
Confidence            999999999999998742       3678999999999999999999999999999999999999999999999999986


Q ss_pred             ccccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 011359          333 EEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       333 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      .....   .......++..|+|||.+....++.++||||||+++|+|++ |..||......+....+.. ......+..+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~  232 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYC  232 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccC
Confidence            54332   12334557889999999988889999999999999999999 6999999877665555444 5566677888


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      +.++.+++.+||..+|++||++.++++.|+
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            999999999999999999999999998774

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-39  Score=318.24  Aligned_cols=252  Identities=27%  Similarity=0.536  Sum_probs=212.5

Q ss_pred             ceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      +|.+++.||.|+||.||+|... ++.+|||.+.......  ....+....+.+|++++++++|+||+++++++.....++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV--LAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccch--hhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence            4668899999999999999874 6889999987643322  112233567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc--
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY--  336 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~--  336 (488)
                      +|+||+++++|.+++.+  ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.....  
T Consensus        79 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          79 IFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999999976  35688999999999999999999999999999999999999999999999998854311  


Q ss_pred             -----cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCCCCCCcH
Q 011359          337 -----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK-NLRPAIPGDCPP  410 (488)
Q Consensus       337 -----~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~  410 (488)
                           ........++..|+|||++.+..++.++||||||+++|+|++|..||...+.......+... ...+..+..++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA  236 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence                 11122345888999999999888999999999999999999999999887766554444333 344567778999


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.++|.+||+.+|++||++.+++.
T Consensus       237 ~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         237 AAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999998875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.1e-40  Score=325.43  Aligned_cols=255  Identities=31%  Similarity=0.571  Sum_probs=210.7

Q ss_pred             cccceeccceeeeeccEEEEEEEECC------------------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYKD------------------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR  238 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~~------------------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~  238 (488)
                      ..++|.+++.||+|+||.||++.+.+                  ..||+|++......       ...+.+.+|++++.+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-------~~~~~~~~e~~~l~~   75 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-------NAREDFLKEVKILSR   75 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-------HHHHHHHHHHHHHHh
Confidence            35678899999999999999998653                  35899998754321       225678899999999


Q ss_pred             cCCCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 011359          239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE---------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRD  309 (488)
Q Consensus       239 l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrD  309 (488)
                      ++|+||+++++++..+..++++|||+.+++|.+++....         ...+++..++.++.|++.||+|||+.||+|||
T Consensus        76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~d  155 (296)
T cd05051          76 LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD  155 (296)
T ss_pred             cCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Confidence            999999999999999999999999999999999997642         12688999999999999999999999999999


Q ss_pred             CCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh--CCCCCC
Q 011359          310 LKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA--GTIPYE  384 (488)
Q Consensus       310 Ikp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt--G~~Pf~  384 (488)
                      |||+||+++.++.++|+|||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++  |..||.
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            99999999999999999999985432211   1223346778999999988889999999999999999998  788998


Q ss_pred             CCCHHHHHHHHHhc------cCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          385 EMNPIQAAFAVVNK------NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       385 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      .....+........      ......+..++.++.++|.+||+.+|++||++.+|++.|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            77665544333321      1112334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-39  Score=321.38  Aligned_cols=256  Identities=26%  Similarity=0.520  Sum_probs=212.3

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~----~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ...+|.+.+.||+|+||+||+|.+.  ++    .||||++......       .....+.+|+.++..++|+||++++++
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~   77 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-------KANKEILDEAYVMAGVGSPYVCRLLGI   77 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH-------HHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence            4467888899999999999999874  33    4899998754322       224578899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +... ..++++||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~-~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          78 CLTS-TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             EcCC-CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCc
Confidence            9765 467999999999999999763 34689999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          331 ACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       331 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      +........   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......... .+........+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~  234 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLPQPP  234 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCCCCc
Confidence            864332111   122335678999999988889999999999999999998 999998877655433 444444555667


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      .++..+.++|.+||..||++||++.++++.|+.+..
T Consensus       235 ~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         235 ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            889999999999999999999999999998877744

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9e-40  Score=324.13  Aligned_cols=245  Identities=19%  Similarity=0.315  Sum_probs=204.3

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |...+.||+|+||+||+|.+.  ++.||||++.......     ......+.+|++++++++|+||+.+++++..+...+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-----RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-----hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEE
Confidence            456678999999999999985  6899999986532111     112345778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            99999999999999876555679999999999999999999999999999999999999999999999999985443333


Q ss_pred             cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCCCCCCCcHHHHHHH
Q 011359          339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN--KNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       339 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~Li  416 (488)
                      ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...........+..  .......+..++..+.+|+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            33445789999999999888899999999999999999999999988765433322221  1122345567889999999


Q ss_pred             HHHhhhCCCCCCCH
Q 011359          417 EQCWSLQPDKRPEF  430 (488)
Q Consensus       417 ~~cL~~dp~~RPs~  430 (488)
                      ..||+.+|++||++
T Consensus       237 ~~~l~~~P~~R~~~  250 (285)
T cd05632         237 KMLLTKDPKQRLGC  250 (285)
T ss_pred             HHHccCCHhHcCCC
Confidence            99999999999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-40  Score=336.09  Aligned_cols=240  Identities=25%  Similarity=0.380  Sum_probs=199.3

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHH-HHHhcCCCCeeeEeeeeecCCeeeEEEe
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVA-LLSRLHNPNVIKFVAACKKPPVYCVITE  262 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E  262 (488)
                      .||+|+||+||+|.+.  ++.||+|++......     .......+..|.. +++.++|+||+++++++.....+++|||
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e   76 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL-----KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD   76 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH-----hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEe
Confidence            5899999999999986  578999999742211     1111234444544 5678999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcCC
Q 011359          263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALS  341 (488)
Q Consensus       263 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~~  341 (488)
                      |+.+|+|.+++..  ...+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus        77 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          77 YINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            9999999999976  45678889999999999999999999999999999999999999999999999864322 22233


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS  421 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~  421 (488)
                      ...||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ...+..++..+.++|.+||+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~  232 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQ  232 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHcc
Confidence            4569999999999998899999999999999999999999999888776665555443  23456789999999999999


Q ss_pred             hCCCCCCCHHHHH
Q 011359          422 LQPDKRPEFWHIV  434 (488)
Q Consensus       422 ~dp~~RPs~~eil  434 (488)
                      .+|.+|+++.+.+
T Consensus       233 ~~p~~R~~~~~~~  245 (325)
T cd05602         233 KDRTKRLGAKDDF  245 (325)
T ss_pred             cCHHHCCCCCCCH
Confidence            9999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.8e-40  Score=320.22  Aligned_cols=248  Identities=26%  Similarity=0.450  Sum_probs=207.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeec--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK--  253 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--  253 (488)
                      +.|.+.+.||+|+||.||+|.+.  ++.||||++......         ...+.+|+.++.++ +|+||+++++++..  
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---------EEEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            34778889999999999999885  688999999754322         24577899999998 69999999999864  


Q ss_pred             ----CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          254 ----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       254 ----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                          ...+++||||+.+++|.+++.......+++..+..++.|++.||+|||+.||+||||+|+||+++.++.++|+|||
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCC
Confidence                2468999999999999999987555678999999999999999999999999999999999999999999999999


Q ss_pred             cccccccc-CcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          330 IACEEVYC-DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       330 la~~~~~~-~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      ++...... .......|+..|+|||++.     ...++.++|||||||++|+|++|..||.................+..
T Consensus       157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06637         157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL  236 (272)
T ss_pred             CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence            98643221 2233456889999999985     33578899999999999999999999988776665555444444444


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ....++..+.+||.+||..+|.+||++.++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            45678899999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=317.32  Aligned_cols=246  Identities=28%  Similarity=0.566  Sum_probs=206.3

Q ss_pred             ceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeE
Q 011359          185 LRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV  259 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  259 (488)
                      ++||+|+||.||+|.+..     ..||+|.+......       ...+++.+|+.+++.++|+||+++++++.. ..+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   72 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLML   72 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEE
Confidence            368999999999998742     57999998754322       225678899999999999999999998864 45789


Q ss_pred             EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCc
Q 011359          260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA  339 (488)
Q Consensus       260 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~  339 (488)
                      ||||+.+++|.+++...  ..+++..++.++.|++.||+|||+.|++||||||+|||++.++.++|+|||++........
T Consensus        73 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          73 VMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            99999999999999863  3789999999999999999999999999999999999999999999999999864322221


Q ss_pred             ----CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          340 ----LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       340 ----~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                          .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.... +........+..++..+.+
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~  229 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-LESGERLPRPEECPQEIYS  229 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCcCCCCCCCCHHHHH
Confidence                111223567999999988889999999999999999998 9999988877554433 3444455677788999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      +|.+||..+|++||++.++++.|+.+.
T Consensus       230 li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         230 IMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=343.31  Aligned_cols=262  Identities=27%  Similarity=0.578  Sum_probs=229.1

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECC------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV  244 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI  244 (488)
                      ..+..++++.+.+++.||.|.||.||.|.+.+      -.||||..+.....++       .+.|..|..+|+.++||||
T Consensus       381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-------tekflqEa~iMrnfdHphI  453 (974)
T KOG4257|consen  381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-------TEKFLQEASIMRNFDHPHI  453 (974)
T ss_pred             CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-------HHHHHHHHHHHHhCCCcch
Confidence            35778888899999999999999999999863      2589999987554433       4679999999999999999


Q ss_pred             eeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEE
Q 011359          245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK  324 (488)
Q Consensus       245 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vk  324 (488)
                      |+++|+|.+... |||||.++.|.|+.||+. +...++...+..+++||+.||+|||+.++|||||-..|||+.....+|
T Consensus       454 ikLIGv~~e~P~-WivmEL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVK  531 (974)
T KOG4257|consen  454 IKLIGVCVEQPM-WIVMELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVK  531 (974)
T ss_pred             hheeeeeeccce-eEEEecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceee
Confidence            999999987654 699999999999999987 456789999999999999999999999999999999999999999999


Q ss_pred             EeeecccccccccCcC--CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 011359          325 IADFGIACEEVYCDAL--SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLR  401 (488)
Q Consensus       325 l~DFgla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  401 (488)
                      |+|||+++...+....  +...-...|||||-++-..++.++|||.|||++||++. |..||.+..+.+.+. .+..+.+
T Consensus       532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-~iEnGeR  610 (974)
T KOG4257|consen  532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-HIENGER  610 (974)
T ss_pred             ecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-EecCCCC
Confidence            9999999755443332  23334678999999998999999999999999999987 999999988766543 3456678


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       402 ~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +..|+.||+.+..|+.+||+.+|.+||.+.+|...|..+..
T Consensus       611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            89999999999999999999999999999999999998876

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.2e-40  Score=324.58  Aligned_cols=249  Identities=26%  Similarity=0.410  Sum_probs=200.0

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeeEeeeeec-
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACKK-  253 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-  253 (488)
                      +|.+.+.||+|+||+||+|.+.  ++.||||.+.........      ...+.+|+.+++.+   +|+||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL------PLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC------chHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            4778899999999999999985  688999999764322211      12345677776655   79999999998764 


Q ss_pred             ----CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          254 ----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       254 ----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                          ...+++||||+. ++|.+++.......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence                346899999996 589999987655668999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN----------  399 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~----------  399 (488)
                      ++.............|+..|+|||++.+..++.++|||||||++|+|++|..||......+....+....          
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            9865433333344568999999999988889999999999999999999999998776655443333210          


Q ss_pred             --------CCC-------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 --------LRP-------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 --------~~~-------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                              ..+       .....++..+.+||.+||+.||++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                    000       012356788999999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.2e-40  Score=338.51  Aligned_cols=248  Identities=24%  Similarity=0.330  Sum_probs=206.0

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||++...  ++.||||++.....     ........+..|+.++.+++|+||+++++.+.....+
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-----LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            5778899999999999999885  68999999974221     1122346688999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      |+||||++||+|.+++.+  ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus        77 ~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             EEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            999999999999999976  456899999999999999999999999999999999999999999999999987532110


Q ss_pred             ------------------------------------CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCC
Q 011359          338 ------------------------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI  381 (488)
Q Consensus       338 ------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~  381 (488)
                                                          .......||..|+|||++.+..++.++|||||||++|||++|..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence                                                00113468999999999998999999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHHhhhCCCCCCC---HHHHHH
Q 011359          382 PYEEMNPIQAAFAVVNKNLRPAIPG--DCPPAMAALIEQCWSLQPDKRPE---FWHIVK  435 (488)
Q Consensus       382 Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~Li~~cL~~dp~~RPs---~~eil~  435 (488)
                      ||...+..+....+........++.  .++.++.+||.+|+ .+|.+|++   +.++++
T Consensus       235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            9999888776666655333333333  36889999999987 49999986   455553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8e-41  Score=321.29  Aligned_cols=250  Identities=22%  Similarity=0.324  Sum_probs=208.1

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  254 (488)
                      .++|....+|++|.||.||+|+++  ++.||+|.++.....+.-      .-.-.+||.+|.+++|||||.+-.+.... 
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF------PItsLREIniLl~~~H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF------PITSLREINILLKARHPNIVEVKEVVVGSN  148 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC------cchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence            357888899999999999999986  789999999976643322      22346999999999999999998876543 


Q ss_pred             -CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          255 -PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       255 -~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                       +.+|||||||+. +|..++.... ..+...++.-++.|+++||+|||.+.|+|||||++|+|++..|.+||+|||+|+.
T Consensus       149 ~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  149 MDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             cceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence             468999999954 9999998743 6788999999999999999999999999999999999999999999999999987


Q ss_pred             cccc-CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------cCC----
Q 011359          334 EVYC-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK------NLR----  401 (488)
Q Consensus       334 ~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~------~~~----  401 (488)
                      .... ...+..+.|.+|.|||++.+ ..|+...|+||+|||+.||+++.+-|.+....+.+..++..      .++    
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            6543 33566778999999999865 47999999999999999999999999988777666555431      111    


Q ss_pred             -------------------CCCCCC-CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 -------------------PAIPGD-CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 -------------------~~~~~~-~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                         ..++.. ++..-.+|++.+|.+||.+|.++.+.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                               111111 4578899999999999999999999876

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=353.99  Aligned_cols=259  Identities=27%  Similarity=0.544  Sum_probs=231.2

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--C---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--D---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~---~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      +||.+.+.|.+.||.|.||.||+|+++  +   ..||||.++....       ++.+.+|+.|+.||.+++||||++|.|
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-------ekqrrdFL~EAsIMGQFdHPNIIrLEG  697 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-------EKQRRDFLSEASIMGQFDHPNIIRLEG  697 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-------HHHHhhhhhhhhhcccCCCCcEEEEEE
Confidence            688899999999999999999999986  3   5799999986554       344788999999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +.....-.+||+|||++|+|+.||+... +.++..+++.+++.|+.|+.||-+.|+|||||-..|||++.+-.+||+|||
T Consensus       698 VVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  698 VVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             EEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccc
Confidence            9999999999999999999999999854 669999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC--cCCCCC--CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 011359          330 IACEEVYCD--ALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       330 la~~~~~~~--~~~~~~--gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  404 (488)
                      +++......  ..++..  -..+|.|||.+....++.++||||+|+++||+++ |..||.++.+.+.+.. +..+++...
T Consensus       777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-Ie~gyRLPp  855 (996)
T KOG0196|consen  777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-IEQGYRLPP  855 (996)
T ss_pred             ceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-HHhccCCCC
Confidence            997432221  122222  2468999999999999999999999999999987 9999999998776654 567788889


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      |-+||..|.+|+..||++|-.+||.|.+|+..|+++..
T Consensus       856 PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  856 PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            99999999999999999999999999999999999865

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.7e-39  Score=317.02  Aligned_cols=258  Identities=24%  Similarity=0.435  Sum_probs=213.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|.+.  |+.||+|.++.....+.     ...+.+.+|++++++++|+||+++++++.....
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA-----KARQDCLKEIDLLKQLDHPNVIKYLASFIENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            46888999999999999999985  78999999875433221     124678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      .++||||+++++|.+++...  ....+++..++.++.+++.||+|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            99999999999999998753  2345889999999999999999999999999999999999999999999999988543


Q ss_pred             cccC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCCCCC-CCcHH
Q 011359          335 VYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNKNLRPAIPG-DCPPA  411 (488)
Q Consensus       335 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~  411 (488)
                      .... ......++..|+|||.+.+..++.++|||||||++|+|++|..||.... ..............+..+. .++..
T Consensus       157 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             cCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence            2211 1223458889999999988889999999999999999999999996543 1112222222233333444 78889


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      +.++|.+||..+|++||++.+|++.|+++.
T Consensus       237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         237 LRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            999999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.6e-40  Score=321.31  Aligned_cols=249  Identities=23%  Similarity=0.405  Sum_probs=205.5

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||.||+|.+.  ++.||+|++.......        ...+.+|+.++++++|+||+++++++..+.
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~--------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~   79 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD--------FSLIQQEIFMVKECKHCNIVAYFGSYLSRE   79 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch--------HHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence            356889999999999999999974  6889999997543211        235778999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            99999999999999999875  3568899999999999999999999999999999999999999999999999986443


Q ss_pred             cc-CcCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC---CCCCC
Q 011359          336 YC-DALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA---IPGDC  408 (488)
Q Consensus       336 ~~-~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~  408 (488)
                      .. .......|+..|+|||.+.   ...++.++|||||||++|+|++|..||....+.+....+......+.   ....+
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW  237 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccccc
Confidence            21 1123345888999999984   34578899999999999999999999977665544333323222222   12356


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      +..+.+||.+||+.+|++||++.+|++.
T Consensus       238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         238 SSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            8899999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.7e-40  Score=324.20  Aligned_cols=239  Identities=24%  Similarity=0.399  Sum_probs=195.0

Q ss_pred             eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeec
Q 011359          187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  264 (488)
                      ||+|+||+||++.+.  ++.||||++.......     ....+.+..|+.+++.++|+||+++++++.....+++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK-----RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh-----hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence            699999999999875  6899999987432111     112356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC-cCC
Q 011359          265 SEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD-ALS  341 (488)
Q Consensus       265 ~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~-~~~  341 (488)
                      ++|+|..++...  ....+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            999999888643  34568999999999999999999999999999999999999999999999999985433221 123


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCCCCCCcHHHHHHHHHH
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--NLRPAIPGDCPPAMAALIEQC  419 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~Li~~c  419 (488)
                      ...||..|+|||++.+..++.++|||||||++|+|++|..||...........+...  ......+..++..+.+++.+|
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence            346899999999999899999999999999999999999999865432111111111  112345667899999999999


Q ss_pred             hhhCCCCCCCH
Q 011359          420 WSLQPDKRPEF  430 (488)
Q Consensus       420 L~~dp~~RPs~  430 (488)
                      |+.||++||++
T Consensus       236 l~~~P~~R~~~  246 (280)
T cd05608         236 LAKDPEKRLGF  246 (280)
T ss_pred             hcCCHHHhcCC
Confidence            99999999944

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-42  Score=316.23  Aligned_cols=248  Identities=24%  Similarity=0.374  Sum_probs=216.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+-+.||+|.|+.||++...  |+.+|+|++....      +.++--+++.+|+.|-+.|+|||||++.+.+.....
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k------~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~   84 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK------LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF   84 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhh------hccccHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence            45778889999999999999764  8899999986432      223335678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC---CCcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~---~~~vkl~DFgla~~  333 (488)
                      .|||+|+|+|++|..-|-..  ...++..+-.++.||+.+|.|+|.+||||||+||+|+|+..   ..-+||+|||+|..
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             eEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            99999999999998777653  45677888899999999999999999999999999999953   34699999999988


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  411 (488)
                      ...+.......||+.|||||+++..+|+..+|||+-||+||-|+.|.+||.+.+.......+....+..  .....++++
T Consensus       163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~  242 (355)
T KOG0033|consen  163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE  242 (355)
T ss_pred             eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence            777777788899999999999999999999999999999999999999999988888888888776543  234678899


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIV  434 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil  434 (488)
                      .++||++||..||.+|.++.|.+
T Consensus       243 Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  243 AKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             HHHHHHHHhccChhhhccHHHHh
Confidence            99999999999999999987665

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.4e-40  Score=333.55  Aligned_cols=238  Identities=23%  Similarity=0.419  Sum_probs=196.3

Q ss_pred             ceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeeeEEE
Q 011359          185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      +.||+|+||.||++.+.  ++.||+|++........     .....+..|+.++.++ +||||+++++++.....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch-----hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence            35899999999999985  57899999985432211     1235577899988877 7999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc-ccCcC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDAL  340 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~-~~~~~  340 (488)
                      ||+++|+|..++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... .....
T Consensus        76 E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          76 EYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence            99999999988875  4578999999999999999999999999999999999999999999999999985422 12223


Q ss_pred             CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN--------PIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      ....||..|+|||++.+..++.++|||||||++|+|++|..||....        ........... ....+|..++..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~  232 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKA  232 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHH
Confidence            34568999999999998899999999999999999999999995311        11222222222 2345778889999


Q ss_pred             HHHHHHHhhhCCCCCCCH
Q 011359          413 AALIEQCWSLQPDKRPEF  430 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~  430 (488)
                      .+||.+||+.||++||++
T Consensus       233 ~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         233 ASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHHhcCCHHHcCCC
Confidence            999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.3e-39  Score=321.01  Aligned_cols=253  Identities=27%  Similarity=0.519  Sum_probs=209.2

Q ss_pred             ccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      .++|.+.+.||+|+||.||+|.+.+       ..||+|.+......       ..+..|.+|+.+++.++|+||++++++
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~   77 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-------QDESDFLMEALIMSKFNHQNIVRLIGV   77 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3567888999999999999999854       56888887532221       124568899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC---c
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEH-----KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF---H  322 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~---~  322 (488)
                      +......++||||+.+++|.+++.....     ..+++..++.++.||+.||+|||++|++||||||+||+++.++   .
T Consensus        78 ~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          78 SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             EccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcc
Confidence            9988899999999999999999987432     2588999999999999999999999999999999999998654   5


Q ss_pred             EEEeeecccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 011359          323 LKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK  398 (488)
Q Consensus       323 vkl~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~  398 (488)
                      +||+|||++........   ......+..|+|||++.+..++.++|||||||++|+|++ |..||......+... .+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~-~~~~  236 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-FVTG  236 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHc
Confidence            99999999864321111   112223567999999988889999999999999999997 999999877655443 3444


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       399 ~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      ......+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            4455667888999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-39  Score=317.51  Aligned_cols=255  Identities=28%  Similarity=0.543  Sum_probs=212.2

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--C---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--D---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~---~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      ..++|...+.||+|+||.||+|...  +   ..+|||.+......       ...+.+..|++++.+++|+||+++++++
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-------KQRQDFLSEASIMGQFSHHNIIRLEGVV   75 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH-------HHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence            4456778899999999999999875  2   26999998643221       1245688999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ......++||||+++++|.+++... ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          76 TKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             ccCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccc
Confidence            9999999999999999999999763 356899999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCcC----CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          332 CEEVYCDAL----SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       332 ~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      .........    .....+..|+|||++....++.++|||||||++|+|++ |..||......+....+. .......+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~  233 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPM  233 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCC
Confidence            543221111    11223457999999988889999999999999999997 999998877665544443 334444566


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         234 DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            7899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=334.46  Aligned_cols=247  Identities=26%  Similarity=0.373  Sum_probs=223.6

Q ss_pred             ceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      -|.+.+.||+|.|.+|-++++  +|+.||||++.....+.-.      ...+.+|+++|+.++|||||++|.+......+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s------t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS------TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh------hhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence            366788999999999999875  5999999999765544322      45788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc-CCCcEEEeeecccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIACEEVY  336 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~-~~~~vkl~DFgla~~~~~  336 (488)
                      |||+|+-++|+|++||-+. ...+.++.+.+++.||+.|+.|||...+|||||||+||.+- .-|-+||.|||++.....
T Consensus        93 yLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            9999999999999999874 45689999999999999999999999999999999999775 568899999999988888


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSYG-RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~~-~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      +..+.+.+|+..|.|||++.+..|+ +++||||||||||.|+||+.||+..+..+.+..+++.++  ..|..++.+.++|
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~eCrdL  249 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSKECRDL  249 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhHHHHHH
Confidence            8888999999999999999998885 789999999999999999999999999998888888765  4788999999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      |..||..||++|.++++|+.
T Consensus       250 I~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  250 IQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             HHHHHhcCchhhccHHHHhc
Confidence            99999999999999999884

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=329.53  Aligned_cols=252  Identities=21%  Similarity=0.321  Sum_probs=205.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||++...  ++.||||++....     .......+.+..|+.++..++|+||+++++++..+..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE-----MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-----HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence            36888999999999999999975  6899999997421     1112224568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|+||||+.+|+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999999999999753 35688999999999999999999999999999999999999999999999999854332


Q ss_pred             cCc--CCCCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC---C
Q 011359          337 CDA--LSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP---G  406 (488)
Q Consensus       337 ~~~--~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~  406 (488)
                      ...  .....||..|+|||++..     ..++.++|||||||++|+|++|..||......+....+........++   .
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  234 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT  234 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccC
Confidence            221  122458999999999963     457889999999999999999999999887766666555433222222   3


Q ss_pred             CCcHHHHHHHHHHhhhCCCC--CCCHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDK--RPEFWHIVKV  436 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~--RPs~~eil~~  436 (488)
                      .++..+.+||.+||..++++  |+++.++++.
T Consensus       235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            57899999999998754443  7788888764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-39  Score=333.55  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=200.6

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  254 (488)
                      .++|.+.+.||+|+||.||++.+.  ++.||||++........      ..+.+.+|+.+++.++|+||+++++++... 
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   89 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT------HAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChH------HHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence            468999999999999999999875  68999999975433221      135677899999999999999999988543 


Q ss_pred             -----CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          255 -----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       255 -----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                           ...++||||+++ +|.+.+..    .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          90 SLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCc
Confidence                 357899999965 67776653    48888999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL---------  400 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~---------  400 (488)
                      ++.............||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....++....         
T Consensus       165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             ccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            99654433334455789999999999988999999999999999999999999988765443322211000         


Q ss_pred             -------------------------------CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          401 -------------------------------RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       401 -------------------------------~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                                                     ........+..+++||.+||..||++||++.++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                                           000112235678999999999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.3e-39  Score=317.68  Aligned_cols=257  Identities=25%  Similarity=0.536  Sum_probs=213.8

Q ss_pred             ccccceeccceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ++..+|.+.+.||+|+||.||+|.+.+     ..||||.+......       ...+.+.+|+.++++++|+||++++++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~h~~i~~~~~~   75 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-------SVREKFLQEAYIMRQFDHPHIVKLIGV   75 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-------HHHHHHHHHHHHHHhCCCCchhceeEE
Confidence            445678889999999999999998753     36899988654321       124578899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +... ..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||+
T Consensus        76 ~~~~-~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          76 ITEN-PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             EcCC-CcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCce
Confidence            8764 467999999999999999763 33589999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc--CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          331 ACEEVYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       331 a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      +........  .....++..|+|||.+....++.++||||||+++|+|++ |..||......+....+ ....+...+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~  232 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-ENGERLPMPPN  232 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCcCCCCCC
Confidence            854322211  112234567999999988889999999999999999996 99999888776555443 33445566788


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ++..+.++|.+||..+|++||++.++++.|+.+..
T Consensus       233 ~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.1e-39  Score=313.34  Aligned_cols=251  Identities=29%  Similarity=0.528  Sum_probs=214.0

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|..++.||+|+||.||+|...  ++.||+|++........   .....+.+.+|+.+++.++|+||+++++++.....+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   77 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT---GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNL   77 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc---chHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeE
Confidence            3567788999999999999985  68999999976443221   122346788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++++||+++++|.+++..  ...+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus        78 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          78 YIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEEEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            999999999999999976  346889999999999999999999999999999999999999999999999988654333


Q ss_pred             CcCCCCCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          338 DALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~~~~-~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      .......++..|++||.+.... ++.++|+||||+++|+|++|..||......+....+......+.++..++..+.+++
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  235 (258)
T cd06632         156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI  235 (258)
T ss_pred             ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence            3334556889999999997666 899999999999999999999999887766655555543445667778899999999


Q ss_pred             HHHhhhCCCCCCCHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||+.+|++||++.+++.
T Consensus       236 ~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         236 LKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHhhcCcccCcCHHHHhc
Confidence            9999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.4e-39  Score=313.53  Aligned_cols=251  Identities=27%  Similarity=0.564  Sum_probs=211.6

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      +|.++|.+.+.||.|+||.||++.+. +..+|||.+......         ..+|.+|++++++++|+||+++++++...
T Consensus         1 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05112           1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTER   71 (256)
T ss_pred             CChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence            35678889999999999999999886 688999998743322         24578999999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ...++||||+.+++|.+++... ...++++.++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  150 (256)
T cd05112          72 SPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV  150 (256)
T ss_pred             CceEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeec
Confidence            9999999999999999998763 345789999999999999999999999999999999999999999999999988543


Q ss_pred             cccCc--CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          335 VYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       335 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      .....  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+ ..+.+...+...+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  229 (256)
T cd05112         151 LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLYKPRLASQS  229 (256)
T ss_pred             ccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-hCCCCCCCCCCCCHH
Confidence            22111  112235678999999988889999999999999999998 99999887765544443 333444456667899


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~L  437 (488)
                      +.+|+.+||+.+|++||++.++++.|
T Consensus       230 ~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         230 VYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHHHHcccChhhCCCHHHHHHhh
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=318.19  Aligned_cols=248  Identities=30%  Similarity=0.548  Sum_probs=204.6

Q ss_pred             eeeeeccEEEEEEEECC--c--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeeeEE
Q 011359          186 RFAHGAHSRLYHGIYKD--E--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~~--~--~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV  260 (488)
                      .||+|+||.||+|.+.+  .  .+|+|.+......       .....+.+|++++.++ +||||+++++++.....+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv   74 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-------DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   74 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH-------HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEE
Confidence            47999999999999853  2  4688887632211       1245688999999999 799999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          261 TEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       261 ~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      |||+.+|+|.+++....              ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence            99999999999997632              1247889999999999999999999999999999999999999999999


Q ss_pred             eecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          327 DFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       327 DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      |||++..............+..|+|||++....++.++||||||+++|||++ |..||.+.+..+.... +........+
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~  233 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKP  233 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH-HhCCCCCCCC
Confidence            9999853222111122234567999999988889999999999999999997 9999988776554433 3344455566


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      ..++.++.+|+.+||..+|.+||++.+++..|+++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         234 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            778899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.1e-39  Score=315.22  Aligned_cols=245  Identities=27%  Similarity=0.505  Sum_probs=209.3

Q ss_pred             eeeeeccEEEEEEEECC---c--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEE
Q 011359          186 RFAHGAHSRLYHGIYKD---E--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~~---~--~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  260 (488)
                      .||+|++|.||+|.+..   +  .||||.+......       ...+.|.+|+.++++++|+||+++++.+.. ..+++|
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v   73 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV   73 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence            57999999999998742   2  6999999754322       335788999999999999999999999988 889999


Q ss_pred             EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC--
Q 011359          261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD--  338 (488)
Q Consensus       261 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~--  338 (488)
                      |||+++++|.+++.......+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++.......  
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            999999999999987543568999999999999999999999999999999999999999999999999985432211  


Q ss_pred             --cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          339 --ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       339 --~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                        ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.........+..++..+.++
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV  233 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence              1123456788999999998899999999999999999998 9999988887776655554444555667789999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      +.+||+.+|++||++.++++.|.
T Consensus       234 i~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         234 MLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHHCCCCcccCCCHHHHHHHhc
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.8e-40  Score=334.18  Aligned_cols=239  Identities=23%  Similarity=0.373  Sum_probs=199.8

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHH-HHHhcCCCCeeeEeeeeecCCeeeEEEe
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVA-LLSRLHNPNVIKFVAACKKPPVYCVITE  262 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E  262 (488)
                      .||+|+||+||+|...  |+.||||++......     .......+..|.. +++.++||||+++++++..+..+++|||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e   76 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-----NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD   76 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEc
Confidence            5899999999999875  689999999743211     1122344556655 4677999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc-ccCcCC
Q 011359          263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDALS  341 (488)
Q Consensus       263 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~-~~~~~~  341 (488)
                      |+.+|+|..++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ......
T Consensus        77 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          77 FVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            9999999998875  4578999999999999999999999999999999999999999999999999985422 122234


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS  421 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~  421 (488)
                      ...||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ..++...+..+.++|.+||.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll~  232 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--LVLRPGASLTAWSILEELLE  232 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHhc
Confidence            4568999999999998899999999999999999999999999888776666555443  23455688999999999999


Q ss_pred             hCCCCCCCHHHH
Q 011359          422 LQPDKRPEFWHI  433 (488)
Q Consensus       422 ~dp~~RPs~~ei  433 (488)
                      .+|.+||++.+.
T Consensus       233 ~~p~~R~~~~~~  244 (325)
T cd05604         233 KDRQRRLGAKED  244 (325)
T ss_pred             cCHHhcCCCCCC
Confidence            999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.2e-40  Score=330.88  Aligned_cols=238  Identities=24%  Similarity=0.410  Sum_probs=197.8

Q ss_pred             ceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeeeEEE
Q 011359          185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      +.||+|+||.||+|...  ++.||||++.......     ....+.+.+|+.++.++ +|+||+.+++++.....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD-----DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence            36899999999999875  5789999998532111     12245678999999998 5999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc-ccCcC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDAL  340 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~-~~~~~  340 (488)
                      ||+++|+|..++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... .....
T Consensus        76 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          76 EYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence            99999999998875  3579999999999999999999999999999999999999999999999999986422 22223


Q ss_pred             CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM------NPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      ....||..|+|||++.+..++.++|||||||++|+|++|..||...      ...+......... ...+|..++..+.+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~  232 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRFLSVKASH  232 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCCCCHHHHH
Confidence            4456899999999999889999999999999999999999999632      2223333333222 33467788999999


Q ss_pred             HHHHHhhhCCCCCCCH
Q 011359          415 LIEQCWSLQPDKRPEF  430 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~  430 (488)
                      +|.+||..||++|+++
T Consensus       233 li~~~L~~dP~~R~~~  248 (327)
T cd05617         233 VLKGFLNKDPKERLGC  248 (327)
T ss_pred             HHHHHhccCHHHcCCC
Confidence            9999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-39  Score=337.92  Aligned_cols=243  Identities=23%  Similarity=0.394  Sum_probs=196.4

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      +...+|.+.+.||+|+||.||++.+.  ++.||||...              ...+.+|+++|++|+||||+++++++..
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------------~~~~~~E~~il~~l~HpnIv~~~~~~~~  154 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------------RGGTATEAHILRAINHPSIIQLKGTFTY  154 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------------hhhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence            45567999999999999999999985  6899999753              2345689999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      +...++|+|++ +++|..++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus       155 ~~~~~lv~e~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~  231 (391)
T PHA03212        155 NKFTCLILPRY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF  231 (391)
T ss_pred             CCeeEEEEecC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence            99999999999 4789888875  35688999999999999999999999999999999999999999999999999854


Q ss_pred             ccc--cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHH--------
Q 011359          334 EVY--CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP-------IQAAFAVV--------  396 (488)
Q Consensus       334 ~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~-------~~~~~~~~--------  396 (488)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|..||.....       ...+..++        
T Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence            221  1222345699999999999988999999999999999999999987643211       01110000        


Q ss_pred             ------------------hccC-CCC-C-----CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          397 ------------------NKNL-RPA-I-----PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       397 ------------------~~~~-~~~-~-----~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                        .... .+. .     ...++.++.+||.+||+.||.+||++.++++
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                              0000 000 0     0134678999999999999999999999885

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.7e-40  Score=332.57  Aligned_cols=237  Identities=25%  Similarity=0.385  Sum_probs=198.1

Q ss_pred             eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHH-HHHhcCCCCeeeEeeeeecCCeeeEEEe
Q 011359          186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVA-LLSRLHNPNVIKFVAACKKPPVYCVITE  262 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E  262 (488)
                      .||+|+||.||+|.+.  ++.||||++......     .......+..|+. +++.++||||+++++++......|+|||
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   76 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-----KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLD   76 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEc
Confidence            5899999999999985  688999999742211     1122344555554 6788999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcCC
Q 011359          263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALS  341 (488)
Q Consensus       263 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~~  341 (488)
                      |+++++|..++..  ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..... .....
T Consensus        77 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          77 YVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            9999999988875  45688899999999999999999999999999999999999999999999999864221 12233


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS  421 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~  421 (488)
                      ...||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...++...+..+.++|.+||+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~  232 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLH  232 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHcc
Confidence            456899999999999888999999999999999999999999988776655555543  344667788999999999999


Q ss_pred             hCCCCCCCHH
Q 011359          422 LQPDKRPEFW  431 (488)
Q Consensus       422 ~dp~~RPs~~  431 (488)
                      .+|.+|+++.
T Consensus       233 ~~p~~R~~~~  242 (321)
T cd05603         233 KDQRRRLGAK  242 (321)
T ss_pred             CCHhhcCCCC
Confidence            9999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=323.99  Aligned_cols=254  Identities=30%  Similarity=0.532  Sum_probs=207.1

Q ss_pred             ccceeccceeeeeccEEEEEEEECC----------------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYKD----------------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN  241 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~~----------------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H  241 (488)
                      ..+|.+.++||+|+||.||++...+                ..||||++......       .....|.+|++++++++|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~ei~~l~~l~h   76 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-------TARNDFLKEIKIMSRLKN   76 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH-------HHHHHHHHHHHHHHhCCC
Confidence            4578899999999999999987642                24899998743221       124568899999999999


Q ss_pred             CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Q 011359          242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH----------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK  311 (488)
Q Consensus       242 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIk  311 (488)
                      +||+++++++......++||||+.+++|.+++.....          ..+++..++.++.|++.||+|||+.|++|||||
T Consensus        77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk  156 (295)
T cd05097          77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA  156 (295)
T ss_pred             CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence            9999999999999999999999999999999965321          236788999999999999999999999999999


Q ss_pred             CCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh--CCCCCCCC
Q 011359          312 PENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA--GTIPYEEM  386 (488)
Q Consensus       312 p~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt--G~~Pf~~~  386 (488)
                      |+||+++.++.+||+|||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++  |..||...
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            999999999999999999985432211   1122335678999999988889999999999999999988  67899887


Q ss_pred             CHHHHHHHHHh------ccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          387 NPIQAAFAVVN------KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       387 ~~~~~~~~~~~------~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      ...+.......      .......+..++..+.+||.+||+.+|++||++.+|++.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            76554433221      11223345567899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-39  Score=329.42  Aligned_cols=242  Identities=24%  Similarity=0.378  Sum_probs=204.4

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVY  257 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~  257 (488)
                      |.+.+.||+|+||.||+|...  ++.||||++......     .....+.+..|+.++..+. |++|+++++++.....+
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   76 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRL   76 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEE
Confidence            557788999999999999875  689999999742211     1112355778999998886 57788899999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      |+||||+++|+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus        77 ~lv~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            999999999999999876  356899999999999999999999999999999999999999999999999998643221


Q ss_pred             -CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          338 -DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       338 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                       .......||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+....  ...+..++..+.+++
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li  232 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSIC  232 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHH
Confidence             12234568999999999998889999999999999999999999999988777666665543  346678899999999


Q ss_pred             HHHhhhCCCCCCCHH
Q 011359          417 EQCWSLQPDKRPEFW  431 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~  431 (488)
                      .+||+.+|.+|++..
T Consensus       233 ~~~l~~~p~~R~~~~  247 (323)
T cd05615         233 KGLMTKHPSKRLGCG  247 (323)
T ss_pred             HHHcccCHhhCCCCC
Confidence            999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.8e-39  Score=325.55  Aligned_cols=250  Identities=23%  Similarity=0.392  Sum_probs=203.4

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      ++++|.+.+.||+|+||.||+|++.  ++.||||.+........       ...+.+|+.++++++|+||+++++++..+
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-------PCTAIREVSLLKDLKHANIVTLHDIVHTD   76 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-------chhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence            3467889999999999999999875  67899999976543221       23466899999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+++||||+.+ +|.+++... ...+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++...
T Consensus        77 ~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          77 KSLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             CeEEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceec
Confidence            999999999964 888888653 345788999999999999999999999999999999999999999999999998543


Q ss_pred             ccc-CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------
Q 011359          335 VYC-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--------------  398 (488)
Q Consensus       335 ~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~--------------  398 (488)
                      ... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+...              
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence            221 22234467899999999864 46899999999999999999999999887655443332210              


Q ss_pred             -------cCCC-------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          399 -------NLRP-------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       399 -------~~~~-------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                             ....       .....++.++.+||.+||..||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                   0000       011346788999999999999999999999886

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-39  Score=333.50  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=201.3

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  254 (488)
                      .++|.+.+.||+|+||.||++.+.  ++.||||++........      ..+.+.+|+.+++.++|+||+++++++... 
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~   96 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT------HAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   96 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCch------hHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence            467999999999999999999875  68899999975432221      135677899999999999999999987543 


Q ss_pred             -----CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          255 -----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       255 -----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                           ..+|+||||+. ++|.+++..    .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875          97 SLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence                 35799999996 477777753    47888999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL---------  400 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~---------  400 (488)
                      ++.............||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....++..-.         
T Consensus       172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             CccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            99654443334456789999999999988999999999999999999999999998776555444332100         


Q ss_pred             -----------CC--------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 -----------RP--------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 -----------~~--------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                 ++                    ......+..+.+||.+||..||.+||++.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                       00                    001113457899999999999999999999887

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.2e-40  Score=319.84  Aligned_cols=247  Identities=32%  Similarity=0.583  Sum_probs=204.1

Q ss_pred             eeccceeeeeccEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~~--~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |++++.||+|+||+||++...+  +.||+|++.........      .....+|+.++++++|+||+++++++......+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE------REENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH------HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc------cchhhhhhhcccccccccccccccccccccccc
Confidence            6788999999999999999974  57999999865432211      223456999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc-cccc
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-EVYC  337 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~-~~~~  337 (488)
                      +||||+.+++|.+++..  ...+++..++.++.||+.||++||+.||+|+||||+||+++.++.++|+|||++.. ....
T Consensus        75 ~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             EEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999983  46789999999999999999999999999999999999999999999999999864 2223


Q ss_pred             CcCCCCCCCcccCChhhhh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCCC--CCCCCCcHH
Q 011359          338 DALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA---AFAVVNKNLRP--AIPGDCPPA  411 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~  411 (488)
                      .......++..|+|||++. +..++.++||||||+++|+|++|..||........   ...........  ......+..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEE  232 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHH
Confidence            3445667899999999998 78899999999999999999999999998843222   22222211111  111223489


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.++|.+||+.+|++||++.++++
T Consensus       233 l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  233 LRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4e-39  Score=313.04  Aligned_cols=250  Identities=21%  Similarity=0.331  Sum_probs=214.0

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||.|+||.||.+...  ++.+++|.+........      ...++.+|++++++++|+||+++++++.....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK------ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh------HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            4778899999999988888764  68899999876543221      245678999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      +++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            99999999999999998755567899999999999999999999999999999999999999999999999998544322


Q ss_pred             C-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          338 D-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       338 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|..||......+....+...... ..+..++..+.++|
T Consensus       155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i  233 (256)
T cd08221         155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVYSSELISLV  233 (256)
T ss_pred             cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCccccCHHHHHHH
Confidence            2 223456899999999998888899999999999999999999999987776666666554443 34567889999999


Q ss_pred             HHHhhhCCCCCCCHHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~~  436 (488)
                      .+||..+|++||++.++++.
T Consensus       234 ~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         234 HSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HHHcccCcccCCCHHHHhhC
Confidence            99999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-40  Score=323.84  Aligned_cols=249  Identities=23%  Similarity=0.421  Sum_probs=205.8

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC----
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP----  254 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----  254 (488)
                      |.-.+.+|.|.||.||+|...  ++.||||.........+            +|+++|+.++|||||++..+|...    
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn------------rEl~im~~l~HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN------------RELQIMRKLDHPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc------------HHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence            556678999999999999975  68999999986655443            899999999999999999888542    


Q ss_pred             -CeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-CcEEEeeecc
Q 011359          255 -PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGI  330 (488)
Q Consensus       255 -~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-~~vkl~DFgl  330 (488)
                       -...+|||||+. +|..+++..  .+..++.-.+.-+.+||++||+|||+.||+||||||.|+|+|.+ |.+||||||.
T Consensus        94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence             245689999965 999999854  34567777889999999999999999999999999999999977 9999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK-----------  398 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~-----------  398 (488)
                      |.....+........|..|.|||.+.+ ..|+.+.||||.||++.||+-|.+-|.+.+..+.+..++.-           
T Consensus       173 AK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  173 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             ceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            987777776667778999999999965 57999999999999999999999999998876665554431           


Q ss_pred             ---c--------CC-----CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH--HHHHHHH
Q 011359          399 ---N--------LR-----PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK--VLEQFET  442 (488)
Q Consensus       399 ---~--------~~-----~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~--~Le~~~~  442 (488)
                         +        +.     ..+....+++..+|+.++|..+|.+|.++.+++.  .+..+..
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence               0        00     0133467899999999999999999999998884  3444433

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.2e-39  Score=311.83  Aligned_cols=244  Identities=31%  Similarity=0.599  Sum_probs=205.9

Q ss_pred             eeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeec
Q 011359          186 RFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  264 (488)
                      .||+|+||.||+|... +..||+|++.....       .+....|.+|++++++++|+||+++++++......++||||+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   74 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-------QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELV   74 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCC-------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECC
Confidence            5799999999999875 57899999874332       122456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCc--CCC
Q 011359          265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSD  342 (488)
Q Consensus       265 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~--~~~  342 (488)
                      ++++|.+++... ...+.+..++.++.|++.+|.|||+.|++||||+|+||+++.++.++|+|||++........  ...
T Consensus        75 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          75 PGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            999999998763 34678999999999999999999999999999999999999999999999999854322111  112


Q ss_pred             CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 011359          343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS  421 (488)
Q Consensus       343 ~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~  421 (488)
                      ..++..|+|||++.+..++.++||||||+++|+|++ |..||...........+ ....+...+..++..+.+++.+||+
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~  232 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-EKGYRMSCPQKCPDDVYKVMQRCWD  232 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            234567999999988889999999999999999998 99999888766554443 3455556677889999999999999


Q ss_pred             hCCCCCCCHHHHHHHHH
Q 011359          422 LQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       422 ~dp~~RPs~~eil~~Le  438 (488)
                      .+|++||++.++++.|.
T Consensus       233 ~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         233 YKPENRPKFSELQKELA  249 (250)
T ss_pred             cCcccCCCHHHHHHHhc
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.2e-39  Score=311.66  Aligned_cols=249  Identities=24%  Similarity=0.420  Sum_probs=210.1

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCe
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-PPV  256 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~  256 (488)
                      .|.+.+.||.|++|.||++...  ++.||||.+.......      ...+.+.+|++++++++|+|++++++.+.. +..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR------RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH------HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            3778899999999999999875  5789999997543221      124567899999999999999999998764 446


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||+++++|.+++.......+++.+++.++.+++.||+|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            88999999999999999875556789999999999999999999999999999999999999999999999999854322


Q ss_pred             c-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          337 C-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       337 ~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      . .......++..|+|||++.+..++.++||||||+++|+|++|..||...+.......+... ..+..+..++..+.++
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  233 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-KLPPMPKDYSPELGEL  233 (257)
T ss_pred             cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCccccCHHHHHH
Confidence            1 1223445888999999999888999999999999999999999999887765555544443 3345667789999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      |.+||+.+|++||++.++++
T Consensus       234 i~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         234 IATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HHHHhccCcccCCCHHHHhc
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.8e-39  Score=329.20  Aligned_cols=251  Identities=22%  Similarity=0.313  Sum_probs=206.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||++.+.  ++.||||++....     .........+..|+.++..++|+||+++++++..+..
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-----MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            46888999999999999999986  5789999986421     1112224557889999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .|+||||+.||+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999999999863 35688999999999999999999999999999999999999999999999999854432


Q ss_pred             cCc--CCCCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC---C
Q 011359          337 CDA--LSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP---G  406 (488)
Q Consensus       337 ~~~--~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~  406 (488)
                      ...  .....||..|+|||++.+     ..++.++|||||||++|+|++|..||...+..+....+.....+..++   .
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  234 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHIT  234 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccc
Confidence            221  123468999999999875     467899999999999999999999999888777666666544333333   3


Q ss_pred             CCcHHHHHHHHHHhhhCCCC--CCCHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDK--RPEFWHIVK  435 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~--RPs~~eil~  435 (488)
                      .++.++.++|.+||..++++  |+++.++++
T Consensus       235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            46899999999999865544  456777764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-39  Score=358.66  Aligned_cols=256  Identities=21%  Similarity=0.359  Sum_probs=209.3

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      +..+.+++|.+.+.||+|+||+||++.+.  ++.||+|++.......      .....|..|+.+|.+|+|||||+++++
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e------~~~~~~~~EI~IL~~L~HPNIVrl~d~   80 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE------REKSQLVIEVNVMRELKHKNIVRYIDR   80 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH------HHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence            34455678999999999999999999986  5789999997644322      124678899999999999999999998


Q ss_pred             eec--CCeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CcccCCCCCCeEEEcC
Q 011359          251 CKK--PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQ-------GVIHRDLKPENVLIDQ  319 (488)
Q Consensus       251 ~~~--~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-------giiHrDIkp~NILl~~  319 (488)
                      |..  ...+||||||+.+|+|.++|...  ....+++..++.|+.||+.||+|||+.       +||||||||+||||+.
T Consensus        81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            854  45789999999999999999764  235699999999999999999999985       4999999999999964


Q ss_pred             -----------------CCcEEEeeecccccccccCcCCCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCC
Q 011359          320 -----------------EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGT  380 (488)
Q Consensus       320 -----------------~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvll~elltG~  380 (488)
                                       .+.+||+|||++.............||+.|+|||++.+  ..++.++||||||||||+|++|.
T Consensus       161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence                             23589999999865433333345579999999999854  45889999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       381 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .||............+...... ....++.++.+||.+||..+|.+||++.+++.
T Consensus       241 ~PF~~~~~~~qli~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        241 TPFHKANNFSQLISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCcCCcHHHHHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9998776655554444433222 12456889999999999999999999999984

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-41  Score=340.09  Aligned_cols=244  Identities=27%  Similarity=0.426  Sum_probs=214.3

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.-.+.||+|.||.||.+++.  .+.||||.+.......++.     ..++.+|+..|.+|+|||+|.+-|+|..+...|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EK-----WqDIlKEVrFL~~l~HPntieYkgCyLre~TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK-----WQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHH-----HHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence            334567899999999999985  5899999998766554443     467899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      |||||| -|+-.|++.- -.+++.+-++..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|...   .
T Consensus       103 LVMEYC-lGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---~  177 (948)
T KOG0577|consen  103 LVMEYC-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---A  177 (948)
T ss_pred             HHHHHH-hccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---C
Confidence            999999 5688888765 3467889999999999999999999999999999999999999999999999998543   2


Q ss_pred             cCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          339 ALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       339 ~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      .....+||++|||||++.   .+.|+-++||||||++..||...++|+..++.+..++-+............++..|++|
T Consensus       178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F  257 (948)
T KOG0577|consen  178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF  257 (948)
T ss_pred             chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence            345678999999999984   46799999999999999999999999999999998888877665555567899999999


Q ss_pred             HHHHhhhCCCCCCCHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIV  434 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil  434 (488)
                      +..||++-|.+||+..+++
T Consensus       258 vd~CLqKipqeRptse~ll  276 (948)
T KOG0577|consen  258 VDSCLQKIPQERPTSEELL  276 (948)
T ss_pred             HHHHHhhCcccCCcHHHHh
Confidence            9999999999999988776

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4e-39  Score=320.91  Aligned_cols=254  Identities=30%  Similarity=0.543  Sum_probs=206.4

Q ss_pred             ccceeccceeeeeccEEEEEEEECC------------------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYKD------------------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL  239 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~~------------------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l  239 (488)
                      .++|.+.+.||+|+||.||++.+.+                  ..||||++......       ...++|.+|+.+++.+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~~~E~~~l~~l   76 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK-------NARNDFLKEIKIMSRL   76 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH-------HHHHHHHHHHHHHHhC
Confidence            3568899999999999999986432                  36899998743221       2246788999999999


Q ss_pred             CCCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Q 011359          240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH---------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDL  310 (488)
Q Consensus       240 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDI  310 (488)
                      +|+||+++++++......++||||+.+++|.+++.....         ..+++..++.++.||+.||+|||+.|++||||
T Consensus        77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl  156 (296)
T cd05095          77 KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL  156 (296)
T ss_pred             CCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence            999999999999999999999999999999999986421         24677889999999999999999999999999


Q ss_pred             CCCeEEEcCCCcEEEeeecccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh--CCCCCCC
Q 011359          311 KPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA--GTIPYEE  385 (488)
Q Consensus       311 kp~NILl~~~~~vkl~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt--G~~Pf~~  385 (488)
                      ||+|||++.++.++|+|||++........   .....++..|++||......++.++|||||||++|||++  |..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999999999864322111   112234578999999888889999999999999999998  7889987


Q ss_pred             CCHHHHHHHHHh------ccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          386 MNPIQAAFAVVN------KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       386 ~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      ....+.......      .......+..++..+.+||.+||+.+|++||++.+|++.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            765554332211      11122345678899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.8e-39  Score=327.87  Aligned_cols=252  Identities=21%  Similarity=0.323  Sum_probs=207.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||++.+.  ++.||+|++....     .........+..|+.++..++|+||+++++++..+..
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-----MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH-----HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence            36788999999999999999986  5789999986321     1112223457889999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||+.+|+|.+++.+. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999999999763 34688999999999999999999999999999999999999999999999999854322


Q ss_pred             cCc--CCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC---C
Q 011359          337 CDA--LSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP---G  406 (488)
Q Consensus       337 ~~~--~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~  406 (488)
                      ...  .....||..|+|||++.     ...++.++|||||||++|||++|..||...+..+....+.....+..++   .
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  234 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT  234 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccc
Confidence            211  22346899999999986     3457899999999999999999999999988877777766554333333   4


Q ss_pred             CCcHHHHHHHHHHhhhCCCC--CCCHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDK--RPEFWHIVKV  436 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~--RPs~~eil~~  436 (488)
                      .++.++.+||.+||..++++  |+++.++++.
T Consensus       235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            67899999999999765544  6788888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.6e-39  Score=317.89  Aligned_cols=253  Identities=28%  Similarity=0.500  Sum_probs=203.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .+|.+.+.||+|+||.||++.+.      ++.||||.+.....        ...+.|.+|++++++++|+||+++++++.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   75 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--------EHLRDFEREIEILKSLQHDNIVKYKGVCY   75 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--------HHHHHHHHHHHHHHhCCCCCeeEEEEEEc
Confidence            46778899999999999999752      57899999874321        12456889999999999999999999874


Q ss_pred             c--CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          253 K--PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       253 ~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      .  ...+++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||+
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          76 SAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             cCCCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcc
Confidence            3  34688999999999999999763 34588999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc----CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---------------HH
Q 011359          331 ACEEVYCDA----LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI---------------QA  391 (488)
Q Consensus       331 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~---------------~~  391 (488)
                      +........    .....++..|+|||++.+..++.++|||||||++|||++|..++......               ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence            864322111    11122345699999998888999999999999999999987665432211               01


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ....+........+..++..+.+||.+||..+|++||++.+|++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1122333344455677899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.9e-39  Score=316.72  Aligned_cols=255  Identities=25%  Similarity=0.537  Sum_probs=213.9

Q ss_pred             cccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ..++|.+...||.|+||.||+|+..       .+.||+|.+......       ...+.+.+|++++++++|+||+++++
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~   75 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-------NLQSEFRRELDMFRKLSHKNVVRLLG   75 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-------HHHHHHHHHHHHHHhcCCcceeeeEE
Confidence            3467888899999999999999864       357999988643221       12456889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEH-------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH  322 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~  322 (488)
                      ++......++||||+++|+|.+++.....       ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          76 LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             EECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc
Confidence            99998999999999999999999986442       25899999999999999999999999999999999999999999


Q ss_pred             EEEeeeccccccccc--CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 011359          323 LKIADFGIACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKN  399 (488)
Q Consensus       323 vkl~DFgla~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~  399 (488)
                      ++|+|||++......  .......++..|+|||.+.+..++.++||||||+++|+|++ |..||................
T Consensus       156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~  235 (275)
T cd05046         156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK  235 (275)
T ss_pred             EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence            999999987532211  11223345778999999988888999999999999999998 889998877766655555455


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          400 LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       400 ~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      .....+..++..+.++|.+||+.+|++||++.++++.|.
T Consensus       236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            445556778999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-39  Score=315.37  Aligned_cols=257  Identities=26%  Similarity=0.538  Sum_probs=214.6

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~----~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      +...+|.+++.||+|+||.||+|.+.  ++    .||+|++.....       ......+.+|+.++++++|+||+++++
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~   76 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-------PKANKEILDEAYVMASVDHPHVVRLLG   76 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            34567889999999999999999874  32    589998865432       122456889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++.. ...++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||
T Consensus        77 ~~~~-~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg  154 (279)
T cd05057          77 ICLS-SQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFG  154 (279)
T ss_pred             EEec-CceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCc
Confidence            9987 7788999999999999999863 3458999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          330 IACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       330 la~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      ++........   .....++..|+|||.+....++.++|+||||+++||+++ |..||......+....+ ........+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~  233 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL-EKGERLPQP  233 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hCCCCCCCC
Confidence            9854332111   111223567999999988889999999999999999998 99999988776554443 344445566


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ..++..+.+++.+||..+|.+||++.++++.|+++..
T Consensus       234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         234 PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            7788999999999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.9e-39  Score=332.87  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=200.5

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC--
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP--  255 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--  255 (488)
                      +|.+++.||+|+||.||++.+.  ++.||||.+.......      ...+.+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL------VSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch------HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            3567889999999999999974  7899999986432211      11356889999999999999999999998776  


Q ss_pred             ---eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          256 ---VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       256 ---~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                         .+|+||||+. ++|.+++..  ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecccccee
Confidence               7899999995 678887764  4578999999999999999999999999999999999999999999999999986


Q ss_pred             ccccc--CcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Q 011359          333 EEVYC--DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN------------  397 (488)
Q Consensus       333 ~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~------------  397 (488)
                      .....  .......++..|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+..            
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            43222  122344678999999999764 579999999999999999999999988776544333221            


Q ss_pred             -----------ccCCC-------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          398 -----------KNLRP-------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       398 -----------~~~~~-------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                 ....+       ......+.++.+||.+||+.||++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                       01111       123456789999999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=320.92  Aligned_cols=253  Identities=26%  Similarity=0.363  Sum_probs=206.7

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-----  253 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----  253 (488)
                      |...+.||.|+||.|..+.++  |+.||||.+..+-..      .-..+...+|+.+|++++|+||+.+++++..     
T Consensus        24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~------~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFEN------QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhc------hHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            444688999999999999986  789999998732211      1124667899999999999999999998865     


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      -..+|+|+|+| +.+|...++.  +..++.+.+..+++||++||.|+|+.||+||||||.|+|++.+..+||+|||+|+.
T Consensus        98 f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence            34689999999 6799999986  34599999999999999999999999999999999999999999999999999976


Q ss_pred             ccc---cCcCCCCCCCcccCChhhhh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Q 011359          334 EVY---CDALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN------------  397 (488)
Q Consensus       334 ~~~---~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~------------  397 (488)
                      ...   ....+..+.|.+|.|||++. ...|+.+.||||+|||+.||++|+.-|.+.+....+..++.            
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            542   44456777899999999884 56899999999999999999999999998776544333221            


Q ss_pred             ------------ccCCCCC-----CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH--HHHHHHH
Q 011359          398 ------------KNLRPAI-----PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK--VLEQFET  442 (488)
Q Consensus       398 ------------~~~~~~~-----~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~--~Le~~~~  442 (488)
                                  ....+..     ...+++...+|+.+||..||.+|+|++|.++  -|..+..
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence                        1111111     1467889999999999999999999999986  3555444

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=313.47  Aligned_cols=248  Identities=25%  Similarity=0.462  Sum_probs=210.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||.|+||.||+|.+.  ++.+|+|++......        ..+.+.+|+.++++++|+||+++++++.....
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--------DFEIIQQEISMLKECRHPNIVAYFGSYLRRDK   74 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--------hHHHHHHHHHHHHhCCCCChhceEEEEEeCCE
Confidence            56888999999999999999975  578999999864332        14678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      ++++|||+.+++|.+++... ...+++..+..++.|++.||+|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            99999999999999998763 25688999999999999999999999999999999999999999999999998854332


Q ss_pred             cC-cCCCCCCCcccCChhhhhcC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---CCCCCCc
Q 011359          337 CD-ALSDDPGTYRWMAPEMIKHK---SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP---AIPGDCP  409 (488)
Q Consensus       337 ~~-~~~~~~gt~~y~aPE~l~~~---~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~  409 (488)
                      .. ......++..|+|||.+...   .++.++|+||||+++|+|++|..||......+...........+   ..+..++
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS  233 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence            21 22344688899999999766   78999999999999999999999999887766655544443222   1234567


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .++.++|.+||..+|.+||++.+|+.
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         234 PVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            88999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-39  Score=318.47  Aligned_cols=252  Identities=26%  Similarity=0.413  Sum_probs=210.9

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeeEeeeeecC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKKP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~  254 (488)
                      +..|...++||+|+||+||+|+..  |+.||+|.++....++.      ......+|+.+|+.|+|+| |+.+++++...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG------~P~taiREisllk~L~~~~~iv~L~dv~~~~   83 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG------VPSTAIREISLLKRLSHANHIVRLHDVIHTS   83 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC------CCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence            456777888999999999999975  78999999998765422      2344569999999999999 99999999877


Q ss_pred             C------eeeEEEeecCCCCHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          255 P------VYCVITEYLSEGSLRAYLHKLEH--KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       255 ~------~~~lV~E~~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      .      .+++|+||+ .-+|..++.....  ..++...+..+++||+.||+|||++||+||||||+||||+.+|.+||+
T Consensus        84 ~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   84 NNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             ccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeee
Confidence            6      899999999 4599999987543  367778999999999999999999999999999999999999999999


Q ss_pred             eeccccccc-ccCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----
Q 011359          327 DFGIACEEV-YCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-----  399 (488)
Q Consensus       327 DFgla~~~~-~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-----  399 (488)
                      |||+|+... .....+...+|.+|.|||++.+. .|+...||||+|||++||+++..-|.+....+.+..+...-     
T Consensus       163 DFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  163 DFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE  242 (323)
T ss_pred             ccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence            999997554 33446778899999999999776 79999999999999999999999999998877776665411     


Q ss_pred             -----------CCCCCC------------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          400 -----------LRPAIP------------GDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       400 -----------~~~~~~------------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                                 ....++            ....+...+++.+||+.+|.+|.++..++..
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                       000111            1122478899999999999999999988874

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.5e-39  Score=311.56  Aligned_cols=249  Identities=23%  Similarity=0.370  Sum_probs=212.3

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||++...  ++.+|||.+.......      ...+.+.+|++++++++|+||+++++.+..+..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK------DERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc------HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            4778889999999999999875  6889999997543322      1246788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-CcEEEeeecccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIACEEVY  336 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-~~vkl~DFgla~~~~~  336 (488)
                      ++||||+++++|.+++.......+++..++.++.+++.||+|||++|++||||+|+||+++.+ +.++|+|||++.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            999999999999999987655668999999999999999999999999999999999999865 4689999999865443


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      ........++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.... ...++..++..+.++|
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li  233 (256)
T cd08220         155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-FAPISDRYSPDLRQLI  233 (256)
T ss_pred             CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC-CCCCCCCcCHHHHHHH
Confidence            333334568889999999988888999999999999999999999998877665554444433 3446677899999999


Q ss_pred             HHHhhhCCCCCCCHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||..+|++||++.+++.
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHHccCChhhCCCHHHHhh
Confidence            9999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.8e-39  Score=314.93  Aligned_cols=245  Identities=24%  Similarity=0.471  Sum_probs=196.8

Q ss_pred             eeeeeccEEEEEEEECC----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEE
Q 011359          186 RFAHGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~~----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      .||+|+||.||+|.+.+    ..+|+|.++......       ....+.+|+.++++++||||+++++++.+...+++||
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   74 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ-------EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVM   74 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEE
Confidence            57999999999998753    468999887543221       1346889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          262 EYLSEGSLRAYLHKLE---HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      ||+++|+|.+++....   ....++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9999999999997642   2245677888999999999999999999999999999999999999999999985432211


Q ss_pred             ---cCCCCCCCcccCChhhhhcC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-C---CCC
Q 011359          339 ---ALSDDPGTYRWMAPEMIKHK-------SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKN-L---RPA  403 (488)
Q Consensus       339 ---~~~~~~gt~~y~aPE~l~~~-------~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~-~---~~~  403 (488)
                         ......++..|+|||++.+.       .++.++|+||||+++|||++ |..||......+.....+... .   .+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence               11233467889999998632       35789999999999999996 999998877665544333221 1   122


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      +....+..+.+++.+|| .+|++||++.+|+..|+
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            33456789999999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.8e-39  Score=316.37  Aligned_cols=248  Identities=22%  Similarity=0.423  Sum_probs=206.1

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+.+.||+|+||.||+|.+.  ++.||+|+++......        ...+.+|+.+++.++||||+++++.+....
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~   79 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED--------FAVVQQEIIMMKDCKHSNIVAYFGSYLRRD   79 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH--------HHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence            357888899999999999999874  6899999997543211        245678999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+++++|.+++..  .+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            99999999999999999876  3578999999999999999999999999999999999999999999999999985432


Q ss_pred             cc-CcCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC---CCCC
Q 011359          336 YC-DALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI---PGDC  408 (488)
Q Consensus       336 ~~-~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~  408 (488)
                      .. .......|+..|+|||++.   ...++.++|+|||||++|+|++|..||....+.............+..   ...+
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW  237 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence            21 1223446899999999984   456889999999999999999999999876655544444333332221   1256


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +..+.++|.+||..+|++||++.++++
T Consensus       238 ~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         238 SNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            789999999999999999999998875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-39  Score=322.03  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=211.1

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||+|...  ++.||||.+.......     ....+.+..|++++..++|+||+++++.+......
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-----RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-----HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEE
Confidence            5778899999999999999985  5899999998654322     11246788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999999999998755567899999999999999999999999999999999999999999999999987432211


Q ss_pred             C------------------------------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 011359          338 D------------------------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN  387 (488)
Q Consensus       338 ~------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~  387 (488)
                      .                              ......|+..|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1                              0112357889999999998889999999999999999999999999888


Q ss_pred             HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCC----HHHHHH
Q 011359          388 PIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE----FWHIVK  435 (488)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs----~~eil~  435 (488)
                      .......+............++..+.++|.+||..+|++||+    +.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            766666665544433333347899999999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-39  Score=315.79  Aligned_cols=245  Identities=28%  Similarity=0.519  Sum_probs=209.8

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||.|++|.||+|.+.  ++.||+|++.......       ....+.+|+.+++.++|+||+++++++..+..+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-------EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL   74 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch-------HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence            5778899999999999999985  6899999997543211       134578999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++|+||+.+++|.+++..   ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        75 ~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EEEEEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999999999976   37899999999999999999999999999999999999999999999999998654332


Q ss_pred             -CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC-CcHHHHHH
Q 011359          338 -DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD-CPPAMAAL  415 (488)
Q Consensus       338 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~L  415 (488)
                       .......++..|+|||.+.+..++.++||||||+++|+|++|..||...++.+....+.. ...+..+.. ++..+.++
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  230 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSLEGNKFSKPFKDF  230 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCCcccccCHHHHHH
Confidence             223345688899999999888899999999999999999999999988776555444333 334444444 88999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||..+|++||++.++++
T Consensus       231 l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         231 VSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             HHHHhhCChhhCcCHHHHhh
Confidence            99999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.2e-39  Score=319.51  Aligned_cols=246  Identities=24%  Similarity=0.482  Sum_probs=208.1

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      .+|.+.+.||+|+||.||+|++.  ++.||||.+.......        ...+.+|+.+++.+.|+||+++++.+..+..
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~   91 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--------HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence            46888899999999999999874  6899999987544322        2457799999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .++||||+.+++|.+++..   ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        92 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             EEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999999999865   4578899999999999999999999999999999999999999999999998854322


Q ss_pred             cC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHH
Q 011359          337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RPAIPGDCPPAMAA  414 (488)
Q Consensus       337 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  414 (488)
                      .. ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+............ ....+..++..+.+
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  248 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD  248 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence            11 12334688999999999888889999999999999999999999988776554443332221 22235567889999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +|.+||..+|++||++.++++
T Consensus       249 li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         249 FLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HHHHHCcCCcccCcCHHHHhh
Confidence            999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.7e-38  Score=335.51  Aligned_cols=245  Identities=19%  Similarity=0.339  Sum_probs=192.1

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC------CCCeeeEe
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH------NPNVIKFV  248 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~  248 (488)
                      ..++|.+.+.||+|+||+||+|.+.  ++.||||+++....         ....+..|+.+++.+.      |.++++++
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~  197 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---------YTRDAKIEIQFMEKVRQADPADRFPLMKIQ  197 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---------hHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence            4478999999999999999999875  67899999964211         1233445666666654      45689999


Q ss_pred             eeeecC-CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCC-----
Q 011359          249 AACKKP-PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEF-----  321 (488)
Q Consensus       249 ~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~-----  321 (488)
                      +++..+ ..+|+|||++ |++|.+++.+  ...+++..+..|+.||+.||+|||+ .|||||||||+|||++.++     
T Consensus       198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        198 RYFQNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             EEEEcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence            988754 5789999998 7889998876  3578999999999999999999998 5999999999999998765     


Q ss_pred             -----------cEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Q 011359          322 -----------HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ  390 (488)
Q Consensus       322 -----------~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~  390 (488)
                                 .+||+|||++....  .......||..|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                       49999999875432  22345679999999999999999999999999999999999999998877654


Q ss_pred             HHHHHHhcc-------------------------CCCCCC---------------CCCcHHHHHHHHHHhhhCCCCCCCH
Q 011359          391 AAFAVVNKN-------------------------LRPAIP---------------GDCPPAMAALIEQCWSLQPDKRPEF  430 (488)
Q Consensus       391 ~~~~~~~~~-------------------------~~~~~~---------------~~~~~~l~~Li~~cL~~dp~~RPs~  430 (488)
                      ....+....                         +.+...               ......+.+||.+||..||++||++
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            433221100                         000000               0113567899999999999999999


Q ss_pred             HHHHH
Q 011359          431 WHIVK  435 (488)
Q Consensus       431 ~eil~  435 (488)
                      .|+++
T Consensus       433 ~e~L~  437 (467)
T PTZ00284        433 RQMTT  437 (467)
T ss_pred             HHHhc
Confidence            99986

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.4e-39  Score=311.85  Aligned_cols=248  Identities=29%  Similarity=0.565  Sum_probs=201.8

Q ss_pred             eeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee-cCCeeeE
Q 011359          186 RFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYCV  259 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~l  259 (488)
                      .||+|+||.||+|.+.     ...||||.+......       ...+.+.+|+.+++.++||||+++++++. .+...++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l   74 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL-------EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV   74 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCH-------HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence            5799999999999863     246999987532211       12456889999999999999999999775 4556889


Q ss_pred             EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc--
Q 011359          260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC--  337 (488)
Q Consensus       260 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~--  337 (488)
                      ||||+.+++|.+++... ...+.+..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||++......  
T Consensus        75 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          75 VLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            99999999999999763 344677788999999999999999999999999999999999999999999998543211  


Q ss_pred             ---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          338 ---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       338 ---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                         .......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+ .....+..+..++..+.
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  232 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLY  232 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCCCCcCCHHHH
Confidence               11123345678999999988889999999999999999999 56778777765554443 33334455667889999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          414 ALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +++.+||..+|++||++.++++.|+++..
T Consensus       233 ~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         233 EVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            99999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5e-39  Score=319.39  Aligned_cols=253  Identities=24%  Similarity=0.425  Sum_probs=209.0

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      +....+.|++.++||+|+||.||+|...  ++.||+|++.....        ...+.+.+|+.+++.++|+||+++++.+
T Consensus         7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (292)
T cd06644           7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--------EELEDYMVEIEILATCNHPYIVKLLGAF   78 (292)
T ss_pred             ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH--------HHHHHHHHHHHHHHhCCCCcEeeeEEEE
Confidence            3334466899999999999999999985  68899999875321        1245688999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ..+..+++||||+++++|..++.+. ...+++..+..++.|++.+|+|||+.||+||||||+||+++.++.++|+|||++
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~  157 (292)
T cd06644          79 YWDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS  157 (292)
T ss_pred             EeCCeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccc
Confidence            9999999999999999999888653 356899999999999999999999999999999999999999999999999987


Q ss_pred             cccccc-CcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCC
Q 011359          332 CEEVYC-DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RPAI  404 (488)
Q Consensus       332 ~~~~~~-~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~  404 (488)
                      ...... .......++..|+|||++.     ...++.++|||||||++|+|++|..||...+..+....+..... ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T cd06644         158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ  237 (292)
T ss_pred             eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCC
Confidence            542211 1123345788999999984     34578899999999999999999999988776655544433221 2234


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +..++..+.++|.+||..+|++||++.++++
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            5678889999999999999999999999876

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8e-39  Score=313.70  Aligned_cols=245  Identities=25%  Similarity=0.479  Sum_probs=197.1

Q ss_pred             eeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEE
Q 011359          186 RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      +||+|+||.||+|...    ...+|+|.+......       .....|.+|+.+++.++|+||+++++.+.....+++||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~   74 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP-------DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL   74 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh-------HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence            5799999999999753    246788877543221       12456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          262 EYLSEGSLRAYLHKLEH---KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      ||+++|+|.+++.....   ...++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence            99999999999987432   234677889999999999999999999999999999999999999999999985432211


Q ss_pred             ---cCCCCCCCcccCChhhhhc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC----CCC
Q 011359          339 ---ALSDDPGTYRWMAPEMIKH-------KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL----RPA  403 (488)
Q Consensus       339 ---~~~~~~gt~~y~aPE~l~~-------~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~----~~~  403 (488)
                         ......++..|+|||++..       ..++.++|||||||++|||++ |..||......+..........    .+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence               1123345678999999753       356889999999999999999 8899988877665555444321    233


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      .+..++..+.+++..|| .||++||++.+|++.|.
T Consensus       235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            45578899999999999 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-38  Score=312.02  Aligned_cols=251  Identities=24%  Similarity=0.439  Sum_probs=208.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      .+|.+++.||+|+||.||.|.+.  ++.||||.+.........   ....+.+.+|+.++++++|+||+++++++.+.  
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET---SKEVNALECEIQLLKNLLHERIVQYYGCLRDPME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCccc---HHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence            46788999999999999999875  688999998754322111   12245788999999999999999999988663  


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+++||||+++++|.+++..  ...+++..++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            467899999999999999976  345788899999999999999999999999999999999999999999999988543


Q ss_pred             cc----cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          335 VY----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       335 ~~----~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      ..    ........++..|+|||.+.+..++.++|||||||++|+|++|..||..................+..+...+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD  236 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence            21    11122345888999999998888899999999999999999999999887766665555544445666777888


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.++|.+||. +|++||++.+|++
T Consensus       237 ~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         237 HCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            99999999994 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.9e-39  Score=317.56  Aligned_cols=253  Identities=27%  Similarity=0.484  Sum_probs=205.2

Q ss_pred             ceeccceeeeeccEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      -|.+.+.||+|+||.||.+.+.      +..||||.++.....       .....+.+|+.++++++|+||+++++++..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-------NHIADLKKEIEILRNLYHENIVKYKGICTE   77 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-------HHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            3667889999999999999752      578999998744321       124568899999999999999999999877


Q ss_pred             C--CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          254 P--PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       254 ~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .  ..+++||||++|++|.+++.+. ...+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++
T Consensus        78 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          78 DGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             CCCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccc
Confidence            5  5688999999999999999763 346899999999999999999999999999999999999999999999999998


Q ss_pred             ccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHH
Q 011359          332 CEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN--------------PIQAAF  393 (488)
Q Consensus       332 ~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~--------------~~~~~~  393 (488)
                      .......    ......++..|+|||.+.+..++.++||||||+++|+|+++..|+....              ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            6433211    1123446778999999988889999999999999999999776543210              111122


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .......+...+..++..+.+||.+||+.+|++||++.++++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            23333444455677899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.6e-39  Score=315.67  Aligned_cols=249  Identities=26%  Similarity=0.370  Sum_probs=201.8

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|++|.||+|...  ++.||||++........      ..+.+.+|+.++++++|+||+++++++..+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG------VPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC------chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            4678899999999999999985  68999999976433221      135677899999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      ++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            99999996 68988887643 35689999999999999999999999999999999999999999999999999854322


Q ss_pred             c-CcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------------
Q 011359          337 C-DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN---------------  399 (488)
Q Consensus       337 ~-~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~---------------  399 (488)
                      . .......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.........+....               
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence            1 122334578899999998654 57899999999999999999999998766544333322110               


Q ss_pred             ------------CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 ------------LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 ------------~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                  ........++.++.++|.+||+.||++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                        000112357889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.9e-39  Score=309.85  Aligned_cols=248  Identities=36%  Similarity=0.694  Sum_probs=210.5

Q ss_pred             eccceeeeeccEEEEEEEECC------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          182 FLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~~~------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .+++.||.|+||.||++.+.+      ..||+|++.......       ..+.+..|+.++..++|+||+++++++....
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-------QIEEFLREARIMRKLDHPNIVKLLGVCTEEE   74 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-------HHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            467889999999999999874      779999996543321       2467889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus        75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            99999999999999999987443338999999999999999999999999999999999999999999999999985443


Q ss_pred             ccCcCC--CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          336 YCDALS--DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       336 ~~~~~~--~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      ......  ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.. ......+..++.++
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  233 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCPPEI  233 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHH
Confidence            321111  2336789999999988889999999999999999998 8899988776555544443 34555667789999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~~L  437 (488)
                      .+++.+||..+|++||++.++++.|
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      234 YKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHHHCcCChhhCcCHHHHHhhC
Confidence            9999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.7e-39  Score=316.94  Aligned_cols=248  Identities=25%  Similarity=0.427  Sum_probs=205.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeec--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK--  253 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--  253 (488)
                      +.|.+.+.||.|+||.||+|.+.  ++.||+|++.....         ...++..|+.++.++ +|+||+++++++..  
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---------EEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH---------HHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            56778899999999999999985  68999999865321         134577899999998 69999999999853  


Q ss_pred             ----CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          254 ----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       254 ----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                          ...++++|||+.+|+|.+++.......+++..++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg  166 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG  166 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence                4578999999999999999987666678898999999999999999999999999999999999999999999999


Q ss_pred             ccccccc-cCcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          330 IACEEVY-CDALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       330 la~~~~~-~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      ++..... ........|+..|+|||.+.     ...++.++|||||||++|+|++|..||....+......+........
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  246 (282)
T cd06636         167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL  246 (282)
T ss_pred             chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence            9854321 12223456889999999985     34578899999999999999999999988776555544433333333


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ....++..+.+||.+||+.+|.+||++.+|++
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            44568999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1e-38  Score=310.12  Aligned_cols=249  Identities=20%  Similarity=0.376  Sum_probs=213.0

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||.+...  |+.||||.+.......      ...+++.+|+.++++++|+||+++++++......
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP------KEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh------HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            4778899999999999999874  6899999997543221      1245788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++|+||+.+++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            99999999999999998755556889999999999999999999999999999999999999999999999988543221


Q ss_pred             C-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          338 D-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       338 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      . ......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+... ..+..+..++..+.++|
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  233 (256)
T cd08218         155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-SYPPVSSHYSYDLRNLV  233 (256)
T ss_pred             hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC-CCCCCcccCCHHHHHHH
Confidence            1 112345788899999998888899999999999999999999999887776665555443 34456778899999999


Q ss_pred             HHHhhhCCCCCCCHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||+.+|++||++.++++
T Consensus       234 ~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         234 SQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HHHhhCChhhCcCHHHHhh
Confidence            9999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.7e-39  Score=323.79  Aligned_cols=247  Identities=20%  Similarity=0.379  Sum_probs=197.9

Q ss_pred             ccceeeee--ccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          183 LGLRFAHG--AHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       183 i~~~lG~G--~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      +++.||+|  +|++||++...  |+.||||.+.......      .....+.+|+.+++.++||||++++++|..+..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN------EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            45678888  78999999875  6899999997543321      12456778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-  337 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-  337 (488)
                      +||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+...... 
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            9999999999999997654556899999999999999999999999999999999999999999999999865322110 


Q ss_pred             -------CcCCCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Q 011359          338 -------DALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-------  401 (488)
Q Consensus       338 -------~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-------  401 (488)
                             .......++..|+|||++.+  ..++.++|||||||++|+|++|..||......+...........       
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT  235 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence                   01122346778999999975  46899999999999999999999999876654433332221110       


Q ss_pred             -------------------------------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 -------------------------------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 -------------------------------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                                           ......+++.+.+||.+||+.||++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                                                 0011234678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.4e-39  Score=316.77  Aligned_cols=246  Identities=24%  Similarity=0.437  Sum_probs=205.3

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.+.+.||+|+||.||+|.+.  +..+|+|.+.....        ...+.+.+|+++++.++|+||+++++++......+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   78 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--------EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   78 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--------HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEE
Confidence            567788999999999999986  56788888854321        11456889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-  337 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-  337 (488)
                      +|+||+.+++|..++... ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...... 
T Consensus        79 ~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          79 ILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            999999999999988752 356899999999999999999999999999999999999999999999999998543221 


Q ss_pred             CcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCcHH
Q 011359          338 DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-LRPAIPGDCPPA  411 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  411 (488)
                      .......++..|+|||++.     +..++.++|||||||++|+|++|..||...+..+....+.... .....+..++..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE  237 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHH
Confidence            1223446889999999984     3457889999999999999999999999887766555554332 123345678899


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.+|++||++.++++
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         238 FKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999998875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-38  Score=311.61  Aligned_cols=250  Identities=24%  Similarity=0.446  Sum_probs=209.4

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CC
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--PP  255 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~  255 (488)
                      +|..++.||+|+||.||+|...  +..||+|++........   ..+....+.+|+.++++++|+||+++++++..  ..
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE---TSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCch---hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCC
Confidence            4678889999999999999874  68999999875543221   12234568899999999999999999998865  35


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++++||+++++|.+++..  ...+++..++.++.|++.||+|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            78899999999999999976  3458889999999999999999999999999999999999999999999999985432


Q ss_pred             c----cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          336 Y----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       336 ~----~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      .    ........++..|+|||.+.+..++.++|||||||++|+|++|..||......+...........+.++..++..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH  237 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence            1    111223457889999999988889999999999999999999999999887766666555555566777788899


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.++| +||..+|++||++.+|++
T Consensus       238 ~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         238 ARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHH-HHhcCChhhCcCHHHHhc
Confidence            99999 688899999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.9e-39  Score=352.58  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=209.9

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||.||+|.+.  ++.||||++.......     ....+.|.+|+.++++++||||+++++++.++.
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~-----e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN-----PLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC-----HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            367899999999999999999985  6899999997533221     123567899999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          256 VYCVITEYLSEGSLRAYLHKLE---------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      ..++||||++||+|.+++....         ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLi  155 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL  155 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEE
Confidence            9999999999999999997531         1234567788999999999999999999999999999999999999999


Q ss_pred             eeccccccccc-------------------CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 011359          327 DFGIACEEVYC-------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN  387 (488)
Q Consensus       327 DFgla~~~~~~-------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~  387 (488)
                      |||++......                   .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~  235 (932)
T PRK13184        156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK  235 (932)
T ss_pred             ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence            99998543110                   00112458999999999998899999999999999999999999998755


Q ss_pred             HHHHHHHHHh-ccCCCCCCCCCcHHHHHHHHHHhhhCCCCCC-CHHHHHHHHHHHHHh
Q 011359          388 PIQAAFAVVN-KNLRPAIPGDCPPAMAALIEQCWSLQPDKRP-EFWHIVKVLEQFETS  443 (488)
Q Consensus       388 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RP-s~~eil~~Le~~~~~  443 (488)
                      .......... ..........+++.+.+++.+||+.||++|+ +++++++.|+.+...
T Consensus       236 ~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        236 GRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            4433222111 1111111246789999999999999999996 567777778877553

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-38  Score=315.79  Aligned_cols=246  Identities=26%  Similarity=0.398  Sum_probs=210.1

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||++.+.  ++.||||++.....     ...+..+.+.+|++++++++||||+++++++..+..
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-----VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence            36788899999999999999985  68999999974321     112235678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||+++++|.+++...  ..+++..+..++.||+.||+|||+.||+||||+|.||+++.++.++|+|||++.....
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            99999999999999999873  5789999999999999999999999999999999999999999999999999865433


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++|..||......+....+...  ...++..++..++++|
T Consensus       154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li  229 (290)
T cd05580         154 R--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KVRFPSFFSPDAKDLI  229 (290)
T ss_pred             C--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CccCCccCCHHHHHHH
Confidence            2  33456889999999998888899999999999999999999999887765555554433  3456777899999999


Q ss_pred             HHHhhhCCCCCC-----CHHHHHH
Q 011359          417 EQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RP-----s~~eil~  435 (488)
                      .+||..+|.+|+     ++.++++
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         230 RNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             HHHccCCHHHccCcccCCHHHHHc
Confidence            999999999998     5555553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.7e-38  Score=316.92  Aligned_cols=246  Identities=27%  Similarity=0.508  Sum_probs=209.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      .+|.+.+.||.|+||.||+|.+.  ++.||||.+.......        .+.+.+|+.+++.++|+||+++++++..+..
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK--------KELIINEILVMKELKNPNIVNFLDSFLVGDE   90 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch--------HHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence            56889999999999999999864  7899999997543221        3457789999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++|+||+.+++|..++..   ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus        91 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          91 LFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            9999999999999999875   4689999999999999999999999999999999999999999999999998854322


Q ss_pred             cC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHH
Q 011359          337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RPAIPGDCPPAMAA  414 (488)
Q Consensus       337 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  414 (488)
                      .. ......++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+..... ....+..++..+.+
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD  247 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence            21 12334688899999999888899999999999999999999999998877665544433221 22345678899999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +|.+||..+|++||++.++++
T Consensus       248 li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         248 FLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHHHhhcChhhCCCHHHHhh
Confidence            999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-40  Score=332.13  Aligned_cols=259  Identities=30%  Similarity=0.525  Sum_probs=220.4

Q ss_pred             cccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      ++..+.+.++++||+|.||.|.++...+ ..||||+++.....       ...++|.+|+++|.+|+||||+.++|+|..
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~-------~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK-------NARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch-------hHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            4566788999999999999999999887 89999999854322       226889999999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      +.-+++|+||+++|+|.+|+.+.....+.-...+.|+.||+.||+||.+.++|||||.+.|+|+|.++++||+|||+++.
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccc
Confidence            99999999999999999999986444455667788999999999999999999999999999999999999999999975


Q ss_pred             ccccCcC---CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHH---Hhcc---CCC
Q 011359          334 EVYCDAL---SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV--AGTIPYEEMNPIQAAFAV---VNKN---LRP  402 (488)
Q Consensus       334 ~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ell--tG~~Pf~~~~~~~~~~~~---~~~~---~~~  402 (488)
                      ...+...   ...+...+|||+|.+..++++.++|||+||+++||++  |...||..+...+.....   ....   .-+
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL  766 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence            4333222   2234568999999999999999999999999999985  588999998877654332   2221   224


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ..|.-||..+.++|..||..+.++||+|+++...|.+.
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            56788999999999999999999999999999988754

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.7e-39  Score=315.73  Aligned_cols=242  Identities=28%  Similarity=0.472  Sum_probs=199.5

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||+|.+.  ++.||||++......       ...+.+.+|+.++.+++||||+++++++......
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV-------ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRI   74 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh-------HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEE
Confidence            5677889999999999999874  688999999754221       1245688999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+++++|..+.      .+++..+..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++..... 
T Consensus        75 ~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~-  147 (279)
T cd06619          75 SICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-  147 (279)
T ss_pred             EEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-
Confidence            9999999999996542      467888999999999999999999999999999999999999999999999854332 


Q ss_pred             CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCCCCCCCCCcH
Q 011359          338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI-------QAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      .......|+..|+|||.+.+..++.++||||||+++|+|++|..||......       .....+.............+.
T Consensus       148 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (279)
T cd06619         148 SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE  227 (279)
T ss_pred             ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCH
Confidence            2233456899999999998888999999999999999999999999753321       111222222212222345788


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.++|.+||+.+|++||++.++++
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhc
Confidence            9999999999999999999999886

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=307.84  Aligned_cols=245  Identities=33%  Similarity=0.613  Sum_probs=206.6

Q ss_pred             ceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEee
Q 011359          185 LRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY  263 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  263 (488)
                      +.||+|+||.||++.+. ++.||+|++......       .....+.+|++++++++|+||+++++++......++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence            35899999999999986 799999998754432       1246788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcC---
Q 011359          264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL---  340 (488)
Q Consensus       264 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~---  340 (488)
                      +.+++|.+++... ...+++..++.++.+++.||+|||++|++||||+|+||+++.++.++|+|||++.........   
T Consensus        74 ~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          74 VPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            9999999999763 346788999999999999999999999999999999999999999999999998543211111   


Q ss_pred             CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 011359          341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC  419 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~c  419 (488)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+ ........+..++..+.++|.+|
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~  231 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQC  231 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHHHHHHHHH
Confidence            11223567999999988889999999999999999998 89999887765544333 33345556778899999999999


Q ss_pred             hhhCCCCCCCHHHHHHHHH
Q 011359          420 WSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       420 L~~dp~~RPs~~eil~~Le  438 (488)
                      |..+|++||++.++++.|+
T Consensus       232 l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         232 WAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             hccChhhCcCHHHHHHHhh
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.7e-39  Score=314.29  Aligned_cols=245  Identities=33%  Similarity=0.613  Sum_probs=204.4

Q ss_pred             eeeeeccEEEEEEEECC--------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          186 RFAHGAHSRLYHGIYKD--------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~~--------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      .||+|+||.||+|.+.+        +.||||.+......       .....+.+|+.+++.++||||+++++++......
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD-------QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQ   74 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccch-------hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCe
Confidence            57999999999998753        57999998643211       1135688999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC-----cEEEee
Q 011359          258 CVITEYLSEGSLRAYLHKLE-----HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-----HLKIAD  327 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~-----~vkl~D  327 (488)
                      ++||||+++++|.+++....     ...+++..++.++.|++.||+|||+.+++|+||+|+||+++.++     .++|+|
T Consensus        75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999999999999997642     23478899999999999999999999999999999999999877     899999


Q ss_pred             ecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          328 FGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       328 Fgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      ||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+ .......
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~  233 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAGGRLQ  233 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcCCccC
Confidence            99985432211   1122345678999999998899999999999999999998 99999887766554433 3334455


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      .+..++..+.++|.+||..+|++||++.+|++.|+
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         234 KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            66788999999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-42  Score=323.24  Aligned_cols=244  Identities=25%  Similarity=0.457  Sum_probs=213.6

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.+.++||+|.||.||+++++  |..||||.+....+          .+++.+|+.||++++.++||++||.|.....+|
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD----------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW  104 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD----------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW  104 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch----------HHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence            347889999999999999875  89999999876443          456889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +|||||..|++.+.+.. +.+++++.++..++...++||+|||...-||||||..|||++.+|..||+|||+|......-
T Consensus       105 IVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             eehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            99999999999999876 56899999999999999999999999999999999999999999999999999996544322


Q ss_pred             -cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCcHHHHHHH
Q 011359          339 -ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-LRPAIPGDCPPAMAALI  416 (488)
Q Consensus       339 -~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~Li  416 (488)
                       ...+..||+.|||||++..-.|+.++||||||++..||..|++||.+..+...++-+-... ....-|..++.++.++|
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence             2345679999999999999999999999999999999999999999999987766543322 12234567899999999


Q ss_pred             HHHhhhCCCCCCCHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~  435 (488)
                      ++||-++|++|-++.++++
T Consensus       264 ~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhh
Confidence            9999999999999887763

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-38  Score=309.69  Aligned_cols=246  Identities=28%  Similarity=0.535  Sum_probs=208.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||.|+||.||+|.+.  ++.||+|.+.....          ..++.+|++++++++|+||+++++.+.....
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~   72 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----------LQEIIKEISILKQCDSPYIVKYYGSYFKNTD   72 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCc
Confidence            46788899999999999999986  58899999864211          4678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|+++||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++.....
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            99999999999999999753 35789999999999999999999999999999999999999999999999999864432


Q ss_pred             cC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHH
Q 011359          337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RPAIPGDCPPAMAA  414 (488)
Q Consensus       337 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  414 (488)
                      .. ......++..|+|||.+.+..++.++||||||+++|+|++|..||......+....+..... ....+..++..+.+
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (256)
T cd06612         152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFND  231 (256)
T ss_pred             CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHH
Confidence            22 22334578899999999988899999999999999999999999998776554443322211 12234567789999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +|.+||+.+|++||++.++++
T Consensus       232 ~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         232 FVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHHHHhcChhhCcCHHHHhc
Confidence            999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-39  Score=316.53  Aligned_cols=248  Identities=25%  Similarity=0.459  Sum_probs=208.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.++||.|+||.||+|.+.  +..||+|++.....        ...+.|..|+.++++++|+||+++++++..+..
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE--------EELEDFMVEIDILSECKHPNIVGLYEAYFYENK   76 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH--------HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe
Confidence            46889999999999999999985  68899999975421        113568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||+++++|.+++... ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          77 LWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            99999999999999998763 34689999999999999999999999999999999999999999999999998754322


Q ss_pred             c-CcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCc
Q 011359          337 C-DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RPAIPGDCP  409 (488)
Q Consensus       337 ~-~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~  409 (488)
                      . .......++..|+|||.+.     ...++.++|+||||+++|+|++|..||......+....+..... ....+..++
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (280)
T cd06611         156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWS  235 (280)
T ss_pred             cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCC
Confidence            1 1223345888999999985     34567899999999999999999999998877665555443321 123356788


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .++.++|.+||+.+|++||++.++++
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhc
Confidence            99999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-38  Score=311.89  Aligned_cols=254  Identities=28%  Similarity=0.524  Sum_probs=209.1

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChh--HHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDEN--ETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~--~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +|.+++.||.|+||.||+|...  ++.||||.++.......  ........+.+.+|+.++++++|+||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4678889999999999999864  68999999875432211  1122233567889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ..++||||+.+++|.+++...  ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            999999999999999999763  578899999999999999999999999999999999999999999999999985432


Q ss_pred             cc---CcCCCCCCCcccCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC----C
Q 011359          336 YC---DALSDDPGTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP----G  406 (488)
Q Consensus       336 ~~---~~~~~~~gt~~y~aPE~l~~~~--~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----~  406 (488)
                      ..   .......|+..|+|||.+....  ++.++|+||||+++|+|++|..||......+.............++    .
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM  239 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence            11   1122345788999999987654  7899999999999999999999998777666555544433333333    3


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .++..+.++|.+||..+|++||++.++++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         240 NLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            56889999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-38  Score=312.54  Aligned_cols=258  Identities=21%  Similarity=0.423  Sum_probs=213.7

Q ss_pred             eeccceeeeeccEEEEEEEECC---ccEEEEEEecCCCChhH--HHHHHHHHHHHHHHHHHHh-cCCCCeeeEeeeeecC
Q 011359          181 LFLGLRFAHGAHSRLYHGIYKD---EPVAVKIIRIPDDDENE--TLAARLEKQFNREVALLSR-LHNPNVIKFVAACKKP  254 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~~---~~vAVK~i~~~~~~~~~--~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~  254 (488)
                      |.+.+.||+|+||.||+|.+.+   +.+|||.+.........  ........++.+|+.++.+ ++|+||+++++++..+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            5677889999999999999864   78999998754322110  0112224567789998875 7899999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ...++||||+++++|.+++...  ....+++..++.++.|++.||.|||+ .|++||||+|.||+++.++.++|+|||++
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence            9999999999999999998653  34568899999999999999999996 68999999999999999999999999998


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      .............|+..|++||.+.+..++.++||||||+++|+|++|..||...........+......+.....++..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (269)
T cd08528         162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSED  241 (269)
T ss_pred             eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHH
Confidence            65443333345568899999999998889999999999999999999999998877766665555554444344467899


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      +.++|.+||+.||++||++.++..+++
T Consensus       242 l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         242 VTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=327.91  Aligned_cols=241  Identities=21%  Similarity=0.327  Sum_probs=196.4

Q ss_pred             eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeeEeeeeecCCeeeEEE
Q 011359          187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      ||+|+||+||+|.+.  ++.||||++......     .......+..|..++..+   +||||+++++++.....+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-----AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-----hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence            699999999999875  689999999642211     111233455677777665   6999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-cCcC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL  340 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-~~~~  340 (488)
                      ||+.+|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ....
T Consensus        76 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~  153 (330)
T cd05586          76 DYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT  153 (330)
T ss_pred             cCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence            99999999999875  45789999999999999999999999999999999999999999999999999854322 2223


Q ss_pred             CCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 011359          341 SDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC  419 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~c  419 (488)
                      ....||..|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.....+. ....++..+.+||.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~  232 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGL  232 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHH
Confidence            345699999999998754 47999999999999999999999999887766655554443322 1235789999999999


Q ss_pred             hhhCCCCCC----CHHHHHH
Q 011359          420 WSLQPDKRP----EFWHIVK  435 (488)
Q Consensus       420 L~~dp~~RP----s~~eil~  435 (488)
                      |..+|++||    ++.++++
T Consensus       233 L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         233 LNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cCCCHHHCCCCCCCHHHHhc
Confidence            999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.7e-38  Score=317.09  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=203.5

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      .+++|.+.++||.|+||.||+|.+.  ++.||+|.+........       ...+.+|+.+++.++|+||+++++++..+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~nI~~~~~~~~~~   76 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-------PCTAIREVSLLKDLKHANIVTLHDIIHTE   76 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-------hhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence            3567899999999999999999875  68899999975443221       23466899999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+++||||+. ++|.+++... ...+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++...
T Consensus        77 ~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          77 KSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             CeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            99999999996 5899888763 346889999999999999999999999999999999999999999999999998543


Q ss_pred             ccc-CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------------
Q 011359          335 VYC-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL------------  400 (488)
Q Consensus       335 ~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~------------  400 (488)
                      ... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+.....            
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            221 12234457889999999865 3578999999999999999999999988776544332221000            


Q ss_pred             -----C---C--------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 -----R---P--------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 -----~---~--------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                           .   +        .....++..+.+||.+||+.||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                 0   0        011356788999999999999999999999886

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=305.09  Aligned_cols=255  Identities=24%  Similarity=0.458  Sum_probs=217.9

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeE
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKF  247 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l  247 (488)
                      .+....|++++.+...||.|.-|.|++++..  |..+|||.++..+..++       .+.+...+.++...+ +|+||+.
T Consensus        84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-------~kRILmDldvv~~s~dcpyIV~c  156 (391)
T KOG0983|consen   84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-------NKRILMDLDVVLKSHDCPYIVQC  156 (391)
T ss_pred             CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-------HHHHHHhhhHHhhccCCCeeeee
Confidence            4566778888999999999999999999987  58999999986554332       467888888887776 8999999


Q ss_pred             eeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEEe
Q 011359          248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       248 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      +|+|..+...++.||.| ...+..++.. ..+++++..+-++...+++||.||.+ +||+|||+||+|||+|+.|.+|||
T Consensus       157 ~GyFi~n~dV~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlC  234 (391)
T KOG0983|consen  157 FGYFITNTDVFICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLC  234 (391)
T ss_pred             eeEEeeCchHHHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEee
Confidence            99999999999999998 4455555554 45679999999999999999999975 499999999999999999999999


Q ss_pred             eecccccccccCcCCCCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCC
Q 011359          327 DFGIACEEVYCDALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNKNLRP  402 (488)
Q Consensus       327 DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~~~~~~  402 (488)
                      |||++.........+...|.+.|||||.+.-   ..|+.++||||||++++||.||..||.+-+ ..+.+..+++ ...|
T Consensus       235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP  313 (391)
T KOG0983|consen  235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPP  313 (391)
T ss_pred             cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCC
Confidence            9999988888888888899999999999953   468999999999999999999999999855 4455566665 4445


Q ss_pred             CCCC--CCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 AIPG--DCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 ~~~~--~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .++.  ..++.+.+|+..||.+|+.+||.+.++++
T Consensus       314 ~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  314 LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            5553  37899999999999999999999999876

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.9e-39  Score=314.54  Aligned_cols=255  Identities=28%  Similarity=0.542  Sum_probs=210.2

Q ss_pred             ccceeccceeeeeccEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      ..+|.+.+.||+|+||.||+|.+.      ++.||||++......       .....|.+|+.+++.+.|+||+++++++
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~ei~~l~~l~~~~i~~~~~~~   75 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-------QHRSDFEREIEILRTLDHENIVKYKGVC   75 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-------HHHHHHHHHHHHHHhCCCCChheEEeee
Confidence            356778899999999999999864      468999999754332       2256789999999999999999999998


Q ss_pred             ec--CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          252 KK--PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       252 ~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ..  ....++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          76 EKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             ecCCCCceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccc
Confidence            77  55789999999999999999863 2358999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCc----CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--------------HH
Q 011359          330 IACEEVYCDA----LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI--------------QA  391 (488)
Q Consensus       330 la~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~--------------~~  391 (488)
                      ++........    .....++..|++||.+.+..++.++||||||+++|+|++|..|+......              ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR  234 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence            9865432111    11223456799999998888999999999999999999999998654221              12


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ....+....+...+..++.++.+|+.+||..+|++||++.+|+++|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            2233334444455677889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-38  Score=313.41  Aligned_cols=246  Identities=29%  Similarity=0.522  Sum_probs=209.4

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      .|...++||.|+||.||+|.+.  +..||||++......       .....+.+|+.++++++|+||+++++++..+..+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-------DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            3567788999999999999875  689999998753321       1246788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+.+++|.+++..   ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        78 ~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            999999999999999865   46888999999999999999999999999999999999999999999999998543322


Q ss_pred             C-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          338 D-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       338 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      . ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+......+ .....+.++..++..+.++|
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li  233 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSKPFKEFI  233 (277)
T ss_pred             ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhhhHHHHHHH
Confidence            2 122345788999999998888999999999999999999999999988766554433 33344556677889999999


Q ss_pred             HHHhhhCCCCCCCHHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~~  436 (488)
                      .+||+.+|++||++.+++..
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHHcccCcccCcCHHHHHhC
Confidence            99999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=339.11  Aligned_cols=246  Identities=23%  Similarity=0.457  Sum_probs=212.8

Q ss_pred             eeccceeeeeccEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~~--~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      +.|+..||.|+||.||++..+.  --.|-|+|......        -..+|.-||+||..++||+||+|+++|..++.+|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseE--------ELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEE--------ELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchh--------HHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            3467789999999999998774  34567888643322        2467889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc-ccc
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-VYC  337 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~-~~~  337 (488)
                      |+.|||.||-+...+-.. ...+++.++.-+++|++.||.|||+++|||||||..|||++-+|.++|+|||++... ...
T Consensus       106 iliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             EEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            999999999999988774 467999999999999999999999999999999999999999999999999987432 222


Q ss_pred             CcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCcHH
Q 011359          338 DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-PAIPGDCPPA  411 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  411 (488)
                      .......||++|||||++.     ..+|+.++||||||++|.||..+.+|....+++.++..+...... ...|..++..
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~  264 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS  264 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence            3344678999999999874     568999999999999999999999999999999998887765433 3457889999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+++.+||.+||+.||++.++++
T Consensus       265 F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  265 FSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHHHHHHhcCCccCCCHHHHhh
Confidence            999999999999999999999884

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-40  Score=337.62  Aligned_cols=257  Identities=25%  Similarity=0.458  Sum_probs=224.7

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEEC---C--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---D--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV  244 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~---~--~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI  244 (488)
                      ..+...|-.+++.+.+.||+|.||.|++|.|+   |  -.||||+++......       ...+|.+|+.+|.+|+|+|+
T Consensus       101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-------~mddflrEas~M~~L~H~hl  173 (1039)
T KOG0199|consen  101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-------IMDDFLREASHMLKLQHPHL  173 (1039)
T ss_pred             CCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-------hHHHHHHHHHHHHhccCcce
Confidence            34566777788999999999999999999997   3  379999998543221       36789999999999999999


Q ss_pred             eeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEE
Q 011359          245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK  324 (488)
Q Consensus       245 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vk  324 (488)
                      |+|||+..+ .-..+|||+++.|+|.+.|++.....+....+..++.||+.||.||.++++|||||-..|+|+-....||
T Consensus       174 iRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVK  252 (1039)
T KOG0199|consen  174 IRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVK  252 (1039)
T ss_pred             eEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceee
Confidence            999999987 5677999999999999999986566788889999999999999999999999999999999999988999


Q ss_pred             EeeecccccccccCcC----CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 011359          325 IADFGIACEEVYCDAL----SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKN  399 (488)
Q Consensus       325 l~DFgla~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~  399 (488)
                      |+|||+.+.....+..    ......+.|+|||.++...++.++|||++||+||||++ |..||.+....+++..+- .+
T Consensus       253 I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~  331 (1039)
T KOG0199|consen  253 ICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AG  331 (1039)
T ss_pred             eecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-cc
Confidence            9999998644332221    22335678999999999999999999999999999998 999999999988776655 77


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 ~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+...|..|++.+.+++.+||..+|.+||+|..|.+
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            788899999999999999999999999999999984

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.1e-38  Score=312.83  Aligned_cols=249  Identities=21%  Similarity=0.375  Sum_probs=203.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+...||+|+||.||+|.+.  ++.||+|++........      ..+.+.+|+.++++++|+||+++++++..+..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV------IKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc------ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            36788899999999999999985  68999999875432211      13457899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||++++.|..++..  ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus        75 ~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             EEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            9999999999888887654  34689999999999999999999999999999999999999999999999999854332


Q ss_pred             cC-cCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------------
Q 011359          337 CD-ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN---------------  399 (488)
Q Consensus       337 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~---------------  399 (488)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+....               
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            22 2223457889999999875 457899999999999999999999999877655444332100               


Q ss_pred             ----CC-CC---------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 ----LR-PA---------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 ----~~-~~---------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                          .. +.         ....++..+.+||.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                00 00         01245788999999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-38  Score=307.57  Aligned_cols=249  Identities=24%  Similarity=0.384  Sum_probs=209.5

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CC
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--PP  255 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~  255 (488)
                      +|.+.+.||.|+||.||++...  ++.||+|++.......      ...+++..|++++++++|+||+++++++..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE------KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH------HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            4677889999999999999875  6889999987543322      124568899999999999999999998753  45


Q ss_pred             eeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          256 VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIH-----SQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH-----~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      ..+++|||+++++|.+++...  ....+++..++.++.||+.||+|||     +.+++||||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            689999999999999999764  2457899999999999999999999     899999999999999999999999999


Q ss_pred             cccccccccCc-CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          329 GIACEEVYCDA-LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       329 gla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      |++........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.... +.....+.++..
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~  233 (265)
T cd08217         155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK-IKEGKFRRIPYR  233 (265)
T ss_pred             cccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH-HhcCCCCCCccc
Confidence            99865433222 2344689999999999888899999999999999999999999998875444433 334444566778


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++..+.+++.+||+.+|++||++.+|++
T Consensus       234 ~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         234 YSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            8999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-38  Score=318.91  Aligned_cols=247  Identities=23%  Similarity=0.397  Sum_probs=202.8

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||++.+.  +..||+|.+.....       .....++.+|++++++++||||++++++|..+..+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-------PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI   74 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence            5788899999999999999875  67899999875322       11245688999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      ++||||+++++|.+++..  ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++.....
T Consensus        75 ~lv~ey~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          75 SICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             EEEeeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            999999999999999986  3568899999999999999999998 5999999999999999999999999998854322


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------------
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV--------------------  396 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~--------------------  396 (488)
                       .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.........                    
T Consensus       153 -~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         153 -SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence             12234568899999999988889999999999999999999999997654322211110                    


Q ss_pred             ---------------hccCCCCCC-CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          397 ---------------NKNLRPAIP-GDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       397 ---------------~~~~~~~~~-~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                                     .....+..+ ..++.++.+||.+||..+|++||++.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                           001111222 2367789999999999999999999998873

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.2e-38  Score=308.90  Aligned_cols=249  Identities=28%  Similarity=0.480  Sum_probs=209.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||.|+||+||+|.+.  +..+|+|++.......       ..+.+.+|+++++.++|+||+++++.+..+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-------SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE   73 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-------HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence            36788999999999999999874  6789999986533221       24678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      +++||||+.+++|.+++..... ..+++..+..++.|++.||+|||+.|++||||+|+||++++++.++|+|||++....
T Consensus        74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            9999999999999999987433 568999999999999999999999999999999999999999999999999885433


Q ss_pred             ccCc-----CCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC----
Q 011359          336 YCDA-----LSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP----  405 (488)
Q Consensus       336 ~~~~-----~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----  405 (488)
                      ....     .....|+..|+|||.+... .++.++|+|||||++|+|++|..||...+..+.......... +...    
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~  232 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-PSLETGAD  232 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-CCcCCccc
Confidence            2211     1234588899999999766 789999999999999999999999998877665555544322 1121    


Q ss_pred             -CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          406 -GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       406 -~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                       ..++..+.+++.+||..+|++||++.++++
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             356789999999999999999999999876

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-38  Score=315.44  Aligned_cols=252  Identities=24%  Similarity=0.426  Sum_probs=208.8

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      ..++|.+.+.||+|+||+||++.+.  ++.||+|++......       ...+++.+|+++++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS-------SVRKQILRELQIMHECRSPYIVSFYGAFLNE   75 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc-------hHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence            4567889999999999999999986  789999998754321       2256788999999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ..+++||||+++++|.+++..  .+.+++..+..++.+++.||.|||+ .|++||||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            999999999999999999876  3568999999999999999999997 5999999999999999999999999998854


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhccCCC
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI-----------QAAFAVVNKNLRP  402 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~-----------~~~~~~~~~~~~~  402 (488)
                      .... ......|+..|+|||++.+..++.++|||||||++|+|++|..||......           +....+... ..+
T Consensus       154 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  231 (284)
T cd06620         154 LINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPP  231 (284)
T ss_pred             hhhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCC
Confidence            3221 122346899999999998888999999999999999999999999865542           112222222 122


Q ss_pred             CCCC-CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHH
Q 011359          403 AIPG-DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ  439 (488)
Q Consensus       403 ~~~~-~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~  439 (488)
                      .++. .++..+.+||.+||..+|++||++.++++...-
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            2333 378899999999999999999999999986433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-38  Score=317.46  Aligned_cols=246  Identities=25%  Similarity=0.484  Sum_probs=207.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      .+|.+.+.||+|+||.||+|...  ++.||||.+.......        ...+.+|+.+++.++|+||+++++++..+..
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            56888999999999999999874  7899999997543221        2457799999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||+++++|.+++.+   ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus        91 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             EEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999999999975   4588899999999999999999999999999999999999999999999998854322


Q ss_pred             cC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCcHHHHH
Q 011359          337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-LRPAIPGDCPPAMAA  414 (488)
Q Consensus       337 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~  414 (488)
                      .. ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.... .....+..++..+.+
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD  247 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence            21 1223468889999999988889999999999999999999999998766544333322222 122345667889999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+||..+|++||++.++++
T Consensus       248 li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         248 FLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-40  Score=304.73  Aligned_cols=260  Identities=22%  Similarity=0.341  Sum_probs=212.9

Q ss_pred             cccccccceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      .-.|+-++|++.+.||+|||+-||.+..  +++-||+|.+......+        .+..++|++..++++||||++++++
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~--------~e~~~rEid~~rkf~s~~vl~l~dh   86 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED--------IEEALREIDNHRKFNSPNVLRLVDH   86 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH--------HHHHHHHHHHHHhhCCcchHHHHHH
Confidence            3456778999999999999999999874  47899999998765322        4567799999999999999999998


Q ss_pred             eecCC-----eeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCeEEEcCCC
Q 011359          251 CKKPP-----VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEF  321 (488)
Q Consensus       251 ~~~~~-----~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~g--iiHrDIkp~NILl~~~~  321 (488)
                      +..+.     ..||+++|...|+|.+.+...  .+..+++.+++.|+.+|++||++||+..  +.||||||.|||+.+.+
T Consensus        87 ~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~  166 (302)
T KOG2345|consen   87 QLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG  166 (302)
T ss_pred             HHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC
Confidence            75443     489999999999999999875  3446899999999999999999999998  99999999999999999


Q ss_pred             cEEEeeeccccccccc----------CcCCCCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 011359          322 HLKIADFGIACEEVYC----------DALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNP  388 (488)
Q Consensus       322 ~vkl~DFgla~~~~~~----------~~~~~~~gt~~y~aPE~l~~---~~~~~k~DvwSlGvll~elltG~~Pf~~~~~  388 (488)
                      .++|.|||.+......          ........|..|.|||.+.-   ...++++|||||||+||+|+.|..||+..-.
T Consensus       167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~  246 (302)
T KOG2345|consen  167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ  246 (302)
T ss_pred             ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence            9999999988543221          11123347999999999963   3568999999999999999999999974321


Q ss_pred             --HHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          389 --IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       389 --~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                        ...+.++.+..+.......++..+.+||+.||+.||.+||+..+++..++.+
T Consensus       247 ~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  247 QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence              1222334444444334455899999999999999999999999999988765

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-38  Score=311.35  Aligned_cols=246  Identities=28%  Similarity=0.504  Sum_probs=207.0

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||.|+||.||++.+.  ++.||+|.+......       ....++.+|++++++++|+||+++++.+.....+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-------AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI   74 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-------HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE
Confidence            5677889999999999999986  688999998764322       2256788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      ++++||+.+++|.+++.... ..+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          75 SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            99999999999999998633 678899999999999999999999 9999999999999999999999999998854332


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhccCCCCCCCC-CcH
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN-----PIQAAFAVVNKNLRPAIPGD-CPP  410 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~-~~~  410 (488)
                      ... ....++..|+|||.+.+..++.++||||||+++|+|++|..||....     ..+....+. ....+..+.. ++.
T Consensus       154 ~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (265)
T cd06605         154 SLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSP  231 (265)
T ss_pred             HHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCH
Confidence            211 12668889999999988899999999999999999999999997652     222222222 2333444444 889


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.++|.+||..+|++||++.+++.
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhh
Confidence            9999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.4e-38  Score=307.40  Aligned_cols=248  Identities=29%  Similarity=0.525  Sum_probs=206.9

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||+|...  ++.||||++......      ....+.+..|+.++++++|+||+++++.+.....+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc------hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            4778899999999999999874  689999999865433      22357789999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++|+||+++++|.+++..  ...+++..+..++.+++.||+|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus        75 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          75 YIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             EEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            999999999999999976  345788899999999999999999999999999999999999999999999988543322


Q ss_pred             Cc-----CCCCCCCcccCChhhhhcCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC-
Q 011359          338 DA-----LSDDPGTYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC-  408 (488)
Q Consensus       338 ~~-----~~~~~gt~~y~aPE~l~~~~---~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-  408 (488)
                      ..     .....++..|++||++.+..   ++.++||||||+++|+|++|..||..................+.++... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ  232 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccc
Confidence            11     11345788999999997665   8899999999999999999999998764333222223334444555444 


Q ss_pred             -cHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          409 -PPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       409 -~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                       +..+.++|.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         233 LSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             899999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.6e-38  Score=315.38  Aligned_cols=256  Identities=26%  Similarity=0.542  Sum_probs=209.8

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~----~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ..++|...+.||+|+||.||+|.+.  ++    .||+|++......       ....++.+|+.+++.++|+||++++++
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~~~~l~h~niv~~~~~   77 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP-------KANVEFMDEALIMASMDHPHLVRLLGV   77 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence            3456778889999999999999873  43    4788888643221       113468899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      |... ..++++||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        78 ~~~~-~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          78 CLSP-TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             EcCC-CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccc
Confidence            8765 467999999999999998763 34688999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          331 ACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       331 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      +........   .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+. ...+........+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~  234 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERLPQPP  234 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCCCCCC
Confidence            864322111   112335678999999988889999999999999999997 9999987765443 34444555555567


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      .++..+.+++.+||..+|++||++.++++.|..+..
T Consensus       235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         235 ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            788999999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=310.02  Aligned_cols=248  Identities=27%  Similarity=0.452  Sum_probs=205.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  255 (488)
                      ++|.+.+.||.|++|.||+|.+.  ++.||+|++.....         ...++.+|+.+++++ +|+||+++++++....
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---------hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            57889999999999999999985  57899999875432         135688999999999 6999999999996544


Q ss_pred             ------eeeEEEeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          256 ------VYCVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       256 ------~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                            .+++||||+++++|.+++....  ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence                  5899999999999999987644  56789999999999999999999999999999999999999999999999


Q ss_pred             ecccccccc-cCcCCCCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 011359          328 FGIACEEVY-CDALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR  401 (488)
Q Consensus       328 Fgla~~~~~-~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~  401 (488)
                      ||++..... ........|+..|+|||.+..     ..++.++||||||+++|+|++|..||...........+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            998854322 122234558889999999853     34678999999999999999999999877766655554433221


Q ss_pred             C-CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 P-AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 ~-~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      . ..+..++..+.+||.+||..||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1 122347889999999999999999999999876

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3e-38  Score=308.17  Aligned_cols=242  Identities=26%  Similarity=0.376  Sum_probs=207.2

Q ss_pred             eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeec
Q 011359          187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  264 (488)
                      ||.|+||.||++.+.  ++.||||++.......     ....+.+.+|+.+++.++|+||+++++.+.++..+++|+||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-----TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-----hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence            589999999999997  7899999997543211     123567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCC
Q 011359          265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP  344 (488)
Q Consensus       265 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~  344 (488)
                      ++++|.+++.+  ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.............
T Consensus        76 ~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~  153 (262)
T cd05572          76 LGGELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC  153 (262)
T ss_pred             CCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence            99999999976  3458899999999999999999999999999999999999999999999999986544332233446


Q ss_pred             CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 011359          345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN--PIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSL  422 (488)
Q Consensus       345 gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~  422 (488)
                      ++..|++||.+....++.++|+||||+++|+|++|..||....  ..+....+.........+..++..+.++|.+||+.
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence            8889999999988889999999999999999999999998776  55555555544555667777799999999999999


Q ss_pred             CCCCCCC-----HHHHHH
Q 011359          423 QPDKRPE-----FWHIVK  435 (488)
Q Consensus       423 dp~~RPs-----~~eil~  435 (488)
                      +|++||+     +.++++
T Consensus       234 ~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         234 NPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ChhhCcCCcccCHHHHhc
Confidence            9999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-38  Score=314.38  Aligned_cols=249  Identities=24%  Similarity=0.430  Sum_probs=206.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||++.+.  ++.||+|.+......       ....++.+|+.++++++|+||+++++.+..+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-------SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA   73 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH-------HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence            35778899999999999999986  789999998753221       113568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      +++||||+++++|..++.... ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++...
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999999999999987632 2368999999999999999999997 59999999999999999999999999998543


Q ss_pred             cccCcCCCCCCCcccCChhhhhcC------CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccCCCCCCC
Q 011359          335 VYCDALSDDPGTYRWMAPEMIKHK------SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA--VVNKNLRPAIPG  406 (488)
Q Consensus       335 ~~~~~~~~~~gt~~y~aPE~l~~~------~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~--~~~~~~~~~~~~  406 (488)
                      .. .......++..|+|||.+.+.      .++.++|+|||||++|+|++|..||...........  .......+.++.
T Consensus       154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd06622         154 VA-SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS  232 (286)
T ss_pred             cC-CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc
Confidence            22 122344578899999998543      357899999999999999999999976554332221  122334456677


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .++.++.+||.+||..+|++||++.+++.
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            79999999999999999999999998886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.4e-39  Score=325.49  Aligned_cols=245  Identities=25%  Similarity=0.365  Sum_probs=198.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      ++|.+.+.||.|+||.||+|.+.  ++.||||++......      ......+.+|+.+|++++|+||+++++++...  
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS------LIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh------hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            67889999999999999999875  578999998743211      11235577899999999999999999987533  


Q ss_pred             ----CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          255 ----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       255 ----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                          ..+|+++|++ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence                4578999998 7899888754   5699999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL---------  400 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~---------  400 (488)
                      +.....  ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....         
T Consensus       165 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         165 ARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             ceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            865332  2334568999999999876 5689999999999999999999999987765444333221100         


Q ss_pred             ------------CCC--------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 ------------RPA--------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 ------------~~~--------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                  .+.        ....+++.+.+||.+||..||++||++.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                        000        11235667899999999999999999999995

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-38  Score=312.21  Aligned_cols=237  Identities=23%  Similarity=0.473  Sum_probs=192.3

Q ss_pred             eeeeeccEEEEEEEEC--------------------------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc
Q 011359          186 RFAHGAHSRLYHGIYK--------------------------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL  239 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~--------------------------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l  239 (488)
                      .||+|+||.||+|.+.                          +..||||++....        ......|..|+.+++.+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~~~~~~~~l   73 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--------RDIALAFFETASLMSQV   73 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--------HHHHHHHHHHHHHHhcC
Confidence            5899999999999752                          1258888885321        12245688899999999


Q ss_pred             CCCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC
Q 011359          240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ  319 (488)
Q Consensus       240 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~  319 (488)
                      +|+||++++++|......++||||+++|+|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus        74 ~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~  152 (274)
T cd05076          74 SHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR  152 (274)
T ss_pred             CCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEec
Confidence            999999999999999999999999999999999875 3456889999999999999999999999999999999999976


Q ss_pred             CC-------cEEEeeecccccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCCHHH
Q 011359          320 EF-------HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMV-AGTIPYEEMNPIQ  390 (488)
Q Consensus       320 ~~-------~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~ell-tG~~Pf~~~~~~~  390 (488)
                      .+       .++++|||++.....   .....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||......+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            43       489999998743321   123457888999998865 56899999999999999995 6999998776544


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 011359          391 AAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~L  437 (488)
                      ... .....  ...+...+..+.++|.+||+.+|++||++.+|++.|
T Consensus       230 ~~~-~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         230 KER-FYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHH-HHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            322 22222  223445567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-38  Score=310.39  Aligned_cols=237  Identities=20%  Similarity=0.454  Sum_probs=191.5

Q ss_pred             eeeeeccEEEEEEEECC--------------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          186 RFAHGAHSRLYHGIYKD--------------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~~--------------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      .||+|+||.||+|.+..              ..||+|++....        ......|..|+.++..++||||+++++++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~~~~~l~~l~hp~iv~~~~~~   73 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--------RDISLAFFETASMMRQVSHKHIVLLYGVC   73 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--------hhHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            57999999999998532              258888875422        11245688899999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc-------EE
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-------LK  324 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~-------vk  324 (488)
                      ..+...++||||+++++|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.       ++
T Consensus        74 ~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          74 VRDVENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             ecCCCCEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeE
Confidence            999999999999999999998875 2356899999999999999999999999999999999999987654       89


Q ss_pred             EeeecccccccccCcCCCCCCCcccCChhhhh-cCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhccCCC
Q 011359          325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMV-AGTIPYEEMNPIQAAFAVVNKNLRP  402 (488)
Q Consensus       325 l~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvll~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~  402 (488)
                      ++|||++.....   .....++..|+|||.+. +..++.++|||||||++|+|+ .|..||......+.. .......  
T Consensus       153 l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~--  226 (262)
T cd05077         153 LSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQC--  226 (262)
T ss_pred             eCCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCc--
Confidence            999998854321   12345788899999986 467899999999999999998 588898776543322 2222221  


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~L  437 (488)
                      ......+..+.+||.+||+.||++||++.+|++.|
T Consensus       227 ~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            22334567899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.7e-38  Score=314.66  Aligned_cols=253  Identities=25%  Similarity=0.380  Sum_probs=209.3

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||++...  ++.||||.+.....     ........+.+|+.+++.++|+||+++++.+..+..+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEE
Confidence            5778899999999999999886  57899999874321     1122245788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||++|++|.+++..  ...+++..+..++.|++.||+|||+.|++||||||.||+++.++.++|+|||++......
T Consensus        77 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            999999999999999976  356899999999999999999999999999999999999999999999999987521100


Q ss_pred             C----------------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-
Q 011359          338 D----------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-  400 (488)
Q Consensus       338 ~----------------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-  400 (488)
                      .                ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+.......... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  234 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence            0                01123478889999999888899999999999999999999999998777666555554432 


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHH
Q 011359          401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ  439 (488)
Q Consensus       401 ~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~  439 (488)
                      .+.....++..+.++|.+||+.+|++||++..+.+.|+.
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         235 WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            233334678999999999999999999997766665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-38  Score=313.86  Aligned_cols=245  Identities=30%  Similarity=0.530  Sum_probs=207.7

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      .|...+.||+|+||.||+|.+.  ++.||||++......       ...+.+.+|+.++++++|+||+++++.+..+..+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-------DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL   77 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-------HHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence            3556778999999999999875  678999998744321       1245788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+++++|.+++..   ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        78 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            999999999999998864   56889999999999999999999999999999999999999999999999998543321


Q ss_pred             C-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          338 D-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       338 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|..||....+...... ......+.++..++..+.++|
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li  233 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-IPKNSPPTLEGQYSKPFKEFV  233 (277)
T ss_pred             chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-hhcCCCCCCCcccCHHHHHHH
Confidence            1 11233578899999999988899999999999999999999999987766554433 333344556667889999999


Q ss_pred             HHHhhhCCCCCCCHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||..+|++||++.+++.
T Consensus       234 ~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         234 EACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.9e-38  Score=311.58  Aligned_cols=247  Identities=29%  Similarity=0.473  Sum_probs=199.2

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHH-HHhcCCCCeeeEeeeeecCCe
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVAL-LSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +|.+.+.||+|+||.||++.+.  |+.||||++........       ..++..|+.+ ++.++|+||+++++++..+..
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~   74 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-------QKRLLMDLDISMRSVDCPYTVTFYGALFREGD   74 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-------HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence            5778899999999999999985  78999999975432221       2345566665 566789999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      .++||||++ |+|.+++...  ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~  153 (283)
T cd06617          75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY  153 (283)
T ss_pred             EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            999999995 6888888653  234689999999999999999999997 999999999999999999999999999865


Q ss_pred             ccccCcCCCCCCCcccCChhhhhc----CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCCCC-CC
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKH----KSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNKNLRPAIP-GD  407 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~-~~  407 (488)
                      ...........++..|+|||.+.+    ..++.++|+|||||++|+|++|..||.... ..+....... ...+.++ ..
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  232 (283)
T cd06617         154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEK  232 (283)
T ss_pred             cccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccc
Confidence            433222333568889999998864    456889999999999999999999997643 2233333333 2233333 45


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.++.++|.+||..+|++||++.++++
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            7899999999999999999999999876

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.3e-38  Score=311.10  Aligned_cols=251  Identities=24%  Similarity=0.408  Sum_probs=203.2

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeee-
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACK-  252 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~-  252 (488)
                      -.++|.+.+.||+|+||.||++...  ++.||+|++.....         ...++..|+.+++.+ +|+||+++++++. 
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---------IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---------hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            3467889999999999999999875  68999998764221         124577899999999 6999999999873 


Q ss_pred             ----cCCeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          253 ----KPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       253 ----~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                          .+..+++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence                445789999999999999988643  23568889999999999999999999999999999999999999999999


Q ss_pred             eeccccccccc-CcCCCCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-
Q 011359          327 DFGIACEEVYC-DALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-  399 (488)
Q Consensus       327 DFgla~~~~~~-~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-  399 (488)
                      |||++...... .......|+..|+|||++..     ..++.++|||||||++|+|++|..||................ 
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  246 (286)
T cd06638         167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP  246 (286)
T ss_pred             cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence            99998543221 12233468899999999853     457889999999999999999999998877655443332221 


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          400 LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       400 ~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      .....+..++..+.+||.+||+.+|++||++.++++.
T Consensus       247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            1122345578899999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.7e-38  Score=307.38  Aligned_cols=253  Identities=30%  Similarity=0.532  Sum_probs=205.7

Q ss_pred             eeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      |.+.+.||+|+||.||+|.+.     ++.||||++........      ..+++.+|+.++++++||||+++++++....
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   74 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS------DIEEFLREAACMKEFDHPNVIKLIGVSLRSR   74 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH------HHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            456788999999999999863     47899999975432221      2456889999999999999999999886532


Q ss_pred             ------eeeEEEeecCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEE
Q 011359          256 ------VYCVITEYLSEGSLRAYLHKLE----HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI  325 (488)
Q Consensus       256 ------~~~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl  325 (488)
                            ..++++||+.+|+|.+++....    ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl  154 (273)
T cd05074          75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCV  154 (273)
T ss_pred             CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEE
Confidence                  3478999999999998876432    225788899999999999999999999999999999999999999999


Q ss_pred             eeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 011359          326 ADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLR  401 (488)
Q Consensus       326 ~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  401 (488)
                      +|||++.......   ......++..|++||.+....++.++||||||+++|+|++ |..||...+..+....+.. ...
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~  233 (273)
T cd05074         155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-GNR  233 (273)
T ss_pred             CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCc
Confidence            9999986432211   1122335678999999988889999999999999999999 8999988776554444433 333


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       402 ~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ...+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       234 ~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            445567889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-38  Score=311.22  Aligned_cols=238  Identities=24%  Similarity=0.463  Sum_probs=195.0

Q ss_pred             eeeeeccEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          186 RFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~~---------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      .||+|+||.||+|...+         ..||+|++....        ....+.+..|+.+++.++||||+++++++..+..
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~   73 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--------RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE   73 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchh--------HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC
Confidence            57999999999998642         348888875321        2234568889999999999999999999999889


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc--------EEEeee
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH--------LKIADF  328 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~--------vkl~DF  328 (488)
                      .++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.        ++++||
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            99999999999999999863 336889999999999999999999999999999999999987764        699999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAG-TIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      |++.....   .....++..|+|||++.+ ..++.++||||||+++|+|++| ..||.......... ....  +..++.
T Consensus       153 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--~~~~~~  226 (258)
T cd05078         153 GISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--RHQLPA  226 (258)
T ss_pred             ccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--cccCCC
Confidence            98854322   223457889999999976 4579999999999999999998 56776665544322 2222  344566


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      ..+..+.+||.+||+.+|++||++.+|++.|+
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         227 PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            67789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=304.95  Aligned_cols=251  Identities=25%  Similarity=0.456  Sum_probs=211.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      .+|.+++.||+|+||.||+|.+.  ++.||+|++........   ..+....+.+|++++++++|+||+++++++.+.  
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE---TSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccch---hhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence            46888999999999999999874  68999999864332211   122346788999999999999999999998654  


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+++++||+++++|.+++..  ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            468899999999999999976  345888899999999999999999999999999999999999999999999998643


Q ss_pred             cc----cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          335 VY----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       335 ~~----~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      ..    ........++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.....++.++..++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~  236 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD  236 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence            21    11122345888999999998888899999999999999999999999988777766666666666778889999


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.++|.+||. ++..||++.+++.
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHHHHHhc-CcccCccHHHHhc
Confidence            99999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-38  Score=310.14  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=209.3

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||.|+||.||+|.+.  ++.||+|++.......     .+..+.+.+|++++++++||||+++++.+..+...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-----KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc-----hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence            3678899999999999999986  7899999997533211     12356788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++|+||+.+++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            9999999999999999863  57899999999999999999999999999999999999999999999999998654433


Q ss_pred             CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP--IQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....  .......... .....+..++..+.++
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  232 (258)
T cd05578         154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDA  232 (258)
T ss_pred             ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHH
Confidence            333445688899999999888899999999999999999999999987763  2222222222 4456677889999999


Q ss_pred             HHHHhhhCCCCCCCH--HHHH
Q 011359          416 IEQCWSLQPDKRPEF--WHIV  434 (488)
Q Consensus       416 i~~cL~~dp~~RPs~--~eil  434 (488)
                      |.+||..+|++||++  .+++
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HHHHccCChhHcCCccHHHHh
Confidence            999999999999999  5443

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.4e-38  Score=306.93  Aligned_cols=251  Identities=27%  Similarity=0.504  Sum_probs=207.8

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |..++.||+|++|.||+|...  ++.||+|++........  ...+..+.+.+|+.++++++|+||+++++++.+...++
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSS--EQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCch--hHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence            567788999999999999874  68999999975443221  11234578899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC-cEEEeeeccccccccc
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIACEEVYC  337 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~-~vkl~DFgla~~~~~~  337 (488)
                      +|+||+.+++|.+++..  ...+++..++.++.||+.||+|||++|++||||+|+||+++.++ .++|+|||++......
T Consensus        80 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          80 LFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            99999999999999976  35688999999999999999999999999999999999998776 5999999998543321


Q ss_pred             C-----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCCCCCCCc
Q 011359          338 D-----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP---IQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       338 ~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      .     ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....   .............+..+..++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            1     11223578899999999888899999999999999999999999975432   222333333344566777788


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +++.+++.+||..+|++||++.++++
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            99999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.2e-37  Score=300.90  Aligned_cols=248  Identities=30%  Similarity=0.568  Sum_probs=213.5

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--C
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--P  255 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~  255 (488)
                      +|.+.+.||+|++|.||+|...  ++.|++|++......      ....+.+.+|+.++++++|+||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            3567788999999999999986  789999999765432      12256788999999999999999999999988  8


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++|+||+.+++|.+++...  ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            999999999999999999873  378999999999999999999999999999999999999999999999999986544


Q ss_pred             ccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCCCCCCCcHH
Q 011359          336 YCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       336 ~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      ....   .....++..|++||.+....++.++||||||+++|+|++|..||.... .......+......+.++..++..
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEE  232 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHH
Confidence            4332   344568899999999988889999999999999999999999998776 333444444334556677888999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.++|.+||+.+|++||++.+++.
T Consensus       233 l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         233 AKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             HHHHHHHhCcCChhhCCCHHHHhh
Confidence            999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.4e-38  Score=306.70  Aligned_cols=248  Identities=26%  Similarity=0.427  Sum_probs=200.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +.......||+|+||.||+|.+.  +..||||.+......        ..+.+.+|+.++++++|+||+++++++..+..
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--------YVQPLHEEIALHSYLKHRNIVQYLGSDSENGF   79 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH--------HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence            33334457899999999999875  467999988643321        24568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-CCcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTL--PLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-~~~vkl~DFgla~~  333 (488)
                      +++|+||+.+++|.+++.... ..+  ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++..
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            999999999999999998632 234  77888999999999999999999999999999999976 67999999998854


Q ss_pred             cccc-CcCCCCCCCcccCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCCCCCCCc
Q 011359          334 EVYC-DALSDDPGTYRWMAPEMIKHK--SYGRKVDVYSFGLILWEMVAGTIPYEEMNPI-QAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       334 ~~~~-~~~~~~~gt~~y~aPE~l~~~--~~~~k~DvwSlGvll~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  409 (488)
                      .... .......++..|+|||.+...  .++.++||||||+++|+|++|..||...... ............+.++..++
T Consensus       159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06624         159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS  238 (268)
T ss_pred             cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence            3221 112234578899999998654  3789999999999999999999999765432 22222222233456677889


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .++.+++.+||+.+|++||++.+++.
T Consensus       239 ~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         239 AEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            99999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.8e-38  Score=307.54  Aligned_cols=245  Identities=22%  Similarity=0.468  Sum_probs=195.7

Q ss_pred             eeeeeccEEEEEEEEC-Cc---cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEE
Q 011359          186 RFAHGAHSRLYHGIYK-DE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~-~~---~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      .||+|+||.||+|.+. +.   .+++|.+......       ...+.|.+|+.+++.++||||+++++.|......++||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~   74 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS-------KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF   74 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh-------HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence            5799999999999754 33   4556665543221       12467899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc--
Q 011359          262 EYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC--  337 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~--  337 (488)
                      ||+++|+|.+++.+..  ....++..+..++.||+.||+|||+.+++||||||+|||++.++.++|+|||++......  
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            9999999999998642  234667778899999999999999999999999999999999999999999987432111  


Q ss_pred             -CcCCCCCCCcccCChhhhhc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc----CCCCC
Q 011359          338 -DALSDDPGTYRWMAPEMIKH-------KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKN----LRPAI  404 (488)
Q Consensus       338 -~~~~~~~gt~~y~aPE~l~~-------~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~----~~~~~  404 (488)
                       .......++..|+|||++..       ..++.++||||||+++|||++ |..||......+....+....    .++.+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL  234 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence             11223457889999999843       235789999999999999997 677998877766555544332    23445


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      +..++..+.+++..|| .+|++||++.+|++.|.
T Consensus       235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            5668889999999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.2e-38  Score=304.07  Aligned_cols=246  Identities=31%  Similarity=0.497  Sum_probs=210.3

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||.|++|.||++...  ++.||||++......       .....+.+|+.++.+++|+||+++++++..+..+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-------EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI   74 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence            5778899999999999999986  689999999765432       2246788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999999999863  678999999999999999999999 9999999999999999999999999998854432


Q ss_pred             cCcC-CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCCCCCC-CcHH
Q 011359          337 CDAL-SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN---PIQAAFAVVNKNLRPAIPGD-CPPA  411 (488)
Q Consensus       337 ~~~~-~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~  411 (488)
                      .... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||....   ..+....+. ....+..+.. ++..
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  231 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPE  231 (264)
T ss_pred             CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHH
Confidence            2222 23457889999999988889999999999999999999999998774   333333333 3334445556 8999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.++|.+||..+|++||++.++++
T Consensus       232 l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         232 FRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHh
Confidence            999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.3e-38  Score=307.87  Aligned_cols=245  Identities=30%  Similarity=0.533  Sum_probs=208.8

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.+.+.||.|+||.||+|.+.  ++.||||++......       ...+.+.+|+.++.+++|+||+++++++..+..++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   78 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-------DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   78 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-------HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence            557788999999999999874  689999998643321       12467889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +||||+.+++|.+++..   ..+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus        79 lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          79 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999999999999864   468899999999999999999999999999999999999999999999999885432211


Q ss_pred             -cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 011359          339 -ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIE  417 (488)
Q Consensus       339 -~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~  417 (488)
                       ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+ .....+.++..++.++.++|.
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~  234 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVE  234 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-hcCCCCCCCcccCHHHHHHHH
Confidence             122345788999999998888899999999999999999999999887765544443 334455567788999999999


Q ss_pred             HHhhhCCCCCCCHHHHHHH
Q 011359          418 QCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       418 ~cL~~dp~~RPs~~eil~~  436 (488)
                      +||..+|++||++.++++.
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         235 ACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHccCChhhCcCHHHHHhC
Confidence            9999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.4e-38  Score=309.32  Aligned_cols=248  Identities=27%  Similarity=0.406  Sum_probs=204.7

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+++.||+|+||.||+|.+.  |+.||||++.......      .....+.+|+.++++++|+||+++++++..+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG------GIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc------hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            4778899999999999999974  6899999998654322      1245788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9999999 999999987633 66899999999999999999999999999999999999999999999999988644332


Q ss_pred             C--cCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC------------
Q 011359          338 D--ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP------------  402 (488)
Q Consensus       338 ~--~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------  402 (488)
                      .  ......++..|+|||.+.+. .++.++||||||+++|+|++|..+|...........+...-..+            
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence            2  13345688999999998644 46899999999999999999988887766554443332210000            


Q ss_pred             ----------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 ----------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 ----------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                      ......+..+.+||.+||..+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                            011345789999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.8e-38  Score=306.21  Aligned_cols=237  Identities=24%  Similarity=0.483  Sum_probs=192.7

Q ss_pred             ceeeeeccEEEEEEEECCc------------cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          185 LRFAHGAHSRLYHGIYKDE------------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~~------------~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      +.||+|+||.||+|.+.+.            .|++|++......         ...|.+|+.++++++|+||+++++++.
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---------SLAFFETASLMSQLSHKHLVKLYGVCV   71 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---------HHHHHHHHHHHHcCCCcchhheeeEEe
Confidence            3579999999999998643            3778877533211         356889999999999999999999998


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC-------cEEE
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-------HLKI  325 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~-------~vkl  325 (488)
                      . ...++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++       .++|
T Consensus        72 ~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          72 R-DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             c-CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence            8 77889999999999999998732 2688999999999999999999999999999999999999887       7999


Q ss_pred             eeecccccccccCcCCCCCCCcccCChhhhhcC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 011359          326 ADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK--SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRP  402 (488)
Q Consensus       326 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  402 (488)
                      +|||++.....   .....++..|+|||++...  .++.++||||||+++|+|++ |..||......+...... ..  .
T Consensus       150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~--~  223 (259)
T cd05037         150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQ--H  223 (259)
T ss_pred             CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cC--C
Confidence            99999864332   2234567789999999766  78999999999999999999 688887775433322222 11  1


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      ..+......+.++|.+||..+|++||++.++++.|+
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            122223478999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.1e-38  Score=312.65  Aligned_cols=249  Identities=27%  Similarity=0.443  Sum_probs=200.1

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  254 (488)
                      .++|...+.||+|+||.||++.+.  ++.||||.+......       .....+.+|+.++.++. |+||+++++++..+
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~   75 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE   75 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence            345667788999999999999985  689999998754322       12456889999999996 99999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHH---HHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          255 PVYCVITEYLSEGSLRAYL---HKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      ...+++|||+. ++|.++.   .......+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||+
T Consensus        76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  154 (288)
T cd06616          76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI  154 (288)
T ss_pred             CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecch
Confidence            99999999985 4555543   333346789999999999999999999975 999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCC---
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHK---SYGRKVDVYSFGLILWEMVAGTIPYEEMNPI-QAAFAVVNKNLRPA---  403 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~k~DvwSlGvll~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~---  403 (488)
                      +.............|+..|+|||.+.+.   .++.++|||||||++|+|++|..||...... +....+.. ...+.   
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~  233 (288)
T cd06616         155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSN  233 (288)
T ss_pred             hHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCCC
Confidence            8654333333445688999999999765   6899999999999999999999999876532 22222222 11122   


Q ss_pred             -CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          404 -IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       404 -~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                       .+..++..+.+||.+||+.+|++||++.+|++
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             cCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             22357899999999999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.3e-38  Score=304.28  Aligned_cols=249  Identities=23%  Similarity=0.418  Sum_probs=209.5

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||+|.++  +..||+|.+.......      ...+.+.+|+.++++++|+||+++++.+......
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV------KEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc------hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            4678889999999999999985  6889999997542211      1245678999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC-cEEEeeecccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIACEEVY  336 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~-~vkl~DFgla~~~~~  336 (488)
                      ++|+||+.+++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||++++++ .++|+|||.+.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            9999999999999999875545689999999999999999999999999999999999998885 469999998854332


Q ss_pred             cC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       337 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      .. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+......... .......++..+.++
T Consensus       155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (257)
T cd08225         155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-FAPISPNFSRDLRSL  233 (257)
T ss_pred             CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-CCCCCCCCCHHHHHH
Confidence            21 1223458889999999988889999999999999999999999998877666555544433 334556778899999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      |.+||..+|++||++.++++
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             HHHHhccChhhCcCHHHHhh
Confidence            99999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-38  Score=327.13  Aligned_cols=242  Identities=24%  Similarity=0.397  Sum_probs=196.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      .+|.+++.||+|+||.||++...    ++.||||.+...             +.+.+|+.+|++++|+||+++++++...
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~~~~~  158 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHAYRWK  158 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeeeEeeC
Confidence            46889999999999999999764    367999988632             1245899999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+|+|||++. ++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus       159 ~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        159 STVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             CEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            99999999994 688888843  467899999999999999999999999999999999999999999999999998543


Q ss_pred             cccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh-----------
Q 011359          335 VYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP---IQAAFAVVN-----------  397 (488)
Q Consensus       335 ~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~---~~~~~~~~~-----------  397 (488)
                      ....   ......||..|+|||++....++.++|||||||++|||++|..||.+...   ...+..++.           
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            3221   12235689999999999988999999999999999999999999976432   111111111           


Q ss_pred             --------------ccCCCC--CC-----CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          398 --------------KNLRPA--IP-----GDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       398 --------------~~~~~~--~~-----~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                                    ...++.  .+     ..++.++.++|.+||..||++||++.+++..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                          001111  11     2346788999999999999999999999873

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.3e-38  Score=308.65  Aligned_cols=241  Identities=23%  Similarity=0.371  Sum_probs=197.9

Q ss_pred             eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeec
Q 011359          187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  264 (488)
                      ||+|+||+||++.+.  ++.||||++.......     ......+..|++++++++||||+++++++.....+|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-----RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-----hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence            589999999999875  7899999997432111     112456678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCC
Q 011359          265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP  344 (488)
Q Consensus       265 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~  344 (488)
                      ++++|.+++.......+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.............
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            99999999987555578999999999999999999999999999999999999999999999999886443323333456


Q ss_pred             CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCCCCCCCcHHHHHHHHHHhhh
Q 011359          345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN--KNLRPAIPGDCPPAMAALIEQCWSL  422 (488)
Q Consensus       345 gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~Li~~cL~~  422 (488)
                      ++..|+|||.+.+..++.++||||||+++|+|++|..||...........+..  .......+..+++.+.++|.+||+.
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence            78899999999888899999999999999999999999977543111111111  1223445667899999999999999


Q ss_pred             CCCCCCCHHH
Q 011359          423 QPDKRPEFWH  432 (488)
Q Consensus       423 dp~~RPs~~e  432 (488)
                      +|.+||++.+
T Consensus       236 ~p~~R~~~~~  245 (277)
T cd05577         236 DPEKRLGCRG  245 (277)
T ss_pred             ChhHccCCCc
Confidence            9999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.7e-38  Score=311.24  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=196.9

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||.|+||.||+|.+.  |+.||+|.+.......      .....+.+|+.++++++|+||+++++++.+...+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~------~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------GVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc------cCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            4677889999999999999985  7899999997643221      1134567899999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++|+||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus        75 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          75 TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            99999996 5888887653 356899999999999999999999999999999999999999999999999998543221


Q ss_pred             -CcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhc----------------
Q 011359          338 -DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNK----------------  398 (488)
Q Consensus       338 -~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~-~~~~~~~~~~~~----------------  398 (488)
                       .......++..|+|||.+.+. .++.++|||||||++|+|++|..|+... +..+....+...                
T Consensus       153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence             222344578899999998764 4689999999999999999998886433 322222111110                


Q ss_pred             --cCCC---------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          399 --NLRP---------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       399 --~~~~---------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                        ...+         .....++.++.+||.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence              0000         111346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-38  Score=326.07  Aligned_cols=241  Identities=25%  Similarity=0.409  Sum_probs=192.1

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ..|.+.+.||+|+||.||+|.+.  ++.||+|+...              .....|+.++++++|+||+++++++.....
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  131 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAI  131 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------------cccHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence            46889999999999999999986  46899998542              123469999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .++||||+ .++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus       132 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        132 TCMVLPHY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             eEEEEEcc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            99999999 4688888865 345789999999999999999999999999999999999999999999999999864333


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCHH---------HHHHHHHhc-cC-CCCC
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY-EEMNPI---------QAAFAVVNK-NL-RPAI  404 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf-~~~~~~---------~~~~~~~~~-~~-~~~~  404 (488)
                      ........||..|+|||++.+..++.++|||||||++|||+++..++ ......         ..+..++.. +. ...+
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  289 (357)
T PHA03209        210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF  289 (357)
T ss_pred             CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence            33334456899999999999889999999999999999999854444 332110         011111110 00 0000


Q ss_pred             C------------------------------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          405 P------------------------------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       405 ~------------------------------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +                              ..++..+.+||.+||+.||.+||++.++++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            0                              134667788999999999999999999886

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=330.12  Aligned_cols=245  Identities=24%  Similarity=0.365  Sum_probs=205.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-C-----CCeeeEeee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-N-----PNVIKFVAA  250 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~  250 (488)
                      .+|.+.+.||+|.||.|.+|.+.  ++.||||+++...         .+..+-..|+.+|.+|+ |     -|+|+++++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~  256 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY  256 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence            47899999999999999999985  6899999998532         23456778999999997 4     589999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC--CcEEEeee
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADF  328 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~--~~vkl~DF  328 (488)
                      |...+++|||+|.+ +-+|+++|+......++...+..|+.||+.||.+||+.||||+||||+||||..-  ..+||+||
T Consensus       257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence            99999999999998 6699999999888899999999999999999999999999999999999999643  36999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN-----------  397 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~-----------  397 (488)
                      |.|+......  ....-+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+.+..+.+..++.           
T Consensus       336 GSSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  336 GSSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             ccccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9997654322  255678899999999999999999999999999999999999998887665544432           


Q ss_pred             ----------c-c----------------------------CCCCCCC-----------CCcHHHHHHHHHHhhhCCCCC
Q 011359          398 ----------K-N----------------------------LRPAIPG-----------DCPPAMAALIEQCWSLQPDKR  427 (488)
Q Consensus       398 ----------~-~----------------------------~~~~~~~-----------~~~~~l~~Li~~cL~~dp~~R  427 (488)
                                . .                            .....|.           .-...+.++|.+||..||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                      0 0                            0000110           112468999999999999999


Q ss_pred             CCHHHHHH
Q 011359          428 PEFWHIVK  435 (488)
Q Consensus       428 Ps~~eil~  435 (488)
                      ++..++++
T Consensus       494 ~tp~qal~  501 (586)
T KOG0667|consen  494 ITPAQALN  501 (586)
T ss_pred             CCHHHHhc
Confidence            99999886

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=306.41  Aligned_cols=245  Identities=30%  Similarity=0.499  Sum_probs=203.4

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeeEeeeeecC
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKP  254 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~  254 (488)
                      .|.+.+.||.|+||.||+|.+.  ++.||||++.......       ..+++.+|+.+++++.   |+||+++++++..+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~   74 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD-------DVSDIQREVALLSQLRQSQPPNITKYYGSYLKG   74 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch-------hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence            3567788999999999999974  6899999987543221       1346778999999996   99999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+++||||+.+++|.+++..   ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          75 PRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            999999999999999999865   47899999999999999999999999999999999999999999999999988543


Q ss_pred             cccC-cCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC-CCcHH
Q 011359          335 VYCD-ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG-DCPPA  411 (488)
Q Consensus       335 ~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  411 (488)
                      .... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.. ...+.++. .++.+
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  230 (277)
T cd06917         152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLEDNGYSKL  230 (277)
T ss_pred             CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCCCCCcccCCHH
Confidence            3221 2233468889999999865 4568999999999999999999999988766544332222 22233333 37889


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.++|.+||..+|++||++.+++.
T Consensus       231 ~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         231 LREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhh
Confidence            999999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.8e-37  Score=300.12  Aligned_cols=249  Identities=24%  Similarity=0.474  Sum_probs=214.0

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||.|+||.||++.+.  ++.||+|++.......      ...+.+.+|+++++.++|+|++++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE------KEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh------HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            4677889999999999999987  7899999997654321      2245688999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ++|+||+++++|.+++....  ...+++..++.++.+++.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence            99999999999999998753  4678999999999999999999999999999999999999999999999999885433


Q ss_pred             ccC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          336 YCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       336 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      ... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......+........ ....++..++..+.+
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (258)
T cd08215         155 STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-QYPPIPSQYSSELRN  233 (258)
T ss_pred             cCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC-CCCCCCCCCCHHHHH
Confidence            222 223346888999999998888999999999999999999999999888766555554433 345567788999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.+||..+|++||++.++++
T Consensus       234 ~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         234 LVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHHHHcCCChhhCcCHHHHhc
Confidence            999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-39  Score=328.72  Aligned_cols=248  Identities=29%  Similarity=0.467  Sum_probs=221.3

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      ...|.+.+.||+|.|+.|.+|+..  +..||||+|.....+.      .....+.+|+++|+.|+|||||+++.+.....
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~------~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP------SKRQKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh------HHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            355778999999999999999875  7899999997543322      12344889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+|+||||+.+|.+++++.+  ++.+.+..+..++.|++.|++|||+++|+|||||++||||+.+..+||+|||++....
T Consensus       129 ~lylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             eeEEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence            99999999999999999997  5667778899999999999999999999999999999999999999999999998888


Q ss_pred             ccCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          336 YCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      ......+.+|++.|.|||++.+..| ++.+|+||+|+++|.|++|.+||++.+-.+....++..+++  ++..++.+..+
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~ms~dce~  284 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYMSCDCED  284 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccceeechhHH
Confidence            8888889999999999999998877 68999999999999999999999998777666666666655  56677889999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +|+++|-.+|.+|+++++|.+
T Consensus       285 lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  285 LLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             HHHHhhccCccccCCHHHhhh
Confidence            999999999999999998875

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.2e-37  Score=307.16  Aligned_cols=249  Identities=26%  Similarity=0.414  Sum_probs=204.0

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  254 (488)
                      .++|.+...||+|+||.||++...  ++.+|+|++.....         ....+.+|+.++.++ +|+||+++++++...
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---------~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---------VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---------HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            366889999999999999999985  68999999864221         134567899999999 799999999998643


Q ss_pred             -----CeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          255 -----PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       255 -----~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                           ..+++||||+++++|.++++..  ....+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence                 3689999999999999998743  345689999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccC-cCCCCCCCcccCChhhhhcC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-
Q 011359          328 FGIACEEVYCD-ALSDDPGTYRWMAPEMIKHK-----SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-  400 (488)
Q Consensus       328 Fgla~~~~~~~-~~~~~~gt~~y~aPE~l~~~-----~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-  400 (488)
                      ||++....... ......|+..|+|||.+...     .++.++|||||||++|+|++|..||......+....+..... 
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  251 (291)
T cd06639         172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP  251 (291)
T ss_pred             cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence            99985433211 12334688899999998543     368899999999999999999999998877666555443321 


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 ~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ....+..++..+.+||.+||+.+|++||++.++++
T Consensus       252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            12234567789999999999999999999999886

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-37  Score=313.64  Aligned_cols=241  Identities=24%  Similarity=0.327  Sum_probs=184.8

Q ss_pred             cceeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCee
Q 011359          184 GLRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--PPVY  257 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~  257 (488)
                      +.+||+|+||+||+|.+.    ++.||||.+.....          ...+.+|+.+|++++||||+++++++..  +..+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   75 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKV   75 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence            568999999999999864    46899999864322          1345689999999999999999998854  4578


Q ss_pred             eEEEeecCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE----cCCCcEEEe
Q 011359          258 CVITEYLSEGSLRAYLHKLE-------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIA  326 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl----~~~~~vkl~  326 (488)
                      ++||||+. ++|.+++....       ...+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07868          76 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence            99999984 58888876421       2358889999999999999999999999999999999999    456789999


Q ss_pred             eeccccccccc----CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---------HHH
Q 011359          327 DFGIACEEVYC----DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI---------QAA  392 (488)
Q Consensus       327 DFgla~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~---------~~~  392 (488)
                      |||++......    .......||..|+|||++.+ ..++.++|||||||++|+|++|..||......         ...
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~  234 (317)
T cd07868         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  234 (317)
T ss_pred             ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHH
Confidence            99998643221    12234568999999999976 45899999999999999999999999643310         111


Q ss_pred             HHHHhc-----------------------cCCC-------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          393 FAVVNK-----------------------NLRP-------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       393 ~~~~~~-----------------------~~~~-------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..+...                       ....             ......+..+.+||.+||+.||++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             HHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            111000                       0000             000123456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-38  Score=308.35  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=203.1

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||+|.+.  ++.||||+++......      ...+.+.+|++++++++|+||+++++.+..+..+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE------DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRL   75 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc------cchhHHHHHHHHHHhcCCCCeeehhheEEECCEE
Confidence            6888999999999999999985  6789999987533221      1246788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+.++.+..++..  ...+++..++.++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        76 ~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          76 YLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             EEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            999999988777665544  355899999999999999999999999999999999999999999999999998654332


Q ss_pred             C--cCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--c-------------
Q 011359          338 D--ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--N-------------  399 (488)
Q Consensus       338 ~--~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~--~-------------  399 (488)
                      .  ......++..|+|||++.+. .++.++||||||+++|+|++|..||......+....+...  .             
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            2  22345678899999999877 7899999999999999999999999876654443332210  0             


Q ss_pred             -CC--------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 -LR--------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 -~~--------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                       ..              ...+..++..+.+||.+||..+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence             00              0122345889999999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-38  Score=329.20  Aligned_cols=241  Identities=23%  Similarity=0.355  Sum_probs=193.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ..|.+.+.||+|+||.||++.+.  ++.||||...              ...+.+|+++|++|+|+|||++++++..+..
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~  234 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------------YASSVHEARLLRRLSHPAVLALLDVRVVGGL  234 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            46889999999999999999986  5789999643              1235689999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .++|||++ .++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus       235 ~~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        235 TCLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            99999999 57898888752 34689999999999999999999999999999999999999999999999999864322


Q ss_pred             cC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhc-cC-----
Q 011359          337 CD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP-------IQAAFAVVNK-NL-----  400 (488)
Q Consensus       337 ~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~-------~~~~~~~~~~-~~-----  400 (488)
                      ..   ......||..|+|||++.+..++.++|||||||++|||++|..++.....       ...+..++.. ..     
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            11   11234699999999999988999999999999999999998765532210       1111111111 10     


Q ss_pred             --------------------CCCCC-------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 --------------------RPAIP-------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 --------------------~~~~~-------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                          ++...       ...+..+.+||.+||+.||.+||++.|+++
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                                00000       124457899999999999999999999987

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2e-37  Score=310.39  Aligned_cols=248  Identities=27%  Similarity=0.415  Sum_probs=205.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ..|.+.+.||+|+||.||+|...  ++.||+|++........     ...+.+.+|+.+++.++||||++++++|..+..
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN-----EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH-----HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence            34778889999999999999874  78999999865433221     124568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.... 
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~-  166 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS-  166 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC-
Confidence            999999996 5777777642 3468999999999999999999999999999999999999999999999999885432 


Q ss_pred             cCcCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          337 CDALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                        ......++..|+|||++.   ...++.++||||||+++|+|++|..||...+.......+.........+..++..+.
T Consensus       167 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (307)
T cd06607         167 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR  244 (307)
T ss_pred             --CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence              223446788999999874   356789999999999999999999999988776655554433322233445788999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHH
Q 011359          414 ALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      ++|.+||+.+|++||++.+|+..
T Consensus       245 ~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         245 NFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHHHHhcCChhhCcCHHHHhcC
Confidence            99999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.3e-37  Score=296.61  Aligned_cols=246  Identities=28%  Similarity=0.561  Sum_probs=209.2

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||.|++|.||++.+.  ++.|++|++.....        ...+.+.+|+.++++++|+||+++++.+..+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   72 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL   72 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            3667889999999999999986  68899999975432        1246788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++++||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+......
T Consensus        73 ~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          73 WIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            99999999999999997732 57899999999999999999999999999999999999999999999999988654433


Q ss_pred             CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC--CcHHHHHH
Q 011359          338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD--CPPAMAAL  415 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~L  415 (488)
                      .......++..|++||.+.+..++.++||||||+++|+|++|..||...+.......... ...+..+..  ++..+.++
T Consensus       152 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  230 (253)
T cd05122         152 KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDF  230 (253)
T ss_pred             ccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHH
Confidence            223445688899999999888889999999999999999999999998866555444443 222233333  48899999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      |.+||+.+|++||++.++++
T Consensus       231 i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         231 LKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHHHccCChhhCCCHHHHhc
Confidence            99999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.6e-37  Score=308.56  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=203.2

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  254 (488)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||.++......      .....+.+|+.++.+++||||+++++++... 
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   77 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE------GFPITSLREINILLKLQHPNIVTVKEVVVGSN   77 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc------cchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence            457888999999999999999986  6889999998654321      1234577899999999999999999998877 


Q ss_pred             -CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          255 -PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       255 -~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                       ...++||||+. ++|.+++... ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++..
T Consensus        78 ~~~~~lv~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~  155 (293)
T cd07843          78 LDKIYMVMEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE  155 (293)
T ss_pred             CCcEEEEehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence             88999999996 5999988763 24689999999999999999999999999999999999999999999999998864


Q ss_pred             cccc-CcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Q 011359          334 EVYC-DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK-------------  398 (488)
Q Consensus       334 ~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~-------------  398 (488)
                      .... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+....+...             
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            4332 222334578899999998654 4689999999999999999999999877665443332211             


Q ss_pred             ----------------cCCCCCCCC-CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          399 ----------------NLRPAIPGD-CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       399 ----------------~~~~~~~~~-~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                      .+...++.. +++.+.++|.+||+.+|++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                            001112222 5788999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-37  Score=304.84  Aligned_cols=247  Identities=29%  Similarity=0.462  Sum_probs=201.5

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CC
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--PP  255 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~  255 (488)
                      +|...++||.|++|.||++.+.  ++.||+|.+......       ....++.+|++++++++|+||++++++|..  ..
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   74 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-------DLQKQILRELEINKSCKSPYIVKYYGAFLDESSS   74 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-------HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence            5677889999999999999985  689999999754332       124668899999999999999999998854  34


Q ss_pred             eeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      .+++||||+++++|.+++...  ....+++..+..++.||+.||+|||+.|++|+||+|.||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence            789999999999999988653  345688899999999999999999999999999999999999999999999999854


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhccCCCCCC---
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM-----NPIQAAFAVVNKNLRPAIP---  405 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~-----~~~~~~~~~~~~~~~~~~~---  405 (488)
                      ..... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...     ...+....+.. ...+.++   
T Consensus       155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  232 (287)
T cd06621         155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEP  232 (287)
T ss_pred             ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCC
Confidence            33221 12345788999999999889999999999999999999999999865     22333322222 1111111   


Q ss_pred             ---CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          406 ---GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       406 ---~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                         ..+++.+.++|.+||..+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence               235678999999999999999999999887

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-37  Score=307.66  Aligned_cols=248  Identities=26%  Similarity=0.414  Sum_probs=202.2

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.+.+.||.|++|.||+|.+.  ++.||||.+........      ....+.+|++++++++|+||+++++++......+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG------VPSTAIREISLLKELNHPNIVKLLDVIHTENKLY   75 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc------cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEE
Confidence            667889999999999999885  68999999875432211      1356789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-  337 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-  337 (488)
                      +||||+. ++|.+++.......+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... 
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            9999995 68999998766677899999999999999999999999999999999999999999999999988543221 


Q ss_pred             CcCCCCCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------------
Q 011359          338 DALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--------------  402 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~~~~-~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------------  402 (488)
                      .......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+......+              
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            1223345788999999886543 6889999999999999999999998776554444333211000              


Q ss_pred             -------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 -------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 -------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                   .....++..+.++|.+||+.||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                         012346788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=309.86  Aligned_cols=249  Identities=24%  Similarity=0.412  Sum_probs=220.9

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ..+.+.+++|.+.+.||+|.||.|.+++.+  ++.+|+|+++....-....     ...-..|-++|+..+||.+..+..
T Consensus       161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdE-----VAHTlTE~RVL~~~~HPFLt~LKY  235 (516)
T KOG0690|consen  161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDE-----VAHTLTENRVLQNCRHPFLTSLKY  235 (516)
T ss_pred             ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHH-----hhhhhhHHHHHHhccCcHHHHhhh
Confidence            455677888999999999999999999876  7999999998654333222     234568999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      .|....++|+||||..||.|+-+|.+  ...+++.....+-.+|+.||.|||+++||.||||.+|.|+|.+|++||.|||
T Consensus       236 sFQt~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFG  313 (516)
T KOG0690|consen  236 SFQTQDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFG  313 (516)
T ss_pred             hhccCceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecc
Confidence            99999999999999999999998876  5678999999999999999999999999999999999999999999999999


Q ss_pred             cccccc-ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 011359          330 IACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       330 la~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      ++.+.. ++....+.+||+.|+|||++....|+.++|.|.+||++|||+||++||...+.......++...+  .+|..+
T Consensus       314 LCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--kFPr~l  391 (516)
T KOG0690|consen  314 LCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--KFPRTL  391 (516)
T ss_pred             cchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--cCCccC
Confidence            997644 45566788999999999999999999999999999999999999999999888777766766655  478899


Q ss_pred             cHHHHHHHHHHhhhCCCCCCC
Q 011359          409 PPAMAALIEQCWSLQPDKRPE  429 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs  429 (488)
                      +++.+.|+..+|.+||.+|..
T Consensus       392 s~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  392 SPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             CHHHHHHHHHHhhcChHhhcC
Confidence            999999999999999999954

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-37  Score=310.97  Aligned_cols=245  Identities=24%  Similarity=0.431  Sum_probs=204.3

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.....||+|+||.||++...  ++.||||++.......        .+.+.+|+.++..++||||+++++.+..+..++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   94 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELW   94 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch--------HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEE
Confidence            334557899999999999874  7899999986533211        345789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-  337 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-  337 (488)
                      +|+||+++++|.+++..   ..+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... 
T Consensus        95 iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          95 VLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            99999999999998765   56889999999999999999999999999999999999999999999999988532211 


Q ss_pred             CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHH
Q 011359          338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RPAIPGDCPPAMAALI  416 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~Li  416 (488)
                      .......|+..|+|||++.+..++.++|||||||++|+|++|..||......+....+..... .......++..+.++|
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i  251 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFL  251 (297)
T ss_pred             ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHH
Confidence            112334588999999999888899999999999999999999999988776655444332211 1223346788999999


Q ss_pred             HHHhhhCCCCCCCHHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~~  436 (488)
                      .+||+.+|++||++.++++.
T Consensus       252 ~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         252 ERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHhcCCcccCcCHHHHhhC
Confidence            99999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.6e-37  Score=305.91  Aligned_cols=247  Identities=29%  Similarity=0.539  Sum_probs=209.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +.|.+...||+|++|.||+|.+.  ++.||+|++.....         ....+.+|++++++++|+||+++++.+.....
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            34777889999999999999987  78999999975432         14567899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            999999999999999998733 3789999999999999999999999999999999999999999999999998743322


Q ss_pred             cC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-CCCCCcHHHHH
Q 011359          337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA-IPGDCPPAMAA  414 (488)
Q Consensus       337 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~  414 (488)
                      .. ......++..|++||.+.+..++.++|+||||+++|+|++|..||...++......+........ .+..++..+.+
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  248 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD  248 (286)
T ss_pred             chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence            11 11233478899999999888899999999999999999999999998877665555444333221 22348899999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +|.+||+.+|.+||++.++++
T Consensus       249 li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         249 FLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHHhccChhhCcCHHHHhh
Confidence            999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.7e-38  Score=312.06  Aligned_cols=241  Identities=25%  Similarity=0.464  Sum_probs=201.7

Q ss_pred             ccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEE
Q 011359          183 LGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       183 i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  260 (488)
                      ....||+|+||.||++...  ++.||||.+.....        ...+.+.+|+.+++.++|+||+++++.+..+...++|
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv   97 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--------QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV   97 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--------HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence            4567899999999999874  68999999864221        1245688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-Cc
Q 011359          261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-DA  339 (488)
Q Consensus       261 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-~~  339 (488)
                      |||+++++|.+++..   ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... ..
T Consensus        98 ~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658          98 MEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             EeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            999999999998854   46889999999999999999999999999999999999999999999999988533211 11


Q ss_pred             CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHHHHHHH
Q 011359          340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--IPGDCPPAMAALIE  417 (488)
Q Consensus       340 ~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~Li~  417 (488)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|..||......+....+.. .....  ....++..+.++|.
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~  253 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHKVSSVLRGFLD  253 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCccccccccCHHHHHHHH
Confidence            2234588899999999888899999999999999999999999988776554443322 22222  22356889999999


Q ss_pred             HHhhhCCCCCCCHHHHHH
Q 011359          418 QCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       418 ~cL~~dp~~RPs~~eil~  435 (488)
                      +||..+|.+||++.++++
T Consensus       254 ~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         254 LMLVREPSQRATAQELLQ  271 (292)
T ss_pred             HHccCChhHCcCHHHHhh
Confidence            999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.2e-37  Score=308.39  Aligned_cols=255  Identities=25%  Similarity=0.468  Sum_probs=205.8

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEe
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFV  248 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~  248 (488)
                      ..+.++.++|.+.+.||+|+||.||+|.+.  ++.||||.+.......       ....+..|+.++.++. |+||++++
T Consensus         8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~e~~~~~~~~~~~~i~~~~   80 (296)
T cd06618           8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-------ENKRILMDLDVVLKSHDCPYIVKCY   80 (296)
T ss_pred             eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-------HHHHHHHHHHHHHhccCCCchHhhh
Confidence            456778899999999999999999999997  7899999997543221       1345567777777765 99999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEEee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                      +++......++||||+ +++|.+++... ...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.++|+|
T Consensus        81 ~~~~~~~~~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~d  158 (296)
T cd06618          81 GYFITDSDVFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCD  158 (296)
T ss_pred             eeeecCCeEEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECc
Confidence            9999999999999998 45787777653 3478999999999999999999997 5999999999999999999999999


Q ss_pred             ecccccccccCcCCCCCCCcccCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCC
Q 011359          328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNPI-QAAFAVVNKNLRP  402 (488)
Q Consensus       328 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~k~DvwSlGvll~elltG~~Pf~~~~~~-~~~~~~~~~~~~~  402 (488)
                      ||++.............++..|+|||.+.+..    ++.++||||||+++|+|++|..||...... +....+.... .+
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~  237 (296)
T cd06618         159 FGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PP  237 (296)
T ss_pred             cccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CC
Confidence            99986543333333445788999999986543    788999999999999999999999765432 3333333332 22


Q ss_pred             CCC--CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          403 AIP--GDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       403 ~~~--~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      ..+  ..++.++.+||.+||..+|++||++.+++..
T Consensus       238 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            222  3478999999999999999999999998863

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-37  Score=308.16  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=202.1

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|.+.  ++.||+|++.......      ...+.+.+|+++++.++|+||+++++++..+..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK------MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc------hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            35778899999999999999985  6899999986433221      124567899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++|+||+++++|..+...  ...+++..++.++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             EEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999999999999887764  34589999999999999999999999999999999999999999999999999854322


Q ss_pred             c-CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--c-------------
Q 011359          337 C-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--N-------------  399 (488)
Q Consensus       337 ~-~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~--~-------------  399 (488)
                      . .......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+...  .             
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            2 12233457889999999865 34788999999999999999999999866654433222210  0             


Q ss_pred             -----CCC---------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 -----LRP---------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 -----~~~---------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                           ..+         .....++..+.+|+.+||..+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                 000         012356889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-37  Score=296.44  Aligned_cols=247  Identities=30%  Similarity=0.568  Sum_probs=212.4

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|++|.||++...  ++.||||.+......      ......+.+|++++.+++|+|++++++++.....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            4678899999999999999875  678999999765432      12246788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      +++|||+++++|.+++...  ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus        75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            9999999999999999763  67899999999999999999999999999999999999999999999999998644322


Q ss_pred             Cc-CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 011359          338 DA-LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       338 ~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      .. .....++..|+|||.+.+..++.++|||+||+++|+|++|..||.............. ...+.++..++..+.++|
T Consensus       153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i  231 (254)
T cd06627         153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFL  231 (254)
T ss_pred             cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCCHHHHHHH
Confidence            21 2334678899999999887889999999999999999999999988776655555443 344566778899999999


Q ss_pred             HHHhhhCCCCCCCHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||..+|++||++.+++.
T Consensus       232 ~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         232 MQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHHhCChhhCcCHHHHhc
Confidence            9999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.3e-37  Score=305.57  Aligned_cols=250  Identities=26%  Similarity=0.390  Sum_probs=202.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|++|.||+|.+.  ++.||||.+.......      .....+.+|++++++++|+||+++++++..+..
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE------GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc------cchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            57888999999999999999975  6889999987543221      123567789999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-CCcEEEeeeccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIACEEV  335 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-~~~vkl~DFgla~~~~  335 (488)
                      +++||||++ ++|.+++.......+++..+..++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++....
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            999999995 58888887654455688889999999999999999999999999999999985 5679999999985432


Q ss_pred             cc-CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------------
Q 011359          336 YC-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR------------  401 (488)
Q Consensus       336 ~~-~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~------------  401 (488)
                      .. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+....-.            
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            21 22234457889999999865 45789999999999999999999999887766555443321000            


Q ss_pred             -------CC--------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 -------PA--------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 -------~~--------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                             +.        .....+..+.++|.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   00        12346788999999999999999999999886

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.2e-37  Score=308.03  Aligned_cols=251  Identities=26%  Similarity=0.421  Sum_probs=210.0

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |...+.||+|+||.||+|.+.  +..||||++........     ...+.+.+|++++++++|+|++++++++..+...+
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN-----EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW  101 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch-----HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence            556788999999999999874  68899999875433221     12456889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +||||+. |+|.+++... ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....   
T Consensus       102 lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~---  176 (317)
T cd06635         102 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---  176 (317)
T ss_pred             EEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC---
Confidence            9999996 5787777542 4568999999999999999999999999999999999999999999999999875322   


Q ss_pred             cCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          339 ALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       339 ~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      ......|+..|+|||.+.   ...++.++|||||||++|+|++|..||...........+............++..+.++
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  256 (317)
T cd06635         177 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF  256 (317)
T ss_pred             CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence            223446888999999984   45688999999999999999999999988877776666666554444556788999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      |.+||+.+|.+||++.++++.+..+.
T Consensus       257 i~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         257 VDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             HHHHccCCcccCcCHHHHHhChhhhc
Confidence            99999999999999999998655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=305.38  Aligned_cols=249  Identities=24%  Similarity=0.380  Sum_probs=197.6

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+.+.||.|++|.||+|...  ++.||||.+........       ...+.+|+.++++++|+||+++++++..+.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-------PFTAIREASLLKDLKHANIVTLHDIIHTKK   76 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-------chhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence            367889999999999999999875  68999999976432211       234568999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ..++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus        77 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          77 TLTLVFEYLD-TDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             eEEEEEecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            9999999997 4999988763 3468899999999999999999999999999999999999999999999999985432


Q ss_pred             cc-CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh---cc----------
Q 011359          336 YC-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVN---KN----------  399 (488)
Q Consensus       336 ~~-~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~---~~----------  399 (488)
                      .. .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.... ..+....+..   ..          
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            11 11223356888999999865 457899999999999999999999997665 2222111110   00          


Q ss_pred             --------CCC-------CCCCCCc--HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 --------LRP-------AIPGDCP--PAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 --------~~~-------~~~~~~~--~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                              ...       .....+.  ..+.++|.+||+.+|++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                    000       0001233  78889999999999999999998875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.9e-37  Score=307.20  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=202.3

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||.|+||.||+|.+.  ++.||||.+.........   ......+..|+.++++++|+||+++++++.....+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   77 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAK---DGINFTALREIKLLQELKHPNIIGLLDVFGHKSNI   77 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccccc---chhhHHHHHHHHHHhhcCCCCChhhhheeecCCEE
Confidence            3667889999999999999975  689999999865432110   12245677899999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus        78 ~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          78 NLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999999 899999997632 36899999999999999999999999999999999999999999999999998644322


Q ss_pred             -CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------------
Q 011359          338 -DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--------------  401 (488)
Q Consensus       338 -~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~--------------  401 (488)
                       .......++..|+|||.+.+ ..++.++|||||||++|+|++|..+|......+....+......              
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence             22233456788999999854 46789999999999999999998888776654433333211000              


Q ss_pred             -------C-----CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 -------P-----AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 -------~-----~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                             +     ......+..+.++|.+||..+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                   0     011345678999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3e-37  Score=307.70  Aligned_cols=258  Identities=16%  Similarity=0.220  Sum_probs=191.1

Q ss_pred             cccceeccceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHH---HHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETL---AARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      .-++|.+++.||+|+||.||+|.+.+     ..+|+|+............   ..........++..+..+.|+||++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            34679999999999999999999764     3677776544332111000   011122234455566778899999999


Q ss_pred             eeeecCC----eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEE
Q 011359          249 AACKKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK  324 (488)
Q Consensus       249 ~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vk  324 (488)
                      +.+....    ..++++|++ ..++.+.+...  ...++..+..++.|++.||+|||+.||+||||||+|||++.++.++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             EeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence            9765443    346788877 44677776652  3457888999999999999999999999999999999999999999


Q ss_pred             Eeeeccccccccc--------CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-
Q 011359          325 IADFGIACEEVYC--------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI-QAAFA-  394 (488)
Q Consensus       325 l~DFgla~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~-~~~~~-  394 (488)
                      |+|||+|......        .......||..|+|||++.+..++.++|||||||++|||++|..||...... ..... 
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999998643211        1112346999999999999899999999999999999999999999877322 21111 


Q ss_pred             ---HHhc-cCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 011359          395 ---VVNK-NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       395 ---~~~~-~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~L  437 (488)
                         .... .........++.++.+++..||..+|++||++.+|++.|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        247 KCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence               1111 001112356789999999999999999999999999876

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=300.54  Aligned_cols=243  Identities=24%  Similarity=0.392  Sum_probs=197.6

Q ss_pred             ceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHH-HhcCCCCeeeEeeeeecCCeeeEEE
Q 011359          185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALL-SRLHNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      +.||+|+||.||+|...  ++.||||++........     .....+..|..++ ..++|+||+++++++.....+++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-----NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH-----HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence            46899999999999884  68999999864322111     1122344555444 4558999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS  341 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~  341 (488)
                      ||+.+++|.+++..  ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....   ..
T Consensus        77 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~  151 (260)
T cd05611          77 EYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NK  151 (260)
T ss_pred             eccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cc
Confidence            99999999999976  35688999999999999999999999999999999999999999999999998854332   23


Q ss_pred             CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCcHHHHHHHHHH
Q 011359          342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL--RPAIPGDCPPAMAALIEQC  419 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~Li~~c  419 (488)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.....  .......++..+.++|.+|
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  231 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL  231 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence            44588899999999888889999999999999999999999998877665555443332  2234456889999999999


Q ss_pred             hhhCCCCCCCHHHHHHHH
Q 011359          420 WSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       420 L~~dp~~RPs~~eil~~L  437 (488)
                      |+.+|++||++.++.+.|
T Consensus       232 l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         232 LCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccCCHHHccCCCcHHHHH
Confidence            999999999776554433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.4e-37  Score=297.94  Aligned_cols=248  Identities=25%  Similarity=0.413  Sum_probs=210.9

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||++...  ++.+|||.+.......      .....+.+|+.+++.++|+||+++++++.....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ------KEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH------HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            3677889999999999999875  6789999997543221      1245677899999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ++||||+++++|.+++...  ....+++..++.++.|++.||+|||+.|++||||+|.||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            9999999999999998763  23568899999999999999999999999999999999999999999999999985443


Q ss_pred             ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      .. ......++..|++||.+.+..++.++|+||||+++|+|++|..||...+..+....+.. ...+..+..++.++.++
T Consensus       155 ~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  232 (256)
T cd08530         155 KN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPIYSQDLQNF  232 (256)
T ss_pred             cC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCchhhCHHHHHH
Confidence            32 23345688899999999988899999999999999999999999998877655444433 33445566788999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      |.+||+.+|++||++.++++
T Consensus       233 i~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         233 IRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HHHHcCCCcccCCCHHHHhc
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.9e-37  Score=304.49  Aligned_cols=243  Identities=24%  Similarity=0.456  Sum_probs=203.5

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |...+.||.|++|.||++.+.  ++.||||.+......        ..+.+.+|+.+++.++|+||+++++++......+
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~   92 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ--------RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELW   92 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh--------HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEE
Confidence            334568999999999999874  688999998643221        1356789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-  337 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-  337 (488)
                      +|+||+.+++|.+++..   ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... 
T Consensus        93 ~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          93 VVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             EEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            99999999999999876   56889999999999999999999999999999999999999999999999987432211 


Q ss_pred             CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHHHHH
Q 011359          338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--IPGDCPPAMAAL  415 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~L  415 (488)
                      .......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+... ..+.  .+..++..+.++
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l  248 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSF  248 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHH
Confidence            1122345889999999998888999999999999999999999999887766555444433 2222  233478899999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      |.+||+.+|++||++.++++
T Consensus       249 i~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         249 LDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHcccChhhCcCHHHHcc
Confidence            99999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.5e-37  Score=302.03  Aligned_cols=245  Identities=19%  Similarity=0.317  Sum_probs=196.2

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecC--C
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP--P  255 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~  255 (488)
                      |.+.+.||+|+||.||+|...  ++.||||++........       .....+|+.++.++. |+||+++++++.++  .
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   73 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-------QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG   73 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-------hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence            456788999999999999874  68899999875432211       123457899999986 99999999999887  8


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+. ++|.+++... ...+++..++.++.|++.||+|||+.|++||||+|+||+++. +.++|+|||++....
T Consensus        74 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          74 RLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             cEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            8999999996 5888887653 356899999999999999999999999999999999999999 999999999986543


Q ss_pred             ccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------------
Q 011359          336 YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN---------------  399 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~---------------  399 (488)
                      .........++..|+|||.+.. ..++.++|||||||++|||++|..||.+.+..+....+....               
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            3333334457889999998754 456889999999999999999999998877654433322100               


Q ss_pred             -CCCCC-----------CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 -LRPAI-----------PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 -~~~~~-----------~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                       .....           ...++..+.+||.+||..+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence             00001           1356789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.1e-37  Score=308.56  Aligned_cols=247  Identities=25%  Similarity=0.476  Sum_probs=205.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|...  ++.||+|.+.......        ...+.+|+.+++.++||||+++++.+.....
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   90 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK--------KELIINEILVMRENKHPNIVNYLDSYLVGDE   90 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH--------HHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence            57888899999999999999864  6889999986433221        3457899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .++|+||+++++|.+++.+   ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus        91 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            9999999999999999975   4578899999999999999999999999999999999999999999999998753322


Q ss_pred             cC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCcHHHHH
Q 011359          337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-LRPAIPGDCPPAMAA  414 (488)
Q Consensus       337 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~  414 (488)
                      .. ......++..|+|||.+....++.++|+||||+++|+|++|..||...+.......+.... .....+..++..+.+
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD  247 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHH
Confidence            11 2233458889999999988888999999999999999999999998776544433222211 111223456788999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      +|.+||..+|++||++.+++..
T Consensus       248 li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         248 FLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHHHccCChhhCcCHHHHhcC
Confidence            9999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=303.51  Aligned_cols=248  Identities=27%  Similarity=0.395  Sum_probs=202.3

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.+.+.||.|++|.||+|.+.  |+.||||++........      ....+.+|+.++++++|+|++++++++..+...+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG------VPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc------chhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            456788999999999999874  78999999976432211      1345778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-  337 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-  337 (488)
                      +||||+. ++|.+++.......+++..++.++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++...... 
T Consensus        75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            9999994 69999998754457899999999999999999999999999999999999999999999999998543221 


Q ss_pred             CcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------------
Q 011359          338 DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR---------------  401 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~---------------  401 (488)
                      .......++..|+|||++.+. .++.++||||||+++|+|++|..||...+.......+......               
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            122334568899999988654 5789999999999999999999999887765544443321000               


Q ss_pred             ------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 ------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 ------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                  ......++..+.++|.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                        0112456788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.2e-37  Score=309.38  Aligned_cols=249  Identities=21%  Similarity=0.389  Sum_probs=201.7

Q ss_pred             eeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEE
Q 011359          181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  260 (488)
                      +.+++.+|.|+++.||++..+++.||||++.......      ...+.+.+|+.++++++|+||+++++++.....++++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   77 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK------EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV   77 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccch------hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEE
Confidence            3467777888888888888889999999998643221      1245788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc---
Q 011359          261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC---  337 (488)
Q Consensus       261 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~---  337 (488)
                      |||+.+++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+......   
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            99999999999998765567899999999999999999999999999999999999999999999999987533211   


Q ss_pred             -----CcCCCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------
Q 011359          338 -----DALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR---------  401 (488)
Q Consensus       338 -----~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~---------  401 (488)
                           .......++..|+|||++..  ..++.++|+|||||++|+|++|..||..................         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                 11223446778999999965  35889999999999999999999999887655443332221100         


Q ss_pred             -----------------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 -----------------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 -----------------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                             ......++.++.+||.+||..+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                                   0011123467889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.6e-37  Score=307.30  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=202.4

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      ..++|.+.+.||.|+||.||+|.+.  ++.||+|+++........      ...+.+|+.++++++|+||+++++++...
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI------PISSLREITLLLNLRHPNIVELKEVVVGK   78 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC------cchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence            4567889999999999999999985  789999999764432211      23456899999999999999999998654


Q ss_pred             --CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          255 --PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       255 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                        ..+++||||+. ++|.+++... ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~  156 (309)
T cd07845          79 HLDSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR  156 (309)
T ss_pred             CCCeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceee
Confidence              56899999996 5898888763 3568999999999999999999999999999999999999999999999999986


Q ss_pred             ccccc-CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------
Q 011359          333 EEVYC-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR---------  401 (488)
Q Consensus       333 ~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~---------  401 (488)
                      ..... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+......         
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            54322 12223345788999999865 46789999999999999999999999988776655544431100         


Q ss_pred             --------CCC-----------CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 --------PAI-----------PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 --------~~~-----------~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                              ...           ....++.+.+||.+||+.||++||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                    000           0124788999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.6e-37  Score=314.19  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=199.0

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  254 (488)
                      ..+|.+.+.||+|+||.||+|...  ++.||||++........      ....+.+|+.++++++|+||+++++++... 
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT------HAKRAYRELVLMKLVNHKNIIGLLNVFTPQK   88 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChh------HHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence            367889999999999999999874  78999999864322211      134567899999999999999999988643 


Q ss_pred             -----CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          255 -----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       255 -----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                           ...|+||||+. ++|.+.+..    .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||
T Consensus        89 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          89 SLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence                 35789999995 588888764    28889999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL---------  400 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~---------  400 (488)
                      ++.............++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+...-.         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         164 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             cceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            99654433333345688899999999988999999999999999999999999987765433222211000         


Q ss_pred             -----------CC---------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 -----------RP---------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 -----------~~---------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                 ++                     ..+...+..+.+||.+||+.||++||++.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                       00                     001134667899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.9e-37  Score=300.15  Aligned_cols=244  Identities=28%  Similarity=0.412  Sum_probs=203.3

Q ss_pred             eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeec
Q 011359          187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  264 (488)
                      ||.|+||.||++.+.  ++.||+|++.......     ......+.+|++++++++|+||+++++.+..+..+|+|+||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR-----KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhh-----hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence            589999999999986  7899999986533211     223567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC------
Q 011359          265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD------  338 (488)
Q Consensus       265 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~------  338 (488)
                      .+++|.+++.+.  ..+++..++.++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++.......      
T Consensus        76 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          76 PGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            999999999873  378999999999999999999999999999999999999999999999999885433221      


Q ss_pred             ---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          339 ---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       339 ---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                         ......++..|++||.+....++.++||||||+++|+|++|..||......+....+............++..+.++
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDL  233 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence               12234578899999999888889999999999999999999999998887766655554333222222248999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~~L  437 (488)
                      |.+||+.+|++||++..+.+.|
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHh
Confidence            9999999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3e-37  Score=309.82  Aligned_cols=241  Identities=23%  Similarity=0.335  Sum_probs=183.9

Q ss_pred             cceeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee--cCCee
Q 011359          184 GLRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK--KPPVY  257 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~  257 (488)
                      +.+||+|+||.||+|...    +..||+|.+.....          ...+.+|+.++++++||||+++++++.  .+..+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   75 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRKV   75 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeE
Confidence            467999999999999864    36899999864321          134668999999999999999999884  35678


Q ss_pred             eEEEeecCCCCHHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE----cCCCcEEEe
Q 011359          258 CVITEYLSEGSLRAYLHKL-------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIA  326 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl----~~~~~vkl~  326 (488)
                      ++||||+. ++|.+++...       ....+++..+..++.||+.||.|||+.||+||||||+|||+    +.++.+||+
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07867          76 WLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence            99999985 5888877532       12357888999999999999999999999999999999999    566789999


Q ss_pred             eecccccccccC----cCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---------HHH
Q 011359          327 DFGIACEEVYCD----ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI---------QAA  392 (488)
Q Consensus       327 DFgla~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~---------~~~  392 (488)
                      |||++.......    ......||..|+|||++.+ ..++.++|||||||++|||++|..||......         ...
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  234 (317)
T cd07867         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL  234 (317)
T ss_pred             eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence            999986432211    1233467899999999976 45799999999999999999999999753211         000


Q ss_pred             HHHHh-----------------------ccCC-------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          393 FAVVN-----------------------KNLR-------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       393 ~~~~~-----------------------~~~~-------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..+..                       ....             .......+..+.+||.+||..||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            00000                       0000             0001123456889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=304.19  Aligned_cols=255  Identities=26%  Similarity=0.384  Sum_probs=212.1

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVA  249 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~  249 (488)
                      -|++...++.-...||.|+||+|++..++  |+..|||.|+....       .+..++|..|.+...+- +.||||++||
T Consensus        58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-------~keq~rll~e~d~~mks~~cp~IVkfyG  130 (361)
T KOG1006|consen   58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-------EKEQKRLLMEHDTVMKSSNCPNIVKFYG  130 (361)
T ss_pred             ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-------hHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence            34555566666778899999999999886  79999999986544       23367888999886665 5899999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHH---HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEE
Q 011359          250 ACKKPPVYCVITEYLSEGSLRA---YLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKI  325 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~---~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl  325 (488)
                      ++..++.+|+.||+|+ .+|..   ++.......+++..+..|...++.||.||.. ..||||||||+|||++..|.+||
T Consensus       131 a~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKL  209 (361)
T KOG1006|consen  131 ALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKL  209 (361)
T ss_pred             hhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEee
Confidence            9999999999999994 45544   3344456789999999999999999999975 58999999999999999999999


Q ss_pred             eeecccccccccCcCCCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          326 ADFGIACEEVYCDALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       326 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      ||||++......-..+...|...|||||.+..  ..|+.++||||||++|||+.||..||.+++..-.....+..+-.+.
T Consensus       210 CDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~  289 (361)
T KOG1006|consen  210 CDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI  289 (361)
T ss_pred             ecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe
Confidence            99999987777777788899999999999953  3589999999999999999999999999987554444444443333


Q ss_pred             CC-----CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          404 IP-----GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       404 ~~-----~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.     ..++..+..+|+.||.+|-.+||++.++++
T Consensus       290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            22     247889999999999999999999998876

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.7e-37  Score=301.91  Aligned_cols=241  Identities=23%  Similarity=0.385  Sum_probs=190.9

Q ss_pred             eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHH---HHhcCCCCeeeEeeeeecCCeeeEEE
Q 011359          187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVAL---LSRLHNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~i---l~~l~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      ||+|+||.||++.+.  ++.||||++..........     ...+..|..+   +...+|+||+.+++++..++.+++||
T Consensus         2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   76 (279)
T cd05633           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-----ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFIL   76 (279)
T ss_pred             cccCCCeEEEEEEECCCCcEEEEEEEEccccccchH-----HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEE
Confidence            799999999999875  6899999997543221110     1223344433   33447999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS  341 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~  341 (488)
                      ||+.+++|.+++..  ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++...... ...
T Consensus        77 e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~  153 (279)
T cd05633          77 DLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPH  153 (279)
T ss_pred             ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-Ccc
Confidence            99999999999875  456999999999999999999999999999999999999999999999999998543322 223


Q ss_pred             CCCCCcccCChhhhh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 011359          342 DDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ-AAFAVVNKNLRPAIPGDCPPAMAALIEQC  419 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~Li~~c  419 (488)
                      ...|+..|+|||.+. +..++.++|||||||++|+|++|..||....... .............++..++.++.++|.+|
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  233 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGL  233 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHH
Confidence            346899999999986 4568999999999999999999999997543211 11111222334556778899999999999


Q ss_pred             hhhCCCCCC-----CHHHHHH
Q 011359          420 WSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       420 L~~dp~~RP-----s~~eil~  435 (488)
                      |..||.+||     ++.++++
T Consensus       234 l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         234 LQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             hcCCHHHhcCCCCCCHHHHHh
Confidence            999999999     4776655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-36  Score=301.46  Aligned_cols=248  Identities=24%  Similarity=0.401  Sum_probs=195.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      .+|.+.+.||+|+||.||+|...  ++.||||++........       ...+.+|+.+++.++|+||+++++++..+..
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-------PFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC-------cHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence            56888999999999999999875  78999999975433221       2346689999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            999999995 6787777542 34578888999999999999999999999999999999999999999999998854321


Q ss_pred             -cCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHh----------------
Q 011359          337 -CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA-FAVVN----------------  397 (488)
Q Consensus       337 -~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~-~~~~~----------------  397 (488)
                       ........++..|+|||.+.+. .++.++|||||||++|+|++|..||......... ..+..                
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence             1222344578899999998653 5788999999999999999999999876543221 11110                


Q ss_pred             ccCCCC-----CC---------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          398 KNLRPA-----IP---------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       398 ~~~~~~-----~~---------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ......     .+         ...+..+.+++.+||..||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000     00         123568899999999999999999998874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8e-38  Score=317.06  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=201.5

Q ss_pred             cccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~  252 (488)
                      .|.-..|.+.++||.||.+.||++...+ +.||+|.+.....+.      +...-|.+|+.+|.+|+ |.+||++++|-.
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~------qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv  430 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN------QTLDGYRNEIALLNKLKGHDKIIQLYDYEV  430 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH------HHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence            4566789999999999999999998764 678877765433222      22456889999999997 999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .++.+||||||- ..+|..+|.+.......+ .+..+..||+.++.++|..||||.||||.|+|+- .|.+||+|||+|.
T Consensus       431 ~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~  507 (677)
T KOG0596|consen  431 TDGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIAN  507 (677)
T ss_pred             cCceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhc
Confidence            999999999974 679999998854333334 7888999999999999999999999999999984 4699999999995


Q ss_pred             ccccc---CcCCCCCCCcccCChhhhhcCC-----------CCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Q 011359          333 EEVYC---DALSDDPGTYRWMAPEMIKHKS-----------YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVN  397 (488)
Q Consensus       333 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~-----------~~~k~DvwSlGvll~elltG~~Pf~~~~~-~~~~~~~~~  397 (488)
                      .....   -.....+||+.||+||.+....           .++++||||||||||+|+.|+.||....+ ...+.++.+
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~  587 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD  587 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence            43322   2234568999999999996433           46899999999999999999999988764 344445555


Q ss_pred             ccCCCCCCCCCc-HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          398 KNLRPAIPGDCP-PAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       398 ~~~~~~~~~~~~-~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+-..++|..-+ .++.++++.||+.||++||+..++|+
T Consensus       588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            544334443322 24999999999999999999999886

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.4e-37  Score=302.85  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=199.6

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCe
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPV  256 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~  256 (488)
                      +|.+.+.||+|+||.||+|.+.  ++.||||++........      ....+.+|+.+++.+. |+||+++++++.....
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   75 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG------IPPTALREISLLQMLSESIYIVRLLDVEHVEEK   75 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC------CchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence            5778899999999999999985  68999999875432211      1345778999999996 6999999999876655


Q ss_pred             -----eeEEEeecCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-CCcEEEee
Q 011359          257 -----YCVITEYLSEGSLRAYLHKLE---HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIAD  327 (488)
Q Consensus       257 -----~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-~~~vkl~D  327 (488)
                           +++||||+.+ +|.+++....   ...+++..++.++.||+.||.|||++||+||||+|+||+++. ++.++|+|
T Consensus        76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          76 NGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             CCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEee
Confidence                 8999999975 8988887642   246899999999999999999999999999999999999998 88999999


Q ss_pred             eccccccccc-CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---
Q 011359          328 FGIACEEVYC-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP---  402 (488)
Q Consensus       328 Fgla~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~---  402 (488)
                      ||++...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+...-..+   
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9998543221 12233456888999998864 457899999999999999999999998877666554433210000   


Q ss_pred             -----------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 -----------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 -----------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                             .....++..+.+||.+||..+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                                   011347888999999999999999999998875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-36  Score=300.18  Aligned_cols=248  Identities=23%  Similarity=0.416  Sum_probs=201.1

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.++||.|++|.||+|.+.  ++.||||++........       ...+.+|+.++++++|+||+++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   73 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT-------PSTAIREISLMKELKHENIVRLHDVIHTENKL   73 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc-------hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence            4678899999999999999985  68899999986543221       24567899999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      ++||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+.|++||||+|+||++++++.++|+|||++.....
T Consensus        74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            999999975 8888887543 24689999999999999999999999999999999999999999999999998854322


Q ss_pred             c-CcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------------
Q 011359          337 C-DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN---------------  399 (488)
Q Consensus       337 ~-~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~---------------  399 (488)
                      . .......++..|++||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....               
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence            1 122344578899999998653 56899999999999999999999998776554433332210               


Q ss_pred             -CCCC-----------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 -LRPA-----------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 -~~~~-----------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                       +...           +...++..+.++|.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             0000           11245778999999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.1e-37  Score=308.76  Aligned_cols=249  Identities=22%  Similarity=0.390  Sum_probs=197.4

Q ss_pred             eeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeecC
Q 011359          188 AHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS  265 (488)
Q Consensus       188 G~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  265 (488)
                      |.|+||+||++.+  .++.||||++........      ..+.+.+|+.+++.++||||++++++|..+..+++|+||+.
T Consensus         9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEE------HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             cccCceeEEEEEEcCCCcEEEEEEeccccCCHH------HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            4459999999988  479999999976543321      14678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC-------
Q 011359          266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD-------  338 (488)
Q Consensus       266 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~-------  338 (488)
                      +++|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++++||+.+.......       
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            9999999987655568999999999999999999999999999999999999999999999998542211100       


Q ss_pred             -cCCCCCCCcccCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------------
Q 011359          339 -ALSDDPGTYRWMAPEMIKHK--SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL---------------  400 (488)
Q Consensus       339 -~~~~~~gt~~y~aPE~l~~~--~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~---------------  400 (488)
                       ......++..|+|||++.+.  .++.++|||||||++|+|++|..||......+..........               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence             01112345679999999753  478999999999999999999999988765444333222110               


Q ss_pred             ------------------------------CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH--HHHHHHH
Q 011359          401 ------------------------------RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK--VLEQFET  442 (488)
Q Consensus       401 ------------------------------~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~--~Le~~~~  442 (488)
                                                    .......++..+.+||.+||+.||++||++.++++  .+..+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                          11112345678999999999999999999999985  4555544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=325.76  Aligned_cols=241  Identities=28%  Similarity=0.473  Sum_probs=206.7

Q ss_pred             eeeeeccEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEee
Q 011359          186 RFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY  263 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~~--~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  263 (488)
                      .||+|.||+||.|++.+  ..+|||-+...+..        ..+-+..||.+-++|+|.|||+++|.|..++.+-|.||.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr--------~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq  653 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR--------EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ  653 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccch--------hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence            58999999999999875  46788887643332        234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc-CCCcEEEeeeccccccccc-Cc
Q 011359          264 LSEGSLRAYLHKLEHKTL--PLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIACEEVYC-DA  339 (488)
Q Consensus       264 ~~ggsL~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~-~~~~vkl~DFgla~~~~~~-~~  339 (488)
                      ++||+|.++|.... +++  .+..+..+..||+.||.|||++.|||||||-+|||++ -.|.+||+|||-+...... ..
T Consensus       654 VPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  654 VPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            99999999998743 455  6778888999999999999999999999999999996 5689999999988654432 33


Q ss_pred             CCCCCCCcccCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccCCCCCCCCCcHHHHHHH
Q 011359          340 LSDDPGTYRWMAPEMIKHK--SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA-FAVVNKNLRPAIPGDCPPAMAALI  416 (488)
Q Consensus       340 ~~~~~gt~~y~aPE~l~~~--~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~Li  416 (488)
                      ..+..||..|||||++..+  .|+.++|||||||++.||.||++||..+...+.+ +++-.-+..|.+|..++.+.+.+|
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi  812 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI  812 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence            4567899999999999755  5899999999999999999999999887655543 444455667889999999999999


Q ss_pred             HHHhhhCCCCCCCHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~  435 (488)
                      .+|+..+|.+||++.+++.
T Consensus       813 lrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  813 LRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHcCCCcccCccHHHhcc
Confidence            9999999999999999885

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=333.86  Aligned_cols=264  Identities=31%  Similarity=0.580  Sum_probs=229.7

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH  240 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~---------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~  240 (488)
                      ....|+++.+++.+++.||+|+||.|++|...         ...||||+++......       ..+.+..|+++|+.+.
T Consensus       287 ~~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~-------~~~~~~~El~~m~~~g  359 (609)
T KOG0200|consen  287 EDPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSS-------EKKDLMSELNVLKELG  359 (609)
T ss_pred             cCCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcH-------HHHHHHHHHHHHHHhc
Confidence            33479999999999999999999999999854         2479999998655432       2567899999999995


Q ss_pred             -CCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC------------C--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 011359          241 -NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE------------H--KTLPLPKLIAIALDIARGMEYIHSQGV  305 (488)
Q Consensus       241 -HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~--~~l~~~~~~~i~~qi~~~L~~LH~~gi  305 (488)
                       |+||+.++|+|...+.+++|+||+..|+|..++...+            .  ..++...++.+++||+.|++||++..+
T Consensus       360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~  439 (609)
T KOG0200|consen  360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPC  439 (609)
T ss_pred             CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCc
Confidence             9999999999999999999999999999999998754            0  138889999999999999999999999


Q ss_pred             ccCCCCCCeEEEcCCCcEEEeeecccccccccCcCC--CCC--CCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CC
Q 011359          306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS--DDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT  380 (488)
Q Consensus       306 iHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~--~~~--gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~  380 (488)
                      +||||-..|||+..+..+||+|||+|+.........  ...  -...|||||.+....|+.++||||+||++|||++ |.
T Consensus       440 vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~  519 (609)
T KOG0200|consen  440 VHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG  519 (609)
T ss_pred             cchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence            999999999999999999999999997533322221  122  2456999999999999999999999999999999 99


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       381 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .||.+......+...+..+.+...|..|+.++.++++.||+.+|++||+|.++++.|+..
T Consensus       520 ~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  520 TPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             CCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            999997744555678889999999999999999999999999999999999999999985

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.1e-36  Score=303.01  Aligned_cols=245  Identities=27%  Similarity=0.457  Sum_probs=204.2

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |...++||+|+||+||+|...  ++.||||++........     .....+.+|+.+++.++|+|++++++++.+....|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN-----EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCch-----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            445567999999999999874  78999999975433221     12356788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +||||+. ++|.+++.. ....+++..++.++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++....   
T Consensus        98 lv~e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---  172 (313)
T cd06633          98 LVMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---  172 (313)
T ss_pred             EEEecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence            9999995 578877765 24568999999999999999999999999999999999999999999999999885322   


Q ss_pred             cCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          339 ALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       339 ~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      ......|+..|+|||++.   ...++.++|||||||++|+|++|..||...+.......+............++..+.+|
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  252 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF  252 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence            223456889999999984   35678899999999999999999999988877666665554443333445678889999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      |.+||+.+|.+||++.+++.
T Consensus       253 i~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         253 VDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             HHHHccCChhhCcCHHHHhc
Confidence            99999999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=299.29  Aligned_cols=248  Identities=25%  Similarity=0.408  Sum_probs=200.8

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeeEeeeeecCC
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACKKPP  255 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~  255 (488)
                      |.+.+.||.|+||.||+|.+.  ++.||||+++.......      ....+.+|+.+++++   +|+||+++++++....
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG------IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch------hhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            457788999999999999986  68999999986543221      123455788777766   5999999999998776


Q ss_pred             e-----eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          256 V-----YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       256 ~-----~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      .     ++++|||+. ++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence            6     999999996 4899988775445689999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR---------  401 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~---------  401 (488)
                      +.............++..|+|||.+.+..++.++|+|||||++|+|++|..||......+....+......         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         154 ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            86544333334445788999999998888999999999999999999999999887766554444321100         


Q ss_pred             ---------C-------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 ---------P-------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 ---------~-------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                               .       ......+..+.++|.+||+.||++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                     0       001134577889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.1e-36  Score=302.04  Aligned_cols=251  Identities=22%  Similarity=0.383  Sum_probs=196.4

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      +.++|.+.+.||+|+||.||+|...  ++.||||.+........      ....+.+|+.++++++||||+++++++...
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC------chhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            4578999999999999999999985  68999999875433221      123456899999999999999999998654


Q ss_pred             C--------eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          255 P--------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       255 ~--------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      .        ..++||||+. ++|.+++.. ....+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             cccccCCCceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEEC
Confidence            3        4599999995 588888865 23468999999999999999999999999999999999999999999999


Q ss_pred             eecccccccccC-----cCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--c
Q 011359          327 DFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN--K  398 (488)
Q Consensus       327 DFgla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~--~  398 (488)
                      |||++.......     ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+..  .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999985432211     11234577889999988654 478899999999999999999999987765433221111  0


Q ss_pred             cCCCC---------------C-------------CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          399 NLRPA---------------I-------------PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       399 ~~~~~---------------~-------------~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ...+.               .             +...+..+.+||.+||..+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00000               0             1123467789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-36  Score=299.11  Aligned_cols=248  Identities=28%  Similarity=0.467  Sum_probs=208.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  255 (488)
                      ++|.+.+.||+|+||.||+|...  ++.||+|++.......     ......+..|+.++.++. |+||+++++++..+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-----EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc-----hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence            36888999999999999999984  7899999987532211     122467889999999998 999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ..++||||+.+++|.+++.+.  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999999999999873  479999999999999999999999999999999999999999999999999885332


Q ss_pred             cc---------------------CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 011359          336 YC---------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA  394 (488)
Q Consensus       336 ~~---------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~  394 (488)
                      ..                     .......++..|+|||.+....++.++|+||||++++++++|..||...........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  233 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK  233 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            11                     111233478899999999888899999999999999999999999998876555444


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCH----HHHHH
Q 011359          395 VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF----WHIVK  435 (488)
Q Consensus       395 ~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~----~eil~  435 (488)
                      +.  ......+..+++.+.+||.+||+.+|++||++    .++++
T Consensus       234 ~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         234 IL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            43  23345667789999999999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.4e-36  Score=301.92  Aligned_cols=246  Identities=26%  Similarity=0.415  Sum_probs=203.9

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |...+.||+|+||.||+|++.  ++.||||.+........     ....++.+|+++++.++|+|++++++++......+
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-----EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh-----HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence            556778999999999999985  67899999875322211     12356789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +||||+. |+|.+++... ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....  
T Consensus        92 lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--  167 (308)
T cd06634          92 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (308)
T ss_pred             EEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence            9999996 6888877642 34688999999999999999999999999999999999999999999999998854322  


Q ss_pred             cCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          339 ALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       339 ~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                       .....++..|+|||.+.   ...++.++|||||||++|+|++|..||...+..+....+............++..+.+|
T Consensus       168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (308)
T cd06634         168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF  246 (308)
T ss_pred             -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence             23345788999999984   34678899999999999999999999988776665555544433333445788899999


Q ss_pred             HHHHhhhCCCCCCCHHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~~  436 (488)
                      |.+||..+|++||++.+++..
T Consensus       247 i~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         247 VDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HHHHhhCCcccCCCHHHHhhC
Confidence            999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=312.36  Aligned_cols=253  Identities=21%  Similarity=0.317  Sum_probs=215.8

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      +-+.+..+.|..-+.||+||||.||-+.-  +|+-+|+|.+......     -.+-+....+|-+||.+++.+.||.+-.
T Consensus       178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK-----kr~ge~maLnEk~iL~kV~s~FiVslaY  252 (591)
T KOG0986|consen  178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK-----KRKGETMALNEKQILEKVSSPFIVSLAY  252 (591)
T ss_pred             HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH-----HhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence            33556667788888999999999998865  4889999987532111     1122445678999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +|+..+.+|||+..|+||+|.-+|.......++++.++.++.+|+.||++||..+||.|||||+|||+|+.|+++|+|+|
T Consensus       253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  253 AFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             eecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccc
Confidence            99999999999999999999999988777789999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCCCCCCC
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA---AFAVVNKNLRPAIPG  406 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~---~~~~~~~~~~~~~~~  406 (488)
                      +|............+||.+|||||++++..|+...|.|+|||+||||+.|+.||........   +...+ .......+.
T Consensus       333 LAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~-~~~~~ey~~  411 (591)
T KOG0986|consen  333 LAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT-LEDPEEYSD  411 (591)
T ss_pred             eEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH-hcchhhccc
Confidence            99988888888888999999999999999999999999999999999999999986543222   11111 122345678


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEF  430 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~  430 (488)
                      ..+++.++|.+.+|++||.+|...
T Consensus       412 kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  412 KFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             ccCHHHHHHHHHHHccCHHHhccC
Confidence            899999999999999999999553

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.7e-36  Score=297.17  Aligned_cols=241  Identities=22%  Similarity=0.381  Sum_probs=192.4

Q ss_pred             eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHH---HHHHHhcCCCCeeeEeeeeecCCeeeEEE
Q 011359          187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNRE---VALLSRLHNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~E---i~il~~l~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      ||+|+||.||++...  ++.||||++..........     ...+..|   +.+++...|+||+.+++++.....+++||
T Consensus         2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (278)
T cd05606           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-----ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL   76 (278)
T ss_pred             cccCCCeEEEEEEEecCCCEEEEEEeeccccccchh-----HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEE
Confidence            699999999999874  6899999987543221110     1122333   34455568999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS  341 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~  341 (488)
                      ||+.|++|.+++..  ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++...... ...
T Consensus        77 e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~  153 (278)
T cd05606          77 DLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPH  153 (278)
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCc
Confidence            99999999998875  457899999999999999999999999999999999999999999999999998543221 223


Q ss_pred             CCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 011359          342 DDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ-AAFAVVNKNLRPAIPGDCPPAMAALIEQC  419 (488)
Q Consensus       342 ~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~Li~~c  419 (488)
                      ...|+..|+|||.+.+. .++.++||||+|+++|+|++|..||....... .............++..++..+.++|.+|
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  233 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL  233 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHH
Confidence            44689999999999744 68999999999999999999999998763211 11111222334556777899999999999


Q ss_pred             hhhCCCCCC-----CHHHHHH
Q 011359          420 WSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       420 L~~dp~~RP-----s~~eil~  435 (488)
                      |..+|.+||     ++.++++
T Consensus       234 l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         234 LQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             hhcCHHhccCCCCCCHHHHHh
Confidence            999999999     8888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=350.73  Aligned_cols=245  Identities=27%  Similarity=0.443  Sum_probs=211.3

Q ss_pred             ccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEE
Q 011359          183 LGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       183 i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  260 (488)
                      -+..||.|.||.||-|..  +|+-.|||-|+..+..      .+..+.+.+|+.+|..|+|||+|++||+=.+....+|.
T Consensus      1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             cccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            456789999999999986  4789999999876543      33457788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc---
Q 011359          261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC---  337 (488)
Q Consensus       261 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~---  337 (488)
                      ||||+||+|.+++..  .+..++.....+..|++.|++|||+.|||||||||+||+++.+|.+|++|||.|......   
T Consensus      1313 MEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            999999999999986  344566667778899999999999999999999999999999999999999999643322   


Q ss_pred             --CcCCCCCCCcccCChhhhhcC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          338 --DALSDDPGTYRWMAPEMIKHK---SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       338 --~~~~~~~gt~~y~aPE~l~~~---~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                        .......||+-|||||++.+.   ....++|||||||++.||+||+.||..++..=.+...+..+-.|.+|..++.+-
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence              223355799999999999653   456899999999999999999999999988777777777788899999999999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .++|.+||..||++|.++.|+++
T Consensus      1471 ~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HHHHHHHHhcCchhhhHHHHHHH
Confidence            99999999999999977666554

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=307.45  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=198.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      ++|.+.+.||+|+||.||+|.+.  |+.||||++......       .....+.+|+.++++++|+||+++++++...  
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-------TFCQRTLREIKILRRFKHENIIGILDIIRPPSF   77 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-------hhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence            46889999999999999999875  689999998643221       1235577899999999999999999987543  


Q ss_pred             ---CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          255 ---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       255 ---~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                         ...++|+||+. ++|.+++..   ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          78 ESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             cccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccce
Confidence               35789999995 588877754   57899999999999999999999999999999999999999999999999998


Q ss_pred             ccccccC----cCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Q 011359          332 CEEVYCD----ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN---------  397 (488)
Q Consensus       332 ~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~---------  397 (488)
                      .......    ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+..         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            5432211    1123457889999998754 4689999999999999999999999987654332211110         


Q ss_pred             ------cc---------CCCC-----CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH--HHHHHH
Q 011359          398 ------KN---------LRPA-----IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV--LEQFET  442 (488)
Q Consensus       398 ------~~---------~~~~-----~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~--Le~~~~  442 (488)
                            ..         ....     .....+.++.++|.+||+.+|++||++.++++.  |+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                  00         0000     112456789999999999999999999999875  554443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.8e-36  Score=300.39  Aligned_cols=250  Identities=21%  Similarity=0.343  Sum_probs=199.7

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||+++.......      ....+.+|++++++++||||+++++++....
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~   79 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG------FPITAIREIKILRQLNHRNIVNLKEIVTDKQ   79 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC------chHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence            457888999999999999999985  68999999976543221      1345678999999999999999999987654


Q ss_pred             ----------eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEE
Q 011359          256 ----------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI  325 (488)
Q Consensus       256 ----------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl  325 (488)
                                .+++|+||+++ +|..++... ...+++..++.++.||+.||+|||+.||+||||+|+||++++++.+||
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             hhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEe
Confidence                      78999999975 777777653 346899999999999999999999999999999999999999999999


Q ss_pred             eeecccccccccC--cCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-
Q 011359          326 ADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-  401 (488)
Q Consensus       326 ~DFgla~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-  401 (488)
                      +|||++.......  ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......+....+...... 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999985433221  1122346778999998864 35689999999999999999999999877655444333221000 


Q ss_pred             -----C----------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 -----P----------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 -----~----------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                           +                      .....++..+.++|.+||..+|.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 0                      012246889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=297.39  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=202.9

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.+.+.||.|++|.||+|...  ++.+|+|.+.......      .....+.+|+.++++++|+||+++++++..+..++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE------GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc------hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            456678999999999999875  6889999987544321      12456788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +|+||+.+ +|.+++... ...+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 ~v~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             EEEeccCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            99999965 888888763 3578999999999999999999999999999999999999999999999999885443322


Q ss_pred             -cCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------------
Q 011359          339 -ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR---------------  401 (488)
Q Consensus       339 -~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~---------------  401 (488)
                       ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+......               
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence             22334578899999999766 7899999999999999999999999887765554443221000               


Q ss_pred             -------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 -------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 -------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                   ......++..+.++|.+||+.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                         0112346789999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-36  Score=302.52  Aligned_cols=250  Identities=20%  Similarity=0.279  Sum_probs=194.2

Q ss_pred             ceeccceeeeeccEEEEEEEE----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-
Q 011359          180 QLFLGLRFAHGAHSRLYHGIY----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-  254 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~----~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  254 (488)
                      +|.+.+.||+|+||.||+|.+    .++.||||++........     .....+.+|+.++.+++||||+++++++... 
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-----GISQSACREIALLRELKHENVVSLVEVFLEHA   75 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc-----CccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence            367788999999999999998    458999999986431111     1134567899999999999999999999888 


Q ss_pred             -CeeeEEEeecCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC----CCcEEEe
Q 011359          255 -PVYCVITEYLSEGSLRAYLHKLE---HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ----EFHLKIA  326 (488)
Q Consensus       255 -~~~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~----~~~vkl~  326 (488)
                       ..+++||||++ ++|.+++....   ...+++..++.++.||+.||+|||+.||+||||||+||+++.    ++.+||+
T Consensus        76 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          76 DKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             CceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence             78999999996 47777775432   236889999999999999999999999999999999999999    9999999


Q ss_pred             eecccccccccCc----CCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---------HH
Q 011359          327 DFGIACEEVYCDA----LSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ---------AA  392 (488)
Q Consensus       327 DFgla~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~---------~~  392 (488)
                      |||++........    .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.....         ..
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            9999864322111    123357889999998865 457899999999999999999999997654321         00


Q ss_pred             HHHHh------------------------ccCCCCCC-----------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          393 FAVVN------------------------KNLRPAIP-----------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       393 ~~~~~------------------------~~~~~~~~-----------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..++.                        .......+           ...+..+.++|.+||+.+|++||++.++++
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000                        00011111           145678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.1e-36  Score=299.72  Aligned_cols=251  Identities=21%  Similarity=0.325  Sum_probs=202.8

Q ss_pred             eeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP  254 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  254 (488)
                      |.+.+.||+|+||.||++...     ++.||||+++.....    ......+.+..|+.++.++ +|+||+++++.+..+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~   77 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD   77 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence            667889999999999998753     578999999743211    1122346788999999999 599999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+++||||+.+++|.+++..  ...+++..+..++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++...
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            999999999999999999875  356889999999999999999999999999999999999999999999999988543


Q ss_pred             cccCc--CCCCCCCcccCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCCCCCC
Q 011359          335 VYCDA--LSDDPGTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEEMNP----IQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       335 ~~~~~--~~~~~gt~~y~aPE~l~~~~--~~~k~DvwSlGvll~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~  406 (488)
                      .....  .....|+..|+|||.+.+..  .+.++||||||+++|+|++|..||.....    .+....+..  .....+.
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  233 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--SKPPFPK  233 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc--cCCCCCc
Confidence            32211  12235788999999987654  68899999999999999999999964321    122222222  2345567


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ  439 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~  439 (488)
                      .++..+.++|.+||+.+|++||++.++.+.|+.
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            788999999999999999999998877776554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.5e-36  Score=294.33  Aligned_cols=251  Identities=28%  Similarity=0.474  Sum_probs=205.1

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.+.+.||+|+||.||++.+.  +..+++|+++........   .....++..|+.++++++||||+++++++.....+
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN---PNETVQANQEAQLLSKLDHPAIVKFHASFLERDAF   77 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC---cchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCce
Confidence            4778899999999999999876  355777776542221110   01123566899999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ++|+||+++++|.+++...  ....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++....
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999999998753  3456899999999999999999999999999999999999975 569999999885432


Q ss_pred             cc-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          336 YC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       336 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      .. .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. ...+..+..++.++.+
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  235 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETYSRQLNS  235 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcchhcHHHHH
Confidence            22 222344578899999999888889999999999999999999999987766555544433 3455567788999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +|.+||..+|++||++.++++
T Consensus       236 li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         236 IMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHHHHhcCChhhCcCHHHHhh
Confidence            999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.8e-36  Score=306.24  Aligned_cols=254  Identities=25%  Similarity=0.374  Sum_probs=200.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC-
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP-  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-  254 (488)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||.+........      ....+.+|+.++.++ +|+||++++++|... 
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~------~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~   80 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT------DAQRTFREIMFLQELGDHPNIVKLLNVIKAEN   80 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch------hhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence            46788899999999999999885  68899998864322111      124567899999999 999999999988643 


Q ss_pred             -CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          255 -PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       255 -~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                       ..+++||||+. ++|.+++..   ..+.+..+..++.||+.||+|||+.||+||||+|+||+++.++.++|+|||++..
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          81 DKDIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             CceEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence             46899999996 599998875   3778889999999999999999999999999999999999999999999998854


Q ss_pred             ccccC------cCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------
Q 011359          334 EVYCD------ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL------  400 (488)
Q Consensus       334 ~~~~~------~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~------  400 (488)
                      .....      ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            32211      2223457889999998754 4578999999999999999999999987665443322211100      


Q ss_pred             -----------------------CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH--HHHHHH
Q 011359          401 -----------------------RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV--LEQFET  442 (488)
Q Consensus       401 -----------------------~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~--Le~~~~  442 (488)
                                             .......++.++.++|.+||+.+|++||++.++++.  +.++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                                   001123468899999999999999999999999973  555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.8e-36  Score=299.11  Aligned_cols=248  Identities=21%  Similarity=0.333  Sum_probs=198.2

Q ss_pred             eeccceeeeeccEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC
Q 011359          181 LFLGLRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP  254 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~-----~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  254 (488)
                      |.+.+.||.|+||.||++..     +|+.||+|++.......    .....+.+.+|+.++.++ +|+||+++++.+..+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD   77 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh----cchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence            66788999999999999986     46889999997432111    112245678899999999 589999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++...
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            999999999999999999976  356888999999999999999999999999999999999999999999999998543


Q ss_pred             cccC--cCCCCCCCcccCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCCCCCC
Q 011359          335 VYCD--ALSDDPGTYRWMAPEMIKHK--SYGRKVDVYSFGLILWEMVAGTIPYEEMNPI---QAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       335 ~~~~--~~~~~~gt~~y~aPE~l~~~--~~~~k~DvwSlGvll~elltG~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~  407 (488)
                      ....  ......|+..|+|||.+...  .++.++||||||+++|+|++|..||......   ......+.. ..+..+..
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  234 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQE  234 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCcc
Confidence            2211  12234588899999998643  4678999999999999999999999643221   111111111 23445677


Q ss_pred             CcHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RP-----s~~eil~  435 (488)
                      ++..+.+++.+||+.+|++||     ++.+++.
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            899999999999999999997     5555543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=295.79  Aligned_cols=247  Identities=24%  Similarity=0.384  Sum_probs=199.8

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--Ce
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--PV  256 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~  256 (488)
                      |.+.+.||.|+||.||+|.+.  ++.||||++.......      .....+.+|+.++++++|+|++++++++...  ..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE------GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc------cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            457788999999999999986  5899999998654111      1235678999999999999999999999887  88


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .++|+||++ ++|.+++... ...+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++.....
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          75 IYMVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             EEEEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            999999996 4898888753 25789999999999999999999999999999999999999999999999999864433


Q ss_pred             cC--cCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------C------
Q 011359          337 CD--ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL------R------  401 (488)
Q Consensus       337 ~~--~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~------~------  401 (488)
                      ..  ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.....      .      
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            22  1233457888999998764 4578999999999999999999999988776544333322100      0      


Q ss_pred             -----------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 -----------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 -----------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                       ..+...++..+.++|.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                             0011123788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=296.81  Aligned_cols=247  Identities=27%  Similarity=0.386  Sum_probs=199.9

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVY  257 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~  257 (488)
                      |.+.+.||+|++|.||+|.+.  ++.||||.+........       .....+|+..+.+++ |+||+++++++..+...
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   73 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-------ECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL   73 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-------HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence            457789999999999999985  57899999875432211       223457999999999 99999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      ++||||+ +|+|.+++.......+++..++.++.|++.+|.|||++|++|+||+|.||+++.++.++|+|||++......
T Consensus        74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            9999999 889999998755457899999999999999999999999999999999999999999999999998654433


Q ss_pred             CcCCCCCCCcccCChhhhh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------
Q 011359          338 DALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-----------------  399 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-----------------  399 (488)
                      .......++..|+|||++. ...++.++|+||||+++|+|++|..||......+....+....                 
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            3334456888999999884 3457899999999999999999999998766544433222100                 


Q ss_pred             CCC-----------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 LRP-----------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 ~~~-----------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ...           ......+..+.++|++||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000           001123678999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.6e-36  Score=298.97  Aligned_cols=240  Identities=25%  Similarity=0.457  Sum_probs=200.6

Q ss_pred             cceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEE
Q 011359          184 GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      ...||+|+||.||++...  ++.||||.+.....        .....+.+|+.+++.++|+||+++++.+..+...++||
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence            357899999999999884  68999999854321        12456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-CcC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-DAL  340 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-~~~  340 (488)
                      ||+++++|.+++..   ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... ...
T Consensus        97 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          97 EFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            99999999998754   45889999999999999999999999999999999999999999999999987533221 112


Q ss_pred             CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHHHHHHHH
Q 011359          341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--IPGDCPPAMAALIEQ  418 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~Li~~  418 (488)
                      ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+. ......  ....++..+.++|.+
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~  252 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPPKLKNLHKVSPSLKGFLDR  252 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hhCCcccCCcccCCHHHHHHHHH
Confidence            23457889999999988888999999999999999999999998876655443332 222222  234578899999999


Q ss_pred             HhhhCCCCCCCHHHHHH
Q 011359          419 CWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       419 cL~~dp~~RPs~~eil~  435 (488)
                      ||+.+|.+||++.+++.
T Consensus       253 ~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         253 LLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHhCCcccCcCHHHHhc
Confidence            99999999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-36  Score=288.33  Aligned_cols=237  Identities=27%  Similarity=0.393  Sum_probs=202.7

Q ss_pred             eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeec
Q 011359          187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  264 (488)
                      ||.|+||.||++.+.  ++.||+|++........     .....+..|+.++++++|+||+++++.+..+...++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-----KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch-----HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence            589999999999986  68999999875432211     12457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-CcCCCC
Q 011359          265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-DALSDD  343 (488)
Q Consensus       265 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-~~~~~~  343 (488)
                      .+++|.+++...  ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... ......
T Consensus        76 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (250)
T cd05123          76 PGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF  153 (250)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence            999999999863  46899999999999999999999999999999999999999999999999998554332 223345


Q ss_pred             CCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhC
Q 011359          344 PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQ  423 (488)
Q Consensus       344 ~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~d  423 (488)
                      .++..|++||.+.+...+.++|+||||+++|+|++|..||...+..+....+..  ....++...+..+.++|.+||..|
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCC
Confidence            678899999999888889999999999999999999999988776554444444  345577778999999999999999


Q ss_pred             CCCCCCHHH
Q 011359          424 PDKRPEFWH  432 (488)
Q Consensus       424 p~~RPs~~e  432 (488)
                      |++||++.+
T Consensus       232 p~~R~~~~~  240 (250)
T cd05123         232 PTKRLGSGG  240 (250)
T ss_pred             HhhCCCccc
Confidence            999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-37  Score=317.13  Aligned_cols=245  Identities=31%  Similarity=0.475  Sum_probs=200.4

Q ss_pred             eccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe--e
Q 011359          182 FLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV--Y  257 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~  257 (488)
                      ++...||+|+|-+||+|.+.  |-.||--.++..+-..    ..+-...|..|+.+|+.|+|+|||++|+++.+...  +
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q----~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ----SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhc----ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            45678999999999999986  4455533333222111    12224679999999999999999999999987655  8


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCeEEEcC-CCcEEEeeecccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQ-EFHLKIADFGIACEE  334 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--iiHrDIkp~NILl~~-~~~vkl~DFgla~~~  334 (488)
                      .+|+|.+..|+|+.|+.+  ++.+....+..|++||++||.|||++.  |||||||.+||+|+. -|.|||+|+|+|...
T Consensus       119 n~iTEL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             eeeeecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            899999999999999997  567888899999999999999999995  999999999999975 489999999999766


Q ss_pred             cccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       335 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                      ...... ...||+.|||||++. ..|++.+||||||++++||+|+..||..- ++.+.+.++..+.....+..--.++++
T Consensus       197 r~s~ak-svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr  274 (632)
T KOG0584|consen  197 RKSHAK-SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVR  274 (632)
T ss_pred             hccccc-eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHH
Confidence            554443 478999999999998 89999999999999999999999999764 455555555544333334444468999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHH
Q 011359          414 ALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +||.+||.. ..+|+++.++|+
T Consensus       275 ~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  275 EFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHHHhcC-chhccCHHHHhh
Confidence            999999999 999999999986

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=302.48  Aligned_cols=252  Identities=22%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  255 (488)
                      ++|.+.+.||+|+||.||++...  ++.||||++......      ......+.+|+.+|++++|+||+++++++..+. 
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS------ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc------hHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            56888999999999999999875  689999998643221      122456789999999999999999999987553 


Q ss_pred             -----eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          256 -----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       256 -----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                           .+++||||+ +++|.+++..   ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||+
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence                 468999999 7799988864   5689999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--------  401 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~--------  401 (488)
                      +.....  ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......        
T Consensus       165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07880         165 ARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK  242 (343)
T ss_pred             cccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            864322  2233457889999999875 45789999999999999999999999877654443332221100        


Q ss_pred             ---------------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH--HHHHHHH
Q 011359          402 ---------------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK--VLEQFET  442 (488)
Q Consensus       402 ---------------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~--~Le~~~~  442 (488)
                                           ......++..+.++|.+||+.||++||++.+++.  .++.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                                 0112456788999999999999999999999983  4555433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.3e-36  Score=305.44  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=197.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec---
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK---  253 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---  253 (488)
                      ++|.+.+.||+|+||.||+|...  ++.||||++.......      ...+.+.+|+.+|++++|+||+++++++..   
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   78 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP------TLAKRTLRELKILRHFKHDNIIAIRDILRPPGA   78 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc------cchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence            56778899999999999999875  7899999987533211      113567789999999999999999998753   


Q ss_pred             -CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          254 -PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       254 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                       ...+++||||+. ++|.+++..  ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          79 DFKDVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             CCceEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence             356899999995 689998865  3458999999999999999999999999999999999999999999999999985


Q ss_pred             cccccC-----cCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------
Q 011359          333 EEVYCD-----ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--------  398 (488)
Q Consensus       333 ~~~~~~-----~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~--------  398 (488)
                      ......     ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+...        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            432211     1123468889999999865 45889999999999999999999999876543322211110        


Q ss_pred             --------------cC--CCC-----CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          399 --------------NL--RPA-----IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       399 --------------~~--~~~-----~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                    ..  ...     +....+..+.++|.+||+.+|++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                          00  011     12346889999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-36  Score=304.20  Aligned_cols=254  Identities=26%  Similarity=0.362  Sum_probs=207.2

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC--
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP--  255 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--  255 (488)
                      +|.+.+.||.|++|.||+|...  ++.||||++......      ....+.+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD------LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc------chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            4778899999999999999975  689999998754321      122467889999999999999999999987765  


Q ss_pred             ---eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          256 ---VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       256 ---~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                         .+|+||||+. ++|.+++..  ...+++..++.++.||+.||+|||+.||+||||||.|||++.++.++|+|||++.
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          75 DFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             cccceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence               7899999996 589888875  3478999999999999999999999999999999999999999999999999986


Q ss_pred             cccccC----cCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------
Q 011359          333 EEVYCD----ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR------  401 (488)
Q Consensus       333 ~~~~~~----~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~------  401 (488)
                      ......    ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+....-.      
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            543322    23345678899999999877 7899999999999999999999999887765544433321100      


Q ss_pred             -----------------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH--HHHHHH
Q 011359          402 -----------------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV--LEQFET  442 (488)
Q Consensus       402 -----------------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~--Le~~~~  442 (488)
                                             ......++..+.++|.+||+.+|++||++.+++..  |+.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                                   00123467889999999999999999999999973  555544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.4e-36  Score=304.98  Aligned_cols=255  Identities=25%  Similarity=0.350  Sum_probs=201.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      .+|.+.+.||+|+||+||+|...  ++.||||.+........      ....+.+|+.+++.++|+||+++++++...  
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   78 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI------DAKRTLREIKLLRHLDHENVIAIKDIMPPPHR   78 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc------hhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence            36888899999999999999875  68999999875322111      134567899999999999999999987644  


Q ss_pred             ---CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          255 ---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       255 ---~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                         ...++|+||+. ++|.+++..  ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          79 EAFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence               35799999995 689888875  457899999999999999999999999999999999999999999999999998


Q ss_pred             cccccc-CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Q 011359          332 CEEVYC-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN------------  397 (488)
Q Consensus       332 ~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~------------  397 (488)
                      ...... .......++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+.......+..            
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            644322 22233457889999998864 4688999999999999999999999987654322211110            


Q ss_pred             -----------c---cCC---CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH--HHHHHH
Q 011359          398 -----------K---NLR---PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV--LEQFET  442 (488)
Q Consensus       398 -----------~---~~~---~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~--Le~~~~  442 (488)
                                 .   ...   ......++..+.+||.+||+.+|++||++.++++.  ++.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence                       0   000   01124678899999999999999999999999975  665544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=301.51  Aligned_cols=253  Identities=21%  Similarity=0.326  Sum_probs=199.7

Q ss_pred             cee-ccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHH------HHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          180 QLF-LGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAA------RLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       180 ~~~-i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      +|. +.+.||.|+||+||+|.+.  ++.||||++.............      .....+.+|+.++++++|+||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            343 5577999999999999875  6899999997654322110000      012357799999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +..+...++||||+. |+|.+++..  ...+++..+..++.|++.||+|||+.||+||||+|+||+++.++.++|+|||+
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         89 YVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence            999999999999996 689998865  45689999999999999999999999999999999999999999999999998


Q ss_pred             cccccc---------------cCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 011359          331 ACEEVY---------------CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA  394 (488)
Q Consensus       331 a~~~~~---------------~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~  394 (488)
                      +.....               ........++..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            854320               1111233467889999998754 468999999999999999999999998876654443


Q ss_pred             HHhccCCC--------------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          395 VVNKNLRP--------------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       395 ~~~~~~~~--------------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +......+                          .....++..+.++|.+||+.+|++||++.+++.
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            32210000                          011345788999999999999999999999886

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-36  Score=322.73  Aligned_cols=257  Identities=20%  Similarity=0.282  Sum_probs=188.6

Q ss_pred             ccceeccceeeeeccEEEEEEEECC---ccEEEEEEecCCCChh---------HHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYKD---EPVAVKIIRIPDDDEN---------ETLAARLEKQFNREVALLSRLHNPNVI  245 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~~---~~vAVK~i~~~~~~~~---------~~~~~~~~~~~~~Ei~il~~l~HpnIv  245 (488)
                      .++|.+.++||+|+||+||++.++.   ..+++|.+........         .........++.+|+.+|++++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3679999999999999999987642   2233332211100000         001112345688999999999999999


Q ss_pred             eEeeeeecCCeeeEEEeecCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc
Q 011359          246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLE---HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH  322 (488)
Q Consensus       246 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~  322 (488)
                      ++++++......|+|+|++ +++|.+++....   ........+..|+.||+.||.|||++||+||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            9999999999999999998 457777775421   122345678889999999999999999999999999999999999


Q ss_pred             EEEeeecccccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCC-CCCCC--CHHHHHHHHHh
Q 011359          323 LKIADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI-PYEEM--NPIQAAFAVVN  397 (488)
Q Consensus       323 vkl~DFgla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~-Pf~~~--~~~~~~~~~~~  397 (488)
                      +||+|||++.......  ......||..|+|||++.+..++.++|||||||++|||++|.. ||...  ........++.
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~  385 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID  385 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence            9999999996443221  1223569999999999998899999999999999999999875 44332  22222222211


Q ss_pred             c------cC---------------CCCC---------CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          398 K------NL---------------RPAI---------PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       398 ~------~~---------------~~~~---------~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .      .+               ....         ...++..+.++|.+||+.||.+||++.+++.
T Consensus       386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0      00               0000         1135567888999999999999999999986

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1e-35  Score=292.35  Aligned_cols=238  Identities=20%  Similarity=0.311  Sum_probs=189.7

Q ss_pred             ceeccce--eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC
Q 011359          180 QLFLGLR--FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP  254 (488)
Q Consensus       180 ~~~i~~~--lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  254 (488)
                      +|.+.+.  ||+|+||.||++...  ++.+|+|++.......             .|+.+...+ +|+||+++++.+..+
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444444  599999999999875  6889999987432111             122222222 699999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC-cEEEeeeccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIACE  333 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~-~vkl~DFgla~~  333 (488)
                      ..+++||||+++++|.+++...  ..+++..++.++.||++||.|||+.|++||||+|+||+++.++ .++|+|||++..
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~  159 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI  159 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence            9999999999999999999863  4789999999999999999999999999999999999999998 999999998854


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCCCCCCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN--KNLRPAIPGDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  411 (488)
                      ...   .....++..|+|||++.+..++.++||||||+++|+|++|..||..............  .......+..++..
T Consensus       160 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T PHA03390        160 IGT---PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN  236 (267)
T ss_pred             cCC---CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence            322   1234588999999999988899999999999999999999999986543221111111  12223445578999


Q ss_pred             HHHHHHHHhhhCCCCCCC-HHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPE-FWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs-~~eil~  435 (488)
                      +.++|.+||+.+|.+||+ +.++++
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        237 ANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHHhccChhhCCchHHHHhc
Confidence            999999999999999996 588774

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-35  Score=300.88  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=197.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      ++|.+.+.||+|+||.||+|...  ++.||||++.......      ...+.+.+|+.++++++|+||+++++++...  
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI------IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh------HHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            67889999999999999999864  6899999987532211      1235677899999999999999999987543  


Q ss_pred             ----CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          255 ----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       255 ----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                          ...+++++++ +++|.+++..   ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||+
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~  166 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL  166 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence                3467888887 7899888864   4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL---------  400 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~---------  400 (488)
                      +....  .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+.....         
T Consensus       167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         167 ARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             ccccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            86432  22234467889999999865 4678999999999999999999999987665443332221100         


Q ss_pred             ---------------CCC-----CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          401 ---------------RPA-----IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       401 ---------------~~~-----~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                                     .+.     .....+..+.+||.+||+.+|.+||++.+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                           000     112457889999999999999999999988863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.2e-35  Score=302.44  Aligned_cols=245  Identities=25%  Similarity=0.393  Sum_probs=196.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      ++|.+.+.||.|+||.||+|...  ++.||+|.+.......        .+.+.+|+++++.++|+||+++++.+...  
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~--------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--------VKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch--------HHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            57889999999999999999885  6899999997654321        35677899999999999999999876543  


Q ss_pred             ------------CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-CC
Q 011359          255 ------------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EF  321 (488)
Q Consensus       255 ------------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-~~  321 (488)
                                  ..+++||||+. ++|.+++..   ..+++..+..++.||+.||.|||+.||+||||||+||+++. ++
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~  152 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc
Confidence                        35789999996 588888864   46889999999999999999999999999999999999974 56


Q ss_pred             cEEEeeeccccccccc----CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 011359          322 HLKIADFGIACEEVYC----DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV  396 (488)
Q Consensus       322 ~vkl~DFgla~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~  396 (488)
                      .++|+|||++......    .......++..|+|||.+.. ..++.++|||||||++|+|++|..||...+..+....+.
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            7899999998543211    11123457889999998754 567899999999999999999999998877655443332


Q ss_pred             hcc-----------------------CCC-----CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          397 NKN-----------------------LRP-----AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       397 ~~~-----------------------~~~-----~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ...                       ...     .....++.++.+||.+||+.||++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            210                       000     012356788999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=292.06  Aligned_cols=238  Identities=21%  Similarity=0.327  Sum_probs=201.0

Q ss_pred             ceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeec----CCee
Q 011359          185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK----PPVY  257 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~----~~~~  257 (488)
                      ..||-|-.|.|..+..+  ++.+|+|++..             .....+|+++--..+ |||||.++++|+.    -..+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD-------------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhc-------------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            46799999999998875  78999999873             133458998866665 9999999998864    3467


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC---CCcEEEeeecccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIADFGIACEE  334 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~---~~~vkl~DFgla~~~  334 (488)
                      .+|||.|+||.|+..+....+..+++.++..|+.||+.|+.|||+.+|.||||||+|+|...   +..+||+|||+|...
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence            89999999999999999988889999999999999999999999999999999999999964   567999999999877


Q ss_pred             cccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCC--CCCCCC
Q 011359          335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP----IQAAFAVVNKNLRP--AIPGDC  408 (488)
Q Consensus       335 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~----~~~~~~~~~~~~~~--~~~~~~  408 (488)
                      .....+.+.+.|++|+|||++....|+..+|+||+||++|-|+||.+||.....    ......+....+..  .-...+
T Consensus       215 ~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~V  294 (400)
T KOG0604|consen  215 QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCV  294 (400)
T ss_pred             CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHH
Confidence            766777888899999999999999999999999999999999999999976542    12233343333322  222467


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++..+++|+.+|..+|.+|.+..+++.
T Consensus       295 Se~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  295 SEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            889999999999999999999988774

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.7e-35  Score=324.67  Aligned_cols=148  Identities=26%  Similarity=0.471  Sum_probs=132.4

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+.++||+|+||.||+|.+.  ++.||||+++......     .....++..|+.++..++|+||+++++++....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN-----KNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC-----HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            568899999999999999999987  7899999997543221     223467889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .+||||||+.|++|.+++..  ...+++..++.|+.||+.||.|||..||+||||||+|||++.++.++|+|||++.
T Consensus        78 ~~~lVmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999999976  3468889999999999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.7e-35  Score=295.52  Aligned_cols=250  Identities=23%  Similarity=0.350  Sum_probs=195.9

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  254 (488)
                      .++|.+.+.||.|+||.||+|.+.  ++.||||++......+..      ...+.+|+++++.++|+||+++++++... 
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF------PITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc------chhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            468999999999999999999985  688999998754332211      23456899999999999999999987443 


Q ss_pred             -------CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          255 -------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       255 -------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                             ..+++|+||+. ++|...+.. ....+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|
T Consensus        81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             ccccccCceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence                   34699999995 467777764 245799999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccCc------------CCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 011359          328 FGIACEEVYCDA------------LSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA  394 (488)
Q Consensus       328 Fgla~~~~~~~~------------~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~  394 (488)
                      ||++........            .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            998854322111            122346788999998865 3578999999999999999999999988776554433


Q ss_pred             HHhccCC---------------------CCCC-------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          395 VVNKNLR---------------------PAIP-------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       395 ~~~~~~~---------------------~~~~-------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +......                     ...+       ..+...+.++|.+||..+|++||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            3221000                     0000       234467899999999999999999998875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=297.22  Aligned_cols=251  Identities=32%  Similarity=0.569  Sum_probs=206.5

Q ss_pred             cceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc--CCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~--  254 (488)
                      .++.+.+.||+|.||.||+|.|+|+.||||++...+           +..+.+|.+|.+.+  +|+||+.|+++-..+  
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG  279 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecccc-----------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence            467789999999999999999999999999997433           45577888888874  899999999976443  


Q ss_pred             --CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCeEEEcCCCcEE
Q 011359          255 --PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLK  324 (488)
Q Consensus       255 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------giiHrDIkp~NILl~~~~~vk  324 (488)
                        ..+|||++|-+.|+|+|||..   ..++-+.+++++..+|.||++||..        .|.|||||..|||+..++...
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence              378999999999999999987   6899999999999999999999954        499999999999999999999


Q ss_pred             Eeeeccccccccc-----CcCCCCCCCcccCChhhhhcCC------CCchhHHHHHHHHHHHHHhC----------CCCC
Q 011359          325 IADFGIACEEVYC-----DALSDDPGTYRWMAPEMIKHKS------YGRKVDVYSFGLILWEMVAG----------TIPY  383 (488)
Q Consensus       325 l~DFgla~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~------~~~k~DvwSlGvll~elltG----------~~Pf  383 (488)
                      |+|+|+|......     ......+||.+|||||++...-      --..+||||||+++||++..          .+||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            9999999654432     1234567999999999996432      12479999999999999762          4688


Q ss_pred             CCCCH-----HHHHHHHHhccCCCCCCCCCc-----HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          384 EEMNP-----IQAAFAVVNKNLRPAIPGDCP-----PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       384 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~-----~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      .+.-+     .++..-+...+++|.+|..+.     ..+..||+.||..+|.-|.++-.|.+.|.++...
T Consensus       437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            76532     233333446778888886553     4678899999999999999999999999988753

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-35  Score=302.60  Aligned_cols=245  Identities=26%  Similarity=0.399  Sum_probs=199.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+...||+|++|.||+|.+.  ++.||||++......      ....+.+.+|+.++++++|+||+++++++.....
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS------AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch------hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            56889999999999999999985  688999998643211      1123567789999999999999999988765544


Q ss_pred             ------eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          257 ------YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       257 ------~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                            +++|+||+ +++|.+++..   ..+++..++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||+
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccc
Confidence                  89999998 6799998875   5689999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP-------  402 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------  402 (488)
                      +.....  ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+......+       
T Consensus       165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         165 ARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             cccccc--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            864432  2334467889999999865 367899999999999999999999998777655444332211000       


Q ss_pred             ----------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 ----------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 ----------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                            .....++..+.++|.+||+.+|++||++.+|+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                                  011245789999999999999999999999876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-35  Score=301.01  Aligned_cols=252  Identities=26%  Similarity=0.420  Sum_probs=200.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      .+|.+...||+|+||.||+|.+.  ++.||||++.......      .....+.+|+.+++.++|+||+++++++...  
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE------IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc------cchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            46888899999999999999874  7899999987543221      1234577999999999999999999988654  


Q ss_pred             ----CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          255 ----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       255 ----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                          ..+++|+||+. .+|..++    ...++++.+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||+
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          89 GDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             CCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence                35689999995 4776655    24689999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL---------  400 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~---------  400 (488)
                      +.....  ......++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.+.......+.....         
T Consensus       164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            854321  2233457889999999865 4688999999999999999999999988765544433322100         


Q ss_pred             ------------CCC--------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH--HHHHHHHh
Q 011359          401 ------------RPA--------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK--VLEQFETS  443 (488)
Q Consensus       401 ------------~~~--------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~--~Le~~~~~  443 (488)
                                  .+.        ....++..+.+||.+||+.||++||++.+++.  .++.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                        000        01246778999999999999999999999994  47776553

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.9e-35  Score=296.47  Aligned_cols=246  Identities=27%  Similarity=0.369  Sum_probs=196.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-PP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~  255 (488)
                      ++|.+.+.||.|+||.||++...  ++.||||.+.......      ...+.+..|+.++++++||||++++++|.. ..
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP------VLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc------chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            45888999999999999999875  6889999986533221      124567799999999999999999998865 55


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++|+||+ +++|..++..   ..+++..+..++.||+.||.|||+.||+||||+|.||+++.++.++|+|||++....
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            788999998 6689888864   467888899999999999999999999999999999999999999999999985432


Q ss_pred             ccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------
Q 011359          336 YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN-----------------  397 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~-----------------  397 (488)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+..                 
T Consensus       160 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd07856         160 P--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN  237 (328)
T ss_pred             C--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence            2  2233457889999998765 5689999999999999999999999987665322111110                 


Q ss_pred             -------ccCCCC-----CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          398 -------KNLRPA-----IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       398 -------~~~~~~-----~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                             ......     ....++..+.++|.+||+.+|++||++.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                   000001     113467899999999999999999999998763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=289.07  Aligned_cols=247  Identities=28%  Similarity=0.430  Sum_probs=200.2

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.+.+.||+|++|.||+|...  ++.||+|++.......      ...+.+..|+.++++++|+||+++++++.....++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE------GIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc------cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            345678999999999999986  6899999998654211      12356778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +|+||+. ++|.+++.... ..+++..++.++.|++.||+|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus        75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            9999997 59999998732 468999999999999999999999999999999999999999999999999985443222


Q ss_pred             -cCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------------C
Q 011359          339 -ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN----------------L  400 (488)
Q Consensus       339 -~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~----------------~  400 (488)
                       ......++..|+|||.+.+. .++.++||||||+++|+|++|..||......+....+....                .
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             22334467789999999766 78999999999999999999999998776554433332100                0


Q ss_pred             C---C--------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 R---P--------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 ~---~--------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .   +        ......+..+.++|.+||..+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0   0        001234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.7e-35  Score=296.11  Aligned_cols=247  Identities=24%  Similarity=0.333  Sum_probs=193.5

Q ss_pred             ceeccceeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeec-
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK-  253 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-  253 (488)
                      +|.+.+.||+|+||.||++.+.    ++.||||.+.......      ...+.+.+|+.+++++ +|+||+++++.+.. 
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   74 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK------ILAKRALRELKLLRHFRGHKNITCLYDMDIVF   74 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc------hhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence            3677889999999999999986    4589999986432211      1245677899999999 49999999987532 


Q ss_pred             ---CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       254 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                         ...+++++||+. ++|.+++..  ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||+
T Consensus        75 ~~~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          75 PGNFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cccCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence               245788999985 689998865  45789999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC-----cCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------
Q 011359          331 ACEEVYCD-----ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK------  398 (488)
Q Consensus       331 a~~~~~~~-----~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~------  398 (488)
                      +.......     ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......++..      
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            85432111     1223468899999998865 46899999999999999999999999876644332221110      


Q ss_pred             --------------------cCC---CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          399 --------------------NLR---PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       399 --------------------~~~---~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                          ...   ......++..+.+||.+||+.+|++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                000   0112345788999999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=328.50  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=215.1

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .+..++|.+.+.||+|+||.|..++.+  ++.||+|++..-..-+     .--...|..|-.+|..-+.+.|++++.+|.
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-----r~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-----RAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-----chhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            455678999999999999999999886  6899999986421111     111356888999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      ++.++|+||||++||+|-.++.+..  .+++..+..++..|+-||..||+.|+|||||||+|||||..|++||+|||.+.
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence            9999999999999999999999854  79999999999999999999999999999999999999999999999999885


Q ss_pred             cccccC--cCCCCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          333 EEVYCD--ALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       333 ~~~~~~--~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      ......  .....+|||.|.+||++..     +.|+..+|.||+||++|||+.|..||....-.+.+-.|++-.-...+|
T Consensus       224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP  303 (1317)
T KOG0612|consen  224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP  303 (1317)
T ss_pred             hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence            544222  2345679999999999952     568999999999999999999999999988888888888876556666


Q ss_pred             --CCCcHHHHHHHHHHhhhCCCCCCC---HHHHH
Q 011359          406 --GDCPPAMAALIEQCWSLQPDKRPE---FWHIV  434 (488)
Q Consensus       406 --~~~~~~l~~Li~~cL~~dp~~RPs---~~eil  434 (488)
                        ..++.+.++||.+.+. +|+.|..   +.+|.
T Consensus       304 ~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  304 DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence              5689999999999885 6788876   65554

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=314.62  Aligned_cols=253  Identities=25%  Similarity=0.458  Sum_probs=201.8

Q ss_pred             ccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-----
Q 011359          183 LGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-----  255 (488)
Q Consensus       183 i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----  255 (488)
                      ..+.||+||||.||+|+.+  |+.||||.++.....       +..+...+|+++|++|+|+|||+++++-+...     
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~-------r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL-------RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhccc-------chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            3467899999999999965  899999999864422       22456789999999999999999999765433     


Q ss_pred             -eeeEEEeecCCCCHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc--CCC--cEEEeeec
Q 011359          256 -VYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID--QEF--HLKIADFG  329 (488)
Q Consensus       256 -~~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~--~~~--~vkl~DFg  329 (488)
                       .-.+|||||.||+|+..+.+. ....+++.+++.++.+++.||.|||++||+||||||.||++-  .+|  ..||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence             567999999999999999875 456799999999999999999999999999999999999983  334  47999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccC----
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP----IQAAFAVVNKNL----  400 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~----~~~~~~~~~~~~----  400 (488)
                      .|+............||..|++||++. ...|+..+|.|||||++|+++||..||.....    .+..+.+..++.    
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            998887777888889999999999998 48899999999999999999999999965432    223333332211    


Q ss_pred             ---------------CCCCCCCCcH----HHHHHHHHHhhhCCCCCC--CHHHHHHHHHHHHH
Q 011359          401 ---------------RPAIPGDCPP----AMAALIEQCWSLQPDKRP--EFWHIVKVLEQFET  442 (488)
Q Consensus       401 ---------------~~~~~~~~~~----~l~~Li~~cL~~dp~~RP--s~~eil~~Le~~~~  442 (488)
                                     ...+|...+.    .+-.++..+|.-++.+|.  .+.+....+..+..
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence                           1112223333    355677788889999998  77776666666644

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.4e-36  Score=325.71  Aligned_cols=245  Identities=28%  Similarity=0.453  Sum_probs=186.4

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec----
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK----  253 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----  253 (488)
                      +|+....||+||||.||+++.+  |+.||||.|....       ..+....+.+|+.+|.+|+|||||+++.++.+    
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~  552 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE  552 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence            3455677899999999999875  8999999998754       22335668899999999999999999754311    


Q ss_pred             --------------------------------------------------------------------------------
Q 011359          254 --------------------------------------------------------------------------------  253 (488)
Q Consensus       254 --------------------------------------------------------------------------------  253 (488)
                                                                                                      
T Consensus       553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~  632 (1351)
T KOG1035|consen  553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN  632 (1351)
T ss_pred             cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------C--------CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHH
Q 011359          254 ---------------------------P--------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME  298 (488)
Q Consensus       254 ---------------------------~--------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~  298 (488)
                                                 +        ..+||-||||+..+|.+++....... .-...|+++.+|+.||+
T Consensus       633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLA  711 (1351)
T ss_pred             ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHH
Confidence                                       0        23578999999988888887632211 45689999999999999


Q ss_pred             HHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc-------------------ccCcCCCCCCCcccCChhhhhcC-
Q 011359          299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-------------------YCDALSDDPGTYRWMAPEMIKHK-  358 (488)
Q Consensus       299 ~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~~-  358 (488)
                      |+|++|||||||||.||++++++.|||+|||+|....                   .....+..+||.-|+|||++.+. 
T Consensus       712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            9999999999999999999999999999999996511                   01134456799999999999655 


Q ss_pred             --CCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCC--CCCCCcHHHHHHHHHHhhhCCCCCCCHHHH
Q 011359          359 --SYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNKNLRPA--IPGDCPPAMAALIEQCWSLQPDKRPEFWHI  433 (488)
Q Consensus       359 --~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~Li~~cL~~dp~~RPs~~ei  433 (488)
                        .|+.|+|+||||+||+||+.   ||...- ....+..+....+...  +...--+.-+.+|++|++.||.+||++.++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL  868 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL  868 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence              49999999999999999984   565432 2222222222222211  111222355789999999999999999998


Q ss_pred             HH
Q 011359          434 VK  435 (488)
Q Consensus       434 l~  435 (488)
                      +.
T Consensus       869 L~  870 (1351)
T KOG1035|consen  869 LN  870 (1351)
T ss_pred             hh
Confidence            84

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=302.93  Aligned_cols=247  Identities=27%  Similarity=0.415  Sum_probs=208.3

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      +.-.+.||.|.||+||-|+++  |+.||||+|..-.-.      .+.+.++..|+.||+.+.||.||.+.-.|+.....+
T Consensus       566 if~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp------~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  566 IFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP------TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF  639 (888)
T ss_pred             hhhHhhccCCcceeeecceecccCceeeeeeeecccCC------CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence            445678999999999999875  899999999653322      223577899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC---CcEEEeeeccccccc
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIACEEV  335 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~---~~vkl~DFgla~~~~  335 (488)
                      +|||-+. |++.+.|-....+.+++.....++.||+.||.|||-+||+|.||||+|||+...   -.+||||||+|+...
T Consensus       640 VVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg  718 (888)
T KOG4236|consen  640 VVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG  718 (888)
T ss_pred             EEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence            9999995 566666666678899999999999999999999999999999999999999644   469999999998877


Q ss_pred             ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      ........+||+.|+|||++.++.|...-|+||+|||+|--|.|..||.....+....+-...-+.+.....++.+..+|
T Consensus       719 EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~Aidl  798 (888)
T KOG4236|consen  719 EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDL  798 (888)
T ss_pred             hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHH
Confidence            76777788999999999999999999999999999999999999999987654433322222223344446788999999


Q ss_pred             HHHHhhhCCCCCCCHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIV  434 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil  434 (488)
                      |+.+|+..-.+|-+....+
T Consensus       799 In~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  799 INNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             HHHHHHHHHHHhcchHhhc
Confidence            9999999999999886554

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=287.60  Aligned_cols=240  Identities=23%  Similarity=0.387  Sum_probs=196.3

Q ss_pred             ceeeeeccEEEEEEE--ECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeeeEEE
Q 011359          185 LRFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~--~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      +.||+|+|+.|--+.  .+|..||||++....        +..+..+.+|++++.+++ |+||++++++|+++..+||||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCC--------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            467999999998775  468999999996432        334678899999999997 999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC---CcEEEeeeccccccc---
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIACEEV---  335 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~---~~vkl~DFgla~~~~---  335 (488)
                      |-|.||.|...|++  ...+++.++..+..+|+.||.|||.+||.||||||+|||...-   .-+|||||.++.-..   
T Consensus       156 EKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             ecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            99999999999987  4678999999999999999999999999999999999999544   348999998873211   


Q ss_pred             -----ccCcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--------------HHH
Q 011359          336 -----YCDALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP--------------IQA  391 (488)
Q Consensus       336 -----~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~--------------~~~  391 (488)
                           ....+.+.+|+..|||||+..     ...|+.++|.||||||+|.||+|.+||.+.-.              .+.
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK  313 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence                 112234556899999999873     33589999999999999999999999975421              123


Q ss_pred             HHHHHhccCCCCCC----CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          392 AFAVVNKNLRPAIP----GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       392 ~~~~~~~~~~~~~~----~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.-+.++. .++|    ..++.+.++||..+|..++.+|.++.+++.
T Consensus       314 LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  314 LFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            444444432 2233    357889999999999999999998887775

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=306.60  Aligned_cols=238  Identities=23%  Similarity=0.326  Sum_probs=199.9

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  254 (488)
                      ...|.+...+|.|+|+.|-++...  ++..+||++.....+            -.+|+.++... +|+||+++.+.+.++
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------------~~~e~~~~~~~~~h~niv~~~~v~~~~  388 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------------NQDEIPISLLVRDHPNIVKSHDVYEDG  388 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc------------cccccchhhhhcCCCcceeecceecCC
Confidence            456777888999999999999875  789999999765222            23677676666 599999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE-cCCCcEEEeeeccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI-DQEFHLKIADFGIACE  333 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl-~~~~~vkl~DFgla~~  333 (488)
                      .+.|+|||++.|+.|.+.+...   .....++..|+.+|+.++.|||++|||||||||+|||+ +..++++|+|||.+..
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            9999999999999998888763   23336788899999999999999999999999999999 6899999999999965


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                      ....  ....+-|..|.|||++....|++++|+||||++||+||+|..||........+...+   ..+.+...++.+.+
T Consensus       466 ~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~~s~~vS~~AK  540 (612)
T KOG0603|consen  466 LERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPKFSECVSDEAK  540 (612)
T ss_pred             Cchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCccccccCHHHH
Confidence            4433  334567889999999999999999999999999999999999998876653333222   23344478899999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHH
Q 011359          414 ALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +||++||+.||.+|+++.++..
T Consensus       541 dLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  541 DLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHHHhccCChhhCcChhhhcc
Confidence            9999999999999999999886

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=301.74  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=226.3

Q ss_pred             cccccccceeccceeeeeccEEEEEEEECCcc--EEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP--VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~--vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ...+.++++...-.||-||||+|-++..+++.  +|+|+++.....     ..+.+..+..|-.||..++.+.||++|..
T Consensus       414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-----dtkQqeHv~sEr~Im~~~~s~fIvrLYrT  488 (732)
T KOG0614|consen  414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV-----DTKQQEHVFSERNIMMECRSDFIVRLYRT  488 (732)
T ss_pred             hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc-----chhHHHHHHhHHHHHHhcCchHHHHHHHH
Confidence            34566777888889999999999999888654  899998754322     23345678899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      |.++...|++||-|-||.|+..|..  .+.+.......++.-++.|++|||++|||.|||||+|.+++.+|-+||.|||+
T Consensus       489 frd~kyvYmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGF  566 (732)
T KOG0614|consen  489 FRDSKYVYMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGF  566 (732)
T ss_pred             hccchhhhhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhh
Confidence            9999999999999999999999987  46788888999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      |.....+...-+.+||+.|+|||++.+...+.++|.|+||+++|||++|.+||.+.+++.....++.+-....+|..++.
T Consensus       567 AKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k  646 (732)
T KOG0614|consen  567 AKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITK  646 (732)
T ss_pred             HHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccch
Confidence            98887777778899999999999999999999999999999999999999999999999999888887777788999999


Q ss_pred             HHHHHHHHHhhhCCCCCCC
Q 011359          411 AMAALIEQCWSLQPDKRPE  429 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs  429 (488)
                      ...+||++++..+|.+|..
T Consensus       647 ~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  647 TATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hHHHHHHHHHhcCcHhhhc
Confidence            9999999999999999976

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-35  Score=291.11  Aligned_cols=255  Identities=29%  Similarity=0.493  Sum_probs=207.7

Q ss_pred             ccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc--CCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~  253 (488)
                      ++...+.+.+.+|+|.||.||+|.++++.||||++...           ..+.|..|-.|....  .|+||++|+++-..
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr  275 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----------EKQSFQNEKNIYSLPGMKHENILQFIGAEKR  275 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhccCceeEEEecCHH-----------HHHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence            34556778889999999999999999999999999732           246678888887764  69999999998766


Q ss_pred             CC----eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccCCCCCCeEEEcCC
Q 011359          254 PP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ---------GVIHRDLKPENVLIDQE  320 (488)
Q Consensus       254 ~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------giiHrDIkp~NILl~~~  320 (488)
                      ..    .++||+||.+.|+|.+||..   ..++|....+|+..|++||+|||+.         .|+|||||..|||+..|
T Consensus       276 ~t~~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D  352 (534)
T KOG3653|consen  276 GTADRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND  352 (534)
T ss_pred             CCccccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence            55    89999999999999999987   6899999999999999999999964         49999999999999999


Q ss_pred             CcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCC-CC-----chhHHHHHHHHHHHHHhCCC----------
Q 011359          321 FHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKS-YG-----RKVDVYSFGLILWEMVAGTI----------  381 (488)
Q Consensus       321 ~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~-~~-----~k~DvwSlGvll~elltG~~----------  381 (488)
                      +...|+|||+|.......   .....+||.+|||||++.+.. +.     .+.||||+|.++|||++.-.          
T Consensus       353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y  432 (534)
T KOG3653|consen  353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY  432 (534)
T ss_pred             CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence            999999999996544322   223467999999999996432 22     46899999999999988432          


Q ss_pred             --CCCC-----CCHHHHHHHHHhccCCCCCCCCC-----cHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          382 --PYEE-----MNPIQAAFAVVNKNLRPAIPGDC-----PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       382 --Pf~~-----~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                        ||+.     ..-.+....++.++.||.++..+     ...+++.+..||+.|++.|.|+.=+.+.+..+...-
T Consensus       433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence              3321     12234455677788888888543     457899999999999999999988888777776543

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=308.63  Aligned_cols=253  Identities=26%  Similarity=0.531  Sum_probs=217.8

Q ss_pred             eeccceeeeeccEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      ++..+.||.|+||+||+|.|-      +-+||||++......       +.-.+|..|+.+|.+|+|||+++++|+|...
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-------~~s~e~LdeAl~masldHpnl~RLLgvc~~s  770 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-------KASIELLDEALRMASLDHPNLLRLLGVCMLS  770 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc-------hhhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence            456778999999999999984      358999999743322       1246788999999999999999999999877


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      . +.||++|+++|+|.+|++. ....+-....+.|..||++||.|||+++++||||-..|||+..-..+||.|||+++..
T Consensus       771 ~-~qlvtq~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  771 T-LQLVTQLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             h-HHHHHHhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            6 7799999999999999987 3456888899999999999999999999999999999999999999999999999643


Q ss_pred             cccCc-CC--CCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          335 VYCDA-LS--DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       335 ~~~~~-~~--~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      ..... ..  ...-.+.|||-|.+....|+.++|||||||++||++| |..||.++...+ +...+..+.+...|+.|+.
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~geRLsqPpiCti  927 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGERLSQPPICTI  927 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhccccCCCCCCccH
Confidence            32221 11  2223567999999999999999999999999999999 999999987654 5566777888999999999


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ++..++.+||..|++.||+|.++...+..+...
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            999999999999999999999999999888663

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-35  Score=309.28  Aligned_cols=247  Identities=26%  Similarity=0.434  Sum_probs=211.8

Q ss_pred             ceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeee----
Q 011359          180 QLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACK----  252 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~----  252 (488)
                      .++|.+.||.|.+|.||+++.  +++.+|||++....+.+         .++..|.+||+.+. |||++.++|+|.    
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---------eEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---------EEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---------HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            355788999999999999875  47899999987655443         34557888998885 999999999884    


Q ss_pred             -cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          253 -KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       253 -~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                       .++.+|||||||.||+.-|+++......+.|+.+..|++.++.||.+||...++|||||-.|||++.++.|||+|||++
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence             3568999999999999999999888888999999999999999999999999999999999999999999999999998


Q ss_pred             ccccc-cCcCCCCCCCcccCChhhhhcC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCC
Q 011359          332 CEEVY-CDALSDDPGTYRWMAPEMIKHK-----SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-PAI  404 (488)
Q Consensus       332 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~-----~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~  404 (488)
                      ..... .....+..||+.|||||++...     .|+..+|+||||++..||..|.+|+.++.+...++.+...... ...
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr  250 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR  250 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence            55432 2334567899999999999543     4788999999999999999999999999999988876554322 233


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      |..+++++.++|..||.+|.++||.+.++++
T Consensus       251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            6789999999999999999999999988874

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.7e-34  Score=278.65  Aligned_cols=218  Identities=19%  Similarity=0.282  Sum_probs=180.9

Q ss_pred             eccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeecCCC
Q 011359          190 GAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEG  267 (488)
Q Consensus       190 G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  267 (488)
                      |.+|.||++.+.  ++.||+|.++...             .+.+|...+....||||+++++++.....+++||||+.+|
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   70 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG   70 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence            899999999985  6889999997532             1234555555667999999999999999999999999999


Q ss_pred             CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCCCCc
Q 011359          268 SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY  347 (488)
Q Consensus       268 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~gt~  347 (488)
                      +|.+++...  ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++|||.+.....  ......++.
T Consensus        71 ~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~  146 (237)
T cd05576          71 KLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED--SCDGEAVEN  146 (237)
T ss_pred             CHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc--ccccCCcCc
Confidence            999999763  4589999999999999999999999999999999999999999999999998743322  122344677


Q ss_pred             ccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCC
Q 011359          348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR  427 (488)
Q Consensus       348 ~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~R  427 (488)
                      .|+|||.+....++.++||||+|+++|+|++|..|+......      ........++..++..++++|.+||+.||++|
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  220 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTER  220 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence            899999998888899999999999999999999887643221      11122234567788999999999999999999


Q ss_pred             CCH
Q 011359          428 PEF  430 (488)
Q Consensus       428 Ps~  430 (488)
                      |++
T Consensus       221 ~~~  223 (237)
T cd05576         221 LGA  223 (237)
T ss_pred             cCC
Confidence            986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=290.31  Aligned_cols=249  Identities=25%  Similarity=0.413  Sum_probs=213.9

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEe
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFV  248 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~--~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~  248 (488)
                      ....|...+|.+...||+|.||.|.++..+|  +-+|||+++....-.+..     .+--+.|-++|.... -|.+++++
T Consensus       342 ~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD-----vectm~EKrvLAL~~kppFL~qlH  416 (683)
T KOG0696|consen  342 KRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD-----VECTMVEKRVLALPGKPPFLVQLH  416 (683)
T ss_pred             cccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc-----ccceehhhhheecCCCCchHHHHH
Confidence            3447777889999999999999999998875  789999997543211111     112346777777664 68899999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      ..|..-+++|+||||+.||+|.-.++.  -+.+.+..++.++.+|+-||-+||++|||.||||.+|||+|.+|++||.||
T Consensus       417 ScFQTmDRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DF  494 (683)
T KOG0696|consen  417 SCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADF  494 (683)
T ss_pred             HHhhhhhheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeec
Confidence            999999999999999999999988886  456888899999999999999999999999999999999999999999999


Q ss_pred             ccccccccc-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          329 GIACEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       329 gla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      |++.+.... .+..+.+||+.|+|||++...+|+..+|.||+||+||||+.|..||++.+..+....+...+.  ..|..
T Consensus       495 GmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--syPKs  572 (683)
T KOG0696|consen  495 GMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--SYPKS  572 (683)
T ss_pred             ccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--cCccc
Confidence            999765443 345577899999999999999999999999999999999999999999999888888887764  47888


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCC
Q 011359          408 CPPAMAALIEQCWSLQPDKRPE  429 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs  429 (488)
                      ++.+...+....|.+.|.+|..
T Consensus       573 lSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  573 LSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ccHHHHHHHHHHhhcCCccccC
Confidence            9999999999999999999954

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.3e-33  Score=269.49  Aligned_cols=236  Identities=31%  Similarity=0.529  Sum_probs=199.7

Q ss_pred             ccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeecCCCC
Q 011359          191 AHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGS  268 (488)
Q Consensus       191 ~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs  268 (488)
                      +||.||+|.+.  ++.||+|++........       .+.+.+|++++++++|+||+++++.+......++++||+.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   73 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-------RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD   73 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence            58999999986  58999999976443221       3678899999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCCCCcc
Q 011359          269 LRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR  348 (488)
Q Consensus       269 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~gt~~  348 (488)
                      |.+++....  .+++..++.++.+++.+|.|||+.|++|+||+|.||+++.++.++|+|||.+.............++..
T Consensus        74 L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  151 (244)
T smart00220       74 LFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE  151 (244)
T ss_pred             HHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence            999997632  388999999999999999999999999999999999999999999999999865544334455668889


Q ss_pred             cCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC--CcHHHHHHHHHHhhhCCCC
Q 011359          349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD--CPPAMAALIEQCWSLQPDK  426 (488)
Q Consensus       349 y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~Li~~cL~~dp~~  426 (488)
                      |++||.+....++.++|||+||+++|+|++|..||........................  ++..+.+++.+||..+|++
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  231 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEK  231 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchh
Confidence            99999998888899999999999999999999999884444444444443333222222  8899999999999999999


Q ss_pred             CCCHHHHHH
Q 011359          427 RPEFWHIVK  435 (488)
Q Consensus       427 RPs~~eil~  435 (488)
                      ||++.++++
T Consensus       232 Rp~~~~~~~  240 (244)
T smart00220      232 RLTAEEALQ  240 (244)
T ss_pred             ccCHHHHhh
Confidence            999999886

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.9e-34  Score=331.63  Aligned_cols=244  Identities=24%  Similarity=0.345  Sum_probs=192.0

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      .+.....||+|+||.||+|.+.  +..||||.+......            ...|++++++++|||||+++++|......
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------------PSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------------cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            3555678999999999999974  789999998643221            12468889999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH---SQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ++||||+++|+|.++++.     +++..+..++.|++.||+|||   +.+|+||||||+||+++.++..++. ||.....
T Consensus       759 ~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             EEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            999999999999999964     889999999999999999999   6699999999999999998888775 6654322


Q ss_pred             cccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh-----ccCCCCC
Q 011359          335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP-----IQAAFAVVN-----KNLRPAI  404 (488)
Q Consensus       335 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~-----~~~~~~~~~-----~~~~~~~  404 (488)
                      .   ......++..|+|||++.+..++.++|||||||++|||++|+.||.....     .+.......     .-..+.+
T Consensus       833 ~---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        833 C---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             c---cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence            1   11233688999999999988999999999999999999999999853211     111100000     0011111


Q ss_pred             ------CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          405 ------PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       405 ------~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                            +.....++.+++.+||+.+|++||++.++++.|+++....
T Consensus       910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence                  1122346778999999999999999999999999986643

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-35  Score=263.47  Aligned_cols=222  Identities=31%  Similarity=0.445  Sum_probs=183.9

Q ss_pred             cccccceeccceeeeeccEEEEEEE--ECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC  251 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~--~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  251 (488)
                      +++.+.+..+..||+|++|.|-+.+  ..|+..|||.++..-.       .+..++..+|+.+..+. .+|.+|.|||.+
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-------~q~q~r~L~dldi~~r~~~CPf~V~FyGa~  114 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-------SQEQKRLLMDLDIIMRTVDCPFTVHFYGAL  114 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-------hHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence            3455667788899999999876655  4689999999986443       34467888999997776 589999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeee
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      ......|+.||.| ..+|..+-.+.  ..+.+++..+-+|+..++.||.|||++ .|+|||+||+||||+.+|++|+|||
T Consensus       115 ~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  115 FREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             hccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccc
Confidence            9999999999999 45777766543  567899999999999999999999987 8999999999999999999999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhh----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCC
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIK----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNKNLRPA  403 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~  403 (488)
                      |++......-..+...|...|||||.+.    ...|+.++||||||+++.||.+++.||+.+. +.+.+.+++.+ ..|.
T Consensus       194 GIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee-p~P~  272 (282)
T KOG0984|consen  194 GISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE-PSPQ  272 (282)
T ss_pred             ccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC-CCCC
Confidence            9997766666666678999999999984    3478999999999999999999999999765 55555555543 3343


Q ss_pred             CC
Q 011359          404 IP  405 (488)
Q Consensus       404 ~~  405 (488)
                      +|
T Consensus       273 Lp  274 (282)
T KOG0984|consen  273 LP  274 (282)
T ss_pred             Cc
Confidence            43

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=9.8e-35  Score=276.85  Aligned_cols=259  Identities=25%  Similarity=0.337  Sum_probs=199.1

Q ss_pred             cccceeccceeeeeccEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ++..|++.+.||+|.||.||++.-.      ++.+|||.++...+...-      .....+|+.+++.|+|+||+.+..+
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi------S~SAcREiaL~REl~h~nvi~Lv~V   95 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI------SMSACREIALLRELKHPNVISLVKV   95 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc------CHHHHHHHHHHHHhcCCcchhHHHH
Confidence            4567888899999999999999653      247999999876543221      2345699999999999999999998


Q ss_pred             eec-CCeeeEEEeecCCCCHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC----Cc
Q 011359          251 CKK-PPVYCVITEYLSEGSLRAYLHKL---EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE----FH  322 (488)
Q Consensus       251 ~~~-~~~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~----~~  322 (488)
                      +.. +..+++++||.+. +|...|+-.   ..+.++...+..|++||+.|+.|||++-|+||||||.|||+..+    |.
T Consensus        96 fl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen   96 FLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             HhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCe
Confidence            866 8899999999854 888888743   23568889999999999999999999999999999999999877    89


Q ss_pred             EEEeeecccccccccCc----CCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---------
Q 011359          323 LKIADFGIACEEVYCDA----LSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNP---------  388 (488)
Q Consensus       323 vkl~DFgla~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~---------  388 (488)
                      |||+|||+++.......    ....+.|.+|.|||++.+ ..|+.+.|||++|||+.||++-.+-|.+...         
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq  254 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ  254 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence            99999999975543221    223457999999999865 5799999999999999999998887765321         


Q ss_pred             ---HHHHHHHHhcc---CCCC---CC--------------------------CCCcHHHHHHHHHHhhhCCCCCCCHHHH
Q 011359          389 ---IQAAFAVVNKN---LRPA---IP--------------------------GDCPPAMAALIEQCWSLQPDKRPEFWHI  433 (488)
Q Consensus       389 ---~~~~~~~~~~~---~~~~---~~--------------------------~~~~~~l~~Li~~cL~~dp~~RPs~~ei  433 (488)
                         .+.++.++...   .++.   +|                          ..-++...+|+.+||+.||.+|.++.+.
T Consensus       255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence               11222222110   0110   00                          1123457899999999999999999998


Q ss_pred             HHHHHHHHH
Q 011359          434 VKVLEQFET  442 (488)
Q Consensus       434 l~~Le~~~~  442 (488)
                      ++..--...
T Consensus       335 leh~yF~~d  343 (438)
T KOG0666|consen  335 LEHPYFTED  343 (438)
T ss_pred             hcccccccC
Confidence            875444444

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=253.46  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=201.9

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|.-.++||+|.||+||+|+..  ++.||+|.++..++++.-      .....+|+-+|+.++|.|||++++....+..+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv------pssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV------PSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC------cHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            3455678999999999999875  589999999988776543      23456999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      .+|+|||. .+|..+... -++.++.+.+..++.|+++||.++|++++.|||+||.|.||+.+|.+|++|||+++.....
T Consensus        77 tlvfe~cd-qdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   77 TLVFEFCD-QDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             EEeHHHhh-HHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            99999995 488888876 4577999999999999999999999999999999999999999999999999999754432


Q ss_pred             C-cCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh------ccCCCCC----
Q 011359          338 D-ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN------KNLRPAI----  404 (488)
Q Consensus       338 ~-~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~------~~~~~~~----  404 (488)
                      . -.+..+.|.+|.+|.++.+. -|+...|+||.|||+.|+.. |++-|.+.+-.+.+..+..      +..+|.+    
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            2 34556689999999998764 58999999999999999987 7888888776655544432      1111111    


Q ss_pred             --------C---------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          405 --------P---------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       405 --------~---------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                              |         +.+...-++|+.++|.-+|.+|.+++..++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence                    1         122345678999999999999999987765

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-34  Score=291.56  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=203.3

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .....|-+-|..++.||-|+||+|.++.-.  ...||+|.++..+-     +..........|-.||..-+.+.||+||.
T Consensus       622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-----l~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-----LMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             HHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-----HhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            344567777888999999999999998765  46799999986442     12222345678999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      .|.+...+|+||+|++||++..+|.+  .+-+.++.+..++.++..|+++.|..|+|||||||+|||||.+|++||+|||
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecc
Confidence            99999999999999999999999987  4678888999999999999999999999999999999999999999999999


Q ss_pred             ccccc---------cccCcCC----------------------------------CCCCCcccCChhhhhcCCCCchhHH
Q 011359          330 IACEE---------VYCDALS----------------------------------DDPGTYRWMAPEMIKHKSYGRKVDV  366 (488)
Q Consensus       330 la~~~---------~~~~~~~----------------------------------~~~gt~~y~aPE~l~~~~~~~k~Dv  366 (488)
                      |+.-.         ..+.+..                                  ..+||..|+|||++....|+.-+|.
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw  854 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW  854 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence            98311         0000000                                  1249999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCCCCCCCcHHHHHHHHHHhhhCCCCCC
Q 011359          367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN--LRPAIPGDCPPAMAALIEQCWSLQPDKRP  428 (488)
Q Consensus       367 wSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~Li~~cL~~dp~~RP  428 (488)
                      ||.|||||||+.|+.||....+.+....+++-.  +.......++.+..+||.+++. +++.|.
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence            999999999999999999888877666655433  3333456789999999988663 456663

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=281.03  Aligned_cols=246  Identities=20%  Similarity=0.316  Sum_probs=201.8

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CC----eeeEee
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PN----VIKFVA  249 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pn----Iv~l~~  249 (488)
                      ..+|.+...+|+|.||.|-.+.+.  +..||||+++.         ..++.....-|+++|+++++  |+    +|++.+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---------VDKYREAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            478999999999999999999886  57999999973         34566777899999999953  33    788889


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc-----------
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-----------  318 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~-----------  318 (488)
                      ||...++.|||+|.+ |-++++++....-.+++...+..++.|++.+++|||+.+++|-||||+|||+-           
T Consensus       159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence            999999999999998 77999999987777899999999999999999999999999999999999993           


Q ss_pred             ---------CCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 011359          319 ---------QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI  389 (488)
Q Consensus       319 ---------~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~  389 (488)
                               .+..++|+|||.|......  ....+.|..|.|||++.+-.++..+||||+||||+|+.+|..-|..-++.
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                     1345899999999655433  36677899999999999999999999999999999999999999877755


Q ss_pred             HHH---HHHHhc--------c--------CCCCCC-------------------------CCCcHHHHHHHHHHhhhCCC
Q 011359          390 QAA---FAVVNK--------N--------LRPAIP-------------------------GDCPPAMAALIEQCWSLQPD  425 (488)
Q Consensus       390 ~~~---~~~~~~--------~--------~~~~~~-------------------------~~~~~~l~~Li~~cL~~dp~  425 (488)
                      +.+   ..++..        .        -+...+                         ...-.+|.+||++||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            432   111110        0        000000                         00113689999999999999


Q ss_pred             CCCCHHHHHH
Q 011359          426 KRPEFWHIVK  435 (488)
Q Consensus       426 ~RPs~~eil~  435 (488)
                      +|+++.|++.
T Consensus       396 ~RiTl~EAL~  405 (415)
T KOG0671|consen  396 RRITLREALS  405 (415)
T ss_pred             ccccHHHHhc
Confidence            9999999875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=282.36  Aligned_cols=254  Identities=24%  Similarity=0.409  Sum_probs=203.4

Q ss_pred             ccceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee-cC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~  254 (488)
                      -++|.+...||+|||+.||++.+  ..+.||||+-.+..+..++. -+.+.+...+|..|-+.|+||.||++|++|. +.
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEK-KeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEK-KENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHh-hhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            46788999999999999999976  36899999977655443322 2345677889999999999999999999986 45


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCCCeEEEc---CCCcEEEeeec
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ--GVIHRDLKPENVLID---QEFHLKIADFG  329 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--giiHrDIkp~NILl~---~~~~vkl~DFg  329 (488)
                      ..+|-|+|||+|.+|.-||+.  ++.+++.++..|+.||+.||.||.+.  -|||-||||.|||+-   ..|.+||+|||
T Consensus       541 dsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            689999999999999999986  67899999999999999999999987  599999999999994   45889999999


Q ss_pred             cccccccc--------CcCCCCCCCcccCChhhhhcC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Q 011359          330 IACEEVYC--------DALSDDPGTYRWMAPEMIKHK----SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA---  394 (488)
Q Consensus       330 la~~~~~~--------~~~~~~~gt~~y~aPE~l~~~----~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~---  394 (488)
                      ++..+...        .......||.+|++||.+.-.    ..+.|+||||+|||+|..+.|+.||......+.+..   
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            99643321        223456799999999988422    468899999999999999999999986544333221   


Q ss_pred             HHhcc-CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHH
Q 011359          395 VVNKN-LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIV  434 (488)
Q Consensus       395 ~~~~~-~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil  434 (488)
                      ++... ......+.++.+.++||++||++.-++|.+..++.
T Consensus       699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            22111 11222356788999999999999999998876654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=269.36  Aligned_cols=265  Identities=28%  Similarity=0.552  Sum_probs=221.0

Q ss_pred             cccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI  245 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  245 (488)
                      +-.+...++++...+-+|.||+||+|+|.+       +.|-||.++...       .......|..|--++..+.|||+.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-------S~iQv~~~L~es~lly~~sH~nll  350 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-------SQIQVNLLLQESMLLYGASHPNLL  350 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-------cHHHHHHHHHHHHHHhcCcCCCcc
Confidence            334555667777888999999999998753       356677765322       222345688899999999999999


Q ss_pred             eEeeeeec-CCeeeEEEeecCCCCHHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc
Q 011359          246 KFVAACKK-PPVYCVITEYLSEGSLRAYLHKL------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID  318 (488)
Q Consensus       246 ~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~  318 (488)
                      .+.+++.+ ....++++.++.-|+|..||...      ..+.++..+++.++.|++.|++|||+.||||.||-..|++||
T Consensus       351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID  430 (563)
T ss_pred             ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh
Confidence            99998754 45678899999999999999833      234577778999999999999999999999999999999999


Q ss_pred             CCCcEEEeeecccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 011359          319 QEFHLKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFA  394 (488)
Q Consensus       319 ~~~~vkl~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~  394 (488)
                      +.-++||+|=.+++.....+.   ....-....||++|.+.+..|+.++|||||||++|||++ |..||.+.++.+... 
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-  509 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-  509 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-
Confidence            999999999998865432221   122234568999999999999999999999999999999 999999999988754 


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          395 VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       395 ~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      .+..+.|...|.+||+++..++.-||...|++||++.|++.-|..|..++.
T Consensus       510 ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  510 YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence            556778999999999999999999999999999999999999999988765

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.9e-32  Score=285.89  Aligned_cols=261  Identities=15%  Similarity=0.227  Sum_probs=188.0

Q ss_pred             cccccceeccceeeeeccEEEEEEEE------------------CCccEEEEEEecCCCChhHHHH------HHHHHHHH
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIY------------------KDEPVAVKIIRIPDDDENETLA------ARLEKQFN  230 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~------------------~~~~vAVK~i~~~~~~~~~~~~------~~~~~~~~  230 (488)
                      .+..++|.+.++||+|+||+||+|.+                  .++.||||.+..........+.      ......+.
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            45678899999999999999999974                  2357999999754322111111      11123355


Q ss_pred             HHHHHHHhcCCCCe-----eeEeeeeec--------CCeeeEEEeecCCCCHHHHHHHhC--------------------
Q 011359          231 REVALLSRLHNPNV-----IKFVAACKK--------PPVYCVITEYLSEGSLRAYLHKLE--------------------  277 (488)
Q Consensus       231 ~Ei~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~--------------------  277 (488)
                      .|+.++.+++|.++     ++++++|..        ....+|||||+.+++|.++++...                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            68888888877654     677777643        356789999999999999987521                    


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCC--CCCCCcccCChh
Q 011359          278 --HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS--DDPGTYRWMAPE  353 (488)
Q Consensus       278 --~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~--~~~gt~~y~aPE  353 (488)
                        ...+++..+..++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++..........  ...+++.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence              1124567788999999999999999999999999999999999999999999985433222111  233578999999


Q ss_pred             hhhcCC--------------------C--CchhHHHHHHHHHHHHHhCCC-CCCCCCHHHHHHH-----------HHhcc
Q 011359          354 MIKHKS--------------------Y--GRKVDVYSFGLILWEMVAGTI-PYEEMNPIQAAFA-----------VVNKN  399 (488)
Q Consensus       354 ~l~~~~--------------------~--~~k~DvwSlGvll~elltG~~-Pf~~~~~~~~~~~-----------~~~~~  399 (488)
                      .+....                    |  ..+.||||+||++|+|++|.. ||.+.........           +....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            885322                    1  235799999999999999876 7765332211111           11122


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhhhCC---CCCCCHHHHHH
Q 011359          400 LRPAIPGDCPPAMAALIEQCWSLQP---DKRPEFWHIVK  435 (488)
Q Consensus       400 ~~~~~~~~~~~~l~~Li~~cL~~dp---~~RPs~~eil~  435 (488)
                      ........++....+|+.+||..++   .+|+++.++++
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            2233345678899999999999766   68999999875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-33  Score=266.36  Aligned_cols=249  Identities=24%  Similarity=0.440  Sum_probs=210.1

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVA  249 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~  249 (488)
                      .|.+.+.+|.+...||+|.|..|..+++.  ++.+|+|+++.+--++++.+     .-...|-.+..+- +||.+|-++.
T Consensus       244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedi-----dwvqtek~vfe~asn~pflvglhs  318 (593)
T KOG0695|consen  244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDI-----DWVQTEKHVFEQASNNPFLVGLHS  318 (593)
T ss_pred             ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccc-----hhHHhhHHHHHhccCCCeEEehhh
Confidence            45677788999999999999999999876  68899999986543333322     2345677777766 6999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      .|..+..+++|.||++||+|.-.+++  +..++++.+..+..+|+-||.|||++|||.||||.+|+|+|.+|++||+|+|
T Consensus       319 cfqtesrlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  319 CFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             hhcccceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccc
Confidence            99999999999999999999877765  5679999999999999999999999999999999999999999999999999


Q ss_pred             cccccc-ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCC-------CCCHHHHHHHHHhccCC
Q 011359          330 IACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE-------EMNPIQAAFAVVNKNLR  401 (488)
Q Consensus       330 la~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~-------~~~~~~~~~~~~~~~~~  401 (488)
                      ++.+.. .+...++.+||+.|.|||++.+..|+..+|.|+|||+++||+.|+.||+       +.+..+.++.++.+. .
T Consensus       397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-q  475 (593)
T KOG0695|consen  397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-Q  475 (593)
T ss_pred             hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-c
Confidence            986543 4456678899999999999999999999999999999999999999996       234445555555443 2


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhCCCCCCC
Q 011359          402 PAIPGDCPPAMAALIEQCWSLQPDKRPE  429 (488)
Q Consensus       402 ~~~~~~~~~~l~~Li~~cL~~dp~~RPs  429 (488)
                      ..+|..++-....+++..|++||.+|..
T Consensus       476 iriprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  476 IRIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence            3477788888889999999999999954

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=1.9e-32  Score=251.43  Aligned_cols=243  Identities=23%  Similarity=0.413  Sum_probs=197.3

Q ss_pred             cccceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeec
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK  253 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~  253 (488)
                      ..++|.+.+++|+|-|+.||.|+.  +++.++||+++.-.           .+.+.+|+.||..|. ||||+++++...+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----------kkKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----------KKKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----------HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            456799999999999999999984  57899999998422           577899999999998 9999999999876


Q ss_pred             C--CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-CcEEEeeecc
Q 011359          254 P--PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGI  330 (488)
Q Consensus       254 ~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-~~vkl~DFgl  330 (488)
                      +  ....||+||+++.+...+-.     .++...+..++.++++||.|||++||+|||+||.|++||.. ..++|+|+|+
T Consensus       105 p~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL  179 (338)
T KOG0668|consen  105 PESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL  179 (338)
T ss_pred             ccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence            4  46789999999888777664     47777899999999999999999999999999999999865 5699999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh-----------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYE-EMNPIQAAFAVVN-----------  397 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~-~~~~~~~~~~~~~-----------  397 (488)
                      |............+.+..|--||++.. ..|+..-|+|||||+|..|+..+-||. +.++.+.+..+..           
T Consensus       180 AEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  180 AEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             HhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            977766666666778889999999864 468999999999999999999888875 3333332222110           


Q ss_pred             -c---cCCC--------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          398 -K---NLRP--------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       398 -~---~~~~--------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                       +   .+.+                    ....-++++..+|+.++|..|-++|+++.|.+.
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             0   0111                    111234588999999999999999999998875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=2.2e-31  Score=287.42  Aligned_cols=249  Identities=20%  Similarity=0.244  Sum_probs=169.0

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      ...+..++|.+++.||+|+||.||+|.+.      +..||||.+......+          .+..|  .+.+..+.++..
T Consensus       126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----------~~~~e--~l~~~~~~~~~~  193 (566)
T PLN03225        126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----------IWMNE--RVRRACPNSCAD  193 (566)
T ss_pred             CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----------HHHHH--HHHhhchhhHHH
Confidence            34557788999999999999999999985      4689999876322110          00111  112222222222


Q ss_pred             Eeee------eecCCeeeEEEeecCCCCHHHHHHHhCCC------------------CCCHHHHHHHHHHHHHHHHHHHH
Q 011359          247 FVAA------CKKPPVYCVITEYLSEGSLRAYLHKLEHK------------------TLPLPKLIAIALDIARGMEYIHS  302 (488)
Q Consensus       247 l~~~------~~~~~~~~lV~E~~~ggsL~~~l~~~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~  302 (488)
                      ++..      +..+..+++|+||+.+++|.+++......                  ......+..++.||+.||+|||+
T Consensus       194 ~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~  273 (566)
T PLN03225        194 FVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS  273 (566)
T ss_pred             HHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH
Confidence            2221      24566889999999999999998753210                  11123466799999999999999


Q ss_pred             CCcccCCCCCCeEEEcC-CCcEEEeeeccccccccc--CcCCCCCCCcccCChhhhhcC---------------------
Q 011359          303 QGVIHRDLKPENVLIDQ-EFHLKIADFGIACEEVYC--DALSDDPGTYRWMAPEMIKHK---------------------  358 (488)
Q Consensus       303 ~giiHrDIkp~NILl~~-~~~vkl~DFgla~~~~~~--~~~~~~~gt~~y~aPE~l~~~---------------------  358 (488)
                      +||+||||||+|||++. ++.+||+|||+|......  .......+++.|+|||.+...                     
T Consensus       274 ~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~  353 (566)
T PLN03225        274 TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ  353 (566)
T ss_pred             CCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence            99999999999999986 579999999999643221  222345689999999976322                     


Q ss_pred             -CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-c---------CCCCC----------CCCCcHHHHHHHH
Q 011359          359 -SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK-N---------LRPAI----------PGDCPPAMAALIE  417 (488)
Q Consensus       359 -~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~-~---------~~~~~----------~~~~~~~l~~Li~  417 (488)
                       .++.++|||||||++|||+++..++...  .......+.. +         .....          .........+||.
T Consensus       354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~  431 (566)
T PLN03225        354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK  431 (566)
T ss_pred             ccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence             2345679999999999999987765432  1111111110 0         00000          0112234568999


Q ss_pred             HHhhhCCCCCCCHHHHHH
Q 011359          418 QCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       418 ~cL~~dp~~RPs~~eil~  435 (488)
                      +||+.||++||++.++++
T Consensus       432 ~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        432 SMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHccCCcccCCCHHHHhC
Confidence            999999999999999987

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=290.15  Aligned_cols=234  Identities=26%  Similarity=0.452  Sum_probs=186.8

Q ss_pred             ceeeeeccE-EEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeeeEEEe
Q 011359          185 LRFAHGAHS-RLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVITE  262 (488)
Q Consensus       185 ~~lG~G~~g-~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E  262 (488)
                      +.+|.|+.| .||+|.+.|+.||||.+-..           ......+|+..|+.-+ |||||++++.-.+....||..|
T Consensus       515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYEGREVAVKRLLEE-----------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             HHcccCCCCcEEEEEeeCCceehHHHHhhH-----------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            457899988 57999999999999998632           1344679999999986 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC---C--CcEEEeeeccccccc
Q 011359          263 YLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---E--FHLKIADFGIACEEV  335 (488)
Q Consensus       263 ~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~---~--~~vkl~DFgla~~~~  335 (488)
                      .| ..+|.+++...  ..........+.++.|++.||++||+.+||||||||.||||+.   +  .+++|+|||++....
T Consensus       584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            99 67999999873  1111111356788999999999999999999999999999965   3  468999999996543


Q ss_pred             cc----CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC---CCCC
Q 011359          336 YC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA---IPGD  407 (488)
Q Consensus       336 ~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~  407 (488)
                      ..    .......||.+|+|||++....-+.++|||||||++|+.++ |..||.+.-..+.  .++..+....   ...+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d  740 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPD  740 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCch
Confidence            32    22456679999999999988888889999999999999998 5999987654432  2333332211   1122


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIV  434 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil  434 (488)
                      +  +..+||.+|++.+|..||++.+++
T Consensus       741 ~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  741 C--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             H--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            2  889999999999999999999887

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.2e-33  Score=258.96  Aligned_cols=253  Identities=22%  Similarity=0.380  Sum_probs=198.2

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      .+.+.|.-..+||+|.||.||+++..  |+.||+|++..+...+.      +.....+|+.+|..|.|+|++.++..|..
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG------fpitalreikiL~~lkHenv~nliEic~t   87 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICRT   87 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC------CcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence            34567778889999999999999875  67899988765432211      12345699999999999999999998743


Q ss_pred             --------CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEE
Q 011359          254 --------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI  325 (488)
Q Consensus       254 --------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl  325 (488)
                              ...+|+||.+|+. +|.-+|.. ....++..++.+++.++..||.|+|...|+|||+|++|+||+.+|.+||
T Consensus        88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl  165 (376)
T KOG0669|consen   88 KATPTNRDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL  165 (376)
T ss_pred             ccCCcccccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence                    2358999999954 78887765 3456889999999999999999999999999999999999999999999


Q ss_pred             eeeccccccccc-----CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--
Q 011359          326 ADFGIACEEVYC-----DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN--  397 (488)
Q Consensus       326 ~DFgla~~~~~~-----~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~--  397 (488)
                      +|||+++.....     ...+..+.|.+|.+||.+.+ ..|+++.|||..|||+.||++|.+-+.+....+.+..+..  
T Consensus       166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc  245 (376)
T KOG0669|consen  166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC  245 (376)
T ss_pred             eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence            999999543322     22345566999999999865 5799999999999999999999988888776554433321  


Q ss_pred             ccC----CCC--------------CCC-------------CCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          398 KNL----RPA--------------IPG-------------DCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       398 ~~~----~~~--------------~~~-------------~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      +..    +|.              ++.             .-.++..+|+.++|..||.+|+++.+++..
T Consensus       246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            111    110              110             113478899999999999999999988854

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=283.94  Aligned_cols=247  Identities=24%  Similarity=0.446  Sum_probs=216.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+..++|.|.||.||++++.  ++..|||++++...++.        +-+.+|+-+++.++|+|||.++|.|.....
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~--------~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF--------SGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc--------cccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            56889999999999999999986  79999999998776653        345689999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|+.||||.||+|.+.-+-  .+.+++-++..+.++.++||+|||+.|-+|||||-.|||+++.|.+|+.|||.+.....
T Consensus        87 lwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             cEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence            9999999999999987764  57899999999999999999999999999999999999999999999999998854332


Q ss_pred             c-CcCCCCCCCcccCChhhh---hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC---CCCCCc
Q 011359          337 C-DALSDDPGTYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA---IPGDCP  409 (488)
Q Consensus       337 ~-~~~~~~~gt~~y~aPE~l---~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~  409 (488)
                      . .......||++|||||+.   +...|...+|||++|++..|+-.-..|..+..+.+.++-....++.+.   -+..++
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence            2 223456799999999987   456799999999999999999999999999999999888777766543   235688


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.|.+|++.||.++|++||+++.++.
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhhee
Confidence            99999999999999999999987664

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=278.33  Aligned_cols=206  Identities=24%  Similarity=0.383  Sum_probs=175.5

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeeEeeee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAAC  251 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~  251 (488)
                      .+++|...+.+|.|+||.|+.|+++  ...|+||+|..+.--.+.-+..+-.-.+..||+||..|+   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            4566889999999999999999997  468999999865433222222222334668999999998   99999999999


Q ss_pred             ecCCeeeEEEeec-CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          252 KKPPVYCVITEYL-SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       252 ~~~~~~~lV~E~~-~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      ++++.+||+||-- +|-+|+++|..  +..+++.++..|+.|++.|+++||+.||||||||-+||.++.+|.+||+|||.
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence            9999999999965 55699999986  57799999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEE  385 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~  385 (488)
                      |.. ..........||..|.|||++.+..| +...|||+||++||.++....||..
T Consensus       717 aa~-~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAY-TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhh-hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            832 23344556789999999999998887 7889999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.2e-29  Score=235.67  Aligned_cols=209  Identities=35%  Similarity=0.611  Sum_probs=183.0

Q ss_pred             eeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeec
Q 011359          187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  264 (488)
                      ||.|++|.||++...  ++.++||++.......       ....+.+|+.+++.+.|++|+++++++......++++||+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~   73 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC   73 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence            589999999999997  7999999998544321       2457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-CCcEEEeeecccccccccC-cCCC
Q 011359          265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIACEEVYCD-ALSD  342 (488)
Q Consensus       265 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-~~~vkl~DFgla~~~~~~~-~~~~  342 (488)
                      .+++|.+++.... ..+++..++.++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+....... ....
T Consensus        74 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          74 EGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence            9999999998632 46889999999999999999999999999999999999999 8999999999885443221 1334


Q ss_pred             CCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 011359          343 DPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS  421 (488)
Q Consensus       343 ~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~  421 (488)
                      ..+...|++||.+... .++.+.|+|+||+++++|                                 ..+.+++.+||+
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhh
Confidence            5578899999999876 788999999999999999                                 578999999999


Q ss_pred             hCCCCCCCHHHHHHH
Q 011359          422 LQPDKRPEFWHIVKV  436 (488)
Q Consensus       422 ~dp~~RPs~~eil~~  436 (488)
                      .+|++||++.++++.
T Consensus       200 ~~p~~R~~~~~l~~~  214 (215)
T cd00180         200 KDPEKRPSAKEILEH  214 (215)
T ss_pred             CCcccCcCHHHHhhC
Confidence            999999999998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-30  Score=259.20  Aligned_cols=133  Identities=25%  Similarity=0.446  Sum_probs=117.3

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-----C---CCe
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-----N---PNV  244 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnI  244 (488)
                      .+.-.+|.+.++||.|.|++||++.+.  .+.||+|+.+-         +..+.+....||.+|++++     |   .+|
T Consensus        74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~V  144 (590)
T KOG1290|consen   74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---------AQHYTEAALDEIKLLQQVREGDPNDPGKKCV  144 (590)
T ss_pred             cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---------hhHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence            455578999999999999999999986  58899999973         2345666789999999984     2   469


Q ss_pred             eeEeeeeec----CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEE
Q 011359          245 IKFVAACKK----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLI  317 (488)
Q Consensus       245 v~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl  317 (488)
                      |+|++.|..    +.++|+|+|++ |.+|..+|.....+.++...+.+|++||+.||.|||.+ ||||-||||+|||+
T Consensus       145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            999999965    55899999999 88999999998889999999999999999999999976 99999999999999

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8e-32  Score=252.85  Aligned_cols=245  Identities=24%  Similarity=0.389  Sum_probs=192.0

Q ss_pred             ccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-----
Q 011359          183 LGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-----  255 (488)
Q Consensus       183 i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----  255 (488)
                      -.+.||.|+||+||...+-  |+.||+|.+...-.    .+  -.-+.+.+|+.+|..++|.||+..+++.....     
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq----~L--~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ----NL--ASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHH----HH--HHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            4567899999999998873  79999998853211    11  12567899999999999999999998775443     


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+|+|+|.| ..+|...|-.  ...++.+.+.-+++||++||.|||+.||.||||||.|.|++.+..+||||||+++...
T Consensus       131 EiYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  131 ELYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc
Confidence            467888887 4466666654  5678888999999999999999999999999999999999999999999999996543


Q ss_pred             c--cCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------
Q 011359          336 Y--CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--------------  398 (488)
Q Consensus       336 ~--~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~--------------  398 (488)
                      .  ....+..+.|.+|.|||++.+ ..|+.+.||||+|||+.|++..+.-|...++.+.+.-+.+-              
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            2  234455668999999999976 47999999999999999999999999988887665444321              


Q ss_pred             ---------cCC-CCCC--------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          399 ---------NLR-PAIP--------GDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       399 ---------~~~-~~~~--------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                               ..+ +.++        ..-..+...++.++|..+|++|.+..+.+..
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence                     111 1111        1223467788899999999999998877654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-31  Score=246.52  Aligned_cols=277  Identities=28%  Similarity=0.561  Sum_probs=234.0

Q ss_pred             cccccccccccCCCceeecccccccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHH
Q 011359          149 RKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ  228 (488)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~  228 (488)
                      .++..|.+.-+.    ....-.+....||++++.+.-+|.+...|.+|+|+|+|..+++|++...      ....+...+
T Consensus       164 fkdt~wkgtktr----~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr------~~t~risrd  233 (448)
T KOG0195|consen  164 FKDTTWKGTKTR----TRDATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVR------EVTARISRD  233 (448)
T ss_pred             cccccccccccc----ccccccccccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhh------hcchhhcch
Confidence            567777653221    1111224556789999999999999999999999999999999999753      344666788


Q ss_pred             HHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cc-
Q 011359          229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG-VI-  306 (488)
Q Consensus       229 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g-ii-  306 (488)
                      |..|.-.|+-+.||||+.++|+|..+.++.+|..||+.|+|+..|+....-.++..++++++.+|++|++|||+.. ++ 
T Consensus       234 fneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ip  313 (448)
T KOG0195|consen  234 FNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIP  313 (448)
T ss_pred             hhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhh
Confidence            9999999999999999999999999999999999999999999999876666788899999999999999999984 33 


Q ss_pred             cCCCCCCeEEEcCCCcEEEe--eecccccccccCcCCCCCCCcccCChhhhhcCCCC---chhHHHHHHHHHHHHHhCCC
Q 011359          307 HRDLKPENVLIDQEFHLKIA--DFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYG---RKVDVYSFGLILWEMVAGTI  381 (488)
Q Consensus       307 HrDIkp~NILl~~~~~vkl~--DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~k~DvwSlGvll~elltG~~  381 (488)
                      ---|....++||++...+|+  |--++.+.      ....-.+.||+||.++..+.+   +++|+|||++++|||.|...
T Consensus       314 r~~lns~hvmidedltarismad~kfsfqe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trev  387 (448)
T KOG0195|consen  314 RFYLNSKHVMIDEDLTARISMADTKFSFQE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREV  387 (448)
T ss_pred             hhhcccceEEecchhhhheecccceeeeec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccc
Confidence            33688899999999877664  43333211      122356789999999866543   68999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       382 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      ||.+..+.+-..++..++++..+|+.++..+..|++-|+..||.+||.|..|+-.||++.
T Consensus       388 pfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  388 PFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            999999999999999999999999999999999999999999999999999999999874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=5.8e-29  Score=235.45  Aligned_cols=212  Identities=32%  Similarity=0.516  Sum_probs=178.5

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |.+++.||.|++|.||++...  ++.+|||.+......       +..+.+.+|++.+.+++|+|++++++++......+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   73 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY   73 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence            456788999999999999986  489999999864432       12567889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      +++||+.+++|.+++..... .+++..+..++.+++.+|.+||+.+++|+||++.||+++.++.++|+|||++.......
T Consensus        74 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       74 LVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             EEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            99999999999999987322 27889999999999999999999999999999999999999999999999886544332


Q ss_pred             --cCCCCCCCcccCChhhh-hcCCCCchhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccC
Q 011359          339 --ALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKNL  400 (488)
Q Consensus       339 --~~~~~~gt~~y~aPE~l-~~~~~~~k~DvwSlGvll~elltG~~Pf~~-~~~~~~~~~~~~~~~  400 (488)
                        ......++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++.......+..+.
T Consensus       153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence              23445678889999998 666778899999999999999999999977 555555555555443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=3.6e-31  Score=266.60  Aligned_cols=246  Identities=24%  Similarity=0.362  Sum_probs=198.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC------CCeeeEeee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN------PNVIKFVAA  250 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~  250 (488)
                      ++|.+....|+|-|++|.+|.+.  |..||||+|+..     +.+    .+.=+.|++||++|+.      -|+++|+..
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-----E~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-----EVM----HKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-----hHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            56888888899999999999986  689999999842     222    3445689999999963      579999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-CcEEEeee
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADF  328 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-~~vkl~DF  328 (488)
                      |.+.+++|||+|-+ ..+|.++|.++. +-.|....+..++.|++-||..|...||+|.||||.|||+++. ..+|||||
T Consensus       503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence            99999999999988 569999999873 3468888999999999999999999999999999999999865 56899999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cC------
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--NL------  400 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~--~~------  400 (488)
                      |.|...... ..+....+..|.|||++.+.+|+...|+||+||+||||.||..-|.+..+.+++...+.-  .+      
T Consensus       582 GSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  582 GSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            998543322 223333456799999999999999999999999999999999999998876665433320  00      


Q ss_pred             -----------------------------------CC------------CCCC---CCcHHHHHHHHHHhhhCCCCCCCH
Q 011359          401 -----------------------------------RP------------AIPG---DCPPAMAALIEQCWSLQPDKRPEF  430 (488)
Q Consensus       401 -----------------------------------~~------------~~~~---~~~~~l~~Li~~cL~~dp~~RPs~  430 (488)
                                                         .|            .++.   ..-..|.+|+.+||..||++|.+.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence                                               00            0010   112468999999999999999999


Q ss_pred             HHHHH
Q 011359          431 WHIVK  435 (488)
Q Consensus       431 ~eil~  435 (488)
                      .+.|+
T Consensus       741 nqAL~  745 (752)
T KOG0670|consen  741 NQALK  745 (752)
T ss_pred             HHHhc
Confidence            98775

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=247.40  Aligned_cols=245  Identities=24%  Similarity=0.359  Sum_probs=195.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      .+|.-...+|.|+- .|-.+.+.  +++||+|..-.+-...  .-    .+...+|+.++..++|+||++++.+|.-.  
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~--~~----akra~rel~l~~~v~~~nii~l~n~ftP~~~   89 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQ--TH----AKRAYRELKLMKCVNHKNIISLLNVFTPQKT   89 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccC--cc----chhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence            34555667788888 56555553  7899999987663321  11    34566999999999999999999998543  


Q ss_pred             ----CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          255 ----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       255 ----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                          ...|+||||| ..+|.+.+..    .++-+.+..|++|++.|+.|||+.||+||||||+||++..++.+||.|||+
T Consensus        90 l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   90 LEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchh
Confidence                3678999999 5689888873    467778899999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-----------  399 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-----------  399 (488)
                      |+.....-..+..+.|..|.|||++.+..|.+.+||||+||++.||++|..-|.+.+..+...++...-           
T Consensus       165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            987666556677789999999999998889999999999999999999999998877655443333210           


Q ss_pred             ------------------CCCCCC-----------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 ------------------LRPAIP-----------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 ------------------~~~~~~-----------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                        +...+|           ..-...+++++.+||-.+|++|.++++++.
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                              000001           111245789999999999999999999886

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-28  Score=230.26  Aligned_cols=252  Identities=20%  Similarity=0.374  Sum_probs=194.7

Q ss_pred             cccc-cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEee-
Q 011359          175 TVDL-SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVA-  249 (488)
Q Consensus       175 ~id~-~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~-  249 (488)
                      .+++ +.|.+.+.||+|.||.+-++.++  ++.+++|.+..+-..         .++|.+|...--.|. |.||+.-|+ 
T Consensus        19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---------~~dF~rEfhY~~~Ls~H~hIi~tY~v   89 (378)
T KOG1345|consen   19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---------QADFVREFHYSFFLSPHQHIIDTYEV   89 (378)
T ss_pred             ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---------HHHHHHHhccceeeccchhhhHHHHH
Confidence            3444 45888999999999999999987  478999998765322         467889988777776 899998776 


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE-c-CCCcEEEee
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI-D-QEFHLKIAD  327 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl-~-~~~~vkl~D  327 (488)
                      +|+..+.++++|||++.|+|.+-+..   ..+-+....+++.|++.||.|||++++||||||.+|||| + +..++||||
T Consensus        90 aFqt~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcD  166 (378)
T KOG1345|consen   90 AFQTSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCD  166 (378)
T ss_pred             HhhcCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeee
Confidence            57778889999999999999887754   568888899999999999999999999999999999999 2 345899999


Q ss_pred             ecccccccccCcCCCCCCCcccCChhhhhcC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcc
Q 011359          328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHK-----SYGRKVDVYSFGLILWEMVAGTIPYEEMNP---IQAAFAVVNKN  399 (488)
Q Consensus       328 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~k~DvwSlGvll~elltG~~Pf~~~~~---~~~~~~~~~~~  399 (488)
                      ||+.+....  ......-+..|.+||.....     ...+..|+|.||+++|.+++|..||.....   .-..+....++
T Consensus       167 FG~t~k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  167 FGLTRKVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR  244 (378)
T ss_pred             cccccccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence            998854321  11222346678999987432     246789999999999999999999984322   22223333344


Q ss_pred             CCCCCC---CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          400 LRPAIP---GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       400 ~~~~~~---~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ..+..|   ...++.+..+.++-|..++++|-..++..++....
T Consensus       245 k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~  288 (378)
T KOG1345|consen  245 KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL  288 (378)
T ss_pred             cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence            444444   34678889999999999999998777777655443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=8.7e-27  Score=224.53  Aligned_cols=255  Identities=20%  Similarity=0.314  Sum_probs=214.5

Q ss_pred             cceeccceeeeeccEEEEEEE--ECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~--~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  255 (488)
                      -.|++|++||+|.||+++.|.  +++++||||.-.....          .-++..|....+.|. .++|..+|.+...+.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----------APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~   97 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----------APQLRDEYRTYKLLGGTEGIPQVYYFGQEGK   97 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC----------cchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence            358899999999999999997  4799999999865443          246778999999997 699999999888888


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-----CcEEEeeecc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-----FHLKIADFGI  330 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-----~~vkl~DFgl  330 (488)
                      +-.||+|++ |-+|.|+..- ....++...++.+|.|++.-++|+|++.+|.|||||+|+||+.-     ..+.|+|||+
T Consensus        98 ~NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            889999998 8899998764 56789999999999999999999999999999999999999643     4589999999


Q ss_pred             cccccccCcCCC--------CCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcc
Q 011359          331 ACEEVYCDALSD--------DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP---IQAAFAVVNKN  399 (488)
Q Consensus       331 a~~~~~~~~~~~--------~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~---~~~~~~~~~~~  399 (488)
                      |.......+...        ..||.+||+--...+...+.+.|+-|||-++++.|-|.+||.+...   .+...+|-..+
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            987665554433        3499999999998889999999999999999999999999998753   34444443333


Q ss_pred             CC---CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          400 LR---PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       400 ~~---~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ..   ..+...+|.++..-+...-..+-++-|+++-+...+.++...+.
T Consensus       256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            22   23456789999999999999999999999999999998887654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=6.6e-26  Score=229.28  Aligned_cols=256  Identities=22%  Similarity=0.304  Sum_probs=205.1

Q ss_pred             ceeccceeeeeccEEEEEEEECC---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC----CCeeeEeeee-
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYKD---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN----PNVIKFVAAC-  251 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~~---~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-  251 (488)
                      +|.++++||+|+||.||.+....   +.+|+|+.........        ..+..|+.++..+..    .++..+++.. 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~   90 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR   90 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--------ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence            78899999999999999999865   3699999876433221        146688888888873    6899999998 


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-----CcEEEe
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-----FHLKIA  326 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-----~~vkl~  326 (488)
                      ..+...++||+.+ |.+|.++......+.++...++.|+.|++.+|++||+.|++||||||.|++++..     ..+.|.
T Consensus        91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEE
Confidence            5777889999988 8899998877666789999999999999999999999999999999999999865     469999


Q ss_pred             eecccc--cccccC--------c-CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 011359          327 DFGIAC--EEVYCD--------A-LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV  395 (488)
Q Consensus       327 DFgla~--~~~~~~--------~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~  395 (488)
                      |||+++  ......        . .....||..|+++.+..+...+++.|+||++.++.+++.|.+||...........+
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~  249 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF  249 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence            999997  321111        0 12344999999999999999999999999999999999999999876643222222


Q ss_pred             Hh---ccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          396 VN---KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       396 ~~---~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      ..   ...........+.++..+...+-..+...+|++..+...|.+.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            21   11111134456778888888888899999999999999988776653

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1e-27  Score=269.95  Aligned_cols=194  Identities=18%  Similarity=0.194  Sum_probs=142.8

Q ss_pred             HhcCC-CCeeeEeeee-------ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 011359          237 SRLHN-PNVIKFVAAC-------KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR  308 (488)
Q Consensus       237 ~~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHr  308 (488)
                      +.++| .||+.++++|       .....+++++||+ +++|.++|... ...+++..++.++.||+.||+|||++||+||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            34556 6888888887       2334677889987 67999999752 4568999999999999999999999999999


Q ss_pred             CCCCCeEEEcCC-------------------CcEEEeeeccccccccc-----------------CcCCCCCCCcccCCh
Q 011359          309 DLKPENVLIDQE-------------------FHLKIADFGIACEEVYC-----------------DALSDDPGTYRWMAP  352 (488)
Q Consensus       309 DIkp~NILl~~~-------------------~~vkl~DFgla~~~~~~-----------------~~~~~~~gt~~y~aP  352 (488)
                      ||||+||||+..                   +.+||+|||+++.....                 .......||+.||||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            999999999654                   44566666665421100                 000113578899999


Q ss_pred             hhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHH
Q 011359          353 EMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWH  432 (488)
Q Consensus       353 E~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~e  432 (488)
                      |++.+..|+.++|||||||++|||++|..|+.....  ....+......+.. .........++.+||+.+|.+||++.+
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~e  261 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSE  261 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHH
Confidence            999989999999999999999999999888764321  11111111111111 122445678999999999999999999


Q ss_pred             HHH
Q 011359          433 IVK  435 (488)
Q Consensus       433 il~  435 (488)
                      +++
T Consensus       262 il~  264 (793)
T PLN00181        262 LLQ  264 (793)
T ss_pred             Hhh
Confidence            985

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1.8e-26  Score=211.91  Aligned_cols=163  Identities=24%  Similarity=0.343  Sum_probs=130.7

Q ss_pred             CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCCCC
Q 011359          267 GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT  346 (488)
Q Consensus       267 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~gt  346 (488)
                      |+|.+++... ...+++..++.|+.||+.||.|||+.+      ||+|||++.++.+++  ||++......    ...||
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~   67 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD   67 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence            6899999763 456999999999999999999999998      999999999999999  9988543321    23689


Q ss_pred             cccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC------CCCCCcH--HHHHHHHH
Q 011359          347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA------IPGDCPP--AMAALIEQ  418 (488)
Q Consensus       347 ~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~--~l~~Li~~  418 (488)
                      ..|+|||++.+..++.++|||||||++|||++|..||............+.......      .+..++.  .+.++|.+
T Consensus        68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            999999999999999999999999999999999999976654332222222221111      1122333  69999999


Q ss_pred             HhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          419 CWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       419 cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ||..+|++||++.++++.+..+..
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHHHH
Confidence            999999999999999998877654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=4.4e-27  Score=233.24  Aligned_cols=242  Identities=22%  Similarity=0.389  Sum_probs=189.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACK  252 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~  252 (488)
                      ..|.+.++||.|.|+.||++.+.     ++.||+|.+.....          ...+..|+++|..+. +.||+++.+++.
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----------p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----------PSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----------chHHHHHHHHHHHhccchhhhcchhhhc
Confidence            44778899999999999999753     47899999976443          345789999999997 999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-CCcEEEeeeccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIA  331 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-~~~vkl~DFgla  331 (488)
                      .++..++|+||++.....++...     ++..++..+++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence            99999999999999999999876     678899999999999999999999999999999999975 467899999998


Q ss_pred             cc-cccc------C-------c-------------------------------CCCCCCCcccCChhhhhc-CCCCchhH
Q 011359          332 CE-EVYC------D-------A-------------------------------LSDDPGTYRWMAPEMIKH-KSYGRKVD  365 (488)
Q Consensus       332 ~~-~~~~------~-------~-------------------------------~~~~~gt~~y~aPE~l~~-~~~~~k~D  365 (488)
                      .. ..+.      .       .                               .....||++|.|||++.. ...+.+.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            51 0000      0       0                               001239999999999954 45688999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH--------------hcc---------------------C---------
Q 011359          366 VYSFGLILWEMVAGTIPYEEMNP-IQAAFAVV--------------NKN---------------------L---------  400 (488)
Q Consensus       366 vwSlGvll~elltG~~Pf~~~~~-~~~~~~~~--------------~~~---------------------~---------  400 (488)
                      |||.|||+..++++..||..... ...+..++              .+.                     +         
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            99999999999999999864321 11100000              000                     0         


Q ss_pred             ----CCCC-CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 ----RPAI-PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 ----~~~~-~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                          .... ....+..+.+|+.+||..||.+|.++++.|+
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                0000 1123457899999999999999999999885

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-25  Score=207.25  Aligned_cols=261  Identities=20%  Similarity=0.306  Sum_probs=214.3

Q ss_pred             cccccccceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeeeEee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVA  249 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~  249 (488)
                      +..+-..+|.+.++||.|.||.+|.|..  .|+.||||+-.....          ..++..|..+...|++ ..|..+..
T Consensus         9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----------hpqL~yEskvY~iL~~g~GiP~i~~   78 (341)
T KOG1163|consen    9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----------HPQLLYESKVYRILQGGVGIPHIRH   78 (341)
T ss_pred             hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----------CcchhHHHHHHHHhccCCCCchhhh
Confidence            4456678899999999999999999986  489999999864332          2457789999999985 67777777


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC---CcEEEe
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIA  326 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~---~~vkl~  326 (488)
                      ++.+...-.+||+.+ |.+|.+++.- ....++...++.++-|++.-++|+|.+++|||||||+|+|.+-+   ..+.++
T Consensus        79 y~~e~~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LI  156 (341)
T KOG1163|consen   79 YGTEKDYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLI  156 (341)
T ss_pred             hccccccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEE
Confidence            888888889999998 8899998865 45678999999999999999999999999999999999999643   468999


Q ss_pred             eecccccccccCc--------CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Q 011359          327 DFGIACEEVYCDA--------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI---QAAFAV  395 (488)
Q Consensus       327 DFgla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~---~~~~~~  395 (488)
                      |||+|........        .....||.+|.+-....+...+.+.|+-|+|.+|..+.-|.+||.+....   +....+
T Consensus       157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI  236 (341)
T KOG1163|consen  157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI  236 (341)
T ss_pred             eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence            9999965433222        23446999999988887778899999999999999999999999987643   334445


Q ss_pred             HhccCC---CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          396 VNKNLR---PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       396 ~~~~~~---~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ...+..   ..+....|.++...+..|-..--++-|++.-+.+.+.-+...|.
T Consensus       237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln  289 (341)
T KOG1163|consen  237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN  289 (341)
T ss_pred             HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence            444433   23567889999999999999999999999998888887777655

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=9e-24  Score=207.50  Aligned_cols=250  Identities=25%  Similarity=0.429  Sum_probs=201.6

Q ss_pred             eeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC-CeeeEeeeeecCCeeeE
Q 011359          181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP-NVIKFVAACKKPPVYCV  259 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~l  259 (488)
                      |.+...||.|+||.||++.+. ..+|+|.+........     .....+.+|+.++..+.|+ +|+++++.+......++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYL   75 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEE
Confidence            567788999999999999988 8899999976544332     2356789999999999988 79999999987777899


Q ss_pred             EEeecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC-cEEEeeeccccccccc
Q 011359          260 ITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIACEEVYC  337 (488)
Q Consensus       260 V~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~-~vkl~DFgla~~~~~~  337 (488)
                      +++|+.++++.+++..... ..+.......++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++......
T Consensus        76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999999977765321 2688999999999999999999999999999999999999988 7999999998533322


Q ss_pred             C-------cCCCCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCC--
Q 011359          338 D-------ALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNP---IQAAFAVVNKNLRP--  402 (488)
Q Consensus       338 ~-------~~~~~~gt~~y~aPE~l~~---~~~~~k~DvwSlGvll~elltG~~Pf~~~~~---~~~~~~~~~~~~~~--  402 (488)
                      .       ......|+..|++||.+.+   ..+....|+|++|++++++++|..||.....   .......+.....+  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            2       2356679999999999987   5788999999999999999999999887763   23333333322222  


Q ss_pred             --CCCCCC----cHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          403 --AIPGDC----PPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       403 --~~~~~~----~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                        ......    ...+.+++..|+..+|..|.+.......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              122222    2578999999999999999998877664

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=4.6e-24  Score=217.15  Aligned_cols=164  Identities=17%  Similarity=0.143  Sum_probs=124.5

Q ss_pred             ccceeccceeeeeccEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee-Eeeeeec
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK-FVAACKK  253 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~---~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~  253 (488)
                      .++|.+++.||+|+||+||+|.+.   ++.||||++.........   ......|.+|+++|++++|+||+. ++++   
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~---~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSK---PLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccccc---HHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            467889999999999999999874   567899987532110000   112456899999999999999985 4432   


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCeEEEcCCCcEEEeeecccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL-KPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDI-kp~NILl~~~~~vkl~DFgla~  332 (488)
                       ...+|||||++|++|.. +..     ..   ...++.+++.+|.|||++||+|||| ||+|||++.++.++|+|||+|.
T Consensus        91 -~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence             35789999999999963 211     11   1467889999999999999999999 9999999999999999999996


Q ss_pred             cccccC---------cCCCCCCCcccCChhhhhc
Q 011359          333 EEVYCD---------ALSDDPGTYRWMAPEMIKH  357 (488)
Q Consensus       333 ~~~~~~---------~~~~~~gt~~y~aPE~l~~  357 (488)
                      ......         ......+++.|+|||++..
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            432211         1124457888999999853

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7.2e-24  Score=208.53  Aligned_cols=253  Identities=23%  Similarity=0.391  Sum_probs=186.9

Q ss_pred             cccccccceeccceeeeeccEEEEEEEECC--c-----------------------------------cEEEEEEecCCC
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--E-----------------------------------PVAVKIIRIPDD  215 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~--~-----------------------------------~vAVK~i~~~~~  215 (488)
                      +..+.+++|.||..||+|+...||.+....  .                                   +.|||++..-+.
T Consensus       151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~  230 (598)
T KOG4158|consen  151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH  230 (598)
T ss_pred             hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence            345667899999999999999999887421  0                                   578898876554


Q ss_pred             ChhHHHHHHHHHHHHHHHH------HH--------H-------hc-CCCCeeeEeeeeec--------------------
Q 011359          216 DENETLAARLEKQFNREVA------LL--------S-------RL-HNPNVIKFVAACKK--------------------  253 (488)
Q Consensus       216 ~~~~~~~~~~~~~~~~Ei~------il--------~-------~l-~HpnIv~l~~~~~~--------------------  253 (488)
                      +.+..   .+.+.+-+|+.      ++        +       +| .|||||++.++|.+                    
T Consensus       231 ~s~~~---~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~  307 (598)
T KOG4158|consen  231 DSGDA---HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARW  307 (598)
T ss_pred             CCchH---HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCccccccee
Confidence            43321   12233333321      11        1       12 59999999887633                    


Q ss_pred             -------CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE--cCCC--c
Q 011359          254 -------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI--DQEF--H  322 (488)
Q Consensus       254 -------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl--~~~~--~  322 (488)
                             +..+|+||..+ ..+|..++..   ...+.....-++.|+++|+.|||.+||.|||+|.+|||+  |+|+  .
T Consensus       308 ~p~g~g~~~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~  383 (598)
T KOG4158|consen  308 YPSGAGEPKTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQ  383 (598)
T ss_pred             cccccCCCceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcE
Confidence                   34678999987 4599999976   456666778899999999999999999999999999999  3443  4


Q ss_pred             EEEeeeccccccc-------ccCcCCCCCCCcccCChhhhhcCCC------CchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 011359          323 LKIADFGIACEEV-------YCDALSDDPGTYRWMAPEMIKHKSY------GRKVDVYSFGLILWEMVAGTIPYEEMNPI  389 (488)
Q Consensus       323 vkl~DFgla~~~~-------~~~~~~~~~gt~~y~aPE~l~~~~~------~~k~DvwSlGvll~elltG~~Pf~~~~~~  389 (488)
                      +.|+|||++....       +....-+..|....||||+....+-      -.|+|.|+.|.+.||+++...||......
T Consensus       384 LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem  463 (598)
T KOG4158|consen  384 LVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM  463 (598)
T ss_pred             EEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh
Confidence            8899999873221       1122234457888999999865431      25899999999999999999999875443


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHH
Q 011359          390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWH  432 (488)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~e  432 (488)
                      -.......+..-|.+|..+|+.+++|+..+|+.||.+|++..-
T Consensus       464 ~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  464 LLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             eechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence            3333345556678899999999999999999999999999653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=2.2e-22  Score=197.11  Aligned_cols=234  Identities=20%  Similarity=0.315  Sum_probs=151.8

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-----------CC---
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-----------PN---  243 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-----------pn---  243 (488)
                      .+..+..||.|+++.||.+++.  |+.+|||++..+.......     .+++.+|.-....+.+           ..   
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~-----~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANE-----YEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTH-----HHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHH-----HHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            3567889999999999999997  5999999998877433222     3556666655444322           11   


Q ss_pred             --eeeEee---eeec---CC-----eeeEEEeecCCCCHHHHHHHh---CCC--CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 011359          244 --VIKFVA---ACKK---PP-----VYCVITEYLSEGSLRAYLHKL---EHK--TLPLPKLIAIALDIARGMEYIHSQGV  305 (488)
Q Consensus       244 --Iv~l~~---~~~~---~~-----~~~lV~E~~~ggsL~~~l~~~---~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi  305 (488)
                        ++++-+   ++..   ..     +.+++|+-+ .++|.+++...   ...  .+.....+.+..|+++.+++||..|+
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl  166 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL  166 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence              112111   1111   11     236788877 66888876532   111  22334456677899999999999999


Q ss_pred             ccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcC--------CCCchhHHHHHHHHHHHHH
Q 011359          306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK--------SYGRKVDVYSFGLILWEMV  377 (488)
Q Consensus       306 iHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~--------~~~~k~DvwSlGvll~ell  377 (488)
                      +|+||+|+|++++.+|.+.|+||+...........  ...+..|.+||.....        .++.+.|.|+||+++|.|+
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999999977543322221  3345779999987442        4789999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCC
Q 011359          378 AGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR  427 (488)
Q Consensus       378 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~R  427 (488)
                      ||..||...........      ....+.++|+.++.||..+|+.+|++|
T Consensus       245 C~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99999986643211100      122334889999999999999999988

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=2.2e-23  Score=225.26  Aligned_cols=248  Identities=26%  Similarity=0.343  Sum_probs=188.1

Q ss_pred             eccceeeeeccEEEEEEEEC--CccEEEEEEecCC-CChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          182 FLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPD-DDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~-~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      ..+..+|.|++|.|+.....  .+.++.|.++... ..+.   ...+...+..|+.+-..+.|+|++..+..+.+.....
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s---~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~  397 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTES---ERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL  397 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCccc---HHHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence            35678899999977766543  3445555444210 1111   1112223778888889999999998888777666555


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-  337 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-  337 (488)
                      -+||||++ +|+.++..  ...+...++-.++.|++.||.|||+.||.|||||++|+++..+|.+||+|||.+...... 
T Consensus       398 ~~mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  398 QSMEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hhhhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            66999999 99999986  246888899999999999999999999999999999999999999999999988433322 


Q ss_pred             ----CcCCCCCCCcccCChhhhhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCC------CCCC
Q 011359          338 ----DALSDDPGTYRWMAPEMIKHKSYG-RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF-AVVNKNLR------PAIP  405 (488)
Q Consensus       338 ----~~~~~~~gt~~y~aPE~l~~~~~~-~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~-~~~~~~~~------~~~~  405 (488)
                          .......|+..|+|||++....|+ ...||||.|+++..|++|+.||......+..+ ........      ..+.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~  554 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL  554 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence                223456799999999999988886 57999999999999999999998765544321 11111111      1122


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..++.+.+.+|.+||+.+|.+|.++.+|++
T Consensus       555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  555 SLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            456788999999999999999999999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=2e-22  Score=191.85  Aligned_cols=177  Identities=13%  Similarity=0.141  Sum_probs=134.7

Q ss_pred             cceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHH-HHHHHHHHHHHHHHhcCCCCeeeEeeeeecC---
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAA-RLEKQFNREVALLSRLHNPNVIKFVAACKKP---  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---  254 (488)
                      ++|++.+.||.|+||.||....++..+|||+++............ .....+.+|+..+.++.|++|..+.+++...   
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~  110 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK  110 (232)
T ss_pred             CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence            679999999999999999987777899999997554433221110 0123378999999999999999998875532   


Q ss_pred             -----CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          255 -----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       255 -----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                           ...+|||||++|.+|.++..      +++    ..+.+++.+|..||+.|++|||++|.||+++.+| ++|+|||
T Consensus       111 ~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg  179 (232)
T PRK10359        111 TLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS  179 (232)
T ss_pred             cccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence                 35789999999999988742      222    2456999999999999999999999999999988 9999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHH
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV  377 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ell  377 (488)
                      ..........           ...++....|+.++|+|+||+++..+.
T Consensus       180 ~~~~~~e~~a-----------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        180 GKRCTAQRKA-----------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             Ccccccchhh-----------HHHHHHHhHhcccccccceeEeehHHH
Confidence            7743321111           011334456778999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=7.1e-22  Score=184.66  Aligned_cols=144  Identities=19%  Similarity=0.186  Sum_probs=108.7

Q ss_pred             cceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHH------------------HHHHHHHHHHHHHHHHHhcCCCCe
Q 011359          184 GLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENET------------------LAARLEKQFNREVALLSRLHNPNV  244 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~------------------~~~~~~~~~~~Ei~il~~l~HpnI  244 (488)
                      ...||+|+||.||+|... |+.||||+++.........                  ...........|++++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            357899999999999875 8999999998653211100                  000112344569999999988776


Q ss_pred             eeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCeEEEcCCCcE
Q 011359          245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI-HSQGVIHRDLKPENVLIDQEFHL  323 (488)
Q Consensus       245 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~giiHrDIkp~NILl~~~~~v  323 (488)
                      .........  ..+|||||++|+++...+..  ...++.+.+..++.|++.+|.+| |+.||+||||||+|||++ ++.+
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence            433322222  23799999998877655332  35788999999999999999999 799999999999999998 4789


Q ss_pred             EEeeecccc
Q 011359          324 KIADFGIAC  332 (488)
Q Consensus       324 kl~DFgla~  332 (488)
                      +|+|||+|.
T Consensus       157 ~LiDFG~a~  165 (190)
T cd05147         157 YIIDVSQSV  165 (190)
T ss_pred             EEEEccccc
Confidence            999999984

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-22  Score=210.39  Aligned_cols=225  Identities=24%  Similarity=0.390  Sum_probs=187.8

Q ss_pred             eeeeccEEEEEEE-----ECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeeeEE
Q 011359          187 FAHGAHSRLYHGI-----YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       187 lG~G~~g~Vy~~~-----~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV  260 (488)
                      +|+|.||.|++++     +.|.-+|+|+.+........      ......|..++..++ ||.+|++..+++.+...+++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~------~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~   75 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD------RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLI   75 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccc------ccccccHHHHHhhccCCCceeeeeeeeccccchhHh
Confidence            5899999999764     34678999998765432211      113457888888887 99999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcC
Q 011359          261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL  340 (488)
Q Consensus       261 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~  340 (488)
                      ++|..||.|...+..  ...+.+.....+...++-+++++|+.||+|||+|++||+++.+|++++.|||+++........
T Consensus        76 ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             hhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            999999999888865  345677788889999999999999999999999999999999999999999999765544332


Q ss_pred             CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 011359          341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW  420 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL  420 (488)
                         +||..|||||+++  .....+|.||||++.++|++|..||..    +....+...  ...+|...+...++++.+++
T Consensus       154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~~~~~~l~  222 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEARSLFRQLF  222 (612)
T ss_pred             ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHHHHHHHHH
Confidence               8999999999998  567899999999999999999999988    333334332  34578888999999999999


Q ss_pred             hhCCCCCCCH
Q 011359          421 SLQPDKRPEF  430 (488)
Q Consensus       421 ~~dp~~RPs~  430 (488)
                      ..+|.+|-..
T Consensus       223 ~r~p~nrLg~  232 (612)
T KOG0603|consen  223 KRNPENRLGA  232 (612)
T ss_pred             hhCHHHHhcc
Confidence            9999999765

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1.3e-20  Score=176.19  Aligned_cols=144  Identities=20%  Similarity=0.197  Sum_probs=110.4

Q ss_pred             cceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhH------------------HHHHHHHHHHHHHHHHHHhcCCCCe
Q 011359          184 GLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENE------------------TLAARLEKQFNREVALLSRLHNPNV  244 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~------------------~~~~~~~~~~~~Ei~il~~l~HpnI  244 (488)
                      .+.||+|++|.||+|... |+.||||+++........                  .........+..|...+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            467999999999999875 899999999875322100                  0001112335689999999999987


Q ss_pred             eeEeeeeecCCeeeEEEeecCCCCHHHH-HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCc
Q 011359          245 IKFVAACKKPPVYCVITEYLSEGSLRAY-LHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFH  322 (488)
Q Consensus       245 v~l~~~~~~~~~~~lV~E~~~ggsL~~~-l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~  322 (488)
                      .....+....  .+|||||++|+++... +..   ..++...+..++.|++.+|.+||. .||+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence            5443333222  3799999988855433 332   467788999999999999999999 9999999999999999 889


Q ss_pred             EEEeeeccccc
Q 011359          323 LKIADFGIACE  333 (488)
Q Consensus       323 vkl~DFgla~~  333 (488)
                      ++|+|||++..
T Consensus       156 ~~liDFG~a~~  166 (190)
T cd05145         156 PYIIDVSQAVE  166 (190)
T ss_pred             EEEEEccccee
Confidence            99999999853

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=4e-22  Score=216.34  Aligned_cols=245  Identities=19%  Similarity=0.203  Sum_probs=179.7

Q ss_pred             ceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeE
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV  259 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  259 (488)
                      ++...+.||.+.|-+|.+|.+..-.|+||++...++.-.-.    -.++-..|++ ....+|||++.+.-+...+...||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~----~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAyl   98 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLR----PFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYL   98 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCch----HHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHH
Confidence            67778899999999999999886669999998776543211    1233445555 566789999999999888888999


Q ss_pred             EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-C
Q 011359          260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-D  338 (488)
Q Consensus       260 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-~  338 (488)
                      |-+|+ .-+|+|.|..  ..-+..-+...|++||+.||..+|..||+|||||.+||||+.-+.+.|+||..-+.-... +
T Consensus        99 vRqyv-khnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen   99 VRQYV-KHNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHH-hhhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            99998 4589998865  233566678889999999999999999999999999999999999999999855211110 0


Q ss_pred             cCC-------CCCCCcccCChhhhhcC----------C-CCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 011359          339 ALS-------DDPGTYRWMAPEMIKHK----------S-YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKN  399 (488)
Q Consensus       339 ~~~-------~~~gt~~y~aPE~l~~~----------~-~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~  399 (488)
                      ...       +...-..|+|||.+...          . .+++-||||+||+++||++ |+++|.-..    +++....+
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~  251 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGN  251 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccC
Confidence            000       11123469999998531          1 5789999999999999998 788885311    11111110


Q ss_pred             -CCC--CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          400 -LRP--AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       400 -~~~--~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                       ..+  .+...-+..+++||..|++.||.+|.++++.++.
T Consensus       252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence             000  0001112378999999999999999999999975

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.8e-20  Score=175.22  Aligned_cols=186  Identities=15%  Similarity=0.067  Sum_probs=137.5

Q ss_pred             ccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeeeEEE
Q 011359          183 LGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       183 i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      ++..|+.|+||+||.+...+.+++.+.+....--    ...-....|.+|+++|++|. |++|++++++    ...+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWW----LRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhh----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            4567899999999988777788887776532211    01111235789999999996 5889999886    3358999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCeEEEcCCCcEEEeeecccccccccCcC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL-KPENVLIDQEFHLKIADFGIACEEVYCDAL  340 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDI-kp~NILl~~~~~vkl~DFgla~~~~~~~~~  340 (488)
                      ||+.|.+|...+..         ....++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||++.........
T Consensus        78 eyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         78 SYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            99999998754321         12357789999999999999999999 799999999999999999999633221110


Q ss_pred             ------C--------CCCCCcccCChhhhhcC-CCC-chhHHHHHHHHHHHHHhCCCCCCC
Q 011359          341 ------S--------DDPGTYRWMAPEMIKHK-SYG-RKVDVYSFGLILWEMVAGTIPYEE  385 (488)
Q Consensus       341 ------~--------~~~gt~~y~aPE~l~~~-~~~-~k~DvwSlGvll~elltG~~Pf~~  385 (488)
                            .        -...++.|+.|+...-. ..+ ...+.++.|.-+|.++|+..++-+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                  0        11257778888765322 223 677889999999999999887654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=1.2e-19  Score=171.75  Aligned_cols=141  Identities=21%  Similarity=0.313  Sum_probs=116.3

Q ss_pred             ceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeec
Q 011359          185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  264 (488)
                      +.||+|++|.||+|.+.|..|+||+.........+.........+.+|+.++..+.|++|.....++......++||||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            46899999999999999999999987643322211111222456889999999999999887777777777889999999


Q ss_pred             CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       265 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +|++|.+++...     .. .+..++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++.
T Consensus        82 ~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~  142 (211)
T PRK14879         82 EGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE  142 (211)
T ss_pred             CCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence            999999998752     12 7889999999999999999999999999999999 7889999999873

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.4e-20  Score=207.90  Aligned_cols=249  Identities=19%  Similarity=0.276  Sum_probs=189.1

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCee
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVI  245 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv  245 (488)
                      ...+..+-...|.|.+.||+|+||.||.|... |+.||+|+-+.+..-+           |.--.+++.+|+   -+.|.
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----------fYI~~q~~~RLk~~~~~~~~  757 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----------FYICLQVMERLKPQMLPSIM  757 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----------eeehHHHHHhhchhhhcchH
Confidence            34455666678999999999999999999875 7899999998766432           223344555555   24556


Q ss_pred             eEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc-------
Q 011359          246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-------  318 (488)
Q Consensus       246 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~-------  318 (488)
                      .+..++...+..+||+||.+.|+|.++++  ..+.+++..++.++.|++..|+.||..+||||||||+|+||.       
T Consensus       758 ~~~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  758 HISSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             HHHHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCC
Confidence            66666666777789999999999999998  467899999999999999999999999999999999999994       


Q ss_pred             CCCcEEEeeecccccccc---cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 011359          319 QEFHLKIADFGIACEEVY---CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV  395 (488)
Q Consensus       319 ~~~~vkl~DFgla~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~  395 (488)
                      ....++|+|||.+.....   +.......+|-.+-.+|+..+.+++..+|.|.|+.+++.||.|..       ++    +
T Consensus       836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y-------~q----~  904 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY-------ME----V  904 (974)
T ss_pred             cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH-------HH----h
Confidence            234599999999965432   223445568889999999999999999999999999999999862       11    2


Q ss_pred             HhccCCCC---CCCCCcHH-HHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          396 VNKNLRPA---IPGDCPPA-MAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       396 ~~~~~~~~---~~~~~~~~-l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      .++..+..   ++..+-.+ ...++..+|..+-..=|.+.++...|+....
T Consensus       905 ~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  905 KNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             cCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence            22222211   22222223 3477888888666666888888777776654

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.7e-19  Score=170.73  Aligned_cols=134  Identities=18%  Similarity=0.301  Sum_probs=103.8

Q ss_pred             cceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeEeeeeecCC---
Q 011359          184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-----HNPNVIKFVAACKKPP---  255 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---  255 (488)
                      ...||+|+||.||. .-.....+||++.......        .+++.+|+.+++++     +||||++++|+++.+.   
T Consensus         7 ~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~~~~--------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          7 QSPLGTGRHRKCYA-HPEDAQRCIKIVYHRGDGG--------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             cceecCCCceEEEE-CCCCcCeEEEEEeccccch--------HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            35789999999996 2223345799987643221        35688999999999     5799999999998763   


Q ss_pred             e-eeEEEee--cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHH-HHHHHCCcccCCCCCCeEEEcC----CCcEEEee
Q 011359          256 V-YCVITEY--LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGM-EYIHSQGVIHRDLKPENVLIDQ----EFHLKIAD  327 (488)
Q Consensus       256 ~-~~lV~E~--~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~giiHrDIkp~NILl~~----~~~vkl~D  327 (488)
                      . +.+|+||  +.+++|.+++.+   ..+++.  ..++.+++.++ +|||+++|+||||||+|||++.    ++.++|+|
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            3 4588999  557999999965   235554  35678888777 9999999999999999999974    34799999


Q ss_pred             eccc
Q 011359          328 FGIA  331 (488)
Q Consensus       328 Fgla  331 (488)
                      |+-+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5433

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=4e-19  Score=166.75  Aligned_cols=137  Identities=22%  Similarity=0.291  Sum_probs=108.6

Q ss_pred             eeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeecCC
Q 011359          187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE  266 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  266 (488)
                      ||+|+||.||+|.+.+..|+||+.........+.........+.+|++++..+.|+++.....++......++||||++|
T Consensus         2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g   81 (199)
T TIGR03724         2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG   81 (199)
T ss_pred             CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence            69999999999999999999999764321111111112246688999999999988755544445556667899999999


Q ss_pred             CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          267 GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       267 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ++|.+++....   .      .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus        82 ~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        82 KPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999886511   0      7899999999999999999999999999999 78999999998843

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=3.6e-19  Score=185.01  Aligned_cols=208  Identities=31%  Similarity=0.532  Sum_probs=165.9

Q ss_pred             HHhcCCCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-ccCCCCCCe
Q 011359          236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV-IHRDLKPEN  314 (488)
Q Consensus       236 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi-iHrDIkp~N  314 (488)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++-....++.+|+.||+|||.-.| +|+.++..|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n   79 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN   79 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence            4578899999999999999999999999999999999987 45678888899999999999999998765 999999999


Q ss_pred             EEEcCCCcEEEeeecccccccc---cCcCCCCCCCcccCChhhhhcCC-------CCchhHHHHHHHHHHHHHhCCCCCC
Q 011359          315 VLIDQEFHLKIADFGIACEEVY---CDALSDDPGTYRWMAPEMIKHKS-------YGRKVDVYSFGLILWEMVAGTIPYE  384 (488)
Q Consensus       315 ILl~~~~~vkl~DFgla~~~~~---~~~~~~~~gt~~y~aPE~l~~~~-------~~~k~DvwSlGvll~elltG~~Pf~  384 (488)
                      +++|..+.+||+|||+......   ........-..-|.|||.+....       .+.+.||||||++++|+++...||.
T Consensus        80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~  159 (484)
T KOG1023|consen   80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD  159 (484)
T ss_pred             ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence            9999999999999998743321   01111112345699999997531       4678999999999999999999997


Q ss_pred             CC----CHHHHHHHHHhcc---CCCCCCC--CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          385 EM----NPIQAAFAVVNKN---LRPAIPG--DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       385 ~~----~~~~~~~~~~~~~---~~~~~~~--~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      ..    .+.+....+....   ++|.+..  ..++++..++++||..+|.+||++.+|...++.+....
T Consensus       160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            63    2334444433312   3343331  45668999999999999999999999999888887754

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1.9e-18  Score=186.47  Aligned_cols=141  Identities=19%  Similarity=0.243  Sum_probs=114.5

Q ss_pred             eeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEE
Q 011359          181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  260 (488)
                      |...+.||+|+||+||+|.+.+..+++|+...................+.+|++++..++|++++..+.++......++|
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            35578999999999999999887777776543211111111112245688999999999999998887777777778899


Q ss_pred             EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       261 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      |||++|++|.+++.          ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||++.
T Consensus       415 ~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        415 MEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             EEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            99999999999886          346789999999999999999999999999999 57799999999984

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=9.5e-19  Score=169.12  Aligned_cols=145  Identities=21%  Similarity=0.243  Sum_probs=110.8

Q ss_pred             eeccceeeeeccEEEEEEE-E--CCccEEEEEEecCCCChhH----------------HHHHHHHHHHHHHHHHHHhcCC
Q 011359          181 LFLGLRFAHGAHSRLYHGI-Y--KDEPVAVKIIRIPDDDENE----------------TLAARLEKQFNREVALLSRLHN  241 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~-~--~~~~vAVK~i~~~~~~~~~----------------~~~~~~~~~~~~Ei~il~~l~H  241 (488)
                      |.+.+.||+|+||.||+|. .  .|+.||||+++........                .........+.+|+.++.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            5678899999999999998 2  4799999999864321100                0111123456789999999975


Q ss_pred             C--CeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCeEEEc
Q 011359          242 P--NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG-VIHRDLKPENVLID  318 (488)
Q Consensus       242 p--nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g-iiHrDIkp~NILl~  318 (488)
                      .  .+.+++++    ...++||||+.|++|..+...  ...+....+..++.||+.+|++||+.| |+||||||+||+++
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            3  34455543    234799999999888765432  234556667899999999999999999 99999999999999


Q ss_pred             CCCcEEEeeecccc
Q 011359          319 QEFHLKIADFGIAC  332 (488)
Q Consensus       319 ~~~~vkl~DFgla~  332 (488)
                       ++.++|+|||.+.
T Consensus       184 -~~~i~LiDFg~a~  196 (237)
T smart00090      184 -DGKVVIIDVSQSV  196 (237)
T ss_pred             -CCCEEEEEChhhh
Confidence             8899999999884

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.78  E-value=4.1e-19  Score=193.09  Aligned_cols=203  Identities=32%  Similarity=0.484  Sum_probs=152.2

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      +|..++.|..|+||.||..+++  .+++|+|+-+.       ++       +.+-  ++.....|.+|            
T Consensus        84 df~~IklisngAygavylvrh~~trqrfa~kiNkq-------~l-------ilRn--ilt~a~npfvv------------  135 (1205)
T KOG0606|consen   84 DFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-------NL-------ILRN--ILTFAGNPFVV------------  135 (1205)
T ss_pred             ccceeEeeccCCCCceeeeeccccccchhhccccc-------ch-------hhhc--cccccCCccee------------
Confidence            3446678899999999999887  68899966431       11       1111  33333344444            


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                               |+-...+..  -+.++.        +++.+++|||+.||+|||+||+|.+|+.-|++|+.|||++......
T Consensus       136 ---------gDc~tllk~--~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 ---------GDCATLLKN--IGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             ---------chhhhhccc--CCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                     444444443  233332        2378999999999999999999999999999999999987421110


Q ss_pred             ----------------CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cC
Q 011359          338 ----------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK-NL  400 (488)
Q Consensus       338 ----------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~-~~  400 (488)
                                      -.....+||+.|.|||++....|+..+|.|++|+|+||.+-|..||.+..+.+.+-.++.. ..
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence                            0012346999999999999999999999999999999999999999999998876666543 34


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhCCCCCCC
Q 011359          401 RPAIPGDCPPAMAALIEQCWSLQPDKRPE  429 (488)
Q Consensus       401 ~~~~~~~~~~~l~~Li~~cL~~dp~~RPs  429 (488)
                      +++-...++++.+++|.++|..+|..|--
T Consensus       277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  277 WPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             ccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            45556678899999999999999999944

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=5.9e-18  Score=159.08  Aligned_cols=140  Identities=22%  Similarity=0.225  Sum_probs=108.4

Q ss_pred             eeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhH--------------HHHHHHHHHHHHHHHHHHhcCCC--C
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENE--------------TLAARLEKQFNREVALLSRLHNP--N  243 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~--------------~~~~~~~~~~~~Ei~il~~l~Hp--n  243 (488)
                      |.+++.||+|+||.||++... |+.||||+++........              .........+..|+.++..+.|.  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            567788999999999999884 799999998764321100              00111233477899999999877  4


Q ss_pred             eeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcE
Q 011359          244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL  323 (488)
Q Consensus       244 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~v  323 (488)
                      ++..++.    ...++||||++|++|..+...        .....++.+++.++.++|+.||+||||+|.||+++.++.+
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence            4555542    344799999999998765431        3456788999999999999999999999999999999999


Q ss_pred             EEeeecccc
Q 011359          324 KIADFGIAC  332 (488)
Q Consensus       324 kl~DFgla~  332 (488)
                      +|+|||++.
T Consensus       165 ~liDfg~~~  173 (198)
T cd05144         165 YIIDWPQMV  173 (198)
T ss_pred             EEEECCccc
Confidence            999999984

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=5.5e-19  Score=180.71  Aligned_cols=167  Identities=30%  Similarity=0.538  Sum_probs=132.4

Q ss_pred             CeeeEEEeecCCCCHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ..+||.|++|...+|.+||... .....++..++.++.|++.|+.|   +|.+|||+||.||++..+..+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            3578999999999999999854 33456778899999999999999   9999999999999999999999999999865


Q ss_pred             ccccC-------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC-CCCC
Q 011359          334 EVYCD-------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL-RPAI  404 (488)
Q Consensus       334 ~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~-~~~~  404 (488)
                      .....       ..+...||..||+||.+.+..|+.++|||+||+||+|++. =...++.    ...+..+..+. .+.+
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip~~~  481 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIPPEF  481 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCChHH
Confidence            54444       4566789999999999999999999999999999999997 2222222    22222333333 3233


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCC
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPE  429 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs  429 (488)
                      -.++|. -..|+.+++...|.+||+
T Consensus       482 ~~d~p~-e~~ll~~lls~~p~~RP~  505 (516)
T KOG1033|consen  482 LQDYPE-EYTLLQQLLSPSPEERPS  505 (516)
T ss_pred             hhcCcH-HHHHHHHhcCCCcccCch
Confidence            344443 468999999999999993

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=1.5e-16  Score=154.10  Aligned_cols=142  Identities=17%  Similarity=0.146  Sum_probs=107.0

Q ss_pred             cceee-eeccEEEEEEEECCccEEEEEEecCCC-----ChhHHHHHHHHHHHHHHHHHHHhcCCCCe--eeEeeeeecCC
Q 011359          184 GLRFA-HGAHSRLYHGIYKDEPVAVKIIRIPDD-----DENETLAARLEKQFNREVALLSRLHNPNV--IKFVAACKKPP  255 (488)
Q Consensus       184 ~~~lG-~G~~g~Vy~~~~~~~~vAVK~i~~~~~-----~~~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~~  255 (488)
                      +..|| .||.|+||++...+..++||.+.....     .+.-.........+.+|+.++.+|.|++|  +..+++.....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            34577 899999999988899999999864321     00000001124567899999999998774  67777643322


Q ss_pred             -e---eeEEEeecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          256 -V---YCVITEYLSE-GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       256 -~---~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                       .   .++||||++| .+|.+++..   ..++..    .+.+|+.+|.+||+.||+||||||.|||++.++.++|+|||.
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence             2   2599999997 699998864   345543    357899999999999999999999999999989999999998


Q ss_pred             cc
Q 011359          331 AC  332 (488)
Q Consensus       331 a~  332 (488)
                      +.
T Consensus       189 ~~  190 (239)
T PRK01723        189 GE  190 (239)
T ss_pred             cc
Confidence            73

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=3.1e-16  Score=145.49  Aligned_cols=140  Identities=24%  Similarity=0.256  Sum_probs=98.8

Q ss_pred             cceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHH----------------HHHHHHHHHHHHHHHhcCCCC--e
Q 011359          184 GLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLA----------------ARLEKQFNREVALLSRLHNPN--V  244 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~----------------~~~~~~~~~Ei~il~~l~Hpn--I  244 (488)
                      ++.||+|+||+||+|... |+.||||+++...........                .........|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            567899999999999987 899999998754322111000                000111246677777775433  4


Q ss_pred             eeEeeeeecCCeeeEEEeecCCCCHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCc
Q 011359          245 IKFVAACKKPPVYCVITEYLSEGSLRA-YLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFH  322 (488)
Q Consensus       245 v~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~  322 (488)
                      .+.++..    ..++||||++++.+.. .+...   ... ..+..++.+++.++.++|. .||+||||||+||+++ ++.
T Consensus        82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CceEecC----CCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence            5555432    3589999999854321 11111   011 5678899999999999999 9999999999999999 889


Q ss_pred             EEEeeecccc
Q 011359          323 LKIADFGIAC  332 (488)
Q Consensus       323 vkl~DFgla~  332 (488)
                      ++|+|||.+.
T Consensus       153 ~~liDfg~a~  162 (187)
T cd05119         153 VYIIDVPQAV  162 (187)
T ss_pred             EEEEECcccc
Confidence            9999999984

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=6.8e-16  Score=136.28  Aligned_cols=130  Identities=26%  Similarity=0.263  Sum_probs=111.3

Q ss_pred             cceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeeEeeeeecCCeeeEEE
Q 011359          184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~  261 (488)
                      .+.||.|.++.||++...+..++||++.....          ...+.+|+.++..+.|  .+++++++++...+..+++|
T Consensus         3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~   72 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM   72 (155)
T ss_pred             ceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence            46789999999999999888999999864332          2457799999999986  58999999988888899999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ---GVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      ||+.++.+..+         +......++.+++.+|++||..   +++|+|++|.||+++..+.++++|||.+.
T Consensus        73 e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          73 EWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             EecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            99988777554         4456677899999999999985   79999999999999998999999999873

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=3.4e-17  Score=177.28  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=193.6

Q ss_pred             ceeccceeeeeccEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCC
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPP  255 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~---~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  255 (488)
                      .|.+.+.||+|+|+.|-.....   ...+|+|.+.......      .....+..|..+-+.+. |.|++.+++...+..
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~------~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~   94 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSE------DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR   94 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCcc------chhhhcCccccccccccccccccccCCccCCCc
Confidence            4556677899999999887654   2456666665543111      11345567888888888 999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCeEEEcCCC-cEEEeeeccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH-SQGVIHRDLKPENVLIDQEF-HLKIADFGIACE  333 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~giiHrDIkp~NILl~~~~-~vkl~DFgla~~  333 (488)
                      .++++++|..|+++.+.+........+....-.++.|+..++.|+| ..++.||||||+|.+++..+ .+++.|||+|..
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999999999999884222225666778889999999999999 99999999999999999999 999999999965


Q ss_pred             ccc----cCcCCCCCC-CcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhccC--CCCC
Q 011359          334 EVY----CDALSDDPG-TYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA-VVNKNL--RPAI  404 (488)
Q Consensus       334 ~~~----~~~~~~~~g-t~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~-~~~~~~--~~~~  404 (488)
                      ...    ........| ++.|+|||...+. -.....|+||.|+++..+++|..|+.........+. ......  ....
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP  254 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence            443    122334567 9999999999874 447889999999999999999999987655443222 222211  2334


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ....+....+++.+++..+|..|.+..++..
T Consensus       255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  255 WNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccCChhhhhcccccccCCchhccccccccc
Confidence            4567788999999999999999998877654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=6.3e-14  Score=146.21  Aligned_cols=243  Identities=19%  Similarity=0.234  Sum_probs=182.6

Q ss_pred             ceeccceeee--eccEEEEEEEE----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeee
Q 011359          180 QLFLGLRFAH--GAHSRLYHGIY----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACK  252 (488)
Q Consensus       180 ~~~i~~~lG~--G~~g~Vy~~~~----~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~  252 (488)
                      .+.+...+|.  |.+|.||.+..    .+..+|+|.-+.+-.....      .+.=.+|+...+.++ |+|.++.+..+.
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~------~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD------SKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc------cccccchhhcccccCccccccccCcccc
Confidence            3446678899  99999999887    2578999985444332211      122237777777786 999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH----HHHHHHHCCcccCCCCCCeEEEcCC-CcEEEee
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR----GMEYIHSQGVIHRDLKPENVLIDQE-FHLKIAD  327 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~giiHrDIkp~NILl~~~-~~vkl~D  327 (488)
                      ..+..++-+|+| +.+|.++.+. ....++...++..+.+...    ||.++|+.+++|-|+||.||++..+ ...+++|
T Consensus       189 ~~~~lfiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  189 GSGILFIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             cCCcceeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence            999999999998 5788888876 3445778889999999999    9999999999999999999999999 7899999


Q ss_pred             ecccccccccCc------CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcc
Q 011359          328 FGIACEEVYCDA------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM--NPIQAAFAVVNKN  399 (488)
Q Consensus       328 Fgla~~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~--~~~~~~~~~~~~~  399 (488)
                      ||+.........      .....|...|++||.++ .-++...|+|+||.++.+..+|.......  ..-....   ..-
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r---~~~  342 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR---QGY  342 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc---ccc
Confidence            998754433221      12225788999999997 56789999999999999999887655433  1111000   011


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHH
Q 011359          400 LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIV  434 (488)
Q Consensus       400 ~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil  434 (488)
                      +..++....+.++..++.+|++.++..|++++.++
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            22334445566788899999999999999876554

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=2.7e-13  Score=142.39  Aligned_cols=144  Identities=22%  Similarity=0.281  Sum_probs=99.0

Q ss_pred             ceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhH--------------------------HHHHHH------HHHHHH
Q 011359          185 LRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENE--------------------------TLAARL------EKQFNR  231 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~--------------------------~~~~~~------~~~~~~  231 (488)
                      +.||.|++|.||+|+.. |+.||||+.+......-.                          .+...+      +-+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            56899999999999985 899999999754311100                          011111      113666


Q ss_pred             HHHHHHhcC-----CCCeeeEeeee-ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 011359          232 EVALLSRLH-----NPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR-GMEYIHSQG  304 (488)
Q Consensus       232 Ei~il~~l~-----HpnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~-~L~~LH~~g  304 (488)
                      |+..+.++.     +++| .+-..+ ......+|||||++|++|.++..... ...   ....++..++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHHHHHHHHhCC
Confidence            777777663     3333 222222 22334689999999999998775421 122   23456666665 478889999


Q ss_pred             cccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          305 VIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       305 iiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ++|+|++|.||+++.++.++++|||++..
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~  306 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGR  306 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence            99999999999999999999999998843

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=3.8e-13  Score=143.32  Aligned_cols=149  Identities=17%  Similarity=0.184  Sum_probs=91.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCC--------------------------hhHHHHHHHHHH--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDD--------------------------ENETLAARLEKQ--  228 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~--------------------------~~~~~~~~~~~~--  228 (488)
                      ..|.. +.||.|++|.||+|+..  |+.||||+++.....                          +...+...+.+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34444 68899999999999985  799999999854211                          001122222333  


Q ss_pred             ----HHHHHHHHHhcC----CCCeeeEeeeeec-CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH-HHH
Q 011359          229 ----FNREVALLSRLH----NPNVIKFVAACKK-PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR-GME  298 (488)
Q Consensus       229 ----~~~Ei~il~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~-~L~  298 (488)
                          |.+|+..+.++.    +.+.+.+-.++.+ ....+|||||++|+.+.++..-. ........   ++...+. -+.
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d~~~---la~~~v~~~~~  274 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTDMKL---LAERGVEVFFT  274 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCCHHH---HHHHHHHHHHH
Confidence                445555555542    3333333222221 33457999999999998753211 12222211   1111111 123


Q ss_pred             HHHHCCcccCCCCCCeEEEcCCC----cEEEeeecccc
Q 011359          299 YIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIAC  332 (488)
Q Consensus       299 ~LH~~giiHrDIkp~NILl~~~~----~vkl~DFgla~  332 (488)
                      .+...|++|+|+||.||+++.++    .++++|||+..
T Consensus       275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg  312 (537)
T PRK04750        275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVG  312 (537)
T ss_pred             HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEE
Confidence            34568999999999999999888    99999999874

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.42  E-value=4.8e-13  Score=121.77  Aligned_cols=125  Identities=19%  Similarity=0.160  Sum_probs=95.2

Q ss_pred             ceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eeEeeeeecCCeeeEEEee
Q 011359          185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKPPVYCVITEY  263 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~  263 (488)
                      +.|+.|.++.||++...++.|+||+.......         ...+.+|+.++..+.+.++ .+++....  ...++||||
T Consensus         4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~---------~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~   72 (170)
T cd05151           4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL---------LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEF   72 (170)
T ss_pred             eecCCcccCceEEEEECCeEEEEEeCCCCccc---------ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEe
Confidence            56789999999999999999999997643211         1235689999998875554 44554433  234799999


Q ss_pred             cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----ccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV-----IHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       264 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi-----iHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ++|.++...       ..   ....++.+++.+|+.||..++     +|||++|.||+++ ++.++++|||.+
T Consensus        73 i~G~~l~~~-------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a  134 (170)
T cd05151          73 IEGSELLTE-------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA  134 (170)
T ss_pred             cCCCccccc-------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence            999887543       01   123456789999999999985     9999999999999 668999999987

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=4.1e-12  Score=118.61  Aligned_cols=142  Identities=14%  Similarity=0.174  Sum_probs=101.4

Q ss_pred             cceeeeeccEEEEEEEEC--------CccEEEEEEecCCCC-h--------h---------HHHHHHHHHHHHHHHHHHH
Q 011359          184 GLRFAHGAHSRLYHGIYK--------DEPVAVKIIRIPDDD-E--------N---------ETLAARLEKQFNREVALLS  237 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~--------~~~vAVK~i~~~~~~-~--------~---------~~~~~~~~~~~~~Ei~il~  237 (488)
                      ...||.|--+.||.|...        +..+|||+.+..... +        .         ............+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            456899999999999864        368999999753311 0        0         0001112223348999999


Q ss_pred             hcCC--CCeeeEeeeeecCCeeeEEEeecCCCCHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCC
Q 011359          238 RLHN--PNVIKFVAACKKPPVYCVITEYLSEGSLRA-YLHKLEHKTLPLPKLIAIALDIARGMEYI-HSQGVIHRDLKPE  313 (488)
Q Consensus       238 ~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~giiHrDIkp~  313 (488)
                      ++..  -++.+.+++    ..-+|||||+.++.+.. .+.   ...++.+....+..+++.+|..| |..||+||||++.
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~  154 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY  154 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            9963  566777765    34569999997654422 222   22355566778889999999999 8999999999999


Q ss_pred             eEEEcCCCcEEEeeeccccc
Q 011359          314 NVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       314 NILl~~~~~vkl~DFgla~~  333 (488)
                      ||+++ ++.+.|+|||.+..
T Consensus       155 NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             HEEEE-CCcEEEEECCCcee
Confidence            99997 46799999998853

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=4.9e-12  Score=114.85  Aligned_cols=136  Identities=22%  Similarity=0.364  Sum_probs=105.7

Q ss_pred             eeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHH-HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeec
Q 011359          186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARL-EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  264 (488)
                      .+++|+-+.+|.+.+.|.++++|. +.+.......+..++ .....+|+.++.++.--.|..-+-+..+.....|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            468999999999998887765554 445544444454444 455789999999997655544444455566677999999


Q ss_pred             CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       265 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +|..|.+++...         ...++..+-..+.-||..||+|+||.++||++..++ +.++|||++.
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            999999999863         255777788888899999999999999999998775 9999999984

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=1.5e-11  Score=129.91  Aligned_cols=161  Identities=17%  Similarity=0.306  Sum_probs=123.9

Q ss_pred             CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCC
Q 011359          202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTL  281 (488)
Q Consensus       202 ~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l  281 (488)
                      +.+|.|.++..... +.       .....+.+.-|+.++||||+++++.++.++..|||+|.+  ..|..++.+     +
T Consensus        37 ~~~vsVF~~~~~~~-~~-------~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l  101 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNG-EV-------TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----L  101 (690)
T ss_pred             CCceEEEEEeCCCc-hh-------hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----h
Confidence            67888888876544 11       234567888899999999999999999999999999998  478888876     3


Q ss_pred             CHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCc-CCCCCCCcccCChhhhhcCC
Q 011359          282 PLPKLIAIALDIARGMEYIH-SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA-LSDDPGTYRWMAPEMIKHKS  359 (488)
Q Consensus       282 ~~~~~~~i~~qi~~~L~~LH-~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~  359 (488)
                      ....+...++||+.||.||| +.+++|++|.-..|+++..|++||++|.++........ .....--..|..|+.+....
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            46677888999999999997 66899999999999999999999999988743322111 11111222355565543222


Q ss_pred             CCchhHHHHHHHHHHHHHhC
Q 011359          360 YGRKVDVYSFGLILWEMVAG  379 (488)
Q Consensus       360 ~~~k~DvwSlGvll~elltG  379 (488)
                        -..|.|.||+++++++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              357999999999999998

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.38  E-value=9.8e-12  Score=112.42  Aligned_cols=147  Identities=17%  Similarity=0.229  Sum_probs=110.7

Q ss_pred             ceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHH-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEee
Q 011359          185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAAR-LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY  263 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  263 (488)
                      ..+-+|+-+.|+++.+.|+...||.-... ......+..+ ..+...+|+.+|.++.--.|.--.-++.+...-+|+|||
T Consensus        13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K-~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFSGEAAIIKERFSK-RYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccCCceeEEeecccc-cccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            45679999999999999999888875422 2212223223 366788999999999755554433444455555799999


Q ss_pred             cCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC---cEEEeeecccc
Q 011359          264 LSE-GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF---HLKIADFGIAC  332 (488)
Q Consensus       264 ~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~---~vkl~DFgla~  332 (488)
                      ++| .++.+++..........+....++..|-..+.-||..+|+||||..+||++..++   .+.++|||++.
T Consensus        92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            977 4889999876555555555578999999999999999999999999999996554   35899999983

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.37  E-value=1.6e-11  Score=123.07  Aligned_cols=273  Identities=19%  Similarity=0.295  Sum_probs=184.3

Q ss_pred             eccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeee-------ec
Q 011359          182 FLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC-------KK  253 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~-------~~  253 (488)
                      -.++.||+|+.+.+|-.-..+..|| |++..+..--..           +.+..|... .||-+-.-+.|-       ..
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~a-----------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~   81 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQA-----------QKVAELAATPDAPLLNYRVAWPQATLHGGRR   81 (637)
T ss_pred             CCCccccCCccceeeecchhhchhh-eeecCCCchHHH-----------HHHHHhccCCCCcchhhhhcccHHHhhCCCc
Confidence            3678899999999997544444454 888766542211           223334443 465443312211       12


Q ss_pred             CCeeeEEEeecCCC-CHHHHHH---HhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          254 PPVYCVITEYLSEG-SLRAYLH---KLEH-KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       254 ~~~~~lV~E~~~gg-sL~~~l~---~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      .....++|..+.|. .+.++..   +.++ ....|..++..++.++.+.+.||..|.+-||++++|||+++++.+.|.|-
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc
Confidence            23477888888765 2233322   1122 23678899999999999999999999999999999999999999999986


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhC-CCCCCCCC-------HHHHHHHH
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAG-TIPYEEMN-------PIQAAFAV  395 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG-~~Pf~~~~-------~~~~~~~~  395 (488)
                      +.-.....+......+|...|.+||.-+     +..-+...|.|.|||++++++.| +.||.+..       +.+.....
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            5432223344455677999999999865     33457889999999999999885 99998753       22211110


Q ss_pred             -----Hhc---cCCCC---CC-CCCcHHHHHHHHHHhhh--CCCCCCCHHHHHHHHHHHHHhhcccCc-------ccccc
Q 011359          396 -----VNK---NLRPA---IP-GDCPPAMAALIEQCWSL--QPDKRPEFWHIVKVLEQFETSLACNGT-------LNLVQ  454 (488)
Q Consensus       396 -----~~~---~~~~~---~~-~~~~~~l~~Li~~cL~~--dp~~RPs~~eil~~Le~~~~~l~~~~~-------~~~~~  454 (488)
                           ..+   ++++.   +| .-+++.+..|..+|+..  ++.-||++..++..|..++++|.+...       .....
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~~hl~~  321 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYPVHLTD  321 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccccccCCCCC
Confidence                 011   11111   11 24578999999999964  356899999999999999999865532       33556


Q ss_pred             CccchhhhhhHH
Q 011359          455 NPICQDHKKGLL  466 (488)
Q Consensus       455 ~~~~~~~~~~l~  466 (488)
                      +|.|..++.|..
T Consensus       322 CPwCa~~~~g~~  333 (637)
T COG4248         322 CPWCALDNQGVI  333 (637)
T ss_pred             CchhhhcccCcc
Confidence            778877666643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=1.8e-12  Score=126.04  Aligned_cols=195  Identities=23%  Similarity=0.310  Sum_probs=138.5

Q ss_pred             HHHhcCCCCeeeEeeeeec-----CCeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Q 011359          235 LLSRLHNPNVIKFVAACKK-----PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQG--V  305 (488)
Q Consensus       235 il~~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i  305 (488)
                      -|-++-|.|||+++.|+.+     .....++.||+..|+|..+|++.  .+..+......+|+-||+.||.|||+..  |
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            3456679999999988754     34678999999999999999864  4556778888999999999999999885  9


Q ss_pred             ccCCCCCCeEEEcCCCcEEEeeecccc-----cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCC
Q 011359          306 IHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT  380 (488)
Q Consensus       306 iHrDIkp~NILl~~~~~vkl~DFgla~-----~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~  380 (488)
                      +|+++..+.|++..+|-+|+.--.-..     ............+-++|.+||.=.....+-++|||+||+...+|.-|.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            999999999999999988875322110     000111122334678899999876667788999999999999998876


Q ss_pred             CCCCCC-CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHH
Q 011359          381 IPYEEM-NPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIV  434 (488)
Q Consensus       381 ~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil  434 (488)
                      .--... ........+.+-.+.     --...-+.+|.+|++..|..||++..++
T Consensus       280 iq~tnseS~~~~ee~ia~~i~~-----len~lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANVIIG-----LENGLQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             eccCCCcceeehhhhhhhheee-----ccCccccCcCcccccCCCCCCcchhhhh
Confidence            532211 111111111110000     0111235789999999999999998776

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=9.2e-13  Score=137.59  Aligned_cols=248  Identities=18%  Similarity=0.180  Sum_probs=179.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~---~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  254 (488)
                      .++..+..||.|.|+.||....+   +..|++|.....-......+      .-..|+.+...+. |.+++.++..+...
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di------~sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI------FSLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh------cchhhhhHhhHhhcccccCCCCCCcccc
Confidence            55777788999999999998754   57889888765443322211      1246777777775 89999988887777


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-CcEEEeeeccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIACE  333 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-~~vkl~DFgla~~  333 (488)
                      ...|+--|||+++++...+.-  ...+.+..++.+..|++.++.++|+..++|+|++|+||++..+ +..++.|||++..
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             ccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence            777899999999988777632  3457788899999999999999999999999999999999886 7889999998853


Q ss_pred             ccccCcCCCCCCCccc-CChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          334 EVYCDALSDDPGTYRW-MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y-~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      ... ........+..| .+++.+....+..++|+|+||+.+.+.++|..--......    ..+..+..+..+ .....+
T Consensus       417 ~~~-~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----~~i~~~~~p~~~-~~~~~~  490 (524)
T KOG0601|consen  417 LAF-SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----LTIRSGDTPNLP-GLKLQL  490 (524)
T ss_pred             cce-ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc----eeeecccccCCC-chHHhh
Confidence            111 111222234444 3666666678889999999999999999886433222211    112222222233 333788


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ..+...+...++..||.+.++....+..
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchhh
Confidence            8899999999999999988776655443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.20  E-value=4.7e-10  Score=110.24  Aligned_cols=141  Identities=20%  Similarity=0.152  Sum_probs=100.0

Q ss_pred             eeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHH------HHHHHHHHHHHHhcCCCC--eeeEeeeeec-----C
Q 011359          188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARL------EKQFNREVALLSRLHNPN--VIKFVAACKK-----P  254 (488)
Q Consensus       188 G~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~------~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~-----~  254 (488)
                      -......|++..+.|+.|.||......   .......+      ...+.+|...+.+|..-+  ++..+++.+.     .
T Consensus        31 ~~~~~rrvvr~~~~g~~~~vKr~~~~~---~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         31 RELEGRRTLRFELAGKSYFLKWHRGTG---WGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             ecCCCceEEEEEECCEEEEEEEecCCc---HHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            333444477888888999999764221   00000000      013679999998885433  3344444432     2


Q ss_pred             CeeeEEEeecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-------CCcEEEe
Q 011359          255 PVYCVITEYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-------EFHLKIA  326 (488)
Q Consensus       255 ~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-------~~~vkl~  326 (488)
                      ...+||+|++++. +|.+++...............++.+++..+.-||..||+|+|+++.|||++.       ++.+.|+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            3567999999886 8999986533345566778899999999999999999999999999999975       4689999


Q ss_pred             eeccc
Q 011359          327 DFGIA  331 (488)
Q Consensus       327 DFgla  331 (488)
                      ||+.+
T Consensus       188 Dl~r~  192 (268)
T PRK15123        188 DLHRA  192 (268)
T ss_pred             ECCcc
Confidence            99977

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.19  E-value=1e-10  Score=110.89  Aligned_cols=137  Identities=21%  Similarity=0.242  Sum_probs=103.1

Q ss_pred             ceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeeEeeeeecC---Ceee
Q 011359          185 LRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACKKP---PVYC  258 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~  258 (488)
                      +.|+.|.++.||++...+ +.++||+........       ...++..|+++++.+.+  .++.+++.+....   +..+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~-------~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP-------SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCc-------ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            457999999999998876 899999986543210       12457799999999975  4467777777654   3668


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS------------------------------------  302 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~------------------------------------  302 (488)
                      +||||++|.++.+.+..   ..++.+....++.+++++|..||+                                    
T Consensus        77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999999888765421   245566666777777777777763                                    


Q ss_pred             --------------------CCcccCCCCCCeEEEcC--CCcEEEeeeccc
Q 011359          303 --------------------QGVIHRDLKPENVLIDQ--EFHLKIADFGIA  331 (488)
Q Consensus       303 --------------------~giiHrDIkp~NILl~~--~~~vkl~DFgla  331 (488)
                                          ..++|+|+++.||+++.  ++.+.|+||+.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~  204 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELA  204 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccc
Confidence                                23689999999999998  667899999977

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.18  E-value=6.5e-12  Score=137.69  Aligned_cols=250  Identities=20%  Similarity=0.276  Sum_probs=182.7

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      ....+.+.+.+.+-.|.++.++.+.-.  +...++|+......-...     .......+-.++-...+|-++...-.+.
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~-----~~~s~r~~s~~~i~p~~P~v~~~~~s~~  874 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN-----DYESIRSKSNILITPRSPAVVRSFPSFP  874 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccc-----cccccCCccCccccCCCCceecccCCCC
Confidence            345566777778889999999887654  444555554422110000     0111223333333445577776666655


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .....+|+++|+.+++|...++..  .....+-....+..+..+++|||...+.|||++|.|+|+..+++.++.|||...
T Consensus       875 ~rsP~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  875 CRSPLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             CCCCcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccc
Confidence            566788999999999999999873  356666677788889999999999999999999999999999999999998431


Q ss_pred             cccc-----c---------------------------CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCC
Q 011359          333 EEVY-----C---------------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT  380 (488)
Q Consensus       333 ~~~~-----~---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~  380 (488)
                      ....     .                           .......||+.|.+||.+.+......+|.|++|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            1000     0                           0011234899999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHH
Q 011359          381 IPYEEMNPIQAAFAVVNKNL-RPAIPGDCPPAMAALIEQCWSLQPDKRPEFW  431 (488)
Q Consensus       381 ~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~  431 (488)
                      .||....+.+....+..... ++.-+...+.+.++++...+..++.+|-.+.
T Consensus      1033 pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99999888777655555432 3444566788999999999999999997654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=6.6e-10  Score=103.30  Aligned_cols=131  Identities=26%  Similarity=0.326  Sum_probs=84.7

Q ss_pred             EEEEEEEC-CccEEEEEEecCCCCh------------------hHHHHHHHHHHHHHHHHHHHhcCCC--CeeeEeeeee
Q 011359          194 RLYHGIYK-DEPVAVKIIRIPDDDE------------------NETLAARLEKQFNREVALLSRLHNP--NVIKFVAACK  252 (488)
Q Consensus       194 ~Vy~~~~~-~~~vAVK~i~~~~~~~------------------~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~  252 (488)
                      .||.|... |..+|||+.+.....-                  .............+|.+.|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999874 7899999997542110                  0111222345678999999999865  566776553 


Q ss_pred             cCCeeeEEEeecC--CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH-HHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          253 KPPVYCVITEYLS--EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY-IHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       253 ~~~~~~lV~E~~~--ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                         ..+|||||++  |..+..+...    .+..+....++.+++..+.. +|..||+||||.+.||+++++ .+.|+|||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             ---CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence               2359999998  6555544432    12234566778888885555 589999999999999999988 99999999


Q ss_pred             cccc
Q 011359          330 IACE  333 (488)
Q Consensus       330 la~~  333 (488)
                      .+..
T Consensus       152 qav~  155 (188)
T PF01163_consen  152 QAVD  155 (188)
T ss_dssp             TEEE
T ss_pred             ccee
Confidence            8843

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.98  E-value=3.6e-08  Score=101.73  Aligned_cols=212  Identities=16%  Similarity=0.218  Sum_probs=146.6

Q ss_pred             ccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee----cCCeeeEEEeec
Q 011359          191 AHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK----KPPVYCVITEYL  264 (488)
Q Consensus       191 ~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~~~~lV~E~~  264 (488)
                      .-.+.|++...  |..|++|.+.......        ......-+++|+++.|.|||+|.+++.    .+..+++|++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--------~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy  359 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--------TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY  359 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC--------cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence            45578888754  7889999983221111        112235678899999999999988775    456789999999


Q ss_pred             CC-CCHHHHHHHh-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          265 SE-GSLRAYLHKL-------------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       265 ~g-gsL~~~l~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      ++ ++|.++-...             .....+++.+|.++.|+..||.++|+.|+.-+-|.+.+||++.+.+++|+-.|+
T Consensus       360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i  439 (655)
T KOG3741|consen  360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGI  439 (655)
T ss_pred             CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccc
Confidence            76 4777765422             123467899999999999999999999999999999999999998888876554


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP-YEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ......      ..+       |.+.   --.+-|.=.||.+++.|.||..- +......+....        .+...++
T Consensus       440 ~Dvl~~------d~~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~~~yS  495 (655)
T KOG3741|consen  440 MDVLQE------DPT-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RITTTYS  495 (655)
T ss_pred             eeeecC------CCC-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------Hhhhhhh
Confidence            421111      110       1111   12467888999999999998532 111111111111        1334577


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+++++|......++++ -+..+++.
T Consensus       496 ~D~rn~v~yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  496 TDLRNVVEYLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             HHHHHHHHHHHhcCccc-ccHHHHHH
Confidence            88999999999888886 45666664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.88  E-value=1.1e-08  Score=98.39  Aligned_cols=140  Identities=24%  Similarity=0.241  Sum_probs=101.5

Q ss_pred             eeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChh--------------HHHHHHHHHHHHHHHHHHHhcCCC--C
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDEN--------------ETLAARLEKQFNREVALLSRLHNP--N  243 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~--------------~~~~~~~~~~~~~Ei~il~~l~Hp--n  243 (488)
                      ..+|..||-|--|.||.|... |.++|||.=+.....-.              ....--.+....+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            458899999999999999986 89999999654321100              000111234467999999999754  6


Q ss_pred             eeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcE
Q 011359          244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL  323 (488)
Q Consensus       244 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~v  323 (488)
                      |.+.+++-    .-.+||||++|-.|...-       +..+..-.++..|+.-+.-+-..||||+|+..-||+++++|.+
T Consensus       173 VP~P~~~n----RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         173 VPKPIAWN----RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             CCCccccc----cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence            77776643    446999999987765432       1233444556666666666668999999999999999999999


Q ss_pred             EEeeeccc
Q 011359          324 KIADFGIA  331 (488)
Q Consensus       324 kl~DFgla  331 (488)
                      .++||-.+
T Consensus       242 ~vIDwPQ~  249 (304)
T COG0478         242 VVIDWPQA  249 (304)
T ss_pred             EEEeCccc
Confidence            99999755

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=2.7e-08  Score=94.18  Aligned_cols=104  Identities=27%  Similarity=0.331  Sum_probs=81.9

Q ss_pred             HHHHHHHHHHHhcCC--CCeeeEeeeeecC----CeeeEEEeecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Q 011359          227 KQFNREVALLSRLHN--PNVIKFVAACKKP----PVYCVITEYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGMEY  299 (488)
Q Consensus       227 ~~~~~Ei~il~~l~H--pnIv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~  299 (488)
                      ....+|...+.+|..  =.+.+.+++.+..    ...+||+|++++. +|.+++.....  .+......++.+++..++-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            356788888888853  3344555555432    2457999999884 89999986322  5666788899999999999


Q ss_pred             HHHCCcccCCCCCCeEEEcCCC---cEEEeeecccc
Q 011359          300 IHSQGVIHRDLKPENVLIDQEF---HLKIADFGIAC  332 (488)
Q Consensus       300 LH~~giiHrDIkp~NILl~~~~---~vkl~DFgla~  332 (488)
                      ||+.||+|+|+++.|||++.++   .+.++||+.+.
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            9999999999999999998887   89999999763

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.80  E-value=7.3e-08  Score=90.52  Aligned_cols=142  Identities=15%  Similarity=0.017  Sum_probs=103.0

Q ss_pred             eeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC--CeeeEeeeee---c--CCeeeEE
Q 011359          188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP--NVIKFVAACK---K--PPVYCVI  260 (488)
Q Consensus       188 G~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~---~--~~~~~lV  260 (488)
                      |.||.+-|++-.+.|+.+=||.-...-.....  ...-+..|.+|+..|.+|..-  .+.+.+ ++.   .  .-..+||
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r--~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVR--YPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCccccccc--CCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            77999999999888887888875311100000  000146788999999999642  244444 222   1  2246799


Q ss_pred             EeecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc--EEEeeecccc
Q 011359          261 TEYLSE-GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH--LKIADFGIAC  332 (488)
Q Consensus       261 ~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~--vkl~DFgla~  332 (488)
                      +|-+.| .+|.+++....-...+......++.+++..+.-||+.|+.|+|+.+.||+++.++.  ++++||--++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            998854 48999886643445677778899999999999999999999999999999986666  9999997653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=3.7e-09  Score=112.42  Aligned_cols=144  Identities=15%  Similarity=0.314  Sum_probs=103.0

Q ss_pred             HHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeeeccccccccc-----CcCC-----CCCCCcccCChhhhhcCCC
Q 011359          292 DIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-----DALS-----DDPGTYRWMAPEMIKHKSY  360 (488)
Q Consensus       292 qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-----~~~~-----~~~gt~~y~aPE~l~~~~~  360 (488)
                      +++.|+.|+|.. ++||++|.|++|.++.++.+||+-|+++......     ....     .......|.|||++.....
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            445899999965 8999999999999999999999999987433221     1111     1124567999999998888


Q ss_pred             CchhHHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHH-HhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          361 GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA-AFAV-VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       361 ~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.++|+|||||++|.+.. |..-+........ .+.. ...--.......+|.++++-+.+++..+...||++.++..
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence            999999999999999985 4444433321111 1111 1111122344678999999999999999999997766553

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.61  E-value=5.3e-07  Score=85.15  Aligned_cols=142  Identities=15%  Similarity=0.209  Sum_probs=90.9

Q ss_pred             cceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHH-HHHHHHHHHHHhcCC---CCeeeEeeee---
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLE-KQFNREVALLSRLHN---PNVIKFVAAC---  251 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~-~~~~~Ei~il~~l~H---pnIv~l~~~~---  251 (488)
                      .+|.+.+.+-.....-|.+-..+|+.+++|..+......+..+..-.. ....+++..+.++..   -....++.+.   
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk  110 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK  110 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence            456666677777777788888889999999987544222111100000 012344444444432   2233323322   


Q ss_pred             --ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          252 --KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       252 --~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                        .-....+|||||++|..|.++..      +++    .++..++.++.-||+.|++|+|..|.|++++.+ .++++||+
T Consensus       111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~  179 (229)
T PF06176_consen  111 IFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQ  179 (229)
T ss_pred             eccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECc
Confidence              22345668999999988876542      222    244567788999999999999999999999865 49999998


Q ss_pred             cc
Q 011359          330 IA  331 (488)
Q Consensus       330 la  331 (488)
                      ..
T Consensus       180 ~k  181 (229)
T PF06176_consen  180 GK  181 (229)
T ss_pred             cc
Confidence            65

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.60  E-value=5.2e-06  Score=88.52  Aligned_cols=144  Identities=19%  Similarity=0.267  Sum_probs=93.3

Q ss_pred             ceeeeeccEEEEEEEEC-CccEEEEEEecCCCC--------------------------hhHHHHHHH------HHHHHH
Q 011359          185 LRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDD--------------------------ENETLAARL------EKQFNR  231 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~--------------------------~~~~~~~~~------~~~~~~  231 (488)
                      ..|+.++-|.||+|++. |+.||||+.+..-..                          +-..+...+      +-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            46799999999999998 899999998743311                          011111222      223566


Q ss_pred             HHHHHHhcC-----CCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHH-HHHHHHCCc
Q 011359          232 EVALLSRLH-----NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARG-MEYIHSQGV  305 (488)
Q Consensus       232 Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~-L~~LH~~gi  305 (488)
                      |...+.++.     .++|.--.=+.+-.+.-.|+|||++|-.+.+...... ..++...+.   ..++.+ +..+=..|+
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~~~~~f~~q~~~dgf  286 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---ELLVRAFLRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HHHHHHHHHHHHhcCc
Confidence            776666663     2443222222222344569999999999988854322 345433333   333322 222334899


Q ss_pred             ccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          306 IHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       306 iHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +|.|.+|.||+++.+|.+.+.|||+..
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g  313 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVG  313 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCccee
Confidence            999999999999999999999999873

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.57  E-value=4.3e-07  Score=82.31  Aligned_cols=128  Identities=20%  Similarity=0.238  Sum_probs=94.7

Q ss_pred             eccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee-eEeeeeecCCeeeEE
Q 011359          182 FLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI-KFVAACKKPPVYCVI  260 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV  260 (488)
                      ...+.||+|.+|.||+|.|.|..+|+|+-+.++.          ...+..|+++|..+.-.++- ++|.+..+.    +.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----------r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~   90 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----------RRNLEKEAKILEILAGEGVTPEVYFYGEDF----IR   90 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCceEEEEEecCCcc----------hhhHHHHHHHHHHhhhcCCCceEEEechhh----hh
Confidence            3556799999999999999999999999886543          34577999999999876664 455544433    55


Q ss_pred             EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC-CCeEEEcCCCcEEEeeecccc
Q 011359          261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK-PENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       261 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIk-p~NILl~~~~~vkl~DFgla~  332 (488)
                      |||+.|-.|.++-...     +-    +-+..++..---|-..||-|+.|. |..++|-.++.+.|+||..|.
T Consensus        91 me~i~G~~L~~~~~~~-----~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          91 MEYIDGRPLGKLEIGG-----DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhcCcchhhhhhcc-----cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            9999998887766531     22    233445555555678899999998 565556566699999999884

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.56  E-value=7.3e-07  Score=85.65  Aligned_cols=134  Identities=14%  Similarity=0.148  Sum_probs=83.8

Q ss_pred             ceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC--eeeEeeeeecCCeeeEEEe
Q 011359          185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN--VIKFVAACKKPPVYCVITE  262 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E  262 (488)
                      ..||.|..+.||+.  .+..+++|+......          .....+|.+++..+..-.  +.+.+++......+.+|||
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~----------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD----------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCCC----------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence            46799999999984  366788898864221          123568999999986433  5677888888888889999


Q ss_pred             ecCCCC-HHHH--------------H-------HHhCCCCCCHHHHHH-HHH----------HHHH-HHHHHHH----CC
Q 011359          263 YLSEGS-LRAY--------------L-------HKLEHKTLPLPKLIA-IAL----------DIAR-GMEYIHS----QG  304 (488)
Q Consensus       263 ~~~ggs-L~~~--------------l-------~~~~~~~l~~~~~~~-i~~----------qi~~-~L~~LH~----~g  304 (488)
                      +++|.+ +...              +       +.............. +..          .+.. ...+|..    ..
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            999863 2111              1       110001111111111 100          0111 1222221    24


Q ss_pred             cccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          305 VIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       305 iiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ++|+|+.|.||++++++ +.|+||+.+
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a  180 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDF  180 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhc
Confidence            78999999999999888 999999977

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.48  E-value=1.1e-06  Score=83.83  Aligned_cols=143  Identities=20%  Similarity=0.203  Sum_probs=96.3

Q ss_pred             ccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhH----------------HHHHHHHHHHHHHHHHHHhcC--CCC
Q 011359          183 LGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENE----------------TLAARLEKQFNREVALLSRLH--NPN  243 (488)
Q Consensus       183 i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~----------------~~~~~~~~~~~~Ei~il~~l~--Hpn  243 (488)
                      +...|..|--+.||+|... +..||||+++........                ........-..+|+.-|.++.  +-.
T Consensus        52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            3447788999999999864 789999999864422110                001111222456888888874  344


Q ss_pred             eeeEeeeeecCCeeeEEEeecCCCC-HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCC
Q 011359          244 VIKFVAACKKPPVYCVITEYLSEGS-LRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEF  321 (488)
Q Consensus       244 Iv~l~~~~~~~~~~~lV~E~~~ggs-L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~  321 (488)
                      +.+-+++..    -.|||||+.... -.-.|   ..-.+..++...+..++++.+.-|=. .|+||+||..-|||+. ++
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence            555555443    259999995431 11111   12234444677788889999888855 8999999999999999 88


Q ss_pred             cEEEeeeccccc
Q 011359          322 HLKIADFGIACE  333 (488)
Q Consensus       322 ~vkl~DFgla~~  333 (488)
                      .+.|+|||.|..
T Consensus       204 ~p~iID~~QaV~  215 (268)
T COG1718         204 EPYIIDVSQAVT  215 (268)
T ss_pred             eEEEEECccccc
Confidence            999999998843

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.38  E-value=5.2e-06  Score=78.82  Aligned_cols=137  Identities=23%  Similarity=0.309  Sum_probs=82.9

Q ss_pred             ceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC--CeeeEeeee---ecCCeeeE
Q 011359          185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP--NVIKFVAAC---KKPPVYCV  259 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~---~~~~~~~l  259 (488)
                      +.|+.|..+.||+....+..++||+....          .....+.+|+.++..+...  .+.+++..+   ......++
T Consensus         3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEESSSSEEEEEEETTSEEEEEEESSH----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             ccCCCCCeeeEEEEEECCcEEEEEEeCCC----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            56899999999999998889999997632          1245677899999888633  355666643   23345789


Q ss_pred             EEeecCCCCHHH----------------HHHHh---C--CCCCCHHH---------HHHH------------HHHHHH-H
Q 011359          260 ITEYLSEGSLRA----------------YLHKL---E--HKTLPLPK---------LIAI------------ALDIAR-G  296 (488)
Q Consensus       260 V~E~~~ggsL~~----------------~l~~~---~--~~~l~~~~---------~~~i------------~~qi~~-~  296 (488)
                      +|++++|..+..                .+...   .  ........         ....            ...+.. .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            999999988877                11111   0  01111100         0000            111222 3


Q ss_pred             HHHHHH-------CCcccCCCCCCeEEEc-CCCcEEEeeeccc
Q 011359          297 MEYIHS-------QGVIHRDLKPENVLID-QEFHLKIADFGIA  331 (488)
Q Consensus       297 L~~LH~-------~giiHrDIkp~NILl~-~~~~vkl~DFgla  331 (488)
                      +..+++       ..++|+|+.+.||+++ .++.+-|+||+.+
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence            333332       3599999999999999 6677789999876

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.34  E-value=3.9e-06  Score=78.39  Aligned_cols=133  Identities=22%  Similarity=0.386  Sum_probs=93.4

Q ss_pred             cceeccceeeeecc-EEEEEEEECCccEEEEEEec---CCCC-------hhH---HHHHHHHHHHHHHHHHHHhcC---C
Q 011359          179 SQLFLGLRFAHGAH-SRLYHGIYKDEPVAVKIIRI---PDDD-------ENE---TLAARLEKQFNREVALLSRLH---N  241 (488)
Q Consensus       179 ~~~~i~~~lG~G~~-g~Vy~~~~~~~~vAVK~i~~---~~~~-------~~~---~~~~~~~~~~~~Ei~il~~l~---H  241 (488)
                      .++...+.||.|.. |.||++...|+.+|+|+++.   ....       ..+   .....+..-|..|.+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            45667788999999 99999999999999999432   1110       000   001123346889999988885   3


Q ss_pred             CCe--eeEeeeeec------------------CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 011359          242 PNV--IKFVAACKK------------------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH  301 (488)
Q Consensus       242 pnI--v~l~~~~~~------------------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH  301 (488)
                      .++  |+.+||..-                  .....||.||+....           .+.    ..-+.+|.+-|..+|
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHHH
Confidence            455  899998721                  124568889886533           122    233456777788899


Q ss_pred             HCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       302 ~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ..||+-+|+++.|..     .-+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999986     3588999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.31  E-value=5.6e-06  Score=80.16  Aligned_cols=135  Identities=19%  Similarity=0.151  Sum_probs=83.8

Q ss_pred             eeeeecc-EEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeeeEEEee
Q 011359          186 RFAHGAH-SRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVITEY  263 (488)
Q Consensus       186 ~lG~G~~-g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~  263 (488)
                      .|..|.+ ..||+....+..+.||+.....           ..++.+|++++..+. +--+.+++++...++..++|||+
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   73 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSA   73 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEe
Confidence            3455555 7889987767788888875322           123557888888885 44466778877766678899999


Q ss_pred             cCCCCHHHHH-------------------HHhCCCCCCHH----HHHHHHH--------------------HHHHHHHHH
Q 011359          264 LSEGSLRAYL-------------------HKLEHKTLPLP----KLIAIAL--------------------DIARGMEYI  300 (488)
Q Consensus       264 ~~ggsL~~~l-------------------~~~~~~~l~~~----~~~~i~~--------------------qi~~~L~~L  300 (488)
                      ++|.+|....                   +.......+..    .......                    .+...+..|
T Consensus        74 i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  153 (244)
T cd05150          74 VPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAEL  153 (244)
T ss_pred             eCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHH
Confidence            9998776432                   11000000100    0000000                    011112222


Q ss_pred             H-------HCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          301 H-------SQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       301 H-------~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      -       ...++|+|+.+.|||+++++.+.|+||+.+
T Consensus       154 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a  191 (244)
T cd05150         154 EATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRL  191 (244)
T ss_pred             HhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence            1       124899999999999999877889999876

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.25  E-value=1e-07  Score=100.67  Aligned_cols=182  Identities=19%  Similarity=0.199  Sum_probs=133.7

Q ss_pred             cceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeeEeeeeecCCeeeEEE
Q 011359          184 GLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~  261 (488)
                      -+.+++|+++.+|+.+... +....+++...             ....-++++|.+++||| .+..++-+..+...++++
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            3456899999999988653 33446665432             12346889999999999 888888888899999999


Q ss_pred             eecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcC
Q 011359          262 EYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL  340 (488)
Q Consensus       262 E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~  340 (488)
                      +++.++ +....... ..-.+..-+...+.+.-.+++++||+.-=+|+|    ||+..+ +..+..||+...........
T Consensus       314 ~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  314 RICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccccc
Confidence            999877 22221110 011222334455666778899999998778998    777665 68899999988655444445


Q ss_pred             CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 011359          341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE  384 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~  384 (488)
                      ....+++.++|||+.....+..+.|+|++|+-..+|.-|..|-.
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            66779999999999999999999999999987777766766543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.11  E-value=3.1e-05  Score=72.19  Aligned_cols=99  Identities=23%  Similarity=0.326  Sum_probs=78.8

Q ss_pred             HHHHHHHHhcCC-CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 011359          230 NREVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEYIHS---QG  304 (488)
Q Consensus       230 ~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~g  304 (488)
                      ..|.-+|+.+.+ +++++++|+|.+    ++|.||+..+++...-.. ..-...+|..+.+|+.++++.+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            368889999986 799999999944    478999987665421000 011346899999999999999999987   35


Q ss_pred             cccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          305 VIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       305 iiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +.-.|++++|+-++++|++|++|.+.+.
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcc
Confidence            7788999999999999999999998663

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.07  E-value=2.3e-05  Score=88.26  Aligned_cols=196  Identities=19%  Similarity=0.218  Sum_probs=140.5

Q ss_pred             HHHHHHHHHHhcCCCCeeeEeeeeecCC----eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011359          228 QFNREVALLSRLHNPNVIKFVAACKKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ  303 (488)
Q Consensus       228 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  303 (488)
                      ....|+..+..+.|+|++.++.|.....    ...+..++|...++...+..  -..++.+....+..++..||.|+|+.
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            3456788888899999999999875433    34466788999999988876  35678888999999999999999999


Q ss_pred             CcccCCCCCC---eEEEcCCCcEEEe--eecccccccccCcCCCCCCCcccCChhhhhcCCCC--chhHHHHHHHHHHHH
Q 011359          304 GVIHRDLKPE---NVLIDQEFHLKIA--DFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYG--RKVDVYSFGLILWEM  376 (488)
Q Consensus       304 giiHrDIkp~---NILl~~~~~vkl~--DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~--~k~DvwSlGvll~el  376 (488)
                      ...|.-+...   +...+.++.+.++  ||+...................|.++|......+.  ...|+|++|.++..+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            7666655554   4445566677776  88877554444443444456677888888765554  447999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          377 VAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       377 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      ..|..+-.......           ..++......+.++..+|+..+.++|+...+++..
T Consensus       386 ~~~~~i~~~~~~~~-----------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  386 SQGEDISEKSAVPV-----------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             hhcCcccccccchh-----------hhhccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            88764432211111           11222222368889999999999999999988864

>PLN02876 acyl-CoA dehydrogenase

Probab=98.06  E-value=4.1e-05  Score=87.18  Aligned_cols=78  Identities=18%  Similarity=0.190  Sum_probs=55.6

Q ss_pred             cceeeeeccEEEEEEEECC----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCe--eeEeeeeecC--
Q 011359          184 GLRFAHGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNV--IKFVAACKKP--  254 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~--  254 (488)
                      ..+|+.|.++.+|+..+.+    ..+++|+.........       ...+.+|+++|+.+. |.+|  .+++.+|.+.  
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v  115 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-------AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV  115 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-------HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence            3567899999999987764    4677777543221111       235779999999996 6664  7888888764  


Q ss_pred             -CeeeEEEeecCCCC
Q 011359          255 -PVYCVITEYLSEGS  268 (488)
Q Consensus       255 -~~~~lV~E~~~ggs  268 (488)
                       +..++||||++|..
T Consensus       116 ~G~~flVME~v~G~~  130 (822)
T PLN02876        116 IGTAFYIMEYLEGRI  130 (822)
T ss_pred             CCCceEEEEecCCcc
Confidence             46789999998864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.01  E-value=2.5e-05  Score=75.26  Aligned_cols=72  Identities=14%  Similarity=0.158  Sum_probs=44.5

Q ss_pred             ceeeeeccE-EEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC---CeeeEeeeeecC---Cee
Q 011359          185 LRFAHGAHS-RLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP---NVIKFVAACKKP---PVY  257 (488)
Q Consensus       185 ~~lG~G~~g-~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~---~~~  257 (488)
                      ..|+.||.. .||+.   +..+++|+.....          ....+.+|+++|..+...   -+.++++.....   ...
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----------~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~   69 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----------YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP   69 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCccc----------hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence            356766666 58875   3467778754211          123577899999888632   344455544332   244


Q ss_pred             eEEEeecCCCCH
Q 011359          258 CVITEYLSEGSL  269 (488)
Q Consensus       258 ~lV~E~~~ggsL  269 (488)
                      ++||++++|.++
T Consensus        70 ~~l~~~i~G~~l   81 (235)
T cd05155          70 WSVYRWLEGETA   81 (235)
T ss_pred             eEEEEeecCCCC
Confidence            789999998665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.01  E-value=3.1e-05  Score=82.46  Aligned_cols=142  Identities=18%  Similarity=0.219  Sum_probs=88.8

Q ss_pred             ceeeeeccEEEEEEEEC-CccEEEEEEecCCCCh-----------------------hHHHHHHH------HHHHHHHHH
Q 011359          185 LRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDE-----------------------NETLAARL------EKQFNREVA  234 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~-----------------------~~~~~~~~------~~~~~~Ei~  234 (488)
                      +.||.-..|.||+|+.. |+.||||+-+..-...                       ...+....      +-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            56899999999999987 6889999976432111                       01111111      223556665


Q ss_pred             HHHhc----CCCC------eeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHH-HHHHC
Q 011359          235 LLSRL----HNPN------VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME-YIHSQ  303 (488)
Q Consensus       235 il~~l----~Hpn------Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~  303 (488)
                      -..++    .|-+      |.+++-.+  ...-.|+||||+|..+.+.-.- ....++...+..   .+.++.. -+=..
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~---~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI-DKRGISPHDILN---KLVEAYLEQIFKT  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHH---HHHHHHHHHHHhc
Confidence            55544    3444      33333333  2344699999999877665332 224455554433   3333322 22356


Q ss_pred             CcccCCCCCCeEEEc----CCCcEEEeeecccc
Q 011359          304 GVIHRDLKPENVLID----QEFHLKIADFGIAC  332 (488)
Q Consensus       304 giiHrDIkp~NILl~----~~~~vkl~DFgla~  332 (488)
                      |++|.|-+|.||++.    .++.+.+.|||+..
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~  353 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA  353 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence            899999999999998    36789999999874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.88  E-value=0.00027  Score=66.36  Aligned_cols=135  Identities=18%  Similarity=0.304  Sum_probs=93.4

Q ss_pred             ceeeeeccEEEEEEEECCccEEEEEEecCCCChhH--------HHHHHHHHHHHHHHHHHHhcC------CCCeeeEeee
Q 011359          185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENE--------TLAARLEKQFNREVALLSRLH------NPNVIKFVAA  250 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~--------~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~  250 (488)
                      ..||+|+.-.||.- -.+....||+.+........        .......+++.+|+.-..++.      +.+|.+++|+
T Consensus         7 ~~i~~G~~R~cy~H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~   85 (199)
T PF10707_consen    7 DLIAQGGERDCYQH-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF   85 (199)
T ss_pred             cccccCCCceEEEC-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence            45799999999963 23567899999865500000        000011355667777766665      7889999999


Q ss_pred             eecCCeeeEEEeecCC------CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC---C
Q 011359          251 CKKPPVYCVITEYLSE------GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---F  321 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~g------gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~---~  321 (488)
                      .+.+.-..+|+|.+..      -+|.+++..   ..++. .   +...+-.-..||-+.+|+.+|++|.||++...   .
T Consensus        86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   86 VETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            9999988999998733      378888854   44554 3   33344455677889999999999999999533   2


Q ss_pred             -cEEEee
Q 011359          322 -HLKIAD  327 (488)
Q Consensus       322 -~vkl~D  327 (488)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.87  E-value=0.00018  Score=71.99  Aligned_cols=76  Identities=13%  Similarity=-0.018  Sum_probs=56.9

Q ss_pred             cceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC---CCeeeEeeeeec---CCee
Q 011359          184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN---PNVIKFVAACKK---PPVY  257 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~  257 (488)
                      .+.||.|..+.||+....+..+.||+.+....          ...|..|...|+.|..   -.|.+++++|..   .+..
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~----------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGNPMPLMARSFST----------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             eeecCCccceeEEEEEcCCCCEEEEEeccccc----------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            35689999999999877666788888643111          2357799999998863   467888888754   3568


Q ss_pred             eEEEeecCCCCH
Q 011359          258 CVITEYLSEGSL  269 (488)
Q Consensus       258 ~lV~E~~~ggsL  269 (488)
                      +||||+++|+++
T Consensus        89 ~LVmE~i~G~~~  100 (297)
T PRK10593         89 VLLLERLRGVSV  100 (297)
T ss_pred             EEEEeccCCEec
Confidence            899999998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.70  E-value=0.00063  Score=68.32  Aligned_cols=138  Identities=22%  Similarity=0.255  Sum_probs=81.6

Q ss_pred             cceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeeEeeee------ecCC
Q 011359          184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAAC------KKPP  255 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~------~~~~  255 (488)
                      ...++.|....+|+....+..+++|+......          ...+..|++++..|..  -.|.+++...      ...+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~----------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g   96 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVK----------AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG   96 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCCC----------HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence            45567777789999877667889998754221          1234456777777742  2244444422      2245


Q ss_pred             eeeEEEeecCCCCHH-----------H---HHHHhCCC---C----C---CHHHHH------------HHHHHHHHHHHH
Q 011359          256 VYCVITEYLSEGSLR-----------A---YLHKLEHK---T----L---PLPKLI------------AIALDIARGMEY  299 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~-----------~---~l~~~~~~---~----l---~~~~~~------------~i~~qi~~~L~~  299 (488)
                      ..++++||++|..+.           .   .++.....   .    .   .|....            .....+...+++
T Consensus        97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~  176 (307)
T TIGR00938        97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY  176 (307)
T ss_pred             eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence            678999999885431           1   11211000   0    0   011100            011123345555


Q ss_pred             HHH-------CCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          300 IHS-------QGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       300 LH~-------~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      +..       .+++|+|+.+.||+++.++.+.|+||+.+
T Consensus       177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence            542       58999999999999999887789999976

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.69  E-value=2.7e-05  Score=77.02  Aligned_cols=135  Identities=20%  Similarity=0.244  Sum_probs=96.2

Q ss_pred             eeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCC-----------------hhHHHHHHHHHHHHHHHHHHHhcC-C
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDD-----------------ENETLAARLEKQFNREVALLSRLH-N  241 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~-----------------~~~~~~~~~~~~~~~Ei~il~~l~-H  241 (488)
                      +.+|++||-|--+.||.+-+. |++.++|+=++....                 .|..+   .+-...+|...|+.|. |
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyL---SRlaa~kEfafmkaL~e~  170 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYL---SRLAATKEFAFMKALYER  170 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhh---HHHHHHHHHHHHHHHHHc
Confidence            568999999999999999887 899999986543211                 11111   1233568999999886 3


Q ss_pred             -CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC
Q 011359          242 -PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE  320 (488)
Q Consensus       242 -pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~  320 (488)
                       --|.+.+++.    ..++|||++.|-.|...-+-     .   ..-.+...+..-+--|...|+||+|+.--||+++++
T Consensus       171 gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v-----~---d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd  238 (465)
T KOG2268|consen  171 GFPVPKPIDHN----RHCVVMELVDGYPLRQVRHV-----E---DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD  238 (465)
T ss_pred             CCCCCCccccc----ceeeHHHhhcccceeeeeec-----C---ChHHHHHHHHHHHHHHHHcCceecccchheeEEecC
Confidence             2244555543    44699999998887664432     1   223344455555666778999999999999999999


Q ss_pred             CcEEEeeecc
Q 011359          321 FHLKIADFGI  330 (488)
Q Consensus       321 ~~vkl~DFgl  330 (488)
                      +.++++||-.
T Consensus       239 ~~i~vIDFPQ  248 (465)
T KOG2268|consen  239 DKIVVIDFPQ  248 (465)
T ss_pred             CCEEEeechH
Confidence            9999999964

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.63  E-value=0.00037  Score=69.42  Aligned_cols=137  Identities=20%  Similarity=0.183  Sum_probs=83.0

Q ss_pred             cceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC--CeeeEeee------eecCC
Q 011359          184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP--NVIKFVAA------CKKPP  255 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~------~~~~~  255 (488)
                      .+.|..|....+|+....+..+++|+... . .         ...+..|+.++..+.+.  .+.+++..      ...++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~-~-~---------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEK-V-S---------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCC-C-C---------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            34567788889999887778899998763 1 1         13355788888887532  24454432      12345


Q ss_pred             eeeEEEeecCCCCHHH-----------H---HHHhC-CCC--------CCHHHH----------HHHHHHHHHHHHHHHH
Q 011359          256 VYCVITEYLSEGSLRA-----------Y---LHKLE-HKT--------LPLPKL----------IAIALDIARGMEYIHS  302 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~-----------~---l~~~~-~~~--------l~~~~~----------~~i~~qi~~~L~~LH~  302 (488)
                      ..++|++|++|..+..           .   ++... ...        ..+...          ......+..++.++..
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6689999998865421           1   11110 000        011100          0011122334455543


Q ss_pred             -------CCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          303 -------QGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       303 -------~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                             .+++|+|+.|.||++++++.+.|+||+.+
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a  203 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA  203 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence                   37999999999999999877889999876

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.60  E-value=0.0006  Score=65.42  Aligned_cols=72  Identities=21%  Similarity=0.246  Sum_probs=46.4

Q ss_pred             ceeeeeccEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCCeeeEE
Q 011359          185 LRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~---~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV  260 (488)
                      +.|..|-...+|+....   ++.|++|+........         -...+|+.++..+.. --+.++++.+..    .+|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~---------~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l   70 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI---------IDRERELRIHKLLSKHGLAPKLYATFQN----GLI   70 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce---------ecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEE
Confidence            45677888899998765   4689999765321110         112378888888853 334455554432    379


Q ss_pred             EeecCCCCH
Q 011359          261 TEYLSEGSL  269 (488)
Q Consensus       261 ~E~~~ggsL  269 (488)
                      |||++|.++
T Consensus        71 ~e~i~G~~l   79 (235)
T cd05157          71 YEFIPGRTL   79 (235)
T ss_pred             EEeeCCCcC
Confidence            999998665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.53  E-value=0.00077  Score=65.78  Aligned_cols=132  Identities=19%  Similarity=0.192  Sum_probs=76.8

Q ss_pred             eeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eeEeeeeecCCeeeEEEeecC
Q 011359          187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKPPVYCVITEYLS  265 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~  265 (488)
                      +..|-.+.+|+....++.+++|+.......-        .-...+|..+++.+....+ .+++..+.    -++||||++
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--------~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--------GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCcccccc--------cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEecc
Confidence            4567888999988778889998764322110        0123478888888864323 34444432    258999999


Q ss_pred             CCCHHH--------------HHHHh---C--CCCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCcccC
Q 011359          266 EGSLRA--------------YLHKL---E--HKTLPLP-KLIAIALDI---------ARGMEYIHS--------QGVIHR  308 (488)
Q Consensus       266 ggsL~~--------------~l~~~---~--~~~l~~~-~~~~i~~qi---------~~~L~~LH~--------~giiHr  308 (488)
                      |..+..              .+.+.   .  ...+... .+..+..++         ...+..+-.        ..++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            866531              11111   1  1111211 112221111         112222222        248999


Q ss_pred             CCCCCeEEEcCCCcEEEeeeccc
Q 011359          309 DLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       309 DIkp~NILl~~~~~vkl~DFgla  331 (488)
                      |+.+.||++++++ +.|+||..+
T Consensus       152 Dl~~~Nil~~~~~-~~lIDwE~a  173 (256)
T TIGR02721       152 DVHAYNLVVTPQG-LKLIDWEYA  173 (256)
T ss_pred             CCCcCcEEEeCCC-CEEEecccc
Confidence            9999999999877 789999877

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.52  E-value=0.0018  Score=65.31  Aligned_cols=136  Identities=19%  Similarity=0.189  Sum_probs=75.7

Q ss_pred             ceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC--CeeeEee------eeecCCe
Q 011359          185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP--NVIKFVA------ACKKPPV  256 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~------~~~~~~~  256 (488)
                      +.|+.|....+|+....+..+++|++. ...          .+.+..|+.++..|...  .|.+.+.      +....+.
T Consensus        28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~-~~~----------~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~   96 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQGEYVLTLFE-RLT----------AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGK   96 (319)
T ss_pred             chhccccccceEEEEeCCCcEEEEEec-cCC----------hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCE
Confidence            456778888999988777789999875 111          12233455666655321  1333332      1223456


Q ss_pred             eeEEEeecCCCCH-----------HHHH---HHhC-CC--------CCCH-HHHHH------------HHHH-HHHHHHH
Q 011359          257 YCVITEYLSEGSL-----------RAYL---HKLE-HK--------TLPL-PKLIA------------IALD-IARGMEY  299 (488)
Q Consensus       257 ~~lV~E~~~ggsL-----------~~~l---~~~~-~~--------~l~~-~~~~~------------i~~q-i~~~L~~  299 (488)
                      .++++||++|..+           ...+   +... ..        .+.+ .....            .+.+ +...+..
T Consensus        97 ~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  176 (319)
T PRK05231         97 PAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAF  176 (319)
T ss_pred             EEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHh
Confidence            7899999988643           1111   1110 00        0111 11111            1111 1112233


Q ss_pred             HH-------HCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          300 IH-------SQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       300 LH-------~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      +.       ..++||+|+.+.||+++.+...-|+||+.+
T Consensus       177 ~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~  215 (319)
T PRK05231        177 LASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFA  215 (319)
T ss_pred             hhccccccCCcccCCCCCCCCcEEEECCceEEEEecccc
Confidence            32       237999999999999997766689999977

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.52  E-value=3.5e-05  Score=88.66  Aligned_cols=176  Identities=13%  Similarity=0.084  Sum_probs=125.5

Q ss_pred             EEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee--cCCeeeEEEeecCCCCHHHHHHHhCCC--C
Q 011359          205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK--KPPVYCVITEYLSEGSLRAYLHKLEHK--T  280 (488)
Q Consensus       205 vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~~~--~  280 (488)
                      +.+|+.+..   +-+.+.+-+.+....|..-++...|+++...+.-..  .....+..++|+.+|.+++.|-+....  .
T Consensus      1255 Fk~~I~ke~---d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ 1331 (2724)
T KOG1826|consen 1255 FKFSIYKEY---DFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPD 1331 (2724)
T ss_pred             eEEEeehhh---hHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCc
Confidence            456665432   223344444555666777777788999887766543  234567899999999999999875322  2


Q ss_pred             CCHHHHHHHHHHH-HHHHHHHHHCC-----cccCCCCCCeEEEcCCCcEEEeeecccc-cccccCcCCCCCCCcccCChh
Q 011359          281 LPLPKLIAIALDI-ARGMEYIHSQG-----VIHRDLKPENVLIDQEFHLKIADFGIAC-EEVYCDALSDDPGTYRWMAPE  353 (488)
Q Consensus       281 l~~~~~~~i~~qi-~~~L~~LH~~g-----iiHrDIkp~NILl~~~~~vkl~DFgla~-~~~~~~~~~~~~gt~~y~aPE  353 (488)
                      +... .+...+++ +.+..-+|+..     .+|+++|+-|.+|..+..+++.++|+.+ ............+++.|+.++
T Consensus      1332 ld~~-~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~ql 1410 (2724)
T KOG1826|consen 1332 LDRS-PVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQL 1410 (2724)
T ss_pred             chhc-hHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHH
Confidence            2232 33333443 66666666542     7899999999999999999999999997 332223334556888999999


Q ss_pred             hhhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 011359          354 MIKHKSYGRKVDVYSFGLILWEMVAGTIPYE  384 (488)
Q Consensus       354 ~l~~~~~~~k~DvwSlGvll~elltG~~Pf~  384 (488)
                      ..+.-.++.++|+|..|+.+|+...|..+|-
T Consensus      1411 i~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1411 IKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             HHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence            9998899999999999999999988876663

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.24  E-value=0.0038  Score=64.88  Aligned_cols=80  Identities=15%  Similarity=-0.007  Sum_probs=51.5

Q ss_pred             ceeeeeccEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeeEeeeeecCCeeeE
Q 011359          185 LRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPVYCV  259 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~--~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l  259 (488)
                      +.||.|.+..||++...+  +.|+||.-........+.. ......+..|.+.|..+.   -.++.+++.+.  ....++
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~w-pl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESW-PLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccc-cccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            567999999999999875  3899998642211000000 001234567788887763   24577777763  355679


Q ss_pred             EEeecCCC
Q 011359          260 ITEYLSEG  267 (488)
Q Consensus       260 V~E~~~gg  267 (488)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999764

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.07  E-value=0.0043  Score=62.79  Aligned_cols=146  Identities=20%  Similarity=0.217  Sum_probs=94.7

Q ss_pred             ccceeeeeccEEEEEEEEC-CccEEEEEEecCCC-----C-----hh--------HHHHHHHHHHHHHHHHHHHhcCCCC
Q 011359          183 LGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDD-----D-----EN--------ETLAARLEKQFNREVALLSRLHNPN  243 (488)
Q Consensus       183 i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~-----~-----~~--------~~~~~~~~~~~~~Ei~il~~l~Hpn  243 (488)
                      +-..|..|--+.||++... |..+|||+++...-     +     +.        .+-.....--...|++-|.+|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            4567888999999999875 78899999863210     0     00        0001111222347888888886544


Q ss_pred             eeeEeeeeecCCeeeEEEeecCCCCH-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCeEEEcCCC
Q 011359          244 VIKFVAACKKPPVYCVITEYLSEGSL-RAYLHKLEHKTLPLPKLIAIALDIARGMEYI-HSQGVIHRDLKPENVLIDQEF  321 (488)
Q Consensus       244 Iv~l~~~~~~~~~~~lV~E~~~ggsL-~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~giiHrDIkp~NILl~~~~  321 (488)
                      |.----+.. . ...|||+|+.+... .-.|   ....++...+..+-.+++.-+.-| |..++||.||.--|+|+.+ |
T Consensus       228 IP~PePIlL-k-~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G  301 (520)
T KOG2270|consen  228 IPCPEPILL-K-NHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-G  301 (520)
T ss_pred             CCCCCceee-e-cceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-C
Confidence            321111111 1 23599999953221 1122   235677778888888888888877 6789999999999999965 5


Q ss_pred             cEEEeeecccccc
Q 011359          322 HLKIADFGIACEE  334 (488)
Q Consensus       322 ~vkl~DFgla~~~  334 (488)
                      .+.|+|.+.+...
T Consensus       302 ~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  302 KLYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEEccccccC
Confidence            8999999987543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.02  E-value=0.0082  Score=60.08  Aligned_cols=28  Identities=25%  Similarity=0.503  Sum_probs=24.9

Q ss_pred             CCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          303 QGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       303 ~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .+++|||+.+.||+++. +.+.|+||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            47899999999999988 67899999965

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.97  E-value=0.007  Score=60.44  Aligned_cols=73  Identities=16%  Similarity=0.218  Sum_probs=46.0

Q ss_pred             ceeeeeccEEEEEEEEC--------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeeEeeeeecCC
Q 011359          185 LRFAHGAHSRLYHGIYK--------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKKPP  255 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~--------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~  255 (488)
                      +.|..|-...+|+....        ++.|++|+.......         .....+|+.++..+.... ..++++++..  
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--   72 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---------LIDRERELVVFARLSERNLGPKLYGIFPN--   72 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---------eechHHHHHHHHHHHhCCCCCceEEEeCC--
Confidence            34556777788888765        378999997543211         122447888888886333 3455655542  


Q ss_pred             eeeEEEeecCCCCHH
Q 011359          256 VYCVITEYLSEGSLR  270 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~  270 (488)
                        .+|+||++|..+.
T Consensus        73 --~~v~e~i~G~~l~   85 (302)
T cd05156          73 --GRIEEFIPSRTLT   85 (302)
T ss_pred             --CchhheeCCCcCC
Confidence              3689999887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.75  E-value=0.0093  Score=59.98  Aligned_cols=139  Identities=16%  Similarity=0.239  Sum_probs=80.7

Q ss_pred             eeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeeEeeeeecCC--eeeEEE
Q 011359          186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACKKPP--VYCVIT  261 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~--~~~lV~  261 (488)
                      .+-.|....+|+....++.++|. .. +......     ......+|+.+++.+.-  --+...++.|.++.  ..+.||
T Consensus        32 ~~~~G~sn~t~~~~~~~~~~vlR-~P-~~~~~~~-----~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          32 EISGGWSNDTFRLGDTGQKYVLR-KP-PRGDPVE-----SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             eccCCcccceEEEecCCceEEEe-cC-Cccccch-----hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            33345555677777778888888 22 1111111     12345688888888864  33455677776665  678999


Q ss_pred             eecCCCCHH------------------HHHHHhC-----C-------CCCCHHHHHHHHHH--------------HHHHH
Q 011359          262 EYLSEGSLR------------------AYLHKLE-----H-------KTLPLPKLIAIALD--------------IARGM  297 (488)
Q Consensus       262 E~~~ggsL~------------------~~l~~~~-----~-------~~l~~~~~~~i~~q--------------i~~~L  297 (488)
                      +|++|..+.                  ++|....     .       ......++..+..+              ...-.
T Consensus       105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~  184 (321)
T COG3173         105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI  184 (321)
T ss_pred             EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence            999883221                  2221110     0       00001111111111              12234


Q ss_pred             HHHHHC--------CcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          298 EYIHSQ--------GVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       298 ~~LH~~--------giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .||+.+        .++|||+.+.||+++.++.+-|+||+++
T Consensus       185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~  226 (321)
T COG3173         185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELA  226 (321)
T ss_pred             HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccc
Confidence            455433        3899999999999999989999999987

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.58  E-value=0.0077  Score=63.34  Aligned_cols=152  Identities=23%  Similarity=0.290  Sum_probs=92.9

Q ss_pred             HHHHHHHHHHHhcCCCCeeeEeeeeecC-CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 011359          227 KQFNREVALLSRLHNPNVIKFVAACKKP-PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV  305 (488)
Q Consensus       227 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi  305 (488)
                      .++.--.++++.+.|+|...++++-... .+..+|+|++ +.+|++.+....   +.....          +    ..|+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s~----------~----~~~~   88 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDESL----------L----AHGV   88 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhhh----------c----cccc
Confidence            3456678889999999999999987543 3577899998 679999887622   211111          0    1222


Q ss_pred             ccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 011359          306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE  385 (488)
Q Consensus       306 iHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~  385 (488)
                      .|     .||       ++++| -++.   .            |  |     ...++|+|||++|.++.++.-|..-+..
T Consensus        89 ~~-----~~~-------~~~td-~~~t---~------------~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   89 LH-----LNI-------IYITD-HFLT---K------------Y--P-----SPIGPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             ce-----ehh-------hhccc-cccc---c------------C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence            22     122       22333 0000   0            0  0     1122599999999999999999877766


Q ss_pred             CCHHHHHHHHHhccCCC----------CCCCCCcHHHHHHHHHHhhhCCCCCCCHH
Q 011359          386 MNPIQAAFAVVNKNLRP----------AIPGDCPPAMAALIEQCWSLQPDKRPEFW  431 (488)
Q Consensus       386 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~  431 (488)
                      ....+....+..-...+          .+-..++..+..+..+|+...|..||...
T Consensus       134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~  189 (725)
T KOG1093|consen  134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM  189 (725)
T ss_pred             HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence            55544433322211110          12235677788999999999999887543

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.52  E-value=0.038  Score=57.45  Aligned_cols=80  Identities=11%  Similarity=-0.013  Sum_probs=50.1

Q ss_pred             cceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeeEeeeeecCCeeeEE
Q 011359          184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV  260 (488)
                      .+.||.|....||+....+..|+||.-......-.... ......-..|+..|+.+.   ..+|.+++.++.+  ..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~w-pl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESW-PMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccc-cCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence            45779999999999887777899998752211000000 000112234566666553   3578889988873  35688


Q ss_pred             EeecCC
Q 011359          261 TEYLSE  266 (488)
Q Consensus       261 ~E~~~g  266 (488)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.34  E-value=0.03  Score=56.23  Aligned_cols=29  Identities=21%  Similarity=0.208  Sum_probs=26.9

Q ss_pred             CcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          304 GVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       304 giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +++|+|+.+.|||++.++.+.|+||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998773

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.30  E-value=0.027  Score=57.23  Aligned_cols=134  Identities=18%  Similarity=0.249  Sum_probs=75.5

Q ss_pred             ceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eeEeeeeecCCeee
Q 011359          185 LRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKPPVYC  258 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~  258 (488)
                      +.|..|=...+|+....+     ..|+||+.......   .+      .-.+|..+++.+..-++ .++++++..+    
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~---~I------dR~~E~~il~~l~~~gl~P~~l~~~~~G----   86 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY---VI------DRERELQAIKYLSAAGFGAKLLGVFGNG----   86 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe---Ee------chHHHHHHHHHHHhcCCCCceeEEeCCc----
Confidence            344447777889887554     27888887543211   11      11378888888865444 4556655322    


Q ss_pred             EEEeecCCCCHHH--------------HHHHhCCCC------C-CHHHHHHHHHHH----------------------HH
Q 011359          259 VITEYLSEGSLRA--------------YLHKLEHKT------L-PLPKLIAIALDI----------------------AR  295 (488)
Q Consensus       259 lV~E~~~ggsL~~--------------~l~~~~~~~------l-~~~~~~~i~~qi----------------------~~  295 (488)
                      +|.+|++|..|..              .+.+.-...      . .+..+..+..++                      ..
T Consensus        87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~  166 (330)
T PLN02421         87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD  166 (330)
T ss_pred             EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence            5899997765421              111111111      1 122332222221                      11


Q ss_pred             HHHHHH----HCC----cccCCCCCCeEEEcC-CCcEEEeeeccc
Q 011359          296 GMEYIH----SQG----VIHRDLKPENVLIDQ-EFHLKIADFGIA  331 (488)
Q Consensus       296 ~L~~LH----~~g----iiHrDIkp~NILl~~-~~~vkl~DFgla  331 (488)
                      -+..+.    ..+    ++|.|+.+.|||+++ ++.++++||..|
T Consensus       167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa  211 (330)
T PLN02421        167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG  211 (330)
T ss_pred             HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence            122221    112    799999999999975 578999999987

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.23  E-value=0.022  Score=58.29  Aligned_cols=75  Identities=16%  Similarity=0.109  Sum_probs=45.0

Q ss_pred             eeeeeccEEEEEEEECC--ccEEEEEEecCCC---ChhHHHHHHHHHHHHHHHHHHHhcC--CCC-eeeEeeeeecCCee
Q 011359          186 RFAHGAHSRLYHGIYKD--EPVAVKIIRIPDD---DENETLAARLEKQFNREVALLSRLH--NPN-VIKFVAACKKPPVY  257 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~~--~~vAVK~i~~~~~---~~~~~~~~~~~~~~~~Ei~il~~l~--Hpn-Iv~l~~~~~~~~~~  257 (488)
                      .||.|....||++...+  +.|+||.-.....   ..+..-    ..+...|...|+...  -|. +.++|. | ++...
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~----~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~e~~   75 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLT----LDRARIESSALIRQGEHVPHLVPRIFH-F-DTEMA   75 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCC----ccHHHHHHHHHHHhhccCccccCeEEE-E-ccccc
Confidence            46999999999998764  5799998542111   011100    223346777777664  353 444443 3 34455


Q ss_pred             eEEEeecCC
Q 011359          258 CVITEYLSE  266 (488)
Q Consensus       258 ~lV~E~~~g  266 (488)
                      .+|||+++.
T Consensus        76 ~~vMEdL~~   84 (370)
T TIGR01767        76 VTVMEDLSH   84 (370)
T ss_pred             eehHhhCcc
Confidence            699999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.22  E-value=0.028  Score=55.62  Aligned_cols=28  Identities=32%  Similarity=0.583  Sum_probs=24.0

Q ss_pred             CcccCCCCCCeEEEcCCCc-EEEeeeccc
Q 011359          304 GVIHRDLKPENVLIDQEFH-LKIADFGIA  331 (488)
Q Consensus       304 giiHrDIkp~NILl~~~~~-vkl~DFgla  331 (488)
                      .++|+|+++.||++++++. .-|+||+.+
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a  214 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEA  214 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhc
Confidence            4899999999999997555 569999987

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.17  E-value=0.013  Score=59.40  Aligned_cols=103  Identities=14%  Similarity=0.182  Sum_probs=68.3

Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      ....|++|++- |++|.- +     ....++++..|+.+.+..+.-+..+ ..-|||+.-.||||+ +|.+.|+||-+++
T Consensus       298 ~~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             ceEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence            34567778864 555432 2     2345778999999999888888765 789999999999999 9999999999996


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF  369 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSl  369 (488)
                      .......    ......-.|-.+.+.. +..-|||-+
T Consensus       370 l~~~q~~----isy~rldhp~lF~G~d-d~QFeIYrl  401 (488)
T COG5072         370 LSYSQGI----ISYNRLDHPDLFNGVD-DYQFEIYRL  401 (488)
T ss_pred             cccCCce----eeccccCchhhhcCcc-ceeeeHHHH
Confidence            3322211    1122233444454322 555566654

>PLN02236 choline kinase

Probab=96.16  E-value=0.044  Score=56.03  Aligned_cols=133  Identities=16%  Similarity=0.250  Sum_probs=76.4

Q ss_pred             eeeeeccEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eeEeeeeecCCeee
Q 011359          186 RFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKPPVYC  258 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~  258 (488)
                      +|-.|-...+|+..+.      ++.|++|+.......    +.     .-.+|..+++.+..-++ .++++.+..+    
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~----~i-----dR~~E~~~~~~l~~~gl~P~~~~~~~~g----  109 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL----FF-----DRDDEIRTFECMSRHGQGPRLLGRFPNG----  109 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe----ee-----chHHHHHHHHHHHHcCCCCceEEEECCc----
Confidence            4445888899998753      257888887543211    11     11378888888864333 3556665433    


Q ss_pred             EEEeecCCCCHHHH-----------------HHHhC--CC--CCCHHHHHHHHHHH-----------------HHHHHHH
Q 011359          259 VITEYLSEGSLRAY-----------------LHKLE--HK--TLPLPKLIAIALDI-----------------ARGMEYI  300 (488)
Q Consensus       259 lV~E~~~ggsL~~~-----------------l~~~~--~~--~l~~~~~~~i~~qi-----------------~~~L~~L  300 (488)
                      .|.||+++.+|...                 +|...  ..  ...++.+..++.++                 ...+..|
T Consensus       110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L  189 (344)
T PLN02236        110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL  189 (344)
T ss_pred             eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence            57999987665311                 11111  00  11123333332111                 1112222


Q ss_pred             H--------HCCcccCCCCCCeEEEcC-CCcEEEeeeccc
Q 011359          301 H--------SQGVIHRDLKPENVLIDQ-EFHLKIADFGIA  331 (488)
Q Consensus       301 H--------~~giiHrDIkp~NILl~~-~~~vkl~DFgla  331 (488)
                      .        ...++|+|+++.||++++ ++.+.|+||..+
T Consensus       190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya  229 (344)
T PLN02236        190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYA  229 (344)
T ss_pred             HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence            1        225899999999999986 478999999877

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.07  E-value=0.061  Score=54.58  Aligned_cols=135  Identities=23%  Similarity=0.279  Sum_probs=81.6

Q ss_pred             eeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC------eeeEee----eeecCCe
Q 011359          187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN------VIKFVA----ACKKPPV  256 (488)
Q Consensus       187 lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~----~~~~~~~  256 (488)
                      |.. .-..+|+....+..+++|+.+.. ..         ..++.-|+..|..|.-..      |..+-|    .......
T Consensus        34 l~s-~eN~~f~~~~~~g~~iLki~~~~-~~---------~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r  102 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRYILKIYRPG-WT---------RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPR  102 (331)
T ss_pred             ccc-ccCceEEEEecCCCeEEEEecCC-CC---------HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCce
Confidence            344 56678998888878899999864 21         345667888888874211      222222    2222247


Q ss_pred             eeEEEeecCCCCHHH------------H---HHHh-CCC---------CCCHH----H---------HHHHHHHHHHHHH
Q 011359          257 YCVITEYLSEGSLRA------------Y---LHKL-EHK---------TLPLP----K---------LIAIALDIARGME  298 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~------------~---l~~~-~~~---------~l~~~----~---------~~~i~~qi~~~L~  298 (488)
                      ..-+++|++|..+..            +   ++.. +..         ...|.    .         -.....++...+.
T Consensus       103 ~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~  182 (331)
T COG2334         103 PAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALD  182 (331)
T ss_pred             eEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHH
Confidence            788999999977762            1   1110 000         11221    0         0112334444444


Q ss_pred             HHHH--------CC--cccCCCCCCeEEEcCCCc-EEEeeecccc
Q 011359          299 YIHS--------QG--VIHRDLKPENVLIDQEFH-LKIADFGIAC  332 (488)
Q Consensus       299 ~LH~--------~g--iiHrDIkp~NILl~~~~~-vkl~DFgla~  332 (488)
                      .+.+        .+  +||+|+.+.||+++.+.. +-++|||-++
T Consensus       183 ~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         183 RLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            4443        24  999999999999999885 8899999773

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.04  E-value=0.0091  Score=59.44  Aligned_cols=73  Identities=19%  Similarity=0.101  Sum_probs=47.7

Q ss_pred             cceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeeEeeeeecCCeeeEE
Q 011359          184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV  260 (488)
                      ...++-|....+|+....++.+.||+-....           ...|..|.+-|+.|.   --.|.+++++.......+||
T Consensus        22 ~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             EEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             eEecCCCChhheEEEECCCccEEEEecChhh-----------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            3567889999999988778999999987221           234678888888884   35577888888777777899


Q ss_pred             EeecCCC
Q 011359          261 TEYLSEG  267 (488)
Q Consensus       261 ~E~~~gg  267 (488)
                      +||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.81  E-value=0.043  Score=52.10  Aligned_cols=116  Identities=22%  Similarity=0.210  Sum_probs=73.5

Q ss_pred             eccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEEeecCCCCH
Q 011359          190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSL  269 (488)
Q Consensus       190 G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  269 (488)
                      |+-+++-.|..+=-+..+|.++.-.-.-+       .+-|..+..++.++.  .|+++..-  ..-.+.+|.|+|.... 
T Consensus        73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~-------~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGPLFLKKIRSLPCCIN-------DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-  140 (308)
T ss_pred             CCceEEEEeccccchhhhhhccCCCcccc-------hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-
Confidence            55666666654434566666653332211       234567788887764  46666532  4446789999994311 


Q ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          270 RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ--GVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       270 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                                -..    ..++..=+++|.-+|+.  +.+|||..|+||+-|..|.+||.|-+..
T Consensus       141 ----------i~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  141 ----------INF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ----------cch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence                      111    11222224667778844  7999999999999999999999998754

The function of this family is unknown.

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.47  E-value=0.031  Score=57.83  Aligned_cols=77  Identities=19%  Similarity=0.182  Sum_probs=47.4

Q ss_pred             cceeeeeccEEEEEEEEC--CccEEEEEEecCCC--ChhHHHHHHHHHHHHHHHHHHHhcC--CCC-eeeEeeeeecCCe
Q 011359          184 GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDD--DENETLAARLEKQFNREVALLSRLH--NPN-VIKFVAACKKPPV  256 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~--~~~~~~~~~~~~~~~~Ei~il~~l~--Hpn-Iv~l~~~~~~~~~  256 (488)
                      ...||.|.-..||++.+.  ++.|+||.-...-.  .++..    ...+..-|.++|+.+.  .|. +.++|.+  ++..
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL----~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKL----STNRIRIESDVLQLEEELAPGLVPKVYLF--DSVM  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCC----ChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHH
Confidence            357899999999999975  56899998542211  11111    1234456777777764  354 4445443  3444


Q ss_pred             eeEEEeecCC
Q 011359          257 YCVITEYLSE  266 (488)
Q Consensus       257 ~~lV~E~~~g  266 (488)
                      ..+|||+++.
T Consensus       108 ~~~vMEdL~~  117 (409)
T PRK12396        108 NCCVMEDLSD  117 (409)
T ss_pred             hhHHHHhCcc
Confidence            5688998854

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.21  E-value=0.11  Score=49.78  Aligned_cols=75  Identities=21%  Similarity=0.185  Sum_probs=55.8

Q ss_pred             ceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC---CCeeeEeeeeecCCeeeEEE
Q 011359          185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN---PNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~~~~~lV~  261 (488)
                      +.+.-|..-..|+..+...++-||+-..           .....|..|+.-|..|..   -.|.+++.+.....+.|+|+
T Consensus        22 ~~v~gG~inea~~v~dg~~~~FvK~n~~-----------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVl   90 (286)
T COG3001          22 EEVSGGDINEAWRLRDGTDPFFVKCNQR-----------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVL   90 (286)
T ss_pred             cccCCccccceeEeecCCcceEEEecch-----------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEE
Confidence            3445567777788777778999999642           224567788877777753   55778888888899999999


Q ss_pred             eecCCCCHH
Q 011359          262 EYLSEGSLR  270 (488)
Q Consensus       262 E~~~ggsL~  270 (488)
                      ||++-+.+.
T Consensus        91 e~L~~~~~d   99 (286)
T COG3001          91 EYLPTGPLD   99 (286)
T ss_pred             eeccCCCCC
Confidence            999876554

>PTZ00384 choline kinase; Provisional

Probab=95.21  E-value=0.25  Score=51.24  Aligned_cols=28  Identities=29%  Similarity=0.247  Sum_probs=23.7

Q ss_pred             CCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          303 QGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       303 ~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ...+|.|+-+.||+.+++ .+.++||..|
T Consensus       227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA  254 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFA  254 (383)
T ss_pred             eeeeeccCCcccEEecCC-CEEEEEeccc
Confidence            457999999999997654 6999999876

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.88  E-value=0.31  Score=49.36  Aligned_cols=71  Identities=15%  Similarity=0.098  Sum_probs=41.8

Q ss_pred             eeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC--Ceee---Eee--eeecCCeeeEE
Q 011359          189 HGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP--NVIK---FVA--ACKKPPVYCVI  260 (488)
Q Consensus       189 ~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~---l~~--~~~~~~~~~lV  260 (488)
                      .|.-..||+.... +..+++|+.+.....         ..++..|++.+..|...  .|+.   .-|  ....++..+.+
T Consensus        35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~~~---------~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l  105 (325)
T PRK11768         35 NSYENRVYQFGDEDGRRVVAKFYRPERWS---------DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFAL  105 (325)
T ss_pred             ccccceEEEEecCCCCEEEEEEcCcccCC---------HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEE
Confidence            3566788988775 567999988632211         23455677777766421  1222   112  12334567889


Q ss_pred             EeecCCCC
Q 011359          261 TEYLSEGS  268 (488)
Q Consensus       261 ~E~~~ggs  268 (488)
                      +++++|..
T Consensus       106 ~~~~~G~~  113 (325)
T PRK11768        106 FPRRGGRA  113 (325)
T ss_pred             EeeeCCCC
Confidence            99998753

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=94.33  E-value=0.45  Score=47.16  Aligned_cols=74  Identities=19%  Similarity=0.097  Sum_probs=45.3

Q ss_pred             eeeccEEEEEEEEC------C----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-------------CCCe
Q 011359          188 AHGAHSRLYHGIYK------D----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-------------NPNV  244 (488)
Q Consensus       188 G~G~~g~Vy~~~~~------~----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-------------HpnI  244 (488)
                      |.|-.|.+|+...+      +    ..++||... .+....  ...+....|.+|+.+...+-             ...+
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p-~~~~~~--~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~   78 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPP-TNPSRR--EFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFF   78 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCC-Cchhhh--hhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceee
Confidence            77888999987642      1    368889865 221111  11223466888888877651             1234


Q ss_pred             eeEeeeeecCCeeeEEEeec
Q 011359          245 IKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       245 v~l~~~~~~~~~~~lV~E~~  264 (488)
                      .+++.+..++...+||||-+
T Consensus        79 P~~~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   79 PKCYYADEDPGDEVLVLEDL   98 (294)
T ss_pred             ceEEEeccCCCceeeehhhh
Confidence            56666665555678899866

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PTZ00296 choline kinase; Provisional

Probab=94.28  E-value=0.41  Score=50.67  Aligned_cols=73  Identities=16%  Similarity=0.181  Sum_probs=44.0

Q ss_pred             cceeeeeccEEEEEEEEC----------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee-eEeeeee
Q 011359          184 GLRFAHGAHSRLYHGIYK----------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI-KFVAACK  252 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~----------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~  252 (488)
                      ...|..|-...+|+....          ++.|.|++.-.....    +.     .-..|..+++.+...+|- ++++.+.
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~----lI-----dR~~E~~v~~~ls~~gi~P~l~~~f~  180 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDE----LY-----NPISEFEVYKTMSKYRIAPQLLNTFS  180 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccc----ee-----CHHHHHHHHHHHHHCCCCCceEEEeC
Confidence            345666777788888754          357888887543211    11     123677787777644433 4555553


Q ss_pred             cCCeeeEEEeecCCCCH
Q 011359          253 KPPVYCVITEYLSEGSL  269 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL  269 (488)
                      .    +.|.||++|.+|
T Consensus       181 g----g~I~efi~g~~l  193 (442)
T PTZ00296        181 G----GRIEEWLYGDPL  193 (442)
T ss_pred             C----CEEEEeeCCccC
Confidence            2    367999988643

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.06  E-value=0.28  Score=48.34  Aligned_cols=28  Identities=32%  Similarity=0.432  Sum_probs=26.3

Q ss_pred             CcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          304 GVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       304 giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      -++|+|+.+.|+++++.+.++|+||..|
T Consensus       154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyA  181 (269)
T COG0510         154 VPCHNDLNPGNLLLTDKGGLFLIDWEYA  181 (269)
T ss_pred             eeecCCCCccceEEcCCCcEEEEecccC
Confidence            4899999999999999999999999877

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	488
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-43
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-42
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-39
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-36
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-36
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-35
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-35
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-35
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-35
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-35
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-35
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-35
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-35
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-34
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-34
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-34
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-34
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-34
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-33
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-33
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-33
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-33
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-33
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-33
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-33
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-33
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-32
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-32
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-32
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-32
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-32
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-32
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-32
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-32
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-32
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-32
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-32
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-32
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-32
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-32
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-32
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-32
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-32
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-32
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-32
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-32
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-32
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-32
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-32
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-32
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-32
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-32
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-32
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-32
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-32
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-32
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-32
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-32
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-31
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-31
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-31
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-31
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-31
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-31
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-31
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-31
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-31
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-31
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-31
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-31
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-31
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-31
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-31
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-31
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-31
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-31
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-31
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-31
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-31
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-31
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-31
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-31
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-31
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-31
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-31
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-31
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-31
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-31
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-31
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-31
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-31
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-30
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-30
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-30
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-30
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-30
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-30
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-30
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-30
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-30
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-30
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-30
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-30
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-30
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-30
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-30
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-30
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-30
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-30
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-30
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-30
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-30
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-30
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-30
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-29
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-29
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-29
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-29
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-29
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-29
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-29
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-29
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-29
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-29
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-29
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-29
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-29
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-29
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-29
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-29
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-29
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-29
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-29
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-29
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-29
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-29
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-29
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-29
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-29
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-29
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-29
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-29
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-29
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-28
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-28
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-28
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-28
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-28
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-28
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-28
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-28
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-28
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-28
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-28
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-28
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-28
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-28
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-28
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-28
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-28
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-27
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-27
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-27
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-27
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-27
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-27
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-27
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-27
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-27
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-27
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-27
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-27
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-26
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-26
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-26
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-26
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-26
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-26
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-26
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-26
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-26
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-26
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-26
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-26
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-26
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-26
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-26
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-26
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-26
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-26
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-25
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-25
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-25
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-25
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-25
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-25
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-25
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-25
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-25
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-25
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-25
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-25
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-25
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-25
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-25
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-25
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-25
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-25
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-25
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-25
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-25
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-25
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-25
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-25
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-25
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-25
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-25
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-25
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-25
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-25
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-25
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-25
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-25
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-24
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-24
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-24
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-24
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-24
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-24
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-24
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-24
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-24
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-24
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-24
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-24
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-24
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-24
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-24
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-24
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-24
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-24
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-24
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-24
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-24
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-24
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-24
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-24
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-24
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-24
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-24
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-24
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-24
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-24
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-24
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-24
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-24
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-24
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-24
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-24
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-24
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-24
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-24
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-24
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-24
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-24
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-24
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-24
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-24
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-24
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-24
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-24
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-23
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-23
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-23
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-23
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-23
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-23
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-23
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-23
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-23
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-23
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-23
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-23
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-23
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-23
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-23
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-23
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-23
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-23
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-23
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-23
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-23
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-23
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-23
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-23
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-23
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-23
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-23
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-23
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-23
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-23
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-23
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-23
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-23
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-23
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-23
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-23
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-23
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-23
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-23
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-23
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-23
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-22
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-22
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-22
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-22
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-22
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-22
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-22
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-22
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-22
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-22
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-22
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-22
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-22
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-22
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-22
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-22
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-22
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-22
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-22
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-22
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-22
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-22
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-22
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-22
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-22
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-22
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-21
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-21
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-21
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-21
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-21
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-21
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-21
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-21
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-21
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-21
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-21
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-21
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-21
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-21
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-21
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-21
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-21
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-21
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-20
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-20
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-20
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-20
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-20
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-20
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-20
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-20
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-20
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-20
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-20
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-20
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-20
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-20
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-20
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-20
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-20
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-20
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-20
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-20
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-20
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-20
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-20
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-20
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-20
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-20
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-20
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-19
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-19
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-19
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-19
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-19
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-19
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-19
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-19
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-19
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-19
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-19
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-19
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-19
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-19
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-19
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-19
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-19
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-19
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-19
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-19
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-19
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-19
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-19
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-19
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-19
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-19
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-19
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-19
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-19
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-19
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-19
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-19
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-19
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-19
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-19
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-19
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-19
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-19
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-19
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-19
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-19
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-19
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-19
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-19
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-19
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-19
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-19
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-19
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-19
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-19
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-18
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-18
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-18
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-18
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-18
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-18
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-18
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-18
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-18
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-18
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-18
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-18
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-18
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-18
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-18
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-18
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-18
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-18
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-18
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-18
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-18
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-18
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-18
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-18
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-18
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-18
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-18
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-18
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-18
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-18
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-18
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-18
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-18
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-18
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-18
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-18
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-18
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-18
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-18
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-18
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-18
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-18
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-18
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-18
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-18
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-18
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-18
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-18
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-18
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-18
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-18
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-18
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-18
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-18
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-18
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-18
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-18
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-18
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-18
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-18
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-18
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-18
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-17
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-17
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-17
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-17
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-17
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-17
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-17
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-17
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-17
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-17
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-17
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-17
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-17
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-17
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-17
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-17
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-17
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-17
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-17
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-17
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-17
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-17
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-17
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-17
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-16
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-16
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-16
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-16
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-16
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-16
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-16
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-16
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-16
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-16
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-16
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-16
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-16
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-16
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-16
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-16
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-16
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-16
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-16
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-16
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-16
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-16
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-16
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-16
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-16
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-16
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		9e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-15
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-15
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-15
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-15
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-15
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-15
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-15
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-15
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-15
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-15
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-15
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-15
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-15
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-15
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-15
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-15
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-15
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-15
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-15
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-15
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-15
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-15
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-15
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-15
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-15
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-15
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-15
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-15
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-15
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-15
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-14
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-14
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-14
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-14
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-14
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-14
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-14
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-14
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-14
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-14
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-14
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-13
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-13
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-12
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-12
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-12
3soa_A	444	Full-Length Human Camkii Length = 444		3e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-12
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-12
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		9e-12
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-11
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-11
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-11
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-11
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-10

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 98/271 (36%), Positives = 156/271 (57%), Gaps = 10/271 (3%)
Query: 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFN 230
            D+  +    L +  +   G+   ++   +    VAVKI+      E +  A R+  +F 
Sbjct: 29  GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILM-----EQDFHAERV-NEFL 82
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           REVA++ RL +PN++ F+ A  +PP   ++TEYLS GSL   LHK    + L   + +++
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 290 ALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GT 346
           A D+A+GM Y+H++   ++HRDLK  N+L+D+++ +K+ DFG++  +      S    GT
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
             WMAPE+++ +    K DVYSFG+ILWE+     P+  +NP Q   AV  K  R  IP 
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR 262
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +  P +AA+IE CW+ +P KRP F  I+ +L
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 156/271 (57%), Gaps = 10/271 (3%)
Query: 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFN 230
            D+  +    L +  +   G+   ++   +    VAVKI+      E +  A R+  +F 
Sbjct: 29  GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILM-----EQDFHAERV-NEFL 82
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           REVA++ RL +PN++ F+ A  +PP   ++TEYLS GSL   LHK    + L   + +++
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 290 ALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GT 346
           A D+A+GM Y+H++   ++HR+LK  N+L+D+++ +K+ DFG++  +      S    GT
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
             WMAPE+++ +    K DVYSFG+ILWE+     P+  +NP Q   AV  K  R  IP 
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR 262
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +  P +AA+IE CW+ +P KRP F  I+ +L
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 94/279 (33%), Positives = 143/279 (51%), Gaps = 24/279 (8%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIR-IPDDDENETLAARLEKQFNREVA 234
           +D ++L L      G   ++Y   +  + VAVK  R  PD+D ++T+     +   +E  
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTI-----ENVRQEAK 58
Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
           L + L +PN+I     C K P  C++ E+   G L      L  K +P   L+  A+ IA
Sbjct: 59  LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLN---RVLSGKRIPPDILVNWAVQIA 115
Query: 295 RGMEYIHSQGV---IHRDLKPENVLIDQEFH--------LKIADFGIACEEVYCDALSDD 343
           RGM Y+H + +   IHRDLK  N+LI Q+          LKI DFG+A E      +S  
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA- 174
Query: 344 PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
            G Y WMAPE+I+   + +  DV+S+G++LWE++ G +P+  ++ +  A+ V    L   
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
           IP  CP   A L+E CW+  P  RP F     +L+Q  T
Sbjct: 235 IPSTCPEPFAKLMEDCWNPDPHSRPSF---TNILDQLTT 270

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 152/286 (53%), Gaps = 19/286 (6%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
           D++D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------ 78
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  EV +L +  + N++ F+    KP +  ++T++    SL  +LH +E K   + KLI 
Sbjct: 79  FKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETK-FEMIKLID 136
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPG 345
           IA   A+GM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A E+             G
Sbjct: 137 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSG 196
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLR 401
           +  WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N   Q  F V    L 
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 256
Query: 402 P---AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
           P    +  +CP AM  L+ +C   + D+RP F  I+  +E    SL
Sbjct: 257 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 302

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  149 bits (375), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 152/286 (53%), Gaps = 19/286 (6%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
           D++D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      
Sbjct: 18  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------ 70
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  EV +L +  + N++ F+    KP +  ++T++    SL  +LH +E K   + KLI 
Sbjct: 71  FKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETK-FEMIKLID 128
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPG 345
           IA   A+GM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A E+             G
Sbjct: 129 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSG 188
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLR 401
           +  WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N   Q  F V    L 
Sbjct: 189 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 248
Query: 402 P---AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
           P    +  +CP AM  L+ +C   + D+RP F  I+  +E    SL
Sbjct: 249 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 294

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 152/287 (52%), Gaps = 19/287 (6%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
           D++D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      
Sbjct: 14  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------ 66
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  EV +L +  + N++ F+    KP +  ++T++    SL  +LH  E K   + KLI 
Sbjct: 67  FKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETK-FEMKKLID 124
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPG 345
           IA   ARGM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A E+             G
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK-NLR 401
           +  WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N       +V + +L 
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244
Query: 402 P---AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
           P    +  +CP  M  L+ +C   + D+RP F  I+  +E+    L+
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELS 291

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 151/286 (52%), Gaps = 19/286 (6%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
           D++D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      
Sbjct: 25  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------ 77
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  EV +L +  + N++ F+    KP +  ++T++    SL  +LH +E K   + KLI 
Sbjct: 78  FKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETK-FEMIKLID 135
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPG 345
           IA   A+GM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A  +             G
Sbjct: 136 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 195
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLR 401
           +  WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N   Q  F V    L 
Sbjct: 196 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 255
Query: 402 P---AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
           P    +  +CP AM  L+ +C   + D+RP F  I+  +E    SL
Sbjct: 256 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 301

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 151/286 (52%), Gaps = 19/286 (6%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
           D++D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------ 78
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  EV +L +  + N++ F+    KP +  ++T++    SL  +LH +E K   + KLI 
Sbjct: 79  FKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETK-FEMIKLID 136
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPG 345
           IA   A+GM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A  +             G
Sbjct: 137 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 196
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLR 401
           +  WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N   Q  F V    L 
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 256
Query: 402 P---AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
           P    +  +CP AM  L+ +C   + D+RP F  I+  +E    SL
Sbjct: 257 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 302

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 149/282 (52%), Gaps = 19/282 (6%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
           DAAD+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      
Sbjct: 14  DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------ 66
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  EV +L +  + N++ F+     P +  ++T++    SL  +LH  E K   + KLI 
Sbjct: 67  FKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETK-FEMKKLID 124
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPG 345
           IA   ARGM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A E+             G
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK-NLR 401
           +  WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N       +V + +L 
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244
Query: 402 P---AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           P    +  +CP  M  L+ +C   + D+RP F  I+  +E+ 
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  145 bits (366), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 151/286 (52%), Gaps = 19/286 (6%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
           D++D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      
Sbjct: 3   DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------ 55
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  EV +L +  + N++ F+    KP +  ++T++    SL  +LH +E K   + KLI 
Sbjct: 56  FKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETK-FEMIKLID 113
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPG 345
           IA   A+GM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A  +             G
Sbjct: 114 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLR 401
           +  WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N   Q  F V    L 
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 233
Query: 402 P---AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
           P    +  +CP AM  L+ +C   + D+RP F  I+  +E    SL
Sbjct: 234 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 279

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  145 bits (366), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 151/286 (52%), Gaps = 19/286 (6%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
           D++D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      
Sbjct: 3   DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------ 55
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  EV +L +  + N++ F+    KP +  ++T++    SL  +LH +E K   + KLI 
Sbjct: 56  FKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETK-FEMIKLID 113
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPG 345
           IA   A+GM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A  +             G
Sbjct: 114 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLR 401
           +  WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N   Q  F V    L 
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 233
Query: 402 P---AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
           P    +  +CP AM  L+ +C   + D+RP F  I+  +E    SL
Sbjct: 234 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 279

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 146/269 (54%), Gaps = 21/269 (7%)
Query: 186 RFAHGAHSRLYHG-IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
           +   G    ++ G + KD+ V      I  D E ET      ++F REV ++S L++PN+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI--ALDIARGMEYIHS 302
           +K       PP   ++ E++  G L    H+L  K  P+   + +   LDIA G+EY+ +
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 303 QG--VIHRDLKPENVLI-----DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
           Q   ++HRDL+  N+ +     +     K+ADFG++ + V+  ++S   G ++WMAPE I
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETI 198
Query: 356 --KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF--AVVNKNLRPAIPGDCPPA 411
             + +SY  K D YSF +IL+ ++ G  P++E +  +  F   +  + LRP IP DCPP 
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPR 258
Query: 412 MAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           +  +IE CWS  P KRP F +IVK L + 
Sbjct: 259 LRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 89/283 (31%), Positives = 149/283 (52%), Gaps = 19/283 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      F  
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------FKN 53
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           EV +L +  + N++ F+    KP +  ++T++    SL  +LH +E K   + KLI IA 
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIAR 111
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYR 348
             A+GM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A E+             G+  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 349 WMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLRP-- 402
           WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N   Q  F V    L P  
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231
Query: 403 -AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
             +  +CP AM  L+ +C   + D+RP F  I+  +E    SL
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 145/269 (53%), Gaps = 21/269 (7%)
Query: 186 RFAHGAHSRLYHG-IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
           +   G    ++ G + KD+ V      I  D E ET      ++F REV ++S L++PN+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI--ALDIARGMEYIHS 302
           +K       PP   ++ E++  G L    H+L  K  P+   + +   LDIA G+EY+ +
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 303 QG--VIHRDLKPENVLI-----DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
           Q   ++HRDL+  N+ +     +     K+ADFG + + V+  ++S   G ++WMAPE I
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH--SVSGLLGNFQWMAPETI 198
Query: 356 --KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF--AVVNKNLRPAIPGDCPPA 411
             + +SY  K D YSF +IL+ ++ G  P++E +  +  F   +  + LRP IP DCPP 
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPR 258
Query: 412 MAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           +  +IE CWS  P KRP F +IVK L + 
Sbjct: 259 LRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 151/287 (52%), Gaps = 19/287 (6%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
           D++D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      
Sbjct: 2   DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------ 54
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  EV +L +  + N++ F+    KP +  ++T++    SL  +LH  E K   + KLI 
Sbjct: 55  FKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETK-FEMKKLID 112
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPG 345
           IA   ARGM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A  +             G
Sbjct: 113 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSG 172
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK-NLR 401
           +  WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N       +V + +L 
Sbjct: 173 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 232
Query: 402 P---AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
           P    +  +CP  M  L+ +C   + D+RP F  I+  +E+    L+
Sbjct: 233 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELS 279

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 150/285 (52%), Gaps = 19/285 (6%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQF 229
           ++D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      F
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------F 53
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
             EV +L +  + N++ F+    KP +  ++T++    SL  +LH +E K   + KLI I
Sbjct: 54  KNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETK-FEMIKLIDI 111
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGT 346
           A   A+GM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A  +             G+
Sbjct: 112 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 171
Query: 347 YRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLRP 402
             WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N   Q  F V    L P
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 231
Query: 403 ---AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
               +  +CP AM  L+ +C   + D+RP F  I+  +E    SL
Sbjct: 232 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 276

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 145/269 (53%), Gaps = 21/269 (7%)
Query: 186 RFAHGAHSRLYHG-IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
           +   G    ++ G + KD+ V      I  D E ET      ++F REV ++S L++PN+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI--ALDIARGMEYIHS 302
           +K       PP   ++ E++  G L    H+L  K  P+   + +   LDIA G+EY+ +
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 303 QG--VIHRDLKPENVLI-----DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
           Q   ++HRDL+  N+ +     +     K+ADF ++ + V+  ++S   G ++WMAPE I
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH--SVSGLLGNFQWMAPETI 198
Query: 356 --KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF--AVVNKNLRPAIPGDCPPA 411
             + +SY  K D YSF +IL+ ++ G  P++E +  +  F   +  + LRP IP DCPP 
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPR 258
Query: 412 MAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           +  +IE CWS  P KRP F +IVK L + 
Sbjct: 259 LRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 148/283 (52%), Gaps = 19/283 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      F  
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------FKN 53
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           EV +L +  + N++ F+    KP +  ++T++    SL  +LH +E K   + KLI IA 
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIAR 111
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYR 348
             A+GM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A  +             G+  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 349 WMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLRP-- 402
           WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N   Q  F V    L P  
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231
Query: 403 -AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
             +  +CP AM  L+ +C   + D+RP F  I+  +E    SL
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 141/271 (52%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 56
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTFTAHAGAKFPIK 175
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++P Q  + ++ K+ R   P  
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEG 234
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/286 (32%), Positives = 147/286 (51%), Gaps = 21/286 (7%)
Query: 162 GVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENE 219
           GV ++     D+  ++   L LG +   G    ++ G  +  +  VAVK  R       E
Sbjct: 97  GVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-------E 149
Query: 220 TLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEH 278
           TL   L+ +F +E  +L +  +PN+++ +  C +K P+Y ++ E +  G    +L + E 
Sbjct: 150 TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFL-RTEG 207
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
             L +  L+ +  D A GMEY+ S+  IHRDL   N L+ ++  LKI+DFG++ EE   D
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA--D 265
Query: 339 ALSDDPGTYR-----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
            +    G  R     W APE + +  Y  + DV+SFG++LWE  + G  PY  ++  Q  
Sbjct: 266 GVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQT 324
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
              V K  R   P  CP A+  L+EQCW+ +P +RP F  I + L+
Sbjct: 325 REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 147/284 (51%), Gaps = 17/284 (5%)
Query: 162 GVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP--VAVKIIRIPDDDENE 219
           GV ++     D+  ++   L LG +   G    ++ G  + +   VAVK  R       E
Sbjct: 97  GVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-------E 149
Query: 220 TLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEH 278
           TL   L+ +F +E  +L +  +PN+++ +  C +K P+Y ++ E +  G    +L + E 
Sbjct: 150 TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFL-RTEG 207
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE---V 335
             L +  L+ +  D A GMEY+ S+  IHRDL   N L+ ++  LKI+DFG++ EE   V
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
Query: 336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFA 394
           Y  +        +W APE + +  Y  + DV+SFG++LWE  + G  PY  ++  Q    
Sbjct: 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTRE 326
Query: 395 VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
            V K  R   P  CP A+  L+EQCW+ +P +RP F  I + L+
Sbjct: 327 FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 147/283 (51%), Gaps = 19/283 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +  A      F  
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQA------FKN 53
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           EV +L +  + N++ F+     P +  ++T++    SL  +LH +E K   + KLI IA 
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIAR 111
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYR 348
             A+GM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A  +             G+  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 349 WMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLRP-- 402
           WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N   Q  F V    L P  
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231
Query: 403 -AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
             +  +CP AM  L+ +C   + D+RP F  I+  +E    SL
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 144/274 (52%), Gaps = 28/274 (10%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           H +D  ++ +      GA   +    ++ + VA+K I    + E+E       K F  E+
Sbjct: 4   HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI----ESESE------RKAFIVEL 53
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI---- 289
             LSR+++PN++K   AC  P   C++ EY   GSL   LH  E    PLP   A     
Sbjct: 54  RQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAE----PLPYYTAAHAMS 107
Query: 290 -ALDIARGMEYIHS---QGVIHRDLKPENVL-IDQEFHLKIADFGIACEEVYCDALSDDP 344
             L  ++G+ Y+HS   + +IHRDLKP N+L +     LKI DFG AC+      ++++ 
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNK 165
Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPA 403
           G+  WMAPE+ +  +Y  K DV+S+G+ILWE++    P++E+  P       V+   RP 
Sbjct: 166 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 225
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +  + P  + +L+ +CWS  P +RP    IVK++
Sbjct: 226 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 144/274 (52%), Gaps = 28/274 (10%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           H +D  ++ +      GA   +    ++ + VA+K I    + E+E       K F  E+
Sbjct: 3   HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI----ESESE------RKAFIVEL 52
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI---- 289
             LSR+++PN++K   AC  P   C++ EY   GSL   LH  E    PLP   A     
Sbjct: 53  RQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAE----PLPYYTAAHAMS 106
Query: 290 -ALDIARGMEYIHS---QGVIHRDLKPENVL-IDQEFHLKIADFGIACEEVYCDALSDDP 344
             L  ++G+ Y+HS   + +IHRDLKP N+L +     LKI DFG AC+      ++++ 
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNK 164
Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPA 403
           G+  WMAPE+ +  +Y  K DV+S+G+ILWE++    P++E+  P       V+   RP 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +  + P  + +L+ +CWS  P +RP    IVK++
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G    +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 4   DKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 56
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIK 175
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++P Q  + ++ K+ R   P  
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEG 234
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 146/283 (51%), Gaps = 15/283 (5%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 56
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +I E+++ G+L  YL +   + +    L+ +A 
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIK 175
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++P Q  + ++ K+ R   P  
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEG 234
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF--ETSLACNG 448
           CP  +  L+  CW   P  RP F  I +  E    E+S++  G
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEG 277

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 137/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-------GYTEKQRRDFLG 95
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TEY+  GSL ++L K + +   + +L+ +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLR 154
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG+A        L DDP       
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLA------RVLEDDPEAAYTTR 208
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 267
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 80/219 (36%), Positives = 119/219 (54%), Gaps = 7/219 (3%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  E  ++  L +  ++K  A   K P+Y +ITE++++GSL  +L   E    PLPKLI 
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
            +  IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A       
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAI 404
            +W APE I   S+  K DV+SFG++L E+V  G IPY  M NP       + +  R   
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRMPR 406
Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           P +CP  +  ++ +CW  +P++RP F +I  VL+ F T+
Sbjct: 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 137/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 31  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-------GYTEKQRRDFLG 83
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TEY+  GSL ++L K + +   + +L+ +  
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLR 142
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG++        L DDP       
Sbjct: 143 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTR 196
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 197 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 255
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 256 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 58
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 236
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 137/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 14  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-------YTEKQRRDFLG 66
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TEY+  GSL ++L K + +   + +L+ +  
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLR 125
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG++        L DDP       
Sbjct: 126 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTR 179
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 238
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 239 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 137/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-------GYTEKQRRDFLG 95
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TEY+  GSL ++L K + +   + +L+ +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLR 154
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG++        L DDP       
Sbjct: 155 GIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTR 208
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 267
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 63
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 123
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 182
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 241
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 137/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-------GYTEKQRRDFLG 95
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TEY+  GSL ++L K + +   + +L+ +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLR 154
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG++        L DDP       
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTR 208
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 267
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 137/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-------GYTEKQRRDFLG 95
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TEY+  GSL ++L K + +   + +L+ +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLR 154
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG++        L DDP       
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTR 208
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 267
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 137/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-------GYTEKQRRDFLG 95
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TEY+  GSL ++L K + +   + +L+ +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLR 154
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG++        L DDP       
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTR 208
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 267
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 137/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-------GYTEKQRRDFLG 95
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TEY+  GSL ++L K + +   + +L+ +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLR 154
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG++        L DDP       
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTR 208
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 267
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 92/275 (33%), Positives = 136/275 (49%), Gaps = 17/275 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIY-KDEPVAVKIIRIPDDDENETLAARLEKQFN 230
           D   +    L L  +   G    ++   Y K   VAVK ++ P     E   A       
Sbjct: 8   DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLA------- 59
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  ++  L +  ++K  A   K P+Y +ITE++++GSL  +L   E    PLPKLI  +
Sbjct: 60  -EANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 117
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 118 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I   S+  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 178 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRMPRPE 235
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE 441
           +CP  +  ++ +CW  +P++RP F +I  VL+ FE
Sbjct: 236 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFE 270

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 58
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 236
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 137/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 41  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-------GYTEKQRRDFLG 93
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TEY+  GSL ++L K + +   + +L+ +  
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLR 152
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG++        L DDP       
Sbjct: 153 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTR 206
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 207 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 265
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 266 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 136/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-------GYTEKQRRDFLG 95
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TEY+  GSL ++L K + +   + +L+ +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLR 154
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG+         L DDP       
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG------RVLEDDPEAAYTTR 208
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 267
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 146/287 (50%), Gaps = 26/287 (9%)
Query: 166 NAVDAADEH-----TVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENET 220
            +V A DE       +++ +L L      G    +  G Y+   VAVK I+      N+ 
Sbjct: 3   GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK------NDA 56
Query: 221 LAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKLEH 278
            A    + F  E +++++L + N+++ +     +K  +Y ++TEY+++GSL  YL     
Sbjct: 57  TA----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGR 111
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
             L    L+  +LD+   MEY+     +HRDL   NVL+ ++   K++DFG+  E     
Sbjct: 112 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---- 167
Query: 339 ALSDDPGTY--RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
           + + D G    +W APE ++ K +  K DV+SFG++LWE+ + G +PY  + P++     
Sbjct: 168 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPR 226
Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
           V K  +   P  CPPA+  +++ CW L    RP F  + + LE  +T
Sbjct: 227 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 265
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHR+L   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 384
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 443
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 63
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 182
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 241
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 60
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 179
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 238
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 60
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 179
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 238
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 59
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIK 178
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 237
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 19  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 71
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 72  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 131
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 132 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 190
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 249
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 250 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 280

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 58
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 236
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 63
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIK 182
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 241
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 63
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 182
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 241
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 62
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 122
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 181
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 240
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 58
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 236
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 60
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIK 179
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 238
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 252 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 304
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +A 
Sbjct: 305 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 364
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHR+L   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 365 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 423
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 482
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 483 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 134/262 (51%), Gaps = 15/262 (5%)
Query: 186 RFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
           R  +G    ++ G +  +  VA+K ++ P     E+        F  E  ++ +L +  +
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLK-PGTMSPES--------FLEEAQIMKKLKHDKL 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           ++  A   + P+Y ++TEY+++GSL  +L   E + L LP L+ +A  +A GM YI    
Sbjct: 67  VQLYAVVSEEPIY-IVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 125
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWMAPEMIKHKSYGR 362
            IHRDL+  N+L+      KIADFG+A   E+    A        +W APE   +  +  
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 363 KVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS 421
           K DV+SFG++L E+V  G +PY  MN  +     V +  R   P DCP ++  L+  CW 
Sbjct: 186 KSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHELMIHCWK 244
Query: 422 LQPDKRPEFWHIVKVLEQFETS 443
             P++RP F ++   LE + T+
Sbjct: 245 KDPEERPTFEYLQSFLEDYFTA 266

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  134 bits (338), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 141/273 (51%), Gaps = 21/273 (7%)
Query: 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
            +++ +L L      G    +  G Y+   VAVK I+      N+  A    + F  E +
Sbjct: 2   ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK------NDATA----QAFLAEAS 51
Query: 235 LLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           ++++L + N+++ +     +K  +Y ++TEY+++GSL  YL       L    L+  +LD
Sbjct: 52  VMTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 110
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY--RWM 350
           +   MEY+     +HRDL   NVL+ ++   K++DFG+  E     + + D G    +W 
Sbjct: 111 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWT 166
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           APE ++ K +  K DV+SFG++LWE+ + G +PY  + P++     V K  +   P  CP
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCP 225
Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
           PA+  +++ CW L    RP F  + + LE  +T
Sbjct: 226 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 258

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 145/290 (50%), Gaps = 26/290 (8%)
Query: 163 VRVNAVDAADEH-----TVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDE 217
           V    V A DE       +++ +L L      G    +  G Y+   VAVK I+      
Sbjct: 172 VMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK------ 225
Query: 218 NETLAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHK 275
           N+  A    + F  E +++++L + N+++ +     +K  +Y ++TEY+++GSL  YL  
Sbjct: 226 NDATA----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRS 280
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
                L    L+  +LD+   MEY+     +HRDL   NVL+ ++   K++DFG+  E  
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA- 339
Query: 336 YCDALSDDPGTY--RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
              + + D G    +W APE ++ K +  K DV+SFG++LWE+ + G +PY  + P++  
Sbjct: 340 ---SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDV 395
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
              V K  +   P  CPPA+  +++ CW L    RP F  + + LE   T
Sbjct: 396 VPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 139/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 58
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +I E+++ G+L  YL +   + +    L+ +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 236
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 139/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 58
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +I E+++ G+L  YL +   + +    L+ +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 236
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 136/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-------GYTEKQRRDFLG 95
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TE +  GSL ++L K + +   + +L+ +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-FTVIQLVGMLR 154
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG++        L DDP       
Sbjct: 155 GIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTR 208
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 267
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 149/286 (52%), Gaps = 19/286 (6%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
           D++    ++ S++ L  R   G+   +Y G +  + VAVKI+++ D    +  A      
Sbjct: 26  DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGD-VAVKILKVVDPTPEQFQA------ 78
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  EVA+L +  + N++ F+    K  +  ++T++    SL  +LH  E K   + +LI 
Sbjct: 79  FRNEVAVLRKTRHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLHVQETK-FQMFQLID 136
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPG 345
           IA   A+GM+Y+H++ +IHRD+K  N+ + +   +KI DFG+A  +        +    G
Sbjct: 137 IARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTG 196
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLR 401
           +  WMAPE+I+ +    +  + DVYS+G++L+E++ G +PY  +N   Q  F V      
Sbjct: 197 SVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS 256
Query: 402 PAIP---GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
           P +     +CP AM  L+  C     ++RP F  I+  +E  + SL
Sbjct: 257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 139/278 (50%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 308
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 486
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW  +P++RP F ++   LE + TS
Sbjct: 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 65
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 66  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 123
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 124 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 183
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 184 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 241
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 242 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 278

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 141/273 (51%), Gaps = 21/273 (7%)
Query: 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
            +++ +L L      G    +  G Y+   VAVK I+      N+  A    + F  E +
Sbjct: 8   ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK------NDATA----QAFLAEAS 57
Query: 235 LLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           ++++L + N+++ +     +K  +Y ++TEY+++GSL  YL       L    L+  +LD
Sbjct: 58  VMTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 116
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY--RWM 350
           +   MEY+     +HRDL   NVL+ ++   K++DFG+  E     + + D G    +W 
Sbjct: 117 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWT 172
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           APE ++  ++  K DV+SFG++LWE+ + G +PY  + P++     V K  +   P  CP
Sbjct: 173 APEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCP 231
Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
           PA+  +++ CW L    RP F  + + LE  +T
Sbjct: 232 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 264

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 136/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 14  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-------YTEKQRRDFLG 66
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TE +  GSL ++L K + +   + +L+ +  
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-FTVIQLVGMLR 125
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG++        L DDP       
Sbjct: 126 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTR 179
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 238
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 239 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 58
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 59  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 116
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 117 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 176
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 177 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 234
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 235 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 271

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 63
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 64  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 121
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 122 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 181
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 239
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 240 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 276

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 142/277 (51%), Gaps = 16/277 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQF 229
           + D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F
Sbjct: 23  SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKED----TMEV---EEF 75
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            +E A++  + +PN+++ +  C   P + ++TEY+  G+L  YL +   + +    L+ +
Sbjct: 76  LKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYM 135
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT--- 346
           A  I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G    
Sbjct: 136 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLS-RLMTGDTYTAHAGAKFP 194
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE + + ++  K DV++FG++LWE+   G  PY  ++ +   + ++ K  R   P
Sbjct: 195 IKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYDLLEKGYRMEQP 253
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
             CPP +  L+  CW   P  RP F    +  + FET
Sbjct: 254 EGCPPKVYELMRACWKWSPADRPSF---AETHQAFET 287

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 57
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 58  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 175
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 233
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 66
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 67  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 124
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 125 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 184
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 185 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 242
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 243 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 279

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 62
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 63  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 121 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 180
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 181 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 238
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 239 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 275

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 63
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 64  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 121
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 122 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 181
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 239
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 240 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 276

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/217 (36%), Positives = 118/217 (54%), Gaps = 13/217 (5%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  E  ++  L +  ++K  A   K P+Y +ITE++++GSL  +L   E    PLPKLI 
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLID 282
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348
            +  IA GM +I  +  IHRDL+  N+L+      KIADFG+A         +  P   +
Sbjct: 283 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA------RVGAKFP--IK 334
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I   S+  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 335 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRMPRPE 392
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  ++ +CW  +P++RP F +I  VL+ F T+
Sbjct: 393 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 429

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 57
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 58  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 175
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 233
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 57
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 58  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 233
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 139/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 59
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +I E+++ G+L  YL +   + +    L+ +A 
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIK 178
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 237
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 136/280 (48%), Gaps = 26/280 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     K+  VA+K +++           +  + F  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-------GYTEKQRRDFLG 95
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+      K     ++TE +  GSL ++L K + +   + +L+ +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-FTVIQLVGMLR 154
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM+Y+   G +HRDL   N+LI+     K++DFG++        L DDP       
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTR 208
Query: 347 -----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++  
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 267
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 59
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 60  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 117
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 118 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 178 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 235
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 236 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 272

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 67
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 68  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 125
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 126 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 185
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 186 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 243
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 244 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 280

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 139/271 (51%), Gaps = 13/271 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  ++ + + +  +   G +  +Y G++K   + V +  + +D    T+     ++F +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEV---EEFLK 63
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E A++  + +PN+++ +  C + P + +I E+++ G+L  YL +   + +    L+ +A 
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YR 348
            I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 182
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE + +  +  K DV++FG++LWE+   G  PY  ++ +   + ++ K+ R   P  
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEG 241
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           CP  +  L+  CW   P  RP F  I +  E
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 139/278 (50%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 225
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 403
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW  +P++RP F ++   LE + TS
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 52
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 53  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 110
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 111 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 170
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 171 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 228
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 229 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 265

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 139/278 (50%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 225
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 403
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW  +P++RP F ++   LE + TS
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 133/271 (49%), Gaps = 38/271 (14%)
Query: 190 GAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQ---FNREVALLSRLH 240
           G    +Y G+ K      + PVA+K ++          A   EKQ   F  E  ++ +  
Sbjct: 55  GEFGEVYKGMLKTSSGKKEVPVAIKTLK----------AGYTEKQRVDFLGEAGIMGQFS 104
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           + N+I+      K     +ITEY+  G+L  +L + + +   + +L+ +   IA GM+Y+
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYL 163
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTY---------RWM 350
            +   +HRDL   N+L++     K++DFG++        L DDP  TY         RW 
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLS------RVLEDDPEATYTTSGGKIPIRWT 217
Query: 351 APEMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           APE I ++ +    DV+SFG+++WE M  G  PY E++        +N   R   P DCP
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPMDCP 276
Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            A+  L+ QCW  +  +RP+F  IV +L++ 
Sbjct: 277 SAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 139/278 (50%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 2   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 52
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 53  FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVD 111
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 112 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 171
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 172 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 230
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW  +P++RP F ++   LE + TS
Sbjct: 231 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 268

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  131 bits (330), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 134/277 (48%), Gaps = 17/277 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           D   V    L L  R   G    ++ G Y     VAVK ++      +  LA        
Sbjct: 6   DAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-------- 57
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 58  -EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK 175
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPG 406
           W APE I + ++  K DV+SFG++L E+V  G IPY  M NP       + +  R   P 
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPD 233
Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 41/287 (14%)
Query: 187 FAHGAHSRLYH----GIYKDEP---VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
              GA  R++     G+   EP   VAVK+++       E  +A ++  F RE AL++  
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-------EEASADMQADFQREAALMAEF 107
Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT------------------- 280
            NPN++K +  C      C++ EY++ G L  +L  +   T                   
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 281 ---LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEE 334
              L   + + IA  +A GM Y+  +  +HRDL   N L+ +   +KIADFG++      
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF 393
            Y  A  +D    RWM PE I +  Y  + DV+++G++LWE+ + G  PY  M   +  +
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 287
Query: 394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            V + N+  A P +CP  +  L+  CWS  P  RP F  I ++L++ 
Sbjct: 288 YVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 138/278 (49%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P +   E         
Sbjct: 176 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGNMSPEA-------- 226
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 227 FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 285
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+    E+    A       
Sbjct: 286 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFP 345
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 346 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 404
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW   P++RP F ++   LE + TS
Sbjct: 405 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 442

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 26/265 (9%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
           F      RL     ++ PVA+K +++           +  + F  E +++ +  +PN+I 
Sbjct: 35  FGEVCSGRLKLPGKRELPVAIKTLKV-------GYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                 K     ++TEY+  GSL  +L K + +   + +L+ +   I+ GM+Y+   G +
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ-FTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----------YRWMAPEMIK 356
           HRDL   N+LI+     K++DFG++        L DDP             RW APE I 
Sbjct: 147 HRDLAARNILINSNLVCKVSDFGLS------RVLEDDPEAAYTTRGGKIPIRWTAPEAIA 200
Query: 357 HKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
            + +    DV+S+G+++WE+V+ G  PY EM   Q     V +  R   P DCP A+  L
Sbjct: 201 FRKFTSASDVWSYGIVMWEVVSYGERPYWEMTN-QDVIKAVEEGYRLPSPMDCPAALYQL 259
Query: 416 IEQCWSLQPDKRPEFWHIVKVLEQF 440
           +  CW  + + RP+F  IV +L++ 
Sbjct: 260 MLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 147/303 (48%), Gaps = 34/303 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     GA  ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI EY S+G+LR YL              ++
Sbjct: 92  --EMMKMIGKHK-NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINR 148
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A +  
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 336 YCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
             D            +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLN 451
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T       L+
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327
Query: 452 LVQ 454
           L Q
Sbjct: 328 LSQ 330

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 138/278 (49%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 59
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 237
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW   P++RP F ++   LE + TS
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 147/303 (48%), Gaps = 34/303 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     GA  ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI EY S+G+LR YL              ++
Sbjct: 92  --EMMKMIGKHK-NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A +  
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 336 YCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
             D            +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLN 451
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T       L+
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327
Query: 452 LVQ 454
           L Q
Sbjct: 328 LSQ 330

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 138/278 (49%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 225
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++ EY+S+GSL  +L     K L LP+L+ 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVGEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 403
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW  +P++RP F ++   LE + TS
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 120/236 (50%), Gaps = 17/236 (7%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK 285
           ++ F +EV ++  L +PNV+KF+    K      ITEY+  G+LR  +  ++ +  P  +
Sbjct: 51  QRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQ 109
Query: 286 LIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALS 341
            ++ A DIA GM Y+HS  +IHRDL   N L+ +  ++ +ADFG+A     E+   + L 
Sbjct: 110 RVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
Query: 342 DDP-----------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
                         G   WMAPEMI  +SY  KVDV+SFG++L E++       +  P  
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 391 AAFAV-VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
             F + V   L    P +CPP+   +  +C  L P+KRP F  +   LE     LA
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 139/278 (50%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 6   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 56
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+++GSL  +L     K L LP+L+ 
Sbjct: 57  FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVD 115
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           ++  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 116 MSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFP 175
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 234
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW  +P++RP F ++   LE + TS
Sbjct: 235 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 272

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 139/278 (50%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 6   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 56
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+++GSL  +L     K L LP+L+ 
Sbjct: 57  FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVD 115
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           ++  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 116 MSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 175
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 234
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW  +P++RP F ++   LE + TS
Sbjct: 235 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 272

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 138/278 (49%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 59
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ ++ +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 60  FLQEAQVMKKIRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 237
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW   P++RP F ++   LE + TS
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 144/291 (49%), Gaps = 34/291 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     GA  ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI EY S+G+LR YL              ++
Sbjct: 92  --EMMKMIGKHK-NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A +  
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 336 YCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
             D   +        +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 146/292 (50%), Gaps = 36/292 (12%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     GA  ++      GI KD+P     VAVK+++  DD   E L+       
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEEDLS-----DL 87
Query: 230 NREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------H 274
             E+ ++  +  + N+I  + AC +     VI EY S+G+LR YL              +
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 275 KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334
           ++  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A + 
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 335 V---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390
               Y    ++     +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVE 266
Query: 391 AAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
             F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 137/278 (49%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 59
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL   N+L+ +    K+ADFG+A   E+    A       
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 237
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW   P++RP F ++   LE + TS
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 137/278 (49%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 59
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y VI EY+S+GSL  +L     K L LP+L+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP 178
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 237
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW   P++RP F ++   LE + TS
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 186 RFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
           R   G    ++ G Y     VAVK ++      +  LA         E  L+ +L +  +
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA---------EANLMKQLQHQRL 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           ++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A  IA GM +I  + 
Sbjct: 67  VRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 125
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWMAPEMIKHKSYGR 362
            IHR+L+  N+L+      KIADFG+A   E+    A        +W APE I + ++  
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 185
Query: 363 KVDVYSFGLILWEMVA-GTIPYEEM-NPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
           K DV+SFG++L E+V  G IPY  M NP       + +  R   P +CP  +  L+  CW
Sbjct: 186 KSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPDNCPEELYQLMRLCW 243
Query: 421 SLQPDKRPEFWHIVKVLEQFETS 443
             +P+ RP F ++  VLE F T+
Sbjct: 244 KERPEDRPTFDYLRSVLEDFFTA 266

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 120/249 (48%), Gaps = 26/249 (10%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           +D PVA+K ++            R  + F  E +++ +  +PN+I+      +  +  ++
Sbjct: 76  RDVPVAIKALK-------AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           TEY+  GSL  +L +       + +L+ +   +  GM Y+   G +HRDL   NVL+D  
Sbjct: 129 TEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN 187
Query: 321 FHLKIADFGIACEEVYCDALSDDPGT----------YRWMAPEMIKHKSYGRKVDVYSFG 370
              K++DFG++        L DDP             RW APE I  +++    DV+SFG
Sbjct: 188 LVCKVSDFGLS------RVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFG 241
Query: 371 LILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
           +++WE++A G  PY  M   +   + V +  R   P  CP A+  L+  CW     +RP 
Sbjct: 242 VVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPR 300
Query: 430 FWHIVKVLE 438
           F  IV VL+
Sbjct: 301 FSQIVSVLD 309

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 120/249 (48%), Gaps = 26/249 (10%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           +D PVA+K ++            R  + F  E +++ +  +PN+I+      +  +  ++
Sbjct: 76  RDVPVAIKALK-------AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           TEY+  GSL  +L +       + +L+ +   +  GM Y+   G +HRDL   NVL+D  
Sbjct: 129 TEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN 187
Query: 321 FHLKIADFGIACEEVYCDALSDDPGT----------YRWMAPEMIKHKSYGRKVDVYSFG 370
              K++DFG++        L DDP             RW APE I  +++    DV+SFG
Sbjct: 188 LVCKVSDFGLS------RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFG 241
Query: 371 LILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
           +++WE++A G  PY  M   +   + V +  R   P  CP A+  L+  CW     +RP 
Sbjct: 242 VVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPR 300
Query: 430 FWHIVKVLE 438
           F  IV VL+
Sbjct: 301 FSQIVSVLD 309

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 137/276 (49%), Gaps = 15/276 (5%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           D   +    L L ++   G    ++ G +     VA+K ++ P     E         F 
Sbjct: 2   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA--------FL 52
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E  ++ +L +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ +A
Sbjct: 53  QEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA 111
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A        +
Sbjct: 112 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 171
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P +
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPE 230
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           CP ++  L+ QCW   P++RP F ++   LE + TS
Sbjct: 231 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 266

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 137/278 (49%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 59
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y VI EY+S+GSL  +L     K L LP+L+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 237
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW   P++RP F ++   LE + TS
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 137/278 (49%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 59
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+S+G L  +L     K L LP+L+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGCLLDFLKGEMGKYLRLPQLVD 118
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 237
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW   P++RP F ++   LE + TS
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 135/267 (50%), Gaps = 15/267 (5%)
Query: 181 LFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
           L L ++   G    ++ G +     VA+K ++ P     E         F +E  ++ +L
Sbjct: 9   LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA--------FLQEAQVMKKL 59
Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
            +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ +A  IA GM Y
Sbjct: 60  RHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 118
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWMAPEMIKH 357
           +     +HRDL+  N+L+ +    K+ADFG+A   E+    A        +W APE   +
Sbjct: 119 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 178
Query: 358 KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
             +  K DV+SFG++L E+   G +PY  M   +     V +  R   P +CP ++  L+
Sbjct: 179 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLHDLM 237
Query: 417 EQCWSLQPDKRPEFWHIVKVLEQFETS 443
            QCW   P++RP F ++   LE + TS
Sbjct: 238 CQCWRKDPEERPTFEYLQAFLEDYFTS 264

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 137/278 (49%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 59
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++ EY+S+GSL  +L     K L LP+L+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVCEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 237
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW   P++RP F ++   LE + TS
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 145/291 (49%), Gaps = 34/291 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     GA  ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI EY S+G+LR YL              ++
Sbjct: 92  --EMMKMIGKHK-NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A +  
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 336 ---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
              Y    ++     +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  128 bits (321), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 145/291 (49%), Gaps = 34/291 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     GA  ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI EY S+G+LR YL              ++
Sbjct: 92  --EMMKMIGKHK-NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A +  
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 336 ---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
              Y    ++     +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 137/276 (49%), Gaps = 15/276 (5%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFN 230
           D   +    L L ++   G    ++ G +     VA+K ++ P     E         F 
Sbjct: 1   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA--------FL 51
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E  ++ +L +  +++  A   + P+  ++TEY+S+GSL  +L     K L LP+L+ +A
Sbjct: 52  QEAQVMKKLRHEKLVQLYAVVSEEPIX-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 110
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A        +
Sbjct: 111 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK 170
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P +
Sbjct: 171 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPE 229
Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           CP ++  L+ QCW  +P++RP F ++   LE + TS
Sbjct: 230 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 265

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 145/291 (49%), Gaps = 34/291 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     GA  ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI EY S+G+LR YL              ++
Sbjct: 92  --EMMKMIGKHK-NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   ++IADFG+A +  
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDIN 208
Query: 336 ---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
              Y    ++     +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 144/291 (49%), Gaps = 34/291 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     G   ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 137
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI EY S+G+LR YL              ++
Sbjct: 138 --EMMKMIGKHK-NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A +  
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 336 ---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
              Y    ++     +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 313
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T
Sbjct: 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 16/263 (6%)
Query: 186 RFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
           R   G    ++ G Y +   VAVK ++        T++    + F  E  L+  L +  +
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLK------PGTMSV---QAFLEEANLMKTLQHDKL 70
Query: 245 IKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++  A   ++ P+Y +ITEY+++GSL  +L   E   + LPKLI  +  IA GM YI  +
Sbjct: 71  VRLYAVVTREEPIY-IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 129
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWMAPEMIKHKSYG 361
             IHRDL+  NVL+ +    KIADFG+A   E+    A        +W APE I    + 
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 362 RKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
            K DV+SFG++L+E+V  G IPY          A+      P +  +CP  +  +++ CW
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVE-NCPDELYDIMKMCW 248
Query: 421 SLQPDKRPEFWHIVKVLEQFETS 443
             + ++RP F ++  VL+ F T+
Sbjct: 249 KEKAEERPTFDYLQSVLDDFYTA 271

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 144/291 (49%), Gaps = 34/291 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     G   ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 78
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI EY S+G+LR YL              ++
Sbjct: 79  --EMMKMIGKHK-NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 135
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A +  
Sbjct: 136 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDIN 195
Query: 336 ---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
              Y    ++     +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 254
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T
Sbjct: 255 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 305

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 144/291 (49%), Gaps = 34/291 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     G   ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 83
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI EY S+G+LR YL              ++
Sbjct: 84  --EMMKMIGKHK-NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 140
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A +  
Sbjct: 141 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 200
Query: 336 ---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
              Y    ++     +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 201 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 259
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T
Sbjct: 260 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 310

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 144/291 (49%), Gaps = 34/291 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     G   ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 80
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI EY S+G+LR YL              ++
Sbjct: 81  --EMMKMIGKHK-NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 137
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A +  
Sbjct: 138 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 197
Query: 336 ---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
              Y    ++     +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 256
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T
Sbjct: 257 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 307

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 136/278 (48%), Gaps = 15/278 (5%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++ P     E         
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-------- 59
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++ EY+S+G L  +L     K L LP+L+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVMEYMSKGCLLDFLKGEMGKYLRLPQLVD 118
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 237
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW   P++RP F ++   LE + TS
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 144/291 (49%), Gaps = 34/291 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     GA  ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI  Y S+G+LR YL              ++
Sbjct: 92  --EMMKMIGKHK-NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A +  
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 336 ---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
              Y    ++     +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 144/291 (49%), Gaps = 34/291 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     GA  ++      GI KD+P     VAVK+++   DD  E   + L  + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------------HK 275
             E+  +   H  N+I  + AC +     VI  Y S+G+LR YL              ++
Sbjct: 92  --EMMKMIGKHK-NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
           +  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A +  
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 336 ---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
              Y    ++     +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++  T
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 29/288 (10%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVKIIRIPDDDENETLAAR 224
           DE  V   ++ +      G+   +Y G+     KDEP   VA+K +       NE  + R
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMR 57
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP 282
              +F  E +++   +  +V++ +    +     VI E ++ G L++YL  L  E +  P
Sbjct: 58  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 117
Query: 283 ------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
                 L K+I +A +IA GM Y+++   +HRDL   N ++ ++F +KI DFG+   ++Y
Sbjct: 118 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT-RDIY 176
Query: 337 CDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
                   G      RWM+PE +K   +    DV+SFG++LWE+      PY+ ++  Q 
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 236
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
              V+   L    P +CP  +  L+  CW   P  RP F  I+  +++
Sbjct: 237 LRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 136/287 (47%), Gaps = 27/287 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVKIIRIPDDDENETLAAR 224
           DE  V   ++ +      G+   +Y G+     KDEP   VA+K +       NE  + R
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMR 55
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP 282
              +F  E +++   +  +V++ +    +     VI E ++ G L++YL  L  E +  P
Sbjct: 56  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 115
Query: 283 ------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
                 L K+I +A +IA GM Y+++   +HRDL   N ++ ++F +KI DFG+  +   
Sbjct: 116 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 175
Query: 337 CDALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
            D            RWM+PE +K   +    DV+SFG++LWE+      PY+ ++  Q  
Sbjct: 176 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 235
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
             V+   L    P +CP  +  L+  CW   P  RP F  I+  +++
Sbjct: 236 RFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 281

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 140/299 (46%), Gaps = 29/299 (9%)
Query: 161 GGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVKIIRIP 213
           G      V   DE  V   ++ +      G+   +Y G+     KDEP   VA+K +   
Sbjct: 1   GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--- 57
Query: 214 DDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL 273
               NE  + R   +F  E +++   +  +V++ +    +     VI E ++ G L++YL
Sbjct: 58  ----NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 113
Query: 274 HKL--EHKTLP------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
             L  E +  P      L K+I +A +IA GM Y+++   +HRDL   N ++ ++F +KI
Sbjct: 114 RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 173
Query: 326 ADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
            DFG+   ++Y        G      RWM+PE +K   +    DV+SFG++LWE+     
Sbjct: 174 GDFGMT-RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 232
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            PY+ ++  Q    V+   L    P +CP  +  L+  CW   P  RP F  I+  +++
Sbjct: 233 QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 141/288 (48%), Gaps = 34/288 (11%)
Query: 180 QLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFN 230
           +L LG     GA  ++      G+ KD+P     VAVK+++  D  E +      E +  
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMM 87
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE------------- 277
           + +       + N+I  + AC +     VI EY S+G+LR YL   E             
Sbjct: 88  KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHN 142
Query: 278 -HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
             + L    L++ A  +ARGMEY+ S+  IHRDL   NVL+ ++  +KIADFG+A +  +
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 337 CDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
            D            +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  + P++  
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL 261
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++ 
Sbjct: 262 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 19/225 (8%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           + F  E +++ +  +PN+I       K     +ITEY+  GSL A+L K + +   + +L
Sbjct: 75  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQL 133
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT 346
           + +   I  GM+Y+     +HRDL   N+L++     K++DFG++        L DDP  
Sbjct: 134 VGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMS------RVLEDDPEA 187
Query: 347 ----------YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
                      RW APE I ++ +    DV+S+G+++WE+++ G  PY +M+  Q     
Sbjct: 188 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKA 246
Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           + +  R   P DCP A+  L+  CW  +   RP+F  IV +L++ 
Sbjct: 247 IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 291

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  125 bits (315), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 29/288 (10%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVKIIRIPDDDENETLAAR 224
           DE  V   ++ +      G+   +Y G+     KDEP   VA+K +       NE  + R
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMR 61
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP 282
              +F  E +++   +  +V++ +    +     VI E ++ G L++YL  L  E +  P
Sbjct: 62  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 121
Query: 283 ------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
                 L K+I +A +IA GM Y+++   +HRDL   N ++ ++F +KI DFG+   ++Y
Sbjct: 122 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT-RDIY 180
Query: 337 CDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
                   G      RWM+PE +K   +    DV+SFG++LWE+      PY+ ++  Q 
Sbjct: 181 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 240
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
              V+   L    P +CP  +  L+  CW   P  RP F  I+  +++
Sbjct: 241 LRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 287

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  125 bits (315), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 136/287 (47%), Gaps = 27/287 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVKIIRIPDDDENETLAAR 224
           DE  V   ++ +      G+   +Y G+     KDEP   VA+K +       NE  + R
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMR 64
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP 282
              +F  E +++   +  +V++ +    +     VI E ++ G L++YL  L  E +  P
Sbjct: 65  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 124
Query: 283 ------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
                 L K+I +A +IA GM Y+++   +HRDL   N ++ ++F +KI DFG+  +   
Sbjct: 125 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 337 CDALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
            D            RWM+PE +K   +    DV+SFG++LWE+      PY+ ++  Q  
Sbjct: 185 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 244
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
             V+   L    P +CP  +  L+  CW   P  RP F  I+  +++
Sbjct: 245 RFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  125 bits (315), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 142/297 (47%), Gaps = 31/297 (10%)
Query: 165 VNAVDA--ADEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVKIIRIPDD 215
           V+A D    DE  V   ++ +      G+   +Y G+     KDEP   VA+K +     
Sbjct: 2   VSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----- 56
Query: 216 DENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK 275
             NE  + R   +F  E +++   +  +V++ +    +     VI E ++ G L++YL  
Sbjct: 57  --NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 114
Query: 276 L--EHKTLP------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327
           L  E +  P      L K+I +A +IA GM Y+++   +HRDL   N ++ ++F +KI D
Sbjct: 115 LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 174
Query: 328 FGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP 382
           FG+   ++Y        G      RWM+PE +K   +    DV+SFG++LWE+      P
Sbjct: 175 FGMT-RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 233
Query: 383 YEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
           Y+ ++  Q    V+   L    P +CP  +  L+  CW   P  RP F  I+  +++
Sbjct: 234 YQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 143/304 (47%), Gaps = 34/304 (11%)
Query: 156 KYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVK 208
           +YF    V V      DE  V   ++ +      G+   +Y G+     KDEP   VA+K
Sbjct: 29  EYFSAADVYV-----PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 83
Query: 209 IIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGS 268
            +       NE  + R   +F  E +++   +  +V++ +    +     VI E ++ G 
Sbjct: 84  TV-------NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 136
Query: 269 LRAYLHKL--EHKTLP------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           L++YL  L  E +  P      L K+I +A +IA GM Y+++   +HRDL   N ++ ++
Sbjct: 137 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 196
Query: 321 FHLKIADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           F +KI DFG+   ++Y        G      RWM+PE +K   +    DV+SFG++LWE+
Sbjct: 197 FTVKIGDFGMT-RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255
Query: 377 VA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
                 PY+ ++  Q    V+   L    P +CP  +  L+  CW   P  RP F  I+ 
Sbjct: 256 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 314
Query: 436 VLEQ 439
            +++
Sbjct: 315 SIKE 318

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 142/297 (47%), Gaps = 31/297 (10%)
Query: 165 VNAVDA--ADEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVKIIRIPDD 215
           V+A D    DE  V   ++ +      G+   +Y G+     KDEP   VA+K +     
Sbjct: 2   VSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----- 56
Query: 216 DENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK 275
             NE  + R   +F  E +++   +  +V++ +    +     VI E ++ G L++YL  
Sbjct: 57  --NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 114
Query: 276 L--EHKTLP------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327
           L  E +  P      L K+I +A +IA GM Y+++   +HRDL   N ++ ++F +KI D
Sbjct: 115 LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 174
Query: 328 FGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP 382
           FG+   ++Y        G      RWM+PE +K   +    DV+SFG++LWE+      P
Sbjct: 175 FGMT-RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 233
Query: 383 YEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
           Y+ ++  Q    V+   L    P +CP  +  L+  CW   P  RP F  I+  +++
Sbjct: 234 YQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 143/304 (47%), Gaps = 34/304 (11%)
Query: 156 KYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVK 208
           +YF    V V      DE  V   ++ +      G+   +Y G+     KDEP   VA+K
Sbjct: 7   EYFSAADVYV-----PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 61
Query: 209 IIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGS 268
            +       NE  + R   +F  E +++   +  +V++ +    +     VI E ++ G 
Sbjct: 62  TV-------NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 114
Query: 269 LRAYLHKL--EHKTLP------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           L++YL  L  E +  P      L K+I +A +IA GM Y+++   +HRDL   N ++ ++
Sbjct: 115 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174
Query: 321 FHLKIADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           F +KI DFG+   ++Y        G      RWM+PE +K   +    DV+SFG++LWE+
Sbjct: 175 FTVKIGDFGMT-RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233
Query: 377 VA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
                 PY+ ++  Q    V+   L    P +CP  +  L+  CW   P  RP F  I+ 
Sbjct: 234 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292
Query: 436 VLEQ 439
            +++
Sbjct: 293 SIKE 296

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 19/225 (8%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           + F  E +++ +  +PN+I       K     +ITEY+  GSL A+L K + +   + +L
Sbjct: 60  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQL 118
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT 346
           + +   I  GM+Y+     +HRDL   N+L++     K++DFG++        L DDP  
Sbjct: 119 VGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMS------RVLEDDPEA 172
Query: 347 ----------YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
                      RW APE I ++ +    DV+S+G+++WE+++ G  PY +M+  Q     
Sbjct: 173 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKA 231
Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           + +  R   P DCP A+  L+  CW  +   RP+F  IV +L++ 
Sbjct: 232 IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  125 bits (314), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 19/225 (8%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           + F  E +++ +  +PN+I       K     +ITEY+  GSL A+L K + +   + +L
Sbjct: 54  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQL 112
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT 346
           + +   I  GM+Y+     +HRDL   N+L++     K++DFG++        L DDP  
Sbjct: 113 VGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMS------RVLEDDPEA 166
Query: 347 ----------YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
                      RW APE I ++ +    DV+S+G+++WE+++ G  PY +M+  Q     
Sbjct: 167 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKA 225
Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           + +  R   P DCP A+  L+  CW  +   RP+F  IV +L++ 
Sbjct: 226 IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  125 bits (313), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 180 QLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFN 230
           +L LG     GA  ++      G+ KD+P     VAVK+++  D  E +      E +  
Sbjct: 18  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMM 76
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEH------- 278
           + +       + N+I  + AC +     VI EY S+G+LR YL       LE+       
Sbjct: 77  KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 131
Query: 279 --KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
             + L    L++ A  +ARGMEY+ S+  IHRDL   NVL+ ++  +KIADFG+A +  +
Sbjct: 132 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 191
Query: 337 CDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
            D            +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  + P++  
Sbjct: 192 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL 250
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++ 
Sbjct: 251 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  125 bits (313), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 180 QLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFN 230
           +L LG     GA  ++      G+ KD+P     VAVK+++  D  E +      E +  
Sbjct: 70  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMM 128
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEH------- 278
           + +       + N+I  + AC +     VI EY S+G+LR YL       LE+       
Sbjct: 129 KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 279 --KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
             + L    L++ A  +ARGMEY+ S+  IHRDL   NVL+ ++  +KIADFG+A +  +
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243
Query: 337 CDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
            D            +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  + P++  
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL 302
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++ 
Sbjct: 303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  125 bits (313), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 180 QLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFN 230
           +L LG     GA  ++      G+ KD+P     VAVK+++  D  E +      E +  
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMM 87
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEH------- 278
           + +       + N+I  + AC +     VI EY S+G+LR YL       LE+       
Sbjct: 88  KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 142
Query: 279 --KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
             + L    L++ A  +ARGMEY+ S+  IHRDL   NVL+ ++  +KIADFG+A +  +
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 337 CDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
            D            +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  + P++  
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL 261
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++ 
Sbjct: 262 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 146/300 (48%), Gaps = 34/300 (11%)
Query: 180 QLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFN 230
           +L LG     GA  ++      G+ KD+P     VAVK+++  D  E +      E +  
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMM 87
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LE-------- 277
           + +       + N+I  + AC +     VI EY S+G+LR YL       LE        
Sbjct: 88  KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHN 142
Query: 278 -HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
             + L    L++ A  +ARGMEY+ S+  IHRDL   NVL+ ++  +KIADFG+A +  +
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 337 CDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
            D            +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  + P++  
Sbjct: 203 IDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL 261
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNL 452
           F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++     +    L+L
Sbjct: 262 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEXLDL 321

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 143/289 (49%), Gaps = 34/289 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     GA  ++      G+ KD+P     VAVK+++  D  E +      E + 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEM 71
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEH------ 278
            + +       + N+I  + AC +     VI EY S+G+LR YL       LE+      
Sbjct: 72  MKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 126
Query: 279 ---KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
              + L    L++ A  +ARGMEY+ S+  IHRDL   NVL+ ++  +KIADFG+A +  
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 336 YCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
           + D            +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  + P++ 
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 245
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++ 
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 180 QLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFN 230
           +L LG     GA  ++      G+ KD+P     VAVK+++  D  E +      E +  
Sbjct: 22  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMM 80
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEH------- 278
           + +       + N+I  + AC +     VI EY S+G+LR YL       LE+       
Sbjct: 81  KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 135
Query: 279 --KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
             + L    L++ A  +ARGMEY+ S+  IHRDL   NVL+ ++  +KIADFG+A +  +
Sbjct: 136 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 195
Query: 337 CDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
            D            +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  + P++  
Sbjct: 196 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL 254
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++ 
Sbjct: 255 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 180 QLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFN 230
           +L LG     GA  ++      G+ KD+P     VAVK+++  D  E +      E +  
Sbjct: 21  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMM 79
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEH------- 278
           + +       + N+I  + AC +     VI EY S+G+LR YL       LE+       
Sbjct: 80  KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 134
Query: 279 --KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
             + L    L++ A  +ARGMEY+ S+  IHRDL   NVL+ ++  +KIADFG+A +  +
Sbjct: 135 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 194
Query: 337 CDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
            D            +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  + P++  
Sbjct: 195 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL 253
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++ 
Sbjct: 254 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 143/289 (49%), Gaps = 34/289 (11%)
Query: 179 SQLFLGLRFAHGAHSRLYH----GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQF 229
            +L LG     GA  ++      G+ KD+P     VAVK+++  D  E +      E + 
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEM 86
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEH------ 278
            + +       + N+I  + AC +     VI EY S+G+LR YL       LE+      
Sbjct: 87  MKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 141
Query: 279 ---KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
              + L    L++ A  +ARGMEY+ S+  IHRDL   NVL+ ++  +KIADFG+A +  
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 336 YCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
           + D            +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  + P++ 
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 260
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++ 
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 137/286 (47%), Gaps = 15/286 (5%)
Query: 166 NAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARL 225
           ++V   DE  V   ++ L      G+   +Y G  +D        R+     NE+ + R 
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP- 282
             +F  E +++      +V++ +    K     V+ E ++ G L++YL  L  E +  P 
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 283 -----LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
                L ++I +A +IA GM Y++++  +HRDL   N ++  +F +KI DFG+   ++Y 
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT-RDIYE 182
Query: 338 DALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
            A     G      RWMAPE +K   +    D++SFG++LWE+ +    PY+ ++  Q  
Sbjct: 183 TAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 242
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
             V++       P +CP  +  L+  CW   P  RP F  IV +L+
Sbjct: 243 KFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 137/288 (47%), Gaps = 29/288 (10%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVKIIRIPDDDENETLAAR 224
           DE  V   ++ +      G+   +Y G+     KDEP   VA+K +       NE  + R
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMR 57
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP 282
              +F  E +++   +  +V++ +    +     VI E ++ G L++YL  L  E +  P
Sbjct: 58  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 117
Query: 283 ------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
                 L K+I +A +IA GM Y+++   +HRDL   N  + ++F +KI DFG+   ++Y
Sbjct: 118 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMT-RDIY 176
Query: 337 CDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
                   G      RWM+PE +K   +    DV+SFG++LWE+      PY+ ++  Q 
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 236
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
              V+   L    P +CP  +  L+  CW   P  RP F  I+  +++
Sbjct: 237 LRFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 140/304 (46%), Gaps = 34/304 (11%)
Query: 156 KYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVK 208
           +YF    V V      DE  V   ++ +      G+   +Y G+     KDEP   VA+K
Sbjct: 7   EYFSAADVYV-----PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 61
Query: 209 IIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGS 268
            +       NE  + R   +F  E +++   +  +V++ +    +     VI E ++ G 
Sbjct: 62  TV-------NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 114
Query: 269 LRAYLHKLEHKTL--------PLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           L++YL  L              L K+I +A +IA GM Y+++   +HRDL   N ++ ++
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174
Query: 321 FHLKIADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           F +KI DFG+   ++Y        G      RWM+PE +K   +    DV+SFG++LWE+
Sbjct: 175 FTVKIGDFGMT-RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233
Query: 377 VA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
                 PY+ ++  Q    V+   L    P +CP  +  L+  CW   P  RP F  I+ 
Sbjct: 234 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292
Query: 436 VLEQ 439
            +++
Sbjct: 293 SIKE 296

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 135/288 (46%), Gaps = 29/288 (10%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGI----YKDEP---VAVKIIRIPDDDENETLAAR 224
           DE  V   ++ +      G+   +Y G+     KDEP   VA+K +       NE  + R
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMR 60
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTL--- 281
              +F  E +++   +  +V++ +    +     VI E ++ G L++YL  L        
Sbjct: 61  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 120
Query: 282 -----PLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
                 L K+I +A +IA GM Y+++   +HRDL   N ++ ++F +KI DFG+   ++Y
Sbjct: 121 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT-RDIY 179
Query: 337 CDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
                   G      RWM+PE +K   +    DV+SFG++LWE+      PY+ ++  Q 
Sbjct: 180 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 239
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
              V+   L    P +CP  +  L+  CW   P  RP F  I+  +++
Sbjct: 240 LRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 286

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 134/276 (48%), Gaps = 18/276 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   + + ++     F      RL     +D  VA+K +++           +  + F  
Sbjct: 41  DASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKV-------GYTEKQRRDFLC 93
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PNV+       +     ++ E++  G+L A+L K + +   + +L+ +  
Sbjct: 94  EASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQ-FTVIQLVGMLR 152
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC------EEVYCDALSDDPG 345
            IA GM Y+   G +HRDL   N+L++     K++DFG++       E VY       P 
Sbjct: 153 GIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIP- 211
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI 404
             RW APE I+++ +    DV+S+G+++WE+++ G  PY +M+  Q     + +  R   
Sbjct: 212 -VRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPA 269
Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           P DCP  +  L+  CW  +  +RP+F  IV +L++ 
Sbjct: 270 PMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKM 305

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 135/263 (51%), Gaps = 16/263 (6%)
Query: 186 RFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
           +   G    ++ G Y +   VAVK ++ P      T++ +    F  E  L+  L +  +
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLK-PG-----TMSVQ---AFLEEANLMKTLQHDKL 69
Query: 245 IKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++  A   K+ P+Y +ITE++++GSL  +L   E   + LPKLI  +  IA GM YI  +
Sbjct: 70  VRLYAVVTKEEPIY-IITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 128
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWMAPEMIKHKSYG 361
             IHRDL+  NVL+ +    KIADFG+A   E+    A        +W APE I    + 
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 362 RKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
            K +V+SFG++L+E+V  G IPY          A+      P +  +CP  +  +++ CW
Sbjct: 189 IKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRME-NCPDELYDIMKMCW 247
Query: 421 SLQPDKRPEFWHIVKVLEQFETS 443
             + ++RP F ++  VL+ F T+
Sbjct: 248 KEKAEERPTFDYLQSVLDDFYTA 270

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 139/290 (47%), Gaps = 15/290 (5%)
Query: 162 GVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETL 221
           GV  ++V   DE  V   ++ L      G+   +Y G  +D        R+     NE+ 
Sbjct: 1   GVFPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA 60
Query: 222 AARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHK 279
           + R   +F  E +++      +V++ +    K     V+ E ++ G L++YL  L  E +
Sbjct: 61  SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAE 120
Query: 280 TLP------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333
             P      L ++I +A +IA GM Y++++  +HR+L   N ++  +F +KI DFG+   
Sbjct: 121 NNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMT-R 179
Query: 334 EVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388
           ++Y        G      RWMAPE +K   +    D++SFG++LWE+ +    PY+ ++ 
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 239
Query: 389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
            Q    V++       P +CP  +  L+  CW   P+ RP F  IV +L+
Sbjct: 240 EQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 135/285 (47%), Gaps = 13/285 (4%)
Query: 166 NAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARL 225
           ++V   DE  V   ++ L      G+   +Y G  +D        R+     NE+ + R 
Sbjct: 4   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP- 282
             +F  E +++      +V++ +    K     V+ E ++ G L++YL  L  E +  P 
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 283 -----LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
                L ++I +A +IA GM Y++++  +HRDL   N ++  +F +KI DFG+  +    
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 183
Query: 338 DALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF 393
           D            RWMAPE +K   +    D++SFG++LWE+ +    PY+ ++  Q   
Sbjct: 184 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
            V++       P +CP  +  L+  CW   P+ RP F  IV +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 116/222 (52%), Gaps = 11/222 (4%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           + F  E +++ +  +PNVI       K     +ITE++  GSL ++L + + +   + +L
Sbjct: 79  RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQL 137
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-------CEEVYCDA 339
           + +   IA GM+Y+     +HRDL   N+L++     K++DFG++        +  Y  A
Sbjct: 138 VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398
           L       RW APE I+++ +    DV+S+G+++WE+++ G  PY +M   Q     + +
Sbjct: 198 LGGKI-PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQ 255
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           + R   P DCP A+  L+  CW    + RP+F  IV  L++ 
Sbjct: 256 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 134/285 (47%), Gaps = 13/285 (4%)
Query: 166 NAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARL 225
           ++V   DE  V   ++ L      G+   +Y G  +D        R+     NE+ + R 
Sbjct: 1   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 60
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP- 282
             +F  E +++      +V++ +    K     V+ E ++ G L++YL  L  E +  P 
Sbjct: 61  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 120
Query: 283 -----LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
                L ++I +A +IA GM Y++++  +HRDL   N ++  +F +KI DFG+  +    
Sbjct: 121 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 180
Query: 338 DALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF 393
           D            RWMAPE +K   +    D++SFG++LWE+ +    PY+ ++  Q   
Sbjct: 181 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240
Query: 394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
            V++       P +CP  +  L+  CW   P  RP F  IV +L+
Sbjct: 241 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 136/286 (47%), Gaps = 15/286 (5%)
Query: 166 NAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARL 225
           ++V   DE  V   ++ L      G+   +Y G  +D        R+     NE+ + R 
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP- 282
             +F  E +++      +V++ +    K     V+ E ++ G L++YL  L  E +  P 
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 283 -----LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
                L ++I +A +IA GM Y++++  +HRDL   N ++  +F +KI DFG+   ++Y 
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT-RDIYE 182
Query: 338 DALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
                  G      RWMAPE +K   +    D++SFG++LWE+ +    PY+ ++  Q  
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 242
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
             V++       P +CP  +  L+  CW   P  RP F  IV +L+
Sbjct: 243 KFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 134/285 (47%), Gaps = 13/285 (4%)
Query: 166 NAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARL 225
           ++V   DE  V   ++ L      G+   +Y G  +D        R+     NE+ + R 
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP- 282
             +F  E +++      +V++ +    K     V+ E ++ G L++YL  L  E +  P 
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 283 -----LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
                L ++I +A +IA GM Y++++  +HRDL   N ++  +F +KI DFG+  +    
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 183
Query: 338 DALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF 393
           D            RWMAPE +K   +    D++SFG++LWE+ +    PY+ ++  Q   
Sbjct: 184 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
            V++       P +CP  +  L+  CW   P  RP F  IV +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 124/241 (51%), Gaps = 22/241 (9%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-PVYCVITEY 263
           VAVK+I+     E+E         F +E   + +L +P ++KF   C K  P+Y ++TEY
Sbjct: 35  VAVKMIKEGSMSEDE---------FFQEAQTMMKLSHPKLVKFYGVCSKEYPIY-IVTEY 84
Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
           +S G L  YL +   K L   +L+ +  D+  GM ++ S   IHRDL   N L+D++  +
Sbjct: 85  ISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCV 143
Query: 324 KIADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-G 379
           K++DFG+    V  D      GT    +W APE+  +  Y  K DV++FG+++WE+ + G
Sbjct: 144 KVSDFGMT-RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202
Query: 380 TIPYEEMNPIQAAFAVVNKN--LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
            +PY+     +    V   +   RP +  D    +  ++  CW   P+KRP F  ++  +
Sbjct: 203 KMPYDLYTNSEVVLKVSQGHRLYRPHLASD---TIYQIMYSCWHELPEKRPTFQQLLSSI 259
Query: 438 E 438
           E
Sbjct: 260 E 260

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 142/278 (51%), Gaps = 27/278 (9%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           +D  QL    +        L+ G ++   + VK++++ D       + R  + FN E   
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRD------WSTRKSRDFNEECPR 60
Query: 236 LSRLHNPNVIKFVAACKKPPVY--CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
           L    +PNV+  + AC+ PP     +IT ++  GSL   LH+  +  +   + +  ALD+
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 294 ARGMEYIHS-QGVIHRD-LKPENVLIDQEFHLKI--ADFGIACEE---VYCDALSDDPGT 346
           ARGM ++H+ + +I R  L   +V+ID++   +I  AD   + +    +Y  A       
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA------- 173
Query: 347 YRWMAPEMIKHK---SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
             W+APE ++ K   +  R  D++SF ++LWE+V   +P+ +++ ++    V  + LRP 
Sbjct: 174 --WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE 441
           IP    P ++ L++ C +  P KRP+F  IV +LE+ +
Sbjct: 232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 15/286 (5%)
Query: 166 NAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARL 225
           ++V   DE  V   ++ L      G+   +Y G  +D        R+     NE+ + R 
Sbjct: 4   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP- 282
             +F  E +++      +V++ +    K     V+ E ++ G L++YL  L  E +  P 
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 283 -----LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
                L ++I +A +IA GM Y++++  +HR+L   N ++  +F +KI DFG+   ++Y 
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMT-RDIYE 182
Query: 338 DALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
                  G      RWMAPE +K   +    D++SFG++LWE+ +    PY+ ++  Q  
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 242
Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
             V++       P +CP  +  L+  CW   P+ RP F  IV +L+
Sbjct: 243 KFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 134/262 (51%), Gaps = 34/262 (12%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVK+++   ++ + +    L  +FN    +L ++++P+VIK   AC +     +I EY 
Sbjct: 56  VAVKMLK---ENASPSELRDLLSEFN----VLKQVNHPHVIKLYGACSQDGPLLLIVEYA 108
Query: 265 SEGSLRAYLHK-------------------LEH---KTLPLPKLIAIALDIARGMEYIHS 302
             GSLR +L +                   L+H   + L +  LI+ A  I++GM+Y+  
Sbjct: 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL---SDDPGTYRWMAPEMIKHKS 359
             ++HRDL   N+L+ +   +KI+DFG++ +    D+    S      +WMA E +    
Sbjct: 169 MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI 228
Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
           Y  + DV+SFG++LWE+V  G  PY  + P +  F ++    R   P +C   M  L+ Q
Sbjct: 229 YTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQ 287
Query: 419 CWSLQPDKRPEFWHIVKVLEQF 440
           CW  +PDKRP F  I K LE+ 
Sbjct: 288 CWKQEPDKRPVFADISKDLEKM 309

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 134/262 (51%), Gaps = 34/262 (12%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVK+++   ++ + +    L  +FN    +L ++++P+VIK   AC +     +I EY 
Sbjct: 56  VAVKMLK---ENASPSELRDLLSEFN----VLKQVNHPHVIKLYGACSQDGPLLLIVEYA 108
Query: 265 SEGSLRAYLHK-------------------LEH---KTLPLPKLIAIALDIARGMEYIHS 302
             GSLR +L +                   L+H   + L +  LI+ A  I++GM+Y+  
Sbjct: 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL---SDDPGTYRWMAPEMIKHKS 359
             ++HRDL   N+L+ +   +KI+DFG++ +    D+    S      +WMA E +    
Sbjct: 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI 228
Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
           Y  + DV+SFG++LWE+V  G  PY  + P +  F ++    R   P +C   M  L+ Q
Sbjct: 229 YTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQ 287
Query: 419 CWSLQPDKRPEFWHIVKVLEQF 440
           CW  +PDKRP F  I K LE+ 
Sbjct: 288 CWKQEPDKRPVFADISKDLEKM 309

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 134/262 (51%), Gaps = 34/262 (12%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVK+++   ++ + +    L  +FN    +L ++++P+VIK   AC +     +I EY 
Sbjct: 56  VAVKMLK---ENASPSELRDLLSEFN----VLKQVNHPHVIKLYGACSQDGPLLLIVEYA 108
Query: 265 SEGSLRAYLHK-------------------LEH---KTLPLPKLIAIALDIARGMEYIHS 302
             GSLR +L +                   L+H   + L +  LI+ A  I++GM+Y+  
Sbjct: 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL---SDDPGTYRWMAPEMIKHKS 359
             ++HRDL   N+L+ +   +KI+DFG++ +    D+    S      +WMA E +    
Sbjct: 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI 228
Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
           Y  + DV+SFG++LWE+V  G  PY  + P +  F ++    R   P +C   M  L+ Q
Sbjct: 229 YTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQ 287
Query: 419 CWSLQPDKRPEFWHIVKVLEQF 440
           CW  +PDKRP F  I K LE+ 
Sbjct: 288 CWKQEPDKRPVFADISKDLEKM 309

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 166 NAVDAADEH----TVDLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDEN 218
           + VD   E+    ++D  +LF  L +   G+   ++ GI     + VA+KII +      
Sbjct: 9   SGVDLGTENLYFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL------ 62
Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH 278
              A    +   +E+ +LS+  +P V K+  +  K     +I EYL  GS    L  LE 
Sbjct: 63  -EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEP 118
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
             L   ++  I  +I +G++Y+HS+  IHRD+K  NVL+ +   +K+ADFG+A +     
Sbjct: 119 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 178
Query: 339 ALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
              +   GT  WMAPE+IK  +Y  K D++S G+   E+  G  P+ E++P++  F ++ 
Sbjct: 179 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIP 237
Query: 398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           KN  P + G+    +   +E C + +P  RP    ++K
Sbjct: 238 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 275

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 115/222 (51%), Gaps = 11/222 (4%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           + F  E +++ +  +PNVI       K     +ITE++  GSL ++L + + +   + +L
Sbjct: 53  RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQL 111
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-------CEEVYCDA 339
           + +   IA GM+Y+     +HR L   N+L++     K++DFG++        +  Y  A
Sbjct: 112 VGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 171
Query: 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398
           L       RW APE I+++ +    DV+S+G+++WE+++ G  PY +M   Q     + +
Sbjct: 172 LGGKI-PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQ 229
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           + R   P DCP A+  L+  CW    + RP+F  IV  L++ 
Sbjct: 230 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 136/265 (51%), Gaps = 15/265 (5%)
Query: 175 TVDLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           ++D  +LF  L +   G+   ++ GI     + VA+KII +         A    +   +
Sbjct: 2   SLDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-------EEAEDEIEDIQQ 54
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ +LS+  +P V K+  +  K     +I EYL  GS    L  LE   L   ++  I  
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILR 111
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWM 350
           +I +G++Y+HS+  IHRD+K  NVL+ +   +K+ADFG+A +        +   GT  WM
Sbjct: 112 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 171
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
           APE+IK  +Y  K D++S G+   E+  G  P+ E++P++  F ++ KN  P + G+   
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSK 230
Query: 411 AMAALIEQCWSLQPDKRPEFWHIVK 435
            +   +E C + +P  RP    ++K
Sbjct: 231 PLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 136/265 (51%), Gaps = 15/265 (5%)
Query: 175 TVDLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           ++D  +LF  L +   G+   ++ GI     + VA+KII +         A    +   +
Sbjct: 2   SLDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-------EEAEDEIEDIQQ 54
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ +LS+  +P V K+  +  K     +I EYL  GS    L  LE   L   ++  I  
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILR 111
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWM 350
           +I +G++Y+HS+  IHRD+K  NVL+ +   +K+ADFG+A +        +   GT  WM
Sbjct: 112 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 171
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
           APE+IK  +Y  K D++S G+   E+  G  P+ E++P++  F ++ KN  P + G+   
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSK 230
Query: 411 AMAALIEQCWSLQPDKRPEFWHIVK 435
            +   +E C + +P  RP    ++K
Sbjct: 231 PLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 127/265 (47%), Gaps = 15/265 (5%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
              G+   +Y G  +D        R+     NE+ + R   +F  E +++      +V++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLP------LPKLIAIALDIARGME 298
            +    K     V+ E ++ G L++YL  L  E +  P      L ++I +A +IA GM 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----YRWMAPEM 354
           Y++++  +HRDL   N ++  +F +KI DFG+   ++Y        G      RWMAPE 
Sbjct: 144 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT-RDIYETDYYRKGGKGLLPVRWMAPES 202
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           +K   +    D++SFG++LWE+ +    PY+ ++  Q    V++       P +CP  + 
Sbjct: 203 LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVT 261
Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLE 438
            L+  CW   P  RP F  IV +L+
Sbjct: 262 DLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 134/263 (50%), Gaps = 15/263 (5%)
Query: 177 DLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           D  +LF  L +   G+   ++ GI     + VA+KII +         A    +   +E+
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-------EEAEDEIEDIQQEI 71
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
            +LS+  +P V K+  +  K     +I EYL  GS    L  LE   L   ++  I  +I
Sbjct: 72  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILREI 128
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAP 352
            +G++Y+HS+  IHRD+K  NVL+ +   +K+ADFG+A +        +   GT  WMAP
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 188
Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
           E+IK  +Y  K D++S G+   E+  G  P+ E++P++  F ++ KN  P + G+    +
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPL 247
Query: 413 AALIEQCWSLQPDKRPEFWHIVK 435
              +E C + +P  RP    ++K
Sbjct: 248 KEFVEACLNKEPSFRPTAKELLK 270

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 132/280 (47%), Gaps = 24/280 (8%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   V + ++     F      RL     K+  VA+K ++            R  ++F  
Sbjct: 12  DVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLK-------GGYTERQRREFLS 64
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+            ++TE++  G+L ++L +L      + +L+ +  
Sbjct: 65  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFTVIQLVGMLR 123
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---- 347
            IA GM Y+     +HRDL   N+L++     K++DFG++    + +  S DP TY    
Sbjct: 124 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLS---RFLEENSSDP-TYTSSL 179
Query: 348 ------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 RW APE I  + +    D +S+G+++WE+++ G  PY +M+  Q     + ++ 
Sbjct: 180 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDY 238
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           R   P DCP ++  L+  CW    + RP F  +V  L++ 
Sbjct: 239 RLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 137/270 (50%), Gaps = 16/270 (5%)
Query: 171 ADEHT-VDLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLE 226
           A++H+ VD  +LF  L R   G+   +Y GI  +  E VA+KII +         A    
Sbjct: 9   ANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDL-------EEAEDEI 61
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           +   +E+ +LS+  +P + ++  +  K     +I EYL  GS    L  L+   L    +
Sbjct: 62  EDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSA---LDLLKPGPLEETYI 118
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PG 345
             I  +I +G++Y+HS+  IHRD+K  NVL+ ++  +K+ADFG+A +        +   G
Sbjct: 119 ATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVG 178
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
           T  WMAPE+IK  +Y  K D++S G+   E+  G  P  +++P++  F ++ KN  P + 
Sbjct: 179 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-LIPKNSPPTLE 237
Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           G         +E C +  P  RP    ++K
Sbjct: 238 GQHSKPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 130/279 (46%), Gaps = 22/279 (7%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D   V + ++     F      RL     K+  VA+K ++            R  ++F  
Sbjct: 14  DVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLK-------GGYTERQRREFLS 66
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E +++ +  +PN+I+            ++TE++  G+L ++L +L      + +L+ +  
Sbjct: 67  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFTVIQLVGMLR 125
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----- 346
            IA GM Y+     +HRDL   N+L++     K++DFG++    + +  S DP       
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLS---RFLEENSSDPTETSSLG 182
Query: 347 ----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLR 401
                RW APE I  + +    D +S+G+++WE+++ G  PY +M+  Q     + ++ R
Sbjct: 183 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYR 241
Query: 402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
              P DCP ++  L+  CW    + RP F  +V  L++ 
Sbjct: 242 LPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 129/274 (47%), Gaps = 17/274 (6%)
Query: 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREV 233
            +D S+L        G    ++ G + + + VA+K IR           A  E+ F  E 
Sbjct: 4   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---------EGAMSEEDFIEEA 54
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
            ++ +L +P +++    C +    C++TE++  G L  YL + +        L+ + LD+
Sbjct: 55  EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDV 113
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWM 350
             GM Y+    VIHRDL   N L+ +   +K++DFG+    V  D  +   GT    +W 
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWA 172
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +PE+     Y  K DV+SFG+++WE+ + G IPYE  +  +     ++   R   P    
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLYKPRLAS 231
Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
             +  ++  CW  +P+ RP F  +++ L +   S
Sbjct: 232 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 133/270 (49%), Gaps = 11/270 (4%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
           G    +YHG Y D+  A   I+      +     +  + F RE  L+  L++PNV+  + 
Sbjct: 32  GHFGVVYHGEYIDQ--AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 250 ACKKPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
               P  +  V+  Y+  G L  ++ +   +   +  LI+  L +ARGMEY+  Q  +HR
Sbjct: 90  IMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHR 148
Query: 309 DLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-----RWMAPEMIKHKSYGRK 363
           DL   N ++D+ F +K+ADFG+A + +  +  S     +     +W A E ++   +  K
Sbjct: 149 DLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK 208
Query: 364 VDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSL 422
            DV+SFG++LWE++  G  PY  ++P      +      P  P  CP ++  +++QCW  
Sbjct: 209 SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-PEYCPDSLYQVMQQCWEA 267
Query: 423 QPDKRPEFWHIVKVLEQFETSLACNGTLNL 452
            P  RP F  +V  +EQ  ++L  +  + L
Sbjct: 268 DPAVRPTFRVLVGEVEQIVSALLGDHYVQL 297

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 124/244 (50%), Gaps = 23/244 (9%)
Query: 227 KQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK---LE----- 277
           + F  E+ +L +L H+PN+I  + AC+      +  EY   G+L  +L K   LE     
Sbjct: 70  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 129
Query: 278 ------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
                   TL   +L+  A D+ARGM+Y+  +  IHRDL   N+L+ + +  KIADFG++
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
Query: 332 -CEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388
             +EVY    +   P   RWMA E + +  Y    DV+S+G++LWE+V+ G  PY  M  
Sbjct: 190 RGQEVYVKKTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247
Query: 389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF--ETSLAC 446
            +  +  + +  R   P +C   +  L+ QCW  +P +RP F  I+  L +   E     
Sbjct: 248 AE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306
Query: 447 NGTL 450
           N TL
Sbjct: 307 NTTL 310

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 124/244 (50%), Gaps = 23/244 (9%)
Query: 227 KQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK---LE----- 277
           + F  E+ +L +L H+PN+I  + AC+      +  EY   G+L  +L K   LE     
Sbjct: 60  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 119
Query: 278 ------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
                   TL   +L+  A D+ARGM+Y+  +  IHRDL   N+L+ + +  KIADFG++
Sbjct: 120 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 179
Query: 332 -CEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388
             +EVY    +   P   RWMA E + +  Y    DV+S+G++LWE+V+ G  PY  M  
Sbjct: 180 RGQEVYVKKTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 237
Query: 389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF--ETSLAC 446
            +  +  + +  R   P +C   +  L+ QCW  +P +RP F  I+  L +   E     
Sbjct: 238 AE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 296
Query: 447 NGTL 450
           N TL
Sbjct: 297 NTTL 300

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 141/272 (51%), Gaps = 12/272 (4%)
Query: 166 NAVDAADEHT-VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAAR 224
           N+  +ADE   +   +L   +   + A  +L   I   + VAVKII     D+ +  ++ 
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKII-----DKTQLNSSS 56
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           L+K F REV ++  L++PN++K     +      ++ EY S G +  YL  + H  +   
Sbjct: 57  LQKLF-REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEK 113
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           +  A    I   ++Y H + ++HRDLK EN+L+D + ++KIADFG + E  + + L    
Sbjct: 114 EARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC 173
Query: 345 GTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
           G+  + APE+ + K Y G +VDV+S G+IL+ +V+G++P++  N  +    V+    R  
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-- 231
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           IP         L+++   L P KR     I+K
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 141/272 (51%), Gaps = 12/272 (4%)
Query: 166 NAVDAADEHT-VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAAR 224
           N+  +ADE   +   +L   +   + A  +L   I   + VAVKII     D+ +  ++ 
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKII-----DKTQLNSSS 56
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           L+K F REV ++  L++PN++K     +      ++ EY S G +  YL  + H  +   
Sbjct: 57  LQKLF-REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEK 113
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           +  A    I   ++Y H + ++HRDLK EN+L+D + ++KIADFG + E  + + L    
Sbjct: 114 EARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC 173
Query: 345 GTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
           G+  + APE+ + K Y G +VDV+S G+IL+ +V+G++P++  N  +    V+    R  
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-- 231
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           IP         L+++   L P KR     I+K
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 142/272 (52%), Gaps = 12/272 (4%)
Query: 166 NAVDAADEHT-VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAAR 224
           N+  +ADE   +   +L   +   + A  +L   I   + VAV+II     D+ +  ++ 
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRII-----DKTQLNSSS 56
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           L+K F REV ++  L++PN++K     +      ++ EY S G +  YL  + H  +   
Sbjct: 57  LQKLF-REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEK 113
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           +  A    I   ++Y H + ++HRDLK EN+L+D + ++KIADFG + E  + + L +  
Sbjct: 114 EARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC 173
Query: 345 GTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
           G+  + APE+ + K Y G +VDV+S G+IL+ +V+G++P++  N  +    V+    R  
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-- 231
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           IP         L+++   L P KR     I+K
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 127/274 (46%), Gaps = 17/274 (6%)
Query: 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREV 233
            +D S+L        G    ++ G + + + VA+K IR           A  E+ F  E 
Sbjct: 3   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---------EGAMSEEDFIEEA 53
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
            ++ +L +P +++    C +    C++ E++  G L  YL + +        L+ + LD+
Sbjct: 54  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDV 112
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWM 350
             GM Y+    VIHRDL   N L+ +   +K++DFG+    V  D  +   GT    +W 
Sbjct: 113 CEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWA 171
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +PE+     Y  K DV+SFG+++WE+ + G IPYE  +  +     ++   R   P    
Sbjct: 172 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLYKPRLAS 230
Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
             +  ++  CW  +P+ RP F  +++ L     S
Sbjct: 231 THVYQIMNHCWKERPEDRPAFSRLLRQLAAIAAS 264

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 128/274 (46%), Gaps = 17/274 (6%)
Query: 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREV 233
            +D S+L        G    ++ G + + + VA+K IR           A  E+ F  E 
Sbjct: 3   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---------EGAMSEEDFIEEA 53
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
            ++ +L +P +++    C +    C++ E++  G L  YL + +        L+ + LD+
Sbjct: 54  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDV 112
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWM 350
             GM Y+    VIHRDL   N L+ +   +K++DFG+    V  D  +   GT    +W 
Sbjct: 113 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWA 171
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +PE+     Y  K DV+SFG+++WE+ + G IPYE  +  +     ++   R   P    
Sbjct: 172 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLYKPRLAS 230
Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
             +  ++  CW  +P+ RP F  +++ L +   S
Sbjct: 231 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 264

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 24/263 (9%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
           RF       L+     ++  AV I  + D  E       L ++F  E  L +RL +PNV+
Sbjct: 21  RFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP-----LREEFRHEAMLRARLQHPNVV 75
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYL--------------HKLEHKTLPLPKLIAIAL 291
             +    K     +I  Y S G L  +L               +     L  P  + +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV---YCDALSDDPGTYR 348
            IA GMEY+ S  V+H+DL   NVL+  + ++KI+D G+  E     Y   L +     R
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 195
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I +  +    D++S+G++LWE+ + G  PY   +       + N+ + P  P D
Sbjct: 196 WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC-PDD 254
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CP  + AL+ +CW+  P +RP F
Sbjct: 255 CPAWVYALMIECWNEFPSRRPRF 277

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 128/274 (46%), Gaps = 17/274 (6%)
Query: 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREV 233
            +D S+L        G    ++ G + + + VA+K IR           A  E+ F  E 
Sbjct: 6   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---------EGAMSEEDFIEEA 56
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
            ++ +L +P +++    C +    C++ E++  G L  YL + +        L+ + LD+
Sbjct: 57  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDV 115
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWM 350
             GM Y+    VIHRDL   N L+ +   +K++DFG+    V  D  +   GT    +W 
Sbjct: 116 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWA 174
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +PE+     Y  K DV+SFG+++WE+ + G IPYE  +  +     ++   R   P    
Sbjct: 175 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLYKPRLAS 233
Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
             +  ++  CW  +P+ RP F  +++ L +   S
Sbjct: 234 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 128/274 (46%), Gaps = 17/274 (6%)
Query: 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREV 233
            +D S+L        G    ++ G + + + VA+K IR           A  E+ F  E 
Sbjct: 1   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---------EGAMSEEDFIEEA 51
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
            ++ +L +P +++    C +    C++ E++  G L  YL + +        L+ + LD+
Sbjct: 52  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDV 110
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWM 350
             GM Y+    VIHRDL   N L+ +   +K++DFG+    V  D  +   GT    +W 
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWA 169
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +PE+     Y  K DV+SFG+++WE+ + G IPYE  +  +     ++   R   P    
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLYKPRLAS 228
Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
             +  ++  CW  +P+ RP F  +++ L +   S
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 129/261 (49%), Gaps = 34/261 (13%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y GI+  E      PVA+KI+       NET   +   +F  E  +++ + 
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKIL-------NETTGPKANVEFMDEALIMASMD 98
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           +P++++ +  C  P +  ++T+ +  G L  Y+H  EHK  +    L+   + IA+GM Y
Sbjct: 99  HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVH--EHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWM 350
           +  + ++HRDL   NVL+    H+KI DFG+A        L  D   Y         +WM
Sbjct: 156 LEERRLVHRDLAARNVLVKSPNHVKITDFGLA------RLLEGDEKEYNADGGKMPIKWM 209
Query: 351 APEMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           A E I ++ +  + DV+S+G+ +WE M  G  PY+ + P +    ++ K  R   P  C 
Sbjct: 210 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICT 268
Query: 410 PAMAALIEQCWSLQPDKRPEF 430
             +  ++ +CW +  D RP+F
Sbjct: 269 IDVYMVMVKCWMIDADSRPKF 289

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 141/272 (51%), Gaps = 12/272 (4%)
Query: 166 NAVDAADEHT-VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAAR 224
           N+  +ADE   +   +L   +   + A  +L   I   + VAV+II     D+ +  ++ 
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRII-----DKTQLNSSS 56
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           L+K F REV ++  L++PN++K     +      ++ EY S G +  YL  + H  +   
Sbjct: 57  LQKLF-REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEK 113
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           +  A    I   ++Y H + ++HRDLK EN+L+D + ++KIADFG + E  + + L    
Sbjct: 114 EARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC 173
Query: 345 GTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
           G+  + APE+ + K Y G +VDV+S G+IL+ +V+G++P++  N  +    V+    R  
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-- 231
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           IP         L+++   L P KR     I+K
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 24/263 (9%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
           RF       L+     ++  AV I  + D  E       L ++F  E  L +RL +PNV+
Sbjct: 38  RFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP-----LREEFRHEAMLRARLQHPNVV 92
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYL--------------HKLEHKTLPLPKLIAIAL 291
             +    K     +I  Y S G L  +L               +     L  P  + +  
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV---YCDALSDDPGTYR 348
            IA GMEY+ S  V+H+DL   NVL+  + ++KI+D G+  E     Y   L +     R
Sbjct: 153 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 212
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I +  +    D++S+G++LWE+ + G  PY   +       + N+ + P  P D
Sbjct: 213 WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC-PDD 271
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CP  + AL+ +CW+  P +RP F
Sbjct: 272 CPAWVYALMIECWNEFPSRRPRF 294

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 140/272 (51%), Gaps = 12/272 (4%)
Query: 166 NAVDAADEHT-VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAAR 224
           N+  +ADE   +   +L   +   + A  +L   I   + VAVKII     D+ +  ++ 
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKII-----DKTQLNSSS 56
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           L+K F REV ++  L++PN++K     +      ++ EY S G +  YL  + H  +   
Sbjct: 57  LQKLF-REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEK 113
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           +  A    I   ++Y H + ++HRDLK EN+L+D + ++KIADFG + E  + + L    
Sbjct: 114 EARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC 173
Query: 345 GTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
           G   + APE+ + K Y G +VDV+S G+IL+ +V+G++P++  N  +    V+    R  
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-- 231
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           IP         L+++   L P KR     I+K
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 129/261 (49%), Gaps = 34/261 (13%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y GI+  E      PVA+KI+       NET   +   +F  E  +++ + 
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKIL-------NETTGPKANVEFMDEALIMASMD 75
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           +P++++ +  C  P +  ++T+ +  G L  Y+H  EHK  +    L+   + IA+GM Y
Sbjct: 76  HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVH--EHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWM 350
           +  + ++HRDL   NVL+    H+KI DFG+A        L  D   Y         +WM
Sbjct: 133 LEERRLVHRDLAARNVLVKSPNHVKITDFGLA------RLLEGDEKEYNADGGKMPIKWM 186
Query: 351 APEMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           A E I ++ +  + DV+S+G+ +WE M  G  PY+ + P +    ++ K  R   P  C 
Sbjct: 187 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICT 245
Query: 410 PAMAALIEQCWSLQPDKRPEF 430
             +  ++ +CW +  D RP+F
Sbjct: 246 IDVYMVMVKCWMIDADSRPKF 266

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 79/244 (32%), Positives = 124/244 (50%), Gaps = 23/244 (9%)
Query: 227 KQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK---LE----- 277
           + F  E+ +L +L H+PN+I  + AC+      +  EY   G+L  +L K   LE     
Sbjct: 67  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 126
Query: 278 ------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
                   TL   +L+  A D+ARGM+Y+  +  IHR+L   N+L+ + +  KIADFG++
Sbjct: 127 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLS 186
Query: 332 -CEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388
             +EVY    +   P   RWMA E + +  Y    DV+S+G++LWE+V+ G  PY  M  
Sbjct: 187 RGQEVYVKKTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 244
Query: 389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF--ETSLAC 446
            +  +  + +  R   P +C   +  L+ QCW  +P +RP F  I+  L +   E     
Sbjct: 245 AE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 303
Query: 447 NGTL 450
           N TL
Sbjct: 304 NTTL 307

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 133/299 (44%), Gaps = 34/299 (11%)
Query: 160 HGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHG-IYKDEPVAVKIIRIPDDDEN 218
           H G+ V  +   D        + L      GA  +++    Y   P   K++      ++
Sbjct: 4   HSGIHVQHIKRRD--------IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD 55
Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLH---- 274
            TLAAR  K F RE  LL+ L + +++KF   C       ++ EY+  G L  +L     
Sbjct: 56  PTLAAR--KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGP 113
Query: 275 ----------KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
                     +     L L +++ IA  IA GM Y+ SQ  +HRDL   N L+     +K
Sbjct: 114 DAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 173
Query: 325 IADFGIACEEVYCDALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           I DFG++ +    D       T    RWM PE I ++ +  + DV+SFG+ILWE+   G 
Sbjct: 174 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 233
Query: 381 IPYEEMNPIQAAFAVVNKNL--RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
            P+ +++  +    +    +  RP +   CP  +  ++  CW  +P +R     I K+L
Sbjct: 234 QPWFQLSNTEVIECITQGRVLERPRV---CPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFN 230
           ++ +   ++ LG     G    ++ GIY   + P     I+   +  ++++     ++F 
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV----REKFL 59
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E   + +  +P+++K +    + PV+ +I E  + G LR++L ++   +L L  LI  A
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL-QVRKFSLDLASLILYA 117
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++   E+      S      +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I  + +    DV+ FG+ +WE++  G  P++ +        + N    P +P +
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPN 236
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CPP + +L+ +CW+  P +RP F
Sbjct: 237 CPPTLYSLMTKCWAYDPSRRPRF 259

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 134/274 (48%), Gaps = 19/274 (6%)
Query: 181 LFLGLRFAHGAHSRLYHGIY----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALL 236
           L   +    G    +  G+Y    K   VA+K+++   +  +        ++  RE  ++
Sbjct: 12  LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-------EEMMREAQIM 64
Query: 237 SRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARG 296
            +L NP +++ +  C+   +  V+ E    G L  +L   + + +P+  +  +   ++ G
Sbjct: 65  HQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMG 122
Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPGTYRWMAP 352
           M+Y+  +  +HRDL   NVL+    + KI+DFG++     ++ Y  A S      +W AP
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
           E I  + +  + DV+S+G+ +WE ++ G  PY++M   +   A + +  R   P +CPP 
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPE 241
Query: 412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
           + AL+  CW  + + RP+F  + + +     SLA
Sbjct: 242 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 130/246 (52%), Gaps = 11/246 (4%)
Query: 191 AHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250
           A  +L   I   + VAVKII     D+ +  ++ L+K F REV ++  L++PN++K    
Sbjct: 21  AKVKLARHILTGKEVAVKII-----DKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLFEV 74
Query: 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
            +      ++ EY S G +  YL  + H  +   +  A    I   ++Y H + ++HRDL
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYL--VAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDL 132
Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSF 369
           K EN+L+D + ++KIADFG + E  + + L    G+  + APE+ + K Y G +VDV+S 
Sbjct: 133 KAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSL 192
Query: 370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
           G+IL+ +V+G++P++  N  +    V+    R  IP         L+++   L P KR  
Sbjct: 193 GVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGT 250
Query: 430 FWHIVK 435
              I+K
Sbjct: 251 LEQIMK 256

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFN 230
           ++ +   ++ LG     G    ++ GIY   + P     I+   +  ++++     ++F 
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV----REKFL 59
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E   + +  +P+++K +    + PV+ +I E  + G LR++L ++   +L L  LI  A
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL-QVRKYSLDLASLILYA 117
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++   E+      S      +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I  + +    DV+ FG+ +WE++  G  P++ +        + N    P +P +
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPN 236
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CPP + +L+ +CW+  P +RP F
Sbjct: 237 CPPTLYSLMTKCWAYDPSRRPRF 259

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFN 230
           ++ +   ++ LG     G    ++ GIY   + P     I+   +  ++++     ++F 
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV----REKFL 64
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E   + +  +P+++K +    + PV+ +I E  + G LR++L ++   +L L  LI  A
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL-QVRKYSLDLASLILYA 122
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++   E+      S      +
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I  + +    DV+ FG+ +WE++  G  P++ +        + N    P +P +
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPN 241
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CPP + +L+ +CW+  P +RP F
Sbjct: 242 CPPTLYSLMTKCWAYDPSRRPRF 264

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFN 230
           ++ +   ++ LG     G    ++ GIY   + P     I+   +  ++++     ++F 
Sbjct: 6   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV----REKFL 61
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E   + +  +P+++K +    + PV+ +I E  + G LR++L ++   +L L  LI  A
Sbjct: 62  QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL-QVRKYSLDLASLILYA 119
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++   E+      S      +
Sbjct: 120 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I  + +    DV+ FG+ +WE++  G  P++ +        + N    P +P +
Sbjct: 180 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPN 238
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CPP + +L+ +CW+  P +RP F
Sbjct: 239 CPPTLYSLMTKCWAYDPSRRPRF 261

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFN 230
           ++ +   ++ LG     G    ++ GIY   + P     I+   +  ++++     ++F 
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV----REKFL 59
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E   + +  +P+++K +    + PV+ +I E  + G LR++L ++   +L L  LI  A
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL-QVRKYSLDLASLILYA 117
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++   E+      S      +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I  + +    DV+ FG+ +WE++  G  P++ +        + N    P +P +
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPN 236
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CPP + +L+ +CW+  P +RP F
Sbjct: 237 CPPTLYSLMTKCWAYDPSRRPRF 259

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 132/266 (49%), Gaps = 18/266 (6%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEP---VAVKIIRIPDDDENETLAARLEK 227
           ++ +   ++ LG     G    ++ GIY   + P   VA+K  +    D        + +
Sbjct: 7   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-------VRE 59
Query: 228 QFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI 287
           +F +E   + +  +P+++K +    + PV+ +I E  + G LR++L ++   +L L  LI
Sbjct: 60  KFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL-QVRKYSLDLASLI 117
Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPG 345
             A  ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++   E+      S    
Sbjct: 118 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 177
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI 404
             +WMAPE I  + +    DV+ FG+ +WE++  G  P++ +        + N    P +
Sbjct: 178 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-M 236
Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEF 430
           P +CPP + +L+ +CW+  P +RP F
Sbjct: 237 PPNCPPTLYSLMTKCWAYDPSRRPRF 262

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFN 230
           ++ +   ++ LG     G    ++ GIY   + P     I+   +  ++++     ++F 
Sbjct: 32  DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV----REKFL 87
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E   + +  +P+++K +    + PV+ +I E  + G LR++L ++   +L L  LI  A
Sbjct: 88  QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL-QVRKYSLDLASLILYA 145
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++   E+      S      +
Sbjct: 146 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I  + +    DV+ FG+ +WE++  G  P++ +        + N    P +P +
Sbjct: 206 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPN 264
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CPP + +L+ +CW+  P +RP F
Sbjct: 265 CPPTLYSLMTKCWAYDPSRRPRF 287

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 140/300 (46%), Gaps = 27/300 (9%)
Query: 151 ESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLR--FAHGAHSRLYHGIYKDEP---- 204
           + A T + D   +    V A     +  S L +        G    +YHG   D      
Sbjct: 59  QGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKI 118
Query: 205 -VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVIT 261
             AVK + RI D  E          QF  E  ++    +PNV+  +  C +      V+ 
Sbjct: 119 HCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
            Y+  G LR ++    H    +  LI   L +A+GM+++ S+  +HRDL   N ++D++F
Sbjct: 171 PYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF 229
Query: 322 HLKIADFGIACEEVY---CDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
            +K+ADFG+A  ++Y    D++ +  G     +WMA E ++ + +  K DV+SFG++LWE
Sbjct: 230 TVKVADFGLA-RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288
Query: 376 -MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIV 434
            M  G  PY ++N       ++ +  R   P  CP  +  ++ +CW  + + RP F  +V
Sbjct: 289 LMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 347

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFN 230
           ++ +   ++ LG     G    ++ GIY   + P     I+   +  ++++     ++F 
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV----REKFL 56
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E   + +  +P+++K +    + PV+ +I E  + G LR++L ++   +L L  LI  A
Sbjct: 57  QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL-QVRKYSLDLASLILYA 114
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++   E+      S      +
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I  + +    DV+ FG+ +WE++  G  P++ +        + N    P +P +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPN 233
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CPP + +L+ +CW+  P +RP F
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRF 256

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 131/272 (48%), Gaps = 15/272 (5%)
Query: 168 VDAADEHTVDLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAAR 224
           V     +  D  +LF  L R   G+   ++ GI     + VA+KII +         A  
Sbjct: 11  VPGMQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-------EEAED 63
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
             +   +E+ +LS+  +  V K+  +  K     +I EYL  GS    L         + 
Sbjct: 64  EIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIA 123
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD- 343
            ++    +I +G++Y+HS+  IHRD+K  NVL+ ++  +K+ADFG+A +        +  
Sbjct: 124 TMLK---EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 180
Query: 344 PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
            GT  WMAPE+I+  +Y  K D++S G+   E+  G  P  +M+P++  F ++ KN  P 
Sbjct: 181 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-LIPKNNPPT 239
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           + GD   +    I+ C +  P  RP    ++K
Sbjct: 240 LVGDFTKSFKEFIDACLNKDPSFRPTAKELLK 271

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 128/274 (46%), Gaps = 17/274 (6%)
Query: 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREV 233
            +D S+L        G    ++ G + + + VA+K I+     E++         F  E 
Sbjct: 23  VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD---------FIEEA 73
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
            ++ +L +P +++    C +    C++ E++  G L  YL + +        L+ + LD+
Sbjct: 74  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDV 132
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWM 350
             GM Y+    VIHRDL   N L+ +   +K++DFG+    V  D  +   GT    +W 
Sbjct: 133 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWA 191
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +PE+     Y  K DV+SFG+++WE+ + G IPYE  +  +     ++   R   P    
Sbjct: 192 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLYKPRLAS 250
Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
             +  ++  CW  +P+ RP F  +++ L +   S
Sbjct: 251 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 284

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 134/274 (48%), Gaps = 19/274 (6%)
Query: 181 LFLGLRFAHGAHSRLYHGIY----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALL 236
           L   +    G    +  G+Y    K   VA+K+++   +  +        ++  RE  ++
Sbjct: 338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-------EEMMREAQIM 390
Query: 237 SRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARG 296
            +L NP +++ +  C+   +  V+ E    G L  +L   + + +P+  +  +   ++ G
Sbjct: 391 HQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMG 448
Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPGTYRWMAP 352
           M+Y+  +  +HR+L   NVL+    + KI+DFG++     ++ Y  A S      +W AP
Sbjct: 449 MKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
           E I  + +  + DV+S+G+ +WE ++ G  PY++M   +   A + +  R   P +CPP 
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPE 567
Query: 412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
           + AL+  CW  + + RP+F  + + +     SLA
Sbjct: 568 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFN 230
           ++ +   ++ LG     G    ++ GIY   + P     I+   +  ++++     ++F 
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV----REKFL 59
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E   + +  +P+++K +    + PV+ +I E  + G LR++L ++   +L L  LI  A
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL-QVRKFSLDLASLILYA 117
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++   E+      S      +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I  + +    DV+ FG+ +WE++  G  P++ +        + N    P +P +
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPN 236
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CPP + +L+ +CW+  P +RP F
Sbjct: 237 CPPTLYSLMTKCWAYDPSRRPRF 259

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFN 230
           ++ +   ++ LG     G    ++ GIY   + P     I+   +  ++++     ++F 
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV----REKFL 439
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E   + +  +P+++K +    + PV+ +I E  + G LR++L ++   +L L  LI  A
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL-QVRKFSLDLASLILYA 497
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++   E+      S      +
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I  + +    DV+ FG+ +WE++  G  P++ +        + N    P +P +
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPN 616
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CPP + +L+ +CW+  P +RP F
Sbjct: 617 CPPTLYSLMTKCWAYDPSRRPRF 639

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 128/259 (49%), Gaps = 25/259 (9%)
Query: 190 GAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G    +YHG   D        AVK + RI D  E          QF  E  ++    +PN
Sbjct: 42  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSHPN 93
Query: 244 VIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           V+  +  C +      V+  Y+  G LR ++    H    +  LI   L +A+GM+++ S
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLAS 152
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY---CDALSDDPGT---YRWMAPEMIK 356
           +  +HRDL   N ++D++F +K+ADFG+A  ++Y    D++ +  G     +WMA E ++
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 357 HKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
            + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +  +
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEV 270
Query: 416 IEQCWSLQPDKRPEFWHIV 434
           + +CW  + + RP F  +V
Sbjct: 271 MLKCWHPKAEMRPSFSELV 289

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 128/259 (49%), Gaps = 25/259 (9%)
Query: 190 GAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G    +YHG   D        AVK + RI D  E          QF  E  ++    +PN
Sbjct: 39  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSHPN 90
Query: 244 VIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           V+  +  C +      V+  Y+  G LR ++    H    +  LI   L +A+GM+++ S
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLAS 149
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY---CDALSDDPGT---YRWMAPEMIK 356
           +  +HRDL   N ++D++F +K+ADFG+A  ++Y    D++ +  G     +WMA E ++
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 357 HKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
            + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +  +
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEV 267
Query: 416 IEQCWSLQPDKRPEFWHIV 434
           + +CW  + + RP F  +V
Sbjct: 268 MLKCWHPKAEMRPSFSELV 286

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 128/259 (49%), Gaps = 25/259 (9%)
Query: 190 GAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G    +YHG   D        AVK + RI D  E          QF  E  ++    +PN
Sbjct: 41  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSHPN 92
Query: 244 VIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           V+  +  C +      V+  Y+  G LR ++    H    +  LI   L +A+GM+++ S
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLAS 151
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY---CDALSDDPGT---YRWMAPEMIK 356
           +  +HRDL   N ++D++F +K+ADFG+A  ++Y    D++ +  G     +WMA E ++
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 357 HKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
            + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +  +
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEV 269
Query: 416 IEQCWSLQPDKRPEFWHIV 434
           + +CW  + + RP F  +V
Sbjct: 270 MLKCWHPKAEMRPSFSELV 288

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 128/259 (49%), Gaps = 25/259 (9%)
Query: 190 GAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G    +YHG   D        AVK + RI D  E          QF  E  ++    +PN
Sbjct: 41  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSHPN 92
Query: 244 VIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           V+  +  C +      V+  Y+  G LR ++    H    +  LI   L +A+GM+++ S
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLAS 151
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY---CDALSDDPGT---YRWMAPEMIK 356
           +  +HRDL   N ++D++F +K+ADFG+A  ++Y    D++ +  G     +WMA E ++
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 357 HKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
            + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +  +
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEV 269
Query: 416 IEQCWSLQPDKRPEFWHIV 434
           + +CW  + + RP F  +V
Sbjct: 270 MLKCWHPKAEMRPSFSELV 288

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 9/219 (4%)
Query: 217 ENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL 276
           +NE     L+ +   E  ++ +L NP +++ +  C+    + ++ E    G L  YL + 
Sbjct: 406 KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN 464
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----C 332
            H  +    +I +   ++ GM+Y+     +HRDL   NVL+  + + KI+DFG++     
Sbjct: 465 RH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 522
Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
           +E Y  A +      +W APE I +  +  K DV+SFG+++WE  + G  PY  M   + 
Sbjct: 523 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 582
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             A++ K  R   P  CP  M  L+  CW+   + RP F
Sbjct: 583 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 620

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 128/259 (49%), Gaps = 25/259 (9%)
Query: 190 GAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G    +YHG   D        AVK + RI D  E          QF  E  ++    +PN
Sbjct: 46  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSHPN 97
Query: 244 VIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           V+  +  C +      V+  Y+  G LR ++    H    +  LI   L +A+GM+++ S
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLAS 156
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY---CDALSDDPGT---YRWMAPEMIK 356
           +  +HRDL   N ++D++F +K+ADFG+A  ++Y    D++ +  G     +WMA E ++
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 357 HKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
            + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +  +
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEV 274
Query: 416 IEQCWSLQPDKRPEFWHIV 434
           + +CW  + + RP F  +V
Sbjct: 275 MLKCWHPKAEMRPSFSELV 293

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 23/258 (8%)
Query: 190 GAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G    +YHG   D        AVK + RI D  E          QF  E  ++    +PN
Sbjct: 42  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSHPN 93
Query: 244 VIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           V+  +  C +      V+  Y+  G LR ++    H    +  LI   L +A+GM+++ S
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLAS 152
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEV--YCDALSDDPGT---YRWMAPEMIKH 357
           +  +HRDL   N ++D++F +K+ADFG+A + +    D++ +  G     +WMA E ++ 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 358 KSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
           + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +  ++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVM 271
Query: 417 EQCWSLQPDKRPEFWHIV 434
            +CW  + + RP F  +V
Sbjct: 272 LKCWHPKAEMRPSFSELV 289

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 9/219 (4%)
Query: 217 ENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL 276
           +NE     L+ +   E  ++ +L NP +++ +  C+    + ++ E    G L  YL + 
Sbjct: 405 KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN 463
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----C 332
            H  +    +I +   ++ GM+Y+     +HRDL   NVL+  + + KI+DFG++     
Sbjct: 464 RH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521
Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
           +E Y  A +      +W APE I +  +  K DV+SFG+++WE  + G  PY  M   + 
Sbjct: 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             A++ K  R   P  CP  M  L+  CW+   + RP F
Sbjct: 582 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 619

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFN 230
           ++ +   ++ LG     G    ++ GIY   + P     I+   +  ++++     ++F 
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV----REKFL 439
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E   + +  +P+++K +    + PV+ +I E  + G LR++L ++   +L L  LI  A
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL-QVRKFSLDLASLILYA 497
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++   E+      S      +
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           WMAPE I  + +    DV+ FG+ +WE++  G  P++ +        + N    P +P +
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPN 616
Query: 408 CPPAMAALIEQCWSLQPDKRPEF 430
           CPP + +L+ +CW+  P +RP F
Sbjct: 617 CPPTLYSLMTKCWAYDPSRRPRF 639

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 127/255 (49%), Gaps = 33/255 (12%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
           +   G++  +Y  I+K+    V I ++P + + + +         +E++++ +  +P+V+
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII--------KEISIMQQCDSPHVV 87
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           K+  +  K     ++ EY   GS+   + +L +KTL   ++  I     +G+EY+H    
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDII-RLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---GTYRWMAPEMIKHKSYGR 362
           IHRD+K  N+L++ E H K+ADFG+A +    D ++      GT  WMAPE+I+   Y  
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQ--LTDXMAKRNXVIGTPFWMAPEVIQEIGYNC 204
Query: 363 KVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA----------M 412
             D++S G+   EM  G  PY +++P++A F          IP + PP            
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIF---------MIPTNPPPTFRKPELWSDNF 255
Query: 413 AALIEQCWSLQPDKR 427
              ++QC    P++R
Sbjct: 256 TDFVKQCLVKSPEQR 270

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VITE+   G+L  YL    ++ +P  
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 283 ------------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
                       L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 331 ACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE 385
           A  ++Y D      G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  
Sbjct: 186 A-RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VITE+   G+L  YL    ++ +P  
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 283 ------------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
                       L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 331 ACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE 385
           A  ++Y D      G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  
Sbjct: 186 A-RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 9/219 (4%)
Query: 217 ENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL 276
           +NE     L+ +   E  ++ +L NP +++ +  C+    + ++ E    G L  YL + 
Sbjct: 41  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN 99
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----C 332
            H  +    +I +   ++ GM+Y+     +HRDL   NVL+  + + KI+DFG++     
Sbjct: 100 RH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 157
Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
           +E Y  A +      +W APE I +  +  K DV+SFG+++WE  + G  PY  M   + 
Sbjct: 158 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 217
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             A++ K  R   P  CP  M  L+  CW+   + RP F
Sbjct: 218 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 255

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 27/262 (10%)
Query: 188 AHGAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHN 241
             G    +YHG   D        AVK + RI D  E          QF  E  ++    +
Sbjct: 57  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSH 108
Query: 242 PNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           PNV+  +  C +      V+  Y+  G LR ++    H    +  LI   L +A+GM+Y+
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL 167
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPGT---YRWMAPE 353
            S+  +HRDL   N ++D++F +K+ADFG+A +    E Y  ++ +  G     +WMA E
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALE 225
Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            ++ + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPL 284
Query: 413 AALIEQCWSLQPDKRPEFWHIV 434
             ++ +CW  + + RP F  +V
Sbjct: 285 YEVMLKCWHPKAEMRPSFSELV 306

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 31/264 (11%)
Query: 188 AHGAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHN 241
             G    +YHG   D        AVK + RI D  E          QF  E  ++    +
Sbjct: 31  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSH 82
Query: 242 PNVIKFVAACKKP---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
           PNV+  +  C +    P+  V+  Y+  G LR ++    H    +  LI   L +A+GM+
Sbjct: 83  PNVLSLLGICLRSEGSPL--VVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMK 139
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPGT---YRWMA 351
           Y+ S+  +HRDL   N ++D++F +K+ADFG+A +    E Y  ++ +  G     +WMA
Sbjct: 140 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMA 197
Query: 352 PEMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
            E ++ + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP 
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 256
Query: 411 AMAALIEQCWSLQPDKRPEFWHIV 434
            +  ++ +CW  + + RP F  +V
Sbjct: 257 PLYEVMLKCWHPKAEMRPSFSELV 280

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 117/230 (50%), Gaps = 16/230 (6%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K+I+     E+E         F  E  ++  L +  +++    C K     +ITEY+
Sbjct: 36  VAIKMIKEGSMSEDE---------FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 86
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
           + G L  YL ++ H+     +L+ +  D+   MEY+ S+  +HRDL   N L++ +  +K
Sbjct: 87  ANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 145
Query: 325 IADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           ++DFG++   V  D  +   G+    RW  PE++ +  +  K D+++FG+++WE+ + G 
Sbjct: 146 VSDFGLS-RYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 204
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +PYE     + A   + + LR   P      +  ++  CW  + D+RP F
Sbjct: 205 MPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTF 253

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 124/260 (47%), Gaps = 23/260 (8%)
Query: 188 AHGAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHN 241
             G    +YHG   D        AVK + RI D  E          QF  E  ++    +
Sbjct: 38  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSH 89
Query: 242 PNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           PNV+  +  C +      V+  Y+  G LR ++    H    +  LI   L +A+GM+Y+
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL 148
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT-----YRWMAPEMI 355
            S+  +HRDL   N ++D++F +K+ADFG+A +    +  S    T      +WMA E +
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 356 KHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA 414
           + + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +  
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYE 267
Query: 415 LIEQCWSLQPDKRPEFWHIV 434
           ++ +CW  + + RP F  +V
Sbjct: 268 VMLKCWHPKAEMRPSFSELV 287

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 9/219 (4%)
Query: 217 ENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL 276
           +NE     L+ +   E  ++ +L NP +++ +  C+    + ++ E    G L  YL + 
Sbjct: 43  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN 101
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----C 332
            H  +    +I +   ++ GM+Y+     +HRDL   NVL+  + + KI+DFG++     
Sbjct: 102 RH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159
Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
           +E Y  A +      +W APE I +  +  K DV+SFG+++WE  + G  PY  M   + 
Sbjct: 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             A++ K  R   P  CP  M  L+  CW+   + RP F
Sbjct: 220 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 257

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 117/230 (50%), Gaps = 16/230 (6%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K+I+     E+E         F  E  ++  L +  +++    C K     +ITEY+
Sbjct: 42  VAIKMIKEGSMSEDE---------FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 92
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
           + G L  YL ++ H+     +L+ +  D+   MEY+ S+  +HRDL   N L++ +  +K
Sbjct: 93  ANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 151
Query: 325 IADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           ++DFG++   V  D  +   G+    RW  PE++ +  +  K D+++FG+++WE+ + G 
Sbjct: 152 VSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 210
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +PYE     + A   + + LR   P      +  ++  CW  + D+RP F
Sbjct: 211 MPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTF 259

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 117/230 (50%), Gaps = 16/230 (6%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K+I+     E+E         F  E  ++  L +  +++    C K     +ITEY+
Sbjct: 51  VAIKMIKEGSMSEDE---------FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
           + G L  YL ++ H+     +L+ +  D+   MEY+ S+  +HRDL   N L++ +  +K
Sbjct: 102 ANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 160
Query: 325 IADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           ++DFG++   V  D  +   G+    RW  PE++ +  +  K D+++FG+++WE+ + G 
Sbjct: 161 VSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +PYE     + A  +  + LR   P      +  ++  CW  + D+RP F
Sbjct: 220 MPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTF 268

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 9/219 (4%)
Query: 217 ENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL 276
           +NE     L+ +   E  ++ +L NP +++ +  C+    + ++ E    G L  YL + 
Sbjct: 47  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN 105
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----C 332
            H  +    +I +   ++ GM+Y+     +HRDL   NVL+  + + KI+DFG++     
Sbjct: 106 RH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 163
Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
           +E Y  A +      +W APE I +  +  K DV+SFG+++WE  + G  PY  M   + 
Sbjct: 164 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             A++ K  R   P  CP  M  L+  CW+   + RP F
Sbjct: 224 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 261

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 117/230 (50%), Gaps = 16/230 (6%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K+I+     E+E         F  E  ++  L +  +++    C K     +ITEY+
Sbjct: 31  VAIKMIKEGSMSEDE---------FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
           + G L  YL ++ H+     +L+ +  D+   MEY+ S+  +HRDL   N L++ +  +K
Sbjct: 82  ANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 140
Query: 325 IADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           ++DFG++   V  D  +   G+    RW  PE++ +  +  K D+++FG+++WE+ + G 
Sbjct: 141 VSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 199
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +PYE     + A   + + LR   P      +  ++  CW  + D+RP F
Sbjct: 200 MPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTF 248

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 137/272 (50%), Gaps = 12/272 (4%)
Query: 166 NAVDAADEHT-VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAAR 224
           N+  +ADE   +   +L   +   + A  +L   I   + VAVKII     D+ +  ++ 
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKII-----DKTQLNSSS 56
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           L+K F REV +   L++PN++K     +      ++ EY S G +  YL  + H      
Sbjct: 57  LQKLF-REVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYL--VAHGRXKEK 113
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           +  A    I   ++Y H + ++HRDLK EN+L+D + ++KIADFG + E  + + L    
Sbjct: 114 EARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFC 173
Query: 345 GTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
           G   + APE+ + K Y G +VDV+S G+IL+ +V+G++P++  N  +    V+    R  
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-- 231
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           IP         L+++   L P KR     I K
Sbjct: 232 IPFYXSTDCENLLKKFLILNPSKRGTLEQIXK 263

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 27/262 (10%)
Query: 188 AHGAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHN 241
             G    +YHG   D        AVK + RI D  E          QF  E  ++    +
Sbjct: 39  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSH 90
Query: 242 PNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           PNV+  +  C +      V+  Y+  G LR ++    H    +  LI   L +A+GM+Y+
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL 149
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPGT---YRWMAPE 353
            S+  +HRDL   N ++D++F +K+ADFG+A +    E Y  ++ +  G     +WMA E
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALE 207
Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            ++ + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPL 266
Query: 413 AALIEQCWSLQPDKRPEFWHIV 434
             ++ +CW  + + RP F  +V
Sbjct: 267 YEVMLKCWHPKAEMRPSFSELV 288

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 117/230 (50%), Gaps = 16/230 (6%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K+I+     E+E         F  E  ++  L +  +++    C K     +ITEY+
Sbjct: 35  VAIKMIKEGSMSEDE---------FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 85
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
           + G L  YL ++ H+     +L+ +  D+   MEY+ S+  +HRDL   N L++ +  +K
Sbjct: 86  ANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 144
Query: 325 IADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           ++DFG++   V  D  +   G+    RW  PE++ +  +  K D+++FG+++WE+ + G 
Sbjct: 145 VSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 203
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +PYE     + A   + + LR   P      +  ++  CW  + D+RP F
Sbjct: 204 MPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTF 252

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 9/219 (4%)
Query: 217 ENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL 276
           +NE     L+ +   E  ++ +L NP +++ +  C+    + ++ E    G L  YL + 
Sbjct: 61  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN 119
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----C 332
            H  +    +I +   ++ GM+Y+     +HRDL   NVL+  + + KI+DFG++     
Sbjct: 120 RH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 177
Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
           +E Y  A +      +W APE I +  +  K DV+SFG+++WE  + G  PY  M   + 
Sbjct: 178 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 237
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             A++ K  R   P  CP  M  L+  CW+   + RP F
Sbjct: 238 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 275

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 27/262 (10%)
Query: 188 AHGAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHN 241
             G    +YHG   D        AVK + RI D  E          QF  E  ++    +
Sbjct: 58  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSH 109
Query: 242 PNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           PNV+  +  C +      V+  Y+  G LR ++    H    +  LI   L +A+GM+Y+
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL 168
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPGT---YRWMAPE 353
            S+  +HRDL   N ++D++F +K+ADFG+A +    E Y  ++ +  G     +WMA E
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALE 226
Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            ++ + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPL 285
Query: 413 AALIEQCWSLQPDKRPEFWHIV 434
             ++ +CW  + + RP F  +V
Sbjct: 286 YEVMLKCWHPKAEMRPSFSELV 307

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 117/230 (50%), Gaps = 16/230 (6%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K+I+     E+E         F  E  ++  L +  +++    C K     +ITEY+
Sbjct: 36  VAIKMIKEGSMSEDE---------FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 86
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
           + G L  YL ++ H+     +L+ +  D+   MEY+ S+  +HRDL   N L++ +  +K
Sbjct: 87  ANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 145
Query: 325 IADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           ++DFG++   V  D  +   G+    RW  PE++ +  +  K D+++FG+++WE+ + G 
Sbjct: 146 VSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 204
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +PYE     + A   + + LR   P      +  ++  CW  + D+RP F
Sbjct: 205 MPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTF 253

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 27/262 (10%)
Query: 188 AHGAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHN 241
             G    +YHG   D        AVK + RI D  E          QF  E  ++    +
Sbjct: 37  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSH 88
Query: 242 PNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           PNV+  +  C +      V+  Y+  G LR ++    H    +  LI   L +A+GM+Y+
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL 147
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPGT---YRWMAPE 353
            S+  +HRDL   N ++D++F +K+ADFG+A +    E Y  ++ +  G     +WMA E
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALE 205
Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            ++ + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPL 264
Query: 413 AALIEQCWSLQPDKRPEFWHIV 434
             ++ +CW  + + RP F  +V
Sbjct: 265 YEVMLKCWHPKAEMRPSFSELV 286

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 9/219 (4%)
Query: 217 ENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL 276
           +NE     L+ +   E  ++ +L NP +++ +  C+    + ++ E    G L  YL + 
Sbjct: 53  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN 111
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----C 332
            H  +    +I +   ++ GM+Y+     +HRDL   NVL+  + + KI+DFG++     
Sbjct: 112 RH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169
Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
           +E Y  A +      +W APE I +  +  K DV+SFG+++WE  + G  PY  M   + 
Sbjct: 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             A++ K  R   P  CP  M  L+  CW+   + RP F
Sbjct: 230 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 267

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 31/264 (11%)
Query: 188 AHGAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHN 241
             G    +YHG   D        AVK + RI D  E          QF  E  ++    +
Sbjct: 36  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSH 87
Query: 242 PNVIKFVAACKKP---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
           PNV+  +  C +    P+  V+  Y+  G LR ++    H    +  LI   L +A+GM+
Sbjct: 88  PNVLSLLGICLRSEGSPL--VVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMK 144
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPGT---YRWMA 351
           Y+ S+  +HRDL   N ++D++F +K+ADFG+A +    E Y  ++ +  G     +WMA
Sbjct: 145 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMA 202
Query: 352 PEMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
            E ++ + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP 
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 261
Query: 411 AMAALIEQCWSLQPDKRPEFWHIV 434
            +  ++ +CW  + + RP F  +V
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELV 285

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 190 GAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G    +YHG   D        AVK + RI D  E          QF  E  ++    +PN
Sbjct: 41  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSHPN 92
Query: 244 VIKFVAACKKP---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           V+  +  C +    P+  V+  Y+  G LR ++    H    +  LI   L +A+GM+Y+
Sbjct: 93  VLSLLGICLRSEGSPL--VVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL 149
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPGT---YRWMAPE 353
            S+  +HRDL   N ++D++F +K+ADFG+A +    E Y  ++ +  G     +WMA E
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALE 207
Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            ++ + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPL 266
Query: 413 AALIEQCWSLQPDKRPEFWHIV 434
             ++ +CW  + + RP F  +V
Sbjct: 267 YEVMLKCWHPKAEMRPSFSELV 288

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 31/264 (11%)
Query: 188 AHGAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHN 241
             G    +YHG   D        AVK + RI D  E          QF  E  ++    +
Sbjct: 34  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSH 85
Query: 242 PNVIKFVAACKKP---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
           PNV+  +  C +    P+  V+  Y+  G LR ++    H    +  LI   L +A+GM+
Sbjct: 86  PNVLSLLGICLRSEGSPL--VVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMK 142
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPGT---YRWMA 351
           Y+ S+  +HRDL   N ++D++F +K+ADFG+A +    E Y  ++ +  G     +WMA
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMA 200
Query: 352 PEMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
            E ++ + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP 
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 259
Query: 411 AMAALIEQCWSLQPDKRPEFWHIV 434
            +  ++ +CW  + + RP F  +V
Sbjct: 260 PLYEVMLKCWHPKAEMRPSFSELV 283

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 9/219 (4%)
Query: 217 ENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL 276
           +NE     L+ +   E  ++ +L NP +++ +  C+    + ++ E    G L  YL + 
Sbjct: 63  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN 121
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----C 332
            H  +    +I +   ++ GM+Y+     +HRDL   NVL+  + + KI+DFG++     
Sbjct: 122 RH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 179
Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
           +E Y  A +      +W APE I +  +  K DV+SFG+++WE  + G  PY  M   + 
Sbjct: 180 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             A++ K  R   P  CP  M  L+  CW+   + RP F
Sbjct: 240 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 277

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 9/219 (4%)
Query: 217 ENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL 276
           +NE     L+ +   E  ++ +L NP +++ +  C+    + ++ E    G L  YL + 
Sbjct: 63  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN 121
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----C 332
            H  +    +I +   ++ GM+Y+     +HRDL   NVL+  + + KI+DFG++     
Sbjct: 122 RH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 179
Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
           +E Y  A +      +W APE I +  +  K DV+SFG+++WE  + G  PY  M   + 
Sbjct: 180 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             A++ K  R   P  CP  M  L+  CW+   + RP F
Sbjct: 240 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 277

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 190 GAHSRLYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G    +YHG   D        AVK + RI D  E          QF  E  ++    +PN
Sbjct: 40  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------VSQFLTEGIIMKDFSHPN 91
Query: 244 VIKFVAACKKP---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           V+  +  C +    P+  V+  Y+  G LR ++    H    +  LI   L +A+GM+Y+
Sbjct: 92  VLSLLGICLRSEGSPL--VVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL 148
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPGT---YRWMAPE 353
            S+  +HRDL   N ++D++F +K+ADFG+A +    E Y  ++ +  G     +WMA E
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALE 206
Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            ++ + +  K DV+SFG++LWE M  G  PY ++N       ++ +  R   P  CP  +
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPL 265
Query: 413 AALIEQCWSLQPDKRPEFWHIV 434
             ++ +CW  + + RP F  +V
Sbjct: 266 YEVMLKCWHPKAEMRPSFSELV 287

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/228 (32%), Positives = 115/228 (50%), Gaps = 26/228 (11%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VI E+   G+L  YL    ++ +P  
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPL-MVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 283 --------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334
                   L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+A  +
Sbjct: 135 DLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLA-RD 193
Query: 335 VYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389
           +Y D      G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  +   
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 254 EEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 134/278 (48%), Gaps = 27/278 (9%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           +D  QL    +        L+ G ++   + VK++++ D       + R  + FN E   
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRD------WSTRKSRDFNEECPR 60
Query: 236 LSRLHNPNVIKFVAACKKPPVY--CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
           L    +PNV+  + AC+ PP     +IT +   GSL   LH+  +  +   + +  ALD 
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDX 120
Query: 294 ARGMEYIHS-QGVIHRD-LKPENVLIDQEFHLKI--ADFGIACEEVYCDALSDDPGTY-- 347
           ARG  ++H+ + +I R  L   +V ID++   +I  AD   + +          PG    
Sbjct: 121 ARGXAFLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQS---------PGRXYA 171
Query: 348 -RWMAPEMIKHK---SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
             W+APE ++ K   +  R  D +SF ++LWE+V   +P+ +++  +    V  + LRP 
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPT 231
Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE 441
           IP    P ++ L + C +  P KRP+F  IV +LE+ +
Sbjct: 232 IPPGISPHVSKLXKICXNEDPAKRPKFDXIVPILEKXQ 269

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/228 (32%), Positives = 115/228 (50%), Gaps = 26/228 (11%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VI E+   G+L  YL    ++ +P  
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 283 --------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334
                   L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+A  +
Sbjct: 135 DLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLA-RD 193
Query: 335 VYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389
           +Y D      G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  +   
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 254 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 117/230 (50%), Gaps = 16/230 (6%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K+I+     E+E         F  E  ++  L +  +++    C K     +ITEY+
Sbjct: 51  VAIKMIKEGSMSEDE---------FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
           + G L  YL ++ H+     +L+ +  D+   MEY+ S+  +HRDL   N L++ +  +K
Sbjct: 102 ANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 160
Query: 325 IADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           ++DFG++   V  D  +   G+    RW  PE++ +  +  K D+++FG+++WE+ + G 
Sbjct: 161 VSDFGLS-RYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +PYE     + A  +  + LR   P      +  ++  CW  + D+RP F
Sbjct: 220 MPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTF 268

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 123/250 (49%), Gaps = 24/250 (9%)
Query: 205 VAVKIIR-IPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE 262
           VAVK+++     DE E L +        E+ ++S L  + N++  + AC       VITE
Sbjct: 79  VAVKMLKSTAHADEKEALMS--------ELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 263 YLSEGSL--------RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
           Y   G L         A L K + + L L  L+  +  +A+GM ++ S+  IHRD+   N
Sbjct: 131 YCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 190
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFG 370
           VL+      KI DFG+A  ++  D+     G  R    WMAPE I    Y  + DV+S+G
Sbjct: 191 VLLTNGHVAKIGDFGLA-RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 249
Query: 371 LILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
           ++LWE+ + G  PY  +      + +V    + A P   P  + ++++ CW+L+P  RP 
Sbjct: 250 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 309
Query: 430 FWHIVKVLEQ 439
           F  I   L++
Sbjct: 310 FQQICSFLQE 319

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 123/250 (49%), Gaps = 24/250 (9%)
Query: 205 VAVKIIR-IPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE 262
           VAVK+++     DE E L +        E+ ++S L  + N++  + AC       VITE
Sbjct: 71  VAVKMLKSTAHADEKEALMS--------ELKIMSHLGQHENIVNLLGACTHGGPVLVITE 122
Query: 263 YLSEGSLRAYLH--------KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
           Y   G L  +L         K + + L L  L+  +  +A+GM ++ S+  IHRD+   N
Sbjct: 123 YCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 182
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFG 370
           VL+      KI DFG+A  ++  D+     G  R    WMAPE I    Y  + DV+S+G
Sbjct: 183 VLLTNGHVAKIGDFGLA-RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 241
Query: 371 LILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
           ++LWE+ + G  PY  +      + +V    + A P   P  + ++++ CW+L+P  RP 
Sbjct: 242 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 301
Query: 430 FWHIVKVLEQ 439
           F  I   L++
Sbjct: 302 FQQICSFLQE 311

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 30/232 (12%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VI E+   G+L  YL    ++ +P  
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 283 ------------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
                       L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 331 ACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE 385
           A  ++Y D      G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  
Sbjct: 195 A-RDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 123/254 (48%), Gaps = 28/254 (11%)
Query: 205 VAVKIIR-IPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE 262
           VAVK+++     DE E L +        E+ ++S L  + N++  + AC       VITE
Sbjct: 79  VAVKMLKSTAHADEKEALMS--------ELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 263 YLSEGSLRAYLHK------------LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
           Y   G L  +L +            + + TL    L+  +  +A+GM ++ S+  IHRD+
Sbjct: 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDV 190
Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDV 366
              NVL+      KI DFG+A  ++  D+     G  R    WMAPE I    Y  + DV
Sbjct: 191 AARNVLLTNGHVAKIGDFGLA-RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 367 YSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPD 425
           +S+G++LWE+ + G  PY  +      + +V    + A P   P  + ++++ CW+L+P 
Sbjct: 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPT 309
Query: 426 KRPEFWHIVKVLEQ 439
            RP F  I   L++
Sbjct: 310 HRPTFQQICSFLQE 323

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 30/232 (12%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VI E+   G+L  YL    ++ +P  
Sbjct: 113 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYK 171
Query: 283 ------------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
                       L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+
Sbjct: 172 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 231
Query: 331 ACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE 385
           A  ++Y D      G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  
Sbjct: 232 A-RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290
Query: 386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 30/232 (12%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VI E+   G+L  YL    ++ +P  
Sbjct: 78  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 283 ------------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
                       L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+
Sbjct: 137 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 196
Query: 331 ACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE 385
           A  ++Y D      G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  
Sbjct: 197 A-RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 255
Query: 386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 256 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 30/232 (12%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VI E+   G+L  YL    ++ +P  
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 283 ------------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
                       L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 331 ACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE 385
           A  ++Y D      G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  
Sbjct: 195 A-RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 115/237 (48%), Gaps = 40/237 (16%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VITE+   G+L  YL    ++ +P  
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 283 ------------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
                       L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 331 ACEEVYCDALSDDPGTYR---------WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           A +      +  DP   R         WMAPE I  + Y  + DV+SFG++LWE+ + G 
Sbjct: 186 ARD------IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 239
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
            PY  +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 240 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 18/218 (8%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--HKLEHKTLP-- 282
           + F RE  LL+ L + ++++F   C +     ++ EY+  G L  +L  H  + K L   
Sbjct: 88  QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 147
Query: 283 ---------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333
                    L +L+A+A  +A GM Y+     +HRDL   N L+ Q   +KI DFG++ +
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 207
Query: 334 EVYCDALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389
               D       T    RWM PE I ++ +  + DV+SFG++LWE+   G  P+ +++  
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267
Query: 390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           + A   + +      P  CPP + A++  CW  +P +R
Sbjct: 268 E-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 304

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 85
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 86  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 143 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 200
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 201 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 259
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 260 MIMRKCWMIDADSRPKFRELI 280

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 18/218 (8%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--HKLEHKTLP-- 282
           + F RE  LL+ L + ++++F   C +     ++ EY+  G L  +L  H  + K L   
Sbjct: 59  QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 118
Query: 283 ---------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333
                    L +L+A+A  +A GM Y+     +HRDL   N L+ Q   +KI DFG++ +
Sbjct: 119 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 178
Query: 334 EVYCDALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389
               D       T    RWM PE I ++ +  + DV+SFG++LWE+   G  P+ +++  
Sbjct: 179 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 238
Query: 390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           + A   + +      P  CPP + A++  CW  +P +R
Sbjct: 239 E-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 275

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 75
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 190
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 249
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 250 MIMRKCWMIDADSRPKFRELI 270

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 125/246 (50%), Gaps = 11/246 (4%)
Query: 191 AHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250
           A  +L   I     VA+KII     D+ +     L+K F REV ++  L++PN++K    
Sbjct: 26  AKVKLARHILTGREVAIKII-----DKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFEV 79
Query: 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
            +      +I EY S G +  YL  + H  +   +  +    I   ++Y H + ++HRDL
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDL 137
Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSF 369
           K EN+L+D + ++KIADFG + E      L    G+  + APE+ + K Y G +VDV+S 
Sbjct: 138 KAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSL 197
Query: 370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
           G+IL+ +V+G++P++  N  +    V+    R  IP         L+++   L P KR  
Sbjct: 198 GVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGT 255
Query: 430 FWHIVK 435
              I+K
Sbjct: 256 LEQIMK 261

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 18/218 (8%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL--HKLEHKTLP-- 282
           + F RE  LL+ L + ++++F   C +     ++ EY+  G L  +L  H  + K L   
Sbjct: 65  QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 124
Query: 283 ---------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333
                    L +L+A+A  +A GM Y+     +HRDL   N L+ Q   +KI DFG++ +
Sbjct: 125 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 184
Query: 334 EVYCDALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389
               D       T    RWM PE I ++ +  + DV+SFG++LWE+   G  P+ +++  
Sbjct: 185 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 244
Query: 390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           + A   + +      P  CPP + A++  CW  +P +R
Sbjct: 245 E-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 281

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 106/189 (56%), Gaps = 6/189 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
           N E  +LS + +P +I+     +      +I +Y+  G L + L K +    P+ K  A 
Sbjct: 54  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA 113
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
            + +A  +EY+HS+ +I+RDLKPEN+L+D+  H+KI DFG A  +   D      GT  +
Sbjct: 114 EVCLA--LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA--KYVPDVTYXLCGTPDY 169
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--PAIPGD 407
           +APE++  K Y + +D +SFG++++EM+AG  P+ + N ++    ++N  LR  P    D
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229
Query: 408 CPPAMAALI 416
               ++ LI
Sbjct: 230 VKDLLSRLI 238

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 78
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 193
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 252
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 253 MIMRKCWMIDADSRPKFRELI 273

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 100
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 101 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 158 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 215
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 216 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 274
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 275 MIMVKCWMIDADSRPKFRELI 295

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
            + GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 82
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 197
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 256
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 257 MIMVKCWMIDADSRPKFRELI 277

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 21/225 (9%)
Query: 217 ENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL 276
           +NE     L+ +   E  ++ +L NP +++ +  C+    + ++ E    G L  YL + 
Sbjct: 47  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN 105
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
            H  +    +I +   ++ GM+Y+     +HRDL   NVL+  + + KI+DFG++     
Sbjct: 106 RH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS----- 158
Query: 337 CDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE 385
             AL  D   Y          +W APE I +  +  K DV+SFG+++WE  + G  PY  
Sbjct: 159 -KALRADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 217
Query: 386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           M   +   A++ K  R   P  CP  M  L+  CW+   + RP F
Sbjct: 218 MKGSEVT-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 261

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 81
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 82  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 139 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 196
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 197 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 255
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 256 MIMVKCWMIDADSRPKFRELI 276

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
            + GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 75
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 190
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 249
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 250 MIMVKCWMIDADSRPKFRELI 270

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 75
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 190
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 249
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 250 MIMVKCWMIDADSRPKFRELI 270

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 82
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 197
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 256
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 257 MIMVKCWMIDADSRPKFRELI 277

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 78
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 193
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 252
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 253 MIMVKCWMIDADSRPKFRELI 273

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 78
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 193
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 252
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 253 MIMVKCWMIDADSRPKFRELI 273

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 77
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 192
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 251
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 252 MIMVKCWMIDADSRPKFRELI 272

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 75
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 190
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 249
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 250 MIMVKCWMIDADSRPKFRELI 270

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 69
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 184
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 243
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 244 MIMVKCWMIDADSRPKFRELI 264

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 122/254 (48%), Gaps = 28/254 (11%)
Query: 205 VAVKIIR-IPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE 262
           VAVK+++     DE E L +        E+ ++S L  + N++  + AC       VITE
Sbjct: 79  VAVKMLKSTAHADEKEALMS--------ELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 263 YLSEGSLRAYLHK------------LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
           Y   G L  +L +            + + T     L+  +  +A+GM ++ S+  IHRD+
Sbjct: 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDV 190
Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDV 366
              NVL+      KI DFG+A  ++  D+     G  R    WMAPE I    Y  + DV
Sbjct: 191 AARNVLLTNGHVAKIGDFGLA-RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 367 YSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPD 425
           +S+G++LWE+ + G  PY  +      + +V    + A P   P  + ++++ CW+L+P 
Sbjct: 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPT 309
Query: 426 KRPEFWHIVKVLEQ 439
            RP F  I   L++
Sbjct: 310 HRPTFQQICSFLQE 323

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 124/246 (50%), Gaps = 11/246 (4%)
Query: 191 AHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250
           A  +L   I     VA+KII     D+ +     L+K F REV ++  L++PN++K    
Sbjct: 29  AKVKLARHILTGREVAIKII-----DKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFEV 82
Query: 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
            +      +I EY S G +  YL  + H  +   +  +    I   ++Y H + ++HRDL
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDL 140
Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSF 369
           K EN+L+D + ++KIADFG + E      L    G   + APE+ + K Y G +VDV+S 
Sbjct: 141 KAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSL 200
Query: 370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
           G+IL+ +V+G++P++  N  +    V+    R  IP         L+++   L P KR  
Sbjct: 201 GVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGT 258
Query: 430 FWHIVK 435
              I+K
Sbjct: 259 LEQIMK 264

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 114/236 (48%), Gaps = 39/236 (16%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VI E+   G+L  YL    ++ +P  
Sbjct: 77  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYK 135
Query: 283 -----------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
                      L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+A
Sbjct: 136 TPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 332 CEEVYCDALSDDPGTYR---------WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTI 381
            +      +  DP   R         WMAPE I  + Y  + DV+SFG++LWE+ + G  
Sbjct: 196 RD------IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           PY  +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 114/237 (48%), Gaps = 40/237 (16%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VI E+   G+L  YL    ++ +P  
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 283 ------------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
                       L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 331 ACEEVYCDALSDDPGTYR---------WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           A +      +  DP   R         WMAPE I  + Y  + DV+SFG++LWE+ + G 
Sbjct: 186 ARD------IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 239
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
            PY  +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 240 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 114/235 (48%), Gaps = 38/235 (16%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VI E+   G+L  YL    ++ +P  
Sbjct: 78  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 283 ----------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332
                     L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+A 
Sbjct: 137 PEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 333 EEVYCDALSDDPGTYR---------WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP 382
           +      +  DP   R         WMAPE I  + Y  + DV+SFG++LWE+ + G  P
Sbjct: 197 D------IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 383 YEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           Y  +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 127/260 (48%), Gaps = 24/260 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 77
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMI 355
           +  + ++HRDL   NVL+    H+KI DFG    +  EE    A        +WMA E I
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 193
Query: 356 KHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA 414
            H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   +  
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYM 252
Query: 415 LIEQCWSLQPDKRPEFWHIV 434
           ++ +CW +  D RP+F  ++
Sbjct: 253 IMRKCWMIDADSRPKFRELI 272

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 114/237 (48%), Gaps = 40/237 (16%)
Query: 234 ALLSRL-------HNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLP-- 282
           AL+S L       H+ NV+  + AC KP  P+  VI E+   G+L  YL    ++ +P  
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 283 ------------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
                       L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 331 ACEEVYCDALSDDPGTYR---------WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           A +      +  DP   R         WMAPE I  + Y  + DV+SFG++LWE+ + G 
Sbjct: 195 ARD------IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
            PY  +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 249 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 128/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 72
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA GM Y
Sbjct: 73  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 130 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 187
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 188 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 246
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 247 MIMVKCWMIDADSRPKFRELI 267

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 127/255 (49%), Gaps = 14/255 (5%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
              GA   +Y G++  E   VKI  +   +  E  + +  K+   E  +++ + NP+V +
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKI-PVAIMELREATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHSQGV 305
            +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y+  + +
Sbjct: 116 LLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 172
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           +HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E I H+ Y
Sbjct: 173 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALESILHRIY 230
Query: 361 GRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC 419
             + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   +  ++ +C
Sbjct: 231 THQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKC 289
Query: 420 WSLQPDKRPEFWHIV 434
           W +  D RP+F  ++
Sbjct: 290 WMIDADSRPKFRELI 304

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 127/260 (48%), Gaps = 24/260 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 75
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMI 355
           +  + ++HRDL   NVL+    H+KI DFG    +  EE    A        +WMA E I
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 191
Query: 356 KHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA 414
            H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   +  
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYM 250
Query: 415 LIEQCWSLQPDKRPEFWHIV 434
           ++ +CW +  D RP+F  ++
Sbjct: 251 IMVKCWMIDADSRPKFRELI 270

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 127/260 (48%), Gaps = 24/260 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 82
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +IT+ +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMI 355
           +  + ++HRDL   NVL+    H+KI DFG    +  EE    A        +WMA E I
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 198
Query: 356 KHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA 414
            H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   +  
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYM 257
Query: 415 LIEQCWSLQPDKRPEFWHIV 434
           ++ +CW +  D RP+F  ++
Sbjct: 258 IMVKCWMIDADSRPKFRELI 277

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 127/252 (50%), Gaps = 22/252 (8%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K I IP  ++ ETL     K+F REV   S+L + N++  +   ++   Y ++ EY+
Sbjct: 39  VAIKAIFIPPREKEETL-----KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI 93
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
              +L  Y+    H  L +   I     I  G+++ H   ++HRD+KP+N+LID    LK
Sbjct: 94  EGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLK 151
Query: 325 IADFGI--ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
           I DFGI  A  E      +   GT ++ +PE  K ++     D+YS G++L+EM+ G  P
Sbjct: 152 IFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
Query: 383 YEEMNPIQAAFAVVNKNLRPAIPG-------DCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           +      + A ++  K+++ ++P        D P +++ +I    + + DK   +  I +
Sbjct: 212 FNG----ETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVI--LRATEKDKANRYKTIQE 265
Query: 436 VLEQFETSLACN 447
           + +   + L  N
Sbjct: 266 MKDDLSSVLHEN 277

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNRE 232
           E  +   QL +G     G   ++YHG +  E VA+++I I  D+E++       K F RE
Sbjct: 27  EWDIPFEQLEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQL------KAFKRE 79
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           V    +  + NV+ F+ AC  PP   +IT  L +G     + +     L + K   IA +
Sbjct: 80  VMAYRQTRHENVVLFMGACMSPPHLAIITS-LCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC------DALSDDPGT 346
           I +GM Y+H++G++H+DLK +NV  D    + I DFG+             D L    G 
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 347 YRWMAPEMIKHKS---------YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
              +APE+I+  S         + +  DV++ G I +E+ A   P+ +  P +A    + 
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-KTQPAEAIIWQMG 256
Query: 398 KNLRPAIPG-DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
             ++P +        ++ ++  CW+ + ++RP F  ++ +LE+ 
Sbjct: 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
            + GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 82
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +I + +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 83  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 197
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 256
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 257 MIMVKCWMIDADSRPKFRELI 277

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 138/299 (46%), Gaps = 41/299 (13%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLE 226
           ++  +D + L LG     G    +  G  K E      VAVK +++ +  + E       
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREI------ 80
Query: 227 KQFNREVALLSRLHNPNVIKFVAAC-----KKPPVYCVITEYLSEGSLRAYL--HKLEH- 278
           ++F  E A +    +PNVI+ +  C     +  P   VI  ++  G L  YL   +LE  
Sbjct: 81  EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 279 -KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
            K +PL  L+   +DIA GMEY+ ++  +HRDL   N ++  +  + +ADFG++ +++Y 
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS-KKIY- 198
Query: 338 DALSDDPGTY-----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE 385
                  G Y           +W+A E +  + Y  K DV++FG+ +WE+   G  PY  
Sbjct: 199 ------SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252
Query: 386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
           +   +    +++ + R   P DC   +  ++  CW   P  RP F  +   LE+   SL
Sbjct: 253 VQNHEMYDYLLHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 76
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +I + +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 191
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 250
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 251 MIMVKCWMIDADSRPKFRELI 271

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 79
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +I + +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 137 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 194
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 253
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 254 MIMVKCWMIDADSRPKFRELI 274

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 78
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +I + +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 79  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 193
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 252
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 253 MIMVKCWMIDADSRPKFRELI 273

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 76
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +I + +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 191
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 250
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 251 MIMVKCWMIDADSRPKFRELI 271

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 77
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +I + +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 192
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 251
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 252 MIMVKCWMIDADSRPKFRELI 272

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 136/297 (45%), Gaps = 29/297 (9%)
Query: 180 QLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVA 234
           Q  LG     G    +     K E      VAVK+++       + +A+   ++F RE A
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK------ADIIASSDIEEFLREAA 77
Query: 235 LLSRLHNPNVIKFVA------ACKKPPVYCVITEYLSEGSLRAYL--HKLEHK--TLPLP 284
            +    +P+V K V       A  + P+  VI  ++  G L A+L   ++      LPL 
Sbjct: 78  CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
            L+   +DIA GMEY+ S+  IHRDL   N ++ ++  + +ADFG++ +    D      
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 345 GT---YRWMAPEMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNL 400
            +    +W+A E +    Y    DV++FG+ +WE M  G  PY  +   +    ++  N 
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN- 256
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPI 457
           R   P +C   +  L+ QCWS  P +RP F  +   LE     L+    L+  Q+P+
Sbjct: 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS---VLSTSQDPL 310

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 26/261 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 75
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +I + +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEM 354
           +  + ++HRDL   NVL+    H+KI DFG+A      E+ Y       P   +WMA E 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALES 190
Query: 355 IKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   + 
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVY 249
Query: 414 ALIEQCWSLQPDKRPEFWHIV 434
            ++ +CW +  D RP+F  ++
Sbjct: 250 MIMVKCWMIDADSRPKFRELI 270

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 140/291 (48%), Gaps = 39/291 (13%)
Query: 179 SQLFLGLRFAHGAHSRLY----HGIYKDEP---VAVKIIRIPDDDENETLAARLEKQFNR 231
           ++L  G     GA  ++     +G+ K +    VAVK+++ P     E       +    
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTE------REALMS 75
Query: 232 EVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEHKTLP--- 282
           E+ +LS L N  N++  + AC       VITEY   G L  +L +     +  KT P   
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 283 --------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334
                   L  L++ +  +A+GM ++ S+  IHRDL   N+L+      KI DFG+A  +
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RD 194
Query: 335 VYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389
           +  D+     G  R    WMAPE I +  Y  + DV+S+G+ LWE+ + G+ PY  M P+
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PV 253
Query: 390 QAAF-AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            + F  ++ +  R   P   P  M  +++ CW   P KRP F  IV+++E+
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 109/198 (55%), Gaps = 9/198 (4%)
Query: 191 AHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250
           A  +L   +     VAVKII     D+ +     L+K F REV ++  L++PN++K    
Sbjct: 29  AKVKLARHVLTGREVAVKII-----DKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFEV 82
Query: 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
            +      ++ EY S G +  YL  + H  +   +  A    I   ++Y H + ++HRDL
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDL 140
Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSF 369
           K EN+L+D + ++KIADFG + E    + L    G+  + APE+ + K Y G +VDV+S 
Sbjct: 141 KAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSL 200
Query: 370 GLILWEMVAGTIPYEEMN 387
           G+IL+ +V+G++P++  N
Sbjct: 201 GVILYTLVSGSLPFDGQN 218

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 134/291 (46%), Gaps = 16/291 (5%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
             HGA   +Y G     P     +++      E  + + E  F  E  ++S+L++ N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIH 301
            +    +     ++ E ++ G L+++L +   +     +L +  L+ +A DIA G +Y+ 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 302 SQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEM 354
               IHRD+   N L+         KI DFG+A  ++Y  +     G      +WM PE 
Sbjct: 159 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
                +  K D +SFG++LWE+ + G +PY   +  Q     V    R   P +CP  + 
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVY 276
Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLEQF-ETSLACNGTLNLVQNPICQDHKK 463
            ++ QCW  QP+ RP F  I++ +E   +     N  L +   P+ ++ +K
Sbjct: 277 RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK 327

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 124/256 (48%), Gaps = 30/256 (11%)
Query: 205 VAVKIIR-IPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE 262
           VAVK+++     DE E L +        E+ ++S L  + N++  + AC       VITE
Sbjct: 79  VAVKMLKSTAHADEKEALMS--------ELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 263 YLSEGSLRAYLHK-----LEH---------KTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
           Y   G L  +L +     LE+         + L    L+  +  +A+GM ++ S+  IHR
Sbjct: 131 YCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHR 190
Query: 309 DLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKV 364
           D+   NVL+      KI DFG+A  ++  D+     G  R    WMAPE I    Y  + 
Sbjct: 191 DVAARNVLLTNGHVAKIGDFGLA-RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 249
Query: 365 DVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQ 423
           DV+S+G++LWE+ + G  PY  +      + +V    + A P   P  + ++++ CW+L+
Sbjct: 250 DVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALE 309
Query: 424 PDKRPEFWHIVKVLEQ 439
           P  RP F  I   L++
Sbjct: 310 PTHRPTFQQICSFLQE 325

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 140/291 (48%), Gaps = 39/291 (13%)
Query: 179 SQLFLGLRFAHGAHSRLY----HGIYKDEP---VAVKIIRIPDDDENETLAARLEKQFNR 231
           ++L  G     GA  ++     +G+ K +    VAVK+++ P     E       +    
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTE------REALMS 91
Query: 232 EVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEHKTLP--- 282
           E+ +LS L N  N++  + AC       VITEY   G L  +L +     +  KT P   
Sbjct: 92  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 151
Query: 283 --------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334
                   L  L++ +  +A+GM ++ S+  IHRDL   N+L+      KI DFG+A  +
Sbjct: 152 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RD 210
Query: 335 VYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389
           +  D+     G  R    WMAPE I +  Y  + DV+S+G+ LWE+ + G+ PY  M P+
Sbjct: 211 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PV 269
Query: 390 QAAF-AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            + F  ++ +  R   P   P  M  +++ CW   P KRP F  IV+++E+
Sbjct: 270 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 24/260 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 77
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +I + +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMI 355
           +  + ++HRDL   NVL+    H+KI DFG    +  EE    A        +WMA E I
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 193
Query: 356 KHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA 414
            H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   +  
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYM 252
Query: 415 LIEQCWSLQPDKRPEFWHIV 434
           ++ +CW +  D RP+F  ++
Sbjct: 253 IMRKCWMIDADSRPKFRELI 272

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 16/291 (5%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
             HGA   +Y G     P     +++      E  + + E  F  E  ++S+ ++ N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIH 301
            +    +     ++ E ++ G L+++L +   +     +L +  L+ +A DIA G +Y+ 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 302 SQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEM 354
               IHRD+   N L+         KI DFG+A +++Y  +     G      +WM PE 
Sbjct: 159 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-QDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
                +  K D +SFG++LWE+ + G +PY   +  Q     V    R   P +CP  + 
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVY 276
Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLEQF-ETSLACNGTLNLVQNPICQDHKK 463
            ++ QCW  QP+ RP F  I++ +E   +     N  L +   P+ ++ +K
Sbjct: 277 RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK 327

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
             HGA   +Y G     P     +++      E  + + E  F  E  ++S+L++ N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIH 301
            +    +     ++ E ++ G L+++L +   +     +L +  L+ +A DIA G +Y+ 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 302 SQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEM 354
               IHRD+   N L+         KI DFG+A  ++Y  +     G      +WM PE 
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
                +  K D +SFG++LWE+ + G +PY   +  Q     V    R   P +CP  + 
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVY 290
Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLE 438
            ++ QCW  QP+ RP F  I++ +E
Sbjct: 291 RIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 140/291 (48%), Gaps = 39/291 (13%)
Query: 179 SQLFLGLRFAHGAHSRLY----HGIYKDEP---VAVKIIRIPDDDENETLAARLEKQFNR 231
           ++L  G     GA  ++     +G+ K +    VAVK+++ P     E       +    
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTE------REALMS 98
Query: 232 EVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEHKTLP--- 282
           E+ +LS L N  N++  + AC       VITEY   G L  +L +     +  KT P   
Sbjct: 99  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 158
Query: 283 --------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334
                   L  L++ +  +A+GM ++ S+  IHRDL   N+L+      KI DFG+A  +
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RD 217
Query: 335 VYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389
           +  D+     G  R    WMAPE I +  Y  + DV+S+G+ LWE+ + G+ PY  M P+
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PV 276
Query: 390 QAAF-AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            + F  ++ +  R   P   P  M  +++ CW   P KRP F  IV+++E+
Sbjct: 277 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 131/284 (46%), Gaps = 21/284 (7%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIY---KDEPVAVKIIRIPDDDENETLAARLEKQF 229
           ++ +    + L      G    +Y G+Y   K E + V +     D   +      +++F
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-----KEKF 72
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
             E  ++  L +P+++K +   ++ P + +I E    G L  YL +    +L +  L+  
Sbjct: 73  MSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLER-NKNSLKVLTLVLY 130
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPG 345
           +L I + M Y+ S   +HRD+   N+L+     +K+ DFG    I  E+ Y  +++  P 
Sbjct: 131 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP- 189
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI 404
             +WM+PE I  + +    DV+ F + +WE+++ G  P+  +   +    V+ K  R   
Sbjct: 190 -IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPK 247
Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE---QFETSLA 445
           P  CPP +  L+ +CW   P  RP F  +V  L    Q E  +A
Sbjct: 248 PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 291

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 140/291 (48%), Gaps = 39/291 (13%)
Query: 179 SQLFLGLRFAHGAHSRLY----HGIYKDEP---VAVKIIRIPDDDENETLAARLEKQFNR 231
           ++L  G     GA  ++     +G+ K +    VAVK+++ P     E       +    
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTE------REALMS 93
Query: 232 EVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEHKTLP--- 282
           E+ +LS L N  N++  + AC       VITEY   G L  +L +     +  KT P   
Sbjct: 94  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 153
Query: 283 --------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334
                   L  L++ +  +A+GM ++ S+  IHRDL   N+L+      KI DFG+A  +
Sbjct: 154 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RD 212
Query: 335 VYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389
           +  D+     G  R    WMAPE I +  Y  + DV+S+G+ LWE+ + G+ PY  M P+
Sbjct: 213 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PV 271
Query: 390 QAAF-AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            + F  ++ +  R   P   P  M  +++ CW   P KRP F  IV+++E+
Sbjct: 272 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 322

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 87/364 (23%), Positives = 156/364 (42%), Gaps = 25/364 (6%)
Query: 114 LYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADE 173
           +Y++  QE +A       SP   L  LR +        +  T Y  +          +D 
Sbjct: 1   VYRRKHQELQAMQMELQ-SPEYKLSKLRTS--------TIMTDYNPNYSFAGKTSSISDL 51
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
             V    + L     HGA   +Y G     P     +++      E  + + E  F  E 
Sbjct: 52  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 111
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-----TLPLPKLIA 288
            ++S+ ++ N+++ +    +     ++ E ++ G L+++L +   +     +L +  L+ 
Sbjct: 112 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 171
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPG 345
           +A DIA G +Y+     IHRD+   N L+         KI DFG+A  ++Y  +     G
Sbjct: 172 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGG 230
Query: 346 T----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL 400
                 +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q     V    
Sbjct: 231 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGG 289
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF-ETSLACNGTLNLVQNPICQ 459
           R   P +CP  +  ++ QCW  QP+ RP F  I++ +E   +     N  L +   P+ +
Sbjct: 290 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVE 349
Query: 460 DHKK 463
           + +K
Sbjct: 350 EEEK 353

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/331 (24%), Positives = 144/331 (43%), Gaps = 16/331 (4%)
Query: 147 KSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVA 206
           K R  +  T Y  +          +D   V    + L     HGA   +Y G     P  
Sbjct: 5   KLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 64
Query: 207 VKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE 266
              +++      E  + + E  F  E  ++S+ ++ N+++ +    +     ++ E ++ 
Sbjct: 65  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 124
Query: 267 GSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           G L+++L +   +     +L +  L+ +A DIA G +Y+     IHRD+   N L+    
Sbjct: 125 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 184
Query: 322 H---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILW 374
                KI DFG+A  ++Y  +     G      +WM PE      +  K D +SFG++LW
Sbjct: 185 PGRVAKIGDFGMA-RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 243
Query: 375 EMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
           E+ + G +PY   +  Q     V    R   P +CP  +  ++ QCW  QP+ RP F  I
Sbjct: 244 EIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 302
Query: 434 VKVLEQF-ETSLACNGTLNLVQNPICQDHKK 463
           ++ +E   +     N  L +   P+ ++ +K
Sbjct: 303 LERIEYCTQDPDVINTALPIEYGPLVEEEEK 333

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 124/232 (53%), Gaps = 19/232 (8%)
Query: 202 DEPVAVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
           DE  AVKI++    I DDD   T+  +       +   L++LH        +  +     
Sbjct: 366 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH--------SCFQTMDRL 417
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
             + EY++ G L  ++ ++       P  +  A +IA G+ ++ S+G+I+RDLK +NV++
Sbjct: 418 YFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           D E H+KIADFG+ C+E   D ++     GT  ++APE+I ++ YG+ VD ++FG++L+E
Sbjct: 476 DSEGHIKIADFGM-CKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534
Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           M+AG  P+E  +  +   +++  N+  A P        A+ +   +  P KR
Sbjct: 535 MLAGQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 584

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 126/270 (46%), Gaps = 21/270 (7%)
Query: 187 FAHGAHSRLYHGIY---KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
              G    +Y G+Y   K E + V +     D   +      +++F  E  ++  L +P+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-----KEKFMSEAVIMKNLDHPH 74
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +   ++ P + +I E    G L  YL +    +L +  L+  +L I + M Y+ S 
Sbjct: 75  IVKLIGIIEEEPTW-IIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMIKHKS 359
             +HRD+   N+L+     +K+ DFG    I  E+ Y  +++  P   +WM+PE I  + 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESINFRR 190
Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
           +    DV+ F + +WE+++ G  P+  +   +    V+ K  R   P  CPP +  L+ +
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTR 249
Query: 419 CWSLQPDKRPEFWHIVKVLE---QFETSLA 445
           CW   P  RP F  +V  L    Q E  +A
Sbjct: 250 CWDYDPSDRPRFTELVCSLSDVYQMEKDIA 279

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 123/263 (46%), Gaps = 37/263 (14%)
Query: 205 VAVKIIR-IPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE 262
           VAVK+++     DE E L +        E+ ++S L  + N++  + AC       VITE
Sbjct: 64  VAVKMLKSTAHADEKEALMS--------ELKIMSHLGQHENIVNLLGACTHGGPVLVITE 115
Query: 263 YLSEGSLRAYLH---------------------KLEHKTLPLPKLIAIALDIARGMEYIH 301
           Y   G L  +L                      K + + L L  L+  +  +A+GM ++ 
Sbjct: 116 YCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLA 175
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----WMAPEMIKH 357
           S+  IHRD+   NVL+      KI DFG+A  ++  D+     G  R    WMAPE I  
Sbjct: 176 SKNCIHRDVAARNVLLTNGHVAKIGDFGLA-RDIMNDSNYIVKGNARLPVKWMAPESIFD 234
Query: 358 KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
             Y  + DV+S+G++LWE+ + G  PY  +      + +V    + A P   P  + +++
Sbjct: 235 CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIM 294
Query: 417 EQCWSLQPDKRPEFWHIVKVLEQ 439
           + CW+L+P  RP F  I   L++
Sbjct: 295 QACWALEPTHRPTFQQICSFLQE 317

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 115/246 (46%), Gaps = 34/246 (13%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPV--YCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C         +I EYL  GSLR YL K + +   + 
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 114
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+         L  D 
Sbjct: 115 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT------KVLPQDK 168
Query: 345 GTYR----------WMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM--- 386
             ++          W APE +    +    DV+SFG++L+E+      + + P E M   
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
Query: 387 -NPIQAAFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            N  Q    V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q
Sbjct: 229 GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 440 FETSLA 445
              ++A
Sbjct: 289 IRDNMA 294

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 115/246 (46%), Gaps = 34/246 (13%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I EYL  GSLR YL K + +   + 
Sbjct: 57  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 115
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           KL+     I +GMEY+ ++  IHR+L   N+L++ E  +KI DFG+         L  D 
Sbjct: 116 KLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLT------KVLPQDK 169
Query: 345 GTYR----------WMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM--- 386
             Y+          W APE +    +    DV+SFG++L+E+      + + P E M   
Sbjct: 170 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 229
Query: 387 -NPIQAAFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            N  Q    V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q
Sbjct: 230 GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 289
Query: 440 FETSLA 445
              ++A
Sbjct: 290 IRDNMA 295

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 129/272 (47%), Gaps = 25/272 (9%)
Query: 187 FAHGAHSRLYHGIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN 241
              G    +Y G+Y +       VAVK  +     ++ TL  +  ++F  E  ++  L +
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCK-----KDCTLDNK--EKFMSEAVIMKNLDH 68
Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
           P+++K +   ++ P + +I E    G L  YL +    +L +  L+  +L I + M Y+ 
Sbjct: 69  PHIVKLIGIIEEEPTW-IIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLE 126
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMIKH 357
           S   +HRD+   N+L+     +K+ DFG    I  E+ Y  +++  P   +WM+PE I  
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESINF 184
Query: 358 KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
           + +    DV+ F + +WE+++ G  P+  +   +    V+ K  R   P  CPP +  L+
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLM 243
Query: 417 EQCWSLQPDKRPEFWHIVKVLE---QFETSLA 445
            +CW   P  RP F  +V  L    Q E  +A
Sbjct: 244 TRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 275

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 133/305 (43%), Gaps = 15/305 (4%)
Query: 147 KSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVA 206
           K R  +  T Y  +          +D   V    + L     HGA   +Y G     P  
Sbjct: 39  KLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 98
Query: 207 VKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE 266
              +++      E  + + E  F  E  ++S+ ++ N+++ +    +     ++ E ++ 
Sbjct: 99  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 158
Query: 267 GSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           G L+++L +   +     +L +  L+ +A DIA G +Y+     IHRD+   N L+    
Sbjct: 159 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 218
Query: 322 H---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILW 374
                KI DFG+A  ++Y        G      +WM PE      +  K D +SFG++LW
Sbjct: 219 PGRVAKIGDFGMA-RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 277
Query: 375 EMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
           E+ + G +PY   +  Q     V    R   P +CP  +  ++ QCW  QP+ RP F  I
Sbjct: 278 EIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 336
Query: 434 VKVLE 438
           ++ +E
Sbjct: 337 LERIE 341

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 133/291 (45%), Gaps = 16/291 (5%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
             HGA   +Y G     P     +++      E  + + E  F  E  ++S+ ++ N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIH 301
            +    +     ++ E ++ G L+++L +   +     +L +  L+ +A DIA G +Y+ 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 302 SQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEM 354
               IHRD+   N L+         KI DFG+A  ++Y  +     G      +WM PE 
Sbjct: 159 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
                +  K D +SFG++LWE+ + G +PY   +  Q     V    R   P +CP  + 
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVY 276
Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLEQF-ETSLACNGTLNLVQNPICQDHKK 463
            ++ QCW  QP+ RP F  I++ +E   +     N  L +   P+ ++ +K
Sbjct: 277 RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK 327

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 24/260 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 77
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +I + +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMI 355
           +  + ++HRDL   NVL+    H+KI DFG    +  EE    A        +WMA E I
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 193
Query: 356 KHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA 414
            H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   +  
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYM 252
Query: 415 LIEQCWSLQPDKRPEFWHIV 434
           ++ +CW +  D RP+F  ++
Sbjct: 253 IMVKCWMIDADSRPKFRELI 272

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 139/291 (47%), Gaps = 39/291 (13%)
Query: 179 SQLFLGLRFAHGAHSRLY----HGIYKDEP---VAVKIIRIPDDDENETLAARLEKQFNR 231
           ++L  G     GA  ++     +G+ K +    VAVK+++ P     E       +    
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTE------REALMS 98
Query: 232 EVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEHKTLP--- 282
           E+ +LS L N  N++  + AC       VITEY   G L  +L +     +  KT P   
Sbjct: 99  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 158
Query: 283 --------LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334
                   L  L++ +  +A+GM ++ S+  IHRDL   N+L+      KI DFG+A   
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RH 217
Query: 335 VYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389
           +  D+     G  R    WMAPE I +  Y  + DV+S+G+ LWE+ + G+ PY  M P+
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PV 276
Query: 390 QAAF-AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            + F  ++ +  R   P   P  M  +++ CW   P KRP F  IV+++E+
Sbjct: 277 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 134/305 (43%), Gaps = 15/305 (4%)
Query: 147 KSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVA 206
           K R  +  T Y  +          +D   V    + L     HGA   +Y G     P  
Sbjct: 15  KLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 74
Query: 207 VKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE 266
              +++      E  + + E  F  E  ++S+ ++ N+++ +    +     ++ E ++ 
Sbjct: 75  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 134
Query: 267 GSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           G L+++L +   +     +L +  L+ +A DIA G +Y+     IHRD+   N L+    
Sbjct: 135 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 194
Query: 322 H---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILW 374
                KI DFG+A  ++Y  +     G      +WM PE      +  K D +SFG++LW
Sbjct: 195 PGRVAKIGDFGMA-RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 253
Query: 375 EMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
           E+ + G +PY   +  Q     V    R   P +CP  +  ++ QCW  QP+ RP F  I
Sbjct: 254 EIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 312
Query: 434 VKVLE 438
           ++ +E
Sbjct: 313 LERIE 317

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 124/232 (53%), Gaps = 19/232 (8%)
Query: 202 DEPVAVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
           DE  AVKI++    I DDD   T+  +       +   L++LH        +  +     
Sbjct: 45  DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH--------SCFQTMDRL 96
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
             + EY++ G L  ++ ++       P  +  A +IA G+ ++ S+G+I+RDLK +NV++
Sbjct: 97  YFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           D E H+KIADFG+ C+E   D ++     GT  ++APE+I ++ YG+ VD ++FG++L+E
Sbjct: 155 DSEGHIKIADFGM-CKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213
Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           M+AG  P+E  +  +   +++  N+  A P        A+ +   +  P KR
Sbjct: 214 MLAGQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 263

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 133/305 (43%), Gaps = 15/305 (4%)
Query: 147 KSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVA 206
           K R  +  T Y  +          +D   V    + L     HGA   +Y G     P  
Sbjct: 16  KLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 75
Query: 207 VKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE 266
              +++      E  + + E  F  E  ++S+ ++ N+++ +    +     ++ E ++ 
Sbjct: 76  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 135
Query: 267 GSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           G L+++L +   +     +L +  L+ +A DIA G +Y+     IHRD+   N L+    
Sbjct: 136 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 195
Query: 322 H---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILW 374
                KI DFG+A  ++Y        G      +WM PE      +  K D +SFG++LW
Sbjct: 196 PGRVAKIGDFGMA-RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 254
Query: 375 EMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
           E+ + G +PY   +  Q     V    R   P +CP  +  ++ QCW  QP+ RP F  I
Sbjct: 255 EIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 313
Query: 434 VKVLE 438
           ++ +E
Sbjct: 314 LERIE 318

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 123/265 (46%), Gaps = 15/265 (5%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
             HGA   +Y G     P     +++      E  + + E  F  E  ++S+ ++ N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIH 301
            +    +     ++ E ++ G L+++L +   +     +L +  L+ +A DIA G +Y+ 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 302 SQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEM 354
               IHRD+   N L+         KI DFG+A  ++Y  +     G      +WM PE 
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
                +  K D +SFG++LWE+ + G +PY   +  Q     V    R   P +CP  + 
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVY 290
Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLE 438
            ++ QCW  QP+ RP F  I++ +E
Sbjct: 291 RIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I EYL  GSLR YL K + +   + 
Sbjct: 63  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 121
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 122 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 181
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 182 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 241
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++A
Sbjct: 242 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 301

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 24/260 (9%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y G++  E      PVA+K +R       E  + +  K+   E  +++ + 
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVD 79
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
           NP+V + +  C    V  +I + +  G L  Y+   EHK  +    L+   + IA+GM Y
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMI 355
           +  + ++HRDL   NVL+    H+KI DFG    +  EE    A        +WMA E I
Sbjct: 137 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 195
Query: 356 KHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA 414
            H+ Y  + DV+S+G+ +WE M  G+ PY+ + P     +++ K  R   P  C   +  
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYM 254
Query: 415 LIEQCWSLQPDKRPEFWHIV 434
           ++ +CW +  D RP+F  ++
Sbjct: 255 IMVKCWMIDADSRPKFRELI 274

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 111/227 (48%), Gaps = 25/227 (11%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           ++ F RE+ +L  LH+  ++K+      P  P   ++ EYL  G LR +L +     L  
Sbjct: 52  QRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR-HRARLDA 110
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---AL 340
            +L+  +  I +GMEY+ S+  +HRDL   N+L++ E H+KIADFG+A + +  D    +
Sbjct: 111 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA-KLLPLDKDXXV 169
Query: 341 SDDPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA----GTIPYEEMNPIQAAFA 394
             +PG     W APE +    + R+ DV+SFG++L+E+         P  E   +     
Sbjct: 170 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 229
Query: 395 VVNKNLR-----------PAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
            V    R           PA P  CP  +  L++ CW+  P  RP F
Sbjct: 230 DVPALCRLLELLEEGQRLPAPPA-CPAEVHELMKLCWAPSPQDRPSF 275

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 123/265 (46%), Gaps = 15/265 (5%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
             HGA   +Y G     P     +++      E  + + E  F  E  ++S+ ++ N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIH 301
            +    +     ++ E ++ G L+++L +   +     +L +  L+ +A DIA G +Y+ 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 302 SQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEM 354
               IHRD+   N L+         KI DFG+A  ++Y  +     G      +WM PE 
Sbjct: 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
                +  K D +SFG++LWE+ + G +PY   +  Q     V    R   P +CP  + 
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVY 275
Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLE 438
            ++ QCW  QP+ RP F  I++ +E
Sbjct: 276 RIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 123/265 (46%), Gaps = 15/265 (5%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
             HGA   +Y G     P     +++      E  + + E  F  E  ++S+ ++ N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIH 301
            +    +     ++ E ++ G L+++L +   +     +L +  L+ +A DIA G +Y+ 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 302 SQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEM 354
               IHRD+   N L+         KI DFG+A  ++Y  +     G      +WM PE 
Sbjct: 150 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCAMLPVKWMPPEA 208
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
                +  K D +SFG++LWE+ + G +PY   +  Q     V    R   P +CP  + 
Sbjct: 209 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVY 267
Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLE 438
            ++ QCW  QP+ RP F  I++ +E
Sbjct: 268 RIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I EYL  GSLR YL K + +   + 
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 117
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 118 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 178 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 237
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++A
Sbjct: 238 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I EYL  GSLR YL K + +   + 
Sbjct: 61  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 119
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 120 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 179
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 180 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 239
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++A
Sbjct: 240 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 299

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I EYL  GSLR YL K + +   + 
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 114
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 115 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 174
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++A
Sbjct: 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 123/265 (46%), Gaps = 15/265 (5%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
             HGA   +Y G     P     +++      E  + + E  F  E  ++S+ ++ N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIH 301
            +    +     ++ E ++ G L+++L +   +     +L +  L+ +A DIA G +Y+ 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 302 SQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEM 354
               IHRD+   N L+         KI DFG+A  ++Y  +     G      +WM PE 
Sbjct: 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
                +  K D +SFG++LWE+ + G +PY   +  Q     V    R   P +CP  + 
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVY 275
Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLE 438
            ++ QCW  QP+ RP F  I++ +E
Sbjct: 276 RIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I EYL  GSLR YL K + +   + 
Sbjct: 62  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 120
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 121 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 180
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 181 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 240
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++A
Sbjct: 241 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 300

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I EYL  GSLR YL K + +   + 
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 132
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 133 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++A
Sbjct: 253 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 312

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPV--YCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C         +I EYL  GSLR YL K + +   + 
Sbjct: 55  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 113
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 114 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 173
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 174 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 233
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++A
Sbjct: 234 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 293

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I EYL  GSLR YL K + +   + 
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 114
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 115 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 174
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++A
Sbjct: 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 133/291 (45%), Gaps = 16/291 (5%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
             HGA   +Y G     P     +++      E  + + E  F  E  ++S+ ++ N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-----TLPLPKLIAIALDIARGMEYIH 301
            +    +     ++ E ++ G L+++L +   +     +L +  L+ +A DIA G +Y+ 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 302 SQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGT----YRWMAPEM 354
               IHRD+   N L+         KI DFG+A  ++Y  +     G      +WM PE 
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
                +  K D +SFG++LWE+ + G +PY   +  Q     V    R   P +CP  + 
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVY 290
Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLEQF-ETSLACNGTLNLVQNPICQDHKK 463
            ++ QCW  QP+ RP F  I++ +E   +     N  L +   P+ ++ +K
Sbjct: 291 RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK 341

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 120/256 (46%), Gaps = 30/256 (11%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--I 260
           E VAVK ++       E    +L   + RE+ +L  L++ +++K+   C+      V  +
Sbjct: 39  EMVAVKALK-------EGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLV 91
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY+  GSLR YL +     + L +L+  A  I  GM Y+H+Q  IHR L   NVL+D +
Sbjct: 92  MEYVPLGSLRDYLPR---HCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDND 148
Query: 321 FHLKIADFGIACE----EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
             +KI DFG+A        Y     D      W APE +K   +    DV+SFG+ L+E+
Sbjct: 149 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 208
Query: 377 V----AGTIPYEEMNPI----QAAFAV------VNKNLRPAIPGDCPPAMAALIEQCWSL 422
           +    +   P+ +   +    Q    V      + +  R   P  CP  +  L++ CW  
Sbjct: 209 LTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWET 268
Query: 423 QPDKRPEFWHIVKVLE 438
           +   RP F ++V +L+
Sbjct: 269 EASFRPTFQNLVPILQ 284

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPV--YCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C         +I EYL  GSLR YL K + +   + 
Sbjct: 87  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 145
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 146 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 205
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 206 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q    +A
Sbjct: 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 120/256 (46%), Gaps = 30/256 (11%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--I 260
           E VAVK ++       E    +L   + RE+ +L  L++ +++K+   C+      V  +
Sbjct: 38  EMVAVKALK-------EGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLV 90
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY+  GSLR YL +     + L +L+  A  I  GM Y+H+Q  IHR L   NVL+D +
Sbjct: 91  MEYVPLGSLRDYLPR---HCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDND 147
Query: 321 FHLKIADFGIACE----EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
             +KI DFG+A        Y     D      W APE +K   +    DV+SFG+ L+E+
Sbjct: 148 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 207
Query: 377 V----AGTIPYEEMNPI----QAAFAV------VNKNLRPAIPGDCPPAMAALIEQCWSL 422
           +    +   P+ +   +    Q    V      + +  R   P  CP  +  L++ CW  
Sbjct: 208 LTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWET 267
Query: 423 QPDKRPEFWHIVKVLE 438
           +   RP F ++V +L+
Sbjct: 268 EASFRPTFQNLVPILQ 283

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I EYL  GSLR YL K + +   + 
Sbjct: 60  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 118
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 119 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 178
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 179 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 238
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++A
Sbjct: 239 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 298

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 114/246 (46%), Gaps = 34/246 (13%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPV--YCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C         +I EYL  GSLR YL K + +   + 
Sbjct: 54  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 112
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD- 343
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+         L  D 
Sbjct: 113 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT------KVLPQDK 166
Query: 344 -------PGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM--- 386
                  PG     W APE +    +    DV+SFG++L+E+      + + P E M   
Sbjct: 167 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 226
Query: 387 -NPIQAAFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            N  Q    V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q
Sbjct: 227 GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 286
Query: 440 FETSLA 445
               +A
Sbjct: 287 IRDQMA 292

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 120/256 (46%), Gaps = 28/256 (10%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--I 260
           E VAVK ++ P+   N            +E+ +L  L++ N++K+   C +     +  I
Sbjct: 39  EQVAVKSLK-PESGGNHI------ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 91
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            E+L  GSL+ YL K ++K + L + +  A+ I +GM+Y+ S+  +HRDL   NVL++ E
Sbjct: 92  MEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 150
Query: 321 FHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
             +KI DFG    I  ++       D      W APE +    +    DV+SFG+ L E+
Sbjct: 151 HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 210
Query: 377 VA--------GTIPYEEMNPIQAAFAV------VNKNLRPAIPGDCPPAMAALIEQCWSL 422
           +           +  + + P      V      + +  R   P +CP  +  L+ +CW  
Sbjct: 211 LTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEF 270
Query: 423 QPDKRPEFWHIVKVLE 438
           QP  R  F ++++  E
Sbjct: 271 QPSNRTSFQNLIEGFE 286

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 27/228 (11%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPL 283
           ++ F RE+ +L  LH+  ++K+      P    +  + EYL  G LR +L +     L  
Sbjct: 55  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDA 113
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDA 339
            +L+  +  I +GMEY+ S+  +HRDL   N+L++ E H+KIADFG+A     ++ Y   
Sbjct: 114 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 173
Query: 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN 399
                    W APE +    + R+ DV+SFG++L+E+   T   +  +P  A F  +  +
Sbjct: 174 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF--TYCDKSCSP-SAEFLRMMGS 230
Query: 400 LR--PAI---------------PGDCPPAMAALIEQCWSLQPDKRPEF 430
            R  PA+               P  CP  +  L++ CW+  P  RP F
Sbjct: 231 ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF 278

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 120/256 (46%), Gaps = 28/256 (10%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--I 260
           E VAVK ++ P+   N            +E+ +L  L++ N++K+   C +     +  I
Sbjct: 51  EQVAVKSLK-PESGGNHI------ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 103
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            E+L  GSL+ YL K ++K + L + +  A+ I +GM+Y+ S+  +HRDL   NVL++ E
Sbjct: 104 MEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 162
Query: 321 FHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
             +KI DFG    I  ++       D      W APE +    +    DV+SFG+ L E+
Sbjct: 163 HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222
Query: 377 VA--------GTIPYEEMNPIQAAFAV------VNKNLRPAIPGDCPPAMAALIEQCWSL 422
           +           +  + + P      V      + +  R   P +CP  +  L+ +CW  
Sbjct: 223 LTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEF 282
Query: 423 QPDKRPEFWHIVKVLE 438
           QP  R  F ++++  E
Sbjct: 283 QPSNRTSFQNLIEGFE 298

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 21/225 (9%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPL 283
           ++ F RE+ +L  LH+  ++K+      P    +  + EYL  G LR +L +     L  
Sbjct: 68  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDA 126
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDA 339
            +L+  +  I +GMEY+ S+  +HRDL   N+L++ E H+KIADFG+A     ++ Y   
Sbjct: 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM-------VAGTIPYEEMNPIQAA 392
                    W APE +    + R+ DV+SFG++L+E+        + +  +  M   +  
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246
Query: 393 FAVVNK-------NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
              +++         R   P  CP  +  L++ CW+  P  RP F
Sbjct: 247 VPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF 291

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 115/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I E+L  GSLR YL K + +   + 
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHI- 117
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 118 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 178 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 237
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++A
Sbjct: 238 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 128/250 (51%), Gaps = 23/250 (9%)
Query: 186 RFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   GA   +Y    +   + VA++ + +    + E +          E+ ++    NPN
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNPN 78
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++ ++ +        V+ EYL+ GSL   + +     +   ++ A+  +  + +E++HS 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN 135
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRWMAPEMIKHKSYG 361
            VIHRD+K +N+L+  +  +K+ DFG  C ++  +    S+  GT  WMAPE++  K+YG
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSEMVGTPYWMAPEVVTRKAYG 194
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL----IE 417
            KVD++S G++  EM+ G  PY   NP++A + ++  N  P +    P  ++A+    + 
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQN--PEKLSAIFRDFLN 251
Query: 418 QCWSLQPDKR 427
           +C  +  +KR
Sbjct: 252 RCLDMDVEKR 261

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 106/226 (46%), Gaps = 23/226 (10%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPL 283
           ++ F RE+ +L  LH+  ++K+      P    +  + EYL  G LR +L +     L  
Sbjct: 56  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDA 114
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDA 339
            +L+  +  I +GMEY+ S+  +HRDL   N+L++ E H+KIADFG+A     ++ Y   
Sbjct: 115 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 174
Query: 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA----GTIPYEEMNPIQAAFAV 395
                    W APE +    + R+ DV+SFG++L+E+         P  E   +      
Sbjct: 175 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 234
Query: 396 VNKNLR-----------PAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           V    R           PA P  CP  +  L++ CW+  P  RP F
Sbjct: 235 VPALCRLLELLEEGQRLPAPPA-CPAEVHELMKLCWAPSPQDRPSF 279

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 114/239 (47%), Gaps = 22/239 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I EYL  GSLR YL K + +   + 
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI- 132
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 133 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++
Sbjct: 253 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 127/250 (50%), Gaps = 23/250 (9%)
Query: 186 RFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   GA   +Y    +   + VA++ + +    + E +          E+ ++    NPN
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNPN 78
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++ ++ +        V+ EYL+ GSL   + +     +   ++ A+  +  + +E++HS 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN 135
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRWMAPEMIKHKSYG 361
            VIHRD+K +N+L+  +  +K+ DFG  C ++  +    S   GT  WMAPE++  K+YG
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL----IE 417
            KVD++S G++  EM+ G  PY   NP++A + ++  N  P +    P  ++A+    + 
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQN--PEKLSAIFRDFLN 251
Query: 418 QCWSLQPDKR 427
           +C  +  +KR
Sbjct: 252 RCLDMDVEKR 261

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 127/250 (50%), Gaps = 23/250 (9%)
Query: 186 RFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   GA   +Y    +   + VA++ + +    + E +          E+ ++    NPN
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNPN 78
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++ ++ +        V+ EYL+ GSL   + +     +   ++ A+  +  + +E++HS 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN 135
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRWMAPEMIKHKSYG 361
            VIHRD+K +N+L+  +  +K+ DFG  C ++  +    S   GT  WMAPE++  K+YG
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSXMVGTPYWMAPEVVTRKAYG 194
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL----IE 417
            KVD++S G++  EM+ G  PY   NP++A + ++  N  P +    P  ++A+    + 
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQN--PEKLSAIFRDFLN 251
Query: 418 QCWSLQPDKR 427
           +C  +  +KR
Sbjct: 252 RCLEMDVEKR 261

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 127/250 (50%), Gaps = 23/250 (9%)
Query: 186 RFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   GA   +Y    +   + VA++ + +    + E +          E+ ++    NPN
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNPN 79
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++ ++ +        V+ EYL+ GSL   + +     +   ++ A+  +  + +E++HS 
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN 136
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRWMAPEMIKHKSYG 361
            VIHRD+K +N+L+  +  +K+ DFG  C ++  +    S   GT  WMAPE++  K+YG
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSXMVGTPYWMAPEVVTRKAYG 195
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL----IE 417
            KVD++S G++  EM+ G  PY   NP++A + ++  N  P +    P  ++A+    + 
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQN--PEKLSAIFRDFLN 252
Query: 418 QCWSLQPDKR 427
           +C  +  +KR
Sbjct: 253 RCLEMDVEKR 262

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 116/253 (45%), Gaps = 28/253 (11%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVK ++   D+      AR  K F+RE  LL+ L + +++KF   C +     ++ EY+
Sbjct: 46  VAVKTLKDASDN------AR--KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97
Query: 265 SEGSLRAYLHKLEH-------------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311
             G L  +L    H               L   +++ IA  IA GM Y+ SQ  +HRDL 
Sbjct: 98  KHGDLNKFLRA--HGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLA 155
Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---RWMAPEMIKHKSYGRKVDVYS 368
             N L+ +   +KI DFG++ +    D       T    RWM PE I ++ +  + DV+S
Sbjct: 156 TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 215
Query: 369 FGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
            G++LWE+   G  P+ +++  +    +    +    P  CP  +  L+  CW  +P  R
Sbjct: 216 LGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR-PRTCPQEVYELMLGCWQREPHMR 274
Query: 428 PEFWHIVKVLEQF 440
                I  +L+  
Sbjct: 275 KNIKGIHTLLQNL 287

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 113/240 (47%), Gaps = 22/240 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLP 284
           + F RE+ +L  L + N++K+   C       +  I EYL  GSLR YL     +   + 
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHI- 117
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSD 342
           KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+     +        
Sbjct: 118 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177
Query: 343 DPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMV-----AGTIPYEEM----NPIQA 391
           +PG     W APE +    +    DV+SFG++L+E+      + + P E M    N  Q 
Sbjct: 178 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 237
Query: 392 AFAV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
              V      +  N R   P  CP  +  ++ +CW+   ++RP F  +   ++Q   ++A
Sbjct: 238 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 116/254 (45%), Gaps = 26/254 (10%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
              G +  +Y G      V + I  IP+ D      +R  +  + E+AL   L + N+++
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD------SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI-ALDIARGMEYIHSQGV 305
           ++ +  +     +  E +  GSL A L           + I      I  G++Y+H   +
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 306 IHRDLKPENVLIDQ-EFHLKIADFGIA--------CEEVYCDALSDDPGTYRWMAPEMIK 356
           +HRD+K +NVLI+     LKI+DFG +        C E +        GT ++MAPE+I 
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-------GTLQYMAPEIID 196
Query: 357 H--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA-FAVVNKNLRPAIPGDCPPAMA 413
              + YG+  D++S G  + EM  G  P+ E+   QAA F V    + P IP        
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256
Query: 414 ALIEQCWSLQPDKR 427
           A I +C+   PDKR
Sbjct: 257 AFILKCFEPDPDKR 270

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 25/231 (10%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           + +E+ +L  L++ ++IK+   C+      +  + EY+  GSLR YL +    ++ L +L
Sbjct: 80  WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQL 136
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-----CEEVYCDALS 341
           +  A  I  GM Y+H+Q  IHRDL   NVL+D +  +KI DFG+A       E Y     
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXY-RVRE 195
Query: 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG--------TIPYEEMNPIQAAF 393
           D      W APE +K   +    DV+SFG+ L+E++          T   E +   Q   
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
Query: 394 AV------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
            V      + +  R   P  CP  +  L++ CW  +   RP F +++ +L+
Sbjct: 256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 116/254 (45%), Gaps = 26/254 (10%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
              G +  +Y G      V + I  IP+ D      +R  +  + E+AL   L + N+++
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD------SRYSQPLHEEIALHKHLKHKNIVQ 69
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI-ALDIARGMEYIHSQGV 305
           ++ +  +     +  E +  GSL A L           + I      I  G++Y+H   +
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 306 IHRDLKPENVLIDQ-EFHLKIADFGIA--------CEEVYCDALSDDPGTYRWMAPEMIK 356
           +HRD+K +NVLI+     LKI+DFG +        C E +        GT ++MAPE+I 
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-------GTLQYMAPEIID 182
Query: 357 H--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA-FAVVNKNLRPAIPGDCPPAMA 413
              + YG+  D++S G  + EM  G  P+ E+   QAA F V    + P IP        
Sbjct: 183 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 242
Query: 414 ALIEQCWSLQPDKR 427
           A I +C+   PDKR
Sbjct: 243 AFILKCFEPDPDKR 256

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F REV  +  L + N+I+       PP+  ++TE    GSL   L K +   L L  L  
Sbjct: 62  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL-LGTLSR 119
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY- 347
            A+ +A GM Y+ S+  IHRDL   N+L+     +KI DFG+        AL  +   Y 
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM------RALPQNDDHYV 173
Query: 348 ---------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
                     W APE +K +++    D + FG+ LWEM   G  P+  +N  Q    +  
Sbjct: 174 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233
Query: 398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +  R   P DCP  +  ++ QCW+ +P+ RP F
Sbjct: 234 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F REV  +  L + N+I+       PP+  ++TE    GSL   L K +   L L  L  
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL-LGTLSR 125
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT-- 346
            A+ +A GM Y+ S+  IHRDL   N+L+     +KI DFG+    +     +DD     
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL----MRALPQNDDHXVMQ 181
Query: 347 ------YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKN 399
                 + W APE +K +++    D + FG+ LWEM   G  P+  +N  Q    +  + 
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241
Query: 400 LRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
            R   P DCP  +  ++ QCW+ +P+ RP F
Sbjct: 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 272

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F REV  +  L + N+I+       PP+  ++TE    GSL   L K +   L L  L  
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL-LGTLSR 115
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT-- 346
            A+ +A GM Y+ S+  IHRDL   N+L+     +KI DFG+    +     +DD     
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL----MRALPQNDDHXVMQ 171
Query: 347 ------YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKN 399
                 + W APE +K +++    D + FG+ LWEM   G  P+  +N  Q    +  + 
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231
Query: 400 LRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
            R   P DCP  +  ++ QCW+ +P+ RP F
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 127/250 (50%), Gaps = 23/250 (9%)
Query: 186 RFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   GA   +Y    +   + VA++ + +    + E +          E+ ++    NPN
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNPN 79
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++ ++ +        V+ EYL+ GSL   + +     +   ++ A+  +  + +E++HS 
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN 136
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRWMAPEMIKHKSYG 361
            VIHR++K +N+L+  +  +K+ DFG  C ++  +    S   GT  WMAPE++  K+YG
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 195
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL----IE 417
            KVD++S G++  EM+ G  PY   NP++A + ++  N  P +    P  ++A+    + 
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQN--PEKLSAIFRDFLN 252
Query: 418 QCWSLQPDKR 427
           +C  +  +KR
Sbjct: 253 RCLEMDVEKR 262

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 132/279 (47%), Gaps = 26/279 (9%)
Query: 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G +   G    +Y G   +  VAVK +    D   E     L++QF++E+ ++++  + N
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE----ELKQQFDQEIKVMAKCQHEN 91
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIH 301
           +++ +         C++  Y+  GSL   L  L+  T PL       IA   A G+ ++H
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLH 150
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDAL--SDDPGTYRWMAPEMIKHK 358
               IHRD+K  N+L+D+ F  KI+DFG+A   E +   +  S   GT  +MAPE ++ +
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE 210
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV--------------VNKNLRPAI 404
               K D+YSFG++L E++ G    +E    Q    +              ++K +  A 
Sbjct: 211 -ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA- 268
Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
                 AM ++  QC   + +KRP+   + ++L++   S
Sbjct: 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F REV  +  L + N+I+       PP+  ++TE    GSL   L K +   L L  L  
Sbjct: 62  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL-LGTLSR 119
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY- 347
            A+ +A GM Y+ S+  IHRDL   N+L+     +KI DFG+        AL  +   Y 
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM------RALPQNDDHYV 173
Query: 348 ---------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
                     W APE +K +++    D + FG+ LWEM   G  P+  +N  Q    +  
Sbjct: 174 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233
Query: 398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +  R   P DCP  +  ++ QCW+ +P+ RP F
Sbjct: 234 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F REV  +  L + N+I+       PP+  ++TE    GSL   L K +   L L  L  
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL-LGTLSR 115
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY- 347
            A+ +A GM Y+ S+  IHRDL   N+L+     +KI DFG+        AL  +   Y 
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM------RALPQNDDHYV 169
Query: 348 ---------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
                     W APE +K +++    D + FG+ LWEM   G  P+  +N  Q    +  
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
Query: 398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +  R   P DCP  +  ++ QCW+ +P+ RP F
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F REV  +  L + N+I+       PP+  ++TE    GSL   L K +   L L  L  
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL-LGTLSR 125
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY- 347
            A+ +A GM Y+ S+  IHRDL   N+L+     +KI DFG+        AL  +   Y 
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM------RALPQNDDHYV 179
Query: 348 ---------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
                     W APE +K +++    D + FG+ LWEM   G  P+  +N  Q    +  
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
Query: 398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +  R   P DCP  +  ++ QCW+ +P+ RP F
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 272

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 220 TLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK 279
           TL  R   +   E  +L  +++P ++K   A +      +I ++L  G L   L K    
Sbjct: 64  TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123
Query: 280 TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV---- 335
           T    K     L +A  ++++HS G+I+RDLKPEN+L+D+E H+K+ DFG++ E +    
Sbjct: 124 TEEDVKFYLAELALA--LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 336 ----YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
               +C       GT  +MAPE++  + + +  D +SFG++++EM+ GT+P++  +  + 
Sbjct: 182 KAYSFC-------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
              ++   L   +P    P   +L+   +   P  R
Sbjct: 235 MTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 268

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 220 TLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK 279
           TL  R   +   E  +L  +++P ++K   A +      +I ++L  G L   L K    
Sbjct: 65  TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 124
Query: 280 TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV---- 335
           T    K     L +A  ++++HS G+I+RDLKPEN+L+D+E H+K+ DFG++ E +    
Sbjct: 125 TEEDVKFYLAELALA--LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 182
Query: 336 ----YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
               +C       GT  +MAPE++  + + +  D +SFG++++EM+ GT+P++  +  + 
Sbjct: 183 KAYSFC-------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 235
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
              ++   L   +P    P   +L+   +   P  R
Sbjct: 236 MTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 269

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 220 TLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK 279
           TL  R   +   E  +L  +++P ++K   A +      +I ++L  G L   L K    
Sbjct: 64  TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123
Query: 280 TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV---- 335
           T    K     L +A  ++++HS G+I+RDLKPEN+L+D+E H+K+ DFG++ E +    
Sbjct: 124 TEEDVKFYLAELALA--LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 336 ----YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
               +C       GT  +MAPE++  + + +  D +SFG++++EM+ GT+P++  +  + 
Sbjct: 182 KAYSFC-------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234
Query: 392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
              ++   L   +P    P   +L+   +   P  R
Sbjct: 235 MTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 268

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F REV  +  L + N+I+       PP+  ++TE    GSL   L K +   L L  L  
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL-LGTLSR 115
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY- 347
            A+ +A GM Y+ S+  IHRDL   N+L+     +KI DFG+        AL  +   Y 
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM------RALPQNDDHYV 169
Query: 348 ---------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
                     W APE +K +++    D + FG+ LWEM   G  P+  +N  Q    +  
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
Query: 398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +  R   P DCP  +  ++ QCW+ +P+ RP F
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 23/230 (10%)
Query: 229 FNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           + +E+ +L  L++ ++IK+   C  +      ++ EY+  GSLR YL +    ++ L +L
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR---HSIGLAQL 119
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSD 342
           +  A  I  GM Y+HSQ  IHR+L   NVL+D +  +KI DFG+A        Y     D
Sbjct: 120 LLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG--------TIPYEEMNPIQAAFA 394
                 W APE +K   +    DV+SFG+ L+E++          T   E +   Q    
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 239
Query: 395 V------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           V      + +  R   P  CP  +  L++ CW  +   RP F +++ +L+
Sbjct: 240 VLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 131/279 (46%), Gaps = 26/279 (9%)
Query: 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G +   G    +Y G   +  VAVK +    D   E     L++QF++E+ ++++  + N
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE----ELKQQFDQEIKVMAKCQHEN 91
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIH 301
           +++ +         C++  Y+  GSL   L  L+  T PL       IA   A G+ ++H
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLH 150
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDD--PGTYRWMAPEMIKHK 358
               IHRD+K  N+L+D+ F  KI+DFG+A   E +   +      GT  +MAPE ++ +
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGE 210
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV--------------VNKNLRPAI 404
               K D+YSFG++L E++ G    +E    Q    +              ++K +  A 
Sbjct: 211 -ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA- 268
Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
                 AM ++  QC   + +KRP+   + ++L++   S
Sbjct: 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 50  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 107
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +C        + 
Sbjct: 108 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSC-HAPSSRRTT 166
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 167 LSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 224
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRP 250

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 123/267 (46%), Gaps = 49/267 (18%)
Query: 205 VAVKIIR-IPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACK-KPPVYCVIT 261
           VAVK+++   D  E E L +        E+ ++++L  + N++  + AC    P+Y +I 
Sbjct: 78  VAVKMLKEKADSSEREALMS--------ELKMMTQLGSHENIVNLLGACTLSGPIY-LIF 128
Query: 262 EYLSEGSLRAYLH-----------------KLEHK----TLPLPKLIAIALDIARGMEYI 300
           EY   G L  YL                  +LE +     L    L+  A  +A+GME++
Sbjct: 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR--------WMAP 352
             +  +HRDL   NVL+     +KI DFG+A      D +SD     R        WMAP
Sbjct: 189 EFKSCVHRDLAARNVLVTHGKVVKICDFGLA-----RDIMSDSNYVVRGNARLPVKWMAP 243
Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF-AVVNKNLRPAIPGDCPP 410
           E +    Y  K DV+S+G++LWE+ + G  PY  + P+ A F  ++    +   P     
Sbjct: 244 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI-PVDANFYKLIQNGFKMDQPFYATE 302
Query: 411 AMAALIEQCWSLQPDKRPEFWHIVKVL 437
            +  +++ CW+    KRP F ++   L
Sbjct: 303 EIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 112/189 (59%), Gaps = 17/189 (8%)
Query: 202 DEPVAVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
           +E  A+KI++    I DDD   T+  +      R +ALL +   P + +  +  +     
Sbjct: 44  EELYAIKILKKDVVIQDDDVECTMVEK------RVLALLDK--PPFLTQLHSCFQTVDRL 95
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
             + EY++ G L  ++ ++       P+ +  A +I+ G+ ++H +G+I+RDLK +NV++
Sbjct: 96  YFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVML 153
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           D E H+KIADFG+ C+E   D ++     GT  ++APE+I ++ YG+ VD +++G++L+E
Sbjct: 154 DSEGHIKIADFGM-CKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYE 212
Query: 376 MVAGTIPYE 384
           M+AG  P++
Sbjct: 213 MLAGQPPFD 221

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 101/189 (53%), Gaps = 22/189 (11%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           R E  FN EV ++   H+ NV+   ++        V+ E+L  G+L   +    H  +  
Sbjct: 85  RRELLFN-EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV---THTRMNE 140
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            ++  + L + R + Y+H+QGVIHRD+K +++L+  +  +K++DFG      +C  +S +
Sbjct: 141 EQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFG------FCAQVSKE 194
Query: 344 -------PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
                   GT  WMAPE+I    YG +VD++S G+++ EM+ G  PY    P+QA     
Sbjct: 195 VPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---- 250
Query: 397 NKNLRPAIP 405
            + +R ++P
Sbjct: 251 -RRIRDSLP 258

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 131/279 (46%), Gaps = 26/279 (9%)
Query: 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G +   G    +Y G   +  VAVK +    D   E     L++QF++E+ ++++  + N
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE----ELKQQFDQEIKVMAKCQHEN 85
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIH 301
           +++ +         C++  Y+  GSL   L  L+  T PL       IA   A G+ ++H
Sbjct: 86  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLH 144
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDD--PGTYRWMAPEMIKHK 358
               IHRD+K  N+L+D+ F  KI+DFG+A   E +   +      GT  +MAPE ++ +
Sbjct: 145 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGE 204
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV--------------VNKNLRPAI 404
               K D+YSFG++L E++ G    +E    Q    +              ++K +  A 
Sbjct: 205 -ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA- 262
Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
                 AM ++  QC   + +KRP+   + ++L++   S
Sbjct: 263 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 301

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 116/224 (51%), Gaps = 10/224 (4%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVKI+     +  +  +  +  +  RE+  L    +P++IK       P  + ++ EY+
Sbjct: 39  VAVKIL-----NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
           S G L  Y+ K  H  +   +   +   I   ++Y H   V+HRDLKPENVL+D   + K
Sbjct: 94  SGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAK 151
Query: 325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPY 383
           IADFG++      + L D  G+  + APE+I  + Y G +VD++S G+IL+ ++ GT+P+
Sbjct: 152 IADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211
Query: 384 EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           ++ + +   F  +   +   IP     ++A L+     + P KR
Sbjct: 212 DDEH-VPTLFKKIRGGVF-YIPEYLNRSVATLLMHMLQVDPLKR 253

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 110/230 (47%), Gaps = 23/230 (10%)
Query: 229 FNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           + +E+ +L  L++ ++IK+   C  +      ++ EY+  GSLR YL +    ++ L +L
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR---HSIGLAQL 119
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSD 342
           +  A  I  GM Y+H+Q  IHR+L   NVL+D +  +KI DFG+A        Y     D
Sbjct: 120 LLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG--------TIPYEEMNPIQAAFA 394
                 W APE +K   +    DV+SFG+ L+E++          T   E +   Q    
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 239
Query: 395 V------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           V      + +  R   P  CP  +  L++ CW  +   RP F +++ +L+
Sbjct: 240 VLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 88/162 (54%), Gaps = 6/162 (3%)
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           + +  LI+ +  +ARGME++ S+  IHRDL   N+L+ +   +KI DFG+A  ++Y +  
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLA-RDIYKNPD 254
Query: 341 SDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
               G  R    WMAPE I  K Y  K DV+S+G++LWE+ + G  PY  +   +   + 
Sbjct: 255 YVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSR 314
Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           + + +R   P    P +  ++  CW   P +RP F  +V+ L
Sbjct: 315 LREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 54  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 111
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         +D
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTD 170
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 228
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 50  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 107
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         +D
Sbjct: 108 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTD 166
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 224
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRP 250

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 88/154 (57%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L ++++  V+    A +     C++   ++ G L+ +++ +     P  + +  A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
           +I  G+E +H + +++RDLKPEN+L+D   H++I+D G+A        +    GT  +MA
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           PE++K++ Y    D ++ G +L+EM+AG  P+++
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 49  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 106
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         +D
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTD 165
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 223
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRP 249

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 59/299 (19%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNV 244
              G    ++ G ++ E VAVKI            ++R E+ + RE  +     L + N+
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKI-----------FSSREERSWFREAEIYQTVMLRHENI 85
Query: 245 IKFVAACKKP----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           + F+AA  K         ++++Y   GSL  YL++    T+ +  +I +AL  A G+ ++
Sbjct: 86  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHL 142
Query: 301 H-----SQG---VIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDP----GTY 347
           H     +QG   + HRDLK +N+L+ +     IAD G+A   +   D +   P    GT 
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 202
Query: 348 RWMAPEMI------KHKSYGRKVDVYSFGLILWEM-----VAGT-----IPYEEMNPIQA 391
           R+MAPE++      KH    ++ D+Y+ GL+ WE+     + G      +PY ++ P   
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 262
Query: 392 AF-----AVVNKNLRPAIPG---DCPP--AMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           +       V  + LRP IP     C     MA ++ +CW      R     I K L Q 
Sbjct: 263 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 321

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 132/295 (44%), Gaps = 31/295 (10%)
Query: 164 RVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAA 223
           RV  VD  +E T +    FL     HG   ++Y G+ +D        R P+  +      
Sbjct: 28  RVPLVDL-EEATNNFDHKFL---IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
              +        LS   +P+++  +  C +     +I +Y+  G+L+ +L+  +  T+ +
Sbjct: 84  TEIET-------LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 284 P--KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS 341
              + + I +  ARG+ Y+H++ +IHRD+K  N+L+D+ F  KI DFGI+ +    D   
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196
Query: 342 DD---PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM------VAGTIPYEEMNPIQAA 392
                 GT  ++ PE         K DVYSFG++L+E+      +  ++P E +N  + A
Sbjct: 197 LXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 393 F---------AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
                      +V+ NL   I  +          +C +L  + RP    ++  LE
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 88/154 (57%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L ++++  V+    A +     C++   ++ G L+ +++ +     P  + +  A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
           +I  G+E +H + +++RDLKPEN+L+D   H++I+D G+A        +    GT  +MA
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           PE++K++ Y    D ++ G +L+EM+AG  P+++
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 116/224 (51%), Gaps = 10/224 (4%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVKI+     +  +  +  +  +  RE+  L    +P++IK       P    ++ EY+
Sbjct: 44  VAVKIL-----NRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
           S G L  Y+ K  +  L   +   +   I  G++Y H   V+HRDLKPENVL+D   + K
Sbjct: 99  SGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAK 156
Query: 325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPY 383
           IADFG++      + L    G+  + APE+I  + Y G +VD++S G+IL+ ++ GT+P+
Sbjct: 157 IADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216
Query: 384 EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           ++ + +   F  +   +    P    P++ +L++    + P KR
Sbjct: 217 DD-DHVPTLFKKICDGIF-YTPQYLNPSVISLLKHMLQVDPMKR 258

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 113/217 (52%), Gaps = 21/217 (9%)
Query: 220 TLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK 279
           TL  R   +   E  +L+ +++P V+K   A +      +I ++L  G L     +L  +
Sbjct: 68  TLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKE 124
Query: 280 TLPLPKLIAIAL-DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV--- 335
            +   + +   L ++A G++++HS G+I+RDLKPEN+L+D+E H+K+ DFG++ E +   
Sbjct: 125 VMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHE 184
Query: 336 -----YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
                +C       GT  +MAPE++  + +    D +S+G++++EM+ G++P++  +  +
Sbjct: 185 KKAYSFC-------GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKE 237
Query: 391 AAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
               ++   L   +P        +L+   +   P  R
Sbjct: 238 TMTLILKAKL--GMPQFLSTEAQSLLRALFKRNPANR 272

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 59/299 (19%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNV 244
              G    ++ G ++ E VAVKI            ++R E+ + RE  +     L + N+
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVKI-----------FSSREERSWFREAEIYQTVMLRHENI 98
Query: 245 IKFVAACKKP----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           + F+AA  K         ++++Y   GSL  YL++    T+ +  +I +AL  A G+ ++
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHL 155
Query: 301 H-----SQG---VIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDP----GTY 347
           H     +QG   + HRDLK +N+L+ +     IAD G+A   +   D +   P    GT 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 348 RWMAPEMI------KHKSYGRKVDVYSFGLILWEM-----VAGT-----IPYEEMNPIQA 391
           R+MAPE++      KH    ++ D+Y+ GL+ WE+     + G      +PY ++ P   
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 392 AF-----AVVNKNLRPAIPG-----DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           +       V  + LRP IP      +    MA ++ +CW      R     I K L Q 
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 86/162 (53%), Gaps = 6/162 (3%)
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           L L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+A  ++Y D  
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-RDIYKDPD 246
Query: 341 SDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
               G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  +   +     
Sbjct: 247 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 306
Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 307 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 49  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 106
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         +D
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTD 165
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 223
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRP 249

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 86/162 (53%), Gaps = 6/162 (3%)
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           L L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+A  ++Y D  
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-RDIYKDPD 248
Query: 341 SDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
               G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  +   +     
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308
Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 309 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 5/213 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 75  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 132
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +          D
Sbjct: 133 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRDD 191
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 249
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
             P         LI +     P +RP    +++
Sbjct: 250 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 50  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 107
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +   V+  +   
Sbjct: 108 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRR 164
Query: 343 DP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL 400
           D   GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +
Sbjct: 165 DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-V 222
Query: 401 RPAIPGDCPPAMAALIEQCWSLQPDKRP 428
               P         LI +     P +RP
Sbjct: 223 EFTFPDFVTEGARDLISRLLKHNPSQRP 250

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 59/299 (19%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNV 244
              G    ++ G ++ E VAVKI            ++R E+ + RE  +     L + N+
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKI-----------FSSREERSWFREAEIYQTVMLRHENI 65
Query: 245 IKFVAACKKP----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           + F+AA  K         ++++Y   GSL  YL++    T+ +  +I +AL  A G+ ++
Sbjct: 66  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHL 122
Query: 301 H-----SQG---VIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDP----GTY 347
           H     +QG   + HRDLK +N+L+ +     IAD G+A   +   D +   P    GT 
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 348 RWMAPEMI------KHKSYGRKVDVYSFGLILWEM-----VAGT-----IPYEEMNPIQA 391
           R+MAPE++      KH    ++ D+Y+ GL+ WE+     + G      +PY ++ P   
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 242
Query: 392 AF-----AVVNKNLRPAIPG---DCPP--AMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           +       V  + LRP IP     C     MA ++ +CW      R     I K L Q 
Sbjct: 243 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 301

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 59/299 (19%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNV 244
              G    ++ G ++ E VAVKI            ++R E+ + RE  +     L + N+
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKI-----------FSSREERSWFREAEIYQTVMLRHENI 60
Query: 245 IKFVAACKKP----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           + F+AA  K         ++++Y   GSL  YL++    T+ +  +I +AL  A G+ ++
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHL 117
Query: 301 H-----SQG---VIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDP----GTY 347
           H     +QG   + HRDLK +N+L+ +     IAD G+A   +   D +   P    GT 
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 348 RWMAPEMI------KHKSYGRKVDVYSFGLILWEM-----VAGT-----IPYEEMNPIQA 391
           R+MAPE++      KH    ++ D+Y+ GL+ WE+     + G      +PY ++ P   
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 237
Query: 392 AF-----AVVNKNLRPAIPG---DCPP--AMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           +       V  + LRP IP     C     MA ++ +CW      R     I K L Q 
Sbjct: 238 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 296

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 86/162 (53%), Gaps = 6/162 (3%)
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           L L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+A  ++Y D  
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-RDIYKDPD 253
Query: 341 SDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
               G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  +   +     
Sbjct: 254 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 313
Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 314 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 86/162 (53%), Gaps = 6/162 (3%)
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           L L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DFG+A  ++Y D  
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-RDIYKDPD 255
Query: 341 SDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
               G  R    WMAPE I  + Y  + DV+SFG++LWE+ + G  PY  +   +     
Sbjct: 256 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 315
Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
           + +  R   P    P M   +  CW  +P +RP F  +V+ L
Sbjct: 316 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 115/224 (51%), Gaps = 10/224 (4%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVKI+     +  +  +  +  +  RE+  L    +P++IK       P  + ++ EY+
Sbjct: 39  VAVKIL-----NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
           S G L  Y+ K  H  +   +   +   I   ++Y H   V+HRDLKPENVL+D   + K
Sbjct: 94  SGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAK 151
Query: 325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPY 383
           IADFG++      + L    G+  + APE+I  + Y G +VD++S G+IL+ ++ GT+P+
Sbjct: 152 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211
Query: 384 EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           ++ + +   F  +   +   IP     ++A L+     + P KR
Sbjct: 212 DDEH-VPTLFKKIRGGVF-YIPEYLNRSVATLLMHMLQVDPLKR 253

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 59/299 (19%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNV 244
              G    ++ G ++ E VAVKI            ++R E+ + RE  +     L + N+
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKI-----------FSSREERSWFREAEIYQTVMLRHENI 62
Query: 245 IKFVAACKKP----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           + F+AA  K         ++++Y   GSL  YL++    T+ +  +I +AL  A G+ ++
Sbjct: 63  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHL 119
Query: 301 H-----SQG---VIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDP----GTY 347
           H     +QG   + HRDLK +N+L+ +     IAD G+A   +   D +   P    GT 
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 348 RWMAPEMI------KHKSYGRKVDVYSFGLILWEM-----VAGT-----IPYEEMNPIQA 391
           R+MAPE++      KH    ++ D+Y+ GL+ WE+     + G      +PY ++ P   
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 239
Query: 392 AF-----AVVNKNLRPAIPG---DCPP--AMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           +       V  + LRP IP     C     MA ++ +CW      R     I K L Q 
Sbjct: 240 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 298

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 59/299 (19%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNV 244
              G    ++ G ++ E VAVKI            ++R E+ + RE  +     L + N+
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKI-----------FSSREERSWFREAEIYQTVMLRHENI 59
Query: 245 IKFVAACKKP----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           + F+AA  K         ++++Y   GSL  YL++    T+ +  +I +AL  A G+ ++
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHL 116
Query: 301 H-----SQG---VIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDP----GTY 347
           H     +QG   + HRDLK +N+L+ +     IAD G+A   +   D +   P    GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 348 RWMAPEMI------KHKSYGRKVDVYSFGLILWEM-----VAGT-----IPYEEMNPIQA 391
           R+MAPE++      KH    ++ D+Y+ GL+ WE+     + G      +PY ++ P   
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 392 AF-----AVVNKNLRPAIPG---DCPP--AMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           +       V  + LRP IP     C     MA ++ +CW      R     I K L Q 
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 52  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 109
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +          D
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRDD 168
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 226
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRP 252

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 99/170 (58%), Gaps = 5/170 (2%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
            + EYL+ G L  ++    HK   L +    A +I  G++++HS+G+++RDLK +N+L+D
Sbjct: 96  FVMEYLNGGDLMYHIQSC-HK-FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 153
Query: 319 QEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
           ++ H+KIADFG+  E +  DA +++  GT  ++APE++  + Y   VD +SFG++L+EM+
Sbjct: 154 KDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 213
Query: 378 AGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
            G  P+   +  +   ++   N  P  P         L+ + +  +P+KR
Sbjct: 214 IGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKR 261

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 17/209 (8%)
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-- 291
           +L S  ++P   K  +  K   ++ +  E+  +G+L  ++ K   +   L K++A+ L  
Sbjct: 87  SLESSDYDPENSKNSSRSKTKCLF-IQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFE 143
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
            I +G++YIHS+ +IHRDLKP N+ +     +KI DFG+          +   GT R+M+
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN--KNLRPAIPGDC- 408
           PE I  + YG++VD+Y+ GLIL E+         ++    AF       +LR  I  D  
Sbjct: 204 PEQISSQDYGKEVDLYALGLILAEL---------LHVCDTAFETSKFFTDLRDGIISDIF 254
Query: 409 PPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
                 L+++  S +P+ RP    I++ L
Sbjct: 255 DKKEKTLLQKLLSKKPEDRPNTSEILRTL 283

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 123/258 (47%), Gaps = 20/258 (7%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              GA   +Y GI+  +      PVA+K++R       E  + +  K+   E  +++ + 
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-------ENTSPKANKEILDEAYVMAGVG 77
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           +P V + +  C    V  ++T+ +  G L  ++ +     L    L+   + IA+GM Y+
Sbjct: 78  SPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRE-NRGRLGSQDLLNWCMQIAKGMSYL 135
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTY--RWMAPEMIKH 357
               ++HRDL   NVL+    H+KI DFG+A   ++       D G    +WMA E I  
Sbjct: 136 EDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILR 195
Query: 358 KSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
           + +  + DV+S+G+ +WE M  G  PY+ + P +    ++ K  R   P  C   +  ++
Sbjct: 196 RRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIM 254
Query: 417 EQCWSLQPDKRPEFWHIV 434
            +CW +  + RP F  +V
Sbjct: 255 VKCWMIDSECRPRFRELV 272

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 131/295 (44%), Gaps = 31/295 (10%)
Query: 164 RVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAA 223
           RV  VD  +E T +    FL     HG   ++Y G+ +D        R P+  +      
Sbjct: 28  RVPLVDL-EEATNNFDHKFL---IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
              +        LS   +P+++  +  C +     +I +Y+  G+L+ +L+  +  T+ +
Sbjct: 84  TEIET-------LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 284 P--KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCD 338
              + + I +  ARG+ Y+H++ +IHRD+K  N+L+D+ F  KI DFGI+    E     
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTH 196
Query: 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM------VAGTIPYEEMNPIQAA 392
                 GT  ++ PE         K DVYSFG++L+E+      +  ++P E +N  + A
Sbjct: 197 LXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 393 F---------AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
                      +V+ NL   I  +          +C +L  + RP    ++  LE
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 49  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 106
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         ++
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTE 165
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 223
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRP 249

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G +   L KL      
Sbjct: 54  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--SKFD 111
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTT 170
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 228
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 98/170 (57%), Gaps = 5/170 (2%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
            + EYL+ G L  ++    HK   L +    A +I  G++++HS+G+++RDLK +N+L+D
Sbjct: 95  FVMEYLNGGDLMYHIQSC-HK-FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 152
Query: 319 QEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
           ++ H+KIADFG+  E +  DA ++   GT  ++APE++  + Y   VD +SFG++L+EM+
Sbjct: 153 KDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212
Query: 378 AGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
            G  P+   +  +   ++   N  P  P         L+ + +  +P+KR
Sbjct: 213 IGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKR 260

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G +   L KL      
Sbjct: 54  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--SKFD 111
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +           
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXX 170
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 171 LXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 228
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 66  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 123
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 124 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTT 182
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 183 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 240
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 241 TFPDFVTEGARDLISRLLKHNPSQRP 266

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 96/180 (53%), Gaps = 15/180 (8%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPV----- 256
           VA+K +R+P+ +E   ++        REVALL RL    +PNV++ +  C          
Sbjct: 32  VALKSVRVPNGEEGLPIST------VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 85
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             ++ E++ +  LR YL K     LP   +  +     RG++++H+  ++HRDLKPEN+L
Sbjct: 86  VTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 144
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     +K+ADFG+A    Y  AL+    T  + APE++   +Y   VD++S G I  EM
Sbjct: 145 VTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 111/216 (51%), Gaps = 10/216 (4%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           R E  FN EV ++    + NV++   +        V+ E+L  G+L   +    H  +  
Sbjct: 191 RRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNE 246
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            ++ A+ L + + +  +H+QGVIHRD+K +++L+  +  +K++DFG  C +V  +     
Sbjct: 247 EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF-CAQVSKEVPRRK 305
Query: 344 P--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
              GT  WMAPE+I    YG +VD++S G+++ EMV G  PY    P++ A  ++  NL 
Sbjct: 306 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLP 364
Query: 402 PAIPG--DCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           P +       P++   +++     P +R     ++K
Sbjct: 365 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 54  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 111
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTT 170
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 228
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 52  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 109
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTT 168
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 226
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRP 252

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 140/298 (46%), Gaps = 61/298 (20%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNVIKF 247
           G +  ++ G ++ E VAVKI            ++R EK + RE  L +   L + N++ F
Sbjct: 48  GRYGEVWRGSWQGENVAVKI-----------FSSRDEKSWFRETELYNTVMLRHENILGF 96
Query: 248 VAACK----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH-- 301
           +A+            +IT Y   GSL  YL   +  TL     + I L IA G+ ++H  
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIE 153
Query: 302 ---SQG---VIHRDLKPENVLIDQEFHLKIADFGIAC---EEVYCDALSDDP--GTYRWM 350
              +QG   + HRDLK +N+L+ +     IAD G+A    +      + ++P  GT R+M
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 351 APEMIKHK-------SYGRKVDVYSFGLILWE----MVAGTI------PYEEMNPIQAAF 393
           APE++          SY ++VD+++FGL+LWE    MV+  I      P+ ++ P   +F
Sbjct: 214 APEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 272
Query: 394 AVVNKNL-----RPAIPGD-----CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE 441
             + K +     RP IP          ++A L+++CW   P  R     I K L + +
Sbjct: 273 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 330

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 20/221 (9%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           R E  FN EV ++    + NV++   +        V+ E+L  G+L   +    H  +  
Sbjct: 71  RRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNE 126
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            ++ A+ L + + +  +H+QGVIHRD+K +++L+  +  +K++DFG      +C  +S +
Sbjct: 127 EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG------FCAQVSKE 180
Query: 344 P-------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
                   GT  WMAPE+I    YG +VD++S G+++ EMV G  PY    P++ A  ++
Sbjct: 181 VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMI 239
Query: 397 NKNLRPAIPG--DCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
             NL P +       P++   +++     P +R     ++K
Sbjct: 240 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 280

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 5/213 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 75  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 132
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 133 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTT 191
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 249
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
             P         LI +     P +RP    +++
Sbjct: 250 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 49  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 106
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTT 165
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 223
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRP 249

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 20/221 (9%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           R E  FN EV ++    + NV++   +        V+ E+L  G+L   +    H  +  
Sbjct: 60  RRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNE 115
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            ++ A+ L + + +  +H+QGVIHRD+K +++L+  +  +K++DFG      +C  +S +
Sbjct: 116 EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG------FCAQVSKE 169
Query: 344 P-------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
                   GT  WMAPE+I    YG +VD++S G+++ EMV G  PY    P++ A  ++
Sbjct: 170 VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMI 228
Query: 397 NKNLRPAIPG--DCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
             NL P +       P++   +++     P +R     ++K
Sbjct: 229 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 53  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 110
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 111 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTT 169
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 227
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 228 TFPDFVTEGARDLISRLLKHNPSQRP 253

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 20/221 (9%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           R E  FN EV ++    + NV++   +        V+ E+L  G+L   +    H  +  
Sbjct: 64  RRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNE 119
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            ++ A+ L + + +  +H+QGVIHRD+K +++L+  +  +K++DFG      +C  +S +
Sbjct: 120 EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG------FCAQVSKE 173
Query: 344 P-------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
                   GT  WMAPE+I    YG +VD++S G+++ EMV G  PY    P++ A  ++
Sbjct: 174 VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMI 232
Query: 397 NKNLRPAIPG--DCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
             NL P +       P++   +++     P +R     ++K
Sbjct: 233 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 273

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++K+ADFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 112/234 (47%), Gaps = 32/234 (13%)
Query: 231 REVALLSRLHNPNVIKFV----------------AACKKPPVYCVITEYLSEGSLRAYLH 274
           REV  L++L + N++ +                 ++  K     +  E+  +G+L  ++ 
Sbjct: 53  REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 275 KLEHKTLPLPKLIAIAL--DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332
           K   +   L K++A+ L   I +G++YIHS+ +I+RDLKP N+ +     +KI DFG+  
Sbjct: 113 K--RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392
                       GT R+M+PE I  + YG++VD+Y+ GLIL E+         ++    A
Sbjct: 171 SLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL---------LHVCDTA 221
Query: 393 FAVVN--KNLRPAIPGDC-PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           F       +LR  I  D        L+++  S +P+ RP    I++ L  ++ S
Sbjct: 222 FETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 48  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 105
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 106 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTT 164
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 165 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 222
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 223 TFPDFVTEGARDLISRLLKHNPSQRP 248

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 52  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 109
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTT 168
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 226
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRP 252

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 20/221 (9%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           R E  FN EV ++    + NV++   +        V+ E+L  G+L   +    H  +  
Sbjct: 69  RRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNE 124
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            ++ A+ L + + +  +H+QGVIHRD+K +++L+  +  +K++DFG      +C  +S +
Sbjct: 125 EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG------FCAQVSKE 178
Query: 344 P-------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
                   GT  WMAPE+I    YG +VD++S G+++ EMV G  PY    P++ A  ++
Sbjct: 179 VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMI 237
Query: 397 NKNLRPAIPG--DCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
             NL P +       P++   +++     P +R     ++K
Sbjct: 238 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 278

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 67
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 95/180 (52%), Gaps = 15/180 (8%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPV----- 256
           VA+K +R+P+ +E   ++        REVALL RL    +PNV++ +  C          
Sbjct: 32  VALKSVRVPNGEEGLPIST------VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 85
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             ++ E++ +  LR YL K     LP   +  +     RG++++H+  ++HRDLKPEN+L
Sbjct: 86  VTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 144
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     +K+ADFG+A    Y  AL     T  + APE++   +Y   VD++S G I  EM
Sbjct: 145 VTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 103/198 (52%), Gaps = 6/198 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           RE++ L  L +P++IK       P    ++ EY + G L  Y+  +E K +   +     
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYI--VEKKRMTEDEGRRFF 114
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM 350
             I   +EY H   ++HRDLKPEN+L+D   ++KIADFG++      + L    G+  + 
Sbjct: 115 QQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174
Query: 351 APEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           APE+I  K Y G +VDV+S G++L+ M+ G +P+++   I   F  VN  +   +P    
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVY-VMPDFLS 232
Query: 410 PAMAALIEQCWSLQPDKR 427
           P   +LI +     P +R
Sbjct: 233 PGAQSLIRRMIVADPMQR 250

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 111/216 (51%), Gaps = 10/216 (4%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           R E  FN EV ++    + NV++   +        V+ E+L  G+L   +    H  +  
Sbjct: 114 RRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNE 169
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            ++ A+ L + + +  +H+QGVIHRD+K +++L+  +  +K++DFG  C +V  +     
Sbjct: 170 EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF-CAQVSKEVPRRK 228
Query: 344 P--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
              GT  WMAPE+I    YG +VD++S G+++ EMV G  PY    P++ A  ++  NL 
Sbjct: 229 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLP 287
Query: 402 PAIPG--DCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           P +       P++   +++     P +R     ++K
Sbjct: 288 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 49  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 106
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTX 165
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 223
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRP 249

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++K+ADFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 46  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 103
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 104 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTT 162
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 163 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 220
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 221 TFPDFVTEGARDLISRLLKHNPSQRP 246

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 95/170 (55%), Gaps = 4/170 (2%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 169
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A  +    A     GT  ++A
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGATWTLCGTPEYLA 227
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
           PE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 277

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 52  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 109
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRAA 168
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 226
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRP 252

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 140/298 (46%), Gaps = 61/298 (20%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNVIKF 247
           G +  ++ G ++ E VAVKI            ++R EK + RE  L +   L + N++ F
Sbjct: 19  GRYGEVWRGSWQGENVAVKI-----------FSSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 248 VAACK----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH-- 301
           +A+            +IT Y   GSL  YL   +  TL     + I L IA G+ ++H  
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 302 ---SQG---VIHRDLKPENVLIDQEFHLKIADFGIAC---EEVYCDALSDDP--GTYRWM 350
              +QG   + HRDLK +N+L+ +     IAD G+A    +      + ++P  GT R+M
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 351 APEMIKHK-------SYGRKVDVYSFGLILWE----MVAGTI------PYEEMNPIQAAF 393
           APE++          SY ++VD+++FGL+LWE    MV+  I      P+ ++ P   +F
Sbjct: 185 APEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 394 AVVNKNL-----RPAIPGD-----CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE 441
             + K +     RP IP          ++A L+++CW   P  R     I K L + +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 51  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 108
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +           
Sbjct: 109 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXX 167
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 168 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 225
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 226 TFPDFVTEGARDLISRLLKHNPSQRP 251

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 140/298 (46%), Gaps = 61/298 (20%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNVIKF 247
           G +  ++ G ++ E VAVKI            ++R EK + RE  L +   L + N++ F
Sbjct: 19  GRYGEVWRGSWQGENVAVKI-----------FSSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 248 VAACK----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH-- 301
           +A+            +IT Y   GSL  YL   +  TL     + I L IA G+ ++H  
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 302 ---SQG---VIHRDLKPENVLIDQEFHLKIADFGIAC---EEVYCDALSDDP--GTYRWM 350
              +QG   + HRDLK +N+L+ +     IAD G+A    +      + ++P  GT R+M
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 351 APEMIKHK-------SYGRKVDVYSFGLILWE----MVAGTI------PYEEMNPIQAAF 393
           APE++          SY ++VD+++FGL+LWE    MV+  I      P+ ++ P   +F
Sbjct: 185 APEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 394 AVVNKNL-----RPAIPGD-----CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE 441
             + K +     RP IP          ++A L+++CW   P  R     I K L + +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 49  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKL--SKFD 106
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 107 EQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRAA 165
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQDTYKRISR-VEF 223
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRP 249

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++K+ADFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 95/180 (52%), Gaps = 15/180 (8%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPV----- 256
           VA+K +R+P+ +E   ++        REVALL RL    +PNV++ +  C          
Sbjct: 32  VALKSVRVPNGEEGLPIST------VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 85
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             ++ E++ +  LR YL K     LP   +  +     RG++++H+  ++HRDLKPEN+L
Sbjct: 86  VTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 144
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     +K+ADFG+A    Y  AL     T  + APE++   +Y   VD++S G I  EM
Sbjct: 145 VTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEIXINKMLNHENV 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 49  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 106
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRAA 165
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 223
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRP 249

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 14/211 (6%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAAC---KKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           E    +E+ LL RL + NVI+ V      +K  +Y V+ EY   G ++  L  +  K  P
Sbjct: 50  EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM-EYCVCG-MQEMLDSVPEKRFP 107
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
           + +       +  G+EY+HSQG++H+D+KP N+L+     LKI+  G+A E ++  A  D
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA-EALHPFAADD 166
Query: 343 ----DPGTYRWMAPEMIKHKSY--GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
                 G+  +  PE+        G KVD++S G+ L+ +  G  P+E  N I   F  +
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENI 225
Query: 397 NKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
            K    AIPGDC P ++ L++     +P KR
Sbjct: 226 GKGSY-AIPGDCGPPLSDLLKGMLEYEPAKR 255

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 67
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 67
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 67
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 117/236 (49%), Gaps = 21/236 (8%)
Query: 206 AVKIIRI------PDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV 259
           AVKI+ +      P+  E    A R E    R+VA      +P++I  + + +      +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVA-----GHPHIITLIDSYESSSFMFL 177
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + + + +G L  YL   E   L   +  +I   +   + ++H+  ++HRDLKPEN+L+D 
Sbjct: 178 VFDLMRKGELFDYL--TEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235
Query: 320 EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK------HKSYGRKVDVYSFGLIL 373
              ++++DFG +C     + L +  GT  ++APE++K      H  YG++VD+++ G+IL
Sbjct: 236 NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 374 WEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPAMAALIEQCWSLQPDKR 427
           + ++AG+ P+     I     ++    + + P   D    +  LI +   + P+ R
Sbjct: 296 FTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEAR 351

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEIXINKMLNHENV 67
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 5/213 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 54  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 111
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTT 170
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PE I+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 171 LCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 228
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
             P         LI +     P +RP    +++
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPXLREVLE 261

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ + + L++ NV
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINAMLNHENV 67
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT--LPLPKLIAI 289
           E  +L+++H+  ++    A +     C++   ++ G +R +++ ++        P+ I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPG 345
              I  G+E++H + +I+RDLKPENVL+D + +++I+D G+A E    +      +  PG
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI- 404
              +MAPE++  + Y   VD ++ G+ L+EM+A   P+           V NK L+  + 
Sbjct: 355 ---FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-----KVENKELKQRVL 406
Query: 405 ------PGDCPPAMAALIEQCWSLQPDKRPEF 430
                 P    PA     E      P+KR  F
Sbjct: 407 EQAVTYPDKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT--LPLPKLIAI 289
           E  +L+++H+  ++    A +     C++   ++ G +R +++ ++        P+ I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPG 345
              I  G+E++H + +I+RDLKPENVL+D + +++I+D G+A E    +      +  PG
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI- 404
              +MAPE++  + Y   VD ++ G+ L+EM+A   P+           V NK L+  + 
Sbjct: 355 ---FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-----KVENKELKQRVL 406
Query: 405 ------PGDCPPAMAALIEQCWSLQPDKRPEF 430
                 P    PA     E      P+KR  F
Sbjct: 407 EQAVTYPDKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT--LPLPKLIAI 289
           E  +L+++H+  ++    A +     C++   ++ G +R +++ ++        P+ I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPG 345
              I  G+E++H + +I+RDLKPENVL+D + +++I+D G+A E    +      +  PG
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI- 404
              +MAPE++  + Y   VD ++ G+ L+EM+A   P+           V NK L+  + 
Sbjct: 355 ---FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-----KVENKELKQRVL 406
Query: 405 ------PGDCPPAMAALIEQCWSLQPDKRPEF 430
                 P    PA     E      P+KR  F
Sbjct: 407 EQAVTYPDKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 52  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 109
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +           
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXX 168
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 226
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRP 252

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 65
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 49  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 106
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +           
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXX 165
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 223
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRP 249

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/167 (36%), Positives = 98/167 (58%), Gaps = 17/167 (10%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPP---VYCVITEYLSEGSLRAYLHKLEHKTL-P 282
           +Q  +E+A+L +L +PNV+K V     P    +Y V  E +++G +      +E  TL P
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVF-ELVNQGPV------MEVPTLKP 133
Query: 283 LPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA- 339
           L +  A     D+ +G+EY+H Q +IHRD+KP N+L+ ++ H+KIADFG++ E    DA 
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 340 LSDDPGTYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPY 383
           LS+  GT  +MAPE +        G+ +DV++ G+ L+  V G  P+
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           AVK+++    + DDD   T+         + +  L+R H P + +     + P     + 
Sbjct: 52  AVKVLKKDVILQDDDVECTMT-------EKRILSLARNH-PFLTQLFCCFQTPDRLFFVM 103
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           E+++ G L  ++ K   +     +    A +I   + ++H +G+I+RDLK +NVL+D E 
Sbjct: 104 EFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG 161
Query: 322 HLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
           H K+ADFG+ C+E  C+ ++     GT  ++APE+++   YG  VD ++ G++L+EM+ G
Sbjct: 162 HCKLADFGM-CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220
Query: 380 TIPYEEMNPIQAAFAVVNKNL 400
             P+E  N      A++N  +
Sbjct: 221 HAPFEAENEDDLFEAILNDEV 241

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEIXINKMLNHENV 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 110/206 (53%), Gaps = 11/206 (5%)
Query: 231 REVALLSRLH-NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
           +EV +L ++  +PN+I+     +    + ++ + + +G L  YL   E  TL   +   I
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKI 129
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
              +   +  +H   ++HRDLKPEN+L+D + ++K+ DFG +C+    + L +  GT  +
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189
Query: 350 MAPEMIK------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
           +APE+I+      H  YG++VD++S G+I++ ++AG+ P+     +     +++ N +  
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249
Query: 404 IP--GDCPPAMAALIEQCWSLQPDKR 427
            P   D    +  L+ +   +QP KR
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQKR 275

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT--LPLPKLIAI 289
           E  +L+++H+  ++    A +     C++   ++ G +R +++ ++        P+ I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPG 345
              I  G+E++H + +I+RDLKPENVL+D + +++I+D G+A E    +      +  PG
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI- 404
              +MAPE++  + Y   VD ++ G+ L+EM+A   P+           V NK L+  + 
Sbjct: 355 ---FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-----KVENKELKQRVL 406
Query: 405 ------PGDCPPAMAALIEQCWSLQPDKRPEF 430
                 P    PA     E      P+KR  F
Sbjct: 407 EQAVTYPDKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 121/239 (50%), Gaps = 21/239 (8%)
Query: 203 EPVAVKIIRIPDDDENETLAAR--LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           + VA+KII       N+ + A+  ++ +  RE++ L  L +P++IK     K      ++
Sbjct: 39  QKVALKII-------NKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY +   L  Y+  ++   +   +       I   +EY H   ++HRDLKPEN+L+D+ 
Sbjct: 92  IEY-AGNELFDYI--VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH 148
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAG 379
            ++KIADFG++      + L    G+  + APE+I  K Y G +VDV+S G+IL+ M+  
Sbjct: 149 LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 208
Query: 380 TIPYEEMNPIQAAFAVVNKNLRPAI---PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
            +P+++      +  V+ KN+   +   P    P  A LI++   + P  R     I++
Sbjct: 209 RLPFDD-----ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 67
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L    +P +     A +     C + EY + G L  + H    +     +      
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 112
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRW 349
           +I   +EY+HS+ V++RD+K EN+++D++ H+KI DFG+ C+E   D  +     GT  +
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTPEY 171
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +APE+++   YGR VD +  G++++EM+ G +P+   +  +    ++ + +R   P    
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLS 229
Query: 410 PAMAALIEQCWSLQPDKR 427
           P   +L+       P +R
Sbjct: 230 PEAKSLLAGLLKKDPKQR 247

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 130/276 (47%), Gaps = 14/276 (5%)
Query: 178 LSQLFLGLRFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           L+   +  +   G  S +Y    +    PVA+K ++I D      + A+      +E+ L
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-----LMDAKARADCIKEIDL 85
Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLH--KLEHKTLPLPKLIAIALDI 293
           L +L++PNVIK+ A+  +     ++ E    G L   +   K + + +P   +    + +
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAP 352
              +E++HS+ V+HRD+KP NV I     +K+ D G+         A     GT  +M+P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIPGD-CP 409
           E I    Y  K D++S G +L+EM A   P+  ++MN + +    + +   P +P D   
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPPLPSDHYS 264
Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
             +  L+  C +  P+KRP+  ++  V ++     A
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 67
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 51  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 108
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIA+FG +         + 
Sbjct: 109 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSV-HAPSSRRTT 167
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 168 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 225
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 226 TFPDFVTEGARDLISRLLKHNPSQRP 251

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 87/164 (53%), Gaps = 7/164 (4%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 53  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FD 110
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +   V+  +   
Sbjct: 111 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRR 167
Query: 343 DP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
           D   GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+E
Sbjct: 168 DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L    +P +     A +     C + EY + G L  + H    +     +      
Sbjct: 58  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 115
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRW 349
           +I   +EY+HS+ V++RD+K EN+++D++ H+KI DFG+ C+E   D  +     GT  +
Sbjct: 116 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTPEY 174
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +APE+++   YGR VD +  G++++EM+ G +P+   +  +    ++ + +R   P    
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLS 232
Query: 410 PAMAALIEQCWSLQPDKR 427
           P   +L+       P +R
Sbjct: 233 PEAKSLLAGLLKKDPKQR 250

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 121/248 (48%), Gaps = 18/248 (7%)
Query: 208 KIIRIPDDDENETLAARL-----------EKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
           K   I D D  E  A ++           +++ + E+A+   L NP+V+ F    +    
Sbjct: 41  KCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDF 100
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             V+ E     SL   LHK   K +  P+         +G++Y+H+  VIHRDLK  N+ 
Sbjct: 101 VYVVLEICRRRSLLE-LHK-RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF 158
Query: 317 IDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           ++ +  +KI DFG+A + E   +   D  GT  ++APE++  K +  +VD++S G IL+ 
Sbjct: 159 LNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYT 218
Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           ++ G  P+ E + ++  +  + KN   ++P    P  +ALI +     P  RP    ++ 
Sbjct: 219 LLVGKPPF-ETSCLKETYIRIKKN-EYSVPRHINPVASALIRRMLHADPTLRPSVAELLT 276
Query: 436 VLEQFETS 443
             ++F TS
Sbjct: 277 --DEFFTS 282

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA+  +   + +  +E VAVKI+ +         A    +   +E+ +   L++ NV
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENV 66
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
           +KF    ++  +  +  EY S G L     ++E    +P P        +  G+ Y+H  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY 360
           G+ HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 361 -GRKVDVYSFGLILWEMVAGTIPYEE 385
               VDV+S G++L  M+AG +P+++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 5/206 (2%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 52  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFD 109
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIA+FG +         + 
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSV-HAPSSRRTT 168
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+ E N  Q  +  +++ +  
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR-VEF 226
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKRP 428
             P         LI +     P +RP
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRP 252

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 121/239 (50%), Gaps = 21/239 (8%)
Query: 203 EPVAVKIIRIPDDDENETLAAR--LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           + VA+KII       N+ + A+  ++ +  RE++ L  L +P++IK     K      ++
Sbjct: 40  QKVALKII-------NKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 92
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY +   L  Y+  ++   +   +       I   +EY H   ++HRDLKPEN+L+D+ 
Sbjct: 93  IEY-AGNELFDYI--VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH 149
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAG 379
            ++KIADFG++      + L    G+  + APE+I  K Y G +VDV+S G+IL+ M+  
Sbjct: 150 LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 209
Query: 380 TIPYEEMNPIQAAFAVVNKNLRPAI---PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
            +P+++      +  V+ KN+   +   P    P  A LI++   + P  R     I++
Sbjct: 210 RLPFDD-----ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 263

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 15/189 (7%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           +E VAVKI+ +         A    +   +E+ +   L++ NV+KF    ++  +  +  
Sbjct: 31  EEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 83
Query: 262 EYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           EY S G L     ++E    +P P        +  G+ Y+H  G+ HRD+KPEN+L+D+ 
Sbjct: 84  EYCSGGEL---FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 140
Query: 321 FHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEM 376
            +LKI+DFG+A    Y +    L+   GT  ++APE++K + +    VDV+S G++L  M
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200
Query: 377 VAGTIPYEE 385
           +AG +P+++
Sbjct: 201 LAGELPWDQ 209

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L    +P +     A +     C + EY + G L  + H    +     +      
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 112
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRW 349
           +I   +EY+HS+ V++RD+K EN+++D++ H+KI DFG+ C+E   D   +    GT  +
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKXFCGTPEY 171
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +APE+++   YGR VD +  G++++EM+ G +P+   +  +    ++ + +R   P    
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLS 229
Query: 410 PAMAALIEQCWSLQPDKR 427
           P   +L+       P +R
Sbjct: 230 PEAKSLLAGLLKKDPKQR 247

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 94/170 (55%), Gaps = 4/170 (2%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A  +          GT  ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRTWXLAGTPEYLA 206
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
           PE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 137/310 (44%), Gaps = 61/310 (19%)
Query: 180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR- 238
           Q+ +  +   G +  ++ G ++ E VAVK+    +           E  + RE  +    
Sbjct: 38  QIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----------EASWFRETEIYQTV 86
Query: 239 -LHNPNVIKFVAACKK-----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
            + + N++ F+AA  K       +Y +IT+Y   GSL  YL   +  TL    ++ +A  
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLY-LITDYHENGSLYDYL---KSTTLDAKSMLKLAYS 142
Query: 293 IARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
              G+ ++H++         + HRDLK +N+L+ +     IAD G+A + +      D P
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 345 -----GTYRWMAPEMI------KHKSYGRKVDVYSFGLILWEM----VAGTI------PY 383
                GT R+M PE++       H       D+YSFGLILWE+    V+G I      PY
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 384 EEMNPIQAAFA-----VVNKNLRPAIPG-----DCPPAMAALIEQCWSLQPDKRPEFWHI 433
            ++ P   ++      V  K LRP+ P      +C   M  L+ +CW+  P  R     +
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 434 VKVLEQFETS 443
            K L +   S
Sbjct: 323 KKTLAKMSES 332

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 121/248 (48%), Gaps = 18/248 (7%)
Query: 208 KIIRIPDDDENETLAARL-----------EKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
           K   I D D  E  A ++           +++ + E+A+   L NP+V+ F    +    
Sbjct: 57  KCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDF 116
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             V+ E     SL   LHK   K +  P+         +G++Y+H+  VIHRDLK  N+ 
Sbjct: 117 VYVVLEICRRRSLLE-LHK-RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF 174
Query: 317 IDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           ++ +  +KI DFG+A + E   +   D  GT  ++APE++  K +  +VD++S G IL+ 
Sbjct: 175 LNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYT 234
Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           ++ G  P+ E + ++  +  + KN   ++P    P  +ALI +     P  RP    ++ 
Sbjct: 235 LLVGKPPF-ETSCLKETYIRIKKN-EYSVPRHINPVASALIRRMLHADPTLRPSVAELLT 292
Query: 436 VLEQFETS 443
             ++F TS
Sbjct: 293 --DEFFTS 298

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 110/206 (53%), Gaps = 11/206 (5%)
Query: 231 REVALLSRLH-NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
           +EV +L ++  +PN+I+     +    + ++ + + +G L  YL   E  TL   +   I
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKI 116
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
              +   +  +H   ++HRDLKPEN+L+D + ++K+ DFG +C+    + L +  GT  +
Sbjct: 117 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 176
Query: 350 MAPEMIK------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
           +APE+I+      H  YG++VD++S G+I++ ++AG+ P+     +     +++ N +  
Sbjct: 177 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 236
Query: 404 IP--GDCPPAMAALIEQCWSLQPDKR 427
            P   D    +  L+ +   +QP KR
Sbjct: 237 SPEWDDYSDTVKDLVSRFLVVQPQKR 262

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L    +P +     A +     C + EY + G L  + H    +     +      
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 112
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRW 349
           +I   +EY+HS+ V++RD+K EN+++D++ H+KI DFG+ C+E   D   +    GT  +
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKXFCGTPEY 171
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +APE+++   YGR VD +  G++++EM+ G +P+   +  +    ++ + +R   P    
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLS 229
Query: 410 PAMAALIEQCWSLQPDKR 427
           P   +L+       P +R
Sbjct: 230 PEAKSLLAGLLKKDPKQR 247

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 121/239 (50%), Gaps = 21/239 (8%)
Query: 203 EPVAVKIIRIPDDDENETLAAR--LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           + VA+KII       N+ + A+  ++ +  RE++ L  L +P++IK     K      ++
Sbjct: 34  QKVALKII-------NKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 86
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY +   L  Y+  ++   +   +       I   +EY H   ++HRDLKPEN+L+D+ 
Sbjct: 87  IEY-AGNELFDYI--VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH 143
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAG 379
            ++KIADFG++      + L    G+  + APE+I  K Y G +VDV+S G+IL+ M+  
Sbjct: 144 LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 203
Query: 380 TIPYEEMNPIQAAFAVVNKNLRPAI---PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
            +P+++      +  V+ KN+   +   P    P  A LI++   + P  R     I++
Sbjct: 204 RLPFDD-----ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 257

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L    +P +     A +     C + EY + G L  + H    +     +      
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 112
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRW 349
           +I   +EY+HS+ V++RD+K EN+++D++ H+KI DFG+ C+E   D  +     GT  +
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTPEY 171
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +APE+++   YGR VD +  G++++EM+ G +P+   +  +    ++ + +R   P    
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLS 229
Query: 410 PAMAALIEQCWSLQPDKR 427
           P   +L+       P +R
Sbjct: 230 PEAKSLLAGLLKKDPKQR 247

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 121/239 (50%), Gaps = 21/239 (8%)
Query: 203 EPVAVKIIRIPDDDENETLAAR--LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           + VA+KII       N+ + A+  ++ +  RE++ L  L +P++IK     K      ++
Sbjct: 30  QKVALKII-------NKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 82
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY +   L  Y+  ++   +   +       I   +EY H   ++HRDLKPEN+L+D+ 
Sbjct: 83  IEY-AGNELFDYI--VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH 139
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAG 379
            ++KIADFG++      + L    G+  + APE+I  K Y G +VDV+S G+IL+ M+  
Sbjct: 140 LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 199
Query: 380 TIPYEEMNPIQAAFAVVNKNLRPAI---PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
            +P+++      +  V+ KN+   +   P    P  A LI++   + P  R     I++
Sbjct: 200 RLPFDD-----ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 253

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 6/196 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A  +          GT  ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRTWXLXGTPEYLA 206
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
           PE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R   P      
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSD 264
Query: 412 MAALIEQCWSLQPDKR 427
           +  L+     +   KR
Sbjct: 265 LKDLLRNLLQVDLTKR 280

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 149
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 231 REVALLSRLH-NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
           +EV +L ++  +PN+I+     +    + ++ + + +G L  YL   E  TL   +   I
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKI 129
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
              +   +  +H   ++HRDLKPEN+L+D + ++K+ DFG +C+    + L    GT  +
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSY 189
Query: 350 MAPEMIK------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
           +APE+I+      H  YG++VD++S G+I++ ++AG+ P+     +     +++ N +  
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249
Query: 404 IP--GDCPPAMAALIEQCWSLQPDKR 427
            P   D    +  L+ +   +QP KR
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQKR 275

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 125/264 (47%), Gaps = 26/264 (9%)
Query: 188 AHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNV 244
            +G + ++Y G  +   +  A+K++ +  D+E E           +E+ +L +  H+ N+
Sbjct: 33  GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---------IKQEINMLKKYSHHRNI 83
Query: 245 IKFVAAC--KKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
             +  A   K PP       ++ E+   GS+   +   +  TL    +  I  +I RG+ 
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIK- 356
           ++H   VIHRD+K +NVL+ +   +K+ DFG++ + +      +   GT  WMAPE+I  
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 357 ----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG-DCPPA 411
                 +Y  K D++S G+   EM  G  P  +M+P++A F ++ +N  P +        
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSKKWSKK 262
Query: 412 MAALIEQCWSLQPDKRPEFWHIVK 435
             + IE C      +RP    ++K
Sbjct: 263 FQSFIESCLVKNHSQRPATEQLMK 286

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L    +P +     A +     C + EY + G L  + H    +     +      
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 112
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRW 349
           +I   +EY+HS+ V++RD+K EN+++D++ H+KI DFG+ C+E   D   +    GT  +
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKXFCGTPEY 171
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +APE+++   YGR VD +  G++++EM+ G +P+   +  +    ++ + +R   P    
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLS 229
Query: 410 PAMAALIEQCWSLQPDKR 427
           P   +L+       P +R
Sbjct: 230 PEAKSLLAGLLKKDPKQR 247

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 140 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N     FA + K L    P 
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFAKIIK-LEYDFPE 255
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 256 KFFPKARDLVEKLLVLDATKR 276

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L    +P +     A +     C + EY + G L  + H    +     +      
Sbjct: 60  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 117
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRW 349
           +I   +EY+HS+ V++RD+K EN+++D++ H+KI DFG+ C+E   D   +    GT  +
Sbjct: 118 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKXFCGTPEY 176
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +APE+++   YGR VD +  G++++EM+ G +P+   +  +    ++ + +R   P    
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLS 234
Query: 410 PAMAALIEQCWSLQPDKR 427
           P   +L+       P +R
Sbjct: 235 PEAKSLLAGLLKKDPKQR 252

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVR 256

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 25/213 (11%)
Query: 186 RFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           R   G    +   I++D  E VA+K  R       + L+ +  +++  E+ ++ +L++PN
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCR-------QELSPKNRERWCLEIQIMKKLNHPN 74
Query: 244 VIKF------VAACKKPPVYCVITEYLSEGSLRAYLHKLEH----KTLPLPKLIAIALDI 293
           V+        +       +  +  EY   G LR YL++ E+    K  P+  L++   DI
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS---DI 131
Query: 294 ARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGTYRWM 350
           +  + Y+H   +IHRDLKPEN+++    Q    KI D G A E    +  ++  GT +++
Sbjct: 132 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 191
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           APE+++ K Y   VD +SFG + +E + G  P+
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 25/213 (11%)
Query: 186 RFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           R   G    +   I++D  E VA+K  R       + L+ +  +++  E+ ++ +L++PN
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCR-------QELSPKNRERWCLEIQIMKKLNHPN 73
Query: 244 VIKF------VAACKKPPVYCVITEYLSEGSLRAYLHKLEH----KTLPLPKLIAIALDI 293
           V+        +       +  +  EY   G LR YL++ E+    K  P+  L++   DI
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS---DI 130
Query: 294 ARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGTYRWM 350
           +  + Y+H   +IHRDLKPEN+++    Q    KI D G A E    +  ++  GT +++
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           APE+++ K Y   VD +SFG + +E + G  P+
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 121/250 (48%), Gaps = 30/250 (12%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           K E VA+K I +      E     ++ +  +E+  +S+ H+PN++ +  +        ++
Sbjct: 39  KKEKVAIKRINL------EKCQTSMD-ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91
Query: 261 TEYLSEGS----LRAYLHKLEHKT--LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
            + LS GS    ++  + K EHK+  L    +  I  ++  G+EY+H  G IHRD+K  N
Sbjct: 92  MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDP------GTYRWMAPEMIKH-KSYGRKVDVY 367
           +L+ ++  ++IADFG++        ++ +       GT  WMAPE+++  + Y  K D++
Sbjct: 152 ILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211
Query: 368 SFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP---------PAMAALIEQ 418
           SFG+   E+  G  PY +  P++     + +N  P++               +   +I  
Sbjct: 212 SFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLETGVQDKEMLKKYGKSFRKMISL 270
Query: 419 CWSLQPDKRP 428
           C    P+KRP
Sbjct: 271 CLQKDPEKRP 280

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 93/180 (51%), Gaps = 12/180 (6%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPV----- 256
           VA+K +R+P+          L     REVALL RL    +PNV++ +  C          
Sbjct: 37  VALKSVRVPN---GGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             ++ E++ +  LR YL K     LP   +  +     RG++++H+  ++HRDLKPEN+L
Sbjct: 94  VTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 152
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     +K+ADFG+A    Y  AL+    T  + APE++   +Y   VD++S G I  EM
Sbjct: 153 VTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 34/213 (15%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VAVK++ +      E L       FN EV ++    + NV++   +        V+ E+L
Sbjct: 73  VAVKMMDLRKQQRRELL-------FN-EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
             G+L   + ++    L   ++  +   + + + Y+H+QGVIHRD+K +++L+  +  +K
Sbjct: 125 QGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVK 181
Query: 325 IADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
           ++DFG      +C  +S D        GT  WMAPE+I    Y  +VD++S G+++ EMV
Sbjct: 182 LSDFG------FCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235
Query: 378 AGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
            G  PY   +P+QA      K LR     D PP
Sbjct: 236 DGEPPYFSDSPVQAM-----KRLR-----DSPP 258

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++     P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 121/250 (48%), Gaps = 30/250 (12%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           K E VA+K I +      E     ++ +  +E+  +S+ H+PN++ +  +        ++
Sbjct: 34  KKEKVAIKRINL------EKCQTSMD-ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 86
Query: 261 TEYLSEGS----LRAYLHKLEHKT--LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
            + LS GS    ++  + K EHK+  L    +  I  ++  G+EY+H  G IHRD+K  N
Sbjct: 87  MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 146
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDP------GTYRWMAPEMIKH-KSYGRKVDVY 367
           +L+ ++  ++IADFG++        ++ +       GT  WMAPE+++  + Y  K D++
Sbjct: 147 ILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 206
Query: 368 SFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP---------PAMAALIEQ 418
           SFG+   E+  G  PY +  P++     + +N  P++               +   +I  
Sbjct: 207 SFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLETGVQDKEMLKKYGKSFRKMISL 265
Query: 419 CWSLQPDKRP 428
           C    P+KRP
Sbjct: 266 CLQKDPEKRP 275

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 140 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N     FA + K L    P 
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFAKIIK-LEYDFPE 255
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 256 KFFPKARDLVEKLLVLDATKR 276

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++     P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA------CEEVYCDALSDD 343
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A       ++   +A    
Sbjct: 138 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-- 193
Query: 344 PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA 403
            GT ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L   
Sbjct: 194 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYD 250
Query: 404 IPGDCPPAMAALIEQCWSLQPDKR 427
            P    P    L+E+   L   KR
Sbjct: 251 FPEKFFPKARDLVEKLLVLDATKR 274

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++     P  +  A   
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-- 169
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 222
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 277

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++     P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN++IDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++     P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 149
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-------GT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++     P  +  A   
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-- 143
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 144 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 196
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 197 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 251

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA 139
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 140 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 255
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 256 KFFPKARDLVEKLLVLDATKR 276

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 134
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 135 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-------GT 187
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 188 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 242

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G+++++M AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 3/162 (1%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
           A +E Q  REV + S L +PN+++            +I EY   G++   L KL      
Sbjct: 53  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FD 110
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             +      ++A  + Y HS+ VIHRD+KPEN+L+     LKIADFG +         + 
Sbjct: 111 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP-SSRRTT 169
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
             GT  ++ PEMI+ + +  KVD++S G++ +E + G  P+E
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 149
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 141
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 194
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 195 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 249

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY   G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN++IDQ+ ++K+ DFG+A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 149
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 149
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 169
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 222
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 277

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 149
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 83  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 142
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 143 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPA 258
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 259 AFFPKARDLVEKLLVLDATKR 279

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 187 FAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
              G   ++Y G   D   VAVK ++       E      E QF  EV ++S   + N++
Sbjct: 46  LGRGGFGKVYKGRLADGTLVAVKRLK-------EERXQGGELQFQTEVEMISMAVHRNLL 98
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL--PKLIAIALDIARGMEYIHSQ 303
           +    C  P    ++  Y++ GS+ + L +      PL  PK   IAL  ARG+ Y+H  
Sbjct: 99  RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 158
Query: 304 ---GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHK 358
               +IHRD+K  N+L+D+EF   + DFG+A    Y D        GT   +APE +   
Sbjct: 159 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTG 218
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYE 384
               K DV+ +G++L E++ G   ++
Sbjct: 219 KSSEKTDVFGYGVMLLELITGQRAFD 244

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 77  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 136
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 137 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 252
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 253 KFFPKARDLVEKLLVLDATKR 273

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 88/165 (53%), Gaps = 14/165 (8%)
Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
           P ++K   + K      ++ EY   G + ++L ++   + P  +  A    I    EY+H
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAA--QIVLTFEYLH 159
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGTYRWMAPEMIK 356
           S  +I+RDLKPEN+LIDQ+ ++K+ADFG A          C       GT  ++APE+I 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-------GTPEYLAPEIIL 212
Query: 357 HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
            K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 135
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LID++ ++++ DFG A          C       GT
Sbjct: 136 QIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-------GT 188
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R   P 
Sbjct: 189 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPS 246
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
                +  L+     +   KR
Sbjct: 247 HFSSDLKDLLRNLLQVDLTKR 267

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 81  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 140
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 141 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 256
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 257 KFFPKARDLVEKLLVLDATKR 277

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 142/313 (45%), Gaps = 25/313 (7%)
Query: 161 GGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENET 220
           G ++++     D    DL  L    R A+G+ +++ H     + +AVK IR        T
Sbjct: 7   GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP-SGQIMAVKRIR-------ST 58
Query: 221 LAARLEKQFNREVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEG--SLRAYLHKLE 277
           +  + +KQ   ++ ++ R  + P +++F  A  +     +  E +S        Y++ + 
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 278 HKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
              +P   L  I L   + + ++     +IHRD+KP N+L+D+  ++K+ DFGI+ + V 
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178
Query: 337 CDALSDDPGTYRWMAPEMI----KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392
             A + D G   +MAPE I      + Y  + DV+S G+ L+E+  G  PY + N +   
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238
Query: 393 FAVVNKNLRPAIPG----DCPPAMAALIEQCWSLQPDKRPEFWHIVK-----VLEQFETS 443
              V K   P +      +  P+    +  C +    KRP++  ++K     + E+    
Sbjct: 239 LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVE 298
Query: 444 LACNGTLNLVQNP 456
           +AC     L Q P
Sbjct: 299 VACYVCKILDQMP 311

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY   G + ++L ++   + P  +  A   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-- 149
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN++IDQ+ ++K+ DFG A          C       GT
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 17/218 (7%)
Query: 186 RFAHGAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
               GA  ++Y    K+  V  A K+I    ++E E         +  E+ +L+   +PN
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--------DYMVEIDILASCDHPN 95
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K + A        ++ E+ + G++ A + +LE + L   ++  +       + Y+H  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN 154
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI-----KH 357
            +IHRDLK  N+L   +  +K+ADFG++ +        D   GT  WMAPE++     K 
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
           + Y  K DV+S G+ L EM     P+ E+NP++    +
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 138 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 253
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 254 KFFPKARDLVEKLLVLDATKR 274

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY   G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN++IDQ+ ++K+ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 62  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 121
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 122 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 237
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 238 KFFPKARDLVEKLLVLDATKR 258

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 140 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 255
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 256 KFFPKARDLVEKLLVLDATKR 276

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
              +APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 56  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 115
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 116 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 231
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 232 KFFPKARDLVEKLLVLDATKR 252

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 138 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 253
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 254 KFFPKARDLVEKLLVLDATKR 274

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 55  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 114
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 115 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 230
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 231 KFFPKARDLVEKLLVLDATKR 251

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 138 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 253
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 254 KFFPKARDLVEKLLVLDATKR 274

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 140 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 255
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 256 KFFPKARDLVEKLLVLDATKR 276

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 140 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 255
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 256 KFFPKARDLVEKLLVLDATKR 276

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++     P  +  A   
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-- 141
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 194
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 195 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 249

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 57  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 116
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 117 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 232
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 233 KFFPKARDLVEKLLVLDATKR 253

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 26/279 (9%)
Query: 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           G +   G    +Y G   +  VAVK +    D   E     L++QF++E+ + ++  + N
Sbjct: 27  GNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE----ELKQQFDQEIKVXAKCQHEN 82
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIH 301
           +++ +         C++  Y   GSL   L  L+  T PL       IA   A G+ ++H
Sbjct: 83  LVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD-GTPPLSWHXRCKIAQGAANGINFLH 141
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDAL--SDDPGTYRWMAPEMIKHK 358
               IHRD+K  N+L+D+ F  KI+DFG+A   E +   +  S   GT  + APE ++ +
Sbjct: 142 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE 201
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV--------------VNKNLRPAI 404
               K D+YSFG++L E++ G    +E    Q    +              ++K    A 
Sbjct: 202 -ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDA- 259
Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
                 A  ++  QC   + +KRP+   + ++L++   S
Sbjct: 260 DSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQEXTAS 298

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 58  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 117
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 118 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 233
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 234 KFFPKARDLVEKLLVLDATKR 254

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 77  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 136
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 137 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 252
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 253 KFFPKARDLVEKLLVLDATKR 273

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 81  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 140
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 141 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 256
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 257 KFFPKARDLVEKLLVLDATKR 277

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 122/250 (48%), Gaps = 13/250 (5%)
Query: 190 GAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNRE-VALLSRLHNPNVIK 246
           G+  ++    +K E V  AVK+++     +   L  + EK    E   LL  + +P ++ 
Sbjct: 49  GSFGKVLLARHKAEEVFYAVKVLQ-----KKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
              + +       + +Y++ G L  + H    +    P+    A +IA  + Y+HS  ++
Sbjct: 104 LHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVD 365
           +RDLKPEN+L+D + H+ + DFG+  E + +    S   GT  ++APE++  + Y R VD
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVD 221
Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--NLRPAIPGDCPPAMAALIEQCWSLQ 423
            +  G +L+EM+ G  P+   N  +    ++NK   L+P I       +  L+++  + +
Sbjct: 222 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281
Query: 424 PDKRPEFWHI 433
              + +F  I
Sbjct: 282 LGAKDDFMEI 291

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 93/180 (51%), Gaps = 15/180 (8%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN---PNVIKFVAAC-----KKPPV 256
           VA+K +R+   +E   L+        REVA+L  L     PNV++    C      +   
Sbjct: 40  VALKRVRVQTGEEGMPLST------IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             ++ E++ +  L  YL K+    +P   +  +   + RG++++HS  V+HRDLKP+N+L
Sbjct: 94  LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 152
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     +K+ADFG+A    +  AL+    T  + APE++   SY   VD++S G I  EM
Sbjct: 153 VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++     P  +  A   
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-- 149
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 17/218 (7%)
Query: 186 RFAHGAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
               GA  ++Y    K+  V  A K+I    ++E E         +  E+ +L+   +PN
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--------DYMVEIDILASCDHPN 95
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K + A        ++ E+ + G++ A + +LE + L   ++  +       + Y+H  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN 154
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI-----KH 357
            +IHRDLK  N+L   +  +K+ADFG++ +        D   GT  WMAPE++     K 
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
           + Y  K DV+S G+ L EM     P+ E+NP++    +
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++     P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++AP +I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY+  G + ++L ++     P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 64
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+LS   L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKPEN+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 184 TAVDIWSLGCIFAEMVT 200

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 66
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+LS   L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKPEN+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 126 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 186 TAVDIWSLGCIFAEMVT 202

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 85  TRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 144
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
             +I   +EY+H +G+IHRDLKPEN+L++++ H++I DFG A     E      +   GT
Sbjct: 145 --EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++   L    P 
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPE 260
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
              P    L+E+   L   KR
Sbjct: 261 KFFPKARDLVEKLLVLDATKR 281

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 89/158 (56%), Gaps = 5/158 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  + +P ++  + A +      +I EYLS G L     +LE + + +       L
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYL 127
Query: 292 -DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRW 349
            +I+  + ++H +G+I+RDLKPEN++++ + H+K+ DFG+  E ++   ++    GT  +
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
           MAPE++    + R VD +S G ++++M+ G  P+   N
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 93/180 (51%), Gaps = 15/180 (8%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN---PNVIKFVAACK-----KPPV 256
           VA+K +R+   +E   L+        REVA+L  L     PNV++    C      +   
Sbjct: 40  VALKRVRVQTGEEGMPLST------IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             ++ E++ +  L  YL K+    +P   +  +   + RG++++HS  V+HRDLKP+N+L
Sbjct: 94  LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 152
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     +K+ADFG+A    +  AL+    T  + APE++   SY   VD++S G I  EM
Sbjct: 153 VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 89/158 (56%), Gaps = 5/158 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  + +P ++  + A +      +I EYLS G L     +LE + + +       L
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYL 127
Query: 292 -DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRW 349
            +I+  + ++H +G+I+RDLKPEN++++ + H+K+ DFG+  E ++   ++    GT  +
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEY 187
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
           MAPE++    + R VD +S G ++++M+ G  P+   N
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 187 FAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
              G   ++Y G   D   VAVK ++     E  T    L  QF  EV ++S   + N++
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKRLK-----EERTQGGEL--QFQTEVEMISMAVHRNLL 90
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL--PKLIAIALDIARGMEYIHSQ 303
           +    C  P    ++  Y++ GS+ + L +      PL  PK   IAL  ARG+ Y+H  
Sbjct: 91  RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150
Query: 304 ---GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHK 358
               +IHRD+K  N+L+D+EF   + DFG+A    Y D        G    +APE +   
Sbjct: 151 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTG 210
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYE 384
               K DV+ +G++L E++ G   ++
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAFD 236

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 93/180 (51%), Gaps = 15/180 (8%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN---PNVIKFVAAC-----KKPPV 256
           VA+K +R+   +E   L+        REVA+L  L     PNV++    C      +   
Sbjct: 40  VALKRVRVQTGEEGMPLST------IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             ++ E++ +  L  YL K+    +P   +  +   + RG++++HS  V+HRDLKP+N+L
Sbjct: 94  LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 152
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     +K+ADFG+A    +  AL+    T  + APE++   SY   VD++S G I  EM
Sbjct: 153 VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 17/218 (7%)
Query: 186 RFAHGAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
               GA  ++Y    K+  V  A K+I    ++E E         +  E+ +L+   +PN
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--------DYMVEIDILASCDHPN 95
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K + A        ++ E+ + G++ A + +LE + L   ++  +       + Y+H  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN 154
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI-----KH 357
            +IHRDLK  N+L   +  +K+ADFG++ +        D   GT  WMAPE++     K 
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
           + Y  K DV+S G+ L EM     P+ E+NP++    +
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 120/248 (48%), Gaps = 18/248 (7%)
Query: 208 KIIRIPDDDENETLAARL-----------EKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
           K   I D D  E  A ++           +++ + E+A+   L NP+V+ F    +    
Sbjct: 57  KCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDF 116
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             V+ E     SL   LHK   K +  P+         +G++Y+H+  VIHRDLK  N+ 
Sbjct: 117 VYVVLEICRRRSLLE-LHK-RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF 174
Query: 317 IDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           ++ +  +KI DFG+A + E   +      GT  ++APE++  K +  +VD++S G IL+ 
Sbjct: 175 LNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYT 234
Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           ++ G  P+ E + ++  +  + KN   ++P    P  +ALI +     P  RP    ++ 
Sbjct: 235 LLVGKPPF-ETSCLKETYIRIKKN-EYSVPRHINPVASALIRRMLHADPTLRPSVAELLT 292
Query: 436 VLEQFETS 443
             ++F TS
Sbjct: 293 --DEFFTS 298

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY   G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN++IDQ+ ++++ DFG+A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 70
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y 
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 190 TAVDIWSLGCIFAEMVT 206

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 91/175 (52%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY   G + ++L ++     P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN++IDQ+ ++K+ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 120/248 (48%), Gaps = 18/248 (7%)
Query: 208 KIIRIPDDDENETLAARL-----------EKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
           K   I D D  E  A ++           +++ + E+A+   L NP+V+ F    +    
Sbjct: 57  KCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDF 116
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             V+ E     SL   LHK   K +  P+         +G++Y+H+  VIHRDLK  N+ 
Sbjct: 117 VYVVLEICRRRSLLE-LHK-RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF 174
Query: 317 IDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           ++ +  +KI DFG+A + E   +      GT  ++APE++  K +  +VD++S G IL+ 
Sbjct: 175 LNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYT 234
Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           ++ G  P+ E + ++  +  + KN   ++P    P  +ALI +     P  RP    ++ 
Sbjct: 235 LLVGKPPF-ETSCLKETYIRIKKN-EYSVPRHINPVASALIRRMLHADPTLRPSVAELLT 292
Query: 436 VLEQFETS 443
             ++F TS
Sbjct: 293 --DEFFTS 298

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 63
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 183 TAVDIWSLGCIFAEMVT 199

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 92/175 (52%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P ++K   + K      ++ EY   G + ++L ++   + P  +  A   
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-- 148
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN++IDQ+ ++++ DFG A          C       GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-------GT 201
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 64
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKPEN+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 184 TAVDIWSLGCIFAEMVT 200

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 63
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 183 TAVDIWSLGCIFAEMVT 199

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 91/175 (52%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P + K   + K      ++ EY   G + ++L ++   + P  +  A   
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-- 149
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN++IDQ+ ++K+ DFG A          C       GT
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 65
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKPEN+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 125 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 185 TAVDIWSLGCIFAEMVT 201

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 91/175 (52%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P + K   + K      ++ EY   G + ++L ++   + P  +  A   
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-- 149
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN++IDQ+ ++K+ DFG A          C       GT
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 70
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y 
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 190 TAVDIWSLGCIFAEMVT 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 62
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 182 TAVDIWSLGCIFAEMVT 198

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 108/221 (48%), Gaps = 17/221 (7%)
Query: 187 FAHGAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA  ++Y    K+     A K+I    ++E E         +  E+ +L+   +P +
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE--------DYIVEIEILATCDHPYI 78
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           +K + A        ++ E+   G++ A + +L+ + L  P++  +   +   + ++HS+ 
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI-----KHK 358
           +IHRDLK  NVL+  E  +++ADFG++ + +      D   GT  WMAPE++     K  
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN 399
            Y  K D++S G+ L EM     P+ E+NP++    +   +
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 115/260 (44%), Gaps = 20/260 (7%)
Query: 177 DLSQLFLGLR-FAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           D  +LF  LR   HG+   +Y    +   E VA+K +       NE       +   +EV
Sbjct: 51  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-----QDIIKEV 105
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
             L +L +PN I++     +     ++ EY L   S    +HK   K L   ++ A+   
Sbjct: 106 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHG 162
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
             +G+ Y+HS  +IHRD+K  N+L+ +   +K+ DFG A      +      GT  WMAP
Sbjct: 163 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV---GTPYWMAP 219
Query: 353 EMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI-PGDC 408
           E+I       Y  KVDV+S G+   E+     P   MN + A + +  +N  PA+  G  
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQSGHW 278
Query: 409 PPAMAALIEQCWSLQPDKRP 428
                  ++ C    P  RP
Sbjct: 279 SEYFRNFVDSCLQKIPQDRP 298

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 64
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 184 TAVDIWSLGCIFAEMVT 200

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 115/260 (44%), Gaps = 20/260 (7%)
Query: 177 DLSQLFLGLR-FAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           D  +LF  LR   HG+   +Y    +   E VA+K +       NE       +   +EV
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-----QDIIKEV 66
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
             L +L +PN I++     +     ++ EY L   S    +HK   K L   ++ A+   
Sbjct: 67  RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHG 123
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
             +G+ Y+HS  +IHRD+K  N+L+ +   +K+ DFG A      +      GT  WMAP
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV---GTPYWMAP 180
Query: 353 EMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI-PGDC 408
           E+I       Y  KVDV+S G+   E+     P   MN + A + +  +N  PA+  G  
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQSGHW 239
Query: 409 PPAMAALIEQCWSLQPDKRP 428
                  ++ C    P  RP
Sbjct: 240 SEYFRNFVDSCLQKIPQDRP 259

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 63
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 183 TAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 62
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 182 TAVDIWSLGCIFAEMVT 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 63
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 183 TAVDIWSLGCIFAEMVT 199

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 118/248 (47%), Gaps = 18/248 (7%)
Query: 208 KIIRIPDDDENETLAARL-----------EKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
           K   I D D  E  A ++            ++ + E+++   L + +V+ F    +    
Sbjct: 32  KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 91
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             V+ E     SL   LHK   K L  P+       I  G +Y+H   VIHRDLK  N+ 
Sbjct: 92  VFVVLELCRRRSLLE-LHK-RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 149
Query: 317 IDQEFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           ++++  +KI DFG+A +  Y  +      GT  ++APE++  K +  +VDV+S G I++ 
Sbjct: 150 LNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 209
Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           ++ G  P+ E + ++  +  + KN   +IP    P  A+LI++     P  RP    ++ 
Sbjct: 210 LLVGKPPF-ETSCLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 267
Query: 436 VLEQFETS 443
             ++F TS
Sbjct: 268 --DEFFTS 273

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 206 AVKII--------RIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
           A+K+I        R  DD++N     +  ++   E++LL  L +PN+IK     +    +
Sbjct: 65  AIKVIKKSQFDKGRYSDDNKN---IEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 258 CVITEYLSEGSLRAYL---HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
            ++TE+   G L   +   HK +           I   I  G+ Y+H   ++HRD+KPEN
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDAA-----NIMKQILSGICYLHKHNIVHRDIKPEN 176
Query: 315 VLIDQE---FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGL 371
           +L++ +    ++KI DFG++        L D  GT  ++APE++K K Y  K DV+S G+
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGV 235
Query: 372 ILWEMVAGTIPYEEMNP 388
           I++ ++ G  P+   N 
Sbjct: 236 IMYILLCGYPPFGGQND 252

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 63
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKPEN+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 123 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 183 TAVDIWSLGCIFAEMVT 199

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 108/222 (48%), Gaps = 17/222 (7%)
Query: 186 RFAHGAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
               GA  ++Y    K+     A K+I    ++E E         +  E+ +L+   +P 
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE--------DYIVEIEILATCDHPY 69
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K + A        ++ E+   G++ A + +L+ + L  P++  +   +   + ++HS+
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI-----KH 357
            +IHRDLK  NVL+  E  +++ADFG++ + +      D   GT  WMAPE++     K 
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN 399
             Y  K D++S G+ L EM     P+ E+NP++    +   +
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 230

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 118/248 (47%), Gaps = 18/248 (7%)
Query: 208 KIIRIPDDDENETLAARL-----------EKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
           K   I D D  E  A ++            ++ + E+++   L + +V+ F    +    
Sbjct: 32  KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 91
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             V+ E     SL   LHK   K L  P+       I  G +Y+H   VIHRDLK  N+ 
Sbjct: 92  VFVVLELCRRRSLLE-LHK-RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 149
Query: 317 IDQEFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           ++++  +KI DFG+A +  Y  +      GT  ++APE++  K +  +VDV+S G I++ 
Sbjct: 150 LNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 209
Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           ++ G  P+ E + ++  +  + KN   +IP    P  A+LI++     P  RP    ++ 
Sbjct: 210 LLVGKPPF-ETSCLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 267
Query: 436 VLEQFETS 443
             ++F TS
Sbjct: 268 --DEFFTS 273

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           VD+       +   G +  +Y    K   E VA+K IR+  D E E + +       RE+
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREI 57
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
           +LL  L++PN++K +          ++ E+L +  L+ ++       +PLP + +    +
Sbjct: 58  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAP 352
            +G+ + HS  V+HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + AP
Sbjct: 117 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 176
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVA 378
           E ++  K Y   VD++S G I  EMV 
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 65
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+LS   L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 185 TAVDIWSLGCIFAEMVT 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 66
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 186 TAVDIWSLGCIFAEMVT 202

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 66
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+LS   L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 186 TAVDIWSLGCIFAEMVT 202

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +E Q  RE+ + + LH+PN+++            +I EY   G L   L K    T    
Sbjct: 66  VEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK--SCTFDEQ 123
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           +   I  ++A  + Y H + VIHRD+KPEN+L+  +  LKIADFG +   V+  +L    
Sbjct: 124 RTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWS---VHAPSLRRKT 180
Query: 345 --GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  ++ PEMI+ + +  KVD++  G++ +E++ G  P+E  +  +    +V  +L+ 
Sbjct: 181 MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLK- 239
Query: 403 AIPGDCPPAMAALIEQCWSLQPDKR 427
             P   P     LI +     P +R
Sbjct: 240 -FPASVPTGAQDLISKLLRHNPSER 263

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 90/175 (51%), Gaps = 14/175 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E  +L  ++ P + K   + K      ++ EY   G + ++L ++     P  +  A   
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAA-- 149
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-----VYCDALSDDPGT 346
            I    EY+HS  +I+RDLKPEN++IDQ+ ++K+ DFG A          C       GT
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             ++APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 118/248 (47%), Gaps = 18/248 (7%)
Query: 208 KIIRIPDDDENETLAARL-----------EKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
           K   I D D  E  A ++            ++ + E+++   L + +V+ F    +    
Sbjct: 36  KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 95
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             V+ E     SL   LHK   K L  P+       I  G +Y+H   VIHRDLK  N+ 
Sbjct: 96  VFVVLELCRRRSLLE-LHK-RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 153
Query: 317 IDQEFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
           ++++  +KI DFG+A +  Y  +      GT  ++APE++  K +  +VDV+S G I++ 
Sbjct: 154 LNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 213
Query: 376 MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           ++ G  P+ E + ++  +  + KN   +IP    P  A+LI++     P  RP    ++ 
Sbjct: 214 LLVGKPPF-ETSCLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 271
Query: 436 VLEQFETS 443
             ++F TS
Sbjct: 272 --DEFFTS 277

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 121/259 (46%), Gaps = 30/259 (11%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              G    ++ G++  E      PV +K+I   D    ++  A  +         +  L 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVTDHMLA-----IGSLD 73
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA-IALDIARGMEY 299
           + ++++ +  C    +  ++T+YL  GSL    H  +H+    P+L+    + IA+GM Y
Sbjct: 74  HAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-------CEEVYCDALSDDPGTYRWMAP 352
           +   G++HR+L   NVL+     +++ADFG+A        + +Y +A +      +WMA 
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT----PIKWMAL 186
Query: 353 EMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
           E I    Y  + DV+S+G+ +WE M  G  PY  +  +     ++ K  R A P  C   
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTID 245
Query: 412 MAALIEQCWSLQPDKRPEF 430
           +  ++ +CW +  + RP F
Sbjct: 246 VYMVMVKCWMIDENIRPTF 264

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 93/179 (51%), Gaps = 7/179 (3%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +E Q  RE+ + S L +PN+++            ++ E+   G L   L K  H      
Sbjct: 58  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQ 115
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           +      ++A  + Y H + VIHRD+KPEN+L+  +  LKIADFG +   V+  +L    
Sbjct: 116 RSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRX 172
Query: 345 --GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             GT  ++ PEMI+ K++  KVD++  G++ +E + G  P++  +  +    +VN +L+
Sbjct: 173 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK 231

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 65
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 185 TAVDIWSLGCIFAEMVT 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 63
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 183 TAVDIWSLGCIFAEMVT 199

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 119/255 (46%), Gaps = 32/255 (12%)
Query: 208 KIIRIPDDDENETLAARL-----------EKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
           K   I D D  E  A ++            ++ + E+++   L + +V+ F    +    
Sbjct: 30  KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 89
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             V+ E     SL   LHK   K L  P+       I  G +Y+H   VIHRDLK  N+ 
Sbjct: 90  VFVVLELCRRRSLLE-LHK-RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 147
Query: 317 IDQEFHLKIADFGIAC--------EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
           ++++  +KI DFG+A         ++V C       GT  ++APE++  K +  +VDV+S
Sbjct: 148 LNEDLEVKIGDFGLATKVEYDGERKKVLC-------GTPNYIAPEVLSKKGHSFEVDVWS 200
Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
            G I++ ++ G  P+ E + ++  +  + KN   +IP    P  A+LI++     P  RP
Sbjct: 201 IGCIMYTLLVGKPPF-ETSCLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARP 258
Query: 429 EFWHIVKVLEQFETS 443
               ++   ++F TS
Sbjct: 259 TINELLN--DEFFTS 271

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 64
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 184 TAVDIWSLGCIFAEMVT 200

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 87/156 (55%), Gaps = 6/156 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV LL +L +PN++K     +    + ++ E  + G L  +   ++ K         I 
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARII 127
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTY 347
             +  G+ Y+H   ++HRDLKPEN+L+   +++  +KI DFG++        + D  GT 
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
            ++APE+++  +Y  K DV+S G+IL+ +++GT P+
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 66
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 186 TAVDIWSLGCIFAEMVT 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 63
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 183 TAVDIWSLGCIFAEMVT 199

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 119/255 (46%), Gaps = 32/255 (12%)
Query: 208 KIIRIPDDDENETLAARL-----------EKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
           K   I D D  E  A ++            ++ + E+++   L + +V+ F    +    
Sbjct: 54  KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 113
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             V+ E     SL   LHK   K L  P+       I  G +Y+H   VIHRDLK  N+ 
Sbjct: 114 VFVVLELCRRRSLLE-LHK-RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 171
Query: 317 IDQEFHLKIADFGIAC--------EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
           ++++  +KI DFG+A         ++V C       GT  ++APE++  K +  +VDV+S
Sbjct: 172 LNEDLEVKIGDFGLATKVEYDGERKKVLC-------GTPNYIAPEVLSKKGHSFEVDVWS 224
Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
            G I++ ++ G  P+ E + ++  +  + KN   +IP    P  A+LI++     P  RP
Sbjct: 225 IGCIMYTLLVGKPPF-ETSCLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARP 282
Query: 429 EFWHIVKVLEQFETS 443
               ++   ++F TS
Sbjct: 283 TINELLN--DEFFTS 295

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 66
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 186 TAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 65
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 185 TAVDIWSLGCIFAEMVT 201

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 93/179 (51%), Gaps = 7/179 (3%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +E Q  RE+ + S L +PN+++            ++ E+   G L   L K  H      
Sbjct: 57  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQ 114
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           +      ++A  + Y H + VIHRD+KPEN+L+  +  LKIADFG +   V+  +L    
Sbjct: 115 RSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRX 171
Query: 345 --GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             GT  ++ PEMI+ K++  KVD++  G++ +E + G  P++  +  +    +VN +L+
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK 230

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 62
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 182 TAVDIWSLGCIFAEMVT 198

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 63
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 183 TAVDIWSLGCIFAEMVT 199

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 67
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 187 TAVDIWSLGCIFAEMVT 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 63
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 183 TAVDIWSLGCIFAEMVT 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 64
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 184 TAVDIWSLGCIFAEMVT 200

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 119/255 (46%), Gaps = 32/255 (12%)
Query: 208 KIIRIPDDDENETLAARL-----------EKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
           K   I D D  E  A ++            ++ + E+++   L + +V+ F    +    
Sbjct: 56  KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
             V+ E     SL   LHK   K L  P+       I  G +Y+H   VIHRDLK  N+ 
Sbjct: 116 VFVVLELCRRRSLLE-LHK-RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 173
Query: 317 IDQEFHLKIADFGIAC--------EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
           ++++  +KI DFG+A         ++V C       GT  ++APE++  K +  +VDV+S
Sbjct: 174 LNEDLEVKIGDFGLATKVEYDGERKKVLC-------GTPNYIAPEVLSKKGHSFEVDVWS 226
Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
            G I++ ++ G  P+ E + ++  +  + KN   +IP    P  A+LI++     P  RP
Sbjct: 227 IGCIMYTLLVGKPPF-ETSCLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARP 284
Query: 429 EFWHIVKVLEQFETS 443
               ++   ++F TS
Sbjct: 285 TINELLN--DEFFTS 297

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 62
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 182 TAVDIWSLGCIFAEMVT 198

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 121/259 (46%), Gaps = 30/259 (11%)
Query: 187 FAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
              G    ++ G++  E      PV +K+I   D    ++  A  +         +  L 
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVTDHMLA-----IGSLD 91
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA-IALDIARGMEY 299
           + ++++ +  C    +  ++T+YL  GSL    H  +H+    P+L+    + IA+GM Y
Sbjct: 92  HAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-------CEEVYCDALSDDPGTYRWMAP 352
           +   G++HR+L   NVL+     +++ADFG+A        + +Y +A +      +WMA 
Sbjct: 149 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT----PIKWMAL 204
Query: 353 EMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
           E I    Y  + DV+S+G+ +WE M  G  PY  +  +     ++ K  R A P  C   
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTID 263
Query: 412 MAALIEQCWSLQPDKRPEF 430
           +  ++ +CW +  + RP F
Sbjct: 264 VYMVMVKCWMIDENIRPTF 282

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
           +   G +  +Y    K     V + +I  D E E + +       RE++LL  L++PN++
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA----IREISLLKELNHPNIV 65
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS  V
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRK 363
           +HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 364 VDVYSFGLILWEMVA 378
           VD++S G I  EMV 
Sbjct: 185 VDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
           +   G +  +Y    K     V + +I  D E E + +       RE++LL  L++PN++
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA----IREISLLKELNHPNIV 64
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           K +          ++ E+L +  L+ ++       +PLP + +    + +G+ + HS  V
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRK 363
           +HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 364 VDVYSFGLILWEMVA 378
           VD++S G I  EMV 
Sbjct: 184 VDIWSLGCIFAEMVT 198

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 100/178 (56%), Gaps = 14/178 (7%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + EY++ G L  ++ +   + LP       + +I+  + Y+H +G+I+RDLK +NVL+D 
Sbjct: 99  VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 156
Query: 320 EFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           E H+K+ D+G+  E +   D  S   GT  ++APE+++ + YG  VD ++ G++++EM+A
Sbjct: 157 EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 216
Query: 379 GTIPYEEM----NPIQAA----FAVV-NKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           G  P++ +    NP Q      F V+  K +R  IP       A++++   +  P +R
Sbjct: 217 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSMSVKAASVLKSFLNKDPKER 272

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 100/178 (56%), Gaps = 14/178 (7%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + EY++ G L  ++ +   + LP       + +I+  + Y+H +G+I+RDLK +NVL+D 
Sbjct: 131 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 188
Query: 320 EFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           E H+K+ D+G+  E +   D  S   GT  ++APE+++ + YG  VD ++ G++++EM+A
Sbjct: 189 EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248
Query: 379 GTIPYEEM----NPIQAA----FAVV-NKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           G  P++ +    NP Q      F V+  K +R  IP       A++++   +  P +R
Sbjct: 249 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 304

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 87/160 (54%), Gaps = 6/160 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV LL +L +PN++K     +    + ++ E  + G L  +   +  K         I 
Sbjct: 98  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAARII 155
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGTY 347
             +  G+ Y+H   ++HRDLKPEN+L++   ++ +++I DFG++        + D  GT 
Sbjct: 156 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 215
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
            ++APE++ H +Y  K DV+S G+IL+ +++G  P+   N
Sbjct: 216 YYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGAN 254

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 87/160 (54%), Gaps = 6/160 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV LL +L +PN++K     +    + ++ E  + G L  +   +  K         I 
Sbjct: 99  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAARII 156
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGTY 347
             +  G+ Y+H   ++HRDLKPEN+L++   ++ +++I DFG++        + D  GT 
Sbjct: 157 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 216
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
            ++APE++ H +Y  K DV+S G+IL+ +++G  P+   N
Sbjct: 217 YYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGAN 255

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 111/257 (43%), Gaps = 20/257 (7%)
Query: 181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
           L   +    G+   +Y G+  +  V V    + D      L     ++F  E   L  L 
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD----RKLTKSERQRFKEEAEXLKGLQ 83
Query: 241 NPNVIKFV----AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARG 296
           +PN+++F     +  K      ++TE  + G+L+ YL +   K   +  L +    I +G
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRF--KVXKIKVLRSWCRQILKG 141
Query: 297 MEYIHSQG--VIHRDLKPENVLIDQ-EFHLKIADFGIAC--EEVYCDALSDDPGTYRWMA 351
           ++++H++   +IHRDLK +N+ I      +KI D G+A      +  A+    GT  + A
Sbjct: 142 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFXA 198
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA-IPGDCPP 410
           PE  + K Y   VDVY+FG    E      PY E       +  V   ++PA       P
Sbjct: 199 PEXYEEK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 411 AMAALIEQCWSLQPDKR 427
            +  +IE C     D+R
Sbjct: 258 EVKEIIEGCIRQNKDER 274

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL 316
           C + EY + G L  + H    +     +      +I   ++Y+HS+  V++RDLK EN++
Sbjct: 224 CFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
           +D++ H+KI DFG+ C+E   D  +     GT  ++APE+++   YGR VD +  G++++
Sbjct: 282 LDKDGHIKITDFGL-CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 340
Query: 375 EMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           EM+ G +P+   +  +    ++ + +R   P    P   +L+       P +R
Sbjct: 341 EMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL 316
           C + EY + G L  + H    +     +      +I   ++Y+HS+  V++RDLK EN++
Sbjct: 227 CFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 284
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
           +D++ H+KI DFG+ C+E   D  +     GT  ++APE+++   YGR VD +  G++++
Sbjct: 285 LDKDGHIKITDFGL-CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 343
Query: 375 EMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           EM+ G +P+   +  +    ++ + +R   P    P   +L+       P +R
Sbjct: 344 EMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 100/178 (56%), Gaps = 14/178 (7%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + EY++ G L  ++ +   + LP       + +I+  + Y+H +G+I+RDLK +NVL+D 
Sbjct: 84  VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 141
Query: 320 EFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           E H+K+ D+G+  E +   D  S   GT  ++APE+++ + YG  VD ++ G++++EM+A
Sbjct: 142 EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 201
Query: 379 GTIPYEEM----NPIQAA----FAVV-NKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           G  P++ +    NP Q      F V+  K +R  IP       A++++   +  P +R
Sbjct: 202 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 257

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 125/259 (48%), Gaps = 42/259 (16%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-----------KKP 254
           A+K IR+P    N  LA    ++  REV  L++L +P ++++  A              P
Sbjct: 34  AIKRIRLP----NRELA---REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86
Query: 255 PVYCVITEYLS-EGSLRAYLH---KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
            VY  I   L  + +L+ +++    +E +   +   + I L IA  +E++HS+G++HRDL
Sbjct: 87  KVYLYIQMQLCRKENLKDWMNGRCTIEERERSV--CLHIFLQIAEAVEFLHSKGLMHRDL 144
Query: 311 KPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDP---------GTYRWMAPEMIKH 357
           KP N+    +  +K+ DFG+      +E     L+  P         GT  +M+PE I  
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYE-EMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
            SY  KVD++S GLIL+E++    P+  +M  ++    V N    P       P    ++
Sbjct: 205 NSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFPPLFTQKY-PCEYVMV 260
Query: 417 EQCWSLQPDKRPEFWHIVK 435
           +   S  P +RPE  +I++
Sbjct: 261 QDMLSPSPMERPEAINIIE 279

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 87/160 (54%), Gaps = 6/160 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV LL +L +PN++K     +    + ++ E  + G L  +   +  K         I 
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAARII 132
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGTY 347
             +  G+ Y+H   ++HRDLKPEN+L++   ++ +++I DFG++        + D  GT 
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 192
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
            ++APE++ H +Y  K DV+S G+IL+ +++G  P+   N
Sbjct: 193 YYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 62
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E++ +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE ++  K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 182 TAVDIWSLGCIFAEMVT 198

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 100/178 (56%), Gaps = 14/178 (7%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + EY++ G L  ++ +   + LP       + +I+  + Y+H +G+I+RDLK +NVL+D 
Sbjct: 88  VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 145
Query: 320 EFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           E H+K+ D+G+  E +   D  S   GT  ++APE+++ + YG  VD ++ G++++EM+A
Sbjct: 146 EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205
Query: 379 GTIPYEEM----NPIQAA----FAVV-NKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           G  P++ +    NP Q      F V+  K +R  IP       A++++   +  P +R
Sbjct: 206 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 261

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 88/160 (55%), Gaps = 6/160 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV LL +L +PN++K     +    + ++ E  + G L  +   ++ K         I 
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARII 127
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTY 347
             +  G+ Y+H   ++HRDLKPEN+L+   +++  +KI DFG++        + D  GT 
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
            ++APE+++  +Y  K DV+S G+IL+ +++GT P+   N
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL 316
           C + EY + G L  + H    +     +      +I   ++Y+HS+  V++RDLK EN++
Sbjct: 84  CFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 141
Query: 317 IDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
           +D++ H+KI DFG+ C+E   D   +    GT  ++APE+++   YGR VD +  G++++
Sbjct: 142 LDKDGHIKITDFGL-CKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 200
Query: 375 EMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           EM+ G +P+   +  +    ++ + +R   P    P   +L+       P +R
Sbjct: 201 EMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 88/160 (55%), Gaps = 6/160 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV LL +L +PN++K     +    + ++ E  + G L  +   ++ K         I 
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARII 127
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTY 347
             +  G+ Y+H   ++HRDLKPEN+L+   +++  +KI DFG++        + D  GT 
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
            ++APE+++  +Y  K DV+S G+IL+ +++GT P+   N
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL 316
           C + EY + G L  + H    +     +      +I   ++Y+HS+  V++RDLK EN++
Sbjct: 85  CFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 142
Query: 317 IDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
           +D++ H+KI DFG+ C+E   D   +    GT  ++APE+++   YGR VD +  G++++
Sbjct: 143 LDKDGHIKITDFGL-CKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 201
Query: 375 EMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           EM+ G +P+   +  +    ++ + +R   P    P   +L+       P +R
Sbjct: 202 EMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL 316
           C + EY + G L  + H    +     +      +I   ++Y+HS+  V++RDLK EN++
Sbjct: 86  CFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 143
Query: 317 IDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
           +D++ H+KI DFG+ C+E   D   +    GT  ++APE+++   YGR VD +  G++++
Sbjct: 144 LDKDGHIKITDFGL-CKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 202
Query: 375 EMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           EM+ G +P+   +  +    ++ + +R   P    P   +L+       P +R
Sbjct: 203 EMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 87/160 (54%), Gaps = 6/160 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV LL +L +PN++K     +    + ++ E  + G L  +   +  K         I 
Sbjct: 81  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAARII 138
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGTY 347
             +  G+ Y+H   ++HRDLKPEN+L++   ++ +++I DFG++        + D  GT 
Sbjct: 139 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 198
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
            ++APE++ H +Y  K DV+S G+IL+ +++G  P+   N
Sbjct: 199 YYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGAN 237

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  +Y    K   E VA+K IR+  D E E + +       RE++LL  L++PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTA----IREISLLKELNHPN 66
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++K +          ++ E++ +  L+ ++       +PLP + +    + +G+ + HS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
            V+HRDLKP+N+LI+ E  +K+ADFG+A    V       +  T  + APE ++  K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 362 RKVDVYSFGLILWEMVA 378
             VD++S G I  EMV 
Sbjct: 186 TAVDIWSLGCIFAEMVT 202

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 112/243 (46%), Gaps = 27/243 (11%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           H  D  +L   L F   +   L   +     VAVK++R  D   + +   R    F RE 
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLR----FRREA 63
Query: 234 ALLSRLHNPNVIKFV----AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
              + L++P ++       A     P+  ++ EY+   +LR  +H  E    P  + I +
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTP-KRAIEV 121
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----- 344
             D  + + + H  G+IHRD+KP N+LI     +K+ DFGIA       A++D       
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIA------RAIADSGNSVXQ 175
Query: 345 -----GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN 399
                GT ++++PE  +  S   + DVYS G +L+E++ G  P+   +P+  A+  V ++
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 235
Query: 400 LRP 402
             P
Sbjct: 236 PIP 238

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 90/164 (54%), Gaps = 15/164 (9%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  E  +++  ++P V++   A +      ++ EY+  G L   ++ + +  +P      
Sbjct: 122 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL---VNLMSNYDVPEKWAKF 178
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALSDD 343
              ++   ++ IHS G+IHRD+KP+N+L+D+  HLK+ADFG   +      V+CD     
Sbjct: 179 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-- 236
Query: 344 PGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPY 383
            GT  +++PE++K +     YGR+ D +S G+ L+EM+ G  P+
Sbjct: 237 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 135/301 (44%), Gaps = 63/301 (20%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNVIKF 247
           G +  ++ G++  E VAVKI            ++R E+ + RE  + +   L + N++ F
Sbjct: 19  GRYGEVWRGLWHGESVAVKI-----------FSSRDEQSWFRETEIYNTVLLRHDNILGF 67
Query: 248 VAAC----KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH-- 301
           +A+            +IT Y   GSL  +L +   +TL     + +A+  A G+ ++H  
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQR---QTLEPHLALRLAVSAACGLAHLHVE 124
Query: 302 ---SQG---VIHRDLKPENVLIDQEFHLKIADFGIACEEV----YCDALSDDP--GTYRW 349
              +QG   + HRD K  NVL+       IAD G+A        Y D + ++P  GT R+
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLD-IGNNPRVGTKRY 183
Query: 350 MAPEMIKHK-------SYGRKVDVYSFGLILWEMVAGTI----------PYEEMNPIQAA 392
           MAPE++  +       SY +  D+++FGL+LWE+   TI          P+ ++ P   +
Sbjct: 184 MAPEVLDEQIRTDCFESY-KWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPS 242
Query: 393 FAVVNKNL-----RPAIPGDCPP-----AMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
           F  + K +      P IP           +A ++ +CW   P  R     I K L++   
Sbjct: 243 FEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKISN 302
Query: 443 S 443
           S
Sbjct: 303 S 303

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 53/282 (18%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K     DDD+       ++K   RE+ LL +L + N++  +  CKK   + ++ E++
Sbjct: 53  VAIKKFLESDDDK------MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106
Query: 265 SE---GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
                  L  + + L+++ +           I  G+ + HS  +IHRD+KPEN+L+ Q  
Sbjct: 107 DHTILDDLELFPNGLDYQVVQ-----KYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG 161
Query: 322 HLKIADFGIACEEVYCDALSDDPGTYRWM-APE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
            +K+ DFG A        + DD    RW  APE ++    YG+ VDV++ G ++ EM  G
Sbjct: 162 VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221
Query: 380 T----------------------IP-YEEM---NPIQAAFAVVNKNLRPAIPGDCPPAMA 413
                                  IP ++E+   NP+ A   +     R  +    P    
Sbjct: 222 EPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSE 281
Query: 414 ALIE---QCWSLQPDKRP--------EFWHIVKVLEQFETSL 444
            +I+   +C  + PDKRP        +F+ +    E+F   L
Sbjct: 282 VVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQEL 323

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 94/189 (49%), Gaps = 22/189 (11%)
Query: 228 QFNREVALLSRLHNPNVIKFVAACKKP----PVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           +F RE    + L++P ++   A  +      P+  ++ EY+   +LR  +H  E    P 
Sbjct: 58  RFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTP- 115
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            + I +  D  + + + H  G+IHRD+KP N++I     +K+ DFGIA       A++D 
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA------RAIADS 169
Query: 344 P----------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
                      GT ++++PE  +  S   + DVYS G +L+E++ G  P+   +P+  A+
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229
Query: 394 AVVNKNLRP 402
             V ++  P
Sbjct: 230 QHVREDPIP 238

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 27/243 (11%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           H  D  +L   L F   +   L   +     VAVK++R  D   + +   R    F RE 
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLR----FRREA 63
Query: 234 ALLSRLHNPNVIKFV----AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
              + L++P ++       A     P+  ++ EY+   +LR  +H  E    P  + I +
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTP-KRAIEV 121
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----- 344
             D  + + + H  G+IHRD+KP N++I     +K+ DFGIA       A++D       
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA------RAIADSGNSVTQ 175
Query: 345 -----GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN 399
                GT ++++PE  +  S   + DVYS G +L+E++ G  P+   +P+  A+  V ++
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 235
Query: 400 LRP 402
             P
Sbjct: 236 PIP 238

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 98/187 (52%), Gaps = 14/187 (7%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L   E K +P  
Sbjct: 57  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--EAKRIPEE 114
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + RG+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++ 
Sbjct: 115 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 172
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT--IPYEEMNPIQAAFAVVNKNL 400
             GT  +MAPE ++   Y  + D++S GL L E+  G   IP  +   ++A F       
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFG------ 226
Query: 401 RPAIPGD 407
           RP + G+
Sbjct: 227 RPVVDGE 233

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 95/188 (50%), Gaps = 15/188 (7%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  E  +++  ++P V++   A +      ++ EY+  G L   ++ + +  +P      
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARF 172
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALSDD 343
              ++   ++ IHS G IHRD+KP+N+L+D+  HLK+ADFG   +      V CD     
Sbjct: 173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-- 230
Query: 344 PGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN 399
            GT  +++PE++K +     YGR+ D +S G+ L+EM+ G  P+   + +     ++N  
Sbjct: 231 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289
Query: 400 LRPAIPGD 407
                P D
Sbjct: 290 NSLTFPDD 297

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 95/188 (50%), Gaps = 15/188 (7%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  E  +++  ++P V++   A +      ++ EY+  G L   ++ + +  +P      
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARF 177
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALSDD 343
              ++   ++ IHS G IHRD+KP+N+L+D+  HLK+ADFG   +      V CD     
Sbjct: 178 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-- 235
Query: 344 PGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN 399
            GT  +++PE++K +     YGR+ D +S G+ L+EM+ G  P+   + +     ++N  
Sbjct: 236 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 294
Query: 400 LRPAIPGD 407
                P D
Sbjct: 295 NSLTFPDD 302

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 95/188 (50%), Gaps = 15/188 (7%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  E  +++  ++P V++   A +      ++ EY+  G L   ++ + +  +P      
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARF 177
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALSDD 343
              ++   ++ IHS G IHRD+KP+N+L+D+  HLK+ADFG   +      V CD     
Sbjct: 178 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-- 235
Query: 344 PGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN 399
            GT  +++PE++K +     YGR+ D +S G+ L+EM+ G  P+   + +     ++N  
Sbjct: 236 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 294
Query: 400 LRPAIPGD 407
                P D
Sbjct: 295 NSLTFPDD 302

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 97  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 146
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 147 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 199
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 200 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF--- 255
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 256 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 285

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 97  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 146
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 147 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 199
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 200 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF--- 255
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 256 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 285

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 84/160 (52%), Gaps = 6/160 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV LL +L +PN+ K     +    + ++ E  + G L  +   +  K         I 
Sbjct: 75  REVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAARII 132
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGTY 347
             +  G+ Y H   ++HRDLKPEN+L++   ++ +++I DFG++          D  GT 
Sbjct: 133 RQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTA 192
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
            ++APE++ H +Y  K DV+S G+IL+ +++G  P+   N
Sbjct: 193 YYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 96  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 145
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 146 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 198
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 199 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF--- 254
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 255 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 284

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 93/189 (49%), Gaps = 22/189 (11%)
Query: 228 QFNREVALLSRLHNPNVIKFV----AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           +F RE    + L++P ++       A     P+  ++ EY+   +LR  +H  E    P 
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTP- 115
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            + I +  D  + + + H  G+IHRD+KP N++I     +K+ DFGIA       A++D 
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA------RAIADS 169
Query: 344 P----------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
                      GT ++++PE  +  S   + DVYS G +L+E++ G  P+   +P+  A+
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229
Query: 394 AVVNKNLRP 402
             V ++  P
Sbjct: 230 QHVREDPIP 238

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 111/231 (48%), Gaps = 18/231 (7%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
           +  +G ++ +Y G+ K   V V +  +  D E  T +  +     RE++L+  L + N++
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-----REISLMKELKHENIV 66
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP----LPKLIAIALDIARGMEYIH 301
           +            ++ E++ +  L+ Y+        P    L  +      + +G+ + H
Sbjct: 67  RLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKS 359
              ++HRDLKP+N+LI++   LK+ DFG+A    +  +  S +  T  + AP+ ++  ++
Sbjct: 126 ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRT 185
Query: 360 YGRKVDVYSFGLILWEMVA------GTIPYEEMNPIQAAFAVVNKNLRPAI 404
           Y   +D++S G IL EM+       GT   E++  I       N++L P++
Sbjct: 186 YSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 96  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 145
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 146 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 198
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 199 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF--- 254
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 255 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 284

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 97  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 146
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 147 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 199
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 200 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF--- 255
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 256 -FRQRVSXEC----QHLIRWCLALRPSDRPTFEEI 285

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 95/178 (53%), Gaps = 12/178 (6%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K IR+  +DE     A       RE++LL  LH+PN++  +          ++ E++
Sbjct: 48  VALKRIRLDAEDEGIPSTAI------REISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
            E  L+  L   E+KT      I I L  + RG+ + H   ++HRDLKP+N+LI+ +  L
Sbjct: 102 -EKDLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGAL 158
Query: 324 KIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           K+ADFG+A    +   + + +  T  + AP+ ++  K Y   VD++S G I  EM+ G
Sbjct: 159 KLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 118/249 (47%), Gaps = 51/249 (20%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           +++  A++ I+I + ++   +  +  ++   EV L+ +LH+PN+ +     +     C++
Sbjct: 47  ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV 106
Query: 261 TE-------------YLSEGSLRAYLHKLEHKTLPLP----------------------- 284
            E             ++ + + +  +  ++ +  P P                       
Sbjct: 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQR 166
Query: 285 -KLIA-IALDIARGMEYIHSQGVIHRDLKPENVLI--DQEFHLKIADFGIACE------- 333
            KLI+ I   I   + Y+H+QG+ HRD+KPEN L   ++ F +K+ DFG++ E       
Sbjct: 167 EKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226
Query: 334 EVYCDALSDDPGTYRWMAPEMIK--HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
           E Y   ++   GT  ++APE++   ++SYG K D +S G++L  ++ G +P+  +N    
Sbjct: 227 EYY--GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT 284
Query: 392 AFAVVNKNL 400
              V+NK L
Sbjct: 285 ISQVLNKKL 293

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 93/189 (49%), Gaps = 22/189 (11%)
Query: 228 QFNREVALLSRLHNPNVIKFV----AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           +F RE    + L++P ++       A     P+  ++ EY+   +LR  +H  E    P 
Sbjct: 75  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTP- 132
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            + I +  D  + + + H  G+IHRD+KP N++I     +K+ DFGIA       A++D 
Sbjct: 133 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA------RAIADS 186
Query: 344 P----------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
                      GT ++++PE  +  S   + DVYS G +L+E++ G  P+   +P+  A+
Sbjct: 187 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 246
Query: 394 AVVNKNLRP 402
             V ++  P
Sbjct: 247 QHVREDPIP 255

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 46/272 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 64  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 113
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 114 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 166
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 167 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF--- 222
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             R  +  +C      LI  C +L+P  RP F
Sbjct: 223 -FRQRVSSEC----QHLIRWCLALRPSDRPTF 249

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 97/182 (53%), Gaps = 14/182 (7%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           A+KIIR        +++     +   EVA+L  L +PN++K     +    Y ++ E   
Sbjct: 66  AIKIIR------KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 266 EGSL-RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEF 321
            G L    +H+++   +    +I   L    G+ Y+H   ++HRDLKPEN+L+   +++ 
Sbjct: 120 GGELFDEIIHRMKFNEVDAAVIIKQVL---SGVTYLHKHNIVHRDLKPENLLLESKEKDA 176
Query: 322 HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381
            +KI DFG++        + +  GT  ++APE+++ K Y  K DV+S G+IL+ ++AG  
Sbjct: 177 LIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
Query: 382 PY 383
           P+
Sbjct: 236 PF 237

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 97  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 146
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 147 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 199
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 200 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF--- 255
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 256 -FRQRVSXEC----QHLIRWCLALRPSDRPTFEEI 285

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 95/178 (53%), Gaps = 12/178 (6%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K IR+  +DE     A       RE++LL  LH+PN++  +          ++ E++
Sbjct: 48  VALKRIRLDAEDEGIPSTAI------REISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
            E  L+  L   E+KT      I I L  + RG+ + H   ++HRDLKP+N+LI+ +  L
Sbjct: 102 -EKDLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGAL 158
Query: 324 KIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           K+ADFG+A    +   + + +  T  + AP+ ++  K Y   VD++S G I  EM+ G
Sbjct: 159 KLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 96  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 145
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 146 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 198
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 199 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF--- 254
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 255 -FRQRVSXEC----QHLIRWCLALRPSDRPTFEEI 284

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 69  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 118
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY D 
Sbjct: 119 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 174
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
                GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 175 ----DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 227
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 228 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 257

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 232 EVALLSRLHNPNVIKFVAA-------------CKKPPVYCVITEYLSEGSLRAYLHKLEH 278
           EV LL+ L++  V+++ AA              KK     +  EY   G+L   +H  E+
Sbjct: 52  EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-EN 110
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-- 336
                 +   +   I   + YIHSQG+IHRDLKP N+ ID+  ++KI DFG+A + V+  
Sbjct: 111 LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA-KNVHRS 169
Query: 337 --------------CDALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTI 381
                          D L+   GT  ++A E++     Y  K+D+YS G+I +EM+    
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS 229
Query: 382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
              E   I      V+    P    +       +I       P+KRP
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 96  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 145
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 146 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 198
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 199 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 254
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 255 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 284

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 122/259 (47%), Gaps = 18/259 (6%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR-LHNPNV 244
           R A+G   ++ H +   + +AVK IR        T+ ++ +K+   ++ +  R +  P  
Sbjct: 61  RGAYGVVEKMRH-VPSGQIMAVKRIR-------ATVNSQEQKRLLMDLDISMRTVDCPFT 112
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQ 303
           + F  A  +     +  E +     + Y   ++  +T+P   L  IA+ I + +E++HS+
Sbjct: 113 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 172
Query: 304 -GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI----KHK 358
             VIHRD+KP NVLI+    +K+ DFGI+   V   A + D G   +MAPE I      K
Sbjct: 173 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAIPGDCPPA-MAALI 416
            Y  K D++S G+ + E+     PY+    P Q    VV +   P +P D   A      
Sbjct: 233 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADKFSAEFVDFT 291
Query: 417 EQCWSLQPDKRPEFWHIVK 435
            QC      +RP +  +++
Sbjct: 292 SQCLKKNSKERPTYPELMQ 310

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 122/272 (44%), Gaps = 46/272 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 64  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 113
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY D 
Sbjct: 114 ----SFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 169
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
                GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 170 ----DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 222
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             R  +  +C      LI  C +L+P  RP F
Sbjct: 223 -FRQRVSXEC----QHLIRWCLALRPSDRPTF 249

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 111 VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 160
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 161 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 213
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 214 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 269
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 270 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 299

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 69  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 118
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY D 
Sbjct: 119 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 174
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
                GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 175 ----DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 227
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 228 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 257

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 84  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 133
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 134 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 186
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 187 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 242
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 243 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 272

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 83  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 132
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 133 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 185
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 186 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 241
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 242 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 271

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G ++ +Y G  K  D  VA+K IR+  ++     A R       EV+LL  L + N
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHAN 61
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           ++             ++ EYL +  L+ YL    +  + +  +      + RG+ Y H Q
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPE--MIKHKSYG 361
            V+HRDLKP+N+LI++   LK+ADFG+A  +       D+     W  P   ++    Y 
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 362 RKVDVYSFGLILWEMVAG 379
            ++D++  G I +EM  G
Sbjct: 180 TQIDMWGVGCIFYEMATG 197

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + NVI      +   +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 90  REIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYF 149
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+LI+    LKI DFG+A     E  +   L++   
Sbjct: 150 LYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 68  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 117
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY D 
Sbjct: 118 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 173
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
                GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 174 ----DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 226
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 227 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 256

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 69  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 118
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 119 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 171
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 172 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 227
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 228 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 257

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 103 VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 152
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 153 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 205
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 206 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 261
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 262 -FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 291

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 46/272 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 64  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 113
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 114 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 166
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 167 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 222
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             R  +  +C      LI  C +L+P  RP F
Sbjct: 223 -FRQRVSSEC----QHLIRWCLALRPSDRPTF 249

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 56  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 115
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 116 VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 165
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 166 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 218
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 219 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 274
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 275 -FRQRVSXEC----QHLIRWCLALRPSDRPTFEEI 304

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 111/243 (45%), Gaps = 27/243 (11%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           H  D  +L   L F   +   L   +     VAVK++R  D   + +   R    F RE 
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLR----FRREA 63
Query: 234 ALLSRLHNPNVIKFV----AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
              + L++P ++       A     P+  ++ EY+   +LR  +H  E    P  + I +
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTP-KRAIEV 121
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----- 344
             D  + + + H  G+IHRD+KP N++I     +K+ DFGIA       A++D       
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA------RAIADSGNSVTQ 175
Query: 345 -----GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN 399
                GT ++++PE  +  S   + DVYS G +L+E++ G  P+   +P   A+  V ++
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVRED 235
Query: 400 LRP 402
             P
Sbjct: 236 PIP 238

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 122/272 (44%), Gaps = 46/272 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 67  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 116
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY D 
Sbjct: 117 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 172
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
                GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 173 ----DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 225
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
             R  +  +C      LI  C +L+P  RP F
Sbjct: 226 -FRQRVSSEC----QHLIRWCLALRPSDRPTF 252

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 84  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 133
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 134 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 186
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 187 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 242
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 243 -FRQRVSXEC----QHLIRWCLALRPSDRPTFEEI 272

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 83  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 132
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 133 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 185
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 186 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 241
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 242 -FRQRVSXEC----QHLIRWCLALRPSDRPTFEEI 271

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 111 VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 160
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 161 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 213
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 214 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 269
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 270 -FRQRVSXEC----QHLIRWCLALRPSDRPTFEEI 299

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 31  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 90
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 91  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 140
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY D 
Sbjct: 141 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 196
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
                GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 197 ----DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 249
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 250 -FRQRVSXEC----QHLIRWCLALRPSDRPTFEEI 279

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 46/275 (16%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKII---RIPDDDE--NET-------LAAR 224
           SQ  +G     G    +Y GI   +  PVA+K +   RI D  E  N T       L  +
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPL 283
           +   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +        
Sbjct: 84  VSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR-------- 133
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDA 339
               +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY   
Sbjct: 134 ----SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 186
Query: 340 LSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
            +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I         
Sbjct: 187 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--- 242
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
             R  +  +C      LI  C +L+P  RP F  I
Sbjct: 243 -FRQRVSXEC----QHLIRWCLALRPXDRPTFEEI 272

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 88/169 (52%), Gaps = 13/169 (7%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK 285
           E     E+A+L ++ + N++      + P    ++ + +S G L     ++  K     K
Sbjct: 64  ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGEL---FDRIVEKGFYTEK 120
Query: 286 ----LIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCD 338
               LI   LD    + Y+H  G++HRDLKPEN+L    D+E  + I+DFG++  E   D
Sbjct: 121 DASTLIRQVLD---AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177
Query: 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
            +S   GT  ++APE++  K Y + VD +S G+I + ++ G  P+ + N
Sbjct: 178 VMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 226

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 20/262 (7%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR 238
           SQ  +G     G    +Y GI   + + V I  +  D  ++        +   EV LL +
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 239 LHN--PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARG 296
           + +    VI+ +   ++P  + +I E + E     +    E   L      +    +   
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERM-EPVQDLFDFITERGALQEELARSFFWQVLEA 126
Query: 297 MEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EEVYCDALSDDPGTYRWMAP 352
           + + H+ GV+HRD+K EN+LID     LK+ DFG      + VY D      GT  +  P
Sbjct: 127 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRVYSPP 182
Query: 353 EMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
           E I+ H+ +GR   V+S G++L++MV G IP+E    I           R  +  +C   
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF----FRQRVSSEC--- 235
Query: 412 MAALIEQCWSLQPDKRPEFWHI 433
              LI  C +L+P  RP F  I
Sbjct: 236 -QHLIRWCLALRPSDRPTFEEI 256

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L K     +P  
Sbjct: 66  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQ 123
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + +G+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++ 
Sbjct: 124 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 181
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR- 401
             GT  +M+PE ++   Y  + D++S GL L EM  G  P    +   A F +++  +  
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNE 241
Query: 402 --PAIP-GDCPPAMAALIEQCWSLQPDKRPEFWHIV 434
             P +P G         + +C    P +R +   ++
Sbjct: 242 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 277

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   YL    + A L+KL + + L    +   
Sbjct: 90  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYF 149
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 150 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 107/217 (49%), Gaps = 16/217 (7%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L K     +P  
Sbjct: 50  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQ 107
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + +G+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D ++++
Sbjct: 108 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DEMANE 165
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP 402
             GT  +M+PE ++   Y  + D++S GL L EM  G  P   M   +    +VN+    
Sbjct: 166 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEP--- 222
Query: 403 AIPGDCPPAMAAL-----IEQCWSLQPDKRPEFWHIV 434
             P   P A+ +L     + +C    P +R +   ++
Sbjct: 223 --PPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLM 257

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 75  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 134
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 135 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 229

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 76  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 135
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 136 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 230

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 67  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 126
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 127 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 221

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 68  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 127
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 128 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 222

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 78  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 137
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 138 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 232

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L +   
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 118/266 (44%), Gaps = 28/266 (10%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           H  D  +L   +   +   +RL      +E VAVK I     +  E +AA ++    RE+
Sbjct: 16  HDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI-----ERGEKIAANVK----REI 66
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSL-----RAYLHKLEHKTLPLPKLIA 288
                L +PN+++F      P    ++ EY S G L      A     +       +LI+
Sbjct: 67  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADFGIACEEVYCDALSDDPGT 346
                  G+ Y H+  V HRDLK EN L+D      LKI DFG +   V         GT
Sbjct: 127 -------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 179
Query: 347 YRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--NLRPA 403
             ++APE++  K Y G+  DV+S G+ L+ M+ G  P+E+    +     +++  N++ A
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYA 239
Query: 404 IPG--DCPPAMAALIEQCWSLQPDKR 427
           IP      P    LI + +   P KR
Sbjct: 240 IPDYVHISPECRHLISRIFVADPAKR 265

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 75  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 134
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L +   
Sbjct: 135 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 68  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 127
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 128 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 222

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 72  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 131
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 132 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 90  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 149
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 150 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 116/266 (43%), Gaps = 28/266 (10%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           H  D  +L   +   +   +RL      +E VAVK I             ++++   RE+
Sbjct: 16  HDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE---------RGEKIDENVKREI 66
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSL-----RAYLHKLEHKTLPLPKLIA 288
                L +PN+++F      P    ++ EY S G L      A     +       +LI+
Sbjct: 67  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADFGIACEEVYCDALSDDPGT 346
                  G+ Y H+  V HRDLK EN L+D      LKIADFG +   V         GT
Sbjct: 127 -------GVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGT 179
Query: 347 YRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--NLRPA 403
             ++APE++  K Y G+  DV+S G+ L+ M+ G  P+E+    +     +++  N++ A
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYA 239
Query: 404 IPG--DCPPAMAALIEQCWSLQPDKR 427
           IP      P    LI + +   P KR
Sbjct: 240 IPDYVHISPECRHLISRIFVADPAKR 265

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L R  + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF 133
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 118/254 (46%), Gaps = 18/254 (7%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR-LHNPNV 244
           R A+G   ++ H +   + +AVK IR        T+ ++ +K+   ++ +  R +  P  
Sbjct: 17  RGAYGVVEKMRH-VPSGQIMAVKRIR-------ATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQ 303
           + F  A  +     +  E +     + Y   ++  +T+P   L  IA+ I + +E++HS+
Sbjct: 69  VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 304 -GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI----KHK 358
             VIHRD+KP NVLI+    +K+ DFGI+   V   A   D G   +MAPE I      K
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAIPGDCPPA-MAALI 416
            Y  K D++S G+ + E+     PY+    P Q    VV +   P +P D   A      
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADKFSAEFVDFT 247
Query: 417 EQCWSLQPDKRPEF 430
            QC      +RP +
Sbjct: 248 SQCLKKNSKERPTY 261

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 119/248 (47%), Gaps = 15/248 (6%)
Query: 187 FAHGAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA S +   ++K   +  A KII        + L+AR  ++  RE  +  +L +PN+
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIIN------TKKLSARDFQKLEREARICRKLQHPNI 90
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           ++   + ++   + ++ + ++ G L  +   +  +             I   + Y HS G
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 305 VIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYG 361
           ++HR+LKPEN+L+  +     +K+ADFG+A E    +A     GT  +++PE++K   Y 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 208
Query: 362 RKVDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC 419
           + VD+++ G+IL+ ++ G  P+  E+ + + A       +          P   +LI+  
Sbjct: 209 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 268
Query: 420 WSLQPDKR 427
            ++ P KR
Sbjct: 269 LTVNPKKR 276

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 89/166 (53%), Gaps = 7/166 (4%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSL-RAYLHKLEHKTLPLP 284
           E     E+A+L ++ +PN++      +      +I + +S G L    + K  +      
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVL---IDQEFHLKIADFGIACEEVYCDALS 341
           +LI   LD    ++Y+H  G++HRDLKPEN+L   +D++  + I+DFG++  E     LS
Sbjct: 120 RLIFQVLD---AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
              GT  ++APE++  K Y + VD +S G+I + ++ G  P+ + N
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA S +Y    K   +P A+K+++   D          +K    E+ +L RL +PN+
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVD----------KKIVRTEIGVLLRLSHPNI 110
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYIHSQ 303
           IK     + P    ++ E ++ G L     ++  K     +  A A+  I   + Y+H  
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGEL---FDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 304 GVIHRDLKPENVLIDQ---EFHLKIADFG---IACEEVYCDALSDDPGTYRWMAPEMIKH 357
           G++HRDLKPEN+L      +  LKIADFG   I   +V    +   PG   + APE+++ 
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG---YCAPEILRG 224
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
            +YG +VD++S G+I + ++ G  P+ +    Q  F
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF 260

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 119
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 119
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 115/266 (43%), Gaps = 28/266 (10%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           H  D  +L   +   +   +RL      +E VAVK I             ++++   RE+
Sbjct: 15  HDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---------RGEKIDENVKREI 65
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSL-----RAYLHKLEHKTLPLPKLIA 288
                L +PN+++F      P    ++ EY S G L      A     +       +LI+
Sbjct: 66  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 125
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADFGIACEEVYCDALSDDPGT 346
                  G+ Y H+  V HRDLK EN L+D      LKI DFG +   V         GT
Sbjct: 126 -------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 178
Query: 347 YRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--NLRPA 403
             ++APE++  K Y G+  DV+S G+ L+ M+ G  P+E+    +     +++  N++ A
Sbjct: 179 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYA 238
Query: 404 IPG--DCPPAMAALIEQCWSLQPDKR 427
           IP      P    LI + +   P KR
Sbjct: 239 IPDYVHISPECRHLISRIFVADPAKR 264

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 196 YHGIYKDEPVAVKIIRIPDDDENETLA---ARLEKQFN-------REVALLSRLHNPNVI 245
           YHG+ K       ++    ++  ET A    RLEK+         RE+++L  L + N++
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           K            ++ E+L +  L+  L   E   L      +  L +  G+ Y H + V
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRK 363
           +HRDLKP+N+LI++E  LKIADFG+A    +     + +  T  + AP+ ++  K Y   
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTT 181
Query: 364 VDVYSFGLILWEMVAGT 380
           +D++S G I  EMV GT
Sbjct: 182 IDIWSVGCIFAEMVNGT 198

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL--AEKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 196 YHGIYKDEPVAVKIIRIPDDDENETLA---ARLEKQFN-------REVALLSRLHNPNVI 245
           YHG+ K       ++    ++  ET A    RLEK+         RE+++L  L + N++
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           K            ++ E+L +  L+  L   E   L      +  L +  G+ Y H + V
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRK 363
           +HRDLKP+N+LI++E  LKIADFG+A    +     + +  T  + AP+ ++  K Y   
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 364 VDVYSFGLILWEMVAGT 380
           +D++S G I  EMV GT
Sbjct: 182 IDIWSVGCIFAEMVNGT 198

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 90/161 (55%), Gaps = 6/161 (3%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           ++  REV++L ++ +PN+I      +      +I E +S G L  +L + E  +L   + 
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEA 117
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSD 342
            +    I  G+ Y+H++ + H DLKPEN+ L+D+     H+K+ DFG+A E        +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             GT  ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L K     +P  
Sbjct: 109 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQ 166
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + +G+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++ 
Sbjct: 167 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 224
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
             GT  +M+PE ++   Y  + D++S GL L EM  G  P
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
           L   N +K + A KK     +  EY    +L   +H  E+      +   +   I   + 
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHS-ENLNQQRDEYWRLFRQILEALS 130
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY----------------CDALSD 342
           YIHSQG+IHRDLKP N+ ID+  ++KI DFG+A + V+                 D L+ 
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA-KNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 343 DPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             GT  ++A E++     Y  K+D+YS G+I +EM+       E   I      V+    
Sbjct: 190 AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFP 249
Query: 402 PAIPGDCPPAMAALIEQCWSLQPDKRP 428
           P    +       +I       P+KRP
Sbjct: 250 PDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 60/286 (20%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G    ++     ++ VAVKI  + D         +   Q  RE+     + + N+++F
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFPLQD---------KQSWQSEREIFSTPGMKHENLLQF 74
Query: 248 VAACKKPPVYCV----ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           +AA K+     V    IT +  +GSL  YL   +   +   +L  +A  ++RG+ Y+H  
Sbjct: 75  IAAEKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHED 131
Query: 304 -----------GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD---DPGTYRW 349
                       + HRD K +NVL+  +    +ADFG+A          D     GT R+
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRY 191
Query: 350 MAPEMIK-----HKSYGRKVDVYSFGLILWEMVAG-----------TIPYEE-------M 386
           MAPE+++      +    ++D+Y+ GL+LWE+V+             +P+EE       +
Sbjct: 192 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSL 251
Query: 387 NPIQAAFAVVNKNLRPAIPGDC--PPAMAAL---IEQCWSLQPDKR 427
             +Q    VV+K +RP I       P +A L   IE+CW    + R
Sbjct: 252 EELQE--VVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEAR 295

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 89/166 (53%), Gaps = 7/166 (4%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSL-RAYLHKLEHKTLPLP 284
           E     E+A+L ++ +PN++      +      +I + +S G L    + K  +      
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVL---IDQEFHLKIADFGIACEEVYCDALS 341
           +LI   LD    ++Y+H  G++HRDLKPEN+L   +D++  + I+DFG++  E     LS
Sbjct: 120 RLIFQVLD---AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
              GT  ++APE++  K Y + VD +S G+I + ++ G  P+ + N
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 97/187 (51%), Gaps = 14/187 (7%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K I        E L  + E     E+A+L ++ +PN++      +      +I + +
Sbjct: 46  VAIKCIA------KEALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 98
Query: 265 SEGSL-RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL---IDQE 320
           S G L    + K  +      +LI   LD    ++Y+H  G++HRDLKPEN+L   +D++
Sbjct: 99  SGGELFDRIVEKGFYTERDASRLIFQVLD---AVKYLHDLGIVHRDLKPENLLYYSLDED 155
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
             + I+DFG++  E     LS   GT  ++APE++  K Y + VD +S G+I + ++ G 
Sbjct: 156 SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 381 IPYEEMN 387
            P+ + N
Sbjct: 216 PPFYDEN 222

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 89/166 (53%), Gaps = 7/166 (4%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSL-RAYLHKLEHKTLPLP 284
           E     E+A+L ++ +PN++      +      +I + +S G L    + K  +      
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVL---IDQEFHLKIADFGIACEEVYCDALS 341
           +LI   LD    ++Y+H  G++HRDLKPEN+L   +D++  + I+DFG++  E     LS
Sbjct: 120 RLIFQVLD---AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
              GT  ++APE++  K Y + VD +S G+I + ++ G  P+ + N
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 94/181 (51%), Gaps = 12/181 (6%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L K     +P  
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQ 104
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + +G+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++ 
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 162
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY------EEMNPIQAAFAVV 396
             GT  +M+PE ++   Y  + D++S GL L EM  G  P       E+  P  A F ++
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELL 222
Query: 397 N 397
           +
Sbjct: 223 D 223

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 6/201 (2%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E+ ++  L +P ++    + +      ++ + L  G LR +L +  H      KL    
Sbjct: 64  KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE 123
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM 350
           L +A  ++Y+ +Q +IHRD+KP+N+L+D+  H+ I DF IA        ++   GT  +M
Sbjct: 124 LVMA--LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 351 APEMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV-VNKNLRPAIPG 406
           APEM    K   Y   VD +S G+  +E++ G  PY   +   +   V   +      P 
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
                M +L+++     PD+R
Sbjct: 242 AWSQEMVSLLKKLLEPNPDQR 262

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 85/160 (53%), Gaps = 8/160 (5%)
Query: 230 NREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           + E+ +L R   +PN+I             ++TE +  G L   +  L  K     +   
Sbjct: 68  SEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI--LRQKFFSEREASF 125
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVL-IDQEFH---LKIADFGIACEEVYCDALSDDP 344
           +   I + +EY+HSQGV+HRDLKP N+L +D+  +   L+I DFG A +    + L   P
Sbjct: 126 VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP 185
Query: 345 G-TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             T  ++APE++K + Y    D++S G++L+ M+AG  P+
Sbjct: 186 CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 115/266 (43%), Gaps = 28/266 (10%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           H  D  +L   +   +   +RL      +E VAVK I             ++++   RE+
Sbjct: 16  HDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---------RGEKIDENVKREI 66
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSL-----RAYLHKLEHKTLPLPKLIA 288
                L +PN+++F      P    ++ EY S G L      A     +       +LI+
Sbjct: 67  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADFGIACEEVYCDALSDDPGT 346
                  G+ Y H+  V HRDLK EN L+D      LKI  FG +   V      D  GT
Sbjct: 127 -------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGT 179
Query: 347 YRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--NLRPA 403
             ++APE++  K Y G+  DV+S G+ L+ M+ G  P+E+    +     +++  N++ A
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYA 239
Query: 404 IPG--DCPPAMAALIEQCWSLQPDKR 427
           IP      P    LI + +   P KR
Sbjct: 240 IPDYVHISPECRHLISRIFVADPAKR 265

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           REV++L  + +PNVI      +      +I E ++ G L  +L   E ++L   +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFL 120
Query: 291 LDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSDDPGT 346
             I  G+ Y+HS  + H DLKPEN+ L+D+      +KI DFG+A +  + +   +  GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 119/248 (47%), Gaps = 15/248 (6%)
Query: 187 FAHGAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA S +   ++K   +  A KII        + L+AR  ++  RE  +  +L +PN+
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIIN------TKKLSARDFQKLEREARICRKLQHPNI 67
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           ++   + ++   + ++ + ++ G L  +   +  +             I   + Y HS G
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 305 VIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYG 361
           ++HR+LKPEN+L+  +     +K+ADFG+A E    +A     GT  +++PE++K   Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 362 RKVDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC 419
           + VD+++ G+IL+ ++ G  P+  E+ + + A       +          P   +LI+  
Sbjct: 186 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 420 WSLQPDKR 427
            ++ P KR
Sbjct: 246 LTVNPKKR 253

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 119/245 (48%), Gaps = 15/245 (6%)
Query: 190 GAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           GA S +   ++K   +  A KII        + L+AR  ++  RE  +  +L +PN+++ 
Sbjct: 16  GAFSVVRRCVHKTTGLEFAAKIIN------TKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
             + ++   + ++ + ++ G L  +   +  +             I   + Y HS G++H
Sbjct: 70  HDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 127
Query: 308 RDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKV 364
           R+LKPEN+L+  +     +K+ADFG+A E    +A     GT  +++PE++K   Y + V
Sbjct: 128 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPV 187
Query: 365 DVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSL 422
           D+++ G+IL+ ++ G  P+  E+ + + A       +          P   +LI+   ++
Sbjct: 188 DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 247
Query: 423 QPDKR 427
            P KR
Sbjct: 248 NPKKR 252

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 85/160 (53%), Gaps = 8/160 (5%)
Query: 230 NREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           + E+ +L R   +PN+I             ++TE +  G L   +  L  K     +   
Sbjct: 68  SEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI--LRQKFFSEREASF 125
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVL-IDQEFH---LKIADFGIACEEVYCDALSDDP 344
           +   I + +EY+HSQGV+HRDLKP N+L +D+  +   L+I DFG A +    + L   P
Sbjct: 126 VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP 185
Query: 345 G-TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             T  ++APE++K + Y    D++S G++L+ M+AG  P+
Sbjct: 186 CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L K     +P  
Sbjct: 74  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQ 131
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + +G+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++ 
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 189
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
             GT  +M+PE ++   Y  + D++S GL L EM  G  P
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 8/158 (5%)
Query: 232 EVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           E+ +L R   +PN+I             V+TE +  G L   +  L  K     +  A+ 
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVL 122
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVL-IDQEFH---LKIADFGIACEEVYCDALSDDPG- 345
             I + +EY+H+QGV+HRDLKP N+L +D+  +   ++I DFG A +    + L   P  
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           T  ++APE+++ + Y    D++S G++L+ M+ G  P+
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L K     +P  
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQ 104
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + +G+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++ 
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 162
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
             GT  +M+PE ++   Y  + D++S GL L EM  G  P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 119/248 (47%), Gaps = 15/248 (6%)
Query: 187 FAHGAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
              GA S +   ++K   +  A KII        + L+AR  ++  RE  +  +L +PN+
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIIN------TKKLSARDFQKLEREARICRKLQHPNI 67
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           ++   + ++   + ++ + ++ G L  +   +  +             I   + Y HS G
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 305 VIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYG 361
           ++HR+LKPEN+L+  +     +K+ADFG+A E    +A     GT  +++PE++K   Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 362 RKVDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC 419
           + VD+++ G+IL+ ++ G  P+  E+ + + A       +          P   +LI+  
Sbjct: 186 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 420 WSLQPDKR 427
            ++ P KR
Sbjct: 246 LTVNPKKR 253

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L K     +P  
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQ 104
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + +G+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++ 
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 162
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
             GT  +M+PE ++   Y  + D++S GL L EM  G  P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L K     +P  
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQ 104
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + +G+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++ 
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 162
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
             GT  +M+PE ++   Y  + D++S GL L EM  G  P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           +  Q  RE+ +L   ++P ++ F  A        +  E++  GSL   L K     +P  
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQ 104
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
            L  +++ + +G+ Y+  +  ++HRD+KP N+L++    +K+ DFG++ + +  D++++ 
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 162
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
             GT  +M+PE ++   Y  + D++S GL L EM  G  P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 11/181 (6%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           A+KII+           A L+     EVA+L +L +PN++K     +    Y ++ E   
Sbjct: 50  AIKIIKKSSVTTTSNSGALLD-----EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYR 104
Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH--- 322
            G L  +   +  +         I   +  G  Y+H   ++HRDLKPEN+L++ +     
Sbjct: 105 GGEL--FDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDAL 162
Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
           +KI DFG++        + +  GT  ++APE+++ K Y  K DV+S G+IL+ ++ G  P
Sbjct: 163 IKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPP 221
Query: 383 Y 383
           +
Sbjct: 222 F 222

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 55/283 (19%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G    ++     +E VAVKI  I D         +   Q   EV  L  + + N+++F
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIFPIQD---------KQSWQNEYEVYSLPGMKHENILQF 83
Query: 248 VAACKKPPVYCV----ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           + A K+     V    IT +  +GSL  +L   +   +   +L  IA  +ARG+ Y+H  
Sbjct: 84  IGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHED 140
Query: 304 ----------GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD---DPGTYRWM 350
                      + HRD+K +NVL+       IADFG+A +     +  D     GT R+M
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 351 APEMIK-----HKSYGRKVDVYSFGLILWEM----VAGTIPYEE-MNPIQAAFA------ 394
           APE+++      +    ++D+Y+ GL+LWE+     A   P +E M P +          
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260
Query: 395 -----VVNKNLRPAIPG--DCPPAMAAL---IEQCWSLQPDKR 427
                VV+K  RP +         MA L   IE+CW    + R
Sbjct: 261 DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 127/266 (47%), Gaps = 31/266 (11%)
Query: 187 FAHGAHSRL-YHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNV 244
             HGA   + Y G++ +  VAVK I +P   E  + A       +REV LL     +PNV
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRI-LP---ECFSFA-------DREVQLLRESDEHPNV 80
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           I++    K      +  E L   +L+ Y+ + +   L L   I +      G+ ++HS  
Sbjct: 81  IRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAHLHSLN 138
Query: 305 VIHRDLKPENVLIDQ-----EFHLKIADFGIACEEVYC-----DALSDDPGTYRWMAPEM 354
           ++HRDLKP N+LI       +    I+DFG+ C+++          S  PGT  W+APEM
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGL-CKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 355 IKH---KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
           +     ++    VD++S G + + +++ G+ P+ +    QA   +   +L    P     
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257
Query: 411 AMA-ALIEQCWSLQPDKRPEFWHIVK 435
            +A  LIE+  ++ P KRP   H++K
Sbjct: 258 VIARELIEKMIAMDPQKRPSAKHVLK 283

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 96/231 (41%), Gaps = 14/231 (6%)
Query: 158 FDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDE 217
            D   V    +D    H  D       +   +   +RL       E VAVK I       
Sbjct: 1   MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE------ 54
Query: 218 NETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE 277
                A +++   RE+     L +PN+++F      P    +I EY S G L   +    
Sbjct: 55  ---RGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG 111
Query: 278 HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADFGIACEEV 335
             +    +     L    G+ Y HS  + HRDLK EN L+D      LKI DFG +   V
Sbjct: 112 RFSEDEARFFFQQL--LSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169
Query: 336 YCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEE 385
                    GT  ++APE++  + Y G+  DV+S G+ L+ M+ G  P+E+
Sbjct: 170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 11/181 (6%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           A+KII+           A L+     EVA+L +L +PN++K     +    Y ++ E   
Sbjct: 33  AIKIIKKSSVTTTSNSGALLD-----EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYR 87
Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH--- 322
            G L  +   +  +         I   +  G  Y+H   ++HRDLKPEN+L++ +     
Sbjct: 88  GGEL--FDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDAL 145
Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
           +KI DFG++        + +  GT  ++APE+++ K Y  K DV+S G+IL+ ++ G  P
Sbjct: 146 IKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPP 204
Query: 383 Y 383
           +
Sbjct: 205 F 205

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 87/161 (54%), Gaps = 6/161 (3%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           ++  REV +L  + +PN+I      +      +I E +S G L  +L   E ++L   + 
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEA 117
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSD 342
                 I  G+ Y+HS+ + H DLKPEN+ L+D+      +K+ DFGIA +    +   +
Sbjct: 118 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 177
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             GT  ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 94/196 (47%), Gaps = 16/196 (8%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK--- 246
           GA+  +   I K     V I ++    ++E  A R      RE+ LL  + + NVI    
Sbjct: 53  GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA----YRELLLLKHMQHENVIGLLD 108
Query: 247 -FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
            F  A      Y     YL    ++  L K+        K+  +   + +G++YIHS GV
Sbjct: 109 VFTPASSLRNFYDF---YLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGV 165
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM-APEMI-KHKSYGRK 363
           +HRDLKP N+ ++++  LKI DFG+A    + DA        RW  APE+I     Y + 
Sbjct: 166 VHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEVILSWMHYNQT 222
Query: 364 VDVYSFGLILWEMVAG 379
           VD++S G I+ EM+ G
Sbjct: 223 VDIWSVGCIMAEMLTG 238

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 12/213 (5%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           RLE     E+   + L +P ++    A ++ P   +  E L  GSL   +   E   LP 
Sbjct: 108 RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVK--EQGCLPE 165
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIAC----EEVYCD 338
            + +        G+EY+HS+ ++H D+K +NVL+  +  H  + DFG A     + +  D
Sbjct: 166 DRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKD 225
Query: 339 ALSDD--PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM--NPIQAAFA 394
            L+ D  PGT   MAPE++  +S   KVDV+S   ++  M+ G  P+ +    P+    A
Sbjct: 226 LLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIA 285
Query: 395 VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
                +R  IP  C P  A  I++    +P  R
Sbjct: 286 SEPPPVR-EIPPSCAPLTAQAIQEGLRKEPIHR 317

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 87/161 (54%), Gaps = 6/161 (3%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           ++  REV +L  + +PN+I      +      +I E +S G L  +L   E ++L   + 
Sbjct: 53  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEA 110
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSD 342
                 I  G+ Y+HS+ + H DLKPEN+ L+D+      +K+ DFGIA +    +   +
Sbjct: 111 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             GT  ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 126/314 (40%), Gaps = 70/314 (22%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQF 229
           AA E ++DL  L L      G +  +Y G   + PVAVK+          + A R     
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF---------SFANRQNFIN 54
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPV-----YCVITEYLSEGSLRAYLHKLEHKTLPLP 284
            + +  +  + + N+ +F+   ++        Y ++ EY   GSL  YL       +   
Sbjct: 55  EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC 114
Query: 285 KLIAIALDIARGMEYIHSQ---------GVIHRDLKPENVLIDQEFHLKIADFGIAC--- 332
           +L   A  + RG+ Y+H++          + HRDL   NVL+  +    I+DFG++    
Sbjct: 115 RL---AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 333 --------EEVYCDALSDDPGTYRWMAPEMIK-------HKSYGRKVDVYSFGLILWEMV 377
                   EE   +A   + GT R+MAPE+++        +S  ++VD+Y+ GLI WE+ 
Sbjct: 172 GNRLVRPGEE--DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 378 ---AGTIPYEEMNPIQAAFA---------------VVNKNLRPAIPGDCPPAMAAL---- 415
                  P E +   Q AF                V  +  RP  P        A+    
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 416 --IEQCWSLQPDKR 427
             IE CW    + R
Sbjct: 290 ETIEDCWDQDAEAR 303

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 87/161 (54%), Gaps = 6/161 (3%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           ++  REV +L  + +PN+I      +      +I E +S G L  +L   E ++L   + 
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEA 131
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSD 342
                 I  G+ Y+HS+ + H DLKPEN+ L+D+      +K+ DFGIA +    +   +
Sbjct: 132 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 191
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             GT  ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L    + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 72  REIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 131
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 132 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAI 289
           RE+ +L    + N+I      + P +  +   Y+ +  +   L+KL + + L    +   
Sbjct: 72  REIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 131
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPG 345
              I RG++YIHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   
Sbjct: 132 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 346 TYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           T  + APE M+  K Y + +D++S G IL EM++ 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 94/196 (47%), Gaps = 16/196 (8%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK--- 246
           GA+  +   I K     V I ++    ++E  A R      RE+ LL  + + NVI    
Sbjct: 35  GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA----YRELLLLKHMQHENVIGLLD 90
Query: 247 -FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
            F  A      Y     YL    ++  L K+        K+  +   + +G++YIHS GV
Sbjct: 91  VFTPASSLRNFYDF---YLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGV 147
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM-APEMI-KHKSYGRK 363
           +HRDLKP N+ ++++  LKI DFG+A    + DA        RW  APE+I     Y + 
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEVILSWMHYNQT 204
Query: 364 VDVYSFGLILWEMVAG 379
           VD++S G I+ EM+ G
Sbjct: 205 VDIWSVGCIMAEMLTG 220

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 196 YHGIYKDEPVAVKIIRIPDDDENETLA---ARLEKQFN-------REVALLSRLHNPNVI 245
           YHG+ K       ++    ++  ET A    RLEK+         RE+++L  L + N++
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           K            ++ E+L +  L+  L   E   L      +  L +  G+ Y H + V
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRK 363
           +HRDLKP+N+LI++E  LKIADFG+A    +     + +  T  + AP+ ++  K Y   
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTT 181
Query: 364 VDVYSFGLILWEMVAG 379
           +D++S G I  EMV G
Sbjct: 182 IDIWSVGCIFAEMVNG 197

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/234 (21%), Positives = 117/234 (50%), Gaps = 22/234 (9%)
Query: 221 LAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT 280
           ++++  ++  REVA+L+ + +PN++++  + ++     ++ +Y   G L   ++  +   
Sbjct: 62  MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL 121
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDA 339
               +++   + I   ++++H + ++HRD+K +N+ + ++  +++ DFGIA       + 
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181
Query: 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN 399
                GT  +++PE+ ++K Y  K D+++ G +L+E+      +E       A ++ N  
Sbjct: 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE-------AGSMKNLV 234
Query: 400 LRPAIPGDCPPA-------MAALIEQCWSLQPDKRP------EFWHIVKVLEQF 440
           L+  I G  PP        + +L+ Q +   P  RP      E   I K +E+F
Sbjct: 235 LK-IISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKF 287

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 109/216 (50%), Gaps = 29/216 (13%)
Query: 187 FAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPN 243
              GAH+R+   I     +  AVKII        E     +  +  REV +L +   + N
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKII--------EKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           V++ +   ++   + ++ E +  GS+ +++HK  H      +   +  D+A  ++++H++
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNK 130
Query: 304 GVIHRDLKPENVLI---DQEFHLKIADFGIA--------CEEVYCDALSDDPGTYRWMAP 352
           G+ HRDLKPEN+L    +Q   +KI DFG+         C  +    L    G+  +MAP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 353 EMIKHKS-----YGRKVDVYSFGLILWEMVAGTIPY 383
           E+++  S     Y ++ D++S G+IL+ +++G  P+
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 32/220 (14%)
Query: 220 TLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE-GSLRAYLHKLEH 278
            L  ++   F+  + LL     P+   FV   ++P     + ++++E G+L+  L +   
Sbjct: 106 VLLKKVSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELAR--- 160
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIAC---EE 334
                    +    +   + + H+ GV+HRD+K EN+LID     LK+ DFG      + 
Sbjct: 161 ---------SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 211
Query: 335 VYCDALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
           VY    +D  GT  +  PE I+ H+ +GR   V+S G++L++MV G IP+E    I    
Sbjct: 212 VY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 267
Query: 394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
                  R  +  +C      LI  C +L+P  RP F  I
Sbjct: 268 VF----FRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 299

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 12/158 (7%)
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           ++L+S    P ++    A   P     I + ++ G L  + H  +H       +   A +
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFYAAE 300
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----GTYR 348
           I  G+E++H++ V++RDLKP N+L+D+  H++I+D G+A     CD     P    GT+ 
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 355
Query: 349 WMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           +MAPE++ K  +Y    D +S G +L++++ G  P+ +
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 12/158 (7%)
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           ++L+S    P ++    A   P     I + ++ G L  + H  +H       +   A +
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFYAAE 299
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----GTYR 348
           I  G+E++H++ V++RDLKP N+L+D+  H++I+D G+A     CD     P    GT+ 
Sbjct: 300 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 354
Query: 349 WMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           +MAPE++ K  +Y    D +S G +L++++ G  P+ +
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 392

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 12/158 (7%)
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           ++L+S    P ++    A   P     I + ++ G L  + H  +H       +   A +
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFYAAE 300
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----GTYR 348
           I  G+E++H++ V++RDLKP N+L+D+  H++I+D G+A     CD     P    GT+ 
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 355
Query: 349 WMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           +MAPE++ K  +Y    D +S G +L++++ G  P+ +
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 12/158 (7%)
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           ++L+S    P ++    A   P     I + ++ G L  + H  +H       +   A +
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFYAAE 300
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----GTYR 348
           I  G+E++H++ V++RDLKP N+L+D+  H++I+D G+A     CD     P    GT+ 
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 355
Query: 349 WMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           +MAPE++ K  +Y    D +S G +L++++ G  P+ +
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 114/266 (42%), Gaps = 28/266 (10%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           H  D  +L   +   +   +RL      +E VAVK I             ++++   RE+
Sbjct: 16  HDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---------RGEKIDENVKREI 66
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSL-----RAYLHKLEHKTLPLPKLIA 288
                L +PN+++F      P    ++ EY S G L      A     +       +LI+
Sbjct: 67  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADFGIACEEVYCDALSDDPGT 346
                  G+ Y H+  V HRDLK EN L+D      LKI  FG +   V         GT
Sbjct: 127 -------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGT 179
Query: 347 YRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--NLRPA 403
             ++APE++  K Y G+  DV+S G+ L+ M+ G  P+E+    +     +++  N++ A
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYA 239
Query: 404 IPG--DCPPAMAALIEQCWSLQPDKR 427
           IP      P    LI + +   P KR
Sbjct: 240 IPDYVHISPECRHLISRIFVADPAKR 265

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 16/189 (8%)
Query: 267 GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKI 325
           G+    L K     +P   L  + + I + + Y+  + GVIHRD+KP N+L+D+   +K+
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKL 166
Query: 326 ADFGIACEEVYCDALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGT 380
            DFGI+   V   A     G   +MAPE I         Y  + DV+S G+ L E+  G 
Sbjct: 167 CDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
Query: 381 IPYEEMNPIQAAFAVVNKNLR---PAIPG--DCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
            PY+     +  F V+ K L+   P +PG         + ++ C +    KRP++  +++
Sbjct: 227 FPYKN---CKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283
Query: 436 --VLEQFET 442
              ++++ET
Sbjct: 284 HSFIKRYET 292

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSL--RAYLHKLEHKTLPLP 284
           +Q   E+ +L  L +PN+IK     +      ++ E    G L  R    +   K L   
Sbjct: 65  EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLI-DQEFH--LKIADFGIACEEVYCDALS 341
            +  +   +   + Y HSQ V+H+DLKPEN+L  D   H  +KI DFG+A E    D  S
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA-ELFKSDEHS 183
Query: 342 DD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL 400
            +  GT  +MAPE+ K +    K D++S G++++ ++ G +P+   +  +       K  
Sbjct: 184 TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-- 240
Query: 401 RPAIPGDC---PPAMAALIEQCWSLQPDKRP 428
            P    +C    P    L++Q  +  P++RP
Sbjct: 241 EPNYAVECRPLTPQAVDLLKQMLTKDPERRP 271

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 89/161 (55%), Gaps = 6/161 (3%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           ++  REV++L ++ + NVI      +      +I E +S G L  +L + E  +L   + 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEA 117
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSD 342
            +    I  G+ Y+H++ + H DLKPEN+ L+D+     H+K+ DFG+A E        +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             GT  ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 89/161 (55%), Gaps = 6/161 (3%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           ++  REV++L ++ + NVI      +      +I E +S G L  +L + E  +L   + 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEA 117
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSD 342
            +    I  G+ Y+H++ + H DLKPEN+ L+D+     H+K+ DFG+A E        +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             GT  ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 89/161 (55%), Gaps = 6/161 (3%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           ++  REV++L ++ + NVI      +      +I E +S G L  +L + E  +L   + 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEA 117
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSD 342
            +    I  G+ Y+H++ + H DLKPEN+ L+D+     H+K+ DFG+A E        +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             GT  ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 89/161 (55%), Gaps = 6/161 (3%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           ++  REV++L ++ + NVI      +      +I E +S G L  +L + E  +L   + 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEA 117
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSD 342
            +    I  G+ Y+H++ + H DLKPEN+ L+D+     H+K+ DFG+A E        +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             GT  ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 89/161 (55%), Gaps = 6/161 (3%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
           ++  REV++L ++ + NVI      +      +I E +S G L  +L + E  +L   + 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEA 117
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENV-LIDQEF---HLKIADFGIACEEVYCDALSD 342
            +    I  G+ Y+H++ + H DLKPEN+ L+D+     H+K+ DFG+A E        +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             GT  ++APE++ ++  G + D++S G+I + +++G  P+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 84/157 (53%), Gaps = 7/157 (4%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE-YLSEGSLRAYLHKL-EHKTLPLP 284
           K+  RE+ LL  + + NVI  +            T+ YL    +   L KL +H+ L   
Sbjct: 69  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
           ++  +   + +G+ YIH+ G+IHRDLKP N+ ++++  LKI DFG+A +    D+     
Sbjct: 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---ADSEMXGX 185
Query: 345 GTYRWM-APEMIKH-KSYGRKVDVYSFGLILWEMVAG 379
              RW  APE+I +   Y + VD++S G I+ EM+ G
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 232 EVALLSRLHNPNVIKFVAA-------------CKKPPVYCVITEYLSEGSLRAYLHKLEH 278
           EV LL+ L++  V+++ AA              KK     +  EY    +L   +H  E+
Sbjct: 52  EVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHS-EN 110
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-- 336
                 +   +   I   + YIHSQG+IHR+LKP N+ ID+  ++KI DFG+A + V+  
Sbjct: 111 LNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLA-KNVHRS 169
Query: 337 --------------CDALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTI 381
                          D L+   GT  ++A E++     Y  K+D YS G+I +E +    
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFS 229
Query: 382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
              E   I      V+    P    +       +I       P+KRP
Sbjct: 230 TGXERVNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRP 276

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 108/224 (48%), Gaps = 11/224 (4%)
Query: 168 VDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARL 225
           +D AD+  +      L      GA S +   I ++  +  AVKI+ +     +  L+   
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST-- 70
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK 285
            +   RE ++   L +P++++ +       +  ++ E++    L   + K         +
Sbjct: 71  -EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE 129
Query: 286 LIA--IALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDAL 340
            +A      I   + Y H   +IHRD+KPENVL+   +    +K+ DFG+A +      +
Sbjct: 130 AVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLV 189
Query: 341 SDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           +    GT  +MAPE++K + YG+ VDV+  G+IL+ +++G +P+
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 12/213 (5%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           RLE     E+   + L +P ++    A ++ P   +  E L  GSL   +   E   LP 
Sbjct: 127 RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVK--EQGCLPE 184
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIAC----EEVYCD 338
            + +        G+EY+HS+ ++H D+K +NVL+  +  H  + DFG A     + +   
Sbjct: 185 DRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKS 244
Query: 339 ALSDD--PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM--NPIQAAFA 394
            L+ D  PGT   MAPE++  +S   KVDV+S   ++  M+ G  P+ +    P+    A
Sbjct: 245 LLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIA 304
Query: 395 VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
                +R  IP  C P  A  I++    +P  R
Sbjct: 305 SEPPPVR-EIPPSCAPLTAQAIQEGLRKEPIHR 336

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 8/158 (5%)
Query: 232 EVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           E+ +L R   +PN+I             V+TE    G L   +  L  K     +  A+ 
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKI--LRQKFFSEREASAVL 122
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVL-IDQEFH---LKIADFGIACEEVYCDALSDDPG- 345
             I + +EY+H+QGV+HRDLKP N+L +D+  +   ++I DFG A +    + L   P  
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY 182
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           T  ++APE+++ + Y    D++S G++L+  + G  P+
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 7/200 (3%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE-Y 263
           VAVK +  P   +N+T A R      RE+ LL  +++ N+I  +             + Y
Sbjct: 50  VAVKKLSRPF--QNQTHAKRA----YRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVY 103
Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
           L    + A L ++ H  L   ++  +   +  G++++HS G+IHRDLKP N+++  +  L
Sbjct: 104 LVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 163
Query: 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           KI DFG+A        ++    T  + APE+I    Y   VD++S G I+ E+V G++ +
Sbjct: 164 KILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 223
Query: 384 EEMNPIQAAFAVVNKNLRPA 403
           +  + I     V+ +   P+
Sbjct: 224 QGTDHIDQWNKVIEQLGTPS 243

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 7/200 (3%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE-Y 263
           VAVK +  P   +N+T A R      RE+ LL  +++ N+I  +             + Y
Sbjct: 52  VAVKKLSRPF--QNQTHAKRA----YRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVY 105
Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
           L    + A L ++ H  L   ++  +   +  G++++HS G+IHRDLKP N+++  +  L
Sbjct: 106 LVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           KI DFG+A        ++    T  + APE+I    Y   VD++S G I+ E+V G + +
Sbjct: 166 KILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIF 225
Query: 384 EEMNPIQAAFAVVNKNLRPA 403
           +  + I     V+ +   P+
Sbjct: 226 QGTDHIDQWNKVIEQLGTPS 245

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 187 FAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPN 243
              GA++++   +     +  AVKII        E  A     +  REV  L +   N N
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKII--------EKQAGHSRSRVFREVETLYQCQGNKN 72
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           +++ +   +    + ++ E L  GS+ A++ K +H      +   +  D+A  ++++H++
Sbjct: 73  ILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH--FNEREASRVVRDVAAALDFLHTK 130
Query: 304 GVIHRDLKPENVLIDQEFH---LKIADFGI--------ACEEVYCDALSDDPGTYRWMAP 352
           G+ HRDLKPEN+L +       +KI DF +        +C  +    L+   G+  +MAP
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 353 EMI-----KHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           E++     +   Y ++ D++S G++L+ M++G  P+
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 99/193 (51%), Gaps = 7/193 (3%)
Query: 196 YHGIYKDEPVAVKI-IRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254
           + G+Y+ E +   + + I   D+     A + ++   EV +  +L +P++++     +  
Sbjct: 24  FAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS 83
Query: 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKP 312
               ++ E    G +  YL   +++  P  +  A      I  GM Y+HS G++HRDL  
Sbjct: 84  NYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTL 140
Query: 313 ENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGL 371
            N+L+ +  ++KIADFG+A + ++  +      GT  +++PE+    ++G + DV+S G 
Sbjct: 141 SNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGC 200
Query: 372 ILWEMVAGTIPYE 384
           + + ++ G  P++
Sbjct: 201 MFYTLLIGRPPFD 213

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 187 FAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPN 243
              GAH+R+   I     +  AVKII        E     +  +  REV +L +   + N
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKII--------EKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           V++ +   ++   + ++ E +  GS+ +++HK  H      +   +  D+A  ++++H++
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNK 130
Query: 304 GVIHRDLKPENVLI---DQEFHLKIADFGIA--------CEEVYCDALSDDPGTYRWMAP 352
           G+ HRDLKPEN+L    +Q   +KI DF +         C  +    L    G+  +MAP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 353 EMIKHKS-----YGRKVDVYSFGLILWEMVAGTIPY 383
           E+++  S     Y ++ D++S G+IL+ +++G  P+
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 25/234 (10%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPP----VYCVITEYLSEGSLRAYLHKLEHKT--LPL 283
            RE  +    ++PN+++ VA C +         ++  +   G+L   + +L+ K   L  
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI---ACEEVYCD-- 338
            +++ + L I RG+E IH++G  HRDLKP N+L+  E    + D G    AC  V     
Sbjct: 134 DQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 339 --ALSDDPG---TYRWMAPEMIKHKSY---GRKVDVYSFGLILWEMVAGTIPYEEM--NP 388
              L D      T  + APE+   +S+     + DV+S G +L+ M+ G  PY+ +    
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
Query: 389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
              A AV N+   P  P     A+  L+    ++ P +RP   HI  +L Q E 
Sbjct: 254 DSVALAVQNQLSIPQSPRH-SSALWQLLNSMMTVDPHQRP---HIPLLLSQLEA 303

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 90  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 149
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 210 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 115/255 (45%), Gaps = 20/255 (7%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR-LHNPNV 244
           R A+G   +  H +   +  AVK IR        T+ ++ +K+   ++ +  R +  P  
Sbjct: 44  RGAYGVVEKXRH-VPSGQIXAVKRIR-------ATVNSQEQKRLLXDLDISXRTVDCPFT 95
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK--TLPLPKLIAIALDIARGMEYIHS 302
           + F  A  +     +  E L + SL  +  ++  K  T+P   L  IA+ I + +E++HS
Sbjct: 96  VTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 154
Query: 303 Q-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI----KH 357
           +  VIHRD+KP NVLI+    +K  DFGI+   V   A   D G   + APE I      
Sbjct: 155 KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQ 214
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAIPGDCPPA-MAAL 415
           K Y  K D++S G+   E+     PY+    P Q    VV +   P +P D   A     
Sbjct: 215 KGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADKFSAEFVDF 273
Query: 416 IEQCWSLQPDKRPEF 430
             QC      +RP +
Sbjct: 274 TSQCLKKNSKERPTY 288

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 11/214 (5%)
Query: 232 EVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHK--LEHKTLPLPKLI 287
           EV LL  L +PN++++      +      ++ EY   G L + + K   E + L    ++
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 288 AIALDIARGMEYIHSQG-----VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
            +   +   ++  H +      V+HRDLKP NV +D + ++K+ DFG+A    + +  + 
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK 174
Query: 343 D-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
           +  GT  +M+PE +   SY  K D++S G +L+E+ A   P+   +  + A  +     R
Sbjct: 175 EFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234
Query: 402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
             IP      +  +I +  +L+   RP    I++
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDP 344
           I + IA  +E++HS+G++HRDLKP N+    +  +K+ DFG+      +E     L+  P
Sbjct: 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 345 ---------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
                    GT  +M+PE I   +Y  KVD++S GLIL+E++       +M  ++    V
Sbjct: 229 AYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF--STQMERVRIITDV 286
Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
            N    P +     P    +++   S  P +RPE   I++
Sbjct: 287 RNLKF-PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 68  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 127
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 128 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 187
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 188 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             
Sbjct: 49  DRNVAIKKLSRPF--QNQTHAKRA----YRELVLMKXVNHKNIISLLNVFTPQKTLEEFQ 102
Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           + YL    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +
Sbjct: 103 DVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSD 162
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
             LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ EMV   
Sbjct: 163 XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           I +   + I     V+ +   P     CP  M  L
Sbjct: 223 ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 252

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 68  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 127
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 128 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 187
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 188 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 64  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 123
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 124 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 183
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 184 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 227

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 18/188 (9%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVI 260
           ++  AVKII           + R+E    +E+  L     +PN++K            ++
Sbjct: 36  NQAFAVKII-----------SKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            E L+ G L   + K +H      +   I   +   + ++H  GV+HRDLKPEN+L   E
Sbjct: 85  MELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE 142
Query: 321 ---FHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
                +KI DFG A  +      L     T  + APE++    Y    D++S G+IL+ M
Sbjct: 143 NDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTM 202
Query: 377 VAGTIPYE 384
           ++G +P++
Sbjct: 203 LSGQVPFQ 210

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 75  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 134
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 135 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 194
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 195 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 238

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 82/152 (53%), Gaps = 5/152 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITE-YLSEGSLRAYLHKL-EHKTLPLPKLIA 288
           RE+ LL  L + NVI  +            +E YL    + A L+ + + + L    +  
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF 135
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348
           +   + RG++YIHS G+IHRDLKP NV ++++  L+I DFG+A +    + ++    T  
Sbjct: 136 LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQA--DEEMTGYVATRW 193
Query: 349 WMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           + APE M+    Y + VD++S G I+ E++ G
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 84  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 143
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 144 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 203
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 204 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 247

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 90  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 149
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 94  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 153
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 154 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 213
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 214 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 257

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 135 DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 194
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 195 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 254
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 255 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 298

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 232 EVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHK--LEHKTLPLPKLI 287
           EV LL  L +PN++++      +      ++ EY   G L + + K   E + L    ++
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 288 AIALDIARGMEYIHSQG-----VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
            +   +   ++  H +      V+HRDLKP NV +D + ++K+ DFG+A        L+ 
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA------RILNH 168
Query: 343 DP-------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
           D        GT  +M+PE +   SY  K D++S G +L+E+ A   P+   +  + A  +
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228
Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
                R  IP      +  +I +  +L+   RP    I++
Sbjct: 229 REGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 25/235 (10%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  I  +  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 36  AQGIVCAAYDAIL-ERNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIIGL 88
Query: 248 VAACKKPP-------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           +              VY ++ E +     +    +L+H+     ++  +   +  G++++
Sbjct: 89  LNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 142
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HS G+IHRDLKP N+++  +  LKI DFG+A        ++ +  T  + APE+I    Y
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGY 202
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
              VD++S G I+ EM+ G + +   + I     V+ +   P     CP  M  L
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKL 252

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 92  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 151
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 152 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 211
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 212 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 255

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 17/217 (7%)
Query: 232 EVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHK--LEHKTLPLPKLI 287
           EV LL  L +PN++++      +      ++ EY   G L + + K   E + L    ++
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 288 AIALDIARGMEYIHSQG-----VIHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCD 338
            +   +   ++  H +      V+HRDLKP NV +D + ++K+ DFG+A     +  +  
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
           A     GT  +M+PE +   SY  K D++S G +L+E+ A   P+   +  + A  +   
Sbjct: 175 AFV---GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 231
Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
             R  IP      +  +I +  +L+   RP    I++
Sbjct: 232 KFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 176 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 60  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 119
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 120 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 179
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 180 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 223

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 176 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
            +P ++    A +      +I +Y++ G L  +L + E  T    ++     +I   +E+
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG--EIVLALEH 174
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY--CDALSDDPGTYRWMAPEMIKH 357
           +H  G+I+RD+K EN+L+D   H+ + DFG++ E V    +   D  GT  +MAP++++ 
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 358 KSYG--RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--PAIPGDCPPAMA 413
              G  + VD +S G++++E++ G  P+       +   +  + L+  P  P +      
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 294
Query: 414 ALIEQCWSLQPDKR 427
            LI++     P KR
Sbjct: 295 DLIQRLLMKDPKKR 308

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 57  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 116
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 117 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 176
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 177 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 61  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 120
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 121 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 180
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 181 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 224

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             
Sbjct: 49  DRNVAIKKLSRPF--QNQTHAKRAY----RELVLMKXVNHKNIISLLNVFTPQKTLEEFQ 102
Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           + YL    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +
Sbjct: 103 DVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 162
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
             LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ EMV   
Sbjct: 163 XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           I +   + I     V+ +   P     CP  M  L
Sbjct: 223 ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 252

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 90/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRA 115
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 337 CDALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I   + Y   +DV+S G +L E++ G
Sbjct: 176 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 132/299 (44%), Gaps = 49/299 (16%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN---- 241
           +   GA+  ++  I +     V + +I D  +N T A R      RE+ +L+ L      
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHENI 71
Query: 242 PNVIKFVAACKKPPVYCVITEYLS---EGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
            N++  + A     VY V  +Y+       +RA + +  HK   + +LI +       ++
Sbjct: 72  VNLLNVLRADNDRDVYLVF-DYMETDLHAVIRANILEPVHKQYVVYQLIKV-------IK 123
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-------------------CEEVYCD- 338
           Y+HS G++HRD+KP N+L++ E H+K+ADFG++                     E + D 
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 339 --ALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAGTIPY---EEMNPIQAA 392
              L+D   T  + APE ++    Y + +D++S G IL E++ G   +     MN ++  
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 393 FAVV----NKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACN 447
             V+    N+++           + +L E+    Q +KR  F     +L +      CN
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 69  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 128
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 129 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 188
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 189 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 232

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
           K++ V VK I+     E+  +      +   E+A+LSR+ + N+IK +   +    + ++
Sbjct: 48  KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107
Query: 261 TEYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
            E    G  L A++ +  H  L  P    I   +   + Y+  + +IHRD+K EN++I +
Sbjct: 108 MEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE 165
Query: 320 EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVA 378
           +F +K+ DFG A             GT  + APE++    Y G +++++S G+ L+ +V 
Sbjct: 166 DFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
Query: 379 GTIPYEEM-NPIQAAF---AVVNKNLRPAIPGDCPPA------MAALIEQCWSLQPDKRP 428
              P+ E+   ++AA     +V+K L   + G   P       +  L+   W  QP    
Sbjct: 226 EENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLA 285
Query: 429 EF-WHIVKVLEQFETSLACNGTLNL 452
           ++ W  V  + + E+ +    +L +
Sbjct: 286 DYTWEEVFRVNKPESGVLSAASLEM 310

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             
Sbjct: 42  DRNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95
Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           + YL    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +
Sbjct: 96  DVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSD 155
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
             LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ EMV   
Sbjct: 156 XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           I +   + I     V+ +   P     CP  M  L
Sbjct: 216 ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 245

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 226 EKQF-NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEH 278
           +K+F NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115
Query: 279 K-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVY 336
           K TLP+  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V 
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 337 CDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            +       +  + APE+I     Y   +DV+S G +L E++ G
Sbjct: 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             
Sbjct: 49  DRNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 102
Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           + YL    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +
Sbjct: 103 DVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSD 162
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
             LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ EMV   
Sbjct: 163 XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           I +   + I     V+ +   P     CP  M  L
Sbjct: 223 ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 252

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 82/152 (53%), Gaps = 5/152 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITE-YLSEGSLRAYLHKL-EHKTLPLPKLIA 288
           RE+ LL  L + NVI  +            +E YL    + A L+ + + + L    +  
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF 135
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348
           +   + RG++YIHS G+IHRDLKP NV ++++  L+I DFG+A +    + ++    T  
Sbjct: 136 LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQA--DEEMTGYVATRW 193
Query: 349 WMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           + APE M+    Y + VD++S G I+ E++ G
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             
Sbjct: 49  DRNVAIKKLSRPF--QNQTHAKRAY----RELVLMKXVNHKNIISLLNVFTPQKTLEEFQ 102
Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           + YL    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +
Sbjct: 103 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 162
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
             LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ EMV   
Sbjct: 163 XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           I +   + I     V+ +   P     CP  M  L
Sbjct: 223 ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 252

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 82/152 (53%), Gaps = 5/152 (3%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITE-YLSEGSLRAYLHKL-EHKTLPLPKLIA 288
           RE+ LL  L + NVI  +            +E YL    + A L+ + + + L    +  
Sbjct: 68  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF 127
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348
           +   + RG++YIHS G+IHRDLKP NV ++++  L+I DFG+A +    + ++    T  
Sbjct: 128 LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA--DEEMTGYVATRW 185
Query: 349 WMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           + APE M+    Y + VD++S G I+ E++ G
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 14/224 (6%)
Query: 166 NAVDAADEHTVDLSQLFLGLRFAHGAHS--RLYHGIYKDEPVAVKIIRIPDDDENETLAA 223
           + VD   E+    S   L      GA S  R    +   +  A KII        + L+A
Sbjct: 9   SGVDLGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIIN------TKKLSA 62
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
           R  ++  RE  +   L +PN+++   +  +   + +I + ++ G L   +   E+ +   
Sbjct: 63  RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD 122
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIACE-EVYCDA 339
                    I   + + H  GV+HRDLKPEN+L+  +     +K+ADFG+A E E    A
Sbjct: 123 AS--HCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 180
Query: 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
                GT  +++PE+++   YG+ VD+++ G+IL+ ++ G  P+
Sbjct: 181 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 7/178 (3%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           ++ VA+K I++    E +     + +   RE+ LL  L +PN+I  + A        ++ 
Sbjct: 35  NQIVAIKKIKLGHRSEAKD---GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           +++ E  L   + K     L    + A  L   +G+EY+H   ++HRDLKP N+L+D+  
Sbjct: 92  DFM-ETDLEVII-KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG 149
Query: 322 HLKIADFGIACEEVYCDALSDDPGTYRWM-APEMI-KHKSYGRKVDVYSFGLILWEMV 377
            LK+ADFG+A      +         RW  APE++   + YG  VD+++ G IL E++
Sbjct: 150 VLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 86/159 (54%), Gaps = 9/159 (5%)
Query: 230 NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEHK-TLP 282
           NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    K TLP
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDALS 341
           +  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V  +   
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 342 DDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAG 379
               +  + APE+I   + Y   +DV+S G +L E++ G
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 186 RFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  ++    ++  E VA+K +R+ DDDE    +A       RE+ LL  L + N
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKN 62
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           +++            ++ E+  +  L+ Y         P   + +    + +G+ + HS+
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFCHSR 120
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMI-KHKSYG 361
            V+HRDLKP+N+LI++   LK+ADFG+A    +     S +  T  +  P+++   K Y 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 362 RKVDVYSFGLILWEMVAGTIP 382
             +D++S G I  E+     P
Sbjct: 181 TSIDMWSAGCIFAELANAARP 201

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 120/260 (46%), Gaps = 18/260 (6%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREV 233
            D  QLF  L    GA S +   + K   +  A KII        + L+AR  ++  RE 
Sbjct: 30  TDDYQLFEEL--GKGAFSVVRRCVKKTPTQEYAAKII------NTKKLSARDHQKLEREA 81
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
            +   L +PN+++   +  +   + ++ + ++ G L   +   E+ +            I
Sbjct: 82  RICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS--HCIHQI 139
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIACE-EVYCDALSDDPGTYRW 349
              + +IH   ++HRDLKPEN+L+  +     +K+ADFG+A E +    A     GT  +
Sbjct: 140 LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGY 199
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIPGD 407
           ++PE+++   YG+ VD+++ G+IL+ ++ G  P+  E+ + +         +        
Sbjct: 200 LSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDT 259
Query: 408 CPPAMAALIEQCWSLQPDKR 427
             P    LI Q  ++ P KR
Sbjct: 260 VTPEAKNLINQMLTINPAKR 279

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 86/159 (54%), Gaps = 9/159 (5%)
Query: 230 NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEHK-TLP 282
           NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+ E   R   H    K TLP
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDALS 341
           +  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V  +   
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 342 DDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAG 379
               +  + APE+I   + Y   +DV+S G +L E++ G
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 91/180 (50%), Gaps = 7/180 (3%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE-Y 263
           VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             + Y
Sbjct: 52  VAIKKLSRPF--QNQTHAKRA----YRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
           +    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +  L
Sbjct: 106 IVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           KI DFG+A        ++    T  + APE+I    Y   VD++S G+I+ EM+ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 6/163 (3%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK 285
           +     E+A+L ++ + N++      +    Y ++ + +S G L  +   LE        
Sbjct: 50  DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL--FDRILERGVYTEKD 107
Query: 286 LIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSD 342
              +   +   ++Y+H  G++HRDLKPEN+L    ++   + I DFG++  E     +S 
Sbjct: 108 ASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMST 166
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
             GT  ++APE++  K Y + VD +S G+I + ++ G  P+ E
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 91/180 (50%), Gaps = 7/180 (3%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE-Y 263
           VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             + Y
Sbjct: 52  VAIKKLSRPF--QNQTHAKRA----YRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
           +    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +  L
Sbjct: 106 IVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           KI DFG+A        ++    T  + APE+I    Y   VD++S G+I+ EM+ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 78/144 (54%), Gaps = 11/144 (7%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
           +   +++ HS+GV+HRD+K EN+LID +    K+ DFG +   ++ +  +D  GT  +  
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPYTDFDGTRVYSP 206
Query: 352 PEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
           PE I +H+ +     V+S G++L++MV G IP+E    I  A      ++ P    DC  
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSP----DC-- 260
Query: 411 AMAALIEQCWSLQPDKRPEFWHIV 434
              ALI +C + +P  RP    I+
Sbjct: 261 --CALIRRCLAPKPSSRPSLEEIL 282

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 25/235 (10%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  I  +  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 37  AQGIVCAAYDAIL-ERNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIIGL 89
Query: 248 VAAC-------KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           +          +   VY ++ E +     +    +L+H+     ++  +   +  G++++
Sbjct: 90  LNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 143
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HS G+IHRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
              VD++S G I+ EM+ G + +   + I     V+ +   P     CP  M  L
Sbjct: 204 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKL 253

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 25/235 (10%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  I  +  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 36  AQGIVCAAYDAIL-ERNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIIGL 88
Query: 248 VAAC-------KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           +          +   VY ++ E +     +    +L+H+     ++  +   +  G++++
Sbjct: 89  LNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 142
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HS G+IHRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
              VD++S G I+ EM+ G + +   + I     V+ +   P     CP  M  L
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKL 252

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 98/191 (51%), Gaps = 15/191 (7%)
Query: 205 VAVKIIRIPDDDE-------NETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
           V  + ++IP   E        + L+AR  ++  RE  +   L +PN+++   +  +   +
Sbjct: 19  VVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFH 78
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
            ++ + ++ G L   +   E+ +            I   + + H  G++HRDLKPEN+L+
Sbjct: 79  YLVFDLVTGGELFEDIVAREYYSEA--DASHCIQQILESVNHCHLNGIVHRDLKPENLLL 136
Query: 318 DQEFH---LKIADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
             +     +K+ADFG+A E V  D  A     GT  +++PE+++   YG+ VD+++ G+I
Sbjct: 137 ASKSKGAAVKLADFGLAIE-VQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVI 195
Query: 373 LWEMVAGTIPY 383
           L+ ++ G  P+
Sbjct: 196 LYILLVGYPPF 206

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTGYVATRWYRAP 198
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 93/179 (51%), Gaps = 10/179 (5%)
Query: 211 RIPDDDENETLAARLEKQF-NREVALLSRLHNPNVIKFVA-----ACKKPPVYC-VITEY 263
           ++ + DE        +K+F NRE+ ++  + +PNV+   A       KK  V+  ++ EY
Sbjct: 60  KLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 264 LSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
           + E   RA  H  + K T+P+  +      + R + YIHS G+ HRD+KP+N+L+D    
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG 179
Query: 323 -LKIADFGIACEEVYCDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
            LK+ DFG A   +  +       +  + APE+I    +Y   +D++S G ++ E++ G
Sbjct: 180 VLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTGYVATRWYRAP 198
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 13/229 (5%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  +  D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 74  AQGIVCAAYDAVL-DRNVAIKKLSRPF--QNQTHAKRAY----RELVLMKCVNHKNIISL 126
Query: 248 VAACKKPPVYCVITE-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           +             + YL    + A L ++    L   ++  +   +  G++++HS G+I
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGII 186
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           HRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y   VD+
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           +S G I+ EMV   I +   + I     V+ +   P     CP  M  L
Sbjct: 247 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 290

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTGYVATRWYRAP 198
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 92/183 (50%), Gaps = 17/183 (9%)
Query: 207 VKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI-TEYLS 265
           V I +IP+  +  T A    K+  RE+ +L    + N+I      +    Y    + Y+ 
Sbjct: 82  VAIKKIPNAFDVVTNA----KRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 137
Query: 266 EGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
              + + LH++ H + PL    +      + RG++Y+HS  VIHRDLKP N+L+++   L
Sbjct: 138 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCEL 197
Query: 324 KIADFGIA-------CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWE 375
           KI DFG+A        E  Y   +++   T  + APE M+    Y + +D++S G I  E
Sbjct: 198 KIGDFGMARGLCTSPAEHQYF--MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGE 255
Query: 376 MVA 378
           M+A
Sbjct: 256 MLA 258

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 13/229 (5%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  +  D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 35  AQGIVCAAYDAVL-DRNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIISL 87
Query: 248 VAACKKPPVYCVITE-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           +             + YL    + A L ++    L   ++  +   +  G++++HS G+I
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGII 147
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           HRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y   VD+
Sbjct: 148 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 207
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           +S G I+ EMV   I +   + I     V+ +   P     CP  M  L
Sbjct: 208 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 251

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             
Sbjct: 87  DRNVAIKKLSRPF--QNQTHAKRAY----RELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140
Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           + YL    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +
Sbjct: 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
             LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ EMV   
Sbjct: 201 CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           I +   + I     V+ +   P     CP  M  L
Sbjct: 261 ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 290

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 13/229 (5%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  +  D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 37  AQGIVCAAYDAVL-DRNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIISL 89
Query: 248 VAACKKPPVYCVITE-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           +             + YL    + A L ++    L   ++  +   +  G++++HS G+I
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGII 149
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           HRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y   VD+
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           +S G I+ EMV   I +   + I     V+ +   P     CP  M  L
Sbjct: 210 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 253

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 92/183 (50%), Gaps = 17/183 (9%)
Query: 207 VKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI-TEYLS 265
           V I +IP+  +  T A    K+  RE+ +L    + N+I      +    Y    + Y+ 
Sbjct: 83  VAIKKIPNAFDVVTNA----KRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 138
Query: 266 EGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
              + + LH++ H + PL    +      + RG++Y+HS  VIHRDLKP N+L+++   L
Sbjct: 139 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCEL 198
Query: 324 KIADFGIA-------CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWE 375
           KI DFG+A        E  Y   +++   T  + APE M+    Y + +D++S G I  E
Sbjct: 199 KIGDFGMARGLCTSPAEHQYF--MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGE 256
Query: 376 MVA 378
           M+A
Sbjct: 257 MLA 259

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 13/229 (5%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  +  D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 36  AQGIVCAAYDAVL-DRNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIISL 88
Query: 248 VAACKKPPVYCVITE-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           +             + YL    + A L ++    L   ++  +   +  G++++HS G+I
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGII 148
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           HRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y   VD+
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           +S G I+ EMV   I +   + I     V+ +   P     CP  M  L
Sbjct: 209 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 252

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 98/191 (51%), Gaps = 15/191 (7%)
Query: 205 VAVKIIRIPDDDE-------NETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
           V  + ++IP   E        + L+AR  ++  RE  +   L +PN+++   +  +   +
Sbjct: 19  VVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFH 78
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
            ++ + ++ G L   +   E+ +            I   + + H  G++HRDLKPEN+L+
Sbjct: 79  YLVFDLVTGGELFEDIVAREYYSEADAS--HCIQQILESVNHCHLNGIVHRDLKPENLLL 136
Query: 318 DQEFH---LKIADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
             +     +K+ADFG+A E V  D  A     GT  +++PE+++   YG+ VD+++ G+I
Sbjct: 137 ASKSKGAAVKLADFGLAIE-VQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVI 195
Query: 373 LWEMVAGTIPY 383
           L+ ++ G  P+
Sbjct: 196 LYILLVGYPPF 206

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGXVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 13/229 (5%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  +  D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 36  AQGIVCAAYDAVL-DRNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIISL 88
Query: 248 VAACKKPPVYCVITE-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           +             + YL    + A L ++    L   ++  +   +  G++++HS G+I
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGII 148
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           HRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y   VD+
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           +S G I+ EMV   I +   + I     V+ +   P     CP  M  L
Sbjct: 209 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 252

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 13/229 (5%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  +  D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 37  AQGIVCAAYDAVL-DRNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIISL 89
Query: 248 VAACKKPPVYCVITE-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           +             + YL    + A L ++    L   ++  +   +  G++++HS G+I
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGII 149
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           HRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y   VD+
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           +S G I+ EMV   I +   + I     V+ +   P     CP  M  L
Sbjct: 210 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 253

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 90/180 (50%), Gaps = 7/180 (3%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE-Y 263
           VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             + Y
Sbjct: 52  VAIKKLSRPF--QNQTHAKRA----YRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
           +    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +  L
Sbjct: 106 IVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           KI DFG+A        ++    T  + APE+I    Y   VD++S G I+ EM+ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             
Sbjct: 42  DRNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95
Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           + YL    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +
Sbjct: 96  DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 155
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
             LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ EMV   
Sbjct: 156 CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           I +   + I     V+ +   P     CP  M  L
Sbjct: 216 ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 245

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 13/229 (5%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  +  D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 30  AQGIVCAAYDAVL-DRNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIISL 82
Query: 248 VAACKKPPVYCVITE-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           +             + YL    + A L ++    L   ++  +   +  G++++HS G+I
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGII 142
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           HRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y   VD+
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 202
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           +S G I+ EMV   I +   + I     V+ +   P     CP  M  L
Sbjct: 203 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 246

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +          V T   
Sbjct: 52  VAIKKLSRPF--QNQTHAKRA----YRELVLMKVVNHKNIIGLLN---------VFTPQK 96
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIAR----------GMEYIHSQGVIHRDLKPEN 314
           S    +     +E     L ++I + LD  R          G++++HS G+IHRDLKP N
Sbjct: 97  SLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
           +++  +  LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ 
Sbjct: 157 IVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 375 EMVAGTIPY 383
           EM+ G + +
Sbjct: 217 EMIKGGVLF 225

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 85/159 (53%), Gaps = 9/159 (5%)
Query: 230 NREVALLSRLHNPNVIK-----FVAACKKPPVYC-VITEYLSEGSLRAYLHKLEHK-TLP 282
           NRE+ ++ +L + N+++     + +  KK  VY  ++ +Y+     R   H    K TLP
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLP 120
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDALS 341
           +  +      + R + YIHS G+ HRD+KP+N+L+D +   LK+ DFG A + V  +   
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 342 DDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAG 379
               +  + APE+I   + Y   +DV+S G +L E++ G
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  I  +  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 38  AQGIVCAAYDAIL-ERNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIIGL 90
Query: 248 VAAC-------KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           +          +   VY ++ E +     +    +L+H+     ++  +   +  G++++
Sbjct: 91  LNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 144
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HS G+IHRDLKP N+++  +  LKI DFG+A        +     T  + APE+I    Y
Sbjct: 145 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGY 204
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
              VD++S G I+ EM+ G + +   + I     V+ +   P     CP  M  L
Sbjct: 205 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKL 254

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           D  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +             
Sbjct: 43  DRNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 96
Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           + YL    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +
Sbjct: 97  DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 156
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
             LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ EMV   
Sbjct: 157 CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216
Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
           I +   + I     V+ +   P     CP  M  L
Sbjct: 217 ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 246

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 89/167 (53%), Gaps = 6/167 (3%)
Query: 221 LAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT 280
           L+AR  ++  RE  +   L +PN+++   +  +   + +I + ++ G L   +   E+ +
Sbjct: 49  LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS 108
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIACE-EVY 336
                       I   + + H  GV+HR+LKPEN+L+  +     +K+ADFG+A E E  
Sbjct: 109 EADAS--HCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
             A     GT  +++PE+++   YG+ VD+++ G+IL+ ++ G  P+
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT--DDEMTGYVATRWYRAP 196
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT--DDEMTGYVATRWYRAP 196
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  I  +  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 36  AQGIVCAAYDAIL-ERNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIIGL 88
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR----------GM 297
           +          V T   S    +     +E     L ++I + LD  R          G+
Sbjct: 89  LN---------VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 298 EYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH 357
           +++HS G+IHRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I  
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPY 383
             Y   VD++S G I+ EM+ G + +
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 9/179 (5%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI--A 288
           RE+ +L +L +PN++  +   ++     ++ EY         LH+L+     +P+ +  +
Sbjct: 51  REIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKS 106
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348
           I     + + + H    IHRD+KPEN+LI +   +K+ DFG A          DD    R
Sbjct: 107 ITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR 166
Query: 349 WM-APE-MIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
           W  +PE ++    YG  VDV++ G +  E+++G   +   + +   + ++ K L   IP
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LIRKTLGDLIP 224

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  I  +  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 36  AQGIVCAAYDAIL-ERNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIIGL 88
Query: 248 VAAC-------KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           +          +   VY ++ E +     +    +L+H+     ++  +   +  G++++
Sbjct: 89  LNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 142
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HS G+IHRDLKP N+++  +  LKI DFG+A        +  +  T  + APE+I    Y
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGY 202
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
              VD++S G I+ EMV   I +   + I     V+ +   P     CP  M  L
Sbjct: 203 KENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP-----CPAFMKKL 252

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 106/217 (48%), Gaps = 10/217 (4%)
Query: 218 NETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE 277
            + L+AR  ++  RE  +   L + N+++   +  +   + ++ + ++ G L   +   E
Sbjct: 39  TKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE 98
Query: 278 HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIACEE 334
           + +            I   + + H  GV+HRDLKPEN+L+  +     +K+ADFG+A E 
Sbjct: 99  YYSEADAS--HCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE- 155
Query: 335 VYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY--EEMNPIQ 390
           V  D  A     GT  +++PE+++ ++YG+ VD+++ G+IL+ ++ G  P+  E+ + + 
Sbjct: 156 VQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLY 215
Query: 391 AAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
                   +          P    LI Q  ++ P KR
Sbjct: 216 QQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKR 252

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
           VA+K +  P   +N+T A R      RE+ L+  +++ N+I  +          V T   
Sbjct: 52  VAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIIGLLN---------VFTPQK 96
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIAR----------GMEYIHSQGVIHRDLKPEN 314
           S    +     +E     L ++I + LD  R          G++++HS G+IHRDLKP N
Sbjct: 97  SLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
           +++  +  LKI DFG+A        ++    T  + APE+I    Y   VD++S G I+ 
Sbjct: 157 IVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 375 EMVAGTIPY 383
           EM+ G + +
Sbjct: 217 EMIKGGVLF 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT--DDEMTGYVATRWYRAP 202
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 114/236 (48%), Gaps = 30/236 (12%)
Query: 158 FDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE------PVAVKIIR 211
           FDH  V          +TV  +++  G RF           ++K E       +A KII+
Sbjct: 73  FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQ---------VHKCEETATGLKLAAKIIK 123
Query: 212 IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRA 271
                   T   + +++   E++++++L + N+I+   A +      ++ EY+  G L  
Sbjct: 124 --------TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL-- 173
Query: 272 YLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQGVIHRDLKPENVL-IDQEF-HLKIAD 327
              ++  ++  L +L  I     I  G+ ++H   ++H DLKPEN+L ++++   +KI D
Sbjct: 174 -FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIID 232
Query: 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           FG+A      + L  + GT  ++APE++ +       D++S G+I + +++G  P+
Sbjct: 233 FGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  I  +  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 36  AQGIVCAAYDAIL-ERNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIIGL 88
Query: 248 VAAC-------KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           +          +   VY ++ E +     +    +L+H+     ++  +   +  G++++
Sbjct: 89  LNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 142
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HS G+IHRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 361 GRKVDVYSFGLILWEMVAGTIPY 383
              VD++S G I+ EM+ G + +
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 188
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHT--DDEMTGYVATRWYRAP 197
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 193
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 196
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 133 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 190
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 188
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 186 RFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
           +   G +  ++    ++  E VA+K +R+ DDDE    +A       RE+ LL  L + N
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKN 62
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           +++            ++ E+  +  L+ Y         P   + +    + +G+ + HS+
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFCHSR 120
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMI-KHKSYG 361
            V+HRDLKP+N+LI++   LK+A+FG+A    +     S +  T  +  P+++   K Y 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 362 RKVDVYSFGLILWEMVAGTIP 382
             +D++S G I  E+     P
Sbjct: 181 TSIDMWSAGCIFAELANAGRP 201

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 196
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 132 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 189
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 198
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 193
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHT--DDEMTGYVATRWYRAP 193
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 211
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 193
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 197
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 197
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 144 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 201
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 203
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 202
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 214
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 203
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 203
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMAGFVATRWYRAP 187
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 197
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 210
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 27/174 (15%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVY--CVITEYLSEGSLRAYLHKLEHK-TLPLPKLI 287
           RE  +L +L++ N++K  A  ++       +I E+   GSL   L +  +   LP  + +
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIADFGIACEEVYCDALSDD 343
            +  D+  GM ++   G++HR++KP N++     D +   K+ DFG A E      L DD
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE------LEDD 169
Query: 344 P------GTYRWMAPEMIK--------HKSYGRKVDVYSFGLILWEMVAGTIPY 383
                  GT  ++ P+M +         K YG  VD++S G+  +    G++P+
Sbjct: 170 EQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMAGFVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 211
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVY--CVITEYLSEGSLRAYLHKLEHK-TLPLPKLI 287
           RE  +L +L++ N++K  A  ++       +I E+   GSL   L +  +   LP  + +
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIADFGIACEEVYCDALSDD 343
            +  D+  GM ++   G++HR++KP N++     D +   K+ DFG A E    +     
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175
Query: 344 PGTYRWMAPEMIK--------HKSYGRKVDVYSFGLILWEMVAGTIPY 383
            GT  ++ P+M +         K YG  VD++S G+  +    G++P+
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 210
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMAGFVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  I  +  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 36  AQGIVCAAYDAIL-ERNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIIGL 88
Query: 248 VAAC-------KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           +          +   VY ++ E +     +    +L+H+     ++  +   +  G++++
Sbjct: 89  LNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 142
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HS G+IHRDLKP N+++  +  LKI DFG+A        +  +  T  + APE+I    Y
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGY 202
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
              VD++S G I+ EMV   I +   + I     V+ +   P     CP  M  L
Sbjct: 203 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 252

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 55/92 (59%), Gaps = 11/92 (11%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---RW 349
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+      C    D+   Y   RW
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGL------CRHTDDEMTGYVATRW 187
Query: 350 M-APE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
             APE M+    Y + VD++S G I+ E++ G
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 54/88 (61%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D +     T  + AP
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMXGXVATRWYRAP 211
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 259 VITEYLSEGSLRAY------LHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLK 311
           +I EY+   S+  +      L K     +P+  +  I   +     YIH++  + HRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKS--YGRKVDVYSF 369
           P N+L+D+   +K++DFG   E +    +    GTY +M PE   ++S   G KVD++S 
Sbjct: 180 PSNILMDKNGRVKLSDFG-ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL 238
Query: 370 GLILWEMVAGTIPY 383
           G+ L+ M    +P+
Sbjct: 239 GICLYVMFYNVVPF 252

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 54/88 (61%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D +     T  + AP
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMXGYVATRWYRAP 214
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 54/88 (61%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T  + AP
Sbjct: 163 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 220
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y   VD++S G I+ E++ G
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 86/180 (47%), Gaps = 11/180 (6%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           A K +  P + + ET+         +E+  +S L +P ++    A +      +I E++S
Sbjct: 80  AAKFVMTPHESDKETV--------RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 131
Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI--DQEFHL 323
            G L   +   EH  +   + +     + +G+ ++H    +H DLKPEN++    +   L
Sbjct: 132 GGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL 190
Query: 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           K+ DFG+        ++    GT  + APE+ + K  G   D++S G++ + +++G  P+
Sbjct: 191 KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 204 PVAVKII--RIPDDDENETLA-ARLEKQFNREVALLSRLHNPNVI---KFVAACKKPPVY 257
           PVA+K +   + D      L+ + L K+  RE+ LL+  H+PN++         ++P ++
Sbjct: 48  PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH 107
Query: 258 CVITEYLSEGSLRAYLHKLEH--KTLPLPKLIAIAL-DIARGMEYIHSQGVIHRDLKPEN 314
            +   YL    +R  L ++ H  + +  P+ I   +  I  G+  +H  GV+HRDL P N
Sbjct: 108 KL---YLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGN 164
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM-APEMI-KHKSYGRKVDVYSFGLI 372
           +L+     + I DF +A E+   DA      T+RW  APE++ + K + + VD++S G +
Sbjct: 165 ILLADNNDITICDFNLAREDT-ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCV 223
Query: 373 LWEMVA------GTIPYEEMNPI 389
           + EM        G+  Y ++N I
Sbjct: 224 MAEMFNRKALFRGSTFYNQLNKI 246

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 204 PVAVKII--RIPDDDENETLA-ARLEKQFNREVALLSRLHNPNVI---KFVAACKKPPVY 257
           PVA+K +   + D      L+ + L K+  RE+ LL+  H+PN++         ++P ++
Sbjct: 48  PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH 107
Query: 258 CVITEYLSEGSLRAYLHKLEH--KTLPLPKLIAIAL-DIARGMEYIHSQGVIHRDLKPEN 314
            +   YL    +R  L ++ H  + +  P+ I   +  I  G+  +H  GV+HRDL P N
Sbjct: 108 KL---YLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGN 164
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM-APEMI-KHKSYGRKVDVYSFGLI 372
           +L+     + I DF +A E+   DA      T+RW  APE++ + K + + VD++S G +
Sbjct: 165 ILLADNNDITICDFNLAREDT-ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCV 223
Query: 373 LWEMVA------GTIPYEEMNPI 389
           + EM        G+  Y ++N I
Sbjct: 224 MAEMFNRKALFRGSTFYNQLNKI 246

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 124/285 (43%), Gaps = 28/285 (9%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEK------ 227
           H +    L        G  ++++ G+ ++     ++       E E L   L+K      
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQL------HETEVLLKVLDKAHRNYS 56
Query: 228 -QFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
             F    +++S+L + +++     C       ++ E++  GSL  YL K ++    L KL
Sbjct: 57  ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL 116
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF--------HLKIADFGIACEEVYCD 338
             +A  +A  M ++    +IH ++  +N+L+ +E          +K++D GI+   +  D
Sbjct: 117 -EVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 339 ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
            L +      W+ PE I++ K+     D +SFG  LWE+ +G    + ++ + +   +  
Sbjct: 176 ILQE---RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGG--DKPLSALDSQRKLQF 230
Query: 398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
              R  +P      +A LI  C   +PD RP F  I++ L    T
Sbjct: 231 YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 77/136 (56%), Gaps = 14/136 (10%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL 316
            ++ E L E +L A + K EH+ +PL  +  I+  +  G++Y+H + G+IH D+KPENVL
Sbjct: 106 VMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 317 I------DQEFHLKIADFGIAC--EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
           +      +    +KIAD G AC  +E Y +++     T  + +PE++    +G   D++S
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ----TREYRSPEVLLGAPWGCGADIWS 220
Query: 369 FGLILWEMVAGTIPYE 384
              +++E++ G   +E
Sbjct: 221 TACLIFELITGDFLFE 236

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 87/184 (47%), Gaps = 11/184 (5%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           A K +  P + + ET+         +E+  +S L +P ++    A +      +I E++S
Sbjct: 186 AAKFVMTPHESDKETV--------RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237
Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI--DQEFHL 323
            G L   +   EH  +   + +     + +G+ ++H    +H DLKPEN++    +   L
Sbjct: 238 GGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL 296
Query: 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           K+ DFG+        ++    GT  + APE+ + K  G   D++S G++ + +++G  P+
Sbjct: 297 KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356
Query: 384 EEMN 387
              N
Sbjct: 357 GGEN 360

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  I  +  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 41  AQGIVCAAYDAIL-ERNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIIGL 93
Query: 248 VAAC-------KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           +          +   VY ++ E +     +    +L+H+     ++  +   +  G++++
Sbjct: 94  LNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 147
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HS G+IHRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y
Sbjct: 148 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 207
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
              VD++S G I+ EMV   I +   + I     V+ +   P     CP  M  L
Sbjct: 208 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 257

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 77/136 (56%), Gaps = 14/136 (10%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL 316
            ++ E L E +L A + K EH+ +PL  +  I+  +  G++Y+H + G+IH D+KPENVL
Sbjct: 106 VMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 317 I------DQEFHLKIADFGIAC--EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
           +      +    +KIAD G AC  +E Y +++     T  + +PE++    +G   D++S
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ----TREYRSPEVLLGAPWGCGADIWS 220
Query: 369 FGLILWEMVAGTIPYE 384
              +++E++ G   +E
Sbjct: 221 TACLIFELITGDFLFE 236

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 90/184 (48%), Gaps = 9/184 (4%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           AVKI+ +     +  L+    +   RE ++   L +P++++ +       +  ++ E++ 
Sbjct: 55  AVKIVDVAKFTSSPGLST---EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD 111
Query: 266 EGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVLI---DQE 320
              L   + K         + +A      I   + Y H   +IHRD+KP  VL+   +  
Sbjct: 112 GADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENS 171
Query: 321 FHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
             +K+  FG+A +      ++    GT  +MAPE++K + YG+ VDV+  G+IL+ +++G
Sbjct: 172 APVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231
Query: 380 TIPY 383
            +P+
Sbjct: 232 CLPF 235

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI D+G+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           A G     Y  I  +  VA+K +  P   +N+T A R      RE+ L+  +++ N+I  
Sbjct: 30  AQGIVCAAYDAIL-ERNVAIKKLSRPF--QNQTHAKRA----YRELVLMKCVNHKNIIGL 82
Query: 248 VAAC-------KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           +          +   VY ++ E +     +    +L+H+     ++  +   +  G++++
Sbjct: 83  LNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 136
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HS G+IHRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
              VD++S G I+ EMV   I +   + I     V+ +   P     CP  M  L
Sbjct: 197 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKL 246

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 124/285 (43%), Gaps = 28/285 (9%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEK------ 227
           H +    L        G  ++++ G+ ++     ++       E E L   L+K      
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQL------HETEVLLKVLDKAHRNYS 56
Query: 228 -QFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
             F    +++S+L + +++     C       ++ E++  GSL  YL K ++    L KL
Sbjct: 57  ESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL 116
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF--------HLKIADFGIACEEVYCD 338
             +A  +A  M ++    +IH ++  +N+L+ +E          +K++D GI+   +  D
Sbjct: 117 -EVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 339 ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
            L +      W+ PE I++ K+     D +SFG  LWE+ +G    + ++ + +   +  
Sbjct: 176 ILQE---RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGG--DKPLSALDSQRKLQF 230
Query: 398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET 442
              R  +P      +A LI  C   +PD RP F  I++ L    T
Sbjct: 231 YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ +L +L++P +IK +        Y ++ E +  G L  +   + +K L          
Sbjct: 204 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYFY 260
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFG---IACEEVYCDALSDDPG 345
            +   ++Y+H  G+IHRDLKPENVL+   +++  +KI DFG   I  E      L    G
Sbjct: 261 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 317
Query: 346 TYRWMAPEM---IKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           T  ++APE+   +    Y R VD +S G+IL+  ++G  P+ E
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ +L +L++P +IK +        Y ++ E +  G L  +   + +K L          
Sbjct: 190 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYFY 246
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFG---IACEEVYCDALSDDPG 345
            +   ++Y+H  G+IHRDLKPENVL+   +++  +KI DFG   I  E      L    G
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 303
Query: 346 TYRWMAPEM---IKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           T  ++APE+   +    Y R VD +S G+IL+  ++G  P+ E
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 90/184 (48%), Gaps = 9/184 (4%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           AVKI+ +     +  L+    +   RE ++   L +P++++ +       +  ++ E++ 
Sbjct: 53  AVKIVDVAKFTSSPGLST---EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD 109
Query: 266 EGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVLI---DQE 320
              L   + K         + +A      I   + Y H   +IHRD+KP  VL+   +  
Sbjct: 110 GADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENS 169
Query: 321 FHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
             +K+  FG+A +      ++    GT  +MAPE++K + YG+ VDV+  G+IL+ +++G
Sbjct: 170 APVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
Query: 380 TIPY 383
            +P+
Sbjct: 230 CLPF 233

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 20/160 (12%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           ++ +Y   G L   L K E K LP         ++   ++ IH    +HRD+KP+NVL+D
Sbjct: 167 LVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD 225
Query: 319 QEFHLKIADFGIACEEVYCDALSDDP--------GTYRWMAPEMIK-----HKSYGRKVD 365
              H+++ADFG       C  ++DD         GT  +++PE+++        YG + D
Sbjct: 226 VNGHIRLADFG------SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 279
Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +S G+ ++EM+ G  P+   + ++    ++N   R   P
Sbjct: 280 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 319

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ +L +L++P +IK +        Y ++ E +  G L  +   + +K L          
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYFY 121
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFG---IACEEVYCDALSDDPG 345
            +   ++Y+H  G+IHRDLKPENVL+   +++  +KI DFG   I  E      L    G
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 178
Query: 346 TYRWMAPEM---IKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           T  ++APE+   +    Y R VD +S G+IL+  ++G  P+ E
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ +L +L++P +IK +        Y ++ E +  G L  +   + +K L          
Sbjct: 64  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYFY 120
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFG---IACEEVYCDALSDDPG 345
            +   ++Y+H  G+IHRDLKPENVL+   +++  +KI DFG   I  E      L    G
Sbjct: 121 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 177
Query: 346 TYRWMAPEM---IKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           T  ++APE+   +    Y R VD +S G+IL+  ++G  P+ E
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ +L +L++P +IK +        Y ++ E +  G L  +   + +K L          
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYFY 121
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFG---IACEEVYCDALSDDPG 345
            +   ++Y+H  G+IHRDLKPENVL+   +++  +KI DFG   I  E      L    G
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 178
Query: 346 TYRWMAPEM---IKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           T  ++APE+   +    Y R VD +S G+IL+  ++G  P+ E
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ +L +L++P +IK +        Y ++ E +  G L  +   + +K L          
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYFY 121
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFG---IACEEVYCDALSDDPG 345
            +   ++Y+H  G+IHRDLKPENVL+   +++  +KI DFG   I  E      L    G
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 178
Query: 346 TYRWMAPEM---IKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           T  ++APE+   +    Y R VD +S G+IL+  ++G  P+ E
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 20/160 (12%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           ++ +Y   G L   L K E K LP         ++   ++ IH    +HRD+KP+NVL+D
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD 209
Query: 319 QEFHLKIADFGIACEEVYCDALSDDP--------GTYRWMAPEMIK-----HKSYGRKVD 365
              H+++ADFG       C  ++DD         GT  +++PE+++        YG + D
Sbjct: 210 VNGHIRLADFG------SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 263
Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +S G+ ++EM+ G  P+   + ++    ++N   R   P
Sbjct: 264 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 303

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E+ +L +L++P +IK +        Y ++ E +  G L  +   + +K L          
Sbjct: 71  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYFY 127
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFG---IACEEVYCDALSDDPG 345
            +   ++Y+H  G+IHRDLKPENVL+   +++  +KI DFG   I  E      L    G
Sbjct: 128 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 184
Query: 346 TYRWMAPEM---IKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
           T  ++APE+   +    Y R VD +S G+IL+  ++G  P+ E
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 90/186 (48%), Gaps = 26/186 (13%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL------HNPNVIKFVAACKKPPVYC 258
           VA+K++R      NE    R  +Q   E+ +L  L      +  NVI  +         C
Sbjct: 125 VALKMVR------NEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           +  E LS  +L   + K + +   LP +   A  I + ++ +H   +IH DLKPEN+L+ 
Sbjct: 176 MTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK 234
Query: 319 QEFH--LKIADFGIACEE---VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
           Q+    +K+ DFG +C E   VY    S     YR  APE+I    YG  +D++S G IL
Sbjct: 235 QQGRSGIKVIDFGSSCYEHQRVYTXIQSR---FYR--APEVILGARYGMPIDMWSLGCIL 289
Query: 374 WEMVAG 379
            E++ G
Sbjct: 290 AELLTG 295

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 81/157 (51%), Gaps = 14/157 (8%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVL 316
           ++ +Y   G L   L K E +   LP+ +A     ++   ++ +H    +HRD+KP+N+L
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDR---LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP---GTYRWMAPEMIK-----HKSYGRKVDVYS 368
           +D   H+++ADFG +C ++  D         GT  +++PE+++        YG + D +S
Sbjct: 208 MDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWS 266
Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            G+ ++EM+ G  P+   + ++    ++N   R   P
Sbjct: 267 LGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 84/154 (54%), Gaps = 3/154 (1%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E++++++LH+P +I    A +      +I E+LS G L   +   ++K +   ++I    
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMR 156
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLID--QEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
               G++++H   ++H D+KPEN++ +  +   +KI DFG+A +    + +     T  +
Sbjct: 157 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
            APE++  +  G   D+++ G++ + +++G  P+
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 90/186 (48%), Gaps = 26/186 (13%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL------HNPNVIKFVAACKKPPVYC 258
           VA+K++R      NE    R  +Q   E+ +L  L      +  NVI  +         C
Sbjct: 125 VALKMVR------NEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           +  E LS  +L   + K + +   LP +   A  I + ++ +H   +IH DLKPEN+L+ 
Sbjct: 176 MTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK 234
Query: 319 QEFH--LKIADFGIACEE---VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
           Q+    +K+ DFG +C E   VY    S     YR  APE+I    YG  +D++S G IL
Sbjct: 235 QQGRSGIKVIDFGSSCYEHQRVYTXIQSR---FYR--APEVILGARYGMPIDMWSLGCIL 289
Query: 374 WEMVAG 379
            E++ G
Sbjct: 290 AELLTG 295

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI- 317
           +I E +  G L + + +   +     +   I  DI   ++++HS  + HRD+KPEN+L  
Sbjct: 84  IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 143
Query: 318 --DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
             +++  LK+ DFG A +E   +AL     T  ++APE++  + Y +  D++S G+I++ 
Sbjct: 144 SKEKDAVLKLTDFGFA-KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 202
Query: 376 MVAGTIPY 383
           ++ G  P+
Sbjct: 203 LLCGFPPF 210

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI- 317
           +I E +  G L + + +   +     +   I  DI   ++++HS  + HRD+KPEN+L  
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 162
Query: 318 --DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
             +++  LK+ DFG A +E   +AL     T  ++APE++  + Y +  D++S G+I++ 
Sbjct: 163 SKEKDAVLKLTDFGFA-KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 221
Query: 376 MVAGTIPY 383
           ++ G  P+
Sbjct: 222 LLCGFPPF 229

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 1/98 (1%)
Query: 280 TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA 339
           +LP  ++     D    + ++HSQG++H D+KP N+ +      K+ DFG+  E     A
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212
Query: 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
                G  R+MAPE+++  SYG   DV+S GL + E+ 
Sbjct: 213 GEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVA 249

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 54/88 (61%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI  FG+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 121/262 (46%), Gaps = 32/262 (12%)
Query: 186 RFAHGAHSRLYHGIYKDEPV-AVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNP 242
           +   G  S+++  + + + + A+K + + + D N+TL +     +  E+A L++L  H+ 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDS-----YRNEIAYLNKLQQHSD 116
Query: 243 NVIK-FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
            +I+ +        +Y V+        L ++L K   K++   +  +   ++   +  IH
Sbjct: 117 KIIRLYDYEITDQYIYMVME--CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 172
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS----DDPGTYRWMAPEMIKH 357
             G++H DLKP N LI  +  LK+ DFGIA  ++  D  S       GT  +M PE IK 
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIA-NQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 358 KSYGRK-----------VDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKNLRPAIP 405
            S  R+            DV+S G IL+ M  G  P+++ +N I    A+++ N     P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 406 GDCPPAMAALIEQCWSLQPDKR 427
                 +  +++ C    P +R
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQR 312

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 121/262 (46%), Gaps = 32/262 (12%)
Query: 186 RFAHGAHSRLYHGIYKDEPV-AVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNP 242
           +   G  S+++  + + + + A+K + + + D N+TL +     +  E+A L++L  H+ 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDS-----YRNEIAYLNKLQQHSD 69
Query: 243 NVIK-FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
            +I+ +        +Y V+        L ++L K   K++   +  +   ++   +  IH
Sbjct: 70  KIIRLYDYEITDQYIYMVME--CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 125
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS----DDPGTYRWMAPEMIKH 357
             G++H DLKP N LI  +  LK+ DFGIA  ++  D  S       GT  +M PE IK 
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIA-NQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 358 KSYGRK-----------VDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKNLRPAIP 405
            S  R+            DV+S G IL+ M  G  P+++ +N I    A+++ N     P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243
Query: 406 GDCPPAMAALIEQCWSLQPDKR 427
                 +  +++ C    P +R
Sbjct: 244 DIPEKDLQDVLKCCLKRDPKQR 265

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 90/186 (48%), Gaps = 26/186 (13%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL------HNPNVIKFVAACKKPPVYC 258
           VA+K++R      NE    R  +Q   E+ +L  L      +  NVI  +         C
Sbjct: 125 VALKMVR------NEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           +  E LS  +L   + K + +   LP +   A  I + ++ +H   +IH DLKPEN+L+ 
Sbjct: 176 MTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK 234
Query: 319 QEFH--LKIADFGIACEE---VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
           Q+    +K+ DFG +C E   VY    S     YR  APE+I    YG  +D++S G IL
Sbjct: 235 QQGRSGIKVIDFGSSCYEHQRVYXXIQSR---FYR--APEVILGARYGMPIDMWSLGCIL 289
Query: 374 WEMVAG 379
            E++ G
Sbjct: 290 AELLTG 295

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 121/262 (46%), Gaps = 32/262 (12%)
Query: 186 RFAHGAHSRLYHGIYKDEPV-AVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNP 242
           +   G  S+++  + + + + A+K + + + D N+TL +     +  E+A L++L  H+ 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDS-----YRNEIAYLNKLQQHSD 116
Query: 243 NVIK-FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
            +I+ +        +Y V+        L ++L K   K++   +  +   ++   +  IH
Sbjct: 117 KIIRLYDYEITDQYIYMVME--CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 172
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS----DDPGTYRWMAPEMIKH 357
             G++H DLKP N LI  +  LK+ DFGIA  ++  D  S       GT  +M PE IK 
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIA-NQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 358 KSYGRK-----------VDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKNLRPAIP 405
            S  R+            DV+S G IL+ M  G  P+++ +N I    A+++ N     P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 406 GDCPPAMAALIEQCWSLQPDKR 427
                 +  +++ C    P +R
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQR 312

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 121/262 (46%), Gaps = 32/262 (12%)
Query: 186 RFAHGAHSRLYHGIYKDEPV-AVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNP 242
           +   G  S+++  + + + + A+K + + + D N+TL +     +  E+A L++L  H+ 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDS-----YRNEIAYLNKLQQHSD 88
Query: 243 NVIK-FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
            +I+ +        +Y V+        L ++L K   K++   +  +   ++   +  IH
Sbjct: 89  KIIRLYDYEITDQYIYMVME--CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 144
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS----DDPGTYRWMAPEMIKH 357
             G++H DLKP N LI  +  LK+ DFGIA  ++  D  S       GT  +M PE IK 
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIA-NQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 358 KSYGRK-----------VDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKNLRPAIP 405
            S  R+            DV+S G IL+ M  G  P+++ +N I    A+++ N     P
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262
Query: 406 GDCPPAMAALIEQCWSLQPDKR 427
                 +  +++ C    P +R
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQR 284

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 54/88 (61%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI D G+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 54/88 (61%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI DF +A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 54/88 (61%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI D G+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 54/88 (61%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
           I RG++YIHS  +IHRDLKP N+ ++++  LKI D G+A      D ++    T  + AP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHT--DDEMTGYVATRWYRAP 191
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
           E M+    Y + VD++S G I+ E++ G
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 92/187 (49%), Gaps = 11/187 (5%)
Query: 208 KIIRIPDDDENETLAARLEK---QFNREVALLSRLHN-PNVIKFVAACKK----PPVYCV 259
           K+++I +    E  A ++ +   +  REV L  R    P++++ V   +          +
Sbjct: 31  KVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 90
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + E L  G L + +     +     +   I   I   ++Y+HS  + HRD+KPEN+L   
Sbjct: 91  VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 150
Query: 320 E---FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     LK+ DFG A E    ++L++   T  ++APE++  + Y +  D++S G+I++ +
Sbjct: 151 KRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 210
Query: 377 VAGTIPY 383
           + G  P+
Sbjct: 211 LCGYPPF 217

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 121/262 (46%), Gaps = 32/262 (12%)
Query: 186 RFAHGAHSRLYHGIYKDEPV-AVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNP 242
           +   G  S+++  + + + + A+K + + + D N+TL +     +  E+A L++L  H+ 
Sbjct: 15  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDS-----YRNEIAYLNKLQQHSD 68
Query: 243 NVIK-FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
            +I+ +        +Y V+        L ++L K   K++   +  +   ++   +  IH
Sbjct: 69  KIIRLYDYEITDQYIYMVME--CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 124
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS----DDPGTYRWMAPEMIKH 357
             G++H DLKP N LI  +  LK+ DFGIA  ++  D  S       GT  +M PE IK 
Sbjct: 125 QHGIVHSDLKPANFLI-VDGMLKLIDFGIA-NQMQPDTTSVVKDSQVGTVNYMPPEAIKD 182
Query: 358 KSYGRK-----------VDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKNLRPAIP 405
            S  R+            DV+S G IL+ M  G  P+++ +N I    A+++ N     P
Sbjct: 183 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 242
Query: 406 GDCPPAMAALIEQCWSLQPDKR 427
                 +  +++ C    P +R
Sbjct: 243 DIPEKDLQDVLKCCLKRDPKQR 264

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 121/262 (46%), Gaps = 32/262 (12%)
Query: 186 RFAHGAHSRLYHGIYKDEPV-AVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNP 242
           +   G  S+++  + + + + A+K + + + D N+TL +     +  E+A L++L  H+ 
Sbjct: 19  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDS-----YRNEIAYLNKLQQHSD 72
Query: 243 NVIK-FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
            +I+ +        +Y V+        L ++L K   K++   +  +   ++   +  IH
Sbjct: 73  KIIRLYDYEITDQYIYMVME--CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 128
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS----DDPGTYRWMAPEMIKH 357
             G++H DLKP N LI  +  LK+ DFGIA  ++  D  S       GT  +M PE IK 
Sbjct: 129 QHGIVHSDLKPANFLI-VDGMLKLIDFGIA-NQMQPDTTSVVKDSQVGTVNYMPPEAIKD 186
Query: 358 KSYGRK-----------VDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKNLRPAIP 405
            S  R+            DV+S G IL+ M  G  P+++ +N I    A+++ N     P
Sbjct: 187 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 246
Query: 406 GDCPPAMAALIEQCWSLQPDKR 427
                 +  +++ C    P +R
Sbjct: 247 DIPEKDLQDVLKCCLKRDPKQR 268

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 91/187 (48%), Gaps = 11/187 (5%)
Query: 208 KIIRIPDDDENETLAARLEK---QFNREVALLSRLHN-PNVIKFVAACKK----PPVYCV 259
           K+++I +    E  A ++ +   +  REV L  R    P++++ V   +          +
Sbjct: 47  KVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 106
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + E L  G L + +     +     +   I   I   ++Y+HS  + HRD+KPEN+L   
Sbjct: 107 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 166
Query: 320 E---FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     LK+ DFG A E    ++L+    T  ++APE++  + Y +  D++S G+I++ +
Sbjct: 167 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 226
Query: 377 VAGTIPY 383
           + G  P+
Sbjct: 227 LCGYPPF 233

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 91/187 (48%), Gaps = 11/187 (5%)
Query: 208 KIIRIPDDDENETLAARLEK---QFNREVALLSRLHN-PNVIKFVAACKK----PPVYCV 259
           K+++I +    E  A ++ +   +  REV L  R    P++++ V   +          +
Sbjct: 39  KVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 98
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + E L  G L + +     +     +   I   I   ++Y+HS  + HRD+KPEN+L   
Sbjct: 99  VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 158
Query: 320 E---FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     LK+ DFG A E    ++L+    T  ++APE++  + Y +  D++S G+I++ +
Sbjct: 159 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 218
Query: 377 VAGTIPY 383
           + G  P+
Sbjct: 219 LCGYPPF 225

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 186 RFAHGAHSRLYHGIYKDEPV-AVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNP 242
           +   G  S+++  + + + + A+K + + + D N+TL +     +  E+A L++L  H+ 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDS-----YRNEIAYLNKLQQHSD 88
Query: 243 NVIK-FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
            +I+ +        +Y V+        L ++L K   K++   +  +   ++   +  IH
Sbjct: 89  KIIRLYDYEITDQYIYMVME--CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 144
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACE---EVYCDALSDDPGTYRWMAPEMIKHK 358
             G++H DLKP N LI  +  LK+ DFGIA +   +          GT  +M PE IK  
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDM 203
Query: 359 SYGRK-----------VDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKNLRPAIPG 406
           S  R+            DV+S G IL+ M  G  P+++ +N I    A+++ N     P 
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 407 DCPPAMAALIEQCWSLQPDKR 427
                +  +++ C    P +R
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQR 284

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 91/187 (48%), Gaps = 11/187 (5%)
Query: 208 KIIRIPDDDENETLAARLEK---QFNREVALLSRLHN-PNVIKFVAACKK----PPVYCV 259
           K+++I +    E  A ++ +   +  REV L  R    P++++ V   +          +
Sbjct: 38  KVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 97
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + E L  G L + +     +     +   I   I   ++Y+HS  + HRD+KPEN+L   
Sbjct: 98  VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 157
Query: 320 E---FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     LK+ DFG A E    ++L+    T  ++APE++  + Y +  D++S G+I++ +
Sbjct: 158 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 217
Query: 377 VAGTIPY 383
           + G  P+
Sbjct: 218 LCGYPPF 224

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 91/187 (48%), Gaps = 11/187 (5%)
Query: 208 KIIRIPDDDENETLAARLEK---QFNREVALLSRLHN-PNVIKFVAACKK----PPVYCV 259
           K+++I +    E  A ++ +   +  REV L  R    P++++ V   +          +
Sbjct: 37  KVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 96
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
           + E L  G L + +     +     +   I   I   ++Y+HS  + HRD+KPEN+L   
Sbjct: 97  VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 156
Query: 320 E---FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           +     LK+ DFG A E    ++L+    T  ++APE++  + Y +  D++S G+I++ +
Sbjct: 157 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 216
Query: 377 VAGTIPY 383
           + G  P+
Sbjct: 217 LCGYPPF 223

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK---KPPVYCV 259
           + VA+K + + ++ E   + A       RE+ +L  L + NV+  +  C+    P   C 
Sbjct: 44  QKVALKKVLMENEKEGFPITAL------REIKILQLLKHENVVNLIEICRTKASPYNRCK 97
Query: 260 ITEYL----SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
            + YL     E  L   L  +  K   L ++  +   +  G+ YIH   ++HRD+K  NV
Sbjct: 98  ASIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 156
Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTYR------WMAPE--MIKHKSYGRKVDVY 367
           LI ++  LK+ADFG+A    +  A +  P  Y       W  P   ++  + YG  +D++
Sbjct: 157 LITRDGVLKLADFGLA--RAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLW 214
Query: 368 SFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
             G I+ EM   + P  + N  Q   A++++
Sbjct: 215 GAGCIMAEMWTRS-PIMQGNTEQHQLALISQ 244
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	488
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-134
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-130
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-128
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-125
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-124
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-124
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-121
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-120
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-120
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-103
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-102
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-101
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-99
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-88
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-81
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-67
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-67
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-65
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-65
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-64
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-64
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-64
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-64
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-63
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-63
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-62
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-62
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-62
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-62
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-62
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-62
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-62
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-61
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-61
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-61
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-61
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-61
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-61
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-60
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-60
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-60
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-60
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-60
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-60
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-60
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-60
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-59
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-59
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-58
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-58
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-58
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-57
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-57
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-57
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-57
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-57
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-57
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-56
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-56
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-56
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-56
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-55
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-55
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-55
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-55
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-54
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-54
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-53
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-52
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-52
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-52
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-51
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-50
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-50
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-50
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-49
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-49
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-47
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-47
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-46
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-45
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-45
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-43
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-43
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-42
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-42
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-41
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-41
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-41
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-41
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-41
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-41
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-41
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-41
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-40
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-40
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-40
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-40
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-39
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-39
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-39
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-07
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-39
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-39
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-38
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-38
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-38
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-38
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-37
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-37
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-37
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-36
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-36
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-36
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-36
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-36
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-35
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-35
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-35
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-35
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-35
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-35
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-35
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-34
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-34
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-34
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-33
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-33
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-33
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-32
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-32
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-32
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-31
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-31
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-31
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-31
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-31
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-31
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-31
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-30
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-29
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-29
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-29
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-29
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-29
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-28
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-28
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-28
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-28
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-28
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-28
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-28
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-27
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-27
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-27
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-27
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-27
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-27
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-27
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-26
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-26
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-26
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-26
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-26
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-26
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-26
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-25
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-25
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-25
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-25
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-25
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-25
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-24
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-24
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-24
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-24
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-24
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-24
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-23
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-23
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-23
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-21
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-20
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-20
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-19
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-15
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-14
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-14
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	1e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	2e-04
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	2e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  388 bits (999), Expect = e-134
 Identities = 96/278 (34%), Positives = 153/278 (55%), Gaps = 10/278 (3%)

Query: 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFN 230
            D+  +    L +  +   G+   ++   +    VAVKI+   D             +F 
Sbjct: 29  GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE------RVNEFL 82

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAI 289
           REVA++ RL +PN++ F+ A  +PP   ++TEYLS GSL   LHK    + L   + +++
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142

Query: 290 ALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GT 346
           A D+A+GM Y+H++   ++HR+LK  N+L+D+++ +K+ DFG++  +      S    GT
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGT 202

Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
             WMAPE+++ +    K DVYSFG+ILWE+     P+  +NP Q   AV  K  R  IP 
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR 262

Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
           +  P +AA+IE CW+ +P KRP F  I+ +L     S 
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  378 bits (973), Expect = e-130
 Identities = 90/275 (32%), Positives = 139/275 (50%), Gaps = 19/275 (6%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           +D ++L L      G   ++Y   +  + VAVK  R   D++     ++  +   +E  L
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDED----ISQTIENVRQEAKL 59

Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
            + L +PN+I     C K P  C++ E+   G L   L     K +P   L+  A+ IAR
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIAR 116

Query: 296 GMEYIHSQG---VIHRDLKPENVLIDQEFH--------LKIADFGIACEEVYCDALSDDP 344
           GM Y+H +    +IHRDLK  N+LI Q+          LKI DFG+A E      +S   
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-A 175

Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI 404
           G Y WMAPE+I+   + +  DV+S+G++LWE++ G +P+  ++ +  A+ V    L   I
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235

Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
           P  CP   A L+E CW+  P  RP F +I+  L  
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  371 bits (956), Expect = e-128
 Identities = 72/273 (26%), Positives = 133/273 (48%), Gaps = 17/273 (6%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           +D  QL    +        L+ G ++   + VK++++ D         R  + FN E   
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWST------RKSRDFNEECPR 60

Query: 236 LSRLHNPNVIKFVAACKKPPV--YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
           L    +PNV+  + AC+ PP     +IT ++  GSL   LH+  +  +   + +  ALD+
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120

Query: 294 ARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
           ARGM ++H+    +    L   +V+ID++   +I+   +         +        W+A
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM----YAPAWVA 176

Query: 352 PEMIKHKSYG---RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC 408
           PE ++ K      R  D++SF ++LWE+V   +P+ +++ ++    V  + LRP IP   
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236

Query: 409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE 441
            P ++ L++ C +  P KRP+F  IV +LE+ +
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  366 bits (941), Expect = e-125
 Identities = 84/282 (29%), Positives = 145/282 (51%), Gaps = 19/282 (6%)

Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
           DAAD+  +   Q+ +G R   G+   +Y G +  + VAVK++ +           +  + 
Sbjct: 14  DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTP------QQLQA 66

Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F  EV +L +  + N++ F+     P    ++T++    SL  +LH  E K   + KLI 
Sbjct: 67  FKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETK-FEMKKLID 124

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPG 345
           IA   ARGM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A E+             G
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184

Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR- 401
           +  WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N       +V +    
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244

Query: 402 ---PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
                +  +CP  M  L+ +C   + D+RP F  I+  +E+ 
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  363 bits (935), Expect = e-124
 Identities = 86/293 (29%), Positives = 150/293 (51%), Gaps = 19/293 (6%)

Query: 161 GGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDEN 218
           G +  +    +   T+  +++    +   G    ++ G        VA+K + + D +  
Sbjct: 1   GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60

Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH 278
             +  + + +F REV ++S L++PN++K       PP   ++ E++  G L   L   + 
Sbjct: 61  TEMIEKFQ-EFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD-KA 116

Query: 279 KTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQ-----EFHLKIADFGIA 331
             +     + + LDIA G+EY+ +Q   ++HRDL+  N+ +           K+ADFG++
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176

Query: 332 CEEVYCDALSDDPGTYRWMAPEMI--KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389
            + V+   +S   G ++WMAPE I  + +SY  K D YSF +IL+ ++ G  P++E +  
Sbjct: 177 QQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

Query: 390 QAAF--AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           +  F   +  + LRP IP DCPP +  +IE CWS  P KRP F +IVK L + 
Sbjct: 235 KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  362 bits (932), Expect = e-124
 Identities = 88/298 (29%), Positives = 144/298 (48%), Gaps = 22/298 (7%)

Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNRE 232
            H +D  ++ +      GA   +    ++ + VA+K I    +           K F  E
Sbjct: 2   LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE----------RKAFIVE 51

Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIAL 291
           +  LSR+++PN++K   AC  P   C++ EY   GSL   LH  E          ++  L
Sbjct: 52  LRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109

Query: 292 DIARGMEYIHS---QGVIHRDLKPENVLIDQEF-HLKIADFGIACEEVYCDALSDDPGTY 347
             ++G+ Y+HS   + +IHRDLKP N+L+      LKI DFG AC+      ++++ G+ 
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSA 167

Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNKNLRPAIPG 406
            WMAPE+ +  +Y  K DV+S+G+ILWE++    P++E+  P       V+   RP +  
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK 227

Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKG 464
           + P  + +L+ +CWS  P +RP    IVK++          G    +Q P       G
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP--GADEPLQYPCQHSLPPG 283

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  356 bits (916), Expect = e-121
 Identities = 84/290 (28%), Positives = 131/290 (45%), Gaps = 23/290 (7%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
                  S L  G     G   +     +++    + +  +   DE        ++ F +
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET------QRTFLK 56

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           EV ++  L +PNV+KF+    K      ITEY+  G+LR  +  ++ +  P  + ++ A 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAK 115

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------- 344
           DIA GM Y+HS  +IHRDL   N L+ +  ++ +ADFG+A   V      +         
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175

Query: 345 --------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV- 395
                   G   WMAPEMI  +SY  KVDV+SFG++L E++       +  P    F + 
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235

Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA 445
           V   L    P +CPP+   +  +C  L P+KRP F  +   LE     LA
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  354 bits (910), Expect = e-120
 Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 24/284 (8%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
            E  +   QL +G     G   ++YHG +  E VA+++I I  D+E++       K F R
Sbjct: 26  QEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQ------LKAFKR 78

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           EV    +  + NV+ F+ AC  PP   +IT      +L + +   +   L + K   IA 
Sbjct: 79  EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQ 137

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC------DALSDDPG 345
           +I +GM Y+H++G++H+DLK +NV  D    + I DFG+             D L    G
Sbjct: 138 EIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196

Query: 346 TYRWMAPEMIKH---------KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
               +APE+I+            + +  DV++ G I +E+ A   P++        + + 
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256

Query: 397 NKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
                          ++ ++  CW+ + ++RP F  ++ +LE+ 
Sbjct: 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  310 bits (796), Expect = e-103
 Identities = 79/307 (25%), Positives = 125/307 (40%), Gaps = 59/307 (19%)

Query: 180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNRE--VALLS 237
            + L      G +  ++ G ++ E VAVKI    D           EK + RE  +    
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----------EKSWFRETELYNTV 57

Query: 238 RLHNPNVIKFVAACKK----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
            L + N++ F+A+            +IT Y   GSL  YL      TL     + I L I
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSI 114

Query: 294 ARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP- 344
           A G+ ++H +         + HRDLK +N+L+ +     IAD G+A          D   
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 345 ----GTYRWMAPEMIKHK------SYGRKVDVYSFGLILWEMVAGT----------IPYE 384
               GT R+MAPE++            ++VD+++FGL+LWE+               P+ 
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234

Query: 385 EMNPIQAAF-----AVVNKNLRPAIPGD-----CPPAMAALIEQCWSLQPDKRPEFWHIV 434
           ++ P   +F      V     RP IP          ++A L+++CW   P  R     I 
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

Query: 435 KVLEQFE 441
           K L + +
Sbjct: 295 KTLTKID 301

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  308 bits (791), Expect = e-102
 Identities = 77/315 (24%), Positives = 129/315 (40%), Gaps = 55/315 (17%)

Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNRE 232
                  Q+ +  +   G +  ++ G ++ E VAVK+    ++                E
Sbjct: 31  VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEAS---------WFRETE 81

Query: 233 VALLSRLHNPNVIKFVAACKKPPV----YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           +     + + N++ F+AA  K         +IT+Y   GSL  YL      TL    ++ 
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLK 138

Query: 289 IALDIARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           +A     G+ ++H++         + HRDLK +N+L+ +     IAD G+A + +     
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198

Query: 341 SDDP-----GTYRWMAPEMI------KHKSYGRKVDVYSFGLILWEMVAGT--------- 380
            D P     GT R+M PE++       H       D+YSFGLILWE+             
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258

Query: 381 -IPYEEMNPIQAAF-----AVVNKNLRPAIPG-----DCPPAMAALIEQCWSLQPDKRPE 429
            +PY ++ P   ++      V  K LRP+ P      +C   M  L+ +CW+  P  R  
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318

Query: 430 FWHIVKVLEQFETSL 444
              + K L +   S 
Sbjct: 319 ALRVKKTLAKMSESQ 333

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  300 bits (770), Expect = 5e-99
 Identities = 75/314 (23%), Positives = 125/314 (39%), Gaps = 55/314 (17%)

Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNRE 232
                   + L      G    ++ G ++ E VAVKI    ++                E
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSW---------FREAE 86

Query: 233 VALLSRLHNPNVIKFVAACKK----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           +     L + N++ F+AA  K         ++++Y   GSL  YL++    T+ +  +I 
Sbjct: 87  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIK 143

Query: 289 IALDIARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           +AL  A G+ ++H +         + HRDLK +N+L+ +     IAD G+A         
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203

Query: 341 SDDP-----GTYRWMAPEMI------KHKSYGRKVDVYSFGLILWEMVAGT--------- 380
            D       GT R+MAPE++      KH    ++ D+Y+ GL+ WE+             
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263

Query: 381 -IPYEEMNPIQAAF-----AVVNKNLRPAIPG-----DCPPAMAALIEQCWSLQPDKRPE 429
            +PY ++ P   +       V  + LRP IP      +    MA ++ +CW      R  
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323

Query: 430 FWHIVKVLEQFETS 443
              I K L Q    
Sbjct: 324 ALRIKKTLSQLSQQ 337

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  273 bits (699), Expect = 2e-88
 Identities = 74/331 (22%), Positives = 124/331 (37%), Gaps = 70/331 (21%)

Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQF 229
           AA E ++DL  L L      G +  +Y G   + PVAVK+    +            + F
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----------RQNF 52

Query: 230 NRE--VALLSRLHNPNVIKFVAACKKPPV-----YCVITEYLSEGSLRAYLHKLEHKTLP 282
             E  +  +  + + N+ +F+   ++        Y ++ EY   GSL  YL      T  
Sbjct: 53  INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSD 109

Query: 283 LPKLIAIALDIARGMEYIHSQ---------GVIHRDLKPENVLIDQEFHLKIADFGIACE 333
                 +A  + RG+ Y+H++          + HRDL   NVL+  +    I+DFG++  
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169

Query: 334 EVYCDALSDDP---------GTYRWMAPEMIK-------HKSYGRKVDVYSFGLILWEMV 377
                 +             GT R+MAPE+++        +S  ++VD+Y+ GLI WE+ 
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

Query: 378 AGT---IPYEEMNPIQAAFA---------------VVNKNLRPAIPGDC------PPAMA 413
                  P E +   Q AF                V  +  RP  P           ++ 
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289

Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
             IE CW    + R       + + +     
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIW 320

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  253 bits (648), Expect = 6e-81
 Identities = 76/313 (24%), Positives = 125/313 (39%), Gaps = 59/313 (18%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           +        L L    A G    ++     +E VAVKI  I D             Q   
Sbjct: 17  ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS---------WQNEY 67

Query: 232 EVALLSRLHNPNVIKFVAACKKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI 287
           EV  L  + + N+++F+ A K+         +IT +  +GSL  +L       +   +L 
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELC 124

Query: 288 AIALDIARGMEYIHSQ----------GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
            IA  +ARG+ Y+H             + HRD+K +NVL+       IADFG+A    + 
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL--KFE 182

Query: 338 DALSDDP-----GTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGT------- 380
              S        GT R+MAPE+++      +    ++D+Y+ GL+LWE+ +         
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 381 ----IPYEEMNPIQAAF-----AVVNKNLRPAIPGDCPP-----AMAALIEQCWSLQPDK 426
               +P+EE      +       VV+K  RP +            +   IE+CW    + 
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 427 RPEFWHIVKVLEQ 439
           R     + + + Q
Sbjct: 303 RLSAGCVGERITQ 315

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  222 bits (569), Expect = 1e-67
 Identities = 80/288 (27%), Positives = 135/288 (46%), Gaps = 17/288 (5%)

Query: 159 DHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDEN 218
             G V            +++ +L L      G    +  G Y+   VAVK I+      +
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----ND 227

Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKL 276
            T      + F  E +++++L + N+++ +     +K  +Y ++TEY+++GSL  YL   
Sbjct: 228 AT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSR 281

Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
               L    L+  +LD+   MEY+     +HRDL   NVL+ ++   K++DFG+  E   
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341

Query: 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
                  P   +W APE ++ K +  K DV+SFG++LWE+ + G +PY  +         
Sbjct: 342 TQDTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPR 398

Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           V K  +   P  CPPA+  +++ CW L    RP F  + + LE   T 
Sbjct: 399 VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  215 bits (550), Expect = 7e-67
 Identities = 79/271 (29%), Positives = 137/271 (50%), Gaps = 17/271 (6%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           +++ +L L      G    +  G Y+   VAVK I+      + T      + F  E ++
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----NDAT-----AQAFLAEASV 67

Query: 236 LSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
           +++L + N+++ +     +K  +Y ++TEY+++GSL  YL       L    L+  +LD+
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126

Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPE 353
              MEY+     +HRDL   NVL+ ++   K++DFG+  E          P   +W APE
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPE 184

Query: 354 MIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
            ++ K +  K DV+SFG++LWE+ + G +PY  + P++     V K  +   P  CPPA+
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAV 243

Query: 413 AALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
             +++ CW L    RP F  + + LE  +T 
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  214 bits (546), Expect = 1e-65
 Identities = 68/261 (26%), Positives = 123/261 (47%), Gaps = 32/261 (12%)

Query: 196 YHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
           Y G++  E      PVA+K +R               K+   E  +++ + NP+V + + 
Sbjct: 32  YKGLWIPEGEKVKIPVAIKELR-EATSPKA------NKEILDEAYVMASVDNPHVCRLLG 84

Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
            C    V  +IT+ +  G L  Y+ + +   +    L+   + IA+GM Y+  + ++HRD
Sbjct: 85  ICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142

Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPEMIKHKSY 360
           L   NVL+    H+KI DFG+A        L  +   Y         +WMA E I H+ Y
Sbjct: 143 LAARNVLVKTPQHVKITDFGLA------KLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 361 GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC 419
             + DV+S+G+ +WE++  G+ PY+ +   +   +++ K  R   P  C   +  ++ +C
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMRKC 255

Query: 420 WSLQPDKRPEFWHIVKVLEQF 440
           W +  D RP+F  ++    + 
Sbjct: 256 WMIDADSRPKFRELIIEFSKM 276

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  212 bits (541), Expect = 1e-65
 Identities = 87/277 (31%), Positives = 134/277 (48%), Gaps = 17/277 (6%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++      +          F 
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---------FL 56

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y +ITEY+  GSL  +L       L + KL+ +A
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115

Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---Y 347
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   +  +  +   G     
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPI 174

Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
           +W APE I + ++  K DV+SFG++L E+V  G IPY  M   +     + +  R   P 
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPD 233

Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           +CP  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  212 bits (541), Expect = 2e-64
 Identities = 87/277 (31%), Positives = 140/277 (50%), Gaps = 19/277 (6%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQF 229
           D+  ++   L LG +   G    ++ G  + +   VAVK  R       ETL   L+ +F
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-------ETLPPDLKAKF 159

Query: 230 NREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
            +E  +L +  +PN+++ +  C +K P+Y ++ E +  G    +L   E   L +  L+ 
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRT-EGARLRVKTLLQ 217

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT-- 346
           +  D A GMEY+ S+  IHRDL   N L+ ++  LKI+DFG++  E      +   G   
Sbjct: 218 MVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS-REEADGVYAASGGLRQ 276

Query: 347 --YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA 403
              +W APE + +  Y  + DV+SFG++LWE  + G  PY  ++  Q     V K  R  
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-TREFVEKGGRLP 335

Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            P  CP A+  L+EQCW+ +P +RP F  I + L+  
Sbjct: 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  214 bits (546), Expect = 3e-64
 Identities = 81/278 (29%), Positives = 137/278 (49%), Gaps = 15/278 (5%)

Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++                 
Sbjct: 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--------- 225

Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344

Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP 405
            +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   P
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPCP 403

Query: 406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
            +CP ++  L+ QCW  +P++RP F ++   LE + TS
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  213 bits (545), Expect = 4e-64
 Identities = 82/253 (32%), Positives = 128/253 (50%), Gaps = 17/253 (6%)

Query: 196 YHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254
           +   Y     VAVK ++                 F  E  ++  L +  ++K  A   K 
Sbjct: 205 WMATYNKHTKVAVKTMKPGSMSVEA---------FLAEANVMKTLQHDKLVKLHAVVTKE 255

Query: 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
           P+Y +ITE++++GSL  +L   E    PLPKLI  +  IA GM +I  +  IHRDL+  N
Sbjct: 256 PIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 314

Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGL 371
           +L+      KIADFG+A   +  +  +   G     +W APE I   S+  K DV+SFG+
Sbjct: 315 ILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 373

Query: 372 ILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +L E+V  G IPY  M+  +     + +  R   P +CP  +  ++ +CW  +P++RP F
Sbjct: 374 LLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTF 432

Query: 431 WHIVKVLEQFETS 443
            +I  VL+ F T+
Sbjct: 433 EYIQSVLDDFYTA 445

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  207 bits (530), Expect = 8e-64
 Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 31/265 (11%)

Query: 196 YHGIYKDE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251
             G Y+ +     VAVKI++      NE     L+ +   E  ++ +L NP +++ +  C
Sbjct: 34  KKGYYQMKKVVKTVAVKILK------NEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87

Query: 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311
           +      ++ E    G L  YL +  ++ +    +I +   ++ GM+Y+     +HRDL 
Sbjct: 88  EAESWM-LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 144

Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYG 361
             NVL+  + + KI+DFG++       AL  D   Y          +W APE I +  + 
Sbjct: 145 ARNVLLVTQHYAKISDFGLS------KALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198

Query: 362 RKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
            K DV+SFG+++WE  + G  PY  M   +   A++ K  R   P  CP  M  L+  CW
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCW 257

Query: 421 SLQPDKRPEFWHIVKVLEQFETSLA 445
           +   + RP F  +   L  +   + 
Sbjct: 258 TYDVENRPGFAAVELRLRNYYYDVV 282

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  206 bits (527), Expect = 2e-63
 Identities = 69/283 (24%), Positives = 126/283 (44%), Gaps = 26/283 (9%)

Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAAR 224
              ++ +    + L      G    +Y G+Y +       VAVK  +       +     
Sbjct: 3   GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-------KDCTLD 55

Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
            +++F  E  ++  L +P+++K +   ++ P + +I E    G L  YL + ++  L + 
Sbjct: 56  NKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS-LKVL 113

Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALS 341
            L+  +L I + M Y+ S   +HRD+   N+L+     +K+ DFG++    +E Y  A  
Sbjct: 114 TLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS- 172

Query: 342 DDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
               T    +WM+PE I  + +    DV+ F + +WE+++ G  P+  +        V+ 
Sbjct: 173 ---VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLE 228

Query: 398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           K  R   P  CPP +  L+ +CW   P  RP F  +V  L   
Sbjct: 229 KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  206 bits (526), Expect = 3e-63
 Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 29/291 (9%)

Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAA 223
             +    +    L L  +   G+   +  G +         VAVK ++      +     
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-----PDVLSQP 62

Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
                F REV  +  L + N+I+       PP+  ++TE    GSL   L K +     L
Sbjct: 63  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLL 120

Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
             L   A+ +A GM Y+ S+  IHRDL   N+L+     +KI DFG+        AL  +
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM------RALPQN 174

Query: 344 PGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
              Y           W APE +K +++    D + FG+ LWEM   G  P+  +N  Q  
Sbjct: 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 234

Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
             +  +  R   P DCP  +  ++ QCW+ +P+ RP F  +   L + + +
Sbjct: 235 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  203 bits (518), Expect = 3e-62
 Identities = 67/281 (23%), Positives = 130/281 (46%), Gaps = 22/281 (7%)

Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAAR 224
           +  ++ +   ++ LG     G    ++ GIY         VA+K  +          +  
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDS 58

Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
           + ++F +E   + +  +P+++K +    + PV+ +I E  + G LR++L   ++  L L 
Sbjct: 59  VREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLA 116

Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDAL 340
            LI  A  ++  + Y+ S+  +HRD+   NVL+     +K+ DFG    +     Y  + 
Sbjct: 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176

Query: 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKN 399
              P   +WMAPE I  + +    DV+ FG+ +WE++  G  P++ +         +   
Sbjct: 177 GKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENG 233

Query: 400 LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            R  +P +CPP + +L+ +CW+  P +RP F  +   L   
Sbjct: 234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  203 bits (519), Expect = 3e-62
 Identities = 75/272 (27%), Positives = 138/272 (50%), Gaps = 19/272 (6%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQFNREV 233
           ++ + + +  +   G +  +Y G++K     VAVK ++    +  E         F +E 
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---------FLKEA 60

Query: 234 ALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
           A++  + +PN+++ +  C ++PP Y +ITE+++ G+L  YL +   + +    L+ +A  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRW 349
           I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++   +  D  +   G     +W
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 178

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDC 408
            APE + +  +  K DV++FG++LWE+   G  PY  ++  Q  + ++ K+ R   P  C
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGC 237

Query: 409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           P  +  L+  CW   P  RP F  I +  E  
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  203 bits (519), Expect = 5e-62
 Identities = 74/263 (28%), Positives = 126/263 (47%), Gaps = 23/263 (8%)

Query: 196 YHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250
           YHG Y D+       A+K +       +     +  + F RE  L+  L++PNV+  +  
Sbjct: 38  YHGEYIDQAQNRIQCAIKSL-------SRITEMQQVEAFLREGLLMRGLNHPNVLALIGI 90

Query: 251 C--KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
               +   + V+  Y+  G L  ++     +   +  LI+  L +ARGMEY+  Q  +HR
Sbjct: 91  MLPPEGLPH-VLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHR 148

Query: 309 DLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTY--RWMAPEMIKHKSYGRK 363
           DL   N ++D+ F +K+ADFG+A    +  Y             +W A E ++   +  K
Sbjct: 149 DLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK 208

Query: 364 VDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSL 422
            DV+SFG++LWE++  G  PY  ++P       + +  R   P  CP ++  +++QCW  
Sbjct: 209 SDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRLPQPEYCPDSLYQVMQQCWEA 267

Query: 423 QPDKRPEFWHIVKVLEQFETSLA 445
            P  RP F  +V  +EQ  ++L 
Sbjct: 268 DPAVRPTFRVLVGEVEQIVSALL 290

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  202 bits (517), Expect = 6e-62
 Identities = 66/265 (24%), Positives = 129/265 (48%), Gaps = 31/265 (11%)

Query: 196 YHGIYKDE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251
             G+Y+       VA+K+++    ++ +       ++  RE  ++ +L NP +++ +  C
Sbjct: 27  RQGVYRMRKKQIDVAIKVLK-QGTEKAD------TEEMMREAQIMHQLDNPYIVRLIGVC 79

Query: 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311
           +   +  ++ E    G L  +L   + + +P+  +  +   ++ GM+Y+  +  +HRDL 
Sbjct: 80  QAEALM-LVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137

Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYG 361
             NVL+    + KI+DFG++       AL  D   Y          +W APE I  + + 
Sbjct: 138 ARNVLLVNRHYAKISDFGLS------KALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191

Query: 362 RKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
            + DV+S+G+ +WE ++ G  PY++M       A + +  R   P +CPP + AL+  CW
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRMECPPECPPELYALMSDCW 250

Query: 421 SLQPDKRPEFWHIVKVLEQFETSLA 445
             + + RP+F  + + +     SLA
Sbjct: 251 IYKWEDRPDFLTVEQRMRACYYSLA 275

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  204 bits (520), Expect = 7e-62
 Identities = 68/261 (26%), Positives = 123/261 (47%), Gaps = 32/261 (12%)

Query: 196 YHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
           Y G++  E      PVA+K +R               K+   E  +++ + NP+V + + 
Sbjct: 32  YKGLWIPEGEKVKIPVAIKELR-EATSPKA------NKEILDEAYVMASVDNPHVCRLLG 84

Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
            C    V  +IT+ +  G L  Y+ + +   +    L+   + IA+GM Y+  + ++HRD
Sbjct: 85  ICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142

Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPEMIKHKSY 360
           L   NVL+    H+KI DFG+A        L  +   Y         +WMA E I H+ Y
Sbjct: 143 LAARNVLVKTPQHVKITDFGLA------KLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 361 GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC 419
             + DV+S+G+ +WE++  G+ PY+ +   +   +++ K  R   P  C   +  ++ +C
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKC 255

Query: 420 WSLQPDKRPEFWHIVKVLEQF 440
           W +  D RP+F  ++    + 
Sbjct: 256 WMIDADSRPKFRELIIEFSKM 276

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  209 bits (534), Expect = 8e-62
 Identities = 81/279 (29%), Positives = 137/279 (49%), Gaps = 17/279 (6%)

Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++                 
Sbjct: 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--------- 308

Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y ++TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPG 345
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A    +  Y  A      
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKF 426

Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI 404
             +W APE   +  +  K DV+SFG++L E+   G +PY  M   +     V +  R   
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPC 485

Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           P +CP ++  L+ QCW  +P++RP F ++   LE + TS
Sbjct: 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  208 bits (532), Expect = 8e-62
 Identities = 74/251 (29%), Positives = 128/251 (50%), Gaps = 17/251 (6%)

Query: 196 YHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-K 252
           Y G++K     VAVK ++  D  E E         F +E A++  + +PN+++ +  C +
Sbjct: 237 YEGVWKKYSLTVAVKTLK-EDTMEVEE--------FLKEAAVMKEIKHPNLVQLLGVCTR 287

Query: 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312
           +PP Y +ITE+++ G+L  YL +   + +    L+ +A  I+  MEY+  +  IHR+L  
Sbjct: 288 EPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAA 346

Query: 313 ENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFG 370
            N L+ +   +K+ADFG++         A +      +W APE + +  +  K DV++FG
Sbjct: 347 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 406

Query: 371 LILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
           ++LWE+   G  PY  ++  Q  + ++ K+ R   P  CP  +  L+  CW   P  RP 
Sbjct: 407 VLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 465

Query: 430 FWHIVKVLEQF 440
           F  I +  E  
Sbjct: 466 FAEIHQAFETM 476

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  202 bits (516), Expect = 1e-61
 Identities = 75/311 (24%), Positives = 127/311 (40%), Gaps = 52/311 (16%)

Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAA 223
            +D    +   L    +   G    +    Y        E VAVK ++   ++       
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---- 56

Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKP---PVYCVITEYLSEGSLRAYLHKLEHKT 280
                F RE+ +L  L + N++K+   C       +  +I EYL  GSLR YL K + + 
Sbjct: 57  ----DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER- 110

Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
           +   KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+         L
Sbjct: 111 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT------KVL 164

Query: 341 SDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMV------------- 377
             D   +           W APE +    +    DV+SFG++L+E+              
Sbjct: 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224

Query: 378 ---AGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIV 434
               G     +M        ++  N R   P  CP  +  ++ +CW+   ++RP F  + 
Sbjct: 225 MRMIGNDKQGQMIVFH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283

Query: 435 KVLEQFETSLA 445
             ++Q   ++A
Sbjct: 284 LRVDQIRDNMA 294

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  203 bits (518), Expect = 1e-61
 Identities = 61/261 (23%), Positives = 116/261 (44%), Gaps = 32/261 (12%)

Query: 196 YHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
           + G++  E      PV +K+I        +    +  +     +  +  L + ++++ + 
Sbjct: 30  HKGVWIPEGESIKIPVCIKVIE-------DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG 82

Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
            C    +  ++T+YL  GSL  ++ +     L    L+   + IA+GM Y+   G++HR+
Sbjct: 83  LCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEHGMVHRN 140

Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPEMIKHKSY 360
           L   NVL+     +++ADFG+A      D L  D             +WMA E I    Y
Sbjct: 141 LAARNVLLKSPSQVQVADFGVA------DLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194

Query: 361 GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC 419
             + DV+S+G+ +WE++  G  PY  +   +    ++ K  R A P  C   +  ++ +C
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGERLAQPQICTIDVYMVMVKC 253

Query: 420 WSLQPDKRPEFWHIVKVLEQF 440
           W +  + RP F  +     + 
Sbjct: 254 WMIDENIRPTFKELANEFTRM 274

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  200 bits (512), Expect = 2e-61
 Identities = 72/274 (26%), Positives = 127/274 (46%), Gaps = 19/274 (6%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVA 234
           +D S+L        G    ++ G + ++  VA+K IR     E +         F  E  
Sbjct: 5   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAE 55

Query: 235 LLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
           ++ +L +P +++    C ++ P+  ++TE++  G L  YL            L+ + LD+
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDV 113

Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWM 350
             GM Y+    VIHRDL   N L+ +   +K++DFG+    V  D  +   GT    +W 
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWA 172

Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           +PE+     Y  K DV+SFG+++WE+ + G IPYE  +        ++   R   P    
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLAS 231

Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
             +  ++  CW  +P+ RP F  +++ L +   S
Sbjct: 232 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  201 bits (513), Expect = 3e-61
 Identities = 76/305 (24%), Positives = 135/305 (44%), Gaps = 27/305 (8%)

Query: 157 YFDHGGVRVNAVDAADEHTVDLSQLFLGL--RFAHGAHSRLYHGIYKDE-----PVAVKI 209
           + D   +    V A     +  S L +        G    +YHG   D        AVK 
Sbjct: 1   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60

Query: 210 IRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEG 267
           +          +    +  F  E  ++    +PNV+  +  C   +     V+  Y+  G
Sbjct: 61  LN-----RITDIGEVSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHG 112

Query: 268 SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327
            LR ++    H    +  LI   L +A+GM+Y+ S+  +HRDL   N ++D++F +K+AD
Sbjct: 113 DLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 171

Query: 328 FGIACEEVY-CDALSDDPGTY-----RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
           FG+A  ++Y  +  S    T      +WMA E ++ + +  K DV+SFG++LWE++  G 
Sbjct: 172 FGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230

Query: 381 IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            PY ++N        + +  R   P  CP  +  ++ +CW  + + RP F  +V  +   
Sbjct: 231 PPYPDVNTFD-ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

Query: 441 ETSLA 445
            ++  
Sbjct: 290 FSTFI 294

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  200 bits (510), Expect = 3e-61
 Identities = 76/251 (30%), Positives = 127/251 (50%), Gaps = 19/251 (7%)

Query: 196 YHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KK 253
             G +K +  VAVK+I+     E+E         F +E   + +L +P ++KF   C K+
Sbjct: 25  KLGKWKGQYDVAVKMIKEGSMSEDE---------FFQEAQTMMKLSHPKLVKFYGVCSKE 75

Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
            P+Y ++TEY+S G L  YL     K L   +L+ +  D+  GM ++ S   IHRDL   
Sbjct: 76  YPIY-IVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAAR 133

Query: 314 NVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFG 370
           N L+D++  +K++DFG+    V  D      GT    +W APE+  +  Y  K DV++FG
Sbjct: 134 NCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFG 192

Query: 371 LILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
           +++WE+ + G +PY+     +     V++  R   P      +  ++  CW   P+KRP 
Sbjct: 193 ILMWEVFSLGKMPYDLYTNSE-VVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPT 251

Query: 430 FWHIVKVLEQF 440
           F  ++  +E  
Sbjct: 252 FQQLLSSIEPL 262

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  203 bits (518), Expect = 4e-61
 Identities = 78/367 (21%), Positives = 144/367 (39%), Gaps = 37/367 (10%)

Query: 99  HPRRKESDKGLVGKFLYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYF 158
           H       +          P+                 L     +E    +  +  T + 
Sbjct: 9   HHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN--TVHI 66

Query: 159 DHGGVRVNAVDAADEHTVDLSQLFLGL--RFAHGAHSRLYHGIYKDE-----PVAVKIIR 211
           D   +    V A     +  S L +        G    +YHG   D        AVK + 
Sbjct: 67  DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 126

Query: 212 IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSL 269
                    +    +  F  E  ++    +PNV+  +  C   +     V+  Y+  G L
Sbjct: 127 -----RITDIGEVSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 178

Query: 270 RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329
           R ++    H    +  LI   L +A+GM+++ S+  +HRDL   N ++D++F +K+ADFG
Sbjct: 179 RNFIRNETHN-PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 237

Query: 330 IACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA- 378
           +A  ++Y      +  +           +WMA E ++ + +  K DV+SFG++LWE++  
Sbjct: 238 LA-RDMY----DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 292

Query: 379 GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           G  PY ++N        + +  R   P  CP  +  ++ +CW  + + RP F  +V  + 
Sbjct: 293 GAPPYPDVNTFD-ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351

Query: 439 QFETSLA 445
              ++  
Sbjct: 352 AIFSTFI 358

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  201 bits (512), Expect = 1e-60
 Identities = 84/325 (25%), Positives = 141/325 (43%), Gaps = 43/325 (13%)

Query: 159 DHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIP 213
           D  G+     +  ++  +   Q  LG     G    +     K E      VAVK+++  
Sbjct: 3   DSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD 62

Query: 214 DDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC------KKPPVYCVITEYLSEG 267
               ++       ++F RE A +    +P+V K V          + P+  VI  ++  G
Sbjct: 63  IIASSD------IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG 116

Query: 268 SLRAYL----HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
            L A+L           LPL  L+   +DIA GMEY+ S+  IHRDL   N ++ ++  +
Sbjct: 117 DLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176

Query: 324 KIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLIL 373
            +ADFG++  ++Y    S D   Y          +W+A E +    Y    DV++FG+ +
Sbjct: 177 CVADFGLS-RKIY----SGD--YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229

Query: 374 WEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWH 432
           WE++  G  PY  +   +  +  +    R   P +C   +  L+ QCWS  P +RP F  
Sbjct: 230 WEIMTRGQTPYAGIENAE-IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTC 288

Query: 433 IVKVLEQFETSLACNGTLNLVQNPI 457
           +   LE     L+    L+  Q+P+
Sbjct: 289 LRMELENILGHLS---VLSTSQDPL 310

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  200 bits (511), Expect = 1e-60
 Identities = 80/298 (26%), Positives = 135/298 (45%), Gaps = 39/298 (13%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLE 226
           ++  +D + L LG     G    +  G  K E      VAVK +++ +  + E       
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE------I 80

Query: 227 KQFNREVALLSRLHNPNVIKFVAACKK-----PPVYCVITEYLSEGSLRAYL----HKLE 277
           ++F  E A +    +PNVI+ +  C +      P   VI  ++  G L  YL     +  
Sbjct: 81  EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140

Query: 278 HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
            K +PL  L+   +DIA GMEY+ ++  +HRDL   N ++  +  + +ADFG++ +++Y 
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS-KKIY- 198

Query: 338 DALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM 386
              S D   Y          +W+A E +  + Y  K DV++FG+ +WE+   G  PY  +
Sbjct: 199 ---SGD--YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253

Query: 387 NPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
              +  +  +    R   P DC   +  ++  CW   P  RP F  +   LE+   SL
Sbjct: 254 QNHE-MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  199 bits (508), Expect = 1e-60
 Identities = 64/251 (25%), Positives = 127/251 (50%), Gaps = 19/251 (7%)

Query: 196 YHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KK 253
            +G ++ +  VA+K+I+     E+E         F  E  ++  L +  +++    C K+
Sbjct: 41  KYGKWRGQYDVAIKMIKEGSMSEDE---------FIEEAKVMMNLSHEKLVQLYGVCTKQ 91

Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
            P++ +ITEY++ G L  YL ++ H+     +L+ +  D+   MEY+ S+  +HRDL   
Sbjct: 92  RPIF-IITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR 149

Query: 314 NVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFG 370
           N L++ +  +K++DFG++   V  D  +   G+    RW  PE++ +  +  K D+++FG
Sbjct: 150 NCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 208

Query: 371 LILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPE 429
           +++WE+ + G +PYE           + + LR   P      +  ++  CW  + D+RP 
Sbjct: 209 VLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 267

Query: 430 FWHIVKVLEQF 440
           F  ++  +   
Sbjct: 268 FKILLSNILDV 278

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  208 bits (532), Expect = 2e-60
 Identities = 74/339 (21%), Positives = 146/339 (43%), Gaps = 25/339 (7%)

Query: 112 KFLYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAA 171
           +    +PQ+E + +  S           +R +      +   + +  D        + + 
Sbjct: 326 QSFIIRPQKEGERALPSIPKLANNEKQGVR-SHTVSVSETDDYAEIIDEEDT--YTMPST 382

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLE 226
            ++ +   ++ LG     G    ++ GIY         VA+K  +        + + R +
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-----NCTSDSVREK 437

Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
             F +E   + +  +P+++K +    + PV+ +I E  + G LR++L   +   L L  L
Sbjct: 438 --FLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFS-LDLASL 493

Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSD 342
           I  A  ++  + Y+ S+  +HRD+   NVL+     +K+ DFG    +     Y  +   
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553

Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLR 401
            P   +WMAPE I  + +    DV+ FG+ +WE++  G  P++ +         +    R
Sbjct: 554 LP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGER 610

Query: 402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
             +P +CPP + +L+ +CW+  P +RP F  +   L   
Sbjct: 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  199 bits (509), Expect = 2e-60
 Identities = 74/265 (27%), Positives = 123/265 (46%), Gaps = 33/265 (12%)

Query: 196 YHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250
            +G  +       PVA+K ++     E +       + F  E +++ +  +PN+I+    
Sbjct: 66  CYGRLRVPGQRDVPVAIKALK-AGYTERQ------RRDFLSEASIMGQFDHPNIIRLEGV 118

Query: 251 C-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
             +      ++TEY+  GSL  +L   + +   + +L+ +   +  GM Y+   G +HRD
Sbjct: 119 VTRGRLAM-IVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLGYVHRD 176

Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKS 359
           L   NVL+D     K++DFG++        L DDP             RW APE I  ++
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRV------LEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
           +    DV+SFG+++WE++A G  PY  M   +   + V +  R   P  CP A+  L+  
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHALHQLMLD 289

Query: 419 CWSLQPDKRPEFWHIVKVLEQFETS 443
           CW     +RP F  IV VL+    S
Sbjct: 290 CWHKDRAQRPRFSQIVSVLDALIRS 314

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  199 bits (508), Expect = 4e-60
 Identities = 78/319 (24%), Positives = 130/319 (40%), Gaps = 52/319 (16%)

Query: 162 GVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDD 215
           G   +A +  D    +   L    +   G    +    Y        E VAVK ++   +
Sbjct: 24  GAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 83

Query: 216 DENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC---KKPPVYCVITEYLSEGSLRAY 272
           +            F RE+ +L  L + N++K+   C    +  +  +I EYL  GSLR Y
Sbjct: 84  EHLR--------DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDY 134

Query: 273 LHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332
           L K + + +   KL+     I +GMEY+ ++  IHRDL   N+L++ E  +KI DFG+  
Sbjct: 135 LQKHKER-IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT- 192

Query: 333 EEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMV----- 377
                  L  D   Y           W APE +    +    DV+SFG++L+E+      
Sbjct: 193 -----KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247

Query: 378 -----------AGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
                       G     +M        ++  N R   P  CP  +  ++ +CW+   ++
Sbjct: 248 SKSPPAEFMRMIGNDKQGQMIVFH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 306

Query: 427 RPEFWHIVKVLEQFETSLA 445
           RP F  +   ++Q    +A
Sbjct: 307 RPSFRDLALRVDQIRDQMA 325

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  199 bits (507), Expect = 4e-60
 Identities = 79/319 (24%), Positives = 132/319 (41%), Gaps = 52/319 (16%)

Query: 159 DHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRI 212
            HG + V      D        L        G   ++    Y        E VAVK ++ 
Sbjct: 11  HHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK- 69

Query: 213 PDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC---KKPPVYCVITEYLSEGSL 269
            D              + +E+ +L  L++ ++IK+   C       +  ++ EY+  GSL
Sbjct: 70  ADAGPQH------RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ-LVMEYVPLGSL 122

Query: 270 RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329
           R YL +    ++ L +L+  A  I  GM Y+H+Q  IHRDL   NVL+D +  +KI DFG
Sbjct: 123 RDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179

Query: 330 IACEEVYCDALSDDPGTYR----------WMAPEMIKHKSYGRKVDVYSFGLILWEMV-- 377
           +A       A+ +    YR          W APE +K   +    DV+SFG+ L+E++  
Sbjct: 180 LA------KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233

Query: 378 -------------AGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQP 424
                           I   +M  ++    ++ +  R   P  CP  +  L++ CW  + 
Sbjct: 234 CDSSQSPPTKFLELIGIAQGQMTVLR-LTELLERGERLPRPDKCPAEVYHLMKNCWETEA 292

Query: 425 DKRPEFWHIVKVLEQFETS 443
             RP F +++ +L+     
Sbjct: 293 SFRPTFENLIPILKTVHEK 311

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  198 bits (505), Expect = 5e-60
 Identities = 74/303 (24%), Positives = 128/303 (42%), Gaps = 50/303 (16%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARL 225
           D    +   L        G   ++    Y        E VAVK ++ P+   N       
Sbjct: 14  DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNH------ 66

Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKP---PVYCVITEYLSEGSLRAYLHKLEHKTLP 282
                +E+ +L  L++ N++K+   C +     +  +I E+L  GSL+ YL K ++K + 
Sbjct: 67  IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYLPKNKNK-IN 124

Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
           L + +  A+ I +GM+Y+ S+  +HRDL   NVL++ E  +KI DFG+        A+  
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT------KAIET 178

Query: 343 DPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMV--------------- 377
           D   Y           W APE +    +    DV+SFG+ L E++               
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238

Query: 378 AGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
                + +M   +     + +  R   P +CP  +  L+ +CW  QP  R  F ++++  
Sbjct: 239 MIGPTHGQMTVTR-LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

Query: 438 EQF 440
           E  
Sbjct: 298 EAL 300

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  197 bits (502), Expect = 4e-59
 Identities = 76/286 (26%), Positives = 134/286 (46%), Gaps = 34/286 (11%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQF 229
           +  S +        G    +Y G+ K        PVA+K ++            +    F
Sbjct: 41  IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-------AGYTEKQRVDF 93

Query: 230 NREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
             E  ++ +  + N+I+      K  P+  +ITEY+  G+L  +L + + +   + +L+ 
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMM-IITEYMENGALDKFLREKDGE-FSVLQLVG 151

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY- 347
           +   IA GM+Y+ +   +HRDL   N+L++     K++DFG++        L DDP    
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV------LEDDPEATY 205

Query: 348 ---------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
                    RW APE I ++ +    DV+SFG+++WE++  G  PY E++        +N
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAIN 264

Query: 398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
              R   P DCP A+  L+ QCW  +  +RP+F  IV +L++   +
Sbjct: 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  198 bits (505), Expect = 4e-59
 Identities = 81/282 (28%), Positives = 137/282 (48%), Gaps = 33/282 (11%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFN 230
           +D + + +      G    +  G  K        VA+K ++        T   R +  F 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-----VGYTEKQRRD--FL 94

Query: 231 REVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            E +++ +  +PN+I+      K  PV  ++TEY+  GSL ++L K + +   + +L+ +
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQ-FTVIQLVGM 152

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-- 347
              IA GM+Y+   G +HRDL   N+LI+     K++DFG+         L DDP     
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV------LEDDPEAAYT 206

Query: 348 --------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398
                   RW +PE I ++ +    DV+S+G++LWE+++ G  PY EM+  Q     V++
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDE 265

Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
             R   P DCP A+  L+  CW    + RP+F  IV +L++ 
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  194 bits (495), Expect = 1e-58
 Identities = 80/298 (26%), Positives = 125/298 (41%), Gaps = 49/298 (16%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE-------PVAVKIIRIPDDDENETLAARLEKQ 228
           + LS +            ++Y G             VA+K ++     +      R E  
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-----DKAEGPLREE-- 58

Query: 229 FNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHK------------ 275
           F  E  L +RL +PNV+  +    K  P+  +I  Y S G L  +L              
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117

Query: 276 --LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333
                  L  P  + +   IA GMEY+ S  V+H+DL   NVL+  + ++KI+D G+   
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF-R 176

Query: 334 EVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP 382
           EVY    + D   Y          RWMAPE I +  +    D++S+G++LWE+ + G  P
Sbjct: 177 EVY----AAD--YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

Query: 383 YEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           Y   +       ++        P DCP  + AL+ +CW+  P +RP F  I   L  +
Sbjct: 231 YCGYSNQD-VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  193 bits (493), Expect = 6e-58
 Identities = 77/296 (26%), Positives = 134/296 (45%), Gaps = 43/296 (14%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-------PVAVKIIRIPDDDENETLAAR 224
           DE  V   ++ +      G+   +Y G+ K          VA+K +      E  ++  R
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-----EAASMRER 72

Query: 225 LEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKT--- 280
           +E  F  E +++   +  +V++ +    +  P   VI E ++ G L++YL  L       
Sbjct: 73  IE--FLNEASVMKEFNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANN 129

Query: 281 -----LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
                  L K+I +A +IA GM Y+++   +HRDL   N ++ ++F +KI DFG+   ++
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT-RDI 188

Query: 336 YCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE 384
           Y      D   Y          RWM+PE +K   +    DV+SFG++LWE+      PY+
Sbjct: 189 Y----ETD--YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242

Query: 385 EMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            ++  Q     V +      P +CP  +  L+  CW   P  RP F  I+  +++ 
Sbjct: 243 GLSNEQ-VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  193 bits (492), Expect = 9e-58
 Identities = 74/317 (23%), Positives = 124/317 (39%), Gaps = 49/317 (15%)

Query: 160 HGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIP 213
           H           D    +   L    +   G    +    Y          VAVK ++  
Sbjct: 4   HHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS 63

Query: 214 DDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC---KKPPVYCVITEYLSEGSLR 270
             D+        ++ F RE+ +L  LH+  ++K+        +  +  ++ EYL  G LR
Sbjct: 64  GPDQ--------QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLR 114

Query: 271 AYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
            +L +   + L   +L+  +  I +GMEY+ S+  +HRDL   N+L++ E H+KIADFG+
Sbjct: 115 DFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173

Query: 331 ACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-G 379
           A        L  D   Y           W APE +    + R+ DV+SFG++L+E+    
Sbjct: 174 A------KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC 227

Query: 380 TIPYEEMNPIQAAFAV-------------VNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
                                        + +  R   P  CP  +  L++ CW+  P  
Sbjct: 228 DKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQD 287

Query: 427 RPEFWHIVKVLEQFETS 443
           RP F  +   L+   + 
Sbjct: 288 RPSFSALGPQLDMLWSG 304

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  192 bits (489), Expect = 1e-57
 Identities = 78/308 (25%), Positives = 128/308 (41%), Gaps = 50/308 (16%)

Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETL 221
                  +    + L      GA  +++     +         VAVK ++ P        
Sbjct: 5   SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---- 60

Query: 222 AARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYL------- 273
                K F RE  LL+ L + +++KF   C    P+  ++ EY+  G L  +L       
Sbjct: 61  ----RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDA 115

Query: 274 -------HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326
                   +     L L +++ IA  IA GM Y+ SQ  +HRDL   N L+     +KI 
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG 175

Query: 327 DFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           DFG++  +VY    S D   Y          RWM PE I ++ +  + DV+SFG+ILWE+
Sbjct: 176 DFGMS-RDVY----STD--YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

Query: 377 VA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
              G  P+ +++  +     + +      P  CP  +  ++  CW  +P +R     I K
Sbjct: 229 FTYGKQPWFQLSNTE-VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

Query: 436 VLEQFETS 443
           +L     +
Sbjct: 288 ILHALGKA 295

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  194 bits (494), Expect = 2e-57
 Identities = 86/363 (23%), Positives = 153/363 (42%), Gaps = 62/363 (17%)

Query: 114 LYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADE 173
           L +Q     ++SS+  S +PL  + +   +                        +    +
Sbjct: 26  LRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYE----------LPEDPK 75

Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDE---------PVAVKIIRIPDDDENETLAAR 224
                 +L LG     G   ++                  VAVK+++     ++ T    
Sbjct: 76  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDL 130

Query: 225 LEKQFNREVALLSRLHN-PNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYL--------- 273
            +     E+ ++  +    N+I  + AC +  P+Y VI EY S+G+LR YL         
Sbjct: 131 SD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGME 187

Query: 274 -----HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328
                +++  + +    L++    +ARGMEY+ SQ  IHRDL   NVL+ +   +KIADF
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247

Query: 329 GIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           G+A  ++           Y          +WMAPE +  + Y  + DV+SFG+++WE+  
Sbjct: 248 GLA-RDINNI------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

Query: 379 -GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL 437
            G  PY  +   +  F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L
Sbjct: 301 LGGSPYPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

Query: 438 EQF 440
           ++ 
Sbjct: 360 DRI 362

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  191 bits (486), Expect = 2e-57
 Identities = 66/249 (26%), Positives = 116/249 (46%), Gaps = 20/249 (8%)

Query: 190 GAHSRLYHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G+   +Y G+  +    VA   ++     ++E       ++F  E  +L  L +PN+++F
Sbjct: 37  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSE------RQRFKEEAEMLKGLQHPNIVRF 90

Query: 248 ----VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
                +  K      ++TE ++ G+L+ YL +   K + +  L +    I +G++++H++
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 304 G--VIHRDLKPENVLIDQEF-HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
              +IHRDLK +N+ I      +KI D G+A  +    A +   GT  +MAPEM + K Y
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMYEEK-Y 206

Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN-KNLRPAIPGDCPPAMAALIEQC 419
              VDVY+FG+ + EM     PY E       +  V       +      P +  +IE C
Sbjct: 207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266

Query: 420 WSLQPDKRP 428
                D+R 
Sbjct: 267 IRQNKDERY 275

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  190 bits (486), Expect = 4e-57
 Identities = 78/276 (28%), Positives = 126/276 (45%), Gaps = 45/276 (16%)

Query: 196 YHGIYKDE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAAC 251
            +G+ K +    VAVK+++      +  L  R       E+ +LS L N  N++  + AC
Sbjct: 44  AYGLIKSDAAMTVAVKMLK-----PSAHLTEREA--LMSELKVLSYLGNHMNIVNLLGAC 96

Query: 252 KKPPVYCVITEYLSEGSLRAYL----------------HKLEHKTLPLPKLIAIALDIAR 295
                  VITEY   G L  +L                 + +   L L  L++ +  +A+
Sbjct: 97  TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156

Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-------- 347
           GM ++ S+  IHRDL   N+L+      KI DFG+A  ++  D        Y        
Sbjct: 157 GMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RDIKND------SNYVVKGNARL 209

Query: 348 --RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI 404
             +WMAPE I +  Y  + DV+S+G+ LWE+ + G+ PY  M      + ++ +  R   
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 269

Query: 405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           P   P  M  +++ CW   P KRP F  IV+++E+ 
Sbjct: 270 PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  198 bits (505), Expect = 5e-57
 Identities = 65/265 (24%), Positives = 126/265 (47%), Gaps = 31/265 (11%)

Query: 196 YHGIYKDE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251
             G+Y+       VA+K+++       +       ++  RE  ++ +L NP +++ +  C
Sbjct: 353 RQGVYRMRKKQIDVAIKVLK-------QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 405

Query: 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311
           +   +  ++ E    G L  +L     + +P+  +  +   ++ GM+Y+  +  +HR+L 
Sbjct: 406 QAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463

Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYG 361
             NVL+    + KI+DFG++       AL  D   Y          +W APE I  + + 
Sbjct: 464 ARNVLLVNRHYAKISDFGLS------KALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517

Query: 362 RKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
            + DV+S+G+ +WE ++ G  PY++M       A + +  R   P +CPP + AL+  CW
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRMECPPECPPELYALMSDCW 576

Query: 421 SLQPDKRPEFWHIVKVLEQFETSLA 445
             + + RP+F  + + +     SLA
Sbjct: 577 IYKWEDRPDFLTVEQRMRACYYSLA 601

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  190 bits (484), Expect = 9e-57
 Identities = 81/305 (26%), Positives = 130/305 (42%), Gaps = 50/305 (16%)

Query: 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAA 223
           A +      +L LG     GA  ++                VAVK+++     E  T + 
Sbjct: 19  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-----EGATHSE 73

Query: 224 RLEKQFNREVALLSRLHN-PNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKLEH-- 278
                   E+ +L  + +  NV+  + AC     P+  VI E+   G+L  YL    +  
Sbjct: 74  HRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEF 130

Query: 279 ------------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326
                         L L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI 
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190

Query: 327 DFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
           DFG+A  ++Y D        Y          +WMAPE I  + Y  + DV+SFG++LWE+
Sbjct: 191 DFGLA-RDIYKD------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

Query: 377 VA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
            + G  PY  +   +     + +  R   P    P M   +  CW  +P +RP F  +V+
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303

Query: 436 VLEQF 440
            L   
Sbjct: 304 HLGNL 308

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  190 bits (484), Expect = 1e-56
 Identities = 74/306 (24%), Positives = 130/306 (42%), Gaps = 47/306 (15%)

Query: 166 NAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-------PVAVKIIRIPDDDEN 218
                A  H +    + L      GA  +++     +         VAVK ++   +   
Sbjct: 28  QYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA- 86

Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL----- 273
                   + F RE  LL+ L + ++++F   C +     ++ EY+  G L  +L     
Sbjct: 87  -------RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGP 139

Query: 274 --------HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
                     +    L L +L+A+A  +A GM Y+     +HRDL   N L+ Q   +KI
Sbjct: 140 DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199

Query: 326 ADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWE 375
            DFG++  ++Y    S D   Y          RWM PE I ++ +  + DV+SFG++LWE
Sbjct: 200 GDFGMS-RDIY----STD--YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252

Query: 376 MVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIV 434
           +   G  P+ +++  + A   + +      P  CPP + A++  CW  +P +R     + 
Sbjct: 253 IFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVH 311

Query: 435 KVLEQF 440
             L+  
Sbjct: 312 ARLQAL 317

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  189 bits (481), Expect = 5e-56
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 46/277 (16%)

Query: 195 LYHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFV 248
              GI KD+      VAVK+++     ++ T     +     E+ ++  +    N+I  +
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSD--LVSEMEMMKMIGKHKNIINLL 107

Query: 249 AACKKPPVYCVITEYLSEGSLRAYL--------------HKLEHKTLPLPKLIAIALDIA 294
            AC +     VI EY S+G+LR YL              +++  + +    L++    +A
Sbjct: 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------- 347
           RGMEY+ SQ  IHRDL   NVL+ +   +KIADFG+A  ++           Y       
Sbjct: 168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA-RDINNI------DYYKKTTNGR 220

Query: 348 ---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA 403
              +WMAPE +  + Y  + DV+SFG+++WE+   G  PY  +   +  F ++ +  R  
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-LFKLLKEGHRMD 279

Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            P +C   +  ++  CW   P +RP F  +V+ L++ 
Sbjct: 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  189 bits (481), Expect = 5e-56
 Identities = 78/327 (23%), Positives = 134/327 (40%), Gaps = 40/327 (12%)

Query: 145 RYKSRKESAWTKYFDHGGVRVNAVDAA-----DEHTVDLSQLFLGLRFAHGAHSRLYHGI 199
           + K + +  W     + G     +D       ++     + L  G     GA  ++    
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT 66

Query: 200 YKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAAC 251
                       VAVK+++            +       E+ ++S L    N++  + AC
Sbjct: 67  AFGLGKEDAVLKVAVKMLK-----STAHADEKEA--LMSELKIMSHLGQHENIVNLLGAC 119

Query: 252 -KKPPVYCVITEYLSEGSLRAYLHK------------LEHKTLPLPKLIAIALDIARGME 298
               PV  VITEY   G L  +L +            + + T     L+  +  +A+GM 
Sbjct: 120 THGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA 178

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEM 354
           ++ S+  IHRD+   NVL+      KI DFG    I  +  Y     +     +WMAPE 
Sbjct: 179 FLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPES 237

Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA 413
           I    Y  + DV+S+G++LWE+ + G  PY  +      + +V    + A P   P  + 
Sbjct: 238 IFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIY 297

Query: 414 ALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           ++++ CW+L+P  RP F  I   L++ 
Sbjct: 298 SIMQACWALEPTHRPTFQQICSFLQEQ 324

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  188 bits (479), Expect = 7e-56
 Identities = 80/296 (27%), Positives = 130/296 (43%), Gaps = 50/296 (16%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE----PVAVKIIRIPDDDENETLAARLEKQFNR 231
           +D + +        G   ++     K +      A+K ++     E  +     +  F  
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDHRD--FAG 74

Query: 232 EVALLSRL-HNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHK-------------- 275
           E+ +L +L H+PN+I  + AC  +  +Y +  EY   G+L  +L K              
Sbjct: 75  ELEVLCKLGHHPNIINLLGACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
               TL   +L+  A D+ARGM+Y+  +  IHRDL   N+L+ + +  KIADFG      
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG------ 187

Query: 336 YCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE 384
               LS     Y          RWMA E + +  Y    DV+S+G++LWE+V+ G  PY 
Sbjct: 188 ----LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243

Query: 385 EMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            M      +  + +  R   P +C   +  L+ QCW  +P +RP F  I+  L + 
Sbjct: 244 GMTC-AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  187 bits (477), Expect = 1e-55
 Identities = 79/326 (24%), Positives = 139/326 (42%), Gaps = 44/326 (13%)

Query: 166 NAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-------PVAVKIIRIPDDDEN 218
                +D   V    + L     HGA   +Y G             VAVK +      E 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EV 71

Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYL---- 273
            +    L+  F  E  ++S+ ++ N+++ +    +  P + ++ E ++ G L+++L    
Sbjct: 72  CSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRETR 128

Query: 274 -HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFG 329
               +  +L +  L+ +A DIA G +Y+     IHRD+   N L+         KI DFG
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188

Query: 330 IACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA- 378
           +A  ++Y          Y          +WM PE      +  K D +SFG++LWE+ + 
Sbjct: 189 MA-RDIYRA------SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241

Query: 379 GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           G +PY   +  +     V    R   P +CP  +  ++ QCW  QP+ RP F  I++ +E
Sbjct: 242 GYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

Query: 439 QF-ETSLACNGTLNLVQNPICQDHKK 463
              +     N  L +   P+ ++ +K
Sbjct: 301 YCTQDPDVINTALPIEYGPLVEEEEK 326

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  187 bits (478), Expect = 3e-55
 Identities = 88/369 (23%), Positives = 152/369 (41%), Gaps = 52/369 (14%)

Query: 123 KASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLF 182
           + +  S   SP   L  LR +           T Y  +          +D   V    + 
Sbjct: 23  QGAMGSELQSPEYKLSKLRTSTIM--------TDYNPNYCFAGKTSSISDLKEVPRKNIT 74

Query: 183 LGLRFAHGAHSRLYHGIYKDE-------PVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           L     HGA   +Y G             VAVK +      E  +    L+  F  E  +
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EVCSEQDELD--FLMEALI 127

Query: 236 LSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYL-----HKLEHKTLPLPKLIAI 289
           +S+ ++ N+++ +    +  P + ++ E ++ G L+++L        +  +L +  L+ +
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGT 346
           A DIA G +Y+     IHRD+   N L+         KI DFG+A  ++Y        G 
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRA------GY 239

Query: 347 Y----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
           Y          +WM PE      +  K D +SFG++LWE+ + G +PY   +  +     
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEF 298

Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF-ETSLACNGTLNLVQ 454
           V    R   P +CP  +  ++ QCW  QP+ RP F  I++ +E   +     N  L +  
Sbjct: 299 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEY 358

Query: 455 NPICQDHKK 463
            P+ ++ +K
Sbjct: 359 GPLVEEEEK 367

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  187 bits (476), Expect = 3e-55
 Identities = 79/310 (25%), Positives = 129/310 (41%), Gaps = 57/310 (18%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAAR 224
                  + +        GA  R++               VAVK+++     E  +   +
Sbjct: 40  LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-----EEASADMQ 94

Query: 225 LEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYL---------- 273
            +  F RE AL++   NPN++K +  C    P+  ++ EY++ G L  +L          
Sbjct: 95  AD--FQREAALMAEFDNPNIVKLLGVCAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCS 151

Query: 274 ------------HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
                              L   + + IA  +A GM Y+  +  +HRDL   N L+ +  
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 211

Query: 322 HLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGL 371
            +KIADFG++   +Y    S D   Y          RWM PE I +  Y  + DV+++G+
Sbjct: 212 VVKIADFGLS-RNIY----SAD--YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264

Query: 372 ILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEF 430
           +LWE+ + G  PY  M   +     V      A P +CP  +  L+  CWS  P  RP F
Sbjct: 265 VLWEIFSYGLQPYYGMAHEE-VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF 323

Query: 431 WHIVKVLEQF 440
             I ++L++ 
Sbjct: 324 CSIHRILQRM 333

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  185 bits (471), Expect = 7e-55
 Identities = 82/282 (29%), Positives = 134/282 (47%), Gaps = 53/282 (18%)

Query: 196 YHGIYKDE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC- 251
              +        VAVK+++     EN + +   +     E  +L ++++P+VIK   AC 
Sbjct: 44  AFHLKGRAGYTTVAVKMLK-----ENASPSELRD--LLSEFNVLKQVNHPHVIKLYGACS 96

Query: 252 KKPPVYCVITEYLSEGSLRAYL----------------------HKLEHKTLPLPKLIAI 289
           +  P+  +I EY   GSLR +L                         + + L +  LI+ 
Sbjct: 97  QDGPLL-LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-- 347
           A  I++GM+Y+    ++HRDL   N+L+ +   +KI+DFG++  +VY +       +Y  
Sbjct: 156 AWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-RDVYEE------DSYVK 208

Query: 348 --------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398
                   +WMA E +    Y  + DV+SFG++LWE+V  G  PY  + P +  F ++  
Sbjct: 209 RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER-LFNLLKT 267

Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
             R   P +C   M  L+ QCW  +PDKRP F  I K LE+ 
Sbjct: 268 GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  185 bits (471), Expect = 2e-54
 Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 52/282 (18%)

Query: 196 YHGIYKDE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAAC 251
            +GI K      VAVK+++     E    + R       E+ ++++L +  N++  + AC
Sbjct: 66  AYGISKTGVSIQVAVKMLK-----EKADSSEREA--LMSELKMMTQLGSHENIVNLLGAC 118

Query: 252 -KKPPVYCVITEYLSEGSLRAYLHKL---------------------EHKTLPLPKLIAI 289
               P+Y +I EY   G L  YL                        +   L    L+  
Sbjct: 119 TLSGPIY-LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-- 347
           A  +A+GME++  +  +HRDL   NVL+     +KI DFG+A  ++  D        Y  
Sbjct: 178 AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA-RDIMSD------SNYVV 230

Query: 348 --------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398
                   +WMAPE +    Y  K DV+S+G++LWE+ + G  PY  +      + ++  
Sbjct: 231 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN 290

Query: 399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
             +   P      +  +++ CW+    KRP F ++   L   
Sbjct: 291 GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  184 bits (470), Expect = 6e-54
 Identities = 81/277 (29%), Positives = 134/277 (48%), Gaps = 48/277 (17%)

Query: 196 YHGIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVA 249
             G+ KD+P     VAVK+++      + T     +     E+ ++  +    N+I  + 
Sbjct: 90  AIGLDKDKPNRVTKVAVKMLK-----SDATEKDLSD--LISEMEMMKMIGKHKNIINLLG 142

Query: 250 AC-KKPPVYCVITEYLSEGSLRAYL--------------HKLEHKTLPLPKLIAIALDIA 294
           AC +  P+Y VI EY S+G+LR YL                   + L    L++ A  +A
Sbjct: 143 ACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 201

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------- 347
           RGMEY+ S+  IHRDL   NVL+ ++  +KIADFG+A  +++          Y       
Sbjct: 202 RGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA-RDIHHI------DYYKKTTNGR 254

Query: 348 ---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA 403
              +WMAPE +  + Y  + DV+SFG++LWE+   G  PY  +   +  F ++ +  R  
Sbjct: 255 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFKLLKEGHRMD 313

Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            P +C   +  ++  CW   P +RP F  +V+ L++ 
Sbjct: 314 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  180 bits (458), Expect = 3e-53
 Identities = 58/290 (20%), Positives = 118/290 (40%), Gaps = 36/290 (12%)

Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDE---------PVAVKIIRIPDDDENETLAAR 224
           H +    L        G  ++++ G+ ++           V +K++       N      
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD--KAHRNY----- 55

Query: 225 LEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
             + F    +++S+L + +++     C        ++ E++  GSL  YL K ++  + +
Sbjct: 56  -SESFFEAASMMSKLSHKHLVLNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNC-INI 112

Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL--------KIADFGIACEEV 335
              + +A  +A  M ++    +IH ++  +N+L+ +E           K++D GI+   V
Sbjct: 113 LWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITV 171

Query: 336 YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF 393
               +  +     W+ PE I++ K+     D +SFG  LWE+ + G  P   ++  +   
Sbjct: 172 LPKDILQER--IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KL 228

Query: 394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
                  +   P      +A LI  C   +PD RP F  I++ L    T 
Sbjct: 229 QFYEDRHQLPAPKAAE--LANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  177 bits (452), Expect = 2e-52
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 34/240 (14%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF----------------V 248
             +K ++      NE           REV  L++L + N++ +                 
Sbjct: 39  YVIKRVKY----NNEKAE--------REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86

Query: 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
           ++  K     +  E+  +G+L  ++ K   + L     + +   I +G++YIHS+ +I+R
Sbjct: 87  SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINR 146

Query: 309 DLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
           DLKP N+ +     +KI DFG+          +   GT R+M+PE I  + YG++VD+Y+
Sbjct: 147 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYA 206

Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
            GLIL E++       E +                I          L+++  S +P+ RP
Sbjct: 207 LGLILAELLHVCDTAFETS------KFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRP 260

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  178 bits (453), Expect = 5e-52
 Identities = 69/320 (21%), Positives = 121/320 (37%), Gaps = 36/320 (11%)

Query: 126 SNSYSTSPLRHLGSLRVTERYKSRKESAW-TKYFDHGGVRVNAVDAADEHTVDLS----- 179
           S S S+     L SL  T    S K      +  D+ GV +       ++          
Sbjct: 2   SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61

Query: 180 -QLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALL 236
            Q  +G     G+   ++    K      AVK +R+                   E+   
Sbjct: 62  HQPRVG----RGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------------EELVAC 104

Query: 237 SRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARG 296
           + L +P ++    A ++ P   +  E L  GSL   + +     LP  + +        G
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEG 162

Query: 297 MEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIA---CEEVYCDALSDDP---GTYRW 349
           +EY+H++ ++H D+K +NVL+  +     + DFG A     +    +L       GT   
Sbjct: 163 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-LRPAIPGDC 408
           MAPE++  K    KVD++S   ++  M+ G  P+ +         + ++      IP  C
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282

Query: 409 PPAMAALIEQCWSLQPDKRP 428
            P  A  I++    +P  R 
Sbjct: 283 APLTAQAIQEGLRKEPVHRA 302

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  178 bits (453), Expect = 8e-52
 Identities = 45/225 (20%), Positives = 108/225 (48%), Gaps = 8/225 (3%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
             +K I I      E   +R      REVA+L+ + +PN++++  + ++     ++ +Y 
Sbjct: 52  YVIKEINISRMSSKEREESR------REVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105

Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
             G L   ++  +       +++   + I   ++++H + ++HRD+K +N+ + ++  ++
Sbjct: 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQ 165

Query: 325 IADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
           + DFGIA       +      GT  +++PE+ ++K Y  K D+++ G +L+E+      +
Sbjct: 166 LGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF 225

Query: 384 EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
           E  +       +++ +  P +       + +L+ Q +   P  RP
Sbjct: 226 EAGSMKNLVLKIISGSFPP-VSLHYSYDLRSLVSQLFKRNPRDRP 269

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  175 bits (446), Expect = 6e-51
 Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 40/264 (15%)

Query: 189 HGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVI 245
            G  S+++  + +  +  A+K + + + D            +  E+A L++L  H+  +I
Sbjct: 19  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL------DSYRNEIAYLNKLQQHSDKII 72

Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           +            ++ E      L ++L K   K++   +  +   ++   +  IH  G+
Sbjct: 73  RLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGI 129

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---------GTYRWMAPEMIK 356
           +H DLKP N LI     LK+ DFGIA      + +  D          GT  +M PE IK
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIA------NQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 357 HKS-----------YGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAI 404
             S              K DV+S G IL+ M  G  P++++ N I    A+++ N     
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242

Query: 405 PGDCPPAMAALIEQCWSLQPDKRP 428
           P      +  +++ C    P +R 
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRI 266

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  173 bits (440), Expect = 1e-50
 Identities = 69/248 (27%), Positives = 111/248 (44%), Gaps = 18/248 (7%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G +  +Y G        +A+K I   D            +  + E+AL   L + N++++
Sbjct: 33  GTYGIVYAGRDLSNQVRIAIKEIPERDSRY--------SQPLHEEIALHKHLKHKNIVQY 84

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP-KLIA-IALDIARGMEYIHSQGV 305
           + +  +     +  E +  GSL A L + +   L    + I      I  G++Y+H   +
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143

Query: 306 IHRDLKPENVLIDQEF-HLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKS--YG 361
           +HRD+K +NVLI+     LKI+DFG +              GT ++MAPE+I      YG
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203

Query: 362 RKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
           +  D++S G  + EM  G  P+ E+  P  A F V    + P IP        A I +C+
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 263

Query: 421 SLQPDKRP 428
              PDKR 
Sbjct: 264 EPDPDKRA 271

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  173 bits (441), Expect = 2e-50
 Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 40/264 (15%)

Query: 189 HGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVI 245
            G  S+++  + +  +  A+K + + + D            +  E+A L++L  H+  +I
Sbjct: 38  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL------DSYRNEIAYLNKLQQHSDKII 91

Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           +            ++ E      L ++L K   K++   +  +   ++   +  IH  G+
Sbjct: 92  RLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGI 148

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---------GTYRWMAPEMIK 356
           +H DLKP N LI     LK+ DFGIA      + +  D          GT  +M PE IK
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIA------NQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 357 HKS-----------YGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAI 404
             S              K DV+S G IL+ M  G  P++++ N I    A+++ N     
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261

Query: 405 PGDCPPAMAALIEQCWSLQPDKRP 428
           P      +  +++ C    P +R 
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQRI 285

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  172 bits (437), Expect = 6e-50
 Identities = 51/242 (21%), Positives = 92/242 (38%), Gaps = 13/242 (5%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
           HG++  ++    K+     AVK    P     +      E       +      +P  ++
Sbjct: 67  HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAE-----VGSHEKVGQHPCCVR 121

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
              A ++  +  + TE     SL+ +       +LP  ++     D    + ++HSQG++
Sbjct: 122 LEQAWEEGGILYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQGLV 179

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           H D+KP N+ +      K+ DFG+  E     A     G  R+MAPE+++   YG   DV
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS-YGTAADV 238

Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
           +S GL + E+             Q    +    L P         + +++       P  
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKL 295

Query: 427 RP 428
           R 
Sbjct: 296 RA 297

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  173 bits (440), Expect = 2e-49
 Identities = 60/263 (22%), Positives = 108/263 (41%), Gaps = 40/263 (15%)

Query: 190 GAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIK 246
           G  S+++  + +  +  A+K + + + D            +  E+A L++L  H+  +I+
Sbjct: 67  GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL------DSYRNEIAYLNKLQQHSDKIIR 120

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                       ++ E      L ++L K   K++   +  +   ++   +  IH  G++
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIV 177

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---------GTYRWMAPEMIKH 357
           H DLKP N LI     LK+ DFGIA      + +  D          G   +M PE IK 
Sbjct: 178 HSDLKPANFLIVDG-MLKLIDFGIA------NQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 358 KS-----------YGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAIP 405
            S              K DV+S G IL+ M  G  P++++ N I    A+++ N     P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290

Query: 406 GDCPPAMAALIEQCWSLQPDKRP 428
                 +  +++ C    P +R 
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRI 313

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  168 bits (428), Expect = 8e-49
 Identities = 58/253 (22%), Positives = 105/253 (41%), Gaps = 36/253 (14%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC---------- 251
           D   A+K IR+P+ +          ++  REV  L++L +P ++++  A           
Sbjct: 30  DCNYAIKRIRLPNRELAR-------EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82

Query: 252 --KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA-IALDIARGMEYIHSQGVIHR 308
                    +  +   + +L+ +++           +   I L IA  +E++HS+G++HR
Sbjct: 83  PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHR 142

Query: 309 DLKPENVLIDQEFHLKIADFGIAC-------------EEVYCDALSDDPGTYRWMAPEMI 355
           DLKP N+    +  +K+ DFG+                       +   GT  +M+PE I
Sbjct: 143 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI 202

Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL 415
              SY  KVD++S GLIL+E++    P+            V     P +     P    +
Sbjct: 203 HGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVM 259

Query: 416 IEQCWSLQPDKRP 428
           ++   S  P +RP
Sbjct: 260 VQDMLSPSPMERP 272

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  165 bits (421), Expect = 2e-47
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 31/255 (12%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV----YCVI 260
            A+K I   +  + E           RE  +    ++PN+++ VA C +         ++
Sbjct: 57  YALKRILCHEQQDREEA--------QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108

Query: 261 TEYLSEGSLRAYL--HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
             +   G+L   +   K +   L   +++ + L I RG+E IH++G  HRDLKP N+L+ 
Sbjct: 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG 168

Query: 319 QEFHLKIADFGIACEEVY-------CDALSDDP---GTYRWMAPEMIKHKSY---GRKVD 365
            E    + D G   +             L D      T  + APE+   +S+     + D
Sbjct: 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD 228

Query: 366 VYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQP 424
           V+S G +L+ M+ G  PY+ +     +    V   L          A+  L+    ++ P
Sbjct: 229 VWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDP 288

Query: 425 DKRPEFWHIVKVLEQ 439
            +RP   HI  +L Q
Sbjct: 289 HQRP---HIPLLLSQ 300

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  163 bits (415), Expect = 8e-47
 Identities = 65/247 (26%), Positives = 110/247 (44%), Gaps = 14/247 (5%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDD-DENETLAARLEKQFNREVALLSRLHNPNVIK 246
           G  S +Y         PVA+K ++I D  D              +E+ LL +L++PNVIK
Sbjct: 43  GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI------KEIDLLKQLNHPNVIK 96

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIHSQG 304
           + A+  +     ++ E    G L   +   + +   +P   +    + +   +E++HS+ 
Sbjct: 97  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156

Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
           V+HRD+KP NV I     +K+ D G+         A     GT  +M+PE I    Y  K
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 216

Query: 364 VDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS 421
            D++S G +L+EM A   P+  ++MN       +   +  P         +  L+  C +
Sbjct: 217 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCIN 276

Query: 422 LQPDKRP 428
             P+KRP
Sbjct: 277 PDPEKRP 283

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  160 bits (407), Expect = 8e-46
 Identities = 49/267 (18%), Positives = 97/267 (36%), Gaps = 44/267 (16%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIK 246
           G    ++  + +      A+K  + P     +   A       REV   + L  + +V++
Sbjct: 22  GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL------REVYAHAVLGQHSHVVR 75

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIHSQG 304
           + +A  +     +  EY + GSL   + +           +L  + L + RG+ YIHS  
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135

Query: 305 VIHRDLKPENVLIDQE-------------------FHLKIADFGIACEEVYCDALSDDP- 344
           ++H D+KP N+ I +                       KI D G          +S    
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV------TRISSPQV 189

Query: 345 --GTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
             G  R++A E+++ + ++  K D+++  L +             +        + +   
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE----IRQGRL 245

Query: 402 PAIPGDCPPAMAALIEQCWSLQPDKRP 428
           P IP         L++      P++RP
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRP 272

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  160 bits (407), Expect = 1e-45
 Identities = 65/274 (23%), Positives = 109/274 (39%), Gaps = 49/274 (17%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           GA  ++            A+K IR  ++  +  L          EV LL+ L++  V+++
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---------SEVMLLASLNHQYVVRY 67

Query: 248 -------------VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALD 292
                        + A KK     +  EY   G+L   +H    + L   +     +   
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQ 124

Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------- 344
           I   + YIHSQG+IHRDLKP N+ ID+  ++KI DFG+A        +            
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 345 -------GTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
                  GT  ++A E++     Y  K+D+YS G+I +EM+        M  +     + 
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLR 242

Query: 397 NKNLR--PAIPGDCPPAMAALIEQCWSLQPDKRP 428
           + ++   P    +       +I       P+KRP
Sbjct: 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  157 bits (400), Expect = 6e-45
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 17/234 (7%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA--CKKPPVYCVITE 262
           +  K +      E E            EV LL  L +PN++++      +      ++ E
Sbjct: 34  LVWKELDYGSMTEAEKQMLV------SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87

Query: 263 YLSEGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIHSQG-----VIHRDLKPENV 315
           Y   G L + + K   +   L    ++ +   +   ++  H +      V+HRDLKP NV
Sbjct: 88  YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147

Query: 316 LIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
            +D + ++K+ DFG+A              GT  +M+PE +   SY  K D++S G +L+
Sbjct: 148 FLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207

Query: 375 EMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
           E+ A   P+   +  + A  +     R  IP      +  +I +  +L+   RP
Sbjct: 208 ELCALMPPFTAFSQKELAGKIREGKFRR-IPYRYSDELNEIITRMLNLKDYHRP 260

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  153 bits (390), Expect = 2e-43
 Identities = 63/250 (25%), Positives = 108/250 (43%), Gaps = 30/250 (12%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G    +Y    K     +A+K++      + +   A +E Q  REV + S L +PN+++
Sbjct: 19  KGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73

Query: 247 ---FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
              +     +  VY ++ EY   G++   L K         +      ++A  + Y HS+
Sbjct: 74  LYGYFHDATR--VYLIL-EYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK 128

Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------GTYRWMAPEMIKH 357
            VIHRD+KPEN+L+     LKIADFG +         +         GT  ++ PEMI+ 
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEMIEG 181

Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIE 417
           + +  KVD++S G++ +E + G  P+E     +    +         P         LI 
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLIS 239

Query: 418 QCWSLQPDKR 427
           +     P +R
Sbjct: 240 RLLKHNPSQR 249

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  154 bits (391), Expect = 2e-43
 Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 28/240 (11%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK-FVAACKKPPVYCVI 260
           +  VA+K I      E E    R    F REV   S+L + N++       +    Y V+
Sbjct: 36  NIKVAIKAIF-IPPREKEETLKR----FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY+   +L  Y+    H  L +   I     I  G+++ H   ++HRD+KP+N+LID  
Sbjct: 91  -EYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN 147

Query: 321 FHLKIADFGIACEEVYCDALSDDP--------GTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
             LKI DFGIA       ALS+          GT ++ +PE  K ++     D+YS G++
Sbjct: 148 KTLKIFDFGIA------KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIV 201

Query: 373 LWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG----DCPPAMAALIEQCWSLQPDKRP 428
           L+EM+ G  P+     +  A   +  ++ P +      D P +++ +I +        R 
Sbjct: 202 LYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKDIPQSLSNVILRATEKDKANRY 260

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  151 bits (384), Expect = 2e-42
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 29/273 (10%)

Query: 167 AVDAADEHTVDLSQLFLGL-RFAHGAHSRLYHGIYKD--EPVAVKIIRI-PDDDENETLA 222
            +        D  +LF  L +   G+   ++ GI     + VA+KII +   +DE E + 
Sbjct: 9   GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ 68

Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
                   +E+ +LS+  +P V K+  +  K     +I EYL  GS    L  LE   L 
Sbjct: 69  --------QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLD 117

Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
             ++  I  +I +G++Y+HS+  IHRD+K  NVL+ +   +K+ADFG+A +      L+D
Sbjct: 118 ETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ------LTD 171

Query: 343 DP-------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
                    GT  WMAPE+IK  +Y  K D++S G+   E+  G  P+ E++P++  F +
Sbjct: 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-L 230

Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
           + KN  P + G+    +   +E C + +P  RP
Sbjct: 231 IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 263

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  151 bits (383), Expect = 3e-42
 Identities = 63/251 (25%), Positives = 121/251 (48%), Gaps = 29/251 (11%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA   +Y  +     + VA++ + +    + E +          E+ ++    NPN++ 
Sbjct: 30  QGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNPNIVN 81

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           ++ +        V+ EYL+ GSL   +       +   ++ A+  +  + +E++HS  VI
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKS 359
           HRD+K +N+L+  +  +K+ DFG      +C  ++ +        GT  WMAPE++  K+
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFG------FCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPAMAALIE 417
           YG KVD++S G++  EM+ G  PY   NP++A + ++  N  P +  P          + 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDFLN 251

Query: 418 QCWSLQPDKRP 428
           +C  +  +KR 
Sbjct: 252 RCLEMDVEKRG 262

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  150 bits (380), Expect = 1e-41
 Identities = 53/230 (23%), Positives = 100/230 (43%), Gaps = 24/230 (10%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA + ++ G +K   +  A+K+        N     R      RE  +L +L++ N++K
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVF-------NNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 247 F--VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
              +          +I E+   GSL   L +  +   LP  + + +  D+  GM ++   
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 304 GVIHRDLKPENVLI----DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK--- 356
           G++HR++KP N++     D +   K+ DFG A E    +      GT  ++ P+M +   
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191

Query: 357 -----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
                 K YG  VD++S G+  +    G++P+      +    V+ K + 
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  149 bits (379), Expect = 2e-41
 Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 73/286 (25%)

Query: 196 YHGIYKD-EPVAVKIIRIPDDDENETLAARL-------EKQFNREVALLSRLHNPNVIKF 247
           Y G+ +D   VA+K               R         ++F  E+  LS   +P+++  
Sbjct: 56  YKGVLRDGAKVALK---------------RRTPESSQGIEEFETEIETLSFCRHPHLVSL 100

Query: 248 VAACKKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPL--PKLIAIALDIARGMEYIH 301
           +  C +      +Y    +Y+  G+L+ +L+  +  T+ +   + + I +  ARG+ Y+H
Sbjct: 101 IGFCDERNEMILIY----KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156

Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--------GTYRWMAPE 353
           ++ +IHRD+K  N+L+D+ F  KI DFGI+           D         GT  ++ PE
Sbjct: 157 TRAIIHRDVKSINILLDENFVPKITDFGIS-----KKGTELDQTHLSTVVKGTLGYIDPE 211

Query: 354 MIKHKSYGR------KVDVYSFGLILWEMVAG------TIPYEEMNPIQ-AAFAVVNKNL 400
                 Y        K DVYSFG++L+E++        ++P E +N  + A  +  N  L
Sbjct: 212 ------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265

Query: 401 R----PAIPGDCPPA----MAALIEQCWSLQPDKRPEFWHIVKVLE 438
                P +     P           +C +L  + RP    ++  LE
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  148 bits (375), Expect = 3e-41
 Identities = 63/250 (25%), Positives = 115/250 (46%), Gaps = 30/250 (12%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G    +Y    K     +A+K++      +++     +E Q  RE+ + S L +PN+++
Sbjct: 24  KGKFGNVYLAREKQNKFIMALKVL-----FKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78

Query: 247 ---FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
              +    K+  +Y ++ E+   G L   L K  H      +      ++A  + Y H +
Sbjct: 79  MYNYFHDRKR--IY-LMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER 133

Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------GTYRWMAPEMIKH 357
            VIHRD+KPEN+L+  +  LKIADFG +         +         GT  ++ PEMI+ 
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRTMCGTLDYLPPEMIEG 186

Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIE 417
           K++  KVD++  G++ +E + G  P++  +  +    +VN +L+   P         LI 
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLIS 244

Query: 418 QCWSLQPDKR 427
           +     P +R
Sbjct: 245 KLLRYHPPQR 254

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  148 bits (377), Expect = 3e-41
 Identities = 62/244 (25%), Positives = 111/244 (45%), Gaps = 31/244 (12%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK-----FVAACKKPPV 256
              VAVK++R  D   + +   R    F RE    + L++P ++             P  
Sbjct: 37  HRDVAVKVLR-ADLARDPSFYLR----FRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91

Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
           Y V+ EY+   +LR  +H      +   + I +  D  + + + H  G+IHRD+KP N++
Sbjct: 92  YIVM-EYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148

Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP----------GTYRWMAPEMIKHKSYGRKVDV 366
           I     +K+ DFGIA       A++D            GT ++++PE  +  S   + DV
Sbjct: 149 ISATNAVKVMDFGIA------RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202

Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPPAMAALIEQCWSLQP 424
           YS G +L+E++ G  P+   +P+  A+  V ++  P  A        + A++ +  +  P
Sbjct: 203 YSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNP 262

Query: 425 DKRP 428
           + R 
Sbjct: 263 ENRY 266

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  147 bits (373), Expect = 5e-41
 Identities = 60/259 (23%), Positives = 106/259 (40%), Gaps = 33/259 (12%)

Query: 182 FLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
            LG     G+ + +Y          VA+K+I     D+     A + ++   EV +  +L
Sbjct: 18  LLG----KGSFAGVYRAESIHTGLEVAIKMI-----DKKAMYKAGMVQRVQNEVKIHCQL 68

Query: 240 HNPNVIKF--VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGM 297
            +P++++           VY ++ E    G +  YL     K     +       I  GM
Sbjct: 69  KHPSILELYNYFEDSNY-VY-LVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGM 125

Query: 298 EYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--------GTYRW 349
            Y+HS G++HRDL   N+L+ +  ++KIADFG+A            P        GT  +
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHEKHYTLCGTPNY 178

Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP 409
           ++PE+    ++G + DV+S G + + ++ G  P++    ++     V       +P    
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT-VKNTLNKVVLA-DYEMPSFLS 236

Query: 410 PAMAALIEQCWSLQPDKRP 428
                LI Q     P  R 
Sbjct: 237 IEAKDLIHQLLRRNPADRL 255

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  148 bits (376), Expect = 6e-41
 Identities = 59/265 (22%), Positives = 112/265 (42%), Gaps = 44/265 (16%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP-------- 255
            A+K +   ++++N  +         +EV  + +L  +PN+++F +A             
Sbjct: 56  YALKRLLSNEEEKNRAII--------QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107

Query: 256 VYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQG--VIHRDLKP 312
            + ++TE   +G L  +L K+E +  L    ++ I     R ++++H Q   +IHRDLK 
Sbjct: 108 EFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV 166

Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------------GTYRWMAPEMI---K 356
           EN+L+  +  +K+ DFG A    +    S                 T  +  PE+I    
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226

Query: 357 HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
           +   G K D+++ G IL+ +     P+E+     A   +VN                +LI
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRIVNGKYSIPPHDTQYTVFHSLI 282

Query: 417 EQCWSLQPDKRPEFWHIVKVLEQFE 441
                + P++R     I +V+ Q +
Sbjct: 283 RAMLQVNPEERL---SIAEVVHQLQ 304

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  148 bits (375), Expect = 6e-41
 Identities = 47/255 (18%), Positives = 99/255 (38%), Gaps = 25/255 (9%)

Query: 192 HSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251
           ++ L     K +    +I    +  +    +       + ++  +      N +  +   
Sbjct: 71  NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130

Query: 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI-AIALDIARGMEYIHSQGVIHRDL 310
                  +  +   + +L+ ++++          +   I + IA  +E++HS+G++HRDL
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDL 190

Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------------GTYRWMAPEMIKH 357
           KP N+    +  +K+ DFG+       +                   GT  +M+PE I  
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250

Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR----PAIPGDCPPAMA 413
            +Y  KVD++S GLIL+E++       E          +  ++R    P +     P   
Sbjct: 251 NNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDVRNLKFPLLFTQKYPQEH 303

Query: 414 ALIEQCWSLQPDKRP 428
            +++   S  P +RP
Sbjct: 304 MMVQDMLSPSPTERP 318

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  148 bits (375), Expect = 7e-41
 Identities = 63/250 (25%), Positives = 113/250 (45%), Gaps = 29/250 (11%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G+   +     K     VAVK++ +      E L          EV ++    + NV++ 
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF--------NEVVIMRDYQHFNVVEM 107

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
             +        V+ E+L  G+L   +       L   ++  +   + + + Y+H+QGVIH
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQGVIH 164

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKSY 360
           RD+K +++L+  +  +K++DFG      +C  +S D        GT  WMAPE+I    Y
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFG------FCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218

Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPAMAALIEQ 418
             +VD++S G+++ EMV G  PY   +P+QA    +  +  P +       P +   +E+
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFLER 277

Query: 419 CWSLQPDKRP 428
                P +R 
Sbjct: 278 MLVRDPQERA 287

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  153 bits (388), Expect = 2e-40
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 21/230 (9%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G    +   I++D  E VA+K          + L+ +  +++  E+ ++ +L++PNV+ 
Sbjct: 24  TGGFGYVLRWIHQDTGEQVAIKQC-------RQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 247 FVA------ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGME 298
                          +  +  EY   G LR YL++ E+    L +     L  DI+  + 
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISSALR 135

Query: 299 YIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
           Y+H   +IHRDLKPEN+++    Q    KI D G A E    +  ++  GT +++APE++
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195

Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
           + K Y   VD +SFG + +E + G  P+            V +     I 
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  146 bits (371), Expect = 2e-40
 Identities = 64/264 (24%), Positives = 116/264 (43%), Gaps = 30/264 (11%)

Query: 182 FLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
           FLG     G  ++ +     D  E  A KI+      ++  L     ++ + E+++   L
Sbjct: 22  FLG----KGGFAKCFEISDADTKEVFAGKIV-----PKSLLLKPHQREKMSMEISIHRSL 72

Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
            + +V+ F    +      V+ E     SL     +   K L  P+       I  G +Y
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQY 130

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR--------WMA 351
           +H   VIHRDLK  N+ ++++  +KI DFG+A          +  G  +        ++A
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIA 183

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
           PE++  K +  +VDV+S G I++ ++ G  P+E    ++  +  + KN   +IP    P 
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETYLRIKKN-EYSIPKHINPV 241

Query: 412 MAALIEQCWSLQPDKRPEFWHIVK 435
            A+LI++     P  RP    ++ 
Sbjct: 242 AASLIQKMLQTDPTARPTINELLN 265

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  148 bits (375), Expect = 3e-40
 Identities = 53/230 (23%), Positives = 100/230 (43%), Gaps = 24/230 (10%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA + ++ G +K   +  A+K+        N     R      RE  +L +L++ N++K
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVF-------NNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 247 F--VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
              +          +I E+   GSL   L +  +   LP  + + +  D+  GM ++   
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 304 GVIHRDLKPENVLI----DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK--- 356
           G++HR++KP N++     D +   K+ DFG A E    +      GT  ++ P+M +   
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191

Query: 357 -----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
                 K YG  VD++S G+  +    G++P+      +    V+ K + 
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  145 bits (369), Expect = 4e-40
 Identities = 68/276 (24%), Positives = 120/276 (43%), Gaps = 44/276 (15%)

Query: 196 YHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255
           Y G   +  VAVK +    D   E     L++QF++E+ ++++  + N+++ +       
Sbjct: 48  YKGYVNNTTVAVKKLAAMVDITTE----ELKQQFDQEIKVMAKCQHENLVELLGFSSDGD 103

Query: 256 VYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
             C++  Y+  GSL   L  L+    L       IA   A G+ ++H    IHRD+K  N
Sbjct: 104 DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSAN 163

Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDP--------GTYRWMAPE-MIKHKSYGRKVD 365
           +L+D+ F  KI+DFG+A       +             GT  +MAPE +    +   K D
Sbjct: 164 ILLDEAFTAKISDFGLA-----RASEKFAQTVMTSRIVGTTAYMAPEALRGEITP--KSD 216

Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQ--------------AAFAVVNKNLRPAIPGDCPPA 411
           +YSFG++L E++ G    +E    Q                   ++K +      D    
Sbjct: 217 IYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-----NDADST 271

Query: 412 ----MAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
               M ++  QC   + +KRP+   + ++L++   S
Sbjct: 272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  145 bits (367), Expect = 1e-39
 Identities = 64/264 (24%), Positives = 116/264 (43%), Gaps = 30/264 (11%)

Query: 182 FLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
           FLG     G  ++ +     D  E  A KI+      ++  L     ++ + E+++   L
Sbjct: 48  FLG----KGGFAKCFEISDADTKEVFAGKIV-----PKSLLLKPHQREKMSMEISIHRSL 98

Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
            + +V+ F    +      V+ E     SL     +   K L  P+       I  G +Y
Sbjct: 99  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQY 156

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR--------WMA 351
           +H   VIHRDLK  N+ ++++  +KI DFG+A          +  G  +        ++A
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIA 209

Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
           PE++  K +  +VDV+S G I++ ++ G  P+E    ++  +  + KN   +IP    P 
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETYLRIKKN-EYSIPKHINPV 267

Query: 412 MAALIEQCWSLQPDKRPEFWHIVK 435
            A+LI++     P  RP    ++ 
Sbjct: 268 AASLIQKMLQTDPTARPTINELLN 291

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  143 bits (363), Expect = 3e-39
 Identities = 70/252 (27%), Positives = 127/252 (50%), Gaps = 29/252 (11%)

Query: 188 AHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
             G++  +Y  I+K+  + VA+K + +  D           ++  +E++++ +  +P+V+
Sbjct: 38  GEGSYGSVYKAIHKETGQIVAIKQVPVESD----------LQEIIKEISIMQQCDSPHVV 87

Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
           K+  +  K     ++ EY   GS+   + +L +KTL   ++  I     +G+EY+H    
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHK 358
           IHRD+K  N+L++ E H K+ADFG+A +      L+D         GT  WMAPE+I+  
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQ------LTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPAMAALI 416
            Y    D++S G+   EM  G  PY +++P++A F ++  N  P    P          +
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFV 259

Query: 417 EQCWSLQPDKRP 428
           +QC    P++R 
Sbjct: 260 KQCLVKSPEQRA 271

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  144 bits (365), Expect = 3e-39
 Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 4/187 (2%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
            V  + LS+         L    L L  LI  +  +A+GME++ S+  IHRDL   N+L+
Sbjct: 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 226

Query: 318 DQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
            ++  +KI DFG+A    ++       D     +WMAPE I  + Y  + DV+SFG++LW
Sbjct: 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 286

Query: 375 EMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI 433
           E+ + G  PY  +   +     + +  R   P    P M   +  CW  +P +RP F  +
Sbjct: 287 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 346

Query: 434 VKVLEQF 440
           V+ L   
Sbjct: 347 VEHLGNL 353

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 35/163 (21%), Positives = 59/163 (36%), Gaps = 22/163 (13%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQ 228
               +L LG     GA  ++                VAVK+++      +E       + 
Sbjct: 19  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEH------RA 71

Query: 229 FNREVALLSRL-HNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
              E+ +L  + H+ NV+  + AC K      VI E+   G+L  YL    ++ +P    
Sbjct: 72  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131

Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329
            A      +G +Y+ +   I  DLK     I        + F 
Sbjct: 132 GA---RFRQGKDYVGA---IPVDLKRRLDSITSSQSSASSGFV 168

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  143 bits (363), Expect = 5e-39
 Identities = 46/224 (20%), Positives = 91/224 (40%), Gaps = 37/224 (16%)

Query: 189 HGAHSRLYHGIYKDEPVAVKIIR---------IPDDDENETLAARLEKQFNREVALLSRL 239
            G  +++      ++  A+K                + ++         F  E+ +++ +
Sbjct: 41  QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100

Query: 240 HNPNVIK---FVAACKKPPVYCVITEYLSEGSLRAYLHK------LEHKTLPLPKLIAIA 290
            N   +     +    +  VY +I EY+   S+  +              +P+  +  I 
Sbjct: 101 KNEYCLTCEGIITNYDE--VY-IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 291 LDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----- 344
             +     YIH++  + HRD+KP N+L+D+   +K++DFG +           D      
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-------EYMVDKKIKGS 210

Query: 345 -GTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEE 385
            GTY +M PE   ++S   G KVD++S G+ L+ M    +P+  
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  145 bits (367), Expect = 9e-39
 Identities = 64/256 (25%), Positives = 108/256 (42%), Gaps = 29/256 (11%)

Query: 189 HGAHSRLYH-GIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIK 246
           HGA   + + G++ +  VAVK I                   +REV LL      PNVI+
Sbjct: 34  HGAEGTIVYRGMFDNRDVAVKRILP-----------ECFSFADREVQLLRESDEHPNVIR 82

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           +    K      +  E     +L+ Y+ + +       + I +      G+ ++HS  ++
Sbjct: 83  YFCTEKDRQFQYIAIELC-AATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 307 HRDLKPENVLI-----DQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIK- 356
           HRDLKP N+LI       +    I+DFG+              S  PGT  W+APEM+  
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 357 --HKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL-RPAIPGDCPPAM 412
              ++    VD++S G + + +++ G+ P+ +    QA   +   +L             
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIA 260

Query: 413 AALIEQCWSLQPDKRP 428
             LIE+  ++ P KRP
Sbjct: 261 RELIEKMIAMDPQKRP 276

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  143 bits (363), Expect = 1e-38
 Identities = 44/335 (13%), Positives = 99/335 (29%), Gaps = 53/335 (15%)

Query: 134 LRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQL-FLGLRFAHGAH 192
           +        +E  +S  +S  +    + G          E    L +   LG        
Sbjct: 31  IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLG----QEDP 86

Query: 193 SRLYHGIYKD--EPVAVKIIRIP--------DDDENETLAARLEKQFNREVALLSRLHNP 242
                   ++  E   V +               + E L  RL +    +      L   
Sbjct: 87  YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146

Query: 243 NVIKFVAACKKPPVYC-------------VITEYLSEGSLRAYLHKL-----EHKTLPLP 284
                V   +K  +                      + +L+ +   L      HK+L   
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 206

Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
             + + L + R +  +H  G++H  L+P ++++DQ   + +  F     +    A     
Sbjct: 207 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD---GARVVSS 263

Query: 345 GTYRWMAPEMIKHKS-----------YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
            +  +  PE+   ++                D ++ GL+++ +    +P  +   +  + 
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE 323

Query: 394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
            +           + P  + AL+E       + R 
Sbjct: 324 WIFRS------CKNIPQPVRALLEGFLRYPKEDRL 352

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  141 bits (358), Expect = 2e-38
 Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 42/247 (17%)

Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV- 259
           ++  VA+K++       +     R      RE     RL  P+V+         P++   
Sbjct: 58  RERIVALKLMS-ETLSSDPVFRTR----MQREARTAGRLQEPHVV---------PIHDFG 103

Query: 260 --------ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311
                       ++   L A L       L  P+ +AI   I   ++  H+ G  HRD+K
Sbjct: 104 EIDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVK 161

Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDP--------GTYRWMAPEMIKHKSYGRK 363
           PEN+L+  +    + DFGIA       A +D+         GT  +MAPE         +
Sbjct: 162 PENILVSADDFAYLVDFGIA------SATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPPAMAALIEQCWS 421
            D+Y+   +L+E + G+ PY+  + +    A +N+ +     +    P A  A+I +  +
Sbjct: 216 ADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMA 274

Query: 422 LQPDKRP 428
             P+ R 
Sbjct: 275 KNPEDRY 281

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  140 bits (356), Expect = 2e-38
 Identities = 62/256 (24%), Positives = 115/256 (44%), Gaps = 32/256 (12%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA  ++Y    K+     A K+I    ++E E            E+ +L+   +P ++K
Sbjct: 29  DGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI--------VEIEILATCDHPYIVK 80

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
            + A        ++ E+   G++ A + +L+ + L  P++  +   +   + ++HS+ +I
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRII 139

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMI---- 355
           HRDLK  NVL+  E  +++ADFG++ +                  GT  WMAPE++    
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAK------NLKTLQKRDSFIGTPYWMAPEVVMCET 193

Query: 356 -KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPAM 412
            K   Y  K D++S G+ L EM     P+ E+NP++     + K+  P +  P       
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVEF 252

Query: 413 AALIEQCWSLQPDKRP 428
              ++      P+ RP
Sbjct: 253 RDFLKIALDKNPETRP 268

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  140 bits (356), Expect = 2e-38
 Identities = 68/265 (25%), Positives = 123/265 (46%), Gaps = 34/265 (12%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
            GA + +         E VA+K I +       + L         +E+  +S+ H+PN++
Sbjct: 25  SGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL--------KEIQAMSQCHHPNIV 76

Query: 246 KFVAACKKPPVYCVITEYLSEGSL----RAYLHKLEHKTLPLP-KLIAIAL-DIARGMEY 299
            +  +        ++ + LS GS+    +  + K EHK+  L    IA  L ++  G+EY
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------GTYRWMAPE 353
           +H  G IHRD+K  N+L+ ++  ++IADFG++        ++ +       GT  WMAPE
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196

Query: 354 MIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP--- 409
           +++  + Y  K D++SFG+   E+  G  PY +  P++     + +N  P++        
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLETGVQDKE 255

Query: 410 ------PAMAALIEQCWSLQPDKRP 428
                  +   +I  C    P+KRP
Sbjct: 256 MLKKYGKSFRKMISLCLQKDPEKRP 280

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  140 bits (356), Expect = 4e-38
 Identities = 69/234 (29%), Positives = 117/234 (50%), Gaps = 11/234 (4%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
             VA+KII      +   L     ++  REV ++  L++PN++K     +      +I E
Sbjct: 41  REVAIKII------DKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
           Y S G +  YL  + H  +   +  +    I   ++Y H + ++HRDLK EN+L+D + +
Sbjct: 95  YASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN 152

Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTI 381
           +KIADFG + E      L    G   + APE+ + K Y G +VDV+S G+IL+ +V+G++
Sbjct: 153 IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212

Query: 382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK 435
           P++  N ++     V    +  IP         L+++   L P KR     I+K
Sbjct: 213 PFDGQN-LKELRERV-LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  140 bits (354), Expect = 7e-38
 Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 21/254 (8%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
            GA+  +   ++K   + +AVK IR    DE E      +KQ   ++ ++ R  + P ++
Sbjct: 32  RGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKE------QKQLLMDLDVVMRSSDCPYIV 84

Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAY--LHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           +F  A  +     +  E +S    + Y  ++ +    +P   L  I L   + + ++   
Sbjct: 85  QFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144

Query: 304 G-VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK----HK 358
             +IHRD+KP N+L+D+  ++K+ DFGI+ + V   A + D G   +MAPE I      +
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA-FAVVNKN---LRPAIPGDCPPAMAA 414
            Y  + DV+S G+ L+E+  G  PY + N +      VV  +   L  +   +  P+   
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFIN 264

Query: 415 LIEQCWSLQPDKRP 428
            +  C +    KRP
Sbjct: 265 FVNLCLTKDESKRP 278

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  139 bits (352), Expect = 4e-37
 Identities = 43/227 (18%), Positives = 87/227 (38%), Gaps = 27/227 (11%)

Query: 196 YHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253
               YK   E V V+ I + +   NE +          E+ +    ++PN++ + A    
Sbjct: 44  NLARYKPTGEYVTVRRINL-EACSNEMV-----TFLQGELHVSKLFNHPNIVPYRATFIA 97

Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
                V+T +++ GS +  +       +    +  I   + + ++YIH  G +HR +K  
Sbjct: 98  DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKAS 157

Query: 314 NVLIDQEFHLKIADFGIACE--------EVYCDALSDDPGTYRWMAPEMIKH--KSYGRK 363
           ++LI  +  + ++                V  D          W++PE+++   + Y  K
Sbjct: 158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 217

Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
            D+YS G+   E+  G +P+++M   Q                   P
Sbjct: 218 SDIYSVGITACELANGHVPFKDMPATQMLL---------EKLNGTVP 255

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  136 bits (346), Expect = 5e-37
 Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 19/251 (7%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
            GA+  +    +    + +AVK IR    +  E      +K+   ++ +  R  + P  +
Sbjct: 17  RGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQE------QKRLLMDLDISMRTVDCPFTV 69

Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQ 303
            F  A  +     +  E + + SL  +  ++  + +T+P   L  IA+ I + +E++HS+
Sbjct: 70  TFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 304 G-VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK----HK 358
             VIHRD+KP NVLI+    +K+ DFGI+   V   A   D G   +MAPE I      K
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAIPGDCPPAMAALIE 417
            Y  K D++S G+ + E+     PY+    P Q    VV +                   
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS 248

Query: 418 QCWSLQPDKRP 428
           QC      +RP
Sbjct: 249 QCLKKNSKERP 259

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  137 bits (346), Expect = 9e-37
 Identities = 66/262 (25%), Positives = 118/262 (45%), Gaps = 38/262 (14%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245
           +G + ++Y G +    +  A+K++ +  D+E E           +E+ +L +  H+ N+ 
Sbjct: 34  NGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---------IKQEINMLKKYSHHRNIA 84

Query: 246 KFVAACKKPPVYC------VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
            +  A  K           ++ E+   GS+   +   +  TL    +  I  +I RG+ +
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAP 352
           +H   VIHRD+K +NVL+ +   +K+ DFG++ +      L           GT  WMAP
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ------LDRTVGRRNTFIGTPYWMAP 198

Query: 353 EMIKHK-----SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI-PG 406
           E+I        +Y  K D++S G+   EM  G  P  +M+P++A F +  +N  P +   
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPAPRLKSK 257

Query: 407 DCPPAMAALIEQCWSLQPDKRP 428
                  + IE C      +RP
Sbjct: 258 KWSKKFQSFIESCLVKNHSQRP 279

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  136 bits (345), Expect = 1e-36
 Identities = 57/252 (22%), Positives = 108/252 (42%), Gaps = 22/252 (8%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
            G   +++   ++     +AVK +R    ++ E       K+   ++ ++ + H+ P ++
Sbjct: 35  SGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEE------NKRILMDLDVVLKSHDCPYIV 87

Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-G 304
           +            +  E +   + +    K     +P   L  + + I + + Y+  + G
Sbjct: 88  QCFGTFITNTDVFIAMELMGTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLKEKHG 145

Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK-----HKS 359
           VIHRD+KP N+L+D+   +K+ DFGI+   V   A     G   +MAPE I         
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205

Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEMNPI-QAAFAVVNKNLRPAIPGDC--PPAMAALI 416
           Y  + DV+S G+ L E+  G  PY+      +    V+ +   P +PG         + +
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-PLLPGHMGFSGDFQSFV 264

Query: 417 EQCWSLQPDKRP 428
           + C +    KRP
Sbjct: 265 KDCLTKDHRKRP 276

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  137 bits (346), Expect = 5e-36
 Identities = 40/287 (13%), Positives = 81/287 (28%), Gaps = 47/287 (16%)

Query: 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDD--------ENETLAARLEKQF 229
            L  G                +   E   V +    +          + E L  RL +  
Sbjct: 79  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL---------------- 273
             +      L        V   +K  +  V  +      L  +                 
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 274 --HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
             H   HK+L     + + L + R +  +H  G++H  L+P ++++DQ   + +  F   
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 332 CEEVYCDALSDDPGTYRWMAPEMI----------KHKSYGRKVDVYSFGLILWEMVAGTI 381
             +    A +  P    +  PE                     D ++ GL ++ +    +
Sbjct: 259 VRD---GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
           P  +   +  +  +             P  + AL+E       + R 
Sbjct: 316 PNTDDAALGGSEWIFRSCKNI------PQPVRALLEGFLRYPKEDRL 356

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  133 bits (338), Expect = 7e-36
 Identities = 68/234 (29%), Positives = 112/234 (47%), Gaps = 18/234 (7%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF--VAACKKPPVYCVI 260
              AVKI+      +        E    +E+ LL RL + NVI+   V   ++     ++
Sbjct: 31  CRRAVKIL----KKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY     ++  L  +  K  P+ +       +  G+EY+HSQG++H+D+KP N+L+   
Sbjct: 87  MEYCV-CGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG 145

Query: 321 FHLKIADFGIACEEVYCDALSDDP-----GTYRWMAPEMIK-HKSY-GRKVDVYSFGLIL 373
             LKI+  G+A  E      +DD      G+  +  PE+     ++ G KVD++S G+ L
Sbjct: 146 GTLKISALGVA--EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203

Query: 374 WEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           + +  G  P+E  N I   F  + K    AIPGDC P ++ L++     +P KR
Sbjct: 204 YNITTGLYPFEGDN-IYKLFENIGKG-SYAIPGDCGPPLSDLLKGMLEYEPAKR 255

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  135 bits (341), Expect = 9e-36
 Identities = 53/255 (20%), Positives = 108/255 (42%), Gaps = 19/255 (7%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G    ++   +K     +A K+I +            +  Q  RE+ +L   ++P ++ 
Sbjct: 43  AGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-------IRNQIIRELQVLHECNSPYIVG 95

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG-V 305
           F  A        +  E++  GSL   L K     +P   L  +++ + +G+ Y+  +  +
Sbjct: 96  FYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKI 153

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKV 364
           +HRD+KP N+L++    +K+ DFG++ + +  D++++   GT  +M+PE ++   Y  + 
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQS 211

Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQP 424
           D++S GL L EM  G  P    +  +       +    A      P         + +  
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271

Query: 425 DKRPEFW----HIVK 435
                 +    +IV 
Sbjct: 272 RPPMAIFELLDYIVN 286

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  133 bits (336), Expect = 2e-35
 Identities = 75/282 (26%), Positives = 116/282 (41%), Gaps = 60/282 (21%)

Query: 196 YHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254
           Y G   D   VAVK +        E      E QF  EV ++S   + N+++    C  P
Sbjct: 47  YKGRLADGTLVAVKRL-------KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99

Query: 255 P----VYCVITEYLSEGSLRAYLHKLEHKTLPL--PKLIAIALDIARGMEYIHSQG---V 305
                VY     Y++ GS+ + L +      PL  PK   IAL  ARG+ Y+H      +
Sbjct: 100 TERLLVY----PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---------GTYRWMAPEMIK 356
           IHRD+K  N+L+D+EF   + DFG+A        L D           GT   +APE + 
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLA-------KLMDYKDTHVTTAVRGTIGHIAPEYLS 208

Query: 357 HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV---------NKNLR----PA 403
                 K DV+ +G++L E++ G   ++          ++          K L       
Sbjct: 209 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD 268

Query: 404 IPGDCPP-------AMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           + G+           +A L   C    P +RP+   +V++LE
Sbjct: 269 LQGNYKDEEVEQLIQVALL---CTQSSPMERPKMSEVVRMLE 307

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  133 bits (337), Expect = 3e-35
 Identities = 77/322 (23%), Positives = 125/322 (38%), Gaps = 33/322 (10%)

Query: 114 LYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADE 173
            Y            + +      +  +    R  S K+    + F               
Sbjct: 3   YYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKD------------ 50

Query: 174 HTVDLSQLFLGL-RFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFN 230
              D  +LF  L    HG+   +Y        E VA+K +       NE       +   
Sbjct: 51  ---DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-----QDII 102

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +EV  L +L +PN I++     +     ++ EY   GS    L ++  K L   ++ A+ 
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVT 160

Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM 350
               +G+ Y+HS  +IHRD+K  N+L+ +   +K+ DFG A      ++     GT  WM
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV---GTPYWM 217

Query: 351 APEMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI-PG 406
           APE+I       Y  KVDV+S G+   E+     P   MN + A + +  +N  PA+  G
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQSG 276

Query: 407 DCPPAMAALIEQCWSLQPDKRP 428
                    ++ C    P  RP
Sbjct: 277 HWSEYFRNFVDSCLQKIPQDRP 298

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  134 bits (337), Expect = 3e-35
 Identities = 31/280 (11%), Positives = 77/280 (27%), Gaps = 48/280 (17%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G  S ++     +  E  A+K+  +         +    ++ +      +RL   +  + 
Sbjct: 73  GDRSVVFLVRDVERLEDFALKVFTMG-----AENSRSELERLHEATFAAARLLGESPEEA 127

Query: 248 VAACK------------KPPVYCVITEY-------------LSEGSLRAYLHKL-----E 277
               +            +PP   +                  +   L      L      
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 278 HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
                +  L  +   + R    + S+G++H    P+N+ I  +  L + D     +    
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV--G 245

Query: 338 DALSDDPGTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
                      +   E +   +  +   ++ +  GL ++ +    +P+  + P       
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305

Query: 396 VNKNLRPAIP-------GDCPPAMAALIEQCWSLQPDKRP 428
                 P             P  +  LI +  +    +R 
Sbjct: 306 RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  131 bits (332), Expect = 4e-35
 Identities = 65/226 (28%), Positives = 115/226 (50%), Gaps = 10/226 (4%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
             VAVKI+     +  +  +  +  +  RE+  L    +P++IK       P  + ++ E
Sbjct: 37  HKVAVKIL-----NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
           Y+S G L  Y+   +H  +   +   +   I   ++Y H   V+HRDLKPENVL+D   +
Sbjct: 92  YVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN 149

Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTI 381
            KIADFG++      + L    G+  + APE+I  + Y G +VD++S G+IL+ ++ GT+
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTL 209

Query: 382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           P+++ + +   F  + +     IP     ++A L+     + P KR
Sbjct: 210 PFDDEH-VPTLFKKI-RGGVFYIPEYLNRSVATLLMHMLQVDPLKR 253

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  131 bits (332), Expect = 5e-35
 Identities = 68/268 (25%), Positives = 121/268 (45%), Gaps = 35/268 (13%)

Query: 189 HGAHSRLYHG--IYKDEPVAVKII------------------RIPDDDENETLAARLEKQ 228
            G++  +        +   A+K++                                  +Q
Sbjct: 23  KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82

Query: 229 FNREVALLSRLHNPNVIKFV---AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK 285
             +E+A+L +L +PNV+K V       +  +Y V  E +++G +   +     K L   +
Sbjct: 83  VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVF-ELVNQGPV---MEVPTLKPLSEDQ 138

Query: 286 LIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA-LSDDP 344
                 D+ +G+EY+H Q +IHRD+KP N+L+ ++ H+KIADFG++ E    DA LS+  
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198

Query: 345 GTYRWMAPEMI--KHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
           GT  +MAPE +    K + G+ +DV++ G+ L+  V G  P+ +   I    + + K+  
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLHSKI-KSQA 256

Query: 402 PAIPG--DCPPAMAALIEQCWSLQPDKR 427
              P   D    +  LI +     P+ R
Sbjct: 257 LEFPDQPDIAEDLKDLITRMLDKNPESR 284

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  132 bits (334), Expect = 6e-35
 Identities = 59/258 (22%), Positives = 112/258 (43%), Gaps = 28/258 (10%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA   ++  + K+  + V VK I+     E+  +      +   E+A+LSR+ + N+IK
Sbjct: 34  SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93

Query: 247 FVAACKKPPVYCVITEYLSEGS-LRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
            +   +    + ++ E    G  L A++    H  L  P    I   +   + Y+  + +
Sbjct: 94  VLDIFENQGFFQLVMEKHGSGLDLFAFI--DRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACE-------EVYCDALSDDPGTYRWMAPEMIKHK 358
           IHRD+K EN++I ++F +K+ DFG A           +C       GT  + APE++   
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-------GTIEYCAPEVLMGN 204

Query: 359 SY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIE 417
            Y G +++++S G+ L+ +V    P+ E+     A            P      + +L+ 
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA--------AIHPPYLVSKELMSLVS 256

Query: 418 QCWSLQPDKRPEFWHIVK 435
                 P++R     +V 
Sbjct: 257 GLLQPVPERRTTLEKLVT 274

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  131 bits (332), Expect = 7e-35
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 22/248 (8%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNV 244
            G    +Y GI      PVA+K +    D  ++        +   EV LL ++ +    V
Sbjct: 53  SGGFGSVYSGIRVSDNLPVAIKHV--EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 245 IKFVAACKKPPVYCVITEYLS-EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           I+ +   ++P  + +I E       L  ++   E   L      +    +   + + H+ 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHNC 168

Query: 304 GVIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSY- 360
           GV+HRD+K EN+LID     LK+ DFG     +  D +  D  GT  +  PE I++  Y 
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 226

Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCW 420
           GR   V+S G++L++MV G IP+E    I           +             LI  C 
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQHLIRWCL 278

Query: 421 SLQPDKRP 428
           +L+P  RP
Sbjct: 279 ALRPSDRP 286

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  134 bits (338), Expect = 9e-35
 Identities = 59/276 (21%), Positives = 109/276 (39%), Gaps = 48/276 (17%)

Query: 189 HGAHSRLYH-GIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIK 246
           +G+   +   G ++  PVAVK + I                   E+ LL+   + PNVI+
Sbjct: 25  YGSSGTVVFQGSFQGRPVAVKRMLI-----------DFCDIALMEIKLLTESDDHPNVIR 73

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEHKTLPLPKLIAIALDIARGMEYIH 301
           +  +        +  E     +L+  +          K       I++   IA G+ ++H
Sbjct: 74  YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 302 SQGVIHRDLKPENVLID-------------QEFHLKIADFGIAC-----EEVYCDALSDD 343
           S  +IHRDLKP+N+L+              +   + I+DFG+       +  +   L++ 
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 344 PGTYRWMAPEMIK-------HKSYGRKVDVYSFGLILWEMV-AGTIPYEEMNPIQAAFAV 395
            GT  W APE+++        +   R +D++S G + + ++  G  P+ +    ++    
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252

Query: 396 VNKNLRPAIPGDCPPAMAA---LIEQCWSLQPDKRP 428
              +L           +A    LI Q     P KRP
Sbjct: 253 GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  130 bits (329), Expect = 3e-34
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 11/226 (4%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
           + VA+K I            + +  +  RE++ L  L +P++IK       P    ++ E
Sbjct: 35  QKVALKFI-----SRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
           Y   G L  Y+  +E K +   +       I   +EY H   ++HRDLKPEN+L+D   +
Sbjct: 90  YAG-GELFDYI--VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN 146

Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTI 381
           +KIADFG++      + L    G+  + APE+I  K Y G +VDV+S G++L+ M+ G +
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206

Query: 382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           P+++   I   F  V  +    +P    P   +LI +     P +R
Sbjct: 207 PFDDEF-IPNLFKKV-NSCVYVMPDFLSPGAQSLIRRMIVADPMQR 250

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  130 bits (328), Expect = 5e-34
 Identities = 38/219 (17%), Positives = 83/219 (37%), Gaps = 32/219 (14%)

Query: 189 HGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN 241
            GA +++Y     D       +   +K+ +  +  E             + +  L     
Sbjct: 75  EGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG--------TQLMERLKPSMQ 126

Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH---KTLPLPKLIAIALDIARGME 298
              +KF +A        ++ E  S G+L   ++  ++   K +P   +I+ A+ +   +E
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186

Query: 299 YIHSQGVIHRDLKPENVLI-----------DQEFHLKIADFGIACEEVYCD---ALSDDP 344
            +H   +IH D+KP+N ++           D    L + D G + +          +   
Sbjct: 187 QVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246

Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
            T  +   EM+ +K +  ++D +     ++ M+ GT   
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  128 bits (323), Expect = 7e-34
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 49/220 (22%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA+  +   + +   E VAVKI+       +   A    +   +E+ +   L++ NV+K
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 247 F--VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR--------G 296
           F          +  +  EY S G L   +       +P           A+        G
Sbjct: 70  FYGHRREGN--IQYLFLEYCSGGELFDRI--EPDIGMPE--------PDAQRFFHQLMAG 117

Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM------ 350
           + Y+H  G+ HRD+KPEN+L+D+  +LKI+DFG+A        +       R +      
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA-------TVFRYNNRERLLNKMCGT 170

Query: 351 ----APEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEE 385
               APE++K + +    VDV+S G++L  M+AG +P+++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  127 bits (322), Expect = 2e-33
 Identities = 66/250 (26%), Positives = 100/250 (40%), Gaps = 24/250 (9%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN----P 242
            G    ++ G        VA+K+I  P +                EVALL ++      P
Sbjct: 41  KGGFGTVFAGHRLTDRLQVAIKVI--PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 243 NVIKFVAACKKPPVYCVITEYLSEGS-LRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
            VI+ +   +    + ++ E       L  Y+   E   L           +   +++ H
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEGPSRCFFGQVVAAIQHCH 156

Query: 302 SQGVIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKS 359
           S+GV+HRD+K EN+LID      K+ DFG     +  D    D  GT  +  PE I    
Sbjct: 157 SRGVVHRDIKDENILIDLRRGCAKLIDFG--SGALLHDEPYTDFDGTRVYSPPEWISRHQ 214

Query: 360 Y-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
           Y      V+S G++L++MV G IP+E    I  A            P    P   ALI +
Sbjct: 215 YHALPATVWSLGILLYDMVCGDIPFERDQEILEA--------ELHFPAHVSPDCCALIRR 266

Query: 419 CWSLQPDKRP 428
           C + +P  RP
Sbjct: 267 CLAPKPSSRP 276

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  129 bits (325), Expect = 4e-33
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 12/208 (5%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           GA   +     +   + VA++II            A        E+ +L +L++P +IK 
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 205

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
                    Y ++ E +  G L   +  + +K L           +   ++Y+H  G+IH
Sbjct: 206 KNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262

Query: 308 RDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI---KHKSYG 361
           RDLKPENVL+   +++  +KI DFG +        +    GT  ++APE++       Y 
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 322

Query: 362 RKVDVYSFGLILWEMVAGTIP-YEEMNP 388
           R VD +S G+IL+  ++G  P  E    
Sbjct: 323 RAVDCWSLGVILFICLSGYPPFSEHRTQ 350

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  126 bits (319), Expect = 5e-33
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 49/220 (22%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA+  +   + +   E VAVKI+       +   A    +   +E+ +   L++ NV+K
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 247 F--VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR--------G 296
           F          +  +  EY S G L   +       +P           A+        G
Sbjct: 70  FYGHRREGN--IQYLFLEYCSGGELFDRI--EPDIGMPE--------PDAQRFFHQLMAG 117

Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM------ 350
           + Y+H  G+ HRD+KPEN+L+D+  +LKI+DFG+A        +       R +      
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA-------TVFRYNNRERLLNKMCGT 170

Query: 351 ----APEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEE 385
               APE++K + +    VDV+S G++L  M+AG +P+++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  128 bits (324), Expect = 1e-32
 Identities = 65/226 (28%), Positives = 116/226 (51%), Gaps = 10/226 (4%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
             VAVKI+     +  +  +  +  +  RE+  L    +P++IK       P    ++ E
Sbjct: 42  HKVAVKIL-----NRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
           Y+S G L  Y+   ++  L   +   +   I  G++Y H   V+HRDLKPENVL+D   +
Sbjct: 97  YVSGGELFDYI--CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN 154

Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTI 381
            KIADFG++      + L    G+  + APE+I  + Y G +VD++S G+IL+ ++ GT+
Sbjct: 155 AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTL 214

Query: 382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           P+++ + +   F  +  +     P    P++ +L++    + P KR
Sbjct: 215 PFDDDH-VPTLFKKI-CDGIFYTPQYLNPSVISLLKHMLQVDPMKR 258

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  127 bits (321), Expect = 4e-32
 Identities = 59/245 (24%), Positives = 109/245 (44%), Gaps = 15/245 (6%)

Query: 145 RYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLF-LGLRFAHGAHSRLYHGIYK-- 201
            +     S     +  G ++             LS+++    +   GA+  +     K  
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
               A+KIIR        +++     +   EVA+L  L +PN++K     +    Y ++ 
Sbjct: 62  HVERAIKIIRK------TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---D 318
           E    G L   +  +            I   +  G+ Y+H   ++HRDLKPEN+L+   +
Sbjct: 116 ECYKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE 173

Query: 319 QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
           ++  +KI DFG++        + +  GT  ++APE+++ K Y  K DV+S G+IL+ ++A
Sbjct: 174 KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232

Query: 379 GTIPY 383
           G  P+
Sbjct: 233 GYPPF 237

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  124 bits (313), Expect = 8e-32
 Identities = 68/337 (20%), Positives = 136/337 (40%), Gaps = 48/337 (14%)

Query: 57  NSSQSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYK 116
           +   S  +   NK R  +      LP+  +E R A  R     P +  +      K    
Sbjct: 5   HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64

Query: 117 QPQQETKASSNSYSTSPLRHLGSL--RVTERYKSRKESAWTKYFDHGGVRVNAVDAADEH 174
           QP+        S          +      ++Y  +                         
Sbjct: 65  QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDV----------------------- 101

Query: 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNRE 232
                   +G     G  S +   +++      AVKI+ +  +  +      + +   RE
Sbjct: 102 --------IG----RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149

Query: 233 VALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
             +L ++   P++I  + + +      ++ + + +G L  YL   E   L   +  +I  
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALSEKETRSIMR 207

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
            +   + ++H+  ++HRDLKPEN+L+D    ++++DFG +C     + L +  GT  ++A
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267

Query: 352 PEMIK------HKSYGRKVDVYSFGLILWEMVAGTIP 382
           PE++K      H  YG++VD+++ G+IL+ ++AG+ P
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  126 bits (318), Expect = 1e-31
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 13/204 (6%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIR-----IPDDDENETLAARLEKQFNREVALLSRLHN 241
            GA+  +     K      A+K+I+          ++     +  ++   E++LL  L +
Sbjct: 46  SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105

Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
           PN+IK     +    + ++TE+   G L   +  +            I   I  G+ Y+H
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECDAANIMKQILSGICYLH 163

Query: 302 SQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
              ++HRD+KPEN+L+   +   ++KI DFG++        L D  GT  ++APE++K K
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-K 222

Query: 359 SYGRKVDVYSFGLILWEMVAGTIP 382
            Y  K DV+S G+I++ ++ G  P
Sbjct: 223 KYNEKCDVWSCGVIMYILLCGYPP 246

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  127 bits (320), Expect = 2e-31
 Identities = 50/263 (19%), Positives = 95/263 (36%), Gaps = 56/263 (21%)

Query: 186 RFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
             AHG    +Y     D      PV +K +    D E     A        E   L+ + 
Sbjct: 87  CIAHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAE---AQAM----AMAERQFLAEVV 137

Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAY----------LHKLEHKTLPLPKLIAIA 290
           +P++++         ++  +      G    Y          L + + + LP+ + IA  
Sbjct: 138 HPSIVQ---------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYL 188

Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---GTY 347
           L+I   + Y+HS G+++ DLKPEN+++ +E  LK+ D G          ++      GT 
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV------SRINSFGYLYGTP 241

Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNKNLRPAIP 405
            + APE+++        D+Y+ G  L  +           ++ +                
Sbjct: 242 GFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPTRNGRYVDGLP----------EDDPV 290

Query: 406 GDCPPAMAALIEQCWSLQPDKRP 428
                +   L+ +     P +R 
Sbjct: 291 LKTYDSYGRLLRRAIDPDPRQRF 313

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  121 bits (305), Expect = 3e-31
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)

Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL--- 286
            RE  ++SRL +P  +K     +          Y   G L  Y+ K+        +    
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137

Query: 287 -IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP- 344
            I  AL      EY+H +G+IHRDLKPEN+L++++ H++I DFG   + +  ++      
Sbjct: 138 EIVSAL------EYLHGKGIIHRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARAN 190

Query: 345 ---GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR 401
              GT ++++PE++  KS  +  D+++ G I++++VAG  P+   N       ++     
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250

Query: 402 PAIPGDCPPAMAALIEQCWSLQPDKR 427
              P    P    L+E+   L   KR
Sbjct: 251 --FPEKFFPKARDLVEKLLVLDATKR 274

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  124 bits (314), Expect = 4e-31
 Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 13/200 (6%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+   +     K   +  AVK+I        +      ++   REV LL +L +PN++K
Sbjct: 36  KGSFGEVILCKDKITGQECAVKVISK-----RQVKQKTDKESLLREVQLLKQLDHPNIMK 90

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                +    + ++ E  + G L   +  +  K         I   +  G+ Y+H   ++
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITYMHKNKIV 148

Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
           HRDLKPEN+L+    ++ +++I DFG++        + D  GT  ++APE++   +Y  K
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEK 207

Query: 364 VDVYSFGLILWEMVAGTIPY 383
            DV+S G+IL+ +++G  P+
Sbjct: 208 CDVWSTGVILYILLSGCPPF 227

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  125 bits (316), Expect = 4e-31
 Identities = 55/230 (23%), Positives = 105/230 (45%), Gaps = 19/230 (8%)

Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           A K +          E   L    EKQ      +L ++++  V+    A +     C++ 
Sbjct: 213 ACKKLEKKRIKKRKGEAMALN---EKQ------ILEKVNSRFVVSLAYAYETKDALCLVL 263

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
             ++ G L+ +++ +     P  + +  A +I  G+E +H + +++RDLKPEN+L+D   
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG 323

Query: 322 HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381
           H++I+D G+A        +    GT  +MAPE++K++ Y    D ++ G +L+EM+AG  
Sbjct: 324 HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

Query: 382 PY----EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           P+    +++   +    V              P   +L  Q     P +R
Sbjct: 384 PFQQRKKKIKREEVERLVKEVPEE--YSERFSPQARSLCSQLLCKDPAER 431

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  124 bits (312), Expect = 6e-31
 Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 14/199 (7%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+   +     +   +  AVK+I         +   +      REV LL +L +PN++K
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVKVINK------ASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                +    + ++ E  + G L   +  ++ K         I   +  G+ Y+H   ++
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143

Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
           HRDLKPEN+L+   +++  +KI DFG++        + D  GT  ++APE+++  +Y  K
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEK 202

Query: 364 VDVYSFGLILWEMVAGTIP 382
            DV+S G+IL+ +++GT P
Sbjct: 203 CDVWSAGVILYILLSGTPP 221

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  121 bits (306), Expect = 7e-31
 Identities = 59/196 (30%), Positives = 85/196 (43%), Gaps = 30/196 (15%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
           E VAVK I      E       +++   RE+     L +PN+++F      P    +I E
Sbjct: 46  ELVAVKYI------ERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR--------GMEYIHSQGVIHRDLKPEN 314
           Y S G L   +                  D AR        G+ Y HS  + HRDLK EN
Sbjct: 97  YASGGELYERI--CNAGRFSE--------DEARFFFQQLLSGVSYCHSMQICHRDLKLEN 146

Query: 315 VLIDQEF--HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGL 371
            L+D      LKI DFG +   V         GT  ++APE++  + Y G+  DV+S G+
Sbjct: 147 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206

Query: 372 ILWEMVAGTIPYEEMN 387
            L+ M+ G  P+E+  
Sbjct: 207 TLYVMLVGAYPFEDPE 222

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  120 bits (302), Expect = 7e-31
 Identities = 58/204 (28%), Positives = 107/204 (52%), Gaps = 12/204 (5%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRLHN-PNV 244
            G  S +   I+K   +  AVKII +      +      L +   +EV +L ++   PN+
Sbjct: 27  RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86

Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           I+     +    + ++ + + +G L  YL   E  TL   +   I   +   +  +H   
Sbjct: 87  IQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHKLN 144

Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK------HK 358
           ++HRDLKPEN+L+D + ++K+ DFG +C+    + L +  GT  ++APE+I+      H 
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 204

Query: 359 SYGRKVDVYSFGLILWEMVAGTIP 382
            YG++VD++S G+I++ ++AG+ P
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPP 228

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  118 bits (297), Expect = 6e-30
 Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 10/193 (5%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
           + VA+KII            A        E+ +L +L++P +IK          Y ++ E
Sbjct: 36  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLE 94

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQ 319
            +  G L   +  + +K L           +   ++Y+H  G+IHRDLKPENVL+   ++
Sbjct: 95  LMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 152

Query: 320 EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI---KHKSYGRKVDVYSFGLILWEM 376
           +  +KI DFG +        +    GT  ++APE++       Y R VD +S G+IL+  
Sbjct: 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212

Query: 377 VAGTIP-YEEMNP 388
           ++G  P  E    
Sbjct: 213 LSGYPPFSEHRTQ 225

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  121 bits (304), Expect = 1e-29
 Identities = 57/240 (23%), Positives = 109/240 (45%), Gaps = 36/240 (15%)

Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           A K +              +    EK+      +L+++H+  ++    A +     C++ 
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMV---EKK------ILAKVHSRFIVSLAYAFETKTDLCLVM 264

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAI--ALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
             ++ G +R +++ ++       +  AI     I  G+E++H + +I+RDLKPENVL+D 
Sbjct: 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD 324

Query: 320 EFHLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGL 371
           + +++I+D G+A E          Y        GT  +MAPE++  + Y   VD ++ G+
Sbjct: 325 DGNVRISDLGLAVELKAGQTKTKGYA-------GTPGFMAPELLLGEEYDFSVDYFALGV 377

Query: 372 ILWEMVAGTIPY----EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
            L+EM+A   P+    E++   +    V+ + +    P    PA     E      P+KR
Sbjct: 378 TLYEMIAARGPFRARGEKVENKELKQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  116 bits (294), Expect = 2e-29
 Identities = 30/191 (15%), Positives = 78/191 (40%), Gaps = 18/191 (9%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G    ++  +     +    K +++   D+             +E+++L+   + N++ 
Sbjct: 15  RGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---------VKKEISILNIARHRNILH 65

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQG 304
              + +      +I E++S   +     ++      L +   ++    +   ++++HS  
Sbjct: 66  LHESFESMEELVMIFEFISGLDI---FERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122

Query: 305 VIHRDLKPENVLI--DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGR 362
           + H D++PEN++    +   +KI +FG A +    D          + APE+ +H     
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182

Query: 363 KVDVYSFGLIL 373
             D++S G ++
Sbjct: 183 ATDMWSLGTLV 193

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  115 bits (291), Expect = 2e-29
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 21/204 (10%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKII---RIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
            GA   ++    +       +K I   R     E          Q   E+ +L  L +PN
Sbjct: 32  SGAFGDVHLVEERSSGLERVIKTINKDRSQVPME----------QIEAEIEVLKSLDHPN 81

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIH 301
           +IK     +      ++ E    G L   +   + +   L +     L   +   + Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 302 SQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
           SQ V+H+DLKPEN+L         +KI DFG+A      +  ++  GT  +MAPE+ K +
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-R 200

Query: 359 SYGRKVDVYSFGLILWEMVAGTIP 382
               K D++S G++++ ++ G +P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLP 224

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  114 bits (289), Expect = 4e-29
 Identities = 50/190 (26%), Positives = 96/190 (50%), Gaps = 13/190 (6%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA S +   ++K      A KII        + L+AR  ++  RE  +  +L +PN+++
Sbjct: 16  KGAFSVVRRCVHKTTGLEFAAKIINT------KKLSARDFQKLEREARICRKLQHPNIVR 69

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
              + ++   + ++ + ++ G L   +  +  +             I   + Y HS G++
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCHSNGIV 127

Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
           HR+LKPEN+L+    +   +K+ADFG+A E    +A     GT  +++PE++K   Y + 
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187

Query: 364 VDVYSFGLIL 373
           VD+++ G+IL
Sbjct: 188 VDIWACGVIL 197

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  116 bits (292), Expect = 4e-29
 Identities = 51/242 (21%), Positives = 97/242 (40%), Gaps = 52/242 (21%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G++  +   I        A+KI+      +   +  +  ++   EV L+ +LH+PN+ + 
Sbjct: 37  GSYGVVRVAIENQTRAIRAIKIMNKN---KIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI-------------------- 287
               +     C++ E    G L   L+     +     +                     
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 288 ------------------AIALDIARGMEYIHSQGVIHRDLKPENVLI--DQEFHLKIAD 327
                              I   I   + Y+H+QG+ HRD+KPEN L   ++ F +K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213

Query: 328 FGIA-----CEEVYCDALSDDPGTYRWMAPEMIK--HKSYGRKVDVYSFGLILWEMVAGT 380
           FG++             ++   GT  ++APE++   ++SYG K D +S G++L  ++ G 
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

Query: 381 IP 382
           +P
Sbjct: 274 VP 275

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  115 bits (291), Expect = 5e-29
 Identities = 62/237 (26%), Positives = 117/237 (49%), Gaps = 39/237 (16%)

Query: 206 AVKIIR---IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
           A+K+++   +   D   T     E+       +L  +++P ++K   A +      +I +
Sbjct: 56  AMKVLKKATLKVRDRVRTKM---ERD------ILVEVNHPFIVKLHYAFQTEGKLYLILD 106

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
           +L  G L   L K    T    K     +A+AL      +++HS G+I+RDLKPEN+L+D
Sbjct: 107 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL------DHLHSLGIIYRDLKPENILLD 160

Query: 319 QEFHLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFG 370
           +E H+K+ DFG++ E +        +C       GT  +MAPE++  + + +  D +SFG
Sbjct: 161 EEGHIKLTDFGLSKESIDHEKKAYSFC-------GTVEYMAPEVVNRRGHTQSADWWSFG 213

Query: 371 LILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           ++++EM+ GT+P++  +  +    ++   L   +P    P   +L+   +   P  R
Sbjct: 214 VLMFEMLTGTLPFQGKDRKETMTMILKAKLG--MPQFLSPEAQSLLRMLFKRNPANR 268

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  116 bits (293), Expect = 6e-29
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)

Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL--- 286
            +E+ ++  L +P ++    + +      ++ + L  G LR +L +  H      KL   
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122

Query: 287 -IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG 345
            + +AL      +Y+ +Q +IHRD+KP+N+L+D+  H+ I DF IA        ++   G
Sbjct: 123 ELVMAL------DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAG 176

Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEM---NPIQAAFAVVNKN 399
           T  +MAPEM   +    Y   VD +S G+  +E++ G  PY      +  +         
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV 236

Query: 400 LRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           +    P      M +L+++     PD+R
Sbjct: 237 VT--YPSAWSQEMVSLLKKLLEPNPDQR 262

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  113 bits (286), Expect = 1e-28
 Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+   +     +   +  AVK+I         +   +      REV LL +L +PN++K
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVKVINK------ASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
                +    + ++ E  + G L     + ++ K         I   +  G+ Y+H   +
Sbjct: 86  LFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142

Query: 306 IHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGR 362
           +HRDLKPEN+L+   +++  +KI DFG++        + D  GT  ++APE+++  +Y  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDE 201

Query: 363 KVDVYSFGLILWEMVAGTIP 382
           K DV+S G+IL+ +++GT P
Sbjct: 202 KCDVWSAGVILYILLSGTPP 221

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  113 bits (285), Expect = 1e-28
 Identities = 35/255 (13%), Positives = 67/255 (26%), Gaps = 46/255 (18%)

Query: 183 LGLRFAHGAHSRLYHGIYKDE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSR 238
           L +        + +     D      VA+  +  P     + +              LSR
Sbjct: 35  LLIFHGGVPPLQFWQA--LDTALDRQVALTFVD-PQGVLPDDVLQE----TLSRTLRLSR 87

Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
           +  P V + +          V+ E++  GSL+         +      I     +A   +
Sbjct: 88  IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAAD 143

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
             H  GV      P  V +  +  + +A                       M        
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-------------------MPDA----- 179

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEE---MNPIQAAFAVVNKNLRP--AIPGDCPPAMA 413
               + D+   G  L+ ++    P  E    + +  A             I  D P  ++
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237

Query: 414 ALIEQCWSLQPDKRP 428
           A+  +        R 
Sbjct: 238 AVAARSVQGDGGIRS 252

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  113 bits (285), Expect = 2e-28
 Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 10/176 (5%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
           +  A K I+      +    +R  ++  REV +L  + +PN+I      +      +I E
Sbjct: 31  KEYAAKFIKKRRLSSSRRGVSR--EEIEREVNILREIRHPNIITLHDIFENKTDVVLILE 88

Query: 263 YLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---- 317
            +S G L      L E ++L   +       I  G+ Y+HS+ + H DLKPEN+++    
Sbjct: 89  LVSGGEL---FDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN 145

Query: 318 DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
                +K+ DFGIA +    +   +  GT  ++APE++ ++  G + D++S G+I 
Sbjct: 146 VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  114 bits (288), Expect = 2e-28
 Identities = 46/194 (23%), Positives = 88/194 (45%), Gaps = 13/194 (6%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G  S +   I ++  +  AVKI+ +     +  L+    +   RE ++   L +P++++
Sbjct: 34  KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS---TEDLKREASICHMLKHPHIVE 90

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQG 304
            +       +  ++ E++    L   + K         + +A      I   + Y H   
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150

Query: 305 VIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKS 359
           +IHRD+KP  VL+   +    +K+  FG+A  ++           GT  +MAPE++K + 
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAI-QLGESGLVAGGRVGTPHFMAPEVVKREP 209

Query: 360 YGRKVDVYSFGLIL 373
           YG+ VDV+  G+IL
Sbjct: 210 YGKPVDVWGCGVIL 223

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  117 bits (294), Expect = 2e-28
 Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 17/200 (8%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA   ++    +      A K +  P + + E           +E+  +S L +P ++ 
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKE--------TVRKEIQTMSVLRHPTLVN 218

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQG 304
              A +      +I E++S G L     K+  +   + +  A+     + +G+ ++H   
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 305 VIHRDLKPENVLI--DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGR 362
            +H DLKPEN++    +   LK+ DFG+        ++    GT  + APE+ + K  G 
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335

Query: 363 KVDVYSFGLILWEMVAGTIP 382
             D++S G++ + +++G  P
Sbjct: 336 YTDMWSVGVLSYILLSGLSP 355

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  113 bits (284), Expect = 4e-28
 Identities = 39/181 (21%), Positives = 73/181 (40%), Gaps = 22/181 (12%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT 261
           +  A K ++                +   E+A+L      P VI      +      +I 
Sbjct: 55  QEYAAKFLKKR------RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108

Query: 262 EYLSEGSL------RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
           EY + G +             E+        I +   I  G+ Y+H   ++H DLKP+N+
Sbjct: 109 EYAAGGEIFSLCLPELAEMVSENDV------IRLIKQILEGVYYLHQNNIVHLDLKPQNI 162

Query: 316 LI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
           L+        +KI DFG++ +  +   L +  GT  ++APE++ +       D+++ G+I
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222

Query: 373 L 373
            
Sbjct: 223 A 223

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  113 bits (285), Expect = 5e-28
 Identities = 60/234 (25%), Positives = 112/234 (47%), Gaps = 31/234 (13%)

Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           A+K ++    + DDD   T+    EK+      L     +P +       +       + 
Sbjct: 46  AIKALKKDVVLMDDDVECTMV---EKR-----VLSLAWEHPFLTHMFCTFQTKENLFFVM 97

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           EYL+ G L  ++         L +    A +I  G++++HS+G+++RDLK +N+L+D++ 
Sbjct: 98  EYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG 155

Query: 322 HLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
           H+KIADFG+  E +        +C       GT  ++APE++  + Y   VD +SFG++L
Sbjct: 156 HIKIADFGMCKENMLGDAKTNTFC-------GTPDYIAPEILLGQKYNHSVDWWSFGVLL 208

Query: 374 WEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           +EM+ G  P+   +  +   ++   N     P         L+ + +  +P+KR
Sbjct: 209 YEMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKR 260

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  112 bits (282), Expect = 5e-28
 Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 24/194 (12%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA S ++    +   +  A+K I+           A  +     E+A+L ++ + N++ 
Sbjct: 19  SGAFSEVFLVKQRLTGKLFALKCIK--------KSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 247 FVAACKKPPVYCVITEYLSEGSL----RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
                +    Y ++ + +S G L           E           +   +   ++Y+H 
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA------SLVIQQVLSAVKYLHE 124

Query: 303 QGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKS 359
            G++HRDLKPEN+L    ++   + I DFG++  E     +S   GT  ++APE++  K 
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVLAQKP 183

Query: 360 YGRKVDVYSFGLIL 373
           Y + VD +S G+I 
Sbjct: 184 YSKAVDCWSIGVIT 197

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  113 bits (285), Expect = 5e-28
 Identities = 50/190 (26%), Positives = 96/190 (50%), Gaps = 13/190 (6%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA S +   ++K      A KII        + L+AR  ++  RE  +  +L +PN+++
Sbjct: 39  KGAFSVVRRCVHKTTGLEFAAKIINT------KKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
              + ++   + ++ + ++ G L   +  +  +             I   + Y HS G++
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCHSNGIV 150

Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
           HR+LKPEN+L+    +   +K+ADFG+A E    +A     GT  +++PE++K   Y + 
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 210

Query: 364 VDVYSFGLIL 373
           VD+++ G+IL
Sbjct: 211 VDIWACGVIL 220

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  113 bits (284), Expect = 6e-28
 Identities = 58/234 (24%), Positives = 110/234 (47%), Gaps = 32/234 (13%)

Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           A+KI+R    I  D+   T+    E +      +L    +P +     A +     C + 
Sbjct: 34  AMKILRKEVIIAKDEVAHTVT---ESR------VLQNTRHPFLTALKYAFQTHDRLCFVM 84

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           EY + G L  +L +   +     +      +I   +EY+HS+ V++RD+K EN+++D++ 
Sbjct: 85  EYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 142

Query: 322 HLKIADFGIACEEVY--------CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
           H+KI DFG+  E +         C       GT  ++APE+++   YGR VD +  G+++
Sbjct: 143 HIKITDFGLCKEGISDGATMKTFC-------GTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195

Query: 374 WEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           +EM+ G +P+   +  +    ++ + +R   P    P   +L+       P +R
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  112 bits (282), Expect = 6e-28
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 8/175 (4%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
              A K I+      +    +R  ++  REV++L ++ + NVI      +      +I E
Sbjct: 38  LEYAAKFIKKRQSRASRRGVSR--EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----D 318
            +S G L  +L + E   L   +  +    I  G+ Y+H++ + H DLKPEN+++     
Sbjct: 96  LVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153

Query: 319 QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
              H+K+ DFG+A E        +  GT  ++APE++ ++  G + D++S G+I 
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  112 bits (282), Expect = 6e-28
 Identities = 63/235 (26%), Positives = 113/235 (48%), Gaps = 37/235 (15%)

Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           A+K+++    +       T           E  +LS + +P +I+     +      +I 
Sbjct: 35  AMKVLKKEIVVRLKQVEHTND---------ERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
           +Y+  G L + L K +    P+ K     + +AL      EY+HS+ +I+RDLKPEN+L+
Sbjct: 86  DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL------EYLHSKDIIYRDLKPENILL 139

Query: 318 DQEFHLKIADFGIACEEV-----YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
           D+  H+KI DFG A          C       GT  ++APE++  K Y + +D +SFG++
Sbjct: 140 DKNGHIKITDFGFAKYVPDVTYTLC-------GTPDYIAPEVVSTKPYNKSIDWWSFGIL 192

Query: 373 LWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           ++EM+AG  P+ + N ++    ++N  LR   P      +  L+ +  +    +R
Sbjct: 193 IYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  113 bits (284), Expect = 7e-28
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 20/203 (9%)

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--I 289
           E  +L  ++ P ++K   + K      ++ EY++ G + ++L ++   + P  +  A  I
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-----YCDALSDDP 344
            L      EY+HS  +I+RDLKPEN+LIDQ+ ++++ DFG A          C       
Sbjct: 151 VL----TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC------- 199

Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI 404
           GT   +APE+I  K Y + VD ++ G++++EM AG  P+    PIQ    +V+  +R   
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--F 257

Query: 405 PGDCPPAMAALIEQCWSLQPDKR 427
           P      +  L+     +   KR
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  112 bits (283), Expect = 1e-27
 Identities = 62/234 (26%), Positives = 112/234 (47%), Gaps = 31/234 (13%)

Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           AVK+++    + DDD   T+    EK+    +  L+R H P + +     + P     + 
Sbjct: 52  AVKVLKKDVILQDDDVECTMT---EKR----ILSLARNH-PFLTQLFCCFQTPDRLFFVM 103

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           E+++ G L  ++ K   +     +    A +I   + ++H +G+I+RDLK +NVL+D E 
Sbjct: 104 EFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG 161

Query: 322 HLKIADFGIACEEVY--------CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
           H K+ADFG+  E +         C       GT  ++APE+++   YG  VD ++ G++L
Sbjct: 162 HCKLADFGMCKEGICNGVTTATFC-------GTPDYIAPEILQEMLYGPAVDWWAMGVLL 214

Query: 374 WEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           +EM+ G  P+E  N      A++N  +    P         +++   +  P  R
Sbjct: 215 YEMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLHEDATGILKSFMTKNPTMR 266

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  112 bits (283), Expect = 1e-27
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 8/175 (4%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
              A K I+      +     R  ++  REV++L ++ +PN+I      +      +I E
Sbjct: 38  LEYAAKFIKKRQSRASRRGVCR--EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILE 95

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----D 318
            +S G L  +L + E   L   +  +    I  G+ Y+H++ + H DLKPEN+++     
Sbjct: 96  LVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153

Query: 319 QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
              H+K+ DFG+A E        +  GT  ++APE++ ++  G + D++S G+I 
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  111 bits (281), Expect = 1e-27
 Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 45/212 (21%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
            G +S ++  I    +E V VKI++ P            +K+  RE+ +L  L   PN+I
Sbjct: 46  RGKYSEVFEAINITNNEKVVVKILK-PVK----------KKKIKREIKILENLRGGPNII 94

Query: 246 K----FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYI 300
                      + P    + E+++    +     L          I   + +I + ++Y 
Sbjct: 95  TLADIVKDPVSRTPAL--VFEHVNNTDFKQLYQTLT------DYDIRFYMYEILKALDYC 146

Query: 301 HSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDALSDDPGTY-------RWM-A 351
           HS G++HRD+KP NV+ID E   L++ D+G+A  E Y       PG         R+   
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFY------HPGQEYNVRVASRYFKG 198

Query: 352 PE-MIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
           PE ++ ++ Y   +D++S G +L  M+    P
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  110 bits (277), Expect = 2e-27
 Identities = 44/199 (22%), Positives = 83/199 (41%), Gaps = 16/199 (8%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+   +   + K      A K I                 +F +E+ ++  L +PN+I+
Sbjct: 19  RGSWGEVKIAVQKGTRIRRAAKKIP--------KYFVEDVDRFKQEIEIMKSLDHPNIIR 70

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                +      ++ E  + G L   +  +  +         I  D+   + Y H   V 
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128

Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
           HRDLKPEN L      +  LK+ DFG+A        +    GT  +++P++++   YG +
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPE 187

Query: 364 VDVYSFGLILWEMVAGTIP 382
            D +S G++++ ++ G  P
Sbjct: 188 CDEWSAGVMMYVLLCGYPP 206

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  111 bits (280), Expect = 2e-27
 Identities = 54/178 (30%), Positives = 97/178 (54%), Gaps = 19/178 (10%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
             + EY++ G L  ++ +        P  +  A +IA G+ ++ S+G+I+RDLK +NV++
Sbjct: 97  YFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154

Query: 318 DQEFHLKIADFGIACEEVY--------CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
           D E H+KIADFG+  E ++        C       GT  ++APE+I ++ YG+ VD ++F
Sbjct: 155 DSEGHIKIADFGMCKENIWDGVTTKTFC-------GTPDYIAPEIIAYQPYGKSVDWWAF 207

Query: 370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           G++L+EM+AG  P+E  +  +   +++  N+    P        A+ +   +  P KR
Sbjct: 208 GVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 263

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  111 bits (281), Expect = 3e-27
 Identities = 58/238 (24%), Positives = 108/238 (45%), Gaps = 39/238 (16%)

Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           AVK+++    +   +E   ++   E+       LL  + +P ++    + +       + 
Sbjct: 67  AVKVLQKKAILKKKEEKHIMS---ERNV-----LLKNVKHPFLVGLHFSFQTADKLYFVL 118

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
           +Y++ G L  +L +      P  +     IA AL       Y+HS  +++RDLKPEN+L+
Sbjct: 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASAL------GYLHSLNIVYRDLKPENILL 172

Query: 318 DQEFHLKIADFGIACEEVY--------CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
           D + H+ + DFG+  E +         C       GT  ++APE++  + Y R VD +  
Sbjct: 173 DSQGHIVLTDFGLCKENIEHNSTTSTFC-------GTPEYLAPEVLHKQPYDRTVDWWCL 225

Query: 370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           G +L+EM+ G  P+   N  +    ++NK L+  +  +   +   L+E        KR
Sbjct: 226 GAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKR 281

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (278), Expect = 3e-27
 Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 10/176 (5%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
              A K I+      +    +R  +   REV++L  + +PNVI      +      +I E
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSR--EDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94

Query: 263 YLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---- 317
            ++ G L      L E ++L   +       I  G+ Y+HS  + H DLKPEN+++    
Sbjct: 95  LVAGGEL---FDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 151

Query: 318 DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
             +  +KI DFG+A +  + +   +  GT  ++APE++ ++  G + D++S G+I 
Sbjct: 152 VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  110 bits (278), Expect = 4e-27
 Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 29/196 (14%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA S +Y    K   +P A+K+++   D          +K    E+ +L RL +PN+IK
Sbjct: 63  RGATSIVYRCKQKGTQKPYALKVLKKTVD----------KKIVRTEIGVLLRLSHPNIIK 112

Query: 247 FVAACKKPPVYCVITEYLSEGSL------RAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
                + P    ++ E ++ G L      + Y    E               I   + Y+
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYS--ERDA------ADAVKQILEAVAYL 164

Query: 301 HSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH 357
           H  G++HRDLKPEN+L      +  LKIADFG++    +   +    GT  + APE+++ 
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG 224

Query: 358 KSYGRKVDVYSFGLIL 373
            +YG +VD++S G+I 
Sbjct: 225 CAYGPEVDMWSVGIIT 240

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  111 bits (279), Expect = 4e-27
 Identities = 42/199 (21%), Positives = 90/199 (45%), Gaps = 17/199 (8%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           GA   ++  + K        K I  P   +              E++++++LH+P +I  
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--------TVKNEISIMNQLHHPKLINL 113

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQGV 305
             A +      +I E+LS G L     ++  +   + +   I        G++++H   +
Sbjct: 114 HDAFEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170

Query: 306 IHRDLKPENVLI--DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
           +H D+KPEN++    +   +KI DFG+A +    + +     T  + APE++  +  G  
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 230

Query: 364 VDVYSFGLILWEMVAGTIP 382
            D+++ G++ + +++G  P
Sbjct: 231 TDMWAIGVLGYVLLSGLSP 249

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  109 bits (275), Expect = 6e-27
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 26/219 (11%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQF 229
             + +DL    LG     G+ S     ++K   +  AVKII           + R+E   
Sbjct: 8   QHYDLDLKDKPLG----EGSFSICRKCVHKKSNQAFAVKII-----------SKRMEANT 52

Query: 230 NREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLI 287
            +E+  L     +PN++K            ++ E L+ G L     +  + K     +  
Sbjct: 53  QKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEAS 109

Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACE-EVYCDALSDD 343
            I   +   + ++H  GV+HRDLKPEN+L    +    +KI DFG A         L   
Sbjct: 110 YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169

Query: 344 PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
             T  + APE++    Y    D++S G+IL+ M++G +P
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  110 bits (277), Expect = 7e-27
 Identities = 65/291 (22%), Positives = 119/291 (40%), Gaps = 32/291 (10%)

Query: 99  HPRRKESDKGLVGKFLYKQPQQET---KASSNSYSTSPLRHLGSLRVTERYKSRKESAWT 155
           H     S   L  + LY Q  + +    + S       +     L      KS++ SA  
Sbjct: 4   HHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALA 63

Query: 156 KY-------FDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVA 206
                    FDH  V          +TV  +++ LG     G   +++          +A
Sbjct: 64  VDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEI-LG----GGRFGQVHKCEETATGLKLA 118

Query: 207 VKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE 266
            KII+     + E        +   E++++++L + N+I+   A +      ++ EY+  
Sbjct: 119 AKIIKTRGMKDKE--------EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170

Query: 267 GSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQGVIHRDLKPENVLI--DQEFH 322
           G L     ++  ++  L +L  I     I  G+ ++H   ++H DLKPEN+L        
Sbjct: 171 GEL---FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ 227

Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
           +KI DFG+A      + L  + GT  ++APE++ +       D++S G+I 
Sbjct: 228 IKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  109 bits (274), Expect = 9e-27
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPE 313
            +I EYLS G L   L +               I++AL       ++H +G+I+RDLKPE
Sbjct: 97  YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL------GHLHQKGIIYRDLKPE 150

Query: 314 NVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
           N++++ + H+K+ DFG+  E ++   ++    GT  +MAPE++    + R VD +S G +
Sbjct: 151 NIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210

Query: 373 LWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           +++M+ G  P+   N  +    ++   L   +P         L+++        R
Sbjct: 211 MYDMLTGAPPFTGENRKKTIDKILKCKLN--LPPYLTQEARDLLKKLLKRNAASR 263

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  109 bits (274), Expect = 2e-26
 Identities = 71/280 (25%), Positives = 112/280 (40%), Gaps = 55/280 (19%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA+  +   I K   E VA+K  ++    ++E  A R      RE+ LL  + + NVI 
Sbjct: 34  SGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAY----RELLLLKHMQHENVIG 87

Query: 247 FVAACKKPP-------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
            +               Y V   ++        L K+        K+  +   + +G++Y
Sbjct: 88  LLDVFTPASSLRNFYDFYLV-MPFMQ-----TDLQKIMGLKFSEEKIQYLVYQMLKGLKY 141

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW-MAPE-MIKH 357
           IHS GV+HRDLKP N+ ++++  LKI DFG+A        ++    T RW  APE ++  
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLA--RHADAEMTGYVVT-RWYRAPEVILSW 198

Query: 358 KSYGRKVDVYSFGLILWEM---------------------VAGTIPYEEMNPIQAAFA-- 394
             Y + VD++S G I+ EM                     V G    E +  +    A  
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258

Query: 395 -VVNKNLRPAIP-----GDCPPAMAALIEQCWSLQPDKRP 428
            + +    P            P  A L+E+   L  DKR 
Sbjct: 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  109 bits (274), Expect = 2e-26
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 21/185 (11%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------- 255
             VA+K  ++    +N+T A R      RE+ L+  +++ N+I  +              
Sbjct: 51  RNVAIK--KLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104

Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
           VY V  E +      A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+
Sbjct: 105 VYIV-MELMD-----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158

Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM-APEMIKHKSYGRKVDVYSFGLILW 374
           ++  +  LKI DFG+A        ++    T R+  APE+I    Y   VD++S G I+ 
Sbjct: 159 VVKSDCTLKILDFGLARTAGTSFMMTPYVVT-RYYRAPEVILGMGYKENVDIWSVGCIMG 217

Query: 375 EMVAG 379
           EM+ G
Sbjct: 218 EMIKG 222

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  108 bits (273), Expect = 2e-26
 Identities = 48/187 (25%), Positives = 96/187 (51%), Gaps = 28/187 (14%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
             + EY++ G L  ++ +   + LP       + +I+  + Y+H +G+I+RDLK +NVL+
Sbjct: 86  FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143

Query: 318 DQEFHLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
           D E H+K+ D+G+  E +        +C       GT  ++APE+++ + YG  VD ++ 
Sbjct: 144 DSEGHIKLTDYGMCKEGLRPGDTTSTFC-------GTPNYIAPEILRGEDYGFSVDWWAL 196

Query: 370 GLILWEMVAGTIPYEEMNPIQAAF---------AVVNKNLRPAIPGDCPPAMAALIEQCW 420
           G++++EM+AG  P++ +                 ++ K +R  IP       A++++   
Sbjct: 197 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFL 254

Query: 421 SLQPDKR 427
           +  P +R
Sbjct: 255 NKDPKER 261

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  110 bits (277), Expect = 2e-26
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 26/197 (13%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA S +   +     +  A  II        + L+AR  ++  RE  +   L +PN+++
Sbjct: 21  KGAFSVVRRCVKVLAGQEYAAMIINT------KKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 247 FVAACKKPPVYCVITEYLSEGSL------RAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
              +  +   + +I + ++ G L      R Y    E               I   + + 
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS--EADA------SHCIQQILEAVLHC 126

Query: 301 HSQGVIHRDLKPENVLI---DQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIK 356
           H  GV+HR+LKPEN+L+    +   +K+ADFG+A E E    A     GT  +++PE+++
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186

Query: 357 HKSYGRKVDVYSFGLIL 373
              YG+ VD+++ G+IL
Sbjct: 187 KDPYGKPVDLWACGVIL 203

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  111 bits (278), Expect = 4e-26
 Identities = 54/178 (30%), Positives = 97/178 (54%), Gaps = 19/178 (10%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
             + EY++ G L  ++ +        P  +  A +IA G+ ++ S+G+I+RDLK +NV++
Sbjct: 418 YFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475

Query: 318 DQEFHLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
           D E H+KIADFG+  E +        +C       GT  ++APE+I ++ YG+ VD ++F
Sbjct: 476 DSEGHIKIADFGMCKENIWDGVTTKTFC-------GTPDYIAPEIIAYQPYGKSVDWWAF 528

Query: 370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           G++L+EM+AG  P+E  +  +   +++  N+    P        A+ +   +  P KR
Sbjct: 529 GVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 584

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  109 bits (274), Expect = 4e-26
 Identities = 56/228 (24%), Positives = 110/228 (48%), Gaps = 19/228 (8%)

Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           A+KI++    +  D+   TL    E +      +L    +P +     + +     C + 
Sbjct: 177 AMKILKKEVIVAKDEVAHTLT---ENR------VLQNSRHPFLTALKYSFQTHDRLCFVM 227

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQE 320
           EY + G L  +L +   +     +      +I   ++Y+HS+  V++RDLK EN+++D++
Sbjct: 228 EYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 285

Query: 321 FHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
            H+KI DFG+  E +   A      GT  ++APE+++   YGR VD +  G++++EM+ G
Sbjct: 286 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345

Query: 380 TIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
            +P+   +  +    ++ + +R   P    P   +L+       P +R
Sbjct: 346 RLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 391

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  107 bits (270), Expect = 4e-26
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)

Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIK 246
           G++S     I+K      AVKII             + ++    E+ +L R   +PN+I 
Sbjct: 33  GSYSVCKRCIHKATNMEFAVKII------------DKSKRDPTEEIEILLRYGQHPNIIT 80

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                       V+TE +  G L   +  L  K     +  A+   I + +EY+H+QGV+
Sbjct: 81  LKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVLFTITKTVEYLHAQGVV 138

Query: 307 HRDLKPENVLI----DQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYG 361
           HRDLKP N+L          ++I DFG A +    + L   P  T  ++APE+++ + Y 
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD 198

Query: 362 RKVDVYSFGLILWEMVAGTIP 382
              D++S G++L+ M+ G  P
Sbjct: 199 AACDIWSLGVLLYTMLTGYTP 219

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  108 bits (272), Expect = 4e-26
 Identities = 48/187 (25%), Positives = 96/187 (51%), Gaps = 28/187 (14%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
             + EY++ G L  ++ +   + LP       + +I+  + Y+H +G+I+RDLK +NVL+
Sbjct: 129 FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186

Query: 318 DQEFHLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
           D E H+K+ D+G+  E +        +C       GT  ++APE+++ + YG  VD ++ 
Sbjct: 187 DSEGHIKLTDYGMCKEGLRPGDTTSTFC-------GTPNYIAPEILRGEDYGFSVDWWAL 239

Query: 370 GLILWEMVAGTIPYEEMNPIQAAF---------AVVNKNLRPAIPGDCPPAMAALIEQCW 420
           G++++EM+AG  P++ +                 ++ K +R  IP       A++++   
Sbjct: 240 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFL 297

Query: 421 SLQPDKR 427
           +  P +R
Sbjct: 298 NKDPKER 304

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  107 bits (268), Expect = 6e-26
 Identities = 49/217 (22%), Positives = 100/217 (46%), Gaps = 30/217 (13%)

Query: 177 DLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
            LS+  LG     G + ++    ++   +  A+K++     D           +  +EV 
Sbjct: 31  QLSKQVLG----LGVNGKVLECFHRRTGQKCALKLL----YDS---------PKARQEVD 73

Query: 235 LLSRLHN-PNVIKFVAAC-----KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
              +    P+++  +         K  +  +I E +  G L + + +   +     +   
Sbjct: 74  HHWQASGGPHIVCILDVYENMHHGKRCLL-IIMECMEGGELFSRIQERGDQAFTEREAAE 132

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPG 345
           I  DI   ++++HS  + HRD+KPEN+L    +++  LK+ DFG A +E   +AL     
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCY 191

Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
           T  ++APE++  + Y +  D++S G+I++ ++ G  P
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  109 bits (273), Expect = 6e-26
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 11/181 (6%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           D  VA+K  ++    +N+T A R      RE+ L+  +++ N+I  +             
Sbjct: 87  DRNVAIK--KLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140

Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
           + YL    + A L ++    L   ++  +   +  G++++HS G+IHRDLKP N+++  +
Sbjct: 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200

Query: 321 FHLKIADFGIACEEVYCDALSDDPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
             LKI DFG+A        ++    T  YR  APE+I    Y   VD++S G I+ EMV 
Sbjct: 201 CTLKILDFGLARTAGTSFMMTPYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVR 258

Query: 379 G 379
            
Sbjct: 259 H 259

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  109 bits (274), Expect = 1e-25
 Identities = 53/236 (22%), Positives = 106/236 (44%), Gaps = 31/236 (13%)

Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
           A+K +          E   L    E+     ++L+S    P ++    A   P     I 
Sbjct: 218 AMKCLDKKRIKMKQGETLALN---ERIM---LSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           + ++ G L  +L +  H       +   A +I  G+E++H++ V++RDLKP N+L+D+  
Sbjct: 272 DLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG 329

Query: 322 HLKIADFGIACEEV------YCDALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILW 374
           H++I+D G+AC+                 GT+ +MAPE+++    Y    D +S G +L+
Sbjct: 330 HVRISDLGLACDFSKKKPHASV-------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382

Query: 375 EMVAGTIPY---EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR 427
           +++ G  P+   +  +  +     +   +   +P    P + +L+E       ++R
Sbjct: 383 KLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNRR 436

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  106 bits (266), Expect = 2e-25
 Identities = 61/272 (22%), Positives = 102/272 (37%), Gaps = 51/272 (18%)

Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFN-----REVALLSRLHNPNVIKFVAACKKPP 255
           +  PVA+K  R+ +   +      L   F      RE+ LL+  H+PN++          
Sbjct: 45  EGIPVAIK--RVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102

Query: 256 ------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
                 +Y V TE +    L   +H  +   +    +      I  G+  +H  GV+HRD
Sbjct: 103 EPAMHKLYLV-TELM-RTDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRD 159

Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT--YRWMAPE-MIKHKSYGRKVDV 366
           L P N+L+     + I DF +A E+      +       YR  APE +++ K + + VD+
Sbjct: 160 LHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR--APELVMQFKGFTKLVDM 217

Query: 367 YSFGLILWEM---------------------VAGTIPYEEMNPIQAAFAVVN-KNLRPAI 404
           +S G ++ EM                     V GT   E++    +  A    +N    +
Sbjct: 218 WSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277

Query: 405 PG--------DCPPAMAALIEQCWSLQPDKRP 428
           P            P    LI +     P +R 
Sbjct: 278 PARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  106 bits (267), Expect = 3e-25
 Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 39/195 (20%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK-----FVAACKKPPVY 257
           E VA+K  ++  D   +          NRE+ ++ +L + N+++     + +  KK  VY
Sbjct: 80  ELVAIK--KVLQDKRFK----------NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127

Query: 258 -CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL---DIARGMEYIHSQGVIHRDLKPE 313
             ++ +Y+ E ++             LP +I + L    + R + YIHS G+ HRD+KP+
Sbjct: 128 LNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 185

Query: 314 NVLIDQEFH-LKIADFGIACEEVYCDALSDDPGT-------YRWMAPE-MIKHKSYGRKV 364
           N+L+D +   LK+ DFG A + V       +P         YR  APE +     Y   +
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQLV-----RGEPNVSYICSRYYR--APELIFGATDYTSSI 238

Query: 365 DVYSFGLILWEMVAG 379
           DV+S G +L E++ G
Sbjct: 239 DVWSAGCVLAELLLG 253

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  106 bits (266), Expect = 4e-25
 Identities = 54/267 (20%), Positives = 102/267 (38%), Gaps = 54/267 (20%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------V 256
           + VA+K  ++    E+     R+     RE+ +L+RL +  +I+               +
Sbjct: 52  KNVAIK--KVNRMFEDLIDCKRIL----REITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105

Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPK--LIAIALDIARGMEYIHSQGVIHRDLKPEN 314
           Y V  E        + L KL    + L +  +  I  ++  G  +IH  G+IHRDLKP N
Sbjct: 106 YIV-LEIAD-----SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPAN 159

Query: 315 VLIDQEFHLKIADFGIA-------------CEEVYCDALSDDPGTYRWM----------A 351
            L++Q+  +K+ DFG+A               E   +    +    + +          A
Sbjct: 160 CLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRA 219

Query: 352 PE-MIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
           PE ++  ++Y + +D++S G I  E++              +      N  P  PG    
Sbjct: 220 PELILLQENYTKSIDIWSTGCIFAELLNM----------LQSHINDPTNRFPLFPGSSCF 269

Query: 411 AMAALIEQCWSLQPDKRPEFWHIVKVL 437
            ++         +   R +   I  ++
Sbjct: 270 PLSPDRNSKKVHEKSNRDQLNIIFNII 296

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  103 bits (260), Expect = 6e-25
 Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 24/188 (12%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYCVI 260
            + VA+K     +DD      A       RE+ +L +L +PN++  +   + K  ++ V 
Sbjct: 28  GQIVAIKKFLESEDDPVIKKIAL------REIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY  + ++   L     + +P   + +I     + + + H    IHRD+KPEN+LI + 
Sbjct: 82  -EYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH 138

Query: 321 FHLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMI-KHKSYGRKVDVYSFGLI 372
             +K+ DFG A        L+     Y      RW  +PE++     YG  VDV++ G +
Sbjct: 139 SVIKLCDFGFA------RLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCV 192

Query: 373 LWEMVAGT 380
             E+++G 
Sbjct: 193 FAELLSGV 200

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (259), Expect = 7e-25
 Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 34/197 (17%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFN----REVALLSRLHN---PNVIKF--VAACK 252
              VA+K +R+P+                    REVALL RL     PNV++   V A  
Sbjct: 34  GHFVALKSVRVPNGGGGGG-------GLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86

Query: 253 KPPVYCVIT---EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
           +      +T   E++ +  LR YL K     LP   +  +     RG++++H+  ++HRD
Sbjct: 87  RTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRD 145

Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMIKHKSYGR 362
           LKPEN+L+     +K+ADFG+A                       W  APE++   +Y  
Sbjct: 146 LKPENILVTSGGTVKLADFGLARI-------YSYQMALTPVVVTLWYRAPEVLLQSTYAT 198

Query: 363 KVDVYSFGLILWEMVAG 379
            VD++S G I  EM   
Sbjct: 199 PVDMWSVGCIFAEMFRR 215

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  104 bits (262), Expect = 8e-25
 Identities = 64/264 (24%), Positives = 108/264 (40%), Gaps = 52/264 (19%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------- 255
             VA+K  ++    ++E  A R      RE+ LL  + + NVI  +              
Sbjct: 51  AKVAIK--KLYRPFQSELFAKRAY----RELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104

Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
            Y V   ++    L   +    H+ L   ++  +   + +G+ YIH+ G+IHRDLKP N+
Sbjct: 105 FYLV-MPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL 159

Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM-APE-MIKHKSYGRKVDVYSFGLIL 373
            ++++  LKI DFG+A        ++    T RW  APE ++    Y + VD++S G I+
Sbjct: 160 AVNEDCELKILDFGLA--RQADSEMTGYVVT-RWYRAPEVILNWMRYTQTVDIWSVGCIM 216

Query: 374 WEM---------------------VAGTIPYEEMNPIQAAFA---VVNKNLRPAIP---- 405
            EM                     V GT P E +  +Q+  A   +              
Sbjct: 217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 276

Query: 406 -GDCPPAMAALIEQCWSLQPDKRP 428
             +  P    L+E+   L  ++R 
Sbjct: 277 LTNASPLAVNLLEKMLVLDAEQRV 300

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  105 bits (264), Expect = 9e-25
 Identities = 40/161 (24%), Positives = 77/161 (47%), Gaps = 10/161 (6%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
            ++ +Y   G L   L K E + LP         ++   ++ +H    +HRD+KP+N+L+
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208

Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP---GTYRWMAPEMIK-----HKSYGRKVDVYSF 369
           D   H+++ADFG  C ++  D         GT  +++PE+++        YG + D +S 
Sbjct: 209 DMNGHIRLADFGS-CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267

Query: 370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
           G+ ++EM+ G  P+   + ++    ++N   R   P     
Sbjct: 268 GVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  105 bits (263), Expect = 9e-25
 Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 23/218 (10%)

Query: 206 AVKIIR---IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
           A+KI+    +    E           F  E  +L       + +   A +      ++ E
Sbjct: 90  AMKIMNKWDMLKRGEVS--------CFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141

Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
           Y   G L   L K   + +P         +I   ++ +H  G +HRD+KP+N+L+D+  H
Sbjct: 142 YYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH 200

Query: 323 LKIADFGIACEEVYCDALSDDP---GTYRWMAPEMIK-------HKSYGRKVDVYSFGLI 372
           +++ADFG  C ++  D         GT  +++PE+++         SYG + D ++ G+ 
Sbjct: 201 IRLADFGS-CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259

Query: 373 LWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP 410
            +EM  G  P+   +  +    +V+     ++P     
Sbjct: 260 AYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  103 bits (258), Expect = 1e-24
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 37/227 (16%)

Query: 177 DLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
            L +  LG     GAH+R+   I     +  AVKII        E     +  +  REV 
Sbjct: 15  QLQEDVLG----EGAHARVQTCINLITSQEYAVKII--------EKQPGHIRSRVFREVE 62

Query: 235 LLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IAL 291
           +L +     NV++ +   ++   + ++ E +  GS+ +++HK  H      +L A  +  
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----ELEASVVVQ 118

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIA--------CEEVYCDAL 340
           D+A  ++++H++G+ HRDLKPEN+L    +Q   +KI DF +         C  +    L
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 341 SDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIP 382
               G+  +MAPE+++        Y ++ D++S G+IL+ +++G  P
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  102 bits (257), Expect = 2e-24
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 24/186 (12%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYCVIT 261
             VA+K     DDD+     A       RE+ LL +L + N++  +  CK K   Y V  
Sbjct: 51  RIVAIKKFLESDDDKMVKKIAM------REIKLLKQLRHENLVNLLEVCKKKKRWYLVF- 103

Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
           E++ + ++   L    +  L    +      I  G+ + HS  +IHRD+KPEN+L+ Q  
Sbjct: 104 EFV-DHTILDDLELFPNG-LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG 161

Query: 322 HLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMI-KHKSYGRKVDVYSFGLIL 373
            +K+ DFG A        L+     Y      RW  APE++     YG+ VDV++ G ++
Sbjct: 162 VVKLCDFGFA------RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLV 215

Query: 374 WEMVAG 379
            EM  G
Sbjct: 216 TEMFMG 221

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  103 bits (259), Expect = 3e-24
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 25/205 (12%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
            G + ++     K   E  A+K++     D           +  REV L  R    P+++
Sbjct: 72  LGINGKVLQIFNKRTQEKFALKML----QDC---------PKARREVELHWRASQCPHIV 118

Query: 246 KFVAAC-----KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           + V         +  +  ++ E L  G L + +     +     +   I   I   ++Y+
Sbjct: 119 RIVDVYENLYAGRKCLL-IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177

Query: 301 HSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH 357
           HS  + HRD+KPEN+L         LK+ DFG A E    ++L+    T  ++APE++  
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 237

Query: 358 KSYGRKVDVYSFGLILWEMVAGTIP 382
           + Y +  D++S G+I++ ++ G  P
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYPP 262

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  102 bits (256), Expect = 6e-24
 Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 37/192 (19%)

Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK-----FVAACKKPPVY-C 258
           VA+K +      +N            RE+ ++  + +PNV+      +    KK  V+  
Sbjct: 67  VAIKKVLQDKRFKN------------RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLI--AIALDIARGMEYIHSQGVIHRDLKPENVL 316
           ++ EY+ E ++             +P L+       + R + YIHS G+ HRD+KP+N+L
Sbjct: 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173

Query: 317 IDQEFH-LKIADFGIACEEVYCDALSDDPGT-------YRWMAPE-MIKHKSYGRKVDVY 367
           +D     LK+ DFG A   +     + +P         YR  APE +    +Y   +D++
Sbjct: 174 LDPPSGVLKLIDFGSAKILI-----AGEPNVSYICSRYYR--APELIFGATNYTTNIDIW 226

Query: 368 SFGLILWEMVAG 379
           S G ++ E++ G
Sbjct: 227 STGCVMAELMQG 238

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  102 bits (256), Expect = 7e-24
 Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 16/209 (7%)

Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
           A+K++        E +       F  E  +++  ++P V++   A +      ++ EY+ 
Sbjct: 98  AMKLLSK-----FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152

Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
            G L   ++ + +  +P         ++   ++ IHS G IHRD+KP+N+L+D+  HLK+
Sbjct: 153 GGDL---VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 209

Query: 326 ADFGIACEEVYCDALSDDP---GTYRWMAPEMIKHK----SYGRKVDVYSFGLILWEMVA 378
           ADFG  C ++  + +       GT  +++PE++K +     YGR+ D +S G+ L+EM+ 
Sbjct: 210 ADFGT-CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

Query: 379 GTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           G  P+   + +     ++N       P D
Sbjct: 269 GDTPFYADSLVGTYSKIMNHKNSLTFPDD 297

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  101 bits (253), Expect = 8e-24
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 37/197 (18%)

Query: 202 DEPVAVKIIRIPDDDE---NETLAARLEKQFNREVALLSRLHN---PNVIK------FVA 249
              VA+K +R+   +E     T+         REVA+L  L     PNV++         
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTI---------REVAVLRHLETFEHPNVVRLFDVCTVSR 87

Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
             ++  +  V  E++ +  L  YL K+    +P   +  +   + RG++++HS  V+HRD
Sbjct: 88  TDRETKLTLV-FEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD 145

Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMIKHKSYGR 362
           LKP+N+L+     +K+ADFG+A                       W  APE++   SY  
Sbjct: 146 LKPQNILVTSSGQIKLADFGLARI-------YSFQMALTSVVVTLWYRAPEVLLQSSYAT 198

Query: 363 KVDVYSFGLILWEMVAG 379
            VD++S G I  EM   
Sbjct: 199 PVDLWSVGCIFAEMFRR 215

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  101 bits (254), Expect = 8e-24
 Identities = 48/189 (25%), Positives = 92/189 (48%), Gaps = 34/189 (17%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPE 313
            +I +Y++ G L  +L + E  T    ++    I +AL      E++H  G+I+RD+K E
Sbjct: 135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL------EHLHKLGIIYRDIKLE 188

Query: 314 NVLIDQEFHLKIADFGIACEEV---------YCDALSDDPGTYRWMAPEMIKHKSYG--R 362
           N+L+D   H+ + DFG++ E V         +C       GT  +MAP++++    G  +
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFC-------GTIEYMAPDIVRGGDSGHDK 241

Query: 363 KVDVYSFGLILWEMVAGTIPY----EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
            VD +S G++++E++ G  P+    E+ +  + +  ++        P +       LI++
Sbjct: 242 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQR 299

Query: 419 CWSLQPDKR 427
                P KR
Sbjct: 300 LLMKDPKKR 308

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  100 bits (252), Expect = 8e-24
 Identities = 60/274 (21%), Positives = 99/274 (36%), Gaps = 58/274 (21%)

Query: 202 DEPVAVKIIRIPDDDENETLAAR-LEKQFNREVALLSRLHNPNVIK----FVAACKKPPV 256
           D+ VA+K I +     +       L     RE+ ++ RL + N++K       +  +   
Sbjct: 36  DKRVAIKKIVL----TDPQSVKHAL-----REIKIIRRLDHDNIVKVFEILGPSGSQLTD 86

Query: 257 YCVITE-----YLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
                      Y+ +  +   L   LE   L           + RG++YIHS  V+HRDL
Sbjct: 87  DVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDL 146

Query: 311 KPENVLIDQEF-HLKIADFGIA----CEEVYCDALSDDPGT--YRWMAPE-MIKHKSYGR 362
           KP N+ I+ E   LKI DFG+A        +   LS+   T  YR  +P  ++   +Y +
Sbjct: 147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR--SPRLLLSPNNYTK 204

Query: 363 KVDVYSFGLILWEM---------------------VAGTIPYEEMNPIQ--AAFAVVNKN 399
            +D+++ G I  EM                         +  E+   +       + N  
Sbjct: 205 AIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDM 264

Query: 400 LRPAIP-----GDCPPAMAALIEQCWSLQPDKRP 428
             P  P               +EQ  +  P  R 
Sbjct: 265 TEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  102 bits (256), Expect = 9e-24
 Identities = 63/325 (19%), Positives = 118/325 (36%), Gaps = 78/325 (24%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------V 256
             VA+K  +I    E+     R+     RE+A+L+RL++ +V+K +             +
Sbjct: 79  RVVAIK--KILRVFEDLIDCKRIL----REIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132

Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPEN 314
           Y V  E        +   KL    + L +L    +  ++  G++Y+HS G++HRDLKP N
Sbjct: 133 YVV-LEIAD-----SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186

Query: 315 VLIDQEFHLKIADFGIA------------------CEEVYCDALSDDPGTYRWM------ 350
            L++Q+  +K+ DFG+A                   +++            R +      
Sbjct: 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT 246

Query: 351 ----APE-MIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP 405
               APE ++  ++Y   +DV+S G I  E++         +  +           P  P
Sbjct: 247 RWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR----------GPLFP 296

Query: 406 GDCPPAMAALIEQCWSLQPDKRPE---FWHIVKVLEQFETSLACNGT-----LNLVQNPI 457
           G     ++   +     +   R        I  +L          GT     +  ++   
Sbjct: 297 GSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL----------GTPSEEDIEALEKED 346

Query: 458 CQDHKKGLLHWIQK-LGPMHPHSSP 481
            + + +         L    P SS 
Sbjct: 347 AKRYIRIFPKREGTDLAERFPASSA 371

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  101 bits (253), Expect = 1e-23
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 56/281 (19%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA+  +           VAVK +  P   ++   A R      RE+ LL  + + NVI 
Sbjct: 39  SGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTY----RELRLLKHMKHENVIG 92

Query: 247 FVAACKKPP-------VYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGME 298
            +              VY V T  +      A L+  ++ + L    +  +   I RG++
Sbjct: 93  LLDVFTPARSLEEFNDVYLV-THLMG-----ADLNNIVKCQKLTDDHVQFLIYQILRGLK 146

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW-MAPE-MIK 356
           YIHS  +IHRDLKP N+ ++++  LKI DFG+A      D ++    T RW  APE M+ 
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVAT-RWYRAPEIMLN 203

Query: 357 HKSYGRKVDVYSFGLILWEM---------------------VAGTIPYEEMNPIQAAFA- 394
              Y + VD++S G I+ E+                     + GT   E +  I +  A 
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263

Query: 395 --VVNKNLRPAIP-----GDCPPAMAALIEQCWSLQPDKRP 428
             + +    P +          P    L+E+   L  DKR 
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  100 bits (252), Expect = 1e-23
 Identities = 54/203 (26%), Positives = 79/203 (38%), Gaps = 46/203 (22%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------V 256
           E VA+K I      +    A R      RE+ +L    + N+I      +         V
Sbjct: 37  EIVAIKKIEP---FDKPLFALRTL----REIKILKHFKHENIITIFNIQRPDSFENFNEV 89

Query: 257 YCVITEYLSEGSLRAYLHKL--------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
           Y +  E +        LH++        +H                R ++ +H   VIHR
Sbjct: 90  YII-QELMQ-----TDLHRVISTQMLSDDHIQY-------FIYQTLRAVKVLHGSNVIHR 136

Query: 309 DLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWM-APE-MIK 356
           DLKP N+LI+    LK+ DFG+A       A + +P             RW  APE M+ 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196

Query: 357 HKSYGRKVDVYSFGLILWEMVAG 379
              Y R +DV+S G IL E+   
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLR 219

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  100 bits (252), Expect = 2e-23
 Identities = 73/285 (25%), Positives = 119/285 (41%), Gaps = 60/285 (21%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA+  +           VA+K I      E++T   R      RE+ +L R  + N+I 
Sbjct: 37  EGAYGMVCSAYDNLNKVRVAIKKI---SPFEHQTYCQRTL----REIKILLRFRHENIIG 89

Query: 247 FVAACKKPP------VYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEY 299
                + P       VY V  + +        L+K L+ + L    +      I RG++Y
Sbjct: 90  INDIIRAPTIEQMKDVYIV-QDLME-----TDLYKLLKTQHLSNDHICYFLYQILRGLKY 143

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPGT--YRWMAPE 353
           IHS  V+HRDLKP N+L++    LKI DFG+A     +  +   L++   T  YR  APE
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR--APE 201

Query: 354 -MIKHKSYGRKVDVYSFGLILWEM---------------------VAGTIPYEEMNPIQA 391
            M+  K Y + +D++S G IL EM                     + G+   E++N I  
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261

Query: 392 AFA---VVNKNLRPAIP-----GDCPPAMAALIEQCWSLQPDKRP 428
             A   +++   +  +P      +       L+++  +  P KR 
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 98.0 bits (245), Expect = 5e-23
 Identities = 61/196 (31%), Positives = 90/196 (45%), Gaps = 40/196 (20%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
            E  A+K IR+  +DE             RE+++L  L + N++K         +Y VI 
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTI------REISILKELKHSNIVK---------LYDVIH 70

Query: 262 ---------EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312
                    E+L +  L+  L   E   L      +  L +  G+ Y H + V+HRDLKP
Sbjct: 71  TKKRLVLVFEHL-DQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKP 128

Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGRKV 364
           +N+LI++E  LKIADFG+A       A       Y       W  AP+ ++  K Y   +
Sbjct: 129 QNLLINREGELKIADFGLAR------AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 365 DVYSFGLILWEMVAGT 380
           D++S G I  EMV GT
Sbjct: 183 DIWSVGCIFAEMVNGT 198

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 56/213 (26%)

Query: 203 EPVAVKIIRIPDDDENETLAAR-LEKQFNREVALLSRLHN-PNVIKFVAACKKPP---VY 257
           E VAVK  +I D  +N T A R       RE+ +L+ L    N++  +   +      VY
Sbjct: 35  EVVAVK--KIFDAFQNSTDAQRTF-----REIMILTELSGHENIVNLLNVLRADNDRDVY 87

Query: 258 CVITEYLSEGSLRAYLHKL--------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
            V  +Y+        LH +         HK         +   + + ++Y+HS G++HRD
Sbjct: 88  LV-FDYME-----TDLHAVIRANILEPVHKQY-------VVYQLIKVIKYLHSGGLLHRD 134

Query: 310 LKPENVLIDQEFHLKIADFGIA------------CEEVYCDALSDDPGTYRWM------- 350
           +KP N+L++ E H+K+ADFG++                  +   +       +       
Sbjct: 135 MKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATR 194

Query: 351 ---APE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
              APE ++    Y + +D++S G IL E++ G
Sbjct: 195 WYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 96.4 bits (241), Expect = 2e-22
 Identities = 52/191 (27%), Positives = 86/191 (45%), Gaps = 24/191 (12%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVI 260
            E VA+K +R+ DDDE    +A       RE+ LL  L + N+++          +  V 
Sbjct: 27  HEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKNIVRLHDVLHSDKKLTLVF 80

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            E+  +  L+ Y        L    + +    + +G+ + HS+ V+HRDLKP+N+LI++ 
Sbjct: 81  -EFC-DQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137

Query: 321 FHLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGRKVDVYSFGLI 372
             LK+A+FG+A       A       Y       W   P+ +   K Y   +D++S G I
Sbjct: 138 GELKLANFGLAR------AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191

Query: 373 LWEMVAGTIPY 383
             E+     P 
Sbjct: 192 FAELANAGRPL 202

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 32/192 (16%)

Query: 202 DEPVAVKIIRIPDDDE--NETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYC 258
              VA+K IR+  +DE    T          RE++LL  LH+PN++  +     +  +  
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAI--------REISLLKELHHPNIVSLIDVIHSERCLTL 96

Query: 259 VITEYLSEGSLRAYLHKLEHKTLPL-PKLI-AIALDIARGMEYIHSQGVIHRDLKPENVL 316
           V  E++ E  L+  L   +     L    I      + RG+ + H   ++HRDLKP+N+L
Sbjct: 97  VF-EFM-EKDLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLL 151

Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGRKVDVYS 368
           I+ +  LK+ADFG+A       A      +Y       W  AP+ ++  K Y   VD++S
Sbjct: 152 INSDGALKLADFGLAR------AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWS 205

Query: 369 FGLILWEMVAGT 380
            G I  EM+ G 
Sbjct: 206 IGCIFAEMITGK 217

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 37/196 (18%)

Query: 202 DEPVAVKIIRIPDDDENE------TLAARLEKQFNREVALLSRLHNPNVIKFV-AACKKP 254
           ++ VA+K I++    E +       L         RE+ LL  L +PN+I  + A   K 
Sbjct: 35  NQIVAIKKIKLGHRSEAKDGINRTAL---------REIKLLQELSHPNIIGLLDAFGHKS 85

Query: 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPL-PKLI-AIALDIARGMEYIHSQGVIHRDLKP 312
            +  V  +++ E  L   +   +  +L L P  I A  L   +G+EY+H   ++HRDLKP
Sbjct: 86  NISLV-FDFM-ETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140

Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMIKH-KSYGRKV 364
            N+L+D+   LK+ADFG+A       +       Y      RW  APE++   + YG  V
Sbjct: 141 NNLLLDENGVLKLADFGLAK------SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 194

Query: 365 DVYSFGLILWEMVAGT 380
           D+++ G IL E++   
Sbjct: 195 DMWAVGCILAELLLRV 210

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 96.1 bits (240), Expect = 5e-22
 Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 28/195 (14%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK---------FVAACK 252
            + VA+K + + ++ E   + A       RE+ +L  L + NV+                
Sbjct: 42  GQKVALKKVLMENEKEGFPITAL------REIKILQLLKHENVVNLIEICRTKASPYNRC 95

Query: 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312
           K  +Y V  ++  E  L   L  +  K   L ++  +   +  G+ YIH   ++HRD+K 
Sbjct: 96  KGSIYLV-FDFC-EHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA 152

Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMI-KHKSYGRKV 364
            NVLI ++  LK+ADFG+A    +  A +  P  Y       W   PE++   + YG  +
Sbjct: 153 ANVLITRDGVLKLADFGLA--RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI 210

Query: 365 DVYSFGLILWEMVAG 379
           D++  G I+ EM   
Sbjct: 211 DLWGAGCIMAEMWTR 225

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 95.8 bits (239), Expect = 8e-22
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 43/200 (21%)

Query: 203 EPVAVKIIRIPDD--DENETLAARLEKQFNREVALLSRLHNPNVIK----FVAACKKPP- 255
             VA+K  ++  D    N  L         + +  L+ LH+PN+++    F    ++   
Sbjct: 49  MSVAIK--KVIQDPRFRNREL---------QIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97

Query: 256 -VY-CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL---DIARGMEYIH--SQGVIHR 308
            +Y  V+ EY+ + +L         + +  P  I I +    + R +  +H  S  V HR
Sbjct: 98  DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PILIKVFLFQLIRSIGCLHLPSVNVCHR 155

Query: 309 DLKPENVLIDQEFH-LKIADFGIACEEVYCDALSDDPGT-------YRWMAPE-MIKHKS 359
           D+KP NVL+++    LK+ DFG A +         +P         YR  APE +  ++ 
Sbjct: 156 DIKPHNVLVNEADGTLKLCDFGSAKKLS-----PSEPNVAYICSRYYR--APELIFGNQH 208

Query: 360 YGRKVDVYSFGLILWEMVAG 379
           Y   VD++S G I  EM+ G
Sbjct: 209 YTTAVDIWSVGCIFAEMMLG 228

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 43/210 (20%)

Query: 190 GAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
           G ++ +Y G  K  D  VA+K IR+ + +E     A       REV+LL  L + N++  
Sbjct: 13  GTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAI------REVSLLKDLKHANIVT- 64

Query: 248 VAACKKPPVYCVIT---------EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
                   ++ +I          EYL +  L+ YL    +  + +  +      + RG+ 
Sbjct: 65  --------LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNI-INMHNVKLFLFQLLRGLA 114

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-A 351
           Y H Q V+HRDLKP+N+LI++   LK+ADFG+A       A S    TY       W   
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYDNEVVTLWYRP 168

Query: 352 PE-MIKHKSYGRKVDVYSFGLILWEMVAGT 380
           P+ ++    Y  ++D++  G I +EM  G 
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 93.0 bits (232), Expect = 4e-21
 Identities = 45/198 (22%), Positives = 89/198 (44%), Gaps = 40/198 (20%)

Query: 202 DEPVAVKIIRIPDDDENE------TLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKP 254
              VA+K +++    ++E       +         RE++L+  L + N+++       + 
Sbjct: 30  GVYVALKEVKL----DSEEGTPSTAI---------REISLMKELKHENIVRLYDVIHTEN 76

Query: 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA----IALDIARGMEYIHSQGVIHRDL 310
            +  V  E++ +  L+ Y+        P    +         + +G+ + H   ++HRDL
Sbjct: 77  KLTLVF-EFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL 134

Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGR 362
           KP+N+LI++   LK+ DFG+A       A      T+       W  AP+ ++  ++Y  
Sbjct: 135 KPQNLLINKRGQLKLGDFGLAR------AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYST 188

Query: 363 KVDVYSFGLILWEMVAGT 380
            +D++S G IL EM+ G 
Sbjct: 189 SIDIWSCGCILAEMITGK 206

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 92.7 bits (231), Expect = 6e-21
 Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 30/193 (15%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVI 260
           +E VA+K IR+  ++E     A       REV+LL  L + N+I+  +       ++ + 
Sbjct: 59  NETVAIKRIRLEHEEEGVPGTAI------REVSLLKELQHRNIIELKSVIHHNHRLHLIF 112

Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
            EY  E  L+ Y+ K  +  + +  + +    +  G+ + HS+  +HRDLKP+N+L+   
Sbjct: 113 -EYA-ENDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVS 168

Query: 321 F-----HLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGRKVDVY 367
                  LKI DFG+A       A       +       W   PE ++  + Y   VD++
Sbjct: 169 DASETPVLKIGDFGLAR------AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIW 222

Query: 368 SFGLILWEMVAGT 380
           S   I  EM+  T
Sbjct: 223 SIACIWAEMLMKT 235

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 40/205 (19%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP-----------NVIK---- 246
           +  VA+KI+R               +    E+ LL R+++            +++K    
Sbjct: 44  NTHVAMKIVR------G---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GV 305
           F           ++ E L E +L A + K EH+ +PL  +  I+  +  G++Y+H + G+
Sbjct: 95  FNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI 153

Query: 306 IHRDLKPENVLIDQE------FHLKIADFGIAC---EEVYCDALSDDPGTYRWMAPEMIK 356
           IH D+KPENVL++          +KIAD G AC   E       +     YR  +PE++ 
Sbjct: 154 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR---EYR--SPEVLL 208

Query: 357 HKSYGRKVDVYSFGLILWEMVAGTI 381
              +G   D++S   +++E++ G  
Sbjct: 209 GAPWGCGADIWSTACLIFELITGDF 233

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 90.6 bits (225), Expect = 5e-20
 Identities = 62/304 (20%), Positives = 108/304 (35%), Gaps = 100/304 (32%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQF-NREVALLSRLHNPNVIK--------------- 246
           +  A+K  ++  D            ++ NRE+ ++  L + N+IK               
Sbjct: 33  KRFALK--KVLQD-----------PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79

Query: 247 -----------------FVAACKKPP-------VYCVITEYLSEGSLRAYLHKLEHKTLP 282
                                            +  VI EY+ + +L   L         
Sbjct: 80  PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN-VIMEYVPD-TLHKVLKSFIRSGRS 137

Query: 283 LPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDA 339
           +P  +       + R + +IHS G+ HRD+KP+N+L++ + + LK+ DFG A + +    
Sbjct: 138 IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI---- 193

Query: 340 LSDDPGT-------YRWMAPE-MIKHKSYGRKVDVYSFGLILWEM--------------- 376
              +P         YR  APE M+    Y   +D++S G +  E+               
Sbjct: 194 -PSEPSVAYICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ 250

Query: 377 ------VAGTIPYEEMNPIQAAFAVVN------KNLRPAIPGDCPPAMAALIEQCWSLQP 424
                 + GT   E+M  +   +  V       K+ R  +P   P     L+EQ    +P
Sbjct: 251 LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310

Query: 425 DKRP 428
           D R 
Sbjct: 311 DLRI 314

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 44/205 (21%), Positives = 79/205 (38%), Gaps = 46/205 (22%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
            G + ++     K   E  A+K++     D           +  REV L  R    P+++
Sbjct: 28  LGINGKVLQIFNKRTQEKFALKML----QDC---------PKARREVELHWRASQCPHIV 74

Query: 246 KFVAAC-----KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
           + V         +  +  ++ E L  G L + +     +     +   I   I   ++Y+
Sbjct: 75  RIVDVYENLYAGRKCLL-IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133

Query: 301 HSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH 357
           HS  + HRD+KPEN+L         LK+ DFG                     A E    
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTG- 172

Query: 358 KSYGRKVDVYSFGLILWEMVAGTIP 382
           + Y +  D++S G+I++ ++ G  P
Sbjct: 173 EKYDKSCDMWSLGVIMYILLCGYPP 197

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 90.2 bits (224), Expect = 1e-19
 Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 32/194 (16%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIKFVAACKKPPVY-- 257
            + VA+K++R      NE    R  +Q   E+ +L  L   + +    V    +   +  
Sbjct: 122 HQHVALKMVR------NEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172

Query: 258 --CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
             C+  E LS  +L   + K + +   LP +   A  I + ++ +H   +IH DLKPEN+
Sbjct: 173 HICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231

Query: 316 LIDQEFH--LKIADFGIACEEVYCDALSDDPGT------YRWMAPEMIKHKSYGRKVDVY 367
           L+ Q+    +K+ DFG +C E           T      YR  APE+I    YG  +D++
Sbjct: 232 LLKQQGRSGIKVIDFGSSCYE------HQRVYTYIQSRFYR--APEVILGARYGMPIDMW 283

Query: 368 SFGLILWEMVAGTI 381
           S G IL E++ G  
Sbjct: 284 SLGCILAELLTGYP 297

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.5 bits (217), Expect = 7e-19
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 43/225 (19%)

Query: 182 FLGLRFAHGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLS 237
           + G +   G +  +Y    KD    +  A+K I         +++A       RE+ALL 
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSAC------REIALLR 73

Query: 238 RLHNPNVIKF---VAACKKPPVYCVITEYLSEGSLRAYLH-----KLEHKTLPLPKLI-- 287
            L +PNVI       +     V+ +  +Y  E  L   +      K   K + LP+ +  
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLF-DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIACE-EVYCDALSD 342
           ++   I  G+ Y+H+  V+HRDLKP N+L+  E      +KIAD G A         L+D
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 343 DPGT-----YRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAG 379
                    YR  APE++   +H  Y + +D+++ G I  E++  
Sbjct: 192 LDPVVVTFWYR--APELLLGARH--YTKAIDIWAIGCIFAELLTS 232

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 34/196 (17%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIKFVAACKKPPVY-- 257
            E VA+KII+      N+        Q   EV LL  +  H+  +  ++   K+  ++  
Sbjct: 79  QEWVAIKIIK------NKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129

Query: 258 --CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ--GVIHRDLKPE 313
             C++ E LS  +L   L     + + L      A  +   + ++ +    +IH DLKPE
Sbjct: 130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188

Query: 314 NVLIDQEFH--LKIADFGIACEEVYCDALSDDPGT------YRWMAPEMIKHKSYGRKVD 365
           N+L+       +KI DFG +C+                   YR  +PE++    Y   +D
Sbjct: 189 NILLCNPKRSAIKIVDFGSSCQL------GQRIYQYIQSRFYR--SPEVLLGMPYDLAID 240

Query: 366 VYSFGLILWEMVAGTI 381
           ++S G IL EM  G  
Sbjct: 241 MWSLGCILVEMHTGEP 256

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 54/250 (21%), Positives = 100/250 (40%), Gaps = 34/250 (13%)

Query: 218 NETLAARLEK------QFNREVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLR 270
            E +A +LE       Q + E  +   +     +        +     ++ E L   SL 
Sbjct: 34  GEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SL- 91

Query: 271 AYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIAD 327
             L     +   L  ++ +A  +   +EYIHS+  IHRD+KP+N L+    +   + I D
Sbjct: 92  EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIID 151

Query: 328 FGIACEEVYCDALSDDP----------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
           FG+A +  Y DA +             GT R+ +          R+ D+ S G +L    
Sbjct: 152 FGLAKK--YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 209

Query: 378 AGTIPYEEM---NPIQAAFAVVNKNLRPAIP-----GDCPPAMAALIEQCWSLQPDKRPE 429
            G++P++ +      Q    +  K +  + P        P   A  +  C SL+ D +P+
Sbjct: 210 LGSLPWQGLKAATKRQKYERISEKKM--STPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 267

Query: 430 FWHIVKVLEQ 439
           + ++ ++   
Sbjct: 268 YSYLRQLFRN 277

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 51/219 (23%), Positives = 83/219 (37%), Gaps = 65/219 (29%)

Query: 200 YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNP----NVIK----FVA 249
                VAVKI++   + +    AAR       E+ +L  L   +P      ++    F  
Sbjct: 38  AGGRHVAVKIVK---NVDRYCEAARS------EIQVLEHLNTTDPNSTFRCVQMLEWF-- 86

Query: 250 ACKKPPVY----CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
                  +    C++ E L   S   ++ +       L  +  +A  I + + ++HS  +
Sbjct: 87  ------EHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKL 139

Query: 306 IHRDLKPENVLIDQEFH-------------------LKIADFGIACEEVYCDALSDDPGT 346
            H DLKPEN+L  Q  +                   +K+ DFG A  +       +   T
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD------DEHHST 193

Query: 347 ------YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
                 YR  APE+I    + +  DV+S G IL E   G
Sbjct: 194 LVSTRHYR--APEVILALGWSQPCDVWSIGCILIEYYLG 230

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 46/218 (21%), Positives = 80/218 (36%), Gaps = 65/218 (29%)

Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNP----NVIK----FVAACK 252
             VA+KIIR      N     +  +    E+ +L ++   +       +     F     
Sbjct: 46  SQVALKIIR------NVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWF----- 91

Query: 253 KPPVY----CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
               +    C+  E L + +   +L +   +  PLP +  +A  +   + ++H   + H 
Sbjct: 92  ---NFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHT 147

Query: 309 DLKPENVLIDQEFH-------------------LKIADFGIACEEVYCDALSDDPGT--- 346
           DLKPEN+L                         +++ADFG A  +       +   T   
Sbjct: 148 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD------HEHHTTIVA 201

Query: 347 ---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381
              YR   PE+I    + +  DV+S G IL+E   G  
Sbjct: 202 TRHYR--PPEVILELGWAQPCDVWSIGCILFEYYRGFT 237

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 51/222 (22%), Positives = 92/222 (41%), Gaps = 70/222 (31%)

Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-----HNPNVIK----FVAACK 252
            +  AVK++R   + +  T +A++E        +L ++     +N N++K    F+    
Sbjct: 60  KKYYAVKVVR---NIKKYTRSAKIE------ADILKKIQNDDINNNNIVKYHGKFM---- 106

Query: 253 KPPVY----CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
               Y    C+I E L   SL   + +  +    +  +    ++I + + Y+    + H 
Sbjct: 107 ----YYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHT 161

Query: 309 DLKPENVLIDQEFH-------------------------LKIADFGIACEEVYCDALSDD 343
           DLKPEN+L+D  +                          +K+ DFG A  +      SD 
Sbjct: 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK------SDY 215

Query: 344 PGT------YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
            G+      YR  APE+I +  +    D++SFG +L E+  G
Sbjct: 216 HGSIINTRQYR--APEVILNLGWDVSSDMWSFGCVLAELYTG 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 63/280 (22%), Positives = 115/280 (41%), Gaps = 37/280 (13%)

Query: 183 LGLRFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
           +G +   G    L  G  +Y +E VA+K+         E + +R   Q + E     +L 
Sbjct: 13  VGKKIGCGNFGELRLGKNLYTNEYVAIKL---------EPMKSR-APQLHLEYRFYKQLG 62

Query: 241 N-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
           +   + +            ++ E L   SL   L  L  +T  L  ++ IA+ +   MEY
Sbjct: 63  SGDGIPQVYYFGPCGKYNAMVLELLGP-SL-EDLFDLCDRTFSLKTVLMIAIQLISRMEY 120

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLK-----IADFGIACEEVYCDALSDDP---------- 344
           +HS+ +I+RD+KPEN LI +  +       I DF +A E  Y D  +             
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE--YIDPETKKHIPYREHKSLT 178

Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM---NPIQAAFAVVNKNLR 401
           GT R+M+      K   R+ D+ + G +    + G++P++ +      +    + +    
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238

Query: 402 PAIPGDC--PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
             I   C   P MA  +     L   ++P++ ++ K+   
Sbjct: 239 TPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTD 278

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 46/281 (16%), Positives = 99/281 (35%), Gaps = 38/281 (13%)

Query: 183 LGLRFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
           +G R   G+   ++ G  +  ++ VA+K          E   +    Q   E      L 
Sbjct: 14  VGRRIGEGSFGVIFEGTNLLNNQQVAIK---------FEPRRSD-APQLRDEYRTYKLLA 63

Query: 241 N-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
               +       ++     ++ + L   SL   L  L  +   +  +   A  +   ++ 
Sbjct: 64  GCTGIPNVYYFGQEGLHNVLVIDLLGP-SL-EDLLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 300 IHSQGVIHRDLKPENVLIDQEFHLK-----IADFGIACEEVYCDALSDDP---------- 344
           IH + +++RD+KP+N LI +          + DFG+     Y D ++             
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF--YRDPVTKQHIPYREKKNLS 179

Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP---YEEMNPIQAAFAVVNKNLR 401
           GT R+M+      +   R+ D+ + G +    + G++P    +     Q    +  K   
Sbjct: 180 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239

Query: 402 PAIP---GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
             +       P      +    +L  D  P++ ++  +  +
Sbjct: 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 36/172 (20%), Positives = 65/172 (37%), Gaps = 53/172 (30%)

Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL 316
           C++ E L    L  ++ K  ++ LPLP +  I   + +G++Y+H++  +IH D+KPEN+L
Sbjct: 121 CMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179

Query: 317 I-------------------------------------------------DQEFHLKIAD 327
           +                                                  ++  +KIAD
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239

Query: 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
            G AC              YR  + E++    Y    D++S   + +E+  G
Sbjct: 240 LGNACWVHKHFTEDIQTRQYR--SLEVLIGSGYNTPADIWSTACMAFELATG 289

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 42/251 (16%), Positives = 90/251 (35%), Gaps = 40/251 (15%)

Query: 227 KQFNREVALLSRLHNPNVIKFVAACKK------PPVYCVITEYLSEGSLRA--------- 271
                E+    R   P  I+     +K      P  +       +  S R          
Sbjct: 78  GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD 137

Query: 272 --YLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID--QEFHLKIAD 327
              +++   K      ++ ++L I   +EYIH    +H D+K  N+L++      + + D
Sbjct: 138 LQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVD 197

Query: 328 FGIACEEVYCDALSDDP----------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
           +G+A    YC                 GT  + + +     +  R+ D+   G  + + +
Sbjct: 198 YGLAYR--YCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255

Query: 378 AGTIPYEEM--NPIQAAFAVVN--KNLRP-----AIPGDCPPAMAALIEQCWSLQPDKRP 428
            G +P+E+   +P     + +   +N+           + P  +A  +E    L   ++P
Sbjct: 256 TGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKP 315

Query: 429 EFWHIVKVLEQ 439
            + ++  +L Q
Sbjct: 316 LYENLRDILLQ 326

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 49/270 (18%), Positives = 97/270 (35%), Gaps = 46/270 (17%)

Query: 214 DDDENETLAARLEK-------QFNREVALLSRLHNPNVIKFVAACKK------PPVYCVI 260
             ++ E  A  + K           E+    R+   + IK     K+      P  Y   
Sbjct: 58  PTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117

Query: 261 TEYLSEGSLRAY--------LHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
                  S R          L K+  ++ T     ++ + + +   +EYIH    +H D+
Sbjct: 118 LTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDI 177

Query: 311 KPENVLIDQEFHLKI--ADFGIACEEVYCDALSDDP----------GTYRWMAPEMIKHK 358
           K  N+L+  +   ++  AD+G++    YC   +             GT  + + +  K  
Sbjct: 178 KAANLLLGYKNPDQVYLADYGLSYR--YCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV 235

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV--------VNKNLRPAIP-GDCP 409
           +  R+ DV   G  +   + G +P+E+      A           + +++    P G   
Sbjct: 236 ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSC 295

Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
             +A  +    SL  D++P +  + K+L  
Sbjct: 296 CEIAQFLVCAHSLAYDEKPNYQALKKILNP 325

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 41/293 (13%), Positives = 100/293 (34%), Gaps = 49/293 (16%)

Query: 180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQF------NREV 233
            L+          +       + +  ++K+       + +      E+ F        +V
Sbjct: 57  ILYEAAP----TSTLTCDSGPQKQKFSLKL-------DAKDGRLFNEQNFFQRAAKPLQV 105

Query: 234 ALLSRLHN------PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI 287
               +L++      P  + F     K     ++   L   SL++ L       L    ++
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDK--YRFLVLPSLGR-SLQSALDVSPKHVLSERSVL 162

Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLI--DQEFHLKIADFGIACEEVYCD-----AL 340
            +A  +   +E++H    +H ++  EN+ +  + +  + +A +G A    YC      A 
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR--YCPSGKHVAY 220

Query: 341 SDDP-----GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM--NPIQAAF 393
            +       G   +++ ++ K     R+ D+ S G  + + + G +P+     N      
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMK 280

Query: 394 A-VVNKNLRPAIPGDC------PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
                 +      G C         +   ++   +L  +++P +  +   LE 
Sbjct: 281 QKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.7 bits (159), Expect = 7e-12
 Identities = 29/180 (16%), Positives = 51/180 (28%), Gaps = 43/180 (23%)

Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-------- 241
           G    ++  I    PVA+KII I   D       +  ++   E+ +   L          
Sbjct: 31  GVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR 90

Query: 242 -PNVIKFVAAC----KKPPVYC--------------------------VITEYLSEGSLR 270
               I   +        PP+                            ++ E+   G   
Sbjct: 91  TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID- 149

Query: 271 AYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFG 329
             L ++  K   L    +I   +   +    +     HRDL   NVL+ +    K+    
Sbjct: 150 --LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTL 207

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 56/255 (21%), Positives = 101/255 (39%), Gaps = 36/255 (14%)

Query: 214 DDDENETLAARLEK------QFNREVALLSRLHN----PNVIKFVAACKKPPVYCVITEY 263
           +   NE +A +LE       Q   E  +   L      PNV  F           ++ + 
Sbjct: 28  NIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDY---NVLVMDL 84

Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH- 322
           L   SL   L     + L L  ++ +A  +   +E++HS+  +HRD+KP+N L+      
Sbjct: 85  LGP-SL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142

Query: 323 --LKIADFGIACEEVYCDALSDDP----------GTYRWMAPEMIKHKSYGRKVDVYSFG 370
             + I DFG+A +  Y D  +             GT R+ +          R+ D+ S G
Sbjct: 143 NQVYIIDFGLAKK--YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLG 200

Query: 371 LILWEMVAGTIP---YEEMNPIQAAFAVVNKNLRPAIP---GDCPPAMAALIEQCWSLQP 424
            +L   + G++P    +     Q    +  K +  +I       P   A+    C SL+ 
Sbjct: 201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRF 260

Query: 425 DKRPEFWHIVKVLEQ 439
           D +P++ ++ ++   
Sbjct: 261 DDKPDYSYLKRLFRD 275

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 4e-05
 Identities = 58/401 (14%), Positives = 105/401 (26%), Gaps = 121/401 (30%)

Query: 112 KFLYKQPQQETKASS---NSYSTSPLRHLGSLRVTERYK-SRKESAWT-----------K 156
           KFL    + E +  S     Y     R     +V  +Y  SR +               K
Sbjct: 92  KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAK 151

Query: 157 Y-FDHG----GVRVNAVDAADEHTVDLSQLF----LGLRFAHGAHS------RLYHGI-- 199
                G    G    A+D    + V     F    L L+  +   +      +L + I  
Sbjct: 152 NVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP 211

Query: 200 -YKDEPVAVKIIRIPDDDENETLAARL--EKQFNREVALLSRLHNPNVIK-FVAACKKPP 255
            +         I++        L  RL   K +   + +L  + N      F  +CK   
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELR-RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK--- 267

Query: 256 VYCVITEYLS----EGSLRAYLHKLEHKTLPLPK-----LIAIALDIARGMEYIHSQGVI 306
              + T +        +       L+H ++ L       L+   LD              
Sbjct: 268 -ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ---------- 316

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-RWMAPEMIKHKSYGRKVD 365
             DL  E +  +     +++           +++ D   T+  W            + V+
Sbjct: 317 --DLPREVLTTNP---RRLSIIA--------ESIRDGLATWDNW------------KHVN 351

Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPD 425
                 I+ E     +   E   +    +V   +    IP         L+   W     
Sbjct: 352 CDKLTTII-ESSLNVLEPAEYRKMFDRLSVFPPSAH--IP-------TILLSLIWFDVIK 401

Query: 426 KRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKKGLL 466
                     V+ +                     HK  L+
Sbjct: 402 SDVM-----VVVNKL--------------------HKYSLV 417

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.8 bits (97), Expect = 5e-04
 Identities = 51/342 (14%), Positives = 97/342 (28%), Gaps = 107/342 (31%)

Query: 13  KFSHTVCHRLDSSILASLPLNLPETISVL--KSRPGPASSNQ---------KSAPNSSQS 61
           K+       L   +L + P      +S++    R G A+ +           +   SS +
Sbjct: 309 KYLDCRPQDLPREVLTTNPR----RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364

Query: 62  QQNPAANK---------PRSVSPLPETVLP-----DTFKEARSATKRFSTPHPRRKESDK 107
              PA  +         P S   +P  +L          +      +             
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSA-HIPTILLSLIWFDVIKSDVMVVVNKLH---------KY 414

Query: 108 GLVGKFLYKQPQQETKASSNSYS--------TSPLRHLGSL--RVTERYKSRKESAWTK- 156
            L    + KQP++ T       S           L +  +L   + + Y   K       
Sbjct: 415 SL----VEKQPKEST------ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464

Query: 157 -------YF-DHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVK 208
                  YF  H G  +  ++  +  T+    +FL  RF                 +  K
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTL-FRMVFLDFRF-----------------LEQK 506

Query: 209 IIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGS 268
           I     D      +  +       +  L +L       ++  C   P Y      ++  +
Sbjct: 507 IRH---DSTAWNASGSI-------LNTLQQLKFYK--PYI--CDNDPKY---ERLVN--A 547

Query: 269 LRAYLHKLEHKTL--PLPKLIAIALDIARGMEYIHSQGVIHR 308
           +  +L K+E   +      L+ IAL       +  +   + R
Sbjct: 548 ILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 27/145 (18%), Positives = 52/145 (35%), Gaps = 14/145 (9%)

Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR-EVALLSRLHNPNVIK 246
             GA + +    Y D  V +K  R+     +E L   + K     E   L+ + +  +  
Sbjct: 345 GKGAEADIKRDSYLDFDVIIKE-RVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA 403

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                       ++  Y++    +  +             + IA  I   +  +H   VI
Sbjct: 404 PYIFDVDLDNKRIMMSYINGKLAKDVIEDN----------LDIAYKIGEIVGKLHKNDVI 453

Query: 307 HRDLKPENVLIDQEFHLKIADFGIA 331
           H DL   N + D++ ++   DFG+ 
Sbjct: 454 HNDLTTSNFIFDKDLYI--IDFGLG 476

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 25/151 (16%), Positives = 48/151 (31%), Gaps = 25/151 (16%)

Query: 190 GAHSRLYHGIYKDE-PVAVKIIRIP------DDDENETLAARLEKQF----NREVALLSR 238
           G  S +++   +      VK  ++         ++ +                E   L +
Sbjct: 101 GKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160

Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
           L    V K  A         V+ E +    L           + +     +   I   + 
Sbjct: 161 LQGLAVPKVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVA 207

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329
             + +G++H DL   NVL+ +E  + I DF 
Sbjct: 208 KFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 237

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 42.0 bits (98), Expect = 2e-04
 Identities = 31/170 (18%), Positives = 61/170 (35%), Gaps = 29/170 (17%)

Query: 183 LGLRFAHGAHSRLYHGI----YKDEPVAVKIIRIP-------------DDDENETLAARL 225
           +G   + G  + +++       K   +AVKI RI              D+  +    +  
Sbjct: 51  MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPK 110

Query: 226 EKQF---NREVALLSRLHNP--NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT 280
           EK F    +E   L R      +V +     K      ++ E++ E  L A       + 
Sbjct: 111 EKVFIWTEKEFRNLERAKEAGVSVPQPYTYMK----NVLLMEFIGEDELPAPTLVELGRE 166

Query: 281 LPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFG 329
           L    +  I  D+   ++ ++ +  ++H DL   N++      +   D G
Sbjct: 167 LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMG 214

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	488
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.86
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.55
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.37
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.19
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.19
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.08
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.89
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.89
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.73
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.63
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.57
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.5
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.41
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.28
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.12
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.04
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.03
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.77
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.65
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.57
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.15
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.06
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.24
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.68
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.08

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-58  Score=460.92  Aligned_cols=266  Identities=29%  Similarity=0.585  Sum_probs=226.1

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      .+.|+|+.++|.++++||+|+||+||+|++.+ .||||+++.......      ..+.|.+|+.+|++++|||||+++|+
T Consensus        28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~------~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPE------QFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHH------HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHH------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            36799999999999999999999999999876 599999986544322      24679999999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      |.+ +.++||||||+||+|.++|+. ....+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus       101 ~~~-~~~~iVmEy~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          101 MTK-DNLAIVTQWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             ECS-SSCEEEEECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             EEC-CeEEEEEEcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccC
Confidence            865 467899999999999999976 345799999999999999999999999999999999999999999999999999


Q ss_pred             cccccc---cCcCCCCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---
Q 011359          331 ACEEVY---CDALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR---  401 (488)
Q Consensus       331 a~~~~~---~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~---  401 (488)
                      |+....   ........||+.|||||++.+   ..|+.++|||||||++|||+||..||.+.+........+..+..   
T Consensus       179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~  258 (307)
T 3omv_A          179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD  258 (307)
T ss_dssp             CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC
T ss_pred             ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence            964322   223345679999999999964   35899999999999999999999999988776666655554432   


Q ss_pred             -CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          402 -PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       402 -~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                       +..+..+++++.+||.+||+.||++||++.+|++.|+.++..+.
T Consensus       259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence             23567899999999999999999999999999999999887654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.6e-58  Score=455.05  Aligned_cols=261  Identities=26%  Similarity=0.515  Sum_probs=227.7

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      +.|+.++|.++++||+|+||+||+|.+.       +..||||+++...  .      ...++|.+|+++|++|+|||||+
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~------~~~~~f~~E~~il~~l~HpnIV~   79 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--D------NARKDFHREAELLTNLQHEHIVK   79 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--H------HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--h------HHHHHHHHHHHHHHhCCCCCCcc
Confidence            3577889999999999999999999874       4679999997432  1      12567999999999999999999


Q ss_pred             EeeeeecCCeeeEEEeecCCCCHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeE
Q 011359          247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLE-----------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV  315 (488)
Q Consensus       247 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NI  315 (488)
                      ++|+|.++..++||||||++|+|.++|+...           ...+++..++.|+.||+.||+|||+++|+||||||+||
T Consensus        80 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NI  159 (299)
T 4asz_A           80 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC  159 (299)
T ss_dssp             EEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhE
Confidence            9999999999999999999999999998632           34699999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 011359          316 LIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA  391 (488)
Q Consensus       316 Ll~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~  391 (488)
                      |++.++.+||+|||+|+......   ......||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..+.
T Consensus       160 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~  239 (299)
T 4asz_A          160 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV  239 (299)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             EECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999996433222   1223458999999999999999999999999999999998 9999999998877


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          392 AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ...+.. +.++..|..+|+++.+||.+||+.||++||++.+|++.|+++...
T Consensus       240 ~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          240 IECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            766655 446678899999999999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3e-57  Score=453.32  Aligned_cols=260  Identities=29%  Similarity=0.535  Sum_probs=227.4

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI  245 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  245 (488)
                      -.+|+.+++.+.++||+|+||+||+|.+.       ++.||||+++......       ..++|.+|+.+|++++|||||
T Consensus        20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~-------~~~~f~~E~~il~~l~HpNIV   92 (308)
T 4gt4_A           20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP-------LREEFRHEAMLRARLQHPNVV   92 (308)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--------CHHHHHHHHHHHHHCCCTTBC
T ss_pred             cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH-------HHHHHHHHHHHHHhCCCCCCC
Confidence            34577888999999999999999999973       4689999997543322       146799999999999999999


Q ss_pred             eEeeeeecCCeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Q 011359          246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK  311 (488)
Q Consensus       246 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIk  311 (488)
                      +++|+|..+..++||||||++|+|.++|....              ...+++..++.|+.||+.||+|||+++|||||||
T Consensus        93 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK  172 (308)
T 4gt4_A           93 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA  172 (308)
T ss_dssp             CEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            99999999999999999999999999997532              2458999999999999999999999999999999


Q ss_pred             CCeEEEcCCCcEEEeeeccccccccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 011359          312 PENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMN  387 (488)
Q Consensus       312 p~NILl~~~~~vkl~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~  387 (488)
                      |+||||+.++.+||+|||+|+.....   .......||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+
T Consensus       173 ~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             GGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             ccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999654322   22345679999999999999999999999999999999998 899999999


Q ss_pred             HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          388 PIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      ..+....+. .+.++..|..||..+.+||.+||+.||++||++.+|++.|+.+
T Consensus       253 ~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          253 NQDVVEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            877666554 4456678899999999999999999999999999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.3e-57  Score=455.02  Aligned_cols=262  Identities=27%  Similarity=0.541  Sum_probs=224.7

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI  245 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  245 (488)
                      .+.++.++|.+.++||+|+||+||+|.+.       ++.||||+++...  .      ...++|.+|+++|++|+|||||
T Consensus        35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~------~~~~~f~~E~~il~~l~HpnIV  106 (329)
T 4aoj_A           35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--E------SARQDFQREAELLTMLQHQHIV  106 (329)
T ss_dssp             SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--H------HHHHHHHHHHHHHTTCCCTTBC
T ss_pred             hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--H------HHHHHHHHHHHHHHhCCCCCCC
Confidence            35677788999999999999999999874       4689999997432  1      1246799999999999999999


Q ss_pred             eEeeeeecCCeeeEEEeecCCCCHHHHHHHhC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCC
Q 011359          246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLE-------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP  312 (488)
Q Consensus       246 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp  312 (488)
                      +++|+|.++..+|||||||++|+|.++++...             ...+++.+++.|+.||+.||+|||+++||||||||
T Consensus       107 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp  186 (329)
T 4aoj_A          107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLAT  186 (329)
T ss_dssp             CEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             cEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccH
Confidence            99999999999999999999999999998642             24689999999999999999999999999999999


Q ss_pred             CeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 011359          313 ENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP  388 (488)
Q Consensus       313 ~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~  388 (488)
                      +||||+.++.+||+|||+|+......   ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+.
T Consensus       187 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~  266 (329)
T 4aoj_A          187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN  266 (329)
T ss_dssp             GGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred             hhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999999996543221   2234579999999999999999999999999999999999 9999999998


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      .+....+.. +.++..|..+++++.+||.+||+.||++||++.+|++.|+.+.+.
T Consensus       267 ~~~~~~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          267 TEAIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            777665544 457778899999999999999999999999999999999988663

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.8e-57  Score=458.42  Aligned_cols=252  Identities=18%  Similarity=0.355  Sum_probs=219.5

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      .+++|.++++||+|+||+||+|++.  |+.||||++........      ..+.|.+|+.+|++|+|||||++++++.++
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~------~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   95 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK------EREESRREVAVLANMKHPNIVQYRESFEEN   95 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH------HHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            3578999999999999999999986  78999999986554322      246789999999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+|||||||+||+|.++|.......+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..
T Consensus        96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence            99999999999999999998766667899999999999999999999999999999999999999999999999999654


Q ss_pred             cccC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          335 VYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       335 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                      .... .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+..... +..+..+++++.
T Consensus       176 ~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~  254 (350)
T 4b9d_A          176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPVSLHYSYDLR  254 (350)
T ss_dssp             CHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCTTSCHHHH
T ss_pred             cCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccCCHHHH
Confidence            3221 22345699999999999999999999999999999999999999999998888888777654 456778999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHH
Q 011359          414 ALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +||.+||+.||++||++.++++
T Consensus       255 ~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          255 SLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.5e-56  Score=454.57  Aligned_cols=265  Identities=29%  Similarity=0.512  Sum_probs=232.0

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PN  243 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pn  243 (488)
                      ++|+|+.++|.+++.||+|+||+||+|.+.+       +.||||++.......       ..+.|.+|+.+|.+++| ||
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~-------~~~~~~~E~~il~~l~hhpn  129 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------EHRALMSELKILIHIGHHLN  129 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHHHCCCTT
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH-------HHHHHHHHHHHHHHcCCCCc
Confidence            5689999999999999999999999999753       479999997543221       14679999999999975 89


Q ss_pred             eeeEeeeeecC-CeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 011359          244 VIKFVAACKKP-PVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHR  308 (488)
Q Consensus       244 Iv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHr  308 (488)
                      ||+++|+|..+ ..++||||||++|+|.++|+...              ...+++..++.++.||+.||+|||+++||||
T Consensus       130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHR  209 (353)
T 4ase_A          130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR  209 (353)
T ss_dssp             BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecC
Confidence            99999999764 57899999999999999998642              2458999999999999999999999999999


Q ss_pred             CCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 011359          309 DLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE  384 (488)
Q Consensus       309 DIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~  384 (488)
                      ||||+|||++.++.+||+|||+|+......   ......||+.|||||++.+..|+.++|||||||++|||+| |..||.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            999999999999999999999996543221   2234568999999999999999999999999999999998 999999


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          385 EMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      +....+.....+..+.++..|..+++++.+||.+||+.||++||++.+|++.|+.+.+.
T Consensus       290 ~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          290 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            88766667777778888899999999999999999999999999999999999988654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-55  Score=447.12  Aligned_cols=246  Identities=24%  Similarity=0.426  Sum_probs=217.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +.|.+.++||+|+||+||+|++.  |+.||||++.......        .+.+.+|+.+|++++|||||+++++|.++..
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  145 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLVGDE  145 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--------GGGGHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            45888999999999999999986  7899999998654433        2457799999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|||||||+||+|.+++.+   ..+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|.....
T Consensus       146 ~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            9999999999999999976   5699999999999999999999999999999999999999999999999999975433


Q ss_pred             -cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHH
Q 011359          337 -CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RPAIPGDCPPAMAA  414 (488)
Q Consensus       337 -~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  414 (488)
                       .......+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+..... ....+..+++++.+
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d  302 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG  302 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence             2334567899999999999999999999999999999999999999999888877766654321 22334578999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+||+.||++||++.|+++
T Consensus       303 li~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          303 FLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHhc
Confidence            999999999999999998875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.8e-56  Score=446.75  Aligned_cols=255  Identities=22%  Similarity=0.317  Sum_probs=221.1

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      .+.+.|.++++||+|+||+||+|++.  |+.||||+++....             +.+|+.+|++|+|||||++++++.+
T Consensus        55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~E~~il~~l~HpnIV~l~~~~~~  121 (336)
T 4g3f_A           55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------------RVEELVACAGLSSPRIVPLYGAVRE  121 (336)
T ss_dssp             BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred             cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            34567889999999999999999986  78999999986432             2379999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC-cEEEeeecccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIAC  332 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~-~vkl~DFgla~  332 (488)
                      +..+|||||||+||+|.++|.+.  +.+++..+..|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+
T Consensus       122 ~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~  199 (336)
T 4g3f_A          122 GPWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL  199 (336)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred             CCEEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence            99999999999999999999863  5799999999999999999999999999999999999999987 69999999996


Q ss_pred             cccccC------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCCC
Q 011359          333 EEVYCD------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-PAIP  405 (488)
Q Consensus       333 ~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~  405 (488)
                      ......      .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+...... ..++
T Consensus       200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  279 (336)
T 4g3f_A          200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP  279 (336)
T ss_dssp             EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSC
T ss_pred             EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcC
Confidence            543211      122357999999999999999999999999999999999999999987766666666665433 2467


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ..+++.+.+||.+||+.||++||++.|+++.|......+.
T Consensus       280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            8899999999999999999999999999998887766543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.6e-55  Score=439.54  Aligned_cols=247  Identities=24%  Similarity=0.380  Sum_probs=218.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||+||+|++.  |+.||||++.....     ......+.+.+|+++|++|+|||||++++++.++..
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            46889999999999999999986  78999999974210     111124678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|||||||+||+|.+++.+  .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus       107 ~yivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999999999987  35799999999999999999999999999999999999999999999999999965432


Q ss_pred             ---cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          337 ---CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       337 ---~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                         .......+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+....+....+  .+|..++++++
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--~~p~~~s~~~~  262 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY--DFPEKFFPKAR  262 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTCCHHHH
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCcccCHHHH
Confidence               2234466899999999999999999999999999999999999999999988888777777653  56788999999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHH
Q 011359          414 ALIEQCWSLQPDKRPEFWHIV  434 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~eil  434 (488)
                      +||.+||+.||++||++.|++
T Consensus       263 dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHHHHHccCCHhHCcChHHHc
Confidence            999999999999999998764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.3e-55  Score=429.54  Aligned_cols=248  Identities=26%  Similarity=0.431  Sum_probs=203.8

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||+||+|++.  |+.||||++......+.     ...+.+.+|+.+|++++|||||++++++.++.
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS-----DMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCH-----HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            367999999999999999999975  78999999975432221     12467889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+||||||| +|+|.+++.+  .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             EEEEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            999999999 7899999986  4679999999999999999999999999999999999999999999999999997655


Q ss_pred             ccCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          336 YCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      .........||+.|||||++.+..| +.++|||||||++|+|++|..||.+.+..+....+....  ..+|..+++++.+
T Consensus       164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~  241 (275)
T 3hyh_A          164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--YTLPKFLSPGAAG  241 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTSCHHHHH
T ss_pred             CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence            5555566789999999999998876 589999999999999999999999988776666665543  4567889999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+||+.||++||++.|+++
T Consensus       242 li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          242 LIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHHc
Confidence            999999999999999999886

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-54  Score=449.98  Aligned_cols=246  Identities=24%  Similarity=0.422  Sum_probs=218.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +.|.+.++||+|+||.||+|++.  |+.||||++.......        .+.+.+|+.+|++|+|||||+++++|..+..
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  222 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLVGDE  222 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--------GGGHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--------HHHHHHHHHHHHhCCCCCCCceEEEEEECCE
Confidence            56899999999999999999986  7899999998765443        2457799999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|||||||+||+|.+++..   ..+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|.....
T Consensus       223 ~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            9999999999999999976   5699999999999999999999999999999999999999999999999999965433


Q ss_pred             c-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHH
Q 011359          337 C-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RPAIPGDCPPAMAA  414 (488)
Q Consensus       337 ~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  414 (488)
                      . ......+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+..... ....+..+++++++
T Consensus       300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d  379 (423)
T 4fie_A          300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG  379 (423)
T ss_dssp             SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred             CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence            2 334567899999999999999999999999999999999999999999988877766655422 23345678999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+||..||++||++.|+++
T Consensus       380 li~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          380 FLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHhc
Confidence            999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.9e-55  Score=437.26  Aligned_cols=247  Identities=24%  Similarity=0.402  Sum_probs=211.8

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      ..+|.++|.+++.||+|+||+||+|+..     ++.||||++.........      ...+.+|+.+|++++|||||+++
T Consensus        19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~   92 (304)
T 3ubd_A           19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD------RVRTKMERDILVEVNHPFIVKLH   92 (304)
T ss_dssp             CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE------CC------CCCCCCCCTTEECEE
T ss_pred             ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH------HHHHHHHHHHHHHCCCCCCCeEE
Confidence            3467789999999999999999999872     568999999753322111      23467899999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      +++.++..+|||||||+||+|.+++.+  .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus        93 ~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DF  170 (304)
T 3ubd_A           93 YAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDF  170 (304)
T ss_dssp             EEEEETTEEEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESS
T ss_pred             EEEEECCEEEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccc
Confidence            999999999999999999999999987  357999999999999999999999999999999999999999999999999


Q ss_pred             cccccccc-cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          329 GIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       329 gla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      |+|+.... ........||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+....  ..+|..
T Consensus       171 Gla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~  248 (304)
T 3ubd_A          171 GLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQF  248 (304)
T ss_dssp             EEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTT
T ss_pred             ccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCc
Confidence            99965432 233456789999999999999999999999999999999999999999999888887777654  456788


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEF  430 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~  430 (488)
                      +++++.+||.+||+.||++||++
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          249 LSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             CCHHHHHHHHHHcccCHHHCCCC
Confidence            99999999999999999999985

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-54  Score=429.26  Aligned_cols=245  Identities=26%  Similarity=0.487  Sum_probs=209.3

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec----C
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK----P  254 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~  254 (488)
                      |.+.++||+|+||+||+|.+.  +..||||++........      ..+.|.+|+.+|++|+|||||+++++|..    +
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~------~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS------ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH------HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH------HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence            467788999999999999986  67899999975443322      24679999999999999999999999864    3


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCeEEEcC-CCcEEEeeeccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQ-EFHLKIADFGIA  331 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--iiHrDIkp~NILl~~-~~~vkl~DFgla  331 (488)
                      ..+|||||||+||+|.+++.+  ...+++..+..|+.||+.||+|||++|  |+||||||+||||+. ++.+||+|||+|
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            568999999999999999987  357999999999999999999999998  999999999999974 799999999999


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCcH
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-PAIPGDCPP  410 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~  410 (488)
                      ..... .......||+.|||||++.+ .|+.++|||||||++|||++|..||.+..........+..... +.++..+++
T Consensus       180 ~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  257 (290)
T 3fpq_A          180 TLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             GGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             EeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence            64332 23345679999999999874 6999999999999999999999999877665555555554443 345677889


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.+||.+||+.||++||++.++++
T Consensus       258 ~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          258 EVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.9e-53  Score=424.02  Aligned_cols=253  Identities=28%  Similarity=0.475  Sum_probs=204.8

Q ss_pred             cceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC---
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP---  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---  255 (488)
                      .+|.++++||+|+||+||+|+++|+.||||++....   ..      ...+..|+..+.+++|||||+++++|..+.   
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~------~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~   73 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ER------SWFREAEIYQTVMLRHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HH------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hh------hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCc
Confidence            458899999999999999999999999999996421   10      122345666677899999999999997653   


Q ss_pred             -eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCeEEEcCCCcEEEe
Q 011359          256 -VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       256 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------giiHrDIkp~NILl~~~~~vkl~  326 (488)
                       .+|||||||++|+|.++++.   ..++++.++.++.|++.||+|||++        +|+||||||+||||+.++.+||+
T Consensus        74 ~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~  150 (303)
T 3hmm_A           74 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence             57999999999999999986   5699999999999999999999987        99999999999999999999999


Q ss_pred             eecccccccccC-----cCCCCCCCcccCChhhhhcC------CCCchhHHHHHHHHHHHHHhCCCCCC----------C
Q 011359          327 DFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKHK------SYGRKVDVYSFGLILWEMVAGTIPYE----------E  385 (488)
Q Consensus       327 DFgla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~------~~~~k~DvwSlGvll~elltG~~Pf~----------~  385 (488)
                      |||+|+......     ......||+.|||||++.+.      .|+.++|||||||++|||+||..||.          +
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            999996543221     12235799999999999754      36789999999999999999976543          2


Q ss_pred             C-----CHHHHHHHHHhccCCCCCCCC-----CcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          386 M-----NPIQAAFAVVNKNLRPAIPGD-----CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       386 ~-----~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      .     ...+....+.....++.+|..     ++..+.+||.+||+.||++||++.+|++.|+++.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            2     123334445566677777643     346789999999999999999999999999988764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.3e-52  Score=416.46  Aligned_cols=246  Identities=26%  Similarity=0.435  Sum_probs=191.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  255 (488)
                      ++|.+.+.||+|+||+||+|++.  |+.||||++.......       ..+.+.+|+.+|++|+|||||+++++|.+.. 
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   77 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL-------AREKVMREVKALAKLEHPGIVRYFNAWLEKNT   77 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHH-------HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHH-------HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence            46889999999999999999986  7899999998654321       2467889999999999999999999986543 


Q ss_pred             -----------eeeEEEeecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcE
Q 011359          256 -----------VYCVITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL  323 (488)
Q Consensus       256 -----------~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~v  323 (488)
                                 .+|||||||+||+|.+++..... ....+..++.|+.||+.||+|||++||+||||||+|||++.++.+
T Consensus        78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence                       47899999999999999986422 234556788999999999999999999999999999999999999


Q ss_pred             EEeeecccccccccC-------------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-
Q 011359          324 KIADFGIACEEVYCD-------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI-  389 (488)
Q Consensus       324 kl~DFgla~~~~~~~-------------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~-  389 (488)
                      ||+|||+|+......             .....+||+.|||||++.+..|+.++|||||||++|||++   ||...... 
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~  234 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV  234 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence            999999996433211             1233469999999999999999999999999999999996   77653322 


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .....+.... .+......++.+.+||.+||+.||++||++.++++
T Consensus       235 ~~~~~~~~~~-~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 RTLTDVRNLK-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHTTC-CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2222222222 22222344567889999999999999999999876

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-50  Score=414.82  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=209.1

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec---
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK---  253 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---  253 (488)
                      ++|.+++.||+|+||+||+|++.  |+.||||+++.......      ..+.+.+|+.+|++|+|||||++++++..   
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVT------NAKRTLRELKILKHFKHDNIIAIKDILRPTVP  127 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHH------HHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchH------HHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence            46999999999999999999986  78999999975443321      24578899999999999999999998753   


Q ss_pred             ---CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       254 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                         ...+|||||||+ |+|.+++..  .+.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus       128 ~~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          128 YGEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecce
Confidence               367899999995 679999975  56799999999999999999999999999999999999999999999999999


Q ss_pred             cccccc-----cCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-
Q 011359          331 ACEEVY-----CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA-  403 (488)
Q Consensus       331 a~~~~~-----~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-  403 (488)
                      |+....     .......+||+.|||||++.+. .|+.++||||+||++|||++|..||.+.+..+.+..+......+. 
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            964322     2234456899999999998765 569999999999999999999999999888777666553221110 


Q ss_pred             ----------------------------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          404 ----------------------------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       404 ----------------------------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                                  +...+++++.+||.+||..||++||++.++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                        11356889999999999999999999999886

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2e-49  Score=428.54  Aligned_cols=249  Identities=20%  Similarity=0.329  Sum_probs=220.9

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||+||+|++.  |+.||||++......        ..+.+.+|+.+|+.|+|||||+++++|.++.
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  227 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN  227 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--------HHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh--------hHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            368999999999999999999986  789999999764321        1356889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC--CcEEEeeeccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADFGIACE  333 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~--~~vkl~DFgla~~  333 (488)
                      .+|||||||+||+|.++|.. ....+++.++..++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+|..
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEEEEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999999999999999965 34579999999999999999999999999999999999999854  8999999999976


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  411 (488)
                      ..........+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+.......  .....++++
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  386 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  386 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred             ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            555455556689999999999999999999999999999999999999999999888887777655432  334678999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +++||.+||+.||.+||++.|+++
T Consensus       387 ~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          387 GKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-48  Score=399.52  Aligned_cols=242  Identities=20%  Similarity=0.330  Sum_probs=197.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACK  252 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  252 (488)
                      ++|.++++||+|+||+||+|+.+     ++.||||++.....          ..++.+|+++|+.+ +|||||++++++.
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----------~~~~~~E~~~l~~~~~h~nIv~l~~~~~   90 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----------PIRIAAELQCLTVAGGQDNVMGVKYCFR   90 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----------HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----------HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence            46999999999999999999863     57899999864322          24577999999998 5999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-CcEEEeeeccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIA  331 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-~~vkl~DFgla  331 (488)
                      +...+|||||||+||+|.+++.     .+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            9999999999999999999984     48999999999999999999999999999999999999876 89999999999


Q ss_pred             cccccc-----------------------------CcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCC
Q 011359          332 CEEVYC-----------------------------DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTI  381 (488)
Q Consensus       332 ~~~~~~-----------------------------~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~  381 (488)
                      +.....                             ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            532211                             112345799999999999765 58999999999999999999999


Q ss_pred             CCCCCC-HHHHHHHHHhc----------------------------------------------------cCCCCCCCCC
Q 011359          382 PYEEMN-PIQAAFAVVNK----------------------------------------------------NLRPAIPGDC  408 (488)
Q Consensus       382 Pf~~~~-~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~  408 (488)
                      ||.... ..+.+..+..-                                                    .........+
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            996543 33322222110                                                    0001112457


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++++.+||.+||..||++|+++.|+++
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            889999999999999999999999875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.6e-48  Score=385.72  Aligned_cols=269  Identities=35%  Similarity=0.633  Sum_probs=226.8

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      .+++.+..++|.+++.||+|+||+||+|.++++.||||++........      ..+.+.+|+.++++++||||++++++
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~  102 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE------RVNEFLREVAIMKRLRHPNIVLFMGA  102 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHH------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHH------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            466778889999999999999999999999999999999976543321      24678899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCeEEEcCCCcEEEee
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g--iiHrDIkp~NILl~~~~~vkl~D  327 (488)
                      +.....+++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|
T Consensus       103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D  182 (309)
T 3p86_A          103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD  182 (309)
T ss_dssp             ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred             EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence            9999999999999999999999986321 23899999999999999999999999  99999999999999999999999


Q ss_pred             eccccccccc-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          328 FGIACEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       328 Fgla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      ||++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+........++.
T Consensus       183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  262 (309)
T 3p86_A          183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR  262 (309)
T ss_dssp             CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred             CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence            9998643322 123345699999999999999999999999999999999999999999998887777766777778889


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      .+++.+.+||.+||+.+|.+||++.++++.|+.+.....
T Consensus       263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999999999877543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.4e-47  Score=371.29  Aligned_cols=260  Identities=27%  Similarity=0.548  Sum_probs=232.0

Q ss_pred             cccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .+.+++++|.+.+.||+|+||.||+|.++++.||||++........      ..+.|.+|+.++++++||||+++++++.
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR------KSRDFNEECPRLRIFSHPNVLPVLGACQ   77 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHH------HHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHH------HHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence            4567889999999999999999999999999999999986543322      2467899999999999999999999998


Q ss_pred             cC--CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCeEEEcCCCcEEEeee
Q 011359          253 KP--PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       253 ~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--iiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      ..  ..+++||||+++|+|.+++.......+++..++.++.||+.||+|||++|  |+||||||+||+++.++.++|+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~  157 (271)
T 3kmu_A           78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA  157 (271)
T ss_dssp             TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred             cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence            87  78899999999999999998755556999999999999999999999999  999999999999999999999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhcCCCC---chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYG---RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      |++...    ......||+.|+|||.+.+..++   .++||||||+++|+|++|..||.+....+....+......+..+
T Consensus       158 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (271)
T 3kmu_A          158 DVKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP  233 (271)
T ss_dssp             GSCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred             cceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence            887432    22345689999999999865544   48999999999999999999999999888888888888888899


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ..++..+.++|.+||+.||++||++.++++.|+++..
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            9999999999999999999999999999999998753

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.3e-48  Score=416.18  Aligned_cols=254  Identities=21%  Similarity=0.346  Sum_probs=209.4

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .+.+++|.+++.||+|+||+||+|+..  |+.||||++..........  .........++.+++.++|||||+++++|.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~--~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC--HHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh--HHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            456788999999999999999999986  7899999997421100000  001122234567778889999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +...+|||||||+||+|.++|.+  .+.+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|.
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ECCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceee
Confidence            99999999999999999999987  3679999999999999999999999999999999999999999999999999996


Q ss_pred             cccccCcCCCCCCCcccCChhhhh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCCCCCCCCC
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEM---NPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvll~elltG~~Pf~~~---~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      ..... .....+||+.|||||++. +..|+.++|+|||||++|||++|..||.+.   +..+....+...  ...+|..+
T Consensus       341 ~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~~~p~~~  417 (689)
T 3v5w_A          341 DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSF  417 (689)
T ss_dssp             ECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CCCCCTTS
T ss_pred             ecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CCCCCccC
Confidence            54332 334568999999999996 457999999999999999999999999753   233333333333  34578889


Q ss_pred             cHHHHHHHHHHhhhCCCCCCC-----HHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPE-----FWHIVK  435 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs-----~~eil~  435 (488)
                      ++++++||.+||+.||.+|++     +.+|++
T Consensus       418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            999999999999999999998     567663

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-46  Score=366.29  Aligned_cols=260  Identities=25%  Similarity=0.546  Sum_probs=227.5

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ..|.++.++|.+.+.||+|+||.||+|.+. ++.||||++......         .+++.+|+.++++++||||++++++
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~   73 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGV   73 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            457889999999999999999999999985 678999999854432         2457899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +.+...+++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  152 (269)
T 4hcu_A           74 CLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM  152 (269)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred             EecCCceEEEEEeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccc
Confidence            9999999999999999999999976 345689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc--CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          331 ACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       331 a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      +......  .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~  231 (269)
T 4hcu_A          153 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRL  231 (269)
T ss_dssp             GGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred             cccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCc
Confidence            8643221  12334557888999999998999999999999999999999 999999988876655544 3455667788


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ++..+.++|.+||+.+|++||++.++++.|+++.+
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            89999999999999999999999999999999876

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-46  Score=379.80  Aligned_cols=250  Identities=27%  Similarity=0.420  Sum_probs=222.0

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      ...++|.+.+.||+|+||.||+|.+.  |+.||||++.......      ...+.+.+|+.+|+.++||||+++++++..
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~   85 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP------TSLQKLFREVRIMKILNHPNIVKLFEVIET   85 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH------HHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            34578999999999999999999984  7899999997644322      124568899999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ...+++||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           86 EKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             CCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            99999999999999999999763  5699999999999999999999999999999999999999999999999999976


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYG-RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      ...........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+....+.....  .+|..++..+
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~  241 (328)
T 3fe3_A          164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--RIPFYMSTDC  241 (328)
T ss_dssp             GSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred             cCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHH
Confidence            5555555667899999999999888765 899999999999999999999999988877777766544  4677889999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||.+||..||.+||++.++++
T Consensus       242 ~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          242 ENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHCCCChhHCcCHHHHhc
Confidence            99999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1e-46  Score=386.73  Aligned_cols=266  Identities=29%  Similarity=0.546  Sum_probs=228.5

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN  241 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~---------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H  241 (488)
                      ..|.+..++|.+++.||+|+||.||+|.+.         +..||||++......       ...+.+.+|+.+|+++ +|
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~~h  146 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-------KDLSDLVSEMEMMKMIGKH  146 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH-------HHHHHHHHHHHHHHHSCCC
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH-------HHHHHHHHHHHHHHHhcCC
Confidence            456777889999999999999999999873         246999999754221       1246788999999999 89


Q ss_pred             CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 011359          242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIH  307 (488)
Q Consensus       242 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiH  307 (488)
                      |||++++++|.....+|+||||+++|+|.+++....              ...+++..++.++.||+.||+|||++||+|
T Consensus       147 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  226 (370)
T 2psq_A          147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH  226 (370)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             CCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            999999999999999999999999999999998743              235889999999999999999999999999


Q ss_pred             CCCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 011359          308 RDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY  383 (488)
Q Consensus       308 rDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf  383 (488)
                      |||||+|||++.++.+||+|||++.......   ......+|..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       227 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          227 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             SCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999996433221   2234457889999999999999999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          384 EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      .+....+.. ..+....++..+..++.++.+||.+||+.+|++||++.++++.|+++.....
T Consensus       307 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          307 PGIPVEELF-KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             TTCCGGGHH-HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCCHHHHH-HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            987765544 3445556677888999999999999999999999999999999999877543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-46  Score=367.54  Aligned_cols=258  Identities=34%  Similarity=0.688  Sum_probs=217.4

Q ss_pred             cccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      .++.++|.+.+.||+|+||.||+|.+.++.||||++........    ....+.+.+|+.+++.++||||+++++++..+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDI----SQTIENVRQEAKLFAMLKHPNIIALRGVCLKE   78 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccH----HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            35678999999999999999999999999999999975433221    12246788999999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCCCeEEEcC--------CCcE
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG---VIHRDLKPENVLIDQ--------EFHL  323 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---iiHrDIkp~NILl~~--------~~~v  323 (488)
                      ..+++||||+++++|.+++..   ..+++..++.++.|++.||+|||++|   |+||||||+|||++.        ++.+
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             CceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence            999999999999999999853   57999999999999999999999999   899999999999986        6789


Q ss_pred             EEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       324 kl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      ||+|||++...... ......||..|+|||.+.+..++.++||||||+++|+|++|..||.+.........+........
T Consensus       156 kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  234 (271)
T 3dtc_A          156 KITDFGLAREWHRT-TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP  234 (271)
T ss_dssp             EECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC
T ss_pred             EEccCCcccccccc-cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC
Confidence            99999998643322 22345689999999999999999999999999999999999999999998888888888877788


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .+..++..+.++|.+||+.+|++||++.++++.|+++
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            8899999999999999999999999999999999753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-46  Score=395.76  Aligned_cols=260  Identities=28%  Similarity=0.573  Sum_probs=228.8

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ...|.++.++|.+++.||+|+||.||+|.+.++.||||+++....          .+.|.+|+.+|++++||||++++++
T Consensus       185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~  254 (450)
T 1k9a_A          185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGV  254 (450)
T ss_dssp             HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT----------SHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH----------HHHHHHHHHHHHhccCCCEEEEEEE
Confidence            367899999999999999999999999999999999999975431          3568899999999999999999999


Q ss_pred             eecCC-eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          251 CKKPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       251 ~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +.... .+++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       255 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG  334 (450)
T 1k9a_A          255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG  334 (450)
T ss_dssp             EECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence            87655 78999999999999999998655568999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      ++......  .....++..|+|||++.+..++.++|||||||++|||++ |..||......+.... +..+.+...+..+
T Consensus       335 ~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~p~~~  411 (450)
T 1k9a_A          335 LTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGC  411 (450)
T ss_dssp             TCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-HHTTCCCCCCTTC
T ss_pred             Cccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcC
Confidence            99643322  223467889999999999999999999999999999998 9999998876555443 4455677788999


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ++.+.+||.+||+.||.+||++.++++.|+++...
T Consensus       412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=377.79  Aligned_cols=262  Identities=28%  Similarity=0.568  Sum_probs=225.0

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      ..++.++|.+++.||+|+||.||+|.+.     +..||||++......       ...+.|.+|+.++++++||||++++
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~  116 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-------RQRRDFLSEASIMGQFDHPNIIRLE  116 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH-------HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH-------HHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3466788999999999999999999984     345999999754321       1246789999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      +++.....+++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+||
T Consensus       117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  195 (325)
T 3kul_A          117 GVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF  195 (325)
T ss_dssp             EEECGGGCCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEeCCccEEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCC
Confidence            999999999999999999999999975 3457999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          329 GIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       329 gla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      |++.......    ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. ......
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~  274 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLP  274 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCC
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCC
Confidence            9996433211    1223446788999999998899999999999999999999 999999988877655544 445666


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      .+..++..+.+||.+||..||++||++.+|++.|+.+....
T Consensus       275 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          275 APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            78889999999999999999999999999999999997753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.1e-47  Score=389.67  Aligned_cols=264  Identities=30%  Similarity=0.559  Sum_probs=229.1

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      .+.|.++.++|.+++.||+|+||.||+|.+.  ++.||||+++....       ......|.+|+.+|++++||||++++
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~  178 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-------PDLKAKFLQEARILKQYSHPNIVRLI  178 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-------HHHHTTTTHHHHHHTTCCCTTBCCEE
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-------HHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            4678999999999999999999999999996  78999999874322       11245688999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      +++.....+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus       179 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~Df  257 (377)
T 3cbl_A          179 GVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF  257 (377)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred             EEEecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcC
Confidence            9999999999999999999999999863 346899999999999999999999999999999999999999999999999


Q ss_pred             cccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 011359          329 GIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       329 gla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  404 (488)
                      |++........   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+... .+..+.+...
T Consensus       258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~  336 (377)
T 3cbl_A          258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPC  336 (377)
T ss_dssp             GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-HHHTTCCCCC
T ss_pred             CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCC
Confidence            99864322111   112235678999999998899999999999999999998 999999988766544 4445566777


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      +..++..+.+||.+||+.||++||++.+|++.|+.+...
T Consensus       337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            888999999999999999999999999999999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5e-46  Score=369.70  Aligned_cols=247  Identities=24%  Similarity=0.475  Sum_probs=216.9

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+.+.||+|+||+||+|.+.  ++.||||++.......        .+.+.+|+.++++++||||+++++++..+.
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLVGD   90 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--------HHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence            357889999999999999999864  7899999998654433        345779999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+++|+|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            99999999999999999986   468999999999999999999999999999999999999999999999999986433


Q ss_pred             cc-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCcHHHH
Q 011359          336 YC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-LRPAIPGDCPPAMA  413 (488)
Q Consensus       336 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~  413 (488)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... .....+..++..+.
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR  247 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred             CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence            22 22345679999999999999999999999999999999999999999988877666555443 23445678899999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHH
Q 011359          414 ALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +||.+||+.||++||++.++++
T Consensus       248 ~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          248 DFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHccCChhHCcCHHHHhh
Confidence            9999999999999999999886

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.2e-46  Score=370.76  Aligned_cols=269  Identities=28%  Similarity=0.499  Sum_probs=233.1

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEE-------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIY-------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN  241 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~-------~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H  241 (488)
                      ...+|.+..++|.+++.||+|+||.||+|.+       .++.||||++.......       ..+.+.+|+.+++++ +|
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~h   86 (313)
T 1t46_A           14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-------EREALMSELKVLSYLGNH   86 (313)
T ss_dssp             CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHHHCCC
T ss_pred             CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH-------HHHHHHHHHHHHhhcccC
Confidence            3467888889999999999999999999986       24789999997543211       146788999999999 89


Q ss_pred             CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 011359          242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK----------------TLPLPKLIAIALDIARGMEYIHSQGV  305 (488)
Q Consensus       242 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~gi  305 (488)
                      |||+++++++..+...++||||+++|+|.+++......                .+++..++.++.||+.||+|||++||
T Consensus        87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  166 (313)
T 1t46_A           87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC  166 (313)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            99999999999999999999999999999999875322                48999999999999999999999999


Q ss_pred             ccCCCCCCeEEEcCCCcEEEeeecccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 011359          306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTI  381 (488)
Q Consensus       306 iHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~  381 (488)
                      +||||||+||+++.++.+||+|||++........   .....+|..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       167 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  246 (313)
T 1t46_A          167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS  246 (313)
T ss_dssp             CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999864432221   223446788999999998999999999999999999998 999


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       382 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ||.+..........+........+..++..+.+||.+||+.||.+||++.++++.|+++.....
T Consensus       247 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             SSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            9998876666666777777777788899999999999999999999999999999999877543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-46  Score=382.20  Aligned_cols=265  Identities=29%  Similarity=0.515  Sum_probs=227.9

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPN  243 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn  243 (488)
                      ..|.+..++|.+++.||+|+||.||+|.+.       ++.||||++.......       ..+.+.+|+.++.++ +|||
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~hpn   87 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------EHRALMSELKILIHIGHHLN   87 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHHHCCCTT
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH-------HHHHHHHHHHHHHhhcCCcc
Confidence            567888899999999999999999999853       3689999997543221       146788999999999 7899


Q ss_pred             eeeEeeeeecCC-eeeEEEeecCCCCHHHHHHHhCC--------------------------------------------
Q 011359          244 VIKFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEH--------------------------------------------  278 (488)
Q Consensus       244 Iv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------  278 (488)
                      |+++++++.... .+++||||+++|+|.+++.....                                            
T Consensus        88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            999999998755 48999999999999999986432                                            


Q ss_pred             --------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-
Q 011359          279 --------------------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-  337 (488)
Q Consensus       279 --------------------~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-  337 (488)
                                          ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                                12889999999999999999999999999999999999999999999999999643221 


Q ss_pred             --CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          338 --DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       338 --~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                        .......||..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.....+........+..+++++.+
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  327 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ  327 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence              12234457889999999999999999999999999999998 999999887666666667777777788899999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          415 LIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      +|.+||+.||.+||++.++++.|+.+...
T Consensus       328 li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            99999999999999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=379.92  Aligned_cols=267  Identities=29%  Similarity=0.546  Sum_probs=231.8

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-C
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-H  240 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~---------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~  240 (488)
                      ...|.+..++|.+++.||+|+||.||+|.+.+         ..||||++......       ....++.+|+++++++ +
T Consensus        61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~~  133 (382)
T 3tt0_A           61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-------KDLSDLISEMEMMKMIGK  133 (382)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-------HHHHHHHHHHHHHHHHCC
T ss_pred             CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-------HHHHHHHHHHHHHHHhcC
Confidence            45678888999999999999999999999742         46999999754321       1246788999999999 8


Q ss_pred             CCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 011359          241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVI  306 (488)
Q Consensus       241 HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~gii  306 (488)
                      ||||+++++++..+..+++||||+++|+|.+++....              ...+++..++.++.||+.||+|||++||+
T Consensus       134 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  213 (382)
T 3tt0_A          134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI  213 (382)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             CchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            9999999999999999999999999999999998753              24589999999999999999999999999


Q ss_pred             cCCCCCCeEEEcCCCcEEEeeeccccccccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 011359          307 HRDLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP  382 (488)
Q Consensus       307 HrDIkp~NILl~~~~~vkl~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~P  382 (488)
                      ||||||+|||++.++.+||+|||++......   .......+|..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       214 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          214 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             CSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999999644322   22334457889999999999999999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          383 YEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       383 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      |.+....+.. ..+........+..++.++.+||.+||+.+|++||++.++++.|+++.....
T Consensus       294 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          294 YPGVPVEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             STTCCHHHHH-HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             CCCCCHHHHH-HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            9988876554 4445556677788999999999999999999999999999999999987654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-46  Score=378.06  Aligned_cols=268  Identities=25%  Similarity=0.465  Sum_probs=228.0

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEE-------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCC
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIY-------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNP  242 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~-------~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hp  242 (488)
                      ..+|.++.++|.+++.||+|+||.||+|.+       .+..||||++......       ...+.+.+|+.++.++ +||
T Consensus        37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~~hp  109 (344)
T 1rjb_A           37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-------SEREALMSELKMMTQLGSHE  109 (344)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCT
T ss_pred             CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH-------HHHHHHHHHHHHHHhhcCCC
Confidence            457888999999999999999999999997       2357999999743221       1246788999999999 899


Q ss_pred             CeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC---------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 011359          243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH---------------------KTLPLPKLIAIALDIARGMEYIH  301 (488)
Q Consensus       243 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH  301 (488)
                      ||+++++++.....+++||||+++|+|.+++.....                     ..+++..++.++.||+.||+|||
T Consensus       110 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  189 (344)
T 1rjb_A          110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE  189 (344)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred             CeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999986432                     23789999999999999999999


Q ss_pred             HCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh
Q 011359          302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA  378 (488)
Q Consensus       302 ~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt  378 (488)
                      ++||+||||||+|||++.++.+||+|||++........   .....||..|+|||++.+..++.++||||||+++|+|++
T Consensus       190 ~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  269 (344)
T 1rjb_A          190 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS  269 (344)
T ss_dssp             HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHc
Confidence            99999999999999999999999999999964432211   223346788999999998999999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          379 -GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       379 -G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                       |..||.+..........+........+..++..+.+||.+||+.||.+||++.++++.|+.+.....
T Consensus       270 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          270 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             CCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence             9999998876666667777777778888999999999999999999999999999999998876544

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=375.25  Aligned_cols=261  Identities=31%  Similarity=0.533  Sum_probs=220.9

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ...++.++|.+++.||+|+||+||+|.+.  ++.||||++...+        ....+.|.+|+.++++++||||++++++
T Consensus         4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~E~~~l~~l~hp~iv~~~~~   75 (310)
T 3s95_A            4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--------EETQRTFLKEVKVMRCLEHPNVLKFIGV   75 (310)
T ss_dssp             CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--------HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCcCcccEEEE
Confidence            44577789999999999999999999986  7899999985432        1225678999999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +.++..+++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  154 (310)
T 3s95_A           76 LYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL  154 (310)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred             EecCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccc
Confidence            99999999999999999999999873 46799999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcC---------------CCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH----
Q 011359          331 ACEEVYCDAL---------------SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA----  391 (488)
Q Consensus       331 a~~~~~~~~~---------------~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~----  391 (488)
                      +.........               ....||+.|+|||++.+..++.++||||||+++|+|++|..||........    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~  234 (310)
T 3s95_A          155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL  234 (310)
T ss_dssp             CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB
T ss_pred             ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh
Confidence            8643222111               145699999999999999999999999999999999999999875432110    


Q ss_pred             -HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhcc
Q 011359          392 -AFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLAC  446 (488)
Q Consensus       392 -~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~  446 (488)
                       ......    ...+..+++.+.+||.+||+.||++||++.++++.|+.+...+..
T Consensus       235 ~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          235 NVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             CHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             hhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence             111111    224667888999999999999999999999999999999988763

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-46  Score=375.15  Aligned_cols=265  Identities=29%  Similarity=0.562  Sum_probs=226.2

Q ss_pred             cccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI  245 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  245 (488)
                      .+.+..++|.+++.||+|+||.||+|.+.+       +.||||++......       ...+.|.+|+.++++++||||+
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv  113 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------DMQADFQREAALMAEFDNPNIV  113 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-------HHHHHHHHHHHHHHhCCCCCEE
Confidence            345667889999999999999999999864       78999999754321       2246789999999999999999


Q ss_pred             eEeeeeecCCeeeEEEeecCCCCHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011359          246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLE----------------------HKTLPLPKLIAIALDIARGMEYIHSQ  303 (488)
Q Consensus       246 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~  303 (488)
                      ++++++.....+++||||+++|+|.+++....                      ...+++..++.++.||+.||+|||++
T Consensus       114 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~  193 (343)
T 1luf_A          114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER  193 (343)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            99999999999999999999999999998742                      15689999999999999999999999


Q ss_pred             CcccCCCCCCeEEEcCCCcEEEeeeccccccccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-C
Q 011359          304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-G  379 (488)
Q Consensus       304 giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G  379 (488)
                      ||+||||||+|||++.++.+||+|||++......   .......+|..|+|||++.+..++.++||||||+++|+|++ |
T Consensus       194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  273 (343)
T 1luf_A          194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  273 (343)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence            9999999999999999999999999998543222   22334568899999999998899999999999999999999 9


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          380 TIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       380 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ..||.+....+....+... .....+..++..+.+||.+||+.||++||++.++++.|+++...+.
T Consensus       274 ~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          274 LQPYYGMAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             CCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CCcCCCCChHHHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            9999998887766555443 4456778899999999999999999999999999999999876544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.8e-46  Score=392.62  Aligned_cols=263  Identities=32%  Similarity=0.551  Sum_probs=229.5

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .+.|.+..++|.+++.||+|+||.||+|.+. +..||||+++.....         .+.|.+|+.+|++++||||+++++
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~iv~l~~  250 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---------VEAFLAEANVMKTLQHDKLVKLHA  250 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---------HHHHHHHHHHHhhCCCCCEeeEEE
Confidence            4678999999999999999999999999997 678999999754321         356889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++. ...+++||||+.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       251 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             EEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             EEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence            987 5578899999999999999986544578899999999999999999999999999999999999999999999999


Q ss_pred             cccccccc--CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          330 IACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       330 la~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      ++......  .......++..|+|||++....++.++|||||||++|||++ |..||.+....+....+. .+.+...+.
T Consensus       330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~  408 (454)
T 1qcf_A          330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPE  408 (454)
T ss_dssp             GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCT
T ss_pred             CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence            99653221  11233446788999999998999999999999999999999 999999998877665544 456667788


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      .++.++.+||.+||+.||++||++.+|++.|+.+....
T Consensus       409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            99999999999999999999999999999999876543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-45  Score=356.88  Aligned_cols=259  Identities=26%  Similarity=0.550  Sum_probs=226.9

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      +|.++.++|.+.+.||+|+||.||+|.+. ++.||||++......         .+.+.+|+.++++++||||+++++++
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~   72 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVC   72 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            57889999999999999999999999985 678999999854432         24678999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .....+++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           73 LEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             ccCCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccc
Confidence            9999999999999999999999863 356899999999999999999999999999999999999999999999999998


Q ss_pred             cccccc--CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 011359          332 CEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       332 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      ......  .......++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~  230 (267)
T 3t9t_A          152 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLA  230 (267)
T ss_dssp             GGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTS
T ss_pred             cccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcCCCCccC
Confidence            643221  12234457889999999998899999999999999999999 999999888766655544 34455667788


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +..+.++|.+||+.+|++||++.++++.|+++.+
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999999999999876

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-45  Score=361.96  Aligned_cols=260  Identities=24%  Similarity=0.493  Sum_probs=225.0

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ..|.++.++|.+.+.||+|+||.||+|.+.+ ..||||++......         .+++.+|+.++.+++|+||++++++
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~   87 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGV   87 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---------HHHHHHHHHHHhcCCCCCEeeEEEE
Confidence            4678889999999999999999999999875 58999999854332         2457899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +.....+++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~  166 (283)
T 3gen_A           88 CTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL  166 (283)
T ss_dssp             ECSSSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred             EecCCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccc
Confidence            99999999999999999999999763 34699999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc--CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          331 ACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       331 a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      +......  .......+|..|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~  245 (283)
T 3gen_A          167 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHL  245 (283)
T ss_dssp             GGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTT
T ss_pred             cccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCc
Confidence            8643221  12234457888999999998899999999999999999998 999999988776655544 4455667788


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +++.+.+||.+||+.+|.+||++.++++.|+++..
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            89999999999999999999999999999998865

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.6e-45  Score=373.31  Aligned_cols=251  Identities=23%  Similarity=0.387  Sum_probs=219.1

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      +.+++|.+++.||+|+||.||+|...  |+.||||++....     .........+.+|+.+|+.++||||+++++++..
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~   76 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV-----IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence            45688999999999999999999986  7899999997421     0111124567899999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ...+|+||||++||+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus        77 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           77 HDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            9999999999999999999986  35789999999999999999999999999999999999999999999999999965


Q ss_pred             cc-ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          334 EV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       334 ~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      .. .........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....  ..++..+++++
T Consensus       155 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~  232 (337)
T 1o6l_A          155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEA  232 (337)
T ss_dssp             SCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHH
T ss_pred             cccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHH
Confidence            32 2233445679999999999998899999999999999999999999999988877766666554  34677899999


Q ss_pred             HHHHHHHhhhCCCCCC-----CHHHHHH
Q 011359          413 AALIEQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RP-----s~~eil~  435 (488)
                      .+||.+||+.||.+||     ++.+|++
T Consensus       233 ~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          233 KSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            9999999999999999     8888875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-45  Score=360.31  Aligned_cols=259  Identities=27%  Similarity=0.535  Sum_probs=225.2

Q ss_pred             cccccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      ++.+..++|.+.+.||+|+||.||+|.+.+ ..||||++......         .+++.+|+.++.+++||||+++++++
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~   72 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---------EDEFFQEAQTMMKLSHPKLVKFYGVC   72 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            356777899999999999999999999875 57999999764432         24578999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .....+++||||+++++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           73 SKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             ccCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccc
Confidence            9999999999999999999999873 346899999999999999999999999999999999999999999999999998


Q ss_pred             ccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 011359          332 CEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       332 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      .......  ......+|..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.. ......+..+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~  230 (268)
T 3sxs_A          152 RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRLYRPHLA  230 (268)
T ss_dssp             EECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTS
T ss_pred             eecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc-CCCCCCCCcC
Confidence            5433221  2233456778999999998899999999999999999999 9999999888776655444 3455567788


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ++.+.++|.+||+.+|++||++.++++.|+.+..
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            9999999999999999999999999999988754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-45  Score=365.16  Aligned_cols=263  Identities=27%  Similarity=0.480  Sum_probs=216.9

Q ss_pred             ccccccceeccceeeeeccEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF  247 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~------~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  247 (488)
                      ..+..++|.+++.||+|+||.||+|.+      .++.||||++.....        ...+.|.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~   76 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--------EHLRDFEREIEILKSLQHDNIVKY   76 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence            346678899999999999999999986      368899999974321        124578899999999999999999


Q ss_pred             eeeeec--CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEE
Q 011359          248 VAACKK--PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI  325 (488)
Q Consensus       248 ~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl  325 (488)
                      ++++..  ...+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||
T Consensus        77 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl  155 (295)
T 3ugc_A           77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI  155 (295)
T ss_dssp             EEEECHHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred             EEEEecCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEE
Confidence            999854  35689999999999999999873 345899999999999999999999999999999999999999999999


Q ss_pred             eeeccccccccc----CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH------------
Q 011359          326 ADFGIACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI------------  389 (488)
Q Consensus       326 ~DFgla~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~------------  389 (488)
                      +|||++......    .......++..|+|||.+.+..++.++||||||+++|+|++|..||......            
T Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T 3ugc_A          156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ  235 (295)
T ss_dssp             CCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTH
T ss_pred             ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccc
Confidence            999999643322    1223345777899999999999999999999999999999999998653221            


Q ss_pred             ---HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          390 ---QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       390 ---~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                         ......+....+...+..++.++.+||.+||+.||++||++.++++.|+++...+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence               12233344555667788999999999999999999999999999999999987653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-45  Score=363.80  Aligned_cols=258  Identities=25%  Similarity=0.412  Sum_probs=219.2

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||.||+|.+.  ++.||||++.........     ..+.|.+|+.++.+++||||+++++++..+.
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEE-----TLKRFEREVHNSSQLSHQNIVSMIDVDEEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHH-----HHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHH-----HHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence            367999999999999999999975  689999999765544322     2467899999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||++|++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             eEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999999999999873  579999999999999999999999999999999999999999999999999986433


Q ss_pred             ccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---CCCCCCcH
Q 011359          336 YCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP---AIPGDCPP  410 (488)
Q Consensus       336 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~  410 (488)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.................   ..+..+++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence            221  2233468999999999999999999999999999999999999999998877766665544322   24567899


Q ss_pred             HHHHHHHHHhhhCCCCCC-CHHHHHHHHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRP-EFWHIVKVLEQFET  442 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RP-s~~eil~~Le~~~~  442 (488)
                      .+.++|.+||+.||.+|| ++.++.+.|+.+..
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            999999999999999998 88888888876644

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.5e-45  Score=359.80  Aligned_cols=264  Identities=32%  Similarity=0.550  Sum_probs=227.7

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .++|.+..++|.+++.||+|+||.||+|.+.+ ..||||++......         .+.+.+|+.++++++||||+++++
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~   75 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLYA   75 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---------HHHHHHHHHHHHhCCCcCcceEEE
Confidence            46889999999999999999999999999874 68999999754322         346789999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++.. ...++||||+.+++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        76 ~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  154 (279)
T 1qpc_A           76 VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG  154 (279)
T ss_dssp             EECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence            9874 457899999999999999976433469999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          330 IACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       330 la~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      ++.......  ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+ ........+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~  233 (279)
T 1qpc_A          155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPD  233 (279)
T ss_dssp             TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCT
T ss_pred             ccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH-hcccCCCCcc
Confidence            986443221  2233457789999999998889999999999999999999 99999988876655444 4445666778


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      .++..+.+||.+||+.+|++||++.++++.|+.+.....
T Consensus       234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence            899999999999999999999999999999999987644

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.9e-45  Score=374.80  Aligned_cols=250  Identities=23%  Similarity=0.387  Sum_probs=218.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++........      ..+.+.+|+.++++++||||+++++++.+...
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHH------HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            46889999999999999999986  78999999986544321      24568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC---CcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~---~~vkl~DFgla~~  333 (488)
                      +++||||+.||+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.+   +.+||+|||++..
T Consensus       103 ~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999999999975  4568999999999999999999999999999999999999765   4599999999976


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  411 (488)
                      ...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.........+  ..++++
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            554444556689999999999998899999999999999999999999999988877776666655443222  467899


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      +.+||.+||+.||++||++.++++.
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcC
Confidence            9999999999999999999998863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=375.52  Aligned_cols=255  Identities=23%  Similarity=0.369  Sum_probs=213.3

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEe
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFV  248 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~  248 (488)
                      ....+.+++|.+.+.||+|+||.||+|++.  ++.||||++....     .........+.+|+.++..+ +||||++++
T Consensus        16 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~   90 (353)
T 3txo_A           16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV-----ILQDDDVECTMTEKRILSLARNHPFLTQLF   90 (353)
T ss_dssp             -------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTTHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             CcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH-----hcchhHHHHHHHHHHHHHhccCCCceeeEE
Confidence            334567789999999999999999999986  6899999997421     11122245678999999998 699999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      +++.....+|+||||++||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        91 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DF  168 (353)
T 3txo_A           91 CCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADF  168 (353)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccc
Confidence            9999999999999999999999999873  56999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc-ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          329 GIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       329 gla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      |++.... .........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.....  .++..
T Consensus       169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~  246 (353)
T 3txo_A          169 GMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPTW  246 (353)
T ss_dssp             TTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTT
T ss_pred             cceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCCC
Confidence            9996432 22333456799999999999988999999999999999999999999999998887777776543  45777


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCH------HHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEF------WHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~------~eil~  435 (488)
                      ++..+.+||.+||+.||.+||++      .+|++
T Consensus       247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            99999999999999999999998      66664

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.7e-45  Score=366.59  Aligned_cols=264  Identities=31%  Similarity=0.550  Sum_probs=227.4

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN  243 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn  243 (488)
                      ...|.+..++|.+++.||+|+||.||+|.+.       ++.||||++......       ...+.+.+|+.++++++|||
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~   87 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP-------SELRDLLSEFNVLKQVNHPH   87 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH-------HHHHHHHHHHHHHTTCCCTT
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH-------HHHHHHHHHHHHHhhCCCCc
Confidence            3567888899999999999999999999872       378999999754321       12467889999999999999


Q ss_pred             eeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 011359          244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH----------------------KTLPLPKLIAIALDIARGMEYIH  301 (488)
Q Consensus       244 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~~L~~LH  301 (488)
                      |+++++++.....+++||||+++++|.+++.....                      ..+++..++.++.||+.||+|||
T Consensus        88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH  167 (314)
T 2ivs_A           88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA  167 (314)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred             eeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999987432                      34889999999999999999999


Q ss_pred             HCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh
Q 011359          302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA  378 (488)
Q Consensus       302 ~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt  378 (488)
                      ++||+||||||+|||++.++.+||+|||++.......   ......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus       168 ~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          168 EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999999986432221   2234457889999999998899999999999999999999


Q ss_pred             -CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          379 -GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       379 -G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                       |..||.+....+.. ..+........+..++..+.+||.+||+.||++||++.++++.|+++..
T Consensus       248 ~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          248 LGGNPYPGIPPERLF-NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             TSCCSSTTCCGGGHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHH-HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             99999988765544 3444555667788899999999999999999999999999999998865

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.4e-45  Score=374.41  Aligned_cols=253  Identities=21%  Similarity=0.338  Sum_probs=218.6

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  |+.||||++..........  ....+.+.+|+.+|++++||||+++++++.....
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc--hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            46889999999999999999986  7899999998654321100  0013568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC----cEEEeeecccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIAC  332 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~----~vkl~DFgla~  332 (488)
                      +++||||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++.
T Consensus        90 ~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            9999999999999999975  45799999999999999999999999999999999999998776    79999999997


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPP  410 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~  410 (488)
                      ............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......  .....++.
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  247 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE  247 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence            6554444566779999999999998899999999999999999999999999988877776666554332  22357889


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.+||.+||..||.+||++.++++
T Consensus       248 ~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          248 LAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            9999999999999999999999884

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-45  Score=370.84  Aligned_cols=268  Identities=26%  Similarity=0.490  Sum_probs=231.7

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN  241 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H  241 (488)
                      ..+.+.++.++|.+++.||+|+||.||+|.+.+       ..||||++......       ...+.+.+|+.+++++ +|
T Consensus        37 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~~h  109 (333)
T 2i1m_A           37 YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-------DEKEALMSELKIMSHLGQH  109 (333)
T ss_dssp             CCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-------HHHHHHHHHHHHHHHHCCC
T ss_pred             ccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-------HHHHHHHHHHHHHHhhcCC
Confidence            345688889999999999999999999999853       36999999754321       1246788999999999 89


Q ss_pred             CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 011359          242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRD  309 (488)
Q Consensus       242 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrD  309 (488)
                      |||+++++++.....+++||||+++|+|.+++....            ...+++..++.++.||+.||+|||++||+|||
T Consensus       110 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D  189 (333)
T 2i1m_A          110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD  189 (333)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             CCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCC
Confidence            999999999999999999999999999999998642            34689999999999999999999999999999


Q ss_pred             CCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 011359          310 LKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE  385 (488)
Q Consensus       310 Ikp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~  385 (488)
                      |||+|||++.++.+||+|||++.......   ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus       190 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  269 (333)
T 2i1m_A          190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG  269 (333)
T ss_dssp             CSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence            99999999999999999999996433221   1223446788999999998999999999999999999998 9999998


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          386 MNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      ..........+........+..++..+.+||.+||+.||.+||++.++++.|+++....
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          270 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             CCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            77666666677777777778889999999999999999999999999999999887643

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.7e-46  Score=362.82  Aligned_cols=260  Identities=28%  Similarity=0.570  Sum_probs=219.6

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ...|.++.++|.+++.||+|+||.||+|.++++.||||++.....          .+.+.+|+.++++++||||++++++
T Consensus        13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~   82 (278)
T 1byg_A           13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGV   82 (278)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred             hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            356788999999999999999999999999999999999974321          3568899999999999999999998


Q ss_pred             eecC-CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          251 CKKP-PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       251 ~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +... ..+++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg  162 (278)
T 1byg_A           83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG  162 (278)
T ss_dssp             ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecc
Confidence            7544 578999999999999999987544458899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      ++......  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+... .+........+..+
T Consensus       163 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~  239 (278)
T 1byg_A          163 LTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-RVEKGYKMDAPDGC  239 (278)
T ss_dssp             C--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH-HHTTTCCCCCCTTC
T ss_pred             cccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHhcCCCCCCcccC
Confidence            98643322  233457889999999998999999999999999999998 999998876654443 34445566778899


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ++.+.++|.+||+.||++||++.++++.|+++...
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            99999999999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=376.97  Aligned_cols=265  Identities=27%  Similarity=0.468  Sum_probs=225.5

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV  244 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI  244 (488)
                      +.+.+..++|.+++.||+|+||+||+|.+.       ++.||||++......       ....++.+|+.++++++||||
T Consensus        64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~hpnI  136 (367)
T 3l9p_A           64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-------QDELDFLMEALIISKFNHQNI  136 (367)
T ss_dssp             GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH-------HHHHHHHHHHHHHHHCCCTTB
T ss_pred             chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh-------hhHHHHHHHHHHHHhCCCCCC
Confidence            345667788999999999999999999964       357999999643221       124568899999999999999


Q ss_pred             eeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC
Q 011359          245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH-----KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ  319 (488)
Q Consensus       245 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~  319 (488)
                      +++++++......++||||+++|+|.+++.....     ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus       137 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  216 (367)
T 3l9p_A          137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC  216 (367)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred             CeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEec
Confidence            9999999999999999999999999999987532     45899999999999999999999999999999999999985


Q ss_pred             CC---cEEEeeeccccccccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 011359          320 EF---HLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA  392 (488)
Q Consensus       320 ~~---~vkl~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~  392 (488)
                      ++   .+||+|||++......   .......||..|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus       217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~  296 (367)
T 3l9p_A          217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  296 (367)
T ss_dssp             SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            55   5999999999643221   12233457889999999998999999999999999999998 99999998877665


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      ..+. .......+..++..+.+||.+||+.+|++||++.+|++.|+.+....
T Consensus       297 ~~i~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          297 EFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHH-cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            5544 44456677889999999999999999999999999999999987753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.4e-45  Score=360.88  Aligned_cols=262  Identities=25%  Similarity=0.514  Sum_probs=214.3

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      .++.+..++|.+++.||+|+||.||+|.+.     +..||||++.....       ....+.+.+|+.++++++||||++
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~   80 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-------DSVREKFLQEALTMRQFDHPHIVK   80 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-------HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCccce
Confidence            467788899999999999999999999985     24699999864322       122467889999999999999999


Q ss_pred             EeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       247 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      +++++. +...++||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus        81 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~  158 (281)
T 1mp8_A           81 LIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG  158 (281)
T ss_dssp             EEEEEC-SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             EEEEEc-cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEEC
Confidence            999985 45678999999999999999863 4568999999999999999999999999999999999999999999999


Q ss_pred             eecccccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          327 DFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       327 DFgla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      |||++.......  ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.. .....
T Consensus       159 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~-~~~~~  237 (281)
T 1mp8_A          159 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLP  237 (281)
T ss_dssp             C-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCC
T ss_pred             ccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-CCCCC
Confidence            999986543222  1233456788999999998999999999999999999996 9999998876665554443 34556


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      .+..++..+.++|.+||+.||++||++.++++.|+++...
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            7788999999999999999999999999999999998664

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-45  Score=368.52  Aligned_cols=270  Identities=27%  Similarity=0.485  Sum_probs=212.4

Q ss_pred             cccccccccccceeccceeeeeccEEEEEEEECC--c---cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC
Q 011359          169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--E---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN  243 (488)
Q Consensus       169 ~~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~--~---~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn  243 (488)
                      ...++..+..++|.+++.||+|+||.||+|.+.+  .   .||||++.......      ...+.+.+|+.++++++|||
T Consensus        13 ~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~   86 (323)
T 3qup_A           13 EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS------SDIEEFLREAACMKEFDHPH   86 (323)
T ss_dssp             ---CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C------HHHHHHHHHHHHHTTCCCTT
T ss_pred             HHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH------HHHHHHHHHHHHHHHCCCCc
Confidence            3446677888899999999999999999998753  2   79999997543222      12467889999999999999


Q ss_pred             eeeEeeeeecCCee------eEEEeecCCCCHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 011359          244 VIKFVAACKKPPVY------CVITEYLSEGSLRAYLHKLEH----KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE  313 (488)
Q Consensus       244 Iv~l~~~~~~~~~~------~lV~E~~~ggsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~  313 (488)
                      |+++++++......      ++||||+.+|+|.+++.....    ..+++..++.++.||+.||+|||++||+||||||+
T Consensus        87 iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~  166 (323)
T 3qup_A           87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAAR  166 (323)
T ss_dssp             BCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             eehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcc
Confidence            99999999877654      899999999999999976432    25899999999999999999999999999999999


Q ss_pred             eEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 011359          314 NVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI  389 (488)
Q Consensus       314 NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~  389 (488)
                      |||++.++.+||+|||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus       167 NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~  246 (323)
T 3qup_A          167 NCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA  246 (323)
T ss_dssp             GEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             eEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999996433222   1223446788999999999999999999999999999999 99999988876


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      +....+.. ......+..++..+.+||.+||+.||++||++.++++.|+++.....
T Consensus       247 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          247 EIYNYLIG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             GHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHHhc-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            65555444 34556778899999999999999999999999999999999977543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.2e-46  Score=375.11  Aligned_cols=260  Identities=28%  Similarity=0.420  Sum_probs=215.0

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      +++.++.++|.+++.||+|+||.||+|.+.++.||||++.....         ...++.+|+.++.+++||||+++++++
T Consensus        17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~~~~~~   87 (322)
T 3soc_A           17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK---------QSWQNEYEVYSLPGMKHENILQFIGAE   87 (322)
T ss_dssp             CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH---------HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCch---------HHHHHHHHHHHHhcCCCCCchhhccee
Confidence            56678889999999999999999999999999999999964321         123456799999999999999999999


Q ss_pred             ecCC----eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcccCCCCCCeEEE
Q 011359          252 KKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ----------GVIHRDLKPENVLI  317 (488)
Q Consensus       252 ~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------giiHrDIkp~NILl  317 (488)
                      ....    .+++||||+++|+|.+++..   ..+++..++.++.||+.||+|||+.          ||+||||||+|||+
T Consensus        88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill  164 (322)
T 3soc_A           88 KRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL  164 (322)
T ss_dssp             EEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE
T ss_pred             ccCCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE
Confidence            7643    47999999999999999986   4599999999999999999999999          99999999999999


Q ss_pred             cCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCC--
Q 011359          318 DQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMN--  387 (488)
Q Consensus       318 ~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvll~elltG~~Pf~~~~--  387 (488)
                      +.++.+||+|||++.......   ......||..|+|||++.+     ..++.++|||||||++|||++|..||.+..  
T Consensus       165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  244 (322)
T 3soc_A          165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE  244 (322)
T ss_dssp             CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred             CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence            999999999999996433222   2233579999999999976     345678999999999999999999997532  


Q ss_pred             --------------HHHHHHHHHhccCCCCCCC-----CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          388 --------------PIQAAFAVVNKNLRPAIPG-----DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       388 --------------~~~~~~~~~~~~~~~~~~~-----~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                                    .......+.....++.++.     .++.++.+||.+||+.||++||++.++++.|+++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                          2222233333444444333     2345699999999999999999999999999999764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.7e-45  Score=378.15  Aligned_cols=260  Identities=28%  Similarity=0.574  Sum_probs=214.6

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .++.++|.+++.||+|+||.||+|++.     +..||||++......       ...+.|.+|+.++++++||||+++++
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~  113 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-------KQRRDFLGEASIMGQFDHPNIIRLEG  113 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-------HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            566788999999999999999999874     567999999754321       12467899999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++.....+++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       114 ~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  192 (373)
T 2qol_A          114 VVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG  192 (373)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEeeCCceEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence            99999999999999999999999976 34568999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 011359          330 IACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       330 la~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  404 (488)
                      ++.......    ......++..|+|||++.+..++.++|||||||++|||++ |..||......+....+ ....+...
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i-~~~~~~~~  271 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-DEGYRLPP  271 (373)
T ss_dssp             ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH-HTTEECCC
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCC
Confidence            986433211    1122345778999999999999999999999999999998 99999998876655444 44445566


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      +..++..+.+||.+||+.+|.+||++.+|++.|+++...
T Consensus       272 ~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            778999999999999999999999999999999999764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.5e-45  Score=362.84  Aligned_cols=263  Identities=27%  Similarity=0.584  Sum_probs=230.4

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ++|.+..++|.+.+.||+|+||.||+|.+.  +..||||++......         .+.+.+|+.++++++||||+++++
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~   76 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------VEEFLKEAAVMKEIKHPNLVQLLG   76 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH---------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence            578888999999999999999999999987  678999999743221         356889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++..+..+++||||+.+++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||
T Consensus        77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCc
Confidence            99999999999999999999999988666779999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          330 IACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       330 la~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      ++.......  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.. ..+........+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~  235 (288)
T 3kfa_A          157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPE  235 (288)
T ss_dssp             GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHHHTTCCCCCCT
T ss_pred             cceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhccCCCCCCC
Confidence            986433221  1223346788999999998999999999999999999999 99999987765443 3445556667788


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      .+++.+.+||.+||..||.+||++.++++.|+.+....
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            99999999999999999999999999999999987754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.8e-46  Score=394.47  Aligned_cols=261  Identities=27%  Similarity=0.585  Sum_probs=230.1

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      .+.|.++.++|.+++.||+|+||.||+|.+.  +..||||++......         .+.|.+|+.+|++++||||++++
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~l~  282 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------VEEFLKEAAVMKEIKHPNLVQLL  282 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---------hHHHHHHHHHHHhcCCCCEeeEE
Confidence            3678999999999999999999999999997  678999999754322         35688999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      ++|.....++|||||+.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus       283 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred             EEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeec
Confidence            99999999999999999999999998866667999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          329 GIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       329 gla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      |++.......  ......++..|+|||++....++.++|||||||++|||++ |..||.+.+..+.. ..+....+...+
T Consensus       363 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~  441 (495)
T 1opk_A          363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERP  441 (495)
T ss_dssp             TCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHHHTTCCCCCC
T ss_pred             ccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCCC
Confidence            9996433211  1223446788999999998899999999999999999999 99999988765543 445566777788


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      ..++..+.+||.+||+.||++||++.+|++.|+.+.
T Consensus       442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            899999999999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.9e-45  Score=362.00  Aligned_cols=261  Identities=31%  Similarity=0.637  Sum_probs=210.9

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      +.++|..++|.++++||+|+||.||+|.+.+ .||||++........      ..+.|.+|+.++++++|+||+++++++
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ------QLQAFKNEVGVLRKTRHVNILLFMGYS   89 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHH------HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHH------HHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence            4567888999999999999999999998765 599999986554332      246788999999999999999999966


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                       ....+++||||+.+++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        90 -~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           90 -TAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             -CSSSCEEEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             -cCCccEEEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence             45567899999999999999965 3456899999999999999999999999999999999999999999999999998


Q ss_pred             ccccc---cCcCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CC--
Q 011359          332 CEEVY---CDALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RP--  402 (488)
Q Consensus       332 ~~~~~---~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~--  402 (488)
                      .....   ........||..|+|||++.   +..++.++||||||+++|+|++|..||......+.....+.... .+  
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence            54322   12223456899999999996   56788999999999999999999999998776555555544332 22  


Q ss_pred             -CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          403 -AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       403 -~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                       .....++..+.+||.+||+.+|++||++.++++.|+++.
T Consensus       248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence             234578999999999999999999999999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.6e-45  Score=387.66  Aligned_cols=263  Identities=29%  Similarity=0.540  Sum_probs=225.9

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .+.|.++.++|.+++.||+|+||.||+|.+.+ ..||||++......         .+.|.+|+.+|++++||||+++++
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~  246 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYA  246 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence            46789999999999999999999999999985 67999999754322         246889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++.. ..+++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       247 ~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCc
Confidence            9976 668899999999999999986545679999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          330 IACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       330 la~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      ++.......  ......++..|+|||++....++.++|||||||++|||++ |..||.+....+....+ ..+.+...+.
T Consensus       326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~  404 (452)
T 1fmk_A          326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPP  404 (452)
T ss_dssp             TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCT
T ss_pred             cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCC
Confidence            996433211  1223446788999999998999999999999999999999 99999998887665544 4556677788


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      .++..+.+||.+||+.+|++||++.+|++.|+.+....
T Consensus       405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            99999999999999999999999999999999886543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.9e-45  Score=367.38  Aligned_cols=269  Identities=29%  Similarity=0.531  Sum_probs=229.6

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-  239 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~---------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-  239 (488)
                      ....|.+..++|.+++.||+|+||.||+|.+.         +..||||++......       ...+.+.+|+.+++++ 
T Consensus        26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~   98 (334)
T 2pvf_A           26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-------KDLSDLVSEMEMMKMIG   98 (334)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-------HHHHHHHHHHHHHHHHC
T ss_pred             CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-------HHHHHHHHHHHHHHHhh
Confidence            34677888899999999999999999999874         357999999754321       1246788999999999 


Q ss_pred             CCCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 011359          240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH--------------KTLPLPKLIAIALDIARGMEYIHSQGV  305 (488)
Q Consensus       240 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~gi  305 (488)
                      +||||+++++++.....+++||||+++|+|.+++.....              ..+++..++.++.||+.||+|||++||
T Consensus        99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  178 (334)
T 2pvf_A           99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC  178 (334)
T ss_dssp             CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            899999999999999999999999999999999986432              348899999999999999999999999


Q ss_pred             ccCCCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 011359          306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTI  381 (488)
Q Consensus       306 iHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~  381 (488)
                      +||||||+|||++.++.+||+|||++.......   ......++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  258 (334)
T 2pvf_A          179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS  258 (334)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999986433221   2234457889999999998889999999999999999999 999


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhcc
Q 011359          382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLAC  446 (488)
Q Consensus       382 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~  446 (488)
                      ||.+....+.... +........+..++..+.+||.+||+.+|.+||++.++++.|+++......
T Consensus       259 p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          259 PYPGIPVEELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             SSTTCCHHHHHHH-HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             CcCcCCHHHHHHH-HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            9998877655443 444455667888999999999999999999999999999999999876543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=370.55  Aligned_cols=247  Identities=14%  Similarity=0.248  Sum_probs=216.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||+|++.....         ....+.+|+.+++.++||||+++++++.+...
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   75 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---------DQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc---------cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence            57899999999999999999986  68899999974321         13457899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC--CCcEEEeeecccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ--EFHLKIADFGIACEE  334 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~--~~~vkl~DFgla~~~  334 (488)
                      +++||||++||+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||++...
T Consensus        76 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            9999999999999999975 3346899999999999999999999999999999999999987  789999999999655


Q ss_pred             cccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHH
Q 011359          335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--IPGDCPPAM  412 (488)
Q Consensus       335 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  412 (488)
                      ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+........  ....++.++
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence            443333445689999999999988889999999999999999999999999888877777766554322  124789999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||.+||..||.+||++.++++
T Consensus       235 ~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHhc
Confidence            99999999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=357.36  Aligned_cols=266  Identities=25%  Similarity=0.549  Sum_probs=226.3

Q ss_pred             cccccccceeccc-eeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Q 011359          173 EHTVDLSQLFLGL-RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF  247 (488)
Q Consensus       173 ~~~id~~~~~i~~-~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  247 (488)
                      ++.++.++|.+.+ .||+|+||.||+|.+.    +..||||++......       ...+.+.+|+.++++++||||+++
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~   75 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------ADTEEMMREAQIMHQLDNPYIVRL   75 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-------hHHHHHHHHHHHHHhCCCCCEeEE
Confidence            4567778888877 9999999999999863    578999999764321       124678899999999999999999


Q ss_pred             eeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       248 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                      ++++. ...+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|
T Consensus        76 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~D  153 (287)
T 1u59_A           76 IGVCQ-AEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISD  153 (287)
T ss_dssp             EEEEE-SSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECC
T ss_pred             EEEec-CCCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECc
Confidence            99994 5568899999999999999975 345699999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 011359          328 FGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRP  402 (488)
Q Consensus       328 Fgla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  402 (488)
                      ||++.......    ......+|..|+|||++.+..++.++||||||+++|+|++ |..||......+....+ ....++
T Consensus       154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i-~~~~~~  232 (287)
T 1u59_A          154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRM  232 (287)
T ss_dssp             CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-HTTCCC
T ss_pred             ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-hcCCcC
Confidence            99986432211    1233456889999999998889999999999999999998 99999988776554443 445566


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhcccC
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNG  448 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~~~  448 (488)
                      ..+..++..+.+||.+||+.+|.+||++.++++.|+.+..+...+.
T Consensus       233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence            7788999999999999999999999999999999999988766443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=379.54  Aligned_cols=249  Identities=22%  Similarity=0.329  Sum_probs=215.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  |+.||+|++.......      ...+.+.+|+.++++++||||+++++++.++..
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA------RDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH------HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH------HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            56889999999999999999885  7899999998654322      224678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc---CCCcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~---~~~~vkl~DFgla~~  333 (488)
                      +++|||||.||+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        85 ~~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999999999999987  35699999999999999999999999999999999999998   467899999999965


Q ss_pred             cccc-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcH
Q 011359          334 EVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPP  410 (488)
Q Consensus       334 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~  410 (488)
                      .... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.........  ...+++
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  242 (444)
T 3soa_A          163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP  242 (444)
T ss_dssp             CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence            4332 2234567999999999999889999999999999999999999999998888777777766544332  247899


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.+||.+||+.||++||++.++++
T Consensus       243 ~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          243 EAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhc
Confidence            9999999999999999999999885

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=363.61  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=218.6

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      +.+++|.+.+.||+|+||.||+++..  |+.||||++....     .......+.+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   77 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI-----VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD   77 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence            45678999999999999999999985  7899999997421     0111124567899999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ...+|+||||++||+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus        78 ~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           78 AQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             CCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCccee
Confidence            9999999999999999999986  45789999999999999999999999999999999999999999999999999964


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....  ..++..++.++.
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~  231 (318)
T 1fot_A          156 VP--DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVK  231 (318)
T ss_dssp             CS--SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHH
T ss_pred             cC--CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHH
Confidence            33  22345679999999999998999999999999999999999999999988888777777654  346778999999


Q ss_pred             HHHHHHhhhCCCCCC-----CHHHHHH
Q 011359          414 ALIEQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       414 ~Li~~cL~~dp~~RP-----s~~eil~  435 (488)
                      +||.+||..||.+||     ++.++++
T Consensus       232 ~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          232 DLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            999999999999999     7888774

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.2e-44  Score=357.64  Aligned_cols=264  Identities=27%  Similarity=0.536  Sum_probs=222.0

Q ss_pred             ccccccccceeccc-eeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          172 DEHTVDLSQLFLGL-RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       172 ~~~~id~~~~~i~~-~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      .+..++.++|.+.+ .||+|+||.||+|.+.    ++.||||++.......      ...+.+.+|+.++++++||||++
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~   82 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP------ALKDELLAEANVMQQLDNPYIVR   82 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH------HHHHHHHHHHHHHHhCCCCCEEE
Confidence            45667888999988 9999999999999763    4789999997543221      22567899999999999999999


Q ss_pred             EeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       247 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      +++++ ....+++||||+.+++|.+++..  ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+
T Consensus        83 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           83 MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             EEEEE-ESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             EEEEE-CCCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEc
Confidence            99999 55677899999999999999987  4569999999999999999999999999999999999999999999999


Q ss_pred             eecccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 011359          327 DFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLR  401 (488)
Q Consensus       327 DFgla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  401 (488)
                      |||++.......    ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.... +....+
T Consensus       160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~  238 (291)
T 1xbb_A          160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGER  238 (291)
T ss_dssp             CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCC
T ss_pred             cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCC
Confidence            999985432221    1223446788999999998889999999999999999999 9999999887665444 444556


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       402 ~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      +..+..++..+.++|.+||+.||++||++.++++.|+++.....
T Consensus       239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            67788999999999999999999999999999999999988655

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-44  Score=362.65  Aligned_cols=263  Identities=27%  Similarity=0.539  Sum_probs=221.5

Q ss_pred             ccccccceeccceeeeeccEEEEEEEECC------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF  247 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~~------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  247 (488)
                      +.++.++|.+.+.||+|+||.||+|.+..      ..||||++......       .....+.+|+.++++++||||+++
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~  111 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-------KQRVDFLGEAGIMGQFSHHNIIRL  111 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-------HHHHHHHHHHHHHHhCCCCCCCcE
Confidence            46778899999999999999999998752      25999999754321       124578899999999999999999


Q ss_pred             eeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       248 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                      ++++.....+++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus       112 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~D  190 (333)
T 1mqb_A          112 EGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD  190 (333)
T ss_dssp             EEEECSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             EEEEecCCCcEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECC
Confidence            9999999999999999999999999986 345799999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 011359          328 FGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRP  402 (488)
Q Consensus       328 Fgla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  402 (488)
                      ||++.......    ......+|..|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ...+.
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~  269 (333)
T 1mqb_A          191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRL  269 (333)
T ss_dssp             CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCC
T ss_pred             CCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcC
Confidence            99986433211    1123346788999999998899999999999999999999 999999888766555443 44556


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ..+..++..+.+||.+||+.+|++||++.++++.|+++.....
T Consensus       270 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            6678899999999999999999999999999999999877543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=364.01  Aligned_cols=253  Identities=22%  Similarity=0.342  Sum_probs=217.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++..........  ....+.+.+|+.+|++++||||+++++++.....
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            46889999999999999999986  7899999998654321100  0013568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC----cEEEeeecccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIAC  332 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~----~vkl~DFgla~  332 (488)
                      +++||||+++++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++.
T Consensus        89 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            9999999999999999975  46799999999999999999999999999999999999998887    89999999997


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPP  410 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~  410 (488)
                      ............||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+.......  .....++.
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  246 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence            6544444556679999999999998899999999999999999999999999888777666655443322  12357889


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.+||.+||+.||++||++.++++
T Consensus       247 ~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          247 LAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhc
Confidence            9999999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.8e-45  Score=363.65  Aligned_cols=265  Identities=27%  Similarity=0.541  Sum_probs=227.2

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP  242 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp  242 (488)
                      ..++|.+..++|.+++.||+|+||.||+|.+.       ++.||||++......       .....+.+|+.++++++|+
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~   88 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-------RERIEFLNEASVMKEFNCH   88 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-------HHHHHHHHHHHHGGGCCCT
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-------HHHHHHHHHHHHHHhcCCC
Confidence            45788888999999999999999999999865       468999999743321       1245688999999999999


Q ss_pred             CeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCe
Q 011359          243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN  314 (488)
Q Consensus       243 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~N  314 (488)
                      ||+++++++......++||||+++|+|.+++....        ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus        89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N  168 (322)
T 1p4o_A           89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN  168 (322)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred             CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccce
Confidence            99999999999999999999999999999998642        1457899999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 011359          315 VLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ  390 (488)
Q Consensus       315 ILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~  390 (488)
                      ||++.++.+||+|||++.......   ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.+....+
T Consensus       169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  248 (322)
T 1p4o_A          169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ  248 (322)
T ss_dssp             EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred             EEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence            999999999999999986433221   1223456889999999998999999999999999999999 899999988776


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          391 AAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ....+.... ....+..++..+.+||.+||+.+|.+||++.++++.|+++..
T Consensus       249 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 VLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            665555443 455678899999999999999999999999999999887644

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-44  Score=364.16  Aligned_cols=253  Identities=21%  Similarity=0.326  Sum_probs=209.6

Q ss_pred             cccccceeccceeeeeccEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~-----~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .+..++|.+++.||+|+||.||+++.     .++.||||++........    ......+.+|+.+|++++||||+++++
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~   88 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN----AKDTAHTKAERNILEEVKHPFIVDLIY   88 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEE
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh----hhHHHHHHHHHHHHHhCCCCCccceeE
Confidence            45667899999999999999999987     368999999975432211    112355779999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++.....+|+||||++|++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           89 AFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             EEECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence            999999999999999999999999863  568999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc-cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 011359          330 IACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       330 la~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      ++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....  ..++..+
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~  244 (327)
T 3a62_A          167 LCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPYL  244 (327)
T ss_dssp             CC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCCCTTS
T ss_pred             cccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCCCCCC
Confidence            9864322 222345579999999999998899999999999999999999999999988877776666553  3467788


Q ss_pred             cHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RP-----s~~eil~  435 (488)
                      +..+.+||.+||..||.+||     ++.++++
T Consensus       245 ~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            99999999999999999999     6777765

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.5e-45  Score=393.06  Aligned_cols=263  Identities=29%  Similarity=0.537  Sum_probs=229.5

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .+.|.++.++|.+.+.||+|+||.||+|.+.+ ..||||+++.....         .+.|.+|+.+|++++|+||+++++
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~  329 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYA  329 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence            46788999999999999999999999999985 67999999854422         246889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++.. ..++|||||+.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             EECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             EEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence            9976 668899999999999999986545679999999999999999999999999999999999999999999999999


Q ss_pred             cccccccc--CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          330 IACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       330 la~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      ++......  .......++..|+|||++....++.++|||||||++|||++ |..||.+....+....+ ..+.+...+.
T Consensus       409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~  487 (535)
T 2h8h_A          409 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPP  487 (535)
T ss_dssp             STTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-HTTCCCCCCT
T ss_pred             cceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCC
Confidence            99643221  11233457789999999998999999999999999999999 99999998887665544 4556677788


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      .++..+.+||.+||+.||++||++.+|++.|+.+....
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            99999999999999999999999999999999876543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=361.70  Aligned_cols=257  Identities=32%  Similarity=0.614  Sum_probs=214.2

Q ss_pred             cccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      .++.++|.+.+.||+|+||.||+|.+.++.||||++....          ..+.|.+|+.++++++||||+++++++.+ 
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   72 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES----------ERKAFIVELRQLSRVNHPNIVKLYGACLN-   72 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT----------HHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh----------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            5678899999999999999999999999999999986321          14578899999999999999999999874 


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCCCeEEEcCCCc-EEEeeec
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHS---QGVIHRDLKPENVLIDQEFH-LKIADFG  329 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~giiHrDIkp~NILl~~~~~-vkl~DFg  329 (488)
                       ..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+   +||+||||||+|||++.++. +||+|||
T Consensus        73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg  151 (307)
T 2eva_A           73 -PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG  151 (307)
T ss_dssp             -TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred             -CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence             47899999999999999986432 247888999999999999999999   89999999999999998886 7999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCCCCCCC
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~  408 (488)
                      ++.....  ......||..|+|||++.+..++.++||||||+++|+|++|..||..... .............+..+..+
T Consensus       152 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (307)
T 2eva_A          152 TACDIQT--HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL  229 (307)
T ss_dssp             C--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred             ccccccc--ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence            9854332  22345689999999999988999999999999999999999999986532 22222233445566677889


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      +..+.+||.+||+.||++||++.++++.|+.+...+.
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            9999999999999999999999999999999987764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.5e-44  Score=365.68  Aligned_cols=247  Identities=23%  Similarity=0.403  Sum_probs=210.8

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC  251 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  251 (488)
                      .+.+++|.+++.||+|+||.||+|++.  ++.||||++.........     ..+.+.+|+.++.++ +||||+++++++
T Consensus         5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~~~~hp~iv~l~~~~   79 (345)
T 3a8x_A            5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-----DIDWVQTEKHVFEQASNHPFLVGLHSCF   79 (345)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHH-----HHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchH-----HHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence            356688999999999999999999986  689999999865433221     245678999999988 799999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .....+|+||||++||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a  157 (345)
T 3a8x_A           80 QTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC  157 (345)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccc
Confidence            9999999999999999999999863  56999999999999999999999999999999999999999999999999999


Q ss_pred             cccc-ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhccCC
Q 011359          332 CEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM---------NPIQAAFAVVNKNLR  401 (488)
Q Consensus       332 ~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~---------~~~~~~~~~~~~~~~  401 (488)
                      .... .........||+.|+|||++.+..++.++|||||||++|||++|..||...         ........+...  .
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~  235 (345)
T 3a8x_A          158 KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--Q  235 (345)
T ss_dssp             BCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--C
T ss_pred             ccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--C
Confidence            6532 223345667999999999999989999999999999999999999999752         122222233333  3


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhCCCCCCCH
Q 011359          402 PAIPGDCPPAMAALIEQCWSLQPDKRPEF  430 (488)
Q Consensus       402 ~~~~~~~~~~l~~Li~~cL~~dp~~RPs~  430 (488)
                      ..+|..++..+.+||.+||+.||.+||++
T Consensus       236 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            45678899999999999999999999995

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.1e-44  Score=351.82  Aligned_cols=249  Identities=22%  Similarity=0.366  Sum_probs=218.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++........      ..+.+.+|+.++++++||||+++++++.....
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEESF   79 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHH------HHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence            57889999999999999999986  68999999986543321      24568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc---EEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~---vkl~DFgla~~  333 (488)
                      .++||||+.+++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.   +||+|||++..
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            99999999999999998763  56899999999999999999999999999999999999986655   99999999966


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  411 (488)
                      ...........||..|+|||++.+..++.++||||||+++|+|++|..||.+....+....+.........  ...+++.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T 3kk8_A          158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  237 (284)
T ss_dssp             CCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             cccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence            55555555667999999999999889999999999999999999999999998887777666665543322  3578999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.||++||++.++++
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          238 AKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHcccChhhCCCHHHHhc
Confidence            999999999999999999999987

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-45  Score=361.40  Aligned_cols=258  Identities=26%  Similarity=0.371  Sum_probs=210.5

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHH------------------HHHHHHHHHHHHH
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETL------------------AARLEKQFNREVA  234 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~------------------~~~~~~~~~~Ei~  234 (488)
                      .+..++|.+++.||+|+||.||+|.+.  ++.||||++...........                  .....+.+.+|+.
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            355678999999999999999999885  68999999976542211100                  0112356889999


Q ss_pred             HHHhcCCCCeeeEeeeeec--CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCC
Q 011359          235 LLSRLHNPNVIKFVAACKK--PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP  312 (488)
Q Consensus       235 il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp  312 (488)
                      +|++++||||+++++++..  ...+++||||+++++|.+++.   ...+++..++.++.||+.||+|||++||+||||||
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  165 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP  165 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            9999999999999999986  568999999999999987653   35799999999999999999999999999999999


Q ss_pred             CeEEEcCCCcEEEeeeccccccccc-CcCCCCCCCcccCChhhhhcCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 011359          313 ENVLIDQEFHLKIADFGIACEEVYC-DALSDDPGTYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNP  388 (488)
Q Consensus       313 ~NILl~~~~~vkl~DFgla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~---~~~k~DvwSlGvll~elltG~~Pf~~~~~  388 (488)
                      +|||++.++.+||+|||++...... .......||..|+|||++.+..   ++.++|||||||++|+|++|..||.+...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            9999999999999999998654322 2234567999999999997654   37899999999999999999999998887


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          389 IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ......+............++..+.+||.+||+.||++||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            76666666555554455678999999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.2e-45  Score=358.02  Aligned_cols=260  Identities=33%  Similarity=0.620  Sum_probs=219.7

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .+..++|.+.+.||+|+||.||+|.+.  ++.||||++........... ....+.+.+|+.++++++||||+++++++.
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM-IEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHH-HCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhH-HHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            455678999999999999999999985  78999999976554433221 111257889999999999999999999997


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCeEEEcCCCc-----EEE
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFH-----LKI  325 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--iiHrDIkp~NILl~~~~~-----vkl  325 (488)
                      ...  ++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.|  |+||||||+|||++.++.     +||
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             CCC--eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            665  699999999999999876 3457999999999999999999999999  999999999999988776     999


Q ss_pred             eeecccccccccCcCCCCCCCcccCChhhhh--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCC
Q 011359          326 ADFGIACEEVYCDALSDDPGTYRWMAPEMIK--HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP--IQAAFAVVNKNLR  401 (488)
Q Consensus       326 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~--~~~~~~~~~~~~~  401 (488)
                      +|||++.....  ......||..|+|||++.  ...++.++|||||||++|+|++|..||.....  ......+......
T Consensus       171 ~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  248 (287)
T 4f0f_A          171 ADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR  248 (287)
T ss_dssp             CCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred             CCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence            99999864332  334567999999999983  45678999999999999999999999987653  3334555666777


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       402 ~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      +..+..+++.+.+||.+||+.||.+||++.++++.|+++
T Consensus       249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            888899999999999999999999999999999998753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.1e-44  Score=372.73  Aligned_cols=247  Identities=23%  Similarity=0.399  Sum_probs=209.0

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC  251 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  251 (488)
                      .+.+++|.+++.||+|+||.||+|++.  ++.||||+++........     ....+.+|..+|.++ +||||+++++++
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~-----~~~~~~~E~~il~~~~~hp~Iv~l~~~~  122 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE-----DIDWVQTEKHVFEQASNHPFLVGLHSCF  122 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC---------CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHH-----HHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence            466788999999999999999999986  678999999864322211     134577899999887 799999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .....+++||||++||+|..++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       123 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla  200 (396)
T 4dc2_A          123 QTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC  200 (396)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeeccee
Confidence            9999999999999999999999873  56999999999999999999999999999999999999999999999999999


Q ss_pred             ccc-cccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhccCC
Q 011359          332 CEE-VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN---------PIQAAFAVVNKNLR  401 (488)
Q Consensus       332 ~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~---------~~~~~~~~~~~~~~  401 (488)
                      ... ..........||+.|+|||++.+..++.++|||||||++|||++|..||....         .......+...  .
T Consensus       201 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~  278 (396)
T 4dc2_A          201 KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--Q  278 (396)
T ss_dssp             BCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--C
T ss_pred             eecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--c
Confidence            652 23334556789999999999999999999999999999999999999996432         11222233333  4


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhCCCCCCCH
Q 011359          402 PAIPGDCPPAMAALIEQCWSLQPDKRPEF  430 (488)
Q Consensus       402 ~~~~~~~~~~l~~Li~~cL~~dp~~RPs~  430 (488)
                      ..+|..++.++.+||.+||+.||.+||++
T Consensus       279 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            45778899999999999999999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.3e-45  Score=362.80  Aligned_cols=266  Identities=29%  Similarity=0.512  Sum_probs=225.5

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPN  243 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn  243 (488)
                      ..|.+..++|.+++.||+|+||.||+|.+.       ++.||||++......       ...+.+.+|+.++.++ +|||
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~~hp~   92 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------SEHRALMSELKILIHIGHHLN   92 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-------HHHHHHHHHHHHHHHHCCCTT
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-------HHHHHHHHHHHHHHhcccCCC
Confidence            456777889999999999999999999852       478999999754321       1245788999999999 6999


Q ss_pred             eeeEeeeeecCC-eeeEEEeecCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 011359          244 VIKFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEH--------------KTLPLPKLIAIALDIARGMEYIHSQGVIHR  308 (488)
Q Consensus       244 Iv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~giiHr  308 (488)
                      |+++++++.... .+++||||+++++|.+++.....              ..+++..++.++.||+.||.|||+.||+||
T Consensus        93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~  172 (316)
T 2xir_A           93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR  172 (316)
T ss_dssp             BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            999999987654 58999999999999999987432              127899999999999999999999999999


Q ss_pred             CCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 011359          309 DLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE  384 (488)
Q Consensus       309 DIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~  384 (488)
                      ||||+||+++.++.+||+|||++.......   ......||..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            999999999999999999999986432211   1223447889999999999999999999999999999998 999998


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          385 EMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      +....+.....+........+..+++.+.++|.+||+.||.+||++.++++.|+.+....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            876555555556666667778889999999999999999999999999999999987643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2e-44  Score=357.15  Aligned_cols=261  Identities=26%  Similarity=0.462  Sum_probs=218.0

Q ss_pred             cccccccceeccceeeeeccEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~------~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      ...++..+|.+++.||+|+||.||+|.+      .++.||||++.......       ....+.+|+.++++++||||++
T Consensus        15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~   87 (302)
T 4e5w_A           15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-------HIADLKKEIEILRNLYHENIVK   87 (302)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C-------CHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch-------hHHHHHHHHHHHHhCCCCCeee
Confidence            3445567799999999999999999995      36899999997543221       1356889999999999999999


Q ss_pred             EeeeeecC--CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEE
Q 011359          247 FVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK  324 (488)
Q Consensus       247 l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vk  324 (488)
                      +++++...  ..+++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++
T Consensus        88 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k  166 (302)
T 4e5w_A           88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK  166 (302)
T ss_dssp             EEEEEEC---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             eeeEEecCCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEE
Confidence            99999876  6789999999999999999763 35699999999999999999999999999999999999999999999


Q ss_pred             Eeeeccccccccc----CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCC--------------C
Q 011359          325 IADFGIACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE--------------M  386 (488)
Q Consensus       325 l~DFgla~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~--------------~  386 (488)
                      |+|||++......    .......||..|+|||++.+..++.++||||||+++|+|++|..|+..              .
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  246 (302)
T 4e5w_A          167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ  246 (302)
T ss_dssp             ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred             ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence            9999998643322    123345688889999999988999999999999999999999887532              2


Q ss_pred             CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          387 NPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      .........+........+..+++.+.+||.+||+.||.+||++.++++.|+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            2333344455566667788899999999999999999999999999999999874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.5e-44  Score=366.87  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=216.4

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC  251 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  251 (488)
                      .+..++|.+.+.||+|+||.||+|.+.  ++.||||++.....     ........+..|..+|..+ +||||+++++++
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            456788999999999999999999987  57899999974211     0111235678999999988 799999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .....+|+||||++||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus        91 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           91 QTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence            9999999999999999999999863  46999999999999999999999999999999999999999999999999999


Q ss_pred             cccc-ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          332 CEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       332 ~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      .... .........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....  ..+|..++.
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~  246 (353)
T 2i0e_A          169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSK  246 (353)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCH
T ss_pred             cccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCH
Confidence            6532 2233456679999999999998999999999999999999999999999988887777777654  346778999


Q ss_pred             HHHHHHHHHhhhCCCCCCC-----HHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPE-----FWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs-----~~eil~  435 (488)
                      ++.+||.+||..||.+||+     +.+|++
T Consensus       247 ~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          247 EAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            9999999999999999996     466554

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.1e-44  Score=366.96  Aligned_cols=250  Identities=26%  Similarity=0.358  Sum_probs=219.2

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      ...+++|.+++.||+|+||.||++.+.  |+.||||++....     .........+.+|+.+|+.++||||+++++++.
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  111 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-----VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH-----hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            456788999999999999999999985  7899999997421     111122456889999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +...+|+||||++||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus       112 ~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          112 DNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccce
Confidence            999999999999999999999873  568999999999999999999999999999999999999999999999999996


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....  ..++..++..+
T Consensus       190 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~  265 (350)
T 1rdq_E          190 RVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDL  265 (350)
T ss_dssp             ECSS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHH
T ss_pred             eccC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHH
Confidence            4432  2345579999999999998999999999999999999999999999988887777776654  34677899999


Q ss_pred             HHHHHHHhhhCCCCCCC-----HHHHHH
Q 011359          413 AALIEQCWSLQPDKRPE-----FWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs-----~~eil~  435 (488)
                      .+||.+||+.||.+||+     +.+|++
T Consensus       266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          266 KDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            99999999999999998     777764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=371.63  Aligned_cols=254  Identities=20%  Similarity=0.360  Sum_probs=215.7

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ..+.+.+++|.+.+.||+|+||.||++.+.  ++.||||++....     .........+.+|+.+|+.++||||+++++
T Consensus         8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~   82 (384)
T 4fr4_A            8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK-----CVERNEVRNVFKELQIMQGLEHPFLVNLWY   82 (384)
T ss_dssp             CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh-----cccHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            456778899999999999999999999986  5789999997421     111112456889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +|.....+|+||||+.||+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG  160 (384)
T 4fr4_A           83 SFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFN  160 (384)
T ss_dssp             EEECSSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEeCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccc
Confidence            99999999999999999999999986  4579999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCC
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMN---PIQAAFAVVNKNLRPA  403 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DvwSlGvll~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~  403 (488)
                      ++.............||+.|+|||++..   ..++.++|||||||++|+|++|..||....   ..+....+..  ....
T Consensus       161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~  238 (384)
T 4fr4_A          161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVT  238 (384)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCC
T ss_pred             eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccC
Confidence            9976555555567789999999999964   458999999999999999999999997533   2233222222  2345


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCC-HHHHH
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPE-FWHIV  434 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs-~~eil  434 (488)
                      .+..++..+.+||.+||+.||.+||+ +.+++
T Consensus       239 ~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          239 YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence            67889999999999999999999998 66555

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.5e-44  Score=372.16  Aligned_cols=255  Identities=20%  Similarity=0.352  Sum_probs=211.5

Q ss_pred             cccccceeccceeeee--ccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          175 TVDLSQLFLGLRFAHG--AHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G--~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ..+.++|.+++.||+|  +||.||+|.+.  ++.||||++.......      ...+.+.+|+.++++++||||++++++
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~   94 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN------EMVTFLQGELHVSKLFNHPNIVPYRAT   94 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh------HHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence            4466789999999999  99999999986  7899999998654332      225678899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +..+..+++|||||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B           95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence            99999999999999999999999886667799999999999999999999999999999999999999999999999998


Q ss_pred             cccccc--------cCcCCCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 011359          331 ACEEVY--------CDALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL  400 (488)
Q Consensus       331 a~~~~~--------~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  400 (488)
                      +.....        ........||..|+|||++.+  ..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            743221        112233468999999999987  5789999999999999999999999987654443333222111


Q ss_pred             --------------------------------------------CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 --------------------------------------------RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 --------------------------------------------~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                                                  ....+..+++.+.+||.+||+.||.+||++.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                                        01134567889999999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-44  Score=367.92  Aligned_cols=250  Identities=26%  Similarity=0.344  Sum_probs=202.3

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      .+.++|.+.+.||+|+||+||++...  ++.||||++.......         +.+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~~~~~~~~   87 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---------ENVQREIINHRSLRHPNIVRFKEVILT   87 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---------HHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---------HHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence            45678999999999999999999985  7899999997644322         346799999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc--EEEeeeccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH--LKIADFGIA  331 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~--vkl~DFgla  331 (488)
                      ...+++||||+.+|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++
T Consensus        88 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a  165 (361)
T 3uc3_A           88 PTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS  165 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence            99999999999999999999763  46999999999999999999999999999999999999987765  999999999


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCCCCCC
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK-VDVYSFGLILWEMVAGTIPYEEMNP----IQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k-~DvwSlGvll~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~  406 (488)
                      .............||+.|+|||++.+..+..+ +|||||||++|+|++|..||.+...    ......+...........
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (361)
T 3uc3_A          166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI  245 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTS
T ss_pred             ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcC
Confidence            65444444455679999999999988887655 8999999999999999999987543    333344444444434445


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      .+++.+.+||.+||+.||.+||++.++++.
T Consensus       246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          246 RISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            689999999999999999999999999863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.6e-44  Score=353.27  Aligned_cols=262  Identities=25%  Similarity=0.481  Sum_probs=219.8

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      ..+.+..++|.+++.||+|+||.||+|.+.+     ..||||++......       ...+.+.+|+.++++++||||++
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~   77 (281)
T 3cc6_A            5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-------DNKEKFMSEAVIMKNLDHPHIVK   77 (281)
T ss_dssp             CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-------HHHHHHHHHHHHHHHHCCTTBCC
T ss_pred             ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-------hHHHHHHHHHHHHHhCCCCCcce
Confidence            3466778899999999999999999998753     24999998754321       12467889999999999999999


Q ss_pred             EeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       247 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      +++++..+ ..++||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus        78 ~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~  155 (281)
T 3cc6_A           78 LIGIIEEE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLG  155 (281)
T ss_dssp             EEEEECSS-SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEEC
T ss_pred             EEEEEcCC-CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeC
Confidence            99998755 467999999999999999863 3568999999999999999999999999999999999999999999999


Q ss_pred             eecccccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          327 DFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       327 DFgla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      |||++.......  ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+ .......
T Consensus       156 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-~~~~~~~  234 (281)
T 3cc6_A          156 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EKGDRLP  234 (281)
T ss_dssp             CCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-HHTCCCC
T ss_pred             ccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-hcCCCCC
Confidence            999986433221  1234457889999999998999999999999999999998 99999877665544333 3344556


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      .+..+++.+.+||.+||+.+|++||++.++++.|+++...
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            6778999999999999999999999999999999988764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1e-44  Score=368.51  Aligned_cols=251  Identities=24%  Similarity=0.410  Sum_probs=215.4

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC  251 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  251 (488)
                      .+..++|.+++.||+|+||.||+|++.  ++.||||++.....     ........+..|..++..+ +||||+++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~   87 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   87 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-----hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence            456788999999999999999999986  68999999974210     0111134577899999887 899999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .....+|+||||++||+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus        88 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           88 QTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            9999999999999999999999863  56899999999999999999999999999999999999999999999999999


Q ss_pred             ccccc-cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          332 CEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       332 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      ..... ........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....  +.++..++.
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~  243 (345)
T 1xjd_A          166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEK  243 (345)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCH
T ss_pred             hhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--CCCCcccCH
Confidence            65322 223455679999999999998899999999999999999999999999988877776666543  456778999


Q ss_pred             HHHHHHHHHhhhCCCCCCCHH-HHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFW-HIV  434 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~-eil  434 (488)
                      ++.+||.+||..||.+||++. +|+
T Consensus       244 ~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          244 EAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHHHHHHHhcCCHhHcCCChHHHH
Confidence            999999999999999999987 554

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-44  Score=353.38  Aligned_cols=266  Identities=27%  Similarity=0.539  Sum_probs=219.1

Q ss_pred             cccccccc--eeccceeeeeccEEEEEEEEC--C---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011359          173 EHTVDLSQ--LFLGLRFAHGAHSRLYHGIYK--D---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI  245 (488)
Q Consensus       173 ~~~id~~~--~~i~~~lG~G~~g~Vy~~~~~--~---~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  245 (488)
                      +..++.++  |.+++.||+|+||.||+|.+.  +   ..||||++......       ...+.+.+|+.++++++||||+
T Consensus        13 ~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv   85 (298)
T 3pls_A           13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-------QQVEAFLREGLLMRGLNHPNVL   85 (298)
T ss_dssp             GGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred             heEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH-------HHHHHHHHHHHHHHhCCCCCee
Confidence            34444443  556799999999999999873  2   26999998743321       1246788999999999999999


Q ss_pred             eEeeeeecCCee-eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEE
Q 011359          246 KFVAACKKPPVY-CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK  324 (488)
Q Consensus       246 ~l~~~~~~~~~~-~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vk  324 (488)
                      ++++++...... ++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~k  164 (298)
T 3pls_A           86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVK  164 (298)
T ss_dssp             CCCEEECCSSSCCEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred             eEEEEEecCCCCcEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence            999999766554 899999999999999976 346789999999999999999999999999999999999999999999


Q ss_pred             Eeeecccccccc-----cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhc
Q 011359          325 IADFGIACEEVY-----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG-TIPYEEMNPIQAAFAVVNK  398 (488)
Q Consensus       325 l~DFgla~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG-~~Pf~~~~~~~~~~~~~~~  398 (488)
                      |+|||++.....     ........++..|+|||.+.+..++.++||||||+++|+|++| .+||...+..+. ...+..
T Consensus       165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~-~~~~~~  243 (298)
T 3pls_A          165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-THFLAQ  243 (298)
T ss_dssp             ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH-HHHHHT
T ss_pred             eCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH-HHHhhc
Confidence            999999853322     1223345678899999999999999999999999999999995 555555555443 334444


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhccc
Q 011359          399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACN  447 (488)
Q Consensus       399 ~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~~  447 (488)
                      ......+..++..+.+||.+||+.+|.+||++.++++.|+++...+...
T Consensus       244 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          244 GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence            5556677889999999999999999999999999999999998887644

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.1e-44  Score=362.11  Aligned_cols=264  Identities=28%  Similarity=0.515  Sum_probs=223.4

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC--Cc--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEe
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFV  248 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~--~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~  248 (488)
                      -.++.++|.+++.||+|+||.||+|.+.  +.  .||||.+......       ...+.+.+|+.++.++ +||||++++
T Consensus        20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~~hp~iv~~~   92 (327)
T 1fvr_A           20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-------DDHRDFAGELEVLCKLGHHPNIINLL   92 (327)
T ss_dssp             SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred             ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch-------HHHHHHHHHHHHHHhccCCCchhhhc
Confidence            3467789999999999999999999875  44  3599998743221       1245688999999999 899999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCe
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN  314 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~N  314 (488)
                      +++.....+++||||+++++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N  172 (327)
T 1fvr_A           93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN  172 (327)
T ss_dssp             EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence            99999999999999999999999998632              2468999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 011359          315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF  393 (488)
Q Consensus       315 ILl~~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~  393 (488)
                      ||++.++.+||+|||++.............++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+...
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~  252 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  252 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             EEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence            9999999999999999864433333344567889999999998889999999999999999998 999999988766544


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      . +........+..++..+.+||.+||+.+|.+||++.++++.|+++.....
T Consensus       253 ~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          253 K-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             H-GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             H-hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            3 44455666778899999999999999999999999999999999887643

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.4e-44  Score=353.07  Aligned_cols=259  Identities=17%  Similarity=0.242  Sum_probs=217.9

Q ss_pred             ccccceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACK  252 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  252 (488)
                      +-.++|.+++.||+|+||.||+|.+  .++.||||++......          ..+.+|+.++..+ +|+|++++++++.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~   76 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQ   76 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----------HHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence            3456799999999999999999996  4789999999754332          3466899999999 6999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc-----EEEee
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-----LKIAD  327 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~-----vkl~D  327 (488)
                      .....++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.     +||+|
T Consensus        77 ~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D  154 (298)
T 1csn_A           77 EGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD  154 (298)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             CCceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence            999999999999 99999999863 356999999999999999999999999999999999999987776     99999


Q ss_pred             ecccccccccC--------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH
Q 011359          328 FGIACEEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN---PIQAAFAVV  396 (488)
Q Consensus       328 Fgla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~---~~~~~~~~~  396 (488)
                      ||++.......        ......||..|+|||++.+..++.++||||||+++|+|++|..||.+..   ..+....+.
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            99996443221        1244569999999999999899999999999999999999999998743   333333333


Q ss_pred             hccC---CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhcc
Q 011359          397 NKNL---RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLAC  446 (488)
Q Consensus       397 ~~~~---~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~  446 (488)
                      ....   .......++..+.+||.+||+.+|++||++.+|++.|+++...+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          235 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            2221   1223457899999999999999999999999999999999887653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.3e-44  Score=362.43  Aligned_cols=258  Identities=26%  Similarity=0.530  Sum_probs=214.3

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~----~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      +..++|.+.+.||+|+||.||+|.+.  ++    .||+|.+.....       ....+.|.+|+.++++++||||+++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~   84 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-------PKANKEILDEAYVMASVDNPHVCRLLG   84 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC-------HHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            45578999999999999999999975  33    357887753221       122467889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +|..+. .++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~-~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg  162 (327)
T 3poz_A           85 ICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EEESSS-EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             EEecCC-eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCc
Confidence            998765 67899999999999999873 4579999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          330 IACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       330 la~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      ++.......   ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+....+. ...+........+
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~  241 (327)
T 3poz_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQP  241 (327)
T ss_dssp             HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTCCCCCC
T ss_pred             ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-HHHHHcCCCCCCC
Confidence            986433221   1223456889999999999999999999999999999999 9999998776544 3444555566678


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ..++..+.+||.+||+.+|++||++.++++.|+.+...
T Consensus       242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          242 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            88999999999999999999999999999999988654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.3e-44  Score=357.91  Aligned_cols=268  Identities=28%  Similarity=0.512  Sum_probs=218.5

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI  245 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  245 (488)
                      ..+..++.++|.+++.||+|+||.||+|.+..     ..||||++........      ..+.+.+|+.++++++||||+
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv   99 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR------EIEEFLSEAACMKDFSHPNVI   99 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHH------HHHHHHHHHHHHHTCCCTTBC
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchh------HHHHHHHHHHHHhcCCCCCee
Confidence            45667888999999999999999999998742     4799999976543322      245688999999999999999


Q ss_pred             eEeeeeecCC-----eeeEEEeecCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEE
Q 011359          246 KFVAACKKPP-----VYCVITEYLSEGSLRAYLHKL----EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL  316 (488)
Q Consensus       246 ~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NIL  316 (488)
                      ++++++....     ..++||||+.+++|.+++...    ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       100 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIl  179 (313)
T 3brb_A          100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM  179 (313)
T ss_dssp             CCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEE
T ss_pred             eeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence            9999997654     458999999999999999643    3456999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 011359          317 IDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA  392 (488)
Q Consensus       317 l~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~  392 (488)
                      ++.++.+||+|||++.......   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..
T Consensus       180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  259 (313)
T 3brb_A          180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY  259 (313)
T ss_dssp             ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence            9999999999999986433221   1233457889999999999999999999999999999999 99999988766555


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ..+. .......+..++..+.+||.+||+.+|.+||++.++++.|+.+...+.
T Consensus       260 ~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          260 DYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             HHHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HHHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            4443 344566778899999999999999999999999999999999987654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-44  Score=354.87  Aligned_cols=250  Identities=25%  Similarity=0.384  Sum_probs=206.3

Q ss_pred             ccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +++|.+.+.||+|+||.||+|.+. ++.||||++........      ....+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG------IPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC------CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccc------cchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            367999999999999999999986 78999999976542211      13457799999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||+.+ +|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        75 ~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             EEEEEEecCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            9999999975 99999876 346789999999999999999999999999999999999999999999999999854322


Q ss_pred             -cCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--------------
Q 011359          337 -CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL--------------  400 (488)
Q Consensus       337 -~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~--------------  400 (488)
                       ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.....              
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence             122344568999999999975 4589999999999999999999999999887766555443100              


Q ss_pred             --CC-----------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 --RP-----------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 --~~-----------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                        .+           .....++.++.+||.+||+.||++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              00           112457899999999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6e-44  Score=352.83  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=205.8

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+.+.||+|+||+||+|.+.  ++.||||++.........      ...+.+|+.++++++||||+++++++..+.
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   74 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV------PSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH------HHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc------chHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence            367999999999999999999985  688999999866543321      356789999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+++ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        75 ~~~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           75 KLTLVFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EEEEEEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence            99999999975 66666654 34679999999999999999999999999999999999999999999999999996443


Q ss_pred             c-cCcCCCCCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhccCC-----------
Q 011359          336 Y-CDALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIP-YEEMNPIQAAFAVVNKNLR-----------  401 (488)
Q Consensus       336 ~-~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DvwSlGvll~elltG~~P-f~~~~~~~~~~~~~~~~~~-----------  401 (488)
                      . ........||..|+|||++.+.. ++.++|||||||++|+|++|..| |...+..+....+......           
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence            2 22334557899999999997665 79999999999999999988777 4555554444444321100           


Q ss_pred             ----------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 ----------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 ----------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                      ......++..+.+||.+||+.||++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                            1122357899999999999999999999999876

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.5e-45  Score=365.39  Aligned_cols=249  Identities=27%  Similarity=0.431  Sum_probs=208.2

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||.||+|.+.  ++.||||++.......       ..+.+.+|+.+++.++||||+++++++..+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   78 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-------CPENIKKEICINKMLNHENVVKFYGHRREGN   78 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-------hHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            367999999999999999999986  7899999997543321       1356789999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ..++||||+++|+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             eEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            99999999999999999865  4569999999999999999999999999999999999999999999999999996432


Q ss_pred             c---cCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhccCCCCCCCCCcH
Q 011359          336 Y---CDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA-VVNKNLRPAIPGDCPP  410 (488)
Q Consensus       336 ~---~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~  410 (488)
                      .   ........||..|+|||++.+..+ +.++|||||||++|+|++|..||........... .............++.
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS  236 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCH
Confidence            2   222345679999999999987765 7899999999999999999999987654322222 2233333333456889


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.+||.+||+.||++||++.++++
T Consensus       237 ~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          237 APLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhh
Confidence            9999999999999999999999876

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.1e-44  Score=358.20  Aligned_cols=249  Identities=23%  Similarity=0.373  Sum_probs=204.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      ++|.+.+.||+|+||+||+|.+. ++.||||++.......      .....+.+|+.++++++||||+++++++..+..+
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE------GIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc------hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            67999999999999999999985 7899999997543221      2246688999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc-
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-  336 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~-  336 (488)
                      ++||||++ ++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus        95 ~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           95 TLVFEFME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             EEEEECCS-EEHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             EEEEcCCC-CCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99999997 488888876 345699999999999999999999999999999999999999999999999999965432 


Q ss_pred             cCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---ccCCC----------
Q 011359          337 CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN---KNLRP----------  402 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~---~~~~~----------  402 (488)
                      ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+..   .....          
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence            223345578999999999976 5689999999999999999999999987765544444332   11000          


Q ss_pred             ---------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 ---------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 ---------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                     .....+++++.+||.+||+.||++||++.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                           012346789999999999999999999999886

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.3e-45  Score=359.41  Aligned_cols=249  Identities=31%  Similarity=0.527  Sum_probs=203.3

Q ss_pred             ccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh--cCCCCeeeEeeeeec--
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNVIKFVAACKK--  253 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~--  253 (488)
                      .++|.+++.||+|+||+||+|.++++.||||++....           ...+..|.+++..  ++||||+++++++..  
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----------EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            4678899999999999999999999999999996421           2345567777776  789999999998643  


Q ss_pred             --CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccCCCCCCeEEEcCCCcE
Q 011359          254 --PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH--------SQGVIHRDLKPENVLIDQEFHL  323 (488)
Q Consensus       254 --~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~giiHrDIkp~NILl~~~~~v  323 (488)
                        ...+++||||+++|+|.+++..   ..+++..++.++.||+.||+|||        +.||+||||||+|||++.++.+
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCE
Confidence              3568999999999999999954   57999999999999999999999        9999999999999999999999


Q ss_pred             EEeeecccccccccCc-----CCCCCCCcccCChhhhhcC------CCCchhHHHHHHHHHHHHHhC----------CCC
Q 011359          324 KIADFGIACEEVYCDA-----LSDDPGTYRWMAPEMIKHK------SYGRKVDVYSFGLILWEMVAG----------TIP  382 (488)
Q Consensus       324 kl~DFgla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~------~~~~k~DvwSlGvll~elltG----------~~P  382 (488)
                      ||+|||++........     .....||..|+|||++.+.      .++.++|||||||++|||++|          ..|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            9999999854322211     2334799999999999866      445799999999999999999          888


Q ss_pred             CCCCCH----HHHHHH-HHhccCCCCCCC-----CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          383 YEEMNP----IQAAFA-VVNKNLRPAIPG-----DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       383 f~~~~~----~~~~~~-~~~~~~~~~~~~-----~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      |.....    ...... ......++.++.     .++..+.+||.+||+.||++||++.++++.|+++
T Consensus       233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            865321    122222 223333444442     3567899999999999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-44  Score=379.96  Aligned_cols=254  Identities=22%  Similarity=0.378  Sum_probs=210.9

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      .+.+..++|.+++.||+|+||.||+|.+.  ++.||||++......     .......+.+|+.+++.++||||++++++
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~l~~~  216 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHPFLTALKYS  216 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEE
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-----hhHHHHHHHHHHHHHHhCCCCeEeeEEEE
Confidence            34566788999999999999999999985  689999999742111     11123567899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      |.....++|||||+++|+|.+++...  ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus       217 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          217 FQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             EEETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             EeeCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCC
Confidence            99999999999999999999999863  578999999999999999999998 999999999999999999999999999


Q ss_pred             cccccc-ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 011359          330 IACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       330 la~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      ++.... .........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.....  .++..+
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~  372 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--RFPRTL  372 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTS
T ss_pred             CceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--CCCccC
Confidence            996432 22334556799999999999999999999999999999999999999999888777776666543  467789


Q ss_pred             cHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RP-----s~~eil~  435 (488)
                      ++++.+||.+||+.||.+||     ++.++++
T Consensus       373 ~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          373 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            99999999999999999999     9998875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-44  Score=372.19  Aligned_cols=248  Identities=20%  Similarity=0.338  Sum_probs=215.6

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|.+.  ++.||+|++......        ....+.+|+.+|++++||||+++++++.....
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--------DKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--------HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh--------hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            57999999999999999999986  688999999754311        13468899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC--CCcEEEeeecccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ--EFHLKIADFGIACEE  334 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~--~~~vkl~DFgla~~~  334 (488)
                      +++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||++...
T Consensus       123 ~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence            9999999999999999875 3346899999999999999999999999999999999999974  477999999999655


Q ss_pred             cccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHH
Q 011359          335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--PAIPGDCPPAM  412 (488)
Q Consensus       335 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  412 (488)
                      ..........||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......  ......++.++
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  281 (387)
T 1kob_A          202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  281 (387)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            4333334457999999999999889999999999999999999999999998887776666654432  33445789999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||.+||+.||++||++.++++
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          282 KDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHcCCChhHCcCHHHHhh
Confidence            99999999999999999999886

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.2e-44  Score=363.73  Aligned_cols=253  Identities=20%  Similarity=0.352  Sum_probs=209.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++.........   ....+.+.+|+.+++.++||||+++++++..+..
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP---GLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS---SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc---cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            56899999999999999999985  789999999642100000   0013568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc---EEEeeeccc
Q 011359          257 YCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIA  331 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~---vkl~DFgla  331 (488)
                      +|+|||||+|++|.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999999999888754  2346899999999999999999999999999999999999986654   999999999


Q ss_pred             ccccccC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CCCCC
Q 011359          332 CEEVYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--IPGDC  408 (488)
Q Consensus       332 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~  408 (488)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .+....+........  ....+
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~  259 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI  259 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTS
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccC
Confidence            6543322 2345679999999999998899999999999999999999999998753 344444444433221  12568


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.++.+||.+||+.||++||++.++++
T Consensus       260 s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          260 SESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            899999999999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.7e-44  Score=359.28  Aligned_cols=261  Identities=27%  Similarity=0.478  Sum_probs=220.0

Q ss_pred             cccccceeccceeeeeccEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~------~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      .++...|.+++.||+|+||.||++.+      .++.||||++......       ...+.+.+|+.+|++++||||++++
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~   99 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP-------QHRSGWKQEIDILRTLYHEHIIKYK   99 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH-------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh-------HHHHHHHHHHHHHHhCCCcchhhEE
Confidence            44445568999999999999999876      3678999999754321       2246788999999999999999999


Q ss_pred             eeeec--CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          249 AACKK--PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       249 ~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      +++..  ...+++||||+++++|.+++..   ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~  176 (318)
T 3lxp_A          100 GCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIG  176 (318)
T ss_dssp             EEEEETTTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEecCCCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEEC
Confidence            99987  4678999999999999999976   459999999999999999999999999999999999999999999999


Q ss_pred             eecccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-------------
Q 011359          327 DFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI-------------  389 (488)
Q Consensus       327 DFgla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~-------------  389 (488)
                      |||++.......    ......++..|+|||++.+..++.++||||||+++|+|++|..||......             
T Consensus       177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  256 (318)
T 3lxp_A          177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT  256 (318)
T ss_dssp             CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred             CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence            999996543221    223455788899999999889999999999999999999999999754221             


Q ss_pred             -HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          390 -QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       390 -~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                       ......+........+..++..+.+||.+||+.||.+||++.++++.|+.+...+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence             12333445566677788999999999999999999999999999999999988765

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.8e-44  Score=360.90  Aligned_cols=255  Identities=21%  Similarity=0.308  Sum_probs=213.8

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  254 (488)
                      .++|.+++.||+|+||.||+|.+.  ++.||||++......          ..+.+|+.+++++ +|+||+++++++...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   77 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----------PQLHLEYRFYKQLGSGDGIPQVYYFGPCG   77 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----------CCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----------HHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence            367899999999999999999964  789999999765432          2467999999999 899999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc-----EEEeeec
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-----LKIADFG  329 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~-----vkl~DFg  329 (488)
                      ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.     +||+|||
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           78 KYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             CccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            9999999999 99999999864 467999999999999999999999999999999999999998887     9999999


Q ss_pred             ccccccccCc--------CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc
Q 011359          330 IACEEVYCDA--------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN---PIQAAFAVVNK  398 (488)
Q Consensus       330 la~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~---~~~~~~~~~~~  398 (488)
                      ++........        .....||..|+|||++.+..++.++|||||||++|||++|..||.+..   ..+....+...
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  235 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT  235 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence            9965332221        235679999999999999999999999999999999999999998743   22333333222


Q ss_pred             cCC---CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          399 NLR---PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       399 ~~~---~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ...   ......+| ++.+||.+||+.+|.+||++.+|++.|+++...+.
T Consensus       236 ~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          236 KRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            111   11234466 99999999999999999999999999998887654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-43  Score=357.02  Aligned_cols=244  Identities=24%  Similarity=0.409  Sum_probs=211.5

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  258 (488)
                      |...+.||+|+||.||+|.+.  |+.||||++.......        .+.+.+|+.++++++||||+++++++......+
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELW  118 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--------HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence            556678999999999999985  7899999998654432        345789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-  337 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-  337 (488)
                      +||||+++++|.+++..   ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...... 
T Consensus       119 lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          119 VLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             EEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence            99999999999999864   56999999999999999999999999999999999999999999999999998644322 


Q ss_pred             CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCcHHHHHHH
Q 011359          338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-PAIPGDCPPAMAALI  416 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~Li  416 (488)
                      .......||..|+|||++.+..++.++||||||+++|+|++|..||......+....+...... ......+++.+.+||
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  275 (321)
T 2c30_A          196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL  275 (321)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHH
T ss_pred             cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHH
Confidence            2234567999999999999889999999999999999999999999988877766555443321 123346789999999


Q ss_pred             HHHhhhCCCCCCCHHHHHH
Q 011359          417 EQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       417 ~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||+.||++||++.++++
T Consensus       276 ~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          276 ERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHSCSSTTTSCCHHHHHT
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            9999999999999999886

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.7e-45  Score=370.51  Aligned_cols=267  Identities=17%  Similarity=0.232  Sum_probs=209.9

Q ss_pred             cccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHH---HHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETL---AARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      ..++|.+++.||+|+||.||+|.+.       ++.||||++...........   .......+..|+..+..++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            3467999999999999999999885       36899999975432111100   0011123556777888899999999


Q ss_pred             EeeeeecC----CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc--CC
Q 011359          247 FVAACKKP----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID--QE  320 (488)
Q Consensus       247 l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~--~~  320 (488)
                      +++++...    ...+|||||+ |++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++  .+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            99998764    4589999999 9999999987 346799999999999999999999999999999999999999  88


Q ss_pred             CcEEEeeecccccccccCc--------CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 011359          321 FHLKIADFGIACEEVYCDA--------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA  392 (488)
Q Consensus       321 ~~vkl~DFgla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~  392 (488)
                      +.+||+|||++........        .....||..|+|||++.+..++.++|||||||++|||++|..||.+.......
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            9999999999954332211        13345999999999999989999999999999999999999999864322211


Q ss_pred             HHHHhccCCC---------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          393 FAVVNKNLRP---------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       393 ~~~~~~~~~~---------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ..........         .....++.++.+||..||+.+|++||++.+|++.|+++...+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            1111100000         0125789999999999999999999999999999999988765

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-44  Score=376.36  Aligned_cols=255  Identities=23%  Similarity=0.335  Sum_probs=217.4

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      +..+..++|.+++.||+|+||+||+|++.  ++.||||++....     .........+.+|+.++..++||||++++++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~  137 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-----MIKRSDSAFFWEERDIMAFANSPWVVQLFYA  137 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhh-----hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            44566788999999999999999999986  6889999997411     0000112347799999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      |.++..+|||||||+||+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       138 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          138 FQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccce
Confidence            9999999999999999999999976   4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC--cCCCCCCCcccCChhhhhcCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCC
Q 011359          331 ACEEVYCD--ALSDDPGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN--LRP  402 (488)
Q Consensus       331 a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~----~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~--~~~  402 (488)
                      +.......  ......||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+..+....+....  +..
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  294 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF  294 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC
Confidence            96543222  234567999999999998665    7899999999999999999999999998888777776643  222


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCC--CCCHHHHHH
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDK--RPEFWHIVK  435 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~--RPs~~eil~  435 (488)
                      .....++.++.+||.+||..+|.+  ||++.+|++
T Consensus       295 p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          295 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            333578999999999999988988  999999886

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.3e-44  Score=349.03  Aligned_cols=246  Identities=20%  Similarity=0.331  Sum_probs=214.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|.+.  +..||+|++.......        .+.+.+|+.++++++||||+++++++.....
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--------VDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            46889999999999999999987  4689999997644332        3467899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE---cCCCcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl---~~~~~vkl~DFgla~~  333 (488)
                      +++||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+||++   +.++.++|+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            99999999999999999763  568999999999999999999999999999999999999   7889999999999976


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI--PGDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  411 (488)
                      ...........||..|+|||++.+ .++.++||||||+++|+|++|..||......+....+.........  ...+++.
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (277)
T 3f3z_A          159 FKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ  237 (277)
T ss_dssp             CCTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred             ccCccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence            554455566779999999999875 4899999999999999999999999998887777766665433221  1368899


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.||++||++.++++
T Consensus       238 ~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          238 AESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999999886

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.9e-44  Score=349.41  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=215.3

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .+.+++|.+++.||+|+||.||+|.+.  ++.||||++....     .........+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   79 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-----cchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence            345678999999999999999999987  4689999997421     111223567889999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .....++||||+++++|.+++...  ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           80 DATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            999999999999999999999874  568999999999999999999999999999999999999999999999999885


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      .... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||......+....+...  ....+..++..+
T Consensus       158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  234 (279)
T 3fdn_A          158 HAPS-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGA  234 (279)
T ss_dssp             CC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHH
T ss_pred             cCCc-ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--CCCCCCcCCHHH
Confidence            4332 2234557899999999999889999999999999999999999999988877666555443  345677899999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      .+||.+||+.||.+||++.++++.
T Consensus       235 ~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          235 RDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHHhccChhhCCCHHHHhhC
Confidence            999999999999999999999973

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.9e-43  Score=351.91  Aligned_cols=264  Identities=25%  Similarity=0.408  Sum_probs=212.6

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      .+++|.+.+.||+|+||.||+|.+.  ++.||||++........     .....+.+|+.++++++||||+++++++...
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA-----KARADCIKEIDLLKQLNHPNVIKYYASFIED  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCH-----HHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            4467999999999999999999974  78999999986443322     2246788999999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      ..+++||||+.+++|.+++...  ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            9999999999999999999753  35668999999999999999999999999999999999999999999999999985


Q ss_pred             ccccc-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhccCCCCCCCCCc
Q 011359          333 EEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM--NPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       333 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ..... .......|+..|+|||++.+..++.++||||||+++|+|++|..||.+.  ........+......+.....++
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS  264 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred             eecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence            43322 1223446899999999999889999999999999999999999999754  23333334444444444446789


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      .++.+||.+||+.||++||++.++++.|+++.....
T Consensus       265 ~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            999999999999999999999999999999988765

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.4e-44  Score=359.73  Aligned_cols=263  Identities=26%  Similarity=0.474  Sum_probs=220.3

Q ss_pred             ccccccceeccceeeeeccEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF  247 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~------~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  247 (488)
                      ..++.++|.+++.||+|+||.||+|.+      .++.||||++.....        ...+.+.+|+.++++++|+||+++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~   89 (327)
T 3lxl_A           18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--------DQQRDFQREIQILKALHSDFIVKY   89 (327)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH--------HHHHHHHHHHHHHHhcCCCceeEE
Confidence            346678899999999999999999986      367899999975421        124568899999999999999999


Q ss_pred             eeeee--cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEE
Q 011359          248 VAACK--KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI  325 (488)
Q Consensus       248 ~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl  325 (488)
                      ++++.  ....+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl  168 (327)
T 3lxl_A           90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKI  168 (327)
T ss_dssp             EEEEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             EEEEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEE
Confidence            99886  4567899999999999999998632 46899999999999999999999999999999999999999999999


Q ss_pred             eeecccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-------------
Q 011359          326 ADFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP-------------  388 (488)
Q Consensus       326 ~DFgla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~-------------  388 (488)
                      +|||++.......    ......||..|+|||++.+..++.++||||||+++|+|++|..||.....             
T Consensus       169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  248 (327)
T 3lxl_A          169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP  248 (327)
T ss_dssp             CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC
T ss_pred             cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc
Confidence            9999986432211    22345688889999999988899999999999999999999999865332             


Q ss_pred             -HHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          389 -IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       389 -~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                       .......+........+..+++.+.+||.+||+.||++||++.++++.|+.+.....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence             233444555666777788999999999999999999999999999999998876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.8e-44  Score=370.58  Aligned_cols=248  Identities=24%  Similarity=0.369  Sum_probs=207.6

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHH-HHhcCCCCeeeEeeeee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVAL-LSRLHNPNVIKFVAACK  252 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~  252 (488)
                      +..++|.+.+.||+|+||.||+|++.  ++.||||++........     .....+.+|..+ ++.++||||+++++++.
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-----~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~  109 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-----KEEKHIMSERNVLLKNVKHPFLVGLHFSFQ  109 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-----HHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence            34578899999999999999999986  57899999976432221     113456677776 57789999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      ....+|+||||++||+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            99999999999999999999986  3568899999999999999999999999999999999999999999999999996


Q ss_pred             ccc-ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          333 EEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       333 ~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      ... .........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....  ..++..++..
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~  265 (373)
T 2r5t_A          188 ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNS  265 (373)
T ss_dssp             GGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--CCCCSSSCHH
T ss_pred             ccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHH
Confidence            532 2233445679999999999999999999999999999999999999999988887777777654  3456789999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWH  432 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~e  432 (488)
                      +.+||.+||+.||.+||++.+
T Consensus       266 ~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          266 ARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHHHHHHHTCSSGGGSTTTTT
T ss_pred             HHHHHHHHcccCHHhCCCCCC
Confidence            999999999999999999853

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=364.76  Aligned_cols=245  Identities=26%  Similarity=0.402  Sum_probs=196.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++.....          .+.+.+|+.+|++++||||+++++++.....
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTE  122 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----------HHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence            56889999999999999999996  57899999985321          3457799999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC---CCcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~---~~~vkl~DFgla~~  333 (488)
                      +++||||+++++|.+++..  ...+++..++.++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||++..
T Consensus       123 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            9999999999999999975  456899999999999999999999999999999999999975   88999999999865


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCC--CCCCCCCcH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ-AAFAVVNKNLR--PAIPGDCPP  410 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~-~~~~~~~~~~~--~~~~~~~~~  410 (488)
                      ...........||+.|+|||++.+..++.++|||||||++|+|++|..||......+ ....+......  ......++.
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence            444334455679999999999998899999999999999999999999998766554 33334443322  223357899


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.+||.+||+.||++||++.++++
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999999886

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.3e-44  Score=388.61  Aligned_cols=264  Identities=25%  Similarity=0.561  Sum_probs=221.3

Q ss_pred             cccccccceeccc-eeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Q 011359          173 EHTVDLSQLFLGL-RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF  247 (488)
Q Consensus       173 ~~~id~~~~~i~~-~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  247 (488)
                      .+.+..+++.+.. .||+|+||.||+|.+.    +..||||+++.......       .++|.+|+.+|++++|||||++
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-------~~~~~~E~~il~~l~hpniv~l  401 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-------TEEMMREAQIMHQLDNPYIVRL  401 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTT-------HHHHHHHHHHHTTCCCTTBCCE
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHH-------HHHHHHHHHHHHhCCCCCEeeE
Confidence            3455566666666 8999999999999874    35799999986533221       4578899999999999999999


Q ss_pred             eeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       248 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                      +++|.. ..+++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus       402 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~D  479 (613)
T 2ozo_A          402 IGVCQA-EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISD  479 (613)
T ss_dssp             EEEEES-SSEEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             EEEecc-CCeEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEee
Confidence            999986 458899999999999999975 345699999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 011359          328 FGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRP  402 (488)
Q Consensus       328 Fgla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  402 (488)
                      ||++.......    ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.... +..+.+.
T Consensus       480 FGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~  558 (613)
T 2ozo_A          480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRM  558 (613)
T ss_dssp             CSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-HHTTCCC
T ss_pred             ccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCC
Confidence            99996532211    1123345688999999999999999999999999999998 9999999887665544 4455677


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhcc
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLAC  446 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~  446 (488)
                      ..+..++.++.+||.+||+.+|++||++.+|++.|+.+...+..
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence            78889999999999999999999999999999999999887654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-43  Score=349.65  Aligned_cols=249  Identities=23%  Similarity=0.352  Sum_probs=207.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||++.+.  ++.||||++........       .+.+.+|+.++++++||||+++++++.....
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-------MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-------HHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            56889999999999999999986  68999999986543221       3567899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE---cCCCcEEEeeeccc
Q 011359          257 YCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIA  331 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl---~~~~~vkl~DFgla  331 (488)
                      +++||||+++|+|.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            99999999999999999754  34679999999999999999999999999999999999999   45688999999999


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-CCCCCcH
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA-IPGDCPP  410 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  410 (488)
                      .............||..|+|||++. ..++.++||||||+++|+|++|..||.+....+............. ....+++
T Consensus       175 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (285)
T 3is5_A          175 ELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP  253 (285)
T ss_dssp             CC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred             eecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCH
Confidence            6544444445667999999999986 5789999999999999999999999999887766555544433222 2345789


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.+||.+||+.||++||++.++++
T Consensus       254 ~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          254 QAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999999885

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=359.43  Aligned_cols=256  Identities=21%  Similarity=0.361  Sum_probs=210.8

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||+||+|.+.  ++.||||++........       .+.+.+|+.++++++||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNHKNIVKLFAIEEETT   80 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-------HHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence            367899999999999999999997  78999999975332111       345779999999999999999999987655


Q ss_pred             --eeeEEEeecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE----cCCCcEEEeee
Q 011359          256 --VYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIADF  328 (488)
Q Consensus       256 --~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl----~~~~~vkl~DF  328 (488)
                        .+++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df  160 (319)
T 4euu_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (319)
T ss_dssp             TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred             CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence              7899999999999999998643 2349999999999999999999999999999999999999    78888999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhh--------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIK--------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP----IQAAFAVV  396 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~----~~~~~~~~  396 (488)
                      |++.............||..|+|||++.        +..++.++|||||||++|||++|..||.....    .+....+.
T Consensus       161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            9997655544555667999999999986        46789999999999999999999999975432    33344444


Q ss_pred             hccCC-----------------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          397 NKNLR-----------------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       397 ~~~~~-----------------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      .....                       ..+...++..+.+||.+||+.||++||++.++++...+-
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            33211                       012234457899999999999999999999999877644

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.6e-44  Score=355.61  Aligned_cols=255  Identities=22%  Similarity=0.442  Sum_probs=211.7

Q ss_pred             cccccceeccceeeeeccEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI  245 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~~---------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  245 (488)
                      .+..++|.+++.||+|+||.||+|.+..         ..||+|++......        ..+.+.+|+.++++++||||+
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv   75 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN--------YSESFFEAASMMSKLSHKHLV   75 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG--------GHHHHHHHHHHHHTSCCTTBC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH--------HHHHHHHHHHHHHhCCCCCEe
Confidence            4567889999999999999999998753         46999999643221        145688999999999999999


Q ss_pred             eEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc---
Q 011359          246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---  322 (488)
Q Consensus       246 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~---  322 (488)
                      ++++++..+...++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.   
T Consensus        76 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~  154 (289)
T 4fvq_A           76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKT  154 (289)
T ss_dssp             CEEEEECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGG
T ss_pred             EEEEEEEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccc
Confidence            9999999999999999999999999999873 334899999999999999999999999999999999999998887   


Q ss_pred             -----EEEeeecccccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 011359          323 -----LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV  395 (488)
Q Consensus       323 -----vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~  395 (488)
                           +||+|||++......   ....||..|+|||++.+ ..++.++||||||+++|+|++ |..||........... 
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-  230 (289)
T 4fvq_A          155 GNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-  230 (289)
T ss_dssp             TBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-
T ss_pred             cccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-
Confidence                 999999998543221   12247888999999987 678999999999999999999 5566666655443332 


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       396 ~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      ...  ....+..++.++.+||.+||+.||++||++.++++.|+++...-
T Consensus       231 ~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          231 YED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             HHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             hhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            222  34456677889999999999999999999999999999886643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.1e-44  Score=352.05  Aligned_cols=258  Identities=27%  Similarity=0.549  Sum_probs=214.7

Q ss_pred             cceeccceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee-e
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-K  252 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~  252 (488)
                      .+|.+++.||+|+||.||+|.+.+     ..||||.+......       ...+.+.+|+.++++++||||+++++++ .
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-------GEVSQFLTEGIIMKDFSHPNVLSLLGICLR   97 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-------HHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-------HHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence            357889999999999999998742     25889988753321       1246788999999999999999999986 4


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .+...++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             CCCceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccc
Confidence            56688999999999999999975 34568999999999999999999999999999999999999999999999999996


Q ss_pred             ccccc-----CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          333 EEVYC-----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       333 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      .....     .......+|..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  255 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPE  255 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCT
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCc
Confidence            43221     12234457889999999999999999999999999999999 677777766555444443 344556678


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      .++..+.++|.+||+.+|++||++.++++.|+.+...+.
T Consensus       256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            899999999999999999999999999999999988654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-43  Score=360.99  Aligned_cols=248  Identities=27%  Similarity=0.413  Sum_probs=215.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +.|.+.+.||+|+||.||+|.+.  ++.||||++.........     ..+.+.+|+.++++++||||+++++++..+..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-----KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHH-----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe
Confidence            34788899999999999999974  789999999865443322     24678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .++||||+. |+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            999999996 6888888653 46799999999999999999999999999999999999999999999999999864432


Q ss_pred             cCcCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          337 CDALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                         .....||+.|+|||++.   ...++.++|||||||++|||++|..||...+.......+.........+..++..+.
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  283 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR  283 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence               23457999999999985   467899999999999999999999999999888777777766655555678899999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHHH
Q 011359          414 ALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      +||.+||+.+|++||++.++++.
T Consensus       284 ~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          284 NFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHcccChhhCcCHHHHhhC
Confidence            99999999999999999998863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.7e-43  Score=362.02  Aligned_cols=255  Identities=22%  Similarity=0.441  Sum_probs=220.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  255 (488)
                      ++|.+.+.||.|+||.||+|.+.  |+.||||++................+.+.+|+.++.++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            46889999999999999999985  78999999987654333333344567789999999999 7999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ..++||||++|++|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            999999999999999999863  568999999999999999999999999999999999999999999999999986655


Q ss_pred             ccCcCCCCCCCcccCChhhhhcC------CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CC
Q 011359          336 YCDALSDDPGTYRWMAPEMIKHK------SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GD  407 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~~------~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~  407 (488)
                      .........||+.|+|||++.+.      .++.++|||||||++|+|++|..||...........+.........+  ..
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  331 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD  331 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            44445567899999999998633      57899999999999999999999999888777666666554443222  46


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++..+.+||.+||+.||++||++.++++
T Consensus       332 ~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          332 RSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            7889999999999999999999999886

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=8.2e-44  Score=389.55  Aligned_cols=263  Identities=27%  Similarity=0.537  Sum_probs=220.1

Q ss_pred             ccccccccceecc-ceeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          172 DEHTVDLSQLFLG-LRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       172 ~~~~id~~~~~i~-~~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      .++.++...+.+. +.||+|+||.||+|.+.    ++.||||+++.......      ..++|.+|+.+|++++|||||+
T Consensus       361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~  434 (635)
T 4fl3_A          361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA------LKDELLAEANVMQQLDNPYIVR  434 (635)
T ss_dssp             SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG------GHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH------HHHHHHHHHHHHHhCCCCCEee
Confidence            3455666666664 47999999999999773    46899999975433221      2467899999999999999999


Q ss_pred             EeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       247 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      ++++|..+ .+++||||+.+|+|.+++..  ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus       435 l~~~~~~~-~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~  511 (635)
T 4fl3_A          435 MIGICEAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS  511 (635)
T ss_dssp             EEEEEESS-SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             EEEEEecC-CEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEE
Confidence            99999754 57899999999999999976  4678999999999999999999999999999999999999999999999


Q ss_pred             eeccccccccc----CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 011359          327 DFGIACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLR  401 (488)
Q Consensus       327 DFgla~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  401 (488)
                      |||++......    .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+....+.... +....+
T Consensus       512 DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~  590 (635)
T 4fl3_A          512 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGER  590 (635)
T ss_dssp             CTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCC
T ss_pred             EcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCC
Confidence            99998643221    12233456788999999999999999999999999999998 9999999888665544 445556


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       402 ~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      ...+..++.++.+||.+||+.||++||++.+|++.|+++...+
T Consensus       591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            7788899999999999999999999999999999999987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=367.72  Aligned_cols=250  Identities=21%  Similarity=0.271  Sum_probs=211.1

Q ss_pred             eccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeE
Q 011359          182 FLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV  259 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  259 (488)
                      ...+.||+|+||.||+|.+.  |+.||||++.....        ...+.+.+|+.+|++++||||+++++++.....++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--------KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--------HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            34678999999999999985  78999999985431        124578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE--cCCCcEEEeeeccccccccc
Q 011359          260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI--DQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       260 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl--~~~~~vkl~DFgla~~~~~~  337 (488)
                      ||||+++++|.+++.. ....+++..++.++.||+.||+|||+.||+||||||+|||+  +.++.+||+|||++......
T Consensus       164 v~E~~~~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          164 VMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EEECCTTCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             EEeCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            9999999999999876 23468999999999999999999999999999999999999  56789999999999765544


Q ss_pred             CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHHHHH
Q 011359          338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--IPGDCPPAMAAL  415 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~L  415 (488)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........  ....+++++.+|
T Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  322 (373)
T 2x4f_A          243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF  322 (373)
T ss_dssp             CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred             cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence            445566799999999999988999999999999999999999999999988877777766544322  235789999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH--HHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK--VLEQF  440 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~--~Le~~  440 (488)
                      |.+||+.||.+||++.++++  .|...
T Consensus       323 i~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          323 ISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            99999999999999999987  44443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.7e-45  Score=369.11  Aligned_cols=248  Identities=26%  Similarity=0.425  Sum_probs=210.4

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||.||+|.+.  ++.||||++.....     ........+.+|+.+++.++||||+++++++....
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-----KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc-----cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            478999999999999999999984  78999999973210     00111346889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+ +|+|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            999999999 78999988763  569999999999999999999999999999999999999999999999999997655


Q ss_pred             ccCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          336 YCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+  ......++..+++.+.+
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~  237 (336)
T 3h4j_B          160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQS  237 (336)
T ss_dssp             TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHH
T ss_pred             CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHH
Confidence            5555566789999999999987776 78999999999999999999999875432211111  11223466778999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+||+.||.+||++.++++
T Consensus       238 li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          238 LIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             HHHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHHh
Confidence            999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-44  Score=362.53  Aligned_cols=259  Identities=24%  Similarity=0.466  Sum_probs=215.2

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--Ccc----EEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEP----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~----vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      .+..++|.+.+.||+|+||.||+|.+.  ++.    ||+|++........       ...+.+|+.++.+++||||++++
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~   81 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-------FQAVTDHMLAIGSLDHAHIVRLL   81 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-------BCSCCHHHHHHHTCCCTTBCCEE
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-------HHHHHHHHHHHhcCCCCCcCeEE
Confidence            455678999999999999999999985  343    78888754332211       23466899999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      +++.. ...++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        82 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df  159 (325)
T 3kex_A           82 GLCPG-SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF  159 (325)
T ss_dssp             EEECB-SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSC
T ss_pred             EEEcC-CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCC
Confidence            99874 5678999999999999999763 346889999999999999999999999999999999999999999999999


Q ss_pred             cccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 011359          329 GIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       329 gla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  404 (488)
                      |++.......   ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+... .+........
T Consensus       160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~  238 (325)
T 3kex_A          160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-LLEKGERLAQ  238 (325)
T ss_dssp             SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-HHHTTCBCCC
T ss_pred             CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-HHHcCCCCCC
Confidence            9996543221   2234457889999999998999999999999999999999 999999877655443 3444455667


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      +..++..+.+||.+||+.||.+||++.++++.|+.+...
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          239 PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            778899999999999999999999999999999988653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=358.67  Aligned_cols=251  Identities=23%  Similarity=0.377  Sum_probs=211.1

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeeEeeeee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACK  252 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~  252 (488)
                      +..++|.+++.||+|+||.||++.+. ++.||||++........      ..+.+.+|+.+|.+++|  +||+++++++.
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   79 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ------TLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   79 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHH------HHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchH------HHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence            45567999999999999999999875 67899999986554322      24678899999999986  99999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .+..+++|||+ .+++|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.
T Consensus        80 ~~~~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           80 TDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             CSSEEEEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             eCCEEEEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence            99999999995 58899999987  46789999999999999999999999999999999999997 6789999999996


Q ss_pred             cccccC---cCCCCCCCcccCChhhhhc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh
Q 011359          333 EEVYCD---ALSDDPGTYRWMAPEMIKH-----------KSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVN  397 (488)
Q Consensus       333 ~~~~~~---~~~~~~gt~~y~aPE~l~~-----------~~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~  397 (488)
                      ......   ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||.... .......+..
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  235 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  235 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence            543221   2234579999999999965           678999999999999999999999998754 4455566666


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       398 ~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      .......+..++..+.+||.+||+.||.+||++.++++.
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            666677888889999999999999999999999999863

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.8e-44  Score=377.82  Aligned_cols=253  Identities=28%  Similarity=0.456  Sum_probs=220.2

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      ..+..++|.+++.||+|+||.||+|.+.  |+.||||++.....     ........+.+|+.+|+.++||||+++++++
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~   85 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-----RSLDVVGKIRREIQNLKLFRHPHIIKLYQVI   85 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH-----HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-----cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3455688999999999999999999986  78999999974210     0111245688999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .....+++||||++||+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a  163 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS  163 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccch
Confidence            999999999999999999999975  467999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      .............||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....  ...+..+++
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~  241 (476)
T 2y94_A          164 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQYLNP  241 (476)
T ss_dssp             EECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--CCCCTTCCH
T ss_pred             hhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--cCCCccCCH
Confidence            76554445566789999999999987765 789999999999999999999999887766666655543  345677899


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.+||.+||+.||.+||++.++++
T Consensus       242 ~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          242 SVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHh
Confidence            9999999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.1e-44  Score=359.75  Aligned_cols=257  Identities=23%  Similarity=0.386  Sum_probs=210.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++........     .....+.+|+.++.+++||||+++++++.....
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP-----SFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH-----HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH-----HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            57999999999999999999974  68999999986543332     224678899999999999999999999876543


Q ss_pred             ----eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          257 ----YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       257 ----~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                          .|+||||++|++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             CCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence                48999999999999999863  568999999999999999999999999999999999999999999999999985


Q ss_pred             ccccc----CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CCC
Q 011359          333 EEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--IPG  406 (488)
Q Consensus       333 ~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~  406 (488)
                      .....    .......||..|+|||++.+..++.++||||||+++|+|++|..||.+....+...........+.  ...
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  244 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence            43221    112234589999999999999999999999999999999999999999988877776666543322  235


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHH-HHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIV-KVLEQFET  442 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil-~~Le~~~~  442 (488)
                      .++.++.+||.+||+.||++||+..+++ ..|.+...
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            6899999999999999999999766544 45555433

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-43  Score=356.91  Aligned_cols=264  Identities=27%  Similarity=0.468  Sum_probs=220.1

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI  245 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  245 (488)
                      -..+..++|.+++.||+|+||.||+|.+.       ++.||||++......       ....++.+|+.++++++||||+
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv   96 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-------QDELDFLMEALIISKFNHQNIV   96 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH-------HHHHHHHHHHHHHHHCCCTTBC
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch-------hhHHHHHHHHHHHhhCCCCCCC
Confidence            34566788999999999999999999842       467999999643321       1245788999999999999999


Q ss_pred             eEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-
Q 011359          246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH-----KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-  319 (488)
Q Consensus       246 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-  319 (488)
                      ++++++......++||||+++++|.+++.....     ..+++..++.++.||+.||.|||++||+||||||+|||++. 
T Consensus        97 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A           97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP  176 (327)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred             eEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecC
Confidence            999999999999999999999999999987532     35889999999999999999999999999999999999984 


Q ss_pred             --CCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 011359          320 --EFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF  393 (488)
Q Consensus       320 --~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~  393 (488)
                        +..+||+|||++.......   ......|+..|+|||++.+..++.++||||||+++|+|++ |..||......+...
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  256 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE  256 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence              4569999999985332211   1223457889999999998999999999999999999998 999999887766554


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      .+. .......+..++..+.+||.+||+.||.+||++.++++.|+.+....
T Consensus       257 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          257 FVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHh-cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            444 44456677889999999999999999999999999999999987754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.6e-43  Score=354.87  Aligned_cols=253  Identities=21%  Similarity=0.327  Sum_probs=217.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++..........  ....+.+.+|+.++++++||||+++++++.....
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc--chhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            46889999999999999999986  6899999998654322100  0013568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC----cEEEeeecccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIAC  332 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~----~vkl~DFgla~  332 (488)
                      +++||||+++++|.+++..  ...+++..++.++.||+.||+|||+.||+||||||+|||++.++    .+||+|||++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            9999999999999999975  45789999999999999999999999999999999999999887    79999999996


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPP  410 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~  410 (488)
                      ............||..|+|||++.+..++.++||||||+++|+|++|..||.+....+....+.......  ..+..++.
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE  247 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence            6554444456679999999999998899999999999999999999999999888777666655443221  12357889


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.+||.+||+.||++||++.++++
T Consensus       248 ~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          248 LAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhc
Confidence            9999999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-44  Score=376.85  Aligned_cols=256  Identities=21%  Similarity=0.303  Sum_probs=216.3

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      ..+..++|.+++.||+|+||+||+|++.  ++.||||++....     .........+.+|+.++..++||||++++++|
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-----MLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH-----hhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3456678999999999999999999986  5889999997411     01111123378999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .+...+|||||||.||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            9999999999999999999999863 457999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC--cCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 011359          332 CEEVYCD--ALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       332 ~~~~~~~--~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  404 (488)
                      .......  ......||+.|+|||++.     ...++.++|||||||++|||++|..||.+.+..+....++.......+
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  302 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF  302 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence            6443222  223457999999999997     456899999999999999999999999999888877777654322223


Q ss_pred             ---CCCCcHHHHHHHHHHhhhCCCC--CCCHHHHHH
Q 011359          405 ---PGDCPPAMAALIEQCWSLQPDK--RPEFWHIVK  435 (488)
Q Consensus       405 ---~~~~~~~l~~Li~~cL~~dp~~--RPs~~eil~  435 (488)
                         ...+++++.+||.+||..+|++  |+++.++++
T Consensus       303 p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          303 PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence               3458999999999999888888  999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.5e-44  Score=352.45  Aligned_cols=262  Identities=28%  Similarity=0.488  Sum_probs=214.7

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC---Cc--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK---DE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~---~~--~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .++.++|.+++.||+|+||.||+|.+.   ++  .||||++........     ...+.+.+|+.++++++||||+++++
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~   88 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-----EAMDDFIREVNAMHSLDHRNLIRLYG   88 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C-----HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCH-----HHHHHHHHHHHHHHhCCCCCcccEEE
Confidence            456678999999999999999999863   22  589999875432211     12467889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++..+. .++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        89 ~~~~~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           89 VVLTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             EECSSS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             EEccCC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccc
Confidence            998765 78999999999999999864 3568999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 011359          330 IACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       330 la~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  404 (488)
                      ++.......    ......++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.........
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR  246 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC
Confidence            985432221    1223457888999999998889999999999999999999 99999999988887777777767777


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      +..++..+.++|.+||+.+|++||++.++++.|+++...
T Consensus       247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            888999999999999999999999999999999987653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=360.68  Aligned_cols=264  Identities=26%  Similarity=0.451  Sum_probs=206.5

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHH--HHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL--LSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~  249 (488)
                      .+..+++++|.+++.||+|+||.||+|.++++.||||++....           ...+..|.++  +..++|+||+++++
T Consensus         6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~   74 (336)
T 3g2f_A            6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----------RQNFINEKNIYRVPLMEHDNIARFIV   74 (336)
T ss_dssp             ---CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             cCCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----------hhhHHHHHHHHHHHhccCcchhhhee
Confidence            3456788999999999999999999999999999999997432           1223344444  45589999999998


Q ss_pred             eee-----cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccCCCCCCeE
Q 011359          250 ACK-----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ---------GVIHRDLKPENV  315 (488)
Q Consensus       250 ~~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------giiHrDIkp~NI  315 (488)
                      .+.     ....+++||||+++|+|.+++..   ...++..++.++.||+.||+|||+.         ||+||||||+||
T Consensus        75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Ni  151 (336)
T 3g2f_A           75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV  151 (336)
T ss_dssp             EEEEECTTSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGE
T ss_pred             cccccccCCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceE
Confidence            543     23467899999999999999976   4458889999999999999999999         999999999999


Q ss_pred             EEcCCCcEEEeeeccccccccc---------CcCCCCCCCcccCChhhhhc-------CCCCchhHHHHHHHHHHHHHhC
Q 011359          316 LIDQEFHLKIADFGIACEEVYC---------DALSDDPGTYRWMAPEMIKH-------KSYGRKVDVYSFGLILWEMVAG  379 (488)
Q Consensus       316 Ll~~~~~vkl~DFgla~~~~~~---------~~~~~~~gt~~y~aPE~l~~-------~~~~~k~DvwSlGvll~elltG  379 (488)
                      |++.++.+||+|||++......         .......||..|+|||++.+       ..++.++|||||||++|||++|
T Consensus       152 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g  231 (336)
T 3g2f_A          152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR  231 (336)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence            9999999999999999643221         12234469999999999976       4567899999999999999999


Q ss_pred             CCCCCCCC------------------HHHHHHHHHhccCCCCCCCC------CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          380 TIPYEEMN------------------PIQAAFAVVNKNLRPAIPGD------CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       380 ~~Pf~~~~------------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..||....                  .......+.....++.++..      ++..+.+||.+||+.||++||++.++++
T Consensus       232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            77653221                  11122223334445555544      3458999999999999999999999999


Q ss_pred             HHHHHHHhhcccCc
Q 011359          436 VLEQFETSLACNGT  449 (488)
Q Consensus       436 ~Le~~~~~l~~~~~  449 (488)
                      .|+++.....++.+
T Consensus       312 ~L~~ll~~~~~~~~  325 (336)
T 3g2f_A          312 RMAELMMIWERNKS  325 (336)
T ss_dssp             HHHHHHHCCCC---
T ss_pred             HHHHHHHHHHhccc
Confidence            99999988776543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-43  Score=349.26  Aligned_cols=254  Identities=26%  Similarity=0.368  Sum_probs=201.4

Q ss_pred             cccccceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .+..++|.+++.||+|+||.||+|.+  .++.||||++.......      .....+..+..+++.++||||+++++++.
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~~~~~~~~~h~~iv~~~~~~~   76 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ------EQKRLLMDLDISMRTVDCPFTVTFYGALF   76 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH------HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH------HHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence            45678899999999999999999998  47899999997543221      11334555666688889999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      .+...++||||++ |+|.+++...  ....+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus        77 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           77 REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence            9999999999996 5888887653  456799999999999999999999998 99999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhh----hcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCCC
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMI----KHKSYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~k~DvwSlGvll~elltG~~Pf~~~-~~~~~~~~~~~~~~~~~~  404 (488)
                      ++.............||..|+|||++    .+..++.++||||||+++|+|++|..||... ..................
T Consensus       156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (290)
T 3fme_A          156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP  235 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC
T ss_pred             CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc
Confidence            99655444444455799999999996    4567899999999999999999999999874 455555555555544445


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ...++..+.+||.+||+.||++||++.++++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            5678999999999999999999999999987

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1e-43  Score=356.18  Aligned_cols=250  Identities=22%  Similarity=0.395  Sum_probs=196.6

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++........       ...+.+|+.++++++||||+++++++..+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   76 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-------PSTAIREISLMKELKHENIVRLYDVIHTEN   76 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS-------CHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc-------HHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence            357889999999999999999875  78999999986543221       245779999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLE----HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .+++||||++ |+|.+++....    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            9999999997 59999997642    245889999999999999999999999999999999999999999999999998


Q ss_pred             ccccc-cCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 011359          332 CEEVY-CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL---------  400 (488)
Q Consensus       332 ~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~---------  400 (488)
                      ..... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....         
T Consensus       156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence            65432 223345678999999999976 4689999999999999999999999999887766555443100         


Q ss_pred             -----------------------CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 -----------------------RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 -----------------------~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                             .+..+..++.++.+||.+||+.||++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                                   00112357889999999999999999999998875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.6e-45  Score=364.37  Aligned_cols=258  Identities=25%  Similarity=0.431  Sum_probs=212.8

Q ss_pred             ccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      .++|.+.+.||+|+||.||+|.+. ++.||||++.......        .+.+.+|+.++++++||||+++++++.....
T Consensus        38 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           38 TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG--------IEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH--------HHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             HhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH--------HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            367889999999999999999986 6899999987554322        3568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      +++||||+++|+|.+++....  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999999999999999987543  235899999999999999999999999999999999999999999999999998643


Q ss_pred             ccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-h-------
Q 011359          335 VYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ------AAFAVV-N-------  397 (488)
Q Consensus       335 ~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~------~~~~~~-~-------  397 (488)
                      ...   .......||..|+|||++.+..++.++||||||+++|+|++|..||....+.+      ...... .       
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            221   11233458999999999998999999999999999999999999997643211      111111 1       


Q ss_pred             -ccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          398 -KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       398 -~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                       .......+..++..+.++|.+||+.||++||++.++++.|+.+...
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence             1112223344567899999999999999999999999999988664

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=356.83  Aligned_cols=258  Identities=26%  Similarity=0.526  Sum_probs=214.0

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--Ccc----EEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEP----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~----vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      +..++|.+++.||+|+||.||+|.+.  ++.    ||+|.+........       .+.+.+|+.++++++||||+++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~   84 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-------NKEILDEAYVMASVDNPHVCRLLG   84 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCC-------HHHHHHHHHHHTTCCBTTBCCCCE
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHH-------HHHHHHHHHHHHhCCCCCeeEEEE
Confidence            45578999999999999999999985  444    57777754332221       456889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++..+. .++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG  162 (327)
T 3lzb_A           85 ICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EEESSS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             EEecCC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCc
Confidence            998765 67899999999999999873 4568999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          330 IACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       330 la~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      ++.......   ......+|..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.. ..+........+
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~~~~~~~~~  241 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQP  241 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCC
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCCC
Confidence            996432221   2233456788999999999999999999999999999999 99999988765544 344455566678


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ..++..+.+||.+||+.||.+||++.++++.|+.+...
T Consensus       242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          242 PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            88999999999999999999999999999999999754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=371.96  Aligned_cols=257  Identities=22%  Similarity=0.315  Sum_probs=215.2

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .+..+..++|.+.+.||+|+||.||+++..  ++.||||++....     .........+.+|+.++..++||||+++++
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  128 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-----MLKRGEVSCFREERDVLVNGDRRWITQLHF  128 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            345667789999999999999999999985  7899999997411     111112345789999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++.+...+||||||++||+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          129 AFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeech
Confidence            999999999999999999999999864 3479999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCc--CCCCCCCcccCChhhhh-------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 011359          330 IACEEVYCDA--LSDDPGTYRWMAPEMIK-------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL  400 (488)
Q Consensus       330 la~~~~~~~~--~~~~~gt~~y~aPE~l~-------~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  400 (488)
                      ++........  .....||+.|+|||++.       ...|+.++|||||||++|||++|..||...+..+....++....
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  287 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE  287 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            9965433222  23457999999999997       35689999999999999999999999999888877777665322


Q ss_pred             ---CCCCCCCCcHHHHHHHHHHhhhCCCCC---CCHHHHHH
Q 011359          401 ---RPAIPGDCPPAMAALIEQCWSLQPDKR---PEFWHIVK  435 (488)
Q Consensus       401 ---~~~~~~~~~~~l~~Li~~cL~~dp~~R---Ps~~eil~  435 (488)
                         .+..+..++.++.+||.+||. +|.+|   |++.+|++
T Consensus       288 ~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence               233346799999999999999 99998   58888764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=356.16  Aligned_cols=265  Identities=27%  Similarity=0.485  Sum_probs=219.4

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI  245 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~------~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  245 (488)
                      +...+..++|.+++.||+|+||.||+|.+      .++.||||++......        ..+.+.+|+.++++++||||+
T Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv  105 (326)
T 2w1i_A           34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--------HLRDFEREIEILKSLQHDNIV  105 (326)
T ss_dssp             ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH--------HHHHHHHHHHHHHTCCCTTBC
T ss_pred             CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH--------HHHHHHHHHHHHHhCCCCCee
Confidence            34456678899999999999999999986      3689999999753321        145788999999999999999


Q ss_pred             eEeeeeecCC--eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcE
Q 011359          246 KFVAACKKPP--VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL  323 (488)
Q Consensus       246 ~l~~~~~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~v  323 (488)
                      ++++++....  .+++||||+++++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~  184 (326)
T 2w1i_A          106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV  184 (326)
T ss_dssp             CEEEEECC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE
T ss_pred             eEEEEEEecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcE
Confidence            9999987654  789999999999999999873 3568999999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH----------
Q 011359          324 KIADFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI----------  389 (488)
Q Consensus       324 kl~DFgla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~----------  389 (488)
                      ||+|||++.......    ......++..|+|||.+.+..++.++||||||+++|+|++|..||......          
T Consensus       185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~  264 (326)
T 2w1i_A          185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ  264 (326)
T ss_dssp             EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCC
T ss_pred             EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccc
Confidence            999999986433221    123345778899999999888999999999999999999999988643110          


Q ss_pred             -----HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          390 -----QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       390 -----~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                           ......+....+...+..++.++.+||.+||+.||++||++.++++.|+++...+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          265 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             hhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence                 11223344455566778899999999999999999999999999999999988764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-44  Score=354.57  Aligned_cols=254  Identities=27%  Similarity=0.401  Sum_probs=208.3

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeeEeeeee
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACK  252 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~  252 (488)
                      .++|.+++.||+|+||+||+|.+.  ++.||||++..........   .....+.+|+.+++++   +||||+++++++.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG---GLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS---CCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc---ccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            468999999999999999999964  7899999997543221100   0013455777777666   4999999999997


Q ss_pred             cCC-----eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          253 KPP-----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       253 ~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                      ...     .+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            655     5899999996 6999999886556699999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---C-
Q 011359          328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP---A-  403 (488)
Q Consensus       328 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~-  403 (488)
                      ||++.............||..|+|||++.+..++.++|||||||++|+|++|..||.+....+....+......+   . 
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            999965544444455678999999999998999999999999999999999999999988877666654421100   0 


Q ss_pred             ---------------------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          404 ---------------------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       404 ---------------------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                           ....++..+.+||.+||+.||++||++.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                                 11357889999999999999999999999876

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.1e-44  Score=349.08  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=212.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec---
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK---  253 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---  253 (488)
                      .+|.+++.||+|+||.||+|.+.  ++.||||++....            ..+.+|+.++++++||||+++++++..   
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence            46889999999999999999986  7899999998543            235689999999999999999998854   


Q ss_pred             -------------CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC
Q 011359          254 -------------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE  320 (488)
Q Consensus       254 -------------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~  320 (488)
                                   ...+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence                         4468999999999999999987666789999999999999999999999999999999999999999


Q ss_pred             CcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 011359          321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL  400 (488)
Q Consensus       321 ~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  400 (488)
                      +.+||+|||++.............|+..|+|||++.+..++.++||||||+++|+|++|..|+....   .......   
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~---  232 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---KFFTDLR---  232 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---HHHHHHH---
T ss_pred             CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---HHHHHhh---
Confidence            9999999999865544444455679999999999998899999999999999999999998875321   1112222   


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          401 RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       401 ~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ...++..++..+.+||.+||+.||.+||++.++++.|+.+.....
T Consensus       233 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          233 DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            223556789999999999999999999999999999999877544

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-44  Score=366.98  Aligned_cols=260  Identities=27%  Similarity=0.538  Sum_probs=211.1

Q ss_pred             ceeccceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee-c
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-K  253 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~  253 (488)
                      .|.+++.||+|+||.||+|.+.+     ..||||++.......       ..++|.+|+.++++++||||++++++|. .
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  162 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-------EVSQFLTEGIIMKDFSHPNVLSLLGICLRS  162 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSH-------HHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHH-------HHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence            46788999999999999998742     358999987533322       1467889999999999999999999875 4


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      +...++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~  241 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD  241 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             CCCeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccc
Confidence            5678999999999999999975 345688999999999999999999999999999999999999999999999999964


Q ss_pred             ccccC-----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          334 EVYCD-----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       334 ~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      .....     ......++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+. ...+...+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~  320 (373)
T 3c1x_A          242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEY  320 (373)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTT
T ss_pred             ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence            32211     1223457788999999999999999999999999999999 788888776555444443 3445667788


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhcccC
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLACNG  448 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~~~  448 (488)
                      ++..+.++|.+||+.+|++||++.++++.|+.+...+....
T Consensus       321 ~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~  361 (373)
T 3c1x_A          321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH  361 (373)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence            99999999999999999999999999999999998776443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.1e-44  Score=354.79  Aligned_cols=258  Identities=27%  Similarity=0.445  Sum_probs=210.3

Q ss_pred             ceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeE
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV  259 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  259 (488)
                      .|..++.||+|+||.||+|.++++.||||++.........    ...+.+.+|+.++++++||||+++++++......++
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  107 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE----ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCL  107 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTT----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchH----HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEE
Confidence            3556789999999999999999999999999754322211    124678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccC
Q 011359          260 ITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD  338 (488)
Q Consensus       260 V~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~  338 (488)
                      ||||+++++|.+++.... ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA  187 (307)
T ss_dssp             EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred             EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence            999999999999998543 4568999999999999999999999999999999999999999999999999985432211


Q ss_pred             ---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHh---------ccCCC
Q 011359          339 ---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA----FAVVN---------KNLRP  402 (488)
Q Consensus       339 ---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~----~~~~~---------~~~~~  402 (488)
                         ......||..|+|||.+.+ .++.++||||||+++|+|++|..||......+..    ..+..         .....
T Consensus       188 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          188 QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence               1234568999999999874 5789999999999999999999999865432111    11111         01112


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ..+..++..+.++|.+||+.+|.+||++.++++.|+++..
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            2334456789999999999999999999999999998864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=351.38  Aligned_cols=250  Identities=20%  Similarity=0.364  Sum_probs=205.3

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||.||+|.+.  ++.||||++.......      ...+.+.+|+.++++++||||+++++++....
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP------VIKKIALREIRMLKQLKHPNLVNLLEVFRRKR   75 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H------HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch------HHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence            367999999999999999999986  7899999997554322      22467889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+++++|.+++..  ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             eEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            99999999999999998875  4568999999999999999999999999999999999999999999999999996543


Q ss_pred             c-cCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------
Q 011359          336 Y-CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN--------------  399 (488)
Q Consensus       336 ~-~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~--------------  399 (488)
                      . ........||..|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+....              
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          154 GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            2 222345578999999999976 578999999999999999999999999988766554433210              


Q ss_pred             -----CCCCC----------CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 -----LRPAI----------PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 -----~~~~~----------~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                           .....          ...++..+.+||.+||+.||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                 00000          1357889999999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=354.28  Aligned_cols=245  Identities=22%  Similarity=0.287  Sum_probs=201.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  255 (488)
                      ++|.+.++||+|+||+||+|.+.  ++.||||++.........      ..++..|+..+.++ +|+||++++++|....
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD------RARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH------HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            56889999999999999999986  789999998765443321      23455666666655 8999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            999999999 77999988774 4579999999999999999999999999999999999999999999999999986655


Q ss_pred             ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      .........||+.|+|||++.+ .++.++|||||||++|||++|..|+.....   ...+......+..+..++.++.+|
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l  284 (311)
T 3p1a_A          209 TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSV  284 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred             cCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHH
Confidence            4444455679999999999875 789999999999999999999776655332   222333333334556789999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      |.+||+.||++||++.++++
T Consensus       285 i~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          285 LVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCChhhCcCHHHHHh
Confidence            99999999999999999886

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3e-43  Score=346.16  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=218.3

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ...+..++|.+++.||+|+||.||+|.+.  ++.||||++.....     ........+.+|+.++++++||||++++++
T Consensus         8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   82 (284)
T 2vgo_A            8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-----EKEGVEHQLRREIEIQSHLRHPNILRMYNY   82 (284)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc-----chHHHHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence            44566789999999999999999999986  57899999974210     011124578899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +.....+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~  160 (284)
T 2vgo_A           83 FHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW  160 (284)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEcCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccc
Confidence            99999999999999999999999874  4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      +..... .......|+..|+|||++.+..++.++||||||+++|+|++|..||......+....+...  ...++..++.
T Consensus       161 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~  237 (284)
T 2vgo_A          161 SVHAPS-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPFLSD  237 (284)
T ss_dssp             CEECSS-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCH
T ss_pred             cccCcc-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--ccCCCCcCCH
Confidence            854332 2234557899999999999888999999999999999999999999988877766655544  3456778899


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.+||.+||+.||.+||++.++++
T Consensus       238 ~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          238 GSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            9999999999999999999999886

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.3e-43  Score=363.11  Aligned_cols=251  Identities=23%  Similarity=0.375  Sum_probs=211.1

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC--CCCeeeEeeeee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH--NPNVIKFVAACK  252 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~  252 (488)
                      +...+|.+++.||+|+||.||+|.+. ++.||||++.......      .....+.+|+.+|.++.  |+||+++++++.
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~  126 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN------QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI  126 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCH------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccH------HHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence            33456999999999999999999876 6889999998654432      12467889999999997  599999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .+..++|||| +.+++|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.
T Consensus       127 ~~~~~~lv~E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          127 TDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             CSSEEEEEEE-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             cCCEEEEEEe-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence            9999999999 568899999987  35788999999999999999999999999999999999995 5799999999996


Q ss_pred             cccccC---cCCCCCCCcccCChhhhhc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh
Q 011359          333 EEVYCD---ALSDDPGTYRWMAPEMIKH-----------KSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVN  397 (488)
Q Consensus       333 ~~~~~~---~~~~~~gt~~y~aPE~l~~-----------~~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~  397 (488)
                      ......   ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||.... .......++.
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  282 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  282 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence            543221   2245579999999999975           368999999999999999999999998764 4455666666


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       398 ~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                      .......+...+..+.+||.+||+.||.+||++.++++.
T Consensus       283 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            666667778889999999999999999999999999863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-43  Score=355.16  Aligned_cols=253  Identities=30%  Similarity=0.533  Sum_probs=206.8

Q ss_pred             cceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc--CCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~--  254 (488)
                      ++|.+++.||+|+||.||+|.++++.||||++....           ...+.+|.+++..+  +||||+++++++...  
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----------EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            578899999999999999999999999999996421           23344566666554  899999999999877  


Q ss_pred             --CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCeEEEcCCCcEE
Q 011359          255 --PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLK  324 (488)
Q Consensus       255 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------giiHrDIkp~NILl~~~~~vk  324 (488)
                        ..+++||||+++|+|.+++..   ..+++..++.++.|++.||+|||++        ||+||||||+|||++.++.+|
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence              789999999999999999976   4699999999999999999999999        999999999999999999999


Q ss_pred             EeeecccccccccCc-----CCCCCCCcccCChhhhhcCCCCch------hHHHHHHHHHHHHHhC----------CCCC
Q 011359          325 IADFGIACEEVYCDA-----LSDDPGTYRWMAPEMIKHKSYGRK------VDVYSFGLILWEMVAG----------TIPY  383 (488)
Q Consensus       325 l~DFgla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~k------~DvwSlGvll~elltG----------~~Pf  383 (488)
                      |+|||++........     .....||..|+|||++.+..+...      +|||||||++|||++|          ..||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            999999854322211     124569999999999987666554      9999999999999999          7777


Q ss_pred             CCCC-----HHHHHHHHHhccCCCCCCC-----CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          384 EEMN-----PIQAAFAVVNKNLRPAIPG-----DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       384 ~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ....     .......+.....++..+.     .++.++.+||.+||+.||.+||++.++++.|+++.....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            6542     1222222333444555543     567889999999999999999999999999999987643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.6e-44  Score=369.67  Aligned_cols=245  Identities=21%  Similarity=0.347  Sum_probs=195.6

Q ss_pred             cceecc-ceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh-cCCCCeeeEeeeeec-
Q 011359          179 SQLFLG-LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR-LHNPNVIKFVAACKK-  253 (488)
Q Consensus       179 ~~~~i~-~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~-  253 (488)
                      ++|.+. +.||+|+||+||+|.+.  ++.||||++...             ..+.+|+.++.+ .+||||++++++|.. 
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            455555 68999999999999986  688999999631             245688888755 479999999998865 


Q ss_pred             ---CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC---CCcEEEee
Q 011359          254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIAD  327 (488)
Q Consensus       254 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~---~~~vkl~D  327 (488)
                         ...+|||||||+||+|.+++.......+++..++.|+.||+.||.|||+.||+||||||+|||++.   ++.+||+|
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence               567899999999999999998755557999999999999999999999999999999999999987   78999999


Q ss_pred             ecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccCCCC
Q 011359          328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ----AAFAVVNKNLRPA  403 (488)
Q Consensus       328 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~----~~~~~~~~~~~~~  403 (488)
                      ||++.............||..|+|||++.+..++.++|||||||++|+|++|..||.+.....    ....+........
T Consensus       208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  287 (400)
T ss_dssp             CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred             cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence            999976544444556678999999999998999999999999999999999999997654321    2222333333222


Q ss_pred             --CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 011359          404 --IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV  436 (488)
Q Consensus       404 --~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~  436 (488)
                        ....++.++.+||.+||+.||++||++.++++.
T Consensus       288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              225689999999999999999999999999873

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=361.53  Aligned_cols=265  Identities=27%  Similarity=0.495  Sum_probs=220.0

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ..+|.++.++|.+++.||+|+||.||+|.+.+ .||||++.........      .+.+.+|+.++++++|+||++++++
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~   97 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ------LKAFKREVMAYRQTRHENVVLFMGA   97 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC------CCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH------HHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            46788999999999999999999999999876 5999999765432211      2346789999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +.....+++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++ ++.++|+|||+
T Consensus        98 ~~~~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B           98 CMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             EECSSCEEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             EecCCceEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCC
Confidence            9999999999999999999999976 334689999999999999999999999999999999999998 67999999998


Q ss_pred             ccccc------ccCcCCCCCCCcccCChhhhhc---------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 011359          331 ACEEV------YCDALSDDPGTYRWMAPEMIKH---------KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV  395 (488)
Q Consensus       331 a~~~~------~~~~~~~~~gt~~y~aPE~l~~---------~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~  395 (488)
                      +....      .........|+..|+|||++..         ..++.++||||||+++|+|++|..||...........+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            75321      1122234458999999999964         35789999999999999999999999998887766666


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       396 ~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      .........+..++.++.+||.+||+.+|++||++.++++.|+++....
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            5554433444578899999999999999999999999999999887653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.5e-44  Score=357.80  Aligned_cols=247  Identities=25%  Similarity=0.416  Sum_probs=198.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  255 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++........       .+.+.+|+.+|++++||||++++++|.+.. 
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-------REKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTH-------HHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhH-------HHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            56889999999999999999986  78999999986553321       467889999999999999999999885443 


Q ss_pred             --------------------------------------------------------eeeEEEeecCCCCHHHHHHHhCC-
Q 011359          256 --------------------------------------------------------VYCVITEYLSEGSLRAYLHKLEH-  278 (488)
Q Consensus       256 --------------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~~-  278 (488)
                                                                              .+++|||||++++|.+++..... 
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    37999999999999999987422 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-------------CcCCCCCC
Q 011359          279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-------------DALSDDPG  345 (488)
Q Consensus       279 ~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-------------~~~~~~~g  345 (488)
                      ...++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......             .......|
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            23556678999999999999999999999999999999999999999999998644322             12234569


Q ss_pred             CcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCC
Q 011359          346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPD  425 (488)
Q Consensus       346 t~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~  425 (488)
                      |..|+|||++.+..++.++|||||||++|+|++|..|+...   ............+.....+++.+.+||.+||+.||+
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCC
Confidence            99999999999999999999999999999999987664321   111122222222222344567889999999999999


Q ss_pred             CCCCHHHHHH
Q 011359          426 KRPEFWHIVK  435 (488)
Q Consensus       426 ~RPs~~eil~  435 (488)
                      +||++.++++
T Consensus       316 ~Rps~~~~l~  325 (332)
T 3qd2_B          316 ERPEATDIIE  325 (332)
T ss_dssp             GSCCHHHHHH
T ss_pred             cCCCHHHHhh
Confidence            9999999886

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=352.56  Aligned_cols=250  Identities=26%  Similarity=0.446  Sum_probs=210.6

Q ss_pred             cccceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeec
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK  253 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  253 (488)
                      ..++|.+++.||+|+||.||+|.+  .++.||||++......         ...+.+|+.+++++ +||||+++++++..
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---------EEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---------THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---------HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            346789999999999999999998  4789999999765432         24577999999999 79999999999876


Q ss_pred             ------CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          254 ------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       254 ------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                            ...+++||||+++++|.+++.......+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence                  56889999999999999999876556799999999999999999999999999999999999999999999999


Q ss_pred             eccccccccc-CcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 011359          328 FGIACEEVYC-DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR  401 (488)
Q Consensus       328 Fgla~~~~~~-~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~  401 (488)
                      ||++...... .......||..|+|||++.     +..++.++|||||||++|+|++|..||.+.........+......
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  252 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP  252 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence            9998643321 1223456899999999996     567899999999999999999999999998887777666665555


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 ~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ...+..++..+.+||.+||..||.+||++.++++
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            4556788999999999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.1e-43  Score=346.91  Aligned_cols=249  Identities=24%  Similarity=0.372  Sum_probs=217.1

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||.||++.+.  ++.||+|++........     ...+.+.+|+.+++.++|+||+++++++....
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----HQREKMSMEISIHRSLAHQHVVGFHGFFEDND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH-----HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCH-----HHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            467999999999999999999986  67899999976433221     12467889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ..++||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            999999999999999998763  578999999999999999999999999999999999999999999999999986533


Q ss_pred             c-cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          336 Y-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       336 ~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      . ........||..|+|||.+.+..++.++||||||+++|+|++|..||......+....+....  ..++..++..+.+
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  244 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAAS  244 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHH
T ss_pred             cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--CCCccccCHHHHH
Confidence            2 223344568999999999998889999999999999999999999999988776655554433  3467788999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+||+.||++||++.++++
T Consensus       245 li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          245 LIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHHcccChhhCcCHHHHhh
Confidence            999999999999999999886

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=364.99  Aligned_cols=263  Identities=19%  Similarity=0.299  Sum_probs=205.2

Q ss_pred             cccceeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHH---HHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETL---AARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      ..++|.+++.||+|+||.||+|.+.     +..||||++...........   .......+.+|+.++..++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            3478999999999999999999984     47899999986543211111   111123477899999999999999999


Q ss_pred             eeeec----CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC--c
Q 011359          249 AACKK----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF--H  322 (488)
Q Consensus       249 ~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~--~  322 (488)
                      +++..    ...+++||||+ +++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++  .
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence            99887    77899999999 99999999763  3799999999999999999999999999999999999998887  9


Q ss_pred             EEEeeecccccccccC--------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC--CHHHHH
Q 011359          323 LKIADFGIACEEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM--NPIQAA  392 (488)
Q Consensus       323 vkl~DFgla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~--~~~~~~  392 (488)
                      +||+|||++.......        ......||..|+|||++.+..++.++|||||||++|+|++|..||...  ......
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            9999999995432211        113456999999999999889999999999999999999999999652  222111


Q ss_pred             HHHHhccCCCCCC---------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          393 FAVVNKNLRPAIP---------GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       393 ~~~~~~~~~~~~~---------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                        .........++         ..++.++.+||.+||+.||++||++.+|++.|+++...+
T Consensus       272 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  330 (345)
T 2v62_A          272 --TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL  330 (345)
T ss_dssp             --HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred             --HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence              11111111112         278999999999999999999999999999998765533

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.7e-43  Score=343.51  Aligned_cols=253  Identities=28%  Similarity=0.439  Sum_probs=208.7

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      ..+..++|.+++.||+|+||.||+|.+.  ++.||||++.....     ......+.+.+|+.+++.++||||+++++++
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-----RSLDVVGKIKREIQNLKLFRHPHIIKLYQVI   80 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc-----cchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            3456688999999999999999999986  78999999974210     0111245788999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .....+++||||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~  158 (276)
T 2h6d_A           81 STPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS  158 (276)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred             ecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccc
Confidence            9999999999999999999999863  56899999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      .............|+..|+|||.+.+..+ +.++||||||+++|+|++|..||...........+...  ....+..++.
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (276)
T 2h6d_A          159 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNR  236 (276)
T ss_dssp             GCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCH
T ss_pred             cccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCH
Confidence            65544333445678999999999987765 68999999999999999999999988776655554443  2345778899


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.++|.+||+.||++||++.++++
T Consensus       237 ~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          237 SVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHh
Confidence            9999999999999999999999987

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.6e-43  Score=354.83  Aligned_cols=249  Identities=24%  Similarity=0.372  Sum_probs=217.0

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||.||++.+.  ++.||+|++........     ...+.+.+|+.+++.++|+||+++++++.+..
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----HQREKMSMEISIHRSLAHQHVVGFHGFFEDND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH-----HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            357889999999999999999986  57899999975433221     12467889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+.+++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            999999999999999998763  578999999999999999999999999999999999999999999999999986543


Q ss_pred             c-cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          336 Y-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       336 ~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      . ........||..|+|||++.+..++.++||||||+++|+|++|..||......+....+....  ..++..++..+.+
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  270 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAAS  270 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTTSCHHHHH
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--CCCCccCCHHHHH
Confidence            2 223345579999999999998889999999999999999999999999888766665555443  3467788999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+||+.||++||++.++++
T Consensus       271 li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999886

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.7e-43  Score=345.10  Aligned_cols=256  Identities=25%  Similarity=0.440  Sum_probs=219.3

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCCh-hHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeec
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDE-NETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK  253 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~-~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~  253 (488)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++....... .........+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            367889999999999999999985  6899999998654221 11222334677899999999996 9999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence            99999999999999999999863  5789999999999999999999999999999999999999999999999999966


Q ss_pred             ccccCcCCCCCCCcccCChhhhh------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIK------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--  405 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--  405 (488)
                      ...........|+..|+|||++.      ...++.++||||||+++|+|++|..||...........+.........+  
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW  253 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence            54444455667999999999985      3467899999999999999999999999988877766666655443322  


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..++..+.+||.+||+.||.+||++.++++
T Consensus       254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            468899999999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3e-43  Score=374.29  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=211.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||+||+|.+.  +..||||++........      ....+.+|+.+|+.++||||++++++|.....
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  110 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS------SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN  110 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C------TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch------HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            46889999999999999999986  68899999986432211      13567899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC---CCcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~---~~~vkl~DFgla~~  333 (488)
                      +|+|||||.+|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++..
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999999999998763  56899999999999999999999999999999999999976   45599999999976


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  411 (488)
                      ...........||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+.........+  ..++..
T Consensus       189 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  267 (494)
T 3lij_A          189 FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG  267 (494)
T ss_dssp             CBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred             CCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence            55555556678999999999987 568999999999999999999999999999888777777665543332  578999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.+|.+||++.++++
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHCCCChhhCccHHHHhc
Confidence            999999999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-43  Score=354.18  Aligned_cols=260  Identities=22%  Similarity=0.338  Sum_probs=209.3

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||.||+|.+.  ++.||||++......+     ....+.+.+|+.++++++||||+++++++..+.
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD-----PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC-----HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            478999999999999999999985  6889999997543221     123567889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999999999863  568999999999999999999999999999999999999999999999999985433


Q ss_pred             cc--CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHH
Q 011359          336 YC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--PAIPGDCPPA  411 (488)
Q Consensus       336 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  411 (488)
                      ..  .......|+..|+|||++.+..++.++||||||+++|+|++|..||........ ...+.....  ...+..++..
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  264 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPSTVRPGIPVA  264 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCCGGGTSTTCCTH
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCCccccCCCCCHH
Confidence            22  122345689999999999988899999999999999999999999988765433 333333222  2345678999


Q ss_pred             HHHHHHHHhhhCCCCCC-CHHHHHHHHHHHHHhhc
Q 011359          412 MAALIEQCWSLQPDKRP-EFWHIVKVLEQFETSLA  445 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RP-s~~eil~~Le~~~~~l~  445 (488)
                      +.+||.+||+.||++|| ++.++++.|+++.....
T Consensus       265 l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          265 FDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             HHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            99999999999999999 99999999998765543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.1e-43  Score=347.18  Aligned_cols=248  Identities=29%  Similarity=0.527  Sum_probs=217.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +.|.+++.||+|+||.||+|.+.  ++.||||++........       .+.+.+|+.++++++||||+++++++.....
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-------IEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT-------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH-------HHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            45888999999999999999985  68999999986543322       3568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++||||+++++|.+++..   ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        95 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            9999999999999999864   5799999999999999999999999999999999999999999999999999865432


Q ss_pred             cC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       337 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      .. ......|+..|+|||++.+..++.++||||||+++|+|++|..||......+....+.. ...+.++..++..+.+|
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l  250 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEF  250 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCCSSCCHHHHHH
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-CCCCCCccccCHHHHHH
Confidence            22 23455789999999999988999999999999999999999999999887766555443 44556778899999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~~L  437 (488)
                      |.+||+.+|.+||++.++++..
T Consensus       251 i~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          251 VEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTCH
T ss_pred             HHHHcCCChhhCcCHHHHhhCh
Confidence            9999999999999999998743

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-43  Score=375.35  Aligned_cols=248  Identities=25%  Similarity=0.423  Sum_probs=213.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||+||+|.+.  ++.||||++.......      .....+.+|+.+|++++||||+++++++.....
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN------KDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC------SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc------hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence            56889999999999999999986  7899999996422111      113568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc---CCCcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~---~~~~vkl~DFgla~~  333 (488)
                      +++|||||.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999999999999763  5689999999999999999999999999999999999995   456799999999975


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  411 (488)
                      ...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.........+  ..+++.
T Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             BCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             CCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            554444556679999999999975 69999999999999999999999999998888777777665544333  468899


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.||.+||++.++++
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhc
Confidence            999999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-43  Score=381.46  Aligned_cols=256  Identities=21%  Similarity=0.349  Sum_probs=218.5

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      ...+..++|.+.+.||+|+||.||+|.+.  |+.||||++.....     ........+.+|+.+|++++||||++++++
T Consensus       178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~  252 (576)
T 2acx_A          178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGEAMALNEKQILEKVNSRFVVSLAYA  252 (576)
T ss_dssp             TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh-----hhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence            44577788999999999999999999985  78999999974210     111124567899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      +.....+|+||||++||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus       253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccc
Confidence            99999999999999999999999875556699999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCCCCCCC
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN----PIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~----~~~~~~~~~~~~~~~~~~~  406 (488)
                      +.............||+.|+|||++.+..++.++|||||||++|||++|..||....    ..+....+..  ....++.
T Consensus       333 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~  410 (576)
T 2acx_A          333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSE  410 (576)
T ss_dssp             CEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCCT
T ss_pred             ceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCCc
Confidence            976544444455689999999999998899999999999999999999999998753    2223222222  3445678


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RP-----s~~eil~  435 (488)
                      .++.++.+||.+||+.||.+||     ++.+|++
T Consensus       411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            8999999999999999999999     6788874

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-43  Score=362.84  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=198.0

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  254 (488)
                      .++|.+++.||+|+||.||+|.+.  ++.||||++........      ..+.+.+|+.+|.++. ||||+++++++..+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~   81 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST------DAQRTFREIMILTELSGHENIVNLLNVLRAD   81 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHH------HHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChH------HHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence            367999999999999999999985  78999999964432221      2456789999999997 99999999999754


Q ss_pred             C--eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          255 P--VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       255 ~--~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .  .+|+|||||+ ++|.+++..   ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus        82 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           82 NDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             TSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            3  7899999996 689999976   578999999999999999999999999999999999999999999999999996


Q ss_pred             cccc----------------------cCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 011359          333 EEVY----------------------CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI  389 (488)
Q Consensus       333 ~~~~----------------------~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~  389 (488)
                      ....                      ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            4321                      112234579999999999976 67899999999999999999999999998877


Q ss_pred             HHHHHHHhccCCC---------------------------------------------CCCCCCcHHHHHHHHHHhhhCC
Q 011359          390 QAAFAVVNKNLRP---------------------------------------------AIPGDCPPAMAALIEQCWSLQP  424 (488)
Q Consensus       390 ~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~l~~Li~~cL~~dp  424 (488)
                      +....++.....+                                             .....+++++.+||.+||..||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            6655554211100                                             0122678899999999999999


Q ss_pred             CCCCCHHHHHHH
Q 011359          425 DKRPEFWHIVKV  436 (488)
Q Consensus       425 ~~RPs~~eil~~  436 (488)
                      ++||++.++++.
T Consensus       318 ~~R~t~~e~l~H  329 (388)
T 3oz6_A          318 NKRISANDALKH  329 (388)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             ccCCCHHHHhCC
Confidence            999999998863

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-43  Score=376.14  Aligned_cols=249  Identities=24%  Similarity=0.401  Sum_probs=217.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++..........     ...+.+|+.+|++++||||+++++++.....
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----KESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC-----HHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            57889999999999999999985  7899999997554321111     3568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE---cCCCcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl---~~~~~vkl~DFgla~~  333 (488)
                      +++||||+.+|+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       101 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999999999976  4579999999999999999999999999999999999999   5678999999999865


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  411 (488)
                      ...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.........+  ..+++.
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  257 (484)
T 3nyv_A          179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES  257 (484)
T ss_dssp             BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred             cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence            444333344569999999999975 69999999999999999999999999999888877777766554433  468999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.+|.+||++.++++
T Consensus       258 ~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          258 AKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhh
Confidence            999999999999999999999985

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-43  Score=357.35  Aligned_cols=254  Identities=24%  Similarity=0.402  Sum_probs=209.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++......   .......+.+.+|+.++++++||||+++++++.+...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR---QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---C---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhc---ccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence            56889999999999999999986  578999999742100   0011224678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhC--------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 011359          257 YCVITEYLSEGSLRAYLHKLE--------------------------------------HKTLPLPKLIAIALDIARGME  298 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qi~~~L~  298 (488)
                      +++||||+++|+|.+++....                                      ...+++..++.++.||+.||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            999999999999999985210                                      112356788899999999999


Q ss_pred             HHHHCCcccCCCCCCeEEEcCCC--cEEEeeecccccccccC-----cCCCCCCCcccCChhhhhc--CCCCchhHHHHH
Q 011359          299 YIHSQGVIHRDLKPENVLIDQEF--HLKIADFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSF  369 (488)
Q Consensus       299 ~LH~~giiHrDIkp~NILl~~~~--~vkl~DFgla~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSl  369 (488)
                      |||++||+||||||+|||++.++  .+||+|||++.......     ......||+.|+|||++.+  ..++.++|||||
T Consensus       183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence            99999999999999999998776  89999999996432211     1345569999999999975  678999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       370 Gvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||++|+|++|..||.+....+....+.........+  ..+++.+.+||.+||+.+|.+||++.++++
T Consensus       263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999999888888777766544333  347899999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.7e-43  Score=345.04  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=213.7

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee--c
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK--K  253 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~  253 (488)
                      .++|.+++.||+|+||.||+|.+.  ++.||||++........      ..+.+.+|+.++++++||||+++++++.  .
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA------EKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHH------HHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            467899999999999999999985  68999999986543321      2467889999999999999999999874  4


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCeEEEcCCCcEEEe
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQG-----VIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~g-----iiHrDIkp~NILl~~~~~vkl~  326 (488)
                      ...+++||||+++++|.+++...  ....+++..++.++.||+.||+|||+.|     |+||||||+||+++.++.+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            67899999999999999999864  2345899999999999999999999999     9999999999999999999999


Q ss_pred             eecccccccccC-cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          327 DFGIACEEVYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       327 DFgla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      |||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||......+....+... ..+.++
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~  237 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIP  237 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCCCC
T ss_pred             cCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-ccccCC
Confidence            999985432211 111235889999999999889999999999999999999999999998876665555444 345677


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVL  437 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~L  437 (488)
                      ..++.++.+||.+||+.||++||++.++++.+
T Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          238 YRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            88999999999999999999999999998854

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.6e-43  Score=345.83  Aligned_cols=260  Identities=21%  Similarity=0.343  Sum_probs=215.6

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++..........  ....+.+.+|+.++++++||||+++++++.....
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR--GVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc--chHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            46889999999999999999986  7899999998654321100  0013568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC----cEEEeeecccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIAC  332 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~----~vkl~DFgla~  332 (488)
                      +++||||+++++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999999976  35689999999999999999999999999999999999998877    89999999996


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPP  410 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~  410 (488)
                      ............|+..|+|||++.+..++.++||||||+++|+|++|..||......+....+.......  .....++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T 3bhy_A          161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE  240 (283)
T ss_dssp             ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence            5544444455679999999999998899999999999999999999999999988776665554433221  22357889


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH--HHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK--VLEQFET  442 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~--~Le~~~~  442 (488)
                      .+.+||.+||..||++||++.++++  .++.+..
T Consensus       241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            9999999999999999999999997  4555543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.3e-43  Score=356.98  Aligned_cols=243  Identities=25%  Similarity=0.390  Sum_probs=206.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  255 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++......            +.+|++++.++ +||||+++++++.++.
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------------~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------------PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            56889999999999999999986  689999999764332            23688888888 6999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC----CcEEEeeeccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE----FHLKIADFGIA  331 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~----~~vkl~DFgla  331 (488)
                      .+|+||||++||+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||+..+    +.+||+|||++
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            99999999999999999976  4579999999999999999999999999999999999998433    35999999999


Q ss_pred             cccccc-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCCC--CCC
Q 011359          332 CEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM---NPIQAAFAVVNKNLRP--AIP  405 (488)
Q Consensus       332 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~---~~~~~~~~~~~~~~~~--~~~  405 (488)
                      ...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...   ...+....+.......  ...
T Consensus       168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  247 (342)
T 2qr7_A          168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW  247 (342)
T ss_dssp             EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred             ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence            654322 2334567899999999998888999999999999999999999999863   4444555555444332  234


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..++.++.+||.+||..||++||++.++++
T Consensus       248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            578999999999999999999999999886

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.6e-43  Score=355.34  Aligned_cols=252  Identities=29%  Similarity=0.538  Sum_probs=211.2

Q ss_pred             cceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh--cCCCCeeeEeeeeecCC-
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNVIKFVAACKKPP-  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~-  255 (488)
                      ++|.+++.||+|+||.||+|.++++.||||++....           ...+.+|++++..  ++||||+++++++.... 
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            568899999999999999999999999999996321           3456789999888  78999999999998776 


Q ss_pred             ---eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccCCCCCCeEEEcCCCcEE
Q 011359          256 ---VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH--------SQGVIHRDLKPENVLIDQEFHLK  324 (488)
Q Consensus       256 ---~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~giiHrDIkp~NILl~~~~~vk  324 (488)
                         .+++||||+++|+|.+++..   ..+++..++.++.||+.||+|||        +.||+||||||+|||++.++.+|
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             ccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence               78999999999999999976   46899999999999999999999        89999999999999999999999


Q ss_pred             EeeecccccccccC-----cCCCCCCCcccCChhhhhcCC------CCchhHHHHHHHHHHHHHhC----------CCCC
Q 011359          325 IADFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKHKS------YGRKVDVYSFGLILWEMVAG----------TIPY  383 (488)
Q Consensus       325 l~DFgla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~------~~~k~DvwSlGvll~elltG----------~~Pf  383 (488)
                      |+|||++.......     ......||..|+|||++.+..      ++.++|||||||++|+|++|          ..||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            99999986443322     234557999999999997652      33789999999999999999          7898


Q ss_pred             CCCC-----HHHHHHHHHhccCCCCCCC-----CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          384 EEMN-----PIQAAFAVVNKNLRPAIPG-----DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       384 ~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      ....     .......+.....++.++.     .++..+.+||.+||+.||++||++.++++.|+++....
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            7652     2333333444455555553     34568999999999999999999999999999997753

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5e-43  Score=345.80  Aligned_cols=256  Identities=22%  Similarity=0.350  Sum_probs=210.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee-ecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~  255 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++......          .++.+|+.+++.++|++++..++.+ ....
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----------CHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----------hHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence            57999999999999999999974  789999999765432          2467999999999988766666554 6677


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE---cCCCcEEEeeecccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIAC  332 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl---~~~~~vkl~DFgla~  332 (488)
                      ..++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             ceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            889999999 99999999753 4579999999999999999999999999999999999999   488899999999986


Q ss_pred             cccccCc--------CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccC-
Q 011359          333 EEVYCDA--------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP---IQAAFAVVNKNL-  400 (488)
Q Consensus       333 ~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~---~~~~~~~~~~~~-  400 (488)
                      .......        .....||..|+|||++.+..++.++|||||||++|+|++|..||.....   .+....+..... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            4433221        2455799999999999998999999999999999999999999986432   112222222111 


Q ss_pred             --CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhcc
Q 011359          401 --RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLAC  446 (488)
Q Consensus       401 --~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~  446 (488)
                        ....+..+++.+.+||.+||+.||++||++.++++.|+++......
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence              1123467899999999999999999999999999999999887653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-43  Score=355.17  Aligned_cols=250  Identities=24%  Similarity=0.371  Sum_probs=200.5

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      .+++|.+++.||+|+||+||+|.+.  ++.||||++.......      ...+.+.+|+.++++++||||+++++++..+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE------GVPGTAIREVSLLKELQHRNIIELKSVIHHN  105 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc------ccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            3467999999999999999999875  7899999997654322      2245678999999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE-----cCCCcEEEeeec
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI-----DQEFHLKIADFG  329 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl-----~~~~~vkl~DFg  329 (488)
                      ..+++||||++ |+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||+     +.++.+||+|||
T Consensus       106 ~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          106 HRLHLIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             TEEEEEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             CEEEEEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999999997 599999987  3569999999999999999999999999999999999999     455569999999


Q ss_pred             ccccccc-cCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----
Q 011359          330 IACEEVY-CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA----  403 (488)
Q Consensus       330 la~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----  403 (488)
                      ++..... ........||..|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+......+.    
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            9864332 2233445689999999999764 589999999999999999999999999888777666654211110    


Q ss_pred             ------------C------------CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          404 ------------I------------PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       404 ------------~------------~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                  .            +..++.++.+||.+||+.||++||++.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                        0            0126789999999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.3e-43  Score=373.29  Aligned_cols=254  Identities=24%  Similarity=0.388  Sum_probs=214.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChh-----HHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDEN-----ETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~-----~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      ++|.+++.||+|+||+||+|.+.  ++.||||++........     ........+.+.+|+.+|++++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            57889999999999999999986  58899999976432211     001112356788999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC---cEEEeee
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF---HLKIADF  328 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~---~vkl~DF  328 (488)
                      .....+++|||||+||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+||
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999763  5699999999999999999999999999999999999998776   6999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--C
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--G  406 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~  406 (488)
                      |++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.........+  .
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK  272 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence            9997655544556678999999999987 568999999999999999999999999998888777776665443222  5


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .++.++.+||.+||+.||.+||++.++++
T Consensus       273 ~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          273 NISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            78999999999999999999999999885

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8e-43  Score=341.80  Aligned_cols=244  Identities=20%  Similarity=0.327  Sum_probs=207.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  255 (488)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++.........      ..++.+|+.++..+ +||||+++++++....
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD------EQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH------HHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH------HHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            56889999999999999999986  789999999865443322      45678999999999 8999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-------------
Q 011359          256 VYCVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-------------  320 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-------------  320 (488)
                      .+++||||+++++|.+++....  ...+++..++.++.||+.||+|||++||+||||||+|||++.+             
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            9999999999999999998642  2668999999999999999999999999999999999999844             


Q ss_pred             ------CcEEEeeecccccccccCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 011359          321 ------FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF  393 (488)
Q Consensus       321 ------~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~  393 (488)
                            ..+||+|||++.....   .....||..|+|||++.+. .++.++|||||||++|+|++|..++......    
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----  237 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW----  237 (289)
T ss_dssp             -----CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----
T ss_pred             cccCCceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----
Confidence                  4799999999865432   2344699999999999765 5678999999999999999999877654332    


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          394 AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..+.....+.++..++..+.+||.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            223344556778889999999999999999999999999876

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-44  Score=363.42  Aligned_cols=260  Identities=27%  Similarity=0.440  Sum_probs=209.3

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      +..+..++|.+.+.||+|+||.||+|.+. ++.||||++........       ...+.+|+.++++++||||+++++++
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-------CCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-------HHHHHHHHHHHHhccCCCccceEEEE
Confidence            34455678999999999999999999875 78999999975432211       23578999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCeEEEcCCCcEEEe
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQ---GVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      ......++||||+.+|+|.+++....  ...+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999998743  23489999999999999999999999   99999999999999999999999


Q ss_pred             eeccccccccc--CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhc--
Q 011359          327 DFGIACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP----IQAAFAVVNK--  398 (488)
Q Consensus       327 DFgla~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~----~~~~~~~~~~--  398 (488)
                      |||++......  .......||..|+|||++.+..++.++||||||+++|+|++|..||.....    .......+..  
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            99999643321  223345599999999999888999999999999999999999999962110    0001111111  


Q ss_pred             -----------cCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHH
Q 011359          399 -----------NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ  439 (488)
Q Consensus       399 -----------~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~  439 (488)
                                 ......+...+..+.++|.+||+.||.+||++.++++.|+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                       11112223345789999999999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.9e-43  Score=345.79  Aligned_cols=250  Identities=27%  Similarity=0.436  Sum_probs=209.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee--ecC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKP  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~  254 (488)
                      ++|.+++.||+|+||.||++.+.  ++.||||++.......    .......+.+|+.++++++|+||+++++++  ...
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR----IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK   80 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH----STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc----cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence            67899999999999999999985  6799999997421100    011246789999999999999999999998  445


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+++||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            6889999999876 888888766778999999999999999999999999999999999999999999999999998543


Q ss_pred             cc---cCcCCCCCCCcccCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          335 VY---CDALSDDPGTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       335 ~~---~~~~~~~~gt~~y~aPE~l~~~~--~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      ..   ........||..|+|||++.+..  ++.++||||||+++|+|++|..||.+.+..+....+...  ...++..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~  237 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCG  237 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSC
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccC
Confidence            21   12223456899999999997644  378999999999999999999999988876665555444  335677899


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..+.+||.+||+.||.+||++.++++
T Consensus       238 ~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          238 PPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhc
Confidence            99999999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.2e-43  Score=355.24  Aligned_cols=250  Identities=20%  Similarity=0.324  Sum_probs=211.2

Q ss_pred             ceecc-ceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCC
Q 011359          180 QLFLG-LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPP  255 (488)
Q Consensus       180 ~~~i~-~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  255 (488)
                      +|.+. +.||+|+||.||+|.+.  ++.||||++.........      ...+.+|+.++..+. ||||+++++++....
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC------RAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH------HHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            45555 88999999999999986  789999999864433221      356789999999995 699999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC---CCcEEEeeecccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIADFGIAC  332 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~---~~~vkl~DFgla~  332 (488)
                      .+++||||+.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++.
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            9999999999999999987655577999999999999999999999999999999999999987   7899999999997


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCcH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL--RPAIPGDCPP  410 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~  410 (488)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+.....  .......++.
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          183 KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             EC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence            65444444556799999999999989999999999999999999999999999888777666655433  3344467899


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.+||.+||+.||++||++.++++
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          263 LATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhC
Confidence            9999999999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.1e-43  Score=356.08  Aligned_cols=251  Identities=22%  Similarity=0.377  Sum_probs=211.3

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .+..++|.+.+.||+|+||.||+|.+.  ++.||+|++......       ...+.+.+|+.++++++||||+++++++.
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  101 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-------AIRNQIIRELQVLHECNSPYIVGFYGAFY  101 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH-------HHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH-------HHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence            455678999999999999999999997  789999999865321       22467889999999999999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .+..+++||||+++++|.+++...  ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.++|+|||++
T Consensus       102 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  179 (360)
T 3eqc_A          102 SDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  179 (360)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence            999999999999999999999873  4689999999999999999999996 9999999999999999999999999998


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------------
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF------------------  393 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~------------------  393 (488)
                      ...... ......||..|+|||++.+..++.++|||||||++|+|++|..||...+..+...                  
T Consensus       180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          180 GQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             cccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            543222 2344579999999999999999999999999999999999999998766543221                  


Q ss_pred             ------------------------HHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          394 ------------------------AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       394 ------------------------~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                              .+............++.++.+||.+||+.||++||++.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                                    112222222223457899999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7e-44  Score=355.97  Aligned_cols=266  Identities=22%  Similarity=0.351  Sum_probs=213.4

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      +...++.++|.+++.||+|+||.||++...  ++.||||++.....        ...+.+.+|+.+++.++||||+++++
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~   93 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--------QDREEAQREADMHRLFNHPNILRLVA   93 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH--------HHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH--------HHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            445677789999999999999999999974  78999999975321        12467889999999999999999999


Q ss_pred             eee----cCCeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcE
Q 011359          250 ACK----KPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL  323 (488)
Q Consensus       250 ~~~----~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~v  323 (488)
                      ++.    ....+++||||+.+|+|.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~  173 (317)
T 2buj_A           94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP  173 (317)
T ss_dssp             EEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE
T ss_pred             EEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCE
Confidence            986    345789999999999999999864  34679999999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccccCc----------CCCCCCCcccCChhhhhcCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCHH-
Q 011359          324 KIADFGIACEEVYCDA----------LSDDPGTYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNPI-  389 (488)
Q Consensus       324 kl~DFgla~~~~~~~~----------~~~~~gt~~y~aPE~l~~~~---~~~k~DvwSlGvll~elltG~~Pf~~~~~~-  389 (488)
                      ||+|||++........          .....||..|+|||++....   ++.++||||||+++|+|++|..||...... 
T Consensus       174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  253 (317)
T 2buj_A          174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG  253 (317)
T ss_dssp             EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred             EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence            9999998753321100          11234689999999987543   689999999999999999999999642111 


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ...............+..++..+.+||.+||+.||.+||++.++++.|+.+.....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            01112223334444556789999999999999999999999999999998865433

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.2e-43  Score=347.53  Aligned_cols=246  Identities=21%  Similarity=0.360  Sum_probs=211.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||++.+.  |+.||||++.......        ...+.+|+.++++++||||+++++++.....
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR--------DSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc--------hHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            56889999999999999999985  7899999998543221        3457799999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE---cCCCcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl---~~~~~vkl~DFgla~~  333 (488)
                      +++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             EEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            99999999999999999763  568999999999999999999999999999999999999   7889999999999854


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--PAIPGDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  411 (488)
                      .... ......||..|+|||++.+..++.++||||||+++|+|++|..||......+....+......  ......++..
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (304)
T 2jam_A          159 EQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES  237 (304)
T ss_dssp             CCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred             cCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence            3221 122234899999999999889999999999999999999999999998877766666555433  2344678999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||..||++||++.++++
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          238 AKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhc
Confidence            999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=357.76  Aligned_cols=253  Identities=15%  Similarity=0.217  Sum_probs=209.7

Q ss_pred             ccceeccceeeeeccEEEEEEEEC----------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK----------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK-  246 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~----------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~-  246 (488)
                      .++|.+++.||+|+||.||+|.+.          ++.||||++...             ..+.+|+.++++++||||++ 
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------~~~~~E~~~l~~l~h~niv~~  107 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------GRLFNEQNFFQRAAKPLQVNK  107 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------STHHHHHHHHHHHCCHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------chHHHHHHHHHHhcccchhhh
Confidence            367999999999999999999975          579999999743             24669999999999999987 


Q ss_pred             --------------Eeeeeec-CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Q 011359          247 --------------FVAACKK-PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK  311 (488)
Q Consensus       247 --------------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIk  311 (488)
                                    +++++.. +..+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+|||||
T Consensus       108 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dik  186 (352)
T 2jii_A          108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVT  186 (352)
T ss_dssp             HHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCC
T ss_pred             hhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence                          5666665 67899999999 9999999997545779999999999999999999999999999999


Q ss_pred             CCeEEEcCCC--cEEEeeecccccccccC--------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCC
Q 011359          312 PENVLIDQEF--HLKIADFGIACEEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI  381 (488)
Q Consensus       312 p~NILl~~~~--~vkl~DFgla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~  381 (488)
                      |+|||++.++  .+||+|||++.......        ......||..|+|||++.+..++.++|||||||++|+|++|..
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999998  89999999995433211        1233479999999999998899999999999999999999999


Q ss_pred             CCCCCC-HHHHHHHHH---hccCCCCCC------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          382 PYEEMN-PIQAAFAVV---NKNLRPAIP------GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       382 Pf~~~~-~~~~~~~~~---~~~~~~~~~------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      ||.... .........   .... ..+.      ..++..+.+||.+||+.||++||++.++++.|+++...+.
T Consensus       267 pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          267 PWTNCLPNTEDIMKQKQKFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             TTGGGTTCHHHHHHHHHHHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CcccCCcCHHHHHHHHHhccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            998764 222222211   1111 1111      2568999999999999999999999999999999988765

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-42  Score=342.61  Aligned_cols=255  Identities=22%  Similarity=0.347  Sum_probs=207.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee-ecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~  255 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++......          .++.+|+.+++.++|++++..++.+ ....
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----------CCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----------hHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            56889999999999999999964  789999997754322          3467899999999987776666655 6777


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE---cCCCcEEEeeecccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIAC  332 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl---~~~~~vkl~DFgla~  332 (488)
                      ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             ceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            889999999 99999999853 4569999999999999999999999999999999999999   788999999999996


Q ss_pred             cccccC--------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcc--
Q 011359          333 EEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI---QAAFAVVNKN--  399 (488)
Q Consensus       333 ~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~---~~~~~~~~~~--  399 (488)
                      ......        ......||..|+|||++.+..++.++|||||||++|+|++|..||.+....   +....+....  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            443221        123457999999999999999999999999999999999999999864321   1111222111  


Q ss_pred             -CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          400 -LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       400 -~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                       ........++..+.+||.+||+.+|++||++.++++.|+++.....
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence             1112336788999999999999999999999999999999988765

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=345.94  Aligned_cols=250  Identities=22%  Similarity=0.382  Sum_probs=189.4

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||.||+|.+.  ++.||||++....     .......+.+.+|+.++++++||||+++++++....
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-----MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh-----hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            467899999999999999999974  7899999997321     011112467889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      ..++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            99999999999999999986 33578999999999999999999999999999999999999999999999999986433


Q ss_pred             cc-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          336 YC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       336 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      .. .......||..|+|||.+.+..++.++||||||+++|+|++|..||......+....+...  ....+..++.++.+
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  241 (278)
T 3cok_A          164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSFLSIEAKD  241 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS--CCCCCTTSCHHHHH
T ss_pred             CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc--ccCCccccCHHHHH
Confidence            21 2223456899999999999888999999999999999999999999876543333322222  23456778999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+||+.||++||++.++++
T Consensus       242 li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHcccCHhhCCCHHHHhc
Confidence            999999999999999999876

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.8e-43  Score=347.85  Aligned_cols=247  Identities=23%  Similarity=0.358  Sum_probs=199.1

Q ss_pred             cceec-cceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC
Q 011359          179 SQLFL-GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP  254 (488)
Q Consensus       179 ~~~~i-~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  254 (488)
                      +.|.+ ++.||+|+||.||+|.+.  ++.||||++.......        ...+.+|+.++.++ +||||+++++++..+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--------RSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC--------HHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh--------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            35666 477999999999999874  7899999997654322        35678999999995 699999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc---EEEeeeccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIA  331 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~---vkl~DFgla  331 (488)
                      ..+++||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             CEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            9999999999999999999873  56899999999999999999999999999999999999988766   999999998


Q ss_pred             cccccc--------CcCCCCCCCcccCChhhhhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----------
Q 011359          332 CEEVYC--------DALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNP----------  388 (488)
Q Consensus       332 ~~~~~~--------~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvll~elltG~~Pf~~~~~----------  388 (488)
                      ......        .......||..|+|||++.+     ..++.++|||||||++|+|++|..||.....          
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            543211        11223459999999999975     5578999999999999999999999986532          


Q ss_pred             -----HHHHHHHHhccCCCCC--CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          389 -----IQAAFAVVNKNLRPAI--PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       389 -----~~~~~~~~~~~~~~~~--~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                           ......+.........  ...++..+.+||.+||+.||.+||++.++++
T Consensus       242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                 1222233333222111  1467899999999999999999999999887

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.2e-42  Score=353.73  Aligned_cols=247  Identities=21%  Similarity=0.318  Sum_probs=207.4

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeEee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-----NPNVIKFVA  249 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~  249 (488)
                      -.++|.+.+.||+|+||.||+|.+.  ++.||||++...         ......+..|+.+++.+.     ||||+++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---------KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---------hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            3468999999999999999999984  788999999631         112455778999999996     999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC----------
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ----------  319 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~----------  319 (488)
                      ++.....+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.          
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence            999999999999999 999999999866667999999999999999999999999999999999999975          


Q ss_pred             ---------------CCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 011359          320 ---------------EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE  384 (488)
Q Consensus       320 ---------------~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~  384 (488)
                                     ++.+||+|||++....  .......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             hcccccccccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                           7899999999996433  23345678999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhccCCC------------------------CCC--------------------CCCcHHHHHHHHHHh
Q 011359          385 EMNPIQAAFAVVNKNLRP------------------------AIP--------------------GDCPPAMAALIEQCW  420 (488)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~------------------------~~~--------------------~~~~~~l~~Li~~cL  420 (488)
                      .....+....+.......                        ..+                    ...++.+.+||.+||
T Consensus       261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  340 (360)
T 3llt_A          261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL  340 (360)
T ss_dssp             CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred             CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence            887765544433211000                        001                    112367889999999


Q ss_pred             hhCCCCCCCHHHHHH
Q 011359          421 SLQPDKRPEFWHIVK  435 (488)
Q Consensus       421 ~~dp~~RPs~~eil~  435 (488)
                      +.||.+||++.++++
T Consensus       341 ~~dP~~Rpta~elL~  355 (360)
T 3llt_A          341 QIDPTLRPSPAELLK  355 (360)
T ss_dssp             CSSGGGSCCHHHHTT
T ss_pred             cCChhhCCCHHHHhc
Confidence            999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.2e-42  Score=342.92  Aligned_cols=248  Identities=25%  Similarity=0.471  Sum_probs=208.7

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec--
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--  253 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--  253 (488)
                      ...|.+++.||+|+||.||+|.+.  +..||+|++........      ..+.+.+|+.++++++||||+++++++..  
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS------ERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH------HHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHH------HHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence            345888999999999999999986  57899999986443321      24678899999999999999999998865  


Q ss_pred             --CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCeEEEc-CCCcEEEeee
Q 011359          254 --PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLID-QEFHLKIADF  328 (488)
Q Consensus       254 --~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--iiHrDIkp~NILl~-~~~~vkl~DF  328 (488)
                        ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.|  |+||||||+|||++ .++.+||+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A           99 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             CCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence              45689999999999999999863  56899999999999999999999999  99999999999997 7899999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCC
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RPAIPGD  407 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~  407 (488)
                      |++..... .......||..|+|||++. ..++.++||||||+++|+|++|..||............+.... ....+..
T Consensus       177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (290)
T 1t4h_A          177 GLATLKRA-SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV  254 (290)
T ss_dssp             TGGGGCCT-TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred             CCcccccc-cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence            99854322 2223456899999999887 4589999999999999999999999998665555554444433 3345567


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +++++.+||.+||+.||.+||++.++++
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            7899999999999999999999999886

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=362.23  Aligned_cols=247  Identities=23%  Similarity=0.380  Sum_probs=207.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++..................+.+|+.+|++++||||+++++++.....
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            56889999999999999999875  6899999998654221100000002346689999999999999999999999999


Q ss_pred             eeEEEeecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          257 YCVITEYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       257 ~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      +++||||+.+| +|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            99999999776 99999976  4579999999999999999999999999999999999999999999999999996554


Q ss_pred             ccCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          336 YCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                      .........||..|+|||++.+..+ +.++|||||||++|+|++|..||.....      ..  ......+..++.++.+
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~--~~~~~~~~~~~~~l~~  253 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TV--EAAIHPPYLVSKELMS  253 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GT--TTCCCCSSCCCHHHHH
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HH--hhccCCCcccCHHHHH
Confidence            4444445679999999999987776 8899999999999999999999976432      11  1223446678999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+||+.||++||++.++++
T Consensus       254 li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          254 LVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=354.95  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=202.2

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||.||+|.+.  ++.||||++.......       ....+.+|+.++++++||||+++++++..+.
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIIHTEK   73 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc-------cchhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence            367999999999999999999986  6889999997543211       1224558999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        74 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           74 SLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             CEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            9999999996 5999998863 4568999999999999999999999999999999999999999999999999986433


Q ss_pred             c-cCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---C-------
Q 011359          336 Y-CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP---A-------  403 (488)
Q Consensus       336 ~-~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~-------  403 (488)
                      . ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+   .       
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            2 222334568999999999976 568999999999999999999999999988776655544321110   0       


Q ss_pred             ------------------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          404 ------------------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       404 ------------------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                        ....++..+.+||.+||+.||.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                              11356789999999999999999999999987

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-43  Score=353.59  Aligned_cols=253  Identities=24%  Similarity=0.341  Sum_probs=204.4

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||.||+|.+.  |+.||||++........   .......+.+|+.++++++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA---KDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh---hhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            467889999999999999999985  78999999975432211   1112346789999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+++ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             ceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            99999999975 89888875 34568899999999999999999999999999999999999999999999999996543


Q ss_pred             c-cCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----------
Q 011359          336 Y-CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA----------  403 (488)
Q Consensus       336 ~-~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------  403 (488)
                      . ........||..|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+......+.          
T Consensus       164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  243 (346)
T 1ua2_A          164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  243 (346)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence            2 2233456789999999999654 589999999999999999999999999888777666554211100          


Q ss_pred             ----------------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          404 ----------------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       404 ----------------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                      +...++..+.+||.+||+.||.+||++.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                            01456789999999999999999999999887

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-42  Score=357.09  Aligned_cols=253  Identities=23%  Similarity=0.378  Sum_probs=209.6

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec-
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-  253 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-  253 (488)
                      ..++|.+++.||+|+||+||+|.+.  |+.||||++......            ..+|+.+|+.++||||+++++++.. 
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------------~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------------KNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------------CCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------------HHHHHHHHHHcCCCCccchhheeeec
Confidence            3467999999999999999999984  789999999754322            2379999999999999999999843 


Q ss_pred             -------------------------------------CCeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHH
Q 011359          254 -------------------------------------PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIA  294 (488)
Q Consensus       254 -------------------------------------~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~  294 (488)
                                                           ...+++||||++ |+|.+.+...  ....+++..+..++.||+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                 334889999997 5888887653  456799999999999999


Q ss_pred             HHHHHHHHCCcccCCCCCCeEEEc-CCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHH
Q 011359          295 RGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLI  372 (488)
Q Consensus       295 ~~L~~LH~~giiHrDIkp~NILl~-~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvl  372 (488)
                      .||+|||++||+||||||+|||++ .++.+||+|||++.............||..|+|||++.+. .++.++|||||||+
T Consensus       152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            999999999999999999999997 6889999999999765555555667789999999998764 58999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhccC---------------------------CCCCCCCCcHHHHHHHHHHhhhCCC
Q 011359          373 LWEMVAGTIPYEEMNPIQAAFAVVNKNL---------------------------RPAIPGDCPPAMAALIEQCWSLQPD  425 (488)
Q Consensus       373 l~elltG~~Pf~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~Li~~cL~~dp~  425 (488)
                      +|+|++|..||.+....+....++....                           ...++..++..+.+||.+||+.||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999888776665543110                           0113456889999999999999999


Q ss_pred             CCCCHHHHHH--HHHHHHH
Q 011359          426 KRPEFWHIVK--VLEQFET  442 (488)
Q Consensus       426 ~RPs~~eil~--~Le~~~~  442 (488)
                      +||++.++++  .++.+..
T Consensus       312 ~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          312 LRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             GSCCHHHHHTSGGGHHHHH
T ss_pred             hCCCHHHHhcCHHHHHHHh
Confidence            9999999984  4554443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=355.96  Aligned_cols=245  Identities=23%  Similarity=0.386  Sum_probs=202.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  255 (488)
                      ++|.+.+.||+|+||.||+|.+.  |+.||||++.......      ...+.+.+|+.+|++++||||+++++++.... 
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE------LFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH------HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH------HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            57999999999999999999985  7899999996543322      22467889999999999999999999997653 


Q ss_pred             -----eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          256 -----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       256 -----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                           .+|+||||+ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence                 469999999 8899999986   5689999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--------  401 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~--------  401 (488)
                      +....  .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......        
T Consensus       175 a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          175 ARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccccc--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            96543  23445678999999999976 67999999999999999999999999988876655544321100        


Q ss_pred             ---------------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 ---------------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 ---------------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                           ......+++.+.+||.+||..||++||++.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                                 1123567899999999999999999999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=341.27  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=210.3

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      +.++.++|.....||+|+||.||+|.+.  ++.||||++......        ..+.+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~   88 (295)
T 2clq_A           17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR--------YSQPLHEEIALHKHLKHKNIVQYLGSF   88 (295)
T ss_dssp             EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----------HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH--------HHHHHHHHHHHHHhCCCCCEeeEeeEE
Confidence            3344555666678999999999999985  678999999765322        135688999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-CCcEEEeeec
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFG  329 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-~~~vkl~DFg  329 (488)
                      .....+++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg  168 (295)
T 2clq_A           89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG  168 (295)
T ss_dssp             EETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred             EeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecc
Confidence            99999999999999999999998743 235678889999999999999999999999999999999987 8999999999


Q ss_pred             cccccccc-CcCCCCCCCcccCChhhhhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCCCC
Q 011359          330 IACEEVYC-DALSDDPGTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEEMNPI-QAAFAVVNKNLRPAIP  405 (488)
Q Consensus       330 la~~~~~~-~~~~~~~gt~~y~aPE~l~~~~--~~~k~DvwSlGvll~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~  405 (488)
                      ++...... .......|+..|+|||++.+..  ++.++||||||+++|+|++|..||...... ............+.++
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T 2clq_A          169 TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP  248 (295)
T ss_dssp             TCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC
T ss_pred             cccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc
Confidence            98644321 2234557899999999997643  899999999999999999999999765432 2333333445566778


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..++.++.+||.+||+.||++||++.++++
T Consensus       249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          249 ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            899999999999999999999999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.4e-43  Score=354.03  Aligned_cols=239  Identities=25%  Similarity=0.398  Sum_probs=182.5

Q ss_pred             cceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeeeEE
Q 011359          184 GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV  260 (488)
                      ++.||+|+||.||+|.+.  ++.||||++...           ....+.+|+.+++.+. ||||+++++++.+....++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            477999999999999986  689999999742           1355779999999997 99999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC---cEEEeeecccccccc-
Q 011359          261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF---HLKIADFGIACEEVY-  336 (488)
Q Consensus       261 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~---~vkl~DFgla~~~~~-  336 (488)
                      |||+++|+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||++..... 
T Consensus        85 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           85 MELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             ECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             EEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            999999999999987  46799999999999999999999999999999999999997765   899999999964332 


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccCCCCC--CCC
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP-------IQAAFAVVNKNLRPAI--PGD  407 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~-------~~~~~~~~~~~~~~~~--~~~  407 (488)
                      ........||..|+|||++.+..++.++|||||||++|+|++|..||.....       .+....+.........  ...
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (325)
T 3kn6_A          163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN  242 (325)
T ss_dssp             ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred             CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC
Confidence            2233455689999999999999999999999999999999999999986543       2333333333222111  135


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +++++.+||.+||+.||.+||++.++++
T Consensus       243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          243 VSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             SCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            7899999999999999999999998874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.1e-43  Score=369.86  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  254 (488)
                      .++|.+++.||+|+||+||+|.+.  ++.||||++.......      ...+++.+|+.+|+.++||||+++++++... 
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ------THAKRAYRELVLMKCVNHKNIISLLNVFTPQK  134 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH------HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh------HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence            478999999999999999999886  7899999997542221      2246788999999999999999999999654 


Q ss_pred             -----CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          255 -----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       255 -----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                           ..+||||||+++ +|.+.+.    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       135 ~~~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             ccccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence                 357999999965 5666664    358999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-------
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP-------  402 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------  402 (488)
                      ++.............||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....++.....+       
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             CC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9976555445566789999999999999999999999999999999999999999988776655554321100       


Q ss_pred             -------------CCC---------CC-----------CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 -------------AIP---------GD-----------CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 -------------~~~---------~~-----------~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                   ...         ..           .++++.+||.+||..||++||++.++++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                         000         00           1567899999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-42  Score=344.42  Aligned_cols=249  Identities=23%  Similarity=0.446  Sum_probs=208.7

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||.||+|.+.  ++.||+|++.......        .+.+.+|+.++..++||||+++++++..+.
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--------LEDYIVEIEILATCDHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC--------HHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH--------HHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence            367999999999999999999996  6899999997543322        356789999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999999998763 4569999999999999999999999999999999999999999999999999874322


Q ss_pred             c-cCcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCCCCCC
Q 011359          336 Y-CDALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-PAIPGDC  408 (488)
Q Consensus       336 ~-~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~  408 (488)
                      . ........||..|+|||++.     ...++.++||||||+++|+|++|..||...+.......+...... ...+..+
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW  248 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcccc
Confidence            1 11223456899999999983     567899999999999999999999999998887766665554432 2345678


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +..+.+||.+||+.||++||++.++++
T Consensus       249 ~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          249 SVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            999999999999999999999998875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=364.14  Aligned_cols=259  Identities=20%  Similarity=0.355  Sum_probs=213.6

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||.||+|.+.  ++.||||++........       ...+.+|++++++++||||+++++++....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   80 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNHKNIVKLFAIEEETT   80 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-------HHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence            367899999999999999999987  78999999974332111       345779999999999999999999998655


Q ss_pred             --eeeEEEeecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE----cCCCcEEEeee
Q 011359          256 --VYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIADF  328 (488)
Q Consensus       256 --~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl----~~~~~vkl~DF  328 (488)
                        ..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence              7899999999999999998643 2349999999999999999999999999999999999999    77888999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhc--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHH
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKH--------KSYGRKVDVYSFGLILWEMVAGTIPYEEMN----PIQAAFAVV  396 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~k~DvwSlGvll~elltG~~Pf~~~~----~~~~~~~~~  396 (488)
                      |++.............||..|+|||++.+        ..++.++|||||||++|||++|..||....    ..+....+.
T Consensus       161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            99976554445556679999999999865        567889999999999999999999997432    234444444


Q ss_pred             hccCCC-----------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          397 NKNLRP-----------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       397 ~~~~~~-----------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ......                       .+...++..+.++|.+||+.||++||++.++++.++.+...
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            432110                       11233457899999999999999999999999999888664

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-42  Score=372.00  Aligned_cols=250  Identities=23%  Similarity=0.370  Sum_probs=212.6

Q ss_pred             ccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      ..+..++|.+.+.||+|+||.||+|++.  |+.||||++.....     ........+.+|+.+|++++||||+++++++
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-----KKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh-----hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            4466788999999999999999999985  78999999974211     0111235688999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      .....+|+||||++||+|.+++....  ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence            99999999999999999999998643  4569999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCc-CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCCCCC
Q 011359          330 IACEEVYCDA-LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN----PIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       330 la~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~----~~~~~~~~~~~~~~~~~  404 (488)
                      ++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||....    ..+....+...  ...+
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~  412 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTY  412 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCC
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCC
Confidence            9965443322 234579999999999999899999999999999999999999998753    33444444443  3456


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCH
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEF  430 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~  430 (488)
                      +..++..+.+||.+||+.||.+||++
T Consensus       413 p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          413 PDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             CcccCHHHHHHHHHhccCCHhHCCCC
Confidence            78899999999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.1e-43  Score=353.46  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=208.9

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      ..+++|.+.+.||+|+||.||+|.+.  ++.||||++........      ..+.+.+|+.++++++||||+++++++..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   95 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM------VKKIAMREIKLLKQLRHENLVNLLEVCKK   95 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchH------HHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence            45678999999999999999999986  78999999976544321      24567899999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ...+++||||+++++|.+++..  ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CCEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            9999999999999999888764  45699999999999999999999999999999999999999999999999999854


Q ss_pred             ccc-cCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------
Q 011359          334 EVY-CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN------------  399 (488)
Q Consensus       334 ~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~------------  399 (488)
                      ... ........||..|+|||++.+. .++.++|||||||++|+|++|..||......+....+....            
T Consensus       174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            332 2233455789999999999765 78999999999999999999999999988766655443210            


Q ss_pred             -------CC-CC---------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 -------LR-PA---------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 -------~~-~~---------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                             .. +.         ....++..+.+||.+||+.||++||++.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   00 00         11357899999999999999999999998886

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-42  Score=346.50  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=210.1

Q ss_pred             cceeccceeeeeccEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeeEeeeee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACK  252 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~---~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~  252 (488)
                      ++|.+++.||+|+||.||+|.+.   ++.||||++.........      ...+.+|+.+++.+   +||||+++++++.
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   84 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVCT   84 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC------CchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence            67999999999999999999983   578999999754322110      12345777777766   8999999999987


Q ss_pred             -----cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          253 -----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       253 -----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                           ....+++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence                 5678999999997 6999999886666799999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------
Q 011359          328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR------  401 (488)
Q Consensus       328 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~------  401 (488)
                      ||++.............||..|+|||++.+..++.++||||||+++|+|++|..||.+....+....++.....      
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            99996554444445667999999999999889999999999999999999999999998877666555431100      


Q ss_pred             -------------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 -------------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 -------------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                         ..+...++..+.+||.+||+.||++||++.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                               1123568899999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.1e-43  Score=350.91  Aligned_cols=260  Identities=22%  Similarity=0.370  Sum_probs=197.5

Q ss_pred             cccccccceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVA  249 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~  249 (488)
                      ...+...+|.+++.||+|+||.||+|.+  .++.||||++.....        .....+.+|+.++.++. ||||+++++
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~~h~~iv~~~~   93 (337)
T 3ll6_A           22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--------EKNRAIIQEVCFMKKLSGHPNIVQFCS   93 (337)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH--------HHHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch--------HHHHHHHHHHHHHHHhccCCChhhccc
Confidence            3345556899999999999999999998  478999999865421        12456889999999996 999999999


Q ss_pred             eee--------cCCeeeEEEeecCCCCHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCeEEEc
Q 011359          250 ACK--------KPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLID  318 (488)
Q Consensus       250 ~~~--------~~~~~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g--iiHrDIkp~NILl~  318 (488)
                      ++.        ....+++||||+. |+|.+++... ....+++..++.++.||+.||+|||+.|  |+||||||+|||++
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~  172 (337)
T 3ll6_A           94 AASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS  172 (337)
T ss_dssp             EEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC
T ss_pred             cccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC
Confidence            983        4456899999995 7999988764 3456999999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeeecccccccccCc-------------CCCCCCCcccCChhhh---hcCCCCchhHHHHHHHHHHHHHhCCCC
Q 011359          319 QEFHLKIADFGIACEEVYCDA-------------LSDDPGTYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAGTIP  382 (488)
Q Consensus       319 ~~~~vkl~DFgla~~~~~~~~-------------~~~~~gt~~y~aPE~l---~~~~~~~k~DvwSlGvll~elltG~~P  382 (488)
                      .++.+||+|||++........             .....||..|+|||++   .+..++.++|||||||++|+|++|..|
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p  252 (337)
T 3ll6_A          173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP  252 (337)
T ss_dssp             TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred             CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence            999999999999864332111             1134589999999998   566789999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          383 YEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       383 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      |.......    +.........+..++..+.+||.+||+.||.+||++.++++.|+.+.....
T Consensus       253 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          253 FEDGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             C----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             CcchhHHH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            98755433    333344444556778889999999999999999999999999999987644

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.5e-43  Score=348.76  Aligned_cols=256  Identities=24%  Similarity=0.450  Sum_probs=196.6

Q ss_pred             cccccccceeccceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      .|.++.++|.+++.||+|+||.||+|.+  +++.||||++......       ...+.+.+|+.++++++||||++++++
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~   81 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-------TSMDELLKEIQAMSQCHHPNIVSYYTS   81 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEE
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-------hhHHHHHHHHHHHhhcCCCCEeeEEEE
Confidence            4667888999999999999999999987  4789999998653321       124568899999999999999999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEE
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKL------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK  324 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vk  324 (488)
                      +......++||||+++++|.+++...      ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             EESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred             EeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence            99999999999999999999999753      245689999999999999999999999999999999999999999999


Q ss_pred             Eeeeccccccccc------CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 011359          325 IADFGIACEEVYC------DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN  397 (488)
Q Consensus       325 l~DFgla~~~~~~------~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~  397 (488)
                      |+|||++......      .......||..|+|||++.+ ..++.++||||||+++|+|++|..||..............
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  241 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ  241 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence            9999988543221      11234468999999999975 5689999999999999999999999998776655544443


Q ss_pred             ccCC--------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          398 KNLR--------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       398 ~~~~--------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ....        ......++..+.+||.+||+.||.+||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            3211        1233568899999999999999999999999886

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.5e-43  Score=341.51  Aligned_cols=248  Identities=27%  Similarity=0.416  Sum_probs=208.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++.......       ..+.+.+|+.+++.++||||+++++++.....
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-------CPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT-------HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh-------hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence            57889999999999999999986  7899999997544322       13568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .++||||+++++|.+++..  ...+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999999999998864  45689999999999999999999999999999999999999999999999999854322


Q ss_pred             c---CcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCCCCCCCCcHH
Q 011359          337 C---DALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQA-AFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       337 ~---~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  411 (488)
                      .   .......|+..|+|||.+.+..+ +.++||||||+++|+|++|..||........ ................++..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA  237 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHH
Confidence            1   22345678999999999987665 7899999999999999999999987654322 22222222222233568899


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.||.+||++.++++
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          238 PLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHCCCCchhCCCHHHHhc
Confidence            999999999999999999998876

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-43  Score=368.69  Aligned_cols=255  Identities=22%  Similarity=0.338  Sum_probs=197.2

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||.||+|.+.  ++.||||++..................+.+|+.+|++++||||+++++++..+ 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            367999999999999999999986  58999999975432111111111234578999999999999999999998654 


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC---CcEEEeeecccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIAC  332 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~---~~vkl~DFgla~  332 (488)
                      .+++||||+++|+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.+   +.+||+|||++.
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             ceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            57899999999999998865  4679999999999999999999999999999999999999654   459999999997


Q ss_pred             cccccCcCCCCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---CCCC
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP---AIPG  406 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~  406 (488)
                      ............||+.|+|||++.+   ..++.++|||||||++|+|++|..||............+......   ....
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~  370 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA  370 (419)
T ss_dssp             SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHT
T ss_pred             ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhc
Confidence            6544444456679999999999853   567899999999999999999999998754332222333322221   1225


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .++..+.+||.+||+.||++||++.++++
T Consensus       371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          371 EVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            68899999999999999999999999886

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.1e-42  Score=340.94  Aligned_cols=248  Identities=25%  Similarity=0.426  Sum_probs=212.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++.........      ...+.+|+.++++++||||+++++++.....
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD------TSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH------HHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            57889999999999999999985  789999999754332211      3568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC---CcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~---~~vkl~DFgla~~  333 (488)
                      +++||||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999999999998763  468999999999999999999999999999999999999754   4699999999865


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  411 (488)
                      ...........|+..|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+....+.........+  ..++.+
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (287)
T 2wei_A          174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (287)
T ss_dssp             BCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred             ecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence            443333344458899999999875 58999999999999999999999999988877766666655443333  578999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.+|++||++.++++
T Consensus       253 ~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          253 AKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcccChhhCcCHHHHhc
Confidence            999999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=343.46  Aligned_cols=247  Identities=26%  Similarity=0.469  Sum_probs=209.1

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+.+.||+|+||.||+|.+.  |+.||||++.....          .+.+.+|+.++++++||||+++++++....
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----------LQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----------CHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----------HHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            356889999999999999999986  78999999986432          245779999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             EEEEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            99999999999999999974 34679999999999999999999999999999999999999999999999999985433


Q ss_pred             cc-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHH
Q 011359          336 YC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RPAIPGDCPPAMA  413 (488)
Q Consensus       336 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~  413 (488)
                      .. .......|+..|+|||++.+..++.++||||||+++|+|++|..||...........+..... ....+..++..+.
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  256 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT  256 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence            22 223445689999999999988899999999999999999999999999887766554443321 2233556789999


Q ss_pred             HHHHHHhhhCCCCCCCHHHHHH
Q 011359          414 ALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +||.+||..||.+||++.++++
T Consensus       257 ~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          257 DFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHccCChhhCcCHHHHHh
Confidence            9999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.7e-42  Score=351.80  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=197.8

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||.||+|.+.  ++.||||++.......      ...+.+.+|+.+++.++||||+++++++....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ------THAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSH------HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCCh------HHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            468999999999999999999885  7899999998644322      12456889999999999999999999997654


Q ss_pred             ------eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          256 ------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       256 ------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                            .+++||||++ ++|.+++.    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        98 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             STTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEee
Confidence                  7899999996 57888885    358999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--------  401 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~--------  401 (488)
                      ++.............||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....++.....        
T Consensus       173 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          173 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             C----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             cccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            996554433445567999999999999889999999999999999999999999998877665555432111        


Q ss_pred             ------------CCC--------------CC------CCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 ------------PAI--------------PG------DCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 ------------~~~--------------~~------~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                  +..              +.      ..+..+.+||.+||..||.+||++.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                        000              00      11567999999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-42  Score=382.97  Aligned_cols=249  Identities=27%  Similarity=0.410  Sum_probs=214.9

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVA  249 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~  249 (488)
                      ...+.+++|.+++.||+|+||.||+|.+.  ++.||||++....     .........+..|..+|..+ +|+||+++++
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~-----~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~  409 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV-----VIQDDDVECTMVEKRVLALPGKPPFLTQLHS  409 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHH-----HHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccc-----cccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            34567789999999999999999999986  5789999997421     01111234577899999988 6999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++.+...+||||||++||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus       410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          410 CFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             ECBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecc
Confidence            999999999999999999999999874  569999999999999999999999999999999999999999999999999


Q ss_pred             cccccc-ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 011359          330 IACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       330 la~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      ++.... .........||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+....  ..+|..+
T Consensus       488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~  565 (674)
T 3pfq_A          488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSM  565 (674)
T ss_dssp             TCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--CCCCTTS
T ss_pred             eeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCccC
Confidence            996532 2233456679999999999999999999999999999999999999999998888877777654  4567889


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCH
Q 011359          409 PPAMAALIEQCWSLQPDKRPEF  430 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~  430 (488)
                      +.++.+||.+||+.||.+||++
T Consensus       566 s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          566 SKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             CHHHHHHHHHHSCSSSTTCTTC
T ss_pred             CHHHHHHHHHHccCCHHHCCCC
Confidence            9999999999999999999997

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.8e-43  Score=353.12  Aligned_cols=254  Identities=23%  Similarity=0.356  Sum_probs=199.6

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++..................+.+|+.+|++++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            56889999999999999999986  589999999754321111111122345889999999999999999999997665 


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc---EEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~---vkl~DFgla~~  333 (488)
                      +++||||+++++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        89 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            7899999999999999875  467899999999999999999999999999999999999987654   99999999864


Q ss_pred             ccccCcCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---CCCCCC
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR---PAIPGD  407 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~  407 (488)
                      ...........||..|+|||++.   ...++.++|||||||++|+|++|..||............+.....   +.....
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (322)
T 2ycf_A          167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  246 (322)
T ss_dssp             CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT
T ss_pred             cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh
Confidence            43222222345899999999984   457899999999999999999999999865432222222222211   122356


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++..+.+||.+||+.||++||++.++++
T Consensus       247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          247 VSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            8899999999999999999999999885

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=352.79  Aligned_cols=256  Identities=16%  Similarity=0.225  Sum_probs=211.0

Q ss_pred             ccccccccceeccceeeeeccEEEEEEE-------ECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---C
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGI-------YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---N  241 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~-------~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---H  241 (488)
                      .+..+..++|.+++.||+|+||+||+|.       ..++.||||++....           ..++..|+.++.+++   |
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~l~~~~~  126 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----------PWEFYIGTQLMERLKPSMQ  126 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----------HHHHHHHHHHHHHSCGGGG
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----------hhHHHHHHHHHHHhhhhhh
Confidence            4455667889999999999999999994       237899999997432           245678888888887   8


Q ss_pred             CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc
Q 011359          242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL---EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID  318 (488)
Q Consensus       242 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~  318 (488)
                      +||+++++++......+||||||++|+|.+++...   ....+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus       127 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~  206 (365)
T 3e7e_A          127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG  206 (365)
T ss_dssp             GGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred             hhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence            99999999999999999999999999999999864   345799999999999999999999999999999999999999


Q ss_pred             C-----------CCcEEEeeeccccccc---ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 011359          319 Q-----------EFHLKIADFGIACEEV---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE  384 (488)
Q Consensus       319 ~-----------~~~vkl~DFgla~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~  384 (488)
                      .           ++.+||+|||++....   .........||..|+|||++.+..++.++|||||||++|||++|..||.
T Consensus       207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence            8           8999999999995432   2233455679999999999999899999999999999999999999996


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCC-CCHHHHHHHHHHHHHhh
Q 011359          385 EMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKR-PEFWHIVKVLEQFETSL  444 (488)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~R-Ps~~eil~~Le~~~~~l  444 (488)
                      ........   . ..  .......+..+.+++..||+.+|.+| |++.++.+.|+.+....
T Consensus       287 ~~~~~~~~---~-~~--~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          287 KNEGGECK---P-EG--LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             EEETTEEE---E-CS--CCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cCCCCcee---e-ch--hccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            54321100   0 00  01111347789999999999999998 67888888888887653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-42  Score=363.07  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=187.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec---
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK---  253 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---  253 (488)
                      ++|.+++.||+|+||+||+|++.  ++.||||++........      ..+.+.+|+.+|++++||||+++++++..   
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI------DCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHH------HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHH------HHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            57999999999999999999876  68999999975433221      24678899999999999999999999843   


Q ss_pred             --CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          254 --PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       254 --~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                        ...+|+||||+ +++|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          127 EKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             TTCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccc
Confidence              35789999998 5799999875  467999999999999999999999999999999999999999999999999999


Q ss_pred             cccccc----------------------------CcCCCCCCCcccCChhhh-hcCCCCchhHHHHHHHHHHHHHh----
Q 011359          332 CEEVYC----------------------------DALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVA----  378 (488)
Q Consensus       332 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~l-~~~~~~~k~DvwSlGvll~ellt----  378 (488)
                      ......                            .......||+.|+|||++ ....|+.++|||||||++|||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            653211                            122345689999999986 55679999999999999999998    


Q ss_pred             -------CCCCCCCCCH--------------------HHHHHHHHh---c-------------------cCC-------C
Q 011359          379 -------GTIPYEEMNP--------------------IQAAFAVVN---K-------------------NLR-------P  402 (488)
Q Consensus       379 -------G~~Pf~~~~~--------------------~~~~~~~~~---~-------------------~~~-------~  402 (488)
                             |..+|.+...                    .+.+..+..   .                   .+.       .
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   6667765431                    111111110   0                   000       0


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .....++.++.+||.+||..||++||++.++++
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            112456889999999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-42  Score=365.52  Aligned_cols=255  Identities=21%  Similarity=0.350  Sum_probs=213.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~  255 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++......          .++.+|+.+++.|.| ++|..+..++....
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~   76 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKIYRILQGGTGIPNVRWFGVEGD   76 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----------CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence            67999999999999999999975  789999998765433          246789999999986 56666667777888


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE---cCCCcEEEeeecccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIAC  332 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl---~~~~~vkl~DFgla~  332 (488)
                      ..+|||||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+||||   +.++.+||+|||++.
T Consensus        77 ~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           77 YNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            999999999 99999999853 4579999999999999999999999999999999999999   688999999999996


Q ss_pred             cccccCc--------CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccC-
Q 011359          333 EEVYCDA--------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP---IQAAFAVVNKNL-  400 (488)
Q Consensus       333 ~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~---~~~~~~~~~~~~-  400 (488)
                      .......        .....||..|+|||++.+..++.++|||||||++|||++|..||.+...   .+....+..... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            5433221        2255799999999999999999999999999999999999999987543   233333322221 


Q ss_pred             --CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          401 --RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       401 --~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                        ...++..++.++.+||.+||+.+|++||++.+|++.|+++.....
T Consensus       235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence              122346789999999999999999999999999999999987654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.5e-42  Score=344.75  Aligned_cols=242  Identities=21%  Similarity=0.373  Sum_probs=202.1

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeec-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK-  253 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~-  253 (488)
                      .++|.+++.||+|+||.||+|.+.  ++.||||++....           .+.+.+|+.++++++ ||||+++++++.. 
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~  103 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKDP  103 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----------hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence            367999999999999999999874  7899999997422           356789999999997 9999999999987 


Q ss_pred             -CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC-cEEEeeeccc
Q 011359          254 -PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIA  331 (488)
Q Consensus       254 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~-~vkl~DFgla  331 (488)
                       ....++||||+.+++|.+++..     +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence             6678999999999999998854     88999999999999999999999999999999999999776 8999999999


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh------------
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVN------------  397 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~------------  397 (488)
                      .............|+..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+..            
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            75554445556679999999999976 678999999999999999999999995433 2222211111            


Q ss_pred             c-c----------------------CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          398 K-N----------------------LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       398 ~-~----------------------~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      . .                      .....+..++.++.+||.+||+.||++||++.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0 0                      011112237899999999999999999999999886

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-43  Score=364.11  Aligned_cols=253  Identities=17%  Similarity=0.235  Sum_probs=198.0

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHH---HHHHhcCCCCeeeEe--
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREV---ALLSRLHNPNVIKFV--  248 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei---~il~~l~HpnIv~l~--  248 (488)
                      ...++|.+++.||+|+||.||+|.+.  |+.||||++.........     ..+.|.+|+   .+|++++|||||+++  
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~l~hpniv~~~~~  144 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN-----AIKQMKEEVLRLRLLRGIKNQKQAKVHLR  144 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT-----HHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH-----HHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence            34567999999999999999999964  789999999854332221     146788999   555566899999998  


Q ss_pred             -----eeeecCC-----------------eeeEEEeecCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH
Q 011359          249 -----AACKKPP-----------------VYCVITEYLSEGSLRAYLHKLEH-----KTLPLPKLIAIALDIARGMEYIH  301 (488)
Q Consensus       249 -----~~~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH  301 (488)
                           +++...+                 ..+|||||+ +|+|.+++.....     ..+++..++.|+.||+.||+|||
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  223 (377)
T 3byv_A          145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH  223 (377)
T ss_dssp             BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence                 5555443                 378999999 6899999986421     12334788889999999999999


Q ss_pred             HCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcC-----------CCCchhHHHHHH
Q 011359          302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-----------SYGRKVDVYSFG  370 (488)
Q Consensus       302 ~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~k~DvwSlG  370 (488)
                      ++||+||||||+|||++.++.+||+|||++.....  ......| ..|+|||++.+.           .++.++||||||
T Consensus       224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            99999999999999999999999999999964322  2334567 999999999887           899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH--HHHHHHHh
Q 011359          371 LILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK--VLEQFETS  443 (488)
Q Consensus       371 vll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~--~Le~~~~~  443 (488)
                      |++|||++|..||.+.........+      ......+++.+.+||.+||+.||++||++.++++  .+..+...
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  369 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE  369 (377)
T ss_dssp             HHHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence            9999999999999775543221111      1123678999999999999999999999999996  55555544

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.9e-42  Score=358.52  Aligned_cols=244  Identities=23%  Similarity=0.331  Sum_probs=201.4

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec---
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK---  253 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---  253 (488)
                      .+|.+++.||+|+||.||+|.+.  ++.||||++......            +.+|+++|++++|+||++++++|..   
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~------------~~~E~~il~~l~hpniv~l~~~~~~~~~  121 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------------KNRELQIMRKLDHCNIVRLRYFFYSSGE  121 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS------------CCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh------------HHHHHHHHHHcCCCCccceeeEEeccCC
Confidence            46889999999999999999985  789999999753321            2379999999999999999998843   


Q ss_pred             ---CCeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-CcEEEee
Q 011359          254 ---PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIAD  327 (488)
Q Consensus       254 ---~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-~~vkl~D  327 (488)
                         ...+++||||+.+ +|.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus       122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEecc
Confidence               2246799999975 676666542  45679999999999999999999999999999999999999965 6789999


Q ss_pred             ecccccccccCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------
Q 011359          328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--------  398 (488)
Q Consensus       328 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~--------  398 (488)
                      ||++.............||..|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..++..        
T Consensus       201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9999765444444566799999999999764 7899999999999999999999999998876665554431        


Q ss_pred             ------cCC-CC------------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          399 ------NLR-PA------------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       399 ------~~~-~~------------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                            ... ..            ++..++.++.+||.+||..||.+||++.++++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                  000 00            23457899999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.6e-42  Score=356.58  Aligned_cols=245  Identities=25%  Similarity=0.373  Sum_probs=207.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc------CCCCeeeEeee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL------HNPNVIKFVAA  250 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~  250 (488)
                      .+|.+++.||+|+||.||+|.+.  ++.||||++....         ....++.+|+.+++.+      +|+||++++++
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---------RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---------chHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            57999999999999999999986  6899999997421         1245677888888877      57799999999


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc--EEEeee
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH--LKIADF  328 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~--vkl~DF  328 (488)
                      +.....+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+||
T Consensus       168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence            999999999999995 69999998866667999999999999999999999999999999999999999887  999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC------
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP------  402 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~------  402 (488)
                      |++....  .......||..|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....-.+      
T Consensus       247 G~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          247 GSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            9995433  23345679999999999999999999999999999999999999999988766654443210000      


Q ss_pred             ---------------------------------------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHH
Q 011359          403 ---------------------------------------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFW  431 (488)
Q Consensus       403 ---------------------------------------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~  431 (488)
                                                                         .++...++.+.+||.+||+.||++||++.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                                                               01123478899999999999999999999


Q ss_pred             HHHH
Q 011359          432 HIVK  435 (488)
Q Consensus       432 eil~  435 (488)
                      ++++
T Consensus       405 e~L~  408 (429)
T 3kvw_A          405 QALR  408 (429)
T ss_dssp             HHHT
T ss_pred             HHhC
Confidence            9986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5e-42  Score=376.71  Aligned_cols=262  Identities=25%  Similarity=0.526  Sum_probs=222.0

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK  246 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  246 (488)
                      .++.+..++|.+++.||+|+||.||+|.+.     +..||||++......       ...+.|.+|+.++++++||||++
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~  455 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-------SVREKFLQEALTMRQFDHPHIVK  455 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH-------HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH-------HHHHHHHHHHHHHHhCCCCCCCe
Confidence            566778889999999999999999999985     246999988643321       22467899999999999999999


Q ss_pred             EeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       247 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                      +++++.+ +.+++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus       456 l~~~~~~-~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~  533 (656)
T 2j0j_A          456 LIGVITE-NPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG  533 (656)
T ss_dssp             EEEEECS-SSCEEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             EEEEEec-CceEEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEE
Confidence            9999854 567899999999999999986 34568999999999999999999999999999999999999999999999


Q ss_pred             eecccccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          327 DFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       327 DFgla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      |||++.......  ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.. ..+..
T Consensus       534 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~  612 (656)
T 2j0j_A          534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLP  612 (656)
T ss_dssp             CCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-TCCCC
T ss_pred             ecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence            999996543222  1223456789999999998999999999999999999997 9999999888776655544 34556


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      .+..+++.+.+||.+||+.||.+||++.++++.|+++...
T Consensus       613 ~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            7889999999999999999999999999999999988653

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.9e-42  Score=347.55  Aligned_cols=257  Identities=25%  Similarity=0.430  Sum_probs=189.4

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHH-HHHhcCCCCeeeE
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVA-LLSRLHNPNVIKF  247 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l  247 (488)
                      ...|.+..++|.+++.||+|+||.||+|.+.  ++.||||++.......       ...++..|+. +++.++||||+++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~~~~~~~h~niv~~   86 (327)
T 3aln_A           14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-------EQKQLLMDLDVVMRSSDCPYIVQF   86 (327)
T ss_dssp             CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-------HHHHHHHHHHHHHSSCCCTTBCCE
T ss_pred             HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-------HHHHHHHHHHHHHHcCCCCcEeee
Confidence            3567788899999999999999999999986  7899999998643221       1344556666 6777899999999


Q ss_pred             eeeeecCCeeeEEEeecCCCCHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcE
Q 011359          248 VAACKKPPVYCVITEYLSEGSLRAYLHKL---EHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHL  323 (488)
Q Consensus       248 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~v  323 (488)
                      ++++..+...++||||+.+ +|.+++...   ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~  165 (327)
T 3aln_A           87 YGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNI  165 (327)
T ss_dssp             EEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEE
T ss_pred             eeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCE
Confidence            9999999999999999975 888877642   356789999999999999999999999 99999999999999999999


Q ss_pred             EEeeecccccccccCcCCCCCCCcccCChhhh----hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 011359          324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMI----KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN  399 (488)
Q Consensus       324 kl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~  399 (488)
                      ||+|||++.............||..|+|||++    .+..++.++||||||+++|+|++|..||................
T Consensus       166 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (327)
T 3aln_A          166 KLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG  245 (327)
T ss_dssp             EECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS
T ss_pred             EEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC
Confidence            99999999655443334445799999999998    45678999999999999999999999998765432211111112


Q ss_pred             CCCCC----CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 LRPAI----PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 ~~~~~----~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..+.+    ...++..+.+||.+||+.||++||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            22222    2468999999999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.3e-42  Score=349.43  Aligned_cols=251  Identities=21%  Similarity=0.355  Sum_probs=205.3

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec-
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-  253 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-  253 (488)
                      ..++|.+++.||+|+||.||+|.+.  |+.||||++.........      ...+.+|+.++++++||||+++++++.. 
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   88 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF------PITALREIKILQLLKHENVVNLIEICRTK   88 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS------CHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc------hHHHHHHHHHHHhccCCCcccHhheeecc
Confidence            3578999999999999999999985  789999999765433221      2456799999999999999999999876 


Q ss_pred             -------CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          254 -------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       254 -------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                             ...+++||||+.+ +|.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             --------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             ccccccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEc
Confidence                   4568999999965 787777653 3569999999999999999999999999999999999999999999999


Q ss_pred             eecccccccc-----cCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Q 011359          327 DFGIACEEVY-----CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK--  398 (488)
Q Consensus       327 DFgla~~~~~-----~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~--  398 (488)
                      |||++.....     ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...  
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999864321     122344568999999999975 46899999999999999999999999998876655544331  


Q ss_pred             cCCCCCCCC----------------------------CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          399 NLRPAIPGD----------------------------CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       399 ~~~~~~~~~----------------------------~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ...+.....                            .++.+.+||.+||+.||++||++.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            111111111                            2677999999999999999999999887

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-43  Score=358.67  Aligned_cols=254  Identities=21%  Similarity=0.358  Sum_probs=207.2

Q ss_pred             ccccccceeccceeeeeccEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeE
Q 011359          174 HTVDLSQLFLGLRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKF  247 (488)
Q Consensus       174 ~~id~~~~~i~~~lG~G~~g~Vy~~~~-----~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l  247 (488)
                      ..+..++|.+++.||+|+||.||++++     .++.||||+++........    .....+.+|+.+|.++ +|+||+++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~  124 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSPFLVTL  124 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----SSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh----hHHHHHHHHHHHHHHccCCCceeEE
Confidence            345668899999999999999999998     4789999998643211000    0023466899999999 69999999


Q ss_pred             eeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       248 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                      ++++.....+++||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus       125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          125 HYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             EEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred             EEEEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEee
Confidence            99999999999999999999999999863  4689999999999999999999999999999999999999999999999


Q ss_pred             ecccccccc--cCcCCCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcc
Q 011359          328 FGIACEEVY--CDALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMN----PIQAAFAVVNKN  399 (488)
Q Consensus       328 Fgla~~~~~--~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvll~elltG~~Pf~~~~----~~~~~~~~~~~~  399 (488)
                      ||++.....  ........||..|+|||++.+  ..++.++|||||||++|+|++|..||....    .......+..  
T Consensus       203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--  280 (355)
T 1vzo_A          203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--  280 (355)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--
T ss_pred             CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--
Confidence            999864322  122234469999999999975  357899999999999999999999997432    2222222322  


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 011359          400 LRPAIPGDCPPAMAALIEQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       400 ~~~~~~~~~~~~l~~Li~~cL~~dp~~RP-----s~~eil~  435 (488)
                      ..+..+..++..+.+||.+||..||.+||     ++.++++
T Consensus       281 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          281 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            24556788999999999999999999999     8888776

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.5e-42  Score=353.40  Aligned_cols=245  Identities=23%  Similarity=0.335  Sum_probs=201.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP--  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--  255 (488)
                      .+|.+++.||+|+||+||+|.+. +..||||.+......            ..+|+.+|+.++||||++++++|....  
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------------~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------------KNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            56999999999999999999985 456999988754322            227999999999999999999985433  


Q ss_pred             ----eeeEEEeecCCCCHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc-CCCcEEEeeec
Q 011359          256 ----VYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFG  329 (488)
Q Consensus       256 ----~~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~-~~~~vkl~DFg  329 (488)
                          .+++||||+.++.+...... .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus       108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence                38899999977544443332 1356799999999999999999999999999999999999999 79999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-------  401 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-------  401 (488)
                      ++.............||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....++...-.       
T Consensus       188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99765544555566789999999999754 5899999999999999999999999998877666555431000       


Q ss_pred             -----------C---------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 -----------P---------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 -----------~---------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                 +         .++..+++++.+||.+||+.||.+||++.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                       0         123457899999999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-41  Score=355.77  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=196.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++.......      ...+.+.+|+.+|++++|+||+++++++...  
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL------IDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSH------HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcCh------HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            67999999999999999999986  6889999997543322      1246788999999999999999999999766  


Q ss_pred             ---CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          255 ---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       255 ---~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                         ..+|+||||+. ++|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence               57899999985 699999975  456999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC-----------------------cCCCCCCCcccCChhhh-hcCCCCchhHHHHHHHHHHHHHhCCC------
Q 011359          332 CEEVYCD-----------------------ALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTI------  381 (488)
Q Consensus       332 ~~~~~~~-----------------------~~~~~~gt~~y~aPE~l-~~~~~~~k~DvwSlGvll~elltG~~------  381 (488)
                      .......                       ......||..|+|||++ ....++.++|||||||++|||++|..      
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~  256 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP  256 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence            6533221                       23556799999999986 55679999999999999999998443      


Q ss_pred             -----CCCCCC-----------------HHHHHHHHHh------------------------ccCCCCC-----CCCCcH
Q 011359          382 -----PYEEMN-----------------PIQAAFAVVN------------------------KNLRPAI-----PGDCPP  410 (488)
Q Consensus       382 -----Pf~~~~-----------------~~~~~~~~~~------------------------~~~~~~~-----~~~~~~  410 (488)
                           +|.+.+                 ....+..+..                        .......     ...+++
T Consensus       257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  336 (432)
T 3n9x_A          257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD  336 (432)
T ss_dssp             GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred             ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence                 343322                 0111111110                        0001111     145789


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.+||.+||..||.+||++.++++
T Consensus       337 ~~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          337 DGINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.4e-42  Score=340.89  Aligned_cols=255  Identities=22%  Similarity=0.402  Sum_probs=194.4

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ..+.+.+++|.+++.||+|+||.||+|.+.  |+.||||++........      ....+..+..+++.++||||+++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~~~~~~~~~h~~i~~~~~   91 (318)
T 2dyl_A           18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE------NKRILMDLDVVLKSHDCPYIVQCFG   91 (318)
T ss_dssp             SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH------HHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH------HHHHHHHHHHHHHhcCCCceeeEEE
Confidence            456677889999999999999999999985  78999999986543221      1234455556788889999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeee
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      ++..+..+++||||+ ++.+..+... ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+||
T Consensus        92 ~~~~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A           92 TFITNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             EEECSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEecCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEEC
Confidence            999999999999999 5666665554 356799999999999999999999996 9999999999999999999999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCC
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNKNLRP  402 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~~~~~~  402 (488)
                      |++.............||..|+|||++.     ...++.++||||||+++|+|++|..||.... ..+....+... ..+
T Consensus       170 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~  248 (318)
T 2dyl_A          170 GISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPP  248 (318)
T ss_dssp             TTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCC
T ss_pred             CCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCC
Confidence            9986544444444557999999999994     4568899999999999999999999998754 43444444433 333


Q ss_pred             CCC--CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 AIP--GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 ~~~--~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..+  ..++..+.+||.+||+.||.+||++.++++
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            333  468999999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2e-42  Score=349.84  Aligned_cols=261  Identities=20%  Similarity=0.330  Sum_probs=214.9

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHH---------HHHHHHHHHHHHHHHHHhcCCC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENET---------LAARLEKQFNREVALLSRLHNP  242 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~---------~~~~~~~~~~~Ei~il~~l~Hp  242 (488)
                      ....+..++|.+++.||+|+||.||+|.+.++.||||++..........         ......+.+.+|+.++++++||
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           24 KEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             SSSCEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             hhcccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            3344556899999999999999999999999999999997432110000         0000015788999999999999


Q ss_pred             CeeeEeeeeecCCeeeEEEeecCCCCHHHH------HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeE
Q 011359          243 NVIKFVAACKKPPVYCVITEYLSEGSLRAY------LHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENV  315 (488)
Q Consensus       243 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NI  315 (488)
                      ||+++++++.....+++||||+++++|.++      +.......+++..++.++.||+.||+|||+ .||+||||||+||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            999999999999999999999999999998      654446789999999999999999999999 9999999999999


Q ss_pred             EEcCCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcC-CCCc-hhHHHHHHHHHHHHHhCCCCCCCCCH-HHHH
Q 011359          316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGR-KVDVYSFGLILWEMVAGTIPYEEMNP-IQAA  392 (488)
Q Consensus       316 Ll~~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-k~DvwSlGvll~elltG~~Pf~~~~~-~~~~  392 (488)
                      +++.++.++|+|||++...... ......|+..|+|||++.+. .++. ++||||||+++|+|++|..||..... .+..
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             EEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9999999999999998654322 33456799999999999876 5666 99999999999999999999998766 4444


Q ss_pred             HHHHhccCCCCCC-------------------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          393 FAVVNKNLRPAIP-------------------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       393 ~~~~~~~~~~~~~-------------------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..+.....  ..+                   ..++..+.+||.+||+.||.+||++.++++
T Consensus       263 ~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          263 NNIRTKNI--EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHTSCCC--CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhccCc--CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            44433322  222                   568999999999999999999999999886

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.1e-42  Score=348.86  Aligned_cols=246  Identities=24%  Similarity=0.344  Sum_probs=204.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++......       ...+.+.+|+.+|.+++||||+++++++...  
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-------TYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH-------HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc-------HHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            57999999999999999999986  678999999743321       1246688999999999999999999998654  


Q ss_pred             ---CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          255 ---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       255 ---~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                         ..+++||||+. |+|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence               46899999996 599999976   56999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC----cCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------
Q 011359          332 CEEVYCD----ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL------  400 (488)
Q Consensus       332 ~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~------  400 (488)
                      .......    ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.....      
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6433221    1244579999999998754 4589999999999999999999999988765554444332100      


Q ss_pred             ------------------CC-----CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 ------------------RP-----AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 ------------------~~-----~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                        ..     .....++..+.+||.+||+.||++||++.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                              00     012467889999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.6e-42  Score=349.60  Aligned_cols=256  Identities=22%  Similarity=0.325  Sum_probs=201.3

Q ss_pred             ccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChh---HHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDEN---ETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~---~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      .++|.+++.||+|+||.||+|.+. ++.||||++........   ........+.+.+|+.++++++||||+++++++..
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            467999999999999999999875 78999999965433211   00112234678999999999999999999999843


Q ss_pred             -----CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          254 -----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       254 -----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                           ...+++||||+. |+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             CCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             ccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence                 346899999997 688888875 3457999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP-----  402 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----  402 (488)
                      |++.............||..|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+......+     
T Consensus       179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (362)
T 3pg1_A          179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV  258 (362)
T ss_dssp             TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence            99965544444555678999999999976 678999999999999999999999999988766655543311100     


Q ss_pred             -------------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 -------------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 -------------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                               .....+++.+.+||.+||+.||.+||++.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                                     112456888999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-41  Score=337.64  Aligned_cols=253  Identities=23%  Similarity=0.374  Sum_probs=210.2

Q ss_pred             cccccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC--CCCeeeEee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH--NPNVIKFVA  249 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~  249 (488)
                      ...+..++|.+++.||+|+||.||++.+. ++.||||++........      ....+.+|+.++.+++  |+||+++++
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ------TLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHH------HHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccccc------chHHHHHHHHHHHhccccCCceEEEEE
Confidence            34455677999999999999999999876 68899999986544321      2467889999999997  599999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++..+..+++||| +.+++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecc
Confidence            9999999999999 568899999987  357899999999999999999999999999999999999964 899999999


Q ss_pred             ccccccccC---cCCCCCCCcccCChhhhhc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Q 011359          330 IACEEVYCD---ALSDDPGTYRWMAPEMIKH-----------KSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFA  394 (488)
Q Consensus       330 la~~~~~~~---~~~~~~gt~~y~aPE~l~~-----------~~~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~  394 (488)
                      ++.......   ......||..|+|||++.+           ..++.++||||||+++|+|++|..||.... .......
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  251 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence            986433221   1234468999999999975           468899999999999999999999998764 4445555


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          395 VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       395 ~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.........+..++..+.+||.+||+.||.+||++.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            66666666777888999999999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-41  Score=340.36  Aligned_cols=246  Identities=23%  Similarity=0.304  Sum_probs=205.1

Q ss_pred             ccceeccceeeeeccEEEEEEEE---CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC------CeeeEe
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIY---KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP------NVIKFV  248 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~---~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~  248 (488)
                      .++|.+++.||+|+||.||+|.+   .++.||||++....         ...+.+.+|+.+++.++|+      +|++++
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---------RYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---------HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---------chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            46899999999999999999987   36889999996321         2245678999999988765      499999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC---------
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---------  319 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~---------  319 (488)
                      +++.....+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.         
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999999 899999998865567899999999999999999999999999999999999987         


Q ss_pred             ----------CCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 011359          320 ----------EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI  389 (488)
Q Consensus       320 ----------~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~  389 (488)
                                ++.+||+|||++....  .......||..|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                      6689999999986433  2234557899999999999889999999999999999999999999988766


Q ss_pred             HHHHHHHhccC--C----------------------------------------CCCCCCCcHHHHHHHHHHhhhCCCCC
Q 011359          390 QAAFAVVNKNL--R----------------------------------------PAIPGDCPPAMAALIEQCWSLQPDKR  427 (488)
Q Consensus       390 ~~~~~~~~~~~--~----------------------------------------~~~~~~~~~~l~~Li~~cL~~dp~~R  427 (488)
                      +....+.....  .                                        ......++..+.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            54433221100  0                                        01122346789999999999999999


Q ss_pred             CCHHHHHH
Q 011359          428 PEFWHIVK  435 (488)
Q Consensus       428 Ps~~eil~  435 (488)
                      |++.++++
T Consensus       321 pt~~ell~  328 (339)
T 1z57_A          321 ITLREALK  328 (339)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.7e-42  Score=352.55  Aligned_cols=245  Identities=25%  Similarity=0.352  Sum_probs=189.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      ++|.+.+.||+|+||.||+|.+.  |+.||||++.......      ...+.+.+|+.+|++++||||+++++++...  
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI------IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS  102 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSH------HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH------HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence            67999999999999999999875  7899999997543322      1246788999999999999999999998654  


Q ss_pred             ----CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          255 ----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       255 ----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                          ..+++|+||+ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence                5679999999 7899998875   5799999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--------  401 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~--------  401 (488)
                      +.....  ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......        
T Consensus       179 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          179 ARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            965332  2345578999999999976 67899999999999999999999999998876655444321000        


Q ss_pred             ----------------CC-----CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 ----------------PA-----IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 ----------------~~-----~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                      +.     ....+++.+.+||.+||..||.+||++.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                            00     11356789999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-41  Score=343.49  Aligned_cols=246  Identities=24%  Similarity=0.309  Sum_probs=203.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      ++|.+++.||+|+||.||+|.+.  |+.||||++......       .....+.+|+.++++++||||+++++++...  
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-------LFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH-------HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc-------hHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            57899999999999999999986  789999999643221       1245678999999999999999999988654  


Q ss_pred             ---CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          255 ---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       255 ---~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                         ...++||||+. ++|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence               67899999996 699999976   57999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccC-----------cCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 011359          332 CEEVYCD-----------ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN  399 (488)
Q Consensus       332 ~~~~~~~-----------~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~  399 (488)
                      .......           ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  239 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII  239 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            5432211           1223468999999998864 678999999999999999999999999887655544332210


Q ss_pred             CCC------------------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 LRP------------------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 ~~~------------------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..+                              .....++..+.+||.+||+.||++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000                              012467899999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.2e-41  Score=346.80  Aligned_cols=244  Identities=26%  Similarity=0.415  Sum_probs=203.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  |+.||||++.......      ...+.+.+|+.+++.++||||+++++++.....
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  115 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE------IFAKRAYRELLLLKHMQHENVIGLLDVFTPASS  115 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH------HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch------hHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence            67999999999999999999986  7899999997654332      225678899999999999999999999987765


Q ss_pred             e------eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          257 Y------CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       257 ~------~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      .      ++||||+. ++|.+++.    ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          116 LRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             STTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             cccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence            4      99999996 68887774    3599999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP-------  402 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------  402 (488)
                      +....  .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+       
T Consensus       191 a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          191 ARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            96433  22345578999999999987 678999999999999999999999999988766655543311000       


Q ss_pred             ----------------------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 ----------------------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 ----------------------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                            .....+++.+.+||.+||+.||++||++.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                                  012457899999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-41  Score=345.40  Aligned_cols=251  Identities=21%  Similarity=0.260  Sum_probs=195.4

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      ...+++|.+++.||+|+||.||+|.+.  ++.||||++.......         ..+.+|+..+..++||||+++++++.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---------NRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---------CHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---------HHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            345578999999999999999999986  7899999987543322         23557888889999999999999986


Q ss_pred             cCC-------eeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCCCeEEEcC-C
Q 011359          253 KPP-------VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIH--SQGVIHRDLKPENVLIDQ-E  320 (488)
Q Consensus       253 ~~~-------~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH--~~giiHrDIkp~NILl~~-~  320 (488)
                      ...       .+++||||+.+ +|...+...  ....+++..+..++.||+.||.|||  +.||+||||||+|||++. +
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTT
T ss_pred             ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCC
Confidence            533       27899999976 555544432  4567889999999999999999999  999999999999999996 8


Q ss_pred             CcEEEeeecccccccccCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 011359          321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN  399 (488)
Q Consensus       321 ~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~  399 (488)
                      +.+||+|||++.............||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             CcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            99999999999765554555566789999999999654 48999999999999999999999999988776665554311


Q ss_pred             C------------------------------CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 L------------------------------RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 ~------------------------------~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .                              .......++..+.+||.+||+.||.+||++.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0                              11222346789999999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=336.82  Aligned_cols=245  Identities=24%  Similarity=0.382  Sum_probs=198.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee----
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK----  252 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----  252 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++...+.        ...+.+.+|+.++++++||||+++++++.    
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH--------HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh--------HHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            67999999999999999999987  78999999975431        12467889999999999999999999873    


Q ss_pred             ----------cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc-CCC
Q 011359          253 ----------KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEF  321 (488)
Q Consensus       253 ----------~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~-~~~  321 (488)
                                ....+++||||+. |+|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence                      4467899999997 699999864   5789999999999999999999999999999999999997 567


Q ss_pred             cEEEeeeccccccccc----CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 011359          322 HLKIADFGIACEEVYC----DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV  396 (488)
Q Consensus       322 ~vkl~DFgla~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~  396 (488)
                      .+||+|||++......    .......+|..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+.
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999998643211    11233457889999999865 678999999999999999999999999988766555444


Q ss_pred             hccCC-----------------------C-----CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          397 NKNLR-----------------------P-----AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       397 ~~~~~-----------------------~-----~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .....                       +     .....++.++.+||.+||+.||++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            32110                       0     112468899999999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.6e-42  Score=355.03  Aligned_cols=258  Identities=14%  Similarity=0.158  Sum_probs=189.9

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc--CCCCeeeEe---
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIKFV---  248 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~---  248 (488)
                      ....+|.+++.||+|+||.||+|.+.  ++.||||++........     .....+.+|+.+++.|  +||||++++   
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~  133 (371)
T 3q60_A           59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR-----SELERLHEATFAAARLLGESPEEARDRRRL  133 (371)
T ss_dssp             CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHH-----HHHHHHHHHHHHHHHHHC----------CB
T ss_pred             CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccc-----cHHHHHHHHHHHHHHhcccChhhhhhceeE
Confidence            33456899999999999999999985  68899999997654322     2245677885555444  699988865   


Q ss_pred             ----eeeecC-----------------CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHH------HHHHHHHHHHHHHHH
Q 011359          249 ----AACKKP-----------------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL------IAIALDIARGMEYIH  301 (488)
Q Consensus       249 ----~~~~~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~------~~i~~qi~~~L~~LH  301 (488)
                          +++...                 ..+||||||++ |+|.+++.... ..+.+..+      +.++.||+.||+|||
T Consensus       134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH  211 (371)
T 3q60_A          134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQ  211 (371)
T ss_dssp             CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence                344322                 34799999998 89999998742 23455555      678899999999999


Q ss_pred             HCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhC
Q 011359          302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAG  379 (488)
Q Consensus       302 ~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvll~elltG  379 (488)
                      ++||+||||||+|||++.++.+||+|||++......  .....+|..|+|||++.+  ..++.++|||||||++|+|++|
T Consensus       212 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999999644321  113456799999999987  6899999999999999999999


Q ss_pred             CCCCCCCCHHHHHH-------HHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH--HHHHHHH
Q 011359          380 TIPYEEMNPIQAAF-------AVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK--VLEQFET  442 (488)
Q Consensus       380 ~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~--~Le~~~~  442 (488)
                      ..||..........       ..............+++.+.+||.+||+.||++||++.++++  .+..+..
T Consensus       290 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            99998764321100       000011222233578999999999999999999999999985  4444443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-41  Score=348.73  Aligned_cols=246  Identities=21%  Similarity=0.364  Sum_probs=200.3

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC--------CCCeeeE
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH--------NPNVIKF  247 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l  247 (488)
                      .++|.+++.||+|+||+||+|++.  ++.||||++...         ....+.+.+|+.+++++.        |+||+++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~  106 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL  106 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence            367999999999999999999875  689999999732         112456889999999985        7889999


Q ss_pred             eeeee----cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCC-
Q 011359          248 VAACK----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEF-  321 (488)
Q Consensus       248 ~~~~~----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~-  321 (488)
                      ++++.    ....+++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++ 
T Consensus       107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred             ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence            99987    566899999999 67777777765556799999999999999999999998 999999999999998775 


Q ss_pred             ------------------------------------------------cEEEeeecccccccccCcCCCCCCCcccCChh
Q 011359          322 ------------------------------------------------HLKIADFGIACEEVYCDALSDDPGTYRWMAPE  353 (488)
Q Consensus       322 ------------------------------------------------~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE  353 (488)
                                                                      .+||+|||++.....  ......||..|+|||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE  263 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHH
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCCh
Confidence                                                            799999999965432  344567999999999


Q ss_pred             hhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHh--ccC-------------------------
Q 011359          354 MIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN------PIQAAFAVVN--KNL-------------------------  400 (488)
Q Consensus       354 ~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~------~~~~~~~~~~--~~~-------------------------  400 (488)
                      ++.+..++.++|||||||++|+|++|..||....      .......+..  ...                         
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            9999999999999999999999999999998654      2222211111  000                         


Q ss_pred             -------------CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 -------------RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 -------------~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                   ....+..++..+.+||.+||+.||++||++.++++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                         00112234567899999999999999999999885

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=342.02  Aligned_cols=244  Identities=26%  Similarity=0.408  Sum_probs=202.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||.||+|.+.  |+.||||++.......      ...+.+.+|+.++++++||||+++++++.....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE------IFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH------HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch------HHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            57999999999999999999985  7899999997644322      224678899999999999999999999987654


Q ss_pred             ------eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          257 ------YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       257 ------~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                            +++||||+. ++|.+++.    ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             GGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             cccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence                  499999996 58877664    3589999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN----------  399 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~----------  399 (488)
                      +.....  ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....          
T Consensus       173 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          173 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             ccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            864332  2344578999999999976 678999999999999999999999999888765544433210          


Q ss_pred             -------------------CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 -------------------LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 -------------------~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                         ........++..+.+||.+||+.||++||++.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                               011233567899999999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.6e-41  Score=331.30  Aligned_cols=244  Identities=27%  Similarity=0.423  Sum_probs=195.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec---
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK---  253 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---  253 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++....         ...+.+.+|+.++++++||||+++++++.+   
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---------EKLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---------HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            46889999999999999999985  7899999996421         124678899999999999999999998754   


Q ss_pred             ----------CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcE
Q 011359          254 ----------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL  323 (488)
Q Consensus       254 ----------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~v  323 (488)
                                ...+++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCE
Confidence                      4578999999999999999986 34567888999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccc---------------cCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 011359          324 KIADFGIACEEVY---------------CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMN  387 (488)
Q Consensus       324 kl~DFgla~~~~~---------------~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~  387 (488)
                      ||+|||++.....               ........||..|+|||++.+. .++.++|||||||++|+|++   ||....
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            9999999854321               1122345689999999999754 68999999999999999998   665433


Q ss_pred             HHHHHHHHHhc---cCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          388 PIQAAFAVVNK---NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       388 ~~~~~~~~~~~---~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ........+..   ...+..+..++..+.+||.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            22222222221   2334455677889999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=350.77  Aligned_cols=244  Identities=24%  Similarity=0.311  Sum_probs=182.3

Q ss_pred             eec-cceeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee--c
Q 011359          181 LFL-GLRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK--K  253 (488)
Q Consensus       181 ~~i-~~~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~  253 (488)
                      |.+ +++||+|+||+||+|.+.    ++.||||++......          ..+.+|+.+|++++||||+++++++.  .
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----------MSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----------HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----------HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            444 668999999999999975    578999999744322          34679999999999999999999994  4


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE----cCCCc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLE-------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEFH  322 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl----~~~~~  322 (488)
                      ...+++||||+. ++|.+++....       ...+++..++.++.||+.||+|||++||+||||||+|||+    +.++.
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence            778999999995 58888876421       2248999999999999999999999999999999999999    67789


Q ss_pred             EEEeeeccccccccc----CcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--------
Q 011359          323 LKIADFGIACEEVYC----DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI--------  389 (488)
Q Consensus       323 vkl~DFgla~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~--------  389 (488)
                      +||+|||++......    .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+....        
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            999999999644321    22334568999999999976 45899999999999999999999999765432        


Q ss_pred             -HHHHHHHhccCCCC------------------------------------CCCCCcHHHHHHHHHHhhhCCCCCCCHHH
Q 011359          390 -QAAFAVVNKNLRPA------------------------------------IPGDCPPAMAALIEQCWSLQPDKRPEFWH  432 (488)
Q Consensus       390 -~~~~~~~~~~~~~~------------------------------------~~~~~~~~l~~Li~~cL~~dp~~RPs~~e  432 (488)
                       +.+..++...-.+.                                    .....+..+.+||.+||..||.+||++.+
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence             22222221100000                                    01122668899999999999999999999


Q ss_pred             HHH
Q 011359          433 IVK  435 (488)
Q Consensus       433 il~  435 (488)
                      +++
T Consensus       331 ~L~  333 (405)
T 3rgf_A          331 AMQ  333 (405)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.9e-41  Score=339.07  Aligned_cols=244  Identities=19%  Similarity=0.316  Sum_probs=175.3

Q ss_pred             cceeccc-eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec--
Q 011359          179 SQLFLGL-RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--  253 (488)
Q Consensus       179 ~~~~i~~-~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--  253 (488)
                      ++|.+.+ .||+|+||.||+|.+.  ++.||||++....            .........++.+.|+||+++++++..  
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------------KARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------------HHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------------HHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            5677755 5999999999999987  7899999997421            111122233566789999999999875  


Q ss_pred             --CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC---CCcEEEeee
Q 011359          254 --PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIADF  328 (488)
Q Consensus       254 --~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~---~~~vkl~DF  328 (488)
                        ...+++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence              456899999999999999998765567999999999999999999999999999999999999976   455999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhc--cCCC
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA----VVNK--NLRP  402 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~----~~~~--~~~~  402 (488)
                      |++..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........    +...  ....
T Consensus       176 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3fhr_A          176 GFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN  254 (336)
T ss_dssp             TTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred             ccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence            99864432 233455689999999999888899999999999999999999999977654332111    1111  1222


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .....++..+.+||.+||+.||.+||++.++++
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            233578999999999999999999999999997

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.8e-40  Score=335.30  Aligned_cols=246  Identities=19%  Similarity=0.297  Sum_probs=202.9

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--C-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC------eeeEe
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--D-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN------VIKFV  248 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~  248 (488)
                      .++|.+++.||+|+||.||+|.+.  + +.||||++....         .....+.+|+.++++++|++      ++.++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---------KYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---------cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            368999999999999999999985  3 689999996321         12456788999999987655      99999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEE-----------
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI-----------  317 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl-----------  317 (488)
                      +++.....+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+           
T Consensus        89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence            9999999999999999 6788888877555679999999999999999999999999999999999999           


Q ss_pred             --------cCCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 011359          318 --------DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI  389 (488)
Q Consensus       318 --------~~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~  389 (488)
                              +.++.+||+|||++....  .......||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                    567899999999996433  2334567999999999999889999999999999999999999999988765


Q ss_pred             HHHHHHHhccCC------------------------------------------CCCCCCCcHHHHHHHHHHhhhCCCCC
Q 011359          390 QAAFAVVNKNLR------------------------------------------PAIPGDCPPAMAALIEQCWSLQPDKR  427 (488)
Q Consensus       390 ~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~Li~~cL~~dp~~R  427 (488)
                      +....+......                                          .......+..+.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            544332221000                                          00111224589999999999999999


Q ss_pred             CCHHHHHH
Q 011359          428 PEFWHIVK  435 (488)
Q Consensus       428 Ps~~eil~  435 (488)
                      |++.++++
T Consensus       326 pt~~e~l~  333 (355)
T 2eu9_A          326 ITLAEALL  333 (355)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5e-41  Score=342.58  Aligned_cols=249  Identities=23%  Similarity=0.400  Sum_probs=201.4

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-----------C
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-----------N  241 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-----------H  241 (488)
                      .+..++|.+++.||+|+||+||+|.+.  ++.||||++....         .....+.+|+.++++++           |
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~   85 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---------VYTEAAEDEIKLLQRVNDADNTKEDSMGA   85 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---------cchhhhhHHHHHHHHhhcccccchhcccc
Confidence            445678999999999999999999974  7899999997321         12456778999999886           7


Q ss_pred             CCeeeEeeeeecCC----eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEE
Q 011359          242 PNVIKFVAACKKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL  316 (488)
Q Consensus       242 pnIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NIL  316 (488)
                      +||+++++++....    .+++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||
T Consensus        86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIl  164 (373)
T 1q8y_A           86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL  164 (373)
T ss_dssp             TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred             chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeE
Confidence            99999999987644    789999999 89999999987677799999999999999999999998 9999999999999


Q ss_pred             Ec------CCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--
Q 011359          317 ID------QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP--  388 (488)
Q Consensus       317 l~------~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~--  388 (488)
                      ++      ..+.+||+|||++.....  ......||..|+|||++.+..++.++|||||||++|+|++|..||.....  
T Consensus       165 l~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  242 (373)
T 1q8y_A          165 MEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  242 (373)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             EeccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence            94      445899999999965432  33455799999999999999999999999999999999999999986542  


Q ss_pred             ----HHHHHHHHhc--c--------------------------------------CCCCCCCCCcHHHHHHHHHHhhhCC
Q 011359          389 ----IQAAFAVVNK--N--------------------------------------LRPAIPGDCPPAMAALIEQCWSLQP  424 (488)
Q Consensus       389 ----~~~~~~~~~~--~--------------------------------------~~~~~~~~~~~~l~~Li~~cL~~dp  424 (488)
                          ......+...  .                                      ....++..++.++.+||.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence                1222221110  0                                      0112334556789999999999999


Q ss_pred             CCCCCHHHHHH
Q 011359          425 DKRPEFWHIVK  435 (488)
Q Consensus       425 ~~RPs~~eil~  435 (488)
                      ++||++.++++
T Consensus       323 ~~Rpt~~ell~  333 (373)
T 1q8y_A          323 RKRADAGGLVN  333 (373)
T ss_dssp             TTCBCHHHHHT
T ss_pred             cccCCHHHHhh
Confidence            99999999886

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-41  Score=333.91  Aligned_cols=244  Identities=27%  Similarity=0.418  Sum_probs=198.1

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc----CCCCeeeEeeeee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL----HNPNVIKFVAACK  252 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l----~HpnIv~l~~~~~  252 (488)
                      ++|.+++.||+|+||.||+|.+.  ++.||||++...........  .....+.+|+.++.++    +|+||+++++++.
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPL--SDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccc--hhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            56889999999999999999874  68999999976543322111  1134466899999999    8999999999999


Q ss_pred             cCCeeeEEEee-cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc-CCCcEEEeeecc
Q 011359          253 KPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGI  330 (488)
Q Consensus       253 ~~~~~~lV~E~-~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~-~~~~vkl~DFgl  330 (488)
                      .....++|||| +.+++|.+++...  ..+++..++.++.||+.||+|||+.||+||||||+||+++ .++.+||+|||+
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            99999999999 7899999999873  4689999999999999999999999999999999999999 889999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCP  409 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (488)
                      +..... .......|+..|+|||++.+..+ +.++||||||+++|+|++|..||.....      +...  ...++..++
T Consensus       187 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~--~~~~~~~~~  257 (312)
T 2iwi_A          187 GALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA--ELHFPAHVS  257 (312)
T ss_dssp             CEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT--CCCCCTTSC
T ss_pred             hhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh--ccCCcccCC
Confidence            865433 23345679999999999987666 4599999999999999999999976422      2222  344677899


Q ss_pred             HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ..+.+||.+||+.+|++||++.++++
T Consensus       258 ~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          258 PDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.1e-40  Score=339.46  Aligned_cols=246  Identities=22%  Similarity=0.324  Sum_probs=203.7

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CC-----CeeeEee
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NP-----NVIKFVA  249 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~  249 (488)
                      .++|.+++.||+|+||+||+|.+.  ++.||||++....         ....++..|+.+++.++ |+     +|+++++
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---------HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            478999999999999999999986  6789999997321         12456778999988885 55     4999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCCCeEEEc--CCCcEEE
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH--SQGVIHRDLKPENVLID--QEFHLKI  325 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~giiHrDIkp~NILl~--~~~~vkl  325 (488)
                      ++.....+++||||+. ++|.+++.......+++..+..++.||+.||.|||  +.||+||||||+|||++  .++.+||
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            9999999999999995 59999998866567999999999999999999999  57999999999999994  4788999


Q ss_pred             eeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--
Q 011359          326 ADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--  403 (488)
Q Consensus       326 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--  403 (488)
                      +|||++....  .......||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+.  
T Consensus       203 ~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          203 VDFGSSCQLG--QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CCCTTCEETT--CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             EeccCceecc--cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999996543  233456799999999999998999999999999999999999999999887766555543110000  


Q ss_pred             --------------CC------------------CC----------------------------CcHHHHHHHHHHhhhC
Q 011359          404 --------------IP------------------GD----------------------------CPPAMAALIEQCWSLQ  423 (488)
Q Consensus       404 --------------~~------------------~~----------------------------~~~~l~~Li~~cL~~d  423 (488)
                                    ++                  ..                            ....+.+||.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence                          00                  00                            0147899999999999


Q ss_pred             CCCCCCHHHHHH
Q 011359          424 PDKRPEFWHIVK  435 (488)
Q Consensus       424 p~~RPs~~eil~  435 (488)
                      |++||++.++++
T Consensus       361 P~~Rpta~e~L~  372 (382)
T 2vx3_A          361 PKTRIQPYYALQ  372 (382)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.7e-41  Score=334.92  Aligned_cols=248  Identities=27%  Similarity=0.432  Sum_probs=205.6

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC--CCCeeeEeee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH--NPNVIKFVAA  250 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~  250 (488)
                      ..-.++|.+++.||+|+||.||+|.+.  ++.||||++...........  .....+.+|+.++++++  |+||++++++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh--hhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            344578999999999999999999984  68999999976433211000  00134668999999996  5999999999


Q ss_pred             eecCCeeeEEEeecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc-CCCcEEEeee
Q 011359          251 CKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADF  328 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~-~~~~vkl~DF  328 (488)
                      +..+..+++||||+.+ ++|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            9999999999999976 899999986  35789999999999999999999999999999999999999 7899999999


Q ss_pred             cccccccccCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       329 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      |++..... .......||..|+|||++.+..+ +.++||||||+++|+|++|..||.....      +...  ....+..
T Consensus       195 g~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~~~~~~~  265 (320)
T 3a99_A          195 GSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--QVFFRQR  265 (320)
T ss_dssp             TTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--CCCCSSC
T ss_pred             cccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--ccccccc
Confidence            99865432 23345679999999999987665 6889999999999999999999976421      2222  2345678


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.++.+||.+||+.||++||++.++++
T Consensus       266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          266 VSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            8999999999999999999999999876

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.9e-40  Score=325.96  Aligned_cols=231  Identities=15%  Similarity=0.142  Sum_probs=190.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++.........     ..+.|.+|+.++.+++||||+++++++..++.
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDD-----VLQETLSRTLRLSRIDKPGVARVLDVVHTRAG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHH-----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHH-----HHHHHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence            57889999999999999999987  789999999865443321     24678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|+||||++|++|.+++..   + ....++..++.||+.||+|||++||+||||||+|||++.++.+||+++|       
T Consensus       106 ~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999999999954   2 4566789999999999999999999999999999999999999998554       


Q ss_pred             cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhccCCC--CCCCCCcHH
Q 011359          337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF---AVVNKNLRP--AIPGDCPPA  411 (488)
Q Consensus       337 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~  411 (488)
                                  |++       .++.++|||||||++|+|++|..||.+.+..+...   .........  .....++++
T Consensus       175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred             ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence                        232       37899999999999999999999998765422110   001111110  123578999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      +.+||.+||+.||++| ++.++++.|+++.....
T Consensus       236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            9999999999999999 99999999999876544

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-39  Score=340.81  Aligned_cols=246  Identities=23%  Similarity=0.381  Sum_probs=187.1

Q ss_pred             ccccc-eeccceeeeeccEEEEEE-EECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeee
Q 011359          176 VDLSQ-LFLGLRFAHGAHSRLYHG-IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACK  252 (488)
Q Consensus       176 id~~~-~~i~~~lG~G~~g~Vy~~-~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  252 (488)
                      .++.+ |.+.+.||+|+||+||.+ ..+|+.||||++....           ...+.+|+.+|.++ +||||+++++++.
T Consensus        11 ~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----------~~~~~~E~~~l~~l~~HpnIv~~~~~~~   79 (434)
T 2rio_A           11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----------CDIALMEIKLLTESDDHPNVIRYYCSET   79 (434)
T ss_dssp             CSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             hhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----------HHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence            33444 455788999999999654 4568999999997421           23467899999987 7999999999999


Q ss_pred             cCCeeeEEEeecCCCCHHHHHHHhCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC-------
Q 011359          253 KPPVYCVITEYLSEGSLRAYLHKLEHKT-----LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-------  320 (488)
Q Consensus       253 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~-------  320 (488)
                      .+..++||||||. |+|.+++.......     ..+..++.++.||+.||+|||++||+||||||+|||++.+       
T Consensus        80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~  158 (434)
T 2rio_A           80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ  158 (434)
T ss_dssp             CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred             cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence            9999999999995 69999998642211     1233467899999999999999999999999999999754       


Q ss_pred             ------CcEEEeeecccccccccC-----cCCCCCCCcccCChhhhhc-------CCCCchhHHHHHHHHHHHHHh-CCC
Q 011359          321 ------FHLKIADFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKH-------KSYGRKVDVYSFGLILWEMVA-GTI  381 (488)
Q Consensus       321 ------~~vkl~DFgla~~~~~~~-----~~~~~~gt~~y~aPE~l~~-------~~~~~k~DvwSlGvll~ellt-G~~  381 (488)
                            +.+||+|||++.......     ......||+.|+|||++.+       ..++.++|||||||++|||++ |..
T Consensus       159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~  238 (434)
T 2rio_A          159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH  238 (434)
T ss_dssp             TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence                  489999999996543221     1234569999999999975       568999999999999999999 999


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCC-----CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          382 PYEEMNPIQAAFAVVNKNLRPAI-----PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       382 Pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+....+.  .+.........     ...++.++.+||.+||+.||.+||++.++++
T Consensus       239 Pf~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          239 PFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TTCSTTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            9987654332  23333222111     1234678999999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.3e-40  Score=342.66  Aligned_cols=246  Identities=27%  Similarity=0.415  Sum_probs=189.8

Q ss_pred             ccccceeccceeeeeccEE-EEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSR-LYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~-Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  253 (488)
                      +...+|.+.+.||+|+||+ ||++..+++.||||++.....           ..+.+|+.+|+++ +|||||++++++.+
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----------~~~~~E~~~l~~l~~HpnIv~l~~~~~~   89 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----------SFADREVQLLRESDEHPNVIRYFCTEKD   89 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----------EECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred             EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----------HHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence            3445688899999999998 566667789999999964322           1245899999999 79999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-----CCcEEEeee
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-----EFHLKIADF  328 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-----~~~vkl~DF  328 (488)
                      ...+|||||||. |+|.+++.... ..+.+..++.++.||+.||+|||++||+||||||+|||++.     ...+||+||
T Consensus        90 ~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF  167 (432)
T 3p23_A           90 RQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF  167 (432)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred             CCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence            999999999995 69999998632 34555567899999999999999999999999999999943     335889999


Q ss_pred             ccccccccc----CcCCCCCCCcccCChhhhh---cCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC
Q 011359          329 GIACEEVYC----DALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNL  400 (488)
Q Consensus       329 gla~~~~~~----~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~  400 (488)
                      |++......    .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.................
T Consensus       168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  247 (432)
T 3p23_A          168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL  247 (432)
T ss_dssp             TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC
T ss_pred             cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc
Confidence            998654322    2234457999999999997   4567889999999999999999 9999976654433222111111


Q ss_pred             CCC-CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHH
Q 011359          401 RPA-IPGDCPPAMAALIEQCWSLQPDKRPEFWHIV  434 (488)
Q Consensus       401 ~~~-~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil  434 (488)
                      ... .....+..+.+||.+||+.||.+||++.+++
T Consensus       248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl  282 (432)
T 3p23_A          248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL  282 (432)
T ss_dssp             TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence            111 1223456689999999999999999999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.8e-39  Score=318.53  Aligned_cols=223  Identities=21%  Similarity=0.381  Sum_probs=181.2

Q ss_pred             cceecc-ceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHH-HhcCCCCeeeEeeeeec-
Q 011359          179 SQLFLG-LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALL-SRLHNPNVIKFVAACKK-  253 (488)
Q Consensus       179 ~~~~i~-~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~-  253 (488)
                      ++|.+. +.||+|+||.||+|.+.  ++.||||++..             ...+.+|+.++ +.++||||+++++++.. 
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------------cHHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            456565 77999999999999985  68999999963             13456888888 55689999999999876 


Q ss_pred             ---CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC---CCcEEEee
Q 011359          254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIAD  327 (488)
Q Consensus       254 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~---~~~vkl~D  327 (488)
                         ...+++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               678999999999999999999865667999999999999999999999999999999999999998   78899999


Q ss_pred             ecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--CCCCC
Q 011359          328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL--RPAIP  405 (488)
Q Consensus       328 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~  405 (488)
                      ||++....                     +..++.++|||||||++|+|++|..||.................  ....+
T Consensus       164 fg~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          164 FGFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  222 (299)
T ss_dssp             CTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred             cccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence            99984321                     24578899999999999999999999987654332111111110  11122


Q ss_pred             ----CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          406 ----GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       406 ----~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                          ..++.++.+||.+||+.||.+||++.++++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                468899999999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-39  Score=337.92  Aligned_cols=254  Identities=16%  Similarity=0.216  Sum_probs=191.3

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeee-----
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIK-----  246 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~-----  246 (488)
                      ......|.+++.||+|+||+||+|.+.  |+.||||++........     ...+.|.+|+.+++.+.| .|+..     
T Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~-----~~~~~~~~E~~~~~~l~~~~~~~~~~~~~  148 (413)
T 3dzo_A           74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-----NAIKQMKEEVLRLRLLRGIKNQKQAKVHL  148 (413)
T ss_dssp             SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC---------CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred             CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH-----HHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence            334456889999999999999999987  89999999984433221     124568899999999987 32111     


Q ss_pred             ----------------Eeeeeec-----CCeeeEEEeecCCCCHHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHH
Q 011359          247 ----------------FVAACKK-----PPVYCVITEYLSEGSLRAYLHKL-----EHKTLPLPKLIAIALDIARGMEYI  300 (488)
Q Consensus       247 ----------------l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~-----~~~~l~~~~~~~i~~qi~~~L~~L  300 (488)
                                      ++.++..     ...++++|+++ +++|.+++...     ....+++..++.++.||+.||+||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  227 (413)
T 3dzo_A          149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL  227 (413)
T ss_dssp             CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence                            1111111     22466777765 78999999632     234577889999999999999999


Q ss_pred             HHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCCCCcccCChhhh----------hcCCCCchhHHHHHH
Q 011359          301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI----------KHKSYGRKVDVYSFG  370 (488)
Q Consensus       301 H~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~k~DvwSlG  370 (488)
                      |++||+||||||+|||++.++.+||+|||++......  .....| ..|+|||++          ....++.++||||||
T Consensus       228 H~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG  304 (413)
T 3dzo_A          228 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG  304 (413)
T ss_dssp             HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred             HhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence            9999999999999999999999999999998654332  345567 999999999          455688899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHH--HHHHHHh
Q 011359          371 LILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKV--LEQFETS  443 (488)
Q Consensus       371 vll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~--Le~~~~~  443 (488)
                      |++|+|++|..||......+....+.      .....+|..+.+||.+||+.||++||++.++++.  ++.+...
T Consensus       305 vil~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~  373 (413)
T 3dzo_A          305 LAIYWIWCADLPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE  373 (413)
T ss_dssp             HHHHHHHHSSCCCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHH
Confidence            99999999999998765432211111      1224678999999999999999999999888753  4444443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.9e-39  Score=353.13  Aligned_cols=258  Identities=23%  Similarity=0.344  Sum_probs=203.4

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec--
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--  253 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--  253 (488)
                      .++|.+++.||+|+||.||+|.+.  |+.||||++......       ...+.+.+|+.++++++||||+++++++..  
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~-------~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-------KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH-------HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH-------HHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            367899999999999999999874  789999998754321       224678899999999999999999998765  


Q ss_pred             ----CCeeeEEEeecCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCc---EEE
Q 011359          254 ----PPVYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKI  325 (488)
Q Consensus       254 ----~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~---vkl  325 (488)
                          ....++||||++||+|.+++.... ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.   +||
T Consensus        86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence                677899999999999999998743 236889999999999999999999999999999999999987664   999


Q ss_pred             eeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------HH
Q 011359          326 ADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA---------VV  396 (488)
Q Consensus       326 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~---------~~  396 (488)
                      +|||++.............||..|+|||++.+..++.++||||||+++|+|++|..||...........         ..
T Consensus       166 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          166 IDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            999999765554455566899999999999989999999999999999999999999976543221100         00


Q ss_pred             -h----cc--C------CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHH-----HHHHHHHHH
Q 011359          397 -N----KN--L------RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHI-----VKVLEQFET  442 (488)
Q Consensus       397 -~----~~--~------~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~ei-----l~~Le~~~~  442 (488)
                       .    ..  +      ...+...++..+.+||.+||..||++||++.++     .+.++.+..
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence             0    00  0      011223467899999999999999999999884     455555544

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.1e-40  Score=331.55  Aligned_cols=247  Identities=14%  Similarity=0.136  Sum_probs=186.6

Q ss_pred             cccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---------CCCee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---------NPNVI  245 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---------HpnIv  245 (488)
                      .+..++|.+++.||+|+||+||+|+++|+.||||++................+.+.+|+.+|+.++         |+||+
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           16 CLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             HSCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             hcccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            355678999999999999999999999999999999875432100000001245778888888885         66766


Q ss_pred             eEeeee-----------------ec-------------CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH
Q 011359          246 KFVAAC-----------------KK-------------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR  295 (488)
Q Consensus       246 ~l~~~~-----------------~~-------------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~  295 (488)
                      ++++.+                 ..             ...+||||||+++|++.+.+.+   ..+++..++.++.||+.
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence            666653                 32             6789999999999976666533   56899999999999999


Q ss_pred             HHHHHH-HCCcccCCCCCCeEEEcCCC--------------------cEEEeeecccccccccCcCCCCCCCcccCChhh
Q 011359          296 GMEYIH-SQGVIHRDLKPENVLIDQEF--------------------HLKIADFGIACEEVYCDALSDDPGTYRWMAPEM  354 (488)
Q Consensus       296 ~L~~LH-~~giiHrDIkp~NILl~~~~--------------------~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~  354 (488)
                      ||+||| ++||+||||||+|||++.++                    .+||+|||+|+.....    ...||+.|+|||+
T Consensus       173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~  248 (336)
T 2vuw_A          173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGG
T ss_pred             HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhh
Confidence            999999 99999999999999999887                    8999999999654322    3368999999999


Q ss_pred             hhcCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCHHH-HHHHHHhcc-CCCC----CCCCCcHHHHHHHHHHhhhCCCCC
Q 011359          355 IKHKSYGRKVDVYSFGLI-LWEMVAGTIPYEEMNPIQ-AAFAVVNKN-LRPA----IPGDCPPAMAALIEQCWSLQPDKR  427 (488)
Q Consensus       355 l~~~~~~~k~DvwSlGvl-l~elltG~~Pf~~~~~~~-~~~~~~~~~-~~~~----~~~~~~~~l~~Li~~cL~~dp~~R  427 (488)
                      +.+.. +.++||||||++ .++++.|..||.+..... ....+.... ....    .+..+++++.+||.+||+.|    
T Consensus       249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            98666 899999998777 778888999985432111 112222111 1111    12346789999999999976    


Q ss_pred             CCHHHHH
Q 011359          428 PEFWHIV  434 (488)
Q Consensus       428 Ps~~eil  434 (488)
                       ++.+++
T Consensus       324 -sa~e~l  329 (336)
T 2vuw_A          324 -SATDLL  329 (336)
T ss_dssp             -SHHHHH
T ss_pred             -CHHHHH
Confidence             888777

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-38  Score=347.58  Aligned_cols=239  Identities=21%  Similarity=0.292  Sum_probs=193.3

Q ss_pred             ccceeccceeeeeccEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~---~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      .++|.+++.||+|+||.||+|.+.   ++.||||++......       .....+.+|+.++.+++||||+++++++...
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-------EAQAMAMAERQFLAEVVHPSIVQIFNFVEHT  151 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH-------HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH-------HHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence            478999999999999999999984   688999998753321       1245688999999999999999999999876


Q ss_pred             Ce-----eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          255 PV-----YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       255 ~~-----~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ..     .||||||++|++|.+++..    .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecc
Confidence            55     7999999999999987753    69999999999999999999999999999999999999986 89999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-CCCCC
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA-IPGDC  408 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~  408 (488)
                      ++......   ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+...         ...... ....+
T Consensus       227 ~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~  293 (681)
T 2pzi_A          227 AVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKT  293 (681)
T ss_dssp             TCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHH
T ss_pred             cchhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc---------cccccccccccc
Confidence            98654322   456799999999999765 48999999999999999999988865210         000000 00123


Q ss_pred             cHHHHHHHHHHhhhCCCCCCC-HHHHHHHHHHHH
Q 011359          409 PPAMAALIEQCWSLQPDKRPE-FWHIVKVLEQFE  441 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs-~~eil~~Le~~~  441 (488)
                      ++.+.+||.+||+.||.+||+ +.++...|..+.
T Consensus       294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            568999999999999999995 666666666654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=9.1e-32  Score=290.44  Aligned_cols=188  Identities=15%  Similarity=0.127  Sum_probs=131.2

Q ss_pred             eeeeeccEEEEEEE--ECCccEEEEEEecCCCC--hhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeeeEE
Q 011359          186 RFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDD--ENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~--~~~~~vAVK~i~~~~~~--~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV  260 (488)
                      ..+.|+.|.+..++  +.|+.||||++......  .......+..++|.+|+++|+++ .|+||++++++++++..+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            34556666555443  35899999999764321  12233445567899999999999 599999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-Cc
Q 011359          261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-DA  339 (488)
Q Consensus       261 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-~~  339 (488)
                      ||||+|++|.++|..  .+.++..   +|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... ..
T Consensus       321 MEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred             EecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence            999999999999986  4556654   47899999999999999999999999999999999999999999644322 22


Q ss_pred             CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhC
Q 011359          340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG  379 (488)
Q Consensus       340 ~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG  379 (488)
                      ....+||+.|||||++.+ .+..++|+|++|+++++|.++
T Consensus       396 ~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             SHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred             ccCceechhhccHHHhCC-CCCCcccccccccchhhhccc
Confidence            334569999999999975 467789999999998776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=5.9e-29  Score=266.91  Aligned_cols=191  Identities=18%  Similarity=0.155  Sum_probs=149.9

Q ss_pred             eccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEE
Q 011359          182 FLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      ...+.||+|+||.||+|.+.++.+|+|..................+.|.+|+.+|++++||||+++..++......||||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            34678999999999999888999999998654333222222334567999999999999999996666666677789999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCc--
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--  339 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~--  339 (488)
                      ||++|++|.+++..          +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++.......  
T Consensus       419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            99999999999865          5689999999999999999999999999999999  999999999965432211  


Q ss_pred             ------CCCCCCCcccCChhhhhc--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 011359          340 ------LSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYE  384 (488)
Q Consensus       340 ------~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvll~elltG~~Pf~  384 (488)
                            .....||+.|||||++..  ..|+..+|+|+..+-..+.+.++-+|.
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                  123468999999999986  568888999999998888888777764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1.3e-24  Score=214.27  Aligned_cols=150  Identities=16%  Similarity=0.152  Sum_probs=117.0

Q ss_pred             eeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChh----------HHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDEN----------ETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~----------~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      |.+++.||+|+||.||+|.+. |+.||||+++.......          ..........+.+|+.+|++++  | +++++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            556799999999999999995 78999999975332110          0001123567899999999999  4 66666


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++.. ...++||||++|++|.+ +.        ......++.||+.||.|||+.||+||||||+|||++ ++.+||+|||
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             EEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            5543 55689999999999987 31        124557999999999999999999999999999999 9999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhh
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIK  356 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~  356 (488)
                      ++.            .+..++|||++.
T Consensus       238 ~a~------------~~~~~~a~e~l~  252 (282)
T 1zar_A          238 QSV------------EVGEEGWREILE  252 (282)
T ss_dssp             TCE------------ETTSTTHHHHHH
T ss_pred             CCe------------ECCCCCHHHHHH
Confidence            984            344578999885

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=1.3e-20  Score=183.13  Aligned_cols=142  Identities=18%  Similarity=0.234  Sum_probs=107.7

Q ss_pred             eeccceeeeeccEEEEEEEE--CCcc--EEEEEEecCCCChhH----------------HHHHHHHHHHHHHHHHHHhcC
Q 011359          181 LFLGLRFAHGAHSRLYHGIY--KDEP--VAVKIIRIPDDDENE----------------TLAARLEKQFNREVALLSRLH  240 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~--~~~~--vAVK~i~~~~~~~~~----------------~~~~~~~~~~~~Ei~il~~l~  240 (488)
                      |.+++.||+|+||.||+|.+  .|+.  ||||+++........                .........+.+|+.+|.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999998  6888  999998654211000                001122346889999999998


Q ss_pred             CCCe--eeEeeeeecCCeeeEEEeecCC-C----CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCC
Q 011359          241 NPNV--IKFVAACKKPPVYCVITEYLSE-G----SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH-SQGVIHRDLKP  312 (488)
Q Consensus       241 HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~giiHrDIkp  312 (488)
                      |++|  ..+++.    ...+|||||+.+ |    +|.++...     .++..+..++.||+.+|.||| +.||+||||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            8754  444442    356899999942 3    77776543     235567899999999999999 99999999999


Q ss_pred             CeEEEcCCCcEEEeeeccccc
Q 011359          313 ENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       313 ~NILl~~~~~vkl~DFgla~~  333 (488)
                      +|||++.  .++|+|||+|..
T Consensus       200 ~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEE
T ss_pred             HHEEEcC--cEEEEECccccc
Confidence            9999998  999999999953

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=7.6e-18  Score=171.92  Aligned_cols=140  Identities=17%  Similarity=0.180  Sum_probs=101.4

Q ss_pred             eeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCC--------------hhHHHHHHHHHHHHHHHHHHHhcCCCCe-
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDD--------------ENETLAARLEKQFNREVALLSRLHNPNV-  244 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~--------------~~~~~~~~~~~~~~~Ei~il~~l~HpnI-  244 (488)
                      |.++++||.|++|.||+|... |+.||||+++.....              ..............+|...|.++.+.++ 
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            889999999999999999875 789999998643110              0011111112223567888888865443 


Q ss_pred             -eeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC--
Q 011359          245 -IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF--  321 (488)
Q Consensus       245 -v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~--  321 (488)
                       ...++..    ..+|||||++|++|..+.        ..+....++.||+.+|.+||+.|||||||||.|||+++++  
T Consensus       177 vp~p~~~~----~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          177 VPEPIAQS----RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             CCCEEEEE----TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred             CCeeeecc----CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence             2233322    236999999998875432        1224567889999999999999999999999999998776  


Q ss_pred             --------cEEEeeecccc
Q 011359          322 --------HLKIADFGIAC  332 (488)
Q Consensus       322 --------~vkl~DFgla~  332 (488)
                              .+.|+||+.+.
T Consensus       245 ~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCE
T ss_pred             ccccccccceEEEEeCCcc
Confidence                    38999999774

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.38  E-value=9.3e-13  Score=127.11  Aligned_cols=137  Identities=13%  Similarity=0.042  Sum_probs=108.5

Q ss_pred             ceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYC  258 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~  258 (488)
                      .|.+...++.|+.+.||++...++.+++|+........        ...+.+|+.+++.+. +..+.++++++...+..|
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--------HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            45566667888889999998778999999987421111        124678999999995 677889999998888999


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS------------------------------------  302 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~------------------------------------  302 (488)
                      +||||++|.+|.+.+.       +......++.+++.+|+.||+                                    
T Consensus        87 lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999999999987531       112345788899999999998                                    


Q ss_pred             -----------------------CCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          303 -----------------------QGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       303 -----------------------~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                                             ..++|||+++.||++++++.+.|+||+.+
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                                   44899999999999987656679999976

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=4.2e-11  Score=121.10  Aligned_cols=138  Identities=16%  Similarity=0.224  Sum_probs=105.5

Q ss_pred             cceeeeeccEEEEEEEECCccEEEEEEe--cCCCChhHHHHHHHHHHHHHHHHHHHhcC--CCCeeeEeeeeecC---Ce
Q 011359          184 GLRFAHGAHSRLYHGIYKDEPVAVKIIR--IPDDDENETLAARLEKQFNREVALLSRLH--NPNVIKFVAACKKP---PV  256 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~i~--~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~  256 (488)
                      .+.|+.|.++.||+....+..+++|+..  .....       .....+.+|+.+++.|.  +..+.+++.++.+.   +.
T Consensus        43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-------~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-------PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             EEECCC-CCSCEEEEECSSCEEEEECCCC-----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-------CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            4567899999999998888889999875  22110       01245778999999997  45688899988776   45


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS----------------------------------  302 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~----------------------------------  302 (488)
                      .++||||++|..+.+.    ....++......++.+++..|+.||+                                  
T Consensus       116 ~~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             CEEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             eEEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            7899999999877431    12346788888999999999999997                                  


Q ss_pred             ------------------------CCcccCCCCCCeEEEcCCCc--EEEeeecccc
Q 011359          303 ------------------------QGVIHRDLKPENVLIDQEFH--LKIADFGIAC  332 (488)
Q Consensus       303 ------------------------~giiHrDIkp~NILl~~~~~--vkl~DFgla~  332 (488)
                                              ..++|||+++.|||++.++.  +.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence                                    35899999999999997753  6899999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.18  E-value=3.4e-11  Score=115.18  Aligned_cols=123  Identities=15%  Similarity=0.091  Sum_probs=92.2

Q ss_pred             eeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC--eeeEeeeeecCCeeeEEEeec
Q 011359          188 AHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN--VIKFVAACKKPPVYCVITEYL  264 (488)
Q Consensus       188 G~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~  264 (488)
                      +.|..+.||++... |+.++||+.....           ...+.+|+.+++.+.+.+  +.++++++..++..++||||+
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-----------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCT-----------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCccc-----------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34556999999765 5789999976431           123568999999986544  566888888888889999999


Q ss_pred             CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------------
Q 011359          265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG----------------------------------------  304 (488)
Q Consensus       265 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g----------------------------------------  304 (488)
                      +|.+|.  ..     ...   ...++.+++..|..||+..                                        
T Consensus        98 ~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A           98 PGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             SSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             CCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            998873  11     111   2356677777777777643                                        


Q ss_pred             ------------------cccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          305 ------------------VIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       305 ------------------iiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                                        ++|||++|.||++++++.+.|+||+.+
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence                              999999999999987766779999987

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=2.5e-10  Score=112.72  Aligned_cols=182  Identities=21%  Similarity=0.216  Sum_probs=120.0

Q ss_pred             ceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCC--eeeEeeeeecCC---eee
Q 011359          185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPN--VIKFVAACKKPP---VYC  258 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~~~~~~~~---~~~  258 (488)
                      +.++.|.+..||+.   +..++||+....          .....+.+|+.+|+.+. +..  +.+++.......   ..|
T Consensus        26 ~~~~~G~~n~v~~v---~~~~vlR~~~~~----------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~   92 (304)
T 3sg8_A           26 EISGEGNDCIAYEI---NRDFIFKFPKHS----------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF   92 (304)
T ss_dssp             CEEEECSSEEEEES---TTSEEEEEESSH----------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred             EecCCCCcceEEEE---CCEEEEEecCCc----------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence            45799999999986   367999996521          12356889999999884 322  445555544333   457


Q ss_pred             EEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 011359          259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS------------------------------------  302 (488)
Q Consensus       259 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~------------------------------------  302 (488)
                      +||+|++|.+|.+...    ..++.++...++.+++..|+.||+                                    
T Consensus        93 ~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (304)
T 3sg8_A           93 AGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP  168 (304)
T ss_dssp             EEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred             EEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence            8999999988875433    246777788888888888888886                                    


Q ss_pred             ----------------------CCcccCCCCCCeEEEcC--CCcEEEeeecccccccccCcCCCCCCCcccCChhhhh--
Q 011359          303 ----------------------QGVIHRDLKPENVLIDQ--EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK--  356 (488)
Q Consensus       303 ----------------------~giiHrDIkp~NILl~~--~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~--  356 (488)
                                            ..++|+|+++.||+++.  .+.+.|+||+.+.................-..++...  
T Consensus       169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence                                  13699999999999998  4567899999874321110000000000002233221  


Q ss_pred             --cCC----------CCchhHHHHHHHHHHHHHhCCCCC
Q 011359          357 --HKS----------YGRKVDVYSFGLILWEMVAGTIPY  383 (488)
Q Consensus       357 --~~~----------~~~k~DvwSlGvll~elltG~~Pf  383 (488)
                        ...          .....+.|++|.++|.+.+|..+|
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              000          122368999999999999998665

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.66  E-value=3.6e-07  Score=90.26  Aligned_cols=131  Identities=21%  Similarity=0.194  Sum_probs=92.0

Q ss_pred             ceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC---CeeeEeeeee-cCCeeeEE
Q 011359          185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP---NVIKFVAACK-KPPVYCVI  260 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lV  260 (488)
                      ..++.|....||+.   +..++||+...      .    .....+.+|+.+|..|.+.   .|.+++.++. ..+..++|
T Consensus        25 ~~l~~G~~n~v~~v---g~~~VlR~~~~------~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v   91 (306)
T 3tdw_A           25 ESLGEGFRNYAILV---NGDWVFRFPKS------Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG   91 (306)
T ss_dssp             EEEEECSSEEEEEE---TTTEEEEEESS------H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred             eecCCCcceeEEEE---CCEEEEEecCC------c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence            45688898999987   78899998531      0    1135688999999999752   3566666664 45567899


Q ss_pred             EeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q 011359          261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-------------------------------------  303 (488)
Q Consensus       261 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------------------------------------  303 (488)
                      |||++|..|.+..-    ..++......++.+++..|+.||+.                                     
T Consensus        92 ~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~  167 (306)
T 3tdw_A           92 YRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES  167 (306)
T ss_dssp             EECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred             EeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence            99999988876321    1234445555555555555555532                                     


Q ss_pred             -----------------------CcccCCCCCCeEEEcC---CCc-EEEeeecccc
Q 011359          304 -----------------------GVIHRDLKPENVLIDQ---EFH-LKIADFGIAC  332 (488)
Q Consensus       304 -----------------------giiHrDIkp~NILl~~---~~~-vkl~DFgla~  332 (488)
                                             .++|+|+++.||+++.   ++. +.|+||+.+.
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                                   3599999999999987   455 4899999773

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.55  E-value=8.5e-07  Score=85.30  Aligned_cols=128  Identities=16%  Similarity=0.110  Sum_probs=93.0

Q ss_pred             eeeeccE-EEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeeeEEEe
Q 011359          187 FAHGAHS-RLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVITE  262 (488)
Q Consensus       187 lG~G~~g-~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E  262 (488)
                      +..|..| .||+....  +..++||+-...           ....+.+|..+|+.+. +--|.++++++.+++..++|||
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme  100 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT  100 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH-----------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence            3556555 68887654  468999997631           1345778999999886 3347788899988899999999


Q ss_pred             ecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q 011359          263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ---------------------------------------  303 (488)
Q Consensus       263 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------------------------------------  303 (488)
                      +++|.++.+.....      ......++.+++..|..||..                                       
T Consensus       101 ~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A          101 AIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             CCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             eeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            99998887765431      122334555666666666631                                       


Q ss_pred             -------------------CcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          304 -------------------GVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       304 -------------------giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                                         .++|+|+.+.||+++.++.+-|+||+.+
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a  221 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV  221 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence                               1689999999999998777789999977

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.19  E-value=1.5e-06  Score=87.23  Aligned_cols=79  Identities=6%  Similarity=0.008  Sum_probs=53.3

Q ss_pred             ccee-eeeccEEEEEEEEC--------CccEEEEEEecCCC--ChhHHHHHHHHHHHHHHHHHHHhcC-C--CCeeeEee
Q 011359          184 GLRF-AHGAHSRLYHGIYK--------DEPVAVKIIRIPDD--DENETLAARLEKQFNREVALLSRLH-N--PNVIKFVA  249 (488)
Q Consensus       184 ~~~l-G~G~~g~Vy~~~~~--------~~~vAVK~i~~~~~--~~~~~~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~  249 (488)
                      .+.| +.|..+.+|+....        ++.+++|+......  ...       ...+.+|+.+++.|. +  -.+.+++.
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~-------~~~~~~E~~~l~~L~~~~~vpvP~v~~   97 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP-------TYRLDHQFEVIRLVGELTDVPVPRVRW   97 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS-------CCCHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc-------hhHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence            3566 78889999998765        67899998653210  000       023557888888885 3  35777888


Q ss_pred             eeecC---CeeeEEEeecCCCCH
Q 011359          250 ACKKP---PVYCVITEYLSEGSL  269 (488)
Q Consensus       250 ~~~~~---~~~~lV~E~~~ggsL  269 (488)
                      ++.+.   +..++||||++|..+
T Consensus        98 ~~~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A           98 IETTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             EECSSTTTSSCEEEEECCCCBCC
T ss_pred             EccCCCccCCceEEEEecCCCCh
Confidence            87655   356799999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.19  E-value=1.4e-05  Score=79.20  Aligned_cols=134  Identities=16%  Similarity=0.158  Sum_probs=77.0

Q ss_pred             eeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeeEee------eeecCCee
Q 011359          186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVA------ACKKPPVY  257 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~------~~~~~~~~  257 (488)
                      .|+.|..+.||+....+..+++|+....   .         ..+..|+.++..|..  -.|.+++.      +....+..
T Consensus        39 ~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~  106 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSGAVCLKRIHRP---E---------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL  106 (346)
T ss_dssp             ECC----CEEEEEEETTEEEEEEEECSC---H---------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred             eccccccCcEEEEEeCCCCEEEEecCCC---H---------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence            4556678899999887777999998741   1         122344555554431  12333332      12345677


Q ss_pred             eEEEeecCCCCHH--------------HHHHHhCC-C--C---------CCHHH--------------------------
Q 011359          258 CVITEYLSEGSLR--------------AYLHKLEH-K--T---------LPLPK--------------------------  285 (488)
Q Consensus       258 ~lV~E~~~ggsL~--------------~~l~~~~~-~--~---------l~~~~--------------------------  285 (488)
                      ++||+|++|..+.              ..++.... .  .         ..+..                          
T Consensus       107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  186 (346)
T 2q83_A          107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ  186 (346)
T ss_dssp             EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred             EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence            8999999986431              11222111 1  0         01111                          


Q ss_pred             -----HHHHHHHHHHHHHHHHH-------------CCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          286 -----LIAIALDIARGMEYIHS-------------QGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       286 -----~~~i~~qi~~~L~~LH~-------------~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                           +..+...+..++.+|++             .+++|||+++.|||++.++.+.|+||+.+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence                 01111223345666652             57999999999999988888999999976

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.08  E-value=9.2e-06  Score=82.85  Aligned_cols=81  Identities=16%  Similarity=0.063  Sum_probs=47.9

Q ss_pred             cceeeeeccEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--C-CeeeEeeeeecCCeee
Q 011359          184 GLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--P-NVIKFVAACKKPPVYC  258 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~--~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--p-nIv~l~~~~~~~~~~~  258 (488)
                      .+.||.|.++.||++..  .++.|+||............ .......+..|.++|+.+..  + .+.+++.+.  ....+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~-~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~  111 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES-WPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAV  111 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCC-CcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccE
Confidence            35679999999999964  46789999875321100000 00001335678888887742  3 344555443  34567


Q ss_pred             EEEeecCCC
Q 011359          259 VITEYLSEG  267 (488)
Q Consensus       259 lV~E~~~gg  267 (488)
                      +||||+++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.89  E-value=3.8e-05  Score=76.03  Aligned_cols=75  Identities=17%  Similarity=0.086  Sum_probs=60.0

Q ss_pred             cceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeeEeeeeecCCeeeEE
Q 011359          184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPVYCVI  260 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV  260 (488)
                      ...|+.|....+|+....+..++||+.....           ...|..|+..|+.|.   ...|.+++.++...+..++|
T Consensus        41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~-----------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEVQTVFVKINERSY-----------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEECCSSSSEEEEEESSSCEEEEEEEEGGG-----------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eEEeCCccceeeeEEEECCCeEEEEeCCccc-----------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            3567899999999998778899999986321           345778999998884   35688888888888889999


Q ss_pred             EeecCCCCH
Q 011359          261 TEYLSEGSL  269 (488)
Q Consensus       261 ~E~~~ggsL  269 (488)
                      |||++|..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.89  E-value=0.00015  Score=67.35  Aligned_cols=138  Identities=12%  Similarity=0.128  Sum_probs=95.1

Q ss_pred             CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCcCCCCCC
Q 011359          267 GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH-SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG  345 (488)
Q Consensus       267 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~~~~~~g  345 (488)
                      -+|.+.|.. .+.+++++++|.+++|.+.+|.-+- .+.-..+=+.|..|++..+|.|-+.+ +.+.           ..
T Consensus        33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~   99 (229)
T 2yle_A           33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG   99 (229)
T ss_dssp             EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence            389999987 4678999999999999999987762 22222334457999999999987764 2110           12


Q ss_pred             CcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh---
Q 011359          346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSL---  422 (488)
Q Consensus       346 t~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~---  422 (488)
                      ...+.+||... ...+.+.=|||||++||..+-                   -++....+..+++.|..||..|...   
T Consensus       100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD-------------------ygL~e~eE~eLS~~LE~LL~~Mt~~~~d  159 (229)
T 2yle_A          100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALD-------------------YGLKENEERELSPPLEQLIDHMANTVEA  159 (229)
T ss_dssp             -------CCSS-SSSCHHHHHHHHHHHHHHHHT-------------------TTCCTTEEECCCHHHHHHHHHHTTCCC-
T ss_pred             ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh-------------------cCCCcccchhhCHHHHHHHHHHHhcccc
Confidence            23456777763 345788999999999998763                   2334445677899999999999865   


Q ss_pred             ----------------------CCCCCCCHHHHHHHH
Q 011359          423 ----------------------QPDKRPEFWHIVKVL  437 (488)
Q Consensus       423 ----------------------dp~~RPs~~eil~~L  437 (488)
                                            .+..|.++.+|++.=
T Consensus       160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C  196 (229)
T 2yle_A          160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLC  196 (229)
T ss_dssp             -------------------CCSCCCCCCSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCcCCHHHHHHHH
Confidence                                  245888888887643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.73  E-value=0.00011  Score=75.57  Aligned_cols=31  Identities=26%  Similarity=0.442  Sum_probs=27.1

Q ss_pred             HHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       301 H~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      +...++|||+++.|||++.++ +.|+||+.+.
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~  260 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSF  260 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence            355799999999999998876 9999999874

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.63  E-value=0.00021  Score=69.80  Aligned_cols=71  Identities=11%  Similarity=0.170  Sum_probs=44.4

Q ss_pred             cceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eeEeeeeecCCeeeEEEe
Q 011359          184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKPPVYCVITE  262 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E  262 (488)
                      .+.|+.|....+|+.    +.+++|+........         -...+|+.+++.+....+ .++++.+  ...-++|+|
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~---------~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e   87 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY---------INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR   87 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC----C---------CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccce---------eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence            467888999999998    679999986421110         012367777777753222 4555544  333468999


Q ss_pred             ec-CCCCH
Q 011359          263 YL-SEGSL  269 (488)
Q Consensus       263 ~~-~ggsL  269 (488)
                      |+ +|.+|
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.57  E-value=0.00043  Score=68.48  Aligned_cols=134  Identities=17%  Similarity=0.097  Sum_probs=70.9

Q ss_pred             eeeeeccEE-EEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeeEeeeeecCCeeeEEE
Q 011359          186 RFAHGAHSR-LYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       186 ~lG~G~~g~-Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~  261 (488)
                      .|+.|+... +|+.... +..+++|.......           ..+..|+.++..+..  -.+.+++.+....+  ++||
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~   91 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLI   91 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT-----------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEE
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEE
Confidence            455565555 6676654 67787776543210           123356777776642  23556666644433  6899


Q ss_pred             eecCCCCHHHHHHHhC---------------------C---CCCCHHHHH-------HHH-------------HHHHHHH
Q 011359          262 EYLSEGSLRAYLHKLE---------------------H---KTLPLPKLI-------AIA-------------LDIARGM  297 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~---------------------~---~~l~~~~~~-------~i~-------------~qi~~~L  297 (488)
                      |++.+..+.+++....                     .   ..+......       .+.             ..+...+
T Consensus        92 e~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~  171 (333)
T 3csv_A           92 EDLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRF  171 (333)
T ss_dssp             CCCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHH
T ss_pred             eeCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            9998777765543210                     0   011111110       000             0111222


Q ss_pred             HHH------HHCCcccCCCCCCeEEEcCC----CcEEEeeecccc
Q 011359          298 EYI------HSQGVIHRDLKPENVLIDQE----FHLKIADFGIAC  332 (488)
Q Consensus       298 ~~L------H~~giiHrDIkp~NILl~~~----~~vkl~DFgla~  332 (488)
                      ..|      +...++|||+.+.||+++.+    +.+.|+||+.+.
T Consensus       172 ~~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          172 AQILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             HHHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             HHHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            333      13469999999999999875    689999999874

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.50  E-value=0.00027  Score=69.43  Aligned_cols=138  Identities=17%  Similarity=0.187  Sum_probs=78.9

Q ss_pred             cceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC--eeeEeee------eecCC
Q 011359          184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN--VIKFVAA------CKKPP  255 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~  255 (488)
                      .+.|+.|....+|+....+..+++|+......          ...+..|+.++..|....  +.+++..      ....+
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g   96 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG   96 (322)
T ss_dssp             EEEECC---EEEEEEEESSCCEEEEEECC-------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred             eeccCCCcccceEEEEeCCccEEEEEeCCCCC----------HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence            35677888899999988777899999874211          123456777777774212  3333321      12235


Q ss_pred             eeeEEEeecCCCCHH-----------H---HHHHhC-CCC------CC---HHHHHH------------HHHHHHHHHHH
Q 011359          256 VYCVITEYLSEGSLR-----------A---YLHKLE-HKT------LP---LPKLIA------------IALDIARGMEY  299 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~-----------~---~l~~~~-~~~------l~---~~~~~~------------i~~qi~~~L~~  299 (488)
                      ..+++++|++|..+.           .   .++... ...      ..   |...+.            +...+...+++
T Consensus        97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~  176 (322)
T 2ppq_A           97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY  176 (322)
T ss_dssp             EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred             EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence            678999999885431           1   122211 100      11   111000            00113445555


Q ss_pred             HHH-------CCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          300 IHS-------QGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       300 LH~-------~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ++.       .+++|+|+.+.|||++.++.+.|+||+.+
T Consensus       177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a  215 (322)
T 2ppq_A          177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA  215 (322)
T ss_dssp             HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence            552       36999999999999998766689999876

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.41  E-value=0.00072  Score=65.49  Aligned_cols=74  Identities=18%  Similarity=0.102  Sum_probs=51.5

Q ss_pred             ccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC---CCeeeEeeeeecCCeee
Q 011359          183 LGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN---PNVIKFVAACKKPPVYC  258 (488)
Q Consensus       183 i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~~~~~  258 (488)
                      -...+|.|..+.||+.... |+.|.||+........        ...|..|+..|+.|..   --+.+++++.    ..+
T Consensus        19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~   86 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--------DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT   86 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--------TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred             EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--------hhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence            4567899999999999986 6899999865332211        1246689999998852   2345555543    236


Q ss_pred             EEEeecCCCC
Q 011359          259 VITEYLSEGS  268 (488)
Q Consensus       259 lV~E~~~ggs  268 (488)
                      +||||+.++.
T Consensus        87 lv~e~l~~~~   96 (288)
T 3f7w_A           87 LAMEWVDERP   96 (288)
T ss_dssp             EEEECCCCCC
T ss_pred             EEEEeecccC
Confidence            8999998754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.28  E-value=0.00075  Score=69.67  Aligned_cols=70  Identities=16%  Similarity=0.228  Sum_probs=47.7

Q ss_pred             ceeeeeccEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeeEeeeeecC
Q 011359          185 LRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKKP  254 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~---------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~  254 (488)
                      ..|+.|....||+....         ++.+++|+..... .         ...+.+|+.++..|...+ ..++++.+.+ 
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---------~~~li~E~~~l~~L~~~g~~P~l~~~~~~-  147 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---------ESHLVAESVIFTLLSERHLGPKLYGIFSG-  147 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---------HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---------HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-
Confidence            56788889999999874         3689999984321 1         023447888888885333 4667776643 


Q ss_pred             CeeeEEEeecCCCC
Q 011359          255 PVYCVITEYLSEGS  268 (488)
Q Consensus       255 ~~~~lV~E~~~ggs  268 (488)
                         .+|+||++|.+
T Consensus       148 ---g~v~e~l~G~~  158 (429)
T 1nw1_A          148 ---GRLEEYIPSRP  158 (429)
T ss_dssp             ---EEEECCCCEEE
T ss_pred             ---CEEEEEeCCcc
Confidence               28999998733

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.12  E-value=0.0035  Score=61.53  Aligned_cols=135  Identities=17%  Similarity=0.161  Sum_probs=76.4

Q ss_pred             eeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC--CeeeEeee-----eecCCee
Q 011359          186 RFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP--NVIKFVAA-----CKKPPVY  257 (488)
Q Consensus       186 ~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~-----~~~~~~~  257 (488)
                      .|+ |....||+.... |+.+++|+.......         ...+..|..++..|...  .+++++..     ....+..
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---------~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~  102 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY  102 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCC---------HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEE
Confidence            456 888899988764 568999998743211         23455678887777421  24444443     1224556


Q ss_pred             eEEEeecCCCCHH-----H------H---HHHhC-C------CCCCHHHH----------------------HHHHHHHH
Q 011359          258 CVITEYLSEGSLR-----A------Y---LHKLE-H------KTLPLPKL----------------------IAIALDIA  294 (488)
Q Consensus       258 ~lV~E~~~ggsL~-----~------~---l~~~~-~------~~l~~~~~----------------------~~i~~qi~  294 (488)
                      ++||+|++|..+.     .      .   ++... .      ........                      ..++.+++
T Consensus       103 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  182 (328)
T 1zyl_A          103 FAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELI  182 (328)
T ss_dssp             EEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHH
T ss_pred             EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHH
Confidence            7899999874321     1      1   12110 0      01111110                      01111222


Q ss_pred             HHHHHH----HHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          295 RGMEYI----HSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       295 ~~L~~L----H~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      ..+.-+    ....++|||+++.||+++ + .+.|+||+.+.
T Consensus       183 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          183 AAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             HHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            222222    123589999999999999 4 89999998763

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.04  E-value=0.002  Score=65.41  Aligned_cols=134  Identities=15%  Similarity=0.186  Sum_probs=79.0

Q ss_pred             ceeeeeccEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecC
Q 011359          185 LRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP  254 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~---------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  254 (488)
                      ++|..|-...+|+....         ++.|++|+...... .        ...+.+|..+++.|. +.-..++++.+.+ 
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~-~--------~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ-G--------VDSLVLESVMFAILAERSLGPQLYGVFPE-  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C-C--------HHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc-h--------HHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence            46677888899998863         36788888532110 1        123458999998885 3334667777654 


Q ss_pred             CeeeEEEeecCCCCHH--------------HHHHHh---C---CCCCC--HHHHHHHHHHHHH-----------------
Q 011359          255 PVYCVITEYLSEGSLR--------------AYLHKL---E---HKTLP--LPKLIAIALDIAR-----------------  295 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~--------------~~l~~~---~---~~~l~--~~~~~~i~~qi~~-----------------  295 (488)
                         .+||||++|.+|.              +.|.+.   .   .+...  +.++.+++.++..                 
T Consensus       126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence               2899999885442              111111   1   11111  3445555544321                 


Q ss_pred             --HHHHHH----H----CCcccCCCCCCeEEEcCC----CcEEEeeeccc
Q 011359          296 --GMEYIH----S----QGVIHRDLKPENVLIDQE----FHLKIADFGIA  331 (488)
Q Consensus       296 --~L~~LH----~----~giiHrDIkp~NILl~~~----~~vkl~DFgla  331 (488)
                        .+..|.    .    ..++|+|+.+.||+++.+    +.+.|+||..+
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a  252 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS  252 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence              233332    2    248999999999999876    78999999877

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.03  E-value=0.00087  Score=67.38  Aligned_cols=71  Identities=15%  Similarity=0.162  Sum_probs=42.6

Q ss_pred             ceeeeeccEEEEEEEECC----------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeeEeeeeec
Q 011359          185 LRFAHGAHSRLYHGIYKD----------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKK  253 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~----------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~  253 (488)
                      ..|+.|....+|+....+          +.+++|+.......    +     .....|..+++.+...+ +.++++... 
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~-----~~~~~E~~~l~~L~~~g~~P~~~~~~~-  108 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----L-----YNTISEFEVYKTMSKYKIAPQLLNTFN-  108 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----T-----SCHHHHHHHHHHHHHTTSSCCEEEEET-
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----e-----ecHHHHHHHHHHHHhcCCCCceEEecC-
Confidence            466788889999998764          67888887532110    0     01247888888775333 446665542 


Q ss_pred             CCeeeEEEeecCCCC
Q 011359          254 PPVYCVITEYLSEGS  268 (488)
Q Consensus       254 ~~~~~lV~E~~~ggs  268 (488)
                         -++||||++|..
T Consensus       109 ---~~~v~e~i~G~~  120 (369)
T 3c5i_A          109 ---GGRIEEWLYGDP  120 (369)
T ss_dssp             ---TEEEEECCCSEE
T ss_pred             ---CcEEEEEecCCc
Confidence               268999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.77  E-value=0.013  Score=60.89  Aligned_cols=73  Identities=16%  Similarity=0.100  Sum_probs=47.8

Q ss_pred             cceeeeeccEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eeEeeeeecCCeeeEE
Q 011359          184 GLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKPPVYCVI  260 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~~--~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV  260 (488)
                      ...|+.|-...+|+....+  ..+++|+.......-   +      .-.+|..++..|...++ .++++.+. +   .+|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---i------dR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v  179 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---I------NREREKKISCILYNKNIAKKIYVFFT-N---GRI  179 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---S------CHHHHHHHHHHHTTSSSBCCEEEEET-T---EEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---c------CHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEE
Confidence            3567889999999999876  789999875322110   0      01378999999875444 56777763 2   259


Q ss_pred             EeecCCCCH
Q 011359          261 TEYLSEGSL  269 (488)
Q Consensus       261 ~E~~~ggsL  269 (488)
                      |||++|.+|
T Consensus       180 ~e~I~G~~l  188 (458)
T 2qg7_A          180 EEFMDGYAL  188 (458)
T ss_dssp             EECCCSEEC
T ss_pred             EEeeCCccC
Confidence            999987443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.65  E-value=0.0083  Score=59.60  Aligned_cols=29  Identities=28%  Similarity=0.397  Sum_probs=26.3

Q ss_pred             CcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          304 GVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       304 giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            59999999999999988889999998763

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.15  E-value=0.011  Score=60.75  Aligned_cols=71  Identities=11%  Similarity=0.067  Sum_probs=46.2

Q ss_pred             ceeeeeccEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecC
Q 011359          185 LRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP  254 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~---------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  254 (488)
                      ++|..|-...+|+....         ++.|++++.......-   +      ...+|..+++.+. +.-..++++.+.  
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~---i------dR~~E~~~l~~L~~~gi~P~l~~~~~--  144 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF---Y------DSKVELDVFRYLSNINIAPNIIADFP--  144 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC---C------CHHHHHHHHHHHHHTTSSCCEEEEET--
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh---c------CHHHHHHHHHHHHhcCCCCCEEEEcC--
Confidence            45677888899999876         5789999864322110   0      1237888888875 333455665443  


Q ss_pred             CeeeEEEeecCCCC
Q 011359          255 PVYCVITEYLSEGS  268 (488)
Q Consensus       255 ~~~~lV~E~~~ggs  268 (488)
                        -++||||++|.+
T Consensus       145 --~~~I~efI~G~~  156 (424)
T 3mes_A          145 --EGRIEEFIDGEP  156 (424)
T ss_dssp             --TEEEEECCCSEE
T ss_pred             --CCEEEEEeCCcc
Confidence              268999999865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.06  E-value=0.17  Score=51.18  Aligned_cols=28  Identities=25%  Similarity=0.475  Sum_probs=24.1

Q ss_pred             cccCCCCCCeEEE------cCCCcEEEeeecccc
Q 011359          305 VIHRDLKPENVLI------DQEFHLKIADFGIAC  332 (488)
Q Consensus       305 iiHrDIkp~NILl------~~~~~vkl~DFgla~  332 (488)
                      ++|+|+.+.|||+      +++..+.|+||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6899999999999      456779999998873

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.24  E-value=0.045  Score=56.83  Aligned_cols=61  Identities=11%  Similarity=-0.024  Sum_probs=18.1

Q ss_pred             eccceeeeeccEEEEEEEECC--ccEEE------EEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          182 FLGLRFAHGAHSRLYHGIYKD--EPVAV------KIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~~~--~~vAV------K~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      .+.++||   ||.||+|.+.+  .+|||      |..+...      ........|.+|..++..++|+|+++.+++.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~------~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG------VSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------------CBCCCEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccc------ccccccccccccccccccccccccCCCcceE
Confidence            4567777   99999999975  58888      6654322      2222235688899999999999999988765

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.68  E-value=1.7  Score=40.00  Aligned_cols=115  Identities=9%  Similarity=0.080  Sum_probs=74.7

Q ss_pred             CCCCeeeEeeeeecCCeeeEEEeecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc
Q 011359          240 HNPNVIKFVAACKKPPVYCVITEYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID  318 (488)
Q Consensus       240 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~  318 (488)
                      .||+.+.. .+-..++.+.+.++.-+.+ ++.. +.     .++....++++.+|+....+++  .=+|--|.|+||+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~  113 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFT  113 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEEC
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEc
Confidence            57888866 4555666666666654322 2222 33     3778889999999988775444  346778999999999


Q ss_pred             CCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 011359          319 QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE  384 (488)
Q Consensus       319 ~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~  384 (488)
                      .++.+++.-.|+-...                +|     ...+...=.-.+=+++..++.+...|+
T Consensus       114 ~~~~p~i~~RGik~~l----------------~P-----~~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          114 RDGLPIAKTRGLQNVV----------------DP-----LPVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             TTSCEEESCCEETTTB----------------SC-----CCCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCCCEEEEEccCccCC----------------CC-----CCCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999988764111                11     111222223346678888888887764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.08  E-value=3  Score=38.42  Aligned_cols=83  Identities=13%  Similarity=0.070  Sum_probs=59.1

Q ss_pred             CCCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHH-HHHHCCcccCCCCCCeEEEc
Q 011359          240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME-YIHSQGVIHRDLKPENVLID  318 (488)
Q Consensus       240 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~giiHrDIkp~NILl~  318 (488)
                      .||++  -..+-..++.+.+.++.-+++.=+..+.     .++....++++.+|+.... +++  .-+|--|.|+||+++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~  118 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFN  118 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEEC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEe
Confidence            47777  3344466777777777654443333443     3788899999998888666 443  446778999999999


Q ss_pred             CCCcEEEeeeccc
Q 011359          319 QEFHLKIADFGIA  331 (488)
Q Consensus       319 ~~~~vkl~DFgla  331 (488)
                      .++.++|.-.|+-
T Consensus       119 ~~~~p~i~hRGi~  131 (219)
T 4ano_A          119 RALEPFFLHVGVK  131 (219)
T ss_dssp             TTCCEEESCCEET
T ss_pred             CCCcEEEEEcCCc
Confidence            9999999988864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	488
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-77
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-72
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-68
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-64
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-64
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-64
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-63
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-62
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-62
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-61
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-61
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-60
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-58
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-57
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-56
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-55
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-54
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-54
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-54
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-53
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-52
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-51
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-50
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-49
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-49
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-49
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-48
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-47
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-44
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-36
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (618), Expect = 1e-77
 Identities = 82/283 (28%), Positives = 144/283 (50%), Gaps = 19/283 (6%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
           D+  +   Q+ +G R   G+   +Y G +  + VAVK++ +      +       + F  
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQ------LQAFKN 53

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           EV +L +  + N++ F+     P +  ++T++    SL  +LH +E K   + KLI IA 
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHIIETK-FEMIKLIDIAR 111

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC---EEVYCDALSDDPGTYR 348
             A+GM+Y+H++ +IHRDLK  N+ + ++  +KI DFG+A                G+  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

Query: 349 WMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR---- 401
           WMAPE+I+ +    Y  + DVY+FG++L+E++ G +PY  +N       +V +       
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231

Query: 402 PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
             +  +CP AM  L+ +C   + D+RP F  I+  +E    SL
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (580), Expect = 3e-72
 Identities = 72/268 (26%), Positives = 127/268 (47%), Gaps = 13/268 (4%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
           +++ +L L      G    +  G Y+   VAVK I+               + F  E ++
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASV 53

Query: 236 LSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
           +++L + N+++ +    ++     ++TEY+++GSL  YL       L    L+  +LD+ 
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEM 354
             MEY+     +HRDL   NVL+ ++   K++DFG+  E              +W APE 
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEA 171

Query: 355 IKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA 414
           ++ K +  K DV+SFG++LWE+ +         P++     V K  +   P  CPPA+  
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231

Query: 415 LIEQCWSLQPDKRPEFWHIVKVLEQFET 442
           +++ CW L    RP F  + + LE  +T
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 3e-68
 Identities = 82/275 (29%), Positives = 125/275 (45%), Gaps = 13/275 (4%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFN 230
           DE  V    L L  R   G    ++ G Y     VAVK ++                 F 
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---------DAFL 56

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E  L+ +L +  +++  A   + P+Y + TEY+  GSL  +L       L + KL+ +A
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQEPIYII-TEYMENGSLVDFLKTPSGIKLTINKLLDMA 115

Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
             IA GM +I  +  IHRDL+  N+L+      KIADFG+A   E+    A        +
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175

Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC 408
           W APE I + ++  K DV+SFG++L E+V                  + +  R   P +C
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235

Query: 409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS 443
           P  +  L+  CW  +P+ RP F ++  VLE F T+
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 2e-64
 Identities = 66/268 (24%), Positives = 132/268 (49%), Gaps = 19/268 (7%)

Query: 189 HGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
            G    +  G+Y+       VA+K+++   +  +        ++  RE  ++ +L NP +
Sbjct: 19  CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-------EEMMREAQIMHQLDNPYI 71

Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           ++ +  C+   +  ++ E    G L  +L   + + +P+  +  +   ++ GM+Y+  + 
Sbjct: 72  VRLIGVCQAEALM-LVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN 129

Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIKHKSY 360
            +HRDL   NVL+    + KI+DFG++     ++ Y  A S      +W APE I  + +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189

Query: 361 GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC 419
             + DV+S+G+ +WE ++ G  PY++M   +   A + +  R   P +CPP + AL+  C
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPPELYALMSDC 248

Query: 420 WSLQPDKRPEFWHIVKVLEQFETSLACN 447
           W  + + RP+F  + + +     SLA  
Sbjct: 249 WIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 2e-64
 Identities = 62/249 (24%), Positives = 108/249 (43%), Gaps = 12/249 (4%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G    +Y    K     +A+K++     ++       +E Q  REV + S L +PN+++
Sbjct: 16  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-----VEHQLRREVEIQSHLRHPNILR 70

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                       +I EY   G++   L K         +      ++A  + Y HS+ VI
Sbjct: 71  LYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVI 128

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           HRD+KPEN+L+     LKIADFG +         +   GT  ++ PEMI+ + +  KVD+
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 187

Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
           +S G++ +E + G  P+E     +    +    +    P         LI +     P +
Sbjct: 188 WSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQ 245

Query: 427 RPEFWHIVK 435
           RP    +++
Sbjct: 246 RPMLREVLE 254

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (527), Expect = 4e-64
 Identities = 68/273 (24%), Positives = 132/273 (48%), Gaps = 13/273 (4%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQF 229
           D+  ++ + + +  +   G +  +Y G++K     VAVK ++               ++F
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEF 60

Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
            +E A++  + +PN+++ +  C + P + +ITE+++ G+L  YL +   + +    L+ +
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120

Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC--EEVYCDALSDDPGTY 347
           A  I+  MEY+  +  IHRDL   N L+ +   +K+ADFG++         A +      
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD 407
           +W APE + +  +  K DV++FG++LWE+    +       +   + ++ K+ R   P  
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240

Query: 408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           CP  +  L+  CW   P  RP F  I +  E  
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 5e-64
 Identities = 78/278 (28%), Positives = 132/278 (47%), Gaps = 13/278 (4%)

Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQ 228
           A D   +    L L ++   G    ++ G +     VA+K ++               + 
Sbjct: 8   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---------EA 58

Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
           F +E  ++ +L +  +++  A   + P+Y V TEY+S+GSL  +L     K L LP+L+ 
Sbjct: 59  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV-TEYMSKGSLLDFLKGETGKYLRLPQLVD 117

Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
           +A  IA GM Y+     +HRDL+  N+L+ +    K+ADFG+A   E+    A       
Sbjct: 118 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177

Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG 406
            +W APE   +  +  K DV+SFG++L E+             +     V +  R   P 
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 237

Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
           +CP ++  L+ QCW  +P++RP F ++   LE + TS 
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 1e-63
 Identities = 71/261 (27%), Positives = 122/261 (46%), Gaps = 19/261 (7%)

Query: 189 HGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
            G    +  G Y+     + VAVKI++   +D        L+ +   E  ++ +L NP +
Sbjct: 17  SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA------LKDELLAEANVMQQLDNPYI 70

Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           ++ +  C+      V  E    G L  YL +  ++ +    +I +   ++ GM+Y+    
Sbjct: 71  VRMIGICEAESWMLV-MEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN 127

Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIKHKSY 360
            +HRDL   NVL+  + + KI+DFG++     +E Y  A +      +W APE I +  +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 361 GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQC 419
             K DV+SFG+++WE  + G  PY  M   +   A++ K  R   P  CP  M  L+  C
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLC 246

Query: 420 WSLQPDKRPEFWHIVKVLEQF 440
           W+   + RP F  +   L  +
Sbjct: 247 WTYDVENRPGFAAVELRLRNY 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 6e-63
 Identities = 64/267 (23%), Positives = 117/267 (43%), Gaps = 13/267 (4%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
           +D S+L        G    ++ G + + + VA+K IR           A  E+ F  E  
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---------EGAMSEEDFIEEAE 52

Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
           ++ +L +P +++    C +    C++ E++  G L  YL   +        L+ + LD+ 
Sbjct: 53  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVC 111

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD--PGTYRWMAP 352
            GM Y+    VIHRDL   N L+ +   +K++DFG+    +     S        +W +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM 412
           E+     Y  K DV+SFG+++WE+ +      E          ++   R   P      +
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231

Query: 413 AALIEQCWSLQPDKRPEFWHIVKVLEQ 439
             ++  CW  +P+ RP F  +++ L +
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLAE 258

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  204 bits (520), Expect = 1e-62
 Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 15/252 (5%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
           HG+   +Y        E VA+K +       NE       +   +EV  L +L +PN I+
Sbjct: 25  HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-----QDIIKEVRFLQKLRHPNTIQ 79

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           +     +     ++ EY    +    L ++  K L   ++ A+     +G+ Y+HS  +I
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI---KHKSYGRK 363
           HRD+K  N+L+ +   +K+ DFG A         +   GT  WMAPE+I       Y  K
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQ 423
           VDV+S G+   E+     P   MN + A + +          G         ++ C    
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 254

Query: 424 PDKRPEFWHIVK 435
           P  RP    ++K
Sbjct: 255 PQDRPTSEVLLK 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 6e-62
 Identities = 61/256 (23%), Positives = 113/256 (44%), Gaps = 18/256 (7%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA  ++Y    K+     A K+I    ++E E         +  E+ +L+   +PN++K
Sbjct: 22  DGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--------DYMVEIDILASCDHPNIVK 73

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
            + A        ++ E+ + G++ A + +L  + L   ++  +       + Y+H   +I
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKII 132

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEV-YCDALSDDPGTYRWMAPEMI-----KHKSY 360
           HRDLK  N+L   +  +K+ADFG++ +            GT  WMAPE++     K + Y
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 192

Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-LRPAIPGDCPPAMAALIEQC 419
             K DV+S G+ L EM     P+ E+NP++    +        A P          +++C
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 252

Query: 420 WSLQPDKRPEFWHIVK 435
                D R     +++
Sbjct: 253 LEKNVDARWTTSQLLQ 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 9e-62
 Identities = 63/268 (23%), Positives = 124/268 (46%), Gaps = 15/268 (5%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
           +D   L        G    + +G ++    VA+K+I+           +  E +F  E  
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---------EGSMSEDEFIEEAK 51

Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
           ++  L +  +++    C K     +ITEY++ G L  YL +         +L+ +  D+ 
Sbjct: 52  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVC 110

Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD--PGTYRWMAP 352
             MEY+ S+  +HRDL   N L++ +  +K++DFG++   +  +  S        RW  P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA 411
           E++ +  +  K D+++FG+++WE+ + G +PYE     + A  +  + LR   P      
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEK 229

Query: 412 MAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
           +  ++  CW  + D+RP F  ++  +  
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNILD 257

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 1e-61
 Identities = 60/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G++ R      K   + +  K +      E E      ++    EV LL  L +PN+++
Sbjct: 14  TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE------KQMLVSEVNLLRELKHPNIVR 67

Query: 247 FVAAC--KKPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHS 302
           +      +      ++ EY   G L + + K   E + L    ++ +   +   ++  H 
Sbjct: 68  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127

Query: 303 QG-----VIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIK 356
           +      V+HRDLKP NV +D + ++K+ DFG+A              GT  +M+PE + 
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187

Query: 357 HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
             SY  K D++S G +L+E+ A   P+   +  + A  +     R  IP      +  +I
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-IPYRYSDELNEII 246

Query: 417 EQCWSLQPDKRPEFWHIVK 435
            +  +L+   RP    I++
Sbjct: 247 TRMLNLKDYHRPSVEEILE 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-61
 Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 40/296 (13%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQ 228
                L  G     GA  ++ +              VAVK+++   D           + 
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-------EA 86

Query: 229 FNREVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-------- 279
              E+ ++++L +  N++  + AC       +I EY   G L  YL     K        
Sbjct: 87  LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 146

Query: 280 -------------TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326
                         L    L+  A  +A+GME++  +  +HRDL   NVL+     +KI 
Sbjct: 147 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 206

Query: 327 DFGIACEEVYCDALSDD---PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP 382
           DFG+A + +               +WMAPE +    Y  K DV+S+G++LWE+ + G  P
Sbjct: 207 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266

Query: 383 YEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE 438
           Y  +      + ++    +   P      +  +++ CW+    KRP F ++   L 
Sbjct: 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 3e-61
 Identities = 74/263 (28%), Positives = 114/263 (43%), Gaps = 17/263 (6%)

Query: 189 HGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
            G+   +  G +         VAVK ++     + E +       F REV  +  L + N
Sbjct: 18  DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-----DDFIREVNAMHSLDHRN 72

Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
           +I+       PP+  V TE    GSL   L K       L  L   A+ +A GM Y+ S+
Sbjct: 73  LIRLYGVVLTPPMKMV-TELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK 130

Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKS 359
             IHRDL   N+L+     +KI DFG+       D            + W APE +K ++
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190

Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
           +    D + FG+ LWEM   G  P+  +N  Q    +  +  R   P DCP  +  ++ Q
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 250

Query: 419 CWSLQPDKRPEFWHIVKVLEQFE 441
           CW+ +P+ RP F  +   L + +
Sbjct: 251 CWAHKPEDRPTFVALRDFLLEAQ 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (507), Expect = 7e-61
 Identities = 70/277 (25%), Positives = 130/277 (46%), Gaps = 21/277 (7%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFN 230
           +D+S + +      G    +  G  K        VA+K ++    ++         + F 
Sbjct: 23  IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-------RDFL 75

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
            E +++ +  +PNVI       K     +ITE++  GSL ++L +       + +L+ + 
Sbjct: 76  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGML 134

Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC------EEVYCDALSDDP 344
             IA GM+Y+     +HRDL   N+L++     K++DFG++        +    +     
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA 403
              RW APE I+++ +    DV+S+G+++WE+++ G  PY +M       A+  ++ R  
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLP 253

Query: 404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            P DCP A+  L+  CW    + RP+F  IV  L++ 
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 4e-60
 Identities = 60/244 (24%), Positives = 116/244 (47%), Gaps = 15/244 (6%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA   +Y  +     + VA++ + +    +        ++    E+ ++    NPN++ 
Sbjct: 30  QGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVN 81

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           ++ +        V+ EYL+ GSL   + +     +   ++ A+  +  + +E++HS  VI
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVD 365
           HRD+K +N+L+  +  +K+ DFG   +     +      GT  WMAPE++  K+YG KVD
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVV-NKNLRPAIPGDCPPAMAALIEQCWSLQP 424
           ++S G++  EM+ G  PY   NP++A + +  N       P          + +C  +  
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258

Query: 425 DKRP 428
           +KR 
Sbjct: 259 EKRG 262

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 7e-60
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 20/257 (7%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+   +Y G+  +    VA   ++     ++E       ++F  E  +L  L +PN+++
Sbjct: 19  RGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE------RQRFKEEAEMLKGLQHPNIVR 72

Query: 247 FVAAC----KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           F  +     K      ++TE ++ G+L+ YL +   K + +  L +    I +G++++H+
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 303 QG--VIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKS 359
           +   +IHRDLK +N+ I      +KI D G+A             GT  +MAPEM + K 
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFMAPEMYEEK- 188

Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA-IPGDCPPAMAALIEQ 418
           Y   VDVY+FG+ + EM     PY E       +  V   ++PA       P +  +IE 
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248

Query: 419 CWSLQPDKRPEFWHIVK 435
           C     D+R     ++ 
Sbjct: 249 CIRQNKDERYSIKDLLN 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (499), Expect = 9e-60
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 41/284 (14%)

Query: 189 HGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN 241
            GA  R++               VAVK+++     +       ++  F RE AL++   N
Sbjct: 23  EGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-------MQADFQREAALMAEFDN 75

Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT--------------------- 280
           PN++K +  C      C++ EY++ G L  +L  +   T                     
Sbjct: 76  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135

Query: 281 -LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVY 336
            L   + + IA  +A GM Y+  +  +HRDL   N L+ +   +KIADFG++       Y
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195

Query: 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI-PYEEMNPIQAAFAV 395
             A  +D    RWM PE I +  Y  + DV+++G++LWE+ +  + PY  M   +  + V
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 255

Query: 396 VNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
            + N   A P +CP  +  L+  CWS  P  RP F  I ++L++
Sbjct: 256 RDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 7e-59
 Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 24/283 (8%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREV 233
           +D + +        G   ++     K     +   I R+ +    +       + F  E+
Sbjct: 7   LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGEL 61

Query: 234 ALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH-------------- 278
            +L +L H+PN+I  + AC+      +  EY   G+L  +L K                 
Sbjct: 62  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121

Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
            TL   +L+  A D+ARGM+Y+  +  IHRDL   N+L+ + +  KIADFG++  +    
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181

Query: 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
             +      RWMA E + +  Y    DV+S+G++LWE+V+ G  PY  M      +  + 
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLP 240

Query: 398 KNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           +  R   P +C   +  L+ QCW  +P +RP F  I+  L + 
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 1e-58
 Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 18/262 (6%)

Query: 189 HGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
            G    +Y G+ K        PVA+K ++    ++           F  E  ++ +  + 
Sbjct: 17  AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-------VDFLGEAGIMGQFSHH 69

Query: 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           N+I+      K     +ITEY+  G+L  +L + +     + +L+ +   IA GM+Y+ +
Sbjct: 70  NIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLAN 128

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIKHK 358
              +HRDL   N+L++     K++DFG++     +       S      RW APE I ++
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
            +    DV+SFG+++WE++                  +N   R   P DCP A+  L+ Q
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQ 248

Query: 419 CWSLQPDKRPEFWHIVKVLEQF 440
           CW  +  +RP+F  IV +L++ 
Sbjct: 249 CWQQERARRPKFADIVSILDKL 270

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  192 bits (488), Expect = 2e-58
 Identities = 65/252 (25%), Positives = 124/252 (49%), Gaps = 14/252 (5%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRLHN-PNV 244
            G  S +   I+K   +  AVKII +      +      L +   +EV +L ++   PN+
Sbjct: 13  RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72

Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           I+     +    + ++ + + +G L  YL +    TL   +   I   +   +  +H   
Sbjct: 73  IQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN 130

Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI------KHK 358
           ++HRDLKPEN+L+D + ++K+ DFG +C+    + L +  GT  ++APE+I       H 
Sbjct: 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 190

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPAMAALI 416
            YG++VD++S G+I++ ++AG+ P+     +     +++ N +   P   D    +  L+
Sbjct: 191 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 250

Query: 417 EQCWSLQPDKRP 428
            +   +QP KR 
Sbjct: 251 SRFLVVQPQKRY 262

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 7e-58
 Identities = 69/262 (26%), Positives = 122/262 (46%), Gaps = 20/262 (7%)

Query: 189 HGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
            GA   +Y G++  E      PVA+K +R     +         K+   E  +++ + NP
Sbjct: 19  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-------KEILDEAYVMASVDNP 71

Query: 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           +V + +  C    V   IT+ +  G L  Y+ +     +    L+   + IA+GM Y+  
Sbjct: 72  HVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIAC---EEVYCDALSDDPGTYRWMAPEMIKHKS 359
           + ++HRDL   NVL+    H+KI DFG+A     E             +WMA E I H+ 
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189

Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQ 418
           Y  + DV+S+G+ +WE++  G+ PY+ +       +++ K  R   P  C   +  ++ +
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLPQPPICTIDVYMIMVK 248

Query: 419 CWSLQPDKRPEFWHIVKVLEQF 440
           CW +  D RP+F  ++    + 
Sbjct: 249 CWMIDADSRPKFRELIIEFSKM 270

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-57
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 16/254 (6%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA+  +   + +  +E VAVKI+ +    +         +   +E+ +   L++ NV+K
Sbjct: 15  EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-------ENIKKEICINKMLNHENVVK 67

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
           F    ++  +  +  EY S G L   +       +P P        +  G+ Y+H  G+ 
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY-GR 362
           HRD+KPEN+L+D+  +LKI+DFG+A    Y +    L+   GT  ++APE++K + +   
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185

Query: 363 KVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA-VVNKNLRPAIPGDCPPAMAALIEQCWS 421
            VDV+S G++L  M+AG +P+++ +     ++    K            A  AL+ +   
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245

Query: 422 LQPDKRPEFWHIVK 435
             P  R     I K
Sbjct: 246 ENPSARITIPDIKK 259

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-57
 Identities = 63/272 (23%), Positives = 120/272 (44%), Gaps = 16/272 (5%)

Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFN 230
           +   ++ LG     G    ++ GIY         VA+K  +    D        + ++F 
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-------VREKFL 56

Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
           +E   + +  +P+++K +    + PV+ +  E  + G LR++L      +L L  LI  A
Sbjct: 57  QEALTMRQFDHPHIVKLIGVITENPVWII-MELCTLGELRSFLQV-RKYSLDLASLILYA 114

Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--GTYR 348
             ++  + Y+ S+  +HRD+   NVL+     +K+ DFG++                  +
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174

Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDC 408
           WMAPE I  + +    DV+ FG+ +WE++   +   +          +    R  +P +C
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234

Query: 409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
           PP + +L+ +CW+  P +RP F  +   L   
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  192 bits (488), Expect = 2e-57
 Identities = 48/246 (19%), Positives = 101/246 (41%), Gaps = 15/246 (6%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA   ++    +      A K +  P + +        ++   +E+  +S L +P ++ 
Sbjct: 36  TGAFGVVHRVTERATGNNFAAKFVMTPHESD--------KETVRKEIQTMSVLRHPTLVN 87

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
              A +      +I E++S G L   +   EH  +   + +     + +G+ ++H    +
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146

Query: 307 HRDLKPENVLIDQEF--HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKV 364
           H DLKPEN++   +    LK+ DFG+        ++    GT  + APE+ + K  G   
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206

Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPPAMAALIEQCWSL 422
           D++S G++ + +++G  P+   N  +    V + +     +            I +    
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA 266

Query: 423 QPDKRP 428
            P+ R 
Sbjct: 267 DPNTRM 272

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 6e-57
 Identities = 78/296 (26%), Positives = 128/296 (43%), Gaps = 35/296 (11%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAAR 224
            +     ++L  G     GA  ++                VAVK+++ P     E     
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTE----- 69

Query: 225 LEKQFNREVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-------- 275
             +    E+ +LS L N  N++  + AC       VITEY   G L  +L +        
Sbjct: 70  -REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128

Query: 276 --------LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327
                    +   L L  L++ +  +A+GM ++ S+  IHRDL   N+L+      KI D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188

Query: 328 FGIAC---EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
           FG+A     +       +     +WMAPE I +  Y  + DV+S+G+ LWE+ + G+ PY
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248

Query: 384 EEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
             M      + ++ +  R   P   P  M  +++ CW   P KRP F  IV+++E+
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-56
 Identities = 54/245 (22%), Positives = 103/245 (42%), Gaps = 15/245 (6%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G    ++   +K     +A K+I +            +  Q  RE+ +L   ++P ++ 
Sbjct: 16  AGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-------IRNQIIRELQVLHECNSPYIVG 68

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GV 305
           F  A        +  E++  GSL   L K     +P   L  +++ + +G+ Y+  +  +
Sbjct: 69  FYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKI 126

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVD 365
           +HRD+KP N+L++    +K+ DFG++ + +     +   GT  +M+PE ++   Y  + D
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYSVQSD 185

Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPD 425
           ++S GL L EM  G  P    +  +       +        + PP          S   D
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE--GDAAETPPRPRTPGRPLSSYGMD 243

Query: 426 KRPEF 430
            RP  
Sbjct: 244 SRPPM 248

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 2e-56
 Identities = 72/294 (24%), Positives = 120/294 (40%), Gaps = 55/294 (18%)

Query: 189 HGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248
            G    ++ G ++ E VAVKI    ++                E+     L + N++ F+
Sbjct: 13  KGRFGEVWRGKWRGEEVAVKIFSSREERS---------WFREAEIYQTVMLRHENILGFI 63

Query: 249 AACKKP----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ- 303
           AA  K         ++++Y   GSL  YL++    T+ +  +I +AL  A G+ ++H + 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 304 -------GVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMA 351
                   + HRDLK +N+L+ +     IAD G+A       +    A +   GT R+MA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 352 PEMI------KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF------------ 393
           PE++      KH    ++ D+Y+ GL+ WE+             Q  +            
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 394 ---AVVNKNLRPAIPG-----DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
               V  + LRP IP      +    MA ++ +CW      R     I K L Q
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 5e-56
 Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 21/268 (7%)

Query: 189 HGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
            G    +YHG   D        AVK +    D            QF  E  ++    +PN
Sbjct: 37  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-------SQFLTEGIIMKDFSHPN 89

Query: 244 VIKFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
           V+  +  C +      V+  Y+  G LR ++   E     +  LI   L +A+GM+++ S
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLAS 148

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-----PGTYRWMAPEMIKH 357
           +  +HRDL   N ++D++F +K+ADFG+A +    +  S           +WMA E ++ 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 358 KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALI 416
           + +  K DV+SFG++LWE++  G  PY ++N       ++ +  R   P  CP  +  ++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVM 267

Query: 417 EQCWSLQPDKRPEFWHIVKVLEQFETSL 444
            +CW  + + RP F  +V  +    ++ 
Sbjct: 268 LKCWHPKAEMRPSFSELVSRISAIFSTF 295

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  187 bits (476), Expect = 1e-55
 Identities = 49/246 (19%), Positives = 105/246 (42%), Gaps = 15/246 (6%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA   ++  + K        K I  P   +        +     E++++++LH+P +I 
Sbjct: 39  SGAFGVVHRCVEKATGRVFVAKFINTPYPLD--------KYTVKNEISIMNQLHHPKLIN 90

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
              A +      +I E+LS G L   +   E   +   ++I        G++++H   ++
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIV 149

Query: 307 HRDLKPENVLID--QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKV 364
           H D+KPEN++ +  +   +KI DFG+A +    + +     T  + APE++  +  G   
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPPAMAALIEQCWSL 422
           D+++ G++ + +++G  P+   + ++    V   +            P     I+     
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK 269

Query: 423 QPDKRP 428
           +P KR 
Sbjct: 270 EPRKRL 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-54
 Identities = 35/246 (14%), Positives = 95/246 (38%), Gaps = 16/246 (6%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G    ++  +     +    K +++   D+             +E+++L+   + N++ 
Sbjct: 15  RGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---------VLVKKEISILNIARHRNILH 65

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
              + +      +I E++S   +   ++      L   ++++    +   ++++HS  + 
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 307 HRDLKPENVLIDQ--EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKV 364
           H D++PEN++        +KI +FG A +    D          + APE+ +H       
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPPAMAALIEQCWSL 422
           D++S G +++ +++G  P+      Q    ++N           +        +++    
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244

Query: 423 QPDKRP 428
           +   R 
Sbjct: 245 ERKSRM 250

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-54
 Identities = 77/295 (26%), Positives = 132/295 (44%), Gaps = 34/295 (11%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLA 222
               +   +L LG     GA  ++                  VAVK+++    +++    
Sbjct: 6   PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--- 62

Query: 223 ARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLH------- 274
                    E+ ++  +  + N+I  + AC +     VI EY S+G+LR YL        
Sbjct: 63  ----SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 275 -------KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327
                      + L    L++ A  +ARGMEY+ S+  IHRDL   NVL+ ++  +KIAD
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178

Query: 328 FGIAC---EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
           FG+A       Y    ++     +WMAPE +  + Y  + DV+SFG++LWE+        
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

Query: 385 EMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
              P++  F ++ +  R   P +C   +  ++  CW   P +RP F  +V+ L++
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 3e-54
 Identities = 59/243 (24%), Positives = 119/243 (48%), Gaps = 11/243 (4%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+  +++   +K   +  A+K ++      ++     +E     +  L     +P +  
Sbjct: 12  KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD----DVECTMVEKRVLSLAWEHPFLTH 67

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                +       + EYL+ G L  ++         L +    A +I  G++++HS+G++
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIV 125

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVD 365
           +RDLK +N+L+D++ H+KIADFG+  E +  DA ++   GT  ++APE++  + Y   VD
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVD 185

Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPD 425
            +SFG++L+EM+ G  P+   +  +   ++   N  P  P         L+ + +  +P+
Sbjct: 186 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPE 243

Query: 426 KRP 428
           KR 
Sbjct: 244 KRL 246

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (462), Expect = 4e-54
 Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 16/247 (6%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA S +     K   + VA+K I     +  E            E+A+L ++ +PN++ 
Sbjct: 19  TGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-------GSMENEIAVLHKIKHPNIVA 71

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                +      +I + +S G L   + +             +   +   ++Y+H  G++
Sbjct: 72  LDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
           HRDLKPEN+L    D++  + I+DFG++  E     LS   GT  ++APE++  K Y + 
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIP--GDCPPAMAALIEQCWS 421
           VD +S G+I + ++ G  P+ + N  +    ++        P   D   +    I     
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249

Query: 422 LQPDKRP 428
             P+KR 
Sbjct: 250 KDPEKRF 256

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 5e-54
 Identities = 73/287 (25%), Positives = 127/287 (44%), Gaps = 27/287 (9%)

Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAAR 224
           DE  V   ++ +      G+   +Y G+ K       +  VA+K +              
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER----- 67

Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK----- 279
              +F  E +++   +  +V++ +    +     VI E ++ G L++YL  L        
Sbjct: 68  --IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125

Query: 280 ---TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC---E 333
                 L K+I +A +IA GM Y+++   +HRDL   N ++ ++F +KI DFG+     E
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185

Query: 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT-IPYEEMNPIQAA 392
             Y           RWM+PE +K   +    DV+SFG++LWE+      PY+ ++  Q  
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245

Query: 393 FAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
             V+   L    P +CP  +  L+  CW   P  RP F  I+  +++
Sbjct: 246 RFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 4e-53
 Identities = 61/245 (24%), Positives = 106/245 (43%), Gaps = 14/245 (5%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+ S +            A+KI+      +   +         RE  ++SRL +P  +K
Sbjct: 18  EGSFSTVVLARELATSREYAIKILEKRHIIKENKV-----PYVTRERDVMSRLDHPFFVK 72

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                +          Y   G L  Y+ K    +           +I   +EY+H +G+I
Sbjct: 73  LYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGII 130

Query: 307 HRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
           HRDLKPEN+L++++ H++I DFG A     E      +   GT ++++PE++  KS  + 
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 190

Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQ 423
            D+++ G I++++VAG  P+   N       ++   L    P    P    L+E+   L 
Sbjct: 191 SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLD 248

Query: 424 PDKRP 428
             KR 
Sbjct: 249 ATKRL 253

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  177 bits (450), Expect = 8e-53
 Identities = 58/252 (23%), Positives = 110/252 (43%), Gaps = 19/252 (7%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G  S ++          VAVK++R     +          +F RE    + L++P ++ 
Sbjct: 17  FGGMSEVHLARDLRLHRDVAVKVLRADLARDPS-----FYLRFRREAQNAAALNHPAIVA 71

Query: 247 FVAAC----KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
                       P+  ++ EY+   +LR  +H      +   + I +  D  + + + H 
Sbjct: 72  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQ 129

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIKHK 358
            G+IHRD+KP N++I     +K+ DFGIA             +   GT ++++PE  +  
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPPAMAALI 416
           S   + DVYS G +L+E++ G  P+   +P+  A+  V ++  P  A        + A++
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVV 249

Query: 417 EQCWSLQPDKRP 428
            +  +  P+ R 
Sbjct: 250 LKALAKNPENRY 261

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 6e-52
 Identities = 78/296 (26%), Positives = 123/296 (41%), Gaps = 32/296 (10%)

Query: 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAA 223
           A +      +L LG     GA  ++                VAVK+++            
Sbjct: 5   ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---- 60

Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPP-VYCVITEYLSEGSLRAYLHK------- 275
                 +    L+   H+ NV+  + AC KP     VI E+   G+L  YL         
Sbjct: 61  --RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118

Query: 276 -------LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328
                  L    L L  LI  +  +A+GME++ S+  IHRDL   N+L+ ++  +KI DF
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 178

Query: 329 GIAC---EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI-PYE 384
           G+A    ++       D     +WMAPE I  + Y  + DV+SFG++LWE+ +    PY 
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238

Query: 385 EMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
            +   +     + +  R   P    P M   +  CW  +P +RP F  +V+ L   
Sbjct: 239 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 3e-51
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 12/248 (4%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G  + +     K      A K I+      +    +R  +   REV++L  + +PNVI 
Sbjct: 20  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR--EDIEREVSILKEIQHPNVIT 77

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                +      +I E ++ G L  +L +   ++L   +       I  G+ Y+HS  + 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIA 135

Query: 307 HRDLKPENVLIDQE----FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGR 362
           H DLKPEN+++         +KI DFG+A +  + +   +  GT  ++APE++ ++  G 
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL 195

Query: 363 KVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN--LRPAIPGDCPPAMAALIEQCW 420
           + D++S G+I + +++G  P+      +    V   N         +        I +  
Sbjct: 196 EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLL 255

Query: 421 SLQPDKRP 428
              P KR 
Sbjct: 256 VKDPKKRM 263

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 5e-50
 Identities = 52/256 (20%), Positives = 104/256 (40%), Gaps = 29/256 (11%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245
            G + ++     K   E  A+K+++                +  REV L  R    P+++
Sbjct: 22  LGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQCPHIV 68

Query: 246 KFVAACK----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
           + V   +          ++ E L  G L + +     +     +   I   I   ++Y+H
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 302 SQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
           S  + HRD+KPEN+L         LK+ DFG A E    ++L+    T  ++APE++  +
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAI------PGDCPPAM 412
            Y +  D++S G+I++ ++ G  P+   + +  +  +  +              +    +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248

Query: 413 AALIEQCWSLQPDKRP 428
             LI      +P +R 
Sbjct: 249 KMLIRNLLKTEPTQRM 264

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  172 bits (437), Expect = 7e-50
 Identities = 54/244 (22%), Positives = 109/244 (44%), Gaps = 9/244 (3%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G    +Y     D  +  A+K +        +     L       ++L+S    P ++ 
Sbjct: 14  RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVC 71

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
              A   P     I + ++ G L  +L +  H       +   A +I  G+E++H++ V+
Sbjct: 72  MSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVV 129

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVD 365
           +RDLKP N+L+D+  H++I+D G+AC +          GT+ +MAPE+++   +Y    D
Sbjct: 130 YRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSAD 188

Query: 366 VYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQP 424
            +S G +L++++ G  P+ +     +     +   +   +P    P + +L+E       
Sbjct: 189 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 248

Query: 425 DKRP 428
           ++R 
Sbjct: 249 NRRL 252

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  169 bits (430), Expect = 1e-49
 Identities = 39/273 (14%), Positives = 92/273 (33%), Gaps = 34/273 (12%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245
            G+   ++ G     ++ VA+K      D            Q   E      L     + 
Sbjct: 15  EGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----------QLRDEYRTYKLLAGCTGIP 64

Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
                 ++     ++ + L  G     L  L  +   +  +   A  +   ++ IH + +
Sbjct: 65  NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122

Query: 306 IHRDLKPENVLIDQEFH-----LKIADFGIAC--------EEVYCDALSDDPGTYRWMAP 352
           ++RD+KP+N LI +        + + DFG+          + +      +  GT R+M+ 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN------KNLRPAIPG 406
                +   R+ D+ + G +    + G++P++ +                       +  
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242

Query: 407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQ 439
             P      +    +L  D  P++ ++  +  +
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  170 bits (432), Expect = 1e-49
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 13/242 (5%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+  R++    +      A+K+++     +   +  +  +  N E  +LS + +P +I+
Sbjct: 14  TGSFGRVHLIRSRHNGRYYAMKVLK-----KEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                +      +I +Y+  G L + L K +    P+ K  A   ++   +EY+HS+ +I
Sbjct: 69  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA--EVCLALEYLHSKDII 126

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           +RDLKPEN+L+D+  H+KI DFG A      D      GT  ++APE++  K Y + +D 
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVSTKPYNKSIDW 184

Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
           +SFG++++EM+AG  P+ + N ++    ++N  LR   P      +  L+ +  +    +
Sbjct: 185 WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQ 242

Query: 427 RP 428
           R 
Sbjct: 243 RL 244

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  169 bits (429), Expect = 1e-49
 Identities = 54/271 (19%), Positives = 102/271 (37%), Gaps = 30/271 (11%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+   +Y G      E VA+K+  +               Q + E  +   +     I 
Sbjct: 17  SGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----------QLHIESKIYKMMQGGVGIP 66

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
            +  C     Y V+   L   SL   L     +   L  ++ +A  +   +EYIHS+  I
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125

Query: 307 HRDLKPENVLI---DQEFHLKIADFGIAC--------EEVYCDALSDDPGTYRWMAPEMI 355
           HRD+KP+N L+    +   + I DFG+A         + +      +  GT R+ +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR------PAIPGDCP 409
                 R+ D+ S G +L     G++P++ +            + +        +    P
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245

Query: 410 PAMAALIEQCWSLQPDKRPEFWHIVKVLEQF 440
              A  +  C SL+ D +P++ ++ ++    
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 3e-48
 Identities = 57/243 (23%), Positives = 110/243 (45%), Gaps = 12/243 (4%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G   ++     K      A+KI+R       + +          E  +L    +P +  
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-----AHTVTESRVLQNTRHPFLTA 69

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
              A +     C + EY + G L  +L +   +     +      +I   +EY+HS+ V+
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVV 127

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVD 365
           +RD+K EN+++D++ H+KI DFG+  E +   A      GT  ++APE+++   YGR VD
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 187

Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPD 425
            +  G++++EM+ G +P+   +  +    ++ + +R   P    P   +L+       P 
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPK 245

Query: 426 KRP 428
           +R 
Sbjct: 246 QRL 248

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 8e-47
 Identities = 66/253 (26%), Positives = 103/253 (40%), Gaps = 18/253 (7%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNV 244
            G    +Y GI      PVA+K +      +   L      +   EV LL ++ +    V
Sbjct: 14  SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG--TRVPMEVVLLKKVSSGFSGV 71

Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
           I+ +   ++P  + +I E              E   L      +    +   + + H+ G
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCG 130

Query: 305 VIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GR 362
           V+HRD+K EN+LID     LK+ DFG     +     +D  GT  +  PE I++  Y GR
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 189

Query: 363 KVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSL 422
              V+S G++L++MV G IP+E    I           +             LI  C +L
Sbjct: 190 SAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHLIRWCLAL 241

Query: 423 QPDKRPEFWHIVK 435
           +P  RP F  I  
Sbjct: 242 RPSDRPTFEEIQN 254

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  158 bits (399), Expect = 1e-44
 Identities = 63/242 (26%), Positives = 112/242 (46%), Gaps = 13/242 (5%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G+  R+    +K+     A+KI+      + + +     +    E  +L  ++ P ++K
Sbjct: 51  TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-----EHTLNEKRILQAVNFPFLVK 105

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
              + K      ++ EY++ G + ++L +        P     A  I    EY+HS  +I
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLDLI 163

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
           +RDLKPEN+LIDQ+ ++++ DFG A             GT   +APE+I  K Y + VD 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDW 221

Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDK 426
           ++ G++++EM AG  P+    PIQ    +V+  +R   P      +  L+     +   K
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSHFSSDLKDLLRNLLQVDLTK 279

Query: 427 RP 428
           R 
Sbjct: 280 RF 281

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 2e-44
 Identities = 63/275 (22%), Positives = 109/275 (39%), Gaps = 41/275 (14%)

Query: 189 HGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNP 242
            GA+ +++           VA+K +R+   +E             REVA+L  L    +P
Sbjct: 17  EGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHP 70

Query: 243 NVIKFVAACKKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
           NV++    C            +     +  L  YL K+    +P   +  +   + RG++
Sbjct: 71  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
           ++HS  V+HRDLKP+N+L+     +K+ADFG+A    +  AL+    T  + APE++   
Sbjct: 131 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 190

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--------------- 403
           SY   VD++S G I  EM      +   + +     +++    P                
Sbjct: 191 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 250

Query: 404 ----------IPGDCPPAMAALIEQCWSLQPDKRP 428
                        D       L+ +C +  P KR 
Sbjct: 251 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 4e-43
 Identities = 51/252 (20%), Positives = 113/252 (44%), Gaps = 18/252 (7%)

Query: 189 HGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNP 242
            GA+ +++           +  A+K+++     +      +  +    E  +L  +  +P
Sbjct: 34  TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSP 89

Query: 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
            ++    A +      +I +Y++ G L  +L +   +     ++     +I   +E++H 
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHK 147

Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACE--EVYCDALSDDPGTYRWMAPEMI--KHK 358
            G+I+RD+K EN+L+D   H+ + DFG++ E      +   D  GT  +MAP+++     
Sbjct: 148 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 207

Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--PAIPGDCPPAMAALI 416
            + + VD +S G++++E++ G  P+       +   +  + L+  P  P +       LI
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 267

Query: 417 EQCWSLQPDKRP 428
           ++     P KR 
Sbjct: 268 QRLLMKDPKKRL 279

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-41
 Identities = 59/270 (21%), Positives = 105/270 (38%), Gaps = 35/270 (12%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G  + +Y    K+  + VA+K I++    E +     + +   RE+ LL  L +PN+I 
Sbjct: 8   EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK---DGINRTALREIKLLQELSHPNIIG 64

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
            + A        ++ +++                L    + A  L   +G+EY+H   ++
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIK-HKSYGRKV 364
           HRDLKP N+L+D+   LK+ADFG+A        A +    T  + APE++   + YG  V
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182

Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--------------------- 403
           D+++ G IL E++         + +     +      P                      
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242

Query: 404 -----IPGDCPPAMAALIEQCWSLQPDKRP 428
                I       +  LI+  +   P  R 
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 6e-40
 Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 38/271 (14%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G +  +Y    K   E VA+K IR+  + E       +     RE++LL  L++PN++K
Sbjct: 12  EGTYGVVYKARNKLTGEVVALKKIRLDTETEG------VPSTAIREISLLKELNHPNIVK 65

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
            +          ++ E+L +   + ++       +PLP + +    + +G+ + HS  V+
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKK-FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSY-GRKV 364
           HRDLKP+N+LI+ E  +K+ADFG+A    V     + +  T  + APE++    Y    V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184

Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP---------------------- 402
           D++S G I  EMV     +   + I   F +      P                      
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244

Query: 403 -----AIPGDCPPAMAALIEQCWSLQPDKRP 428
                 +         +L+ Q     P+KR 
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 8e-40
 Identities = 61/277 (22%), Positives = 112/277 (40%), Gaps = 44/277 (15%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA+  +           VA+K I   +            ++  RE+ +L R  + N+I 
Sbjct: 18  EGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-------QRTLREIKILLRFRHENIIG 70

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
                + P +  +   YL    + A L+K L+ + L    +      I RG++YIHS  V
Sbjct: 71  INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 130

Query: 306 IHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIKHK-SY 360
           +HRDLKP N+L++    LKI DFG+A     +  +   L++   T  + APE++ +   Y
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA----------------- 403
            + +D++S G IL EM++    +   + +     ++     P+                 
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250

Query: 404 ------------IPGDCPPAMAALIEQCWSLQPDKRP 428
                       +  +       L+++  +  P KR 
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  141 bits (355), Expect = 5e-39
 Identities = 58/270 (21%), Positives = 99/270 (36%), Gaps = 38/270 (14%)

Query: 189 HGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
            G +  +Y       E  A+K IR+  +DE       +     RE+++L  L + N++K 
Sbjct: 12  EGTYGVVYKAQNNYGETFALKKIRLEKEDEG------IPSTTIREISILKELKHSNIVKL 65

Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
                      ++ E+L +   +          L      +  L +  G+ Y H + V+H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123

Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI--KHKSYGRKVD 365
           RDLKP+N+LI++E  LKIADFG+A                 W     +    K Y   +D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183

Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP----------------------- 402
           ++S G I  EMV GT  +  ++       +      P                       
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243

Query: 403 ----AIPGDCPPAMAALIEQCWSLQPDKRP 428
               +       +   L+ +   L P++R 
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRI 273

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 7e-39
 Identities = 58/278 (20%), Positives = 105/278 (37%), Gaps = 50/278 (17%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
           +G+   +Y     D  E VA+K +             + ++  NRE+ ++ +L + N+++
Sbjct: 30  NGSFGVVYQAKLCDSGELVAIKKVL------------QDKRFKNRELQIMRKLDHCNIVR 77

Query: 247 FVAAC------KKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
                      K      ++ +Y+ E   R   H    K TLP+  +      + R + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 300 IHSQGVIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDPGTYRWMAP-EMIKH 357
           IHS G+ HRD+KP+N+L+D +   LK+ DFG A + V  +       +  + AP  +   
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197

Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN-------------------- 397
             Y   +DV+S G +L E++ G   +   + +     ++                     
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257

Query: 398 -------KNLRPAIPGDCPPAMAALIEQCWSLQPDKRP 428
                             PP   AL  +     P  R 
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 3e-36
 Identities = 49/286 (17%), Positives = 100/286 (34%), Gaps = 54/286 (18%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G    ++   ++   + VA+K + + ++ E             RE+ +L  L + NV+ 
Sbjct: 20  QGTFGEVFKARHRKTGQKVALKKVLMENEKEGF------PITALREIKILQLLKHENVVN 73

Query: 247 FVAACKKPPVY--------CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
            +  C+              ++ ++          + L      L ++  +   +  G+ 
Sbjct: 74  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNGLY 131

Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-----CEEVYCDALSDDPGTYRWMAPE 353
           YIH   ++HRD+K  NVLI ++  LK+ADFG+A      +    +  ++   T  +  PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 354 MI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP---------- 402
           ++   + YG  +D++  G I+ EM   +   +          +                 
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 403 --------------------AIPGDCPPAMAALIEQCWSLQPDKRP 428
                                      P    LI++   L P +R 
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 3e-36
 Identities = 52/272 (19%), Positives = 98/272 (36%), Gaps = 40/272 (14%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            G +  ++    ++  E VA+K +R+ DDDE       +     RE+ LL  L + N+++
Sbjct: 12  EGTYGTVFKAKNRETHEIVALKRVRLDDDDEG------VPSSALREICLLKELKHKNIVR 65

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
                       ++ E+  +           +  L    + +    + +G+ + HS+ V+
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP--EMIKHKSYGRKV 364
           HRDLKP+N+LI++   LK+A+FG+A                 W  P   +   K Y   +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP---------------------- 402
           D++S G I  E+     P    N +      + + L                        
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 403 ------AIPGDCPPAMAALIEQCWSLQPDKRP 428
                  +          L++      P +R 
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 5e-36
 Identities = 59/274 (21%), Positives = 110/274 (40%), Gaps = 42/274 (15%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA+  +   +       VA+K +  P   E         K+  RE+ LL  + + NVI 
Sbjct: 28  SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE------LFAKRAYRELRLLKHMRHENVIG 81

Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHK--LEHKTLPLPKLIAIALDIARGMEYIHSQG 304
            +            T++              ++H+ L   ++  +   + +G+ YIH+ G
Sbjct: 82  LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141

Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI-KHKSYGRK 363
           +IHRDLKP N+ ++++  LKI DFG+A +      ++    T  + APE+I     Y + 
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQT 199

Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--------------------- 402
           VD++S G I+ EM+ G   ++  + +     ++     P                     
Sbjct: 200 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259

Query: 403 --------AIPGDCPPAMAALIEQCWSLQPDKRP 428
                   +I  +  P    L+E+   L  ++R 
Sbjct: 260 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-33
 Identities = 66/315 (20%), Positives = 123/315 (39%), Gaps = 29/315 (9%)

Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA   +        D  VA+K +  P  ++         K+  RE+ L+  +++ N+I 
Sbjct: 27  SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH------AKRAYRELVLMKCVNHKNIIS 80

Query: 247 FVAACKKPPV------YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
            +                ++ E +     +    +L+H+     ++  +   +  G++++
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 135

Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
           HS G+IHRDLKP N+++  +  LKI DFG+A        ++    T  + APE+I    Y
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195

Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPPAMAALIEQ 418
              VD++S G I+ EMV   I +   + I     V+ +   P         P +   +E 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255

Query: 419 CWSLQPDKRPE-FWHIVKVLEQFETSLACNGTLNLVQNPICQDHKK------GLLH-WIQ 470
                    P+ F   +   +     L  +   +L+   +  D  K       L H +I 
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315

Query: 471 KLGPMHPHSSPMPKP 485
                    +P P+ 
Sbjct: 316 VWYDPAEVEAPPPQI 330

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (305), Expect = 1e-31
 Identities = 57/282 (20%), Positives = 110/282 (39%), Gaps = 24/282 (8%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245
            G +S ++  I     E V VKI++              +K+  RE+ +L  L   PN+I
Sbjct: 45  RGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNII 93

Query: 246 KFVAACKKPP--VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
                 K P      ++ E+++    +       ++TL    +     +I + ++Y HS 
Sbjct: 94  TLADIVKDPVSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCHSM 148

Query: 304 GVIHRDLKPENVLIDQEF-HLKIADFGIACEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
           G++HRD+KP NV+ID E   L++ D+G+A         +    +  +  PE ++ ++ Y 
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208

Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWS 421
             +D++S G +L  M+    P+   +        + K L      D       +      
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID-KYNIELDPRF 267

Query: 422 LQPDKRPEFWHIVKVLEQFETSLACNGTLNLVQNPICQDHKK 463
                R       + +      L     L+ +   +  DH+ 
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 309

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-30
 Identities = 57/276 (20%), Positives = 98/276 (35%), Gaps = 46/276 (16%)

Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
            GA+  +           VAVK +  P             K+  RE+ LL  + + NVI 
Sbjct: 28  SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH------AKRTYRELRLLKHMKHENVIG 81

Query: 247 FVAACKKPP-----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
            +                +  +L         + ++ + L    +  +   I RG++YIH
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGAD---LNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138

Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYG 361
           S  +IHRDLKP N+ ++++  LKI DFG+A      +        +      M+    Y 
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAPEIMLNWMHYN 197

Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA------------------ 403
           + VD++S G I+ E++ G   +   + I     ++     P                   
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257

Query: 404 -----------IPGDCPPAMAALIEQCWSLQPDKRP 428
                      +     P    L+E+   L  DKR 
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (262), Expect = 1e-25
 Identities = 59/324 (18%), Positives = 119/324 (36%), Gaps = 40/324 (12%)

Query: 174 HTVDLSQLFLGLRF------AHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARL 225
           H     + +   R+        G  S ++       +  VA+KI+R              
Sbjct: 2   HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---------GDKVY 52

Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPV--------------YCVITEYLSEGSLRA 271
            +    E+ LL R+++ +  K  +      +              + V+   +   +L A
Sbjct: 53  TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA 112

Query: 272 YLHKLEHKTLPLPKLIAIALDIARGMEYIH-SQGVIHRDLKPENVLIDQE------FHLK 324
            + K EH+ +PL  +  I+  +  G++Y+H   G+IH D+KPENVL++          +K
Sbjct: 113 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172

Query: 325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
           IAD G AC   Y +  ++   T  + +PE++    +G   D++S   +++E++ G   +E
Sbjct: 173 IADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230

Query: 385 EMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL 444
                       +      + G+ P  +    +   +    +              E  L
Sbjct: 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290

Query: 445 ACNGTLNLVQNPICQDHKKGLLHW 468
                 +  +     D    +L  
Sbjct: 291 TEKYKFSKDEAKEISDFLSPMLQL 314

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.7 bits (206), Expect = 3e-19
 Identities = 32/207 (15%), Positives = 63/207 (30%), Gaps = 47/207 (22%)

Query: 183 LGLRFAHGAHSRLYHGIYKD-EPVAVKIIRI----------PDDDENETLAARLEKQFNR 231
           +G     G  S +++   +      VK  ++            D  +   +    +    
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
           E   L +L    V K  A         V+ E +            E   + +     +  
Sbjct: 64  EFRALQKLQGLAVPKVYAWEG----NAVLMELIDAK---------ELYRVRVENPDEVLD 110

Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
            I   +   + +G++H DL   NVL+  E  + I DF  + E                  
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE------------VGEEGW 157

Query: 352 PEMIKH----------KSYGRKVDVYS 368
            E+++           ++Y  + D+ S
Sbjct: 158 REILERDVRNIITYFSRTYRTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	488
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.47
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.94
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.39
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.19
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.92
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.7

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-57  Score=442.83  Aligned_cols=265  Identities=31%  Similarity=0.620  Sum_probs=225.1

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      |+|+|+.++|.+++.||+|+||+||+|++++ .||||+++........      .+.|.+|+.+|++++|||||++++++
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~------~~~~~~E~~~l~~l~HpnIv~~~~~~   73 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ------LQAFKNEVGVLRKTRHVNILLFMGYS   73 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH------HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH------HHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence            6899999999999999999999999998765 5999999765444322      46789999999999999999999988


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .. ..++||||||++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus        74 ~~-~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla  151 (276)
T d1uwha_          74 TA-PQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA  151 (276)
T ss_dssp             CS-SSCEEEEECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred             ec-cEEEEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccce
Confidence            65 567899999999999999976 3456999999999999999999999999999999999999999999999999999


Q ss_pred             ccccc---cCcCCCCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-C--
Q 011359          332 CEEVY---CDALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-P--  402 (488)
Q Consensus       332 ~~~~~---~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-~--  402 (488)
                      .....   ........||+.|||||++.+   ..|+.++|||||||++|||++|..||.+.+........+..+.. +  
T Consensus       152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~  231 (276)
T d1uwha_         152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL  231 (276)
T ss_dssp             CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG
T ss_pred             eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc
Confidence            64332   122345679999999999964   35899999999999999999999999988776666555554433 2  


Q ss_pred             -CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          403 -AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       403 -~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                       ..+..+|+++.+||.+||+.||++||++.+|++.|+.+..++.
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence             3567899999999999999999999999999999999987654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-56  Score=433.67  Aligned_cols=263  Identities=32%  Similarity=0.538  Sum_probs=227.9

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      +.++|+|+.++|.++++||+|+||+||+|.+++ +.||||++......         .+.|.+|+.+|++++|||||+++
T Consensus         4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~   74 (272)
T d1qpca_           4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLY   74 (272)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---------HHHHHHHHHHHHhCCCCCEeEEE
Confidence            457899999999999999999999999999974 78999999754322         35688999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      |++.+ +.+++|||||++|+|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        75 g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             EEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             eeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccc
Confidence            98865 45689999999999999887655557999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccc--CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccCCCCCC
Q 011359          329 GIACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG-TIPYEEMNPIQAAFAVVNKNLRPAIP  405 (488)
Q Consensus       329 gla~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~  405 (488)
                      |+|+.....  .......||..|+|||++.+..++.++|||||||++|||+|| .+||......+. ...+..+.++..|
T Consensus       154 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~-~~~i~~~~~~~~p  232 (272)
T d1qpca_         154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-IQNLERGYRMVRP  232 (272)
T ss_dssp             TTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCCCCC
T ss_pred             cceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcCCCCCc
Confidence            999654322  223455789999999999989999999999999999999995 555565555544 4445566778888


Q ss_pred             CCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          406 GDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       406 ~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ..+++++.+||.+||+.||++||++.+|++.|+.+..+
T Consensus       233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            99999999999999999999999999999999988754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-56  Score=438.58  Aligned_cols=262  Identities=26%  Similarity=0.554  Sum_probs=231.1

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      ++|+|+.++|.++++||+|+||+||+|.+.  ++.||||+++.....         .++|.+|+.+|++++|||||++++
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~il~~l~HpnIv~~~~   80 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------VEEFLKEAAVMKEIKHPNLVQLLG   80 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---------HHHHHHHHHHHHhCCCCCEecCCc
Confidence            579999999999999999999999999986  678999998753322         356889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +|.++..++||||||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG  160 (287)
T d1opja_          81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG  160 (287)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             cEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccc
Confidence            99999999999999999999999988777789999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          330 IACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       330 la~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      +|+......  ......|+..|+|||++.+..|+.++|||||||++|||++|..||............+..+.++..+..
T Consensus       161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~  240 (287)
T d1opja_         161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG  240 (287)
T ss_dssp             CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCcc
Confidence            996543221  123345789999999999999999999999999999999976665554444556667777888889999


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +++++.+||.+||+.||++||++.+|++.|+.+..
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999999998887643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-55  Score=424.34  Aligned_cols=256  Identities=26%  Similarity=0.558  Sum_probs=216.5

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      ||.++|.+++.||+|+||+||+|++. ++.||||+++.....         .++|.+|+.++++++|||||+++|+|..+
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   72 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---------HHHHHHHHHHHHhcCCCCcccccceeccC
Confidence            67889999999999999999999996 578999998753322         35688999999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+++|||||++|+|.+++.. ....++++.++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus        73 ~~~~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          73 APICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             SSCEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             CceEEEEEecCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence            999999999999999999876 3456889999999999999999999999999999999999999999999999999654


Q ss_pred             cccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          335 VYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       335 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      ....  ......||..|+|||++.+..|+.++|||||||++|||++ |..||...+..+.... +..+.++..|..++++
T Consensus       152 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~p~~~~~~  230 (263)
T d1sm2a_         152 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLASTH  230 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-HHHTCCCCCCTTSCHH
T ss_pred             cCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-HHhcCCCCCccccCHH
Confidence            3222  2234568999999999999999999999999999999999 5667777666555544 4456677788899999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +.+||.+||+.||++||++.+|++.|+++.+
T Consensus       231 l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         231 VYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999999999865

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=435.53  Aligned_cols=262  Identities=25%  Similarity=0.482  Sum_probs=228.1

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN  241 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H  241 (488)
                      +...|+|+.++|.+++.||+|+||+||+|++.+       ..||||++......       .....|.+|+.+|.++ +|
T Consensus        28 ~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~~H  100 (325)
T d1rjba_          28 YDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-------SEREALMSELKMMTQLGSH  100 (325)
T ss_dssp             CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCC
T ss_pred             CCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH-------HHHHHHHHHHHHHHHhcCC
Confidence            345688999999999999999999999999753       25999998643322       1245688999999998 89


Q ss_pred             CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhCC---------------------CCCCHHHHHHHHHHHHHHHHHH
Q 011359          242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH---------------------KTLPLPKLIAIALDIARGMEYI  300 (488)
Q Consensus       242 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~L  300 (488)
                      ||||+++++|.+...+++|||||++|+|.++|.....                     ..+++..++.++.||+.||+||
T Consensus       101 pnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL  180 (325)
T d1rjba_         101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL  180 (325)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH
T ss_pred             CcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999986432                     3588999999999999999999


Q ss_pred             HHCCcccCCCCCCeEEEcCCCcEEEeeecccccccccCc---CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHH
Q 011359          301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV  377 (488)
Q Consensus       301 H~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ell  377 (488)
                      |++||+||||||+|||++.++.+||+|||+|+.......   .....||+.|||||++.+..|+.++|||||||++|||+
T Consensus       181 H~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml  260 (325)
T d1rjba_         181 EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF  260 (325)
T ss_dssp             HHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             HhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH
Confidence            999999999999999999999999999999965433222   22445799999999999999999999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 011359          378 A-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLE  438 (488)
Q Consensus       378 t-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le  438 (488)
                      + |..||.+.+..+....++..+.++..|..+++++.+||.+||+.||++||++.+|++.|.
T Consensus       261 t~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            7 899999887777778888888888899999999999999999999999999999999885

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-54  Score=419.39  Aligned_cols=248  Identities=26%  Similarity=0.418  Sum_probs=218.8

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||+||+|++.  ++.||||++.....     ......+.+.+|+.+|++++|||||++++++.++.
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc-----cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            468999999999999999999986  68999999974211     11123567889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+|+|||||++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             EEEEEEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence            99999999999999999986  3569999999999999999999999999999999999999999999999999996543


Q ss_pred             ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                      .. ......||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+....+....  ..+|..+++++.+|
T Consensus       158 ~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~l  234 (263)
T d2j4za1         158 SS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDL  234 (263)
T ss_dssp             CC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHH
T ss_pred             CC-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCccCCHHHHHH
Confidence            22 2344579999999999999999999999999999999999999999988877766665543  45778899999999


Q ss_pred             HHHHhhhCCCCCCCHHHHHH
Q 011359          416 IEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RPs~~eil~  435 (488)
                      |.+||+.||++||++.++++
T Consensus       235 i~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         235 ISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHccCCHhHCcCHHHHHc
Confidence            99999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.6e-54  Score=425.48  Aligned_cols=259  Identities=27%  Similarity=0.550  Sum_probs=216.4

Q ss_pred             cccccceeccceeeeeccEEEEEEEEC--Cc---cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~--~~---~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .++.++|.+++.||+|+||+||+|.+.  ++   .||||.+......       ...+.|.+|+.+|++++|||||+++|
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~l~g   94 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-------KQRRDFLSEASIMGQFDHPNVIHLEG   94 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-------HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-------HHHHHHHHHHHHHHhCCCCCCccEEE
Confidence            477789999999999999999999985  22   4888887643321       12467899999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +|..+..+++|||||++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG  173 (299)
T d1jpaa_          95 VVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFG  173 (299)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEeeCCEEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcc
Confidence            99999999999999999999998876 34569999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCc------CCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 011359          330 IACEEVYCDA------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRP  402 (488)
Q Consensus       330 la~~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  402 (488)
                      +++.......      .....||+.|||||.+.+..++.++|||||||++|||++ |..||.+....+....+ ..+.++
T Consensus       174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i-~~~~~~  252 (299)
T d1jpaa_         174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRL  252 (299)
T ss_dssp             ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCC
T ss_pred             cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCC
Confidence            9964332211      112347899999999999999999999999999999998 89999999887665554 445667


Q ss_pred             CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          403 AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       403 ~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ..+..++..+.+||.+||+.||++||++.+|++.|+++..
T Consensus       253 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            7888999999999999999999999999999999998755

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-54  Score=422.95  Aligned_cols=246  Identities=24%  Similarity=0.481  Sum_probs=218.6

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+.++||+|+||+||+|.+.  |+.||||++.......        .+.+.+|+.+|++++|||||++++++..+..
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   91 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--------HHHHHHHHHHHHhCCCCCEeeEeEEEEECCE
Confidence            46999999999999999999975  7899999998654332        3468899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|||||||+||+|.+++.+   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus        92 ~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            9999999999999998876   4699999999999999999999999999999999999999999999999999965432


Q ss_pred             -cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCcHHHHH
Q 011359          337 -CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-LRPAIPGDCPPAMAA  414 (488)
Q Consensus       337 -~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~  414 (488)
                       ........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+.... .....+..+++++++
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  248 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD  248 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHH
T ss_pred             ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHH
Confidence             223455679999999999999999999999999999999999999999988877776666543 334556788999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+||+.||++||++.++++
T Consensus       249 li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         249 FLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=423.39  Aligned_cols=263  Identities=29%  Similarity=0.515  Sum_probs=222.4

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .++|+|+.++|++++.||+|+||+||+|++++ +.||||++......         .+.|.+|+.+|++++|+|||+++|
T Consensus         9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---------~~~~~~E~~~l~~l~h~nIv~~~g   79 (285)
T d1fmka3           9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYA   79 (285)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---------HHHHHHHHHHHHhcccCCEeEEEE
Confidence            47899999999999999999999999999975 67999999754332         256889999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +|.+ ..+++|||||++|+|..++.......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus        80 ~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfG  158 (285)
T d1fmka3          80 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG  158 (285)
T ss_dssp             EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccc
Confidence            9965 457899999999999999987666779999999999999999999999999999999999999999999999999


Q ss_pred             cccccccc--CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhccCCCCCCC
Q 011359          330 IACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP-YEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       330 la~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      +++.....  .......||+.|+|||++.+..++.++|||||||++|||++|..| +......+ ....+..+.++..+.
T Consensus       159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i~~~~~~~~~~  237 (285)
T d1fmka3         159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPCPP  237 (285)
T ss_dssp             TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCCCCCCT
T ss_pred             hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcCCCCCCc
Confidence            99643222  223345689999999999999999999999999999999996555 45555544 444455566777899


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                      .+++++.+||.+||+.||++||++.+|+++|+.+....
T Consensus       238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            99999999999999999999999999999888766543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=420.69  Aligned_cols=262  Identities=25%  Similarity=0.555  Sum_probs=224.5

Q ss_pred             ccccccceeccc-eeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          174 HTVDLSQLFLGL-RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       174 ~~id~~~~~i~~-~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      +.++.++|.+.+ +||+|+||+||+|.+.    +..||||+++.....       ...+.|.+|+.+|++++|||||+++
T Consensus         3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-------~~~~~~~~E~~il~~l~HpnIv~l~   75 (285)
T d1u59a_           3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------ADTEEMMREAQIMHQLDNPYIVRLI   75 (285)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH-------HHHHHHHHHHHHHHhCCCCCEeeEe
Confidence            445667788887 5999999999999875    346999999754321       1246789999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      |+|..+ .+|||||||++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        76 g~~~~~-~~~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          76 GVCQAE-ALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             EEEESS-SEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCC
T ss_pred             eeeccC-eEEEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccc
Confidence            999765 57899999999999999865 3457999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccc----CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 011359          329 GIACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       329 gla~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      |+++.....    .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+... .+..+.++.
T Consensus       154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~-~i~~~~~~~  232 (285)
T d1u59a_         154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRME  232 (285)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-HHHTTCCCC
T ss_pred             hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCC
Confidence            999643322    22234568999999999999999999999999999999998 999999988766544 445566788


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                      +|..+|+++.+||.+||+.||++||++.+|++.|+.+...+.
T Consensus       233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            899999999999999999999999999999999998877655

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=418.70  Aligned_cols=257  Identities=29%  Similarity=0.580  Sum_probs=221.6

Q ss_pred             cccccccceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK  252 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  252 (488)
                      .|+|+.++|.+++.||+|+||.||+|.++|+.||||+++....          .+.|.+|+.+|++++||||++++|+|.
T Consensus         1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~----------~~~~~~E~~~l~~l~HpnIv~~~g~~~   70 (262)
T d1byga_           1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGVIV   70 (262)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred             CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH----------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3889999999999999999999999999999999999964321          356889999999999999999999985


Q ss_pred             c-CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          253 K-PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       253 ~-~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      + ...+++||||+++|+|.+++.+.....+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++
T Consensus        71 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s  150 (262)
T d1byga_          71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT  150 (262)
T ss_dssp             CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             ecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccc
Confidence            4 467899999999999999998755556899999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPP  410 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (488)
                      .....  ......++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.... +..+.++.++..+++
T Consensus       151 ~~~~~--~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~  227 (262)
T d1byga_         151 KEASS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPP  227 (262)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCH
T ss_pred             eecCC--CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCccCCH
Confidence            65432  2344568899999999999999999999999999999998 7888988776665554 455678888999999


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ++.+||.+||+.||.+||++.++++.|++++.
T Consensus       228 ~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999999999865

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=413.22  Aligned_cols=253  Identities=25%  Similarity=0.514  Sum_probs=224.0

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP  254 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  254 (488)
                      +|.++|.++++||+|+||+||+|+++ ++.||||+++.....         .++|.+|+.++++++||||++++|+|.++
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~   71 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   71 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---------HHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---------HHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence            46788999999999999999999997 468999999865433         34688999999999999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        72 ~~~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~  150 (258)
T d1k2pa_          72 RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  150 (258)
T ss_dssp             SSEEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred             CceEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheec
Confidence            9999999999999999998763 456889999999999999999999999999999999999999999999999999643


Q ss_pred             cccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          335 VYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       335 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      ....  ......||..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....+. .+.++..|..++++
T Consensus       151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~  229 (258)
T d1k2pa_         151 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEK  229 (258)
T ss_dssp             SSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred             cCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHH
Confidence            3222  2234568999999999999999999999999999999998 899999999877665554 45677888999999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVLEQ  439 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~Le~  439 (488)
                      +.+||.+||+.||++||++.+|++.|.+
T Consensus       230 l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         230 VYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            9999999999999999999999998864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=416.26  Aligned_cols=260  Identities=27%  Similarity=0.544  Sum_probs=218.9

Q ss_pred             cccccceeccceeeeeccEEEEEEEECC------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEe
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV  248 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~~------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  248 (488)
                      +|+.++|.+++.||+|+||.||+|.+++      ..||||++.......       ...+|.+|+.+|++++|||||+++
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~~E~~il~~l~H~nIv~~~   75 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-------QRVDFLGEAGIMGQFSHHNIIRLE   75 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-------HHHHHHHHHHHHHhcCCCCEeeee
Confidence            5677889999999999999999998753      369999997543321       245789999999999999999999


Q ss_pred             eeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeee
Q 011359          249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF  328 (488)
Q Consensus       249 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DF  328 (488)
                      |++.....+++|||||.+++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus        76 g~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DF  154 (283)
T d1mqba_          76 GVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF  154 (283)
T ss_dssp             EEECSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEecCCceEEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEccc
Confidence            999999999999999999999998876 3467999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHhccCCCC
Q 011359          329 GIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI-PYEEMNPIQAAFAVVNKNLRPA  403 (488)
Q Consensus       329 gla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~-Pf~~~~~~~~~~~~~~~~~~~~  403 (488)
                      |+++......    ......||..|+|||++.+..++.++|||||||++|||++|.. |+......+ ....+..+.++.
T Consensus       155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~~~~~  233 (283)
T d1mqba_         155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAINDGFRLP  233 (283)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCC
T ss_pred             chhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHHHhccCCCC
Confidence            9996432221    2233468999999999999999999999999999999999554 455555544 455566777888


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      .+..++..+.+||.+||+.||++||++.+|++.|+++...
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            8999999999999999999999999999999999988663

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=417.75  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=208.3

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec--C
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--P  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~  254 (488)
                      ++|.+.+.||+|+||+||+|++.  |+.||||++......+..      .+.|.+|+++|++++|||||++++++.+  +
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE------KQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH------HHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH------HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            57899999999999999999986  789999999865543321      4568899999999999999999999864  4


Q ss_pred             CeeeEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCeEEEcCCCcEEEee
Q 011359          255 PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQG-----VIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~g-----iiHrDIkp~NILl~~~~~vkl~D  327 (488)
                      ..+|||||||++|+|.+++.+.  ....+++..++.++.||+.||+|||++|     |+||||||+|||++.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            5689999999999999999753  3567999999999999999999999976     99999999999999999999999


Q ss_pred             eccccccccc-CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 011359          328 FGIACEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPG  406 (488)
Q Consensus       328 Fgla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  406 (488)
                      ||+|...... .......||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+..... +.++.
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-~~~~~  236 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIPY  236 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCT
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCc
Confidence            9999654322 223456799999999999999999999999999999999999999999888777666665543 45778


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+++++.+||.+||+.||++||++.|+++
T Consensus       237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         237 RYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            89999999999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=417.03  Aligned_cols=255  Identities=27%  Similarity=0.548  Sum_probs=214.5

Q ss_pred             cceecc-ceeeeeccEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          179 SQLFLG-LRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       179 ~~~~i~-~~lG~G~~g~Vy~~~~~----~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      ..+.+. ++||+|+||+||+|.+.    ++.||||+++....+.      ...++|.+|+.+|++++|||||+++|+|..
T Consensus         6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~E~~il~~l~HpnIv~~~g~~~~   79 (277)
T d1xbba_           6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP------ALKDELLAEANVMQQLDNPYIVRMIGICEA   79 (277)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C------HHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred             hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCH------HHHHHHHHHHHHHHhCCCCCCceEEEEecc
Confidence            334443 46999999999999874    2579999997533221      225679999999999999999999999976


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      + .++||||||++|+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~-~~~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~  156 (277)
T d1xbba_          80 E-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  156 (277)
T ss_dssp             S-SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             C-CEEEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhh
Confidence            5 56899999999999999986  46799999999999999999999999999999999999999999999999999964


Q ss_pred             cccc----CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 011359          334 EVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGDC  408 (488)
Q Consensus       334 ~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  408 (488)
                      ....    .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+... .+..+.++..|..+
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~  235 (277)
T d1xbba_         157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC  235 (277)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCCCCCCTTC
T ss_pred             ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH-HHHcCCCCCCCccc
Confidence            3221    12234568999999999999999999999999999999998 999999988766554 44556678888999


Q ss_pred             cHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          409 PPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       409 ~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      |.++.+||.+||+.||++||++.+|++.|+.+...
T Consensus       236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            99999999999999999999999999999887554

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-54  Score=419.28  Aligned_cols=248  Identities=27%  Similarity=0.430  Sum_probs=209.0

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||+||+|++.  |+.||||++......+       ..+.+.+|+.+|++++|||||++++++.++..
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-------CPENIKKEICINKMLNHENVVKFYGHRREGNI   77 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-------HHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence            56899999999999999999986  7899999997643221       23568899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +|||||||+||+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus        78 ~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             eEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            9999999999999999864  46799999999999999999999999999999999999999999999999999965332


Q ss_pred             c---CcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCCCCCCCCCcHH
Q 011359          337 C---DALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF-AVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       337 ~---~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  411 (488)
                      .   .......||+.|||||++.+..+ +.++|||||||++|||++|..||.......... ..............++++
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA  235 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHH
Confidence            2   23455679999999999988776 578999999999999999999998765433333 333333333344678999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.||++||++.++++
T Consensus       236 ~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         236 PLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhc
Confidence            999999999999999999998865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=419.66  Aligned_cols=247  Identities=24%  Similarity=0.435  Sum_probs=215.9

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      .|++++.||+|+||+||+|++.  ++.||||++.......        .+.|.+|+++|++++|||||++++++.++..+
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~   84 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--------LEDYMVEIDILASCDHPNIVKLLDAFYYENNL   84 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG--------GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH--------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeE
Confidence            4889999999999999999986  6889999998654332        34678999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      +||||||++|+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus        85 ~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          85 WILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            9999999999999998763 457999999999999999999999999999999999999999999999999998643322


Q ss_pred             -CcCCCCCCCcccCChhhhh-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcH
Q 011359          338 -DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-RPAIPGDCPP  410 (488)
Q Consensus       338 -~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~  410 (488)
                       .......||+.|+|||++.     ...|+.++|||||||++|||++|..||.+.+..+....+..... ....+..+++
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~  243 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS  243 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence             2234567999999999984     45689999999999999999999999999888887777776543 2344568899


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.+||.+||+.||++||++.|+++
T Consensus       244 ~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         244 NFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999999865

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-53  Score=421.17  Aligned_cols=248  Identities=23%  Similarity=0.350  Sum_probs=203.6

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +.|.+++.||+|+||+||+|++.  |+.||||++.......       ..+.+.+|+.+|++++|||||++++++.++..
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-------KEGSMENEIAVLHKIKHPNIVALDDIYESGGH   81 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            45899999999999999999986  7889999998544321       13567899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc---CCCcEEEeeeccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACE  333 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~---~~~~vkl~DFgla~~  333 (488)
                      +|||||||+||+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||+.   .++.+||+|||+|..
T Consensus        82 ~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             EEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            9999999999999999976  46799999999999999999999999999999999999994   578999999999976


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  411 (488)
                      ...........||+.|||||++.+..|+.++|||||||++|+|++|..||.+....+....+.......  ..+..++++
T Consensus       160 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  239 (307)
T d1a06a_         160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS  239 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             ccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence            555555556779999999999999999999999999999999999999999998888777777665443  344678999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.||++||++.|+++
T Consensus       240 ~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         240 AKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhc
Confidence            999999999999999999999876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-53  Score=412.97  Aligned_cols=261  Identities=25%  Similarity=0.530  Sum_probs=216.5

Q ss_pred             cccccccceeccceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF  247 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  247 (488)
                      +|+|+.++|.+++.||+|+||+||+|++.+     ..||||+++.....       ...+.|.+|+.+|++++|||||++
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~l   73 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-------SVREKFLQEALTMRQFDHPHIVKL   73 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence            588999999999999999999999999852     35777877543221       224678999999999999999999


Q ss_pred             eeeeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       248 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                      ++++.+ +.+++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|
T Consensus        74 ~~~~~~-~~~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~D  151 (273)
T d1mp8a_          74 IGVITE-NPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD  151 (273)
T ss_dssp             EEEECS-SSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             EEEEec-CeEEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEcc
Confidence            999964 578899999999999998876 346789999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccC--cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 011359          328 FGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       328 Fgla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  404 (488)
                      ||+|.......  ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.. +.++.+
T Consensus       152 fG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-~~~~~~  230 (273)
T d1mp8a_         152 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPM  230 (273)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCC
T ss_pred             chhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCC
Confidence            99996533221  2234568999999999999999999999999999999998 8999999888776665544 456678


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      +..+|+.+.+||.+||+.||++||++.+|++.|+.+.+.
T Consensus       231 ~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            889999999999999999999999999999999987553

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-52  Score=418.48  Aligned_cols=246  Identities=26%  Similarity=0.398  Sum_probs=218.4

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCee
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY  257 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  257 (488)
                      .|...++||+|+||+||+|++.  ++.||||++.........     ..+.|.+|+.+|++++|||||++++++.++..+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-----KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHH-----HHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE
Confidence            4888999999999999999985  688999999865543322     246788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc
Q 011359          258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC  337 (488)
Q Consensus       258 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~  337 (488)
                      |||||||.+|+|..++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..... 
T Consensus        91 ~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             EEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            999999999999877655  46799999999999999999999999999999999999999999999999999965432 


Q ss_pred             CcCCCCCCCcccCChhhhhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 011359          338 DALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAA  414 (488)
Q Consensus       338 ~~~~~~~gt~~y~aPE~l~~---~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  414 (488)
                        .....||+.|||||++.+   ..|+.++|||||||++|||++|..||.+.+..+....+.........+..+++++.+
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~  245 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence              345679999999999864   458999999999999999999999999999888888887777666667789999999


Q ss_pred             HHHHHhhhCCCCCCCHHHHHH
Q 011359          415 LIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       415 Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ||.+||+.||++||++.++++
T Consensus       246 li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHCcCChhHCcCHHHHHh
Confidence            999999999999999999876

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-53  Score=418.36  Aligned_cols=253  Identities=22%  Similarity=0.339  Sum_probs=220.6

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|.+++.||+|+||+||+|++.  |+.||||++..........  ....+.|.+|+.+|++++|||||++++++.++..
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            46999999999999999999986  7899999997543322110  0114678899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC----cEEEeeecccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIAC  332 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~----~vkl~DFgla~  332 (488)
                      +|||||||+||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+|.
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            99999999999999999873  5799999999999999999999999999999999999998776    59999999997


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPP  410 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~  410 (488)
                      ............||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.......  ..+..++.
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  245 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence            6655555667789999999999998899999999999999999999999999998888777776654432  23467899


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+.+||.+||+.||++||++.++++
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=416.66  Aligned_cols=249  Identities=24%  Similarity=0.380  Sum_probs=216.3

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||+||+|.+.  |+.||||++.....     ......+.+.+|+.+|++++|||||++++++.++.
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-----cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            367999999999999999999986  78999999974211     11112456889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+|||||||+||+|.+++...  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecc
Confidence            999999999999999998863  579999999999999999999999999999999999999999999999999996543


Q ss_pred             c---cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          336 Y---CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       336 ~---~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      .   ........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+....  ..+|..+++++
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~  237 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEKFFPKA  237 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CCCCTTCCHHH
T ss_pred             cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--CCCCccCCHHH
Confidence            2   122345679999999999999999999999999999999999999999988888777776654  45678899999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||.+||+.||.+||++.|++.
T Consensus       238 ~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         238 RDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             HHHHHHHccCCHhHCcCHHHHcC
Confidence            99999999999999999998754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-52  Score=424.22  Aligned_cols=249  Identities=20%  Similarity=0.330  Sum_probs=219.1

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||.||+|++.  |+.||||++......        ..+.+.+|+.+|++++|||||++++++.++.
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~--------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   96 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN   96 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH--------HHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh--------hHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            358999999999999999999986  789999999754321        1456889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc--CCCcEEEeeeccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID--QEFHLKIADFGIACE  333 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~--~~~~vkl~DFgla~~  333 (488)
                      .+|||||||+||+|.+++.. ....+++..+..|+.||+.||+|||++||+||||||+|||++  .++.+||+|||+|..
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            99999999999999999965 245699999999999999999999999999999999999995  467899999999976


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPGDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  411 (488)
                      ...........||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+....+.......  .....++++
T Consensus       176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  255 (350)
T d1koaa2         176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  255 (350)
T ss_dssp             CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred             cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            554444455679999999999999999999999999999999999999999998888877777665443  233568999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.||++||++.++++
T Consensus       256 ~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         256 GKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999999876

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-52  Score=407.38  Aligned_cols=245  Identities=26%  Similarity=0.491  Sum_probs=208.1

Q ss_pred             eeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec----C
Q 011359          181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK----P  254 (488)
Q Consensus       181 ~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~  254 (488)
                      |++.++||+|+||+||+|++.  ++.||||++........      ..+.|.+|+++|++++|||||++++++..    .
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS------ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH------HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH------HHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence            467788999999999999986  57899999986543322      14578999999999999999999999864    4


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCeEEEc-CCCcEEEeeeccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLID-QEFHLKIADFGIA  331 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--iiHrDIkp~NILl~-~~~~vkl~DFgla  331 (488)
                      ..+|||||||++|+|.+++.+.  ..+++..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            5689999999999999999863  57899999999999999999999998  99999999999996 5789999999999


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCcH
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-PAIPGDCPP  410 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~  410 (488)
                      ..... .......||+.|||||++.+ .|+.++|||||||++|||++|..||.+..........+..+.. ..++..+++
T Consensus       163 ~~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (270)
T d1t4ha_         163 TLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  240 (270)
T ss_dssp             GGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             eeccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence            64332 22345679999999999875 6999999999999999999999999877665555555544433 345667899


Q ss_pred             HHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          411 AMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       411 ~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      ++.+||.+||+.||++||++.|+++
T Consensus       241 ~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhC
Confidence            9999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=412.88  Aligned_cols=264  Identities=29%  Similarity=0.505  Sum_probs=219.3

Q ss_pred             ccccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCC
Q 011359          172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPN  243 (488)
Q Consensus       172 ~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn  243 (488)
                      +.|+|+.++|.+++.||+|+||.||+|.+.+       +.||||++......       ...+.+.+|+.++.++ +|+|
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-------~~~~~~~~e~~~l~~~~~h~~   78 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------SEHRALMSELKILIHIGHHLN   78 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-------HHHHHHHHHHHHHHHHCCCTT
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-------HHHHHHHHHHHHHHhhcCCCe
Confidence            5688999999999999999999999999742       57999998743321       1245678888888887 5899


Q ss_pred             eeeEeeeeecC-CeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 011359          244 VIKFVAACKKP-PVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHR  308 (488)
Q Consensus       244 Iv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHr  308 (488)
                      |+.+++++..+ ..+++|||||++|+|.+++....              ...+++..++.++.||+.||+|||++||+||
T Consensus        79 iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr  158 (299)
T d1ywna1          79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR  158 (299)
T ss_dssp             BCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence            99999987654 56899999999999999998642              2358899999999999999999999999999


Q ss_pred             CCCCCeEEEcCCCcEEEeeeccccccccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCCC
Q 011359          309 DLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG-TIPYE  384 (488)
Q Consensus       309 DIkp~NILl~~~~~vkl~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG-~~Pf~  384 (488)
                      ||||+|||++.++.+||+|||+|+.....   .......||+.|+|||++.+..++.++|||||||++|||++| ..||.
T Consensus       159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999643322   223345799999999999999999999999999999999986 56898


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          385 EMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +....+.....+..+.++..+..+++++.+||.+||+.||++||++.+|++.|+++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         239 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            8776666777777788888999999999999999999999999999999999998754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-52  Score=416.87  Aligned_cols=248  Identities=22%  Similarity=0.399  Sum_probs=207.9

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      -++|.+.+.||+|+||+||+|++.  |+.||||+++......       ...++.+|+.+|++++|||||+++++|.++.
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   77 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-------IRNQIIRELQVLHECNSPYIVGFYGAFYSDG   77 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT-------HHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH-------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            457999999999999999999985  7899999998654332       1457889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      .+|||||||+||+|.+++.+.  +.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|...
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            999999999999999999863  5699999999999999999999975 9999999999999999999999999999754


Q ss_pred             cccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------------
Q 011359          335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF---------------------  393 (488)
Q Consensus       335 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~---------------------  393 (488)
                      ... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+...                     
T Consensus       156 ~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         156 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             HHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             CCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            332 2345689999999999999999999999999999999999999997654322100                     


Q ss_pred             --------------------HHHhccCCCCCC-CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          394 --------------------AVVNKNLRPAIP-GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       394 --------------------~~~~~~~~~~~~-~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                          ........+..+ ..++.++.+||.+||..||.+||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                                000111112222 346789999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=409.71  Aligned_cols=259  Identities=28%  Similarity=0.472  Sum_probs=217.0

Q ss_pred             cccccceeccceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA  249 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  249 (488)
                      .|+.++|.+.++||+|+||+||+|++.+     ..||||++........     ...+.|.+|+.+|++++|||||+++|
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~~~g   78 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-----EAMDDFIREVNAMHSLDHRNLIRLYG   78 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C-----HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH-----HHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            4677889999999999999999998742     3689999875433221     22467999999999999999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      +|.++ .+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~-~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          79 VVLTP-PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             EECSS-SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             EEeec-chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccch
Confidence            99764 678999999999999988763 4569999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 011359          330 IACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAI  404 (488)
Q Consensus       330 la~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  404 (488)
                      ++.......    ......|+..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+...+.++..
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR  236 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC
Confidence            996532221    2233457889999999999999999999999999999998 89999999999988888888888888


Q ss_pred             CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHH
Q 011359          405 PGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQF  440 (488)
Q Consensus       405 ~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~  440 (488)
                      +..+|..+.+||.+||+.||++||++.+|++.|++.
T Consensus       237 ~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            999999999999999999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.2e-52  Score=422.30  Aligned_cols=248  Identities=20%  Similarity=0.340  Sum_probs=219.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      ++|++++.||+|+||+||+|++.  |+.||||++......        ..+.+.+|+.+|++|+|||||++++++.++..
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--------DKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--------HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh--------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            56999999999999999999985  789999999754321        13567899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc--CCCcEEEeeecccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID--QEFHLKIADFGIACEE  334 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~--~~~~vkl~DFgla~~~  334 (488)
                      +|||||||+||+|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+|||++  .++.+||+|||+|...
T Consensus       101 ~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence            9999999999999998765 345699999999999999999999999999999999999997  5789999999999765


Q ss_pred             cccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHH
Q 011359          335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR--PAIPGDCPPAM  412 (488)
Q Consensus       335 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  412 (488)
                      ..........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+......  ......+++++
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  259 (352)
T d1koba_         180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  259 (352)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            5544455567999999999999999999999999999999999999999999988887777766543  33456789999


Q ss_pred             HHHHHHHhhhCCCCCCCHHHHHH
Q 011359          413 AALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+||.+||+.||.+||++.++++
T Consensus       260 ~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         260 KDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            99999999999999999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.8e-52  Score=410.43  Aligned_cols=261  Identities=29%  Similarity=0.561  Sum_probs=225.0

Q ss_pred             cccccccceeccceeeeeccEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011359          173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI  245 (488)
Q Consensus       173 ~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~-------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  245 (488)
                      ++++..++|.+++.||+|+||+||+|++.+       +.||||++......       ...++|.+|+.+|++++||||+
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~E~~il~~l~h~niv   79 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------DMQADFQREAALMAEFDNPNIV   79 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-------HHHHHHHHHHHHHHhcCCCCcc
Confidence            456667889999999999999999999753       57999998743321       2256799999999999999999


Q ss_pred             eEeeeeecCCeeeEEEeecCCCCHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011359          246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLE----------------------HKTLPLPKLIAIALDIARGMEYIHSQ  303 (488)
Q Consensus       246 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~  303 (488)
                      +++++|......++||||+.+|+|.+++....                      ...+++..++.|+.||+.||+|||++
T Consensus        80 ~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~  159 (301)
T d1lufa_          80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER  159 (301)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence            99999999999999999999999999997532                      23478899999999999999999999


Q ss_pred             CcccCCCCCCeEEEcCCCcEEEeeeccccccccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCC
Q 011359          304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT  380 (488)
Q Consensus       304 giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~  380 (488)
                      ||+||||||+|||++.++.+||+|||+|......   .......|++.|+|||.+.+..|+.++|||||||++|||++|.
T Consensus       160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence            9999999999999999999999999998643222   2233456889999999999999999999999999999999985


Q ss_pred             -CCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          381 -IPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       381 -~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                       .||.+.+..+....+.. +.++.++..+++++.+||.+||+.+|++||++.+|+++|+++.
T Consensus       240 ~~p~~~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         240 LQPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence             68988888877766554 4467788899999999999999999999999999999999874

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=414.71  Aligned_cols=251  Identities=23%  Similarity=0.384  Sum_probs=221.1

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      |.+++|.+++.||+|+||.||+|++.  |+.||||++....     .......+++.+|+.+|++++||||+++++++.+
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   76 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV-----IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhh-----ccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence            56788999999999999999999985  7899999997421     0111124668899999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      +..+|+|||||+||+|.+++.+  ...++++.+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus        77 ~~~~~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          77 HDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             ccccccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccc
Confidence            9999999999999999999987  45789999999999999999999999999999999999999999999999999975


Q ss_pred             ccc-cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 011359          334 EVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAM  412 (488)
Q Consensus       334 ~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  412 (488)
                      ... ........||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+....  ..+|..+++++
T Consensus       155 ~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~  232 (337)
T d1o6la_         155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEA  232 (337)
T ss_dssp             SCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHH
T ss_pred             cccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHH
Confidence            433 334455679999999999999999999999999999999999999999999877776666654  45788899999


Q ss_pred             HHHHHHHhhhCCCCCCC-----HHHHHH
Q 011359          413 AALIEQCWSLQPDKRPE-----FWHIVK  435 (488)
Q Consensus       413 ~~Li~~cL~~dp~~RPs-----~~eil~  435 (488)
                      .+||.+||+.||.+|++     +.++++
T Consensus       233 ~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         233 KSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHhhccCCchhhcccccccHHHHHc
Confidence            99999999999999995     777765

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=408.05  Aligned_cols=265  Identities=29%  Similarity=0.556  Sum_probs=226.1

Q ss_pred             cccccccccceeccceeeeeccEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-C
Q 011359          171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-H  240 (488)
Q Consensus       171 ~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~~---------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~  240 (488)
                      .++|.|+.++|.+++.||+|+||.||+|++.+         ..||||++......       +...++.+|+.++.++ +
T Consensus         5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~~e~~~l~~~~~   77 (299)
T d1fgka_           5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-------KDLSDLISEMEMMKMIGK   77 (299)
T ss_dssp             CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH-------HHHHHHHHHHHHHHHHCC
T ss_pred             CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh-------HHHHHHHHHHHHHHHhcC
Confidence            45689999999999999999999999998642         36999999754321       1246788999999998 7


Q ss_pred             CCCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 011359          241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVI  306 (488)
Q Consensus       241 HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~gii  306 (488)
                      |||||+++++|.++..+++|||||++|+|.+++....              ...+++..++.++.||+.||+|||+.||+
T Consensus        78 HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~iv  157 (299)
T d1fgka_          78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI  157 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             CCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEE
Confidence            9999999999999999999999999999999997643              24589999999999999999999999999


Q ss_pred             cCCCCCCeEEEcCCCcEEEeeecccccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 011359          307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP  382 (488)
Q Consensus       307 HrDIkp~NILl~~~~~vkl~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~P  382 (488)
                      ||||||+|||++.++.+||+|||++.......   ......|++.|+|||.+.+..|+.++|||||||++|||++ |..|
T Consensus       158 HrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p  237 (299)
T d1fgka_         158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  237 (299)
T ss_dssp             CSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             eeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence            99999999999999999999999986443322   2334568999999999999999999999999999999998 7999


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          383 YEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       383 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      |.+.+..+.. ..+..+.++..+..+++++.+||.+||+.||.+||++.+|++.|+++.+.
T Consensus       238 ~~~~~~~~~~-~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         238 YPGVPVEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             STTCCHHHHH-HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHH-HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            9988876554 45556778888999999999999999999999999999999999998653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-52  Score=411.98  Aligned_cols=262  Identities=28%  Similarity=0.511  Sum_probs=223.9

Q ss_pred             cccccceeccceeeeeccEEEEEEEECC--c--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEee
Q 011359          175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD--E--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVA  249 (488)
Q Consensus       175 ~id~~~~~i~~~lG~G~~g~Vy~~~~~~--~--~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~  249 (488)
                      .||+++|.+++.||+|+||+||+|++.+  .  .||||.+......+       ..+.|.+|+++|.++ +|||||++++
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~   78 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-------DHRDFAGELEVLCKLGHHPNIINLLG   78 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH-------HHHHHHHHHHHHHhccCCCCEeeEEE
Confidence            4788999999999999999999999863  3  57788876433221       145689999999999 6999999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeE
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKL--------------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV  315 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NI  315 (488)
                      +|..++.+++||||+++|+|.++|+..              ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus        79 ~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NI  158 (309)
T d1fvra_          79 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI  158 (309)
T ss_dssp             EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceE
Confidence            999999999999999999999999753              235789999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCHHHHHHH
Q 011359          316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT-IPYEEMNPIQAAFA  394 (488)
Q Consensus       316 Ll~~~~~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~-~Pf~~~~~~~~~~~  394 (488)
                      |++.++.+||+|||++.............||..|+|||.+.+..++.++|||||||++|||++|. .||.+.+..+....
T Consensus       159 L~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~  238 (309)
T d1fvra_         159 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  238 (309)
T ss_dssp             EECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             EEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999999999997555444445567999999999999999999999999999999999965 67888877666554


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhh
Q 011359          395 VVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSL  444 (488)
Q Consensus       395 ~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l  444 (488)
                       +..+.++..+..+++++.+||.+||+.||++||++.+|++.|+++.+..
T Consensus       239 -i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         239 -LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             -GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence             4456678888999999999999999999999999999999999987643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.6e-51  Score=398.99  Aligned_cols=255  Identities=25%  Similarity=0.413  Sum_probs=223.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChh-HHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDEN-ETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~-~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  254 (488)
                      ++|.+++.||+|+||+||+|++.  |+.||||++........ ........+.+.+|+.+|++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67999999999999999999984  68999999987654332 1223445678999999999997 99999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+|||||||+||+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            999999999999999999986  357999999999999999999999999999999999999999999999999999765


Q ss_pred             cccCcCCCCCCCcccCChhhhhc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CCC
Q 011359          335 VYCDALSDDPGTYRWMAPEMIKH------KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--IPG  406 (488)
Q Consensus       335 ~~~~~~~~~~gt~~y~aPE~l~~------~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~  406 (488)
                      ..........||..|+|||.+.+      ..++.++||||+||++|+|++|+.||.+.+.......+........  ...
T Consensus       161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (277)
T d1phka_         161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  240 (277)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            55555566789999999999863      3468899999999999999999999999998887777777655433  334


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      .+++++++||.+||+.||++||++.++++
T Consensus       241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         241 DYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            78999999999999999999999998865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.5e-51  Score=406.84  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=218.7

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||+||+|++.  |+.||||++.....     ......+.+.+|+.+|++++|||||++++++.++.
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            468999999999999999999986  78999999974211     11122467889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+|+|||||.||+|..++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence            99999999999999999987  4568888999999999999999999999999999999999999999999999996543


Q ss_pred             ccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 011359          336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAAL  415 (488)
Q Consensus       336 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  415 (488)
                        .......||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+....+....  ..+|..+++++.++
T Consensus       156 --~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~l  231 (316)
T d1fota_         156 --DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDL  231 (316)
T ss_dssp             --SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHH
T ss_pred             --cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCCCCHHHHHH
Confidence              23345689999999999999999999999999999999999999999999888877777664  34678899999999


Q ss_pred             HHHHhhhCCCCCC-----CHHHHHH
Q 011359          416 IEQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       416 i~~cL~~dp~~RP-----s~~eil~  435 (488)
                      |.+||..||.+|+     ++.++++
T Consensus       232 i~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         232 LSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHhhhCHHhccccchhhHHHHHc
Confidence            9999999999996     8888875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.2e-51  Score=399.43  Aligned_cols=256  Identities=23%  Similarity=0.399  Sum_probs=215.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  255 (488)
                      ++|.+++.||+|+||+||+|.+.  |+.||||++......+.     .....|.+|+.+|++++|||||++++++.... 
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP-----SFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH-----HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH-----HHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            46899999999999999999985  78999999986544332     22467899999999999999999999987543 


Q ss_pred             ---eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          256 ---VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       256 ---~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                         .+|||||||+|++|.+++..  .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             CCceEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhh
Confidence               48899999999999999876  3579999999999999999999999999999999999999999999999999875


Q ss_pred             ccccc----CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCCC
Q 011359          333 EEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--AIPG  406 (488)
Q Consensus       333 ~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~  406 (488)
                      .....    .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....++.....+  ....
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  239 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence            32221    22344579999999999999999999999999999999999999999999888887777765443  3446


Q ss_pred             CCcHHHHHHHHHHhhhCCCCCC-CHHHHHHHHHHHH
Q 011359          407 DCPPAMAALIEQCWSLQPDKRP-EFWHIVKVLEQFE  441 (488)
Q Consensus       407 ~~~~~l~~Li~~cL~~dp~~RP-s~~eil~~Le~~~  441 (488)
                      .+|+++.+||.+||+.||++|| +++++++.|.++.
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            7899999999999999999999 8999999888764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-51  Score=406.65  Aligned_cols=266  Identities=28%  Similarity=0.498  Sum_probs=232.9

Q ss_pred             ccccccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 011359          170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN  241 (488)
Q Consensus       170 ~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H  241 (488)
                      ....|.|+.++|.+++.||+|+||.||+|.+.       ++.||||+++......       ....|.+|+.+++++ +|
T Consensus        14 ~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~E~~~~~~l~~H   86 (311)
T d1t46a_          14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-------EREALMSELKVLSYLGNH   86 (311)
T ss_dssp             CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHHHCCC
T ss_pred             CcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH-------HHHHHHHHHHHHHhccCC
Confidence            34578999999999999999999999999873       3579999997543221       145788999999999 69


Q ss_pred             CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 011359          242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE----------------HKTLPLPKLIAIALDIARGMEYIHSQGV  305 (488)
Q Consensus       242 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~gi  305 (488)
                      ||||+++++|.....+++|||||++|+|.+++.+..                ...+++..+..++.||+.||+|||++||
T Consensus        87 pnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~i  166 (311)
T d1t46a_          87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC  166 (311)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            999999999999999999999999999999998643                2258899999999999999999999999


Q ss_pred             ccCCCCCCeEEEcCCCcEEEeeeccccccccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 011359          306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTI  381 (488)
Q Consensus       306 iHrDIkp~NILl~~~~~vkl~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~  381 (488)
                      +||||||+|||++.++.+||+|||++......   .......||+.|+|||.+.+..++.++|||||||++|||++ |.+
T Consensus       167 vHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p  246 (311)
T d1t46a_         167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS  246 (311)
T ss_dssp             CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             eecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCC
Confidence            99999999999999999999999999643321   12234568999999999999999999999999999999998 677


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          382 PYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       382 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      ||...+..+.+..++..+.++..+..++..+.+||.+||+.||++||++.+|+++|+++..
T Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             SSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            7777777777788888889999999999999999999999999999999999999987654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=404.99  Aligned_cols=255  Identities=26%  Similarity=0.534  Sum_probs=215.1

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeee
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~----~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      -++|.+++.||+|+||+||+|.+.  |+    .||||.+......       +..++|.+|+.+|++++|||||+++|+|
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~l~g~~   80 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-------KANKEILDEAYVMASVDNPHVCRLLGIC   80 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            356999999999999999999985  33    5888988643322       1256789999999999999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .++. .++++||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus        81 ~~~~-~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          81 LTST-VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             ESSS-EEEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             ecCC-eeEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccc
Confidence            8754 5688899999999998876 4567999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC---cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 011359          332 CEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKNLRPAIPGD  407 (488)
Q Consensus       332 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  407 (488)
                      .......   ......||..|+|||++.+..|+.++|||||||++|||+| |..||.+.+..+. ...+..+.++..+..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~~i~~~~~~~~p~~  237 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPI  237 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HHHHHHTCCCCCCTT
T ss_pred             eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHcCCCCCCCcc
Confidence            6433221   2233468999999999999999999999999999999998 8999998876554 445566677788899


Q ss_pred             CcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHH
Q 011359          408 CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFET  442 (488)
Q Consensus       408 ~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~  442 (488)
                      +++.+.+||.+||+.||.+||++.+|++.|+++..
T Consensus       238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         238 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999999999988765

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-51  Score=404.90  Aligned_cols=265  Identities=27%  Similarity=0.521  Sum_probs=229.3

Q ss_pred             cccccccccccceeccceeeeeccEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC
Q 011359          169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN  241 (488)
Q Consensus       169 ~~~~~~~id~~~~~i~~~lG~G~~g~Vy~~~~~-------~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H  241 (488)
                      ..-++|+|+.++|.++++||+|+||+||+|.+.       ++.||||+++.....       +....|.+|+.++++++|
T Consensus        10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~-------~~~~~~~~E~~il~~l~h   82 (308)
T d1p4oa_          10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-------RERIEFLNEASVMKEFNC   82 (308)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-------HHHHHHHHHHHHGGGCCC
T ss_pred             cCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh-------HHHHHHHHHHHHHHHcCC
Confidence            344789999999999999999999999999875       368999998743321       124578999999999999


Q ss_pred             CCeeeEeeeeecCCeeeEEEeecCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 011359          242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE  313 (488)
Q Consensus       242 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~  313 (488)
                      ||||+++++|..+...++|||||.+|+|.+++....        ...+++..+..++.|++.||.|||+++|+||||||+
T Consensus        83 ~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~  162 (308)
T d1p4oa_          83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR  162 (308)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG
T ss_pred             CCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCC
Confidence            999999999999999999999999999999987532        234788999999999999999999999999999999


Q ss_pred             eEEEcCCCcEEEeeeccccccccc---CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCHH
Q 011359          314 NVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG-TIPYEEMNPI  389 (488)
Q Consensus       314 NILl~~~~~vkl~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG-~~Pf~~~~~~  389 (488)
                      |||++.++.+||+|||++......   .......||+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..
T Consensus       163 NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~  242 (308)
T d1p4oa_         163 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  242 (308)
T ss_dssp             GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             ceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999643322   223344689999999999999999999999999999999997 5889988887


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHH
Q 011359          390 QAAFAVVNKNLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFE  441 (488)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~  441 (488)
                      +....+.. +.++..+..+++.+.+||.+||+.+|++||++.+|++.|++..
T Consensus       243 ~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         243 QVLRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            77766554 4467788899999999999999999999999999999887653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=408.59  Aligned_cols=248  Identities=14%  Similarity=0.259  Sum_probs=217.6

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+++.||+|+||+||+|.+.  ++.||||+++....+         ...+.+|+++|++++|||||++++++.++.
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   74 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---------QVLVKKEISILNIARHRNILHLHESFESME   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---------HHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---------HHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            467999999999999999999986  689999999754211         245789999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCC--CcEEEeeeccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADFGIACE  333 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~--~~vkl~DFgla~~  333 (488)
                      .+|||||||+||+|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||++..
T Consensus        75 ~~~lvmE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          75 ELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence            99999999999999999975 23469999999999999999999999999999999999999854  5899999999976


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPA--IPGDCPPA  411 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  411 (488)
                      ...........+|+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+....+........  ....++++
T Consensus       154 ~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  233 (321)
T d1tkia_         154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE  233 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred             cccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence            5444444455689999999999999999999999999999999999999999998888777777654432  22478999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||..||++||++.++++
T Consensus       234 ~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         234 AMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.6e-50  Score=406.92  Aligned_cols=249  Identities=26%  Similarity=0.356  Sum_probs=219.2

Q ss_pred             ccccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK  253 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  253 (488)
                      ..+++|.+++.||+|+||+||+|++.  |+.||||++....     .......+.+.+|+.+|++++|||||++++++..
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~  112 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-----VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH-----ccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence            34578999999999999999999986  7899999997421     1111224568899999999999999999999999


Q ss_pred             CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccc
Q 011359          254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE  333 (488)
Q Consensus       254 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~  333 (488)
                      ...+++||||+.||+|..++.+.  +.+++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|..
T Consensus       113 ~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         113 NSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            99999999999999999999873  5799999999999999999999999999999999999999999999999999965


Q ss_pred             ccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       334 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                      ...  ......||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+.......+....  ...+..+++++.
T Consensus       191 ~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~  266 (350)
T d1rdqe_         191 VKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLK  266 (350)
T ss_dssp             CSS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHH
T ss_pred             ccc--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHH
Confidence            432  2345679999999999999999999999999999999999999999998888777776664  346778999999


Q ss_pred             HHHHHHhhhCCCCCC-----CHHHHHH
Q 011359          414 ALIEQCWSLQPDKRP-----EFWHIVK  435 (488)
Q Consensus       414 ~Li~~cL~~dp~~RP-----s~~eil~  435 (488)
                      +||.+||+.||.+|+     ++.++++
T Consensus       267 ~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         267 DLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHHhhhCHHhccccccccHHHHHc
Confidence            999999999999994     8888875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=395.58  Aligned_cols=256  Identities=26%  Similarity=0.489  Sum_probs=212.9

Q ss_pred             ccceeeeeccEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCe
Q 011359          183 LGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-PPV  256 (488)
Q Consensus       183 i~~~lG~G~~g~Vy~~~~~~-----~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~  256 (488)
                      +.+.||+|+||+||+|.+.+     ..||||.+......       ...++|.+|+++|++++|||||+++|++.. +..
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~  103 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-------GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  103 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH-------HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH-------HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCc
Confidence            46789999999999999853     25899998643221       124679999999999999999999999864 568


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      +++|||||++|+|.+++.. ....+++..++.++.|++.||.|||+.||+||||||+|||+++++.+||+|||++.....
T Consensus       104 ~~lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         104 PLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             eEEEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            9999999999999999876 445678889999999999999999999999999999999999999999999999965432


Q ss_pred             cC-----cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          337 CD-----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       337 ~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      ..     ......||..|+|||.+.+..++.++||||||+++|||++|..||............+..+.++..|..++++
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~  262 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  262 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHH
T ss_pred             cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHH
Confidence            21     2223468999999999999999999999999999999999777776544433334444555678888999999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhcc
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLAC  446 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~~  446 (488)
                      +.+||.+||+.||++||++.+|++.|+.+......
T Consensus       263 l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         263 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence            99999999999999999999999999999876443

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-50  Score=400.95  Aligned_cols=249  Identities=24%  Similarity=0.410  Sum_probs=214.4

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHH-hcCCCCeeeEeeeeecC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLS-RLHNPNVIKFVAACKKP  254 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~  254 (488)
                      +++|.+++.||+|+||+||+|.+.  |+.||||++.....     ......+.+..|+.++. .++|||||++++++.++
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-----~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc-----cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            367999999999999999999985  78999999974210     00111234567777665 68999999999999999


Q ss_pred             CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccc
Q 011359          255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE  334 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~  334 (488)
                      ..+|||||||++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             CceeEEEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhc
Confidence            999999999999999999986  356899999999999999999999999999999999999999999999999999654


Q ss_pred             cc-cCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 011359          335 VY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPAMA  413 (488)
Q Consensus       335 ~~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  413 (488)
                      .. ........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+...  .+.+|..+++++.
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~  231 (320)
T d1xjda_         154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAK  231 (320)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHH
T ss_pred             ccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHH
Confidence            32 23344567999999999999999999999999999999999999999999888777766654  3567788999999


Q ss_pred             HHHHHHhhhCCCCCCCHH-HHHH
Q 011359          414 ALIEQCWSLQPDKRPEFW-HIVK  435 (488)
Q Consensus       414 ~Li~~cL~~dp~~RPs~~-eil~  435 (488)
                      +||.+||+.||.+||++. ++++
T Consensus       232 dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         232 DLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHHhcccCCCCCcCHHHHHHh
Confidence            999999999999999985 6653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.3e-49  Score=403.01  Aligned_cols=251  Identities=21%  Similarity=0.342  Sum_probs=207.3

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHH---HHHHHHHHhcCCCCeeeEeeee
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQF---NREVALLSRLHNPNVIKFVAAC  251 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~---~~Ei~il~~l~HpnIv~l~~~~  251 (488)
                      .+++|.+++.||+|+||.||+|++.  |+.||||++.....     ........+   ..|+.+++.++|||||++++++
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~-----~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~   76 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-----KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF   76 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHc-----chhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence            4578999999999999999999985  78999999963211     001112223   3457778888999999999999


Q ss_pred             ecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       252 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      ..+..+|||||||+||+|.+++.+  ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus        77 ~~~~~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla  154 (364)
T d1omwa3          77 HTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA  154 (364)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred             EECCEEEEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeecee
Confidence            999999999999999999999987  357889999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCCCCCCCCCc
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF-AVVNKNLRPAIPGDCP  409 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~  409 (488)
                      ...... ......||+.|+|||++.. ..|+.++|||||||++|||++|..||.+........ ..........++..++
T Consensus       155 ~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  233 (364)
T d1omwa3         155 CDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS  233 (364)
T ss_dssp             EECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSC
T ss_pred             eecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Confidence            654332 3345679999999999964 568999999999999999999999998754322211 1122334456678899


Q ss_pred             HHHHHHHHHHhhhCCCCCCC-----HHHHHH
Q 011359          410 PAMAALIEQCWSLQPDKRPE-----FWHIVK  435 (488)
Q Consensus       410 ~~l~~Li~~cL~~dp~~RPs-----~~eil~  435 (488)
                      +++.+||.+||+.||.+||+     +.++++
T Consensus       234 ~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            99999999999999999999     677764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=403.84  Aligned_cols=244  Identities=22%  Similarity=0.377  Sum_probs=202.5

Q ss_pred             cceeccc-eeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeeEeeeeec-
Q 011359          179 SQLFLGL-RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK-  253 (488)
Q Consensus       179 ~~~~i~~-~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-  253 (488)
                      ++|.+.. .||+|+||+||+|++.  ++.||||++..             ...+.+|+.++.++ +|||||+++++|.+ 
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------------cHHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            5677654 5999999999999985  68999999963             13466899987665 79999999999865 


Q ss_pred             ---CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC---CCcEEEee
Q 011359          254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIAD  327 (488)
Q Consensus       254 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~---~~~vkl~D  327 (488)
                         ...+|||||||+||+|.+++.......+++.++..|+.||+.||+|||++||+||||||+|||++.   ++.+||+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence               467899999999999999998755567999999999999999999999999999999999999975   56799999


Q ss_pred             ecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--CCCCC
Q 011359          328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL--RPAIP  405 (488)
Q Consensus       328 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~  405 (488)
                      ||+|.............||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+.....  ...++
T Consensus       158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            9999766555566677899999999999999999999999999999999999999987654333322222111  11122


Q ss_pred             ----CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          406 ----GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       406 ----~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                          ..+++++.+||.+||+.||++||++.++++
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                357889999999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=387.49  Aligned_cols=251  Identities=26%  Similarity=0.421  Sum_probs=208.5

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|.+.+.||+|+||+||+|.+.  |+.||||++......+      ...+++.+|+.+|++++|||||++++++.++.
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~   74 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------GVPSTAIREISLLKELNHPNIVKLLDVIHTEN   74 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh------HHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence            358999999999999999999986  7899999997543221      12467889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+|+||||+.+ .+.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|....
T Consensus        75 ~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          75 KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             EEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             ceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc
Confidence            99999999964 66666666566789999999999999999999999999999999999999999999999999996543


Q ss_pred             c-cCcCCCCCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------------
Q 011359          336 Y-CDALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR------------  401 (488)
Q Consensus       336 ~-~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~------------  401 (488)
                      . ........||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+......            
T Consensus       154 ~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence            3 23344567999999999987665 589999999999999999999999998877766655431100            


Q ss_pred             ----CCC-----------CCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 ----PAI-----------PGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 ----~~~-----------~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                          ...           ...++.++.+||.+||..||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                000           1256789999999999999999999999876

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-49  Score=388.43  Aligned_cols=247  Identities=24%  Similarity=0.335  Sum_probs=200.3

Q ss_pred             cceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeeeEEE
Q 011359          184 GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT  261 (488)
Q Consensus       184 ~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  261 (488)
                      .+.||+|+||+||+|++.  |+.||||+++.......   .....+.+.+|+.+|++++|||||++++++..+..+||||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivm   79 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA---KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF   79 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh---hHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehh
Confidence            367999999999999975  78999999975433221   1122456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccccc-CcC
Q 011359          262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-DAL  340 (488)
Q Consensus       262 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~~-~~~  340 (488)
                      ||+.++++..++.  ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus        80 E~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          80 DFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             ECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence            9998887766554  3567899999999999999999999999999999999999999999999999999654332 233


Q ss_pred             CCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----------------
Q 011359          341 SDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP-----------------  402 (488)
Q Consensus       341 ~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------------  402 (488)
                      ....||+.|+|||++.. ..|+.++|||||||++|||++|..||.+....+....+......+                 
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            45579999999999864 467999999999999999999999999988877666554321000                 


Q ss_pred             ----C-----CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 ----A-----IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 ----~-----~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                          .     ....+++++.+||.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                0     01356789999999999999999999998865

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=385.63  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=207.5

Q ss_pred             cceeccceeeeeccEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeeEeeeee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACK  252 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~---~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~  252 (488)
                      ++|.++++||+|+||+||+|++.   ++.||||+++.....+..      ...+.+|+.+|+.|   +||||++++++|.
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH------HHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            57999999999999999999984   467999999764332211      12345777777666   7999999999985


Q ss_pred             -----cCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEee
Q 011359          253 -----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD  327 (488)
Q Consensus       253 -----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~D  327 (488)
                           ....++++|||+.++.+.... ......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecc
Confidence                 345789999999877665444 34567799999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-------
Q 011359          328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL-------  400 (488)
Q Consensus       328 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-------  400 (488)
                      ||++.............||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+.....       
T Consensus       160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            9999766555666778899999999999999999999999999999999999999999888776665543110       


Q ss_pred             ------------------CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 ------------------RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 ------------------~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                        .......+++.+.+||.+||+.||++||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                              01123567889999999999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=385.97  Aligned_cols=244  Identities=28%  Similarity=0.447  Sum_probs=203.6

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC--CCCeeeEeeeeecC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH--NPNVIKFVAACKKP  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~  254 (488)
                      ++|.+++.||+|+||+||+|++.  |+.||||++......+....  ....++.+|+.+|++++  |||||++++++.++
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~--~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhh--hHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            57999999999999999999986  78999999975432211000  00123568999999997  89999999999999


Q ss_pred             CeeeEEEeecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-CCcEEEeeecccc
Q 011359          255 PVYCVITEYLSE-GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIAC  332 (488)
Q Consensus       255 ~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-~~~vkl~DFgla~  332 (488)
                      ..+++||||+.+ +++.+++..  ...++++.++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|.
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             CeEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence            999999999976 688888876  357999999999999999999999999999999999999985 4799999999996


Q ss_pred             cccccCcCCCCCCCcccCChhhhhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 011359          333 EEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRPAIPGDCPPA  411 (488)
Q Consensus       333 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (488)
                      .... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.      +...  ...++..++++
T Consensus       160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~--~~~~~~~~s~~  230 (273)
T d1xwsa_         160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--QVFFRQRVSSE  230 (273)
T ss_dssp             ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--CCCCSSCCCHH
T ss_pred             eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhc--ccCCCCCCCHH
Confidence            4332 33456779999999999987765 6789999999999999999999986321      2232  23467789999


Q ss_pred             HHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          412 MAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       412 l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                      +.+||.+||+.||++||++.++++
T Consensus       231 ~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         231 CQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhc
Confidence            999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=385.04  Aligned_cols=253  Identities=28%  Similarity=0.457  Sum_probs=203.3

Q ss_pred             cceeccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC---
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP---  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---  255 (488)
                      .+|.+.++||+|+||+||+|+++|+.||||++....   ..      ...+..|+..+.+++|||||+++++|....   
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~------~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~   73 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ER------SWFREAEIYQTVMLRHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HH------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hh------HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence            468899999999999999999999999999996421   00      112234555667789999999999997543   


Q ss_pred             -eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcccCCCCCCeEEEcCCCcEEEe
Q 011359          256 -VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS--------QGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       256 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--------~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                       .+|+|||||++|+|.+++++   ..+++..++.++.|++.||+|||+        +||+||||||+|||++.++.+||+
T Consensus        74 ~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          74 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence             68999999999999999987   469999999999999999999996        599999999999999999999999


Q ss_pred             eecccccccccC-----cCCCCCCCcccCChhhhhcCC------CCchhHHHHHHHHHHHHHhCCCCCCCC---------
Q 011359          327 DFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKHKS------YGRKVDVYSFGLILWEMVAGTIPYEEM---------  386 (488)
Q Consensus       327 DFgla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~------~~~k~DvwSlGvll~elltG~~Pf~~~---------  386 (488)
                      |||++.......     ......||+.|+|||++.+..      ++.++|||||||++|||++|..||...         
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            999986443221     233467999999999987542      577999999999999999998776321         


Q ss_pred             ------CHHHHHHHHHhccCCCCCCCC-----CcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          387 ------NPIQAAFAVVNKNLRPAIPGD-----CPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       387 ------~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                            ..............++.++..     ++..+.+||.+||+.||.+||++.||++.|+++...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence                  223333444455666665543     235699999999999999999999999999998764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.3e-48  Score=379.97  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=206.8

Q ss_pred             ccceeccceeeeeccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV  256 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  256 (488)
                      +++|.+.++||+|+||+||+|+++ |+.||||++......+.      ..+++.+|+.+|++++|||||++++++..+..
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG------IPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC------CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH------HHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            368999999999999999999987 68999999976543221      14578899999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccccccc
Q 011359          257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY  336 (488)
Q Consensus       257 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~~  336 (488)
                      .+++|||+.++.+..+...  .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        75 ~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             eeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            9999999987766666543  57799999999999999999999999999999999999999999999999999865432


Q ss_pred             c-CcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------------
Q 011359          337 C-DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR-------------  401 (488)
Q Consensus       337 ~-~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-------------  401 (488)
                      . .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+......             
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence            2 223344689999999999654 5699999999999999999999999998877766554421100             


Q ss_pred             --------------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 --------------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 --------------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                    ......+++.+.+||.+||+.||++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                          1123457889999999999999999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=379.01  Aligned_cols=244  Identities=23%  Similarity=0.331  Sum_probs=202.1

Q ss_pred             ceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec----
Q 011359          180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK----  253 (488)
Q Consensus       180 ~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----  253 (488)
                      +|..++.||+|+||+||+|++.  |+.||||++......            +.+|+.+|++++|+||++++++|..    
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------------~~~Ei~il~~l~h~niv~~~~~~~~~~~~   88 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------------KNRELQIMRKLDHCNIVRLRYFFYSSGEK   88 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------------CCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------------HHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence            5888899999999999999985  789999999764322            2379999999999999999999843    


Q ss_pred             --CCeeeEEEeecCCCCHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC-cEEEeeec
Q 011359          254 --PPVYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFG  329 (488)
Q Consensus       254 --~~~~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~-~vkl~DFg  329 (488)
                        ...++||||||+++.+..+... .....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus        89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence              3357899999976654444432 2456799999999999999999999999999999999999999775 89999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN---------  399 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~---------  399 (488)
                      ++.............||..|+|||.+.+ ..|+.++|||||||++|||++|..||...+..+....+....         
T Consensus       169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            9976655555666789999999998864 578999999999999999999999999888766655543210         


Q ss_pred             ----------CC--------CCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 ----------LR--------PAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 ----------~~--------~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                +.        ......+++++.+||.+||..||++||++.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      00        0112457889999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=377.19  Aligned_cols=246  Identities=23%  Similarity=0.374  Sum_probs=202.0

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      .++|.+++.||+|+||+||+|.+.  |+.||||+++.....+      ...+.+.+|+.+|++++|||||+++++|....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE------LFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH------HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh------HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            367999999999999999999986  7899999997544332      12467889999999999999999999997654


Q ss_pred             ------eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          256 ------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       256 ------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                            .+|+||||| +.+|..++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccc
Confidence                  579999999 6788888765   579999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--------
Q 011359          330 IACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNL--------  400 (488)
Q Consensus       330 la~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~--------  400 (488)
                      +|....  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.....        
T Consensus       167 ~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         167 LARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             TCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ceeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            996543  334567799999999998764 568999999999999999999999998876655433322110        


Q ss_pred             ---------------------CCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          401 ---------------------RPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       401 ---------------------~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                           .......+++.+.+||.+||..||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                 01123467889999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.3e-46  Score=366.53  Aligned_cols=253  Identities=21%  Similarity=0.324  Sum_probs=203.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~  255 (488)
                      ++|.+++.||+|+||+||+|++.  |+.||||++......          +++..|+++++.++|+| |+.+.+++....
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~   76 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   76 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----------CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----------HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence            46999999999999999999986  789999999865432          24668999999998766 555556667888


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEc---CCCcEEEeeecccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIAC  332 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~---~~~~vkl~DFgla~  332 (488)
                      .+++||||+ +++|.+.+.. ....+++..+..++.|++.||+|||++||+||||||+|||++   .+..++|+|||+|.
T Consensus        77 ~~~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          77 YNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence            999999999 5677776654 356799999999999999999999999999999999999985   45579999999996


Q ss_pred             cccccC--------cCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc---
Q 011359          333 EEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV---NK---  398 (488)
Q Consensus       333 ~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~---~~---  398 (488)
                      ......        ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+.   ..   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            543221        2234579999999999999999999999999999999999999998766544322221   11   


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHh
Q 011359          399 NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETS  443 (488)
Q Consensus       399 ~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~  443 (488)
                      ...+.....+|+++.+||.+||+.+|++||++.+|.+.|+++...
T Consensus       235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            112234567899999999999999999999999999999987553

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-46  Score=376.30  Aligned_cols=247  Identities=24%  Similarity=0.324  Sum_probs=199.8

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  255 (488)
                      ++|.+++.||+|+||+||+|++.  |+.||||++.....       ....+++.+|+.+|++++||||+++++++..+. 
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-------QTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-------HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-------hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            46999999999999999999985  78999999975332       122467889999999999999999999986643 


Q ss_pred             ---eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          256 ---VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       256 ---~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                         ..+++++|+.+|+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence               23455566779999999976   469999999999999999999999999999999999999999999999999985


Q ss_pred             ccccc----CcCCCCCCCcccCChhhhh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------
Q 011359          333 EEVYC----DALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR------  401 (488)
Q Consensus       333 ~~~~~----~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~------  401 (488)
                      .....    .......||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+...........      
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            43322    2234566999999999984 456799999999999999999999999988765544433221000      


Q ss_pred             ----------------C-------CCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 ----------------P-------AIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 ----------------~-------~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                      .       .....++.++.+||.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                            0       112356788999999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-46  Score=369.94  Aligned_cols=251  Identities=20%  Similarity=0.325  Sum_probs=200.5

Q ss_pred             cccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec-
Q 011359          177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-  253 (488)
Q Consensus       177 d~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-  253 (488)
                      +.++|.+.++||+|+||+||+|++.  |+.||||++......+.      ..+++.+|+.+|++++|+||+++++++.. 
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~E~~il~~l~h~nii~~~~~~~~~   81 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICRTK   81 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH------HHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence            3589999999999999999999985  78999999876544332      14567899999999999999999998854 


Q ss_pred             -------CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEe
Q 011359          254 -------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA  326 (488)
Q Consensus       254 -------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~  326 (488)
                             +..+|+||||+.++.+..+..  ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          82 ASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             ---------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             cccccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEee
Confidence                   456899999998776654443  34578899999999999999999999999999999999999999999999


Q ss_pred             eecccccccc-----cCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-
Q 011359          327 DFGIACEEVY-----CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKN-  399 (488)
Q Consensus       327 DFgla~~~~~-----~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-  399 (488)
                      |||++.....     ........||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+.......+.... 
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999853321     1222345699999999998754 68999999999999999999999999888766655443311 


Q ss_pred             -CCCCCCC----------------------------CCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 -LRPAIPG----------------------------DCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 -~~~~~~~----------------------------~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                       ..+....                            ..++.+.+||.+||+.||++||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence             1111000                            12567889999999999999999999886

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-45  Score=364.08  Aligned_cols=255  Identities=17%  Similarity=0.251  Sum_probs=212.1

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCC
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAACKKPP  255 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~  255 (488)
                      ++|.+++.||+|+||+||+|++.  |+.||||++......          .++.+|+++++.+.| +||+.+++++..+.
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   74 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   74 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----------HHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence            57999999999999999999986  789999998754332          235689999999975 89999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcC-----CCcEEEeeecc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-----EFHLKIADFGI  330 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~-----~~~vkl~DFgl  330 (488)
                      ..++||||+ +++|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+
T Consensus        75 ~~~~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          75 HNVLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             ccEEEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence            999999999 7899999876 3457899999999999999999999999999999999999974     57899999999


Q ss_pred             ccccccc--------CcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc-
Q 011359          331 ACEEVYC--------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN---PIQAAFAVVNK-  398 (488)
Q Consensus       331 a~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~---~~~~~~~~~~~-  398 (488)
                      |+.....        .......||+.|||||++.+..++.++|||||||++|||++|..||.+..   .......+... 
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            9653321        12234569999999999999999999999999999999999999997543   33332222222 


Q ss_pred             --cCCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHHHHHHHHHhhc
Q 011359          399 --NLRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVKVLEQFETSLA  445 (488)
Q Consensus       399 --~~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~~Le~~~~~l~  445 (488)
                        .....++..+|+++.+++..||..+|++||++..+.+.|+++...+.
T Consensus       233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence              11223456789999999999999999999999999999988766543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=362.34  Aligned_cols=250  Identities=20%  Similarity=0.291  Sum_probs=207.6

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP  255 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  255 (488)
                      +++|++.++||+|+||+||+|++.  ++.||||+++.......      ..+++.+|+.+|++++||||++++++|.+..
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   74 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG------VPSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH------HHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence            368999999999999999999985  68899999987654332      2467889999999999999999999999999


Q ss_pred             eeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccccccc
Q 011359          256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV  335 (488)
Q Consensus       256 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla~~~~  335 (488)
                      .+++|+|++.+++|..++..  .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.+....
T Consensus        75 ~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          75 KLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ceeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhccc
Confidence            99999999999998888765  5678999999999999999999999999999999999999999999999999996544


Q ss_pred             ccC-cCCCCCCCcccCChhhhhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcc-------------
Q 011359          336 YCD-ALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNKN-------------  399 (488)
Q Consensus       336 ~~~-~~~~~~gt~~y~aPE~l~~~~-~~~k~DvwSlGvll~elltG~~Pf~~~~-~~~~~~~~~~~~-------------  399 (488)
                      ... ......++..|+|||.+.... ++.++|||||||++|||++|..||.... ..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence            322 333445788999999987654 6899999999999999999999975544 333333222110             


Q ss_pred             --------------CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          400 --------------LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       400 --------------~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                    ........+++.+.+||.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                          011223456789999999999999999999998875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-45  Score=369.69  Aligned_cols=242  Identities=21%  Similarity=0.358  Sum_probs=199.4

Q ss_pred             ccceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeec-
Q 011359          178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK-  253 (488)
Q Consensus       178 ~~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~-  253 (488)
                      .++|.++++||+|+||+||+|++.  |+.||||++....           .+++.+|+.+|++++ ||||+++++++.. 
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            357999999999999999999985  7899999997432           346789999999996 9999999999874 


Q ss_pred             -CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCC-cEEEeeeccc
Q 011359          254 -PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIA  331 (488)
Q Consensus       254 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~-~vkl~DFgla  331 (488)
                       ...+++|||||.+++|..+.     +.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a  177 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA  177 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred             CCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccc
Confidence             45689999999999987653     4699999999999999999999999999999999999998655 6999999999


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh------------
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ-AAFAVVN------------  397 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~-~~~~~~~------------  397 (488)
                      .............+|..|+|||.+.+. .++.++|||||||++|+|++|..||....... ....+..            
T Consensus       178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             eeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            765555556677899999999998765 57999999999999999999999997654322 1111110            


Q ss_pred             -cc----------------------CCCCCCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          398 -KN----------------------LRPAIPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       398 -~~----------------------~~~~~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                       ..                      ........+++++.+||++||..||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00                      011112346789999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=377.07  Aligned_cols=254  Identities=21%  Similarity=0.339  Sum_probs=207.0

Q ss_pred             ccccceeccceeeeeccEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeeeEee
Q 011359          176 VDLSQLFLGLRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVA  249 (488)
Q Consensus       176 id~~~~~i~~~lG~G~~g~Vy~~~~-----~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~  249 (488)
                      +.+++|.+++.||+|+||+||+|..     +|+.||||++.......+..    ..+.+.+|+.+|++++| |||+++++
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~----~~~~~~~E~~il~~l~h~pnIv~~~~   96 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK----TTEHTRTERQVLEHIRQSPFLVTLHY   96 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES----SGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchH----HHHHHHHHHHHHHhccCCCeEEEeee
Confidence            5568899999999999999999987     25789999986432111100    12457799999999976 89999999


Q ss_pred             eeecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeec
Q 011359          250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG  329 (488)
Q Consensus       250 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFg  329 (488)
                      ++.+...+++||||+.+|+|.+++...  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_          97 AFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eeccCCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeecc
Confidence            999999999999999999999999873  467888999999999999999999999999999999999999999999999


Q ss_pred             cccccc--ccCcCCCCCCCcccCChhhhhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCC
Q 011359          330 IACEEV--YCDALSDDPGTYRWMAPEMIKHK--SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN--KNLRPA  403 (488)
Q Consensus       330 la~~~~--~~~~~~~~~gt~~y~aPE~l~~~--~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~  403 (488)
                      ++....  .........|++.|+|||.+.+.  .++.++|||||||+||+|++|..||.+....+....+..  ....+.
T Consensus       175 ~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~  254 (322)
T d1vzoa_         175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP  254 (322)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred             chhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC
Confidence            985432  22233455699999999999754  468899999999999999999999977643332222222  123455


Q ss_pred             CCCCCcHHHHHHHHHHhhhCCCCCCC-----HHHHHH
Q 011359          404 IPGDCPPAMAALIEQCWSLQPDKRPE-----FWHIVK  435 (488)
Q Consensus       404 ~~~~~~~~l~~Li~~cL~~dp~~RPs-----~~eil~  435 (488)
                      ++..+++++.+||.+||+.||++||+     ++|+++
T Consensus       255 ~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            67889999999999999999999995     677654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-45  Score=368.67  Aligned_cols=246  Identities=25%  Similarity=0.337  Sum_probs=202.2

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--  254 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  254 (488)
                      ++|.+.+.||+|+||+||+|++.  |+.||||++........      ..+++.+|+.+|++++|||||++++++...  
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~------~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~   91 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII------HAKRTYRELRLLKHMKHENVIGLLDVFTPARS   91 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHH------HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChH------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence            67999999999999999999985  78999999986543322      145688999999999999999999998533  


Q ss_pred             ---CeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          255 ---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       255 ---~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                         ...++|++|+.||+|.+++..   +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||++
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             cccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence               344667788889999999964   57999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCcCCCCCCCcccCChhhhhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------
Q 011359          332 CEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLRP--------  402 (488)
Q Consensus       332 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------  402 (488)
                      ....  .......||..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+......+        
T Consensus       169 ~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         169 RHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             -CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             cccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence            5433  233456799999999987665 46899999999999999999999999888766555444321110        


Q ss_pred             -------------C--------CCCCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          403 -------------A--------IPGDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       403 -------------~--------~~~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                   .        ....+++++.+||.+||..||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                         0        01357889999999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-45  Score=369.63  Aligned_cols=246  Identities=23%  Similarity=0.320  Sum_probs=192.9

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeeeeec---
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK---  253 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---  253 (488)
                      ++|++.+.||+|+||+||+|++.  |+.||||++........      ..+++.+|+.+|++++|||||+++++|..   
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~   90 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT------HAKRAYRELVLMKCVNHKNIISLLNVFTPQKT   90 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHH------HHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHH------HHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence            67999999999999999999986  79999999986544322      14568899999999999999999999853   


Q ss_pred             ---CCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       254 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                         ...+|+|||||.++.+ +.+.    ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||+
T Consensus        91 ~~~~~~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             TTTCCEEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             cccCceeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhh
Confidence               4688999999966544 4443    4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKNLR---------  401 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~---------  401 (488)
                      +.............+|..|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+......         
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            87666656666778999999999999999999999999999999999999999887765544433221100         


Q ss_pred             -----------CC--------------CC------CCCcHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 011359          402 -----------PA--------------IP------GDCPPAMAALIEQCWSLQPDKRPEFWHIVK  435 (488)
Q Consensus       402 -----------~~--------------~~------~~~~~~l~~Li~~cL~~dp~~RPs~~eil~  435 (488)
                                 ..              .+      ...++++.+||++||..||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                       00              00      113567899999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-38  Score=321.53  Aligned_cols=246  Identities=24%  Similarity=0.425  Sum_probs=187.7

Q ss_pred             cceeccceeeeeccEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-----------CCCee
Q 011359          179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-----------NPNVI  245 (488)
Q Consensus       179 ~~~~i~~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv  245 (488)
                      ++|.++++||+|+||+||+|++.  |+.||||+++...         ...+.+.+|+.+++.++           |+||+
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv   83 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL   83 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---------cchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence            56999999999999999999985  7899999997421         11355678888888875           47899


Q ss_pred             eEeeeeec--CCeeeEEEeecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCeEEEcCCC
Q 011359          246 KFVAACKK--PPVYCVITEYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEF  321 (488)
Q Consensus       246 ~l~~~~~~--~~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giiHrDIkp~NILl~~~~  321 (488)
                      ++++++..  ....+++++++..+ .............+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~  163 (362)
T d1q8ya_          84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  163 (362)
T ss_dssp             CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence            99988754  34556666665444 45555555566788999999999999999999998 8999999999999997654


Q ss_pred             ------cEEEeeecccccccccCcCCCCCCCcccCChhhhhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH------
Q 011359          322 ------HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI------  389 (488)
Q Consensus       322 ------~vkl~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvll~elltG~~Pf~~~~~~------  389 (488)
                            .++++|||.+.....  ......||+.|+|||++....++.++||||+||++++|++|..||......      
T Consensus       164 ~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         164 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence                  499999999865432  335567999999999999999999999999999999999999999754321      


Q ss_pred             HHHHHHHh---c-----------------------cC--------------CCCCCCCCcHHHHHHHHHHhhhCCCCCCC
Q 011359          390 QAAFAVVN---K-----------------------NL--------------RPAIPGDCPPAMAALIEQCWSLQPDKRPE  429 (488)
Q Consensus       390 ~~~~~~~~---~-----------------------~~--------------~~~~~~~~~~~l~~Li~~cL~~dp~~RPs  429 (488)
                      ......+.   .                       ..              ........++++.+||.+||..||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            11111100   0                       00              01112234678999999999999999999


Q ss_pred             HHHHHH
Q 011359          430 FWHIVK  435 (488)
Q Consensus       430 ~~eil~  435 (488)
                      +.|+++
T Consensus       322 a~e~L~  327 (362)
T d1q8ya_         322 AGGLVN  327 (362)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=3.7e-25  Score=203.21  Aligned_cols=171  Identities=18%  Similarity=0.183  Sum_probs=122.7

Q ss_pred             eccceeeeeccEEEEEEEEC-CccEEEEEEecCCCC----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeeeEeee
Q 011359          182 FLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDD----------ENETLAARLEKQFNREVALLSRLHNPNVIKFVAA  250 (488)
Q Consensus       182 ~i~~~lG~G~~g~Vy~~~~~-~~~vAVK~i~~~~~~----------~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  250 (488)
                      .++++||+|+||+||+|.+. |+.||||+++.....          ............+.+|+..+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            47899999999999999875 789999998643211          0001112223456789999999999999998876


Q ss_pred             eecCCeeeEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCeEEEcCCCcEEEeeecc
Q 011359          251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI  330 (488)
Q Consensus       251 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giiHrDIkp~NILl~~~~~vkl~DFgl  330 (488)
                      ..    .+++|||++++.+.         .++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+|||+
T Consensus        83 ~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          83 EG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             ET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             cC----CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            43    36999999876542         24555677899999999999999999999999999999865 589999999


Q ss_pred             cccccccCcCCCCCCCcccCChhh-----hhcCCCCchhHHHHHHHHH
Q 011359          331 ACEEVYCDALSDDPGTYRWMAPEM-----IKHKSYGRKVDVYSFGLIL  373 (488)
Q Consensus       331 a~~~~~~~~~~~~~gt~~y~aPE~-----l~~~~~~~k~DvwSlGvll  373 (488)
                      |......       ....|+...+     +....|+.++|+||+.--+
T Consensus       149 a~~~~~~-------~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         149 SVEVGEE-------GWREILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CEETTST-------THHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             cccCCCC-------CcHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            8543211       1112222110     1135678899999976444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.47  E-value=2.3e-07  Score=86.61  Aligned_cols=127  Identities=14%  Similarity=0.093  Sum_probs=85.9

Q ss_pred             eccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeeeEEEeecCCCC
Q 011359          190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVITEYLSEGS  268 (488)
Q Consensus       190 G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggs  268 (488)
                      +..+.||+....++.++||+........        ...+.+|..++..+. +--+.+++.++..++..++||++++|.+
T Consensus        25 ~s~~~v~rv~~~~~~~vlk~~~~~~~~~--------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~   96 (263)
T d1j7la_          25 MSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL   96 (263)
T ss_dssp             CSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred             CCCCcEEEEEeCCCeEEEEEcCCCcccc--------hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccc
Confidence            3346899988778889999886433221        123558888888875 4346778888888889999999999988


Q ss_pred             HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 011359          269 LRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS----------------------------------------------  302 (488)
Q Consensus       269 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~----------------------------------------------  302 (488)
                      +.+....    ..   ....++.+++..++.||+                                              
T Consensus        97 ~~~~~~~----~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (263)
T d1j7la_          97 CSEEYED----EQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE  169 (263)
T ss_dssp             HHHHTTT----CS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHH
T ss_pred             ccccccc----cc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHH
Confidence            7654321    01   111223333333333332                                              


Q ss_pred             -------C------CcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          303 -------Q------GVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       303 -------~------giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                             .      .++|+|+.+.|||+++++.+-|+||+.+
T Consensus       170 ~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a  211 (263)
T d1j7la_         170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             HHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             HHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence                   1      2689999999999998766679999977

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.94  E-value=1.2e-05  Score=74.05  Aligned_cols=133  Identities=14%  Similarity=0.091  Sum_probs=79.9

Q ss_pred             eeecc-EEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeeEeeeeecCCeeeEEEee
Q 011359          188 AHGAH-SRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACKKPPVYCVITEY  263 (488)
Q Consensus       188 G~G~~-g~Vy~~~~~~-~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~  263 (488)
                      ..|.. +.||+....+ ..++||........           .+..|+..|+.+..  -.+.+++.++.+++..++||+|
T Consensus        19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             SCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCcccCCeEEEEEeCCCCEEEEEeCCccCHh-----------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            44554 5789988764 56888987543321           24578888877753  3366788888888889999999


Q ss_pred             cCCCCHHH--------------HHHHhCC-----CCC--CHHHHHHHHH--------------------HHHHHHHHHHH
Q 011359          264 LSEGSLRA--------------YLHKLEH-----KTL--PLPKLIAIAL--------------------DIARGMEYIHS  302 (488)
Q Consensus       264 ~~ggsL~~--------------~l~~~~~-----~~l--~~~~~~~i~~--------------------qi~~~L~~LH~  302 (488)
                      ++|.++.+              .+.+...     ..+  .......-..                    .....+..+..
T Consensus        88 i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  167 (255)
T d1nd4a_          88 VPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA  167 (255)
T ss_dssp             CSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred             eeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence            98865421              1111100     000  0000000000                    01122333332


Q ss_pred             C-------CcccCCCCCCeEEEcCCCcEEEeeeccc
Q 011359          303 Q-------GVIHRDLKPENVLIDQEFHLKIADFGIA  331 (488)
Q Consensus       303 ~-------giiHrDIkp~NILl~~~~~vkl~DFgla  331 (488)
                      .       .++|+|+.+.|||++++..+-|+||+.+
T Consensus       168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~  203 (255)
T d1nd4a_         168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL  203 (255)
T ss_dssp             TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             hCCccCCceEEeCCCCCcceEEeCCceEEEEEchhc
Confidence            2       3799999999999998766789999976

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.39  E-value=0.00017  Score=71.12  Aligned_cols=78  Identities=14%  Similarity=0.051  Sum_probs=45.9

Q ss_pred             ceeeeeccEEEEEEEEC--CccEEEEEEecCC---CChhHHHHHHHHHHHHHHHHHHHhcC-C--CCeeeEeeeeecCCe
Q 011359          185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPD---DDENETLAARLEKQFNREVALLSRLH-N--PNVIKFVAACKKPPV  256 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~i~~~~---~~~~~~~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~  256 (488)
                      +.||.|....||+....  ++.|+||.-....   ......    ...+...|.+.|..+. +  ..+.+++.+.  +..
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~----~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~  105 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPL----TIDRARIESSALIRQGEHVPHLVPRVFYSD--TEM  105 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCC----CTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTT
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCC----CHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCC
Confidence            45799999999998754  5689999753210   000000    0112346777777663 2  3456666553  345


Q ss_pred             eeEEEeecCCCC
Q 011359          257 YCVITEYLSEGS  268 (488)
Q Consensus       257 ~~lV~E~~~ggs  268 (488)
                      .++|||++.+..
T Consensus       106 ~~lvmE~L~~~~  117 (392)
T d2pula1         106 AVTVMEDLSHLK  117 (392)
T ss_dssp             TEEEECCCTTSE
T ss_pred             CEEEEeccCCcc
Confidence            568999997643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.19  E-value=0.00055  Score=65.45  Aligned_cols=68  Identities=18%  Similarity=0.121  Sum_probs=43.8

Q ss_pred             eccEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe--eeEe-----eeeecCCeeeEEE
Q 011359          190 GAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV--IKFV-----AACKKPPVYCVIT  261 (488)
Q Consensus       190 G~~g~Vy~~~~~-~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~-----~~~~~~~~~~lV~  261 (488)
                      |.-..||+.... |+.|++|+.+.....         .+++..|...+..|....|  +..+     ..+...+..+.++
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s---------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~  103 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  103 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCCCCC---------HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence            334689999875 688999998754322         3456678888887753222  1111     1234466778899


Q ss_pred             eecCC
Q 011359          262 EYLSE  266 (488)
Q Consensus       262 E~~~g  266 (488)
                      +++.|
T Consensus       104 ~~~~G  108 (325)
T d1zyla1         104 PSVGG  108 (325)
T ss_dssp             ECCCC
T ss_pred             eecCC
Confidence            99977

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.92  E-value=0.0014  Score=61.88  Aligned_cols=140  Identities=16%  Similarity=0.101  Sum_probs=74.0

Q ss_pred             ccceeeeeccEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-----CCeeeEe-e--eeecC
Q 011359          183 LGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-----PNVIKFV-A--ACKKP  254 (488)
Q Consensus       183 i~~~lG~G~~g~Vy~~~~~~~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-----pnIv~l~-~--~~~~~  254 (488)
                      -.+.|..|---+.|+...++..+++|++.....          .+++..|+.++..|..     |..+... |  +....
T Consensus        22 ~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~----------~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~   91 (316)
T d2ppqa1          22 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   91 (316)
T ss_dssp             EEEEECC---EEEEEEEESSCCEEEEEECC-------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             EeecCCCCcccCeEEEEECCCcEEEEEcCCCCC----------HHHHHHHHHHHHhhhhccccccccceecCCCcceeee
Confidence            334566777789999998888899999864321          1234467777777743     2222211 1  11223


Q ss_pred             CeeeEEEeecCCCCH--------------HHHHHHhC-CC------------------------CCCHHHHHHHHHHHHH
Q 011359          255 PVYCVITEYLSEGSL--------------RAYLHKLE-HK------------------------TLPLPKLIAIALDIAR  295 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL--------------~~~l~~~~-~~------------------------~l~~~~~~~i~~qi~~  295 (488)
                      ...+.++.++.+...              ...++... ..                        ..........+..+..
T Consensus        92 ~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  171 (316)
T d2ppqa1          92 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  171 (316)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             cccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHH
Confidence            445566666655221              11111100 00                        0000112222223333


Q ss_pred             HHHHHH----HCCcccCCCCCCeEEEcCCCcEEEeeecccc
Q 011359          296 GMEYIH----SQGVIHRDLKPENVLIDQEFHLKIADFGIAC  332 (488)
Q Consensus       296 ~L~~LH----~~giiHrDIkp~NILl~~~~~vkl~DFgla~  332 (488)
                      .+...+    ..|+||+|+.+.||+++.+...-|+||+.+.
T Consensus       172 ~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         172 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            333333    2379999999999999998777899999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.70  E-value=0.0033  Score=61.40  Aligned_cols=71  Identities=15%  Similarity=0.208  Sum_probs=47.1

Q ss_pred             ceeeeeccEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeeEeeeeecC
Q 011359          185 LRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP  254 (488)
Q Consensus       185 ~~lG~G~~g~Vy~~~~~~---------~~vAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  254 (488)
                      ++|+-|-.-.+|+....+         +.|.+++.-.. ..   ..      ...+|..+++.+. +.-..++++++.+ 
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~i------dr~~E~~i~~~ls~~gl~Pkll~~~~~-  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ES------HLVAESVIFTLLSERHLGPKLYGIFSG-  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HH------HHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hh------HHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence            567889999999988642         35777776421 11   11      2347888888886 4334577887753 


Q ss_pred             CeeeEEEeecCCCCH
Q 011359          255 PVYCVITEYLSEGSL  269 (488)
Q Consensus       255 ~~~~lV~E~~~ggsL  269 (488)
                         .+|+||++|..|
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               588999987443